data_5o2p_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5o2p _Structure_validation_residue.Date_analyzed 2017-09-15 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 120.871 0.367 . . . . 50.0 110.802 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.8 mt -65.48 -42.15 92.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.598 -0.728 . . . . 50.0 110.294 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 56.27 30.92 17.56 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.206 1.002 . . . . 50.0 111.882 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.7 m -88.62 163.47 2.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 105.526 -2.027 . . . . 50.0 105.526 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.61 173.4 6.56 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.89 -0.782 . . . . 50.0 108.89 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.78 162.46 40.99 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.72 -0.474 . . . . 25.0 109.72 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -126.69 135.6 51.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.817 -1.083 . . . . 50.0 109.648 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.62 120.63 18.5 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.803 -0.635 . . . . 25.0 109.295 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.62 -23.25 24.33 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.922 -0.77 . . . . 50.0 108.922 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -140.54 172.28 12.94 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.456 -1.312 . . . . 50.0 107.456 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.72 164.34 18.62 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 123.129 0.572 . . . . 50.0 110.417 174.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -153.73 130.74 11.01 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.962 0.505 . . . . 50.0 110.725 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.23 118.94 48.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 106.035 -1.839 . . . . 25.0 106.035 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.43 143.08 51.93 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.276 -0.874 . . . . 25.0 109.896 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -116.69 -34.84 4.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.039 -0.982 . . . . 50.0 109.685 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.5 m -93.44 153.97 41.34 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.068 -0.716 . . . . 50.0 109.068 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.43 -22.27 33.83 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 117.782 -1.012 . . . . 50.0 113.645 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -81.12 -16.18 53.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.73 0.776 . . . . 50.0 110.85 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -84.52 138.36 32.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.489 0.661 . . . . 50.0 110.299 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.6 mt -92.84 130.49 38.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.61 0.719 . . . . 50.0 110.048 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.6 t -91.55 137.57 32.26 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.686 -1.598 . . . . 50.0 106.686 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -154.09 166.19 33.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.679 0.752 . . . . 50.0 112.642 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -110.09 158.87 17.84 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.638 -0.875 . . . . 50.0 108.638 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -57.48 131.03 48.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.701 -1.222 . . . . 50.0 107.701 171.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.23 -19.9 46.98 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-O 119.154 -0.803 . . . . 50.0 113.889 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -59.74 144.71 47.47 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.76 0.79 . . . . 50.0 110.545 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.4 mm -114.04 130.69 67.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.58 -1.191 . . . . 50.0 107.836 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -135.34 156.47 48.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.967 -0.383 . . . . 50.0 109.967 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.7 m -92.66 126.17 37.63 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.159 -1.052 . . . . 25.0 108.159 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.5 t -89.86 122.82 41.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.259 -1.015 . . . . 50.0 108.259 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.4 mt -88.26 -48.07 7.95 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.646 -0.706 . . . . 50.0 109.14 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -152.52 167.03 30.14 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.345 -0.983 . . . . 50.0 108.345 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -116.84 154.29 30.99 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 106.811 -1.551 . . . . 50.0 106.811 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 58.13 40.6 24.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.918 1.818 . . . . 50.0 108.982 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -64.87 149.64 49.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 112.59 -2.095 . . . . 25.0 110.925 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 60.33 9.56 2.02 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.98 0.912 . . . . 50.0 113.37 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.99 12.95 80.35 Favored Glycine 0 C--N 1.33 0.244 0 N-CA-C 111.114 -0.795 . . . . 25.0 111.114 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 99.0 mt -91.24 117.87 30.0 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.42 -0.585 . . . . 50.0 109.42 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -63.6 126.47 27.63 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.707 -0.679 . . . . 25.0 110.928 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.12 -0.28 84.02 Favored Glycine 0 CA--C 1.518 0.261 0 N-CA-C 115.515 0.966 . . . . 50.0 115.515 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -100.89 133.49 45.29 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 119.012 1.406 . . . . 50.0 109.873 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -113.47 141.97 46.48 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.771 -0.825 . . . . 50.0 108.771 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.39 121.66 27.0 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.596 -2.001 . . . . 50.0 105.596 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 88.4 m -129.88 160.92 32.05 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.829 -0.348 . . . . 50.0 111.39 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -113.9 122.03 45.75 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.989 -1.856 . . . . 50.0 105.989 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.0 tp -145.5 139.7 26.98 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.819 -1.178 . . . . 50.0 107.819 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.9 m170 57.25 27.0 12.98 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.412 0.685 . . . . 25.0 111.97 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.1 0.29 89.46 Favored Glycine 0 C--O 1.221 -0.704 0 N-CA-C 114.9 0.72 . . . . 25.0 114.9 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -124.15 156.14 37.23 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 117.89 0.845 . . . . 50.0 109.757 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -102.37 154.98 18.55 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.326 -0.62 . . . . 50.0 109.326 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.43 -162.12 29.9 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 106.427 -2.669 . . . . 50.0 106.427 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 pt -118.55 151.49 20.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.649 0.737 . . . . 50.0 111.876 -174.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.2 m -140.38 146.93 47.59 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 114.929 -1.032 . . . . 50.0 110.025 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.87 122.16 7.09 Favored 'Trans proline' 0 C--O 1.241 0.65 0 C-N-CA 118.35 -0.633 . . . . 50.0 112.434 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.94 -23.09 65.38 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 121.607 -0.33 . . . . 50.0 113.01 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.39 -20.42 64.42 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 122.335 -0.509 . . . . 50.0 112.203 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -109.48 12.28 24.58 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 122.194 -0.317 . . . . 50.0 111.777 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.72 156.79 40.57 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 114.946 1.461 . . . . 50.0 114.946 -174.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -129.29 123.1 31.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.444 -0.798 . . . . 50.0 110.297 175.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.4 mm -67.76 137.21 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.772 -0.825 . . . . 50.0 108.772 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.6 mt -117.76 115.75 25.63 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.43 -1.693 . . . . 50.0 106.43 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.322 -0.618 0 N-CA-C 109.38 -0.6 . . . . 50.0 109.38 -179.824 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt . . . . . 0 CA--C 1.547 0.852 0 N-CA-C 106.029 -1.841 . . . . 50.0 106.029 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 CA--C 1.539 0.766 0 O-C-N 121.992 0.469 . . . . 50.0 112.864 -177.453 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 121.634 0.731 . . . . 50.0 111.849 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.9 mt -69.79 -40.72 75.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.045 -0.98 . . . . 50.0 109.899 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.2 m120 57.6 23.61 9.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.614 1.165 . . . . 50.0 113.157 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.7 m -85.65 162.98 2.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.387 -0.968 . . . . 50.0 108.387 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.74 168.18 10.49 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.374 -0.829 . . . . 50.0 110.098 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.6 166.81 26.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.014 0.435 . . . . 25.0 110.781 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -133.31 135.59 44.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.951 -1.022 . . . . 50.0 110.737 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.38 131.99 42.5 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.703 0.627 . . . . 25.0 110.583 173.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.22 -21.96 15.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.983 0.421 . . . . 50.0 110.898 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -143.47 168.38 19.98 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.344 -1.725 . . . . 50.0 106.344 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -75.69 160.44 30.06 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 123.459 0.474 . . . . 50.0 111.027 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -146.81 147.81 31.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.215 -0.291 . . . . 50.0 110.215 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.6 t -120.76 132.11 71.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 104.519 -2.4 . . . . 25.0 104.519 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.58 122.06 21.64 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.336 -0.987 . . . . 25.0 108.336 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -108.86 4.94 24.04 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.324 -0.991 . . . . 50.0 108.324 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.6 m -145.05 152.4 51.22 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 106.771 -1.566 . . . . 50.0 106.771 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.9 -21.58 32.64 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 N-CA-C 115.936 1.475 . . . . 50.0 115.936 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.28 -12.7 54.23 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.95 0.881 . . . . 50.0 110.238 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -82.98 139.34 33.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.943 0.878 . . . . 50.0 111.406 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.1 mt -90.98 127.68 36.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.185 0.993 . . . . 50.0 109.672 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -88.88 139.54 30.35 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 106.225 -1.769 . . . . 50.0 106.225 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -156.66 165.18 36.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.963 0.411 . . . . 50.0 110.605 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -110.83 162.79 14.44 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.566 -0.531 . . . . 50.0 109.566 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -58.5 131.25 50.19 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.545 -0.752 . . . . 50.0 109.386 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.09 -11.17 72.81 Favored Glycine 0 CA--C 1.517 0.205 0 CA-C-O 119.039 -0.867 . . . . 50.0 114.48 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -62.49 150.57 39.79 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 118.193 0.996 . . . . 50.0 109.636 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.6 mm -116.28 134.31 60.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.9 -1.045 . . . . 50.0 109.289 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -139.89 160.27 40.29 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.167 -0.679 . . . . 50.0 109.167 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.7 m -97.22 127.25 43.01 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.043 -1.095 . . . . 25.0 108.043 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.9 t -90.5 126.48 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 107.343 -1.354 . . . . 50.0 107.343 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.1 mt -94.96 -43.1 8.32 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.889 -0.782 . . . . 50.0 108.889 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -150.23 155.08 39.07 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.679 -0.86 . . . . 50.0 108.679 -177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -111.65 149.67 31.21 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.105 -0.702 . . . . 50.0 109.105 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 56.38 39.9 29.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 123.61 1.672 . . . . 50.0 108.654 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -64.31 153.56 37.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 112.591 -2.095 . . . . 25.0 110.777 -176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 60.76 8.95 1.98 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.683 0.793 . . . . 50.0 111.976 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.39 13.62 81.46 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.114 -0.794 . . . . 25.0 111.114 -176.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.5 mt -88.05 126.75 35.26 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.066 0.46 . . . . 50.0 109.8 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -67.64 125.03 24.92 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.352 -0.385 . . . . 25.0 110.665 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.0 1.46 85.26 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 117.038 1.575 . . . . 50.0 117.038 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -100.94 134.23 44.23 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 119.176 1.488 . . . . 50.0 109.849 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -113.79 140.68 48.1 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.909 -0.775 . . . . 50.0 108.909 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.81 123.62 27.89 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 104.821 -2.288 . . . . 50.0 104.821 176.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.46 ' HG ' HG21 ' A' ' 57' ' ' VAL . 98.0 m -134.98 163.07 30.69 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.668 -0.413 . . . . 50.0 111.562 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.0 t -117.21 126.5 52.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.908 -1.886 . . . . 50.0 105.908 170.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.0 tp -138.7 126.82 22.65 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.072 -1.455 . . . . 50.0 107.072 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.0 m170 55.54 30.38 15.13 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.273 0.559 . . . . 25.0 111.6 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.42 -4.87 80.11 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 116.115 1.206 . . . . 25.0 116.115 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -110.01 152.58 25.74 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.865 -1.161 . . . . 50.0 107.865 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -106.75 160.43 15.48 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.57 -0.53 . . . . 50.0 109.57 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.11 -160.11 31.52 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 105.398 -3.081 . . . . 50.0 105.398 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.1 pt -120.48 152.84 23.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.794 0.807 . . . . 50.0 111.485 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.46 HG21 ' HG ' ' A' ' 48' ' ' CYS . 2.9 m -139.0 145.56 45.88 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 114.714 -1.13 . . . . 50.0 109.111 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.73 124.54 7.59 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 117.045 -1.504 . . . . 50.0 112.19 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.84 -10.27 72.01 Favored Glycine 0 C--O 1.223 -0.537 0 CA-C-N 116.032 -0.531 . . . . 50.0 112.774 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.76 -19.32 62.34 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.39 -0.476 . . . . 50.0 112.083 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -130.7 27.34 4.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.117 -0.492 . . . . 50.0 110.47 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.26 156.2 44.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.303 0.573 . . . . 50.0 111.329 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -129.64 127.74 41.22 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.811 -0.631 . . . . 50.0 110.59 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.8 mm -72.09 135.26 28.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.131 -1.063 . . . . 50.0 108.131 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.4 mt -119.35 104.6 10.52 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.161 -0.681 . . . . 50.0 109.161 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 CA--C 1.544 0.712 0 CA-C-O 122.044 0.926 . . . . 50.0 109.208 176.132 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt . . . . . 0 CA--C 1.535 0.404 0 N-CA-C 110.162 -0.31 . . . . 50.0 110.162 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 CA--C 1.546 1.109 0 O-C-N 122.201 0.579 . . . . 50.0 112.988 178.251 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 . . . . . 0 CA--C 1.519 -0.229 0 N-CA-C 114.327 1.232 . . . . 50.0 114.327 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.8 mt -65.59 -39.22 91.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.512 -1.222 . . . . 50.0 110.687 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 57.27 28.72 15.62 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.173 0.989 . . . . 50.0 112.444 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 m -90.35 152.11 3.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.143 -1.058 . . . . 50.0 108.143 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.98 167.38 12.84 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.187 -0.671 . . . . 50.0 109.187 -176.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.35 161.17 43.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.732 0.301 . . . . 25.0 111.27 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -126.9 129.58 48.48 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.688 0.795 . . . . 50.0 110.157 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.46 131.28 43.81 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.746 -0.464 . . . . 25.0 109.746 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.0 mt -95.83 -21.16 18.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.074 0.464 . . . . 50.0 111.034 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -144.48 175.95 9.75 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 103.814 -2.661 . . . . 50.0 103.814 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -92.05 179.17 5.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.301 0.5 . . . . 50.0 111.53 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -159.04 154.77 26.26 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.075 0.55 . . . . 50.0 110.135 173.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.4 t -124.6 127.4 72.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 105.986 -1.857 . . . . 25.0 105.986 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.74 129.6 38.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.961 -0.563 . . . . 25.0 110.783 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -105.33 1.11 27.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.536 0.684 . . . . 50.0 109.838 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.9 p -151.83 158.86 33.83 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.016 -1.105 . . . . 50.0 108.016 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.75 -16.85 33.39 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 118.321 -0.652 . . . . 50.0 112.873 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.75 -21.68 54.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.419 0.628 . . . . 50.0 110.044 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -95.46 146.21 24.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.522 0.677 . . . . 50.0 111.411 -176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.1 mt -100.14 132.61 45.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.55 0.691 . . . . 50.0 110.166 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.6 m -82.64 146.44 29.1 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 105.527 -2.027 . . . . 50.0 105.527 172.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -157.73 164.87 36.67 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.358 -0.608 . . . . 50.0 109.358 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.86 158.59 23.73 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.526 -0.916 . . . . 50.0 108.526 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -56.24 128.13 34.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.571 -0.741 . . . . 50.0 109.891 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.72 -10.85 64.63 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-O 118.985 -0.897 . . . . 50.0 114.061 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -61.52 148.7 41.22 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.033 0.916 . . . . 50.0 110.775 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.4 mm -112.02 134.02 55.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.457 -1.247 . . . . 50.0 108.481 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.4 ptp -143.19 162.23 36.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.057 -0.72 . . . . 50.0 109.057 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.9 m -98.81 125.87 44.29 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.042 -1.096 . . . . 25.0 108.042 177.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.8 t -89.6 125.61 42.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.786 -1.19 . . . . 50.0 107.786 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.1 mt -94.54 -49.48 5.64 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.455 -1.248 . . . . 50.0 109.644 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -143.34 160.39 40.61 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.545 -1.279 . . . . 50.0 107.545 -174.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -125.68 150.71 47.41 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 106.899 -1.519 . . . . 50.0 106.899 175.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 56.27 39.15 30.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.398 1.571 . . . . 50.0 108.274 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -66.08 148.61 51.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.443 -1.708 . . . . 25.0 109.813 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 60.18 11.81 2.96 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.72 0.808 . . . . 50.0 113.013 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.61 13.62 81.25 Favored Glycine 0 C--O 1.229 -0.177 0 N-CA-C 111.296 -0.721 . . . . 25.0 111.296 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.9 mt -91.19 112.19 23.99 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.709 -0.478 . . . . 50.0 109.709 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -58.52 124.92 21.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.497 -0.774 . . . . 25.0 110.858 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.0 -0.19 83.79 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 116.02 1.168 . . . . 50.0 116.02 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -98.03 132.26 43.73 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 119.303 1.552 . . . . 50.0 110.76 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -111.15 138.58 47.42 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.206 -1.035 . . . . 50.0 108.206 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.21 125.82 31.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 104.681 -2.34 . . . . 50.0 104.681 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.403 ' HG ' HG23 ' A' ' 57' ' ' VAL . 89.9 m -134.65 164.29 27.84 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 111.951 0.352 . . . . 50.0 111.951 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.0 t -117.27 123.84 47.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.828 -1.545 . . . . 50.0 106.828 171.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.8 tp -151.73 142.63 22.99 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 106.875 -1.528 . . . . 50.0 106.875 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 56.4 28.25 13.29 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.319 0.647 . . . . 25.0 112.073 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.75 1.15 76.95 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 115.006 0.762 . . . . 25.0 115.006 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -123.62 161.05 25.79 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.026 -0.731 . . . . 50.0 109.026 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -108.53 156.63 19.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.174 -0.676 . . . . 50.0 109.174 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.58 -161.22 28.37 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 105.383 -3.087 . . . . 50.0 105.383 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.9 pt -120.73 153.18 23.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-O 121.728 0.775 . . . . 50.0 111.034 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.403 HG23 ' HG ' ' A' ' 48' ' ' CYS . 3.2 m -141.74 147.38 45.16 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 114.473 -1.239 . . . . 50.0 107.674 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.82 126.48 8.83 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 117.086 -1.476 . . . . 50.0 111.713 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.17 -12.0 75.63 Favored Glycine 0 C--O 1.222 -0.621 0 CA-C-N 116.293 -0.412 . . . . 50.0 113.131 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -66.67 -13.54 61.37 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.781 0.66 . . . . 50.0 112.781 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -131.97 27.13 4.58 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.215 -0.661 . . . . 50.0 109.215 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.8 tp -131.96 147.44 52.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.737 -0.665 . . . . 50.0 109.709 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -125.55 120.09 29.92 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.408 -0.36 . . . . 50.0 111.743 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.98 136.1 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.037 -0.727 . . . . 50.0 109.037 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.1 mt -116.78 81.66 1.67 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.945 -1.502 . . . . 50.0 106.945 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 121.158 0.504 . . . . 50.0 111.704 -176.06 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt . . . . . 0 CA--C 1.542 0.639 0 N-CA-C 109.132 -0.692 . . . . 50.0 109.132 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 CA--C 1.546 1.086 0 O-C-N 121.963 0.454 . . . . 50.0 112.704 179.833 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 . . . . . 0 CA--C 1.514 -0.439 0 CA-C-O 120.704 0.287 . . . . 50.0 110.354 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.2 mt -67.73 -39.86 84.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.652 -0.704 . . . . 50.0 109.228 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 56.45 32.38 20.57 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.947 0.899 . . . . 50.0 111.795 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.4 m -94.6 153.91 3.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 107.032 -1.47 . . . . 50.0 107.032 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.7 167.08 11.68 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.042 -1.095 . . . . 50.0 108.042 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.96 154.46 37.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.674 0.273 . . . . 25.0 110.489 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -118.69 132.13 56.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.835 -0.62 . . . . 50.0 110.838 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.63 125.64 27.38 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.184 -0.673 . . . . 25.0 109.184 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.9 mt -91.7 -21.23 20.86 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.257 0.551 . . . . 50.0 110.397 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -141.97 176.05 9.25 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 104.565 -2.383 . . . . 50.0 104.565 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -91.48 177.78 6.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.715 0.293 . . . . 50.0 110.906 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -155.64 155.1 32.66 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.355 0.262 . . . . 50.0 111.647 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.8 t -124.85 132.28 71.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 103.736 -2.69 . . . . 25.0 103.736 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.73 127.64 33.15 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.857 -0.423 . . . . 25.0 109.857 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -101.83 2.72 38.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.727 0.775 . . . . 50.0 110.535 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.2 p -149.88 157.73 37.74 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 108.014 -1.106 . . . . 75.0 108.014 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.8 -15.21 33.19 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 118.177 -0.749 . . . . 50.0 113.007 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -76.55 -21.43 55.69 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.407 0.622 . . . . 50.0 109.475 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -93.75 139.45 30.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.987 0.898 . . . . 50.0 111.829 -172.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.4 mt -90.16 129.32 36.45 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.21 -0.905 . . . . 50.0 109.546 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -88.21 143.05 27.27 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 105.411 -2.07 . . . . 50.0 105.411 175.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -157.25 167.97 28.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.732 0.301 . . . . 50.0 110.297 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.69 165.4 12.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.737 0.78 . . . . 50.0 110.327 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.1 128.41 36.28 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.218 -0.901 . . . . 50.0 110.069 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.83 -12.49 64.23 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-O 118.922 -0.932 . . . . 50.0 114.933 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -59.65 152.98 21.11 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.977 0.894 . . . . 50.0 112.001 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.0 mm -114.77 130.65 68.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.428 -1.26 . . . . 50.0 109.14 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.8 ptp -137.84 151.57 48.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.469 -0.567 . . . . 50.0 109.469 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.0 m -90.78 124.75 35.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.291 -1.003 . . . . 25.0 108.291 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t -87.34 123.14 39.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 107.893 -1.151 . . . . 50.0 107.893 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.7 mt -89.74 -46.23 8.75 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.051 -0.722 . . . . 50.0 109.051 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -149.56 165.15 33.11 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.771 -0.826 . . . . 50.0 108.771 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.41 ' HE ' ' HB3' ' A' ' 37' ' ' ARG . 38.2 mtp180 -115.77 154.61 29.31 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.19 -0.67 . . . . 50.0 109.19 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 57.67 40.76 26.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 124.12 1.914 . . . . 50.0 107.463 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.6 t -65.74 151.65 46.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 111.808 -2.451 . . . . 25.0 111.699 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 58.03 18.13 4.92 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.373 0.879 . . . . 50.0 113.373 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.52 16.6 80.53 Favored Glycine 0 C--O 1.227 -0.285 0 N-CA-C 111.699 -0.56 . . . . 25.0 111.699 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.7 mt -98.45 113.93 26.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.088 0.471 . . . . 50.0 110.759 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -59.34 127.7 33.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.682 -0.69 . . . . 25.0 110.755 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.09 -2.03 67.07 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 115.85 1.1 . . . . 50.0 115.85 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -95.83 132.8 40.71 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 119.028 1.414 . . . . 50.0 109.023 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -113.52 138.23 50.43 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.793 -1.188 . . . . 50.0 107.793 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.5 tp -81.41 125.43 30.41 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 105.922 -1.881 . . . . 50.0 105.922 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 91.4 m -134.0 161.99 33.3 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.201 0.524 . . . . 50.0 111.784 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.6 t -113.64 122.5 47.35 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.123 -1.436 . . . . 50.0 107.123 170.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.1 tp -144.62 133.03 21.91 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.919 -0.771 . . . . 50.0 108.919 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 54.09 31.98 14.82 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.427 0.691 . . . . 25.0 112.275 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.16 0.15 88.44 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.087 -0.578 . . . . 25.0 114.507 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -109.11 141.63 41.02 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 117.77 0.785 . . . . 50.0 109.346 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -96.89 143.19 28.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 106.553 -1.647 . . . . 50.0 106.553 169.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.69 -163.72 29.45 Favored Glycine 0 CA--C 1.496 -1.117 0 N-CA-C 103.647 -3.781 . . . . 50.0 103.647 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.7 pt -121.82 158.54 25.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-O 121.3 0.571 . . . . 50.0 110.56 -174.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.2 m -142.53 148.68 47.92 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 115.297 -0.865 . . . . 50.0 109.214 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.54 120.43 6.71 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 118.359 -0.627 . . . . 50.0 110.967 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.74 -10.42 80.08 Favored Glycine 0 C--O 1.226 -0.371 0 O-C-N 121.878 -0.514 . . . . 50.0 114.049 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -72.8 -5.88 41.02 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.788 0.662 . . . . 50.0 112.788 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -130.01 26.49 5.21 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.983 -0.747 . . . . 50.0 108.983 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.6 mt -124.03 155.38 38.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.807 0.813 . . . . 50.0 111.435 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -126.73 120.04 28.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.843 -1.072 . . . . 50.0 109.428 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.1 mm -71.33 136.15 26.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.882 -0.785 . . . . 50.0 108.882 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.4 mt -115.42 94.73 4.84 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.546 -1.279 . . . . 50.0 107.546 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.54 0 CA-C-O 121.299 0.571 . . . . 50.0 111.562 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 92.4 mttt . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 110.184 -0.302 . . . . 50.0 110.184 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.539 0.755 0 C-N-CA 117.881 -0.946 . . . . 50.0 111.57 176.064 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 . . . . . 0 N--CA 1.463 0.209 0 N-CA-C 112.204 0.446 . . . . 50.0 112.204 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.2 mt -64.73 -41.63 95.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.248 -0.887 . . . . 50.0 111.161 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 54.91 34.82 23.06 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.919 0.887 . . . . 50.0 112.249 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 m -95.48 158.47 3.0 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 104.485 -2.413 . . . . 50.0 104.485 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.13 174.03 7.11 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.776 -0.824 . . . . 50.0 108.776 -175.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.19 161.54 41.79 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.176 -0.305 . . . . 25.0 110.176 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -128.23 130.52 48.07 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.513 0.725 . . . . 50.0 110.031 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.59 133.66 47.87 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.438 0.461 . . . . 25.0 110.141 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.78 -19.68 16.6 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.351 0.596 . . . . 50.0 110.579 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -143.22 171.73 13.69 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.681 -1.6 . . . . 50.0 106.681 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -77.86 167.46 21.49 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.324 0.39 . . . . 50.0 110.868 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -151.75 150.15 29.86 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-O 120.749 0.309 . . . . 50.0 111.07 170.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.6 t -124.93 136.28 61.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 104.528 -2.397 . . . . 25.0 104.528 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.07 136.96 48.5 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 124.27 0.982 . . . . 25.0 108.548 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -117.9 1.09 12.05 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.864 0.84 . . . . 50.0 109.653 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -128.02 146.29 58.64 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 105.799 -1.926 . . . . 50.0 105.799 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -69.89 -18.34 36.46 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 117.386 -1.276 . . . . 50.0 112.638 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -77.53 -15.64 59.14 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.18 -0.464 . . . . 50.0 110.624 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -101.47 140.58 35.57 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.421 -0.955 . . . . 50.0 108.421 -176.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.8 mt -101.37 126.16 48.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.992 0.901 . . . . 50.0 111.688 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.18 145.57 26.35 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.605 -1.257 . . . . 50.0 107.605 175.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -159.29 165.07 34.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.261 0.553 . . . . 50.0 110.856 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -107.34 153.09 23.27 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.509 -1.293 . . . . 50.0 107.509 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -54.65 129.84 38.1 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.996 -0.742 . . . . 50.0 108.996 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.14 -11.28 70.85 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-O 118.899 -0.945 . . . . 50.0 114.518 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -64.06 156.7 27.38 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.989 0.894 . . . . 50.0 110.077 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.6 mm -120.13 135.36 60.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.68 -1.146 . . . . 50.0 109.322 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -141.81 158.2 44.09 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.5 -0.556 . . . . 50.0 109.5 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 m -92.09 128.93 38.12 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 108.287 -1.005 . . . . 25.0 108.287 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.2 t -92.08 123.82 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 N-CA-C 108.279 -1.008 . . . . 50.0 108.279 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -88.96 -45.81 9.38 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.414 -0.812 . . . . 50.0 109.284 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -155.31 168.78 25.96 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.512 -0.921 . . . . 50.0 108.512 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -120.39 152.63 37.64 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 106.621 -1.622 . . . . 50.0 106.621 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 58.03 43.93 20.26 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 125.731 1.894 . . . . 50.0 109.119 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 t -69.41 155.79 39.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 112.65 -2.068 . . . . 25.0 111.112 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 58.72 14.75 3.33 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.801 1.037 . . . . 50.0 113.801 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.88 13.86 81.64 Favored Glycine 0 C--O 1.23 -0.148 0 N-CA-C 111.59 -0.604 . . . . 25.0 111.59 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.8 mt -94.33 132.61 38.76 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 110.107 -0.331 . . . . 50.0 110.107 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -78.41 128.64 33.92 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.855 -0.795 . . . . 25.0 108.855 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.96 -2.55 83.41 Favored Glycine 0 C--O 1.239 0.423 0 N-CA-C 116.319 1.288 . . . . 50.0 116.319 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -101.87 133.94 45.85 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 118.428 1.114 . . . . 50.0 108.307 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.3 m0 -115.62 143.23 45.64 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.08 -0.711 . . . . 50.0 109.08 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.08 123.76 30.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.916 -1.883 . . . . 50.0 105.916 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.1 m -130.71 162.1 30.2 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.022 0.379 . . . . 50.0 112.022 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.0 t -114.34 119.79 38.15 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.038 -1.838 . . . . 50.0 106.038 171.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.8 tp -141.0 126.87 19.21 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.294 -1.002 . . . . 50.0 108.294 -175.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.0 m170 55.64 31.85 18.13 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.262 0.625 . . . . 25.0 111.279 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.63 0.95 88.65 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 114.676 0.63 . . . . 25.0 114.676 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -107.97 155.2 20.59 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 106.691 -1.596 . . . . 50.0 106.691 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -121.89 144.44 48.85 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.043 -1.466 . . . . 50.0 107.043 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.65 -161.6 27.25 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 107.1 -2.4 . . . . 50.0 107.1 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.7 pt -115.77 150.15 17.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.707 0.765 . . . . 50.0 111.053 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -138.28 145.41 47.09 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 114.639 -1.164 . . . . 50.0 108.565 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.62 120.95 6.72 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 CA-C-O 121.606 0.586 . . . . 50.0 110.821 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.65 -17.04 77.84 Favored Glycine 0 C--O 1.216 -1.007 0 N-CA-C 115.038 0.775 . . . . 50.0 115.038 -174.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -77.93 -1.56 32.49 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.151 0.797 . . . . 50.0 113.151 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -127.74 25.57 5.98 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.682 -1.229 . . . . 50.0 107.682 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.8 tp -135.46 150.34 49.79 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.193 -0.912 . . . . 75.0 109.368 -173.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -126.28 120.75 30.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.568 -0.287 . . . . 50.0 111.556 -177.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.5 mm -67.76 135.45 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.795 -0.446 . . . . 50.0 109.795 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.2 mt -117.1 92.52 3.88 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.457 -1.312 . . . . 50.0 107.457 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 C--N 1.322 -0.611 0 N-CA-C 108.427 -0.953 . . . . 50.0 108.427 179.63 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 N--CA 1.469 0.523 0 N-CA-C 109.395 -0.594 . . . . 50.0 109.395 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 CA--C 1.542 0.919 0 C-N-CA 116.908 -1.595 . . . . 50.0 110.944 174.171 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 . . . . . 0 C--O 1.221 -0.436 0 N-CA-C 115.1 1.519 . . . . 50.0 115.1 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.4 mt -75.56 -36.51 60.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.459 -1.246 . . . . 50.0 110.74 -177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.5 m120 55.88 25.08 8.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.632 1.173 . . . . 50.0 112.768 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.2 m -88.88 177.13 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 105.731 -1.952 . . . . 50.0 105.731 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.22 174.07 6.56 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.083 -0.71 . . . . 50.0 109.083 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.9 161.19 42.36 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.551 -0.537 . . . . 25.0 109.551 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -123.6 135.43 53.95 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.393 -0.822 . . . . 50.0 110.1 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.29 126.74 30.56 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 123.869 0.73 . . . . 25.0 110.276 174.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.5 mt -93.09 -23.51 18.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.236 0.541 . . . . 50.0 110.697 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -142.43 168.1 20.52 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.737 -1.579 . . . . 50.0 106.737 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -76.73 162.99 27.25 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.307 0.379 . . . . 50.0 110.865 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -150.35 133.09 15.89 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 114.041 1.126 . . . . 50.0 114.041 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.8 t -109.55 124.68 66.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 105.473 -2.047 . . . . 25.0 105.473 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.06 139.69 50.48 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.475 -0.784 . . . . 25.0 110.373 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -112.6 -28.84 7.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.296 0.569 . . . . 50.0 109.589 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -102.15 152.35 38.23 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 107.481 -1.303 . . . . 50.0 107.481 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.4 -22.54 33.58 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 117.688 -1.074 . . . . 50.0 113.105 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -83.97 -10.72 57.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.849 -0.614 . . . . 50.0 110.898 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -85.86 135.64 33.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.747 0.785 . . . . 50.0 109.747 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.9 mt -87.89 128.93 35.36 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.731 0.777 . . . . 50.0 109.576 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.1 t -88.31 140.33 29.59 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 105.461 -2.051 . . . . 50.0 105.461 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -156.87 168.95 25.93 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.785 -0.82 . . . . 50.0 108.785 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.5 mtt-85 -122.91 166.98 14.15 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.179 0.514 . . . . 50.0 111.442 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.22 129.32 41.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.893 -0.594 . . . . 50.0 110.631 -176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.04 -13.02 65.36 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-O 119.491 -0.616 . . . . 50.0 113.508 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -62.32 150.11 40.31 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 117.659 0.73 . . . . 50.0 109.751 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.7 mm -116.41 133.25 63.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 107.922 -1.14 . . . . 50.0 107.922 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -136.25 148.86 48.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.143 -0.688 . . . . 50.0 109.143 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 51.8 m -85.14 129.68 34.76 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.967 -1.494 . . . . 25.0 106.967 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.1 t -94.01 126.17 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.805 -0.813 . . . . 50.0 108.805 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.1 mt -95.95 -45.05 7.09 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.368 -0.604 . . . . 50.0 109.368 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -147.48 159.07 44.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.271 -0.172 . . . . 50.0 110.785 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -117.08 153.95 31.84 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.537 -0.912 . . . . 50.0 108.537 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 53.76 39.8 30.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 123.482 1.611 . . . . 50.0 109.685 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.9 t -69.85 157.17 37.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.153 -1.839 . . . . 25.0 111.625 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 59.92 10.51 2.18 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.22 1.008 . . . . 50.0 112.678 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.74 13.66 81.06 Favored Glycine 0 C--O 1.239 0.41 0 N-CA-C 111.184 -0.766 . . . . 25.0 111.184 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.43 125.26 39.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.947 0.403 . . . . 50.0 110.069 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -67.45 126.84 30.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.958 -0.564 . . . . 25.0 110.349 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.74 -0.6 85.89 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 116.466 1.346 . . . . 50.0 116.466 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -99.05 132.95 43.99 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 119.146 1.473 . . . . 50.0 110.066 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -113.45 137.69 51.17 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.483 -0.562 . . . . 50.0 109.483 -177.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.9 tp -80.77 121.09 25.48 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 106.376 -1.712 . . . . 50.0 106.376 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 98.8 m -133.75 167.7 20.05 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.768 0.318 . . . . 50.0 111.151 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.7 t -118.8 126.16 51.22 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.0 -0.741 . . . . 50.0 109.0 172.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.3 tp -147.4 139.59 24.44 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.115 -1.068 . . . . 50.0 108.115 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 27.3 m170 55.99 29.82 15.02 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.364 0.665 . . . . 25.0 112.022 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.26 1.81 86.42 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 120.994 -0.622 . . . . 25.0 114.094 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -109.91 145.97 35.94 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.45 -0.945 . . . . 50.0 108.45 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -99.99 144.91 28.48 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 105.306 -2.109 . . . . 50.0 105.306 170.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.21 -163.58 29.49 Favored Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 105.525 -3.03 . . . . 50.0 105.525 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.9 pt -120.86 154.25 24.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.467 0.651 . . . . 50.0 111.097 -173.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.6 146.03 46.08 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 114.993 -1.003 . . . . 50.0 108.758 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.64 122.15 7.18 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 117.979 -0.881 . . . . 50.0 111.684 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.96 -13.95 72.89 Favored Glycine 0 C--O 1.223 -0.532 0 CA-C-N 116.277 -0.419 . . . . 50.0 114.032 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -68.94 -8.54 45.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.085 0.772 . . . . 50.0 113.085 -178.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -132.63 26.01 4.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.619 -0.882 . . . . 50.0 108.619 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 tp -129.88 157.19 42.95 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.445 -0.798 . . . . 50.0 110.67 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -131.58 120.35 22.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.807 -0.633 . . . . 50.0 110.773 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.9 mm -65.81 136.59 26.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 123.662 0.601 . . . . 50.0 109.511 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.3 mt -117.64 111.56 19.33 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.28 -2.118 . . . . 50.0 105.28 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 108.272 -1.011 . . . . 50.0 108.272 -178.537 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.6 mttt . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 111.538 0.199 . . . . 50.0 111.538 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 CA--C 1.544 0.993 0 O-C-N 121.849 0.394 . . . . 50.0 112.015 174.717 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 . . . . . 0 CA--C 1.513 -0.456 0 N-CA-C 109.651 -0.5 . . . . 50.0 109.651 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.2 mt -61.74 -41.48 97.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.842 -0.617 . . . . 50.0 109.346 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.76 28.16 11.84 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.07 0.948 . . . . 50.0 111.976 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.2 m -87.48 176.24 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 104.72 -2.326 . . . . 50.0 104.72 173.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mp -118.74 173.99 6.54 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 121.732 -0.605 . . . . 50.0 109.58 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.37 160.18 42.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.818 0.342 . . . . 25.0 110.712 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -122.19 129.89 52.69 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.444 -0.798 . . . . 50.0 109.794 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.93 130.64 43.35 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.781 -0.452 . . . . 25.0 109.781 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.6 mt -93.67 -23.78 18.11 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 111.877 0.325 . . . . 50.0 111.877 -177.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -143.88 168.25 20.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.279 -1.378 . . . . 50.0 107.279 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -73.82 165.35 25.28 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.559 0.537 . . . . 50.0 110.178 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.74 163.31 35.34 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.324 -0.991 . . . . 50.0 108.324 177.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.8 t -130.45 129.49 64.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 102.026 -3.324 . . . . 25.0 102.026 169.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.15 122.69 27.13 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.293 -1.373 . . . . 25.0 107.293 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -113.03 12.32 19.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.318 1.056 . . . . 50.0 110.306 -175.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.7 m -148.31 152.83 39.89 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 106.202 -1.777 . . . . 50.0 106.202 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.43 -23.22 32.54 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 118.176 -0.749 . . . . 50.0 113.677 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.8 -17.0 52.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.417 0.627 . . . . 50.0 110.86 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -84.24 131.53 34.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.636 0.731 . . . . 50.0 109.343 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.9 mt -81.69 135.06 35.52 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.315 -0.624 . . . . 50.0 109.315 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -87.35 135.81 33.18 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.253 -1.017 . . . . 50.0 108.253 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -156.09 163.06 40.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.348 0.594 . . . . 50.0 111.948 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -119.63 169.02 10.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.408 0.623 . . . . 50.0 109.832 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -61.29 129.46 41.35 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.668 -0.696 . . . . 50.0 111.297 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.61 -12.41 67.62 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-O 119.012 -0.882 . . . . 50.0 113.836 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -60.08 148.5 35.54 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.595 0.712 . . . . 50.0 110.48 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.1 mm -114.22 132.32 63.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.54 -1.209 . . . . 50.0 108.852 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.0 ptp -137.07 156.55 48.26 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.553 -0.906 . . . . 50.0 108.553 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.7 m -89.53 129.59 35.98 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.377 -1.342 . . . . 25.0 107.377 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.24 126.59 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 107.76 -1.2 . . . . 50.0 107.76 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.8 mt -95.83 -44.7 7.29 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.487 -0.779 . . . . 50.0 109.418 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -153.32 164.02 38.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.353 -0.61 . . . . 50.0 109.353 -175.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -120.35 153.83 35.92 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.234 -1.024 . . . . 50.0 108.234 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 54.98 38.28 30.26 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 123.405 1.574 . . . . 50.0 109.943 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -65.05 151.29 46.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.359 -1.746 . . . . 25.0 110.812 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 61.05 10.72 3.0 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.803 0.841 . . . . 50.0 113.003 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.73 17.46 77.34 Favored Glycine 0 C--O 1.228 -0.234 0 N-CA-C 110.77 -0.932 . . . . 25.0 110.77 -178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.9 mt -94.37 119.18 32.73 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.741 -0.837 . . . . 50.0 108.741 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.53 129.26 39.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.13 0.491 . . . . 25.0 110.568 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.27 -0.72 67.25 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 116.075 1.19 . . . . 50.0 116.075 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -98.75 129.98 45.2 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 119.349 1.575 . . . . 50.0 109.736 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -110.3 140.1 44.81 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.082 -0.71 . . . . 50.0 109.082 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.79 120.93 25.29 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.785 -1.931 . . . . 50.0 105.785 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.2 m -132.5 166.23 22.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.961 0.41 . . . . 50.0 111.686 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -120.64 122.77 41.22 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.799 -1.186 . . . . 50.0 107.799 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.5 tp -155.0 145.92 22.57 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 107.024 -1.473 . . . . 50.0 107.024 -175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 56.36 31.97 19.67 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.091 0.556 . . . . 25.0 112.368 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.05 6.11 72.82 Favored Glycine 0 C--O 1.225 -0.41 0 N-CA-C 114.926 0.73 . . . . 25.0 114.926 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -129.95 165.96 21.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.696 -0.853 . . . . 50.0 108.696 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -112.59 152.1 29.29 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.774 -1.195 . . . . 50.0 107.774 176.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.74 -159.5 22.26 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 106.444 -2.662 . . . . 50.0 106.444 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.5 pt -120.05 153.56 22.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.465 0.65 . . . . 50.0 111.845 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -141.63 147.39 45.6 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 114.996 -1.002 . . . . 50.0 109.607 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.96 120.06 5.62 Favored 'Trans proline' 0 C--O 1.239 0.558 0 CA-C-O 121.398 0.499 . . . . 50.0 112.532 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.04 -18.76 67.18 Favored Glycine 0 C--O 1.222 -0.638 0 CA-C-O 121.45 0.472 . . . . 50.0 112.663 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.17 -20.69 59.69 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.307 0.854 . . . . 50.0 113.307 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -130.79 29.41 4.76 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.151 0.5 . . . . 50.0 110.021 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.0 tp -132.65 150.41 52.16 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.05 -0.523 . . . . 50.0 110.346 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -127.71 120.55 28.23 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.726 0.639 . . . . 50.0 112.726 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.4 mm -65.32 136.94 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.138 0.494 . . . . 50.0 110.256 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.4 mt -121.71 106.42 11.3 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.068 0.947 . . . . 50.0 108.527 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.472 0.673 0 CA-C-O 120.912 0.387 . . . . 50.0 110.933 178.793 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 95.3 mttt . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 107.452 -1.314 . . . . 50.0 107.452 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo . . . . . 0 CA--C 1.543 0.957 0 C-N-CA 116.938 -1.575 . . . . 50.0 110.749 174.438 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 . . . . . 0 CA--C 1.514 -0.411 0 CA-C-O 120.951 0.405 . . . . 50.0 110.382 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.2 mt -67.52 -38.07 83.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.391 -0.822 . . . . 50.0 110.484 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 57.27 31.51 20.22 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.864 0.866 . . . . 50.0 111.64 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.5 m -97.79 176.96 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 105.585 -2.005 . . . . 50.0 105.585 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -120.18 174.02 6.75 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.348 -0.612 . . . . 50.0 109.348 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.69 162.95 34.13 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.899 -0.408 . . . . 25.0 109.899 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -125.68 130.47 51.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.416 -0.811 . . . . 50.0 110.755 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.49 124.53 24.85 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 123.655 0.597 . . . . 25.0 109.516 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.3 mt -94.53 -20.3 19.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.326 0.584 . . . . 50.0 109.83 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -142.71 169.64 17.19 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.559 -1.645 . . . . 50.0 106.559 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -78.07 165.45 23.99 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.901 -0.407 . . . . 50.0 109.901 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -146.1 156.24 43.31 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.96 -0.385 . . . . 50.0 109.96 173.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.4 t -127.73 127.59 68.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 105.724 -1.954 . . . . 25.0 105.724 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.46 135.83 36.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.155 -0.683 . . . . 25.0 109.155 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -120.49 10.19 11.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.304 1.05 . . . . 50.0 109.302 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 t -150.82 150.15 27.26 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 107.103 -1.443 . . . . 50.0 107.103 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.63 -17.59 42.9 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 117.715 -1.057 . . . . 50.0 113.43 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -77.86 -19.98 53.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.188 0.518 . . . . 50.0 110.373 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -93.1 138.4 31.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.721 0.772 . . . . 50.0 111.407 -173.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.3 mt -91.86 128.01 37.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.809 0.814 . . . . 50.0 110.502 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.8 t -88.66 142.56 27.58 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.939 -1.874 . . . . 50.0 105.939 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -158.11 164.37 36.71 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.677 -0.49 . . . . 50.0 109.677 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -110.46 164.94 12.2 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.705 0.764 . . . . 50.0 109.055 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.15 131.81 51.98 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.747 -0.835 . . . . 50.0 108.747 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.15 -12.15 68.53 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-O 118.849 -0.973 . . . . 50.0 114.152 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.65 148.65 33.03 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 118.176 0.988 . . . . 50.0 110.51 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.5 mm -117.99 126.43 74.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.272 -1.331 . . . . 50.0 108.241 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -128.95 152.52 48.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.365 -0.379 . . . . 50.0 110.004 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -84.7 130.97 34.63 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.117 -1.438 . . . . 25.0 107.117 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.88 123.41 51.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.142 -1.058 . . . . 50.0 108.142 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.8 mt -89.38 -49.35 6.75 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.744 -0.836 . . . . 50.0 108.744 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -151.94 169.25 22.78 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.097 -1.075 . . . . 50.0 108.097 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.9 mtm105 -118.65 157.94 26.45 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 107.053 -1.462 . . . . 50.0 107.053 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 58.21 39.41 25.85 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 125.108 1.505 . . . . 50.0 109.153 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.1 t -67.74 155.81 38.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.19 -1.823 . . . . 25.0 110.162 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 59.96 10.82 2.33 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.084 0.954 . . . . 50.0 113.527 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.19 14.86 81.23 Favored Glycine 0 C--O 1.242 0.61 0 N-CA-C 110.94 -0.864 . . . . 25.0 110.94 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.2 mt -93.51 127.76 39.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.361 0.6 . . . . 50.0 109.495 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -69.95 124.05 23.06 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.498 -0.773 . . . . 25.0 109.545 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.01 2.3 86.72 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 117.03 1.572 . . . . 50.0 117.03 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -100.3 132.31 45.75 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 118.799 1.299 . . . . 50.0 109.224 176.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -114.28 141.59 47.39 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.512 -0.551 . . . . 50.0 109.512 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.6 120.01 25.44 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.2 -1.778 . . . . 50.0 106.2 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.5 m -133.07 165.65 24.25 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.016 0.436 . . . . 50.0 112.029 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.0 t -118.65 118.06 30.62 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.459 -1.311 . . . . 50.0 107.459 172.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -147.71 145.68 28.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.511 -1.662 . . . . 50.0 106.511 -174.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 57.23 27.22 13.28 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.412 0.625 . . . . 25.0 111.497 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.45 6.91 86.97 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 114.948 0.739 . . . . 25.0 114.948 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -132.09 160.86 34.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.108 0.954 . . . . 50.0 109.303 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -100.27 152.69 20.01 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.781 -0.822 . . . . 50.0 108.781 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.62 -162.1 28.49 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 105.632 -2.987 . . . . 50.0 105.632 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.9 pt -118.45 154.71 20.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.542 0.687 . . . . 50.0 110.97 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.78 146.75 45.59 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.129 -0.941 . . . . 50.0 109.743 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -73.95 115.56 4.36 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 CA-C-O 121.544 0.56 . . . . 50.0 111.937 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.2 -17.64 68.34 Favored Glycine 0 C--O 1.224 -0.495 0 CA-C-O 121.463 0.48 . . . . 50.0 113.586 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -62.28 -19.0 62.8 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.959 0.725 . . . . 50.0 112.959 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -122.84 27.37 7.75 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.143 0.497 . . . . 50.0 110.686 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.2 mt -123.81 160.64 26.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.054 0.931 . . . . 75.0 112.613 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -125.59 124.17 40.66 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 114.338 -1.301 . . . . 50.0 109.862 174.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.7 mm -73.64 134.25 30.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.413 -0.958 . . . . 50.0 108.413 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.0 mt -116.33 97.91 6.3 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.938 -1.134 . . . . 50.0 107.938 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 C--N 1.325 -0.495 0 N-CA-C 108.416 -0.957 . . . . 50.0 108.416 178.18 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.6 mttt . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 108.098 -1.075 . . . . 50.0 108.098 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.546 1.11 0 C-N-CA 116.539 -1.841 . . . . 50.0 110.589 172.537 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 . . . . . 0 CA--C 1.519 -0.226 0 CA-C-O 121.41 0.624 . . . . 50.0 112.153 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.7 mt -64.29 -41.13 97.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.073 -0.967 . . . . 50.0 110.543 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 55.63 30.1 14.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.918 0.887 . . . . 50.0 111.648 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.1 m -90.0 153.33 3.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.083 -1.451 . . . . 50.0 107.083 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.41 167.98 11.88 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.761 -0.829 . . . . 50.0 108.761 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.36 161.32 41.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.752 0.311 . . . . 25.0 110.693 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -130.84 130.47 43.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.407 -0.815 . . . . 50.0 110.009 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.29 131.52 42.02 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.322 -0.621 . . . . 25.0 109.322 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 74.8 mt -99.99 -18.84 16.85 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.981 0.419 . . . . 50.0 110.897 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -143.38 169.11 18.29 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.269 -2.122 . . . . 50.0 105.269 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.28 165.85 21.05 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 122.873 0.469 . . . . 50.0 110.6 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -151.36 143.05 23.71 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.939 0.348 . . . . 50.0 111.939 174.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 83.9 t -116.71 125.71 73.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 105.154 -2.165 . . . . 25.0 105.154 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.24 137.91 43.31 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.426 -0.806 . . . . 25.0 109.519 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -113.25 4.81 16.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.654 0.74 . . . . 50.0 110.223 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.3 m -152.02 155.69 33.65 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 106.953 -1.499 . . . . 50.0 106.953 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.67 -21.03 39.68 Favored 'Trans proline' 0 C--N 1.346 0.398 0 N-CA-C 113.692 0.612 . . . . 50.0 113.692 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.02 -16.98 59.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.215 0.531 . . . . 50.0 110.629 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -93.78 141.76 28.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.38 0.609 . . . . 50.0 109.672 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.4 mt -95.62 131.26 42.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.735 0.779 . . . . 50.0 110.17 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.0 t -90.44 146.62 23.99 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 105.099 -2.186 . . . . 50.0 105.099 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -157.32 162.77 39.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.085 0.469 . . . . 50.0 110.492 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -103.88 155.88 18.28 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.421 -1.326 . . . . 50.0 107.421 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -60.73 129.31 40.89 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.632 -0.877 . . . . 50.0 108.632 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.07 -5.35 68.44 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-O 119.312 -0.715 . . . . 50.0 113.445 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -63.97 152.25 40.53 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.8 0.81 . . . . 50.0 110.156 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.2 mm -116.84 135.22 57.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.465 -1.243 . . . . 50.0 108.627 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.7 ptp -142.65 166.11 25.55 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.022 -0.732 . . . . 50.0 109.022 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 57.3 m -106.99 123.6 48.42 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.545 -0.909 . . . . 25.0 108.545 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.3 t -86.87 125.48 40.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.301 -1.0 . . . . 50.0 108.301 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -93.43 -44.52 8.22 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.023 -0.732 . . . . 50.0 109.023 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -146.96 159.1 43.96 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.887 -0.412 . . . . 50.0 109.887 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.1 mtm105 -118.75 154.54 32.63 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.579 -0.526 . . . . 50.0 109.579 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 55.08 38.02 29.84 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 123.628 1.68 . . . . 50.0 108.639 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.7 t -72.48 159.68 33.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 112.644 -2.071 . . . . 25.0 111.158 -173.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 58.87 11.52 1.92 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.906 1.076 . . . . 50.0 113.906 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.64 12.63 83.44 Favored Glycine 0 C--O 1.239 0.468 0 N-CA-C 110.847 -0.901 . . . . 25.0 110.847 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.7 mt -97.25 115.82 28.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.806 0.812 . . . . 50.0 109.289 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -65.34 129.11 38.54 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.883 -1.053 . . . . 25.0 109.664 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.57 -0.94 74.32 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 115.659 1.024 . . . . 50.0 115.659 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -98.73 130.88 45.22 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 118.853 1.326 . . . . 50.0 110.281 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -113.54 137.58 51.37 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.734 -0.839 . . . . 50.0 108.734 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.9 tp -80.63 124.71 29.22 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.047 -1.464 . . . . 50.0 107.047 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.9 m -133.6 162.76 31.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.286 0.565 . . . . 50.0 112.234 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.3 t -112.97 123.67 50.85 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.034 -1.839 . . . . 50.0 106.034 171.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 tp -151.58 140.85 21.38 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.653 -1.24 . . . . 50.0 107.653 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.97 27.2 12.82 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.991 0.737 . . . . 25.0 112.991 176.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.47 3.87 90.36 Favored Glycine 0 C--O 1.226 -0.378 0 N-CA-C 114.692 0.637 . . . . 25.0 114.692 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -129.47 161.01 31.38 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 117.951 0.876 . . . . 50.0 110.185 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -105.76 153.5 21.8 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.129 -1.063 . . . . 50.0 108.129 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.61 -163.74 31.8 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 104.03 -3.628 . . . . 50.0 104.03 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.5 pt -121.93 156.84 26.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.532 0.682 . . . . 50.0 110.855 -175.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.15 147.57 50.93 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.013 -0.994 . . . . 50.0 109.328 -177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -75.74 119.97 5.65 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 CA-C-O 121.349 0.479 . . . . 50.0 111.947 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.28 -20.05 66.98 Favored Glycine 0 C--O 1.221 -0.665 0 C-N-CA 121.517 -0.373 . . . . 50.0 113.354 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -66.34 -9.2 30.92 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.699 1.0 . . . . 50.0 113.699 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -134.65 26.11 3.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.265 0.555 . . . . 50.0 109.792 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 24.3 tp -131.23 149.57 52.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.739 -0.664 . . . . 50.0 110.819 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -119.44 127.85 53.47 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 122.838 0.455 . . . . 50.0 110.963 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.2 mm -76.12 135.56 26.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.191 -1.04 . . . . 50.0 108.191 174.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.4 mt -114.66 80.58 1.43 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.192 -0.669 . . . . 50.0 109.192 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.568 0 N-CA-C 107.707 -1.22 . . . . 50.0 107.707 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 88.0 mttt . . . . . 0 N--CA 1.466 0.354 0 N-CA-C 108.835 -0.802 . . . . 50.0 108.835 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 CA--C 1.545 1.058 0 C-N-CA 116.562 -1.826 . . . . 50.0 110.376 171.643 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 . . . . . 0 CA--C 1.519 -0.232 0 CA-C-O 121.565 0.697 . . . . 50.0 111.302 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt -65.48 -38.97 91.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.221 -0.899 . . . . 50.0 110.506 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.4 m120 57.0 25.63 10.91 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.306 1.042 . . . . 50.0 112.295 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -89.56 169.81 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.005 -1.85 . . . . 50.0 106.005 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -115.42 170.23 8.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.037 0.446 . . . . 50.0 110.06 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.83 160.64 41.49 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.689 -0.687 . . . . 25.0 111.017 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -123.87 131.81 53.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.072 -0.967 . . . . 50.0 110.749 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.99 126.2 30.51 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.053 -0.522 . . . . 25.0 109.871 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.7 mt -93.75 -22.07 18.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.198 0.523 . . . . 50.0 110.536 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -138.06 161.44 36.74 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.246 -1.39 . . . . 50.0 107.246 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.71 175.98 7.42 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.032 0.933 . . . . 50.0 110.959 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -156.85 160.01 38.75 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.499 0.555 . . . . 50.0 112.499 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.1 t -127.76 128.67 69.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 104.408 -2.442 . . . . 25.0 104.408 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.41 132.19 44.45 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.29 -0.633 . . . . 25.0 109.29 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -122.22 10.16 9.94 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.719 0.771 . . . . 50.0 109.714 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.2 m -143.93 153.14 56.87 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 105.378 -2.082 . . . . 50.0 105.378 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.03 -23.08 34.52 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 117.919 -0.921 . . . . 50.0 113.165 -177.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.83 -15.97 46.27 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.982 -0.554 . . . . 50.0 110.916 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -80.9 135.51 35.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.97 0.89 . . . . 50.0 111.515 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.8 mt -83.69 130.94 34.97 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.304 -0.862 . . . . 50.0 110.88 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 m -85.5 132.42 34.2 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.837 -1.542 . . . . 50.0 106.837 173.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -159.42 169.55 23.7 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.019 -1.104 . . . . 50.0 108.019 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 mtp85 -125.35 174.45 8.14 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.347 0.869 . . . . 50.0 113.347 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.12 131.85 48.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.191 -0.913 . . . . 50.0 110.878 -175.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.94 -13.97 66.16 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.44 -0.8 . . . . 50.0 113.343 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -60.06 147.7 38.37 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.868 0.842 . . . . 50.0 110.993 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.3 mm -111.07 134.29 53.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.286 -1.324 . . . . 50.0 107.958 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.4 ptp -138.98 150.67 46.13 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.337 -0.616 . . . . 50.0 109.337 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.6 m -85.98 130.98 34.38 Favored 'General case' 0 C--O 1.217 -0.607 0 N-CA-C 107.242 -1.392 . . . . 25.0 107.242 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.9 t -97.9 125.32 51.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.347 -0.983 . . . . 50.0 108.347 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.3 mt -90.94 -51.27 5.43 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.991 -0.744 . . . . 50.0 108.991 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -152.04 171.25 18.14 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.382 -0.97 . . . . 50.0 108.382 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -120.71 155.6 33.57 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 107.342 -1.355 . . . . 50.0 107.342 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 57.7 39.78 27.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 123.331 1.538 . . . . 50.0 108.592 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.9 t -64.85 147.62 52.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 113.235 -1.802 . . . . 25.0 110.547 -176.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 58.5 15.25 3.45 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.146 0.795 . . . . 50.0 113.146 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.62 12.39 84.28 Favored Glycine 0 C--O 1.225 -0.462 0 C-N-CA 121.161 -0.542 . . . . 25.0 111.833 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.6 mt -88.85 109.7 20.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.381 0.61 . . . . 50.0 110.048 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -53.73 118.43 3.93 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.979 -1.009 . . . . 25.0 112.08 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.69 0.37 89.21 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 115.914 1.126 . . . . 50.0 115.914 175.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -97.75 133.62 42.02 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 119.059 1.429 . . . . 50.0 109.234 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -113.36 140.69 47.83 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.883 -0.784 . . . . 50.0 108.883 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.34 121.47 26.73 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 105.973 -1.862 . . . . 50.0 105.973 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 84.4 m -131.3 163.55 27.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.124 0.488 . . . . 50.0 112.161 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.5 t -118.04 126.44 52.3 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.794 -1.188 . . . . 50.0 107.794 174.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 tp -154.4 142.67 20.45 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 107.326 -1.361 . . . . 75.0 107.326 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 55.46 32.03 18.14 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.317 0.579 . . . . 25.0 112.315 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.12 7.05 76.06 Favored Glycine 0 C--O 1.224 -0.472 0 N-CA-C 114.807 0.683 . . . . 25.0 114.807 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -128.2 165.64 20.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.082 -0.71 . . . . 50.0 109.082 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -117.21 155.08 30.03 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.002 -1.11 . . . . 50.0 108.002 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.0 -159.87 25.83 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 106.195 -2.762 . . . . 50.0 106.195 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.5 pt -117.68 153.47 19.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.684 0.754 . . . . 50.0 111.656 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.71 147.22 38.13 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 114.653 -1.158 . . . . 50.0 108.37 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.2 125.08 8.96 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 118.569 -0.488 . . . . 50.0 112.051 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.78 -19.46 79.9 Favored Glycine 0 C--O 1.222 -0.607 0 N-CA-C 116.035 1.174 . . . . 50.0 116.035 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -70.0 -7.26 39.43 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.189 1.552 . . . . 50.0 115.189 -175.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.17 21.64 5.28 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.264 -1.013 . . . . 50.0 108.264 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.0 tp -123.68 149.68 45.18 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.047 -1.094 . . . . 50.0 108.047 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -120.73 123.82 43.63 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 116.706 -0.224 . . . . 50.0 111.147 -178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.3 mm -74.99 133.52 31.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.223 -1.029 . . . . 50.0 108.223 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.3 mt -116.85 75.53 0.97 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.621 -1.622 . . . . 50.0 106.621 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 115.748 1.759 . . . . 50.0 115.748 -168.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.7 mttt . . . . . 0 CA--C 1.534 0.342 0 N-CA-C 110.463 -0.199 . . . . 50.0 110.463 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--O 1.243 0.747 0 O-C-N 121.973 0.459 . . . . 50.0 111.744 175.664 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 120.898 0.38 . . . . 50.0 111.894 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.11 -41.17 95.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.72 -0.673 . . . . 50.0 110.729 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 55.5 40.73 31.23 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.927 0.891 . . . . 50.0 112.144 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.7 m -105.35 151.37 7.55 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.802 0 N-CA-C 107.316 -1.364 . . . . 50.0 107.316 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.38 167.0 12.97 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.485 -0.561 . . . . 50.0 109.485 -172.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.86 157.41 41.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.083 0.468 . . . . 25.0 111.134 175.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -123.9 131.31 53.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.172 -0.922 . . . . 50.0 110.659 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.08 129.32 38.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.992 -0.744 . . . . 25.0 108.992 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.4 mt -96.63 -17.55 20.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.755 0.312 . . . . 50.0 110.368 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -144.99 167.65 22.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.649 -1.611 . . . . 50.0 106.649 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -77.49 168.86 19.3 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 123.447 0.467 . . . . 50.0 110.85 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -153.48 154.01 33.57 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.074 0.464 . . . . 50.0 111.462 176.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -124.53 129.69 73.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 105.073 -2.195 . . . . 25.0 105.073 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.84 121.88 21.59 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.368 -0.975 . . . . 25.0 108.368 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -102.94 1.67 34.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 122.036 0.922 . . . . 50.0 109.495 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.2 m -144.69 153.75 55.0 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 106.499 -1.667 . . . . 50.0 106.499 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.92 -23.83 34.29 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 117.811 -0.992 . . . . 50.0 113.427 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.78 -16.97 59.31 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.339 0.59 . . . . 50.0 110.629 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -84.05 139.54 32.43 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.61 0.719 . . . . 50.0 110.092 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.0 mt -87.42 130.25 34.74 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.95 -0.759 . . . . 50.0 108.95 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 t -87.13 137.94 31.91 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.435 -1.691 . . . . 50.0 106.435 175.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -155.42 164.19 39.05 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 120.777 0.322 . . . . 50.0 110.482 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 -117.05 168.24 10.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.984 0.421 . . . . 50.0 110.821 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -60.88 130.17 45.13 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.948 -0.76 . . . . 50.0 108.948 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.89 -8.26 78.34 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-O 118.647 -1.085 . . . . 50.0 114.623 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.21 142.35 51.98 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.649 1.224 . . . . 50.0 109.714 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.7 mm -108.68 129.79 62.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 107.627 -1.249 . . . . 50.0 107.627 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 14.3 ptp -134.83 163.4 29.91 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.836 -0.801 . . . . 50.0 108.836 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.1 m -104.4 122.58 45.79 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.411 -1.329 . . . . 25.0 107.411 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.7 t -86.34 122.69 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 108.191 -1.041 . . . . 50.0 108.191 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.24 -41.58 8.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.575 -0.739 . . . . 50.0 109.391 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -142.94 156.63 44.92 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.498 -1.297 . . . . 50.0 107.498 -173.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -124.38 150.76 45.21 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 105.111 -2.181 . . . . 75.0 105.111 172.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 57.43 38.93 28.43 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 123.707 1.717 . . . . 50.0 108.504 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -67.98 157.71 34.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 112.671 -2.059 . . . . 25.0 111.818 -177.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 60.35 12.51 3.46 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.078 1.14 . . . . 50.0 114.078 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.12 13.11 81.56 Favored Glycine 0 C--O 1.244 0.723 0 N-CA-C 111.265 -0.734 . . . . 25.0 111.265 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.2 mt -96.24 137.57 35.12 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 122.357 -0.496 . . . . 50.0 109.899 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -81.19 130.45 35.03 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.352 -0.61 . . . . 25.0 109.352 176.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.93 -0.42 82.85 Favored Glycine 0 C--O 1.241 0.566 0 N-CA-C 116.675 1.43 . . . . 50.0 116.675 173.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -99.8 134.42 42.72 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.388 -0.968 . . . . 50.0 108.388 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.7 m0 -114.61 140.35 48.88 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.078 -1.082 . . . . 50.0 108.078 -177.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.4 tp -82.33 127.74 33.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.051 -1.833 . . . . 50.0 106.051 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.2 m -134.9 162.45 32.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.166 0.508 . . . . 50.0 111.811 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.2 t -112.35 123.09 49.51 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.629 -1.989 . . . . 50.0 105.629 169.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.2 tp -153.14 139.26 18.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.893 0.477 . . . . 75.0 110.122 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.6 m170 56.93 32.0 20.76 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.113 0.565 . . . . 25.0 111.548 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.99 -1.17 89.1 Favored Glycine 0 C--O 1.225 -0.429 0 N-CA-C 116.478 1.351 . . . . 25.0 116.478 177.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.5 ptt85 -130.64 158.59 39.62 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 118.798 1.299 . . . . 50.0 111.402 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -97.72 153.6 18.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.82 -1.178 . . . . 50.0 107.82 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.67 -165.9 35.88 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 103.89 -3.684 . . . . 50.0 103.89 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.4 pt -119.78 158.63 21.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.398 0.618 . . . . 50.0 111.443 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.7 m -144.76 148.95 41.42 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.558 -0.747 . . . . 50.0 110.171 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.3 121.72 7.41 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 118.247 -0.702 . . . . 50.0 112.932 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.38 -18.13 73.13 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 121.267 -0.492 . . . . 50.0 113.568 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -67.3 -9.97 46.24 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.602 0.964 . . . . 50.0 113.602 -177.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -129.89 27.61 5.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.472 0.653 . . . . 50.0 109.804 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -123.08 156.52 34.74 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.356 -0.838 . . . . 50.0 112.423 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -122.69 125.27 45.24 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 108.725 -0.842 . . . . 50.0 108.725 174.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.0 mm -77.97 137.1 22.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.224 -1.028 . . . . 50.0 108.224 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.6 mt -116.96 87.13 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.964 -1.124 . . . . 50.0 107.964 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.699 0 CA-C-N 115.392 -0.822 . . . . 50.0 111.841 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 109.322 -0.621 . . . . 50.0 109.322 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 CA--C 1.541 0.868 0 O-C-N 121.785 0.361 . . . . 50.0 112.018 178.68 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 . . . . . 0 CA--C 1.516 -0.332 0 CA-C-O 120.72 0.295 . . . . 50.0 110.53 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.0 mt -65.0 -42.5 94.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.63 -0.714 . . . . 50.0 110.203 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 53.98 36.18 23.81 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.0 0.92 . . . . 50.0 112.02 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.9 m -96.09 159.79 2.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 N-CA-C 106.18 -1.785 . . . . 50.0 106.18 177.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.02 170.94 8.8 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.992 -0.744 . . . . 50.0 108.992 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.58 162.19 41.41 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.228 -0.295 . . . . 25.0 110.701 175.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.75 136.56 52.58 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.846 0.716 . . . . 50.0 111.353 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.453 ' HA ' HD13 ' A' ' 62' ' ' LEU . . . -73.02 123.09 22.83 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.695 0.622 . . . . 25.0 111.679 173.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.2 mt -90.81 -25.2 20.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.222 0.534 . . . . 50.0 110.091 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -142.82 171.68 13.72 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 103.476 -2.787 . . . . 50.0 103.476 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -84.41 175.7 9.17 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 118.056 0.389 . . . . 50.0 110.818 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -149.41 132.29 16.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.761 0.315 . . . . 50.0 110.737 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.7 t -104.04 125.19 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 104.759 -2.312 . . . . 25.0 104.759 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.23 137.86 43.31 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.565 -0.743 . . . . 25.0 110.205 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -119.05 5.33 11.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.783 0.801 . . . . 50.0 109.099 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -147.37 155.65 46.08 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 106.479 -1.675 . . . . 50.0 106.479 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.59 -24.04 26.33 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 118.167 -0.756 . . . . 50.0 113.514 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -77.73 -17.2 57.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.507 0.67 . . . . 50.0 110.203 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -87.09 133.01 33.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.526 0.679 . . . . 50.0 109.969 -176.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.8 mt -87.15 125.97 34.5 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.823 0.82 . . . . 50.0 109.945 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.68 134.01 33.73 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.252 -1.758 . . . . 50.0 106.252 174.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -154.84 166.93 31.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.526 -0.546 . . . . 50.0 109.526 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -113.4 160.51 18.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.365 0.602 . . . . 50.0 110.068 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -57.41 132.56 53.48 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.468 -0.938 . . . . 50.0 108.468 177.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.57 -18.18 57.32 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-O 119.168 -0.795 . . . . 50.0 113.11 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -61.42 147.87 43.6 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.778 0.799 . . . . 50.0 109.988 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.4 mm -115.67 132.95 63.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.296 -1.32 . . . . 50.0 107.894 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -135.24 165.51 25.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.049 -0.723 . . . . 50.0 109.049 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.4 m -104.18 123.47 47.36 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.891 -1.151 . . . . 25.0 107.891 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.1 t -87.47 121.52 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 N-CA-C 108.248 -1.019 . . . . 50.0 108.248 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.1 mt -91.23 -42.71 10.26 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.984 -1.007 . . . . 50.0 109.277 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -150.46 155.87 40.36 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.43 -0.952 . . . . 50.0 108.43 -176.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -115.58 153.11 31.81 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.91 -1.515 . . . . 50.0 106.91 174.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 55.98 41.23 30.05 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 123.63 1.681 . . . . 50.0 109.176 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.2 t -71.05 159.79 34.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 113.234 -1.803 . . . . 25.0 110.665 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 59.51 12.03 2.59 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.18 0.992 . . . . 50.0 112.352 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.61 17.01 78.38 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 111.262 -0.735 . . . . 25.0 111.262 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.4 mt -97.73 131.37 44.33 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 122.44 0.296 . . . . 50.0 110.282 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -71.26 128.3 35.44 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.536 -0.542 . . . . 25.0 109.536 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.5 -1.32 82.64 Favored Glycine 0 CA--C 1.518 0.244 0 N-CA-C 116.569 1.388 . . . . 50.0 116.569 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -100.63 132.99 45.74 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 118.423 1.111 . . . . 50.0 109.621 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -113.05 141.6 46.69 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.939 -0.763 . . . . 50.0 108.939 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.14 122.51 27.46 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 104.823 -2.288 . . . . 50.0 104.823 177.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.487 ' HG ' HG22 ' A' ' 57' ' ' VAL . 96.7 m -133.89 161.7 34.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.823 0.345 . . . . 50.0 111.902 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.6 t -114.63 125.14 53.41 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.833 -1.173 . . . . 50.0 107.833 172.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 tp -145.17 136.98 25.55 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.674 -1.232 . . . . 50.0 107.674 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 55.89 28.39 12.47 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.234 0.54 . . . . 25.0 112.173 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.68 2.53 90.56 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 114.877 0.711 . . . . 25.0 114.877 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -122.55 159.3 28.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 118.282 1.041 . . . . 50.0 108.422 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -112.09 150.34 30.85 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.633 -0.877 . . . . 50.0 108.633 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.84 -160.46 24.4 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 106.547 -2.621 . . . . 50.0 106.547 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.1 pt -116.84 150.36 18.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.796 0.808 . . . . 50.0 111.5 -175.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.487 HG22 ' HG ' ' A' ' 48' ' ' CYS . 2.9 m -137.98 146.59 52.93 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 114.846 -1.07 . . . . 50.0 108.814 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.44 122.82 6.71 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 117.951 -0.899 . . . . 50.0 111.706 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.2 -12.71 72.54 Favored Glycine 0 C--O 1.222 -0.615 0 O-C-N 121.909 -0.494 . . . . 50.0 113.24 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.3 -16.12 63.24 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.486 0.921 . . . . 50.0 113.486 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -129.36 27.65 5.3 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.142 -0.688 . . . . 50.0 109.142 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 12' ' ' ALA . 6.6 tp -129.32 152.22 49.12 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.276 -0.875 . . . . 75.0 111.472 -177.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -131.64 120.66 23.12 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-N 115.777 -0.647 . . . . 50.0 111.755 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.4 mm -66.13 136.13 27.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 O-C-N 123.53 0.519 . . . . 50.0 110.102 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.6 mt -118.75 98.51 6.25 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.303 -1.369 . . . . 50.0 107.303 175.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.3 t . . . . . 0 C--N 1.32 -0.685 0 N-CA-C 107.302 -1.37 . . . . 50.0 107.302 -179.713 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.0 mttt . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 110.123 -0.325 . . . . 50.0 110.123 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 CA--C 1.542 0.916 0 C-N-CA 118.276 -0.683 . . . . 50.0 112.263 176.398 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 CA--C 1.515 -0.386 0 N-CA-C 109.499 -0.556 . . . . 50.0 109.499 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.8 mt -71.88 -33.16 68.13 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.756 -0.656 . . . . 50.0 111.079 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.3 m120 53.43 41.75 32.07 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.35 -0.841 . . . . 50.0 111.954 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.4 m -109.51 165.38 5.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.526 -1.287 . . . . 50.0 107.526 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.73 170.6 7.91 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.467 -0.568 . . . . 50.0 109.467 -176.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.38 162.08 40.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 25.0 110.954 173.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -127.82 130.51 48.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.6 -0.727 . . . . 50.0 109.729 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.38 131.94 46.18 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.061 0.545 . . . . 25.0 109.874 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.9 mt -94.96 -23.19 17.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.24 0.543 . . . . 50.0 110.769 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -144.56 172.09 13.47 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 104.222 -2.51 . . . . 50.0 104.222 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.95 173.89 10.81 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.949 -0.389 . . . . 50.0 109.949 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -155.07 141.01 18.28 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.507 0.323 . . . . 50.0 111.648 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.7 t -108.7 124.48 65.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 105.8 -1.926 . . . . 25.0 105.8 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.53 130.82 41.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.343 -0.844 . . . . 25.0 108.867 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -112.48 11.27 19.8 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.185 0.993 . . . . 50.0 109.044 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 t -153.15 151.26 25.64 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 107.5 -1.296 . . . . 50.0 107.5 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -69.21 -18.2 39.7 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 117.689 -1.074 . . . . 50.0 112.509 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -76.6 -19.62 57.64 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.431 0.634 . . . . 50.0 109.819 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -94.11 140.99 29.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.704 0.764 . . . . 50.0 111.034 -172.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.3 mt -91.17 129.61 37.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.469 -0.787 . . . . 50.0 110.157 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.69 139.52 30.48 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.106 -2.183 . . . . 50.0 105.106 173.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -157.77 166.46 32.7 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.594 -0.521 . . . . 50.0 109.594 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -112.73 164.03 13.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.105 0.955 . . . . 50.0 110.362 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -58.48 129.66 43.09 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.447 -1.252 . . . . 50.0 109.45 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.74 -16.21 61.39 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-O 118.758 -1.024 . . . . 50.0 114.867 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -57.79 146.7 30.58 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 117.984 0.892 . . . . 50.0 111.408 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.4 mm -109.47 133.89 53.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.595 -1.184 . . . . 50.0 108.139 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.2 ptp -138.79 162.61 34.31 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.358 -0.979 . . . . 50.0 108.358 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.8 m -101.38 125.5 48.03 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 108.363 -0.977 . . . . 25.0 108.363 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.53 126.01 43.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.044 -1.095 . . . . 50.0 108.044 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.8 mt -95.47 -43.65 7.89 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.865 -1.061 . . . . 50.0 108.918 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -150.21 162.19 40.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.178 -0.675 . . . . 50.0 109.178 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -121.82 152.34 39.64 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 107.076 -1.453 . . . . 50.0 107.076 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 56.22 39.9 30.14 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 123.309 1.528 . . . . 50.0 108.703 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -69.87 157.51 37.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.737 -1.574 . . . . 25.0 110.177 -175.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 60.53 11.05 2.81 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.611 0.967 . . . . 50.0 113.611 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.57 16.5 77.61 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.173 -0.771 . . . . 25.0 111.173 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.7 mt -103.68 113.71 27.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.003 0.43 . . . . 50.0 110.77 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -63.74 128.08 34.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.973 -0.558 . . . . 25.0 109.696 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.61 -1.92 88.05 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 118.757 -1.024 . . . . 50.0 115.103 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -98.93 131.79 44.74 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 118.969 1.384 . . . . 50.0 109.687 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -111.76 140.06 46.71 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.926 -0.768 . . . . 50.0 108.926 -176.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.05 120.79 25.72 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 105.44 -2.059 . . . . 50.0 105.44 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.415 ' HG ' HG23 ' A' ' 57' ' ' VAL . 92.0 m -132.26 163.55 28.37 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.476 0.547 . . . . 50.0 112.476 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.8 t -115.89 119.26 35.39 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 106.588 -1.634 . . . . 50.0 106.588 171.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -147.37 139.28 24.24 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 107.055 -1.461 . . . . 50.0 107.055 -174.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 56.72 31.49 19.47 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.678 0.752 . . . . 25.0 111.86 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.49 5.27 85.74 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 115.479 0.952 . . . . 25.0 115.479 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -129.78 161.26 31.13 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.125 -1.065 . . . . 50.0 108.125 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -107.09 152.42 24.05 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.385 -0.598 . . . . 50.0 109.385 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.59 -160.55 24.9 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 106.565 -2.614 . . . . 50.0 106.565 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.1 pt -117.28 156.82 18.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.308 0.575 . . . . 50.0 111.043 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.415 HG23 ' HG ' ' A' ' 48' ' ' CYS . 1.4 m -144.67 146.95 33.97 Favored Pre-proline 0 C--O 1.241 0.64 0 CA-C-N 114.96 -1.018 . . . . 50.0 109.874 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -74.45 118.44 5.35 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 CA-C-O 121.441 0.517 . . . . 50.0 112.708 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.8 -20.04 68.02 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 114.784 0.674 . . . . 50.0 114.784 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -25.22 67.3 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.109 0.781 . . . . 50.0 113.109 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -119.18 28.33 8.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.285 0.564 . . . . 50.0 110.347 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.0 tp -133.51 150.06 51.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.132 -0.485 . . . . 75.0 110.162 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -127.94 120.21 27.15 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.851 0.686 . . . . 50.0 112.851 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.7 mm -65.43 137.6 24.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.494 -0.558 . . . . 50.0 109.494 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.9 mt -118.44 105.36 11.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.915 -1.142 . . . . 50.0 107.915 175.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.9 m . . . . . 0 C--N 1.323 -0.55 0 N-CA-C 108.092 -1.077 . . . . 50.0 108.092 177.299 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 108.956 -0.757 . . . . 50.0 108.956 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo . . . . . 0 CA--C 1.545 1.075 0 C-N-CA 117.171 -1.42 . . . . 50.0 110.518 170.957 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 . . . . . 0 C--O 1.235 0.324 0 N-CA-C 112.608 0.596 . . . . 50.0 112.608 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.04 -39.88 90.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.141 -0.936 . . . . 50.0 111.419 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 54.22 41.6 31.92 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.289 1.042 . . . . 50.0 111.91 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.9 m -102.7 171.27 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 N-CA-C 103.743 -2.688 . . . . 50.0 103.743 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -118.96 173.93 6.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 119.42 1.009 . . . . 50.0 110.693 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.04 158.74 44.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.12 -0.491 . . . . 25.0 109.746 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -120.9 132.26 54.86 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.311 0.644 . . . . 50.0 109.793 177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.59 130.43 42.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.016 0.436 . . . . 25.0 110.078 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.8 mt -97.46 -22.18 16.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.337 -0.392 . . . . 50.0 110.944 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -141.88 164.76 29.3 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.539 -1.282 . . . . 50.0 107.539 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -71.78 167.74 19.31 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.598 0.562 . . . . 50.0 110.785 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.45 160.04 42.17 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.516 -0.55 . . . . 50.0 109.516 175.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.1 t -130.85 127.7 61.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 102.87 -3.011 . . . . 25.0 102.87 169.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.53 123.6 31.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.788 -0.819 . . . . 25.0 108.788 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -117.18 -17.28 10.28 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.541 0.686 . . . . 50.0 110.41 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.55 152.91 37.97 Favored Pre-proline 0 N--CA 1.471 0.58 0 N-CA-C 107.973 -1.121 . . . . 50.0 107.973 176.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.8 -24.51 34.31 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 117.906 -0.929 . . . . 50.0 113.59 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -84.13 -16.36 43.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.938 0.399 . . . . 50.0 111.135 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -79.03 129.64 34.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.077 0.941 . . . . 50.0 110.644 -173.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.3 mt -82.77 138.48 34.01 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.497 -0.774 . . . . 50.0 109.605 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.65 130.73 34.69 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.474 -0.935 . . . . 50.0 108.474 177.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -158.37 162.92 37.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.27 0.557 . . . . 50.0 110.958 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.13 166.06 17.73 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.964 -0.562 . . . . 50.0 110.099 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -56.97 131.46 49.84 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 121.116 0.484 . . . . 50.0 109.8 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.06 -19.68 53.24 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-O 118.569 -1.128 . . . . 50.0 113.028 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -62.3 149.07 43.07 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 118.118 0.959 . . . . 50.0 109.98 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.4 mm -116.63 125.3 73.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 114.325 -1.307 . . . . 50.0 108.365 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -126.74 153.22 45.79 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.172 -0.677 . . . . 50.0 109.172 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.8 m -87.26 126.63 34.95 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.736 -1.579 . . . . 25.0 106.736 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.19 119.89 40.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.362 -1.348 . . . . 50.0 107.362 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.1 mt -91.03 -43.92 9.63 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.15 -0.932 . . . . 50.0 110.155 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -150.19 159.61 44.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.831 -1.174 . . . . 50.0 107.831 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -121.62 149.41 43.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.556 -1.275 . . . . 50.0 107.556 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 58.06 39.27 26.42 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 123.517 1.627 . . . . 50.0 109.603 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.3 t -65.29 151.81 45.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.742 -1.572 . . . . 25.0 110.468 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 59.59 11.75 2.51 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.93 0.892 . . . . 50.0 113.265 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.53 18.72 78.84 Favored Glycine 0 C--O 1.241 0.585 0 N-CA-C 110.987 -0.845 . . . . 25.0 110.987 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.9 mt -91.87 123.83 35.54 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.348 -0.612 . . . . 50.0 109.348 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -64.23 118.8 9.13 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.158 -0.928 . . . . 25.0 110.998 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.28 2.63 90.57 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 116.931 1.533 . . . . 50.0 116.931 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -100.82 132.02 46.42 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.809 1.305 . . . . 50.0 110.579 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -110.16 140.8 43.87 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.75 -0.593 . . . . 50.0 110.196 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.25 122.01 26.88 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 104.386 -2.449 . . . . 50.0 104.386 176.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.421 ' HG ' HG21 ' A' ' 57' ' ' VAL . 87.8 m -132.51 164.42 26.63 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.179 0.514 . . . . 50.0 111.362 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.5 t -121.55 125.16 46.12 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 107.485 -1.302 . . . . 50.0 107.485 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.2 tp -148.78 138.49 22.02 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 106.495 -1.668 . . . . 50.0 106.495 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 55.24 28.93 11.91 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.221 0.608 . . . . 25.0 112.168 -176.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.34 1.35 75.13 Favored Glycine 0 C--O 1.226 -0.349 0 N-CA-C 115.151 0.82 . . . . 25.0 115.151 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -117.09 161.47 19.37 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.083 -1.451 . . . . 50.0 107.083 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -118.35 156.75 28.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.508 -0.553 . . . . 50.0 109.508 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.21 -156.82 21.1 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 106.525 -2.63 . . . . 50.0 106.525 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.8 pt -121.12 151.9 24.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.742 0.782 . . . . 50.0 111.545 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.421 HG21 ' HG ' ' A' ' 48' ' ' CYS . 2.4 m -141.18 146.85 44.77 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 114.438 -1.255 . . . . 50.0 109.591 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.65 121.21 5.84 Favored 'Trans proline' 0 C--O 1.24 0.586 0 CA-C-O 121.444 0.518 . . . . 50.0 113.133 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.3 -16.16 68.78 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-O 121.717 0.62 . . . . 50.0 114.334 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -18.3 63.55 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.018 0.527 . . . . 50.0 112.081 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -126.73 30.39 5.51 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.951 0.405 . . . . 50.0 110.692 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.5 mt -126.25 157.09 39.2 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.885 1.068 . . . . 50.0 113.885 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -129.76 119.82 24.06 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.16 -0.927 . . . . 50.0 109.649 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.7 mm -67.81 140.39 19.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 O-C-N 123.902 0.751 . . . . 50.0 109.613 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.4 mt -118.65 101.84 8.41 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.826 0.85 . . . . 50.0 109.152 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 112.701 0.63 . . . . 50.0 112.701 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.8 mttt . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 106.404 -1.702 . . . . 50.0 106.404 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.543 0.942 0 C-N-CA 118.306 -0.662 . . . . 50.0 112.361 177.497 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 . . . . . 0 CA--C 1.53 0.173 0 N-CA-C 114.829 1.418 . . . . 50.0 114.829 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.5 mt -73.57 -42.48 61.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.652 -1.158 . . . . 50.0 110.291 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 55.75 30.05 14.96 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.396 1.078 . . . . 50.0 111.822 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 m -89.65 163.89 2.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 104.842 -2.281 . . . . 50.0 104.842 176.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.23 171.9 7.33 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.966 -1.124 . . . . 50.0 107.966 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.47 157.24 43.34 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.52 -0.548 . . . . 25.0 109.52 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -120.34 131.79 55.01 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 123.901 0.751 . . . . 50.0 109.393 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.8 126.94 31.32 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.658 0.599 . . . . 25.0 110.095 173.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.5 mt -92.56 -26.59 17.83 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.859 -0.423 . . . . 50.0 109.859 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -142.19 166.02 25.83 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.048 -1.834 . . . . 50.0 106.048 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -75.3 163.35 27.57 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 122.998 0.519 . . . . 50.0 112.369 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -143.07 144.03 32.09 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.625 0.602 . . . . 50.0 112.625 173.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -114.14 126.83 71.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 103.355 -2.832 . . . . 25.0 103.355 173.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.42 140.51 33.4 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 108.237 -1.023 . . . . 25.0 108.237 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -125.06 9.77 8.1 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.693 0.759 . . . . 50.0 111.186 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.5 m -145.73 150.98 45.0 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 106.575 -1.639 . . . . 50.0 106.575 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.62 -29.96 84.94 Favored 'Trans proline' 0 C--N 1.351 0.663 0 N-CA-C 114.954 1.098 . . . . 50.0 114.954 -175.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.7 -17.4 59.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.203 -0.453 . . . . 50.0 111.769 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -86.15 136.33 33.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 122.055 0.931 . . . . 50.0 111.886 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.9 mt -91.14 130.95 36.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.508 0.67 . . . . 50.0 111.089 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.6 p -90.92 144.69 25.42 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.61 -1.256 . . . . 50.0 107.61 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -160.09 168.55 25.29 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.61 0.243 . . . . 50.0 110.669 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -116.95 163.55 16.03 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.406 -0.59 . . . . 50.0 109.406 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -59.74 133.78 56.41 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.727 -0.842 . . . . 50.0 108.727 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.4 -21.35 46.45 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-O 118.903 -0.943 . . . . 50.0 113.003 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -57.14 145.69 30.34 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.031 0.919 . . . . 50.0 111.116 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.3 mm -115.7 126.83 73.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.486 -1.234 . . . . 50.0 109.159 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -131.39 153.95 49.14 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.665 -0.494 . . . . 50.0 109.665 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.5 m -89.55 123.69 33.86 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.474 -0.935 . . . . 25.0 108.474 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.9 t -87.1 123.15 39.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.069 -0.715 . . . . 50.0 109.069 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -89.85 -46.05 8.83 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.244 -1.021 . . . . 50.0 108.244 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -153.94 172.85 16.78 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.881 -0.512 . . . . 50.0 109.708 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 mtm105 -120.25 154.5 34.82 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.087 -1.449 . . . . 50.0 107.087 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 59.71 40.47 19.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 123.527 1.632 . . . . 50.0 109.228 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t -66.84 154.77 40.06 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 113.081 -1.872 . . . . 25.0 110.36 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 57.59 14.37 2.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.213 1.005 . . . . 50.0 112.147 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.05 14.84 81.85 Favored Glycine 0 C--O 1.24 0.481 0 N-CA-C 111.287 -0.725 . . . . 25.0 111.287 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.3 mt -93.16 129.07 39.29 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 117.479 0.639 . . . . 75.0 109.602 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -67.84 125.92 27.78 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.039 -0.528 . . . . 25.0 110.305 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.29 -1.76 84.12 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 117.051 1.58 . . . . 50.0 117.051 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -97.75 135.11 40.0 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 117.879 0.839 . . . . 50.0 110.391 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -112.88 143.43 44.16 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.711 -1.218 . . . . 50.0 107.711 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.3 124.34 32.57 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.178 -2.527 . . . . 50.0 104.178 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.478 ' HG ' HG21 ' A' ' 57' ' ' VAL . 93.2 m -133.16 164.11 27.77 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.162 0.506 . . . . 50.0 111.762 177.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.0 t -118.66 124.9 48.53 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.688 -1.227 . . . . 50.0 107.688 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.0 tp -139.78 133.14 30.0 Favored 'General case' 0 C--O 1.212 -0.911 0 N-CA-C 107.306 -1.368 . . . . 50.0 107.306 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.5 m170 54.95 31.62 16.33 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.465 0.706 . . . . 25.0 111.404 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.31 1.2 85.57 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 116.018 1.167 . . . . 25.0 116.018 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -118.46 152.8 35.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 119.09 1.445 . . . . 50.0 107.661 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -108.18 157.14 18.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.353 -0.385 . . . . 50.0 110.176 -178.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.44 -161.37 29.51 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 106.609 -2.597 . . . . 50.0 106.609 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.7 pt -117.13 150.03 19.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.349 0.595 . . . . 50.0 111.032 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.478 HG21 ' HG ' ' A' ' 48' ' ' CYS . 2.5 m -140.53 146.87 46.88 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.084 -0.962 . . . . 50.0 109.107 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.45 122.02 5.42 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 CA-C-O 121.546 0.561 . . . . 50.0 112.904 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.56 -18.23 71.66 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 115.934 1.134 . . . . 50.0 115.934 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -17.74 63.84 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 122.223 -0.575 . . . . 50.0 111.778 -177.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -123.13 27.94 7.37 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.712 0.291 . . . . 50.0 110.523 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.4 mt -127.74 156.03 43.08 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.879 0.847 . . . . 75.0 112.26 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -128.81 121.99 29.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.724 -1.125 . . . . 50.0 110.443 175.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.6 mm -68.75 139.23 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.409 -0.96 . . . . 50.0 108.409 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.6 mt -117.49 103.02 9.68 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.325 -1.361 . . . . 50.0 107.325 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.0 m . . . . . 0 C--N 1.327 -0.406 0 CA-C-O 121.361 0.601 . . . . 50.0 111.287 -177.733 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt . . . . . 0 CA--C 1.542 0.666 0 N-CA-C 106.721 -1.585 . . . . 50.0 106.721 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 CA--C 1.551 1.345 0 O-C-N 122.463 0.717 . . . . 50.0 112.757 178.158 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 . . . . . 0 CA--C 1.52 -0.211 0 N-CA-C 109.794 -0.447 . . . . 50.0 109.794 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.27 -40.74 97.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.017 -0.538 . . . . 50.0 109.758 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 57.3 24.83 10.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.039 0.935 . . . . 50.0 111.856 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.5 m -88.21 175.81 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 N-CA-C 105.531 -2.026 . . . . 50.0 105.531 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mp -117.88 172.28 7.5 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 118.842 0.746 . . . . 50.0 110.813 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.72 163.38 34.19 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.792 -0.64 . . . . 25.0 110.256 177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -126.63 130.52 50.64 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.644 -0.707 . . . . 50.0 110.313 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.78 123.81 21.58 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.143 0.577 . . . . 25.0 110.237 174.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.0 mt -90.54 -23.92 20.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.801 -0.444 . . . . 50.0 109.801 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -141.26 172.53 12.55 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 102.887 -3.005 . . . . 50.0 102.887 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.52 176.4 9.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.767 -0.827 . . . . 50.0 108.767 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -151.61 135.23 16.26 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.199 0.523 . . . . 50.0 112.103 175.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.9 t -101.53 121.38 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 105.333 -2.099 . . . . 25.0 105.333 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.42 131.52 43.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.516 -0.92 . . . . 25.0 108.516 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -105.22 -6.51 19.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.688 0.756 . . . . 50.0 109.897 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 m -138.57 152.61 71.32 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 107.076 -1.453 . . . . 50.0 107.076 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.81 -19.29 36.05 Favored 'Trans proline' 0 C--O 1.222 -0.296 0 C-N-CA 117.721 -1.053 . . . . 50.0 112.374 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -79.41 -15.88 57.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 50.0 110.862 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -91.86 139.38 30.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.87 0.843 . . . . 50.0 110.428 -176.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.2 mt -90.62 129.72 36.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.059 0.933 . . . . 50.0 110.24 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.58 147.18 23.51 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.644 -1.613 . . . . 50.0 106.644 175.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -157.47 167.81 29.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.283 0.564 . . . . 50.0 111.023 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -107.09 159.13 16.54 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.971 -0.752 . . . . 50.0 108.971 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -58.0 128.2 35.89 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.72 -1.215 . . . . 50.0 107.72 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.18 -18.87 53.56 Favored Glycine 0 CA--C 1.517 0.194 0 CA-C-O 118.731 -1.039 . . . . 50.0 113.915 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -59.51 147.61 36.17 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 118.063 0.932 . . . . 50.0 110.738 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.5 mm -115.39 128.52 72.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.453 -1.249 . . . . 50.0 108.92 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -131.09 153.05 49.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.044 -0.354 . . . . 50.0 110.044 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.6 m -84.19 130.09 34.85 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 177.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.51 125.25 47.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.709 -0.849 . . . . 50.0 108.709 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.4 mt -91.09 -48.62 6.86 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.797 -0.816 . . . . 50.0 108.797 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -155.06 173.21 16.91 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.655 -0.869 . . . . 50.0 108.655 177.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -121.99 151.62 40.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.04 -1.096 . . . . 50.0 108.04 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 59.29 40.32 21.45 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 123.329 1.537 . . . . 50.0 108.936 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -65.06 153.78 39.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 112.866 -1.97 . . . . 25.0 110.5 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 59.79 11.61 2.58 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.585 0.957 . . . . 50.0 113.585 176.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.11 19.13 75.39 Favored Glycine 0 C--O 1.225 -0.447 0 N-CA-C 111.052 -0.819 . . . . 25.0 111.052 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 71.9 mt -96.95 112.33 24.13 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.124 0.488 . . . . 50.0 111.288 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.96 119.36 6.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.888 -0.596 . . . . 25.0 111.828 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.99 -0.01 89.55 Favored Glycine 0 C--O 1.239 0.417 0 N-CA-C 115.521 0.968 . . . . 50.0 115.521 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -100.19 134.6 42.88 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 118.525 1.163 . . . . 50.0 109.485 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -112.0 143.09 43.56 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.322 -0.992 . . . . 50.0 108.322 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.03 120.01 26.07 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 105.161 -2.163 . . . . 50.0 105.161 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 92.0 m -130.29 161.14 31.9 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.827 0.346 . . . . 50.0 111.317 178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.3 t -113.71 120.3 40.36 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.184 -1.413 . . . . 50.0 107.184 174.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.5 tp -143.2 135.5 27.19 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.145 -0.687 . . . . 75.0 109.145 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 56.03 28.13 12.35 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.889 1.07 . . . . 25.0 113.889 175.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.28 7.7 86.31 Favored Glycine 0 C--O 1.226 -0.352 0 C-N-CA 121.202 -0.523 . . . . 25.0 113.794 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -118.62 153.22 34.64 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.523 -0.918 . . . . 50.0 108.523 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -117.16 138.46 51.65 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 104.996 -2.224 . . . . 50.0 104.996 173.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.18 -162.71 26.99 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 107.414 -2.274 . . . . 50.0 107.414 -176.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.6 pt -111.31 151.92 13.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 121.599 0.714 . . . . 50.0 111.713 -174.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.2 m -141.47 145.01 35.95 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 114.851 -1.068 . . . . 50.0 108.992 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.72 120.69 6.26 Favored 'Trans proline' 0 C--O 1.238 0.507 0 CA-C-O 121.233 0.431 . . . . 50.0 112.691 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.76 -19.84 71.71 Favored Glycine 0 C--O 1.22 -0.727 0 N-CA-C 114.915 0.726 . . . . 50.0 114.915 -176.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -65.37 -16.68 63.86 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.217 0.821 . . . . 50.0 113.217 -177.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -122.92 27.44 7.69 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.259 0.552 . . . . 50.0 109.817 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.7 mt -126.8 157.82 38.23 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.019 0.914 . . . . 50.0 113.023 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -127.56 125.93 41.22 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 115.01 -0.996 . . . . 50.0 110.194 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.2 mm -75.07 135.85 26.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.699 -0.852 . . . . 50.0 108.699 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.0 mt -115.47 92.13 3.82 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.561 0.744 . . . . 50.0 109.629 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.472 0.654 0 CA-C-N 115.86 -0.609 . . . . 50.0 111.139 179.537 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 107.766 -1.198 . . . . 50.0 107.766 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 CA--C 1.537 0.66 0 O-C-N 122.186 0.571 . . . . 50.0 113.07 -178.739 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 . . . . . 0 CA--C 1.515 -0.367 0 N-CA-C 109.689 -0.486 . . . . 50.0 109.689 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.4 mt -67.34 -39.35 85.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.918 -0.583 . . . . 50.0 109.788 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.7 m120 53.76 30.06 10.6 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.168 0.987 . . . . 50.0 112.683 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.8 m -93.17 175.88 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 104.501 -2.407 . . . . 50.0 104.501 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.55 172.34 7.72 Favored 'General case' 0 CA--C 1.497 -1.093 0 O-C-N 121.934 -0.479 . . . . 50.0 109.837 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.93 162.74 38.69 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.599 -0.728 . . . . 25.0 109.87 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.91 128.19 49.09 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 124.175 0.99 . . . . 50.0 108.333 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.24 138.24 49.28 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 122.763 0.425 . . . . 25.0 110.271 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.2 mt -101.46 -17.38 16.47 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.669 0.618 . . . . 50.0 112.669 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -141.45 159.12 42.87 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.698 -1.223 . . . . 50.0 107.698 -176.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.4 ' C ' HH22 ' A' ' 61' ' ' ARG . 21.5 m-20 -81.18 149.71 28.98 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.036 0.21 . . . . 50.0 111.257 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -133.68 146.29 50.71 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.33 0.652 . . . . 50.0 112.203 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.0 t -119.98 133.38 66.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 103.147 -2.908 . . . . 25.0 103.147 170.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.14 135.53 36.6 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.063 -0.717 . . . . 25.0 109.063 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -108.82 2.44 21.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.39 0.614 . . . . 50.0 111.261 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -142.43 151.73 58.58 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 105.88 -1.896 . . . . 50.0 105.88 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.21 -18.73 34.7 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 118.353 -0.631 . . . . 50.0 112.823 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.03 -16.79 59.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.267 -0.879 . . . . 50.0 110.956 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -97.56 141.68 30.31 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.694 -0.854 . . . . 50.0 108.694 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.3 mt -93.62 127.04 39.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.958 0.885 . . . . 50.0 112.059 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.23 129.3 34.83 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 104.81 -2.293 . . . . 50.0 104.81 174.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -149.35 163.74 36.88 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.998 -0.371 . . . . 50.0 109.998 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -111.01 163.78 13.48 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.577 0.703 . . . . 50.0 110.514 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.52 130.85 46.07 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 107.278 -1.378 . . . . 50.0 107.278 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.14 -9.47 77.56 Favored Glycine 0 C--N 1.312 -0.751 0 CA-C-O 119.03 -0.872 . . . . 50.0 114.279 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -62.38 149.41 42.46 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 117.822 0.811 . . . . 50.0 109.326 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.0 mm -114.77 128.15 72.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.144 -0.935 . . . . 50.0 108.686 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -131.48 149.93 52.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.231 -0.44 . . . . 50.0 109.935 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.1 m -87.18 122.64 31.26 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.746 -1.205 . . . . 25.0 107.746 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -85.4 127.43 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 N-CA-C 108.138 -1.06 . . . . 50.0 108.138 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.9 mt -93.37 -51.0 5.19 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.17 -0.923 . . . . 50.0 109.222 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -152.44 173.75 14.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.332 -0.618 . . . . 50.0 109.332 176.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -121.76 155.46 35.23 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 107.928 -1.138 . . . . 50.0 107.928 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 55.88 42.43 28.88 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 125.641 1.838 . . . . 50.0 109.168 -177.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.8 t -65.98 149.62 49.94 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.415 -1.721 . . . . 25.0 110.517 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 59.72 14.61 4.18 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.774 0.83 . . . . 50.0 112.175 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.29 10.72 85.99 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.28 -0.486 . . . . 25.0 111.982 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.4 mt -89.63 119.4 30.01 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 117.718 0.759 . . . . 50.0 110.001 -178.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -64.32 126.04 26.5 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.238 -0.437 . . . . 25.0 110.064 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.58 -0.09 88.51 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 115.451 0.94 . . . . 50.0 115.451 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -99.45 133.29 43.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 119.101 1.45 . . . . 50.0 108.97 175.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -114.85 142.47 46.52 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.123 -1.436 . . . . 50.0 107.123 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.56 125.49 34.37 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 104.963 -2.236 . . . . 50.0 104.963 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.8 m -135.85 160.82 37.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.834 0.35 . . . . 50.0 110.601 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.2 t -111.46 125.96 54.45 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.314 -1.365 . . . . 50.0 107.314 171.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.7 tp -136.72 128.8 29.56 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.759 -1.2 . . . . 50.0 107.759 -177.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.9 m170 54.9 30.71 14.41 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.942 0.401 . . . . 25.0 110.771 -175.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.66 -7.7 64.62 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 115.937 1.135 . . . . 25.0 115.937 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -110.8 149.05 31.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 118.307 1.053 . . . . 50.0 108.783 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -103.24 154.33 19.46 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.502 -0.772 . . . . 50.0 110.266 -175.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.66 -167.98 39.73 Favored Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 106.429 -2.668 . . . . 50.0 106.429 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.4 pt -111.36 149.84 13.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.976 0.893 . . . . 50.0 111.961 -175.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 m -139.54 145.17 42.54 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 114.29 -1.323 . . . . 50.0 109.413 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.03 123.07 8.1 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 CA-C-O 121.207 0.42 . . . . 50.0 112.646 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.95 -15.01 79.84 Favored Glycine 0 C--O 1.228 -0.27 0 O-C-N 122.088 -0.383 . . . . 50.0 113.525 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -67.57 -5.28 14.65 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.775 0.83 . . . . 50.0 112.368 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.4 HH22 ' C ' ' A' ' 15' ' ' ASP . 0.3 OUTLIER -142.06 27.9 1.75 Allowed 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.139 -1.06 . . . . 50.0 108.139 -178.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 tp -130.65 144.62 51.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.611 -0.722 . . . . 50.0 110.884 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -122.32 117.09 25.26 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.257 -0.429 . . . . 50.0 112.033 -176.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.1 mm -64.92 136.99 25.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 O-C-N 123.961 0.788 . . . . 50.0 109.609 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.5 mt -119.67 106.14 11.87 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.283 -1.377 . . . . 50.0 107.283 176.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.6 0 CA-C-O 121.104 0.478 . . . . 50.0 110.238 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.4 mttt . . . . . 0 C--O 1.226 -0.179 0 N-CA-C 106.957 -1.497 . . . . 50.0 106.957 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 CA--C 1.531 0.33 0 C-N-CA 116.705 -1.73 . . . . 50.0 110.553 173.303 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 . . . . . 0 CA--C 1.513 -0.469 0 N-CA-C 107.182 -1.414 . . . . 50.0 107.182 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.41 -39.97 92.69 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.509 0.506 . . . . 50.0 110.648 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 55.52 31.93 18.05 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.926 0.89 . . . . 50.0 111.695 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.5 m -94.31 170.71 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 104.267 -2.494 . . . . 50.0 104.267 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -115.83 172.21 7.28 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.264 -1.013 . . . . 50.0 108.264 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.29 156.32 41.91 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 123.281 0.363 . . . . 25.0 110.623 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -116.63 127.86 54.85 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 123.998 0.812 . . . . 50.0 110.104 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.52 127.08 31.38 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.913 -0.773 . . . . 25.0 108.913 176.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.6 mt -88.75 -24.19 22.72 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 120.61 0.243 . . . . 50.0 110.488 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -146.2 171.5 14.84 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 104.09 -2.559 . . . . 50.0 104.09 177.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -82.57 174.24 11.22 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.538 -0.541 . . . . 50.0 109.538 177.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -150.85 133.44 15.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.889 0.376 . . . . 50.0 111.74 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.9 t -101.3 120.07 50.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 105.197 -2.149 . . . . 25.0 105.197 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.05 137.49 49.03 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.644 -0.873 . . . . 25.0 108.644 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -116.02 15.27 16.16 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 122.266 1.031 . . . . 50.0 108.891 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 t -157.21 149.47 17.73 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.118 -0.946 . . . . 50.0 108.501 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -69.48 -16.43 38.73 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 117.326 -1.316 . . . . 50.0 113.006 175.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -78.58 -17.1 56.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.524 0.678 . . . . 50.0 109.805 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -98.52 138.21 36.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.599 -0.728 . . . . 50.0 110.904 -173.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.8 mt -89.69 130.77 35.93 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.787 0.804 . . . . 50.0 110.045 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.6 p -90.23 144.49 25.8 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 105.803 -1.925 . . . . 50.0 105.803 174.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -157.9 168.55 26.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.82 0.343 . . . . 50.0 110.268 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.55 161.1 16.04 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.318 0.58 . . . . 50.0 109.789 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -60.31 133.97 56.61 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.318 -0.994 . . . . 50.0 108.318 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.86 -15.46 63.33 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-O 119.079 -0.845 . . . . 50.0 113.69 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -58.41 136.6 57.49 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.553 0.692 . . . . 50.0 109.739 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.0 mm -103.74 127.44 57.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 106.393 -1.706 . . . . 50.0 106.393 176.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 19.5 ptp -131.79 153.62 49.94 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.188 -0.671 . . . . 50.0 109.188 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.1 m -89.33 127.83 35.83 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.046 -1.464 . . . . 25.0 107.046 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.9 t -97.01 122.97 49.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.955 -1.128 . . . . 50.0 107.955 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.0 mt -92.78 -45.22 8.12 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.272 -0.876 . . . . 50.0 109.521 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -147.15 161.18 41.41 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.384 -0.969 . . . . 50.0 108.384 -174.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -126.88 149.59 49.69 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.08 -1.452 . . . . 50.0 107.08 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 56.62 38.52 29.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 123.483 1.611 . . . . 50.0 108.452 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 t -63.03 146.71 52.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.339 -1.755 . . . . 25.0 110.01 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 59.44 13.42 3.22 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.482 0.919 . . . . 50.0 113.482 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.89 16.99 79.24 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 111.003 -0.839 . . . . 25.0 111.003 -178.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.428 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 60.3 mt -91.53 103.65 16.23 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.875 -0.787 . . . . 50.0 108.875 178.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -54.49 123.98 14.73 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.422 -0.808 . . . . 25.0 111.606 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.24 0.27 85.89 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 115.345 0.898 . . . . 50.0 115.345 176.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.428 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 95.0 m95 -100.95 130.73 46.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 118.523 1.162 . . . . 50.0 109.193 177.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -112.23 142.6 44.52 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 121.789 -0.569 . . . . 50.0 109.622 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.02 119.07 24.5 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 105.563 -2.014 . . . . 50.0 105.563 178.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 95.4 m -129.8 162.28 28.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.088 0.47 . . . . 50.0 112.095 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.1 t -111.97 113.38 25.65 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.522 -1.658 . . . . 50.0 106.522 172.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -143.6 136.79 27.83 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.84 -1.17 . . . . 50.0 107.84 -174.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 55.88 27.42 10.99 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.45 0.7 . . . . 25.0 112.803 -176.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.51 6.4 86.64 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 120.859 -0.686 . . . . 25.0 113.046 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -114.16 160.99 18.35 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.53 -1.285 . . . . 50.0 107.53 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -121.75 142.82 49.81 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 105.89 -1.892 . . . . 50.0 105.89 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.09 -158.34 20.71 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 105.461 -3.055 . . . . 50.0 105.461 -177.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.7 pt -118.5 154.23 20.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.493 0.663 . . . . 50.0 111.238 -175.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.42 146.26 41.47 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.069 -0.968 . . . . 50.0 109.347 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.24 117.7 5.21 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 CA-C-O 121.484 0.535 . . . . 50.0 112.189 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.95 -14.75 66.16 Favored Glycine 0 C--O 1.22 -0.767 0 O-C-N 122.079 -0.388 . . . . 50.0 113.202 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -64.23 -15.35 59.86 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.832 0.679 . . . . 50.0 112.832 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -131.21 29.55 4.62 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.348 0.594 . . . . 50.0 109.628 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.1 tp -133.63 148.41 51.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.845 -0.616 . . . . 50.0 109.972 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -127.87 120.12 27.07 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 111.984 0.365 . . . . 50.0 111.984 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.4 mm -69.18 135.47 28.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 123.458 0.474 . . . . 50.0 110.45 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.6 mt -120.85 96.66 5.2 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.951 0.9 . . . . 50.0 109.213 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 C--N 1.322 -0.602 0 N-CA-C 107.712 -1.218 . . . . 50.0 107.712 179.319 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.5 mttt . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 108.886 -0.783 . . . . 50.0 108.886 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 CA--C 1.539 0.763 0 C-N-CA 116.92 -1.587 . . . . 50.0 110.604 175.156 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 . . . . . 0 CA--C 1.508 -0.656 0 CA-C-O 120.893 0.378 . . . . 50.0 111.063 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.6 mt -68.3 -40.61 81.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.765 -0.828 . . . . 50.0 108.765 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 53.46 34.78 19.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.037 0.935 . . . . 50.0 111.58 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.0 m -93.38 -179.25 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 103.946 -2.613 . . . . 50.0 103.946 175.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.89 173.86 6.97 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.276 -0.89 . . . . 50.0 109.938 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.75 157.23 43.02 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.506 0.67 . . . . 25.0 109.598 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -116.96 129.95 56.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.177 -0.92 . . . . 50.0 109.875 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.97 128.09 35.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.091 -0.504 . . . . 25.0 109.666 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.64 -21.79 21.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.315 0.579 . . . . 50.0 111.188 -177.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -141.18 173.27 11.64 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.852 -1.166 . . . . 50.0 107.852 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -76.8 -179.07 5.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 124.113 0.883 . . . . 50.0 109.884 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.09 156.79 29.83 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.777 -0.823 . . . . 50.0 108.777 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.36 122.82 60.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 103.394 -2.817 . . . . 25.0 103.394 167.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.31 133.07 34.16 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.133 -1.062 . . . . 25.0 108.133 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -114.01 -23.56 9.49 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.027 0.441 . . . . 50.0 111.021 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -93.44 151.7 40.41 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.285 -1.006 . . . . 50.0 108.285 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.06 -18.88 30.64 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 116.545 -1.837 . . . . 50.0 111.835 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -85.71 -17.0 37.21 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.228 -0.896 . . . . 50.0 110.036 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -83.11 133.67 35.04 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.442 -0.787 . . . . 50.0 110.142 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.2 mt -84.02 132.86 34.7 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.961 0.41 . . . . 50.0 110.546 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 p -83.48 116.82 22.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.214 -1.032 . . . . 50.0 108.214 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -138.96 161.94 36.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.091 0.948 . . . . 50.0 112.491 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -119.23 166.62 12.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.975 -1.011 . . . . 50.0 108.73 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -61.87 131.61 50.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.882 -0.785 . . . . 50.0 108.882 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.62 -13.94 65.66 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-O 118.844 -0.975 . . . . 50.0 114.683 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.39 141.39 54.7 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 118.117 0.959 . . . . 50.0 108.908 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.6 mm -106.51 130.35 58.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 107.358 -1.349 . . . . 50.0 107.358 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.3 ptp -131.78 151.68 51.49 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 109.037 -0.727 . . . . 50.0 109.037 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.4 m -87.94 124.33 33.59 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 106.895 -1.521 . . . . 25.0 106.895 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.4 t -91.82 124.2 44.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 N-CA-C 108.418 -0.956 . . . . 50.0 108.418 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.6 mt -90.02 -47.56 7.76 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.765 -0.652 . . . . 50.0 109.411 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -156.9 175.72 13.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.737 -0.468 . . . . 50.0 109.737 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -127.95 156.2 43.04 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 106.219 -1.771 . . . . 50.0 106.219 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.4 t0 61.8 36.15 16.29 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.869 1.319 . . . . 50.0 108.218 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -66.7 144.71 56.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.772 -1.103 . . . . 25.0 108.58 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 57.64 15.25 2.76 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.604 0.964 . . . . 50.0 113.604 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.79 15.59 81.21 Favored Glycine 0 C--O 1.254 1.348 0 C-N-CA 121.335 -0.459 . . . . 25.0 112.076 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.416 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 98.0 mt -92.98 101.24 13.57 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 122.238 1.018 . . . . 50.0 108.69 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -60.11 121.7 12.56 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.592 -1.186 . . . . 25.0 110.206 -175.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.08 -2.44 85.43 Favored Glycine 0 C--N 1.318 -0.418 0 CA-C-O 119.06 -0.856 . . . . 50.0 115.139 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.416 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 93.0 m95 -99.17 139.14 35.26 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.388 1.094 . . . . 50.0 108.62 174.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -118.6 139.61 51.21 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.496 -1.298 . . . . 50.0 107.496 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.12 124.29 29.11 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 106.359 -1.719 . . . . 50.0 106.359 177.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 98.2 m -131.76 163.13 28.87 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.622 0.725 . . . . 50.0 109.975 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -117.91 120.25 37.29 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 104.966 -2.235 . . . . 50.0 104.966 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 tp -147.9 134.32 19.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.932 -0.766 . . . . 50.0 108.932 -175.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.3 m170 54.07 32.26 15.31 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.719 1.007 . . . . 25.0 113.719 174.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.73 5.01 86.96 Favored Glycine 0 C--O 1.224 -0.492 0 C-N-CA 120.452 -0.88 . . . . 25.0 114.867 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -120.06 158.83 26.01 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 107.816 -1.179 . . . . 50.0 107.816 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -111.88 154.55 25.02 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 102.95 -2.982 . . . . 50.0 102.95 166.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.25 -167.88 40.72 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 107.723 -2.151 . . . . 50.0 107.723 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 pt -113.03 151.74 14.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.65 0.738 . . . . 50.0 112.241 -175.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.7 m -143.79 147.12 37.45 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-N 114.722 -1.126 . . . . 50.0 110.235 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.38 118.48 5.37 Favored 'Trans proline' 0 C--O 1.244 0.797 0 O-C-N 121.946 0.445 . . . . 50.0 112.586 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.33 -15.13 65.3 Favored Glycine 0 C--O 1.221 -0.677 0 N-CA-C 114.664 0.626 . . . . 50.0 114.664 -176.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -63.67 -23.95 67.59 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 113.004 0.742 . . . . 50.0 113.004 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -118.34 28.39 8.38 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.393 -0.595 . . . . 50.0 109.393 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.1 tp -134.56 150.1 50.7 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.539 -0.755 . . . . 50.0 110.593 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -128.54 119.97 25.84 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.166 0.432 . . . . 50.0 112.166 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.8 mm -64.81 135.86 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.6 0.714 . . . . 50.0 111.33 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.1 mt -118.33 93.71 4.22 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.559 -1.275 . . . . 50.0 107.559 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.321 -0.67 0 N-CA-C 108.629 -0.878 . . . . 50.0 108.629 176.658 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 92.6 mttt . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 108.097 -1.075 . . . . 50.0 108.097 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.542 0.884 0 C-N-CA 118.093 -0.805 . . . . 50.0 110.986 174.922 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 . . . . . 0 C--O 1.224 -0.288 0 N-CA-C 116.345 1.98 . . . . 50.0 116.345 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.5 mt -76.48 -38.73 54.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.496 -1.229 . . . . 50.0 109.645 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.7 m120 54.35 24.96 5.5 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.329 1.052 . . . . 50.0 112.921 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.1 m -84.85 175.1 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 105.439 -2.059 . . . . 50.0 105.439 173.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.82 174.04 6.41 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.736 -0.603 . . . . 50.0 109.81 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.56 162.81 36.57 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.158 -0.474 . . . . 25.0 110.459 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -128.42 129.18 45.78 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.018 -0.992 . . . . 50.0 109.23 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.59 136.9 43.99 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.878 -0.601 . . . . 25.0 109.466 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.4 mt -104.82 -15.83 15.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 111.881 0.326 . . . . 50.0 111.881 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -143.15 165.35 27.67 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.976 -1.12 . . . . 50.0 107.976 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.93 165.03 25.01 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.638 -0.504 . . . . 50.0 109.638 174.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.04 159.91 42.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.104 -0.702 . . . . 50.0 109.104 177.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.01 121.79 56.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 104.866 -2.272 . . . . 25.0 104.866 171.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.82 134.73 33.63 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.462 -1.681 . . . . 25.0 106.462 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -114.35 -8.8 12.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.324 0.583 . . . . 50.0 111.166 -177.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.5 p -132.16 155.9 80.75 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 105.541 -2.022 . . . . 50.0 105.541 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.33 -18.31 39.08 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 118.03 -0.846 . . . . 50.0 112.266 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.48 -20.29 58.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.934 -0.576 . . . . 50.0 110.926 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -95.45 137.08 35.01 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.956 -1.127 . . . . 50.0 107.956 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.5 mt -86.26 134.53 33.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.886 -0.597 . . . . 50.0 109.947 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.06 130.45 34.61 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.232 -1.025 . . . . 50.0 108.232 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -154.27 163.36 40.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.916 0.865 . . . . 50.0 113.329 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -115.83 163.52 15.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.577 -1.192 . . . . 50.0 110.013 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -58.94 129.62 43.04 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.736 -0.839 . . . . 50.0 108.736 175.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.62 -11.04 72.01 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 118.831 -0.983 . . . . 50.0 114.634 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -63.21 150.34 43.26 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 118.39 1.095 . . . . 50.0 110.457 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.2 mm -115.57 131.28 68.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.37 -1.286 . . . . 50.0 108.917 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -135.37 156.02 49.62 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.214 -0.661 . . . . 50.0 109.214 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.1 m -87.63 130.17 34.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.177 -1.416 . . . . 25.0 107.177 176.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.8 t -94.24 124.32 46.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.643 -1.243 . . . . 50.0 107.643 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.2 mt -93.27 -44.98 8.05 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.948 -0.76 . . . . 50.0 108.948 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -149.43 162.25 40.48 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.961 -0.755 . . . . 50.0 108.961 -175.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 mtm105 -121.81 151.11 40.96 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.872 -1.159 . . . . 50.0 107.872 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 56.11 38.86 30.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 123.51 1.624 . . . . 50.0 108.853 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 t -67.1 153.37 43.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.11 -1.859 . . . . 25.0 110.438 -175.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 60.6 9.56 2.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.911 0.884 . . . . 50.0 113.261 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.36 10.84 84.1 Favored Glycine 0 C--N 1.329 0.17 0 N-CA-C 110.803 -0.919 . . . . 25.0 110.803 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.41 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 93.2 mt -88.42 109.44 20.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.853 -0.795 . . . . 50.0 108.853 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -58.6 126.26 26.87 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.588 -0.733 . . . . 25.0 110.983 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.65 -0.58 76.21 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 115.784 1.074 . . . . 50.0 115.784 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.41 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 94.3 m95 -100.89 129.99 46.83 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 119.028 1.414 . . . . 50.0 109.964 178.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -112.89 140.54 47.6 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 121.873 -0.517 . . . . 50.0 109.926 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.3 121.86 26.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 105.949 -1.871 . . . . 50.0 105.949 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 92.5 m -133.51 168.37 18.76 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.926 0.393 . . . . 50.0 111.583 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 t -123.42 125.77 45.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.747 -1.205 . . . . 50.0 107.747 173.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.0 tp -152.82 143.78 22.98 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.806 -1.553 . . . . 50.0 106.806 -176.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 55.69 31.97 18.44 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.153 0.581 . . . . 25.0 112.214 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.36 4.36 68.91 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 115.268 0.867 . . . . 25.0 115.268 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -124.75 165.72 17.47 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.069 -1.086 . . . . 50.0 108.069 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -116.28 154.37 30.28 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.669 -0.863 . . . . 50.0 108.669 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.53 -157.44 20.48 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 106.381 -2.688 . . . . 50.0 106.381 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.4 pt -120.65 157.34 23.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.618 0.723 . . . . 50.0 111.423 -176.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.87 147.12 37.21 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 114.763 -1.108 . . . . 50.0 109.146 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -74.51 117.7 5.06 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 O-C-N 121.999 0.473 . . . . 50.0 112.519 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.51 -19.5 68.93 Favored Glycine 0 C--O 1.22 -0.777 0 CA-C-O 121.422 0.457 . . . . 50.0 114.104 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -66.41 -10.33 42.66 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.552 0.945 . . . . 50.0 113.552 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -130.46 26.34 5.08 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.872 -0.788 . . . . 50.0 108.872 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.2 tp -131.77 150.05 52.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.282 -0.872 . . . . 50.0 111.595 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -121.26 126.67 50.14 Favored 'General case' 0 C--O 1.211 -0.931 0 C-N-CA 122.828 0.451 . . . . 50.0 110.932 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.2 mm -75.59 135.41 27.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.964 -0.754 . . . . 50.0 108.964 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.9 mt -116.66 107.18 14.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.023 -1.843 . . . . 50.0 106.023 174.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.931 -0.577 . . . . 50.0 110.228 -176.961 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 107.69 -1.226 . . . . 50.0 107.69 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo . . . . . 0 C--O 1.244 0.778 0 C-N-CA 117.848 -0.968 . . . . 50.0 111.472 176.886 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 . . . . . 0 CA--C 1.513 -0.476 0 CA-C-O 120.902 0.382 . . . . 50.0 111.389 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.02 -41.23 95.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.109 -0.951 . . . . 50.0 109.661 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 56.65 25.16 9.69 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.268 1.027 . . . . 50.0 111.912 -178.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.6 m -83.42 159.94 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 105.805 -1.924 . . . . 50.0 105.805 176.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.43 170.98 8.85 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.821 -1.177 . . . . 50.0 107.821 -177.207 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.13 163.15 36.25 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.941 -0.392 . . . . 25.0 109.941 175.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -132.21 128.76 38.64 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.621 -0.718 . . . . 50.0 109.669 177.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.26 130.73 42.8 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.496 -0.557 . . . . 25.0 109.496 177.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.9 mt -97.97 -21.86 16.61 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.693 0.282 . . . . 50.0 110.912 -177.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -138.97 165.91 25.87 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.676 -0.861 . . . . 50.0 108.676 178.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -74.58 165.95 24.35 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.03 0.932 . . . . 50.0 111.302 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.0 156.92 42.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.32 0.581 . . . . 50.0 110.861 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.6 t -130.26 125.7 60.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 102.926 -2.99 . . . . 25.0 102.926 170.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.19 136.81 33.11 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.558 -1.275 . . . . 25.0 107.558 178.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -128.6 6.26 5.66 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.294 0.569 . . . . 50.0 111.522 -178.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.2 m -127.63 151.36 75.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 105.82 -1.918 . . . . 50.0 105.82 176.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.62 -25.96 40.1 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 117.35 -1.3 . . . . 50.0 112.712 -177.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -79.29 -16.94 55.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.192 -0.458 . . . . 50.0 111.498 178.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -86.7 132.96 33.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.94 0.876 . . . . 50.0 109.247 -177.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.1 mt -87.07 133.4 33.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.736 -0.665 . . . . 50.0 110.567 -177.192 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.5 121.2 28.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.223 -0.899 . . . . 50.0 108.954 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -147.75 164.01 34.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.046 0.451 . . . . 50.0 111.022 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 55.8 ttt-85 -126.19 165.92 18.02 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.035 -0.728 . . . . 50.0 109.035 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -57.0 132.6 53.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.958 0.409 . . . . 50.0 110.493 -179.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.89 -16.5 61.16 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-O 119.122 -0.821 . . . . 50.0 113.929 178.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.98 151.37 26.38 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.837 0.827 . . . . 50.0 111.145 178.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.2 mm -117.99 131.39 70.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.067 -1.424 . . . . 50.0 108.917 -179.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -138.82 158.05 44.94 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 122.633 0.373 . . . . 50.0 110.202 179.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.3 m -89.91 130.19 36.16 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.689 -0.856 . . . . 25.0 108.689 177.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.3 t -94.53 126.04 47.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.551 -0.907 . . . . 50.0 108.551 178.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.8 mt -90.76 -51.47 5.35 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.097 -0.705 . . . . 50.0 109.097 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -151.84 171.47 17.68 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.04 -1.096 . . . . 50.0 108.04 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -121.9 155.2 35.94 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.049 -1.464 . . . . 50.0 107.049 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 58.17 39.24 26.15 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 123.794 1.759 . . . . 50.0 109.448 178.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.4 t -65.94 155.47 36.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 112.758 -2.019 . . . . 25.0 110.485 -176.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 60.11 9.62 1.92 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.185 0.994 . . . . 50.0 112.992 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.51 20.92 73.63 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.421 -1.071 . . . . 25.0 110.421 -176.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.6 mt -97.4 127.72 43.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.225 0.536 . . . . 50.0 110.279 178.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -67.16 124.08 22.09 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.673 -0.694 . . . . 25.0 110.857 178.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.06 -0.01 84.51 Favored Glycine 0 C--O 1.239 0.426 0 N-CA-C 116.392 1.317 . . . . 50.0 116.392 173.484 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -100.68 132.21 46.19 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 118.384 1.092 . . . . 50.0 109.453 178.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -113.07 141.98 46.26 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.183 -0.673 . . . . 50.0 109.183 -176.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.73 123.19 29.6 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 105.644 -1.984 . . . . 50.0 105.644 178.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 84.3 m -131.62 164.49 25.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.931 0.396 . . . . 50.0 110.741 177.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.0 t -118.85 123.33 44.45 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.771 -1.937 . . . . 50.0 105.771 172.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.1 tp -145.43 136.63 24.89 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.11 -1.071 . . . . 50.0 108.11 -176.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.64 27.69 12.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.885 0.698 . . . . 25.0 112.885 178.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.45 0.1 86.69 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 114.883 0.713 . . . . 25.0 114.883 177.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -124.71 158.63 32.76 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 118.124 0.962 . . . . 50.0 110.135 178.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -109.59 154.65 22.47 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.095 -0.706 . . . . 50.0 109.095 179.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.83 -160.73 28.17 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 107.288 -2.325 . . . . 50.0 107.288 179.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.2 pt -117.06 153.16 18.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.919 0.866 . . . . 50.0 112.534 -174.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.9 m -142.88 146.89 39.45 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 114.313 -1.312 . . . . 50.0 109.839 179.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.12 119.07 5.65 Favored 'Trans proline' 0 C--O 1.239 0.55 0 CA-C-O 121.296 0.457 . . . . 50.0 112.252 178.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.9 -25.33 74.28 Favored Glycine 0 C--O 1.219 -0.842 0 N-CA-C 116.72 1.448 . . . . 50.0 116.72 -174.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -65.19 -22.32 66.88 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.556 -0.967 . . . . 50.0 113.512 -177.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -110.61 24.63 12.72 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.617 0.722 . . . . 50.0 109.389 178.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.9 tp -133.29 150.72 51.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.367 -0.833 . . . . 50.0 109.968 -175.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -122.41 125.88 46.79 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-N 116.558 -0.292 . . . . 50.0 110.494 -179.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.2 mm -75.69 135.63 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.13 -1.063 . . . . 50.0 108.13 175.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.2 mt -118.6 88.72 2.98 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.577 -0.898 . . . . 50.0 108.577 177.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 C--N 1.325 -0.462 0 N-CA-C 108.837 -0.801 . . . . 50.0 108.837 178.77 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 106.976 -1.491 . . . . 50.0 106.976 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 CA--C 1.543 0.942 0 CA-C-N 118.748 0.589 . . . . 50.0 112.055 177.908 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 . . . . . 0 CA--C 1.511 -0.529 0 CA-C-O 120.975 0.417 . . . . 50.0 111.22 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.02 -38.85 89.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.141 -0.936 . . . . 50.0 110.132 178.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 55.86 36.34 27.11 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.933 0.893 . . . . 50.0 111.492 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 m -100.63 161.59 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 106.36 -1.718 . . . . 50.0 106.36 177.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.55 171.97 7.59 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.02 -1.104 . . . . 50.0 108.02 -177.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.75 164.82 34.23 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.694 -0.484 . . . . 25.0 109.694 174.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -128.4 136.22 50.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.105 -0.952 . . . . 50.0 108.712 177.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.18 136.43 42.83 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.799 0.333 . . . . 25.0 110.827 175.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.4 mt -100.6 -20.92 15.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.852 0.358 . . . . 50.0 110.781 -179.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -142.5 171.57 13.88 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 103.297 -2.853 . . . . 50.0 103.297 175.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -83.5 178.57 7.95 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.302 -0.999 . . . . 50.0 108.302 174.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -153.25 135.86 15.19 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.68 0.276 . . . . 50.0 111.108 175.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.8 t -106.04 120.86 57.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 104.946 -2.242 . . . . 25.0 104.946 174.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.6 134.01 46.11 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.37 -0.832 . . . . 25.0 109.394 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -107.53 3.81 25.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.676 0.75 . . . . 50.0 109.683 179.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.7 m -149.4 155.82 39.4 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 107.932 -1.136 . . . . 50.0 107.932 179.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.39 -19.67 32.85 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 118.398 -0.601 . . . . 50.0 113.491 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -15.96 55.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.158 0.504 . . . . 50.0 110.076 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -90.82 139.45 30.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.6 0.714 . . . . 50.0 109.13 -178.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.2 mt -92.06 127.78 37.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.767 0.794 . . . . 50.0 110.567 179.474 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.4 p -87.96 143.43 27.11 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 106.042 -1.836 . . . . 50.0 106.042 173.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -156.98 166.12 34.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.503 -0.925 . . . . 50.0 108.503 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.5 tpp85 -105.85 158.95 16.39 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.994 -0.743 . . . . 50.0 108.994 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -59.83 128.79 38.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.764 -0.653 . . . . 50.0 109.586 178.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.14 -4.45 81.04 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.117 -0.824 . . . . 50.0 114.356 177.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -62.71 160.65 13.8 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 117.885 0.843 . . . . 50.0 110.842 176.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.6 mm -119.93 134.79 62.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.643 -1.162 . . . . 50.0 109.49 178.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -139.85 163.43 32.66 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.736 -0.468 . . . . 50.0 109.736 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -97.45 129.49 44.64 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.508 -1.294 . . . . 25.0 107.508 176.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.5 t -96.28 122.94 48.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 107.773 -1.195 . . . . 50.0 107.773 177.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.7 mt -91.52 -42.85 10.02 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.164 -0.926 . . . . 50.0 109.267 -179.319 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -151.68 158.85 43.97 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.779 -0.823 . . . . 50.0 108.779 -176.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.8 mtm105 -116.11 153.84 31.04 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.642 -1.244 . . . . 50.0 107.642 175.011 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 56.22 37.54 28.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 123.383 1.563 . . . . 50.0 108.62 178.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.0 t -64.36 150.2 46.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.255 -1.793 . . . . 25.0 110.386 -174.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 59.47 13.85 3.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.636 0.774 . . . . 50.0 112.121 -178.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.71 18.22 79.78 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.294 -0.723 . . . . 25.0 111.294 -178.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.2 mt -91.55 121.15 32.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.274 0.537 . . . . 50.0 109.696 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -62.45 125.02 22.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.931 -0.577 . . . . 25.0 110.357 -179.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.4 -0.8 73.81 Favored Glycine 0 CA--C 1.519 0.292 0 N-CA-C 116.762 1.465 . . . . 50.0 116.762 175.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -100.1 130.03 46.2 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 119.149 1.475 . . . . 50.0 110.713 179.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -110.25 140.77 44.06 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.571 -0.529 . . . . 50.0 109.571 -177.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.98 120.8 24.66 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 105.628 -1.99 . . . . 50.0 105.628 177.428 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.401 ' HG ' HG22 ' A' ' 57' ' ' VAL . 84.5 m -132.2 164.79 25.56 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.099 0.407 . . . . 50.0 112.099 179.132 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.5 t -118.92 116.57 26.74 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.932 -1.507 . . . . 50.0 106.932 172.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -146.43 138.99 25.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.936 -1.135 . . . . 50.0 107.936 -175.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 56.96 27.37 13.05 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.94 0.719 . . . . 25.0 112.94 -178.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.65 5.98 89.17 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 121.012 -0.613 . . . . 25.0 113.421 178.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -116.23 154.39 30.19 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 108.308 -0.997 . . . . 50.0 108.308 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -108.3 145.19 34.76 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.058 -1.83 . . . . 50.0 106.058 170.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.36 -155.32 13.54 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 106.877 -2.489 . . . . 50.0 106.877 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.3 pt -123.97 152.86 29.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.449 0.643 . . . . 50.0 110.665 -175.362 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.401 HG22 ' HG ' ' A' ' 48' ' ' CYS . 2.8 m -139.63 147.31 51.43 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.148 -0.933 . . . . 50.0 108.626 -179.612 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.94 114.99 4.19 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 CA-C-O 121.379 0.491 . . . . 50.0 110.961 176.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.56 -17.12 68.48 Favored Glycine 0 C--O 1.222 -0.631 0 N-CA-C 114.304 0.482 . . . . 50.0 114.304 -175.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -63.76 -20.17 65.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.652 0.612 . . . . 50.0 112.652 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -116.48 27.18 9.37 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.746 -0.464 . . . . 50.0 109.746 177.214 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tp -130.34 158.01 41.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.309 0.576 . . . . 50.0 111.769 179.382 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -133.31 120.25 20.79 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.988 -0.551 . . . . 50.0 110.97 178.204 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mm -66.76 136.51 26.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.66 -0.496 . . . . 50.0 109.66 178.494 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.2 mt -117.04 104.58 11.4 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.463 -1.31 . . . . 50.0 107.463 175.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 120.855 0.359 . . . . 50.0 110.51 -178.833 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.2 mttt . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 109.651 -0.5 . . . . 50.0 109.651 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 CA--C 1.538 0.695 0 C-N-CA 118.419 -0.587 . . . . 50.0 112.913 178.556 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 CA--C 1.507 -0.698 0 CA-C-O 121.213 0.53 . . . . 50.0 110.444 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 71.4 mt -67.24 -39.28 86.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.783 -1.099 . . . . 50.0 109.901 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 57.4 29.33 16.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.053 0.941 . . . . 50.0 111.894 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.1 m -94.65 160.91 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 107.014 -1.476 . . . . 50.0 107.014 179.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.13 168.05 10.5 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.987 -1.116 . . . . 50.0 107.987 -178.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.06 156.07 42.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.784 0.326 . . . . 25.0 110.192 175.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -121.56 128.38 51.94 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.715 0.806 . . . . 50.0 110.127 178.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.63 131.58 45.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.498 -0.556 . . . . 25.0 109.498 176.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.1 mt -94.13 -21.28 19.2 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.064 -0.347 . . . . 50.0 110.064 -179.052 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -146.04 171.31 15.07 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.406 -1.701 . . . . 50.0 106.406 177.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -82.01 178.9 8.04 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.257 -0.645 . . . . 50.0 109.257 176.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.95 168.87 23.23 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 122.721 0.408 . . . . 50.0 110.125 176.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.5 t -128.02 129.88 69.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 104.149 -2.537 . . . . 25.0 104.149 171.238 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.88 119.38 23.85 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.78 -0.452 . . . . 25.0 109.78 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -103.68 8.93 37.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.322 0.582 . . . . 50.0 110.861 -177.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.9 m -152.89 155.66 32.36 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 106.827 -1.546 . . . . 50.0 106.827 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.02 -22.11 35.94 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 117.813 -0.991 . . . . 50.0 112.452 178.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.4 -20.72 56.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.239 -0.437 . . . . 50.0 110.516 178.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -85.89 126.75 34.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.769 0.795 . . . . 50.0 109.095 -176.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.1 mt -78.62 135.53 37.27 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.328 -0.99 . . . . 50.0 108.328 178.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.1 t -91.08 125.41 35.86 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.776 -1.194 . . . . 50.0 107.776 176.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -142.21 159.97 41.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.383 0.611 . . . . 50.0 111.531 -179.525 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.51 ' HD3' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -107.9 165.18 11.65 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.938 -0.764 . . . . 50.0 108.938 179.116 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.51 ' H ' ' HD3' ' A' ' 27' ' ' ARG . 87.4 tttt -61.29 129.05 39.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.64 -0.709 . . . . 50.0 109.52 178.459 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.26 -9.83 69.65 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-O 119.316 -0.713 . . . . 50.0 114.059 178.045 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -60.94 150.27 33.83 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.871 0.843 . . . . 50.0 110.92 179.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.3 mm -113.95 127.31 71.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.569 -1.196 . . . . 50.0 109.701 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.7 ptp -132.15 163.13 29.2 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.583 -0.525 . . . . 50.0 109.583 179.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.4 m -99.92 125.83 45.98 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.579 -1.267 . . . . 25.0 107.579 177.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.6 t -90.3 122.13 41.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.118 -1.067 . . . . 50.0 108.118 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.8 mt -90.3 -46.49 8.37 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.226 -0.897 . . . . 50.0 108.608 179.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.03 156.32 42.07 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.979 -0.378 . . . . 50.0 109.979 -176.015 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -111.98 152.01 28.61 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.891 -0.411 . . . . 50.0 109.891 174.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 55.97 39.49 30.53 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 123.6 1.667 . . . . 50.0 108.759 177.101 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.0 t -66.38 152.98 43.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 112.746 -2.024 . . . . 25.0 110.72 -175.174 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 60.39 9.1 1.85 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.227 1.011 . . . . 50.0 113.618 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.79 15.26 75.87 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 111.071 -0.812 . . . . 25.0 111.071 -176.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.8 mt -92.99 113.35 25.61 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.426 -0.583 . . . . 50.0 109.426 179.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.87 128.02 33.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.302 0.572 . . . . 25.0 110.005 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.97 0.35 85.17 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 115.813 1.085 . . . . 50.0 115.813 176.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -101.03 132.84 46.26 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 119.005 1.403 . . . . 50.0 110.415 178.402 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.6 m0 -112.36 138.68 48.74 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.171 -0.677 . . . . 50.0 109.171 -176.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.88 120.81 25.19 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 105.199 -2.148 . . . . 50.0 105.199 177.223 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.9 m -132.34 162.23 31.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.3 0.571 . . . . 50.0 112.488 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.5 t -116.9 123.72 47.69 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 105.987 -1.857 . . . . 50.0 105.987 172.012 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.4 tp -135.73 127.6 29.39 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.234 -1.395 . . . . 50.0 107.234 -177.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 29.4 m170 54.79 32.15 17.01 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.143 0.497 . . . . 25.0 112.241 178.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.35 -3.41 87.23 Favored Glycine 0 C--O 1.225 -0.462 0 N-CA-C 115.852 1.101 . . . . 25.0 115.852 176.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -114.35 157.25 23.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.677 -1.231 . . . . 50.0 107.677 177.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -117.21 154.68 30.71 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.374 -0.232 . . . . 50.0 110.374 -178.47 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.95 -157.11 21.92 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 106.127 -2.789 . . . . 50.0 106.127 178.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.8 pt -119.69 155.39 22.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 121.605 0.717 . . . . 50.0 111.39 -177.143 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.33 148.13 39.67 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.01 -0.995 . . . . 50.0 109.661 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.33 121.7 6.21 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 CA-C-O 121.545 0.56 . . . . 50.0 112.965 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.08 -18.25 70.75 Favored Glycine 0 C--O 1.22 -0.729 0 CA-C-N 116.114 -0.494 . . . . 50.0 114.155 -178.17 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -64.1 -17.2 63.2 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.394 0.516 . . . . 50.0 112.394 -177.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -127.33 30.29 5.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.116 0.484 . . . . 50.0 110.2 176.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.8 mt -129.79 156.38 44.42 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.811 -0.631 . . . . 75.0 111.769 177.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -128.98 125.92 38.44 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.161 -0.472 . . . . 50.0 110.125 176.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.6 mm -74.5 136.91 24.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.558 -0.904 . . . . 50.0 108.558 178.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.6 mt -111.92 77.93 1.08 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.147 0.579 . . . . 50.0 109.597 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.018 0 C-N-CA 123.434 0.693 . . . . 50.0 112.77 179.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt . . . . . 0 CA--C 1.543 0.676 0 N-CA-C 107.625 -1.25 . . . . 50.0 107.625 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo . . . . . 0 CA--C 1.542 0.892 0 O-C-N 122.097 0.525 . . . . 50.0 113.214 -177.445 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 121.062 0.458 . . . . 50.0 111.097 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.4 mt -66.05 -41.65 90.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.256 -0.884 . . . . 50.0 110.762 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.1 m120 55.34 24.36 6.49 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.277 1.031 . . . . 50.0 112.381 -177.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.6 m -83.29 175.35 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 N-CA-C 105.437 -2.06 . . . . 50.0 105.437 175.068 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -120.0 171.85 8.16 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 118.774 0.715 . . . . 50.0 109.951 -179.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.8 162.21 39.69 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.874 0.368 . . . . 25.0 110.354 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -122.24 132.04 54.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.141 -0.936 . . . . 50.0 110.494 178.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.08 128.05 34.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.95 0.405 . . . . 25.0 110.558 177.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.9 mt -98.81 -19.53 17.37 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.26 0.552 . . . . 50.0 110.985 -177.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -142.7 163.31 33.16 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 106.063 -1.829 . . . . 50.0 106.063 177.413 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -82.57 174.5 10.98 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.719 1.007 . . . . 50.0 113.719 -177.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -160.93 157.22 26.1 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 110.125 -0.324 . . . . 50.0 110.125 174.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.7 t -126.73 131.71 70.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 104.744 -2.317 . . . . 25.0 104.744 174.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.93 124.12 27.93 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 110.235 -0.283 . . . . 25.0 110.235 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -116.57 -12.61 10.93 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.054 0.93 . . . . 50.0 110.316 175.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 t -106.76 147.42 35.0 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 107.41 -1.33 . . . . 50.0 107.41 175.339 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.28 -23.74 44.54 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 116.444 -1.904 . . . . 50.0 114.695 -177.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -81.92 -13.16 57.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.086 0.47 . . . . 50.0 110.262 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -84.85 139.23 32.05 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.384 0.611 . . . . 50.0 111.508 -171.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.5 mt -93.1 131.06 38.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.596 0.713 . . . . 50.0 109.833 176.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.2 t -91.87 139.74 30.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.8 -1.556 . . . . 50.0 106.8 177.178 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -162.58 171.72 16.52 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.382 -0.97 . . . . 50.0 108.382 -177.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -126.75 168.03 14.96 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.769 0.795 . . . . 50.0 110.442 174.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.67 133.41 55.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.535 -0.757 . . . . 50.0 109.592 -176.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.96 -20.07 51.75 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 118.64 -1.089 . . . . 50.0 112.828 178.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -58.6 143.8 45.08 Favored 'General case' 0 C--O 1.249 1.056 0 CA-C-N 118.427 1.113 . . . . 50.0 110.645 179.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.6 mm -110.85 128.85 66.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.771 -1.104 . . . . 50.0 108.1 -178.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.7 ptp -132.89 149.41 52.25 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.725 0.41 . . . . 50.0 110.235 -177.384 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.0 m -85.48 126.11 33.57 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 107.541 -1.281 . . . . 25.0 107.541 179.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.43 124.5 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 107.904 -1.147 . . . . 50.0 107.904 178.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.8 mt -90.52 -47.8 7.48 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.723 -0.843 . . . . 50.0 108.723 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -153.69 173.88 15.23 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.426 0.631 . . . . 50.0 109.305 176.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -123.73 151.29 43.36 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.361 -1.718 . . . . 50.0 106.361 -179.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 57.37 43.4 23.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 123.27 1.509 . . . . 50.0 109.399 -176.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.7 t -66.55 149.46 50.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.629 -1.623 . . . . 25.0 110.349 -177.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 59.83 15.3 4.76 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.664 0.785 . . . . 50.0 112.642 178.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.81 14.62 82.18 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.903 -0.665 . . . . 25.0 112.187 -178.171 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.2 mt -94.36 113.68 25.61 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.342 -0.614 . . . . 50.0 109.342 -178.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -59.82 123.26 16.46 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.244 0.545 . . . . 25.0 110.734 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.76 -0.0 89.82 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-O 118.829 -0.984 . . . . 50.0 115.538 175.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -100.12 132.7 45.33 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 119.084 1.442 . . . . 50.0 109.335 177.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -113.08 140.03 48.2 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.592 -1.262 . . . . 50.0 107.592 -175.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.47 123.13 28.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.193 -2.151 . . . . 50.0 105.193 177.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 95.5 m -130.5 163.39 27.13 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.993 0.425 . . . . 50.0 111.408 178.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -116.2 126.9 54.28 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 106.318 -1.734 . . . . 50.0 106.318 173.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.2 tp -151.57 135.58 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.26 -1.015 . . . . 50.0 108.26 -175.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 54.23 30.13 11.81 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.654 0.983 . . . . 25.0 113.654 -178.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.18 6.18 88.92 Favored Glycine 0 C--O 1.22 -0.777 0 C-N-CA 120.936 -0.649 . . . . 25.0 113.919 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -114.82 161.32 18.37 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.499 -1.297 . . . . 50.0 107.499 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -120.26 146.48 46.03 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 106.016 -1.846 . . . . 50.0 106.016 174.067 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.22 -164.48 31.42 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 108.286 -1.926 . . . . 50.0 108.286 -179.372 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.8 pt -114.51 150.19 16.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.596 0.712 . . . . 50.0 112.053 -174.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.78 146.18 30.74 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 114.539 -1.21 . . . . 50.0 108.749 -179.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.23 122.17 6.94 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 118.383 -0.611 . . . . 50.0 112.393 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.81 -17.88 75.55 Favored Glycine 0 C--O 1.219 -0.789 0 N-CA-C 115.148 0.819 . . . . 50.0 115.148 -176.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -59.79 -21.13 60.4 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 113.221 0.823 . . . . 50.0 113.221 -177.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.26 26.3 6.92 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.526 0.679 . . . . 50.0 110.368 -178.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.2 mt -117.46 156.08 28.58 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 121.455 0.645 . . . . 50.0 110.365 175.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -119.14 122.81 42.88 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.507 -0.923 . . . . 50.0 108.507 173.438 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.8 mm -73.23 135.1 28.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.887 -1.153 . . . . 50.0 107.887 176.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt -115.23 97.2 6.06 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.825 -0.805 . . . . 50.0 108.825 178.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.322 -0.628 0 N-CA-C 109.13 -0.692 . . . . 50.0 109.13 178.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.6 mttp . . . . . 0 CA--C 1.549 0.941 0 N-CA-C 108.538 -0.912 . . . . 50.0 108.538 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 C--O 1.239 0.57 0 O-C-N 122.539 0.757 . . . . 50.0 111.932 175.681 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 . . . . . 0 C--O 1.225 -0.207 0 N-CA-C 116.614 2.079 . . . . 50.0 116.614 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 mt -71.97 -41.61 67.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.104 -1.407 . . . . 50.0 110.006 -179.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 56.5 26.5 11.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.343 1.057 . . . . 50.0 112.304 -178.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.4 m -85.86 158.52 3.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.338 -1.727 . . . . 50.0 106.338 177.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.38 172.81 7.97 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 108.77 -0.826 . . . . 50.0 108.77 -177.056 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.14 165.84 32.66 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.719 -0.475 . . . . 25.0 109.719 174.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -131.16 136.26 48.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.092 -0.958 . . . . 50.0 110.113 177.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.36 127.16 31.89 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.861 -0.609 . . . . 25.0 110.453 172.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.3 mt -93.79 -19.54 20.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.216 0.532 . . . . 50.0 110.247 -178.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -146.67 175.96 10.2 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 103.285 -2.857 . . . . 50.0 103.285 178.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -91.42 175.98 6.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 118.719 0.69 . . . . 50.0 111.41 177.553 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -154.59 144.27 21.55 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.678 0.391 . . . . 50.0 111.106 177.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 80.0 t -113.38 125.25 70.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.5 -2.037 . . . . 25.0 105.5 176.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.46 131.41 41.77 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.057 -0.974 . . . . 25.0 109.6 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -104.98 -1.99 25.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.593 0.711 . . . . 50.0 109.934 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -147.07 156.77 46.94 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.167 -1.049 . . . . 50.0 108.167 -177.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.85 -19.7 40.34 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 118.309 -0.661 . . . . 50.0 112.729 177.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -72.96 -16.9 61.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.292 -0.413 . . . . 50.0 111.04 177.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -100.37 142.29 32.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.734 0.778 . . . . 50.0 110.887 -172.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.0 mt -95.3 127.03 41.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.458 -0.792 . . . . 50.0 109.884 179.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.7 p -87.17 145.91 26.23 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 105.31 -2.107 . . . . 50.0 105.31 173.198 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -159.59 165.09 33.52 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.113 -1.069 . . . . 50.0 108.113 -179.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.47 161.76 17.57 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.483 0.658 . . . . 50.0 110.063 177.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -56.99 129.4 41.54 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.509 -0.769 . . . . 50.0 110.48 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.58 -16.41 59.78 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-O 118.941 -0.922 . . . . 50.0 113.603 177.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -58.55 155.21 12.7 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.924 0.869 . . . . 50.0 111.525 179.459 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.0 mm -118.97 135.57 58.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.225 -1.352 . . . . 50.0 109.262 179.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -141.71 156.35 45.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.307 -0.627 . . . . 50.0 109.307 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.9 m -91.15 129.42 37.15 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.179 -1.045 . . . . 25.0 108.179 177.274 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.3 t -94.14 124.97 46.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.121 -1.066 . . . . 50.0 108.121 177.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.9 mt -93.69 -43.48 8.63 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.501 -0.772 . . . . 50.0 109.555 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -149.38 165.16 32.88 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.318 -0.993 . . . . 50.0 108.318 -175.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -126.64 153.32 45.52 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 107.045 -1.465 . . . . 50.0 107.045 176.112 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 56.48 39.43 29.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 123.477 1.608 . . . . 50.0 109.088 -179.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -69.27 155.38 40.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.207 -1.815 . . . . 25.0 110.477 -176.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 60.16 11.45 2.77 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.918 0.887 . . . . 50.0 113.209 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.08 16.93 79.11 Favored Glycine 0 CA--C 1.516 0.135 0 N-CA-C 110.9 -0.88 . . . . 25.0 110.9 -177.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.6 mt -98.18 114.53 26.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.02 0.438 . . . . 50.0 109.999 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -63.58 127.68 32.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.889 -0.596 . . . . 25.0 109.927 -178.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.74 -0.58 85.94 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 115.505 0.962 . . . . 50.0 115.505 176.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -100.86 130.03 46.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 118.565 1.182 . . . . 50.0 109.825 177.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -111.27 140.0 46.2 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.77 -0.456 . . . . 50.0 109.77 -175.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.78 120.88 24.65 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 105.585 -2.006 . . . . 50.0 105.585 178.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 86.0 m -131.52 163.55 27.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.966 0.412 . . . . 50.0 111.716 178.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.8 t -118.87 124.59 47.51 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.706 -1.59 . . . . 50.0 106.706 173.117 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.0 tp -151.72 142.71 23.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.779 -1.193 . . . . 50.0 107.779 -175.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 57.49 27.17 13.61 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.324 0.583 . . . . 25.0 112.235 177.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.62 4.49 90.36 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 114.859 0.703 . . . . 25.0 114.859 178.337 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -130.24 161.02 32.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.091 0.945 . . . . 50.0 109.43 179.432 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -107.89 153.29 23.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.221 -0.659 . . . . 50.0 109.221 177.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.95 -154.3 11.8 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 107.291 -2.324 . . . . 50.0 107.291 177.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.5 pt -124.69 153.22 31.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.378 0.609 . . . . 50.0 110.582 -175.729 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 m -140.48 146.27 44.4 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 114.945 -1.025 . . . . 50.0 108.799 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.68 120.89 6.03 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 118.53 -0.514 . . . . 50.0 112.033 178.426 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.4 -17.05 70.1 Favored Glycine 0 C--O 1.222 -0.652 0 C-N-CA 121.576 -0.345 . . . . 50.0 113.191 -178.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -66.88 -6.91 18.26 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.944 0.72 . . . . 50.0 112.944 -179.282 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -135.79 26.63 3.34 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.577 -0.527 . . . . 50.0 109.577 175.282 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.6 tp -130.09 157.15 43.19 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 121.3 0.571 . . . . 50.0 111.603 -179.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -129.68 123.2 30.58 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.964 -0.562 . . . . 50.0 110.768 177.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.0 mm -70.09 135.93 27.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.797 -0.816 . . . . 50.0 108.797 176.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.7 mt -119.68 102.54 8.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.652 -1.24 . . . . 50.0 107.652 176.053 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--N 1.322 -0.626 0 N-CA-C 109.074 -0.713 . . . . 50.0 109.074 179.576 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 107.534 -1.284 . . . . 50.0 107.534 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 CA--C 1.54 0.799 0 O-C-N 121.952 0.449 . . . . 50.0 112.753 -178.122 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 . . . . . 0 CA--C 1.508 -0.648 0 N-CA-C 108.89 -0.781 . . . . 50.0 108.89 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.4 mt -68.01 -39.2 83.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.366 -0.833 . . . . 50.0 110.492 178.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 57.88 28.58 16.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.142 0.977 . . . . 50.0 111.871 -179.138 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 m -94.79 176.12 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 105.416 -2.068 . . . . 50.0 105.416 176.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -119.74 174.11 6.63 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.999 -0.741 . . . . 50.0 108.999 177.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.44 154.34 36.42 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.189 -0.3 . . . . 25.0 110.189 177.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -111.27 130.89 55.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.924 -0.58 . . . . 50.0 110.172 178.574 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.93 117.67 12.74 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.223 -0.658 . . . . 25.0 109.223 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.6 mt -83.62 -25.64 30.65 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.28 0.562 . . . . 50.0 109.885 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -139.74 164.15 30.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.587 -1.188 . . . . 50.0 108.081 177.771 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.26 178.34 5.87 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 124.285 0.99 . . . . 50.0 112.782 -179.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -155.12 158.37 38.91 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.756 0.312 . . . . 50.0 111.269 172.037 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.0 t -127.51 129.11 70.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 104.13 -2.545 . . . . 25.0 104.13 173.37 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.68 135.91 33.96 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -115.51 -15.6 11.45 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.615 0.721 . . . . 50.0 109.653 175.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.4 t -112.55 146.72 35.57 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 106.396 -1.705 . . . . 50.0 106.396 179.737 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.65 -16.68 42.59 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 117.822 -0.985 . . . . 50.0 113.391 177.816 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -80.73 -18.02 49.16 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.24 1.019 . . . . 50.0 110.58 177.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -86.0 136.06 33.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.72 0.772 . . . . 50.0 111.716 -177.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.9 mt -86.08 127.55 34.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.734 -0.666 . . . . 50.0 110.575 179.515 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.2 t -89.95 132.83 35.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.809 -1.182 . . . . 50.0 107.809 174.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -160.02 172.78 16.91 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.154 -1.054 . . . . 50.0 108.154 -176.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.56 170.4 8.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 122.386 1.088 . . . . 50.0 111.545 178.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.33 135.87 57.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.709 -1.132 . . . . 50.0 109.437 -179.639 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.26 -9.04 78.44 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 118.67 -1.072 . . . . 50.0 113.782 179.155 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -63.78 143.51 57.78 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 118.703 1.251 . . . . 50.0 109.233 174.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.6 mm -106.31 130.86 57.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 106.877 -1.527 . . . . 50.0 106.877 178.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.7 ptp -134.69 146.54 49.56 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.358 0.263 . . . . 50.0 110.294 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -83.13 127.29 33.46 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.161 -1.051 . . . . 25.0 108.161 179.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -94.21 124.65 46.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.164 -1.05 . . . . 50.0 108.164 -179.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.0 mt -94.8 -45.81 7.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.787 -0.642 . . . . 50.0 109.893 -179.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -151.18 159.98 44.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.571 -0.9 . . . . 50.0 108.571 -175.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -118.85 148.96 42.32 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.985 -1.117 . . . . 50.0 107.985 177.108 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 56.68 38.95 29.91 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 123.374 1.559 . . . . 50.0 109.401 -179.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -64.88 150.02 48.49 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 113.129 -1.85 . . . . 25.0 110.91 -176.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 58.97 11.91 2.13 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.644 0.979 . . . . 50.0 113.644 180.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.13 10.33 84.99 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 110.958 -0.857 . . . . 25.0 110.958 -178.33 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.2 mt -86.5 106.99 17.9 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.15 -1.056 . . . . 50.0 108.15 179.226 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.45 125.07 22.68 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.234 -0.893 . . . . 25.0 110.064 -176.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.12 -0.12 89.93 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-O 118.879 -0.956 . . . . 50.0 115.236 178.056 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -101.3 132.6 46.76 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 118.944 1.372 . . . . 50.0 110.638 177.385 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -110.66 140.89 44.59 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.795 -0.817 . . . . 50.0 108.795 -178.481 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.67 121.83 26.86 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.58 -2.007 . . . . 50.0 105.58 178.534 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.419 ' HG ' HG21 ' A' ' 57' ' ' VAL . 96.4 m -132.02 163.93 27.32 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.852 0.686 . . . . 50.0 112.852 179.57 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.0 t -117.43 127.1 53.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.331 -1.359 . . . . 50.0 107.331 174.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tp -140.62 124.7 17.42 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.899 -0.778 . . . . 50.0 108.899 -177.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 54.65 35.03 22.8 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.581 0.585 . . . . 25.0 112.581 -179.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.48 0.33 89.96 Favored Glycine 0 C--O 1.222 -0.601 0 N-CA-C 115.61 1.004 . . . . 25.0 115.61 176.03 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -119.73 159.64 24.12 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 107.464 -1.31 . . . . 50.0 107.464 176.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -117.58 159.6 22.63 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.874 -0.787 . . . . 50.0 108.874 -178.134 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.62 -159.18 27.84 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 105.327 -3.109 . . . . 50.0 105.327 179.259 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.3 pt -119.53 153.66 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.818 0.818 . . . . 50.0 112.253 -176.232 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.419 HG21 ' HG ' ' A' ' 48' ' ' CYS . 3.5 m -144.21 148.22 40.43 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.767 -1.106 . . . . 50.0 108.991 -179.311 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.1 125.19 7.75 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 117.259 -1.361 . . . . 50.0 112.133 -178.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.59 -17.33 76.38 Favored Glycine 0 C--O 1.219 -0.825 0 N-CA-C 114.982 0.753 . . . . 50.0 114.982 -175.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.59 -23.71 63.17 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.106 1.15 . . . . 50.0 114.106 -176.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.12 27.21 7.71 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.567 0.698 . . . . 50.0 110.375 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mt -114.65 155.15 27.11 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 121.339 0.59 . . . . 50.0 110.387 173.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -125.4 118.82 26.7 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 115.344 -0.844 . . . . 50.0 108.981 174.194 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.54 135.84 27.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.561 -0.533 . . . . 50.0 109.561 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.2 mt -115.46 105.37 12.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.525 -2.028 . . . . 50.0 105.525 175.776 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 120.959 0.409 . . . . 50.0 110.449 -177.349 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 108.255 -1.017 . . . . 50.0 108.255 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo . . . . . 0 CA--C 1.544 1.0 0 O-C-N 122.255 0.608 . . . . 50.0 112.775 -179.156 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 . . . . . 0 C--O 1.222 -0.391 0 CA-C-O 120.924 0.393 . . . . 50.0 112.026 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.14 -38.46 69.23 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 115.006 -0.997 . . . . 50.0 109.554 178.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.3 m120 53.37 39.3 29.66 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.295 1.045 . . . . 50.0 112.513 -179.469 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 m -103.11 168.34 2.24 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 N-CA-C 105.558 -2.015 . . . . 50.0 105.558 176.012 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.88 171.85 7.1 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.551 -1.277 . . . . 50.0 107.551 -177.408 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.67 162.27 37.94 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.974 -0.75 . . . . 25.0 108.974 174.649 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -128.18 130.48 48.1 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 123.673 0.789 . . . . 50.0 111.144 175.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.08 130.8 43.11 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 123.783 0.677 . . . . 25.0 109.882 177.045 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.3 mt -97.83 -22.06 16.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.938 0.399 . . . . 50.0 111.241 -178.094 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -141.17 170.01 16.53 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 106.912 -1.514 . . . . 50.0 106.912 178.124 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -76.12 165.73 24.5 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 122.78 0.432 . . . . 50.0 111.146 176.325 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -146.98 150.36 34.98 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.743 -0.598 . . . . 50.0 111.831 174.606 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.02 126.76 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 N-CA-C 105.697 -1.964 . . . . 25.0 105.697 178.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.46 122.82 30.15 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.758 -0.46 . . . . 25.0 109.758 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -104.03 14.03 31.42 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.985 0.898 . . . . 50.0 110.338 -179.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 t -156.47 149.45 18.41 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 106.321 -1.733 . . . . 50.0 106.321 -178.133 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -69.74 -16.4 37.62 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 117.152 -1.432 . . . . 50.0 112.55 175.457 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.28 -21.88 58.18 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.08 -0.711 . . . . 50.0 109.08 176.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -89.25 139.38 30.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.961 0.886 . . . . 50.0 109.338 -178.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.5 mt -90.14 129.48 36.41 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.848 0.833 . . . . 50.0 110.257 179.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.08 134.44 33.83 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.442 -1.688 . . . . 50.0 106.442 178.042 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -154.04 161.97 41.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.831 0.287 . . . . 50.0 111.559 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.71 162.04 17.34 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.722 -1.214 . . . . 50.0 107.722 -179.273 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.19 129.97 44.68 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.974 -0.557 . . . . 50.0 109.8 179.198 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.36 -13.9 63.99 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 119.039 -0.867 . . . . 50.0 114.151 179.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -59.77 148.68 33.47 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-N 117.92 0.86 . . . . 50.0 111.07 177.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.5 mm -118.84 129.8 74.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.31 -1.313 . . . . 50.0 109.043 -179.002 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -136.16 155.45 50.13 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.336 -0.987 . . . . 50.0 108.336 -178.196 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.7 m -88.83 124.39 34.12 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.385 -0.598 . . . . 25.0 109.385 177.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.1 t -87.43 125.08 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 108.424 -0.954 . . . . 50.0 108.424 177.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.4 mt -91.0 -46.29 8.23 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.364 -1.347 . . . . 50.0 107.364 178.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -155.87 170.7 21.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.646 -0.872 . . . . 50.0 108.646 177.438 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.9 mtm105 -117.37 154.57 31.08 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.25 -1.759 . . . . 50.0 106.25 177.067 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 59.05 42.97 18.22 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 125.478 1.736 . . . . 50.0 109.192 179.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -70.83 157.37 38.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.005 -1.452 . . . . 25.0 110.372 -176.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 60.15 10.08 2.14 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.019 0.928 . . . . 50.0 113.363 177.786 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.4 20.62 68.87 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.762 -0.732 . . . . 25.0 111.572 -176.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 70.6 mt -102.49 122.84 45.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.58 0.229 . . . . 50.0 111.287 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.57 123.63 17.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.256 0.551 . . . . 25.0 111.02 177.522 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.81 -0.24 82.87 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 116.131 1.212 . . . . 50.0 116.131 172.444 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -99.49 131.12 45.71 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 118.879 1.34 . . . . 50.0 109.427 177.705 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -110.65 143.45 41.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.729 -0.841 . . . . 50.0 108.729 -176.045 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.15 123.06 30.22 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 106.21 -1.774 . . . . 50.0 106.21 178.407 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.2 m -132.24 166.88 20.86 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.868 -0.333 . . . . 50.0 110.848 178.048 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -118.13 122.03 42.05 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.735 -1.58 . . . . 50.0 106.735 173.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.6 tp -150.58 140.02 21.44 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.79 -0.818 . . . . 50.0 108.79 -177.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.9 m170 57.5 30.77 19.23 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.628 0.771 . . . . 25.0 110.934 -179.534 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.89 0.03 87.68 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 115.381 0.912 . . . . 25.0 115.381 176.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -124.6 158.25 33.5 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 118.006 0.903 . . . . 50.0 110.148 179.266 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -102.1 149.58 24.12 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 106.564 -1.643 . . . . 50.0 106.564 178.661 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.89 -167.49 36.59 Favored Glycine 0 N--CA 1.433 -1.535 0 N-CA-C 107.825 -2.11 . . . . 50.0 107.825 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.6 pt -111.18 153.14 12.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.646 0.736 . . . . 50.0 111.574 -173.364 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.7 m -143.01 142.95 23.12 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.146 -0.934 . . . . 50.0 109.464 179.334 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.08 124.06 8.8 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 118.374 -0.617 . . . . 50.0 112.065 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.32 -12.3 79.86 Favored Glycine 0 C--O 1.221 -0.706 0 C-N-CA 120.83 -0.7 . . . . 50.0 114.505 -176.155 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -71.45 -7.85 50.03 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.084 0.772 . . . . 50.0 113.084 -176.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -132.16 27.23 4.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.666 -0.864 . . . . 50.0 108.666 178.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.3 tp -134.1 149.55 51.11 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.424 -0.807 . . . . 75.0 111.739 -174.116 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -128.17 123.02 33.31 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.38 0.272 . . . . 50.0 111.628 -178.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.9 mm -67.98 136.66 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.225 -0.657 . . . . 50.0 109.225 176.845 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.7 mt -118.43 100.96 7.8 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.396 -1.335 . . . . 50.0 107.396 175.293 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.318 -0.792 0 N-CA-C 107.669 -1.234 . . . . 50.0 107.669 177.244 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.0 mttt . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 108.7 -0.852 . . . . 50.0 108.7 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo . . . . . 0 C--O 1.238 0.481 0 C-N-CA 115.575 -2.483 . . . . 50.0 111.176 173.263 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 . . . . . 0 C--O 1.236 0.388 0 CA-C-O 121.686 0.755 . . . . 50.0 112.502 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.87 -42.21 90.62 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.869 -0.789 . . . . 50.0 108.869 176.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.6 m120 51.6 46.74 26.05 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.783 0.802 . . . . 50.0 110.407 -178.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 m -109.26 166.7 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 104.348 -2.464 . . . . 50.0 104.348 176.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.84 172.16 6.99 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.469 -1.308 . . . . 50.0 107.469 -176.436 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.86 158.61 43.46 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.927 -0.397 . . . . 25.0 109.927 173.455 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -124.88 129.66 50.83 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.417 -0.81 . . . . 50.0 109.817 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.77 130.53 42.57 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.271 -0.64 . . . . 25.0 109.271 178.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.7 mt -95.29 -20.72 18.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.543 -0.299 . . . . 50.0 111.472 -177.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -145.96 170.36 16.78 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.31 -0.996 . . . . 50.0 108.31 -179.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -73.93 160.4 31.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.598 -0.519 . . . . 50.0 109.598 177.041 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -145.97 154.37 41.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.838 0.352 . . . . 50.0 110.724 172.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 p -132.39 136.06 56.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 105.398 -2.075 . . . . 25.0 105.398 178.483 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.94 139.57 33.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.081 -0.509 . . . . 25.0 111.06 -175.192 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -121.68 9.3 10.14 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.577 0.703 . . . . 50.0 109.662 178.177 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 t -148.85 151.02 34.19 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 105.867 -1.901 . . . . 50.0 105.867 -177.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -67.52 -21.69 45.9 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 117.799 -1.0 . . . . 50.0 113.024 178.708 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.32 -17.57 58.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.961 0.41 . . . . 50.0 111.197 178.516 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -89.76 134.38 34.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.927 0.87 . . . . 50.0 111.866 -172.267 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.6 mt -89.08 126.24 35.36 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.266 -0.879 . . . . 50.0 110.822 178.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -86.94 141.31 28.81 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.021 -1.844 . . . . 50.0 106.021 174.082 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.13 168.07 28.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.757 0.313 . . . . 50.0 110.634 -177.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -116.33 162.9 16.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.224 0.535 . . . . 50.0 110.105 178.388 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.48 134.55 57.12 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.744 -0.662 . . . . 50.0 109.466 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.99 -12.73 68.75 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 116.132 -0.486 . . . . 50.0 113.014 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -62.46 138.98 58.57 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.692 -0.855 . . . . 50.0 108.692 177.761 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.1 mm -105.86 132.77 52.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.936 -1.029 . . . . 50.0 108.385 177.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.1 ptp -139.33 152.05 46.88 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.711 -0.478 . . . . 50.0 109.711 -178.446 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 m -89.76 123.11 33.47 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.515 -0.92 . . . . 25.0 108.515 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.97 125.81 41.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 108.847 -0.797 . . . . 50.0 108.847 178.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.8 mt -91.68 -47.77 7.19 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.4 -0.963 . . . . 50.0 108.4 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -155.37 173.88 16.03 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 110.308 -0.256 . . . . 50.0 110.308 178.443 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.9 mtm105 -123.74 157.96 32.77 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 106.029 -1.841 . . . . 75.0 106.029 176.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.8 t0 59.43 40.26 21.01 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 123.419 1.581 . . . . 50.0 107.449 -177.349 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -68.82 144.51 54.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.114 -1.403 . . . . 25.0 107.787 -177.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 59.8 12.28 2.92 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.899 0.88 . . . . 50.0 113.241 -179.276 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.29 16.83 79.01 Favored Glycine 0 C--N 1.331 0.265 0 N-CA-C 111.465 -0.654 . . . . 25.0 111.465 -178.231 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.3 mt -94.36 105.1 17.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.183 -0.673 . . . . 50.0 109.183 179.101 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -58.53 130.15 45.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 122.03 0.919 . . . . 25.0 110.807 -177.749 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.7 -6.35 70.16 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.085 -0.961 . . . . 50.0 115.037 178.009 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -95.83 139.26 32.3 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 118.944 1.372 . . . . 50.0 109.306 176.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 34.6 m0 -118.88 142.88 47.34 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.756 -1.201 . . . . 50.0 107.756 -176.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.71 121.83 28.94 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 105.308 -2.108 . . . . 50.0 105.308 178.888 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.1 m -130.97 157.62 42.46 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.333 0.587 . . . . 50.0 111.907 179.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.5 t -107.46 123.62 48.66 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 105.849 -1.908 . . . . 50.0 105.849 171.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 tp -144.61 135.08 24.5 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.83 -0.804 . . . . 50.0 108.83 -176.074 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 56.73 27.22 12.37 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 176.334 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.6 4.53 82.85 Favored Glycine 0 C--O 1.228 -0.275 0 N-CA-C 114.417 0.527 . . . . 25.0 114.417 178.481 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -131.78 162.09 31.34 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.959 0.879 . . . . 50.0 109.496 178.602 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -110.38 155.07 22.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.207 -0.664 . . . . 50.0 109.207 179.516 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.98 -163.49 31.16 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 106.832 -2.507 . . . . 50.0 106.832 176.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.9 pt -111.77 153.44 13.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 121.671 0.748 . . . . 50.0 110.157 -177.35 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -141.26 145.0 36.56 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.09 -0.959 . . . . 50.0 109.33 179.186 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.17 121.12 6.98 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 CA-C-O 121.659 0.608 . . . . 50.0 111.372 178.417 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.81 -9.21 74.72 Favored Glycine 0 C--O 1.218 -0.846 0 C-N-CA 121.131 -0.557 . . . . 50.0 114.056 -176.218 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -66.43 -17.02 64.55 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.337 -0.507 . . . . 50.0 112.091 -178.073 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -128.2 26.56 5.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.748 -0.66 . . . . 50.0 109.414 -177.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.2 tp -132.99 145.0 50.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.532 0.682 . . . . 50.0 109.973 -176.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -122.72 120.28 33.17 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.504 -0.771 . . . . 50.0 111.425 -177.112 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.2 mm -67.73 134.39 30.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 O-C-N 123.663 0.602 . . . . 50.0 109.652 177.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.3 mt -117.74 99.65 7.08 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.067 -1.827 . . . . 50.0 106.067 174.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 C--N 1.322 -0.622 0 CA-C-O 121.03 0.443 . . . . 50.0 109.848 -177.594 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.0 mttt . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 110.147 -0.316 . . . . 50.0 110.147 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--O 1.244 0.807 0 C-N-CA 117.137 -1.442 . . . . 50.0 110.757 172.333 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 . . . . . 0 CA--C 1.517 -0.299 0 N-CA-C 113.071 0.767 . . . . 50.0 113.071 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.6 mt -63.96 -38.72 92.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.984 -1.007 . . . . 50.0 110.83 179.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 52.61 41.87 31.35 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.267 1.032 . . . . 50.0 110.87 -179.661 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.0 m -103.29 173.23 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 102.97 -2.974 . . . . 50.0 102.97 174.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -118.4 172.61 7.34 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 118.649 0.658 . . . . 50.0 109.401 -178.346 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.43 160.26 43.6 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.918 -0.583 . . . . 25.0 109.533 176.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -118.84 133.09 56.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.101 -0.954 . . . . 50.0 108.863 177.023 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.91 126.28 29.33 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 173.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.8 mt -88.63 -22.29 23.54 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.433 -0.58 . . . . 50.0 109.433 -178.698 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -144.05 175.17 10.24 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 105.116 -2.179 . . . . 50.0 105.116 179.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -86.47 -179.99 6.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 118.15 0.432 . . . . 50.0 109.937 175.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -154.99 143.56 20.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.111 0.481 . . . . 50.0 111.721 174.652 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.6 t -107.26 123.9 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 105.084 -2.191 . . . . 25.0 105.084 175.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.99 121.67 22.32 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.274 -1.01 . . . . 25.0 108.274 178.394 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -110.97 -2.06 16.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.647 0.737 . . . . 50.0 109.197 -179.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.3 m -129.34 152.6 79.78 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 107.55 -1.278 . . . . 50.0 107.55 179.083 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.92 -20.55 33.91 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 118.352 -0.632 . . . . 50.0 113.363 -179.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -16.94 46.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.925 -0.579 . . . . 50.0 110.383 179.565 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -87.19 139.82 30.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.627 0.727 . . . . 50.0 111.602 -172.476 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.8 mt -91.88 129.86 37.76 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.69 0.757 . . . . 50.0 109.75 177.336 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.34 142.48 27.85 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 105.708 -1.96 . . . . 50.0 105.708 173.327 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -156.41 167.72 29.58 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.788 -0.449 . . . . 50.0 109.788 -179.037 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.62 161.56 17.29 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.676 0.75 . . . . 50.0 111.142 -179.079 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -56.89 127.19 30.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.993 -1.003 . . . . 50.0 109.71 178.275 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.23 -11.77 70.01 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-O 119.093 -0.837 . . . . 50.0 114.682 178.01 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.51 138.82 54.72 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 118.18 0.99 . . . . 50.0 111.63 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.1 mm -102.28 130.22 52.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.194 -1.039 . . . . 50.0 108.194 175.333 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.0 ptp -135.65 153.28 51.68 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.439 -0.578 . . . . 50.0 109.439 -178.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.0 m -88.8 128.21 35.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.25 -1.389 . . . . 25.0 107.25 178.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -94.22 121.67 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 107.421 -1.326 . . . . 50.0 107.421 178.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.4 mt -91.7 -43.66 9.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.157 -0.929 . . . . 50.0 109.947 -177.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -152.2 162.6 40.89 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.483 -1.303 . . . . 50.0 107.483 -177.037 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -124.7 153.56 42.15 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.203 -1.036 . . . . 50.0 108.203 176.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 55.8 40.17 30.7 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 123.731 1.729 . . . . 50.0 108.393 -178.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -70.36 158.96 35.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 112.95 -1.932 . . . . 25.0 110.57 -175.457 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 60.87 8.32 1.8 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.112 0.965 . . . . 50.0 113.389 179.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.85 17.85 74.05 Favored Glycine 0 CA--C 1.517 0.174 0 N-CA-C 110.551 -1.019 . . . . 25.0 110.551 -176.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.3 mt -99.51 123.3 43.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.007 0.432 . . . . 50.0 110.397 -179.535 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -64.78 129.69 40.73 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.06 -0.518 . . . . 25.0 110.456 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.13 -0.75 66.29 Favored Glycine 0 C--O 1.24 0.488 0 N-CA-C 116.617 1.407 . . . . 50.0 116.617 174.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -100.5 129.99 46.52 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 118.692 1.246 . . . . 50.0 109.736 178.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -111.65 140.07 46.58 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.74 -0.467 . . . . 50.0 109.74 -175.776 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.45 120.48 24.51 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.237 -1.764 . . . . 50.0 106.237 178.541 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.8 m -131.41 163.75 27.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.096 0.474 . . . . 50.0 111.884 178.683 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.9 t -120.03 123.95 44.69 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.062 -1.458 . . . . 50.0 107.062 173.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.8 tp -148.61 136.59 20.87 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.823 -0.806 . . . . 50.0 108.823 -176.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 56.17 26.98 10.91 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.551 1.315 . . . . 25.0 114.551 174.758 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.36 8.97 84.37 Favored Glycine 0 C--O 1.227 -0.297 0 C-N-CA 121.006 -0.616 . . . . 25.0 113.197 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -119.9 157.52 28.58 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.127 -1.064 . . . . 50.0 108.127 178.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -122.22 147.79 45.76 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 105.353 -2.091 . . . . 50.0 105.353 173.107 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.26 -155.59 17.25 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 107.201 -2.36 . . . . 50.0 107.201 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.9 pt -122.37 149.53 25.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 121.396 0.617 . . . . 50.0 111.05 -174.581 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.6 m -138.22 147.2 54.86 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.087 -0.96 . . . . 50.0 109.166 -178.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.84 119.12 5.73 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 O-C-N 122.037 0.493 . . . . 50.0 112.272 178.539 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.39 -18.65 69.84 Favored Glycine 0 C--O 1.223 -0.575 0 C-N-CA 121.226 -0.511 . . . . 50.0 113.429 -178.275 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -64.18 -17.98 64.04 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.202 0.815 . . . . 50.0 113.202 -178.428 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -122.58 27.29 7.9 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.343 0.592 . . . . 50.0 109.628 177.022 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 tp -128.77 157.62 40.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 50.0 111.757 -179.618 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -131.37 120.03 22.52 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.067 -0.515 . . . . 50.0 110.869 177.339 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.7 mm -69.32 136.95 25.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.293 -0.632 . . . . 50.0 109.293 178.739 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.7 mt -115.55 91.82 3.72 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.713 -1.218 . . . . 50.0 107.713 177.103 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 113.353 0.871 . . . . 50.0 113.353 -176.599 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 107.617 -1.253 . . . . 50.0 107.617 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 C--N 1.347 0.478 0 C-N-CA 117.698 -1.068 . . . . 50.0 111.557 -179.024 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 116.769 2.137 . . . . 50.0 116.769 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.6 mt -79.33 -42.07 26.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.082 -0.963 . . . . 50.0 110.568 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 56.42 27.08 11.54 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.414 1.085 . . . . 50.0 112.287 -178.441 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.7 m -86.53 170.94 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 104.441 -2.429 . . . . 50.0 104.441 174.061 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mp -116.33 172.78 6.97 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.033 -0.729 . . . . 50.0 109.033 179.407 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.04 155.17 42.0 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.731 -0.47 . . . . 25.0 109.731 177.292 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -114.02 131.05 56.5 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.535 -0.757 . . . . 50.0 109.553 176.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.15 127.13 32.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.133 -0.692 . . . . 25.0 109.133 174.171 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.6 mt -92.44 -23.14 19.26 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.939 -0.393 . . . . 50.0 109.939 -178.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -143.16 167.06 23.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.059 -1.089 . . . . 50.0 108.059 -179.159 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -75.73 166.22 23.87 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 122.668 0.387 . . . . 50.0 111.824 177.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -145.57 156.83 43.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.968 0.413 . . . . 50.0 111.373 174.252 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.9 t -123.5 122.62 65.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 105.239 -2.134 . . . . 25.0 105.239 173.51 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.23 127.58 32.87 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.363 -0.977 . . . . 25.0 108.363 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -113.17 12.98 19.18 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.961 0.886 . . . . 50.0 109.52 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 t -152.08 147.44 19.79 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 106.3 -1.741 . . . . 50.0 106.3 -179.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.98 -23.6 67.73 Favored 'Trans proline' 0 C--N 1.347 0.456 0 O-C-N 122.23 0.595 . . . . 50.0 113.079 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -76.26 -21.12 56.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.343 0.592 . . . . 50.0 110.351 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -88.29 130.74 35.03 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.241 -1.022 . . . . 50.0 108.241 -178.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.2 mt -81.76 133.18 35.32 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.697 0.76 . . . . 50.0 109.803 179.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.39 125.09 34.54 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.331 -0.989 . . . . 50.0 108.331 177.568 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -145.43 164.36 31.79 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 120.972 0.415 . . . . 50.0 110.445 -179.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.35 167.73 12.01 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.334 0.587 . . . . 50.0 110.086 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -58.83 130.43 46.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.342 -0.844 . . . . 50.0 109.44 -179.092 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.26 -12.15 69.42 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-O 118.504 -1.164 . . . . 50.0 114.938 177.172 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -59.97 150.01 30.23 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.439 1.119 . . . . 50.0 111.483 177.523 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.2 mm -114.81 127.06 72.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.61 -1.177 . . . . 50.0 108.642 177.283 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.8 ptp -132.74 151.06 52.08 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.293 -0.632 . . . . 50.0 109.293 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -84.82 130.35 34.68 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.247 -1.02 . . . . 25.0 108.247 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.8 t -98.18 121.14 48.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.534 -0.913 . . . . 50.0 108.534 179.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.7 mt -87.7 -46.81 9.17 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.972 -0.558 . . . . 50.0 109.66 -179.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -155.01 171.11 20.27 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.115 -0.698 . . . . 50.0 109.115 178.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -117.66 157.81 25.78 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.323 -1.362 . . . . 50.0 107.323 177.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 57.63 37.93 27.57 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 125.127 1.517 . . . . 50.0 109.85 177.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 t -66.45 152.11 45.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.847 -1.524 . . . . 25.0 110.612 -175.529 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 60.97 6.89 1.32 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.362 1.065 . . . . 50.0 112.766 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.59 12.7 74.65 Favored Glycine 0 C--O 1.224 -0.472 0 N-CA-C 111.414 -0.674 . . . . 25.0 111.414 -177.094 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.2 mt -88.08 125.02 34.35 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.745 -0.465 . . . . 50.0 109.745 179.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -64.53 124.79 22.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.699 0.285 . . . . 25.0 110.272 178.085 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.69 -0.63 76.26 Favored Glycine 0 C--O 1.242 0.596 0 N-CA-C 116.68 1.432 . . . . 50.0 116.68 172.568 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -96.67 135.8 38.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.885 1.343 . . . . 50.0 108.984 179.002 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -111.36 144.32 40.75 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.858 -0.793 . . . . 50.0 108.858 -178.14 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.92 120.49 26.15 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 104.524 -2.398 . . . . 50.0 104.524 176.572 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 93.2 m -129.17 163.03 26.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 121.006 -0.278 . . . . 50.0 111.503 179.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.5 t -116.79 123.84 48.12 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.292 -1.373 . . . . 50.0 107.292 173.619 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.7 tp -146.49 129.1 16.08 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 108.571 -0.9 . . . . 50.0 108.571 -176.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 27.7 m170 55.91 32.7 20.25 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.412 0.523 . . . . 25.0 112.412 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.71 3.15 86.93 Favored Glycine 0 C--O 1.222 -0.64 0 C-N-CA 120.816 -0.707 . . . . 25.0 113.987 178.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 mtt-85 -111.1 153.95 24.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.575 -1.269 . . . . 50.0 107.575 178.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -120.41 147.15 45.45 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 106.683 -1.599 . . . . 50.0 106.683 175.038 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.73 -158.46 22.21 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 106.997 -2.441 . . . . 50.0 106.997 -177.433 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.5 pt -115.36 153.01 16.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.75 0.786 . . . . 50.0 111.572 -175.205 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.5 m -144.47 146.37 32.41 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 114.797 -1.092 . . . . 50.0 109.191 179.348 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.07 114.5 4.06 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 CA-C-O 121.609 0.587 . . . . 50.0 112.175 178.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.19 -17.74 68.43 Favored Glycine 0 C--O 1.221 -0.683 0 N-CA-C 114.551 0.58 . . . . 50.0 114.551 -177.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -65.06 -15.21 62.1 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.722 0.638 . . . . 50.0 112.722 -178.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -123.44 26.24 7.95 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.755 -0.59 . . . . 50.0 110.239 176.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.3 mt -125.88 156.95 38.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.594 0.711 . . . . 75.0 110.949 178.207 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -127.92 119.05 24.74 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.255 -0.884 . . . . 50.0 110.531 177.446 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.0 mm -66.8 133.53 31.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 O-C-N 123.797 0.686 . . . . 50.0 109.531 178.4 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.1 mt -114.3 94.04 4.62 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.712 -1.218 . . . . 50.0 107.712 175.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 121.498 0.666 . . . . 50.0 109.973 176.712 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 95.4 mttt . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 106.51 -1.663 . . . . 50.0 106.51 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--O 1.241 0.661 0 C-N-CA 117.384 -1.278 . . . . 50.0 110.959 176.973 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 . . . . . 0 CA--C 1.512 -0.488 0 CA-C-O 120.864 0.364 . . . . 50.0 110.402 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.0 mt -67.87 -40.25 83.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.752 -0.658 . . . . 50.0 109.655 177.836 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.5 m120 55.75 24.7 7.54 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.972 -1.013 . . . . 50.0 112.787 -178.48 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.1 m -84.57 158.19 3.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.519 -1.289 . . . . 50.0 107.519 177.754 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.48 167.74 11.13 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.781 -0.822 . . . . 50.0 108.781 -177.175 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.29 158.76 44.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.991 0.424 . . . . 25.0 110.427 175.665 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -123.79 132.25 53.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.065 -0.971 . . . . 50.0 109.601 -179.808 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.23 132.18 40.91 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.376 -0.601 . . . . 25.0 109.376 177.274 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.5 mt -100.43 -17.4 17.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.42 -0.355 . . . . 50.0 110.388 -179.514 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -145.56 169.95 17.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 104.598 -2.371 . . . . 50.0 104.598 177.951 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -89.44 177.36 6.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.578 0.626 . . . . 50.0 110.618 176.175 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -154.44 136.4 14.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.971 -0.559 . . . . 50.0 110.492 175.297 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.7 t -104.35 121.36 55.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 104.643 -2.354 . . . . 25.0 104.643 175.368 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.22 135.69 49.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.413 -0.812 . . . . 25.0 109.253 -179.029 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -113.1 9.09 18.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.64 0.733 . . . . 50.0 109.271 -178.472 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 t -156.17 152.75 24.04 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.347 -0.842 . . . . 50.0 108.82 -175.577 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -70.31 -19.05 33.99 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 117.941 -0.906 . . . . 50.0 114.312 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.95 -17.01 56.19 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.481 -0.563 . . . . 50.0 109.481 178.048 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -93.74 142.33 27.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.515 0.674 . . . . 50.0 111.107 -175.729 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.7 mt -94.69 131.96 39.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.682 0.753 . . . . 50.0 110.102 178.959 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.5 p -90.94 140.17 30.07 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 105.882 -1.896 . . . . 50.0 105.882 174.661 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -156.05 164.91 37.84 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 120.806 0.336 . . . . 50.0 110.251 -179.325 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -108.53 158.58 17.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.037 0.922 . . . . 50.0 109.473 179.171 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -57.64 133.91 55.72 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.842 -1.072 . . . . 50.0 109.645 175.363 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.79 -12.32 70.14 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-O 119.022 -0.877 . . . . 50.0 113.644 178.655 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -60.67 146.44 45.61 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 118.116 0.958 . . . . 50.0 110.721 178.187 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.0 mm -110.86 129.23 66.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 107.935 -1.135 . . . . 50.0 107.935 177.6 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.3 ptp -136.79 165.97 24.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.999 -0.741 . . . . 50.0 108.999 -179.091 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -103.81 123.61 47.39 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.752 -0.833 . . . . 25.0 108.752 178.761 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.7 t -88.2 124.41 41.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.698 -1.223 . . . . 50.0 107.698 177.668 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.7 mt -93.68 -43.56 8.59 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.133 -0.939 . . . . 50.0 108.929 -179.667 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -148.49 155.16 40.81 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 106.784 -1.562 . . . . 50.0 106.784 -172.798 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -118.87 154.35 33.06 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 106.241 -1.763 . . . . 50.0 106.241 173.957 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 58.16 37.7 26.32 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 123.477 1.608 . . . . 50.0 108.324 178.638 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -68.46 159.43 31.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.043 -1.89 . . . . 25.0 111.018 -175.933 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 59.31 12.1 2.47 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.795 1.035 . . . . 50.0 113.795 177.131 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.36 18.35 78.14 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 110.628 -0.989 . . . . 25.0 110.628 -177.213 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.7 mt -104.07 115.94 31.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.069 0.462 . . . . 50.0 109.859 -179.454 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -66.25 131.12 45.4 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 -178.239 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.93 -1.56 78.69 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 115.427 0.931 . . . . 50.0 115.427 176.175 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -99.85 132.55 45.13 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 118.866 1.333 . . . . 50.0 109.014 177.059 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -113.09 139.26 48.86 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.429 -0.582 . . . . 50.0 109.429 -175.961 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.54 122.5 27.11 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 106.08 -1.822 . . . . 50.0 106.08 179.684 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 92.9 m -132.81 163.25 29.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.28 0.562 . . . . 50.0 112.288 178.634 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -115.37 127.98 55.77 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.16 -1.793 . . . . 50.0 106.16 171.248 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.8 tp -154.9 141.22 18.62 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 107.244 -1.391 . . . . 50.0 107.244 -175.343 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 55.91 26.99 10.41 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 112.651 0.612 . . . . 25.0 112.651 178.384 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.06 4.53 88.83 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 114.711 0.644 . . . . 25.0 114.711 178.733 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -126.64 161.4 28.16 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.501 -0.926 . . . . 50.0 108.501 -179.677 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -112.89 156.73 22.44 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.92 -1.141 . . . . 50.0 107.92 179.045 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.89 -161.24 30.66 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 106.509 -2.636 . . . . 50.0 106.509 179.521 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.6 pt -117.36 153.99 19.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.327 0.584 . . . . 50.0 111.878 -175.871 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.81 148.63 46.78 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 114.974 -1.012 . . . . 50.0 109.141 -179.023 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.18 122.42 7.11 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 CA-C-O 121.612 0.588 . . . . 50.0 112.799 -179.799 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.08 -24.44 67.05 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 116.308 -0.406 . . . . 50.0 113.739 -178.431 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -24.1 65.46 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.391 -0.476 . . . . 50.0 112.036 179.049 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -105.65 11.86 31.76 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.938 0.347 . . . . 50.0 111.938 -179.543 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.0 mt -121.78 152.5 39.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.704 1.24 . . . . 75.0 113.946 -177.539 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -120.36 123.53 43.32 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 113.687 -1.597 . . . . 50.0 108.812 176.004 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.0 mm -76.59 138.33 20.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.64 -0.874 . . . . 50.0 108.64 179.103 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.5 mt -117.38 88.06 2.83 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.966 -1.494 . . . . 50.0 106.966 176.7 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.1 m . . . . . 0 C--N 1.325 -0.489 0 CA-C-O 121.0 0.428 . . . . 50.0 109.998 -179.77 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt . . . . . 0 CA--C 1.534 0.342 0 N-CA-C 105.755 -1.943 . . . . 50.0 105.755 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo . . . . . 0 CA--C 1.538 0.684 0 C-N-CA 117.83 -0.98 . . . . 50.0 112.647 -175.98 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 . . . . . 0 CA--C 1.51 -0.586 0 CA-C-O 121.231 0.538 . . . . 50.0 110.539 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.21 -40.59 86.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.896 -1.047 . . . . 50.0 109.139 176.797 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.0 m120 54.99 30.47 14.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.138 0.975 . . . . 50.0 111.906 -178.136 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.7 m -89.22 164.77 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 106.362 -1.718 . . . . 50.0 106.362 175.862 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.37 173.49 6.42 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.68 -1.23 . . . . 50.0 107.68 -178.893 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.9 157.76 43.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.661 0.267 . . . . 25.0 110.42 174.865 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -122.71 130.74 53.29 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.648 -0.705 . . . . 50.0 109.781 175.962 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.54 129.64 38.76 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.01 -0.541 . . . . 25.0 109.549 175.71 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.0 mt -94.42 -21.76 18.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.914 0.388 . . . . 50.0 110.859 -178.006 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -143.95 169.41 17.87 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.993 -2.225 . . . . 50.0 104.993 177.856 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -84.03 167.74 16.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.131 0.491 . . . . 50.0 110.407 177.332 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -148.53 130.9 15.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.934 -0.575 . . . . 50.0 110.341 179.257 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.0 t -102.93 123.46 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 105.078 -2.193 . . . . 25.0 105.078 176.16 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.91 135.74 51.5 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.522 -1.217 . . . . 25.0 110.072 179.558 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -113.98 0.46 14.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.337 0.589 . . . . 50.0 110.284 -179.551 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.0 m -145.6 155.34 52.97 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 107.966 -1.124 . . . . 50.0 107.966 -177.421 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.34 -17.71 39.35 Favored 'Trans proline' 0 C--N 1.347 0.468 0 N-CA-C 113.805 0.656 . . . . 50.0 113.805 -177.415 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.91 -16.99 39.26 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.234 0.54 . . . . 50.0 110.22 179.003 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -87.45 136.03 33.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.98 0.895 . . . . 50.0 111.754 -175.605 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.3 mt -86.19 130.79 34.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.746 -0.661 . . . . 50.0 109.4 178.96 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.8 t -91.46 137.15 32.59 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.458 -2.053 . . . . 50.0 105.458 175.025 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -156.46 164.79 37.83 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.924 -0.399 . . . . 50.0 109.924 -177.86 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.49 162.53 15.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.514 0.673 . . . . 50.0 110.465 -177.496 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -57.32 128.39 36.76 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.163 -0.926 . . . . 50.0 109.131 176.165 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.57 -15.67 61.67 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 118.752 -1.027 . . . . 50.0 114.728 178.197 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -59.08 146.19 39.46 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.993 0.897 . . . . 50.0 111.139 -178.845 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.0 mm -110.57 134.17 53.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.448 -1.251 . . . . 50.0 108.627 178.72 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.9 ptp -141.58 157.69 44.78 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.439 0.296 . . . . 50.0 110.334 -177.961 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.5 m -92.27 130.88 37.86 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.531 -0.914 . . . . 25.0 108.531 177.232 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.95 129.6 45.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.322 -0.992 . . . . 50.0 108.322 177.527 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.2 mt -94.43 -52.47 4.32 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.827 -0.805 . . . . 50.0 108.827 -179.671 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -149.99 163.91 36.86 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.902 -1.147 . . . . 50.0 107.902 177.822 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -106.81 157.44 17.75 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 109.672 -0.492 . . . . 50.0 109.672 176.474 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 56.02 39.58 30.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 123.526 1.632 . . . . 50.0 108.859 170.319 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.9 t -64.42 152.29 41.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 112.474 -2.148 . . . . 25.0 110.677 -176.502 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 59.78 11.65 2.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.207 1.003 . . . . 50.0 113.104 -179.595 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.75 20.29 79.56 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.686 -0.965 . . . . 25.0 110.686 -177.402 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.2 mt -94.69 118.89 32.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.293 -1.003 . . . . 50.0 108.293 177.953 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -64.72 128.31 35.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.923 -0.581 . . . . 25.0 110.396 -177.882 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.74 -0.75 70.01 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 115.932 1.133 . . . . 50.0 115.932 176.274 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -99.61 129.98 45.8 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 119.181 1.491 . . . . 50.0 109.59 177.93 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -113.88 141.32 47.49 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.916 -0.772 . . . . 50.0 108.916 -176.149 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.68 120.31 24.95 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.14 -1.8 . . . . 50.0 106.14 179.473 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.401 ' HG ' HG21 ' A' ' 57' ' ' VAL . 88.8 m -133.77 167.78 19.91 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.005 0.431 . . . . 50.0 111.578 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.4 t -120.33 116.54 25.73 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.463 -1.31 . . . . 50.0 107.463 173.826 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -146.03 144.85 30.33 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.441 -1.318 . . . . 50.0 107.441 -175.902 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.55 27.24 15.39 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.378 0.671 . . . . 25.0 112.334 -179.555 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.95 4.84 90.44 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 114.657 0.623 . . . . 25.0 114.657 177.705 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.1 ptt85 -132.82 161.04 35.18 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.067 0.934 . . . . 50.0 109.775 179.379 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -102.6 154.24 19.32 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.282 -0.636 . . . . 50.0 109.282 177.02 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.24 -158.02 22.46 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 106.54 -2.624 . . . . 50.0 106.54 178.297 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.8 pt -118.39 151.64 20.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.542 0.687 . . . . 50.0 110.877 -175.297 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.401 HG21 ' HG ' ' A' ' 48' ' ' CYS . 2.4 m -140.8 146.96 46.46 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 114.931 -1.032 . . . . 50.0 108.85 -179.113 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.91 122.59 5.89 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 118.31 -0.66 . . . . 50.0 112.284 179.235 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.21 -14.87 64.64 Favored Glycine 0 C--O 1.223 -0.581 0 CA-C-N 116.11 -0.495 . . . . 50.0 112.821 -179.703 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.73 -28.26 63.72 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 122.957 0.503 . . . . 50.0 112.346 179.693 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.57 25.42 9.77 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.556 0.217 . . . . 50.0 111.51 178.869 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.4 tp -128.57 144.13 51.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.636 0.731 . . . . 50.0 111.611 -174.626 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -119.59 119.98 35.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.332 -0.849 . . . . 50.0 110.935 -177.921 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.0 mm -68.96 134.93 29.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.212 -0.662 . . . . 50.0 109.212 177.509 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.5 mt -117.91 105.17 11.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.675 -1.602 . . . . 50.0 106.675 176.215 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--N 1.322 -0.616 0 CA-C-O 120.965 0.412 . . . . 50.0 110.001 -178.833 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 107.423 -1.325 . . . . 50.0 107.423 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 CA--C 1.54 0.807 0 C-N-CA 118.339 -0.64 . . . . 50.0 111.791 178.023 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 121.676 0.751 . . . . 50.0 112.632 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.2 mt -70.58 -33.25 70.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.483 -0.78 . . . . 50.0 111.724 -176.292 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.8 m120 60.33 17.85 7.47 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.322 1.049 . . . . 50.0 113.257 -178.752 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.2 m -91.26 162.78 2.38 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 N-CA-C 108.845 -0.798 . . . . 50.0 108.845 -179.649 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.79 172.66 6.81 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.713 -1.217 . . . . 50.0 107.713 -178.633 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.52 161.19 42.62 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.197 -0.668 . . . . 25.0 109.197 173.264 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -125.87 131.72 52.31 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 123.808 0.693 . . . . 50.0 110.722 179.22 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.73 122.01 18.33 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 124.015 0.822 . . . . 25.0 110.215 177.513 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.2 mt -89.47 -24.07 21.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.234 0.54 . . . . 50.0 109.855 -178.115 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -138.58 174.27 10.72 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 103.101 -2.925 . . . . 50.0 103.101 175.876 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -85.38 -179.87 7.03 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.635 -0.876 . . . . 50.0 108.635 175.417 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -155.33 147.54 23.72 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 122.865 0.466 . . . . 50.0 109.804 174.127 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.5 t -116.27 123.57 71.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.677 -1.601 . . . . 25.0 106.677 175.992 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.78 145.22 25.73 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.497 -0.774 . . . . 25.0 109.501 177.773 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.15 -7.67 6.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.924 -0.58 . . . . 50.0 111.02 178.322 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 m -119.76 154.65 55.07 Favored Pre-proline 0 C--O 1.22 -0.448 0 N-CA-C 108.406 -0.961 . . . . 50.0 108.406 178.931 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.11 -24.95 38.03 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 117.563 -1.158 . . . . 50.0 114.323 -178.444 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.06 -16.84 57.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.31 0.576 . . . . 50.0 110.459 179.223 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -91.72 135.73 33.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.358 0.599 . . . . 50.0 110.602 -173.861 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.9 mt -95.37 128.33 42.13 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.958 0.885 . . . . 50.0 111.109 -179.112 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 t -90.44 143.61 26.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.141 -1.8 . . . . 50.0 106.141 176.841 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -158.03 168.24 27.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.104 0.478 . . . . 50.0 110.871 -179.446 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -114.18 159.5 20.03 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.168 -0.679 . . . . 50.0 109.168 178.041 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -57.83 132.05 52.17 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.339 -1.356 . . . . 50.0 107.339 176.348 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.71 -20.58 47.5 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-O 119.521 -0.599 . . . . 50.0 113.606 179.034 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -59.46 145.81 42.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.73 0.776 . . . . 50.0 110.84 178.885 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.3 mm -115.11 128.79 72.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.517 -1.219 . . . . 50.0 108.524 179.868 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -131.2 152.78 50.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.458 -0.201 . . . . 50.0 110.458 179.209 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.7 m -87.43 126.97 35.21 Favored 'General case' 0 C--O 1.218 -0.603 0 N-CA-C 107.823 -1.177 . . . . 25.0 107.823 177.537 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.74 128.58 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 CA-C-O 121.968 0.89 . . . . 50.0 108.807 179.362 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.7 mt -97.36 -46.09 6.22 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.005 -0.998 . . . . 50.0 108.779 179.631 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.07 158.58 44.14 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.956 -0.757 . . . . 50.0 108.956 -175.844 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -118.29 148.51 42.38 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 106.743 -1.576 . . . . 50.0 106.743 174.924 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 57.17 43.32 24.15 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 123.319 1.533 . . . . 50.0 109.832 -177.912 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -72.04 160.91 31.68 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 113.491 -1.686 . . . . 25.0 112.204 -176.134 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 59.68 9.83 1.76 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.177 0.991 . . . . 50.0 113.234 178.264 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.88 14.81 76.73 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.657 -0.977 . . . . 25.0 110.657 -176.185 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.0 mt -99.58 123.14 43.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.538 0.685 . . . . 50.0 110.565 -179.112 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -70.11 125.38 26.61 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.96 -1.018 . . . . 25.0 110.486 179.18 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.94 -1.41 88.6 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 115.43 0.932 . . . . 50.0 115.43 176.208 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -100.98 131.37 46.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 118.159 0.98 . . . . 50.0 109.796 178.45 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -110.73 142.45 42.65 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.179 -0.675 . . . . 50.0 109.179 -177.176 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.52 121.11 27.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 105.176 -2.157 . . . . 50.0 105.176 178.157 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.1 m -134.37 165.96 23.93 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.963 0.411 . . . . 50.0 111.171 179.087 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 t -121.48 123.08 41.17 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.011 -1.477 . . . . 50.0 107.011 173.165 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.9 tp -135.25 122.0 20.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.873 -0.788 . . . . 50.0 108.873 -177.728 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.2 m170 54.01 33.91 18.58 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.522 0.729 . . . . 25.0 111.548 179.799 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.74 -6.53 83.55 Favored Glycine 0 C--O 1.227 -0.314 0 N-CA-C 115.252 0.861 . . . . 25.0 115.252 177.44 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -101.98 137.22 40.55 Favored 'General case' 0 C--O 1.219 -0.553 0 CA-C-N 118.449 1.124 . . . . 50.0 108.403 176.147 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -99.9 145.02 28.27 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.406 -1.702 . . . . 50.0 106.406 173.93 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.73 -161.48 27.37 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 108.368 -1.893 . . . . 50.0 108.368 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.1 pt -115.41 149.89 17.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.603 0.716 . . . . 50.0 110.759 -175.847 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.8 m -139.32 146.63 49.51 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 114.871 -1.059 . . . . 50.0 108.824 -179.092 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.82 119.79 6.06 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 CA-C-O 121.487 0.536 . . . . 50.0 111.626 177.933 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.02 -15.3 74.14 Favored Glycine 0 C--O 1.226 -0.372 0 CA-C-O 121.649 0.583 . . . . 50.0 113.048 -178.466 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -67.46 -6.89 21.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.299 0.64 . . . . 50.0 112.672 -178.849 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -135.48 28.32 3.35 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.711 -0.478 . . . . 50.0 109.711 176.108 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.3 mt -125.32 156.25 38.96 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.352 0.871 . . . . 50.0 113.352 177.839 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -128.09 120.18 26.88 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.969 -1.014 . . . . 50.0 110.075 174.435 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.7 mm -66.95 137.25 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.581 -0.896 . . . . 50.0 108.581 176.62 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.4 mt -117.57 107.51 14.34 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.817 -1.179 . . . . 50.0 107.817 176.491 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--N 1.322 -0.619 0 N-CA-C 109.636 -0.505 . . . . 50.0 109.636 178.94 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 107.715 -1.217 . . . . 50.0 107.715 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 CA--C 1.54 0.812 0 C-N-CA 116.584 -1.811 . . . . 50.0 110.775 175.208 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 . . . . . 0 CA--C 1.518 -0.278 0 CA-C-O 121.06 0.457 . . . . 50.0 111.314 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.8 mt -71.96 -35.64 69.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.73 -1.123 . . . . 50.0 110.156 -179.988 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.5 m120 53.64 36.93 24.85 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.744 0.817 . . . . 50.0 111.84 -179.1 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.7 m -99.06 163.03 2.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 107.427 -1.323 . . . . 50.0 107.427 176.771 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.08 170.9 8.16 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.193 -1.04 . . . . 50.0 108.193 -178.01 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.48 158.64 44.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.891 0.376 . . . . 25.0 110.939 177.032 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -123.91 129.25 50.67 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.457 -0.792 . . . . 50.0 110.12 177.63 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.46 124.68 26.29 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.005 -0.543 . . . . 25.0 109.911 177.029 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.93 -24.73 19.19 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.278 0.561 . . . . 50.0 109.981 -177.762 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -135.75 166.34 23.5 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 104.673 -2.343 . . . . 50.0 104.673 175.913 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -86.67 -173.77 4.65 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.499 0.72 . . . . 50.0 110.937 177.741 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -161.9 154.03 19.39 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 123.613 0.571 . . . . 50.0 112.385 176.662 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.9 t -122.14 126.78 74.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 104.541 -2.392 . . . . 25.0 104.541 173.022 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.37 137.0 44.44 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 -177.247 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -113.32 6.69 17.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.181 0.991 . . . . 50.0 109.237 179.206 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.0 t -149.68 149.3 27.98 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 106.955 -1.498 . . . . 50.0 106.955 -177.178 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.27 -19.31 38.64 Favored 'Trans proline' 0 N--CA 1.475 0.433 0 C-N-CA 117.622 -1.119 . . . . 50.0 112.568 178.184 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -79.21 -15.76 57.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.888 0.852 . . . . 50.0 110.388 178.985 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -93.12 141.22 28.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.801 0.81 . . . . 50.0 111.491 -176.509 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.6 mt -89.1 129.21 35.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.881 -0.599 . . . . 50.0 111.215 -179.936 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 p -94.5 137.87 33.1 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.481 -1.674 . . . . 50.0 106.481 173.813 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -160.86 175.98 11.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.998 -0.742 . . . . 50.0 108.998 -174.634 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.4 167.68 11.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.606 0.717 . . . . 50.0 111.526 177.444 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.48 134.4 56.83 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 107.81 -1.181 . . . . 50.0 107.81 178.39 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.2 -11.32 70.7 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-O 118.98 -0.9 . . . . 50.0 113.782 178.697 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.28 138.57 57.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 118.336 1.068 . . . . 50.0 109.937 176.665 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.3 mm -105.04 129.38 57.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 107.111 -1.44 . . . . 50.0 107.111 177.865 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.0 ptp -137.48 150.1 47.31 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.394 0.277 . . . . 50.0 110.932 -175.706 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.2 m -87.63 122.4 31.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.576 -0.898 . . . . 25.0 108.576 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 63.4 t -89.79 127.59 42.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.404 -0.961 . . . . 50.0 108.404 178.322 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.6 mt -91.46 -52.25 4.88 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.15 -0.932 . . . . 50.0 108.551 179.453 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -151.61 168.69 24.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.487 -0.56 . . . . 50.0 109.487 177.502 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -117.33 154.41 31.31 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.68 -1.6 . . . . 50.0 106.68 179.423 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 56.37 42.73 27.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 123.429 1.585 . . . . 50.0 108.662 -177.559 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -67.98 154.18 42.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.573 -1.649 . . . . 25.0 109.319 -176.701 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 59.09 9.39 1.27 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.544 1.138 . . . . 50.0 113.148 177.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.82 13.89 74.1 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 110.804 -0.918 . . . . 25.0 110.804 -179.366 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.3 mt -90.32 134.44 34.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.273 -0.64 . . . . 50.0 109.273 179.721 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -72.44 126.4 29.76 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.268 0.556 . . . . 25.0 110.47 178.534 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.66 2.41 69.53 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 117.576 1.791 . . . . 50.0 117.576 174.914 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -100.63 134.13 44.06 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.128 1.464 . . . . 50.0 110.906 177.916 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -113.1 142.88 45.24 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.798 -0.815 . . . . 50.0 108.798 -174.872 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.75 123.84 32.34 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 106.599 -1.63 . . . . 50.0 106.599 179.106 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 97.8 m -132.71 160.83 35.64 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.245 0.545 . . . . 50.0 112.204 179.528 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.2 t -113.14 125.93 54.89 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 107.129 -1.434 . . . . 50.0 107.129 172.281 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 tp -147.19 135.94 22.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.437 -1.32 . . . . 50.0 107.437 -175.715 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 55.34 27.15 9.52 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.589 0.755 . . . . 25.0 112.073 -175.592 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.52 0.73 84.93 Favored Glycine 0 C--O 1.217 -0.964 0 N-CA-C 115.201 0.84 . . . . 25.0 115.201 -179.515 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -115.22 161.99 17.69 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.435 -1.321 . . . . 50.0 107.435 178.628 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -114.21 153.41 29.67 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.332 -0.618 . . . . 50.0 109.332 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.23 -163.86 30.88 Favored Glycine 0 CA--C 1.503 -0.683 0 N-CA-C 106.137 -2.785 . . . . 50.0 106.137 178.29 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 pt -115.9 155.95 17.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 120.808 0.337 . . . . 50.0 111.416 -175.299 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.18 147.64 38.26 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.403 -0.817 . . . . 50.0 109.479 179.525 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -74.87 126.02 9.77 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 CA-C-N 118.165 0.38 . . . . 50.0 112.373 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.8 -21.41 79.74 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 115.625 1.01 . . . . 50.0 115.625 -174.72 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -56.14 -28.2 57.05 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.529 0.937 . . . . 50.0 113.529 -176.59 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.12 20.02 12.77 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.936 -0.478 . . . . 50.0 111.721 -178.292 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.7 tp -119.52 146.51 45.39 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.612 -0.885 . . . . 50.0 108.612 -178.672 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -117.56 124.12 47.9 Favored 'General case' 0 C--O 1.208 -1.082 0 CA-C-N 116.085 -0.507 . . . . 50.0 110.757 -178.16 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.1 mm -76.66 136.63 24.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 109.298 -0.63 . . . . 50.0 109.298 177.471 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.0 mt -119.33 101.5 8.02 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.149 -1.797 . . . . 50.0 106.149 176.714 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--N 1.323 -0.553 0 N-CA-C 108.996 -0.742 . . . . 50.0 108.996 -177.017 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 80.1 mttt . . . . . 0 N--CA 1.456 -0.166 0 N-CA-C 106.845 -1.539 . . . . 50.0 106.845 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 C--O 1.242 0.675 0 C-N-CA 116.268 -2.021 . . . . 50.0 111.17 176.266 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 . . . . . 0 C--O 1.221 -0.415 0 N-CA-C 115.74 1.755 . . . . 50.0 115.74 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.8 mt -79.23 -31.31 43.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.503 -1.226 . . . . 50.0 110.267 -177.941 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.4 m120 54.34 25.09 5.62 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.286 1.034 . . . . 50.0 113.028 -177.011 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.6 m -88.51 162.46 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.257 -1.386 . . . . 50.0 107.257 178.102 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.87 173.94 6.17 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.416 -1.698 . . . . 50.0 106.416 -179.393 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.73 158.18 43.03 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.483 -0.191 . . . . 25.0 110.483 174.599 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -121.5 129.4 52.9 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.377 0.671 . . . . 50.0 110.592 176.892 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.32 132.39 45.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.109 -0.496 . . . . 25.0 110.12 176.807 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -98.31 -22.44 16.11 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.318 0.488 . . . . 50.0 112.318 -176.609 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -142.0 162.82 34.51 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.151 -0.685 . . . . 50.0 109.151 -179.801 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -69.37 158.81 34.35 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.698 -0.482 . . . . 50.0 109.698 177.704 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.35 161.53 38.75 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.651 -1.24 . . . . 50.0 107.651 177.168 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 p -136.25 139.26 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 102.071 -3.307 . . . . 25.0 102.071 171.243 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.34 124.4 34.39 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.577 -0.527 . . . . 25.0 109.577 -175.771 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -110.23 15.7 22.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.968 0.89 . . . . 50.0 110.312 -176.746 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.9 t -152.69 148.66 20.91 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 107.037 -1.468 . . . . 50.0 107.037 -175.87 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.59 -19.48 36.88 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 117.719 -1.054 . . . . 50.0 113.081 178.925 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -82.61 -19.29 38.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.363 0.602 . . . . 50.0 110.228 178.868 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -83.64 132.73 34.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 122.021 0.915 . . . . 50.0 111.029 -176.175 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.8 mt -82.75 138.31 34.09 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.711 -0.848 . . . . 50.0 108.711 178.254 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -90.82 131.38 36.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.542 -1.281 . . . . 50.0 107.542 176.404 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -155.27 165.17 37.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.387 0.613 . . . . 50.0 111.313 -178.225 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -125.68 164.28 20.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.855 -0.611 . . . . 50.0 111.174 -177.797 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -56.27 130.81 46.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.209 0.528 . . . . 50.0 110.191 179.333 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.55 -18.65 56.65 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.813 -0.993 . . . . 50.0 113.967 177.484 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -58.83 146.16 38.25 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 117.85 0.825 . . . . 50.0 110.995 179.801 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.4 mm -113.34 133.19 60.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.567 -1.197 . . . . 50.0 108.35 178.682 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.6 ptp -141.92 155.7 45.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.614 -0.513 . . . . 50.0 109.614 -177.96 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.6 m -89.2 128.43 35.81 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 108.69 -0.855 . . . . 25.0 108.69 178.004 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.0 t -93.15 126.54 45.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.929 -1.138 . . . . 50.0 107.929 177.183 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.9 mt -90.94 -51.88 5.13 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.503 -0.925 . . . . 50.0 108.503 179.57 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -149.55 161.04 42.92 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.71 -0.848 . . . . 50.0 108.71 177.985 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -102.86 156.58 17.56 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.729 -0.841 . . . . 50.0 108.729 176.221 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 55.28 41.22 31.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.41 1.576 . . . . 50.0 108.507 172.061 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 t -63.66 147.69 50.92 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 112.625 -2.079 . . . . 25.0 110.859 -175.522 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 59.96 9.97 1.98 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.664 0.786 . . . . 50.0 111.993 -176.575 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.74 9.46 86.33 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 111.122 -0.791 . . . . 25.0 111.122 -177.226 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.6 114.22 21.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.296 -1.002 . . . . 50.0 108.296 -179.759 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.21 129.2 39.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.196 0.522 . . . . 25.0 109.891 -176.567 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.08 -1.4 75.12 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-O 118.613 -1.104 . . . . 50.0 115.433 176.694 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -100.92 130.11 46.87 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 119.409 1.604 . . . . 50.0 109.044 177.095 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -113.4 139.94 48.48 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.299 -1.0 . . . . 50.0 108.299 -176.438 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.02 122.71 28.15 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 105.467 -2.049 . . . . 50.0 105.467 179.255 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.6 m -130.5 163.51 26.85 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.031 0.443 . . . . 50.0 110.98 178.565 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.6 t -116.21 122.03 43.8 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.976 -1.861 . . . . 50.0 105.976 172.524 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.7 tp -147.14 139.77 24.88 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.521 -1.289 . . . . 50.0 107.521 -176.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 57.87 27.2 14.26 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.75 0.648 . . . . 25.0 112.75 177.133 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.8 2.31 90.64 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 114.899 0.72 . . . . 25.0 114.899 178.77 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.4 ptt85 -126.93 160.51 30.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.581 1.19 . . . . 50.0 109.35 177.965 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -109.53 152.68 25.14 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.579 -0.897 . . . . 50.0 108.579 177.627 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.08 -160.59 25.21 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 105.974 -2.851 . . . . 50.0 105.974 179.265 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.3 pt -118.36 154.11 20.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.545 0.688 . . . . 50.0 111.253 -175.817 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.17 146.96 45.29 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.06 -0.973 . . . . 50.0 109.117 179.444 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.59 120.13 6.04 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 CA-C-O 121.669 0.612 . . . . 50.0 111.326 178.246 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.22 -12.05 75.9 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 116.062 -0.517 . . . . 50.0 113.865 -176.477 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -69.36 -9.21 52.39 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.575 0.583 . . . . 50.0 112.575 -178.64 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -133.11 27.67 4.18 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.829 -0.804 . . . . 50.0 108.829 178.554 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.4 tp -133.16 147.51 52.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.449 -0.796 . . . . 75.0 109.393 -177.855 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -123.12 120.05 32.08 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.556 0.342 . . . . 50.0 110.977 -177.801 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.4 mm -66.91 135.45 28.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.427 -0.583 . . . . 50.0 109.427 177.751 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.0 mt -121.27 95.92 4.88 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.741 -1.207 . . . . 50.0 107.741 175.945 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 106.481 -1.674 . . . . 50.0 106.481 176.699 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 95.9 mttt . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 109.35 -0.611 . . . . 50.0 109.35 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo . . . . . 0 CA--C 1.543 0.962 0 O-C-N 122.084 0.518 . . . . 50.0 111.776 175.35 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 . . . . . 0 C--O 1.221 -0.395 0 N-CA-C 110.299 -0.26 . . . . 50.0 110.299 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.8 mt -66.2 -38.1 87.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.165 0.507 . . . . 50.0 110.831 178.432 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 55.29 26.51 8.66 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.97 -1.014 . . . . 50.0 113.173 -178.576 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.5 m -85.25 171.74 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.848 0 N-CA-C 105.982 -1.859 . . . . 50.0 105.982 175.131 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -118.93 169.57 9.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 118.894 0.77 . . . . 50.0 109.624 -178.453 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.96 153.47 40.11 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.745 -0.661 . . . . 25.0 109.801 178.481 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -116.35 130.42 56.76 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.681 -1.145 . . . . 50.0 110.058 178.796 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.55 128.3 36.12 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.853 -0.425 . . . . 25.0 109.853 176.99 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.83 -22.78 17.26 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 121.003 -0.279 . . . . 50.0 111.469 -178.772 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -141.13 166.18 25.48 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.24 -1.763 . . . . 50.0 106.24 178.485 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -74.18 160.17 31.54 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.376 0.423 . . . . 50.0 110.229 178.95 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -144.94 137.08 25.93 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.559 -0.713 . . . . 50.0 112.263 173.732 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.83 123.89 66.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 106.304 -1.739 . . . . 25.0 106.304 176.217 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.68 125.64 27.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.08 -0.964 . . . . 25.0 108.529 177.26 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.13 -1.28 18.89 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.017 0.913 . . . . 50.0 109.34 176.954 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 t -131.85 145.88 59.37 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 105.121 -2.177 . . . . 50.0 105.121 179.589 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -69.37 -14.66 37.68 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 117.346 -1.303 . . . . 50.0 113.105 178.713 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -83.39 -16.81 44.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.48 0.657 . . . . 50.0 110.338 178.622 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -88.02 142.49 27.74 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.279 -0.637 . . . . 50.0 109.279 -178.709 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.4 mt -92.39 129.87 38.21 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.853 0.835 . . . . 50.0 109.597 177.653 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.94 142.64 28.68 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 105.644 -1.984 . . . . 50.0 105.644 175.842 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -161.68 165.94 27.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.256 0.55 . . . . 50.0 111.329 -179.111 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -113.52 159.5 19.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.497 -0.774 . . . . 50.0 109.12 177.546 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.76 133.66 55.57 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.824 -1.176 . . . . 50.0 107.824 177.626 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.18 -22.92 38.5 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-O 119.205 -0.775 . . . . 50.0 114.051 179.6 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -58.6 140.54 54.22 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.529 0.68 . . . . 50.0 109.69 179.731 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.6 mm -108.84 127.3 65.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.734 -1.121 . . . . 50.0 108.059 -178.849 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 12.2 ptp -128.2 150.92 49.8 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.188 -0.671 . . . . 50.0 109.188 -179.986 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.0 m -84.42 127.48 34.03 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 106.883 -1.525 . . . . 25.0 106.883 176.026 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.0 t -94.07 122.63 45.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 107.469 -1.308 . . . . 50.0 107.469 179.013 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.07 -46.94 8.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.603 -0.726 . . . . 50.0 109.127 -177.662 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -155.26 171.55 19.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.51 -0.314 . . . . 50.0 110.218 177.679 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -123.63 155.75 37.13 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.967 -1.864 . . . . 50.0 105.967 179.32 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.3 t0 58.49 41.35 22.79 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.304 1.526 . . . . 50.0 108.126 -175.881 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 t -68.32 142.03 55.64 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.778 -1.193 . . . . 25.0 107.778 -177.625 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 56.54 18.72 3.72 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 113.978 1.103 . . . . 50.0 113.978 -177.526 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.15 20.57 76.6 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.428 -1.069 . . . . 25.0 110.428 -179.656 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 65.7 mt -90.53 99.73 12.7 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 107.725 -1.213 . . . . 50.0 107.725 176.551 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -57.65 123.48 15.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.93 -1.032 . . . . 25.0 110.091 -176.099 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.47 -3.03 85.26 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 118.345 -1.253 . . . . 50.0 115.366 178.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.403 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 85.1 m95 -100.58 143.63 30.52 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 119.461 1.63 . . . . 50.0 109.569 177.84 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -117.66 140.54 49.52 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.345 -0.983 . . . . 50.0 108.345 -178.896 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.71 120.22 25.31 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 103.967 -2.605 . . . . 50.0 103.967 175.84 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 93.8 m -129.72 160.69 32.61 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 110.205 -0.294 . . . . 50.0 110.205 179.158 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.5 t -116.9 121.76 42.39 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.865 -1.161 . . . . 50.0 107.865 173.385 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.5 tp -143.75 141.88 30.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.027 -1.842 . . . . 75.0 106.027 -177.105 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 56.43 27.47 12.18 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.189 0.595 . . . . 25.0 111.388 -176.877 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.39 -0.46 84.7 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-O 119.554 -0.581 . . . . 25.0 114.467 177.682 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -120.93 154.32 36.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.333 1.067 . . . . 50.0 110.06 179.322 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -98.11 157.12 16.33 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.321 -0.992 . . . . 50.0 108.321 178.434 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.61 -168.25 39.7 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 105.515 -3.034 . . . . 50.0 105.515 179.128 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.3 pt -115.89 153.17 17.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 122.339 1.066 . . . . 50.0 110.762 -175.738 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.95 146.07 32.83 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 114.216 -1.356 . . . . 50.0 109.96 -178.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.66 119.12 5.58 Favored 'Trans proline' 0 C--O 1.237 0.431 0 O-C-N 122.051 0.501 . . . . 50.0 113.173 -179.869 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.7 -17.55 69.23 Favored Glycine 0 C--O 1.222 -0.601 0 C-N-CA 120.975 -0.631 . . . . 50.0 113.478 -178.306 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -65.65 -12.22 51.57 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.579 0.585 . . . . 50.0 112.579 -177.868 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -130.56 26.52 5.05 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.587 0.708 . . . . 50.0 110.841 177.018 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -126.14 154.92 42.49 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.406 -0.816 . . . . 50.0 111.871 178.511 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -123.43 122.33 37.98 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.866 -0.606 . . . . 50.0 111.357 177.61 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.0 mm -71.7 137.37 23.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.678 -1.23 . . . . 50.0 107.678 177.779 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.3 mt -118.17 106.48 12.88 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.121 -1.066 . . . . 50.0 108.121 175.925 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 121.425 0.631 . . . . 50.0 110.748 179.537 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.1 mttt . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 107.999 -1.112 . . . . 50.0 107.999 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.539 0.729 0 C-N-CA 118.055 -0.83 . . . . 50.0 112.061 178.308 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 114.825 1.417 . . . . 50.0 114.825 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.4 mt -73.82 -41.68 61.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.339 -0.846 . . . . 50.0 109.881 178.485 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 52.76 33.18 13.52 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.271 1.028 . . . . 50.0 111.587 -177.976 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 m -91.56 162.16 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.75 -1.945 . . . . 50.0 105.75 174.571 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.51 170.99 8.22 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.003 -1.11 . . . . 50.0 108.003 -178.76 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.49 159.15 43.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.16 -0.681 . . . . 25.0 109.16 174.714 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -125.34 129.0 49.07 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.392 -0.822 . . . . 50.0 109.863 176.495 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.08 129.54 39.71 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.217 -0.66 . . . . 25.0 109.217 175.283 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.0 mt -96.01 -20.11 18.95 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.024 0.44 . . . . 50.0 110.489 -178.355 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -146.42 173.32 12.38 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 107.697 -1.223 . . . . 50.0 107.697 -177.664 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -76.04 158.68 31.59 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.992 0.425 . . . . 50.0 111.534 175.246 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -141.71 131.5 24.28 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.386 0.612 . . . . 50.0 112.518 168.642 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.9 t -97.05 122.19 48.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 103.539 -2.763 . . . . 25.0 103.539 173.135 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.42 139.98 36.22 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.837 -1.172 . . . . 25.0 107.837 176.304 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -128.91 -19.65 3.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.902 -0.59 . . . . 50.0 110.839 -179.128 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.44 150.98 39.84 Favored Pre-proline 0 N--CA 1.464 0.252 0 N-CA-C 106.759 -1.571 . . . . 50.0 106.759 171.131 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -68.74 -22.09 37.67 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 117.275 -1.35 . . . . 50.0 112.952 -179.183 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -90.4 -2.23 57.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.771 0.796 . . . . 50.0 110.616 -179.207 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -89.39 139.77 30.18 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.315 0.579 . . . . 50.0 110.471 -175.997 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.3 mt -90.74 128.04 36.53 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.105 0.955 . . . . 50.0 111.727 179.77 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.6 p -87.47 140.41 29.55 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.935 -1.876 . . . . 50.0 105.935 174.309 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.71 167.01 31.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.051 0.453 . . . . 50.0 110.1 178.774 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.32 160.85 19.9 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.639 -0.875 . . . . 50.0 108.639 178.441 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -56.23 134.18 53.01 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 115.221 -0.9 . . . . 50.0 110.096 177.56 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.68 -15.27 63.46 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-O 118.175 -1.347 . . . . 50.0 113.863 177.885 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -60.41 150.53 30.63 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 118.207 1.004 . . . . 50.0 110.826 177.512 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.6 mm -118.29 130.07 73.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.473 -1.239 . . . . 50.0 108.7 179.479 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -136.7 152.77 50.75 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.307 -0.627 . . . . 50.0 109.307 -179.085 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -88.36 128.26 35.5 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.357 -0.608 . . . . 25.0 109.357 177.909 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.4 t -91.91 127.83 43.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.176 -1.046 . . . . 50.0 108.176 179.638 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.3 mt -94.61 -47.84 6.34 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.636 -0.875 . . . . 50.0 108.636 179.889 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -152.05 169.08 23.24 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.517 -0.919 . . . . 50.0 108.517 178.111 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -117.75 153.96 32.53 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 108.029 -1.1 . . . . 50.0 108.029 176.404 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 60.05 40.14 18.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 123.472 1.606 . . . . 50.0 109.855 178.474 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 t -68.26 154.77 41.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.204 -1.816 . . . . 25.0 110.729 -177.122 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 59.46 13.97 3.55 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.486 1.114 . . . . 50.0 110.418 -177.392 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.77 11.41 85.27 Favored Glycine 0 CA--C 1.506 -0.489 0 N-CA-C 111.335 -0.706 . . . . 25.0 111.335 -179.827 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.65 128.83 36.12 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 117.761 0.781 . . . . 50.0 110.067 -177.814 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -70.02 123.24 21.06 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.083 -0.508 . . . . 25.0 110.346 -179.473 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.35 -0.79 88.66 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 116.789 1.475 . . . . 50.0 116.789 175.974 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -100.38 131.73 46.15 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.909 0.855 . . . . 50.0 109.373 176.753 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -114.1 143.2 45.18 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.492 -0.929 . . . . 50.0 108.492 -175.224 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.68 122.44 28.62 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.735 -1.58 . . . . 50.0 106.735 177.952 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.6 m -133.34 162.28 32.26 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.231 0.538 . . . . 50.0 111.9 178.146 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -113.45 122.4 47.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.856 -1.164 . . . . 50.0 107.856 173.484 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.5 tp -139.77 132.58 29.14 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.882 -1.155 . . . . 50.0 107.882 -178.745 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 54.63 29.11 10.92 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.059 0.544 . . . . 25.0 111.438 -174.719 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.93 -3.79 73.95 Favored Glycine 0 C--O 1.222 -0.603 0 N-CA-C 115.305 0.882 . . . . 25.0 115.305 178.207 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -109.19 157.35 18.88 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.824 -1.547 . . . . 50.0 106.824 178.639 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -115.0 151.81 33.52 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.154 -0.684 . . . . 50.0 109.154 -177.747 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.73 -161.0 26.56 Favored Glycine 0 CA--C 1.504 -0.623 0 N-CA-C 107.051 -2.42 . . . . 50.0 107.051 -179.726 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.0 pt -115.97 150.3 17.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.212 0.53 . . . . 50.0 112.308 -175.083 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.85 144.94 43.61 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.226 -0.897 . . . . 50.0 110.488 -179.716 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.9 121.91 6.07 Favored 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 118.501 -0.533 . . . . 50.0 112.388 -179.769 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.58 -20.33 67.86 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 115.375 0.91 . . . . 50.0 115.375 -177.113 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -23.19 67.3 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.324 0.861 . . . . 50.0 113.324 -176.267 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -120.95 26.64 8.94 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.939 -0.763 . . . . 50.0 108.939 -179.045 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.0 tp -131.51 150.37 52.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.735 -0.666 . . . . 50.0 110.666 -176.985 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -124.74 123.55 40.23 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 122.223 -0.298 . . . . 50.0 111.787 179.186 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.4 mm -70.17 136.37 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 123.839 0.712 . . . . 50.0 110.001 176.6 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.8 mt -118.38 99.19 6.68 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.774 -1.565 . . . . 50.0 106.774 174.855 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 C--N 1.323 -0.554 0 N-CA-C 106.905 -1.517 . . . . 50.0 106.905 179.438 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 106.375 -1.713 . . . . 50.0 106.375 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 CA--C 1.547 1.172 0 C-N-CA 118.021 -0.853 . . . . 50.0 112.783 179.672 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 121.287 0.565 . . . . 50.0 109.799 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.9 mt -68.24 -37.59 80.95 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.144 -0.935 . . . . 50.0 110.389 -177.963 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.1 m120 54.11 29.11 9.82 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 122.861 1.315 . . . . 50.0 112.031 -179.007 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.9 m -91.99 165.0 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 104.817 -2.29 . . . . 50.0 104.817 172.939 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.67 175.69 5.33 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 119.704 1.138 . . . . 50.0 108.612 -178.414 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.96 154.93 40.09 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.987 -1.006 . . . . 25.0 110.824 174.775 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -113.9 130.17 56.52 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 125.299 1.44 . . . . 50.0 110.506 175.96 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.76 128.57 36.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.959 0.885 . . . . 25.0 110.898 177.662 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -94.79 -18.55 21.12 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.669 -0.696 . . . . 50.0 109.403 -179.117 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -145.73 173.79 11.78 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 124.154 0.909 . . . . 50.0 109.238 179.215 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -85.39 164.25 18.04 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 123.408 0.683 . . . . 50.0 111.896 176.032 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -152.32 144.31 23.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.518 0.599 . . . . 50.0 111.705 176.374 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.8 t -113.73 123.48 69.44 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 N-CA-C 106.678 -1.601 . . . . 25.0 106.678 171.218 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.68 124.29 30.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.703 -1.135 . . . . 25.0 108.25 179.537 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -107.3 -11.04 15.65 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.758 -0.83 . . . . 50.0 108.758 -178.711 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.9 t -110.76 147.26 36.11 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 104.883 -2.265 . . . . 50.0 104.883 176.768 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.69 -18.49 32.58 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 O-C-N 121.946 0.445 . . . . 50.0 112.242 179.086 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -85.63 -12.97 50.07 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.654 -0.703 . . . . 50.0 109.346 179.235 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -87.91 143.3 27.19 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-O 121.32 0.581 . . . . 50.0 111.446 179.664 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.1 mt -98.31 128.62 44.82 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-O 121.884 0.85 . . . . 50.0 112.237 177.834 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.69 134.33 34.36 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 105.718 -1.956 . . . . 50.0 105.718 174.157 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -152.58 168.08 26.75 Favored 'General case' 0 C--O 1.266 1.946 0 CA-C-O 121.71 0.767 . . . . 50.0 110.984 -179.782 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -118.92 159.72 23.28 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.367 1.067 . . . . 50.0 110.241 178.845 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -56.96 132.75 53.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.853 -1.166 . . . . 50.0 107.853 174.757 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.59 -25.15 28.55 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 115.349 -0.841 . . . . 50.0 114.089 -179.479 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -60.09 134.85 57.44 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.358 -0.979 . . . . 50.0 108.358 -175.226 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.5 mm -103.78 127.08 58.19 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 109.22 -0.659 . . . . 50.0 109.22 176.061 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.3 ptp -132.74 156.21 47.47 Favored 'General case' 0 C--O 1.2 -1.511 0 CA-C-N 115.416 -0.811 . . . . 50.0 108.918 -179.181 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.9 m -93.87 119.24 32.54 Favored 'General case' 0 C--O 1.198 -1.635 0 N-CA-C 108.918 -0.771 . . . . 25.0 108.918 -178.444 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.2 t -79.9 121.69 33.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 106.697 -1.594 . . . . 50.0 106.697 177.702 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.3 mt -94.51 -42.14 8.99 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.949 0.881 . . . . 50.0 109.735 179.854 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -146.33 152.19 38.73 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.566 -0.743 . . . . 50.0 109.577 -176.859 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -113.79 150.64 33.16 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 105.945 -1.872 . . . . 50.0 105.945 171.74 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 55.54 43.1 28.96 Favored 'General case' 0 C--O 1.268 2.027 0 O-C-N 125.021 1.45 . . . . 50.0 109.893 -176.876 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.2 t -70.49 151.2 45.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.397 -1.274 . . . . 25.0 111.145 -178.924 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 58.51 18.86 6.04 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.491 1.116 . . . . 50.0 112.069 179.359 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.5 5.15 90.16 Favored Glycine 0 C--O 1.208 -1.529 0 CA-C-N 115.139 -0.937 . . . . 25.0 112.071 178.06 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.9 mt -84.84 136.62 33.58 Favored 'General case' 0 C--O 1.211 -0.93 0 CA-C-N 117.289 0.544 . . . . 50.0 109.623 -174.512 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -80.03 108.35 13.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.902 -1.044 . . . . 25.0 113.351 -179.065 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.79 0.91 74.39 Favored Glycine 0 C--O 1.221 -0.691 0 C-N-CA 119.473 -1.346 . . . . 50.0 116.189 177.924 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -99.58 136.13 39.96 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 117.807 0.804 . . . . 50.0 109.232 173.43 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -113.01 146.19 39.52 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.711 -0.848 . . . . 50.0 108.711 -176.601 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.9 tp -89.9 127.61 36.04 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 106.076 -1.824 . . . . 50.0 106.076 -179.938 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.9 m -137.97 160.46 39.27 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 119.59 1.086 . . . . 50.0 113.778 -179.169 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.3 t -109.22 123.01 48.55 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 106.295 -1.742 . . . . 50.0 106.295 171.569 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.9 tp -137.91 127.52 25.1 Favored 'General case' 0 C--O 1.204 -1.313 0 N-CA-C 107.743 -1.206 . . . . 50.0 107.743 -177.562 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 54.43 35.53 23.39 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.86 0.838 . . . . 25.0 110.691 -176.504 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.21 6.72 88.81 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.512 -0.852 . . . . 25.0 113.858 175.24 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -127.27 148.9 50.21 Favored 'General case' 0 C--O 1.204 -1.304 0 CA-C-N 119.001 1.4 . . . . 50.0 109.121 -176.3 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -102.03 148.35 25.48 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 123.688 0.618 . . . . 50.0 112.077 -178.02 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.67 -179.94 48.8 Favored Glycine 0 C--O 1.25 1.099 0 N-CA-C 106.76 -2.536 . . . . 50.0 106.76 -177.861 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt -103.52 148.56 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.01 0.924 . . . . 50.0 111.753 -174.831 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.87 148.63 43.18 Favored Pre-proline 0 C--O 1.244 0.795 0 CA-C-O 122.68 1.229 . . . . 50.0 110.863 -177.42 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.05 125.21 7.1 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 116.302 -1.999 . . . . 50.0 114.338 -178.353 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.84 -20.77 60.2 Favored Glycine 0 C--O 1.203 -1.829 0 CA-C-N 116.154 -0.476 . . . . 50.0 113.529 179.3 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -68.2 -15.66 63.67 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 121.053 -1.263 . . . . 50.0 112.36 -178.654 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -115.73 15.48 16.44 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.872 -0.517 . . . . 50.0 109.762 -179.148 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 29.6 mt -130.03 152.5 49.42 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 117.366 2.358 . . . . 75.0 117.366 -176.757 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt -119.64 126.52 51.34 Favored 'General case' 0 C--O 1.197 -1.7 0 N-CA-C 108.055 -1.091 . . . . 50.0 108.055 175.53 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.5 mm -75.16 137.01 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 O-C-N 124.167 0.917 . . . . 50.0 110.204 177.111 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.3 mt -117.74 105.38 11.93 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.493 1.117 . . . . 50.0 108.528 177.666 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.21 -1.012 0 CA-C-N 114.915 -1.039 . . . . 50.0 110.658 -172.991 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 90.0 mttt . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 119.102 -0.475 . . . . 50.0 110.926 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo . . . . . 0 CA--C 1.562 1.883 0 O-C-N 123.159 1.084 . . . . 50.0 111.55 174.496 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 . . . . . 0 CA--C 1.5 -0.945 0 N-CA-C 113.713 1.005 . . . . 50.0 113.713 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.4 mt -71.99 -41.88 67.14 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.793 -1.094 . . . . 50.0 110.492 175.878 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.8 m120 54.39 33.35 18.4 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 113.606 -1.634 . . . . 50.0 113.814 -178.388 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 m -97.7 166.48 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.156 0 N-CA-C 106.408 -1.701 . . . . 50.0 106.408 178.253 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.3 171.72 7.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.32 -1.487 . . . . 50.0 107.3 -176.272 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.22 157.74 43.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 119.232 0.923 . . . . 25.0 111.774 176.896 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -120.33 127.55 52.44 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.498 -0.774 . . . . 50.0 110.935 179.579 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.93 122.12 18.67 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.635 -1.246 . . . . 25.0 107.635 179.749 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.3 mt -84.89 -27.91 26.32 Favored 'General case' 0 C--O 1.212 -0.876 0 O-C-N 121.879 -0.513 . . . . 50.0 110.776 -178.949 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -138.41 177.07 8.16 Favored 'General case' 0 C--O 1.198 -1.649 0 N-CA-C 108.622 -0.881 . . . . 50.0 108.622 177.216 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.63 170.57 15.9 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.317 0.647 . . . . 50.0 111.806 173.491 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -155.83 141.64 18.03 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 113.981 1.104 . . . . 50.0 113.981 175.02 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.6 131.99 62.6 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 105.774 -1.936 . . . . 25.0 105.774 -179.454 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.96 111.79 15.5 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 124.639 1.212 . . . . 25.0 110.274 -178.996 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -106.53 -1.33 23.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.64 0.733 . . . . 50.0 112.249 -179.208 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.3 m -131.7 154.36 81.78 Favored Pre-proline 0 CA--C 1.501 -0.923 0 N-CA-C 107.418 -1.327 . . . . 50.0 107.418 174.956 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.51 -26.56 40.25 Favored 'Trans proline' 0 C--O 1.259 1.533 0 C-N-CA 116.582 -1.812 . . . . 50.0 113.323 -175.631 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -82.57 -6.83 59.56 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 115.9 -0.591 . . . . 50.0 110.806 179.695 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -85.54 142.61 29.03 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-O 121.929 0.871 . . . . 50.0 111.988 -178.08 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.1 mt -93.73 135.19 35.28 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.605 -0.725 . . . . 50.0 109.089 176.071 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.47 130.15 39.4 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 106.413 -1.699 . . . . 50.0 106.413 174.629 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -150.93 165.89 32.31 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.607 0.717 . . . . 50.0 109.681 -178.583 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -115.1 170.33 8.44 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.666 -0.697 . . . . 50.0 109.906 -179.18 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -65.06 135.67 55.85 Favored 'General case' 0 C--O 1.203 -1.35 0 N-CA-C 108.488 -0.93 . . . . 50.0 108.488 175.825 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.02 -23.5 30.62 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 109.937 -1.265 . . . . 50.0 109.937 175.63 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -61.56 143.74 55.51 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 122.065 0.936 . . . . 50.0 111.362 -175.974 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.1 mm -116.04 120.09 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 114.116 -1.402 . . . . 50.0 109.571 -177.554 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -124.54 151.97 44.04 Favored 'General case' 0 C--N 1.313 -0.999 0 O-C-N 124.072 0.857 . . . . 50.0 109.161 179.0 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.6 m -84.39 127.63 34.11 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 106.822 -1.547 . . . . 25.0 106.822 177.103 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.9 t -90.19 120.88 39.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.51 -0.922 . . . . 50.0 108.51 176.009 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -90.39 -45.1 9.22 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.602 -0.726 . . . . 50.0 111.285 177.374 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -148.79 157.57 43.53 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.387 -0.968 . . . . 50.0 108.387 -175.264 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -118.73 147.63 43.65 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 106.513 -1.662 . . . . 50.0 106.513 176.672 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 55.75 46.38 22.57 Favored 'General case' 0 C--O 1.255 1.355 0 CA-C-O 124.206 1.955 . . . . 50.0 109.394 -177.805 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -68.59 157.53 35.89 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-N 112.594 -2.094 . . . . 25.0 110.942 -177.691 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 60.03 13.22 3.6 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.381 0.882 . . . . 50.0 113.381 174.413 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.53 16.09 78.48 Favored Glycine 0 CA--C 1.539 1.558 0 N-CA-C 109.296 -1.522 . . . . 25.0 109.296 179.599 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.6 mt -100.82 129.91 46.77 Favored 'General case' 0 C--O 1.206 -1.207 0 N-CA-C 107.348 -1.353 . . . . 50.0 107.348 -178.67 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.93 123.71 27.53 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 122.169 0.985 . . . . 25.0 111.867 177.93 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.57 -0.35 82.86 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 120.215 -0.993 . . . . 50.0 114.683 175.119 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -100.71 134.15 44.11 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.76 -0.83 . . . . 50.0 108.76 175.575 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -114.85 141.4 47.95 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.54 -0.911 . . . . 50.0 108.54 -178.076 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.4 tp -85.61 120.12 26.69 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.565 -0.902 . . . . 50.0 108.565 178.617 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 98.7 m -135.77 158.56 44.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.183 0.438 . . . . 50.0 112.183 -177.334 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.9 t -105.95 121.34 43.9 Favored 'General case' 0 C--O 1.251 1.168 0 C-N-CA 123.987 0.915 . . . . 50.0 108.787 173.804 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 tp -138.14 132.59 32.2 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.288 1.035 . . . . 50.0 109.164 179.967 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.7 m170 54.09 30.93 12.83 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-O 122.813 1.292 . . . . 25.0 109.655 -176.157 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.45 -5.44 73.38 Favored Glycine 0 N--CA 1.462 0.384 0 N-CA-C 116.528 1.371 . . . . 25.0 116.528 176.727 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -110.83 145.91 37.36 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.919 -0.771 . . . . 50.0 108.919 179.396 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -91.52 151.62 20.68 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 124.451 1.094 . . . . 50.0 108.642 178.849 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.27 -176.19 47.65 Favored Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 107.913 -2.075 . . . . 50.0 107.913 -179.595 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.6 pt -104.73 148.94 8.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-O 121.977 0.894 . . . . 50.0 111.761 -175.341 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.7 m -143.48 146.38 35.49 Favored Pre-proline 0 C--O 1.246 0.896 0 C-N-CA 123.254 0.622 . . . . 50.0 111.969 177.256 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.97 122.17 7.05 Favored 'Trans proline' 0 C--N 1.358 1.049 0 N-CA-C 114.296 0.845 . . . . 50.0 114.296 -175.86 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.49 -25.56 71.48 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.842 -0.617 . . . . 50.0 114.379 -178.197 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.26 -24.68 60.17 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.044 0.757 . . . . 50.0 113.044 -179.157 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -119.09 31.38 6.66 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 120.929 -1.107 . . . . 50.0 108.789 178.962 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.4 mt -128.26 159.77 34.21 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.383 1.087 . . . . 50.0 110.747 176.538 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -134.46 127.04 30.7 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 115.106 -0.952 . . . . 50.0 108.784 174.738 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.5 mm -73.54 136.71 24.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.995 -0.743 . . . . 50.0 108.995 -179.347 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.5 mt -112.04 89.08 2.97 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 106.847 -1.538 . . . . 50.0 106.847 174.347 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.483 1.201 0 C-N-CA 119.226 -0.99 . . . . 50.0 108.843 176.559 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 109.69 -0.485 . . . . 50.0 109.69 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 C--O 1.24 0.614 0 C-N-CA 117.577 -1.149 . . . . 50.0 111.023 178.901 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 . . . . . 0 C--O 1.201 -1.483 0 CA-C-O 122.04 0.924 . . . . 50.0 109.565 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.6 mt -71.1 -40.91 71.23 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.249 -1.341 . . . . 50.0 111.424 178.751 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.0 m120 57.48 35.84 26.32 Favored 'General case' 0 C--O 1.253 1.275 0 C-N-CA 124.136 0.975 . . . . 50.0 110.753 -178.865 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.6 m -101.4 157.09 4.4 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 N-CA-C 107.687 -1.227 . . . . 50.0 107.687 176.044 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.07 166.25 12.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 118.324 -0.846 . . . . 50.0 109.173 -176.929 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.94 154.59 40.54 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.901 0.773 . . . . 25.0 112.953 172.651 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -117.9 129.49 55.66 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 124.07 0.948 . . . . 50.0 111.086 -179.527 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.43 126.36 29.43 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-O 118.614 -0.708 . . . . 25.0 109.294 177.866 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt -89.01 -28.81 19.94 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.013 0.925 . . . . 50.0 111.376 178.797 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -139.85 170.11 16.48 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.12 -1.437 . . . . 50.0 107.12 179.919 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -83.91 176.18 9.07 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 122.968 0.507 . . . . 50.0 110.642 -177.801 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -151.12 153.34 34.83 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 108.008 -1.108 . . . . 50.0 108.008 -178.216 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.4 t -125.26 136.0 62.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 104.507 -2.405 . . . . 25.0 104.507 170.832 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.27 134.62 42.95 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 114.475 -1.238 . . . . 25.0 110.238 178.013 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -125.22 11.37 8.15 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 123.628 0.58 . . . . 50.0 110.777 -177.341 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.4 t -151.21 150.91 28.34 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 106.228 -1.767 . . . . 50.0 106.228 -179.289 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.75 -12.12 28.49 Favored 'Trans proline' 0 N--CA 1.48 0.683 0 N-CA-C 116.607 1.733 . . . . 50.0 116.607 -175.91 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -83.1 -20.67 34.42 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 107.802 -1.184 . . . . 50.0 107.802 177.73 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -84.06 136.58 33.97 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.723 0.773 . . . . 50.0 110.063 -178.927 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.3 mt -93.57 131.26 39.01 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 113.929 1.085 . . . . 50.0 113.929 -177.997 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 p -86.75 95.1 9.71 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-N 115.212 -0.904 . . . . 50.0 110.85 -179.408 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -126.43 160.57 30.14 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 121.743 -0.598 . . . . 50.0 111.8 179.645 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -121.57 165.47 15.64 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 105.087 -2.19 . . . . 50.0 105.087 -177.254 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -59.02 131.42 50.99 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.54 0.686 . . . . 50.0 110.656 177.532 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.74 -20.02 51.05 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 121.754 -0.591 . . . . 50.0 114.295 -179.006 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -62.29 131.32 48.95 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 106.932 -1.507 . . . . 50.0 106.932 178.723 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.6 mm -102.23 132.43 48.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 106.939 -1.504 . . . . 50.0 106.939 177.817 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 11.2 ptp -131.8 161.87 31.9 Favored 'General case' 0 CA--C 1.495 -1.145 0 O-C-N 121.241 -0.912 . . . . 50.0 109.244 -179.836 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.2 m -101.62 119.19 38.39 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.678 -1.601 . . . . 25.0 106.678 -177.979 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 t -81.69 130.63 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 123.513 1.625 . . . . 50.0 109.321 -179.83 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.4 mt -100.41 -42.92 6.41 Favored 'General case' 0 C--O 1.204 -1.306 0 O-C-N 121.197 -0.939 . . . . 50.0 112.895 178.311 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -148.3 147.41 29.28 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-O 118.539 -0.743 . . . . 50.0 109.518 178.808 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -107.05 147.32 30.11 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.311 -1.366 . . . . 50.0 107.311 173.188 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 56.4 39.65 29.97 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 123.279 1.514 . . . . 50.0 110.665 -173.91 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -64.18 150.71 45.18 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 113.744 -1.571 . . . . 25.0 110.252 -175.327 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 56.7 22.65 7.03 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.076 -1.42 . . . . 50.0 113.3 178.225 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.32 16.93 73.8 Favored Glycine 0 CA--C 1.501 -0.788 0 C-N-CA 120.492 -0.861 . . . . 25.0 112.347 -179.24 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.3 mt -92.66 130.5 38.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.528 -1.286 . . . . 50.0 107.528 175.438 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -75.2 122.22 23.31 Favored 'General case' 0 C--O 1.258 1.526 0 O-C-N 121.232 -0.918 . . . . 25.0 110.68 176.996 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.83 -5.13 85.36 Favored Glycine 0 C--N 1.331 0.303 0 N-CA-C 116.089 1.196 . . . . 50.0 116.089 172.686 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -97.07 136.04 38.19 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 117.824 0.812 . . . . 50.0 109.764 177.085 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -114.41 142.85 45.82 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-O 117.595 -1.193 . . . . 50.0 108.019 -177.946 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.5 tp -85.42 125.28 32.87 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.128 -2.175 . . . . 50.0 105.128 175.059 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.8 m -135.47 164.08 28.61 Favored 'General case' 0 C--O 1.253 1.289 0 O-C-N 121.705 -0.622 . . . . 50.0 109.862 177.336 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.9 t -112.61 120.61 42.16 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.215 -1.402 . . . . 50.0 107.215 171.052 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.8 tp -132.52 136.45 46.64 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 105.756 -1.942 . . . . 75.0 105.756 -175.785 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.1 m170 54.16 29.69 10.9 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.527 0.68 . . . . 25.0 109.985 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.91 11.04 81.18 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-O 118.454 -1.192 . . . . 25.0 116.061 178.919 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -122.66 146.86 47.08 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.356 -1.35 . . . . 50.0 107.356 175.477 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -89.08 160.8 16.87 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.15 -1.055 . . . . 50.0 108.15 178.009 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.43 -174.43 41.91 Favored Glycine 0 C--O 1.242 0.623 0 N-CA-C 108.349 -1.901 . . . . 50.0 108.349 -178.758 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 pt -118.57 152.92 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.615 0 CA-C-O 122.71 1.243 . . . . 50.0 111.793 -172.238 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.9 m -143.92 150.91 51.27 Favored Pre-proline 0 C--N 1.306 -1.288 0 CA-C-N 112.384 -2.189 . . . . 50.0 110.807 -174.842 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.3 128.17 10.3 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 O-C-N 121.949 0.447 . . . . 50.0 112.565 -179.318 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.57 -22.42 78.99 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 118.962 -1.59 . . . . 50.0 115.642 -174.624 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -28.18 69.78 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 122.094 -0.651 . . . . 50.0 112.38 -175.54 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -108.35 28.02 8.75 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 122.013 0.911 . . . . 50.0 110.322 178.985 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.5 mt -121.37 159.17 26.7 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 114.423 1.268 . . . . 50.0 114.423 175.126 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -134.94 115.51 13.66 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.779 0.832 . . . . 50.0 109.729 176.36 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.7 mm -67.03 129.15 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 112.422 0.527 . . . . 50.0 112.422 177.834 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.5 mt -105.53 78.03 1.33 Allowed 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.131 -1.433 . . . . 50.0 107.131 179.219 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.813 0 N-CA-C 109.744 -0.465 . . . . 50.0 109.744 178.0 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.9 mttt . . . . . 0 CA--C 1.547 0.86 0 N-CA-C 106.71 -1.589 . . . . 50.0 106.71 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 C--N 1.36 1.156 0 C-N-CA 117.565 -1.157 . . . . 50.0 110.278 174.203 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 CA-C-O 123.084 1.38 . . . . 25.0 115.255 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.5 p -119.41 41.71 3.04 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.438 -1.036 . . . . 25.0 110.683 -177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.82 148.51 42.78 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.844 -0.798 . . . . 25.0 108.844 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -140.38 141.18 35.62 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 120.82 0.343 . . . . 50.0 110.285 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -79.98 167.88 19.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.589 -0.732 . . . . 50.0 110.802 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.8 mt -65.48 -42.15 92.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.598 -0.728 . . . . 50.0 110.294 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 56.27 30.92 17.56 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.206 1.002 . . . . 50.0 111.882 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.7 m -88.62 163.47 2.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 105.526 -2.027 . . . . 50.0 105.526 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.61 173.4 6.56 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.89 -0.782 . . . . 50.0 108.89 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.78 162.46 40.99 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.72 -0.474 . . . . 25.0 109.72 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -126.69 135.6 51.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.817 -1.083 . . . . 50.0 109.648 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.62 120.63 18.5 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.803 -0.635 . . . . 25.0 109.295 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.62 -23.25 24.33 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.922 -0.77 . . . . 50.0 108.922 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -140.54 172.28 12.94 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.456 -1.312 . . . . 50.0 107.456 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.72 164.34 18.62 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 123.129 0.572 . . . . 50.0 110.417 174.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -153.73 130.74 11.01 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.962 0.505 . . . . 50.0 110.725 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.23 118.94 48.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 106.035 -1.839 . . . . 25.0 106.035 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.43 143.08 51.93 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.276 -0.874 . . . . 25.0 109.896 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -116.69 -34.84 4.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.039 -0.982 . . . . 50.0 109.685 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.5 m -93.44 153.97 41.34 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.068 -0.716 . . . . 50.0 109.068 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.43 -22.27 33.83 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 117.782 -1.012 . . . . 50.0 113.645 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -81.12 -16.18 53.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.73 0.776 . . . . 50.0 110.85 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -84.52 138.36 32.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.489 0.661 . . . . 50.0 110.299 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.6 mt -92.84 130.49 38.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.61 0.719 . . . . 50.0 110.048 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.6 t -91.55 137.57 32.26 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.686 -1.598 . . . . 50.0 106.686 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -154.09 166.19 33.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.679 0.752 . . . . 50.0 112.642 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -110.09 158.87 17.84 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.638 -0.875 . . . . 50.0 108.638 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -57.48 131.03 48.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.701 -1.222 . . . . 50.0 107.701 171.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.23 -19.9 46.98 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-O 119.154 -0.803 . . . . 50.0 113.889 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -59.74 144.71 47.47 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.76 0.79 . . . . 50.0 110.545 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.4 mm -114.04 130.69 67.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.58 -1.191 . . . . 50.0 107.836 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -135.34 156.47 48.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.967 -0.383 . . . . 50.0 109.967 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.7 m -92.66 126.17 37.63 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.159 -1.052 . . . . 25.0 108.159 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.5 t -89.86 122.82 41.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.259 -1.015 . . . . 50.0 108.259 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.4 mt -88.26 -48.07 7.95 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.646 -0.706 . . . . 50.0 109.14 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -152.52 167.03 30.14 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.345 -0.983 . . . . 50.0 108.345 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -116.84 154.29 30.99 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 106.811 -1.551 . . . . 50.0 106.811 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 58.13 40.6 24.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.918 1.818 . . . . 50.0 108.982 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -64.87 149.64 49.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 112.59 -2.095 . . . . 25.0 110.925 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 60.33 9.56 2.02 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.98 0.912 . . . . 50.0 113.37 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.99 12.95 80.35 Favored Glycine 0 C--N 1.33 0.244 0 N-CA-C 111.114 -0.795 . . . . 25.0 111.114 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 99.0 mt -91.24 117.87 30.0 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.42 -0.585 . . . . 50.0 109.42 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -63.6 126.47 27.63 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.707 -0.679 . . . . 25.0 110.928 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.12 -0.28 84.02 Favored Glycine 0 CA--C 1.518 0.261 0 N-CA-C 115.515 0.966 . . . . 50.0 115.515 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -100.89 133.49 45.29 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 119.012 1.406 . . . . 50.0 109.873 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -113.47 141.97 46.48 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.771 -0.825 . . . . 50.0 108.771 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.39 121.66 27.0 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.596 -2.001 . . . . 50.0 105.596 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 88.4 m -129.88 160.92 32.05 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.829 -0.348 . . . . 50.0 111.39 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -113.9 122.03 45.75 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.989 -1.856 . . . . 50.0 105.989 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.0 tp -145.5 139.7 26.98 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.819 -1.178 . . . . 50.0 107.819 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.9 m170 57.25 27.0 12.98 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.412 0.685 . . . . 25.0 111.97 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.1 0.29 89.46 Favored Glycine 0 C--O 1.221 -0.704 0 N-CA-C 114.9 0.72 . . . . 25.0 114.9 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -124.15 156.14 37.23 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 117.89 0.845 . . . . 50.0 109.757 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -102.37 154.98 18.55 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.326 -0.62 . . . . 50.0 109.326 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.43 -162.12 29.9 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 106.427 -2.669 . . . . 50.0 106.427 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 pt -118.55 151.49 20.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.649 0.737 . . . . 50.0 111.876 -174.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.2 m -140.38 146.93 47.59 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 114.929 -1.032 . . . . 50.0 110.025 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.87 122.16 7.09 Favored 'Trans proline' 0 C--O 1.241 0.65 0 C-N-CA 118.35 -0.633 . . . . 50.0 112.434 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.94 -23.09 65.38 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 121.607 -0.33 . . . . 50.0 113.01 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.39 -20.42 64.42 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 122.335 -0.509 . . . . 50.0 112.203 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -109.48 12.28 24.58 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 122.194 -0.317 . . . . 50.0 111.777 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.72 156.79 40.57 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 114.946 1.461 . . . . 50.0 114.946 -174.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -129.29 123.1 31.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.444 -0.798 . . . . 50.0 110.297 175.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.4 mm -67.76 137.21 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.772 -0.825 . . . . 50.0 108.772 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.6 mt -117.76 115.75 25.63 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.43 -1.693 . . . . 50.0 106.43 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.1 m -98.52 157.5 3.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.38 -0.6 . . . . 50.0 109.38 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.56 -174.81 45.12 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 108.682 -1.767 . . . . 25.0 108.682 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 97.6 mtp -84.43 160.48 20.58 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.888 -1.153 . . . . 25.0 107.888 176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -83.99 140.44 31.89 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.406 -1.702 . . . . 25.0 106.406 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -90.45 157.45 17.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.178 0.513 . . . . 25.0 109.738 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -106.72 20.1 19.51 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.036 -0.529 . . . . 50.0 109.629 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -134.64 153.05 78.74 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 105.671 -1.974 . . . . 50.0 105.671 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -71.73 153.41 59.27 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 117.896 -0.936 . . . . 50.0 113.86 -176.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.01 158.94 23.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.594 -0.521 . . . . 25.0 109.594 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.14 60.43 0.57 Allowed Glycine 0 C--O 1.224 -0.494 0 CA-C-N 116.259 -0.428 . . . . 25.0 112.426 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.7 t -78.76 156.04 29.03 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 122.621 -0.341 . . . . 25.0 110.794 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -164.33 176.77 40.21 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 109.74 -1.344 . . . . 25.0 109.74 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.9 -174.37 39.36 Favored Glycine 0 C--O 1.226 -0.385 0 N-CA-C 110.531 -1.028 . . . . 25.0 110.531 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.7 t -145.59 153.35 40.96 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.043 -0.725 . . . . 25.0 109.043 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.13 88.49 1.18 Allowed Glycine 0 C--O 1.226 -0.371 0 C-N-CA 121.471 -0.395 . . . . 25.0 112.495 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.8 m -79.13 144.28 34.66 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.553 -0.381 . . . . 25.0 110.221 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.91 153.89 52.44 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 108.398 -1.881 . . . . 25.0 108.398 174.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.9 m -118.02 115.19 24.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.476 0.638 . . . . 25.0 111.04 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -105.25 81.78 1.75 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.212 -1.032 . . . . 50.0 108.212 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.6 pttt -158.24 155.87 29.72 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.529 0.566 . . . . 25.0 112.529 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -113.02 -6.22 13.74 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.012 -1.477 . . . . 50.0 107.012 166.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -59.92 116.37 4.08 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.097 -0.956 . . . . 25.0 108.575 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.4 m -108.7 141.73 23.93 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.698 0.285 . . . . 25.0 111.639 -173.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.52 164.17 34.46 Favored 'Trans proline' 0 C--N 1.346 0.431 0 N-CA-C 114.79 1.035 . . . . 50.0 114.79 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -66.24 158.9 52.49 Favored 'Trans proline' 0 C--N 1.351 0.709 0 CA-C-O 120.984 0.327 . . . . 50.0 112.091 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.28 160.63 48.13 Favored 'Trans proline' 0 C--N 1.347 0.46 0 N-CA-C 114.386 0.879 . . . . 50.0 114.386 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -83.15 140.34 42.54 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 106.029 -1.841 . . . . 50.0 106.029 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.42 167.72 25.54 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 O-C-N 121.992 0.469 . . . . 50.0 112.864 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.58 152.66 53.91 Favored 'Trans proline' 0 C--N 1.353 0.797 0 N-CA-C 114.656 0.983 . . . . 50.0 114.656 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -115.4 43.3 2.07 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.827 -0.624 . . . . 50.0 110.19 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.21 123.47 29.6 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.508 -0.923 . . . . 25.0 108.508 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -77.0 -10.69 59.53 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.147 1.166 . . . . 50.0 114.147 -173.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 36.4 t -162.58 135.01 5.58 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.886 -0.783 . . . . 25.0 108.886 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.8 t 56.46 -160.37 0.21 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.631 0.729 . . . . 25.0 111.565 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--O 1.209 -1.074 0 CA-C-O 124.108 1.909 . . . . 25.0 111.011 -177.886 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.113 0 CA-C-O 123.371 1.54 . . . . 25.0 115.613 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.7 p -122.19 65.71 0.93 Allowed 'General case' 0 C--O 1.223 -0.339 0 O-C-N 120.998 -1.295 . . . . 25.0 111.36 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.6 ttm -62.66 -30.34 71.3 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.48 -0.327 . . . . 25.0 111.149 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? 54.99 80.26 0.13 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.756 0.822 . . . . 50.0 112.867 175.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -66.57 162.88 19.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.634 0.731 . . . . 50.0 111.849 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.9 mt -69.79 -40.72 75.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.045 -0.98 . . . . 50.0 109.899 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.2 m120 57.6 23.61 9.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.614 1.165 . . . . 50.0 113.157 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.7 m -85.65 162.98 2.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.387 -0.968 . . . . 50.0 108.387 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.74 168.18 10.49 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.374 -0.829 . . . . 50.0 110.098 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.6 166.81 26.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.014 0.435 . . . . 25.0 110.781 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -133.31 135.59 44.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.951 -1.022 . . . . 50.0 110.737 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.38 131.99 42.5 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.703 0.627 . . . . 25.0 110.583 173.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.22 -21.96 15.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.983 0.421 . . . . 50.0 110.898 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -143.47 168.38 19.98 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.344 -1.725 . . . . 50.0 106.344 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -75.69 160.44 30.06 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 123.459 0.474 . . . . 50.0 111.027 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -146.81 147.81 31.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.215 -0.291 . . . . 50.0 110.215 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.6 t -120.76 132.11 71.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 104.519 -2.4 . . . . 25.0 104.519 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.58 122.06 21.64 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.336 -0.987 . . . . 25.0 108.336 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -108.86 4.94 24.04 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.324 -0.991 . . . . 50.0 108.324 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.6 m -145.05 152.4 51.22 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 106.771 -1.566 . . . . 50.0 106.771 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.9 -21.58 32.64 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 N-CA-C 115.936 1.475 . . . . 50.0 115.936 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.28 -12.7 54.23 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.95 0.881 . . . . 50.0 110.238 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -82.98 139.34 33.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.943 0.878 . . . . 50.0 111.406 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.1 mt -90.98 127.68 36.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.185 0.993 . . . . 50.0 109.672 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -88.88 139.54 30.35 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 106.225 -1.769 . . . . 50.0 106.225 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -156.66 165.18 36.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.963 0.411 . . . . 50.0 110.605 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -110.83 162.79 14.44 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.566 -0.531 . . . . 50.0 109.566 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -58.5 131.25 50.19 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.545 -0.752 . . . . 50.0 109.386 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.09 -11.17 72.81 Favored Glycine 0 CA--C 1.517 0.205 0 CA-C-O 119.039 -0.867 . . . . 50.0 114.48 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -62.49 150.57 39.79 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 118.193 0.996 . . . . 50.0 109.636 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.6 mm -116.28 134.31 60.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.9 -1.045 . . . . 50.0 109.289 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -139.89 160.27 40.29 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.167 -0.679 . . . . 50.0 109.167 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.7 m -97.22 127.25 43.01 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.043 -1.095 . . . . 25.0 108.043 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.9 t -90.5 126.48 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 107.343 -1.354 . . . . 50.0 107.343 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.1 mt -94.96 -43.1 8.32 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.889 -0.782 . . . . 50.0 108.889 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -150.23 155.08 39.07 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.679 -0.86 . . . . 50.0 108.679 -177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -111.65 149.67 31.21 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.105 -0.702 . . . . 50.0 109.105 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 56.38 39.9 29.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 123.61 1.672 . . . . 50.0 108.654 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -64.31 153.56 37.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 112.591 -2.095 . . . . 25.0 110.777 -176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 60.76 8.95 1.98 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.683 0.793 . . . . 50.0 111.976 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.39 13.62 81.46 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.114 -0.794 . . . . 25.0 111.114 -176.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.5 mt -88.05 126.75 35.26 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.066 0.46 . . . . 50.0 109.8 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -67.64 125.03 24.92 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.352 -0.385 . . . . 25.0 110.665 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.0 1.46 85.26 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 117.038 1.575 . . . . 50.0 117.038 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -100.94 134.23 44.23 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 119.176 1.488 . . . . 50.0 109.849 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -113.79 140.68 48.1 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.909 -0.775 . . . . 50.0 108.909 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.81 123.62 27.89 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 104.821 -2.288 . . . . 50.0 104.821 176.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.46 ' HG ' HG21 ' A' ' 57' ' ' VAL . 98.0 m -134.98 163.07 30.69 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.668 -0.413 . . . . 50.0 111.562 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.0 t -117.21 126.5 52.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.908 -1.886 . . . . 50.0 105.908 170.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.0 tp -138.7 126.82 22.65 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.072 -1.455 . . . . 50.0 107.072 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.0 m170 55.54 30.38 15.13 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.273 0.559 . . . . 25.0 111.6 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.42 -4.87 80.11 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 116.115 1.206 . . . . 25.0 116.115 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -110.01 152.58 25.74 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.865 -1.161 . . . . 50.0 107.865 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -106.75 160.43 15.48 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.57 -0.53 . . . . 50.0 109.57 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.11 -160.11 31.52 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 105.398 -3.081 . . . . 50.0 105.398 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.1 pt -120.48 152.84 23.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.794 0.807 . . . . 50.0 111.485 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.46 HG21 ' HG ' ' A' ' 48' ' ' CYS . 2.9 m -139.0 145.56 45.88 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 114.714 -1.13 . . . . 50.0 109.111 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.73 124.54 7.59 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 117.045 -1.504 . . . . 50.0 112.19 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.84 -10.27 72.01 Favored Glycine 0 C--O 1.223 -0.537 0 CA-C-N 116.032 -0.531 . . . . 50.0 112.774 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.76 -19.32 62.34 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.39 -0.476 . . . . 50.0 112.083 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -130.7 27.34 4.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.117 -0.492 . . . . 50.0 110.47 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.26 156.2 44.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.303 0.573 . . . . 50.0 111.329 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -129.64 127.74 41.22 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.811 -0.631 . . . . 50.0 110.59 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.8 mm -72.09 135.26 28.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.131 -1.063 . . . . 50.0 108.131 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.4 mt -119.35 104.6 10.52 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.161 -0.681 . . . . 50.0 109.161 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.9 m -83.58 61.87 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 122.044 0.926 . . . . 50.0 109.208 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.29 174.07 30.71 Favored Glycine 0 C--O 1.221 -0.714 0 CA-C-N 115.297 -0.865 . . . . 25.0 113.035 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -76.04 7.59 3.95 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.368 0.877 . . . . 25.0 113.368 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -87.66 60.23 5.85 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.439 0.637 . . . . 25.0 112.069 -175.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -66.91 -28.91 68.69 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 114.761 -1.109 . . . . 25.0 108.843 173.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -66.8 149.63 50.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.117 -0.947 . . . . 50.0 109.436 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -55.12 146.06 41.78 Favored Pre-proline 0 C--O 1.24 0.601 0 CA-C-N 115.747 -0.66 . . . . 50.0 111.44 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.82 175.33 10.48 Favored 'Trans proline' 0 C--N 1.348 0.532 0 O-C-N 122.177 0.567 . . . . 50.0 112.944 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.14 170.63 14.71 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.961 -1.126 . . . . 25.0 107.961 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.21 -154.61 30.1 Favored Glycine 0 C--O 1.223 -0.545 0 O-C-N 123.476 0.485 . . . . 25.0 112.235 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 m 56.61 48.32 16.75 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.719 1.007 . . . . 25.0 113.719 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.53 163.86 51.82 Favored Glycine 0 CA--C 1.516 0.142 0 N-CA-C 111.252 -0.739 . . . . 25.0 111.252 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.98 62.26 4.56 Favored Glycine 0 C--O 1.222 -0.639 0 O-C-N 122.386 -0.479 . . . . 25.0 113.478 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.4 m -67.28 -19.81 65.55 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 114.057 1.132 . . . . 25.0 114.057 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.65 -170.7 46.43 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.053 -0.594 . . . . 25.0 112.634 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.9 t -157.08 163.64 38.77 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.669 -1.604 . . . . 25.0 106.669 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.1 -173.85 34.96 Favored Glycine 0 C--O 1.235 0.164 0 N-CA-C 110.687 -0.965 . . . . 25.0 110.687 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.8 t -156.03 144.82 20.33 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.836 -0.801 . . . . 25.0 108.836 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -150.34 148.96 29.45 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.044 -1.835 . . . . 50.0 106.044 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -79.96 114.85 19.18 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.157 -0.682 . . . . 25.0 109.157 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -127.19 168.39 14.76 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.405 -0.591 . . . . 50.0 109.405 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -64.58 154.27 36.73 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.255 0.835 . . . . 25.0 113.255 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.3 m -78.98 149.74 73.99 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.365 -0.834 . . . . 25.0 111.008 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.14 161.41 35.42 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 N-CA-C 114.227 0.818 . . . . 50.0 114.227 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.01 152.6 80.21 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 118.254 -0.697 . . . . 50.0 112.088 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.44 150.67 70.44 Favored 'Trans proline' 0 C--N 1.352 0.714 0 N-CA-C 116.006 1.502 . . . . 50.0 116.006 -173.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -85.35 152.56 58.13 Favored Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 115.522 -0.763 . . . . 50.0 110.162 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.09 161.84 42.29 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 O-C-N 122.201 0.579 . . . . 50.0 112.988 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.63 156.8 55.03 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 120.348 0.699 . . . . 50.0 113.853 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 65.2 mtt85 -101.95 -10.8 19.47 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.271 0.471 . . . . 50.0 112.271 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.6 p -141.27 149.3 41.12 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 106.594 -1.632 . . . . 25.0 106.594 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -148.76 29.24 0.83 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.538 0.685 . . . . 50.0 110.045 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.2 m -118.87 164.02 16.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.419 -0.809 . . . . 25.0 109.734 -176.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.6 t 55.39 55.9 6.91 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.77 1.272 . . . . 25.0 112.334 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.5 mp . . . . . 0 C--O 1.216 -0.702 0 CA-C-O 124.349 2.023 . . . . 25.0 110.059 178.62 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.711 0 CA-C-O 123.891 1.828 . . . . 25.0 113.121 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m 56.63 23.78 8.11 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 112.292 -1.954 . . . . 25.0 113.117 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.9 ttt -99.81 -27.84 13.43 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.517 1.673 . . . . 25.0 115.517 -171.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.18 13.27 2.61 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 112.564 0.579 . . . . 50.0 112.564 -176.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -71.06 162.01 30.16 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.327 1.232 . . . . 50.0 114.327 -174.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.8 mt -65.59 -39.22 91.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.512 -1.222 . . . . 50.0 110.687 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 57.27 28.72 15.62 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.173 0.989 . . . . 50.0 112.444 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 m -90.35 152.11 3.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.143 -1.058 . . . . 50.0 108.143 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.98 167.38 12.84 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.187 -0.671 . . . . 50.0 109.187 -176.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.35 161.17 43.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.732 0.301 . . . . 25.0 111.27 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -126.9 129.58 48.48 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.688 0.795 . . . . 50.0 110.157 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.46 131.28 43.81 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.746 -0.464 . . . . 25.0 109.746 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.0 mt -95.83 -21.16 18.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.074 0.464 . . . . 50.0 111.034 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -144.48 175.95 9.75 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 103.814 -2.661 . . . . 50.0 103.814 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -92.05 179.17 5.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.301 0.5 . . . . 50.0 111.53 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -159.04 154.77 26.26 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.075 0.55 . . . . 50.0 110.135 173.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.4 t -124.6 127.4 72.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 105.986 -1.857 . . . . 25.0 105.986 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.74 129.6 38.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.961 -0.563 . . . . 25.0 110.783 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -105.33 1.11 27.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.536 0.684 . . . . 50.0 109.838 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.9 p -151.83 158.86 33.83 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.016 -1.105 . . . . 50.0 108.016 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.75 -16.85 33.39 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 118.321 -0.652 . . . . 50.0 112.873 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.75 -21.68 54.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.419 0.628 . . . . 50.0 110.044 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -95.46 146.21 24.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.522 0.677 . . . . 50.0 111.411 -176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.1 mt -100.14 132.61 45.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.55 0.691 . . . . 50.0 110.166 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.6 m -82.64 146.44 29.1 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 105.527 -2.027 . . . . 50.0 105.527 172.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -157.73 164.87 36.67 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.358 -0.608 . . . . 50.0 109.358 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.86 158.59 23.73 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.526 -0.916 . . . . 50.0 108.526 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -56.24 128.13 34.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.571 -0.741 . . . . 50.0 109.891 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.72 -10.85 64.63 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-O 118.985 -0.897 . . . . 50.0 114.061 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -61.52 148.7 41.22 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.033 0.916 . . . . 50.0 110.775 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.4 mm -112.02 134.02 55.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.457 -1.247 . . . . 50.0 108.481 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.4 ptp -143.19 162.23 36.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.057 -0.72 . . . . 50.0 109.057 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.9 m -98.81 125.87 44.29 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.042 -1.096 . . . . 25.0 108.042 177.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.8 t -89.6 125.61 42.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.786 -1.19 . . . . 50.0 107.786 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.1 mt -94.54 -49.48 5.64 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.455 -1.248 . . . . 50.0 109.644 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -143.34 160.39 40.61 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.545 -1.279 . . . . 50.0 107.545 -174.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -125.68 150.71 47.41 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 106.899 -1.519 . . . . 50.0 106.899 175.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 56.27 39.15 30.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.398 1.571 . . . . 50.0 108.274 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -66.08 148.61 51.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.443 -1.708 . . . . 25.0 109.813 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 60.18 11.81 2.96 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.72 0.808 . . . . 50.0 113.013 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.61 13.62 81.25 Favored Glycine 0 C--O 1.229 -0.177 0 N-CA-C 111.296 -0.721 . . . . 25.0 111.296 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.9 mt -91.19 112.19 23.99 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.709 -0.478 . . . . 50.0 109.709 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -58.52 124.92 21.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.497 -0.774 . . . . 25.0 110.858 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.0 -0.19 83.79 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 116.02 1.168 . . . . 50.0 116.02 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -98.03 132.26 43.73 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 119.303 1.552 . . . . 50.0 110.76 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -111.15 138.58 47.42 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.206 -1.035 . . . . 50.0 108.206 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.21 125.82 31.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 104.681 -2.34 . . . . 50.0 104.681 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.403 ' HG ' HG23 ' A' ' 57' ' ' VAL . 89.9 m -134.65 164.29 27.84 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 111.951 0.352 . . . . 50.0 111.951 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.0 t -117.27 123.84 47.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.828 -1.545 . . . . 50.0 106.828 171.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.8 tp -151.73 142.63 22.99 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 106.875 -1.528 . . . . 50.0 106.875 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 56.4 28.25 13.29 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.319 0.647 . . . . 25.0 112.073 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.75 1.15 76.95 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 115.006 0.762 . . . . 25.0 115.006 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -123.62 161.05 25.79 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.026 -0.731 . . . . 50.0 109.026 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -108.53 156.63 19.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.174 -0.676 . . . . 50.0 109.174 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.58 -161.22 28.37 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 105.383 -3.087 . . . . 50.0 105.383 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.9 pt -120.73 153.18 23.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-O 121.728 0.775 . . . . 50.0 111.034 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.403 HG23 ' HG ' ' A' ' 48' ' ' CYS . 3.2 m -141.74 147.38 45.16 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 114.473 -1.239 . . . . 50.0 107.674 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.82 126.48 8.83 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 117.086 -1.476 . . . . 50.0 111.713 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.17 -12.0 75.63 Favored Glycine 0 C--O 1.222 -0.621 0 CA-C-N 116.293 -0.412 . . . . 50.0 113.131 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -66.67 -13.54 61.37 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.781 0.66 . . . . 50.0 112.781 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -131.97 27.13 4.58 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.215 -0.661 . . . . 50.0 109.215 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.8 tp -131.96 147.44 52.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.737 -0.665 . . . . 50.0 109.709 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -125.55 120.09 29.92 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.408 -0.36 . . . . 50.0 111.743 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.98 136.1 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.037 -0.727 . . . . 50.0 109.037 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.1 mt -116.78 81.66 1.67 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.945 -1.502 . . . . 50.0 106.945 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.18 -26.04 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.158 0.504 . . . . 50.0 111.704 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.45 162.15 27.61 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 106.272 -2.731 . . . . 25.0 106.272 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 66.2 mmm -157.01 -40.11 0.07 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 117.679 0.739 . . . . 25.0 110.666 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -139.93 148.83 42.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.883 -0.784 . . . . 25.0 108.883 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -95.68 8.67 42.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.729 0.776 . . . . 25.0 111.047 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -117.96 162.64 17.81 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.8 -0.636 . . . . 50.0 110.453 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -59.04 144.57 82.3 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.312 -0.625 . . . . 50.0 109.312 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.36 148.68 68.2 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 117.837 -0.975 . . . . 50.0 113.477 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.93 29.92 0.65 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.647 -0.706 . . . . 25.0 110.052 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.93 118.54 5.88 Favored Glycine 0 C--O 1.22 -0.726 0 C-N-CA 120.954 -0.641 . . . . 25.0 112.174 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.3 t -71.64 -37.65 70.83 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.873 0.694 . . . . 25.0 112.873 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.5 -132.28 10.97 Favored Glycine 0 C--O 1.225 -0.441 0 C-N-CA 120.5 -0.857 . . . . 25.0 111.905 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.85 -14.33 62.07 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 115.071 0.788 . . . . 25.0 115.071 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 65.3 p -87.32 64.84 8.46 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.013 -0.698 . . . . 25.0 112.863 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.75 50.23 0.36 Allowed Glycine 0 C--O 1.219 -0.843 0 N-CA-C 115.717 1.047 . . . . 25.0 115.717 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.8 p -65.58 -32.66 74.37 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.749 1.389 . . . . 25.0 114.749 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.82 33.15 86.13 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 120.827 -0.701 . . . . 25.0 113.924 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.1 t -75.05 145.28 42.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.802 0.301 . . . . 25.0 111.602 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.35 166.0 0.13 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.952 1.301 . . . . 50.0 113.939 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -65.13 -41.15 95.1 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.849 0.685 . . . . 25.0 112.849 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 55.56 -165.36 0.12 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.282 0.845 . . . . 50.0 113.282 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -71.39 148.37 47.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.581 -0.736 . . . . 25.0 110.654 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.7 p -75.29 137.56 71.75 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.429 -0.351 . . . . 25.0 111.008 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.57 158.76 43.56 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 118.263 -0.691 . . . . 50.0 112.772 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.8 148.56 86.65 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 117.705 -1.064 . . . . 50.0 111.75 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.55 151.17 58.49 Favored 'Trans proline' 0 C--N 1.348 0.548 0 N-CA-C 116.481 1.685 . . . . 50.0 116.481 -170.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -73.13 145.11 85.6 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 109.132 -0.692 . . . . 50.0 109.132 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.39 166.47 29.4 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 O-C-N 121.963 0.454 . . . . 50.0 112.704 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -60.37 158.94 29.04 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 120.751 0.968 . . . . 50.0 114.523 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -121.45 24.73 9.76 Favored 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 113.953 1.094 . . . . 50.0 113.953 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.3 p 51.32 -0.57 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 118.828 2.899 . . . . 25.0 118.828 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.8 mtp85 -70.52 -6.99 40.3 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.347 -0.846 . . . . 50.0 111.115 177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.1 t -150.03 90.88 1.72 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.71 -1.219 . . . . 25.0 107.71 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 30.9 p -154.7 172.55 17.74 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.044 -1.095 . . . . 25.0 108.044 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.214 -0.809 0 CA-C-O 124.671 2.177 . . . . 25.0 110.939 175.235 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 CA-C-O 123.046 1.359 . . . . 25.0 115.215 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.0 m -66.87 140.0 57.77 Favored 'General case' 0 C--N 1.338 0.093 0 O-C-N 121.344 -1.091 . . . . 25.0 110.04 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.1 mtt -129.15 123.55 32.42 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.76 -0.459 . . . . 25.0 109.76 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -150.34 114.61 5.14 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 108.198 -1.038 . . . . 50.0 108.198 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -135.7 168.33 19.48 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 123.233 0.333 . . . . 50.0 110.354 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.2 mt -67.73 -39.86 84.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.652 -0.704 . . . . 50.0 109.228 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 56.45 32.38 20.57 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.947 0.899 . . . . 50.0 111.795 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.4 m -94.6 153.91 3.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 107.032 -1.47 . . . . 50.0 107.032 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.7 167.08 11.68 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.042 -1.095 . . . . 50.0 108.042 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.96 154.46 37.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.674 0.273 . . . . 25.0 110.489 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -118.69 132.13 56.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.835 -0.62 . . . . 50.0 110.838 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.63 125.64 27.38 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.184 -0.673 . . . . 25.0 109.184 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.9 mt -91.7 -21.23 20.86 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.257 0.551 . . . . 50.0 110.397 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -141.97 176.05 9.25 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 104.565 -2.383 . . . . 50.0 104.565 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -91.48 177.78 6.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.715 0.293 . . . . 50.0 110.906 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -155.64 155.1 32.66 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.355 0.262 . . . . 50.0 111.647 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.8 t -124.85 132.28 71.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 103.736 -2.69 . . . . 25.0 103.736 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.73 127.64 33.15 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.857 -0.423 . . . . 25.0 109.857 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -101.83 2.72 38.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.727 0.775 . . . . 50.0 110.535 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.2 p -149.88 157.73 37.74 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 108.014 -1.106 . . . . 75.0 108.014 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.8 -15.21 33.19 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 118.177 -0.749 . . . . 50.0 113.007 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -76.55 -21.43 55.69 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.407 0.622 . . . . 50.0 109.475 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -93.75 139.45 30.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.987 0.898 . . . . 50.0 111.829 -172.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.4 mt -90.16 129.32 36.45 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.21 -0.905 . . . . 50.0 109.546 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -88.21 143.05 27.27 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 105.411 -2.07 . . . . 50.0 105.411 175.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -157.25 167.97 28.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.732 0.301 . . . . 50.0 110.297 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.69 165.4 12.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.737 0.78 . . . . 50.0 110.327 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.1 128.41 36.28 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.218 -0.901 . . . . 50.0 110.069 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.83 -12.49 64.23 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-O 118.922 -0.932 . . . . 50.0 114.933 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -59.65 152.98 21.11 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.977 0.894 . . . . 50.0 112.001 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.0 mm -114.77 130.65 68.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.428 -1.26 . . . . 50.0 109.14 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.8 ptp -137.84 151.57 48.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.469 -0.567 . . . . 50.0 109.469 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.0 m -90.78 124.75 35.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.291 -1.003 . . . . 25.0 108.291 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t -87.34 123.14 39.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 107.893 -1.151 . . . . 50.0 107.893 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.7 mt -89.74 -46.23 8.75 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.051 -0.722 . . . . 50.0 109.051 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -149.56 165.15 33.11 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.771 -0.826 . . . . 50.0 108.771 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.41 ' HE ' ' HB3' ' A' ' 37' ' ' ARG . 38.2 mtp180 -115.77 154.61 29.31 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.19 -0.67 . . . . 50.0 109.19 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 57.67 40.76 26.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 124.12 1.914 . . . . 50.0 107.463 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.6 t -65.74 151.65 46.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 111.808 -2.451 . . . . 25.0 111.699 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 58.03 18.13 4.92 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.373 0.879 . . . . 50.0 113.373 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.52 16.6 80.53 Favored Glycine 0 C--O 1.227 -0.285 0 N-CA-C 111.699 -0.56 . . . . 25.0 111.699 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.7 mt -98.45 113.93 26.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.088 0.471 . . . . 50.0 110.759 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -59.34 127.7 33.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.682 -0.69 . . . . 25.0 110.755 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.09 -2.03 67.07 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 115.85 1.1 . . . . 50.0 115.85 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -95.83 132.8 40.71 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 119.028 1.414 . . . . 50.0 109.023 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -113.52 138.23 50.43 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.793 -1.188 . . . . 50.0 107.793 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.5 tp -81.41 125.43 30.41 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 105.922 -1.881 . . . . 50.0 105.922 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 91.4 m -134.0 161.99 33.3 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.201 0.524 . . . . 50.0 111.784 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.6 t -113.64 122.5 47.35 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.123 -1.436 . . . . 50.0 107.123 170.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.1 tp -144.62 133.03 21.91 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.919 -0.771 . . . . 50.0 108.919 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 54.09 31.98 14.82 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.427 0.691 . . . . 25.0 112.275 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.16 0.15 88.44 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.087 -0.578 . . . . 25.0 114.507 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -109.11 141.63 41.02 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 117.77 0.785 . . . . 50.0 109.346 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -96.89 143.19 28.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 106.553 -1.647 . . . . 50.0 106.553 169.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.69 -163.72 29.45 Favored Glycine 0 CA--C 1.496 -1.117 0 N-CA-C 103.647 -3.781 . . . . 50.0 103.647 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.7 pt -121.82 158.54 25.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-O 121.3 0.571 . . . . 50.0 110.56 -174.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.2 m -142.53 148.68 47.92 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 115.297 -0.865 . . . . 50.0 109.214 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.54 120.43 6.71 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 118.359 -0.627 . . . . 50.0 110.967 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.74 -10.42 80.08 Favored Glycine 0 C--O 1.226 -0.371 0 O-C-N 121.878 -0.514 . . . . 50.0 114.049 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -72.8 -5.88 41.02 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.788 0.662 . . . . 50.0 112.788 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -130.01 26.49 5.21 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.983 -0.747 . . . . 50.0 108.983 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.6 mt -124.03 155.38 38.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.807 0.813 . . . . 50.0 111.435 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -126.73 120.04 28.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.843 -1.072 . . . . 50.0 109.428 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.1 mm -71.33 136.15 26.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.882 -0.785 . . . . 50.0 108.882 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.4 mt -115.42 94.73 4.84 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.546 -1.279 . . . . 50.0 107.546 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.65 108.97 20.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.299 0.571 . . . . 50.0 111.562 -177.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.85 44.91 3.27 Favored Glycine 0 C--O 1.218 -0.86 0 CA-C-N 116.07 -0.514 . . . . 25.0 112.93 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 99.5 mmm -69.84 -26.21 64.11 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.272 0.471 . . . . 25.0 112.272 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -144.56 129.44 18.37 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.927 -1.509 . . . . 25.0 106.927 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -75.44 120.39 20.82 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.93 0.872 . . . . 25.0 110.011 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -127.92 -0.1 5.96 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.151 -0.931 . . . . 50.0 109.107 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -159.92 93.46 1.68 Allowed Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 124.549 1.139 . . . . 50.0 108.061 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.74 2.34 6.0 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 121.336 1.357 . . . . 50.0 114.011 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.27 -2.07 17.64 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.555 1.317 . . . . 25.0 114.555 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.12 -25.7 2.62 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 115.804 1.082 . . . . 25.0 115.804 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.1 m 57.26 37.42 28.22 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.738 1.014 . . . . 25.0 113.738 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -138.43 -171.28 12.12 Favored Glycine 0 C--O 1.223 -0.56 0 N-CA-C 109.741 -1.344 . . . . 25.0 109.741 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.55 -6.45 74.45 Favored Glycine 0 C--O 1.225 -0.459 0 CA-C-N 117.375 0.588 . . . . 25.0 114.486 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.7 m -71.6 147.07 47.95 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.273 -0.545 . . . . 25.0 109.794 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.16 174.09 54.99 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 111.415 -0.674 . . . . 25.0 111.415 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.8 p -68.73 151.83 46.14 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.891 -0.411 . . . . 25.0 109.891 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.29 166.18 31.04 Favored Glycine 0 N--CA 1.453 -0.21 0 N-CA-C 110.204 -1.158 . . . . 25.0 110.204 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.9 p -136.44 166.29 23.83 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.1 -1.444 . . . . 25.0 107.1 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -149.99 152.15 34.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.433 -1.321 . . . . 50.0 107.433 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -92.31 71.58 5.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.795 0.331 . . . . 25.0 110.399 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -135.05 164.77 26.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.471 -0.937 . . . . 50.0 108.471 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -61.76 159.01 14.43 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.872 1.064 . . . . 25.0 113.872 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.0 m -60.72 154.28 58.24 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 114.719 -1.128 . . . . 25.0 112.637 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.14 157.78 55.6 Favored 'Trans proline' 0 C--N 1.348 0.536 0 N-CA-C 114.528 0.934 . . . . 50.0 114.528 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -63.35 154.05 70.58 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 N-CA-C 113.282 0.454 . . . . 50.0 113.282 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -56.97 152.19 45.13 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.41 1.407 . . . . 50.0 115.603 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -65.62 147.34 98.74 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.362 -0.836 . . . . 50.0 110.184 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.65 160.66 48.91 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 117.881 -0.946 . . . . 50.0 111.57 176.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -60.83 153.48 62.59 Favored 'Trans proline' 0 C--N 1.349 0.561 0 N-CA-C 114.087 0.764 . . . . 50.0 114.087 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -104.81 26.92 8.57 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.575 -0.284 . . . . 50.0 110.448 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.4 p 45.35 -136.11 0.64 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.908 0.883 . . . . 25.0 110.553 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 53.9 32.66 15.62 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.053 1.501 . . . . 50.0 115.053 172.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.6 t -143.98 132.22 21.91 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.692 -0.855 . . . . 25.0 108.692 176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 10.9 p -149.08 27.94 0.84 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.871 0.843 . . . . 25.0 109.525 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 C--O 1.211 -0.941 0 CA-C-O 124.879 2.276 . . . . 25.0 111.563 -176.935 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 CA-C-O 122.397 0.998 . . . . 25.0 115.186 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t -80.86 105.09 11.82 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.222 -1.163 . . . . 25.0 109.528 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -142.84 20.38 1.98 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.315 0.579 . . . . 25.0 111.257 -176.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -117.62 87.23 2.67 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.469 -0.332 . . . . 50.0 110.426 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -136.28 164.54 27.85 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.204 0.446 . . . . 50.0 112.204 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.2 mt -64.73 -41.63 95.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.248 -0.887 . . . . 50.0 111.161 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 54.91 34.82 23.06 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.919 0.887 . . . . 50.0 112.249 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 m -95.48 158.47 3.0 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 104.485 -2.413 . . . . 50.0 104.485 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.13 174.03 7.11 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.776 -0.824 . . . . 50.0 108.776 -175.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.19 161.54 41.79 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.176 -0.305 . . . . 25.0 110.176 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -128.23 130.52 48.07 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.513 0.725 . . . . 50.0 110.031 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.59 133.66 47.87 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.438 0.461 . . . . 25.0 110.141 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.78 -19.68 16.6 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.351 0.596 . . . . 50.0 110.579 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -143.22 171.73 13.69 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.681 -1.6 . . . . 50.0 106.681 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -77.86 167.46 21.49 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.324 0.39 . . . . 50.0 110.868 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -151.75 150.15 29.86 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-O 120.749 0.309 . . . . 50.0 111.07 170.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.6 t -124.93 136.28 61.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 104.528 -2.397 . . . . 25.0 104.528 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.07 136.96 48.5 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 124.27 0.982 . . . . 25.0 108.548 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -117.9 1.09 12.05 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.864 0.84 . . . . 50.0 109.653 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -128.02 146.29 58.64 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 105.799 -1.926 . . . . 50.0 105.799 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -69.89 -18.34 36.46 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 117.386 -1.276 . . . . 50.0 112.638 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -77.53 -15.64 59.14 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.18 -0.464 . . . . 50.0 110.624 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -101.47 140.58 35.57 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.421 -0.955 . . . . 50.0 108.421 -176.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.8 mt -101.37 126.16 48.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.992 0.901 . . . . 50.0 111.688 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.18 145.57 26.35 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.605 -1.257 . . . . 50.0 107.605 175.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -159.29 165.07 34.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.261 0.553 . . . . 50.0 110.856 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -107.34 153.09 23.27 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.509 -1.293 . . . . 50.0 107.509 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -54.65 129.84 38.1 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.996 -0.742 . . . . 50.0 108.996 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.14 -11.28 70.85 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-O 118.899 -0.945 . . . . 50.0 114.518 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -64.06 156.7 27.38 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.989 0.894 . . . . 50.0 110.077 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.6 mm -120.13 135.36 60.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.68 -1.146 . . . . 50.0 109.322 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -141.81 158.2 44.09 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.5 -0.556 . . . . 50.0 109.5 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 m -92.09 128.93 38.12 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 108.287 -1.005 . . . . 25.0 108.287 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.2 t -92.08 123.82 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 N-CA-C 108.279 -1.008 . . . . 50.0 108.279 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -88.96 -45.81 9.38 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.414 -0.812 . . . . 50.0 109.284 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -155.31 168.78 25.96 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.512 -0.921 . . . . 50.0 108.512 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -120.39 152.63 37.64 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 106.621 -1.622 . . . . 50.0 106.621 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 58.03 43.93 20.26 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 125.731 1.894 . . . . 50.0 109.119 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 t -69.41 155.79 39.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 112.65 -2.068 . . . . 25.0 111.112 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 58.72 14.75 3.33 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.801 1.037 . . . . 50.0 113.801 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.88 13.86 81.64 Favored Glycine 0 C--O 1.23 -0.148 0 N-CA-C 111.59 -0.604 . . . . 25.0 111.59 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.8 mt -94.33 132.61 38.76 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 110.107 -0.331 . . . . 50.0 110.107 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -78.41 128.64 33.92 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.855 -0.795 . . . . 25.0 108.855 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.96 -2.55 83.41 Favored Glycine 0 C--O 1.239 0.423 0 N-CA-C 116.319 1.288 . . . . 50.0 116.319 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -101.87 133.94 45.85 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 118.428 1.114 . . . . 50.0 108.307 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.3 m0 -115.62 143.23 45.64 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.08 -0.711 . . . . 50.0 109.08 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.08 123.76 30.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.916 -1.883 . . . . 50.0 105.916 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.1 m -130.71 162.1 30.2 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.022 0.379 . . . . 50.0 112.022 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.0 t -114.34 119.79 38.15 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.038 -1.838 . . . . 50.0 106.038 171.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.8 tp -141.0 126.87 19.21 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.294 -1.002 . . . . 50.0 108.294 -175.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.0 m170 55.64 31.85 18.13 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.262 0.625 . . . . 25.0 111.279 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.63 0.95 88.65 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 114.676 0.63 . . . . 25.0 114.676 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -107.97 155.2 20.59 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 106.691 -1.596 . . . . 50.0 106.691 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -121.89 144.44 48.85 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.043 -1.466 . . . . 50.0 107.043 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.65 -161.6 27.25 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 107.1 -2.4 . . . . 50.0 107.1 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.7 pt -115.77 150.15 17.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.707 0.765 . . . . 50.0 111.053 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -138.28 145.41 47.09 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 114.639 -1.164 . . . . 50.0 108.565 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.62 120.95 6.72 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 CA-C-O 121.606 0.586 . . . . 50.0 110.821 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.65 -17.04 77.84 Favored Glycine 0 C--O 1.216 -1.007 0 N-CA-C 115.038 0.775 . . . . 50.0 115.038 -174.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -77.93 -1.56 32.49 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.151 0.797 . . . . 50.0 113.151 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -127.74 25.57 5.98 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.682 -1.229 . . . . 50.0 107.682 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.8 tp -135.46 150.34 49.79 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.193 -0.912 . . . . 75.0 109.368 -173.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -126.28 120.75 30.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.568 -0.287 . . . . 50.0 111.556 -177.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.5 mm -67.76 135.45 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.795 -0.446 . . . . 50.0 109.795 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.2 mt -117.1 92.52 3.88 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.457 -1.312 . . . . 50.0 107.457 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.5 p -94.41 140.0 17.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.427 -0.953 . . . . 50.0 108.427 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -152.9 155.3 26.05 Favored Glycine 0 C--O 1.222 -0.631 0 N-CA-C 107.427 -2.269 . . . . 25.0 107.427 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -142.24 11.75 1.96 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.484 0.55 . . . . 25.0 112.484 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.71 19.31 5.13 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.715 1.005 . . . . 25.0 113.715 -172.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -122.79 144.09 49.41 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.161 -2.162 . . . . 25.0 105.161 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -81.04 -39.98 24.94 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.781 0.66 . . . . 50.0 112.781 -172.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -148.89 145.87 20.55 Favored Pre-proline 0 N--CA 1.477 0.89 0 N-CA-C 106.007 -1.849 . . . . 50.0 106.007 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -71.57 145.88 48.13 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 117.396 -1.269 . . . . 50.0 114.064 -177.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.26 145.88 24.14 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.522 -1.288 . . . . 25.0 107.522 174.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -131.9 47.14 1.03 Allowed Glycine 0 C--O 1.219 -0.811 0 N-CA-C 114.93 0.732 . . . . 25.0 114.93 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.1 t -122.91 120.48 33.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.323 0.561 . . . . 25.0 110.026 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 139.5 -165.31 25.82 Favored Glycine 0 C--O 1.224 -0.527 0 N-CA-C 109.953 -1.259 . . . . 25.0 109.953 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.93 177.42 43.94 Favored Glycine 0 C--N 1.321 -0.27 0 N-CA-C 108.854 -1.698 . . . . 25.0 108.854 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.9 p -70.05 -33.29 71.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.893 0.846 . . . . 25.0 112.419 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.06 177.87 49.96 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 121.363 -0.446 . . . . 25.0 112.493 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.1 p -90.94 136.94 32.74 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.528 -0.916 . . . . 25.0 108.528 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.68 37.55 0.16 Allowed Glycine 0 C--O 1.225 -0.431 0 C-N-CA 120.514 -0.85 . . . . 25.0 114.915 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.2 t -150.72 118.26 6.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.404 0.602 . . . . 25.0 109.444 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -129.84 1.07 4.85 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 107.341 -1.355 . . . . 50.0 107.341 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -143.49 160.95 39.66 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 105.11 -2.182 . . . . 25.0 105.11 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -69.96 146.08 51.39 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 123.517 0.511 . . . . 50.0 109.983 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.31 161.12 14.22 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.242 -1.392 . . . . 25.0 107.242 175.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.2 t -123.61 95.61 44.63 Favored Pre-proline 0 N--CA 1.47 0.552 0 N-CA-C 108.314 -0.995 . . . . 25.0 108.314 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -79.19 158.35 26.53 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 N-CA-C 114.215 0.814 . . . . 50.0 114.215 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.45 156.36 65.89 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 117.943 -0.905 . . . . 50.0 111.584 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.28 153.62 76.57 Favored 'Trans proline' 0 C--N 1.347 0.451 0 N-CA-C 114.561 0.946 . . . . 50.0 114.561 -174.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -74.33 140.35 76.02 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 109.395 -0.594 . . . . 50.0 109.395 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.67 160.2 46.95 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 116.908 -1.595 . . . . 50.0 110.944 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -62.51 151.16 84.71 Favored 'Trans proline' 0 C--N 1.351 0.691 0 N-CA-C 114.804 1.04 . . . . 50.0 114.804 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -102.71 -1.92 29.16 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 111.855 0.317 . . . . 50.0 111.855 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 34.2 p -140.78 145.53 36.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.511 -0.551 . . . . 25.0 109.511 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -118.29 19.38 13.48 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 116.609 -0.269 . . . . 50.0 111.275 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.0 t 50.5 50.59 18.52 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 123.62 0.575 . . . . 25.0 110.552 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.5 m 57.14 68.74 0.82 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.918 1.342 . . . . 25.0 111.205 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.5 mt . . . . . 0 N--CA 1.479 1.004 0 C-N-CA 126.486 1.914 . . . . 25.0 115.118 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 CA-C-O 124.642 2.245 . . . . 25.0 113.646 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.2 t -146.78 147.66 31.14 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 113.257 -1.471 . . . . 25.0 108.497 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.2 tpt -138.07 40.41 2.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.704 -1.591 . . . . 25.0 106.704 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.66 144.97 26.19 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.036 -1.468 . . . . 50.0 107.036 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 63.66 164.16 0.12 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 115.1 1.519 . . . . 50.0 115.1 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.4 mt -75.56 -36.51 60.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.459 -1.246 . . . . 50.0 110.74 -177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.5 m120 55.88 25.08 8.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.632 1.173 . . . . 50.0 112.768 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.2 m -88.88 177.13 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 105.731 -1.952 . . . . 50.0 105.731 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.22 174.07 6.56 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.083 -0.71 . . . . 50.0 109.083 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.9 161.19 42.36 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.551 -0.537 . . . . 25.0 109.551 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -123.6 135.43 53.95 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.393 -0.822 . . . . 50.0 110.1 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.29 126.74 30.56 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 123.869 0.73 . . . . 25.0 110.276 174.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.5 mt -93.09 -23.51 18.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.236 0.541 . . . . 50.0 110.697 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -142.43 168.1 20.52 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.737 -1.579 . . . . 50.0 106.737 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -76.73 162.99 27.25 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.307 0.379 . . . . 50.0 110.865 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -150.35 133.09 15.89 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 114.041 1.126 . . . . 50.0 114.041 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.8 t -109.55 124.68 66.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 105.473 -2.047 . . . . 25.0 105.473 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.06 139.69 50.48 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.475 -0.784 . . . . 25.0 110.373 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -112.6 -28.84 7.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.296 0.569 . . . . 50.0 109.589 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -102.15 152.35 38.23 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 107.481 -1.303 . . . . 50.0 107.481 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.4 -22.54 33.58 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 117.688 -1.074 . . . . 50.0 113.105 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -83.97 -10.72 57.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.849 -0.614 . . . . 50.0 110.898 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -85.86 135.64 33.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.747 0.785 . . . . 50.0 109.747 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.9 mt -87.89 128.93 35.36 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.731 0.777 . . . . 50.0 109.576 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.1 t -88.31 140.33 29.59 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 105.461 -2.051 . . . . 50.0 105.461 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -156.87 168.95 25.93 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.785 -0.82 . . . . 50.0 108.785 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.5 mtt-85 -122.91 166.98 14.15 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.179 0.514 . . . . 50.0 111.442 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.22 129.32 41.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.893 -0.594 . . . . 50.0 110.631 -176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.04 -13.02 65.36 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-O 119.491 -0.616 . . . . 50.0 113.508 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -62.32 150.11 40.31 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 117.659 0.73 . . . . 50.0 109.751 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.7 mm -116.41 133.25 63.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 107.922 -1.14 . . . . 50.0 107.922 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -136.25 148.86 48.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.143 -0.688 . . . . 50.0 109.143 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 51.8 m -85.14 129.68 34.76 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.967 -1.494 . . . . 25.0 106.967 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.1 t -94.01 126.17 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.805 -0.813 . . . . 50.0 108.805 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.1 mt -95.95 -45.05 7.09 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.368 -0.604 . . . . 50.0 109.368 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -147.48 159.07 44.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.271 -0.172 . . . . 50.0 110.785 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -117.08 153.95 31.84 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.537 -0.912 . . . . 50.0 108.537 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 53.76 39.8 30.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 123.482 1.611 . . . . 50.0 109.685 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.9 t -69.85 157.17 37.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.153 -1.839 . . . . 25.0 111.625 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 59.92 10.51 2.18 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.22 1.008 . . . . 50.0 112.678 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.74 13.66 81.06 Favored Glycine 0 C--O 1.239 0.41 0 N-CA-C 111.184 -0.766 . . . . 25.0 111.184 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.43 125.26 39.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.947 0.403 . . . . 50.0 110.069 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -67.45 126.84 30.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.958 -0.564 . . . . 25.0 110.349 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.74 -0.6 85.89 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 116.466 1.346 . . . . 50.0 116.466 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -99.05 132.95 43.99 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 119.146 1.473 . . . . 50.0 110.066 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -113.45 137.69 51.17 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.483 -0.562 . . . . 50.0 109.483 -177.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.9 tp -80.77 121.09 25.48 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 106.376 -1.712 . . . . 50.0 106.376 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 98.8 m -133.75 167.7 20.05 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.768 0.318 . . . . 50.0 111.151 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.7 t -118.8 126.16 51.22 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.0 -0.741 . . . . 50.0 109.0 172.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.3 tp -147.4 139.59 24.44 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.115 -1.068 . . . . 50.0 108.115 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 27.3 m170 55.99 29.82 15.02 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.364 0.665 . . . . 25.0 112.022 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.26 1.81 86.42 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 120.994 -0.622 . . . . 25.0 114.094 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -109.91 145.97 35.94 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.45 -0.945 . . . . 50.0 108.45 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -99.99 144.91 28.48 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 105.306 -2.109 . . . . 50.0 105.306 170.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.21 -163.58 29.49 Favored Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 105.525 -3.03 . . . . 50.0 105.525 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.9 pt -120.86 154.25 24.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.467 0.651 . . . . 50.0 111.097 -173.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.6 146.03 46.08 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 114.993 -1.003 . . . . 50.0 108.758 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.64 122.15 7.18 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 117.979 -0.881 . . . . 50.0 111.684 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.96 -13.95 72.89 Favored Glycine 0 C--O 1.223 -0.532 0 CA-C-N 116.277 -0.419 . . . . 50.0 114.032 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -68.94 -8.54 45.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.085 0.772 . . . . 50.0 113.085 -178.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -132.63 26.01 4.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.619 -0.882 . . . . 50.0 108.619 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 tp -129.88 157.19 42.95 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.445 -0.798 . . . . 50.0 110.67 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -131.58 120.35 22.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.807 -0.633 . . . . 50.0 110.773 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.9 mm -65.81 136.59 26.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 123.662 0.601 . . . . 50.0 109.511 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.3 mt -117.64 111.56 19.33 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.28 -2.118 . . . . 50.0 105.28 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.66 157.52 3.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.272 -1.011 . . . . 50.0 108.272 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.99 177.82 29.2 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 110.123 -1.191 . . . . 25.0 110.123 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 7.6 tpt -76.58 -41.19 47.19 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.48 0.548 . . . . 25.0 112.48 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -169.23 155.09 6.23 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.457 -0.942 . . . . 25.0 108.457 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -78.13 -41.21 35.7 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.239 0.542 . . . . 25.0 110.546 175.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -169.77 174.92 5.48 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.198 -0.668 . . . . 50.0 109.198 -173.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.88 147.25 98.53 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 107.409 -1.33 . . . . 50.0 107.409 172.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.74 159.9 47.48 Favored 'Trans proline' 0 C--N 1.348 0.508 0 O-C-N 122.039 0.494 . . . . 50.0 112.59 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -117.97 -22.01 8.07 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.989 0.737 . . . . 25.0 112.989 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.73 -145.87 39.23 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 109.759 -1.337 . . . . 25.0 109.759 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 t 58.96 -157.31 0.32 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.32 0.648 . . . . 25.0 111.247 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.25 -145.73 18.65 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 110.011 -1.236 . . . . 25.0 110.011 -176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.4 28.3 69.97 Favored Glycine 0 C--O 1.225 -0.458 0 C-N-CA 120.534 -0.841 . . . . 25.0 114.852 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.5 t -137.28 146.35 44.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.248 0.524 . . . . 25.0 109.645 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 163.12 174.56 33.16 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 107.798 -2.121 . . . . 25.0 107.798 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.0 p -151.98 152.73 32.84 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.05 -1.093 . . . . 25.0 108.05 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.99 10.82 58.72 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 121.653 -0.308 . . . . 25.0 113.858 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -44.63 78.95 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.641 -0.329 . . . . 25.0 111.409 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -83.29 82.48 8.25 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.123 -1.065 . . . . 50.0 108.123 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -78.79 87.31 4.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.694 -0.685 . . . . 25.0 112.007 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -80.89 78.53 7.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.8 0.81 . . . . 50.0 109.536 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 53.18 -145.43 0.59 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.715 1.206 . . . . 25.0 114.21 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.1 p -143.56 157.46 58.95 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 122.966 0.506 . . . . 25.0 110.272 -174.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.36 158.85 44.24 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 N-CA-C 113.835 0.667 . . . . 50.0 113.835 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -67.94 154.06 73.76 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 N-CA-C 113.435 0.513 . . . . 50.0 113.435 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.59 152.59 74.61 Favored 'Trans proline' 0 C--N 1.353 0.773 0 N-CA-C 116.715 1.775 . . . . 50.0 116.715 -173.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -67.49 147.25 98.81 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 115.575 -0.739 . . . . 50.0 111.538 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.34 162.14 43.45 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 O-C-N 121.849 0.394 . . . . 50.0 112.015 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -61.27 153.18 67.15 Favored 'Trans proline' 0 C--N 1.351 0.671 0 N-CA-C 115.668 1.372 . . . . 50.0 115.668 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -116.64 1.06 12.8 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.736 -0.666 . . . . 50.0 111.771 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.4 p -139.84 166.49 24.5 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.309 -2.108 . . . . 25.0 105.309 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -123.24 20.95 9.71 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.183 0.438 . . . . 50.0 112.183 -176.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.7 m -65.13 -30.31 71.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.279 0.844 . . . . 25.0 113.279 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 67.6 m -131.84 142.81 49.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.87 0.367 . . . . 25.0 111.222 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 N--CA 1.484 1.233 0 C-N-CA 125.801 1.64 . . . . 25.0 114.353 175.333 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.983 0 CA-C-O 123.988 1.882 . . . . 25.0 115.637 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.4 m -152.51 158.87 43.17 Favored 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 121.209 -1.171 . . . . 25.0 107.977 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.1 tpt -142.03 137.87 31.41 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.516 -1.661 . . . . 25.0 106.516 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -146.23 139.51 25.88 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.226 -1.398 . . . . 50.0 107.226 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -95.68 167.86 11.02 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.651 -0.5 . . . . 50.0 109.651 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.2 mt -61.74 -41.48 97.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.842 -0.617 . . . . 50.0 109.346 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.76 28.16 11.84 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.07 0.948 . . . . 50.0 111.976 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.2 m -87.48 176.24 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 104.72 -2.326 . . . . 50.0 104.72 173.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mp -118.74 173.99 6.54 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 121.732 -0.605 . . . . 50.0 109.58 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.37 160.18 42.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.818 0.342 . . . . 25.0 110.712 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -122.19 129.89 52.69 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.444 -0.798 . . . . 50.0 109.794 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.93 130.64 43.35 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.781 -0.452 . . . . 25.0 109.781 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.6 mt -93.67 -23.78 18.11 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 111.877 0.325 . . . . 50.0 111.877 -177.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -143.88 168.25 20.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.279 -1.378 . . . . 50.0 107.279 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -73.82 165.35 25.28 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.559 0.537 . . . . 50.0 110.178 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.74 163.31 35.34 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.324 -0.991 . . . . 50.0 108.324 177.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.8 t -130.45 129.49 64.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 102.026 -3.324 . . . . 25.0 102.026 169.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.15 122.69 27.13 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.293 -1.373 . . . . 25.0 107.293 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -113.03 12.32 19.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.318 1.056 . . . . 50.0 110.306 -175.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.7 m -148.31 152.83 39.89 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 106.202 -1.777 . . . . 50.0 106.202 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.43 -23.22 32.54 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 118.176 -0.749 . . . . 50.0 113.677 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.8 -17.0 52.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.417 0.627 . . . . 50.0 110.86 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -84.24 131.53 34.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.636 0.731 . . . . 50.0 109.343 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.9 mt -81.69 135.06 35.52 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.315 -0.624 . . . . 50.0 109.315 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -87.35 135.81 33.18 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.253 -1.017 . . . . 50.0 108.253 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -156.09 163.06 40.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.348 0.594 . . . . 50.0 111.948 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -119.63 169.02 10.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.408 0.623 . . . . 50.0 109.832 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -61.29 129.46 41.35 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.668 -0.696 . . . . 50.0 111.297 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.61 -12.41 67.62 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-O 119.012 -0.882 . . . . 50.0 113.836 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -60.08 148.5 35.54 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.595 0.712 . . . . 50.0 110.48 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.1 mm -114.22 132.32 63.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.54 -1.209 . . . . 50.0 108.852 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.0 ptp -137.07 156.55 48.26 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.553 -0.906 . . . . 50.0 108.553 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.7 m -89.53 129.59 35.98 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.377 -1.342 . . . . 25.0 107.377 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.24 126.59 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 107.76 -1.2 . . . . 50.0 107.76 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.8 mt -95.83 -44.7 7.29 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.487 -0.779 . . . . 50.0 109.418 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -153.32 164.02 38.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.353 -0.61 . . . . 50.0 109.353 -175.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -120.35 153.83 35.92 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.234 -1.024 . . . . 50.0 108.234 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 54.98 38.28 30.26 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 123.405 1.574 . . . . 50.0 109.943 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -65.05 151.29 46.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.359 -1.746 . . . . 25.0 110.812 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 61.05 10.72 3.0 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.803 0.841 . . . . 50.0 113.003 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.73 17.46 77.34 Favored Glycine 0 C--O 1.228 -0.234 0 N-CA-C 110.77 -0.932 . . . . 25.0 110.77 -178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.9 mt -94.37 119.18 32.73 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.741 -0.837 . . . . 50.0 108.741 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.53 129.26 39.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.13 0.491 . . . . 25.0 110.568 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.27 -0.72 67.25 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 116.075 1.19 . . . . 50.0 116.075 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -98.75 129.98 45.2 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 119.349 1.575 . . . . 50.0 109.736 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -110.3 140.1 44.81 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.082 -0.71 . . . . 50.0 109.082 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.79 120.93 25.29 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.785 -1.931 . . . . 50.0 105.785 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.2 m -132.5 166.23 22.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.961 0.41 . . . . 50.0 111.686 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -120.64 122.77 41.22 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.799 -1.186 . . . . 50.0 107.799 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.5 tp -155.0 145.92 22.57 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 107.024 -1.473 . . . . 50.0 107.024 -175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 56.36 31.97 19.67 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.091 0.556 . . . . 25.0 112.368 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.05 6.11 72.82 Favored Glycine 0 C--O 1.225 -0.41 0 N-CA-C 114.926 0.73 . . . . 25.0 114.926 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -129.95 165.96 21.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.696 -0.853 . . . . 50.0 108.696 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -112.59 152.1 29.29 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.774 -1.195 . . . . 50.0 107.774 176.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.74 -159.5 22.26 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 106.444 -2.662 . . . . 50.0 106.444 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.5 pt -120.05 153.56 22.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.465 0.65 . . . . 50.0 111.845 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -141.63 147.39 45.6 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 114.996 -1.002 . . . . 50.0 109.607 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.96 120.06 5.62 Favored 'Trans proline' 0 C--O 1.239 0.558 0 CA-C-O 121.398 0.499 . . . . 50.0 112.532 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.04 -18.76 67.18 Favored Glycine 0 C--O 1.222 -0.638 0 CA-C-O 121.45 0.472 . . . . 50.0 112.663 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.17 -20.69 59.69 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.307 0.854 . . . . 50.0 113.307 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -130.79 29.41 4.76 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.151 0.5 . . . . 50.0 110.021 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.0 tp -132.65 150.41 52.16 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.05 -0.523 . . . . 50.0 110.346 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -127.71 120.55 28.23 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.726 0.639 . . . . 50.0 112.726 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.4 mm -65.32 136.94 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.138 0.494 . . . . 50.0 110.256 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.4 mt -121.71 106.42 11.3 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.068 0.947 . . . . 50.0 108.527 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.4 m -95.1 -5.82 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.912 0.387 . . . . 50.0 110.933 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.94 143.96 13.83 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 109.486 -1.446 . . . . 25.0 109.486 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -167.38 -60.58 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 117.519 0.66 . . . . 25.0 111.063 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -88.38 137.03 32.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.296 -0.411 . . . . 25.0 111.048 -175.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -38.21 90.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.467 0.651 . . . . 25.0 111.145 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -124.98 158.82 32.7 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.406 0.622 . . . . 50.0 109.901 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -123.3 152.27 63.9 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.197 -1.038 . . . . 50.0 108.197 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.12 163.04 39.98 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 116.536 -1.843 . . . . 50.0 111.237 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.6 148.82 43.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.9 -1.889 . . . . 25.0 105.9 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.62 178.43 39.19 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 108.901 -1.679 . . . . 25.0 108.901 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.4 m -78.83 164.6 24.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.957 0.408 . . . . 25.0 110.607 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.04 -176.79 37.65 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 109.064 -1.614 . . . . 25.0 109.064 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.39 -6.77 57.88 Favored Glycine 0 C--O 1.221 -0.666 0 CA-C-N 117.179 0.489 . . . . 25.0 114.3 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 43.4 t -68.63 128.08 35.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.392 0.596 . . . . 25.0 109.747 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.87 -24.25 77.22 Favored Glycine 0 C--O 1.222 -0.643 0 N-CA-C 111.275 -0.73 . . . . 25.0 111.275 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.9 m 55.34 26.31 8.53 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.622 1.712 . . . . 25.0 115.622 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.6 89.13 0.13 Allowed Glycine 0 C--O 1.227 -0.323 0 C-N-CA 121.226 -0.511 . . . . 25.0 112.565 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.9 p -71.19 146.17 49.25 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.266 -1.013 . . . . 25.0 108.266 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 56.39 23.62 7.55 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.65 0.982 . . . . 50.0 113.65 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -135.88 149.28 48.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.906 -0.405 . . . . 25.0 109.906 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 67.9 mm-40 -122.16 158.45 29.33 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.469 -1.678 . . . . 50.0 106.469 172.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -152.91 166.04 33.61 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.309 -1.737 . . . . 25.0 106.309 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 95.7 p -140.01 150.8 63.41 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 113.288 0.847 . . . . 25.0 113.288 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -76.32 162.0 34.22 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 O-C-N 121.63 0.279 . . . . 50.0 112.624 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.06 151.42 85.8 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 118.456 -0.563 . . . . 50.0 112.674 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.06 172.53 12.75 Favored 'Trans proline' 0 C--N 1.349 0.571 0 N-CA-C 116.255 1.598 . . . . 50.0 116.255 -172.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -86.15 138.68 34.51 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 107.452 -1.314 . . . . 50.0 107.452 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -72.57 162.04 42.42 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 116.938 -1.575 . . . . 50.0 110.749 174.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -63.09 152.88 77.26 Favored 'Trans proline' 0 C--N 1.346 0.417 0 N-CA-C 113.89 0.689 . . . . 50.0 113.89 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -99.73 42.84 1.08 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.17 0.509 . . . . 50.0 109.86 176.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.4 p -138.4 127.36 23.95 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.517 -0.549 . . . . 25.0 109.517 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.7 ptt85 -77.02 -16.05 59.42 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.653 0.612 . . . . 50.0 112.653 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.2 t 46.27 39.37 6.14 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.206 1.558 . . . . 25.0 115.206 175.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 46.6 t -147.57 152.28 37.68 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.525 -0.546 . . . . 25.0 109.525 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--O 1.213 -0.86 0 CA-C-O 124.291 1.996 . . . . 25.0 110.673 176.521 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.59 0 CA-C-O 124.07 1.928 . . . . 25.0 114.111 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 m -66.65 -32.85 74.43 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 113.983 -1.108 . . . . 25.0 111.854 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.1 ttm -157.85 -95.81 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.252 -0.431 . . . . 25.0 110.728 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -126.57 87.15 2.62 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 121.34 0.59 . . . . 50.0 110.077 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -110.73 165.68 11.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.423 -0.808 . . . . 50.0 110.382 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.2 mt -67.52 -38.07 83.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.391 -0.822 . . . . 50.0 110.484 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 57.27 31.51 20.22 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.864 0.866 . . . . 50.0 111.64 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.5 m -97.79 176.96 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 105.585 -2.005 . . . . 50.0 105.585 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -120.18 174.02 6.75 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.348 -0.612 . . . . 50.0 109.348 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.69 162.95 34.13 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.899 -0.408 . . . . 25.0 109.899 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -125.68 130.47 51.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.416 -0.811 . . . . 50.0 110.755 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.49 124.53 24.85 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 123.655 0.597 . . . . 25.0 109.516 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.3 mt -94.53 -20.3 19.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.326 0.584 . . . . 50.0 109.83 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -142.71 169.64 17.19 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.559 -1.645 . . . . 50.0 106.559 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -78.07 165.45 23.99 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.901 -0.407 . . . . 50.0 109.901 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -146.1 156.24 43.31 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.96 -0.385 . . . . 50.0 109.96 173.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.4 t -127.73 127.59 68.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 105.724 -1.954 . . . . 25.0 105.724 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.46 135.83 36.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.155 -0.683 . . . . 25.0 109.155 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -120.49 10.19 11.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.304 1.05 . . . . 50.0 109.302 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 t -150.82 150.15 27.26 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 107.103 -1.443 . . . . 50.0 107.103 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.63 -17.59 42.9 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 117.715 -1.057 . . . . 50.0 113.43 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -77.86 -19.98 53.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.188 0.518 . . . . 50.0 110.373 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -93.1 138.4 31.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.721 0.772 . . . . 50.0 111.407 -173.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.3 mt -91.86 128.01 37.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.809 0.814 . . . . 50.0 110.502 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.8 t -88.66 142.56 27.58 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.939 -1.874 . . . . 50.0 105.939 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -158.11 164.37 36.71 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.677 -0.49 . . . . 50.0 109.677 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -110.46 164.94 12.2 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.705 0.764 . . . . 50.0 109.055 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.15 131.81 51.98 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.747 -0.835 . . . . 50.0 108.747 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.15 -12.15 68.53 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-O 118.849 -0.973 . . . . 50.0 114.152 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.65 148.65 33.03 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 118.176 0.988 . . . . 50.0 110.51 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.5 mm -117.99 126.43 74.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.272 -1.331 . . . . 50.0 108.241 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -128.95 152.52 48.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.365 -0.379 . . . . 50.0 110.004 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -84.7 130.97 34.63 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.117 -1.438 . . . . 25.0 107.117 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.88 123.41 51.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.142 -1.058 . . . . 50.0 108.142 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.8 mt -89.38 -49.35 6.75 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.744 -0.836 . . . . 50.0 108.744 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -151.94 169.25 22.78 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.097 -1.075 . . . . 50.0 108.097 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.9 mtm105 -118.65 157.94 26.45 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 107.053 -1.462 . . . . 50.0 107.053 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 58.21 39.41 25.85 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 125.108 1.505 . . . . 50.0 109.153 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.1 t -67.74 155.81 38.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.19 -1.823 . . . . 25.0 110.162 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 59.96 10.82 2.33 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.084 0.954 . . . . 50.0 113.527 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.19 14.86 81.23 Favored Glycine 0 C--O 1.242 0.61 0 N-CA-C 110.94 -0.864 . . . . 25.0 110.94 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.2 mt -93.51 127.76 39.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.361 0.6 . . . . 50.0 109.495 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -69.95 124.05 23.06 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.498 -0.773 . . . . 25.0 109.545 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.01 2.3 86.72 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 117.03 1.572 . . . . 50.0 117.03 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -100.3 132.31 45.75 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 118.799 1.299 . . . . 50.0 109.224 176.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -114.28 141.59 47.39 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.512 -0.551 . . . . 50.0 109.512 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.6 120.01 25.44 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.2 -1.778 . . . . 50.0 106.2 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.5 m -133.07 165.65 24.25 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.016 0.436 . . . . 50.0 112.029 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.0 t -118.65 118.06 30.62 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.459 -1.311 . . . . 50.0 107.459 172.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -147.71 145.68 28.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.511 -1.662 . . . . 50.0 106.511 -174.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 57.23 27.22 13.28 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.412 0.625 . . . . 25.0 111.497 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.45 6.91 86.97 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 114.948 0.739 . . . . 25.0 114.948 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -132.09 160.86 34.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.108 0.954 . . . . 50.0 109.303 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -100.27 152.69 20.01 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.781 -0.822 . . . . 50.0 108.781 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.62 -162.1 28.49 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 105.632 -2.987 . . . . 50.0 105.632 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.9 pt -118.45 154.71 20.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.542 0.687 . . . . 50.0 110.97 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.78 146.75 45.59 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.129 -0.941 . . . . 50.0 109.743 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -73.95 115.56 4.36 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 CA-C-O 121.544 0.56 . . . . 50.0 111.937 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.2 -17.64 68.34 Favored Glycine 0 C--O 1.224 -0.495 0 CA-C-O 121.463 0.48 . . . . 50.0 113.586 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -62.28 -19.0 62.8 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.959 0.725 . . . . 50.0 112.959 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -122.84 27.37 7.75 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.143 0.497 . . . . 50.0 110.686 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.2 mt -123.81 160.64 26.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.054 0.931 . . . . 75.0 112.613 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -125.59 124.17 40.66 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 114.338 -1.301 . . . . 50.0 109.862 174.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.7 mm -73.64 134.25 30.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.413 -0.958 . . . . 50.0 108.413 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.0 mt -116.33 97.91 6.3 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.938 -1.134 . . . . 50.0 107.938 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.3 m -82.96 164.15 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.416 -0.957 . . . . 50.0 108.416 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -115.19 140.66 16.47 Favored Glycine 0 C--O 1.221 -0.711 0 N-CA-C 110.484 -1.046 . . . . 25.0 110.484 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.3 ttp -79.82 -33.6 40.23 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.695 0.759 . . . . 25.0 109.172 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -147.0 -116.04 0.07 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 104.13 -2.545 . . . . 25.0 104.13 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -123.93 -50.07 1.83 Allowed 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 114.804 1.409 . . . . 25.0 114.804 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -72.33 129.0 37.38 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.648 -0.658 . . . . 50.0 109.997 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -82.37 151.96 66.63 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 109.444 -0.576 . . . . 50.0 109.444 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -73.04 168.74 23.95 Favored 'Trans proline' 0 C--N 1.352 0.758 0 O-C-N 122.046 0.498 . . . . 50.0 112.285 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.64 -32.55 73.61 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.506 0.928 . . . . 25.0 113.506 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.58 -44.43 3.09 Favored Glycine 0 C--O 1.225 -0.417 0 CA-C-O 119.597 -0.557 . . . . 25.0 113.794 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.3 m 51.63 44.72 28.98 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.728 1.01 . . . . 25.0 113.728 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -135.46 147.53 19.22 Favored Glycine 0 C--O 1.226 -0.399 0 C-N-CA 120.876 -0.678 . . . . 25.0 111.928 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.27 172.55 20.25 Favored Glycine 0 CA--C 1.51 -0.265 0 N-CA-C 106.807 -2.517 . . . . 25.0 106.807 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 61.9 p -142.58 147.67 36.26 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.623 -0.88 . . . . 25.0 108.623 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -141.84 -173.69 14.15 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 111.292 -0.723 . . . . 25.0 111.292 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.9 p -80.15 177.58 8.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.351 -0.981 . . . . 25.0 108.351 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.32 38.89 10.38 Favored Glycine 0 C--O 1.218 -0.859 0 C-N-CA 120.25 -0.976 . . . . 25.0 112.007 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.2 p -72.96 89.16 1.4 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.238 -0.566 . . . . 25.0 111.762 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -53.85 -37.65 63.86 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 115.94 1.83 . . . . 50.0 115.94 -175.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -57.1 -34.16 68.05 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.227 1.195 . . . . 25.0 114.227 -172.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 35.26 61.59 0.63 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 115.336 1.606 . . . . 50.0 115.336 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -129.42 159.15 37.14 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.428 0.899 . . . . 25.0 113.428 -174.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 95.9 p -81.33 159.46 67.41 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 114.92 1.452 . . . . 25.0 114.92 -174.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -81.19 155.85 19.55 Favored 'Trans proline' 0 C--N 1.352 0.761 0 N-CA-C 114.278 0.838 . . . . 50.0 114.278 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.12 154.3 52.14 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 117.747 -1.036 . . . . 50.0 111.448 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -61.56 160.0 29.83 Favored 'Trans proline' 0 C--N 1.35 0.616 0 N-CA-C 116.781 1.8 . . . . 50.0 116.781 -175.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -76.79 138.26 66.18 Favored Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 108.098 -1.075 . . . . 50.0 108.098 173.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.06 161.4 43.47 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 116.539 -1.841 . . . . 50.0 110.589 172.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -63.72 152.37 80.8 Favored 'Trans proline' 0 C--N 1.348 0.522 0 N-CA-C 115.325 1.24 . . . . 50.0 115.325 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -105.7 -1.94 23.89 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.209 0.818 . . . . 50.0 113.209 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 79.5 p -140.06 169.17 18.19 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.013 -1.106 . . . . 25.0 108.013 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -119.18 23.2 11.46 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 107.695 -1.224 . . . . 50.0 107.695 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.3 m -66.62 -23.8 66.22 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.862 1.06 . . . . 25.0 113.862 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 24.6 p -155.31 159.5 40.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.16 -1.422 . . . . 25.0 107.16 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.484 1.247 0 C-N-CA 124.659 1.184 . . . . 25.0 113.887 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.681 0 CA-C-O 124.789 2.327 . . . . 25.0 113.666 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.3 m -148.25 144.66 27.8 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 113.493 -1.353 . . . . 25.0 109.693 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.6 ptm -139.49 75.02 1.49 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.636 0.731 . . . . 25.0 109.559 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.77 30.49 7.31 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.658 -0.701 . . . . 50.0 111.163 -177.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -62.28 162.43 9.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.657 -0.701 . . . . 50.0 112.153 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.7 mt -64.29 -41.13 97.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.073 -0.967 . . . . 50.0 110.543 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 55.63 30.1 14.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.918 0.887 . . . . 50.0 111.648 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.1 m -90.0 153.33 3.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.083 -1.451 . . . . 50.0 107.083 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.41 167.98 11.88 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.761 -0.829 . . . . 50.0 108.761 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.36 161.32 41.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.752 0.311 . . . . 25.0 110.693 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -130.84 130.47 43.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.407 -0.815 . . . . 50.0 110.009 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.29 131.52 42.02 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.322 -0.621 . . . . 25.0 109.322 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 74.8 mt -99.99 -18.84 16.85 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.981 0.419 . . . . 50.0 110.897 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -143.38 169.11 18.29 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.269 -2.122 . . . . 50.0 105.269 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.28 165.85 21.05 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 122.873 0.469 . . . . 50.0 110.6 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -151.36 143.05 23.71 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.939 0.348 . . . . 50.0 111.939 174.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 83.9 t -116.71 125.71 73.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 105.154 -2.165 . . . . 25.0 105.154 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.24 137.91 43.31 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.426 -0.806 . . . . 25.0 109.519 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -113.25 4.81 16.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.654 0.74 . . . . 50.0 110.223 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.3 m -152.02 155.69 33.65 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 106.953 -1.499 . . . . 50.0 106.953 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.67 -21.03 39.68 Favored 'Trans proline' 0 C--N 1.346 0.398 0 N-CA-C 113.692 0.612 . . . . 50.0 113.692 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.02 -16.98 59.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.215 0.531 . . . . 50.0 110.629 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -93.78 141.76 28.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.38 0.609 . . . . 50.0 109.672 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.4 mt -95.62 131.26 42.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.735 0.779 . . . . 50.0 110.17 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.0 t -90.44 146.62 23.99 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 105.099 -2.186 . . . . 50.0 105.099 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -157.32 162.77 39.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.085 0.469 . . . . 50.0 110.492 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -103.88 155.88 18.28 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.421 -1.326 . . . . 50.0 107.421 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -60.73 129.31 40.89 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.632 -0.877 . . . . 50.0 108.632 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.07 -5.35 68.44 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-O 119.312 -0.715 . . . . 50.0 113.445 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -63.97 152.25 40.53 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.8 0.81 . . . . 50.0 110.156 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.2 mm -116.84 135.22 57.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.465 -1.243 . . . . 50.0 108.627 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.7 ptp -142.65 166.11 25.55 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.022 -0.732 . . . . 50.0 109.022 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 57.3 m -106.99 123.6 48.42 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.545 -0.909 . . . . 25.0 108.545 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.3 t -86.87 125.48 40.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.301 -1.0 . . . . 50.0 108.301 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -93.43 -44.52 8.22 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.023 -0.732 . . . . 50.0 109.023 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -146.96 159.1 43.96 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.887 -0.412 . . . . 50.0 109.887 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.1 mtm105 -118.75 154.54 32.63 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.579 -0.526 . . . . 50.0 109.579 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 55.08 38.02 29.84 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 123.628 1.68 . . . . 50.0 108.639 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.7 t -72.48 159.68 33.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 112.644 -2.071 . . . . 25.0 111.158 -173.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 58.87 11.52 1.92 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.906 1.076 . . . . 50.0 113.906 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.64 12.63 83.44 Favored Glycine 0 C--O 1.239 0.468 0 N-CA-C 110.847 -0.901 . . . . 25.0 110.847 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.7 mt -97.25 115.82 28.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.806 0.812 . . . . 50.0 109.289 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -65.34 129.11 38.54 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.883 -1.053 . . . . 25.0 109.664 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.57 -0.94 74.32 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 115.659 1.024 . . . . 50.0 115.659 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -98.73 130.88 45.22 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 118.853 1.326 . . . . 50.0 110.281 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -113.54 137.58 51.37 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.734 -0.839 . . . . 50.0 108.734 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.9 tp -80.63 124.71 29.22 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.047 -1.464 . . . . 50.0 107.047 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.9 m -133.6 162.76 31.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.286 0.565 . . . . 50.0 112.234 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.3 t -112.97 123.67 50.85 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.034 -1.839 . . . . 50.0 106.034 171.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 tp -151.58 140.85 21.38 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.653 -1.24 . . . . 50.0 107.653 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.97 27.2 12.82 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.991 0.737 . . . . 25.0 112.991 176.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.47 3.87 90.36 Favored Glycine 0 C--O 1.226 -0.378 0 N-CA-C 114.692 0.637 . . . . 25.0 114.692 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -129.47 161.01 31.38 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 117.951 0.876 . . . . 50.0 110.185 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -105.76 153.5 21.8 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.129 -1.063 . . . . 50.0 108.129 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.61 -163.74 31.8 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 104.03 -3.628 . . . . 50.0 104.03 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.5 pt -121.93 156.84 26.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.532 0.682 . . . . 50.0 110.855 -175.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.15 147.57 50.93 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.013 -0.994 . . . . 50.0 109.328 -177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -75.74 119.97 5.65 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 CA-C-O 121.349 0.479 . . . . 50.0 111.947 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.28 -20.05 66.98 Favored Glycine 0 C--O 1.221 -0.665 0 C-N-CA 121.517 -0.373 . . . . 50.0 113.354 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -66.34 -9.2 30.92 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.699 1.0 . . . . 50.0 113.699 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -134.65 26.11 3.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.265 0.555 . . . . 50.0 109.792 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 24.3 tp -131.23 149.57 52.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.739 -0.664 . . . . 50.0 110.819 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -119.44 127.85 53.47 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 122.838 0.455 . . . . 50.0 110.963 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.2 mm -76.12 135.56 26.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.191 -1.04 . . . . 50.0 108.191 174.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.4 mt -114.66 80.58 1.43 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.192 -0.669 . . . . 50.0 109.192 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.38 126.96 37.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 107.707 -1.22 . . . . 50.0 107.707 175.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.79 87.98 1.05 Allowed Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.599 -0.81 . . . . 25.0 112.397 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.4 mtm -109.62 -50.54 2.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.273 0.472 . . . . 25.0 112.273 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -110.29 -51.92 2.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.034 0.445 . . . . 25.0 111.53 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -95.16 51.39 1.33 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 122.16 0.981 . . . . 25.0 110.354 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.34 105.2 0.32 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.88 -1.055 . . . . 50.0 111.599 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -125.86 103.55 27.43 Favored Pre-proline 0 N--CA 1.47 0.535 0 N-CA-C 108.802 -0.814 . . . . 50.0 108.802 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.57 1.75 8.94 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 N-CA-C 115.086 1.148 . . . . 50.0 115.086 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.52 -90.18 0.58 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.029 0.443 . . . . 25.0 111.282 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.61 -169.53 37.42 Favored Glycine 0 C--O 1.228 -0.229 0 N-CA-C 110.0 -1.24 . . . . 25.0 110.0 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.4 m -147.61 31.75 0.88 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.202 0.501 . . . . 25.0 111.779 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.74 -158.64 30.98 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.744 -0.741 . . . . 25.0 112.156 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -162.68 173.78 38.97 Favored Glycine 0 C--O 1.227 -0.297 0 N-CA-C 108.477 -1.849 . . . . 25.0 108.477 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.8 t -159.91 167.82 27.15 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.797 -1.186 . . . . 25.0 107.797 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.9 168.49 40.31 Favored Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.022 -1.231 . . . . 25.0 110.022 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.3 m -148.41 -67.29 0.23 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 117.273 0.536 . . . . 25.0 111.849 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.42 -156.95 23.62 Favored Glycine 0 N--CA 1.46 0.236 0 N-CA-C 110.586 -1.005 . . . . 25.0 110.586 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.6 m -141.93 149.98 40.85 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.817 -0.809 . . . . 25.0 108.817 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.22 148.46 47.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.823 0.344 . . . . 50.0 111.69 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt 57.59 17.98 4.34 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.127 1.158 . . . . 25.0 114.127 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -89.14 63.87 6.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.514 0.673 . . . . 50.0 109.693 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.51 -154.39 0.33 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.552 -1.204 . . . . 25.0 112.329 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.0 m -140.01 156.67 70.33 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 112.899 0.703 . . . . 25.0 112.899 -176.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -62.99 156.52 54.08 Favored 'Trans proline' 0 C--N 1.353 0.775 0 N-CA-C 114.696 0.999 . . . . 50.0 114.696 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.84 152.61 80.15 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 O-C-N 121.68 0.305 . . . . 50.0 112.438 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -70.71 163.74 37.97 Favored 'Trans proline' 0 C--N 1.348 0.512 0 N-CA-C 116.695 1.767 . . . . 50.0 116.695 -171.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -79.66 140.91 55.43 Favored Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 115.117 -0.947 . . . . 50.0 108.835 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.71 159.28 51.32 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 116.562 -1.826 . . . . 50.0 110.376 171.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -62.91 149.92 90.0 Favored 'Trans proline' 0 C--N 1.349 0.598 0 N-CA-C 115.283 1.224 . . . . 50.0 115.283 -176.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.3 mtm105 -105.43 15.9 26.42 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.26 -0.427 . . . . 50.0 111.526 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 40.7 p -134.9 139.55 45.07 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.073 0.768 . . . . 25.0 113.073 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.26 112.69 11.26 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 105.15 -2.167 . . . . 50.0 105.15 175.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 26.0 t -140.4 71.68 1.38 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.799 0.666 . . . . 25.0 112.799 -175.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 7.7 t 41.46 59.64 2.34 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.459 1.281 . . . . 25.0 114.459 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 C--O 1.214 -0.8 0 CA-C-O 124.582 2.135 . . . . 25.0 110.759 -179.756 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 CA-C-O 122.843 1.246 . . . . 25.0 115.292 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.5 m -64.69 -34.18 77.71 Favored 'General case' 0 C--O 1.22 -0.495 0 O-C-N 121.256 -1.143 . . . . 25.0 113.057 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 93.3 mtp 49.71 36.76 11.47 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.305 0.854 . . . . 25.0 113.305 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt 60.56 10.84 2.72 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.849 1.426 . . . . 50.0 114.849 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -75.79 168.87 19.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.565 0.697 . . . . 50.0 111.302 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt -65.48 -38.97 91.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.221 -0.899 . . . . 50.0 110.506 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.4 m120 57.0 25.63 10.91 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.306 1.042 . . . . 50.0 112.295 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -89.56 169.81 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.005 -1.85 . . . . 50.0 106.005 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -115.42 170.23 8.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.037 0.446 . . . . 50.0 110.06 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.83 160.64 41.49 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.689 -0.687 . . . . 25.0 111.017 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -123.87 131.81 53.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.072 -0.967 . . . . 50.0 110.749 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.99 126.2 30.51 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.053 -0.522 . . . . 25.0 109.871 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.7 mt -93.75 -22.07 18.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.198 0.523 . . . . 50.0 110.536 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -138.06 161.44 36.74 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.246 -1.39 . . . . 50.0 107.246 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.71 175.98 7.42 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.032 0.933 . . . . 50.0 110.959 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -156.85 160.01 38.75 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.499 0.555 . . . . 50.0 112.499 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.1 t -127.76 128.67 69.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 104.408 -2.442 . . . . 25.0 104.408 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.41 132.19 44.45 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.29 -0.633 . . . . 25.0 109.29 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -122.22 10.16 9.94 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.719 0.771 . . . . 50.0 109.714 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.2 m -143.93 153.14 56.87 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 105.378 -2.082 . . . . 50.0 105.378 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.03 -23.08 34.52 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 117.919 -0.921 . . . . 50.0 113.165 -177.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.83 -15.97 46.27 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.982 -0.554 . . . . 50.0 110.916 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -80.9 135.51 35.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.97 0.89 . . . . 50.0 111.515 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.8 mt -83.69 130.94 34.97 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.304 -0.862 . . . . 50.0 110.88 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 m -85.5 132.42 34.2 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.837 -1.542 . . . . 50.0 106.837 173.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -159.42 169.55 23.7 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.019 -1.104 . . . . 50.0 108.019 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 mtp85 -125.35 174.45 8.14 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.347 0.869 . . . . 50.0 113.347 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.12 131.85 48.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.191 -0.913 . . . . 50.0 110.878 -175.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.94 -13.97 66.16 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.44 -0.8 . . . . 50.0 113.343 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -60.06 147.7 38.37 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.868 0.842 . . . . 50.0 110.993 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.3 mm -111.07 134.29 53.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.286 -1.324 . . . . 50.0 107.958 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.4 ptp -138.98 150.67 46.13 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.337 -0.616 . . . . 50.0 109.337 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.6 m -85.98 130.98 34.38 Favored 'General case' 0 C--O 1.217 -0.607 0 N-CA-C 107.242 -1.392 . . . . 25.0 107.242 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.9 t -97.9 125.32 51.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.347 -0.983 . . . . 50.0 108.347 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.3 mt -90.94 -51.27 5.43 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.991 -0.744 . . . . 50.0 108.991 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -152.04 171.25 18.14 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.382 -0.97 . . . . 50.0 108.382 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -120.71 155.6 33.57 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 107.342 -1.355 . . . . 50.0 107.342 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 57.7 39.78 27.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 123.331 1.538 . . . . 50.0 108.592 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.9 t -64.85 147.62 52.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 113.235 -1.802 . . . . 25.0 110.547 -176.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 58.5 15.25 3.45 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.146 0.795 . . . . 50.0 113.146 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.62 12.39 84.28 Favored Glycine 0 C--O 1.225 -0.462 0 C-N-CA 121.161 -0.542 . . . . 25.0 111.833 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.6 mt -88.85 109.7 20.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.381 0.61 . . . . 50.0 110.048 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -53.73 118.43 3.93 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.979 -1.009 . . . . 25.0 112.08 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.69 0.37 89.21 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 115.914 1.126 . . . . 50.0 115.914 175.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -97.75 133.62 42.02 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 119.059 1.429 . . . . 50.0 109.234 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -113.36 140.69 47.83 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.883 -0.784 . . . . 50.0 108.883 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.34 121.47 26.73 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 105.973 -1.862 . . . . 50.0 105.973 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 84.4 m -131.3 163.55 27.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.124 0.488 . . . . 50.0 112.161 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.5 t -118.04 126.44 52.3 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.794 -1.188 . . . . 50.0 107.794 174.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 tp -154.4 142.67 20.45 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 107.326 -1.361 . . . . 75.0 107.326 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 55.46 32.03 18.14 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.317 0.579 . . . . 25.0 112.315 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.12 7.05 76.06 Favored Glycine 0 C--O 1.224 -0.472 0 N-CA-C 114.807 0.683 . . . . 25.0 114.807 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -128.2 165.64 20.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.082 -0.71 . . . . 50.0 109.082 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -117.21 155.08 30.03 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.002 -1.11 . . . . 50.0 108.002 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.0 -159.87 25.83 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 106.195 -2.762 . . . . 50.0 106.195 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.5 pt -117.68 153.47 19.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.684 0.754 . . . . 50.0 111.656 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.71 147.22 38.13 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 114.653 -1.158 . . . . 50.0 108.37 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.2 125.08 8.96 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 118.569 -0.488 . . . . 50.0 112.051 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.78 -19.46 79.9 Favored Glycine 0 C--O 1.222 -0.607 0 N-CA-C 116.035 1.174 . . . . 50.0 116.035 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -70.0 -7.26 39.43 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.189 1.552 . . . . 50.0 115.189 -175.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.17 21.64 5.28 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.264 -1.013 . . . . 50.0 108.264 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.0 tp -123.68 149.68 45.18 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.047 -1.094 . . . . 50.0 108.047 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -120.73 123.82 43.63 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 116.706 -0.224 . . . . 50.0 111.147 -178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.3 mm -74.99 133.52 31.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.223 -1.029 . . . . 50.0 108.223 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.3 mt -116.85 75.53 0.97 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.621 -1.622 . . . . 50.0 106.621 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -50.34 -42.78 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 115.748 1.759 . . . . 50.0 115.748 -168.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -111.77 7.82 27.77 Favored Glycine 0 C--O 1.228 -0.235 0 C-N-CA 121.072 -0.585 . . . . 25.0 114.479 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 7.2 tpt -94.41 82.79 4.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.782 0.791 . . . . 25.0 111.569 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -77.38 -8.99 58.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.19 -0.914 . . . . 25.0 109.482 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 t0 65.92 149.47 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.993 1.717 . . . . 25.0 113.569 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -114.11 5.21 15.9 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.999 -1.0 . . . . 50.0 110.414 -171.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -149.21 156.09 39.92 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 106.351 -1.722 . . . . 50.0 106.351 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.12 159.89 46.6 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 117.383 -1.278 . . . . 50.0 113.309 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -156.05 179.58 9.09 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.201 -2.148 . . . . 25.0 105.201 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.71 5.51 22.2 Favored Glycine 0 C--O 1.225 -0.416 0 N-CA-C 115.91 1.124 . . . . 25.0 115.91 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.9 m -146.33 154.37 41.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.774 0.787 . . . . 25.0 109.748 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.54 162.71 28.64 Favored Glycine 0 C--O 1.224 -0.511 0 N-CA-C 108.785 -1.726 . . . . 25.0 108.785 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.73 36.41 0.43 Allowed Glycine 0 C--O 1.218 -0.891 0 CA-C-N 117.702 0.751 . . . . 25.0 112.851 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.6 t -76.38 -4.47 42.47 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.819 1.044 . . . . 25.0 113.819 -175.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.63 -170.27 20.55 Favored Glycine 0 C--O 1.236 0.258 0 N-CA-C 111.941 -0.464 . . . . 25.0 111.941 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 84.7 p -155.59 178.16 10.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.22 -92.28 1.76 Allowed Glycine 0 C--O 1.228 -0.248 0 CA-C-O 119.35 -0.694 . . . . 25.0 112.103 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 95.5 p 55.44 -174.6 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.624 1.17 . . . . 25.0 112.734 -177.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.55 149.72 40.06 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.533 -0.543 . . . . 50.0 109.533 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -163.2 158.66 21.94 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.858 -0.793 . . . . 25.0 108.858 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -152.7 -60.17 0.15 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.76 -1.2 . . . . 50.0 107.76 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -70.27 157.86 36.94 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.417 0.627 . . . . 25.0 111.307 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.3 p -104.92 153.07 39.64 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 108.772 -0.825 . . . . 25.0 108.772 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -61.31 159.62 30.34 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 117.83 -0.98 . . . . 50.0 111.682 173.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -66.37 155.75 68.5 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 117.33 -1.313 . . . . 50.0 111.919 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.14 157.58 59.2 Favored 'Trans proline' 0 C--N 1.345 0.356 0 N-CA-C 113.692 0.612 . . . . 50.0 113.692 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -71.39 146.23 91.54 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.713 -0.676 . . . . 50.0 110.463 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.24 165.26 32.09 Favored 'Trans proline' 0 C--O 1.243 0.747 0 O-C-N 121.973 0.459 . . . . 50.0 111.744 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.03 154.61 43.96 Favored 'Trans proline' 0 C--N 1.35 0.646 0 N-CA-C 113.33 0.473 . . . . 50.0 113.33 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -109.7 35.34 3.38 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.484 -0.932 . . . . 50.0 108.484 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.7 p 48.16 -153.39 0.09 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.163 -1.38 . . . . 25.0 111.924 -176.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 54.79 30.86 14.43 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.542 0.737 . . . . 50.0 111.753 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.3 m -64.83 136.76 57.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.421 -0.809 . . . . 25.0 112.219 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.5 t -68.75 -33.53 74.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.978 0.895 . . . . 25.0 109.702 175.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.208 -1.106 0 CA-C-O 124.465 2.079 . . . . 25.0 111.515 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.405 0 CA-C-O 122.601 1.112 . . . . 25.0 114.835 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t 55.55 29.74 13.99 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.311 1.044 . . . . 25.0 112.592 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.1 tpt -66.18 134.42 52.7 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.014 -0.736 . . . . 25.0 109.014 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -124.64 107.74 11.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.245 0.545 . . . . 50.0 110.776 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -90.24 169.18 11.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.275 -0.875 . . . . 50.0 111.894 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.11 -41.17 95.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.72 -0.673 . . . . 50.0 110.729 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 55.5 40.73 31.23 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.927 0.891 . . . . 50.0 112.144 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.7 m -105.35 151.37 7.55 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.802 0 N-CA-C 107.316 -1.364 . . . . 50.0 107.316 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.38 167.0 12.97 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.485 -0.561 . . . . 50.0 109.485 -172.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.86 157.41 41.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.083 0.468 . . . . 25.0 111.134 175.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -123.9 131.31 53.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.172 -0.922 . . . . 50.0 110.659 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.08 129.32 38.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.992 -0.744 . . . . 25.0 108.992 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.4 mt -96.63 -17.55 20.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.755 0.312 . . . . 50.0 110.368 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -144.99 167.65 22.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.649 -1.611 . . . . 50.0 106.649 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -77.49 168.86 19.3 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 123.447 0.467 . . . . 50.0 110.85 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -153.48 154.01 33.57 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.074 0.464 . . . . 50.0 111.462 176.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -124.53 129.69 73.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 105.073 -2.195 . . . . 25.0 105.073 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.84 121.88 21.59 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.368 -0.975 . . . . 25.0 108.368 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -102.94 1.67 34.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 122.036 0.922 . . . . 50.0 109.495 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.2 m -144.69 153.75 55.0 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 106.499 -1.667 . . . . 50.0 106.499 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.92 -23.83 34.29 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 117.811 -0.992 . . . . 50.0 113.427 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.78 -16.97 59.31 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.339 0.59 . . . . 50.0 110.629 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -84.05 139.54 32.43 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.61 0.719 . . . . 50.0 110.092 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.0 mt -87.42 130.25 34.74 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.95 -0.759 . . . . 50.0 108.95 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 t -87.13 137.94 31.91 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.435 -1.691 . . . . 50.0 106.435 175.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -155.42 164.19 39.05 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 120.777 0.322 . . . . 50.0 110.482 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 -117.05 168.24 10.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.984 0.421 . . . . 50.0 110.821 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -60.88 130.17 45.13 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.948 -0.76 . . . . 50.0 108.948 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.89 -8.26 78.34 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-O 118.647 -1.085 . . . . 50.0 114.623 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.21 142.35 51.98 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.649 1.224 . . . . 50.0 109.714 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.7 mm -108.68 129.79 62.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 107.627 -1.249 . . . . 50.0 107.627 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 14.3 ptp -134.83 163.4 29.91 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.836 -0.801 . . . . 50.0 108.836 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.1 m -104.4 122.58 45.79 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.411 -1.329 . . . . 25.0 107.411 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.7 t -86.34 122.69 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 108.191 -1.041 . . . . 50.0 108.191 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.24 -41.58 8.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.575 -0.739 . . . . 50.0 109.391 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -142.94 156.63 44.92 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.498 -1.297 . . . . 50.0 107.498 -173.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -124.38 150.76 45.21 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 105.111 -2.181 . . . . 75.0 105.111 172.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 57.43 38.93 28.43 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 123.707 1.717 . . . . 50.0 108.504 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -67.98 157.71 34.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 112.671 -2.059 . . . . 25.0 111.818 -177.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 60.35 12.51 3.46 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.078 1.14 . . . . 50.0 114.078 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.12 13.11 81.56 Favored Glycine 0 C--O 1.244 0.723 0 N-CA-C 111.265 -0.734 . . . . 25.0 111.265 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.2 mt -96.24 137.57 35.12 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 122.357 -0.496 . . . . 50.0 109.899 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -81.19 130.45 35.03 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.352 -0.61 . . . . 25.0 109.352 176.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.93 -0.42 82.85 Favored Glycine 0 C--O 1.241 0.566 0 N-CA-C 116.675 1.43 . . . . 50.0 116.675 173.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -99.8 134.42 42.72 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.388 -0.968 . . . . 50.0 108.388 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.7 m0 -114.61 140.35 48.88 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.078 -1.082 . . . . 50.0 108.078 -177.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.4 tp -82.33 127.74 33.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.051 -1.833 . . . . 50.0 106.051 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.2 m -134.9 162.45 32.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.166 0.508 . . . . 50.0 111.811 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.2 t -112.35 123.09 49.51 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.629 -1.989 . . . . 50.0 105.629 169.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.2 tp -153.14 139.26 18.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.893 0.477 . . . . 75.0 110.122 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.6 m170 56.93 32.0 20.76 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.113 0.565 . . . . 25.0 111.548 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.99 -1.17 89.1 Favored Glycine 0 C--O 1.225 -0.429 0 N-CA-C 116.478 1.351 . . . . 25.0 116.478 177.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.5 ptt85 -130.64 158.59 39.62 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 118.798 1.299 . . . . 50.0 111.402 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -97.72 153.6 18.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.82 -1.178 . . . . 50.0 107.82 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.67 -165.9 35.88 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 103.89 -3.684 . . . . 50.0 103.89 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.4 pt -119.78 158.63 21.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.398 0.618 . . . . 50.0 111.443 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.7 m -144.76 148.95 41.42 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.558 -0.747 . . . . 50.0 110.171 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.3 121.72 7.41 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 118.247 -0.702 . . . . 50.0 112.932 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.38 -18.13 73.13 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 121.267 -0.492 . . . . 50.0 113.568 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -67.3 -9.97 46.24 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.602 0.964 . . . . 50.0 113.602 -177.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -129.89 27.61 5.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.472 0.653 . . . . 50.0 109.804 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -123.08 156.52 34.74 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.356 -0.838 . . . . 50.0 112.423 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -122.69 125.27 45.24 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 108.725 -0.842 . . . . 50.0 108.725 174.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.0 mm -77.97 137.1 22.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.224 -1.028 . . . . 50.0 108.224 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.6 mt -116.96 87.13 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.964 -1.124 . . . . 50.0 107.964 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.41 2.18 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.392 -0.822 . . . . 50.0 111.841 -177.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -156.67 177.92 33.37 Favored Glycine 0 CA--C 1.508 -0.378 0 N-CA-C 109.056 -1.618 . . . . 25.0 109.056 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 9.2 tpt 54.78 63.26 2.2 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 122.174 0.988 . . . . 25.0 111.333 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -65.85 -32.68 74.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.171 -0.922 . . . . 25.0 112.077 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 t0 61.28 139.45 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.874 1.67 . . . . 25.0 115.111 -175.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -81.65 -3.26 53.04 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.396 -0.815 . . . . 50.0 111.025 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -140.91 145.9 41.53 Favored Pre-proline 0 N--CA 1.469 0.5 0 N-CA-C 108.721 -0.844 . . . . 50.0 108.721 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -72.65 153.25 54.24 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 116.885 -1.61 . . . . 50.0 111.906 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.39 129.18 37.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.112 -0.699 . . . . 25.0 109.112 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.47 -36.78 6.4 Favored Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.849 -0.691 . . . . 25.0 114.097 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.7 m -153.55 166.22 33.41 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.042 -0.725 . . . . 25.0 109.042 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -109.11 178.14 20.59 Favored Glycine 0 C--O 1.225 -0.408 0 N-CA-C 110.137 -1.185 . . . . 25.0 110.137 177.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.22 -17.39 65.92 Favored Glycine 0 N--CA 1.463 0.435 0 C-N-CA 120.872 -0.68 . . . . 25.0 113.12 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.4 m 59.99 -171.96 0.13 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.068 0.947 . . . . 25.0 113.42 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.03 -176.36 54.74 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.973 -0.632 . . . . 25.0 113.098 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.9 m 61.75 -48.55 0.15 Allowed 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 119.269 3.063 . . . . 25.0 119.269 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.32 87.54 1.34 Allowed Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.801 -0.919 . . . . 25.0 110.801 -173.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.49 98.52 10.66 Favored 'General case' 0 C--O 1.238 0.483 0 O-C-N 121.643 -0.916 . . . . 25.0 110.367 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -141.14 178.79 7.15 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 123.377 0.671 . . . . 50.0 109.729 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -130.92 89.5 2.76 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.103 -1.814 . . . . 25.0 106.103 172.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 71.73 -46.46 0.64 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.258 1.423 . . . . 50.0 111.882 -174.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 177.94 -66.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 104.838 -2.282 . . . . 25.0 104.838 175.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.3 m -79.89 155.83 75.14 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 114.528 1.307 . . . . 25.0 114.528 -173.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.54 159.87 42.27 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 N-CA-C 113.752 0.635 . . . . 50.0 113.752 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -69.66 154.56 67.97 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 118.575 -0.483 . . . . 50.0 112.284 176.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.91 164.1 36.74 Favored 'Trans proline' 0 C--N 1.346 0.433 0 N-CA-C 115.579 1.338 . . . . 50.0 115.579 -174.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -90.15 150.11 42.69 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 109.322 -0.621 . . . . 50.0 109.322 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -72.95 163.9 37.06 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 O-C-N 121.785 0.361 . . . . 50.0 112.018 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -62.86 159.77 36.36 Favored 'Trans proline' 0 C--N 1.351 0.658 0 N-CA-C 114.827 1.049 . . . . 50.0 114.827 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.1 mtp85 -114.89 -14.9 11.89 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 116.859 2.17 . . . . 50.0 116.859 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 23.5 p -137.58 140.53 41.05 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.415 -0.958 . . . . 25.0 108.415 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -82.2 -36.96 26.76 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 107.247 -1.39 . . . . 50.0 107.247 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 83.2 p -157.68 163.41 38.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.112 -1.81 . . . . 25.0 106.112 174.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 93.8 m -130.0 89.15 2.76 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.207 -1.034 . . . . 25.0 108.207 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.4 tp . . . . . 0 N--CA 1.485 1.293 0 C-N-CA 124.441 1.097 . . . . 25.0 112.057 -174.692 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 115.446 0.938 . . . . 25.0 115.446 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 64.94 -28.57 0.1 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 126.989 2.116 . . . . 25.0 115.325 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.7 mtt -101.9 90.26 3.93 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 122.951 0.501 . . . . 25.0 111.46 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -75.64 131.35 39.88 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.993 -1.484 . . . . 50.0 106.993 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -138.16 167.51 21.68 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.459 0.474 . . . . 50.0 110.53 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.0 mt -65.0 -42.5 94.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.63 -0.714 . . . . 50.0 110.203 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 53.98 36.18 23.81 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.0 0.92 . . . . 50.0 112.02 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.9 m -96.09 159.79 2.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 N-CA-C 106.18 -1.785 . . . . 50.0 106.18 177.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.02 170.94 8.8 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.992 -0.744 . . . . 50.0 108.992 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.58 162.19 41.41 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.228 -0.295 . . . . 25.0 110.701 175.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.75 136.56 52.58 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.846 0.716 . . . . 50.0 111.353 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.453 ' HA ' HD13 ' A' ' 62' ' ' LEU . . . -73.02 123.09 22.83 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.695 0.622 . . . . 25.0 111.679 173.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.2 mt -90.81 -25.2 20.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.222 0.534 . . . . 50.0 110.091 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -142.82 171.68 13.72 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 103.476 -2.787 . . . . 50.0 103.476 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -84.41 175.7 9.17 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 118.056 0.389 . . . . 50.0 110.818 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -149.41 132.29 16.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.761 0.315 . . . . 50.0 110.737 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.7 t -104.04 125.19 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 104.759 -2.312 . . . . 25.0 104.759 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.23 137.86 43.31 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.565 -0.743 . . . . 25.0 110.205 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -119.05 5.33 11.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.783 0.801 . . . . 50.0 109.099 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -147.37 155.65 46.08 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 106.479 -1.675 . . . . 50.0 106.479 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.59 -24.04 26.33 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 118.167 -0.756 . . . . 50.0 113.514 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -77.73 -17.2 57.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.507 0.67 . . . . 50.0 110.203 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -87.09 133.01 33.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.526 0.679 . . . . 50.0 109.969 -176.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.8 mt -87.15 125.97 34.5 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.823 0.82 . . . . 50.0 109.945 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.68 134.01 33.73 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.252 -1.758 . . . . 50.0 106.252 174.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -154.84 166.93 31.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.526 -0.546 . . . . 50.0 109.526 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -113.4 160.51 18.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.365 0.602 . . . . 50.0 110.068 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -57.41 132.56 53.48 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.468 -0.938 . . . . 50.0 108.468 177.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.57 -18.18 57.32 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-O 119.168 -0.795 . . . . 50.0 113.11 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -61.42 147.87 43.6 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.778 0.799 . . . . 50.0 109.988 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.4 mm -115.67 132.95 63.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.296 -1.32 . . . . 50.0 107.894 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -135.24 165.51 25.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.049 -0.723 . . . . 50.0 109.049 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.4 m -104.18 123.47 47.36 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.891 -1.151 . . . . 25.0 107.891 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.1 t -87.47 121.52 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 N-CA-C 108.248 -1.019 . . . . 50.0 108.248 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.1 mt -91.23 -42.71 10.26 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.984 -1.007 . . . . 50.0 109.277 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -150.46 155.87 40.36 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.43 -0.952 . . . . 50.0 108.43 -176.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -115.58 153.11 31.81 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.91 -1.515 . . . . 50.0 106.91 174.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 55.98 41.23 30.05 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 123.63 1.681 . . . . 50.0 109.176 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.2 t -71.05 159.79 34.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 113.234 -1.803 . . . . 25.0 110.665 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 59.51 12.03 2.59 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.18 0.992 . . . . 50.0 112.352 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.61 17.01 78.38 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 111.262 -0.735 . . . . 25.0 111.262 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.4 mt -97.73 131.37 44.33 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 122.44 0.296 . . . . 50.0 110.282 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -71.26 128.3 35.44 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.536 -0.542 . . . . 25.0 109.536 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.5 -1.32 82.64 Favored Glycine 0 CA--C 1.518 0.244 0 N-CA-C 116.569 1.388 . . . . 50.0 116.569 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -100.63 132.99 45.74 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 118.423 1.111 . . . . 50.0 109.621 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -113.05 141.6 46.69 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.939 -0.763 . . . . 50.0 108.939 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.14 122.51 27.46 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 104.823 -2.288 . . . . 50.0 104.823 177.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.487 ' HG ' HG22 ' A' ' 57' ' ' VAL . 96.7 m -133.89 161.7 34.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.823 0.345 . . . . 50.0 111.902 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.6 t -114.63 125.14 53.41 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.833 -1.173 . . . . 50.0 107.833 172.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 tp -145.17 136.98 25.55 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.674 -1.232 . . . . 50.0 107.674 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 55.89 28.39 12.47 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.234 0.54 . . . . 25.0 112.173 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.68 2.53 90.56 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 114.877 0.711 . . . . 25.0 114.877 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -122.55 159.3 28.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 118.282 1.041 . . . . 50.0 108.422 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -112.09 150.34 30.85 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.633 -0.877 . . . . 50.0 108.633 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.84 -160.46 24.4 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 106.547 -2.621 . . . . 50.0 106.547 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.1 pt -116.84 150.36 18.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.796 0.808 . . . . 50.0 111.5 -175.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.487 HG22 ' HG ' ' A' ' 48' ' ' CYS . 2.9 m -137.98 146.59 52.93 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 114.846 -1.07 . . . . 50.0 108.814 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.44 122.82 6.71 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 117.951 -0.899 . . . . 50.0 111.706 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.2 -12.71 72.54 Favored Glycine 0 C--O 1.222 -0.615 0 O-C-N 121.909 -0.494 . . . . 50.0 113.24 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.3 -16.12 63.24 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.486 0.921 . . . . 50.0 113.486 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -129.36 27.65 5.3 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.142 -0.688 . . . . 50.0 109.142 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 12' ' ' ALA . 6.6 tp -129.32 152.22 49.12 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.276 -0.875 . . . . 75.0 111.472 -177.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -131.64 120.66 23.12 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-N 115.777 -0.647 . . . . 50.0 111.755 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.4 mm -66.13 136.13 27.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 O-C-N 123.53 0.519 . . . . 50.0 110.102 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.6 mt -118.75 98.51 6.25 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.303 -1.369 . . . . 50.0 107.303 175.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.3 t -72.47 134.07 30.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 107.302 -1.37 . . . . 50.0 107.302 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -123.72 44.26 1.32 Allowed Glycine 0 C--O 1.228 -0.259 0 C-N-CA 121.68 -0.295 . . . . 25.0 113.181 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 45.7 ttp -128.68 72.68 1.46 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.42 -0.956 . . . . 25.0 108.42 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -140.38 -172.45 3.43 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.731 -1.581 . . . . 25.0 106.731 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -56.49 -37.05 69.85 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.125 0.57 . . . . 25.0 112.051 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.29 162.88 39.18 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.76 -0.83 . . . . 50.0 108.76 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -147.49 143.95 18.73 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 107.544 -1.28 . . . . 50.0 107.544 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.15 156.53 46.83 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 116.621 -1.786 . . . . 50.0 111.316 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.97 -22.65 49.13 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.838 -0.43 . . . . 25.0 109.838 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.96 170.4 43.51 Favored Glycine 0 N--CA 1.453 -0.202 0 N-CA-C 108.636 -1.786 . . . . 25.0 108.636 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.4 m -153.81 75.52 1.04 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.481 -0.563 . . . . 25.0 109.481 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -90.16 -176.3 44.98 Favored Glycine 0 C--O 1.225 -0.426 0 CA-C-N 115.903 -0.59 . . . . 25.0 112.531 -176.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.11 -174.0 43.14 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 107.736 -2.146 . . . . 25.0 107.736 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.5 t -145.99 -176.59 5.21 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.068 -1.827 . . . . 25.0 106.068 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.6 54.57 1.53 Allowed Glycine 0 C--O 1.228 -0.252 0 N-CA-C 111.268 -0.733 . . . . 25.0 111.268 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.6 p -95.08 153.15 17.78 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.134 -0.691 . . . . 25.0 109.134 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.74 124.19 3.3 Favored Glycine 0 C--O 1.224 -0.525 0 N-CA-C 110.201 -1.16 . . . . 25.0 110.201 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.4 m -153.5 148.94 27.18 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.666 -1.235 . . . . 25.0 107.666 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -97.83 161.59 13.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.604 0.183 . . . . 50.0 110.999 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.2 mttm 52.87 39.47 29.08 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.208 0.818 . . . . 25.0 113.208 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -72.97 140.46 47.39 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.25 -0.432 . . . . 50.0 111.954 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.49 161.92 13.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.762 -0.654 . . . . 25.0 110.071 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.9 m -75.22 151.08 85.69 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 114.391 1.256 . . . . 25.0 114.391 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -65.39 154.78 72.08 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 N-CA-C 114.298 0.845 . . . . 50.0 114.298 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.57 152.61 81.08 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 O-C-N 121.695 0.313 . . . . 50.0 112.701 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.63 155.15 63.63 Favored 'Trans proline' 0 C--N 1.352 0.735 0 N-CA-C 117.441 2.054 . . . . 50.0 117.441 -171.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -68.91 145.67 96.87 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 115.138 -0.937 . . . . 50.0 110.123 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.76 161.66 41.24 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 118.276 -0.683 . . . . 50.0 112.263 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -61.98 156.88 46.77 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 N-CA-C 114.985 1.109 . . . . 50.0 114.985 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -113.46 43.53 1.75 Allowed 'General case' 0 N--CA 1.478 0.927 0 O-C-N 122.186 -0.321 . . . . 50.0 111.494 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 80.8 p 44.64 13.25 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 120.305 3.446 . . . . 25.0 120.305 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.9 mtp85 -88.15 -40.79 13.46 Favored 'General case' 0 C--O 1.211 -0.949 0 O-C-N 121.901 -0.5 . . . . 50.0 111.503 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.0 m -101.98 -11.47 18.92 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.515 0.674 . . . . 25.0 110.207 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 50.9 t -105.37 123.27 47.58 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 104.421 -2.437 . . . . 25.0 104.421 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.6 tt . . . . . 0 C--O 1.207 -1.132 0 C-N-CA 124.282 1.033 . . . . 25.0 110.987 -174.601 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 CA-C-O 123.292 1.496 . . . . 25.0 115.478 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 t 55.19 34.26 22.29 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.645 1.178 . . . . 25.0 113.42 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -72.82 102.16 3.32 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.056 -0.72 . . . . 25.0 109.056 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -77.27 108.79 10.64 Favored 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.378 -0.971 . . . . 50.0 108.378 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -133.33 164.78 26.33 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.499 -0.556 . . . . 50.0 109.499 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.8 mt -71.88 -33.16 68.13 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.756 -0.656 . . . . 50.0 111.079 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.3 m120 53.43 41.75 32.07 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.35 -0.841 . . . . 50.0 111.954 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.4 m -109.51 165.38 5.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.526 -1.287 . . . . 50.0 107.526 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.73 170.6 7.91 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.467 -0.568 . . . . 50.0 109.467 -176.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.38 162.08 40.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 25.0 110.954 173.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -127.82 130.51 48.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.6 -0.727 . . . . 50.0 109.729 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.38 131.94 46.18 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.061 0.545 . . . . 25.0 109.874 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.9 mt -94.96 -23.19 17.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.24 0.543 . . . . 50.0 110.769 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -144.56 172.09 13.47 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 104.222 -2.51 . . . . 50.0 104.222 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.95 173.89 10.81 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.949 -0.389 . . . . 50.0 109.949 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -155.07 141.01 18.28 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.507 0.323 . . . . 50.0 111.648 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.7 t -108.7 124.48 65.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 105.8 -1.926 . . . . 25.0 105.8 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.53 130.82 41.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.343 -0.844 . . . . 25.0 108.867 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -112.48 11.27 19.8 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.185 0.993 . . . . 50.0 109.044 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 t -153.15 151.26 25.64 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 107.5 -1.296 . . . . 50.0 107.5 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -69.21 -18.2 39.7 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 117.689 -1.074 . . . . 50.0 112.509 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -76.6 -19.62 57.64 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.431 0.634 . . . . 50.0 109.819 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -94.11 140.99 29.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.704 0.764 . . . . 50.0 111.034 -172.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.3 mt -91.17 129.61 37.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.469 -0.787 . . . . 50.0 110.157 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.69 139.52 30.48 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.106 -2.183 . . . . 50.0 105.106 173.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -157.77 166.46 32.7 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.594 -0.521 . . . . 50.0 109.594 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -112.73 164.03 13.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.105 0.955 . . . . 50.0 110.362 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -58.48 129.66 43.09 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.447 -1.252 . . . . 50.0 109.45 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.74 -16.21 61.39 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-O 118.758 -1.024 . . . . 50.0 114.867 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -57.79 146.7 30.58 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 117.984 0.892 . . . . 50.0 111.408 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.4 mm -109.47 133.89 53.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.595 -1.184 . . . . 50.0 108.139 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.2 ptp -138.79 162.61 34.31 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.358 -0.979 . . . . 50.0 108.358 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.8 m -101.38 125.5 48.03 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 108.363 -0.977 . . . . 25.0 108.363 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.53 126.01 43.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.044 -1.095 . . . . 50.0 108.044 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.8 mt -95.47 -43.65 7.89 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.865 -1.061 . . . . 50.0 108.918 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -150.21 162.19 40.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.178 -0.675 . . . . 50.0 109.178 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -121.82 152.34 39.64 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 107.076 -1.453 . . . . 50.0 107.076 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 56.22 39.9 30.14 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 123.309 1.528 . . . . 50.0 108.703 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -69.87 157.51 37.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.737 -1.574 . . . . 25.0 110.177 -175.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 60.53 11.05 2.81 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.611 0.967 . . . . 50.0 113.611 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.57 16.5 77.61 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.173 -0.771 . . . . 25.0 111.173 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.7 mt -103.68 113.71 27.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.003 0.43 . . . . 50.0 110.77 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -63.74 128.08 34.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.973 -0.558 . . . . 25.0 109.696 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.61 -1.92 88.05 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 118.757 -1.024 . . . . 50.0 115.103 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -98.93 131.79 44.74 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 118.969 1.384 . . . . 50.0 109.687 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -111.76 140.06 46.71 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.926 -0.768 . . . . 50.0 108.926 -176.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.05 120.79 25.72 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 105.44 -2.059 . . . . 50.0 105.44 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.415 ' HG ' HG23 ' A' ' 57' ' ' VAL . 92.0 m -132.26 163.55 28.37 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.476 0.547 . . . . 50.0 112.476 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.8 t -115.89 119.26 35.39 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 106.588 -1.634 . . . . 50.0 106.588 171.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -147.37 139.28 24.24 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 107.055 -1.461 . . . . 50.0 107.055 -174.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 56.72 31.49 19.47 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.678 0.752 . . . . 25.0 111.86 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.49 5.27 85.74 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 115.479 0.952 . . . . 25.0 115.479 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -129.78 161.26 31.13 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.125 -1.065 . . . . 50.0 108.125 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -107.09 152.42 24.05 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.385 -0.598 . . . . 50.0 109.385 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.59 -160.55 24.9 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 106.565 -2.614 . . . . 50.0 106.565 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.1 pt -117.28 156.82 18.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.308 0.575 . . . . 50.0 111.043 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.415 HG23 ' HG ' ' A' ' 48' ' ' CYS . 1.4 m -144.67 146.95 33.97 Favored Pre-proline 0 C--O 1.241 0.64 0 CA-C-N 114.96 -1.018 . . . . 50.0 109.874 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -74.45 118.44 5.35 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 CA-C-O 121.441 0.517 . . . . 50.0 112.708 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.8 -20.04 68.02 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 114.784 0.674 . . . . 50.0 114.784 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -25.22 67.3 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.109 0.781 . . . . 50.0 113.109 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -119.18 28.33 8.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.285 0.564 . . . . 50.0 110.347 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.0 tp -133.51 150.06 51.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.132 -0.485 . . . . 75.0 110.162 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -127.94 120.21 27.15 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.851 0.686 . . . . 50.0 112.851 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.7 mm -65.43 137.6 24.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.494 -0.558 . . . . 50.0 109.494 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.9 mt -118.44 105.36 11.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.915 -1.142 . . . . 50.0 107.915 175.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.9 m -89.89 161.63 2.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.092 -1.077 . . . . 50.0 108.092 177.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.89 -27.6 73.44 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.567 -0.825 . . . . 25.0 113.497 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.5 mtp -72.68 115.16 11.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.457 0.646 . . . . 25.0 110.793 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -89.84 2.58 54.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.368 -0.833 . . . . 25.0 109.443 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -77.91 51.74 0.98 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 122.526 1.155 . . . . 25.0 109.907 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -160.73 29.68 0.15 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.866 -1.061 . . . . 50.0 108.718 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -145.16 149.52 42.05 Favored Pre-proline 0 C--O 1.218 -0.566 0 N-CA-C 107.972 -1.122 . . . . 50.0 107.972 -177.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -80.85 11.04 3.11 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 N-CA-C 114.171 0.797 . . . . 50.0 114.171 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 65.73 -29.79 0.13 Allowed 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.974 1.842 . . . . 25.0 115.974 -177.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.41 100.7 0.32 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 115.857 1.103 . . . . 25.0 115.857 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.1 m 51.15 79.13 0.1 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.852 1.797 . . . . 25.0 115.852 173.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.33 35.68 1.54 Allowed Glycine 0 CA--C 1.526 0.767 0 N-CA-C 115.75 1.06 . . . . 25.0 115.75 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.58 168.92 35.54 Favored Glycine 0 C--O 1.225 -0.438 0 N-CA-C 109.465 -1.454 . . . . 25.0 109.465 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.0 m -152.78 167.15 29.96 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.453 -1.314 . . . . 25.0 107.453 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.41 -160.19 14.34 Favored Glycine 0 C--O 1.224 -0.53 0 N-CA-C 110.454 -1.058 . . . . 25.0 110.454 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.0 m 58.79 29.7 19.06 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.373 1.62 . . . . 25.0 115.373 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.97 -146.75 18.87 Favored Glycine 0 N--CA 1.455 -0.07 0 C-N-CA 121.259 -0.496 . . . . 25.0 113.257 175.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.0 t -154.87 162.05 41.24 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 103.555 -2.757 . . . . 25.0 103.555 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -119.55 160.26 22.77 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.97 -0.381 . . . . 50.0 109.97 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 66.1 163.51 0.17 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.15 1.78 . . . . 25.0 113.365 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -121.06 99.53 6.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 105.255 -2.128 . . . . 50.0 105.255 174.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -148.69 156.45 42.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.244 -1.391 . . . . 25.0 107.244 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 61.8 p -88.56 152.18 49.07 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 112.501 0.556 . . . . 25.0 112.501 -175.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.0 156.91 55.54 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 117.524 -1.184 . . . . 50.0 111.866 174.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.68 151.1 79.5 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 117.478 -1.215 . . . . 50.0 112.309 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -71.66 169.69 20.45 Favored 'Trans proline' 0 C--N 1.349 0.564 0 N-CA-C 115.931 1.473 . . . . 50.0 115.931 -172.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -80.69 141.93 52.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.231 -0.895 . . . . 50.0 108.956 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.39 161.03 43.56 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 117.171 -1.42 . . . . 50.0 110.518 170.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -63.24 155.47 61.39 Favored 'Trans proline' 0 C--N 1.345 0.387 0 N-CA-C 114.818 1.045 . . . . 50.0 114.818 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -106.57 -1.54 22.83 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.072 0.397 . . . . 50.0 112.072 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.5 p -138.16 147.69 44.12 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.737 -1.209 . . . . 25.0 107.737 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -158.24 -33.44 0.07 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.389 0.885 . . . . 50.0 113.389 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.0 t 59.13 -165.12 0.19 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.508 0.723 . . . . 25.0 110.353 -177.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 60.9 m 47.3 48.63 16.14 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.033 1.123 . . . . 25.0 114.033 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.213 -0.83 0 CA-C-O 123.707 1.718 . . . . 25.0 111.211 179.323 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.111 0 CA-C-O 125.4 2.667 . . . . 25.0 112.768 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.7 m -78.54 11.62 2.42 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 111.37 -2.415 . . . . 25.0 115.524 -173.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.0 mtt -112.75 27.09 9.93 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.387 0.613 . . . . 25.0 112.213 -176.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -81.44 88.34 6.15 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.872 -0.518 . . . . 50.0 110.333 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -133.17 166.75 21.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.669 -0.696 . . . . 50.0 112.608 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.04 -39.88 90.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.141 -0.936 . . . . 50.0 111.419 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 54.22 41.6 31.92 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.289 1.042 . . . . 50.0 111.91 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.9 m -102.7 171.27 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 N-CA-C 103.743 -2.688 . . . . 50.0 103.743 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -118.96 173.93 6.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 119.42 1.009 . . . . 50.0 110.693 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.04 158.74 44.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.12 -0.491 . . . . 25.0 109.746 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -120.9 132.26 54.86 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.311 0.644 . . . . 50.0 109.793 177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.59 130.43 42.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.016 0.436 . . . . 25.0 110.078 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.8 mt -97.46 -22.18 16.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.337 -0.392 . . . . 50.0 110.944 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -141.88 164.76 29.3 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.539 -1.282 . . . . 50.0 107.539 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -71.78 167.74 19.31 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.598 0.562 . . . . 50.0 110.785 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.45 160.04 42.17 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.516 -0.55 . . . . 50.0 109.516 175.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.1 t -130.85 127.7 61.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 102.87 -3.011 . . . . 25.0 102.87 169.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.53 123.6 31.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.788 -0.819 . . . . 25.0 108.788 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -117.18 -17.28 10.28 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.541 0.686 . . . . 50.0 110.41 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.55 152.91 37.97 Favored Pre-proline 0 N--CA 1.471 0.58 0 N-CA-C 107.973 -1.121 . . . . 50.0 107.973 176.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.8 -24.51 34.31 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 117.906 -0.929 . . . . 50.0 113.59 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -84.13 -16.36 43.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.938 0.399 . . . . 50.0 111.135 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -79.03 129.64 34.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.077 0.941 . . . . 50.0 110.644 -173.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.3 mt -82.77 138.48 34.01 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.497 -0.774 . . . . 50.0 109.605 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.65 130.73 34.69 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.474 -0.935 . . . . 50.0 108.474 177.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -158.37 162.92 37.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.27 0.557 . . . . 50.0 110.958 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.13 166.06 17.73 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.964 -0.562 . . . . 50.0 110.099 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -56.97 131.46 49.84 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 121.116 0.484 . . . . 50.0 109.8 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.06 -19.68 53.24 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-O 118.569 -1.128 . . . . 50.0 113.028 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -62.3 149.07 43.07 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 118.118 0.959 . . . . 50.0 109.98 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.4 mm -116.63 125.3 73.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 114.325 -1.307 . . . . 50.0 108.365 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -126.74 153.22 45.79 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.172 -0.677 . . . . 50.0 109.172 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.8 m -87.26 126.63 34.95 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.736 -1.579 . . . . 25.0 106.736 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.19 119.89 40.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.362 -1.348 . . . . 50.0 107.362 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.1 mt -91.03 -43.92 9.63 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.15 -0.932 . . . . 50.0 110.155 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -150.19 159.61 44.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.831 -1.174 . . . . 50.0 107.831 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -121.62 149.41 43.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.556 -1.275 . . . . 50.0 107.556 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 58.06 39.27 26.42 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 123.517 1.627 . . . . 50.0 109.603 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.3 t -65.29 151.81 45.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.742 -1.572 . . . . 25.0 110.468 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 59.59 11.75 2.51 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.93 0.892 . . . . 50.0 113.265 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.53 18.72 78.84 Favored Glycine 0 C--O 1.241 0.585 0 N-CA-C 110.987 -0.845 . . . . 25.0 110.987 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.9 mt -91.87 123.83 35.54 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.348 -0.612 . . . . 50.0 109.348 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -64.23 118.8 9.13 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.158 -0.928 . . . . 25.0 110.998 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.28 2.63 90.57 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 116.931 1.533 . . . . 50.0 116.931 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -100.82 132.02 46.42 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.809 1.305 . . . . 50.0 110.579 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -110.16 140.8 43.87 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.75 -0.593 . . . . 50.0 110.196 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.25 122.01 26.88 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 104.386 -2.449 . . . . 50.0 104.386 176.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.421 ' HG ' HG21 ' A' ' 57' ' ' VAL . 87.8 m -132.51 164.42 26.63 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.179 0.514 . . . . 50.0 111.362 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.5 t -121.55 125.16 46.12 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 107.485 -1.302 . . . . 50.0 107.485 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.2 tp -148.78 138.49 22.02 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 106.495 -1.668 . . . . 50.0 106.495 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 55.24 28.93 11.91 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.221 0.608 . . . . 25.0 112.168 -176.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.34 1.35 75.13 Favored Glycine 0 C--O 1.226 -0.349 0 N-CA-C 115.151 0.82 . . . . 25.0 115.151 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -117.09 161.47 19.37 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.083 -1.451 . . . . 50.0 107.083 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -118.35 156.75 28.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.508 -0.553 . . . . 50.0 109.508 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.21 -156.82 21.1 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 106.525 -2.63 . . . . 50.0 106.525 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.8 pt -121.12 151.9 24.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.742 0.782 . . . . 50.0 111.545 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.421 HG21 ' HG ' ' A' ' 48' ' ' CYS . 2.4 m -141.18 146.85 44.77 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 114.438 -1.255 . . . . 50.0 109.591 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.65 121.21 5.84 Favored 'Trans proline' 0 C--O 1.24 0.586 0 CA-C-O 121.444 0.518 . . . . 50.0 113.133 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.3 -16.16 68.78 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-O 121.717 0.62 . . . . 50.0 114.334 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -18.3 63.55 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.018 0.527 . . . . 50.0 112.081 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -126.73 30.39 5.51 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.951 0.405 . . . . 50.0 110.692 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.5 mt -126.25 157.09 39.2 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.885 1.068 . . . . 50.0 113.885 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -129.76 119.82 24.06 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.16 -0.927 . . . . 50.0 109.649 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.7 mm -67.81 140.39 19.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 O-C-N 123.902 0.751 . . . . 50.0 109.613 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.4 mt -118.65 101.84 8.41 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.826 0.85 . . . . 50.0 109.152 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.45 -3.08 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 112.701 0.63 . . . . 50.0 112.701 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.85 67.93 1.71 Allowed Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.3 -0.952 . . . . 25.0 111.004 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 40.6 ttm -55.12 128.91 36.01 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 122.247 -0.561 . . . . 25.0 110.618 -177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 58.16 11.52 1.56 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 117.067 2.247 . . . . 25.0 117.067 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -141.26 -30.09 0.62 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.132 0.79 . . . . 25.0 113.132 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.4 tttt 57.71 36.64 26.8 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.729 1.211 . . . . 50.0 112.115 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -122.49 158.67 55.56 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 106.879 -1.526 . . . . 50.0 106.879 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.37 160.77 48.51 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 117.469 -1.22 . . . . 50.0 111.985 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.98 146.47 54.67 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.831 -0.803 . . . . 25.0 108.831 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.44 164.24 54.6 Favored Glycine 0 C--O 1.235 0.187 0 C-N-CA 120.563 -0.827 . . . . 25.0 111.542 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.5 m -69.69 154.26 42.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.926 0.393 . . . . 25.0 110.188 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.06 81.34 0.14 Allowed Glycine 0 N--CA 1.46 0.262 0 N-CA-C 109.874 -1.29 . . . . 25.0 109.874 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.24 -178.69 23.37 Favored Glycine 0 C--O 1.22 -0.721 0 N-CA-C 111.99 -0.444 . . . . 25.0 111.99 -177.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.9 m 56.64 13.29 1.34 Allowed 'General case' 0 C--O 1.215 -0.716 0 N-CA-C 117.968 2.581 . . . . 25.0 117.968 174.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.31 43.6 2.31 Favored Glycine 0 C--O 1.219 -0.798 0 N-CA-C 114.654 0.622 . . . . 25.0 114.654 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.2 t -117.0 125.27 51.11 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.265 -1.013 . . . . 25.0 108.265 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.04 -1.09 47.22 Favored Glycine 0 C--O 1.214 -1.095 0 O-C-N 123.146 0.279 . . . . 25.0 113.641 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.2 m 55.77 52.15 11.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.658 0.742 . . . . 25.0 111.468 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -67.41 153.03 44.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.715 -1.13 . . . . 50.0 109.762 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.0 tptt 65.38 175.43 0.21 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.784 1.303 . . . . 25.0 112.206 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -139.45 20.74 2.56 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.214 0.53 . . . . 50.0 109.924 -172.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -85.75 157.49 20.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.629 0.728 . . . . 25.0 110.529 -177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -79.03 151.99 76.48 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 116.079 -0.51 . . . . 25.0 112.094 -175.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.84 156.99 40.27 Favored 'Trans proline' 0 C--N 1.349 0.6 0 N-CA-C 113.45 0.519 . . . . 50.0 113.45 178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.44 147.18 90.55 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 118.203 -0.731 . . . . 50.0 112.126 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.71 157.86 26.34 Favored 'Trans proline' 0 C--N 1.351 0.674 0 N-CA-C 116.323 1.624 . . . . 50.0 116.323 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -78.87 138.36 57.56 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.404 -1.702 . . . . 50.0 106.404 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.81 160.97 47.69 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 118.306 -0.662 . . . . 50.0 112.361 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -61.98 151.38 81.74 Favored 'Trans proline' 0 C--N 1.347 0.5 0 N-CA-C 115.448 1.288 . . . . 50.0 115.448 -175.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -105.18 -23.11 12.96 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 115.599 -0.728 . . . . 50.0 112.133 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.7 p -127.92 22.44 6.26 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.348 -0.982 . . . . 25.0 108.348 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 66.43 160.95 0.15 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.753 1.221 . . . . 50.0 110.109 -170.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 44.7 t -165.0 124.94 1.88 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.51 -1.663 . . . . 25.0 106.51 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.4 m -140.44 -63.28 0.48 Allowed 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 121.851 0.834 . . . . 25.0 108.982 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 C--O 1.215 -0.72 0 CA-C-O 124.517 2.103 . . . . 25.0 110.29 176.463 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.202 -1.851 0 N-CA-C 114.699 0.64 . . . . 25.0 114.699 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t 54.69 35.52 24.05 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 123.634 0.774 . . . . 25.0 112.302 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.5 mtt -78.85 60.98 2.97 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.022 0.529 . . . . 25.0 111.879 -176.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -140.87 147.42 38.9 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.097 -1.445 . . . . 50.0 107.097 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 60.32 164.37 0.06 Allowed 'General case' 0 CA--C 1.53 0.173 0 O-C-N 125.013 1.445 . . . . 50.0 114.829 -176.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.5 mt -73.57 -42.48 61.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.652 -1.158 . . . . 50.0 110.291 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 55.75 30.05 14.96 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.396 1.078 . . . . 50.0 111.822 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 m -89.65 163.89 2.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 104.842 -2.281 . . . . 50.0 104.842 176.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.23 171.9 7.33 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.966 -1.124 . . . . 50.0 107.966 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.47 157.24 43.34 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.52 -0.548 . . . . 25.0 109.52 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -120.34 131.79 55.01 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 123.901 0.751 . . . . 50.0 109.393 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.8 126.94 31.32 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.658 0.599 . . . . 25.0 110.095 173.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.5 mt -92.56 -26.59 17.83 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.859 -0.423 . . . . 50.0 109.859 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -142.19 166.02 25.83 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.048 -1.834 . . . . 50.0 106.048 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -75.3 163.35 27.57 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 122.998 0.519 . . . . 50.0 112.369 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -143.07 144.03 32.09 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.625 0.602 . . . . 50.0 112.625 173.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -114.14 126.83 71.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 103.355 -2.832 . . . . 25.0 103.355 173.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.42 140.51 33.4 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 108.237 -1.023 . . . . 25.0 108.237 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -125.06 9.77 8.1 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.693 0.759 . . . . 50.0 111.186 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.5 m -145.73 150.98 45.0 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 106.575 -1.639 . . . . 50.0 106.575 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.62 -29.96 84.94 Favored 'Trans proline' 0 C--N 1.351 0.663 0 N-CA-C 114.954 1.098 . . . . 50.0 114.954 -175.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.7 -17.4 59.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.203 -0.453 . . . . 50.0 111.769 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -86.15 136.33 33.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 122.055 0.931 . . . . 50.0 111.886 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.9 mt -91.14 130.95 36.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.508 0.67 . . . . 50.0 111.089 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.6 p -90.92 144.69 25.42 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.61 -1.256 . . . . 50.0 107.61 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -160.09 168.55 25.29 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.61 0.243 . . . . 50.0 110.669 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -116.95 163.55 16.03 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.406 -0.59 . . . . 50.0 109.406 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -59.74 133.78 56.41 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.727 -0.842 . . . . 50.0 108.727 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.4 -21.35 46.45 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-O 118.903 -0.943 . . . . 50.0 113.003 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -57.14 145.69 30.34 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.031 0.919 . . . . 50.0 111.116 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.3 mm -115.7 126.83 73.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.486 -1.234 . . . . 50.0 109.159 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -131.39 153.95 49.14 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.665 -0.494 . . . . 50.0 109.665 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.5 m -89.55 123.69 33.86 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.474 -0.935 . . . . 25.0 108.474 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.9 t -87.1 123.15 39.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.069 -0.715 . . . . 50.0 109.069 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -89.85 -46.05 8.83 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.244 -1.021 . . . . 50.0 108.244 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -153.94 172.85 16.78 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.881 -0.512 . . . . 50.0 109.708 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 mtm105 -120.25 154.5 34.82 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.087 -1.449 . . . . 50.0 107.087 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 59.71 40.47 19.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 123.527 1.632 . . . . 50.0 109.228 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t -66.84 154.77 40.06 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 113.081 -1.872 . . . . 25.0 110.36 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 57.59 14.37 2.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.213 1.005 . . . . 50.0 112.147 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.05 14.84 81.85 Favored Glycine 0 C--O 1.24 0.481 0 N-CA-C 111.287 -0.725 . . . . 25.0 111.287 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.3 mt -93.16 129.07 39.29 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 117.479 0.639 . . . . 75.0 109.602 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -67.84 125.92 27.78 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.039 -0.528 . . . . 25.0 110.305 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.29 -1.76 84.12 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 117.051 1.58 . . . . 50.0 117.051 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -97.75 135.11 40.0 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 117.879 0.839 . . . . 50.0 110.391 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -112.88 143.43 44.16 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.711 -1.218 . . . . 50.0 107.711 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.3 124.34 32.57 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.178 -2.527 . . . . 50.0 104.178 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.478 ' HG ' HG21 ' A' ' 57' ' ' VAL . 93.2 m -133.16 164.11 27.77 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.162 0.506 . . . . 50.0 111.762 177.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.0 t -118.66 124.9 48.53 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.688 -1.227 . . . . 50.0 107.688 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.0 tp -139.78 133.14 30.0 Favored 'General case' 0 C--O 1.212 -0.911 0 N-CA-C 107.306 -1.368 . . . . 50.0 107.306 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.5 m170 54.95 31.62 16.33 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.465 0.706 . . . . 25.0 111.404 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.31 1.2 85.57 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 116.018 1.167 . . . . 25.0 116.018 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -118.46 152.8 35.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 119.09 1.445 . . . . 50.0 107.661 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -108.18 157.14 18.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.353 -0.385 . . . . 50.0 110.176 -178.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.44 -161.37 29.51 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 106.609 -2.597 . . . . 50.0 106.609 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.7 pt -117.13 150.03 19.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.349 0.595 . . . . 50.0 111.032 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.478 HG21 ' HG ' ' A' ' 48' ' ' CYS . 2.5 m -140.53 146.87 46.88 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.084 -0.962 . . . . 50.0 109.107 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.45 122.02 5.42 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 CA-C-O 121.546 0.561 . . . . 50.0 112.904 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.56 -18.23 71.66 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 115.934 1.134 . . . . 50.0 115.934 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -17.74 63.84 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 122.223 -0.575 . . . . 50.0 111.778 -177.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -123.13 27.94 7.37 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.712 0.291 . . . . 50.0 110.523 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.4 mt -127.74 156.03 43.08 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.879 0.847 . . . . 75.0 112.26 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -128.81 121.99 29.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.724 -1.125 . . . . 50.0 110.443 175.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.6 mm -68.75 139.23 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.409 -0.96 . . . . 50.0 108.409 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.6 mt -117.49 103.02 9.68 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.325 -1.361 . . . . 50.0 107.325 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.0 m -85.63 144.5 9.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.361 0.601 . . . . 50.0 111.287 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.4 42.06 2.21 Favored Glycine 0 C--O 1.226 -0.384 0 CA-C-O 119.761 -0.466 . . . . 25.0 113.238 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 97.2 mtp -60.85 -45.83 92.97 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 117.6 0.7 . . . . 25.0 110.755 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -139.69 -43.15 0.44 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.882 -0.599 . . . . 25.0 109.979 177.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -80.6 60.84 4.09 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.208 1.004 . . . . 25.0 110.996 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -75.63 125.05 28.27 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.262 -1.384 . . . . 50.0 107.262 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -157.78 153.97 23.81 Favored Pre-proline 0 C--N 1.327 -0.408 0 O-C-N 121.986 -0.446 . . . . 50.0 110.032 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -76.86 -175.13 2.47 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 120.209 0.606 . . . . 50.0 111.242 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.53 149.6 42.55 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.327 -1.36 . . . . 25.0 107.327 172.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.53 -28.01 66.9 Favored Glycine 0 C--O 1.216 -0.978 0 C-N-CA 120.528 -0.844 . . . . 25.0 112.879 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.4 m 55.78 23.29 6.22 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.988 1.477 . . . . 25.0 114.988 174.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -98.78 161.98 20.33 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.223 -0.751 . . . . 25.0 111.223 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.46 43.71 1.65 Allowed Glycine 0 C--O 1.221 -0.673 0 N-CA-C 111.171 -0.772 . . . . 25.0 111.171 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 t -146.72 149.73 33.99 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.484 -0.421 . . . . 25.0 111.201 -176.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.85 48.92 0.93 Allowed Glycine 0 C--O 1.223 -0.544 0 N-CA-C 109.794 -1.322 . . . . 25.0 109.794 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.8 m -55.62 135.47 51.09 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.917 1.08 . . . . 25.0 113.917 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.9 178.89 45.12 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 104.793 -3.323 . . . . 25.0 104.793 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.1 m -141.17 146.64 37.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.54 1.17 . . . . 25.0 109.045 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 51.7 -148.63 0.37 Allowed 'General case' 0 CA--C 1.547 0.837 0 O-C-N 124.627 1.204 . . . . 50.0 112.656 176.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HZ2' ' CG ' ' A' ' 87' ' ' ASP . 3.8 tmtt? 50.65 42.39 27.07 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.05 1.5 . . . . 25.0 115.05 176.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -80.17 29.58 0.28 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.642 0.978 . . . . 50.0 113.642 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.413 ' CG ' ' HZ2' ' A' ' 85' ' ' LYS . 1.2 m-20 -60.74 145.83 48.12 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.705 0.631 . . . . 25.0 112.705 -175.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.0 m -62.17 148.44 89.01 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 114.268 1.211 . . . . 25.0 114.268 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.22 155.85 46.69 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 N-CA-C 114.535 0.937 . . . . 50.0 114.535 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -70.44 161.02 47.52 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 117.852 -0.966 . . . . 50.0 111.738 173.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.47 168.2 18.69 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 N-CA-C 113.523 0.547 . . . . 50.0 113.523 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -107.47 147.06 34.57 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 106.721 -1.585 . . . . 50.0 106.721 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.88 162.47 41.85 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 O-C-N 122.463 0.717 . . . . 50.0 112.757 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -62.05 161.37 26.38 Favored 'Trans proline' 0 C--N 1.351 0.706 0 N-CA-C 113.119 0.392 . . . . 50.0 113.119 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.2 mtm-85 -106.88 11.0 30.46 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.008 0.432 . . . . 50.0 111.813 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.3 p -137.5 157.39 46.65 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.897 -1.52 . . . . 25.0 106.897 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -129.08 -45.27 1.26 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 111.332 0.123 . . . . 50.0 111.332 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 t 48.64 35.74 6.65 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 115.728 1.751 . . . . 25.0 115.728 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 44.3 m -72.67 116.23 12.91 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.831 -0.543 . . . . 25.0 110.317 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.8 mm? . . . . . 0 C--O 1.207 -1.174 0 CA-C-O 124.813 2.244 . . . . 25.0 113.174 179.285 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.978 0 CA-C-O 123.709 1.727 . . . . 25.0 115.642 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.3 p -152.39 168.96 23.77 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 121.193 -1.181 . . . . 25.0 108.79 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.5 mmt 61.13 178.69 0.11 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.454 1.096 . . . . 25.0 112.919 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -136.13 79.16 1.75 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.129 -0.693 . . . . 50.0 109.129 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -72.88 168.77 18.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.033 -0.985 . . . . 50.0 109.794 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.27 -40.74 97.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.017 -0.538 . . . . 50.0 109.758 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 57.3 24.83 10.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.039 0.935 . . . . 50.0 111.856 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.5 m -88.21 175.81 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 N-CA-C 105.531 -2.026 . . . . 50.0 105.531 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mp -117.88 172.28 7.5 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 118.842 0.746 . . . . 50.0 110.813 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.72 163.38 34.19 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.792 -0.64 . . . . 25.0 110.256 177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -126.63 130.52 50.64 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.644 -0.707 . . . . 50.0 110.313 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.78 123.81 21.58 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.143 0.577 . . . . 25.0 110.237 174.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.0 mt -90.54 -23.92 20.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.801 -0.444 . . . . 50.0 109.801 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -141.26 172.53 12.55 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 102.887 -3.005 . . . . 50.0 102.887 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.52 176.4 9.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.767 -0.827 . . . . 50.0 108.767 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -151.61 135.23 16.26 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.199 0.523 . . . . 50.0 112.103 175.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.9 t -101.53 121.38 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 105.333 -2.099 . . . . 25.0 105.333 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.42 131.52 43.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.516 -0.92 . . . . 25.0 108.516 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -105.22 -6.51 19.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.688 0.756 . . . . 50.0 109.897 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 m -138.57 152.61 71.32 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 107.076 -1.453 . . . . 50.0 107.076 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.81 -19.29 36.05 Favored 'Trans proline' 0 C--O 1.222 -0.296 0 C-N-CA 117.721 -1.053 . . . . 50.0 112.374 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -79.41 -15.88 57.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 50.0 110.862 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -91.86 139.38 30.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.87 0.843 . . . . 50.0 110.428 -176.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.2 mt -90.62 129.72 36.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.059 0.933 . . . . 50.0 110.24 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.58 147.18 23.51 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.644 -1.613 . . . . 50.0 106.644 175.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -157.47 167.81 29.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.283 0.564 . . . . 50.0 111.023 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -107.09 159.13 16.54 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.971 -0.752 . . . . 50.0 108.971 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -58.0 128.2 35.89 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.72 -1.215 . . . . 50.0 107.72 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.18 -18.87 53.56 Favored Glycine 0 CA--C 1.517 0.194 0 CA-C-O 118.731 -1.039 . . . . 50.0 113.915 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -59.51 147.61 36.17 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 118.063 0.932 . . . . 50.0 110.738 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.5 mm -115.39 128.52 72.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.453 -1.249 . . . . 50.0 108.92 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -131.09 153.05 49.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.044 -0.354 . . . . 50.0 110.044 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.6 m -84.19 130.09 34.85 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 177.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.51 125.25 47.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.709 -0.849 . . . . 50.0 108.709 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.4 mt -91.09 -48.62 6.86 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.797 -0.816 . . . . 50.0 108.797 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -155.06 173.21 16.91 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.655 -0.869 . . . . 50.0 108.655 177.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -121.99 151.62 40.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.04 -1.096 . . . . 50.0 108.04 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 59.29 40.32 21.45 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 123.329 1.537 . . . . 50.0 108.936 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -65.06 153.78 39.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 112.866 -1.97 . . . . 25.0 110.5 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 59.79 11.61 2.58 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.585 0.957 . . . . 50.0 113.585 176.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.11 19.13 75.39 Favored Glycine 0 C--O 1.225 -0.447 0 N-CA-C 111.052 -0.819 . . . . 25.0 111.052 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 71.9 mt -96.95 112.33 24.13 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.124 0.488 . . . . 50.0 111.288 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.96 119.36 6.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.888 -0.596 . . . . 25.0 111.828 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.99 -0.01 89.55 Favored Glycine 0 C--O 1.239 0.417 0 N-CA-C 115.521 0.968 . . . . 50.0 115.521 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -100.19 134.6 42.88 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 118.525 1.163 . . . . 50.0 109.485 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -112.0 143.09 43.56 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.322 -0.992 . . . . 50.0 108.322 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.03 120.01 26.07 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 105.161 -2.163 . . . . 50.0 105.161 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 92.0 m -130.29 161.14 31.9 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.827 0.346 . . . . 50.0 111.317 178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.3 t -113.71 120.3 40.36 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.184 -1.413 . . . . 50.0 107.184 174.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.5 tp -143.2 135.5 27.19 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.145 -0.687 . . . . 75.0 109.145 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 56.03 28.13 12.35 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.889 1.07 . . . . 25.0 113.889 175.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.28 7.7 86.31 Favored Glycine 0 C--O 1.226 -0.352 0 C-N-CA 121.202 -0.523 . . . . 25.0 113.794 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -118.62 153.22 34.64 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.523 -0.918 . . . . 50.0 108.523 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -117.16 138.46 51.65 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 104.996 -2.224 . . . . 50.0 104.996 173.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.18 -162.71 26.99 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 107.414 -2.274 . . . . 50.0 107.414 -176.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.6 pt -111.31 151.92 13.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 121.599 0.714 . . . . 50.0 111.713 -174.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.2 m -141.47 145.01 35.95 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 114.851 -1.068 . . . . 50.0 108.992 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.72 120.69 6.26 Favored 'Trans proline' 0 C--O 1.238 0.507 0 CA-C-O 121.233 0.431 . . . . 50.0 112.691 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.76 -19.84 71.71 Favored Glycine 0 C--O 1.22 -0.727 0 N-CA-C 114.915 0.726 . . . . 50.0 114.915 -176.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -65.37 -16.68 63.86 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.217 0.821 . . . . 50.0 113.217 -177.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -122.92 27.44 7.69 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.259 0.552 . . . . 50.0 109.817 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.7 mt -126.8 157.82 38.23 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.019 0.914 . . . . 50.0 113.023 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -127.56 125.93 41.22 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 115.01 -0.996 . . . . 50.0 110.194 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.2 mm -75.07 135.85 26.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.699 -0.852 . . . . 50.0 108.699 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.0 mt -115.47 92.13 3.82 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.561 0.744 . . . . 50.0 109.629 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 m -105.56 16.77 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.86 -0.609 . . . . 50.0 111.139 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.57 22.27 75.58 Favored Glycine 0 C--O 1.224 -0.49 0 C-N-CA 121.03 -0.605 . . . . 25.0 113.566 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 19.2 ttt -78.09 123.0 26.35 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.908 -0.775 . . . . 25.0 108.908 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 67.36 151.05 0.07 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.685 1.594 . . . . 25.0 111.822 -172.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -55.51 -45.98 77.03 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.279 -0.418 . . . . 25.0 111.81 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt 39.01 44.98 0.94 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.647 0.98 . . . . 50.0 113.647 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -55.44 138.7 68.01 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.804 -0.634 . . . . 50.0 110.472 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.73 151.7 69.29 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 117.853 -0.964 . . . . 50.0 111.959 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -157.15 170.83 21.62 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 104.714 -2.328 . . . . 25.0 104.714 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.05 -96.44 0.17 Allowed Glycine 0 C--O 1.217 -0.947 0 N-CA-C 109.982 -1.247 . . . . 25.0 109.982 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 t 55.12 39.48 31.51 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.359 0.664 . . . . 25.0 111.42 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.24 -163.61 20.18 Favored Glycine 0 CA--C 1.51 -0.254 0 N-CA-C 109.865 -1.294 . . . . 25.0 109.865 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.47 -155.48 11.54 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 114.86 0.704 . . . . 25.0 114.86 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 t 65.51 -155.93 0.27 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.056 0.943 . . . . 25.0 110.343 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.47 -11.41 30.69 Favored Glycine 0 CA--C 1.52 0.35 0 CA-C-O 121.253 0.363 . . . . 25.0 113.052 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.9 t -71.07 156.23 39.86 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.972 -1.121 . . . . 25.0 107.972 176.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.08 28.7 1.84 Allowed Glycine 0 C--O 1.222 -0.63 0 C-N-CA 121.023 -0.608 . . . . 25.0 112.921 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.0 t -95.59 137.1 35.11 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 104.922 -2.251 . . . . 25.0 104.922 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -109.19 134.67 51.44 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.626 -1.62 . . . . 50.0 106.626 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.99 22.03 5.48 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.951 0.723 . . . . 25.0 112.951 -177.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 62.81 25.48 15.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.837 0.855 . . . . 50.0 111.281 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -81.81 167.6 18.87 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 121.61 0.719 . . . . 25.0 112.877 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.3 m -78.03 159.62 75.46 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.474 1.11 . . . . 25.0 113.726 -175.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.02 155.34 68.7 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 118.044 -0.837 . . . . 50.0 112.424 176.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.82 153.53 77.64 Favored 'Trans proline' 0 C--N 1.351 0.702 0 O-C-N 121.623 0.275 . . . . 50.0 112.718 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.56 161.53 44.71 Favored 'Trans proline' 0 C--N 1.345 0.377 0 N-CA-C 115.677 1.376 . . . . 50.0 115.677 -172.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -91.65 149.49 39.34 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 107.766 -1.198 . . . . 50.0 107.766 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.69 165.75 31.57 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 O-C-N 122.186 0.571 . . . . 50.0 113.07 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.91 169.02 9.52 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 118.433 -0.578 . . . . 50.0 111.422 173.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.5 mtm-85 -106.24 -82.24 0.54 Allowed 'General case' 0 C--O 1.206 -1.188 0 CA-C-O 120.863 0.364 . . . . 50.0 110.617 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.95 -42.94 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.666 0.746 . . . . 25.0 110.272 -177.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -129.29 148.06 51.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.259 -0.882 . . . . 50.0 110.677 -174.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.0 m -83.54 117.98 23.48 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.186 -1.412 . . . . 25.0 107.186 176.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 64.4 m -101.02 153.19 19.75 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.065 -0.717 . . . . 25.0 109.065 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.5 tp . . . . . 0 C--O 1.213 -0.851 0 CA-C-O 124.513 2.102 . . . . 25.0 109.877 177.874 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.235 0 CA-C-O 125.322 2.623 . . . . 25.0 114.259 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.8 m -88.55 37.0 0.81 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 112.579 -1.81 . . . . 25.0 113.17 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -72.09 152.91 42.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.188 0.518 . . . . 25.0 109.96 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.14 75.1 5.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.622 -0.51 . . . . 50.0 109.622 177.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -118.31 168.21 10.83 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.641 -0.709 . . . . 50.0 109.689 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.4 mt -67.34 -39.35 85.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.918 -0.583 . . . . 50.0 109.788 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.7 m120 53.76 30.06 10.6 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.168 0.987 . . . . 50.0 112.683 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.8 m -93.17 175.88 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 104.501 -2.407 . . . . 50.0 104.501 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.55 172.34 7.72 Favored 'General case' 0 CA--C 1.497 -1.093 0 O-C-N 121.934 -0.479 . . . . 50.0 109.837 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.93 162.74 38.69 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.599 -0.728 . . . . 25.0 109.87 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.91 128.19 49.09 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 124.175 0.99 . . . . 50.0 108.333 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.24 138.24 49.28 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 122.763 0.425 . . . . 25.0 110.271 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.2 mt -101.46 -17.38 16.47 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.669 0.618 . . . . 50.0 112.669 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -141.45 159.12 42.87 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.698 -1.223 . . . . 50.0 107.698 -176.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.4 ' C ' HH22 ' A' ' 61' ' ' ARG . 21.5 m-20 -81.18 149.71 28.98 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.036 0.21 . . . . 50.0 111.257 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -133.68 146.29 50.71 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.33 0.652 . . . . 50.0 112.203 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.0 t -119.98 133.38 66.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 103.147 -2.908 . . . . 25.0 103.147 170.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.14 135.53 36.6 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.063 -0.717 . . . . 25.0 109.063 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -108.82 2.44 21.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.39 0.614 . . . . 50.0 111.261 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -142.43 151.73 58.58 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 105.88 -1.896 . . . . 50.0 105.88 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.21 -18.73 34.7 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 118.353 -0.631 . . . . 50.0 112.823 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.03 -16.79 59.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.267 -0.879 . . . . 50.0 110.956 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -97.56 141.68 30.31 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.694 -0.854 . . . . 50.0 108.694 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.3 mt -93.62 127.04 39.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.958 0.885 . . . . 50.0 112.059 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.23 129.3 34.83 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 104.81 -2.293 . . . . 50.0 104.81 174.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -149.35 163.74 36.88 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.998 -0.371 . . . . 50.0 109.998 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -111.01 163.78 13.48 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.577 0.703 . . . . 50.0 110.514 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.52 130.85 46.07 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 107.278 -1.378 . . . . 50.0 107.278 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.14 -9.47 77.56 Favored Glycine 0 C--N 1.312 -0.751 0 CA-C-O 119.03 -0.872 . . . . 50.0 114.279 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -62.38 149.41 42.46 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 117.822 0.811 . . . . 50.0 109.326 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.0 mm -114.77 128.15 72.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.144 -0.935 . . . . 50.0 108.686 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -131.48 149.93 52.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.231 -0.44 . . . . 50.0 109.935 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.1 m -87.18 122.64 31.26 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.746 -1.205 . . . . 25.0 107.746 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -85.4 127.43 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 N-CA-C 108.138 -1.06 . . . . 50.0 108.138 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.9 mt -93.37 -51.0 5.19 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.17 -0.923 . . . . 50.0 109.222 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -152.44 173.75 14.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.332 -0.618 . . . . 50.0 109.332 176.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -121.76 155.46 35.23 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 107.928 -1.138 . . . . 50.0 107.928 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 55.88 42.43 28.88 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 125.641 1.838 . . . . 50.0 109.168 -177.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.8 t -65.98 149.62 49.94 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.415 -1.721 . . . . 25.0 110.517 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 59.72 14.61 4.18 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.774 0.83 . . . . 50.0 112.175 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.29 10.72 85.99 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.28 -0.486 . . . . 25.0 111.982 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.4 mt -89.63 119.4 30.01 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 117.718 0.759 . . . . 50.0 110.001 -178.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -64.32 126.04 26.5 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.238 -0.437 . . . . 25.0 110.064 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.58 -0.09 88.51 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 115.451 0.94 . . . . 50.0 115.451 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -99.45 133.29 43.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 119.101 1.45 . . . . 50.0 108.97 175.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -114.85 142.47 46.52 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.123 -1.436 . . . . 50.0 107.123 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.56 125.49 34.37 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 104.963 -2.236 . . . . 50.0 104.963 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.8 m -135.85 160.82 37.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.834 0.35 . . . . 50.0 110.601 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.2 t -111.46 125.96 54.45 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.314 -1.365 . . . . 50.0 107.314 171.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.7 tp -136.72 128.8 29.56 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.759 -1.2 . . . . 50.0 107.759 -177.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.9 m170 54.9 30.71 14.41 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.942 0.401 . . . . 25.0 110.771 -175.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.66 -7.7 64.62 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 115.937 1.135 . . . . 25.0 115.937 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -110.8 149.05 31.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 118.307 1.053 . . . . 50.0 108.783 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -103.24 154.33 19.46 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.502 -0.772 . . . . 50.0 110.266 -175.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.66 -167.98 39.73 Favored Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 106.429 -2.668 . . . . 50.0 106.429 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.4 pt -111.36 149.84 13.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.976 0.893 . . . . 50.0 111.961 -175.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 m -139.54 145.17 42.54 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 114.29 -1.323 . . . . 50.0 109.413 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.03 123.07 8.1 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 CA-C-O 121.207 0.42 . . . . 50.0 112.646 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.95 -15.01 79.84 Favored Glycine 0 C--O 1.228 -0.27 0 O-C-N 122.088 -0.383 . . . . 50.0 113.525 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -67.57 -5.28 14.65 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.775 0.83 . . . . 50.0 112.368 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.4 HH22 ' C ' ' A' ' 15' ' ' ASP . 0.3 OUTLIER -142.06 27.9 1.75 Allowed 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.139 -1.06 . . . . 50.0 108.139 -178.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 tp -130.65 144.62 51.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.611 -0.722 . . . . 50.0 110.884 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -122.32 117.09 25.26 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.257 -0.429 . . . . 50.0 112.033 -176.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.1 mm -64.92 136.99 25.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 O-C-N 123.961 0.788 . . . . 50.0 109.609 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.5 mt -119.67 106.14 11.87 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.283 -1.377 . . . . 50.0 107.283 176.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.42 142.69 13.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.104 0.478 . . . . 50.0 110.238 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.19 -38.88 24.77 Favored Glycine 0 C--O 1.218 -0.869 0 N-CA-C 110.495 -1.042 . . . . 25.0 110.495 177.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.2 ttp 56.99 -2.39 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 117.94 2.57 . . . . 25.0 117.94 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -137.8 148.9 45.91 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.065 0.765 . . . . 25.0 113.065 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -124.59 44.1 2.85 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 105.651 -1.981 . . . . 25.0 105.651 171.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -116.49 -58.52 2.08 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.989 -1.005 . . . . 50.0 111.873 -175.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -156.58 158.53 31.44 Favored Pre-proline 0 CA--C 1.511 -0.532 0 N-CA-C 104.113 -2.551 . . . . 50.0 104.113 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -71.79 162.94 40.48 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 116.395 -1.937 . . . . 50.0 112.112 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.75 -59.65 0.56 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.341 0.591 . . . . 25.0 110.392 176.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.81 -168.42 34.35 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.805 -0.442 . . . . 25.0 112.536 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.7 m -153.23 -43.64 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.939 1.089 . . . . 25.0 113.939 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.86 -139.55 34.9 Favored Glycine 0 C--O 1.246 0.861 0 C-N-CA 120.875 -0.678 . . . . 25.0 113.258 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.89 53.69 3.44 Favored Glycine 0 C--O 1.224 -0.525 0 N-CA-C 115.992 1.157 . . . . 25.0 115.992 175.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -70.55 -27.34 64.07 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.872 1.064 . . . . 25.0 113.872 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.61 -61.6 4.73 Favored Glycine 0 C--O 1.22 -0.779 0 CA-C-O 119.696 -0.502 . . . . 25.0 113.399 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.9 m 54.0 35.43 22.04 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.633 1.345 . . . . 25.0 114.633 178.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.99 172.49 39.85 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 110.814 -0.915 . . . . 25.0 110.814 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.2 t -148.52 147.83 29.51 Favored 'General case' 0 C--O 1.22 -0.482 0 N-CA-C 106.791 -1.559 . . . . 25.0 106.791 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -122.17 117.91 27.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.707 0.289 . . . . 50.0 110.576 -177.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 86' ' ' GLN . 19.3 tttt 54.13 -166.53 0.08 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.857 0.837 . . . . 25.0 112.865 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' A' ' 85' ' ' LYS . 27.8 mp0 -98.77 67.07 1.67 Allowed 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.437 -1.32 . . . . 50.0 107.437 177.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -72.96 145.97 46.37 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.934 -1.136 . . . . 25.0 107.934 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.7 t -96.35 134.72 23.13 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 108.626 -0.879 . . . . 25.0 108.626 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -67.36 154.54 73.63 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 116.664 -1.758 . . . . 50.0 111.527 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -70.68 160.05 50.71 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 117.011 -1.526 . . . . 50.0 111.906 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -69.58 155.57 66.17 Favored 'Trans proline' 0 C--N 1.352 0.76 0 N-CA-C 114.395 0.883 . . . . 50.0 114.395 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -83.12 140.78 42.76 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 106.957 -1.497 . . . . 50.0 106.957 176.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.92 164.71 33.67 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 116.705 -1.73 . . . . 50.0 110.553 173.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.77 153.89 64.05 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 118.578 -0.482 . . . . 50.0 113.138 -176.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -97.14 35.01 1.65 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 120.634 0.254 . . . . 50.0 111.226 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.7 p -138.78 145.07 39.72 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.414 -0.958 . . . . 25.0 108.414 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -163.93 -39.8 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.975 -0.557 . . . . 50.0 111.371 175.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.7 p 54.1 109.22 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 116.726 2.121 . . . . 25.0 116.726 177.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 47.1 t -63.09 -43.37 98.69 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.052 -0.976 . . . . 25.0 112.908 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.8 tp . . . . . 0 N--CA 1.494 1.736 0 C-N-CA 125.354 1.462 . . . . 25.0 112.586 -177.615 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.761 0 CA-C-O 123.511 1.617 . . . . 25.0 113.607 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 m 64.7 -65.27 0.14 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 127.822 2.449 . . . . 25.0 112.608 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.4 -50.59 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.299 -1.741 . . . . 25.0 106.299 176.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -158.95 134.31 8.51 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 106.163 -1.792 . . . . 50.0 106.163 175.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.79 165.81 10.81 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.182 -1.414 . . . . 50.0 107.182 174.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.41 -39.97 92.69 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.509 0.506 . . . . 50.0 110.648 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 55.52 31.93 18.05 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.926 0.89 . . . . 50.0 111.695 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.5 m -94.31 170.71 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 104.267 -2.494 . . . . 50.0 104.267 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -115.83 172.21 7.28 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.264 -1.013 . . . . 50.0 108.264 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.29 156.32 41.91 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 123.281 0.363 . . . . 25.0 110.623 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -116.63 127.86 54.85 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 123.998 0.812 . . . . 50.0 110.104 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.52 127.08 31.38 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.913 -0.773 . . . . 25.0 108.913 176.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.6 mt -88.75 -24.19 22.72 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 120.61 0.243 . . . . 50.0 110.488 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -146.2 171.5 14.84 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 104.09 -2.559 . . . . 50.0 104.09 177.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -82.57 174.24 11.22 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.538 -0.541 . . . . 50.0 109.538 177.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -150.85 133.44 15.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.889 0.376 . . . . 50.0 111.74 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.9 t -101.3 120.07 50.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 105.197 -2.149 . . . . 25.0 105.197 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.05 137.49 49.03 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.644 -0.873 . . . . 25.0 108.644 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -116.02 15.27 16.16 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 122.266 1.031 . . . . 50.0 108.891 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 t -157.21 149.47 17.73 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.118 -0.946 . . . . 50.0 108.501 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -69.48 -16.43 38.73 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 117.326 -1.316 . . . . 50.0 113.006 175.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -78.58 -17.1 56.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.524 0.678 . . . . 50.0 109.805 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -98.52 138.21 36.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.599 -0.728 . . . . 50.0 110.904 -173.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.8 mt -89.69 130.77 35.93 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.787 0.804 . . . . 50.0 110.045 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.6 p -90.23 144.49 25.8 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 105.803 -1.925 . . . . 50.0 105.803 174.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -157.9 168.55 26.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.82 0.343 . . . . 50.0 110.268 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.55 161.1 16.04 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.318 0.58 . . . . 50.0 109.789 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -60.31 133.97 56.61 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.318 -0.994 . . . . 50.0 108.318 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.86 -15.46 63.33 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-O 119.079 -0.845 . . . . 50.0 113.69 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -58.41 136.6 57.49 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.553 0.692 . . . . 50.0 109.739 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.0 mm -103.74 127.44 57.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 106.393 -1.706 . . . . 50.0 106.393 176.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 19.5 ptp -131.79 153.62 49.94 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.188 -0.671 . . . . 50.0 109.188 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.1 m -89.33 127.83 35.83 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.046 -1.464 . . . . 25.0 107.046 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.9 t -97.01 122.97 49.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.955 -1.128 . . . . 50.0 107.955 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.0 mt -92.78 -45.22 8.12 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.272 -0.876 . . . . 50.0 109.521 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -147.15 161.18 41.41 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.384 -0.969 . . . . 50.0 108.384 -174.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -126.88 149.59 49.69 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.08 -1.452 . . . . 50.0 107.08 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 56.62 38.52 29.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 123.483 1.611 . . . . 50.0 108.452 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 t -63.03 146.71 52.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.339 -1.755 . . . . 25.0 110.01 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 59.44 13.42 3.22 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.482 0.919 . . . . 50.0 113.482 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.89 16.99 79.24 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 111.003 -0.839 . . . . 25.0 111.003 -178.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.428 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 60.3 mt -91.53 103.65 16.23 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.875 -0.787 . . . . 50.0 108.875 178.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -54.49 123.98 14.73 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.422 -0.808 . . . . 25.0 111.606 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.24 0.27 85.89 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 115.345 0.898 . . . . 50.0 115.345 176.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.428 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 95.0 m95 -100.95 130.73 46.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 118.523 1.162 . . . . 50.0 109.193 177.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -112.23 142.6 44.52 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 121.789 -0.569 . . . . 50.0 109.622 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.02 119.07 24.5 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 105.563 -2.014 . . . . 50.0 105.563 178.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 95.4 m -129.8 162.28 28.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.088 0.47 . . . . 50.0 112.095 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.1 t -111.97 113.38 25.65 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.522 -1.658 . . . . 50.0 106.522 172.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -143.6 136.79 27.83 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.84 -1.17 . . . . 50.0 107.84 -174.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 55.88 27.42 10.99 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.45 0.7 . . . . 25.0 112.803 -176.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.51 6.4 86.64 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 120.859 -0.686 . . . . 25.0 113.046 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -114.16 160.99 18.35 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.53 -1.285 . . . . 50.0 107.53 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -121.75 142.82 49.81 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 105.89 -1.892 . . . . 50.0 105.89 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.09 -158.34 20.71 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 105.461 -3.055 . . . . 50.0 105.461 -177.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.7 pt -118.5 154.23 20.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.493 0.663 . . . . 50.0 111.238 -175.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.42 146.26 41.47 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.069 -0.968 . . . . 50.0 109.347 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.24 117.7 5.21 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 CA-C-O 121.484 0.535 . . . . 50.0 112.189 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.95 -14.75 66.16 Favored Glycine 0 C--O 1.22 -0.767 0 O-C-N 122.079 -0.388 . . . . 50.0 113.202 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -64.23 -15.35 59.86 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.832 0.679 . . . . 50.0 112.832 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -131.21 29.55 4.62 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.348 0.594 . . . . 50.0 109.628 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.1 tp -133.63 148.41 51.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.845 -0.616 . . . . 50.0 109.972 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -127.87 120.12 27.07 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 111.984 0.365 . . . . 50.0 111.984 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.4 mm -69.18 135.47 28.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 123.458 0.474 . . . . 50.0 110.45 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.6 mt -120.85 96.66 5.2 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.951 0.9 . . . . 50.0 109.213 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.3 t -84.66 146.46 6.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.712 -1.218 . . . . 50.0 107.712 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.13 -47.27 0.43 Allowed Glycine 0 C--O 1.216 -1.004 0 C-N-CA 120.496 -0.859 . . . . 25.0 114.6 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 92.5 mmm -145.74 143.0 29.47 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 106.378 -1.712 . . . . 25.0 106.378 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -86.93 -18.27 31.2 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.802 -1.185 . . . . 25.0 107.802 173.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -80.93 90.44 5.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.961 -1.018 . . . . 25.0 111.37 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 10.7 76.72 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 116.792 2.145 . . . . 50.0 116.792 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -56.97 142.69 73.38 Favored Pre-proline 0 C--O 1.237 0.419 0 N-CA-C 108.701 -0.852 . . . . 50.0 108.701 177.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -66.7 157.29 61.78 Favored 'Trans proline' 0 C--N 1.347 0.488 0 N-CA-C 113.703 0.617 . . . . 50.0 113.703 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.68 164.38 26.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.985 -1.007 . . . . 25.0 108.443 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.16 162.86 34.02 Favored Glycine 0 C--O 1.225 -0.411 0 N-CA-C 108.648 -1.781 . . . . 25.0 108.648 174.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 m -77.89 -11.97 59.94 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.063 0.764 . . . . 25.0 113.063 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.19 -155.96 21.01 Favored Glycine 0 C--O 1.229 -0.198 0 N-CA-C 109.176 -1.57 . . . . 25.0 109.176 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -178.38 -176.95 46.72 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 109.01 -1.636 . . . . 25.0 109.01 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.6 m -65.25 153.45 41.01 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.438 -0.579 . . . . 25.0 109.438 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.35 -148.94 8.04 Favored Glycine 0 C--O 1.223 -0.583 0 C-N-CA 120.653 -0.784 . . . . 25.0 111.887 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.0 t 67.03 16.32 10.3 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.188 0.995 . . . . 25.0 113.157 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.47 34.16 2.0 Favored Glycine 0 CA--C 1.517 0.157 0 N-CA-C 109.072 -1.611 . . . . 25.0 109.072 175.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.6 m 55.67 -153.07 0.35 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.222 0.609 . . . . 25.0 109.824 -173.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -145.04 32.99 1.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.188 -1.042 . . . . 50.0 108.188 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 72.7 tttt 61.87 -141.41 0.45 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 104.63 -2.359 . . . . 25.0 104.63 -171.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 55.91 -150.56 0.42 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.455 0.702 . . . . 50.0 109.985 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -117.11 163.44 16.27 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.54 -0.541 . . . . 25.0 109.54 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.2 m -60.22 147.62 80.82 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 112.506 0.558 . . . . 25.0 112.506 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.4 159.07 54.95 Favored 'Trans proline' 0 C--N 1.35 0.637 0 N-CA-C 113.306 0.464 . . . . 50.0 113.306 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.7 155.55 69.55 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 118.435 -0.577 . . . . 50.0 113.067 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.85 163.24 38.13 Favored 'Trans proline' 0 C--N 1.347 0.48 0 N-CA-C 115.463 1.294 . . . . 50.0 115.463 -174.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.62 143.27 92.51 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.056 -0.974 . . . . 50.0 108.886 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.03 161.7 45.17 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 116.92 -1.587 . . . . 50.0 110.604 175.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -61.11 151.47 78.41 Favored 'Trans proline' 0 C--N 1.349 0.592 0 N-CA-C 114.49 0.919 . . . . 50.0 114.49 -177.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -101.27 76.67 1.73 Allowed 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.713 -0.847 . . . . 50.0 108.713 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -63.8 143.14 58.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.843 -0.617 . . . . 25.0 110.285 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -144.11 43.59 1.44 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 105.494 -2.039 . . . . 50.0 105.494 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.9 p -149.26 150.44 32.57 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.418 -1.697 . . . . 25.0 106.418 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 34.7 m -115.52 157.92 23.36 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.62 -0.511 . . . . 25.0 109.62 -177.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.0 tp . . . . . 0 N--CA 1.483 1.207 0 C-N-CA 124.801 1.24 . . . . 25.0 114.024 178.669 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.055 0 N-CA-C 116.066 1.187 . . . . 25.0 116.066 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m 60.95 -167.28 0.19 Allowed 'General case' 0 C--N 1.351 0.666 0 C-N-CA 124.99 1.316 . . . . 25.0 111.247 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.6 ptt? -141.84 137.72 31.65 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.347 -1.353 . . . . 25.0 107.347 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -109.46 79.18 1.19 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.55 0.691 . . . . 50.0 109.944 -176.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -96.1 161.71 13.85 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.362 -0.835 . . . . 50.0 111.063 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.6 mt -68.3 -40.61 81.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.765 -0.828 . . . . 50.0 108.765 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 53.46 34.78 19.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.037 0.935 . . . . 50.0 111.58 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.0 m -93.38 -179.25 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 103.946 -2.613 . . . . 50.0 103.946 175.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.89 173.86 6.97 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.276 -0.89 . . . . 50.0 109.938 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.75 157.23 43.02 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.506 0.67 . . . . 25.0 109.598 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -116.96 129.95 56.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.177 -0.92 . . . . 50.0 109.875 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.97 128.09 35.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.091 -0.504 . . . . 25.0 109.666 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.64 -21.79 21.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.315 0.579 . . . . 50.0 111.188 -177.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -141.18 173.27 11.64 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.852 -1.166 . . . . 50.0 107.852 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -76.8 -179.07 5.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 124.113 0.883 . . . . 50.0 109.884 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.09 156.79 29.83 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.777 -0.823 . . . . 50.0 108.777 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.36 122.82 60.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 103.394 -2.817 . . . . 25.0 103.394 167.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.31 133.07 34.16 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.133 -1.062 . . . . 25.0 108.133 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -114.01 -23.56 9.49 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.027 0.441 . . . . 50.0 111.021 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -93.44 151.7 40.41 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.285 -1.006 . . . . 50.0 108.285 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.06 -18.88 30.64 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 116.545 -1.837 . . . . 50.0 111.835 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -85.71 -17.0 37.21 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.228 -0.896 . . . . 50.0 110.036 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -83.11 133.67 35.04 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.442 -0.787 . . . . 50.0 110.142 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.2 mt -84.02 132.86 34.7 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.961 0.41 . . . . 50.0 110.546 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 p -83.48 116.82 22.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.214 -1.032 . . . . 50.0 108.214 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -138.96 161.94 36.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.091 0.948 . . . . 50.0 112.491 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -119.23 166.62 12.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.975 -1.011 . . . . 50.0 108.73 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -61.87 131.61 50.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.882 -0.785 . . . . 50.0 108.882 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.62 -13.94 65.66 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-O 118.844 -0.975 . . . . 50.0 114.683 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.39 141.39 54.7 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 118.117 0.959 . . . . 50.0 108.908 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.6 mm -106.51 130.35 58.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 107.358 -1.349 . . . . 50.0 107.358 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.3 ptp -131.78 151.68 51.49 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 109.037 -0.727 . . . . 50.0 109.037 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.4 m -87.94 124.33 33.59 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 106.895 -1.521 . . . . 25.0 106.895 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.4 t -91.82 124.2 44.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 N-CA-C 108.418 -0.956 . . . . 50.0 108.418 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.6 mt -90.02 -47.56 7.76 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.765 -0.652 . . . . 50.0 109.411 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -156.9 175.72 13.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.737 -0.468 . . . . 50.0 109.737 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -127.95 156.2 43.04 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 106.219 -1.771 . . . . 50.0 106.219 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.4 t0 61.8 36.15 16.29 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.869 1.319 . . . . 50.0 108.218 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -66.7 144.71 56.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.772 -1.103 . . . . 25.0 108.58 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 57.64 15.25 2.76 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.604 0.964 . . . . 50.0 113.604 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.79 15.59 81.21 Favored Glycine 0 C--O 1.254 1.348 0 C-N-CA 121.335 -0.459 . . . . 25.0 112.076 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.416 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 98.0 mt -92.98 101.24 13.57 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 122.238 1.018 . . . . 50.0 108.69 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -60.11 121.7 12.56 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.592 -1.186 . . . . 25.0 110.206 -175.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.08 -2.44 85.43 Favored Glycine 0 C--N 1.318 -0.418 0 CA-C-O 119.06 -0.856 . . . . 50.0 115.139 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.416 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 93.0 m95 -99.17 139.14 35.26 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.388 1.094 . . . . 50.0 108.62 174.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -118.6 139.61 51.21 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.496 -1.298 . . . . 50.0 107.496 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.12 124.29 29.11 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 106.359 -1.719 . . . . 50.0 106.359 177.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 98.2 m -131.76 163.13 28.87 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.622 0.725 . . . . 50.0 109.975 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -117.91 120.25 37.29 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 104.966 -2.235 . . . . 50.0 104.966 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 tp -147.9 134.32 19.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.932 -0.766 . . . . 50.0 108.932 -175.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.3 m170 54.07 32.26 15.31 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.719 1.007 . . . . 25.0 113.719 174.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.73 5.01 86.96 Favored Glycine 0 C--O 1.224 -0.492 0 C-N-CA 120.452 -0.88 . . . . 25.0 114.867 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -120.06 158.83 26.01 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 107.816 -1.179 . . . . 50.0 107.816 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -111.88 154.55 25.02 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 102.95 -2.982 . . . . 50.0 102.95 166.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.25 -167.88 40.72 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 107.723 -2.151 . . . . 50.0 107.723 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 pt -113.03 151.74 14.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.65 0.738 . . . . 50.0 112.241 -175.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.7 m -143.79 147.12 37.45 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-N 114.722 -1.126 . . . . 50.0 110.235 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.38 118.48 5.37 Favored 'Trans proline' 0 C--O 1.244 0.797 0 O-C-N 121.946 0.445 . . . . 50.0 112.586 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.33 -15.13 65.3 Favored Glycine 0 C--O 1.221 -0.677 0 N-CA-C 114.664 0.626 . . . . 50.0 114.664 -176.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -63.67 -23.95 67.59 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 113.004 0.742 . . . . 50.0 113.004 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -118.34 28.39 8.38 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.393 -0.595 . . . . 50.0 109.393 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.1 tp -134.56 150.1 50.7 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.539 -0.755 . . . . 50.0 110.593 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -128.54 119.97 25.84 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.166 0.432 . . . . 50.0 112.166 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.8 mm -64.81 135.86 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.6 0.714 . . . . 50.0 111.33 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.1 mt -118.33 93.71 4.22 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.559 -1.275 . . . . 50.0 107.559 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 m -83.26 149.92 4.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.629 -0.878 . . . . 50.0 108.629 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -135.54 49.67 0.88 Allowed Glycine 0 C--O 1.214 -1.102 0 CA-C-N 116.395 -0.366 . . . . 25.0 112.755 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -80.77 3.22 23.11 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.658 -0.907 . . . . 25.0 112.601 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -110.81 146.09 37.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.576 -0.284 . . . . 25.0 110.996 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -114.81 -177.53 3.15 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.898 -1.149 . . . . 25.0 107.898 173.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm 57.21 19.52 4.97 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.829 1.418 . . . . 50.0 114.829 175.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -131.21 146.64 62.94 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 106.521 -1.659 . . . . 50.0 106.521 175.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.55 135.48 31.07 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 116.267 -2.022 . . . . 50.0 112.804 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.27 -37.48 32.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.348 -0.387 . . . . 25.0 110.116 176.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.53 -170.07 54.93 Favored Glycine 0 C--O 1.216 -0.985 0 N-CA-C 110.46 -1.056 . . . . 25.0 110.46 -177.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.6 t -156.46 -60.58 0.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.194 0.521 . . . . 25.0 110.399 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.54 -146.79 18.77 Favored Glycine 0 C--O 1.222 -0.629 0 N-CA-C 108.172 -1.971 . . . . 25.0 108.172 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.08 -15.61 56.4 Favored Glycine 0 C--O 1.226 -0.392 0 CA-C-N 117.018 0.409 . . . . 25.0 113.095 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.8 m -64.56 138.33 58.34 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.325 -0.62 . . . . 25.0 109.325 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.96 161.97 52.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.855 -0.688 . . . . 25.0 111.767 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.0 m -146.0 -32.87 0.34 Allowed 'General case' 0 C--O 1.211 -0.972 0 N-CA-C 112.519 0.563 . . . . 25.0 112.519 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.82 172.0 39.08 Favored Glycine 0 C--N 1.318 -0.438 0 C-N-CA 121.209 -0.52 . . . . 25.0 112.18 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.3 m -104.07 85.35 2.38 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.628 -0.336 . . . . 25.0 110.916 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -131.68 86.6 2.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.016 0.436 . . . . 50.0 110.982 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -149.83 140.21 22.34 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.215 0.82 . . . . 25.0 113.215 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -136.18 21.04 3.21 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.81 0.814 . . . . 50.0 109.999 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -104.85 178.47 4.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.568 -0.742 . . . . 25.0 111.202 -176.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.3 t -135.7 140.62 34.29 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.007 -0.542 . . . . 25.0 110.035 -176.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -72.17 158.83 51.25 Favored 'Trans proline' 0 C--N 1.349 0.595 0 N-CA-C 116.248 1.595 . . . . 50.0 116.248 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.86 157.09 61.37 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 117.909 -0.928 . . . . 50.0 112.361 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -68.82 162.42 41.46 Favored 'Trans proline' 0 C--N 1.349 0.558 0 N-CA-C 116.552 1.712 . . . . 50.0 116.552 -174.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -79.47 140.75 56.08 Favored Pre-proline 0 N--CA 1.473 0.723 0 CA-C-N 114.634 -1.166 . . . . 50.0 108.097 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.77 165.75 30.8 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 118.093 -0.805 . . . . 50.0 110.986 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -64.41 155.38 66.32 Favored 'Trans proline' 0 C--N 1.352 0.736 0 N-CA-C 114.975 1.106 . . . . 50.0 114.975 -175.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.4 mtp-105 -111.54 -23.45 10.7 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.24 1.2 . . . . 50.0 114.24 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.2 p -135.63 41.2 2.74 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.154 0.502 . . . . 25.0 112.153 -172.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -65.44 138.66 58.26 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.577 -0.897 . . . . 50.0 108.577 176.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.0 m -80.99 -31.17 34.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.035 0.445 . . . . 25.0 110.391 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 74.1 m -139.52 165.37 27.41 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.342 -0.614 . . . . 25.0 109.342 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 67.7 tp . . . . . 0 C--O 1.206 -1.229 0 CA-C-O 124.691 2.186 . . . . 25.0 110.918 175.459 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 CA-C-O 122.909 1.283 . . . . 25.0 115.191 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.4 m -67.05 136.29 55.0 Favored 'General case' 0 C--O 1.23 0.062 0 O-C-N 121.381 -1.07 . . . . 25.0 110.5 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.3 ptp -153.3 165.22 36.44 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.319 -1.363 . . . . 25.0 107.319 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -156.53 159.11 38.27 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 104.551 -2.389 . . . . 50.0 104.551 177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 58.01 168.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 116.345 1.98 . . . . 50.0 116.345 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.5 mt -76.48 -38.73 54.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.496 -1.229 . . . . 50.0 109.645 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.7 m120 54.35 24.96 5.5 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.329 1.052 . . . . 50.0 112.921 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.1 m -84.85 175.1 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 105.439 -2.059 . . . . 50.0 105.439 173.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.82 174.04 6.41 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.736 -0.603 . . . . 50.0 109.81 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.56 162.81 36.57 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.158 -0.474 . . . . 25.0 110.459 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -128.42 129.18 45.78 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.018 -0.992 . . . . 50.0 109.23 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.59 136.9 43.99 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.878 -0.601 . . . . 25.0 109.466 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.4 mt -104.82 -15.83 15.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 111.881 0.326 . . . . 50.0 111.881 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -143.15 165.35 27.67 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.976 -1.12 . . . . 50.0 107.976 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.93 165.03 25.01 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.638 -0.504 . . . . 50.0 109.638 174.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.04 159.91 42.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.104 -0.702 . . . . 50.0 109.104 177.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.01 121.79 56.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 104.866 -2.272 . . . . 25.0 104.866 171.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.82 134.73 33.63 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.462 -1.681 . . . . 25.0 106.462 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -114.35 -8.8 12.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.324 0.583 . . . . 50.0 111.166 -177.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.5 p -132.16 155.9 80.75 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 105.541 -2.022 . . . . 50.0 105.541 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.33 -18.31 39.08 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 118.03 -0.846 . . . . 50.0 112.266 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.48 -20.29 58.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.934 -0.576 . . . . 50.0 110.926 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -95.45 137.08 35.01 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.956 -1.127 . . . . 50.0 107.956 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.5 mt -86.26 134.53 33.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.886 -0.597 . . . . 50.0 109.947 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.06 130.45 34.61 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.232 -1.025 . . . . 50.0 108.232 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -154.27 163.36 40.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.916 0.865 . . . . 50.0 113.329 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -115.83 163.52 15.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.577 -1.192 . . . . 50.0 110.013 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -58.94 129.62 43.04 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.736 -0.839 . . . . 50.0 108.736 175.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.62 -11.04 72.01 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 118.831 -0.983 . . . . 50.0 114.634 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -63.21 150.34 43.26 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 118.39 1.095 . . . . 50.0 110.457 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.2 mm -115.57 131.28 68.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.37 -1.286 . . . . 50.0 108.917 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -135.37 156.02 49.62 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.214 -0.661 . . . . 50.0 109.214 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.1 m -87.63 130.17 34.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.177 -1.416 . . . . 25.0 107.177 176.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.8 t -94.24 124.32 46.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.643 -1.243 . . . . 50.0 107.643 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.2 mt -93.27 -44.98 8.05 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.948 -0.76 . . . . 50.0 108.948 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -149.43 162.25 40.48 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.961 -0.755 . . . . 50.0 108.961 -175.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 mtm105 -121.81 151.11 40.96 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.872 -1.159 . . . . 50.0 107.872 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 56.11 38.86 30.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 123.51 1.624 . . . . 50.0 108.853 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 t -67.1 153.37 43.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.11 -1.859 . . . . 25.0 110.438 -175.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 60.6 9.56 2.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.911 0.884 . . . . 50.0 113.261 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.36 10.84 84.1 Favored Glycine 0 C--N 1.329 0.17 0 N-CA-C 110.803 -0.919 . . . . 25.0 110.803 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.41 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 93.2 mt -88.42 109.44 20.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.853 -0.795 . . . . 50.0 108.853 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -58.6 126.26 26.87 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.588 -0.733 . . . . 25.0 110.983 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.65 -0.58 76.21 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 115.784 1.074 . . . . 50.0 115.784 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.41 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 94.3 m95 -100.89 129.99 46.83 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 119.028 1.414 . . . . 50.0 109.964 178.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -112.89 140.54 47.6 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 121.873 -0.517 . . . . 50.0 109.926 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.3 121.86 26.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 105.949 -1.871 . . . . 50.0 105.949 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 92.5 m -133.51 168.37 18.76 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.926 0.393 . . . . 50.0 111.583 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 t -123.42 125.77 45.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.747 -1.205 . . . . 50.0 107.747 173.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.0 tp -152.82 143.78 22.98 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.806 -1.553 . . . . 50.0 106.806 -176.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 55.69 31.97 18.44 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.153 0.581 . . . . 25.0 112.214 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.36 4.36 68.91 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 115.268 0.867 . . . . 25.0 115.268 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -124.75 165.72 17.47 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.069 -1.086 . . . . 50.0 108.069 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -116.28 154.37 30.28 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.669 -0.863 . . . . 50.0 108.669 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.53 -157.44 20.48 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 106.381 -2.688 . . . . 50.0 106.381 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.4 pt -120.65 157.34 23.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.618 0.723 . . . . 50.0 111.423 -176.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.87 147.12 37.21 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 114.763 -1.108 . . . . 50.0 109.146 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -74.51 117.7 5.06 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 O-C-N 121.999 0.473 . . . . 50.0 112.519 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.51 -19.5 68.93 Favored Glycine 0 C--O 1.22 -0.777 0 CA-C-O 121.422 0.457 . . . . 50.0 114.104 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -66.41 -10.33 42.66 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.552 0.945 . . . . 50.0 113.552 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -130.46 26.34 5.08 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.872 -0.788 . . . . 50.0 108.872 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.2 tp -131.77 150.05 52.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.282 -0.872 . . . . 50.0 111.595 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -121.26 126.67 50.14 Favored 'General case' 0 C--O 1.211 -0.931 0 C-N-CA 122.828 0.451 . . . . 50.0 110.932 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.2 mm -75.59 135.41 27.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.964 -0.754 . . . . 50.0 108.964 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.9 mt -116.66 107.18 14.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.023 -1.843 . . . . 50.0 106.023 174.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.0 m -78.99 167.67 2.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.931 -0.577 . . . . 50.0 110.228 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -153.98 -176.76 26.71 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 106.981 -2.447 . . . . 25.0 106.981 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 44.1 ttm 104.05 146.59 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 128.321 2.649 . . . . 25.0 106.347 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 61.86 27.11 16.5 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.756 0.822 . . . . 25.0 111.899 -176.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -73.69 58.49 0.61 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.121 0.968 . . . . 25.0 111.959 177.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -68.32 -18.05 64.41 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.419 0.526 . . . . 50.0 112.419 -174.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -147.66 140.05 14.4 Favored Pre-proline 0 N--CA 1.468 0.467 0 N-CA-C 106.18 -1.785 . . . . 50.0 106.18 174.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.42 142.97 37.87 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 115.775 -2.35 . . . . 50.0 110.715 175.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.13 -37.0 24.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.187 0.518 . . . . 25.0 111.191 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.66 165.08 39.13 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.775 -0.93 . . . . 25.0 110.775 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.3 p -160.36 158.94 30.52 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.967 -0.753 . . . . 25.0 108.967 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.29 168.99 20.28 Favored Glycine 0 CA--C 1.517 0.168 0 N-CA-C 110.516 -1.034 . . . . 25.0 110.516 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.81 -166.64 37.47 Favored Glycine 0 C--O 1.227 -0.335 0 N-CA-C 110.872 -0.891 . . . . 25.0 110.872 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.8 t -153.69 173.9 15.2 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.356 -1.72 . . . . 25.0 106.356 177.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -171.02 -39.64 0.03 OUTLIER Glycine 0 C--O 1.22 -0.748 0 N-CA-C 111.823 -0.511 . . . . 25.0 111.823 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.9 p -69.79 137.37 51.81 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.477 -0.425 . . . . 25.0 110.033 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 147.54 -165.68 28.72 Favored Glycine 0 C--O 1.226 -0.344 0 N-CA-C 109.574 -1.41 . . . . 25.0 109.574 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.59 120.11 15.73 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.928 -0.768 . . . . 25.0 108.928 176.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.33 -0.51 10.4 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.603 0.594 . . . . 50.0 112.603 -177.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -131.63 70.72 1.46 Allowed 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.033 -0.417 . . . . 25.0 110.104 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.99 163.04 0.24 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.909 1.284 . . . . 50.0 111.084 -176.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -151.57 176.51 11.26 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.644 -1.243 . . . . 25.0 107.644 -176.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.7 m -118.89 84.99 27.38 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-O 120.859 0.362 . . . . 25.0 110.043 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.8 160.39 40.78 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 N-CA-C 114.314 0.851 . . . . 50.0 114.314 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.03 158.99 54.12 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 118.782 -0.346 . . . . 50.0 111.975 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -66.56 158.08 57.48 Favored 'Trans proline' 0 C--N 1.346 0.395 0 N-CA-C 115.179 1.184 . . . . 50.0 115.179 -174.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -71.56 143.51 87.6 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.69 -1.226 . . . . 50.0 107.69 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -69.63 162.47 41.86 Favored 'Trans proline' 0 C--O 1.244 0.778 0 C-N-CA 117.848 -0.968 . . . . 50.0 111.472 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -60.68 147.21 95.59 Favored 'Trans proline' 0 C--N 1.348 0.524 0 N-CA-C 114.473 0.913 . . . . 50.0 114.473 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -100.55 52.42 0.87 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.323 -0.621 . . . . 50.0 109.323 176.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 42.4 p 39.55 48.19 1.77 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 114.451 1.278 . . . . 25.0 114.451 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -142.36 39.91 1.58 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.406 1.098 . . . . 50.0 108.378 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.7 m -84.14 172.92 11.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.88 -1.509 . . . . 25.0 109.612 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 7.2 t 52.71 56.55 7.46 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 122.426 1.108 . . . . 25.0 113.252 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.1 tt . . . . . 0 C--O 1.214 -0.802 0 CA-C-O 124.784 2.23 . . . . 25.0 110.207 176.621 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.096 0 CA-C-O 124.947 2.415 . . . . 25.0 113.438 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.7 t -68.03 -44.82 75.61 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 111.193 -2.503 . . . . 25.0 109.03 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 76.2 mtm -92.91 150.39 20.61 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.175 -1.417 . . . . 25.0 107.175 175.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -129.09 137.7 51.41 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 106.469 -1.678 . . . . 50.0 106.469 177.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -117.47 165.13 13.89 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 123.745 0.653 . . . . 50.0 111.389 -175.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.02 -41.23 95.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.109 -0.951 . . . . 50.0 109.661 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 56.65 25.16 9.69 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.268 1.027 . . . . 50.0 111.912 -178.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.6 m -83.42 159.94 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 105.805 -1.924 . . . . 50.0 105.805 176.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.43 170.98 8.85 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.821 -1.177 . . . . 50.0 107.821 -177.207 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.13 163.15 36.25 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.941 -0.392 . . . . 25.0 109.941 175.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -132.21 128.76 38.64 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.621 -0.718 . . . . 50.0 109.669 177.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.26 130.73 42.8 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.496 -0.557 . . . . 25.0 109.496 177.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.9 mt -97.97 -21.86 16.61 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.693 0.282 . . . . 50.0 110.912 -177.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -138.97 165.91 25.87 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.676 -0.861 . . . . 50.0 108.676 178.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -74.58 165.95 24.35 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.03 0.932 . . . . 50.0 111.302 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.0 156.92 42.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.32 0.581 . . . . 50.0 110.861 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.6 t -130.26 125.7 60.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 102.926 -2.99 . . . . 25.0 102.926 170.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.19 136.81 33.11 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.558 -1.275 . . . . 25.0 107.558 178.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -128.6 6.26 5.66 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.294 0.569 . . . . 50.0 111.522 -178.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.2 m -127.63 151.36 75.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 105.82 -1.918 . . . . 50.0 105.82 176.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.62 -25.96 40.1 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 117.35 -1.3 . . . . 50.0 112.712 -177.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -79.29 -16.94 55.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.192 -0.458 . . . . 50.0 111.498 178.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -86.7 132.96 33.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.94 0.876 . . . . 50.0 109.247 -177.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.1 mt -87.07 133.4 33.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.736 -0.665 . . . . 50.0 110.567 -177.192 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.5 121.2 28.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.223 -0.899 . . . . 50.0 108.954 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -147.75 164.01 34.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.046 0.451 . . . . 50.0 111.022 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.457 HH22 ' HB2' ' A' ' 84' ' ' GLU . 55.8 ttt-85 -126.19 165.92 18.02 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.035 -0.728 . . . . 50.0 109.035 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -57.0 132.6 53.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.958 0.409 . . . . 50.0 110.493 -179.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.89 -16.5 61.16 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-O 119.122 -0.821 . . . . 50.0 113.929 178.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.98 151.37 26.38 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.837 0.827 . . . . 50.0 111.145 178.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.2 mm -117.99 131.39 70.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.067 -1.424 . . . . 50.0 108.917 -179.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -138.82 158.05 44.94 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 122.633 0.373 . . . . 50.0 110.202 179.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.3 m -89.91 130.19 36.16 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.689 -0.856 . . . . 25.0 108.689 177.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.3 t -94.53 126.04 47.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.551 -0.907 . . . . 50.0 108.551 178.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.8 mt -90.76 -51.47 5.35 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.097 -0.705 . . . . 50.0 109.097 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -151.84 171.47 17.68 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.04 -1.096 . . . . 50.0 108.04 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -121.9 155.2 35.94 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.049 -1.464 . . . . 50.0 107.049 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 58.17 39.24 26.15 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 123.794 1.759 . . . . 50.0 109.448 178.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.4 t -65.94 155.47 36.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 112.758 -2.019 . . . . 25.0 110.485 -176.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 60.11 9.62 1.92 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.185 0.994 . . . . 50.0 112.992 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.51 20.92 73.63 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.421 -1.071 . . . . 25.0 110.421 -176.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.6 mt -97.4 127.72 43.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.225 0.536 . . . . 50.0 110.279 178.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -67.16 124.08 22.09 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.673 -0.694 . . . . 25.0 110.857 178.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.06 -0.01 84.51 Favored Glycine 0 C--O 1.239 0.426 0 N-CA-C 116.392 1.317 . . . . 50.0 116.392 173.484 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -100.68 132.21 46.19 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 118.384 1.092 . . . . 50.0 109.453 178.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -113.07 141.98 46.26 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.183 -0.673 . . . . 50.0 109.183 -176.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.73 123.19 29.6 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 105.644 -1.984 . . . . 50.0 105.644 178.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 84.3 m -131.62 164.49 25.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.931 0.396 . . . . 50.0 110.741 177.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.0 t -118.85 123.33 44.45 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.771 -1.937 . . . . 50.0 105.771 172.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.1 tp -145.43 136.63 24.89 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.11 -1.071 . . . . 50.0 108.11 -176.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.64 27.69 12.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.885 0.698 . . . . 25.0 112.885 178.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.45 0.1 86.69 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 114.883 0.713 . . . . 25.0 114.883 177.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -124.71 158.63 32.76 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 118.124 0.962 . . . . 50.0 110.135 178.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -109.59 154.65 22.47 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.095 -0.706 . . . . 50.0 109.095 179.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.83 -160.73 28.17 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 107.288 -2.325 . . . . 50.0 107.288 179.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.2 pt -117.06 153.16 18.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.919 0.866 . . . . 50.0 112.534 -174.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.9 m -142.88 146.89 39.45 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 114.313 -1.312 . . . . 50.0 109.839 179.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.12 119.07 5.65 Favored 'Trans proline' 0 C--O 1.239 0.55 0 CA-C-O 121.296 0.457 . . . . 50.0 112.252 178.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.9 -25.33 74.28 Favored Glycine 0 C--O 1.219 -0.842 0 N-CA-C 116.72 1.448 . . . . 50.0 116.72 -174.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -65.19 -22.32 66.88 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.556 -0.967 . . . . 50.0 113.512 -177.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -110.61 24.63 12.72 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.617 0.722 . . . . 50.0 109.389 178.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.9 tp -133.29 150.72 51.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.367 -0.833 . . . . 50.0 109.968 -175.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -122.41 125.88 46.79 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-N 116.558 -0.292 . . . . 50.0 110.494 -179.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.2 mm -75.69 135.63 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.13 -1.063 . . . . 50.0 108.13 175.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.2 mt -118.6 88.72 2.98 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.577 -0.898 . . . . 50.0 108.577 177.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.1 t -77.4 -38.76 27.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.837 -0.801 . . . . 50.0 108.837 178.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.35 170.77 27.43 Favored Glycine 0 C--O 1.234 0.112 0 CA-C-N 115.877 -0.601 . . . . 25.0 112.588 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.27 172.75 10.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.37 0.605 . . . . 25.0 111.55 179.162 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -65.91 143.86 57.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.89 -0.595 . . . . 25.0 110.118 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -115.24 162.99 16.31 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.861 -1.163 . . . . 25.0 107.861 178.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -63.31 169.23 3.77 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.509 1.124 . . . . 50.0 113.455 179.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.84 152.22 77.05 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 105.393 -2.077 . . . . 50.0 105.393 176.04 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.12 -26.61 21.17 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 116.953 -1.565 . . . . 50.0 113.039 179.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.42 160.13 34.47 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.064 -1.828 . . . . 25.0 106.064 177.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.07 155.31 13.92 Favored Glycine 0 C--O 1.229 -0.212 0 N-CA-C 109.191 -1.564 . . . . 25.0 109.191 176.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.8 t -162.0 176.02 11.19 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.642 -1.614 . . . . 25.0 106.642 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -94.86 -175.19 38.16 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 109.17 -1.572 . . . . 25.0 109.17 174.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 167.14 -37.78 0.23 Allowed Glycine 0 C--O 1.225 -0.42 0 C-N-CA 120.33 -0.938 . . . . 25.0 113.675 177.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.5 p -73.72 147.91 43.13 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.168 -0.679 . . . . 25.0 109.168 177.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.84 168.24 34.14 Favored Glycine 0 C--O 1.228 -0.232 0 N-CA-C 110.625 -0.99 . . . . 25.0 110.625 178.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.1 p -62.86 -27.21 69.18 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.118 0.485 . . . . 25.0 112.089 -179.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.95 89.04 0.43 Allowed Glycine 0 C--O 1.227 -0.288 0 N-CA-C 108.701 -1.76 . . . . 25.0 108.701 174.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.7 p -152.67 -174.27 4.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.604 0.702 . . . . 25.0 110.272 -176.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.457 ' HB2' HH22 ' A' ' 27' ' ' ARG . 72.1 mt-10 61.89 -162.46 0.28 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.353 1.061 . . . . 50.0 112.924 178.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -142.48 167.78 21.29 Favored 'General case' 0 C--O 1.215 -0.763 0 N-CA-C 107.817 -1.179 . . . . 25.0 107.817 -175.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -74.28 -21.9 59.54 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.721 -0.474 . . . . 50.0 109.721 171.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 t70 56.73 -157.17 0.28 Allowed 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.05 0.844 . . . . 25.0 112.843 177.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.0 m -123.75 84.81 53.71 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.796 -0.816 . . . . 25.0 108.796 177.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.96 162.29 34.84 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 120.22 0.614 . . . . 50.0 113.591 -178.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -62.66 149.72 90.23 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 118.444 -0.571 . . . . 50.0 111.624 179.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.52 158.42 55.68 Favored 'Trans proline' 0 C--N 1.345 0.388 0 N-CA-C 117.149 1.942 . . . . 50.0 117.149 -167.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.5 138.75 70.88 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 106.976 -1.491 . . . . 50.0 106.976 176.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.87 166.69 28.77 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 CA-C-N 118.748 0.589 . . . . 50.0 112.055 177.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.57 152.92 58.69 Favored 'Trans proline' 0 C--N 1.348 0.538 0 N-CA-C 113.569 0.565 . . . . 50.0 113.569 -179.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.9 mtt85 -109.86 4.71 21.9 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.441 0.638 . . . . 50.0 109.792 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.4 p -143.27 146.24 33.44 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.68 -1.6 . . . . 25.0 106.68 -179.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -93.2 75.41 4.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.84 -1.17 . . . . 50.0 107.84 177.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.2 m -64.57 121.18 13.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.0 -0.545 . . . . 25.0 111.886 -177.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 24.2 t -138.4 98.26 3.56 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.19 -1.041 . . . . 25.0 108.19 177.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.1 tp . . . . . 0 C--O 1.211 -0.967 0 CA-C-O 123.584 1.659 . . . . 25.0 113.237 -174.826 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 115.322 0.889 . . . . 25.0 115.322 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.8 t 65.2 -23.72 0.09 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 127.004 2.121 . . . . 25.0 115.861 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.2 mtt -65.17 149.5 49.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.575 -0.528 . . . . 25.0 109.575 177.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -139.35 133.88 31.74 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.053 -1.832 . . . . 50.0 106.053 178.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -118.54 163.16 17.2 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 123.527 0.517 . . . . 50.0 111.22 -177.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.02 -38.85 89.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.141 -0.936 . . . . 50.0 110.132 178.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 55.86 36.34 27.11 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.933 0.893 . . . . 50.0 111.492 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 m -100.63 161.59 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 106.36 -1.718 . . . . 50.0 106.36 177.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.55 171.97 7.59 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.02 -1.104 . . . . 50.0 108.02 -177.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.75 164.82 34.23 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.694 -0.484 . . . . 25.0 109.694 174.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -128.4 136.22 50.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.105 -0.952 . . . . 50.0 108.712 177.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.18 136.43 42.83 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.799 0.333 . . . . 25.0 110.827 175.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.4 mt -100.6 -20.92 15.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.852 0.358 . . . . 50.0 110.781 -179.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -142.5 171.57 13.88 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 103.297 -2.853 . . . . 50.0 103.297 175.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -83.5 178.57 7.95 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.302 -0.999 . . . . 50.0 108.302 174.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -153.25 135.86 15.19 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.68 0.276 . . . . 50.0 111.108 175.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.8 t -106.04 120.86 57.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 104.946 -2.242 . . . . 25.0 104.946 174.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.6 134.01 46.11 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.37 -0.832 . . . . 25.0 109.394 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -107.53 3.81 25.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.676 0.75 . . . . 50.0 109.683 179.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.7 m -149.4 155.82 39.4 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 107.932 -1.136 . . . . 50.0 107.932 179.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.39 -19.67 32.85 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 118.398 -0.601 . . . . 50.0 113.491 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -15.96 55.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.158 0.504 . . . . 50.0 110.076 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -90.82 139.45 30.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.6 0.714 . . . . 50.0 109.13 -178.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.2 mt -92.06 127.78 37.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.767 0.794 . . . . 50.0 110.567 179.474 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.4 p -87.96 143.43 27.11 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 106.042 -1.836 . . . . 50.0 106.042 173.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -156.98 166.12 34.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.503 -0.925 . . . . 50.0 108.503 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.5 tpp85 -105.85 158.95 16.39 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.994 -0.743 . . . . 50.0 108.994 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -59.83 128.79 38.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.764 -0.653 . . . . 50.0 109.586 178.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.14 -4.45 81.04 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.117 -0.824 . . . . 50.0 114.356 177.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -62.71 160.65 13.8 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 117.885 0.843 . . . . 50.0 110.842 176.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.6 mm -119.93 134.79 62.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.643 -1.162 . . . . 50.0 109.49 178.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -139.85 163.43 32.66 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.736 -0.468 . . . . 50.0 109.736 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -97.45 129.49 44.64 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.508 -1.294 . . . . 25.0 107.508 176.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.5 t -96.28 122.94 48.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 107.773 -1.195 . . . . 50.0 107.773 177.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.7 mt -91.52 -42.85 10.02 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.164 -0.926 . . . . 50.0 109.267 -179.319 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -151.68 158.85 43.97 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.779 -0.823 . . . . 50.0 108.779 -176.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.8 mtm105 -116.11 153.84 31.04 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.642 -1.244 . . . . 50.0 107.642 175.011 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 56.22 37.54 28.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 123.383 1.563 . . . . 50.0 108.62 178.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.0 t -64.36 150.2 46.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.255 -1.793 . . . . 25.0 110.386 -174.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 59.47 13.85 3.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.636 0.774 . . . . 50.0 112.121 -178.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.71 18.22 79.78 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.294 -0.723 . . . . 25.0 111.294 -178.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.2 mt -91.55 121.15 32.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.274 0.537 . . . . 50.0 109.696 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -62.45 125.02 22.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.931 -0.577 . . . . 25.0 110.357 -179.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.4 -0.8 73.81 Favored Glycine 0 CA--C 1.519 0.292 0 N-CA-C 116.762 1.465 . . . . 50.0 116.762 175.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -100.1 130.03 46.2 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 119.149 1.475 . . . . 50.0 110.713 179.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -110.25 140.77 44.06 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.571 -0.529 . . . . 50.0 109.571 -177.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.98 120.8 24.66 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 105.628 -1.99 . . . . 50.0 105.628 177.428 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.401 ' HG ' HG22 ' A' ' 57' ' ' VAL . 84.5 m -132.2 164.79 25.56 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.099 0.407 . . . . 50.0 112.099 179.132 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.5 t -118.92 116.57 26.74 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.932 -1.507 . . . . 50.0 106.932 172.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -146.43 138.99 25.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.936 -1.135 . . . . 50.0 107.936 -175.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 56.96 27.37 13.05 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.94 0.719 . . . . 25.0 112.94 -178.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.65 5.98 89.17 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 121.012 -0.613 . . . . 25.0 113.421 178.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -116.23 154.39 30.19 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 108.308 -0.997 . . . . 50.0 108.308 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -108.3 145.19 34.76 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.058 -1.83 . . . . 50.0 106.058 170.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.36 -155.32 13.54 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 106.877 -2.489 . . . . 50.0 106.877 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.3 pt -123.97 152.86 29.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.449 0.643 . . . . 50.0 110.665 -175.362 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.401 HG22 ' HG ' ' A' ' 48' ' ' CYS . 2.8 m -139.63 147.31 51.43 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.148 -0.933 . . . . 50.0 108.626 -179.612 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.94 114.99 4.19 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 CA-C-O 121.379 0.491 . . . . 50.0 110.961 176.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.56 -17.12 68.48 Favored Glycine 0 C--O 1.222 -0.631 0 N-CA-C 114.304 0.482 . . . . 50.0 114.304 -175.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -63.76 -20.17 65.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.652 0.612 . . . . 50.0 112.652 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -116.48 27.18 9.37 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.746 -0.464 . . . . 50.0 109.746 177.214 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tp -130.34 158.01 41.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.309 0.576 . . . . 50.0 111.769 179.382 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -133.31 120.25 20.79 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.988 -0.551 . . . . 50.0 110.97 178.204 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mm -66.76 136.51 26.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.66 -0.496 . . . . 50.0 109.66 178.494 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.2 mt -117.04 104.58 11.4 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.463 -1.31 . . . . 50.0 107.463 175.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.7 m -76.75 155.76 5.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.855 0.359 . . . . 50.0 110.51 -178.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.92 39.0 3.13 Favored Glycine 0 N--CA 1.462 0.38 0 N-CA-C 112.06 -0.416 . . . . 25.0 112.06 178.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 22.3 ttt -131.96 169.39 16.37 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.771 -1.566 . . . . 25.0 106.771 -175.186 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 63.02 45.43 5.3 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.888 0.852 . . . . 25.0 110.261 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 t0 64.9 176.96 0.2 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 113.427 -1.715 . . . . 25.0 113.648 178.26 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -99.49 164.39 12.11 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.46 -0.941 . . . . 50.0 108.46 -176.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 mtmm -146.03 152.26 47.07 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 104.721 -2.326 . . . . 50.0 104.721 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -73.25 162.32 40.77 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 117.815 -0.99 . . . . 50.0 113.192 -179.382 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.08 168.2 19.45 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.439 -0.948 . . . . 25.0 108.439 175.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.16 -65.5 0.29 Allowed Glycine 0 C--O 1.22 -0.748 0 N-CA-C 110.398 -1.081 . . . . 25.0 110.398 176.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.0 m 55.18 23.21 5.21 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.818 1.784 . . . . 25.0 115.818 175.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.42 165.15 36.95 Favored Glycine 0 C--O 1.228 -0.246 0 N-CA-C 109.192 -1.563 . . . . 25.0 109.192 175.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.42 -175.2 29.08 Favored Glycine 0 C--O 1.229 -0.186 0 N-CA-C 110.265 -1.134 . . . . 25.0 110.265 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 89.2 p -142.48 159.58 41.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.188 -0.671 . . . . 25.0 109.188 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.0 -35.46 34.77 Favored Glycine 0 C--O 1.22 -0.731 0 C-N-CA 120.818 -0.706 . . . . 25.0 112.825 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.8 t -152.19 -54.68 0.13 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.883 0.373 . . . . 25.0 110.71 179.439 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.58 -159.94 13.42 Favored Glycine 0 C--O 1.225 -0.463 0 N-CA-C 109.106 -1.598 . . . . 25.0 109.106 -177.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.4 t -127.17 31.28 5.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.243 0.544 . . . . 25.0 109.552 -179.048 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.41 159.19 43.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.358 -0.978 . . . . 50.0 108.358 179.448 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -84.05 60.58 5.96 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.062 0.764 . . . . 25.0 113.062 -176.346 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 74.57 145.3 0.08 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.526 1.531 . . . . 50.0 113.785 177.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -75.68 160.8 29.68 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.842 -0.799 . . . . 25.0 108.842 178.29 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.7 m -117.11 85.47 18.57 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 122.825 0.45 . . . . 25.0 110.802 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.16 156.79 46.74 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 N-CA-C 114.393 0.882 . . . . 50.0 114.393 -177.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.02 162.81 40.73 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 O-C-N 121.499 0.21 . . . . 50.0 112.344 177.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.03 160.79 47.07 Favored 'Trans proline' 0 C--O 1.236 0.414 0 N-CA-C 114.208 0.811 . . . . 50.0 114.208 -177.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -80.94 144.31 54.98 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 115.486 -0.779 . . . . 50.0 109.651 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.98 155.36 57.53 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 118.419 -0.587 . . . . 50.0 112.913 178.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 96' ' ' THR . 44.1 Cg_exo -63.12 131.23 31.64 Favored 'Trans proline' 0 C--N 1.348 0.518 0 N-CA-C 114.535 0.936 . . . . 50.0 114.535 -178.109 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -78.89 20.72 0.45 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.026 0.441 . . . . 50.0 110.661 175.285 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 94' ' ' PRO . 55.2 p -138.42 1.55 2.18 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.799 0.666 . . . . 25.0 112.799 -176.274 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 56.14 26.23 9.98 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.974 0.731 . . . . 50.0 112.974 -175.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.1 p -71.58 140.69 49.91 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.998 -0.438 . . . . 25.0 110.5 -178.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 79.9 m -126.83 157.3 39.64 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.887 -1.153 . . . . 25.0 107.887 178.383 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.5 mt . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 125.734 2.683 . . . . 25.0 113.023 -179.188 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.756 0 CA-C-O 124.435 2.131 . . . . 25.0 113.104 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m -69.89 -16.11 63.18 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 112.278 -1.961 . . . . 25.0 111.57 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 58.7 ttm -125.53 130.79 52.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.794 -1.558 . . . . 25.0 106.794 176.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -130.24 80.49 1.96 Allowed 'General case' 0 C--O 1.213 -0.865 0 N-CA-C 108.953 -0.758 . . . . 50.0 108.953 -178.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -115.95 157.21 24.91 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.213 0.53 . . . . 50.0 110.444 179.111 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 71.4 mt -67.24 -39.28 86.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.783 -1.099 . . . . 50.0 109.901 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 57.4 29.33 16.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.053 0.941 . . . . 50.0 111.894 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.1 m -94.65 160.91 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 107.014 -1.476 . . . . 50.0 107.014 179.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.13 168.05 10.5 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.987 -1.116 . . . . 50.0 107.987 -178.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.06 156.07 42.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.784 0.326 . . . . 25.0 110.192 175.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -121.56 128.38 51.94 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.715 0.806 . . . . 50.0 110.127 178.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.63 131.58 45.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.498 -0.556 . . . . 25.0 109.498 176.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.1 mt -94.13 -21.28 19.2 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.064 -0.347 . . . . 50.0 110.064 -179.052 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -146.04 171.31 15.07 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.406 -1.701 . . . . 50.0 106.406 177.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -82.01 178.9 8.04 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.257 -0.645 . . . . 50.0 109.257 176.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.95 168.87 23.23 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 122.721 0.408 . . . . 50.0 110.125 176.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.5 t -128.02 129.88 69.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 104.149 -2.537 . . . . 25.0 104.149 171.238 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.88 119.38 23.85 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.78 -0.452 . . . . 25.0 109.78 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -103.68 8.93 37.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.322 0.582 . . . . 50.0 110.861 -177.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.9 m -152.89 155.66 32.36 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 106.827 -1.546 . . . . 50.0 106.827 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.02 -22.11 35.94 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 117.813 -0.991 . . . . 50.0 112.452 178.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.4 -20.72 56.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.239 -0.437 . . . . 50.0 110.516 178.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -85.89 126.75 34.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.769 0.795 . . . . 50.0 109.095 -176.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.1 mt -78.62 135.53 37.27 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.328 -0.99 . . . . 50.0 108.328 178.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.1 t -91.08 125.41 35.86 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.776 -1.194 . . . . 50.0 107.776 176.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -142.21 159.97 41.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.383 0.611 . . . . 50.0 111.531 -179.525 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.51 ' HD3' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -107.9 165.18 11.65 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.938 -0.764 . . . . 50.0 108.938 179.116 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.51 ' H ' ' HD3' ' A' ' 27' ' ' ARG . 87.4 tttt -61.29 129.05 39.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.64 -0.709 . . . . 50.0 109.52 178.459 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.26 -9.83 69.65 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-O 119.316 -0.713 . . . . 50.0 114.059 178.045 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -60.94 150.27 33.83 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.871 0.843 . . . . 50.0 110.92 179.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.3 mm -113.95 127.31 71.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.569 -1.196 . . . . 50.0 109.701 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.7 ptp -132.15 163.13 29.2 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.583 -0.525 . . . . 50.0 109.583 179.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.4 m -99.92 125.83 45.98 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.579 -1.267 . . . . 25.0 107.579 177.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.6 t -90.3 122.13 41.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.118 -1.067 . . . . 50.0 108.118 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.8 mt -90.3 -46.49 8.37 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.226 -0.897 . . . . 50.0 108.608 179.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.03 156.32 42.07 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.979 -0.378 . . . . 50.0 109.979 -176.015 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -111.98 152.01 28.61 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.891 -0.411 . . . . 50.0 109.891 174.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 55.97 39.49 30.53 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 123.6 1.667 . . . . 50.0 108.759 177.101 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.0 t -66.38 152.98 43.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 112.746 -2.024 . . . . 25.0 110.72 -175.174 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 60.39 9.1 1.85 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.227 1.011 . . . . 50.0 113.618 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.79 15.26 75.87 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 111.071 -0.812 . . . . 25.0 111.071 -176.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.8 mt -92.99 113.35 25.61 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.426 -0.583 . . . . 50.0 109.426 179.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.87 128.02 33.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.302 0.572 . . . . 25.0 110.005 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.97 0.35 85.17 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 115.813 1.085 . . . . 50.0 115.813 176.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -101.03 132.84 46.26 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 119.005 1.403 . . . . 50.0 110.415 178.402 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.6 m0 -112.36 138.68 48.74 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.171 -0.677 . . . . 50.0 109.171 -176.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.88 120.81 25.19 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 105.199 -2.148 . . . . 50.0 105.199 177.223 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.9 m -132.34 162.23 31.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.3 0.571 . . . . 50.0 112.488 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.5 t -116.9 123.72 47.69 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 105.987 -1.857 . . . . 50.0 105.987 172.012 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.4 tp -135.73 127.6 29.39 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.234 -1.395 . . . . 50.0 107.234 -177.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 29.4 m170 54.79 32.15 17.01 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.143 0.497 . . . . 25.0 112.241 178.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.35 -3.41 87.23 Favored Glycine 0 C--O 1.225 -0.462 0 N-CA-C 115.852 1.101 . . . . 25.0 115.852 176.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -114.35 157.25 23.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.677 -1.231 . . . . 50.0 107.677 177.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -117.21 154.68 30.71 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.374 -0.232 . . . . 50.0 110.374 -178.47 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.95 -157.11 21.92 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 106.127 -2.789 . . . . 50.0 106.127 178.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.8 pt -119.69 155.39 22.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 121.605 0.717 . . . . 50.0 111.39 -177.143 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.33 148.13 39.67 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.01 -0.995 . . . . 50.0 109.661 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.33 121.7 6.21 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 CA-C-O 121.545 0.56 . . . . 50.0 112.965 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.08 -18.25 70.75 Favored Glycine 0 C--O 1.22 -0.729 0 CA-C-N 116.114 -0.494 . . . . 50.0 114.155 -178.17 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -64.1 -17.2 63.2 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.394 0.516 . . . . 50.0 112.394 -177.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -127.33 30.29 5.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.116 0.484 . . . . 50.0 110.2 176.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.8 mt -129.79 156.38 44.42 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.811 -0.631 . . . . 75.0 111.769 177.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -128.98 125.92 38.44 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.161 -0.472 . . . . 50.0 110.125 176.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.6 mm -74.5 136.91 24.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.558 -0.904 . . . . 50.0 108.558 178.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.6 mt -111.92 77.93 1.08 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.147 0.579 . . . . 50.0 109.597 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.07 27.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.434 0.693 . . . . 50.0 112.77 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.4 -0.69 68.14 Favored Glycine 0 C--O 1.219 -0.821 0 N-CA-C 115.058 0.783 . . . . 25.0 115.058 178.442 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.7 ttp -59.12 -27.84 65.97 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 117.637 0.718 . . . . 25.0 112.652 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -94.13 -0.74 55.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.409 -0.359 . . . . 25.0 110.969 -178.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 56.5 t0 60.89 -77.8 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.08 1.352 . . . . 25.0 113.217 -175.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 58.87 45.93 14.6 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.891 0.876 . . . . 50.0 109.628 -173.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -52.98 151.2 8.99 Favored Pre-proline 0 C--O 1.245 0.841 0 CA-C-N 114.663 -1.153 . . . . 50.0 109.796 174.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.83 166.54 25.99 Favored 'Trans proline' 0 C--O 1.24 0.58 0 N-CA-C 115.46 1.292 . . . . 50.0 115.46 -173.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.02 147.97 29.18 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.817 -1.549 . . . . 25.0 106.817 177.356 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.21 23.47 18.12 Favored Glycine 0 C--O 1.22 -0.764 0 N-CA-C 114.856 0.702 . . . . 25.0 114.856 -177.188 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 72.4 p -98.05 -7.07 30.52 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.206 0.817 . . . . 25.0 113.206 -176.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.29 -161.12 53.6 Favored Glycine 0 C--O 1.237 0.305 0 N-CA-C 108.604 -1.798 . . . . 25.0 108.604 -172.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.45 160.65 27.53 Favored Glycine 0 N--CA 1.453 -0.169 0 CA-C-N 117.593 0.697 . . . . 25.0 111.42 178.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 82.3 p -161.17 -178.28 6.63 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.276 -1.75 . . . . 25.0 106.276 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.21 -142.96 16.72 Favored Glycine 0 C--O 1.222 -0.639 0 C-N-CA 121.114 -0.565 . . . . 25.0 113.683 176.129 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 t 62.64 13.01 5.97 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.072 1.508 . . . . 25.0 115.072 -178.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.79 159.42 53.61 Favored Glycine 0 CA--C 1.518 0.221 0 N-CA-C 110.211 -1.156 . . . . 25.0 110.211 175.082 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 p -152.34 156.32 39.36 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.359 -0.608 . . . . 25.0 109.359 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.72 165.69 23.17 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.526 -0.916 . . . . 50.0 108.526 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 93.8 mttt 63.53 174.46 0.17 Allowed 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.637 1.211 . . . . 25.0 111.811 179.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -97.6 146.83 24.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.408 -0.59 . . . . 50.0 109.408 -177.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -108.7 179.27 4.24 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.15 -1.796 . . . . 25.0 106.15 178.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.3 m -114.45 85.1 10.44 Favored Pre-proline 0 N--CA 1.47 0.569 0 CA-C-O 120.885 0.374 . . . . 25.0 110.317 177.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -80.54 153.05 20.39 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 N-CA-C 114.802 1.039 . . . . 50.0 114.802 -177.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.81 157.24 52.09 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 118.008 -0.861 . . . . 50.0 111.438 173.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.75 158.61 55.18 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 N-CA-C 115.261 1.216 . . . . 50.0 115.261 -173.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -77.78 141.62 64.44 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 107.625 -1.25 . . . . 50.0 107.625 176.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -73.03 167.68 26.72 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 O-C-N 122.097 0.525 . . . . 50.0 113.214 -177.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.53 152.78 52.76 Favored 'Trans proline' 0 C--N 1.352 0.736 0 N-CA-C 114.642 0.978 . . . . 50.0 114.642 -178.353 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -115.95 71.47 0.78 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.443 -0.577 . . . . 50.0 109.443 178.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 49.73 33.53 6.31 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.977 0.894 . . . . 25.0 111.797 -174.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.7 ptm85 -146.76 112.3 5.59 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.041 -1.096 . . . . 50.0 108.041 -179.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.7 m 65.27 164.41 0.16 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.628 -1.169 . . . . 25.0 112.129 -173.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 35.0 m -110.08 32.75 4.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.66 0.743 . . . . 25.0 110.964 -176.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.208 -1.121 0 CA-C-O 124.873 2.273 . . . . 25.0 111.676 -177.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 CA-C-O 123.49 1.606 . . . . 25.0 115.116 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.4 p -106.32 17.73 23.0 Favored 'General case' 0 C--O 1.24 0.588 0 O-C-N 120.873 -1.369 . . . . 25.0 110.934 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.09 144.77 53.84 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.176 -1.046 . . . . 25.0 108.176 178.376 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -90.4 78.7 6.37 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.089 -1.448 . . . . 50.0 107.089 -177.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -75.62 164.83 25.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.12 -0.946 . . . . 50.0 111.097 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.4 mt -66.05 -41.65 90.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.256 -0.884 . . . . 50.0 110.762 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.1 m120 55.34 24.36 6.49 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.277 1.031 . . . . 50.0 112.381 -177.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.6 m -83.29 175.35 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 N-CA-C 105.437 -2.06 . . . . 50.0 105.437 175.068 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -120.0 171.85 8.16 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 118.774 0.715 . . . . 50.0 109.951 -179.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.8 162.21 39.69 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.874 0.368 . . . . 25.0 110.354 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -122.24 132.04 54.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.141 -0.936 . . . . 50.0 110.494 178.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.08 128.05 34.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.95 0.405 . . . . 25.0 110.558 177.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.9 mt -98.81 -19.53 17.37 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.26 0.552 . . . . 50.0 110.985 -177.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -142.7 163.31 33.16 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 106.063 -1.829 . . . . 50.0 106.063 177.413 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -82.57 174.5 10.98 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.719 1.007 . . . . 50.0 113.719 -177.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -160.93 157.22 26.1 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 110.125 -0.324 . . . . 50.0 110.125 174.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.7 t -126.73 131.71 70.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 104.744 -2.317 . . . . 25.0 104.744 174.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.93 124.12 27.93 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 110.235 -0.283 . . . . 25.0 110.235 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -116.57 -12.61 10.93 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.054 0.93 . . . . 50.0 110.316 175.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 t -106.76 147.42 35.0 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 107.41 -1.33 . . . . 50.0 107.41 175.339 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.28 -23.74 44.54 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 116.444 -1.904 . . . . 50.0 114.695 -177.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -81.92 -13.16 57.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.086 0.47 . . . . 50.0 110.262 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -84.85 139.23 32.05 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.384 0.611 . . . . 50.0 111.508 -171.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.5 mt -93.1 131.06 38.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.596 0.713 . . . . 50.0 109.833 176.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.2 t -91.87 139.74 30.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.8 -1.556 . . . . 50.0 106.8 177.178 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -162.58 171.72 16.52 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.382 -0.97 . . . . 50.0 108.382 -177.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -126.75 168.03 14.96 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.769 0.795 . . . . 50.0 110.442 174.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.67 133.41 55.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.535 -0.757 . . . . 50.0 109.592 -176.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.96 -20.07 51.75 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 118.64 -1.089 . . . . 50.0 112.828 178.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -58.6 143.8 45.08 Favored 'General case' 0 C--O 1.249 1.056 0 CA-C-N 118.427 1.113 . . . . 50.0 110.645 179.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.6 mm -110.85 128.85 66.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.771 -1.104 . . . . 50.0 108.1 -178.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.7 ptp -132.89 149.41 52.25 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.725 0.41 . . . . 50.0 110.235 -177.384 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.0 m -85.48 126.11 33.57 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 107.541 -1.281 . . . . 25.0 107.541 179.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.43 124.5 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 107.904 -1.147 . . . . 50.0 107.904 178.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.8 mt -90.52 -47.8 7.48 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.723 -0.843 . . . . 50.0 108.723 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -153.69 173.88 15.23 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.426 0.631 . . . . 50.0 109.305 176.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -123.73 151.29 43.36 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.361 -1.718 . . . . 50.0 106.361 -179.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 57.37 43.4 23.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 123.27 1.509 . . . . 50.0 109.399 -176.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.7 t -66.55 149.46 50.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.629 -1.623 . . . . 25.0 110.349 -177.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 59.83 15.3 4.76 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.664 0.785 . . . . 50.0 112.642 178.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.81 14.62 82.18 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.903 -0.665 . . . . 25.0 112.187 -178.171 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.2 mt -94.36 113.68 25.61 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.342 -0.614 . . . . 50.0 109.342 -178.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -59.82 123.26 16.46 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.244 0.545 . . . . 25.0 110.734 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.76 -0.0 89.82 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-O 118.829 -0.984 . . . . 50.0 115.538 175.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -100.12 132.7 45.33 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 119.084 1.442 . . . . 50.0 109.335 177.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -113.08 140.03 48.2 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.592 -1.262 . . . . 50.0 107.592 -175.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.47 123.13 28.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.193 -2.151 . . . . 50.0 105.193 177.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 95.5 m -130.5 163.39 27.13 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.993 0.425 . . . . 50.0 111.408 178.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -116.2 126.9 54.28 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 106.318 -1.734 . . . . 50.0 106.318 173.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.2 tp -151.57 135.58 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.26 -1.015 . . . . 50.0 108.26 -175.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 54.23 30.13 11.81 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.654 0.983 . . . . 25.0 113.654 -178.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.18 6.18 88.92 Favored Glycine 0 C--O 1.22 -0.777 0 C-N-CA 120.936 -0.649 . . . . 25.0 113.919 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -114.82 161.32 18.37 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.499 -1.297 . . . . 50.0 107.499 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -120.26 146.48 46.03 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 106.016 -1.846 . . . . 50.0 106.016 174.067 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.22 -164.48 31.42 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 108.286 -1.926 . . . . 50.0 108.286 -179.372 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.8 pt -114.51 150.19 16.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.596 0.712 . . . . 50.0 112.053 -174.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.78 146.18 30.74 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 114.539 -1.21 . . . . 50.0 108.749 -179.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.23 122.17 6.94 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 118.383 -0.611 . . . . 50.0 112.393 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.81 -17.88 75.55 Favored Glycine 0 C--O 1.219 -0.789 0 N-CA-C 115.148 0.819 . . . . 50.0 115.148 -176.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -59.79 -21.13 60.4 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 113.221 0.823 . . . . 50.0 113.221 -177.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.26 26.3 6.92 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.526 0.679 . . . . 50.0 110.368 -178.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.2 mt -117.46 156.08 28.58 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 121.455 0.645 . . . . 50.0 110.365 175.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -119.14 122.81 42.88 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.507 -0.923 . . . . 50.0 108.507 173.438 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.8 mm -73.23 135.1 28.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.887 -1.153 . . . . 50.0 107.887 176.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt -115.23 97.2 6.06 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.825 -0.805 . . . . 50.0 108.825 178.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -88.64 165.46 2.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.13 -0.692 . . . . 50.0 109.13 178.285 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.5 155.87 21.01 Favored Glycine 0 C--O 1.219 -0.803 0 C-N-CA 120.687 -0.768 . . . . 25.0 111.758 178.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -137.47 1.69 2.4 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.697 0.399 . . . . 25.0 111.965 179.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -139.21 140.51 37.79 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.628 -1.249 . . . . 25.0 107.628 177.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -81.25 159.26 24.56 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 124.233 0.958 . . . . 25.0 110.073 179.584 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 65.3 mttm 46.0 35.8 2.65 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.909 1.818 . . . . 50.0 115.909 174.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -66.74 128.3 93.8 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 109.413 -0.588 . . . . 50.0 109.413 -179.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -87.41 -4.39 7.56 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 118.138 -0.775 . . . . 50.0 113.187 178.033 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.68 140.39 35.66 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 113.729 1.011 . . . . 25.0 113.729 -173.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.41 175.21 42.52 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 109.162 -1.575 . . . . 25.0 109.162 175.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.5 t 60.57 -173.18 0.13 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.882 0.873 . . . . 25.0 112.271 -177.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.27 -177.8 49.07 Favored Glycine 0 C--O 1.222 -0.63 0 N-CA-C 111.269 -0.732 . . . . 25.0 111.269 -178.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.88 88.06 1.21 Allowed Glycine 0 C--O 1.216 -1.016 0 C-N-CA 121.646 -0.311 . . . . 25.0 112.587 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.8 t -146.46 -179.69 6.93 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.9 -1.889 . . . . 25.0 105.9 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.87 20.86 27.39 Favored Glycine 0 C--O 1.226 -0.351 0 N-CA-C 111.717 -0.553 . . . . 25.0 111.717 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 55.9 m -64.68 139.27 58.75 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.123 -0.633 . . . . 25.0 110.698 178.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.36 -85.5 0.06 OUTLIER Glycine 0 CA--C 1.509 -0.316 0 N-CA-C 108.657 -1.777 . . . . 25.0 108.657 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.6 t 58.67 -157.06 0.32 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.539 0.736 . . . . 25.0 109.904 176.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.45 166.77 23.86 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.959 -1.126 . . . . 50.0 107.959 177.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.37 154.88 32.68 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.327 -0.62 . . . . 25.0 109.327 -175.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -137.71 -51.99 0.63 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.543 -0.91 . . . . 50.0 108.543 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -78.35 158.79 28.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.751 -0.659 . . . . 25.0 109.708 176.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.4 p -77.27 154.73 82.18 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 115.708 -0.678 . . . . 25.0 111.39 -179.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.54 159.32 51.57 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 117.827 -0.982 . . . . 50.0 111.923 178.091 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -65.74 154.39 74.08 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 118.81 -0.327 . . . . 50.0 112.486 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.09 153.88 62.6 Favored 'Trans proline' 0 C--O 1.237 0.473 0 N-CA-C 115.168 1.18 . . . . 50.0 115.168 -173.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -76.8 141.0 67.85 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 108.538 -0.912 . . . . 50.0 108.538 176.137 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.78 162.93 39.85 Favored 'Trans proline' 0 C--O 1.239 0.57 0 O-C-N 122.539 0.757 . . . . 50.0 111.932 175.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.79 150.76 39.73 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 118.282 -0.679 . . . . 50.0 113.485 -177.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -93.72 50.87 1.49 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.488 -0.56 . . . . 50.0 109.488 176.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.2 p 41.08 46.94 2.64 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.117 0.967 . . . . 25.0 112.331 -175.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -87.99 -10.49 50.27 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.127 -0.488 . . . . 50.0 110.874 -177.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 49.6 m -95.95 120.65 36.6 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.83 -0.804 . . . . 25.0 108.83 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 29.8 m 67.31 177.93 0.24 Allowed 'General case' 0 N--CA 1.469 0.501 0 O-C-N 124.377 1.048 . . . . 25.0 111.131 -177.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.6 tp . . . . . 0 C--O 1.208 -1.079 0 CA-C-O 125.117 2.389 . . . . 25.0 111.624 -177.202 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.806 0 CA-C-O 124.225 2.014 . . . . 25.0 113.127 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t 58.09 26.41 13.6 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 111.984 -2.108 . . . . 25.0 112.253 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.6 ttm -78.02 110.05 12.62 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.518 -0.549 . . . . 25.0 109.518 179.407 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -150.84 145.05 25.43 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.6 -1.63 . . . . 50.0 106.6 178.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 61.9 163.47 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 116.614 2.079 . . . . 50.0 116.614 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 mt -71.97 -41.61 67.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.104 -1.407 . . . . 50.0 110.006 -179.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 56.5 26.5 11.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.343 1.057 . . . . 50.0 112.304 -178.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.4 m -85.86 158.52 3.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.338 -1.727 . . . . 50.0 106.338 177.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.38 172.81 7.97 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 108.77 -0.826 . . . . 50.0 108.77 -177.056 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.14 165.84 32.66 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.719 -0.475 . . . . 25.0 109.719 174.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -131.16 136.26 48.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.092 -0.958 . . . . 50.0 110.113 177.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.36 127.16 31.89 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.861 -0.609 . . . . 25.0 110.453 172.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.3 mt -93.79 -19.54 20.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.216 0.532 . . . . 50.0 110.247 -178.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -146.67 175.96 10.2 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 103.285 -2.857 . . . . 50.0 103.285 178.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -91.42 175.98 6.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 118.719 0.69 . . . . 50.0 111.41 177.553 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -154.59 144.27 21.55 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.678 0.391 . . . . 50.0 111.106 177.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 80.0 t -113.38 125.25 70.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.5 -2.037 . . . . 25.0 105.5 176.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.46 131.41 41.77 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.057 -0.974 . . . . 25.0 109.6 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -104.98 -1.99 25.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.593 0.711 . . . . 50.0 109.934 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -147.07 156.77 46.94 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.167 -1.049 . . . . 50.0 108.167 -177.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.85 -19.7 40.34 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 118.309 -0.661 . . . . 50.0 112.729 177.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -72.96 -16.9 61.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.292 -0.413 . . . . 50.0 111.04 177.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -100.37 142.29 32.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.734 0.778 . . . . 50.0 110.887 -172.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.0 mt -95.3 127.03 41.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.458 -0.792 . . . . 50.0 109.884 179.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.7 p -87.17 145.91 26.23 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 105.31 -2.107 . . . . 50.0 105.31 173.198 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -159.59 165.09 33.52 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.113 -1.069 . . . . 50.0 108.113 -179.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.47 161.76 17.57 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.483 0.658 . . . . 50.0 110.063 177.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -56.99 129.4 41.54 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.509 -0.769 . . . . 50.0 110.48 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.58 -16.41 59.78 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-O 118.941 -0.922 . . . . 50.0 113.603 177.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -58.55 155.21 12.7 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.924 0.869 . . . . 50.0 111.525 179.459 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.0 mm -118.97 135.57 58.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.225 -1.352 . . . . 50.0 109.262 179.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -141.71 156.35 45.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.307 -0.627 . . . . 50.0 109.307 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.9 m -91.15 129.42 37.15 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.179 -1.045 . . . . 25.0 108.179 177.274 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.3 t -94.14 124.97 46.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.121 -1.066 . . . . 50.0 108.121 177.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.9 mt -93.69 -43.48 8.63 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.501 -0.772 . . . . 50.0 109.555 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -149.38 165.16 32.88 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.318 -0.993 . . . . 50.0 108.318 -175.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -126.64 153.32 45.52 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 107.045 -1.465 . . . . 50.0 107.045 176.112 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 56.48 39.43 29.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 123.477 1.608 . . . . 50.0 109.088 -179.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -69.27 155.38 40.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.207 -1.815 . . . . 25.0 110.477 -176.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 60.16 11.45 2.77 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.918 0.887 . . . . 50.0 113.209 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.08 16.93 79.11 Favored Glycine 0 CA--C 1.516 0.135 0 N-CA-C 110.9 -0.88 . . . . 25.0 110.9 -177.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.6 mt -98.18 114.53 26.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.02 0.438 . . . . 50.0 109.999 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -63.58 127.68 32.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.889 -0.596 . . . . 25.0 109.927 -178.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.74 -0.58 85.94 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 115.505 0.962 . . . . 50.0 115.505 176.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -100.86 130.03 46.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 118.565 1.182 . . . . 50.0 109.825 177.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -111.27 140.0 46.2 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.77 -0.456 . . . . 50.0 109.77 -175.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.78 120.88 24.65 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 105.585 -2.006 . . . . 50.0 105.585 178.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 86.0 m -131.52 163.55 27.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.966 0.412 . . . . 50.0 111.716 178.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.8 t -118.87 124.59 47.51 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.706 -1.59 . . . . 50.0 106.706 173.117 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.0 tp -151.72 142.71 23.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.779 -1.193 . . . . 50.0 107.779 -175.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 57.49 27.17 13.61 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.324 0.583 . . . . 25.0 112.235 177.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.62 4.49 90.36 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 114.859 0.703 . . . . 25.0 114.859 178.337 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -130.24 161.02 32.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.091 0.945 . . . . 50.0 109.43 179.432 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -107.89 153.29 23.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.221 -0.659 . . . . 50.0 109.221 177.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.95 -154.3 11.8 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 107.291 -2.324 . . . . 50.0 107.291 177.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.5 pt -124.69 153.22 31.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.378 0.609 . . . . 50.0 110.582 -175.729 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 m -140.48 146.27 44.4 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 114.945 -1.025 . . . . 50.0 108.799 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.68 120.89 6.03 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 118.53 -0.514 . . . . 50.0 112.033 178.426 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.4 -17.05 70.1 Favored Glycine 0 C--O 1.222 -0.652 0 C-N-CA 121.576 -0.345 . . . . 50.0 113.191 -178.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -66.88 -6.91 18.26 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.944 0.72 . . . . 50.0 112.944 -179.282 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -135.79 26.63 3.34 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.577 -0.527 . . . . 50.0 109.577 175.282 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.6 tp -130.09 157.15 43.19 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 121.3 0.571 . . . . 50.0 111.603 -179.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -129.68 123.2 30.58 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.964 -0.562 . . . . 50.0 110.768 177.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.0 mm -70.09 135.93 27.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.797 -0.816 . . . . 50.0 108.797 176.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.7 mt -119.68 102.54 8.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.652 -1.24 . . . . 50.0 107.652 176.053 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.41 162.21 3.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.074 -0.713 . . . . 50.0 109.074 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -160.42 175.37 37.17 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 107.555 -2.218 . . . . 25.0 107.555 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.3 mtp -134.05 140.2 46.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.838 0.819 . . . . 25.0 109.614 -179.122 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 63.18 -29.19 0.09 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 118.526 2.787 . . . . 25.0 118.526 175.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -67.44 123.27 19.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.501 -0.925 . . . . 25.0 108.501 178.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -117.5 23.23 11.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.987 -1.006 . . . . 50.0 109.724 -174.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -144.05 160.84 48.03 Favored Pre-proline 0 C--O 1.22 -0.482 0 N-CA-C 106.226 -1.768 . . . . 50.0 106.226 177.39 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -69.86 150.04 67.04 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 114.165 -3.423 . . . . 50.0 110.071 171.424 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.62 4.45 3.14 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.077 1.51 . . . . 25.0 115.077 -176.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.92 16.8 74.06 Favored Glycine 0 CA--C 1.519 0.289 0 N-CA-C 115.899 1.12 . . . . 25.0 115.899 176.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.7 p -86.99 156.08 19.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.117 -0.698 . . . . 25.0 109.117 177.071 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.08 57.45 0.85 Allowed Glycine 0 C--O 1.224 -0.496 0 N-CA-C 111.876 -0.49 . . . . 25.0 111.876 -177.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.39 -156.45 25.76 Favored Glycine 0 C--O 1.227 -0.306 0 CA-C-O 121.4 0.444 . . . . 25.0 114.019 -177.395 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.9 p -62.8 144.79 56.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.126 0.489 . . . . 25.0 112.226 -179.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.61 -166.47 37.37 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 106.373 -2.691 . . . . 25.0 106.373 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.8 t -147.94 -65.36 0.25 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 117.79 0.795 . . . . 25.0 109.613 176.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.59 -152.75 46.65 Favored Glycine 0 C--O 1.226 -0.399 0 C-N-CA 120.478 -0.867 . . . . 25.0 111.477 178.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.5 t -159.49 140.93 12.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.597 -2.001 . . . . 25.0 105.597 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -66.71 138.77 57.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.973 -1.121 . . . . 50.0 107.973 178.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -103.44 -15.34 15.92 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 112.377 0.51 . . . . 25.0 112.377 -178.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 49.51 52.09 15.18 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.288 0.992 . . . . 50.0 110.341 178.093 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.98 161.28 8.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.596 -1.183 . . . . 25.0 112.02 -176.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.4 m -107.71 90.87 6.67 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 116.141 -0.481 . . . . 25.0 110.372 177.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.74 161.37 30.62 Favored 'Trans proline' 0 C--N 1.345 0.395 0 N-CA-C 115.877 1.453 . . . . 50.0 115.877 -176.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -69.57 160.54 49.37 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 117.34 -1.306 . . . . 50.0 110.404 169.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.87 156.48 65.76 Favored 'Trans proline' 0 C--N 1.344 0.307 0 N-CA-C 114.8 1.038 . . . . 50.0 114.8 -174.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -76.78 145.97 75.47 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 107.534 -1.284 . . . . 50.0 107.534 177.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.86 164.84 34.41 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 O-C-N 121.952 0.449 . . . . 50.0 112.753 -178.122 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.91 155.08 34.8 Favored 'Trans proline' 0 C--N 1.354 0.849 0 N-CA-C 114.205 0.81 . . . . 50.0 114.205 -178.348 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -116.08 22.48 12.92 Favored 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 112.876 0.695 . . . . 50.0 112.876 -175.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 44.9 p 55.06 14.53 0.98 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 116.542 2.052 . . . . 25.0 116.542 179.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.9 ptt-85 -158.29 -172.5 3.9 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.614 -1.995 . . . . 50.0 105.614 178.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.9 m 62.51 53.32 2.7 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 124.226 0.953 . . . . 25.0 111.324 -176.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.1 p -145.49 166.71 24.9 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 105.49 -2.041 . . . . 25.0 105.49 176.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 C--O 1.208 -1.1 0 CA-C-O 124.535 2.112 . . . . 25.0 111.43 -179.231 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.656 0 CA-C-O 124.149 1.972 . . . . 25.0 113.968 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m -64.79 -32.44 74.13 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 113.367 -1.417 . . . . 25.0 111.467 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.2 ttm 54.68 17.81 1.84 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.085 1.883 . . . . 25.0 116.085 176.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -86.38 74.62 9.93 Favored 'General case' 0 C--O 1.215 -0.744 0 O-C-N 121.873 -0.517 . . . . 50.0 109.821 178.163 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -136.1 163.53 30.13 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.379 -0.828 . . . . 50.0 108.89 179.52 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.4 mt -68.01 -39.2 83.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.366 -0.833 . . . . 50.0 110.492 178.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 57.88 28.58 16.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.142 0.977 . . . . 50.0 111.871 -179.138 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 m -94.79 176.12 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 105.416 -2.068 . . . . 50.0 105.416 176.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -119.74 174.11 6.63 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.999 -0.741 . . . . 50.0 108.999 177.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.44 154.34 36.42 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.189 -0.3 . . . . 25.0 110.189 177.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -111.27 130.89 55.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.924 -0.58 . . . . 50.0 110.172 178.574 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.93 117.67 12.74 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.223 -0.658 . . . . 25.0 109.223 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.6 mt -83.62 -25.64 30.65 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.28 0.562 . . . . 50.0 109.885 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -139.74 164.15 30.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.587 -1.188 . . . . 50.0 108.081 177.771 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.26 178.34 5.87 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 124.285 0.99 . . . . 50.0 112.782 -179.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -155.12 158.37 38.91 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.756 0.312 . . . . 50.0 111.269 172.037 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.0 t -127.51 129.11 70.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 104.13 -2.545 . . . . 25.0 104.13 173.37 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.68 135.91 33.96 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -115.51 -15.6 11.45 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.615 0.721 . . . . 50.0 109.653 175.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.4 t -112.55 146.72 35.57 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 106.396 -1.705 . . . . 50.0 106.396 179.737 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.65 -16.68 42.59 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 117.822 -0.985 . . . . 50.0 113.391 177.816 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -80.73 -18.02 49.16 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.24 1.019 . . . . 50.0 110.58 177.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -86.0 136.06 33.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.72 0.772 . . . . 50.0 111.716 -177.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.9 mt -86.08 127.55 34.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.734 -0.666 . . . . 50.0 110.575 179.515 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.2 t -89.95 132.83 35.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.809 -1.182 . . . . 50.0 107.809 174.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -160.02 172.78 16.91 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.154 -1.054 . . . . 50.0 108.154 -176.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.56 170.4 8.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 122.386 1.088 . . . . 50.0 111.545 178.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.33 135.87 57.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.709 -1.132 . . . . 50.0 109.437 -179.639 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.26 -9.04 78.44 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 118.67 -1.072 . . . . 50.0 113.782 179.155 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -63.78 143.51 57.78 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 118.703 1.251 . . . . 50.0 109.233 174.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.6 mm -106.31 130.86 57.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 106.877 -1.527 . . . . 50.0 106.877 178.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.7 ptp -134.69 146.54 49.56 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.358 0.263 . . . . 50.0 110.294 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -83.13 127.29 33.46 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.161 -1.051 . . . . 25.0 108.161 179.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -94.21 124.65 46.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.164 -1.05 . . . . 50.0 108.164 -179.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.0 mt -94.8 -45.81 7.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.787 -0.642 . . . . 50.0 109.893 -179.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -151.18 159.98 44.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.571 -0.9 . . . . 50.0 108.571 -175.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -118.85 148.96 42.32 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.985 -1.117 . . . . 50.0 107.985 177.108 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 56.68 38.95 29.91 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 123.374 1.559 . . . . 50.0 109.401 -179.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -64.88 150.02 48.49 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 113.129 -1.85 . . . . 25.0 110.91 -176.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 58.97 11.91 2.13 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.644 0.979 . . . . 50.0 113.644 180.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.13 10.33 84.99 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 110.958 -0.857 . . . . 25.0 110.958 -178.33 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.2 mt -86.5 106.99 17.9 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.15 -1.056 . . . . 50.0 108.15 179.226 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.45 125.07 22.68 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.234 -0.893 . . . . 25.0 110.064 -176.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.12 -0.12 89.93 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-O 118.879 -0.956 . . . . 50.0 115.236 178.056 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -101.3 132.6 46.76 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 118.944 1.372 . . . . 50.0 110.638 177.385 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -110.66 140.89 44.59 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.795 -0.817 . . . . 50.0 108.795 -178.481 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.67 121.83 26.86 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.58 -2.007 . . . . 50.0 105.58 178.534 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.419 ' HG ' HG21 ' A' ' 57' ' ' VAL . 96.4 m -132.02 163.93 27.32 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.852 0.686 . . . . 50.0 112.852 179.57 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.0 t -117.43 127.1 53.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.331 -1.359 . . . . 50.0 107.331 174.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tp -140.62 124.7 17.42 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.899 -0.778 . . . . 50.0 108.899 -177.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 54.65 35.03 22.8 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.581 0.585 . . . . 25.0 112.581 -179.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.48 0.33 89.96 Favored Glycine 0 C--O 1.222 -0.601 0 N-CA-C 115.61 1.004 . . . . 25.0 115.61 176.03 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -119.73 159.64 24.12 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 107.464 -1.31 . . . . 50.0 107.464 176.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -117.58 159.6 22.63 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.874 -0.787 . . . . 50.0 108.874 -178.134 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.62 -159.18 27.84 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 105.327 -3.109 . . . . 50.0 105.327 179.259 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.3 pt -119.53 153.66 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.818 0.818 . . . . 50.0 112.253 -176.232 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.419 HG21 ' HG ' ' A' ' 48' ' ' CYS . 3.5 m -144.21 148.22 40.43 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.767 -1.106 . . . . 50.0 108.991 -179.311 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.1 125.19 7.75 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 117.259 -1.361 . . . . 50.0 112.133 -178.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.59 -17.33 76.38 Favored Glycine 0 C--O 1.219 -0.825 0 N-CA-C 114.982 0.753 . . . . 50.0 114.982 -175.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.59 -23.71 63.17 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.106 1.15 . . . . 50.0 114.106 -176.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.12 27.21 7.71 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.567 0.698 . . . . 50.0 110.375 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mt -114.65 155.15 27.11 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 121.339 0.59 . . . . 50.0 110.387 173.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -125.4 118.82 26.7 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 115.344 -0.844 . . . . 50.0 108.981 174.194 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.54 135.84 27.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.561 -0.533 . . . . 50.0 109.561 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.2 mt -115.46 105.37 12.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.525 -2.028 . . . . 50.0 105.525 175.776 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -78.5 162.21 4.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.959 0.409 . . . . 50.0 110.449 -177.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -147.03 178.55 24.59 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 107.453 -2.259 . . . . 25.0 107.453 178.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 28.1 ttt -133.61 110.35 9.83 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 118.354 1.077 . . . . 25.0 112.0 -177.517 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 55.32 24.42 6.51 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.175 1.546 . . . . 25.0 115.175 176.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -80.27 155.03 27.49 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.508 -0.923 . . . . 25.0 108.508 174.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.07 151.6 12.28 Favored 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 109.608 -0.515 . . . . 50.0 109.608 -174.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm 59.73 101.49 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.276 0 N-CA-C 114.212 1.19 . . . . 50.0 114.212 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -70.24 161.29 46.54 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 117.166 -1.423 . . . . 50.0 112.627 178.226 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.34 162.18 40.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 105.912 -1.885 . . . . 25.0 105.912 177.35 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.51 -168.22 52.59 Favored Glycine 0 C--N 1.323 -0.159 0 N-CA-C 110.842 -0.903 . . . . 25.0 110.842 -177.311 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.5 t -156.14 160.42 39.89 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.061 -1.459 . . . . 25.0 107.061 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.0 179.26 45.47 Favored Glycine 0 C--O 1.236 0.265 0 N-CA-C 110.002 -1.239 . . . . 25.0 110.002 -179.528 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 161.16 -163.8 34.55 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.442 -1.063 . . . . 25.0 110.442 -179.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 m 55.78 58.48 4.44 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.403 0.89 . . . . 25.0 113.403 176.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.17 147.55 38.18 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 121.98 0.767 . . . . 25.0 112.934 177.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.3 m -75.82 88.28 2.84 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 114.703 1.371 . . . . 25.0 114.703 -175.313 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.0 86.47 0.78 Allowed Glycine 0 C--O 1.226 -0.375 0 N-CA-C 109.667 -1.373 . . . . 25.0 109.667 171.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.7 m -89.82 159.01 17.22 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.068 -0.345 . . . . 25.0 110.068 -178.586 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 62.72 -164.27 0.25 Allowed 'General case' 0 N--CA 1.473 0.681 0 O-C-N 124.439 1.087 . . . . 50.0 111.907 -179.347 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.8 165.58 33.94 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.645 -1.613 . . . . 25.0 106.645 -175.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 61.23 -154.26 0.36 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.093 -1.077 . . . . 50.0 108.093 -175.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 t0 53.6 66.51 1.21 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 122.41 1.1 . . . . 25.0 108.564 -170.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -56.25 138.67 73.87 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 114.64 -1.164 . . . . 25.0 111.168 -174.065 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -62.18 158.96 36.93 Favored 'Trans proline' 0 C--O 1.243 0.763 0 N-CA-C 114.392 0.882 . . . . 50.0 114.392 -177.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.8 161.29 39.83 Favored 'Trans proline' 0 C--O 1.24 0.593 0 O-C-N 121.81 0.374 . . . . 50.0 111.389 175.175 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.36 158.22 56.28 Favored 'Trans proline' 0 C--N 1.348 0.54 0 N-CA-C 114.738 1.014 . . . . 50.0 114.738 -176.333 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -108.07 147.92 36.47 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 114.766 -1.106 . . . . 50.0 108.255 179.214 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.06 164.29 34.74 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 O-C-N 122.255 0.608 . . . . 50.0 112.775 -179.156 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -64.46 157.26 55.82 Favored 'Trans proline' 0 C--N 1.356 0.931 0 N-CA-C 113.711 0.62 . . . . 50.0 113.711 179.38 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.1 mtt85 -100.94 24.66 8.97 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.162 1.171 . . . . 50.0 114.162 -177.089 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.9 p -132.67 -63.64 0.78 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.2 -0.296 . . . . 25.0 110.2 177.319 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.95 150.12 33.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 103.597 -2.742 . . . . 50.0 103.597 174.942 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.1 t -78.87 151.82 31.6 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.593 -0.891 . . . . 25.0 108.593 179.485 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 75.7 m -114.84 19.94 15.53 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.571 -0.9 . . . . 25.0 108.571 176.366 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.3 tp . . . . . 0 C--O 1.212 -0.905 0 CA-C-O 124.793 2.235 . . . . 25.0 109.969 179.593 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.219 0 CA-C-O 124.153 1.974 . . . . 25.0 116.145 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 t -94.08 52.91 1.68 Allowed 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.286 -1.126 . . . . 25.0 112.016 -177.487 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 79.0 mtm -131.68 135.67 47.07 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.285 -0.635 . . . . 25.0 109.285 177.403 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -134.36 82.81 1.99 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.514 -1.661 . . . . 50.0 106.514 178.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -120.59 167.67 12.17 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.933 -0.576 . . . . 50.0 112.026 -173.512 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.14 -38.46 69.23 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 115.006 -0.997 . . . . 50.0 109.554 178.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.3 m120 53.37 39.3 29.66 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.295 1.045 . . . . 50.0 112.513 -179.469 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 m -103.11 168.34 2.24 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 N-CA-C 105.558 -2.015 . . . . 50.0 105.558 176.012 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.88 171.85 7.1 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.551 -1.277 . . . . 50.0 107.551 -177.408 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.67 162.27 37.94 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.974 -0.75 . . . . 25.0 108.974 174.649 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -128.18 130.48 48.1 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 123.673 0.789 . . . . 50.0 111.144 175.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.08 130.8 43.11 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 123.783 0.677 . . . . 25.0 109.882 177.045 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.3 mt -97.83 -22.06 16.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.938 0.399 . . . . 50.0 111.241 -178.094 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -141.17 170.01 16.53 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 106.912 -1.514 . . . . 50.0 106.912 178.124 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -76.12 165.73 24.5 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 122.78 0.432 . . . . 50.0 111.146 176.325 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -146.98 150.36 34.98 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.743 -0.598 . . . . 50.0 111.831 174.606 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.02 126.76 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 N-CA-C 105.697 -1.964 . . . . 25.0 105.697 178.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.46 122.82 30.15 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.758 -0.46 . . . . 25.0 109.758 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -104.03 14.03 31.42 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.985 0.898 . . . . 50.0 110.338 -179.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 t -156.47 149.45 18.41 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 106.321 -1.733 . . . . 50.0 106.321 -178.133 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -69.74 -16.4 37.62 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 117.152 -1.432 . . . . 50.0 112.55 175.457 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.28 -21.88 58.18 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.08 -0.711 . . . . 50.0 109.08 176.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -89.25 139.38 30.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.961 0.886 . . . . 50.0 109.338 -178.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.5 mt -90.14 129.48 36.41 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.848 0.833 . . . . 50.0 110.257 179.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.08 134.44 33.83 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.442 -1.688 . . . . 50.0 106.442 178.042 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -154.04 161.97 41.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.831 0.287 . . . . 50.0 111.559 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.71 162.04 17.34 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.722 -1.214 . . . . 50.0 107.722 -179.273 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.19 129.97 44.68 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.974 -0.557 . . . . 50.0 109.8 179.198 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.36 -13.9 63.99 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 119.039 -0.867 . . . . 50.0 114.151 179.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -59.77 148.68 33.47 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-N 117.92 0.86 . . . . 50.0 111.07 177.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.5 mm -118.84 129.8 74.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.31 -1.313 . . . . 50.0 109.043 -179.002 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -136.16 155.45 50.13 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.336 -0.987 . . . . 50.0 108.336 -178.196 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.7 m -88.83 124.39 34.12 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.385 -0.598 . . . . 25.0 109.385 177.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.1 t -87.43 125.08 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 108.424 -0.954 . . . . 50.0 108.424 177.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.4 mt -91.0 -46.29 8.23 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.364 -1.347 . . . . 50.0 107.364 178.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -155.87 170.7 21.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.646 -0.872 . . . . 50.0 108.646 177.438 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.9 mtm105 -117.37 154.57 31.08 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.25 -1.759 . . . . 50.0 106.25 177.067 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 59.05 42.97 18.22 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 125.478 1.736 . . . . 50.0 109.192 179.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -70.83 157.37 38.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.005 -1.452 . . . . 25.0 110.372 -176.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 60.15 10.08 2.14 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.019 0.928 . . . . 50.0 113.363 177.786 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.4 20.62 68.87 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.762 -0.732 . . . . 25.0 111.572 -176.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 70.6 mt -102.49 122.84 45.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.58 0.229 . . . . 50.0 111.287 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.57 123.63 17.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.256 0.551 . . . . 25.0 111.02 177.522 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.81 -0.24 82.87 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 116.131 1.212 . . . . 50.0 116.131 172.444 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -99.49 131.12 45.71 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 118.879 1.34 . . . . 50.0 109.427 177.705 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -110.65 143.45 41.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.729 -0.841 . . . . 50.0 108.729 -176.045 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.15 123.06 30.22 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 106.21 -1.774 . . . . 50.0 106.21 178.407 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.2 m -132.24 166.88 20.86 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.868 -0.333 . . . . 50.0 110.848 178.048 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -118.13 122.03 42.05 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.735 -1.58 . . . . 50.0 106.735 173.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.6 tp -150.58 140.02 21.44 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.79 -0.818 . . . . 50.0 108.79 -177.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.9 m170 57.5 30.77 19.23 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.628 0.771 . . . . 25.0 110.934 -179.534 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.89 0.03 87.68 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 115.381 0.912 . . . . 25.0 115.381 176.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -124.6 158.25 33.5 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 118.006 0.903 . . . . 50.0 110.148 179.266 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -102.1 149.58 24.12 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 106.564 -1.643 . . . . 50.0 106.564 178.661 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.89 -167.49 36.59 Favored Glycine 0 N--CA 1.433 -1.535 0 N-CA-C 107.825 -2.11 . . . . 50.0 107.825 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.6 pt -111.18 153.14 12.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.646 0.736 . . . . 50.0 111.574 -173.364 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.7 m -143.01 142.95 23.12 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.146 -0.934 . . . . 50.0 109.464 179.334 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.08 124.06 8.8 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 118.374 -0.617 . . . . 50.0 112.065 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.32 -12.3 79.86 Favored Glycine 0 C--O 1.221 -0.706 0 C-N-CA 120.83 -0.7 . . . . 50.0 114.505 -176.155 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -71.45 -7.85 50.03 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.084 0.772 . . . . 50.0 113.084 -176.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -132.16 27.23 4.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.666 -0.864 . . . . 50.0 108.666 178.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.3 tp -134.1 149.55 51.11 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.424 -0.807 . . . . 75.0 111.739 -174.116 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -128.17 123.02 33.31 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.38 0.272 . . . . 50.0 111.628 -178.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.9 mm -67.98 136.66 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.225 -0.657 . . . . 50.0 109.225 176.845 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.7 mt -118.43 100.96 7.8 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.396 -1.335 . . . . 50.0 107.396 175.293 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -86.6 132.77 31.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 107.669 -1.234 . . . . 50.0 107.669 177.244 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 170.07 176.82 39.95 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 109.677 -1.369 . . . . 25.0 109.677 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 15.8 tpt -78.48 145.23 35.09 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.114 -1.069 . . . . 25.0 108.114 178.096 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -77.12 160.65 28.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.632 -0.507 . . . . 25.0 109.632 177.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -141.16 154.6 45.94 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 109.924 -0.399 . . . . 25.0 109.924 178.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -72.24 148.58 45.35 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 123.426 0.69 . . . . 50.0 110.344 -178.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -141.79 149.0 51.78 Favored Pre-proline 0 N--CA 1.468 0.464 0 N-CA-C 106.122 -1.807 . . . . 50.0 106.122 178.043 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.26 -13.43 20.89 Favored 'Trans proline' 0 C--N 1.347 0.466 0 N-CA-C 115.415 1.275 . . . . 50.0 115.415 -175.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.95 -44.6 0.12 Allowed 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 121.231 0.539 . . . . 25.0 110.47 -179.823 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.85 -78.12 0.24 Allowed Glycine 0 CA--C 1.511 -0.216 0 N-CA-C 110.953 -0.859 . . . . 25.0 110.953 178.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.8 p -151.35 171.86 16.82 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.512 -0.921 . . . . 25.0 108.512 179.396 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.6 176.21 53.8 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 106.947 -2.461 . . . . 25.0 106.947 170.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -163.5 -173.31 32.05 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.655 -1.26 . . . . 25.0 110.509 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.3 p 67.94 176.81 0.25 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.812 1.245 . . . . 25.0 112.009 -175.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.0 129.69 3.14 Favored Glycine 0 C--O 1.243 0.706 0 N-CA-C 110.463 -1.055 . . . . 25.0 110.463 -176.462 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.7 m -98.75 155.03 17.55 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.85 0.357 . . . . 25.0 110.411 -175.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.27 -109.14 2.71 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.015 -0.612 . . . . 25.0 114.539 177.191 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 t 57.55 48.26 14.66 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.431 -0.951 . . . . 25.0 108.431 -173.753 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -126.89 24.96 6.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 113.968 -1.469 . . . . 50.0 110.391 -174.229 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -102.99 162.56 12.83 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.317 -0.856 . . . . 25.0 110.6 -175.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.448 ' HG2' ' H ' ' A' ' 87' ' ' ASP . 4.5 tt0 71.42 -171.84 0.16 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.933 1.396 . . . . 50.0 112.154 178.562 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.448 ' H ' ' HG2' ' A' ' 86' ' ' GLN . 9.0 m-20 -67.9 150.86 48.01 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.6 0.714 . . . . 25.0 112.71 -175.311 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.1 m -65.84 140.9 97.43 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.924 -0.58 . . . . 25.0 112.459 -178.643 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -62.73 157.94 44.85 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 119.753 0.302 . . . . 50.0 112.617 177.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -62.21 148.23 93.6 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 117.31 -1.327 . . . . 50.0 111.935 176.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.68 147.88 82.18 Favored 'Trans proline' 0 C--O 1.217 -0.545 0 N-CA-C 114.985 1.11 . . . . 50.0 114.985 -169.485 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -64.07 146.91 97.16 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.7 -0.852 . . . . 50.0 108.7 -177.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.94 156.76 64.34 Favored 'Trans proline' 0 C--O 1.238 0.481 0 C-N-CA 115.575 -2.483 . . . . 50.0 111.176 173.263 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -60.69 154.75 52.77 Favored 'Trans proline' 0 C--O 1.212 -0.814 0 C-N-CA 118.389 -0.607 . . . . 50.0 110.552 175.43 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -89.3 -77.42 0.38 Allowed 'General case' 0 C--O 1.211 -0.959 0 CA-C-O 121.009 0.433 . . . . 50.0 110.599 178.065 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.91 -36.46 0.12 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.936 0.874 . . . . 25.0 111.518 -179.74 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -132.57 35.62 3.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.688 -0.687 . . . . 50.0 110.964 -174.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 48.8 m -81.54 152.35 27.32 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.001 -1.0 . . . . 25.0 108.449 178.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 25.8 p -146.77 164.5 32.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.839 -1.912 . . . . 25.0 105.839 175.582 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 C--O 1.206 -1.219 0 CA-C-O 124.137 1.922 . . . . 25.0 112.926 -178.841 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.989 0 CA-C-O 124.202 2.001 . . . . 25.0 113.269 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 m 56.68 31.74 19.83 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 112.359 -1.92 . . . . 25.0 113.043 179.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 83.1 mtp -97.53 144.12 27.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.281 -0.418 . . . . 25.0 110.646 179.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -81.2 108.66 15.03 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.444 -0.576 . . . . 50.0 109.444 179.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -135.0 169.02 18.05 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.686 0.755 . . . . 50.0 112.502 -179.712 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.87 -42.21 90.62 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.869 -0.789 . . . . 50.0 108.869 176.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.6 m120 51.6 46.74 26.05 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.783 0.802 . . . . 50.0 110.407 -178.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 m -109.26 166.7 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 104.348 -2.464 . . . . 50.0 104.348 176.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.84 172.16 6.99 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.469 -1.308 . . . . 50.0 107.469 -176.436 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.86 158.61 43.46 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.927 -0.397 . . . . 25.0 109.927 173.455 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -124.88 129.66 50.83 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.417 -0.81 . . . . 50.0 109.817 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.77 130.53 42.57 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.271 -0.64 . . . . 25.0 109.271 178.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.7 mt -95.29 -20.72 18.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.543 -0.299 . . . . 50.0 111.472 -177.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -145.96 170.36 16.78 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.31 -0.996 . . . . 50.0 108.31 -179.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -73.93 160.4 31.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.598 -0.519 . . . . 50.0 109.598 177.041 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -145.97 154.37 41.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.838 0.352 . . . . 50.0 110.724 172.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 p -132.39 136.06 56.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 105.398 -2.075 . . . . 25.0 105.398 178.483 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.94 139.57 33.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.081 -0.509 . . . . 25.0 111.06 -175.192 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -121.68 9.3 10.14 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.577 0.703 . . . . 50.0 109.662 178.177 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 t -148.85 151.02 34.19 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 105.867 -1.901 . . . . 50.0 105.867 -177.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -67.52 -21.69 45.9 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 117.799 -1.0 . . . . 50.0 113.024 178.708 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.32 -17.57 58.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.961 0.41 . . . . 50.0 111.197 178.516 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -89.76 134.38 34.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.927 0.87 . . . . 50.0 111.866 -172.267 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.6 mt -89.08 126.24 35.36 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.266 -0.879 . . . . 50.0 110.822 178.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -86.94 141.31 28.81 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.021 -1.844 . . . . 50.0 106.021 174.082 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.13 168.07 28.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.757 0.313 . . . . 50.0 110.634 -177.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -116.33 162.9 16.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.224 0.535 . . . . 50.0 110.105 178.388 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.48 134.55 57.12 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.744 -0.662 . . . . 50.0 109.466 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.99 -12.73 68.75 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 116.132 -0.486 . . . . 50.0 113.014 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -62.46 138.98 58.57 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.692 -0.855 . . . . 50.0 108.692 177.761 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.1 mm -105.86 132.77 52.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.936 -1.029 . . . . 50.0 108.385 177.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.1 ptp -139.33 152.05 46.88 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.711 -0.478 . . . . 50.0 109.711 -178.446 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 m -89.76 123.11 33.47 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.515 -0.92 . . . . 25.0 108.515 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.97 125.81 41.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 108.847 -0.797 . . . . 50.0 108.847 178.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.8 mt -91.68 -47.77 7.19 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.4 -0.963 . . . . 50.0 108.4 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -155.37 173.88 16.03 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 110.308 -0.256 . . . . 50.0 110.308 178.443 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.9 mtm105 -123.74 157.96 32.77 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 106.029 -1.841 . . . . 75.0 106.029 176.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.8 t0 59.43 40.26 21.01 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 123.419 1.581 . . . . 50.0 107.449 -177.349 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -68.82 144.51 54.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.114 -1.403 . . . . 25.0 107.787 -177.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 59.8 12.28 2.92 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.899 0.88 . . . . 50.0 113.241 -179.276 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.29 16.83 79.01 Favored Glycine 0 C--N 1.331 0.265 0 N-CA-C 111.465 -0.654 . . . . 25.0 111.465 -178.231 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.3 mt -94.36 105.1 17.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.183 -0.673 . . . . 50.0 109.183 179.101 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -58.53 130.15 45.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 122.03 0.919 . . . . 25.0 110.807 -177.749 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.7 -6.35 70.16 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.085 -0.961 . . . . 50.0 115.037 178.009 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -95.83 139.26 32.3 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 118.944 1.372 . . . . 50.0 109.306 176.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 34.6 m0 -118.88 142.88 47.34 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.756 -1.201 . . . . 50.0 107.756 -176.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.71 121.83 28.94 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 105.308 -2.108 . . . . 50.0 105.308 178.888 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.1 m -130.97 157.62 42.46 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.333 0.587 . . . . 50.0 111.907 179.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.5 t -107.46 123.62 48.66 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 105.849 -1.908 . . . . 50.0 105.849 171.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 tp -144.61 135.08 24.5 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.83 -0.804 . . . . 50.0 108.83 -176.074 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 56.73 27.22 12.37 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 176.334 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.6 4.53 82.85 Favored Glycine 0 C--O 1.228 -0.275 0 N-CA-C 114.417 0.527 . . . . 25.0 114.417 178.481 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -131.78 162.09 31.34 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.959 0.879 . . . . 50.0 109.496 178.602 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -110.38 155.07 22.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.207 -0.664 . . . . 50.0 109.207 179.516 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.98 -163.49 31.16 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 106.832 -2.507 . . . . 50.0 106.832 176.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.9 pt -111.77 153.44 13.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 121.671 0.748 . . . . 50.0 110.157 -177.35 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -141.26 145.0 36.56 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.09 -0.959 . . . . 50.0 109.33 179.186 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.17 121.12 6.98 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 CA-C-O 121.659 0.608 . . . . 50.0 111.372 178.417 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.81 -9.21 74.72 Favored Glycine 0 C--O 1.218 -0.846 0 C-N-CA 121.131 -0.557 . . . . 50.0 114.056 -176.218 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -66.43 -17.02 64.55 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.337 -0.507 . . . . 50.0 112.091 -178.073 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -128.2 26.56 5.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.748 -0.66 . . . . 50.0 109.414 -177.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.2 tp -132.99 145.0 50.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.532 0.682 . . . . 50.0 109.973 -176.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -122.72 120.28 33.17 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.504 -0.771 . . . . 50.0 111.425 -177.112 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.2 mm -67.73 134.39 30.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 O-C-N 123.663 0.602 . . . . 50.0 109.652 177.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.3 mt -117.74 99.65 7.08 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.067 -1.827 . . . . 50.0 106.067 174.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.5 m -74.87 157.09 6.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.03 0.443 . . . . 50.0 109.848 -177.594 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.78 83.43 1.45 Allowed Glycine 0 C--O 1.218 -0.903 0 N-CA-C 109.28 -1.528 . . . . 25.0 109.28 175.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.48 -13.96 60.4 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.109 0.481 . . . . 25.0 110.29 -179.539 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -116.77 138.02 51.78 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 106.025 -1.843 . . . . 25.0 106.025 176.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 58.84 177.46 0.07 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.451 1.095 . . . . 25.0 113.503 -176.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -101.76 80.32 2.02 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.334 -1.358 . . . . 50.0 107.334 -177.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 mttt 54.72 72.39 1.1 Allowed Pre-proline 0 N--CA 1.479 0.998 0 CA-C-N 114.685 -1.143 . . . . 50.0 112.624 -176.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -72.42 -8.97 23.55 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 121.66 1.573 . . . . 50.0 114.882 -178.554 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 59.0 16.89 4.97 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.94 1.459 . . . . 25.0 114.94 177.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.63 160.68 39.74 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 121.179 -0.534 . . . . 25.0 112.102 178.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.1 m -139.77 164.61 29.49 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 109.381 -0.6 . . . . 25.0 109.381 -179.346 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.32 -51.27 0.32 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 116.681 1.432 . . . . 25.0 116.681 174.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.69 82.41 1.41 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 116.177 1.231 . . . . 25.0 116.177 -174.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 66.4 p -65.0 -37.92 89.25 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 112.708 0.633 . . . . 25.0 112.708 -179.239 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.4 -155.51 17.52 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 109.853 -1.299 . . . . 25.0 109.853 -179.166 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.3 m -147.82 163.52 36.51 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.886 -0.783 . . . . 25.0 108.886 -178.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.56 152.2 7.69 Favored Glycine 0 C--O 1.226 -0.404 0 N-CA-C 109.528 -1.429 . . . . 25.0 109.528 179.361 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.7 t -139.19 21.96 2.59 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.567 0.683 . . . . 25.0 111.886 -176.144 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -109.06 -50.66 2.97 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.429 1.27 . . . . 50.0 114.429 -176.605 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt 63.43 -160.18 0.3 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.571 -0.9 . . . . 25.0 108.571 -173.288 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -144.05 130.02 19.48 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.712 -1.588 . . . . 50.0 106.712 178.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -73.17 -30.27 63.44 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.906 0.706 . . . . 25.0 112.906 -177.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.2 m -121.54 84.91 42.87 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 112.122 0.416 . . . . 25.0 112.122 -178.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -77.78 164.32 27.99 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 N-CA-C 113.365 0.486 . . . . 50.0 113.365 178.121 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -64.1 150.71 87.79 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 118.279 -0.681 . . . . 50.0 111.62 175.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.51 160.57 48.06 Favored 'Trans proline' 0 C--N 1.35 0.618 0 N-CA-C 116.456 1.675 . . . . 50.0 116.456 -172.328 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -67.34 149.84 98.19 Favored Pre-proline 0 N--CA 1.468 0.433 0 CA-C-N 115.543 -0.753 . . . . 50.0 110.147 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.25 156.55 61.81 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 117.137 -1.442 . . . . 50.0 110.757 172.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.72 151.42 80.7 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 117.133 -1.445 . . . . 50.0 110.364 174.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -81.62 -61.36 1.95 Allowed 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 119.836 -0.746 . . . . 50.0 109.943 177.136 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.65 -40.13 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 105.537 -2.023 . . . . 25.0 105.537 -176.55 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -56.87 121.12 9.14 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 114.264 -1.335 . . . . 50.0 112.878 -178.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.4 m -97.52 4.88 50.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.719 -0.673 . . . . 25.0 110.909 173.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 48.7 t -140.9 140.88 34.6 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.982 0.896 . . . . 25.0 110.93 -176.17 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 C--O 1.208 -1.089 0 CA-C-O 123.966 1.841 . . . . 25.0 111.218 179.661 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 116.166 1.226 . . . . 25.0 116.166 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 m 71.3 161.73 0.24 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.549 1.939 . . . . 25.0 113.083 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -111.9 27.99 9.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.42 -0.809 . . . . 25.0 109.84 -179.057 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.3 tptp -96.69 17.24 16.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.864 -0.607 . . . . 50.0 110.616 -177.249 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -131.09 159.2 38.28 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.071 0.767 . . . . 50.0 113.071 -175.45 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.6 mt -63.96 -38.72 92.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.984 -1.007 . . . . 50.0 110.83 179.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 52.61 41.87 31.35 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.267 1.032 . . . . 50.0 110.87 -179.661 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.0 m -103.29 173.23 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 102.97 -2.974 . . . . 50.0 102.97 174.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -118.4 172.61 7.34 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 118.649 0.658 . . . . 50.0 109.401 -178.346 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.43 160.26 43.6 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.918 -0.583 . . . . 25.0 109.533 176.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -118.84 133.09 56.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.101 -0.954 . . . . 50.0 108.863 177.023 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.91 126.28 29.33 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 173.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.8 mt -88.63 -22.29 23.54 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.433 -0.58 . . . . 50.0 109.433 -178.698 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -144.05 175.17 10.24 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 105.116 -2.179 . . . . 50.0 105.116 179.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -86.47 -179.99 6.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 118.15 0.432 . . . . 50.0 109.937 175.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -154.99 143.56 20.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.111 0.481 . . . . 50.0 111.721 174.652 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.6 t -107.26 123.9 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 105.084 -2.191 . . . . 25.0 105.084 175.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.99 121.67 22.32 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.274 -1.01 . . . . 25.0 108.274 178.394 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -110.97 -2.06 16.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.647 0.737 . . . . 50.0 109.197 -179.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.3 m -129.34 152.6 79.78 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 107.55 -1.278 . . . . 50.0 107.55 179.083 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.92 -20.55 33.91 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 118.352 -0.632 . . . . 50.0 113.363 -179.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -16.94 46.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.925 -0.579 . . . . 50.0 110.383 179.565 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -87.19 139.82 30.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.627 0.727 . . . . 50.0 111.602 -172.476 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.8 mt -91.88 129.86 37.76 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.69 0.757 . . . . 50.0 109.75 177.336 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.34 142.48 27.85 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 105.708 -1.96 . . . . 50.0 105.708 173.327 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -156.41 167.72 29.58 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.788 -0.449 . . . . 50.0 109.788 -179.037 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.62 161.56 17.29 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.676 0.75 . . . . 50.0 111.142 -179.079 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -56.89 127.19 30.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.993 -1.003 . . . . 50.0 109.71 178.275 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.23 -11.77 70.01 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-O 119.093 -0.837 . . . . 50.0 114.682 178.01 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.51 138.82 54.72 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 118.18 0.99 . . . . 50.0 111.63 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.1 mm -102.28 130.22 52.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.194 -1.039 . . . . 50.0 108.194 175.333 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.0 ptp -135.65 153.28 51.68 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.439 -0.578 . . . . 50.0 109.439 -178.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.0 m -88.8 128.21 35.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.25 -1.389 . . . . 25.0 107.25 178.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -94.22 121.67 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 107.421 -1.326 . . . . 50.0 107.421 178.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.4 mt -91.7 -43.66 9.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.157 -0.929 . . . . 50.0 109.947 -177.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -152.2 162.6 40.89 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.483 -1.303 . . . . 50.0 107.483 -177.037 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -124.7 153.56 42.15 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.203 -1.036 . . . . 50.0 108.203 176.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 55.8 40.17 30.7 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 123.731 1.729 . . . . 50.0 108.393 -178.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -70.36 158.96 35.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 112.95 -1.932 . . . . 25.0 110.57 -175.457 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 60.87 8.32 1.8 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.112 0.965 . . . . 50.0 113.389 179.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.85 17.85 74.05 Favored Glycine 0 CA--C 1.517 0.174 0 N-CA-C 110.551 -1.019 . . . . 25.0 110.551 -176.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.3 mt -99.51 123.3 43.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.007 0.432 . . . . 50.0 110.397 -179.535 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -64.78 129.69 40.73 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.06 -0.518 . . . . 25.0 110.456 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.13 -0.75 66.29 Favored Glycine 0 C--O 1.24 0.488 0 N-CA-C 116.617 1.407 . . . . 50.0 116.617 174.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -100.5 129.99 46.52 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 118.692 1.246 . . . . 50.0 109.736 178.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -111.65 140.07 46.58 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.74 -0.467 . . . . 50.0 109.74 -175.776 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.45 120.48 24.51 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.237 -1.764 . . . . 50.0 106.237 178.541 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.8 m -131.41 163.75 27.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.096 0.474 . . . . 50.0 111.884 178.683 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.9 t -120.03 123.95 44.69 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.062 -1.458 . . . . 50.0 107.062 173.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.8 tp -148.61 136.59 20.87 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.823 -0.806 . . . . 50.0 108.823 -176.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 56.17 26.98 10.91 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.551 1.315 . . . . 25.0 114.551 174.758 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.36 8.97 84.37 Favored Glycine 0 C--O 1.227 -0.297 0 C-N-CA 121.006 -0.616 . . . . 25.0 113.197 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -119.9 157.52 28.58 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.127 -1.064 . . . . 50.0 108.127 178.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -122.22 147.79 45.76 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 105.353 -2.091 . . . . 50.0 105.353 173.107 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.26 -155.59 17.25 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 107.201 -2.36 . . . . 50.0 107.201 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.9 pt -122.37 149.53 25.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 121.396 0.617 . . . . 50.0 111.05 -174.581 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.6 m -138.22 147.2 54.86 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.087 -0.96 . . . . 50.0 109.166 -178.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.84 119.12 5.73 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 O-C-N 122.037 0.493 . . . . 50.0 112.272 178.539 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.39 -18.65 69.84 Favored Glycine 0 C--O 1.223 -0.575 0 C-N-CA 121.226 -0.511 . . . . 50.0 113.429 -178.275 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -64.18 -17.98 64.04 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.202 0.815 . . . . 50.0 113.202 -178.428 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -122.58 27.29 7.9 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.343 0.592 . . . . 50.0 109.628 177.022 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 tp -128.77 157.62 40.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 50.0 111.757 -179.618 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -131.37 120.03 22.52 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.067 -0.515 . . . . 50.0 110.869 177.339 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.7 mm -69.32 136.95 25.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.293 -0.632 . . . . 50.0 109.293 178.739 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.7 mt -115.55 91.82 3.72 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.713 -1.218 . . . . 50.0 107.713 177.103 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.7 m -81.37 -14.47 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 113.353 0.871 . . . . 50.0 113.353 -176.599 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.58 89.55 1.61 Allowed Glycine 0 C--O 1.226 -0.356 0 N-CA-C 106.381 -2.688 . . . . 25.0 106.381 -169.72 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 98.4 mtp -80.53 95.72 6.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 121.892 -0.77 . . . . 25.0 110.959 -173.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 65.49 12.39 8.14 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.628 1.171 . . . . 25.0 113.293 178.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -144.11 169.06 18.58 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.125 -1.435 . . . . 25.0 107.125 174.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -69.96 151.75 45.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.361 0.601 . . . . 50.0 111.543 -176.53 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -69.12 153.34 96.12 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 105.781 -1.933 . . . . 50.0 105.781 172.143 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -66.62 151.76 82.11 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 117.007 -1.529 . . . . 50.0 112.91 -177.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.95 12.31 3.39 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.177 0.806 . . . . 25.0 113.177 -176.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.35 176.3 46.04 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.717 -0.953 . . . . 25.0 110.717 -179.437 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.4 m -68.24 148.67 50.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.661 0.267 . . . . 25.0 110.994 179.586 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.0 -178.45 48.25 Favored Glycine 0 CA--C 1.508 -0.347 0 N-CA-C 109.915 -1.274 . . . . 25.0 109.915 179.413 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 144.6 -51.7 0.62 Allowed Glycine 0 C--O 1.229 -0.212 0 N-CA-C 110.928 -0.869 . . . . 25.0 110.928 178.676 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.8 m 62.34 164.76 0.1 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 115.531 1.678 . . . . 25.0 115.531 177.276 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.14 169.6 35.81 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 107.752 -2.139 . . . . 25.0 107.752 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.8 m -135.7 11.13 3.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.826 0.813 . . . . 25.0 111.933 -178.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.15 -127.48 29.96 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 110.683 -0.967 . . . . 25.0 110.683 -177.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.2 t 71.01 -53.77 0.67 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.498 1.519 . . . . 25.0 112.38 -178.367 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.37 139.81 54.18 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.985 -1.117 . . . . 50.0 107.985 174.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -158.75 10.61 0.14 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.172 0.804 . . . . 25.0 113.172 -174.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.08 113.13 10.42 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 108.095 -1.076 . . . . 50.0 108.095 -179.329 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -153.73 166.22 33.54 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.747 -1.205 . . . . 25.0 107.747 -178.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.0 t -122.3 92.72 48.87 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.908 0.385 . . . . 25.0 110.401 -179.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.21 154.04 36.62 Favored 'Trans proline' 0 C--N 1.346 0.418 0 N-CA-C 115.754 1.405 . . . . 50.0 115.754 -176.293 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -71.91 158.98 51.63 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 118.064 -0.824 . . . . 50.0 110.701 173.163 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -67.94 155.16 70.79 Favored 'Trans proline' 0 C--O 1.234 0.317 0 N-CA-C 114.977 1.106 . . . . 50.0 114.977 -173.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -81.95 144.45 51.48 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 107.617 -1.253 . . . . 50.0 107.617 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.04 156.91 55.41 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 117.698 -1.068 . . . . 50.0 111.557 -179.024 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -64.67 146.06 88.0 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 116.991 -1.539 . . . . 50.0 113.834 -177.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -85.6 49.38 1.75 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.039 -0.413 . . . . 50.0 110.866 174.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 77.6 p 47.27 10.21 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 118.745 2.869 . . . . 25.0 118.745 -178.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -124.5 -12.99 7.18 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.699 1.37 . . . . 50.0 114.699 -178.257 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.9 t 48.56 30.59 2.53 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 116.74 2.126 . . . . 25.0 116.74 177.24 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 81.1 m -72.22 122.6 21.34 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 121.467 -0.77 . . . . 25.0 109.576 177.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.296 0 C-N-CA 126.07 1.748 . . . . 25.0 113.761 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 CA-C-O 123.843 1.801 . . . . 25.0 114.116 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 t -143.02 127.73 18.14 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.067 -1.457 . . . . 25.0 107.067 177.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.0 ttm -157.99 -68.39 0.09 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.115 0.783 . . . . 25.0 113.115 -175.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 65.0 179.57 0.18 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.804 1.242 . . . . 50.0 109.245 -173.797 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 55.53 174.38 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 116.769 2.137 . . . . 50.0 116.769 -177.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.6 mt -79.33 -42.07 26.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.082 -0.963 . . . . 50.0 110.568 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 56.42 27.08 11.54 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.414 1.085 . . . . 50.0 112.287 -178.441 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.7 m -86.53 170.94 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 104.441 -2.429 . . . . 50.0 104.441 174.061 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mp -116.33 172.78 6.97 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.033 -0.729 . . . . 50.0 109.033 179.407 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.04 155.17 42.0 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.731 -0.47 . . . . 25.0 109.731 177.292 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -114.02 131.05 56.5 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.535 -0.757 . . . . 50.0 109.553 176.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.15 127.13 32.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.133 -0.692 . . . . 25.0 109.133 174.171 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.6 mt -92.44 -23.14 19.26 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.939 -0.393 . . . . 50.0 109.939 -178.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -143.16 167.06 23.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.059 -1.089 . . . . 50.0 108.059 -179.159 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -75.73 166.22 23.87 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 122.668 0.387 . . . . 50.0 111.824 177.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -145.57 156.83 43.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.968 0.413 . . . . 50.0 111.373 174.252 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.9 t -123.5 122.62 65.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 105.239 -2.134 . . . . 25.0 105.239 173.51 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.23 127.58 32.87 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.363 -0.977 . . . . 25.0 108.363 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -113.17 12.98 19.18 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.961 0.886 . . . . 50.0 109.52 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 t -152.08 147.44 19.79 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 106.3 -1.741 . . . . 50.0 106.3 -179.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.98 -23.6 67.73 Favored 'Trans proline' 0 C--N 1.347 0.456 0 O-C-N 122.23 0.595 . . . . 50.0 113.079 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -76.26 -21.12 56.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.343 0.592 . . . . 50.0 110.351 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -88.29 130.74 35.03 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.241 -1.022 . . . . 50.0 108.241 -178.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.2 mt -81.76 133.18 35.32 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.697 0.76 . . . . 50.0 109.803 179.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.39 125.09 34.54 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.331 -0.989 . . . . 50.0 108.331 177.568 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -145.43 164.36 31.79 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 120.972 0.415 . . . . 50.0 110.445 -179.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.35 167.73 12.01 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.334 0.587 . . . . 50.0 110.086 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -58.83 130.43 46.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.342 -0.844 . . . . 50.0 109.44 -179.092 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.26 -12.15 69.42 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-O 118.504 -1.164 . . . . 50.0 114.938 177.172 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -59.97 150.01 30.23 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.439 1.119 . . . . 50.0 111.483 177.523 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.2 mm -114.81 127.06 72.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.61 -1.177 . . . . 50.0 108.642 177.283 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.8 ptp -132.74 151.06 52.08 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.293 -0.632 . . . . 50.0 109.293 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -84.82 130.35 34.68 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.247 -1.02 . . . . 25.0 108.247 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.8 t -98.18 121.14 48.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.534 -0.913 . . . . 50.0 108.534 179.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.7 mt -87.7 -46.81 9.17 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.972 -0.558 . . . . 50.0 109.66 -179.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -155.01 171.11 20.27 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.115 -0.698 . . . . 50.0 109.115 178.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -117.66 157.81 25.78 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.323 -1.362 . . . . 50.0 107.323 177.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 57.63 37.93 27.57 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 125.127 1.517 . . . . 50.0 109.85 177.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 t -66.45 152.11 45.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.847 -1.524 . . . . 25.0 110.612 -175.529 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 60.97 6.89 1.32 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.362 1.065 . . . . 50.0 112.766 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.59 12.7 74.65 Favored Glycine 0 C--O 1.224 -0.472 0 N-CA-C 111.414 -0.674 . . . . 25.0 111.414 -177.094 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.2 mt -88.08 125.02 34.35 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.745 -0.465 . . . . 50.0 109.745 179.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -64.53 124.79 22.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.699 0.285 . . . . 25.0 110.272 178.085 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.69 -0.63 76.26 Favored Glycine 0 C--O 1.242 0.596 0 N-CA-C 116.68 1.432 . . . . 50.0 116.68 172.568 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -96.67 135.8 38.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.885 1.343 . . . . 50.0 108.984 179.002 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -111.36 144.32 40.75 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.858 -0.793 . . . . 50.0 108.858 -178.14 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.92 120.49 26.15 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 104.524 -2.398 . . . . 50.0 104.524 176.572 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 93.2 m -129.17 163.03 26.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 121.006 -0.278 . . . . 50.0 111.503 179.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.5 t -116.79 123.84 48.12 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.292 -1.373 . . . . 50.0 107.292 173.619 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.7 tp -146.49 129.1 16.08 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 108.571 -0.9 . . . . 50.0 108.571 -176.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 27.7 m170 55.91 32.7 20.25 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.412 0.523 . . . . 25.0 112.412 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.71 3.15 86.93 Favored Glycine 0 C--O 1.222 -0.64 0 C-N-CA 120.816 -0.707 . . . . 25.0 113.987 178.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 mtt-85 -111.1 153.95 24.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.575 -1.269 . . . . 50.0 107.575 178.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -120.41 147.15 45.45 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 106.683 -1.599 . . . . 50.0 106.683 175.038 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.73 -158.46 22.21 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 106.997 -2.441 . . . . 50.0 106.997 -177.433 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.5 pt -115.36 153.01 16.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.75 0.786 . . . . 50.0 111.572 -175.205 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.5 m -144.47 146.37 32.41 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 114.797 -1.092 . . . . 50.0 109.191 179.348 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.07 114.5 4.06 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 CA-C-O 121.609 0.587 . . . . 50.0 112.175 178.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.19 -17.74 68.43 Favored Glycine 0 C--O 1.221 -0.683 0 N-CA-C 114.551 0.58 . . . . 50.0 114.551 -177.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -65.06 -15.21 62.1 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.722 0.638 . . . . 50.0 112.722 -178.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -123.44 26.24 7.95 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.755 -0.59 . . . . 50.0 110.239 176.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.3 mt -125.88 156.95 38.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.594 0.711 . . . . 75.0 110.949 178.207 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -127.92 119.05 24.74 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.255 -0.884 . . . . 50.0 110.531 177.446 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.0 mm -66.8 133.53 31.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 O-C-N 123.797 0.686 . . . . 50.0 109.531 178.4 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.1 mt -114.3 94.04 4.62 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.712 -1.218 . . . . 50.0 107.712 175.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 m -80.26 7.54 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.498 0.666 . . . . 50.0 109.973 176.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.79 28.59 71.84 Favored Glycine 0 C--O 1.22 -0.771 0 CA-C-N 116.109 -0.496 . . . . 25.0 112.022 -179.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 43.7 ttp -18.51 -54.5 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 120.239 3.422 . . . . 25.0 120.239 -173.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -66.4 -27.72 68.06 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 115.597 1.702 . . . . 25.0 115.597 -173.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -138.83 9.22 2.59 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 122.394 1.092 . . . . 25.0 109.903 -176.534 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 69.1 tttt 58.54 25.53 13.22 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 114.45 -1.25 . . . . 50.0 110.192 -171.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -145.33 149.21 40.41 Favored Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 106.59 -1.633 . . . . 50.0 106.59 -178.231 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.52 151.26 75.55 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 118.309 -0.661 . . . . 50.0 113.461 -176.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.1 -27.26 60.8 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.905 1.076 . . . . 25.0 113.905 -176.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 136.82 -175.33 21.13 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.759 -0.734 . . . . 25.0 112.086 -178.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.1 p -141.08 60.27 1.51 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 122.888 0.475 . . . . 25.0 110.116 -177.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.4 -0.21 56.99 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 115.602 1.001 . . . . 25.0 115.602 -177.557 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.32 164.31 11.29 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 109.257 -1.537 . . . . 25.0 109.257 -179.065 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.1 m -162.77 100.77 1.01 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.689 0.745 . . . . 25.0 111.408 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.4 -176.19 31.2 Favored Glycine 0 C--O 1.22 -0.769 0 C-N-CA 121.182 -0.533 . . . . 25.0 113.034 176.766 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.9 t -161.02 -59.8 0.05 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.637 -1.245 . . . . 25.0 107.637 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.05 167.0 24.96 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 107.897 -2.081 . . . . 25.0 107.897 172.161 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.0 m -119.39 148.24 43.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.684 -0.858 . . . . 25.0 108.684 178.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -98.9 160.66 14.11 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.506 -0.553 . . . . 50.0 109.506 -178.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -132.79 10.82 4.32 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.875 0.369 . . . . 25.0 111.567 178.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -107.99 -8.47 15.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.805 -0.634 . . . . 50.0 110.928 -177.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.87 136.92 57.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.119 -0.492 . . . . 25.0 110.304 -179.13 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.1 m -118.43 86.75 28.96 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.768 -0.651 . . . . 25.0 109.851 -179.668 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.3 155.93 59.72 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 117.87 -0.954 . . . . 50.0 113.36 -178.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -69.72 158.16 57.98 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 116.755 -1.697 . . . . 50.0 111.191 176.258 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -59.21 153.71 51.02 Favored 'Trans proline' 0 C--N 1.346 0.397 0 N-CA-C 113.817 0.66 . . . . 50.0 113.817 -178.613 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -67.21 140.56 95.61 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 106.51 -1.663 . . . . 50.0 106.51 176.207 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.12 160.31 50.41 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 117.384 -1.278 . . . . 50.0 110.959 176.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.57 147.09 96.23 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 116.86 -1.627 . . . . 50.0 114.438 -176.079 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -88.97 64.9 7.34 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.051 -1.092 . . . . 50.0 108.051 174.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.57 110.14 10.89 Favored 'General case' 0 C--O 1.212 -0.868 0 CA-C-N 115.078 -0.964 . . . . 25.0 109.558 -177.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -92.49 29.82 1.64 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.075 0.464 . . . . 50.0 111.87 -176.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.5 m -82.78 75.43 9.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.76 -0.654 . . . . 25.0 110.848 -179.37 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 14.8 t -130.95 156.0 45.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.414 -0.588 . . . . 25.0 109.414 -178.266 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.21 -0.975 0 CA-C-O 124.595 2.14 . . . . 25.0 112.179 178.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 CA-C-O 122.578 1.099 . . . . 25.0 115.484 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 t 57.27 36.94 27.96 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.401 1.081 . . . . 25.0 113.862 176.867 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -78.73 76.81 5.22 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.15 -0.685 . . . . 25.0 109.15 175.252 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -78.1 109.63 12.35 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.177 -0.675 . . . . 50.0 109.177 -177.73 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -133.53 167.23 20.84 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.707 -0.678 . . . . 50.0 110.402 -177.344 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.0 mt -67.87 -40.25 83.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.752 -0.658 . . . . 50.0 109.655 177.836 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.5 m120 55.75 24.7 7.54 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.972 -1.013 . . . . 50.0 112.787 -178.48 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.1 m -84.57 158.19 3.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.519 -1.289 . . . . 50.0 107.519 177.754 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.48 167.74 11.13 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.781 -0.822 . . . . 50.0 108.781 -177.175 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.29 158.76 44.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.991 0.424 . . . . 25.0 110.427 175.665 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -123.79 132.25 53.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.065 -0.971 . . . . 50.0 109.601 -179.808 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.23 132.18 40.91 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.376 -0.601 . . . . 25.0 109.376 177.274 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.5 mt -100.43 -17.4 17.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.42 -0.355 . . . . 50.0 110.388 -179.514 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -145.56 169.95 17.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 104.598 -2.371 . . . . 50.0 104.598 177.951 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -89.44 177.36 6.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.578 0.626 . . . . 50.0 110.618 176.175 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -154.44 136.4 14.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.971 -0.559 . . . . 50.0 110.492 175.297 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.7 t -104.35 121.36 55.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 104.643 -2.354 . . . . 25.0 104.643 175.368 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.22 135.69 49.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.413 -0.812 . . . . 25.0 109.253 -179.029 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -113.1 9.09 18.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.64 0.733 . . . . 50.0 109.271 -178.472 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 t -156.17 152.75 24.04 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.347 -0.842 . . . . 50.0 108.82 -175.577 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -70.31 -19.05 33.99 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 117.941 -0.906 . . . . 50.0 114.312 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.95 -17.01 56.19 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.481 -0.563 . . . . 50.0 109.481 178.048 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -93.74 142.33 27.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.515 0.674 . . . . 50.0 111.107 -175.729 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.7 mt -94.69 131.96 39.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.682 0.753 . . . . 50.0 110.102 178.959 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.5 p -90.94 140.17 30.07 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 105.882 -1.896 . . . . 50.0 105.882 174.661 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -156.05 164.91 37.84 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 120.806 0.336 . . . . 50.0 110.251 -179.325 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -108.53 158.58 17.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.037 0.922 . . . . 50.0 109.473 179.171 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -57.64 133.91 55.72 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.842 -1.072 . . . . 50.0 109.645 175.363 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.79 -12.32 70.14 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-O 119.022 -0.877 . . . . 50.0 113.644 178.655 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -60.67 146.44 45.61 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 118.116 0.958 . . . . 50.0 110.721 178.187 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.0 mm -110.86 129.23 66.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 107.935 -1.135 . . . . 50.0 107.935 177.6 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.3 ptp -136.79 165.97 24.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.999 -0.741 . . . . 50.0 108.999 -179.091 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -103.81 123.61 47.39 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.752 -0.833 . . . . 25.0 108.752 178.761 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.7 t -88.2 124.41 41.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.698 -1.223 . . . . 50.0 107.698 177.668 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.7 mt -93.68 -43.56 8.59 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.133 -0.939 . . . . 50.0 108.929 -179.667 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -148.49 155.16 40.81 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 106.784 -1.562 . . . . 50.0 106.784 -172.798 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -118.87 154.35 33.06 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 106.241 -1.763 . . . . 50.0 106.241 173.957 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 58.16 37.7 26.32 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 123.477 1.608 . . . . 50.0 108.324 178.638 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -68.46 159.43 31.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.043 -1.89 . . . . 25.0 111.018 -175.933 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 59.31 12.1 2.47 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.795 1.035 . . . . 50.0 113.795 177.131 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.36 18.35 78.14 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 110.628 -0.989 . . . . 25.0 110.628 -177.213 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.7 mt -104.07 115.94 31.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.069 0.462 . . . . 50.0 109.859 -179.454 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -66.25 131.12 45.4 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 -178.239 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.93 -1.56 78.69 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 115.427 0.931 . . . . 50.0 115.427 176.175 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -99.85 132.55 45.13 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 118.866 1.333 . . . . 50.0 109.014 177.059 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -113.09 139.26 48.86 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.429 -0.582 . . . . 50.0 109.429 -175.961 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.54 122.5 27.11 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 106.08 -1.822 . . . . 50.0 106.08 179.684 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 92.9 m -132.81 163.25 29.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.28 0.562 . . . . 50.0 112.288 178.634 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -115.37 127.98 55.77 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.16 -1.793 . . . . 50.0 106.16 171.248 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.8 tp -154.9 141.22 18.62 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 107.244 -1.391 . . . . 50.0 107.244 -175.343 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 55.91 26.99 10.41 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 112.651 0.612 . . . . 25.0 112.651 178.384 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.06 4.53 88.83 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 114.711 0.644 . . . . 25.0 114.711 178.733 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -126.64 161.4 28.16 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.501 -0.926 . . . . 50.0 108.501 -179.677 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -112.89 156.73 22.44 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.92 -1.141 . . . . 50.0 107.92 179.045 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.89 -161.24 30.66 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 106.509 -2.636 . . . . 50.0 106.509 179.521 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.6 pt -117.36 153.99 19.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.327 0.584 . . . . 50.0 111.878 -175.871 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.81 148.63 46.78 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 114.974 -1.012 . . . . 50.0 109.141 -179.023 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.18 122.42 7.11 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 CA-C-O 121.612 0.588 . . . . 50.0 112.799 -179.799 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.08 -24.44 67.05 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 116.308 -0.406 . . . . 50.0 113.739 -178.431 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -24.1 65.46 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.391 -0.476 . . . . 50.0 112.036 179.049 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -105.65 11.86 31.76 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.938 0.347 . . . . 50.0 111.938 -179.543 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.0 mt -121.78 152.5 39.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.704 1.24 . . . . 75.0 113.946 -177.539 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -120.36 123.53 43.32 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 113.687 -1.597 . . . . 50.0 108.812 176.004 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.0 mm -76.59 138.33 20.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.64 -0.874 . . . . 50.0 108.64 179.103 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.5 mt -117.38 88.06 2.83 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.966 -1.494 . . . . 50.0 106.966 176.7 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.1 m -73.07 150.57 8.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.0 0.428 . . . . 50.0 109.998 -179.77 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.83 177.39 29.92 Favored Glycine 0 C--O 1.227 -0.324 0 N-CA-C 108.21 -1.956 . . . . 25.0 108.21 179.606 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 23.6 ttt -134.41 126.89 30.46 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 105.783 -1.932 . . . . 25.0 105.783 178.467 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 56.25 75.53 0.34 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 116.325 1.972 . . . . 25.0 116.325 -178.823 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -89.45 -90.48 0.14 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.107 0.48 . . . . 25.0 111.481 173.634 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -136.01 156.89 48.07 Favored 'General case' 0 CA--C 1.512 -0.495 0 O-C-N 121.564 -0.71 . . . . 50.0 110.168 -176.234 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -126.99 84.04 64.47 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.232 -0.655 . . . . 50.0 109.232 177.435 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.29 -19.17 17.51 Favored 'Trans proline' 0 C--N 1.346 0.406 0 N-CA-C 114.523 0.932 . . . . 50.0 114.523 -176.308 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 67.69 -41.64 0.43 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.189 1.552 . . . . 25.0 115.189 -177.864 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.54 -174.7 39.37 Favored Glycine 0 C--O 1.229 -0.204 0 N-CA-C 111.401 -0.68 . . . . 25.0 111.401 178.747 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.2 m -131.85 147.39 52.48 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.729 -0.841 . . . . 25.0 108.729 179.754 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.86 43.54 3.09 Favored Glycine 0 C--O 1.225 -0.459 0 N-CA-C 115.171 0.828 . . . . 25.0 115.171 -176.537 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.77 175.77 44.36 Favored Glycine 0 CA--C 1.511 -0.166 0 CA-C-N 117.857 0.828 . . . . 25.0 112.023 179.684 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 69.6 m -148.35 150.41 33.53 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.832 -1.544 . . . . 25.0 106.832 178.294 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.38 -36.29 20.91 Favored Glycine 0 C--O 1.227 -0.314 0 N-CA-C 115.92 1.128 . . . . 25.0 115.92 -174.783 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.9 m 54.11 -151.44 0.35 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.956 0.378 . . . . 25.0 110.548 -176.611 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.07 -39.65 2.26 Favored Glycine 0 C--O 1.221 -0.682 0 N-CA-C 116.501 1.36 . . . . 25.0 116.501 175.78 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.3 t 62.76 17.01 9.49 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.015 0.926 . . . . 25.0 112.121 -177.134 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -81.97 170.89 15.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.767 -0.652 . . . . 50.0 109.474 177.621 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.35 163.82 31.76 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.398 -1.334 . . . . 25.0 107.398 179.317 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -138.74 171.86 13.72 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.74 0.644 . . . . 50.0 112.74 -174.376 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 58.77 -164.73 0.19 Allowed 'General case' 0 N--CA 1.474 0.753 0 O-C-N 124.411 1.07 . . . . 25.0 112.797 178.028 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.5 m -120.64 84.95 37.81 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 105.524 -2.028 . . . . 25.0 105.524 172.452 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.89 156.41 30.83 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 N-CA-C 114.969 1.104 . . . . 50.0 114.969 -171.46 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.77 164.75 34.44 Favored 'Trans proline' 0 C--O 1.243 0.728 0 C-N-CA 119.914 0.41 . . . . 50.0 111.349 175.231 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.7 166.71 25.16 Favored 'Trans proline' 0 C--N 1.344 0.335 0 N-CA-C 114.429 0.896 . . . . 50.0 114.429 -177.297 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -99.29 136.96 20.31 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 105.755 -1.943 . . . . 50.0 105.755 174.561 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.76 162.5 41.85 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 117.83 -0.98 . . . . 50.0 112.647 -175.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -61.1 155.24 51.92 Favored 'Trans proline' 0 C--N 1.348 0.547 0 N-CA-C 113.867 0.68 . . . . 50.0 113.867 -178.986 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -111.91 41.11 2.01 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.189 -0.46 . . . . 50.0 110.983 179.181 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.0 p 52.56 -21.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 120.406 3.484 . . . . 25.0 120.406 -178.109 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -71.78 32.9 0.05 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.632 1.173 . . . . 50.0 113.538 179.119 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.3 t -90.15 -30.06 17.88 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 122.692 0.397 . . . . 25.0 110.861 -179.029 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.17 -47.2 10.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.842 0.829 . . . . 25.0 111.504 -178.619 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 C--O 1.218 -0.573 0 CA-C-O 123.836 1.779 . . . . 25.0 110.234 179.748 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.632 0 CA-C-O 123.66 1.7 . . . . 25.0 114.152 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.0 m 57.91 31.17 20.2 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 113.159 -1.521 . . . . 25.0 111.611 -179.261 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 48.2 ttm -82.31 54.96 2.72 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.797 -0.638 . . . . 25.0 109.379 178.563 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? 60.46 18.64 8.4 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.524 1.129 . . . . 50.0 112.156 -175.851 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -97.37 161.29 13.86 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.231 0.538 . . . . 50.0 110.539 177.751 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.21 -40.59 86.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.896 -1.047 . . . . 50.0 109.139 176.797 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.0 m120 54.99 30.47 14.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.138 0.975 . . . . 50.0 111.906 -178.136 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.7 m -89.22 164.77 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 106.362 -1.718 . . . . 50.0 106.362 175.862 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.37 173.49 6.42 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.68 -1.23 . . . . 50.0 107.68 -178.893 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.9 157.76 43.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.661 0.267 . . . . 25.0 110.42 174.865 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -122.71 130.74 53.29 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.648 -0.705 . . . . 50.0 109.781 175.962 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.54 129.64 38.76 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.01 -0.541 . . . . 25.0 109.549 175.71 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.0 mt -94.42 -21.76 18.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.914 0.388 . . . . 50.0 110.859 -178.006 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -143.95 169.41 17.87 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.993 -2.225 . . . . 50.0 104.993 177.856 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -84.03 167.74 16.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.131 0.491 . . . . 50.0 110.407 177.332 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -148.53 130.9 15.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.934 -0.575 . . . . 50.0 110.341 179.257 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.0 t -102.93 123.46 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 105.078 -2.193 . . . . 25.0 105.078 176.16 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.91 135.74 51.5 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.522 -1.217 . . . . 25.0 110.072 179.558 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -113.98 0.46 14.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.337 0.589 . . . . 50.0 110.284 -179.551 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.0 m -145.6 155.34 52.97 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 107.966 -1.124 . . . . 50.0 107.966 -177.421 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.34 -17.71 39.35 Favored 'Trans proline' 0 C--N 1.347 0.468 0 N-CA-C 113.805 0.656 . . . . 50.0 113.805 -177.415 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.91 -16.99 39.26 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.234 0.54 . . . . 50.0 110.22 179.003 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -87.45 136.03 33.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.98 0.895 . . . . 50.0 111.754 -175.605 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.3 mt -86.19 130.79 34.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.746 -0.661 . . . . 50.0 109.4 178.96 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.8 t -91.46 137.15 32.59 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.458 -2.053 . . . . 50.0 105.458 175.025 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -156.46 164.79 37.83 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.924 -0.399 . . . . 50.0 109.924 -177.86 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.49 162.53 15.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.514 0.673 . . . . 50.0 110.465 -177.496 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -57.32 128.39 36.76 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.163 -0.926 . . . . 50.0 109.131 176.165 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.57 -15.67 61.67 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 118.752 -1.027 . . . . 50.0 114.728 178.197 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -59.08 146.19 39.46 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.993 0.897 . . . . 50.0 111.139 -178.845 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.0 mm -110.57 134.17 53.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.448 -1.251 . . . . 50.0 108.627 178.72 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.9 ptp -141.58 157.69 44.78 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.439 0.296 . . . . 50.0 110.334 -177.961 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.5 m -92.27 130.88 37.86 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.531 -0.914 . . . . 25.0 108.531 177.232 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.95 129.6 45.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.322 -0.992 . . . . 50.0 108.322 177.527 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.2 mt -94.43 -52.47 4.32 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.827 -0.805 . . . . 50.0 108.827 -179.671 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -149.99 163.91 36.86 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.902 -1.147 . . . . 50.0 107.902 177.822 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -106.81 157.44 17.75 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 109.672 -0.492 . . . . 50.0 109.672 176.474 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 56.02 39.58 30.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 123.526 1.632 . . . . 50.0 108.859 170.319 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.9 t -64.42 152.29 41.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 112.474 -2.148 . . . . 25.0 110.677 -176.502 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 59.78 11.65 2.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.207 1.003 . . . . 50.0 113.104 -179.595 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.75 20.29 79.56 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.686 -0.965 . . . . 25.0 110.686 -177.402 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.2 mt -94.69 118.89 32.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.293 -1.003 . . . . 50.0 108.293 177.953 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -64.72 128.31 35.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.923 -0.581 . . . . 25.0 110.396 -177.882 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.74 -0.75 70.01 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 115.932 1.133 . . . . 50.0 115.932 176.274 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -99.61 129.98 45.8 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 119.181 1.491 . . . . 50.0 109.59 177.93 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -113.88 141.32 47.49 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.916 -0.772 . . . . 50.0 108.916 -176.149 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.68 120.31 24.95 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.14 -1.8 . . . . 50.0 106.14 179.473 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.401 ' HG ' HG21 ' A' ' 57' ' ' VAL . 88.8 m -133.77 167.78 19.91 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.005 0.431 . . . . 50.0 111.578 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.4 t -120.33 116.54 25.73 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.463 -1.31 . . . . 50.0 107.463 173.826 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -146.03 144.85 30.33 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.441 -1.318 . . . . 50.0 107.441 -175.902 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.55 27.24 15.39 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.378 0.671 . . . . 25.0 112.334 -179.555 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.95 4.84 90.44 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 114.657 0.623 . . . . 25.0 114.657 177.705 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.1 ptt85 -132.82 161.04 35.18 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.067 0.934 . . . . 50.0 109.775 179.379 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -102.6 154.24 19.32 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.282 -0.636 . . . . 50.0 109.282 177.02 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.24 -158.02 22.46 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 106.54 -2.624 . . . . 50.0 106.54 178.297 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.8 pt -118.39 151.64 20.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.542 0.687 . . . . 50.0 110.877 -175.297 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.401 HG21 ' HG ' ' A' ' 48' ' ' CYS . 2.4 m -140.8 146.96 46.46 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 114.931 -1.032 . . . . 50.0 108.85 -179.113 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.91 122.59 5.89 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 118.31 -0.66 . . . . 50.0 112.284 179.235 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.21 -14.87 64.64 Favored Glycine 0 C--O 1.223 -0.581 0 CA-C-N 116.11 -0.495 . . . . 50.0 112.821 -179.703 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.73 -28.26 63.72 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 122.957 0.503 . . . . 50.0 112.346 179.693 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.57 25.42 9.77 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.556 0.217 . . . . 50.0 111.51 178.869 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.4 tp -128.57 144.13 51.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.636 0.731 . . . . 50.0 111.611 -174.626 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -119.59 119.98 35.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.332 -0.849 . . . . 50.0 110.935 -177.921 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.0 mm -68.96 134.93 29.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.212 -0.662 . . . . 50.0 109.212 177.509 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.5 mt -117.91 105.17 11.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.675 -1.602 . . . . 50.0 106.675 176.215 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.8 m -68.83 159.57 5.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.965 0.412 . . . . 50.0 110.001 -178.833 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -164.61 175.37 40.61 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 108.569 -1.812 . . . . 25.0 108.569 -179.845 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 97.2 mtp -80.73 150.94 29.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.27 0.535 . . . . 25.0 110.555 -179.429 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -82.87 17.07 2.0 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.302 0.641 . . . . 25.0 111.188 176.902 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -65.69 131.26 45.9 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.983 -1.118 . . . . 25.0 107.983 179.051 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -86.23 70.43 10.54 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.429 0.529 . . . . 50.0 112.429 -170.167 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -113.9 89.82 17.43 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.006 -0.543 . . . . 50.0 110.196 177.762 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -79.28 42.76 1.35 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.724 2.283 . . . . 50.0 114.707 -175.574 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.69 -39.11 90.92 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.127 0.489 . . . . 25.0 110.973 -179.294 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.25 173.72 46.52 Favored Glycine 0 CA--C 1.518 0.271 0 CA-C-N 115.95 -0.568 . . . . 25.0 112.472 -179.386 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.4 m -158.58 156.23 29.75 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.264 -1.384 . . . . 25.0 107.264 179.447 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 146.23 -174.56 26.09 Favored Glycine 0 C--O 1.224 -0.531 0 N-CA-C 109.95 -1.26 . . . . 25.0 109.95 178.81 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.18 12.87 84.21 Favored Glycine 0 C--O 1.224 -0.49 0 N-CA-C 114.658 0.623 . . . . 25.0 114.658 177.316 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.0 t -149.31 155.99 41.39 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.626 -0.879 . . . . 25.0 108.626 -179.319 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.08 143.59 8.43 Favored Glycine 0 C--O 1.227 -0.292 0 N-CA-C 110.791 -0.924 . . . . 25.0 110.791 -178.373 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.3 m -163.05 -179.53 6.78 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 105.756 -1.942 . . . . 25.0 105.756 -177.556 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.28 15.19 39.13 Favored Glycine 0 C--O 1.226 -0.374 0 N-CA-C 115.263 0.865 . . . . 25.0 115.263 174.802 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.8 m -73.26 116.73 14.15 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 176.131 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -148.59 146.28 28.18 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.608 -1.627 . . . . 50.0 106.608 -179.551 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 69.4 tttt 64.65 132.36 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.596 1.558 . . . . 25.0 114.867 -179.547 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -73.19 -7.13 50.09 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.492 -0.776 . . . . 50.0 112.424 179.645 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 t0 59.56 -150.7 0.43 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.973 -0.751 . . . . 25.0 108.973 -179.398 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.3 m -118.9 84.97 27.35 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 108.022 -1.103 . . . . 25.0 108.022 175.693 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.39 147.73 20.46 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 N-CA-C 115.532 1.32 . . . . 50.0 115.532 -172.061 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.87 167.65 25.79 Favored 'Trans proline' 0 C--O 1.241 0.668 0 C-N-CA 119.807 0.338 . . . . 50.0 112.185 176.036 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.03 172.2 15.18 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 118.36 -0.627 . . . . 50.0 112.156 176.21 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -107.83 147.4 35.36 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 107.423 -1.325 . . . . 50.0 107.423 174.958 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.47 162.01 42.61 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 118.339 -0.64 . . . . 50.0 111.791 178.023 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -63.12 153.79 71.62 Favored 'Trans proline' 0 C--N 1.35 0.625 0 N-CA-C 114.323 0.855 . . . . 50.0 114.323 -178.861 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -102.7 4.81 38.52 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 120.67 0.271 . . . . 50.0 111.604 177.161 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 44.5 p -135.32 153.77 51.75 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.166 -0.679 . . . . 25.0 109.166 -178.857 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -122.48 79.81 1.66 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 109.324 -0.621 . . . . 50.0 109.324 -177.518 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.9 t -57.35 -37.76 73.09 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.915 1.08 . . . . 25.0 113.915 -176.325 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.9 t 56.51 28.86 14.45 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.942 0.877 . . . . 25.0 112.853 -179.257 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.1 tp . . . . . 0 C--O 1.214 -0.773 0 CA-C-O 124.604 2.145 . . . . 25.0 110.856 178.66 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.647 0 CA-C-O 122.157 0.865 . . . . 25.0 115.151 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.49 31.01 20.52 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.165 0.986 . . . . 25.0 112.878 178.834 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -118.06 97.89 6.04 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.861 -0.792 . . . . 25.0 108.861 178.433 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -145.72 140.08 26.97 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 105.842 -1.91 . . . . 50.0 105.842 -179.819 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 61.63 167.81 0.1 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.898 1.279 . . . . 50.0 112.632 -173.621 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.2 mt -70.58 -33.25 70.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.483 -0.78 . . . . 50.0 111.724 -176.292 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.8 m120 60.33 17.85 7.47 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.322 1.049 . . . . 50.0 113.257 -178.752 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.2 m -91.26 162.78 2.38 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 N-CA-C 108.845 -0.798 . . . . 50.0 108.845 -179.649 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.79 172.66 6.81 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.713 -1.217 . . . . 50.0 107.713 -178.633 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.52 161.19 42.62 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.197 -0.668 . . . . 25.0 109.197 173.264 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -125.87 131.72 52.31 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 123.808 0.693 . . . . 50.0 110.722 179.22 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.73 122.01 18.33 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 124.015 0.822 . . . . 25.0 110.215 177.513 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.2 mt -89.47 -24.07 21.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.234 0.54 . . . . 50.0 109.855 -178.115 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -138.58 174.27 10.72 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 103.101 -2.925 . . . . 50.0 103.101 175.876 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -85.38 -179.87 7.03 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.635 -0.876 . . . . 50.0 108.635 175.417 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -155.33 147.54 23.72 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 122.865 0.466 . . . . 50.0 109.804 174.127 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.5 t -116.27 123.57 71.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.677 -1.601 . . . . 25.0 106.677 175.992 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.78 145.22 25.73 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.497 -0.774 . . . . 25.0 109.501 177.773 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.15 -7.67 6.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.924 -0.58 . . . . 50.0 111.02 178.322 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 m -119.76 154.65 55.07 Favored Pre-proline 0 C--O 1.22 -0.448 0 N-CA-C 108.406 -0.961 . . . . 50.0 108.406 178.931 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.11 -24.95 38.03 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 117.563 -1.158 . . . . 50.0 114.323 -178.444 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.06 -16.84 57.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.31 0.576 . . . . 50.0 110.459 179.223 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -91.72 135.73 33.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.358 0.599 . . . . 50.0 110.602 -173.861 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.9 mt -95.37 128.33 42.13 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.958 0.885 . . . . 50.0 111.109 -179.112 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 t -90.44 143.61 26.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.141 -1.8 . . . . 50.0 106.141 176.841 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -158.03 168.24 27.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.104 0.478 . . . . 50.0 110.871 -179.446 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -114.18 159.5 20.03 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.168 -0.679 . . . . 50.0 109.168 178.041 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -57.83 132.05 52.17 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.339 -1.356 . . . . 50.0 107.339 176.348 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.71 -20.58 47.5 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-O 119.521 -0.599 . . . . 50.0 113.606 179.034 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -59.46 145.81 42.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.73 0.776 . . . . 50.0 110.84 178.885 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.3 mm -115.11 128.79 72.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.517 -1.219 . . . . 50.0 108.524 179.868 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -131.2 152.78 50.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.458 -0.201 . . . . 50.0 110.458 179.209 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.7 m -87.43 126.97 35.21 Favored 'General case' 0 C--O 1.218 -0.603 0 N-CA-C 107.823 -1.177 . . . . 25.0 107.823 177.537 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.74 128.58 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 CA-C-O 121.968 0.89 . . . . 50.0 108.807 179.362 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.7 mt -97.36 -46.09 6.22 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.005 -0.998 . . . . 50.0 108.779 179.631 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.07 158.58 44.14 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.956 -0.757 . . . . 50.0 108.956 -175.844 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -118.29 148.51 42.38 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 106.743 -1.576 . . . . 50.0 106.743 174.924 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 57.17 43.32 24.15 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 123.319 1.533 . . . . 50.0 109.832 -177.912 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -72.04 160.91 31.68 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 113.491 -1.686 . . . . 25.0 112.204 -176.134 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 59.68 9.83 1.76 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.177 0.991 . . . . 50.0 113.234 178.264 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.88 14.81 76.73 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.657 -0.977 . . . . 25.0 110.657 -176.185 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.0 mt -99.58 123.14 43.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.538 0.685 . . . . 50.0 110.565 -179.112 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -70.11 125.38 26.61 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.96 -1.018 . . . . 25.0 110.486 179.18 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.94 -1.41 88.6 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 115.43 0.932 . . . . 50.0 115.43 176.208 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -100.98 131.37 46.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 118.159 0.98 . . . . 50.0 109.796 178.45 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -110.73 142.45 42.65 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.179 -0.675 . . . . 50.0 109.179 -177.176 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.52 121.11 27.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 105.176 -2.157 . . . . 50.0 105.176 178.157 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.1 m -134.37 165.96 23.93 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.963 0.411 . . . . 50.0 111.171 179.087 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 t -121.48 123.08 41.17 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.011 -1.477 . . . . 50.0 107.011 173.165 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.9 tp -135.25 122.0 20.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.873 -0.788 . . . . 50.0 108.873 -177.728 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.2 m170 54.01 33.91 18.58 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.522 0.729 . . . . 25.0 111.548 179.799 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.74 -6.53 83.55 Favored Glycine 0 C--O 1.227 -0.314 0 N-CA-C 115.252 0.861 . . . . 25.0 115.252 177.44 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -101.98 137.22 40.55 Favored 'General case' 0 C--O 1.219 -0.553 0 CA-C-N 118.449 1.124 . . . . 50.0 108.403 176.147 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -99.9 145.02 28.27 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.406 -1.702 . . . . 50.0 106.406 173.93 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.73 -161.48 27.37 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 108.368 -1.893 . . . . 50.0 108.368 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.1 pt -115.41 149.89 17.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.603 0.716 . . . . 50.0 110.759 -175.847 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.8 m -139.32 146.63 49.51 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 114.871 -1.059 . . . . 50.0 108.824 -179.092 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.82 119.79 6.06 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 CA-C-O 121.487 0.536 . . . . 50.0 111.626 177.933 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.02 -15.3 74.14 Favored Glycine 0 C--O 1.226 -0.372 0 CA-C-O 121.649 0.583 . . . . 50.0 113.048 -178.466 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -67.46 -6.89 21.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.299 0.64 . . . . 50.0 112.672 -178.849 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -135.48 28.32 3.35 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.711 -0.478 . . . . 50.0 109.711 176.108 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.3 mt -125.32 156.25 38.96 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.352 0.871 . . . . 50.0 113.352 177.839 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -128.09 120.18 26.88 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.969 -1.014 . . . . 50.0 110.075 174.435 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.7 mm -66.95 137.25 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.581 -0.896 . . . . 50.0 108.581 176.62 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.4 mt -117.57 107.51 14.34 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.817 -1.179 . . . . 50.0 107.817 176.491 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.0 m -94.17 157.16 3.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.636 -0.505 . . . . 50.0 109.636 178.94 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.81 144.41 6.02 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.089 -1.605 . . . . 25.0 109.089 178.282 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -142.44 -7.47 0.89 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.122 1.156 . . . . 25.0 114.122 -177.906 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -69.33 -50.16 49.05 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 114.019 1.118 . . . . 25.0 114.019 -172.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -81.86 -24.65 35.64 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.238 -0.653 . . . . 25.0 109.238 177.136 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.6 tttm 61.25 -160.21 0.31 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.019 -0.991 . . . . 50.0 108.821 -178.894 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt 66.85 160.65 0.14 Allowed Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 124.387 1.075 . . . . 50.0 111.51 -179.923 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -79.15 4.69 6.34 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 117.39 -1.273 . . . . 50.0 114.019 178.182 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.27 162.1 28.74 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.889 -0.782 . . . . 25.0 108.889 179.737 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.13 -94.71 0.1 OUTLIER Glycine 0 C--O 1.223 -0.573 0 N-CA-C 110.816 -0.913 . . . . 25.0 110.816 178.136 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.6 m 52.59 39.73 28.68 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 113.405 0.891 . . . . 25.0 113.405 177.769 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.89 5.14 19.36 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 114.82 0.688 . . . . 25.0 114.82 -177.268 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.83 161.53 24.1 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 109.444 -1.462 . . . . 25.0 109.444 177.692 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 28.3 t -145.23 -59.48 0.35 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.349 -0.982 . . . . 25.0 108.349 178.34 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.94 25.59 59.74 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.509 -0.853 . . . . 25.0 112.067 177.748 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.3 t -60.14 146.31 43.72 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.853 -0.795 . . . . 25.0 108.853 178.765 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.96 17.09 36.26 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.436 -0.411 . . . . 25.0 113.707 -177.965 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 98.5 p -138.25 147.0 43.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.514 0.657 . . . . 25.0 110.414 177.774 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -140.97 152.69 45.16 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.26 -1.756 . . . . 50.0 106.26 177.005 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.14 -22.68 7.66 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 113.51 0.93 . . . . 25.0 113.51 -178.518 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 47.19 43.27 14.42 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 122.151 0.977 . . . . 50.0 110.943 -177.68 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -89.99 166.48 13.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.847 -1.07 . . . . 25.0 109.925 -176.778 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.8 m -88.62 109.2 27.69 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 110.39 -0.226 . . . . 25.0 110.39 178.227 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -80.61 157.42 21.77 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 116.854 -1.631 . . . . 50.0 113.287 -178.427 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -71.61 155.37 59.2 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 117.96 -0.893 . . . . 50.0 111.193 176.044 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -59.3 156.26 36.32 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 N-CA-C 115.991 1.496 . . . . 50.0 115.991 -175.808 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -70.21 142.37 89.82 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 107.715 -1.217 . . . . 50.0 107.715 175.378 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.94 158.26 53.04 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 116.584 -1.811 . . . . 50.0 110.775 175.208 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -62.93 143.71 91.8 Favored 'Trans proline' 0 C--N 1.35 0.645 0 N-CA-C 115.059 1.138 . . . . 50.0 115.059 -175.458 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -100.57 -16.68 17.39 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.339 0.59 . . . . 50.0 112.014 177.709 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.9 p -129.45 12.76 5.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.263 0.554 . . . . 25.0 110.187 -177.511 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 54.53 20.66 2.94 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.565 0.95 . . . . 50.0 113.565 -178.238 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.0 m -80.15 47.67 0.92 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.212 0.819 . . . . 25.0 113.212 -178.043 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 64.7 m 56.47 -169.2 0.09 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.963 1.097 . . . . 25.0 113.963 -179.429 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.4 tp . . . . . 0 C--O 1.217 -0.614 0 CA-C-O 124.794 2.235 . . . . 25.0 109.155 179.17 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.879 0 CA-C-O 123.727 1.737 . . . . 25.0 113.014 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t 61.13 32.29 19.63 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 111.976 -2.112 . . . . 25.0 113.185 -178.977 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 62.1 mtt -100.75 -12.29 19.22 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.086 1.143 . . . . 25.0 114.086 -176.092 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -142.92 37.04 1.42 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.092 -0.38 . . . . 50.0 111.228 -175.127 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -128.36 158.69 37.55 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 121.956 -0.465 . . . . 50.0 111.314 -179.088 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.8 mt -71.96 -35.64 69.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.73 -1.123 . . . . 50.0 110.156 -179.988 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.5 m120 53.64 36.93 24.85 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.744 0.817 . . . . 50.0 111.84 -179.1 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.7 m -99.06 163.03 2.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 107.427 -1.323 . . . . 50.0 107.427 176.771 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.08 170.9 8.16 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.193 -1.04 . . . . 50.0 108.193 -178.01 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.48 158.64 44.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.891 0.376 . . . . 25.0 110.939 177.032 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -123.91 129.25 50.67 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.457 -0.792 . . . . 50.0 110.12 177.63 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.46 124.68 26.29 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.005 -0.543 . . . . 25.0 109.911 177.029 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.93 -24.73 19.19 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.278 0.561 . . . . 50.0 109.981 -177.762 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -135.75 166.34 23.5 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 104.673 -2.343 . . . . 50.0 104.673 175.913 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -86.67 -173.77 4.65 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.499 0.72 . . . . 50.0 110.937 177.741 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -161.9 154.03 19.39 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 123.613 0.571 . . . . 50.0 112.385 176.662 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.9 t -122.14 126.78 74.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 104.541 -2.392 . . . . 25.0 104.541 173.022 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.37 137.0 44.44 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 -177.247 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -113.32 6.69 17.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.181 0.991 . . . . 50.0 109.237 179.206 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.0 t -149.68 149.3 27.98 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 106.955 -1.498 . . . . 50.0 106.955 -177.178 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.27 -19.31 38.64 Favored 'Trans proline' 0 N--CA 1.475 0.433 0 C-N-CA 117.622 -1.119 . . . . 50.0 112.568 178.184 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -79.21 -15.76 57.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.888 0.852 . . . . 50.0 110.388 178.985 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -93.12 141.22 28.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.801 0.81 . . . . 50.0 111.491 -176.509 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.6 mt -89.1 129.21 35.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.881 -0.599 . . . . 50.0 111.215 -179.936 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 p -94.5 137.87 33.1 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.481 -1.674 . . . . 50.0 106.481 173.813 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -160.86 175.98 11.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.998 -0.742 . . . . 50.0 108.998 -174.634 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.4 167.68 11.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.606 0.717 . . . . 50.0 111.526 177.444 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.48 134.4 56.83 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 107.81 -1.181 . . . . 50.0 107.81 178.39 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.2 -11.32 70.7 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-O 118.98 -0.9 . . . . 50.0 113.782 178.697 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.28 138.57 57.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 118.336 1.068 . . . . 50.0 109.937 176.665 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.3 mm -105.04 129.38 57.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 107.111 -1.44 . . . . 50.0 107.111 177.865 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.0 ptp -137.48 150.1 47.31 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.394 0.277 . . . . 50.0 110.932 -175.706 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.2 m -87.63 122.4 31.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.576 -0.898 . . . . 25.0 108.576 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 63.4 t -89.79 127.59 42.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.404 -0.961 . . . . 50.0 108.404 178.322 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.6 mt -91.46 -52.25 4.88 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.15 -0.932 . . . . 50.0 108.551 179.453 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -151.61 168.69 24.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.487 -0.56 . . . . 50.0 109.487 177.502 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -117.33 154.41 31.31 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.68 -1.6 . . . . 50.0 106.68 179.423 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 56.37 42.73 27.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 123.429 1.585 . . . . 50.0 108.662 -177.559 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -67.98 154.18 42.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.573 -1.649 . . . . 25.0 109.319 -176.701 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 59.09 9.39 1.27 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.544 1.138 . . . . 50.0 113.148 177.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.82 13.89 74.1 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 110.804 -0.918 . . . . 25.0 110.804 -179.366 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.3 mt -90.32 134.44 34.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.273 -0.64 . . . . 50.0 109.273 179.721 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -72.44 126.4 29.76 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.268 0.556 . . . . 25.0 110.47 178.534 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.66 2.41 69.53 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 117.576 1.791 . . . . 50.0 117.576 174.914 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -100.63 134.13 44.06 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.128 1.464 . . . . 50.0 110.906 177.916 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -113.1 142.88 45.24 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.798 -0.815 . . . . 50.0 108.798 -174.872 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.75 123.84 32.34 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 106.599 -1.63 . . . . 50.0 106.599 179.106 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 97.8 m -132.71 160.83 35.64 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.245 0.545 . . . . 50.0 112.204 179.528 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.2 t -113.14 125.93 54.89 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 107.129 -1.434 . . . . 50.0 107.129 172.281 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 tp -147.19 135.94 22.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.437 -1.32 . . . . 50.0 107.437 -175.715 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 55.34 27.15 9.52 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.589 0.755 . . . . 25.0 112.073 -175.592 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.52 0.73 84.93 Favored Glycine 0 C--O 1.217 -0.964 0 N-CA-C 115.201 0.84 . . . . 25.0 115.201 -179.515 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -115.22 161.99 17.69 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.435 -1.321 . . . . 50.0 107.435 178.628 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -114.21 153.41 29.67 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.332 -0.618 . . . . 50.0 109.332 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.23 -163.86 30.88 Favored Glycine 0 CA--C 1.503 -0.683 0 N-CA-C 106.137 -2.785 . . . . 50.0 106.137 178.29 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 pt -115.9 155.95 17.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 120.808 0.337 . . . . 50.0 111.416 -175.299 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.18 147.64 38.26 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.403 -0.817 . . . . 50.0 109.479 179.525 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -74.87 126.02 9.77 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 CA-C-N 118.165 0.38 . . . . 50.0 112.373 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.8 -21.41 79.74 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 115.625 1.01 . . . . 50.0 115.625 -174.72 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -56.14 -28.2 57.05 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.529 0.937 . . . . 50.0 113.529 -176.59 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.12 20.02 12.77 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.936 -0.478 . . . . 50.0 111.721 -178.292 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.7 tp -119.52 146.51 45.39 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.612 -0.885 . . . . 50.0 108.612 -178.672 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -117.56 124.12 47.9 Favored 'General case' 0 C--O 1.208 -1.082 0 CA-C-N 116.085 -0.507 . . . . 50.0 110.757 -178.16 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.1 mm -76.66 136.63 24.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 109.298 -0.63 . . . . 50.0 109.298 177.471 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.0 mt -119.33 101.5 8.02 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.149 -1.797 . . . . 50.0 106.149 176.714 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.7 m -78.57 155.92 4.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.996 -0.742 . . . . 50.0 108.996 -177.017 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.47 -164.1 35.45 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 108.4 -1.88 . . . . 25.0 108.4 -177.728 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 25.1 ptm -121.76 175.57 6.19 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.981 -1.489 . . . . 25.0 106.981 177.319 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -68.11 160.87 28.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.545 0.688 . . . . 25.0 112.211 -179.091 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -137.56 159.74 41.12 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 104.281 -2.489 . . . . 25.0 104.281 174.269 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -114.74 -4.12 12.75 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 122.269 0.228 . . . . 50.0 111.169 178.615 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -90.13 149.31 41.23 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 110.478 -0.193 . . . . 50.0 110.478 179.772 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -72.62 157.72 51.96 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 117.451 -1.233 . . . . 50.0 111.669 177.746 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.18 -32.85 73.39 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.907 0.384 . . . . 25.0 111.681 179.872 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 136.21 -173.89 21.73 Favored Glycine 0 C--O 1.227 -0.309 0 N-CA-C 108.358 -1.897 . . . . 25.0 108.358 -177.911 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.7 m -76.52 -28.64 56.46 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.435 0.531 . . . . 25.0 112.435 -178.754 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.61 -148.94 44.34 Favored Glycine 0 C--O 1.231 -0.081 0 N-CA-C 111.871 -0.491 . . . . 25.0 111.871 -178.819 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -178.16 176.06 47.81 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 105.993 -2.843 . . . . 25.0 105.993 -178.167 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.6 t -154.5 161.73 41.51 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 108.199 -1.037 . . . . 25.0 108.199 -178.739 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.96 170.5 42.88 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 108.82 -1.712 . . . . 25.0 108.82 179.148 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.7 m -150.8 159.06 44.79 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 108.328 -0.99 . . . . 25.0 108.328 179.306 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.08 170.05 42.26 Favored Glycine 0 C--N 1.323 -0.171 0 N-CA-C 108.002 -2.039 . . . . 25.0 108.002 175.849 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.42 87.25 7.37 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.311 -0.626 . . . . 25.0 109.311 179.009 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.05 142.7 58.28 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.166 -0.47 . . . . 50.0 110.101 -179.809 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -138.54 17.84 2.72 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.734 0.778 . . . . 25.0 112.078 -178.919 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -73.21 170.46 14.94 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.489 -0.93 . . . . 50.0 108.489 173.412 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -65.13 157.3 29.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.972 -0.558 . . . . 25.0 111.776 -179.698 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -58.43 148.63 63.94 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.436 -0.802 . . . . 25.0 109.935 -179.598 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.03 158.83 52.29 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 117.069 -1.488 . . . . 50.0 112.043 177.76 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.04 152.17 80.91 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 117.099 -1.468 . . . . 50.0 112.998 -178.242 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -58.42 148.81 78.3 Favored 'Trans proline' 0 C--N 1.35 0.65 0 N-CA-C 115.581 1.339 . . . . 50.0 115.581 -174.652 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -75.45 143.29 75.79 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 106.845 -1.539 . . . . 50.0 106.845 177.921 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -68.84 156.64 64.77 Favored 'Trans proline' 0 C--O 1.242 0.675 0 C-N-CA 116.268 -2.021 . . . . 50.0 111.17 176.266 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -59.55 147.36 91.98 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 117.776 -1.016 . . . . 50.0 110.494 175.647 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.0 mtt-85 -81.47 -66.18 0.92 Allowed 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 109.057 -0.72 . . . . 50.0 109.057 -177.96 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.65 -46.93 0.09 Allowed 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 121.341 0.591 . . . . 25.0 111.996 -179.68 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.49 150.62 50.76 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 121.815 -0.553 . . . . 50.0 109.949 -179.331 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.0 p -121.92 -80.88 0.63 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.372 0.42 . . . . 25.0 111.016 176.084 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.7 t 69.6 -158.43 0.16 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.118 1.367 . . . . 25.0 108.36 -175.932 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 77.2 mt . . . . . 0 C--O 1.207 -1.152 0 CA-C-O 125.514 2.578 . . . . 25.0 111.795 -177.311 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.452 0 CA-C-O 121.611 0.562 . . . . 25.0 113.662 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.77 -8.71 22.78 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.898 1.444 . . . . 25.0 114.898 -177.336 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.8 ptp -130.44 18.99 5.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.468 0.651 . . . . 25.0 109.606 178.433 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -83.66 116.14 22.5 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 108.552 -0.907 . . . . 50.0 108.552 -179.215 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 65.97 164.41 0.18 Allowed 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 115.74 1.755 . . . . 50.0 115.74 177.215 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.8 mt -79.23 -31.31 43.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.503 -1.226 . . . . 50.0 110.267 -177.941 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.4 m120 54.34 25.09 5.62 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.286 1.034 . . . . 50.0 113.028 -177.011 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.6 m -88.51 162.46 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.257 -1.386 . . . . 50.0 107.257 178.102 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.87 173.94 6.17 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.416 -1.698 . . . . 50.0 106.416 -179.393 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.73 158.18 43.03 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.483 -0.191 . . . . 25.0 110.483 174.599 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -121.5 129.4 52.9 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.377 0.671 . . . . 50.0 110.592 176.892 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.32 132.39 45.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.109 -0.496 . . . . 25.0 110.12 176.807 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -98.31 -22.44 16.11 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.318 0.488 . . . . 50.0 112.318 -176.609 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -142.0 162.82 34.51 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.151 -0.685 . . . . 50.0 109.151 -179.801 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -69.37 158.81 34.35 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.698 -0.482 . . . . 50.0 109.698 177.704 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.35 161.53 38.75 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.651 -1.24 . . . . 50.0 107.651 177.168 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 p -136.25 139.26 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 102.071 -3.307 . . . . 25.0 102.071 171.243 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.34 124.4 34.39 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.577 -0.527 . . . . 25.0 109.577 -175.771 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -110.23 15.7 22.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.968 0.89 . . . . 50.0 110.312 -176.746 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.9 t -152.69 148.66 20.91 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 107.037 -1.468 . . . . 50.0 107.037 -175.87 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.59 -19.48 36.88 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 117.719 -1.054 . . . . 50.0 113.081 178.925 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -82.61 -19.29 38.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.363 0.602 . . . . 50.0 110.228 178.868 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -83.64 132.73 34.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 122.021 0.915 . . . . 50.0 111.029 -176.175 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.8 mt -82.75 138.31 34.09 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.711 -0.848 . . . . 50.0 108.711 178.254 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -90.82 131.38 36.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.542 -1.281 . . . . 50.0 107.542 176.404 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -155.27 165.17 37.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.387 0.613 . . . . 50.0 111.313 -178.225 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -125.68 164.28 20.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.855 -0.611 . . . . 50.0 111.174 -177.797 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -56.27 130.81 46.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.209 0.528 . . . . 50.0 110.191 179.333 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.55 -18.65 56.65 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.813 -0.993 . . . . 50.0 113.967 177.484 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -58.83 146.16 38.25 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 117.85 0.825 . . . . 50.0 110.995 179.801 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.4 mm -113.34 133.19 60.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.567 -1.197 . . . . 50.0 108.35 178.682 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.6 ptp -141.92 155.7 45.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.614 -0.513 . . . . 50.0 109.614 -177.96 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.6 m -89.2 128.43 35.81 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 108.69 -0.855 . . . . 25.0 108.69 178.004 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.0 t -93.15 126.54 45.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.929 -1.138 . . . . 50.0 107.929 177.183 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.9 mt -90.94 -51.88 5.13 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.503 -0.925 . . . . 50.0 108.503 179.57 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -149.55 161.04 42.92 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.71 -0.848 . . . . 50.0 108.71 177.985 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -102.86 156.58 17.56 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.729 -0.841 . . . . 50.0 108.729 176.221 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 55.28 41.22 31.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.41 1.576 . . . . 50.0 108.507 172.061 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 t -63.66 147.69 50.92 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 112.625 -2.079 . . . . 25.0 110.859 -175.522 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 59.96 9.97 1.98 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.664 0.786 . . . . 50.0 111.993 -176.575 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.74 9.46 86.33 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 111.122 -0.791 . . . . 25.0 111.122 -177.226 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.6 114.22 21.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.296 -1.002 . . . . 50.0 108.296 -179.759 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.21 129.2 39.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.196 0.522 . . . . 25.0 109.891 -176.567 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.08 -1.4 75.12 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-O 118.613 -1.104 . . . . 50.0 115.433 176.694 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -100.92 130.11 46.87 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 119.409 1.604 . . . . 50.0 109.044 177.095 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -113.4 139.94 48.48 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.299 -1.0 . . . . 50.0 108.299 -176.438 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.02 122.71 28.15 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 105.467 -2.049 . . . . 50.0 105.467 179.255 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.6 m -130.5 163.51 26.85 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.031 0.443 . . . . 50.0 110.98 178.565 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.6 t -116.21 122.03 43.8 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.976 -1.861 . . . . 50.0 105.976 172.524 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.7 tp -147.14 139.77 24.88 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.521 -1.289 . . . . 50.0 107.521 -176.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 57.87 27.2 14.26 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.75 0.648 . . . . 25.0 112.75 177.133 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.8 2.31 90.64 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 114.899 0.72 . . . . 25.0 114.899 178.77 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.4 ptt85 -126.93 160.51 30.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.581 1.19 . . . . 50.0 109.35 177.965 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -109.53 152.68 25.14 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.579 -0.897 . . . . 50.0 108.579 177.627 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.08 -160.59 25.21 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 105.974 -2.851 . . . . 50.0 105.974 179.265 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.3 pt -118.36 154.11 20.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.545 0.688 . . . . 50.0 111.253 -175.817 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.17 146.96 45.29 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.06 -0.973 . . . . 50.0 109.117 179.444 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.59 120.13 6.04 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 CA-C-O 121.669 0.612 . . . . 50.0 111.326 178.246 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.22 -12.05 75.9 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 116.062 -0.517 . . . . 50.0 113.865 -176.477 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -69.36 -9.21 52.39 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.575 0.583 . . . . 50.0 112.575 -178.64 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -133.11 27.67 4.18 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.829 -0.804 . . . . 50.0 108.829 178.554 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.4 tp -133.16 147.51 52.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.449 -0.796 . . . . 75.0 109.393 -177.855 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -123.12 120.05 32.08 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.556 0.342 . . . . 50.0 110.977 -177.801 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.4 mm -66.91 135.45 28.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.427 -0.583 . . . . 50.0 109.427 177.751 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.0 mt -121.27 95.92 4.88 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.741 -1.207 . . . . 50.0 107.741 175.945 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.4 p -70.08 149.49 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.481 -1.674 . . . . 50.0 106.481 176.699 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.66 -88.37 0.37 Allowed Glycine 0 C--O 1.221 -0.703 0 C-N-CA 120.818 -0.706 . . . . 25.0 113.297 -178.689 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 21.9 ttt 53.72 70.05 0.64 Allowed 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.561 0.696 . . . . 25.0 110.948 -176.956 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 73.73 150.55 0.11 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.712 1.605 . . . . 25.0 111.772 -175.262 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -102.85 -19.06 14.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.147 -0.933 . . . . 25.0 113.047 -175.849 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -73.94 94.94 2.4 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.478 0.918 . . . . 50.0 113.478 -173.143 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -135.43 147.06 60.34 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 107.869 -1.16 . . . . 50.0 107.869 177.645 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -70.75 154.59 63.74 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 116.258 -2.028 . . . . 50.0 111.439 176.65 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.83 165.53 11.0 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.399 -0.593 . . . . 25.0 109.399 179.418 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.76 -167.34 35.19 Favored Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 110.687 -0.965 . . . . 25.0 110.687 -179.658 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.9 t 77.61 171.25 0.21 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.535 1.534 . . . . 25.0 111.602 -179.54 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.21 -164.2 34.6 Favored Glycine 0 C--O 1.225 -0.468 0 N-CA-C 108.795 -1.722 . . . . 25.0 108.795 -175.694 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.07 -41.43 0.29 Allowed Glycine 0 C--O 1.22 -0.767 0 CA-C-N 117.675 0.737 . . . . 25.0 112.666 177.491 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.9 t 54.58 28.34 9.73 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.439 1.274 . . . . 25.0 114.439 177.412 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.08 -168.81 40.35 Favored Glycine 0 CA--C 1.511 -0.189 0 N-CA-C 109.009 -1.636 . . . . 25.0 109.009 -179.121 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.2 m -144.1 140.05 29.23 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.452 -0.944 . . . . 25.0 108.452 177.829 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.28 18.83 32.8 Favored Glycine 0 C--O 1.222 -0.621 0 O-C-N 123.421 0.451 . . . . 25.0 114.108 -177.229 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.2 m 54.73 35.67 24.49 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.031 0.752 . . . . 25.0 113.031 -178.611 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -74.04 85.65 1.81 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.65 0.738 . . . . 50.0 111.738 -179.432 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.01 58.57 1.76 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.344 -0.984 . . . . 25.0 108.344 179.491 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -69.52 141.06 53.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.1 -0.954 . . . . 50.0 109.811 -179.972 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 50.62 -150.75 0.23 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.71 1.004 . . . . 25.0 113.71 177.507 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 77.4 p -132.32 150.05 74.87 Favored Pre-proline 0 C--N 1.327 -0.38 0 O-C-N 121.85 -0.531 . . . . 25.0 110.214 -176.115 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.3 155.43 60.5 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 117.403 -1.265 . . . . 50.0 112.933 179.374 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -63.99 151.38 85.51 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 O-C-N 121.936 0.44 . . . . 50.0 112.748 179.391 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -68.18 151.0 77.3 Favored 'Trans proline' 0 C--N 1.349 0.6 0 N-CA-C 116.212 1.581 . . . . 50.0 116.212 -171.427 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -67.77 144.99 97.84 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 115.606 -0.725 . . . . 50.0 109.35 179.854 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -70.93 162.35 42.96 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 O-C-N 122.084 0.518 . . . . 50.0 111.776 175.35 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -61.12 149.78 87.54 Favored 'Trans proline' 0 C--N 1.349 0.604 0 N-CA-C 114.149 0.788 . . . . 50.0 114.149 -178.157 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -95.79 17.76 14.48 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.799 0.333 . . . . 50.0 110.653 177.658 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.1 p -138.21 164.22 29.76 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.345 -0.983 . . . . 25.0 108.345 -179.16 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -113.01 12.78 19.34 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.158 -0.682 . . . . 50.0 109.158 177.351 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.7 m -118.53 55.48 0.91 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.654 -0.703 . . . . 25.0 112.222 -172.876 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 41.9 t -65.7 -44.94 84.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.582 0.706 . . . . 25.0 110.59 179.978 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.214 -0.814 0 CA-C-O 124.558 2.123 . . . . 25.0 110.842 179.208 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.695 0 CA-C-O 124.722 2.29 . . . . 25.0 111.648 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.0 p -160.52 141.07 11.63 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 112.276 -1.962 . . . . 25.0 107.623 179.215 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.6 ttm -144.93 -41.54 0.24 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.517 0.675 . . . . 25.0 112.338 178.484 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -130.37 79.1 1.88 Allowed 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 116.268 -0.424 . . . . 50.0 111.631 -175.939 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -139.29 168.19 20.38 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.539 -0.301 . . . . 50.0 110.299 -177.689 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.8 mt -66.2 -38.1 87.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.165 0.507 . . . . 50.0 110.831 178.432 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 55.29 26.51 8.66 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.97 -1.014 . . . . 50.0 113.173 -178.576 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.5 m -85.25 171.74 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.848 0 N-CA-C 105.982 -1.859 . . . . 50.0 105.982 175.131 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -118.93 169.57 9.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 118.894 0.77 . . . . 50.0 109.624 -178.453 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.96 153.47 40.11 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.745 -0.661 . . . . 25.0 109.801 178.481 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -116.35 130.42 56.76 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.681 -1.145 . . . . 50.0 110.058 178.796 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.55 128.3 36.12 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.853 -0.425 . . . . 25.0 109.853 176.99 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.83 -22.78 17.26 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 121.003 -0.279 . . . . 50.0 111.469 -178.772 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -141.13 166.18 25.48 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.24 -1.763 . . . . 50.0 106.24 178.485 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -74.18 160.17 31.54 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.376 0.423 . . . . 50.0 110.229 178.95 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -144.94 137.08 25.93 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.559 -0.713 . . . . 50.0 112.263 173.732 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.83 123.89 66.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 106.304 -1.739 . . . . 25.0 106.304 176.217 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.68 125.64 27.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.08 -0.964 . . . . 25.0 108.529 177.26 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.13 -1.28 18.89 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.017 0.913 . . . . 50.0 109.34 176.954 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 t -131.85 145.88 59.37 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 105.121 -2.177 . . . . 50.0 105.121 179.589 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -69.37 -14.66 37.68 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 117.346 -1.303 . . . . 50.0 113.105 178.713 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -83.39 -16.81 44.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.48 0.657 . . . . 50.0 110.338 178.622 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -88.02 142.49 27.74 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.279 -0.637 . . . . 50.0 109.279 -178.709 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.4 mt -92.39 129.87 38.21 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.853 0.835 . . . . 50.0 109.597 177.653 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.94 142.64 28.68 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 105.644 -1.984 . . . . 50.0 105.644 175.842 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -161.68 165.94 27.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.256 0.55 . . . . 50.0 111.329 -179.111 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -113.52 159.5 19.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.497 -0.774 . . . . 50.0 109.12 177.546 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.76 133.66 55.57 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.824 -1.176 . . . . 50.0 107.824 177.626 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.18 -22.92 38.5 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-O 119.205 -0.775 . . . . 50.0 114.051 179.6 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -58.6 140.54 54.22 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.529 0.68 . . . . 50.0 109.69 179.731 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.6 mm -108.84 127.3 65.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.734 -1.121 . . . . 50.0 108.059 -178.849 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 12.2 ptp -128.2 150.92 49.8 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.188 -0.671 . . . . 50.0 109.188 -179.986 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.0 m -84.42 127.48 34.03 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 106.883 -1.525 . . . . 25.0 106.883 176.026 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.0 t -94.07 122.63 45.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 107.469 -1.308 . . . . 50.0 107.469 179.013 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.07 -46.94 8.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.603 -0.726 . . . . 50.0 109.127 -177.662 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -155.26 171.55 19.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.51 -0.314 . . . . 50.0 110.218 177.679 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -123.63 155.75 37.13 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.967 -1.864 . . . . 50.0 105.967 179.32 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.3 t0 58.49 41.35 22.79 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.304 1.526 . . . . 50.0 108.126 -175.881 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 t -68.32 142.03 55.64 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.778 -1.193 . . . . 25.0 107.778 -177.625 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 56.54 18.72 3.72 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 113.978 1.103 . . . . 50.0 113.978 -177.526 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.15 20.57 76.6 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.428 -1.069 . . . . 25.0 110.428 -179.656 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 65.7 mt -90.53 99.73 12.7 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 107.725 -1.213 . . . . 50.0 107.725 176.551 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -57.65 123.48 15.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.93 -1.032 . . . . 25.0 110.091 -176.099 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.47 -3.03 85.26 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 118.345 -1.253 . . . . 50.0 115.366 178.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.403 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 85.1 m95 -100.58 143.63 30.52 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 119.461 1.63 . . . . 50.0 109.569 177.84 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -117.66 140.54 49.52 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.345 -0.983 . . . . 50.0 108.345 -178.896 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.71 120.22 25.31 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 103.967 -2.605 . . . . 50.0 103.967 175.84 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 93.8 m -129.72 160.69 32.61 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 110.205 -0.294 . . . . 50.0 110.205 179.158 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.5 t -116.9 121.76 42.39 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.865 -1.161 . . . . 50.0 107.865 173.385 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.5 tp -143.75 141.88 30.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.027 -1.842 . . . . 75.0 106.027 -177.105 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 56.43 27.47 12.18 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.189 0.595 . . . . 25.0 111.388 -176.877 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.39 -0.46 84.7 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-O 119.554 -0.581 . . . . 25.0 114.467 177.682 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -120.93 154.32 36.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.333 1.067 . . . . 50.0 110.06 179.322 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -98.11 157.12 16.33 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.321 -0.992 . . . . 50.0 108.321 178.434 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.61 -168.25 39.7 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 105.515 -3.034 . . . . 50.0 105.515 179.128 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.3 pt -115.89 153.17 17.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 122.339 1.066 . . . . 50.0 110.762 -175.738 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.95 146.07 32.83 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 114.216 -1.356 . . . . 50.0 109.96 -178.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.66 119.12 5.58 Favored 'Trans proline' 0 C--O 1.237 0.431 0 O-C-N 122.051 0.501 . . . . 50.0 113.173 -179.869 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.7 -17.55 69.23 Favored Glycine 0 C--O 1.222 -0.601 0 C-N-CA 120.975 -0.631 . . . . 50.0 113.478 -178.306 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -65.65 -12.22 51.57 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.579 0.585 . . . . 50.0 112.579 -177.868 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -130.56 26.52 5.05 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.587 0.708 . . . . 50.0 110.841 177.018 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -126.14 154.92 42.49 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.406 -0.816 . . . . 50.0 111.871 178.511 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -123.43 122.33 37.98 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.866 -0.606 . . . . 50.0 111.357 177.61 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.0 mm -71.7 137.37 23.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.678 -1.23 . . . . 50.0 107.678 177.779 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.3 mt -118.17 106.48 12.88 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.121 -1.066 . . . . 50.0 108.121 175.925 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.5 m -97.01 13.04 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 121.425 0.631 . . . . 50.0 110.748 179.537 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.85 30.3 57.92 Favored Glycine 0 C--O 1.219 -0.818 0 C-N-CA 120.444 -0.884 . . . . 25.0 112.268 -176.72 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 7.6 tpt -71.84 97.93 1.9 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.907 -0.761 . . . . 25.0 111.301 -179.296 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 67.2 160.25 0.15 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.44 1.496 . . . . 25.0 112.81 -178.2 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -73.61 156.01 38.49 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.845 0.355 . . . . 25.0 110.509 179.421 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -156.07 117.82 3.96 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.958 0.903 . . . . 50.0 108.568 177.602 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -129.39 150.25 75.05 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 108.024 -1.102 . . . . 50.0 108.024 178.971 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -70.06 156.78 61.73 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 117.839 -0.974 . . . . 50.0 111.309 177.994 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -121.04 -10.32 9.06 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.123 1.157 . . . . 25.0 114.123 -177.196 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.06 179.29 48.68 Favored Glycine 0 C--N 1.319 -0.372 0 C-N-CA 120.277 -0.963 . . . . 25.0 112.48 -176.171 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.4 p -71.81 149.94 44.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.921 0.391 . . . . 25.0 111.243 179.733 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 161.49 -166.46 35.96 Favored Glycine 0 CA--C 1.505 -0.571 0 N-CA-C 107.862 -2.095 . . . . 25.0 107.862 -179.177 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 162.25 -52.87 0.31 Allowed Glycine 0 CA--C 1.512 -0.095 0 C-N-CA 120.421 -0.895 . . . . 25.0 112.692 177.279 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.2 t 54.5 38.1 29.08 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.709 0.633 . . . . 25.0 112.709 178.303 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.07 36.18 0.15 Allowed Glycine 0 C--O 1.218 -0.883 0 N-CA-C 115.137 0.815 . . . . 25.0 115.137 -178.315 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.2 m -85.5 1.81 47.34 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.032 0.753 . . . . 25.0 113.032 -177.029 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.77 -172.92 33.72 Favored Glycine 0 CA--C 1.508 -0.387 0 N-CA-C 106.617 -2.593 . . . . 25.0 106.617 179.304 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.4 p -72.86 158.69 35.04 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.552 0.575 . . . . 25.0 112.552 -179.482 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -120.56 179.7 4.25 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.765 -1.198 . . . . 50.0 107.765 175.649 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.64 141.69 48.09 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.918 0.487 . . . . 25.0 111.158 -178.446 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 61.49 -166.96 0.2 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.303 1.041 . . . . 50.0 110.957 -178.782 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.3 t0 50.6 52.55 14.65 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 122.737 1.256 . . . . 25.0 113.016 -178.361 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -58.57 148.34 66.45 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 114.719 -1.128 . . . . 25.0 112.433 -178.776 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -68.09 157.1 63.26 Favored 'Trans proline' 0 C--O 1.239 0.566 0 N-CA-C 113.989 0.727 . . . . 50.0 113.989 -177.348 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -64.69 153.42 77.67 Favored 'Trans proline' 0 C--N 1.355 0.878 0 O-C-N 121.819 0.378 . . . . 50.0 112.941 -179.031 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -67.78 158.06 58.96 Favored 'Trans proline' 0 C--O 1.241 0.646 0 N-CA-C 115.381 1.262 . . . . 50.0 115.381 -171.691 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -75.02 140.33 73.67 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 107.999 -1.112 . . . . 50.0 107.999 177.264 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.54 167.2 27.7 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 118.055 -0.83 . . . . 50.0 112.061 178.308 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -60.11 156.29 40.5 Favored 'Trans proline' 0 C--N 1.351 0.662 0 N-CA-C 114.82 1.046 . . . . 50.0 114.82 -177.491 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -122.17 47.26 1.94 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.17 -0.468 . . . . 50.0 111.938 -176.874 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 m 66.05 -49.02 0.41 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 115.628 1.714 . . . . 25.0 115.628 178.425 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -54.62 -12.93 0.83 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.672 1.73 . . . . 50.0 115.672 -177.973 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.7 m -80.06 -26.96 39.45 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.844 1.054 . . . . 25.0 113.844 -179.436 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.3 m -165.5 -38.99 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.904 1.076 . . . . 25.0 113.904 -173.025 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.3 tp . . . . . 0 C--O 1.209 -1.064 0 CA-C-O 125.132 2.396 . . . . 25.0 112.135 -172.024 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 CA-C-O 123.149 1.416 . . . . 25.0 114.942 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.44 4.41 3.03 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.685 1.365 . . . . 25.0 114.685 -174.524 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.3 mtt -86.53 0.49 54.19 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.914 -0.491 . . . . 25.0 112.058 -179.185 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -87.33 108.63 19.05 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.061 -0.718 . . . . 50.0 109.061 178.997 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 61.98 166.97 0.11 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.825 1.417 . . . . 50.0 114.825 -179.151 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.4 mt -73.82 -41.68 61.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.339 -0.846 . . . . 50.0 109.881 178.485 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 52.76 33.18 13.52 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.271 1.028 . . . . 50.0 111.587 -177.976 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 m -91.56 162.16 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.75 -1.945 . . . . 50.0 105.75 174.571 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.51 170.99 8.22 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.003 -1.11 . . . . 50.0 108.003 -178.76 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.49 159.15 43.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.16 -0.681 . . . . 25.0 109.16 174.714 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -125.34 129.0 49.07 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.392 -0.822 . . . . 50.0 109.863 176.495 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.08 129.54 39.71 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.217 -0.66 . . . . 25.0 109.217 175.283 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.0 mt -96.01 -20.11 18.95 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.024 0.44 . . . . 50.0 110.489 -178.355 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -146.42 173.32 12.38 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 107.697 -1.223 . . . . 50.0 107.697 -177.664 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -76.04 158.68 31.59 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.992 0.425 . . . . 50.0 111.534 175.246 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -141.71 131.5 24.28 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.386 0.612 . . . . 50.0 112.518 168.642 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.9 t -97.05 122.19 48.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 103.539 -2.763 . . . . 25.0 103.539 173.135 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.42 139.98 36.22 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.837 -1.172 . . . . 25.0 107.837 176.304 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -128.91 -19.65 3.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.902 -0.59 . . . . 50.0 110.839 -179.128 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.44 150.98 39.84 Favored Pre-proline 0 N--CA 1.464 0.252 0 N-CA-C 106.759 -1.571 . . . . 50.0 106.759 171.131 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -68.74 -22.09 37.67 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 117.275 -1.35 . . . . 50.0 112.952 -179.183 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -90.4 -2.23 57.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.771 0.796 . . . . 50.0 110.616 -179.207 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -89.39 139.77 30.18 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.315 0.579 . . . . 50.0 110.471 -175.997 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.3 mt -90.74 128.04 36.53 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.105 0.955 . . . . 50.0 111.727 179.77 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.6 p -87.47 140.41 29.55 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.935 -1.876 . . . . 50.0 105.935 174.309 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.71 167.01 31.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.051 0.453 . . . . 50.0 110.1 178.774 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.32 160.85 19.9 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.639 -0.875 . . . . 50.0 108.639 178.441 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -56.23 134.18 53.01 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 115.221 -0.9 . . . . 50.0 110.096 177.56 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.68 -15.27 63.46 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-O 118.175 -1.347 . . . . 50.0 113.863 177.885 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -60.41 150.53 30.63 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 118.207 1.004 . . . . 50.0 110.826 177.512 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.6 mm -118.29 130.07 73.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.473 -1.239 . . . . 50.0 108.7 179.479 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -136.7 152.77 50.75 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.307 -0.627 . . . . 50.0 109.307 -179.085 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -88.36 128.26 35.5 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.357 -0.608 . . . . 25.0 109.357 177.909 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.4 t -91.91 127.83 43.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.176 -1.046 . . . . 50.0 108.176 179.638 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.3 mt -94.61 -47.84 6.34 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.636 -0.875 . . . . 50.0 108.636 179.889 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -152.05 169.08 23.24 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.517 -0.919 . . . . 50.0 108.517 178.111 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -117.75 153.96 32.53 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 108.029 -1.1 . . . . 50.0 108.029 176.404 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 60.05 40.14 18.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 123.472 1.606 . . . . 50.0 109.855 178.474 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 t -68.26 154.77 41.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.204 -1.816 . . . . 25.0 110.729 -177.122 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 59.46 13.97 3.55 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.486 1.114 . . . . 50.0 110.418 -177.392 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.77 11.41 85.27 Favored Glycine 0 CA--C 1.506 -0.489 0 N-CA-C 111.335 -0.706 . . . . 25.0 111.335 -179.827 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.65 128.83 36.12 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 117.761 0.781 . . . . 50.0 110.067 -177.814 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -70.02 123.24 21.06 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.083 -0.508 . . . . 25.0 110.346 -179.473 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.35 -0.79 88.66 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 116.789 1.475 . . . . 50.0 116.789 175.974 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -100.38 131.73 46.15 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.909 0.855 . . . . 50.0 109.373 176.753 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -114.1 143.2 45.18 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.492 -0.929 . . . . 50.0 108.492 -175.224 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.68 122.44 28.62 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.735 -1.58 . . . . 50.0 106.735 177.952 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.6 m -133.34 162.28 32.26 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.231 0.538 . . . . 50.0 111.9 178.146 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -113.45 122.4 47.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.856 -1.164 . . . . 50.0 107.856 173.484 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.5 tp -139.77 132.58 29.14 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.882 -1.155 . . . . 50.0 107.882 -178.745 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 54.63 29.11 10.92 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.059 0.544 . . . . 25.0 111.438 -174.719 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.93 -3.79 73.95 Favored Glycine 0 C--O 1.222 -0.603 0 N-CA-C 115.305 0.882 . . . . 25.0 115.305 178.207 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -109.19 157.35 18.88 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.824 -1.547 . . . . 50.0 106.824 178.639 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -115.0 151.81 33.52 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.154 -0.684 . . . . 50.0 109.154 -177.747 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.73 -161.0 26.56 Favored Glycine 0 CA--C 1.504 -0.623 0 N-CA-C 107.051 -2.42 . . . . 50.0 107.051 -179.726 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.0 pt -115.97 150.3 17.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.212 0.53 . . . . 50.0 112.308 -175.083 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.85 144.94 43.61 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.226 -0.897 . . . . 50.0 110.488 -179.716 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.9 121.91 6.07 Favored 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 118.501 -0.533 . . . . 50.0 112.388 -179.769 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.58 -20.33 67.86 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 115.375 0.91 . . . . 50.0 115.375 -177.113 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -23.19 67.3 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.324 0.861 . . . . 50.0 113.324 -176.267 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -120.95 26.64 8.94 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.939 -0.763 . . . . 50.0 108.939 -179.045 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.0 tp -131.51 150.37 52.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.735 -0.666 . . . . 50.0 110.666 -176.985 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -124.74 123.55 40.23 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 122.223 -0.298 . . . . 50.0 111.787 179.186 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.4 mm -70.17 136.37 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 123.839 0.712 . . . . 50.0 110.001 176.6 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.8 mt -118.38 99.19 6.68 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.774 -1.565 . . . . 50.0 106.774 174.855 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.46 131.83 34.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 106.905 -1.517 . . . . 50.0 106.905 179.438 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.18 107.91 2.28 Favored Glycine 0 C--O 1.225 -0.413 0 N-CA-C 109.938 -1.265 . . . . 25.0 109.938 179.088 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 96.6 mmm -137.29 -42.67 0.56 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 113.202 0.816 . . . . 25.0 113.202 -176.133 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -137.48 46.47 2.13 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-O 121.264 0.554 . . . . 25.0 110.552 -173.099 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.0 67.22 2.96 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 122.475 1.131 . . . . 25.0 112.541 -173.416 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -72.79 -2.38 20.3 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.751 -1.113 . . . . 50.0 113.048 177.924 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -149.09 154.88 39.92 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 104.405 -2.443 . . . . 50.0 104.405 176.235 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.3 156.89 54.47 Favored 'Trans proline' 0 C--N 1.349 0.577 0 N-CA-C 114.727 1.01 . . . . 50.0 114.727 -178.153 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.27 162.22 14.51 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 106.213 -1.773 . . . . 25.0 106.213 173.246 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.71 15.95 81.16 Favored Glycine 0 C--O 1.218 -0.906 0 C-N-CA 119.836 -1.173 . . . . 25.0 111.843 -179.681 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.1 t -70.22 -8.08 47.15 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.344 0.868 . . . . 25.0 113.344 -177.449 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.32 173.57 39.06 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 109.205 -1.558 . . . . 25.0 109.205 -179.446 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -179.52 167.63 37.69 Favored Glycine 0 C--O 1.24 0.47 0 N-CA-C 107.131 -2.387 . . . . 25.0 107.131 178.304 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t 54.88 -156.63 0.23 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 117.931 0.865 . . . . 25.0 111.366 -179.504 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.0 158.53 28.37 Favored Glycine 0 C--O 1.228 -0.275 0 CA-C-N 116.549 -0.296 . . . . 25.0 113.338 178.191 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 t 59.23 -175.23 0.1 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.922 1.453 . . . . 25.0 114.922 178.983 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.45 90.17 1.42 Allowed Glycine 0 N--CA 1.459 0.167 0 N-CA-C 109.86 -1.296 . . . . 25.0 109.86 178.802 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.0 t -100.2 -23.79 14.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.368 0.877 . . . . 25.0 113.368 -176.201 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 39.02 -123.82 0.33 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.113 0.965 . . . . 50.0 112.234 -177.344 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -121.97 94.52 4.33 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.043 -1.465 . . . . 25.0 107.043 176.463 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -94.94 167.35 11.46 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.4 0.518 . . . . 50.0 112.4 -174.442 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 t0 64.71 179.84 0.18 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.536 1.68 . . . . 25.0 115.536 170.267 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.3 p -124.32 85.05 55.77 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 108.671 -0.863 . . . . 25.0 108.671 180.0 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.24 153.08 50.96 Favored 'Trans proline' 0 C--O 1.239 0.573 0 N-CA-C 116.711 1.774 . . . . 50.0 116.711 -175.09 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -69.77 164.47 34.42 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 N-CA-C 110.762 -0.514 . . . . 50.0 110.762 171.864 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.15 157.65 52.46 Favored 'Trans proline' 0 C--N 1.349 0.555 0 N-CA-C 114.279 0.838 . . . . 50.0 114.279 -175.801 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -95.23 144.17 27.34 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 106.375 -1.713 . . . . 50.0 106.375 175.487 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.46 161.15 46.43 Favored 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 118.021 -0.853 . . . . 50.0 112.783 179.672 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.65 157.24 48.19 Favored 'Trans proline' 0 C--N 1.352 0.713 0 N-CA-C 113.613 0.582 . . . . 50.0 113.613 -179.696 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -103.58 7.91 37.62 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.331 0.586 . . . . 50.0 110.189 177.728 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.3 p -137.13 142.54 42.25 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.109 -1.441 . . . . 25.0 107.109 178.756 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -150.57 21.42 0.82 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.065 0.46 . . . . 50.0 111.793 -177.825 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.5 p -124.84 171.36 10.22 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.751 -0.833 . . . . 25.0 108.751 -177.063 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 66.6 m 48.95 64.74 1.6 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 122.778 1.275 . . . . 25.0 113.494 178.471 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 123.955 1.836 . . . . 25.0 110.56 177.756 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.208 -1.49 0 N-CA-C 118.487 2.155 . . . . 25.0 118.487 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 t 51.84 52.26 14.89 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.658 1.183 . . . . 25.0 111.989 177.908 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.1 ttt -125.75 70.66 1.21 Allowed 'General case' 0 C--O 1.21 -1.013 0 CA-C-O 122.015 0.912 . . . . 25.0 109.668 -179.748 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -135.97 78.66 1.73 Allowed 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 114.186 -1.37 . . . . 50.0 108.793 179.875 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -116.56 167.09 11.37 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.903 -1.044 . . . . 50.0 109.799 -177.646 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.9 mt -68.24 -37.59 80.95 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.144 -0.935 . . . . 50.0 110.389 -177.963 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.1 m120 54.11 29.11 9.82 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 122.861 1.315 . . . . 50.0 112.031 -179.007 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.9 m -91.99 165.0 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 104.817 -2.29 . . . . 50.0 104.817 172.939 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.67 175.69 5.33 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 119.704 1.138 . . . . 50.0 108.612 -178.414 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.96 154.93 40.09 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.987 -1.006 . . . . 25.0 110.824 174.775 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -113.9 130.17 56.52 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 125.299 1.44 . . . . 50.0 110.506 175.96 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.76 128.57 36.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.959 0.885 . . . . 25.0 110.898 177.662 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -94.79 -18.55 21.12 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.669 -0.696 . . . . 50.0 109.403 -179.117 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -145.73 173.79 11.78 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 124.154 0.909 . . . . 50.0 109.238 179.215 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -85.39 164.25 18.04 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 123.408 0.683 . . . . 50.0 111.896 176.032 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -152.32 144.31 23.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.518 0.599 . . . . 50.0 111.705 176.374 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.8 t -113.73 123.48 69.44 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 N-CA-C 106.678 -1.601 . . . . 25.0 106.678 171.218 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.68 124.29 30.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.703 -1.135 . . . . 25.0 108.25 179.537 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -107.3 -11.04 15.65 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.758 -0.83 . . . . 50.0 108.758 -178.711 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.9 t -110.76 147.26 36.11 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 104.883 -2.265 . . . . 50.0 104.883 176.768 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.69 -18.49 32.58 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 O-C-N 121.946 0.445 . . . . 50.0 112.242 179.086 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -85.63 -12.97 50.07 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.654 -0.703 . . . . 50.0 109.346 179.235 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -87.91 143.3 27.19 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-O 121.32 0.581 . . . . 50.0 111.446 179.664 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.1 mt -98.31 128.62 44.82 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-O 121.884 0.85 . . . . 50.0 112.237 177.834 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.69 134.33 34.36 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 105.718 -1.956 . . . . 50.0 105.718 174.157 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -152.58 168.08 26.75 Favored 'General case' 0 C--O 1.266 1.946 0 CA-C-O 121.71 0.767 . . . . 50.0 110.984 -179.782 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -118.92 159.72 23.28 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.367 1.067 . . . . 50.0 110.241 178.845 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -56.96 132.75 53.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.853 -1.166 . . . . 50.0 107.853 174.757 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.59 -25.15 28.55 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 115.349 -0.841 . . . . 50.0 114.089 -179.479 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -60.09 134.85 57.44 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.358 -0.979 . . . . 50.0 108.358 -175.226 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.5 mm -103.78 127.08 58.19 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 109.22 -0.659 . . . . 50.0 109.22 176.061 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.3 ptp -132.74 156.21 47.47 Favored 'General case' 0 C--O 1.2 -1.511 0 CA-C-N 115.416 -0.811 . . . . 50.0 108.918 -179.181 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.9 m -93.87 119.24 32.54 Favored 'General case' 0 C--O 1.198 -1.635 0 N-CA-C 108.918 -0.771 . . . . 25.0 108.918 -178.444 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.2 t -79.9 121.69 33.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 106.697 -1.594 . . . . 50.0 106.697 177.702 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.3 mt -94.51 -42.14 8.99 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.949 0.881 . . . . 50.0 109.735 179.854 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -146.33 152.19 38.73 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.566 -0.743 . . . . 50.0 109.577 -176.859 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -113.79 150.64 33.16 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 105.945 -1.872 . . . . 50.0 105.945 171.74 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 55.54 43.1 28.96 Favored 'General case' 0 C--O 1.268 2.027 0 O-C-N 125.021 1.45 . . . . 50.0 109.893 -176.876 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.2 t -70.49 151.2 45.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.397 -1.274 . . . . 25.0 111.145 -178.924 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 58.51 18.86 6.04 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.491 1.116 . . . . 50.0 112.069 179.359 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.5 5.15 90.16 Favored Glycine 0 C--O 1.208 -1.529 0 CA-C-N 115.139 -0.937 . . . . 25.0 112.071 178.06 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.9 mt -84.84 136.62 33.58 Favored 'General case' 0 C--O 1.211 -0.93 0 CA-C-N 117.289 0.544 . . . . 50.0 109.623 -174.512 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -80.03 108.35 13.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.902 -1.044 . . . . 25.0 113.351 -179.065 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.79 0.91 74.39 Favored Glycine 0 C--O 1.221 -0.691 0 C-N-CA 119.473 -1.346 . . . . 50.0 116.189 177.924 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -99.58 136.13 39.96 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 117.807 0.804 . . . . 50.0 109.232 173.43 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -113.01 146.19 39.52 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.711 -0.848 . . . . 50.0 108.711 -176.601 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.9 tp -89.9 127.61 36.04 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 106.076 -1.824 . . . . 50.0 106.076 -179.938 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.9 m -137.97 160.46 39.27 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 119.59 1.086 . . . . 50.0 113.778 -179.169 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.3 t -109.22 123.01 48.55 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 106.295 -1.742 . . . . 50.0 106.295 171.569 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.9 tp -137.91 127.52 25.1 Favored 'General case' 0 C--O 1.204 -1.313 0 N-CA-C 107.743 -1.206 . . . . 50.0 107.743 -177.562 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 54.43 35.53 23.39 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.86 0.838 . . . . 25.0 110.691 -176.504 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.21 6.72 88.81 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.512 -0.852 . . . . 25.0 113.858 175.24 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -127.27 148.9 50.21 Favored 'General case' 0 C--O 1.204 -1.304 0 CA-C-N 119.001 1.4 . . . . 50.0 109.121 -176.3 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -102.03 148.35 25.48 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 123.688 0.618 . . . . 50.0 112.077 -178.02 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.67 -179.94 48.8 Favored Glycine 0 C--O 1.25 1.099 0 N-CA-C 106.76 -2.536 . . . . 50.0 106.76 -177.861 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt -103.52 148.56 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.01 0.924 . . . . 50.0 111.753 -174.831 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.87 148.63 43.18 Favored Pre-proline 0 C--O 1.244 0.795 0 CA-C-O 122.68 1.229 . . . . 50.0 110.863 -177.42 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.05 125.21 7.1 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 116.302 -1.999 . . . . 50.0 114.338 -178.353 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.84 -20.77 60.2 Favored Glycine 0 C--O 1.203 -1.829 0 CA-C-N 116.154 -0.476 . . . . 50.0 113.529 179.3 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -68.2 -15.66 63.67 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 121.053 -1.263 . . . . 50.0 112.36 -178.654 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -115.73 15.48 16.44 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.872 -0.517 . . . . 50.0 109.762 -179.148 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 29.6 mt -130.03 152.5 49.42 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 117.366 2.358 . . . . 75.0 117.366 -176.757 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt -119.64 126.52 51.34 Favored 'General case' 0 C--O 1.197 -1.7 0 N-CA-C 108.055 -1.091 . . . . 50.0 108.055 175.53 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.5 mm -75.16 137.01 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 O-C-N 124.167 0.917 . . . . 50.0 110.204 177.111 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.3 mt -117.74 105.38 11.93 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.493 1.117 . . . . 50.0 108.528 177.666 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.09 162.41 2.49 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 CA-C-N 114.915 -1.039 . . . . 50.0 110.658 -172.991 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -103.28 38.44 3.23 Favored Glycine 0 C--O 1.207 -1.543 0 N-CA-C 116.813 1.485 . . . . 25.0 116.813 176.953 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.2 ttt -85.53 178.46 7.4 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.841 0.829 . . . . 25.0 109.337 -178.269 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -63.81 124.58 21.87 Favored 'General case' 0 C--O 1.199 -1.564 0 CA-C-N 115.992 -0.549 . . . . 25.0 110.944 -178.651 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -139.42 -54.94 0.57 Allowed 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 114.886 1.439 . . . . 25.0 114.886 175.661 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 57.04 37.4 28.67 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.644 -0.707 . . . . 50.0 111.389 -173.445 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.8 mttt -118.91 107.86 41.58 Favored Pre-proline 0 N--CA 1.485 1.319 0 O-C-N 121.899 -0.5 . . . . 50.0 109.892 -179.934 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.28 174.38 12.9 Favored 'Trans proline' 0 C--N 1.351 0.686 0 N-CA-C 113.913 0.697 . . . . 50.0 113.913 176.794 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.88 -58.12 0.31 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.988 0.515 . . . . 25.0 110.47 179.582 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.94 7.21 86.44 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 115.069 0.788 . . . . 25.0 115.069 178.291 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.3 m -60.41 141.06 56.85 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 109.258 -0.645 . . . . 25.0 109.258 179.713 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -159.48 51.23 0.38 Allowed Glycine 0 CA--C 1.531 1.055 0 CA-C-O 119.456 -0.636 . . . . 25.0 114.459 -179.213 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.99 148.08 16.53 Favored Glycine 0 C--O 1.216 -0.975 0 CA-C-N 119.67 1.735 . . . . 25.0 110.713 -178.338 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 62.6 p -163.29 173.09 13.75 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 123.665 0.786 . . . . 25.0 109.277 -175.949 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.72 -11.71 61.05 Favored Glycine 0 C--O 1.202 -1.85 0 CA-C-O 118.379 -1.234 . . . . 25.0 115.044 171.077 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 95.7 p -81.29 155.78 25.87 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 118.643 1.222 . . . . 25.0 111.075 179.755 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 173.47 134.17 1.79 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.36 -1.096 . . . . 25.0 110.36 173.584 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.0 t -161.0 132.53 5.62 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 104.609 -2.367 . . . . 25.0 104.609 178.303 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 61.64 159.2 0.05 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 125.561 1.788 . . . . 50.0 115.519 -172.414 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.0 tttm 61.16 169.91 0.1 Allowed 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 124.24 1.016 . . . . 25.0 112.616 179.579 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.28 156.92 29.6 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 108.405 -0.961 . . . . 50.0 108.405 -176.141 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -116.83 156.16 27.75 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.217 0.607 . . . . 25.0 109.719 179.167 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.3 p -111.06 93.43 17.73 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 123.717 0.807 . . . . 25.0 111.475 178.51 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.78 156.2 63.89 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 116.663 -1.758 . . . . 50.0 113.912 -175.427 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.85 154.14 63.57 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 116.624 -1.784 . . . . 50.0 112.517 178.011 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.47 157.89 57.65 Favored 'Trans proline' 0 C--N 1.354 0.846 0 N-CA-C 114.251 0.827 . . . . 50.0 114.251 -177.818 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -69.54 138.26 88.63 Favored Pre-proline 0 N--CA 1.479 1.022 0 CA-C-O 119.102 -0.475 . . . . 50.0 110.926 -177.822 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -69.36 166.4 27.23 Favored 'Trans proline' 0 CA--C 1.562 1.883 0 O-C-N 123.159 1.084 . . . . 50.0 111.55 174.496 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.2 150.09 89.58 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 N-CA-C 116.05 1.519 . . . . 50.0 116.05 -174.208 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.9 mtm180 -110.32 10.32 23.55 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.594 -0.276 . . . . 50.0 110.261 -179.598 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.8 p 54.21 -164.83 0.1 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.87 1.804 . . . . 25.0 115.87 -178.978 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 61.3 -164.19 0.24 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.727 1.211 . . . . 50.0 108.758 -176.706 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.5 t 54.16 59.91 3.93 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 115.128 1.529 . . . . 25.0 115.128 178.493 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.5 t 59.09 60.44 2.41 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 123.115 1.436 . . . . 25.0 109.559 -178.041 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.0 tp . . . . . 0 C--N 1.316 -0.871 0 CA-C-N 112.871 -1.968 . . . . 25.0 113.971 -175.187 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.763 0 CA-C-O 124.008 1.893 . . . . 25.0 115.944 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.0 m -142.0 140.3 32.63 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 120.424 -1.633 . . . . 25.0 110.936 177.37 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.15 148.27 31.0 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 103.074 -2.935 . . . . 25.0 103.074 174.581 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.07 111.19 8.99 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 106.338 -1.726 . . . . 50.0 106.338 179.261 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -110.16 171.55 7.39 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 113.713 1.005 . . . . 50.0 113.713 -177.392 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.4 mt -71.99 -41.88 67.14 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.793 -1.094 . . . . 50.0 110.492 175.878 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.8 m120 54.39 33.35 18.4 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 113.606 -1.634 . . . . 50.0 113.814 -178.388 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 m -97.7 166.48 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.156 0 N-CA-C 106.408 -1.701 . . . . 50.0 106.408 178.253 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.3 171.72 7.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.32 -1.487 . . . . 50.0 107.3 -176.272 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.22 157.74 43.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 119.232 0.923 . . . . 25.0 111.774 176.896 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -120.33 127.55 52.44 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.498 -0.774 . . . . 50.0 110.935 179.579 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.93 122.12 18.67 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.635 -1.246 . . . . 25.0 107.635 179.749 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.3 mt -84.89 -27.91 26.32 Favored 'General case' 0 C--O 1.212 -0.876 0 O-C-N 121.879 -0.513 . . . . 50.0 110.776 -178.949 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -138.41 177.07 8.16 Favored 'General case' 0 C--O 1.198 -1.649 0 N-CA-C 108.622 -0.881 . . . . 50.0 108.622 177.216 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.63 170.57 15.9 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.317 0.647 . . . . 50.0 111.806 173.491 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -155.83 141.64 18.03 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 113.981 1.104 . . . . 50.0 113.981 175.02 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.6 131.99 62.6 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 105.774 -1.936 . . . . 25.0 105.774 -179.454 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.96 111.79 15.5 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 124.639 1.212 . . . . 25.0 110.274 -178.996 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -106.53 -1.33 23.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.64 0.733 . . . . 50.0 112.249 -179.208 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.3 m -131.7 154.36 81.78 Favored Pre-proline 0 CA--C 1.501 -0.923 0 N-CA-C 107.418 -1.327 . . . . 50.0 107.418 174.956 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.51 -26.56 40.25 Favored 'Trans proline' 0 C--O 1.259 1.533 0 C-N-CA 116.582 -1.812 . . . . 50.0 113.323 -175.631 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -82.57 -6.83 59.56 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 115.9 -0.591 . . . . 50.0 110.806 179.695 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -85.54 142.61 29.03 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-O 121.929 0.871 . . . . 50.0 111.988 -178.08 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.1 mt -93.73 135.19 35.28 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.605 -0.725 . . . . 50.0 109.089 176.071 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.47 130.15 39.4 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 106.413 -1.699 . . . . 50.0 106.413 174.629 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -150.93 165.89 32.31 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.607 0.717 . . . . 50.0 109.681 -178.583 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -115.1 170.33 8.44 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.666 -0.697 . . . . 50.0 109.906 -179.18 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -65.06 135.67 55.85 Favored 'General case' 0 C--O 1.203 -1.35 0 N-CA-C 108.488 -0.93 . . . . 50.0 108.488 175.825 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.02 -23.5 30.62 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 109.937 -1.265 . . . . 50.0 109.937 175.63 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -61.56 143.74 55.51 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 122.065 0.936 . . . . 50.0 111.362 -175.974 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.1 mm -116.04 120.09 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 114.116 -1.402 . . . . 50.0 109.571 -177.554 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -124.54 151.97 44.04 Favored 'General case' 0 C--N 1.313 -0.999 0 O-C-N 124.072 0.857 . . . . 50.0 109.161 179.0 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.6 m -84.39 127.63 34.11 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 106.822 -1.547 . . . . 25.0 106.822 177.103 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.9 t -90.19 120.88 39.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.51 -0.922 . . . . 50.0 108.51 176.009 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -90.39 -45.1 9.22 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.602 -0.726 . . . . 50.0 111.285 177.374 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -148.79 157.57 43.53 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.387 -0.968 . . . . 50.0 108.387 -175.264 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -118.73 147.63 43.65 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 106.513 -1.662 . . . . 50.0 106.513 176.672 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 55.75 46.38 22.57 Favored 'General case' 0 C--O 1.255 1.355 0 CA-C-O 124.206 1.955 . . . . 50.0 109.394 -177.805 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -68.59 157.53 35.89 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-N 112.594 -2.094 . . . . 25.0 110.942 -177.691 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 60.03 13.22 3.6 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.381 0.882 . . . . 50.0 113.381 174.413 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.53 16.09 78.48 Favored Glycine 0 CA--C 1.539 1.558 0 N-CA-C 109.296 -1.522 . . . . 25.0 109.296 179.599 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.6 mt -100.82 129.91 46.77 Favored 'General case' 0 C--O 1.206 -1.207 0 N-CA-C 107.348 -1.353 . . . . 50.0 107.348 -178.67 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.93 123.71 27.53 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 122.169 0.985 . . . . 25.0 111.867 177.93 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.57 -0.35 82.86 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 120.215 -0.993 . . . . 50.0 114.683 175.119 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -100.71 134.15 44.11 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.76 -0.83 . . . . 50.0 108.76 175.575 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -114.85 141.4 47.95 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.54 -0.911 . . . . 50.0 108.54 -178.076 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.4 tp -85.61 120.12 26.69 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.565 -0.902 . . . . 50.0 108.565 178.617 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 98.7 m -135.77 158.56 44.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.183 0.438 . . . . 50.0 112.183 -177.334 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.9 t -105.95 121.34 43.9 Favored 'General case' 0 C--O 1.251 1.168 0 C-N-CA 123.987 0.915 . . . . 50.0 108.787 173.804 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 tp -138.14 132.59 32.2 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.288 1.035 . . . . 50.0 109.164 179.967 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.7 m170 54.09 30.93 12.83 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-O 122.813 1.292 . . . . 25.0 109.655 -176.157 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.45 -5.44 73.38 Favored Glycine 0 N--CA 1.462 0.384 0 N-CA-C 116.528 1.371 . . . . 25.0 116.528 176.727 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -110.83 145.91 37.36 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.919 -0.771 . . . . 50.0 108.919 179.396 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -91.52 151.62 20.68 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 124.451 1.094 . . . . 50.0 108.642 178.849 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.27 -176.19 47.65 Favored Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 107.913 -2.075 . . . . 50.0 107.913 -179.595 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.6 pt -104.73 148.94 8.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-O 121.977 0.894 . . . . 50.0 111.761 -175.341 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.7 m -143.48 146.38 35.49 Favored Pre-proline 0 C--O 1.246 0.896 0 C-N-CA 123.254 0.622 . . . . 50.0 111.969 177.256 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.97 122.17 7.05 Favored 'Trans proline' 0 C--N 1.358 1.049 0 N-CA-C 114.296 0.845 . . . . 50.0 114.296 -175.86 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.49 -25.56 71.48 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.842 -0.617 . . . . 50.0 114.379 -178.197 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.26 -24.68 60.17 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.044 0.757 . . . . 50.0 113.044 -179.157 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -119.09 31.38 6.66 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 120.929 -1.107 . . . . 50.0 108.789 178.962 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.4 mt -128.26 159.77 34.21 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.383 1.087 . . . . 50.0 110.747 176.538 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -134.46 127.04 30.7 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 115.106 -0.952 . . . . 50.0 108.784 174.738 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.5 mm -73.54 136.71 24.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.995 -0.743 . . . . 50.0 108.995 -179.347 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.5 mt -112.04 89.08 2.97 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 106.847 -1.538 . . . . 50.0 106.847 174.347 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.7 m -74.54 158.19 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 119.226 -0.99 . . . . 50.0 108.843 176.559 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.38 -173.62 24.19 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-N 114.003 -1.453 . . . . 25.0 113.311 176.46 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 13.8 tpt -144.23 119.57 10.24 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 107.855 -1.165 . . . . 25.0 107.855 178.952 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 60.23 2.34 0.43 Allowed 'General case' 0 CA--C 1.577 2.006 0 C-N-CA 123.051 0.541 . . . . 25.0 112.366 -169.302 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.13 -31.54 67.28 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.558 0.743 . . . . 25.0 112.186 174.272 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -132.1 -35.51 1.21 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.104 1.15 . . . . 50.0 114.104 -179.046 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.7 mttt 62.05 159.36 0.12 Allowed Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 125.347 1.459 . . . . 50.0 110.969 -171.563 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.99 -10.19 21.12 Favored 'Trans proline' 0 C--O 1.205 -1.14 0 C-N-CA 115.386 -2.61 . . . . 50.0 114.908 -178.54 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -157.37 168.71 26.56 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.717 -1.586 . . . . 25.0 106.717 -179.646 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -157.98 95.87 0.15 Allowed Glycine 0 N--CA 1.472 1.039 0 N-CA-C 110.541 -1.024 . . . . 25.0 110.541 176.153 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.0 t 57.12 40.71 28.11 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 121.671 0.748 . . . . 25.0 111.237 -175.589 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.26 -172.86 14.53 Favored Glycine 0 C--O 1.247 0.945 0 N-CA-C 108.75 -1.74 . . . . 25.0 108.75 -176.15 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.0 179.53 39.56 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.708 -1.051 . . . . 25.0 112.195 -178.986 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.1 m -89.15 150.23 22.8 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 118.66 1.23 . . . . 25.0 109.829 -179.034 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.24 -34.04 0.65 Allowed Glycine 0 C--O 1.201 -1.944 0 CA-C-N 116.042 -0.526 . . . . 25.0 113.568 178.483 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.93 81.55 3.48 Favored 'General case' 0 C--O 1.206 -1.236 0 CA-C-O 124.033 1.873 . . . . 25.0 113.14 -179.711 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.83 166.68 39.84 Favored Glycine 0 C--O 1.203 -1.819 0 O-C-N 119.845 -1.784 . . . . 25.0 111.933 -176.681 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.5 m -130.76 26.53 4.99 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 114.006 1.113 . . . . 25.0 114.006 -175.874 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -64.6 143.76 57.69 Favored 'General case' 0 CA--C 1.501 -0.906 0 O-C-N 120.823 -1.173 . . . . 50.0 108.85 -172.872 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -76.23 58.6 1.28 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.527 1.156 . . . . 25.0 113.186 -179.903 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -64.06 142.52 58.38 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-N 115.208 -0.905 . . . . 50.0 110.596 179.44 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -77.95 166.39 22.92 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.494 -0.775 . . . . 25.0 111.673 -177.033 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.4 m -56.0 152.6 20.53 Favored Pre-proline 0 CA--C 1.559 1.321 0 C-N-CA 125.515 1.526 . . . . 25.0 113.133 -178.742 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -71.6 159.79 50.11 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 N-CA-C 114.051 0.75 . . . . 50.0 114.051 179.418 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.73 152.09 78.11 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 120.652 0.901 . . . . 50.0 111.157 169.938 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.58 155.68 65.87 Favored 'Trans proline' 0 C--N 1.352 0.733 0 N-CA-C 115.279 1.223 . . . . 50.0 115.279 -173.269 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -85.05 147.4 47.82 Favored Pre-proline 0 N--CA 1.478 0.963 0 CA-C-N 115.652 -0.704 . . . . 50.0 109.69 176.732 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.03 161.69 42.8 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 117.577 -1.149 . . . . 50.0 111.023 178.901 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -65.29 160.32 42.95 Favored 'Trans proline' 0 C--N 1.348 0.512 0 N-CA-C 114.62 0.969 . . . . 50.0 114.62 179.17 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -107.36 -25.38 11.47 Favored 'General case' 0 C--O 1.193 -1.906 0 CA-C-N 115.869 -0.605 . . . . 50.0 112.353 178.339 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.5 p -138.44 133.51 32.88 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.225 1.012 . . . . 25.0 109.822 -175.859 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -161.24 150.31 16.4 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.149 1.379 . . . . 50.0 109.37 -178.734 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.9 t -145.35 140.54 27.78 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.865 -0.791 . . . . 25.0 108.865 179.133 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 80.4 m -80.62 147.93 30.49 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.618 -0.882 . . . . 25.0 108.618 176.596 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 124.479 2.085 . . . . 25.0 112.784 -178.196 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.618 0 N-CA-C 115.24 0.856 . . . . 25.0 115.24 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.4 m 57.39 39.74 27.98 Favored 'General case' 0 C--O 1.19 -2.052 0 C-N-CA 124.835 1.254 . . . . 25.0 112.407 178.62 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 61.2 mtt -92.11 -68.94 0.77 Allowed 'General case' 0 C--O 1.206 -1.194 0 N-CA-C 114.124 1.157 . . . . 25.0 114.124 -179.067 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -125.95 61.96 1.25 Allowed 'General case' 0 C--O 1.198 -1.629 0 N-CA-C 106.361 -1.718 . . . . 50.0 106.361 -178.814 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -124.27 163.02 22.51 Favored 'General case' 0 C--O 1.201 -1.483 0 CA-C-N 113.54 -1.664 . . . . 50.0 109.565 -175.168 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.6 mt -71.1 -40.91 71.23 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.249 -1.341 . . . . 50.0 111.424 178.751 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.0 m120 57.48 35.84 26.32 Favored 'General case' 0 C--O 1.253 1.275 0 C-N-CA 124.136 0.975 . . . . 50.0 110.753 -178.865 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.6 m -101.4 157.09 4.4 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 N-CA-C 107.687 -1.227 . . . . 50.0 107.687 176.044 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.07 166.25 12.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 118.324 -0.846 . . . . 50.0 109.173 -176.929 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.94 154.59 40.54 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.901 0.773 . . . . 25.0 112.953 172.651 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -117.9 129.49 55.66 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 124.07 0.948 . . . . 50.0 111.086 -179.527 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.43 126.36 29.43 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-O 118.614 -0.708 . . . . 25.0 109.294 177.866 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt -89.01 -28.81 19.94 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.013 0.925 . . . . 50.0 111.376 178.797 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -139.85 170.11 16.48 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.12 -1.437 . . . . 50.0 107.12 179.919 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -83.91 176.18 9.07 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 122.968 0.507 . . . . 50.0 110.642 -177.801 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -151.12 153.34 34.83 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 108.008 -1.108 . . . . 50.0 108.008 -178.216 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.4 t -125.26 136.0 62.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 104.507 -2.405 . . . . 25.0 104.507 170.832 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.27 134.62 42.95 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 114.475 -1.238 . . . . 25.0 110.238 178.013 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -125.22 11.37 8.15 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 123.628 0.58 . . . . 50.0 110.777 -177.341 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.4 t -151.21 150.91 28.34 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 106.228 -1.767 . . . . 50.0 106.228 -179.289 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.75 -12.12 28.49 Favored 'Trans proline' 0 N--CA 1.48 0.683 0 N-CA-C 116.607 1.733 . . . . 50.0 116.607 -175.91 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -83.1 -20.67 34.42 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 107.802 -1.184 . . . . 50.0 107.802 177.73 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -84.06 136.58 33.97 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.723 0.773 . . . . 50.0 110.063 -178.927 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.3 mt -93.57 131.26 39.01 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 113.929 1.085 . . . . 50.0 113.929 -177.997 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 p -86.75 95.1 9.71 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-N 115.212 -0.904 . . . . 50.0 110.85 -179.408 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -126.43 160.57 30.14 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 121.743 -0.598 . . . . 50.0 111.8 179.645 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -121.57 165.47 15.64 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 105.087 -2.19 . . . . 50.0 105.087 -177.254 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -59.02 131.42 50.99 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.54 0.686 . . . . 50.0 110.656 177.532 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.74 -20.02 51.05 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 121.754 -0.591 . . . . 50.0 114.295 -179.006 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -62.29 131.32 48.95 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 106.932 -1.507 . . . . 50.0 106.932 178.723 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.6 mm -102.23 132.43 48.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 106.939 -1.504 . . . . 50.0 106.939 177.817 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 11.2 ptp -131.8 161.87 31.9 Favored 'General case' 0 CA--C 1.495 -1.145 0 O-C-N 121.241 -0.912 . . . . 50.0 109.244 -179.836 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.2 m -101.62 119.19 38.39 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.678 -1.601 . . . . 25.0 106.678 -177.979 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 t -81.69 130.63 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 123.513 1.625 . . . . 50.0 109.321 -179.83 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.4 mt -100.41 -42.92 6.41 Favored 'General case' 0 C--O 1.204 -1.306 0 O-C-N 121.197 -0.939 . . . . 50.0 112.895 178.311 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -148.3 147.41 29.28 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-O 118.539 -0.743 . . . . 50.0 109.518 178.808 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -107.05 147.32 30.11 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.311 -1.366 . . . . 50.0 107.311 173.188 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 56.4 39.65 29.97 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 123.279 1.514 . . . . 50.0 110.665 -173.91 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -64.18 150.71 45.18 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 113.744 -1.571 . . . . 25.0 110.252 -175.327 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 56.7 22.65 7.03 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.076 -1.42 . . . . 50.0 113.3 178.225 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.32 16.93 73.8 Favored Glycine 0 CA--C 1.501 -0.788 0 C-N-CA 120.492 -0.861 . . . . 25.0 112.347 -179.24 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.3 mt -92.66 130.5 38.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.528 -1.286 . . . . 50.0 107.528 175.438 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -75.2 122.22 23.31 Favored 'General case' 0 C--O 1.258 1.526 0 O-C-N 121.232 -0.918 . . . . 25.0 110.68 176.996 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.83 -5.13 85.36 Favored Glycine 0 C--N 1.331 0.303 0 N-CA-C 116.089 1.196 . . . . 50.0 116.089 172.686 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -97.07 136.04 38.19 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 117.824 0.812 . . . . 50.0 109.764 177.085 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -114.41 142.85 45.82 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-O 117.595 -1.193 . . . . 50.0 108.019 -177.946 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.5 tp -85.42 125.28 32.87 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.128 -2.175 . . . . 50.0 105.128 175.059 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.8 m -135.47 164.08 28.61 Favored 'General case' 0 C--O 1.253 1.289 0 O-C-N 121.705 -0.622 . . . . 50.0 109.862 177.336 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.9 t -112.61 120.61 42.16 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.215 -1.402 . . . . 50.0 107.215 171.052 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.8 tp -132.52 136.45 46.64 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 105.756 -1.942 . . . . 75.0 105.756 -175.785 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.1 m170 54.16 29.69 10.9 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.527 0.68 . . . . 25.0 109.985 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.91 11.04 81.18 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-O 118.454 -1.192 . . . . 25.0 116.061 178.919 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -122.66 146.86 47.08 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.356 -1.35 . . . . 50.0 107.356 175.477 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -89.08 160.8 16.87 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.15 -1.055 . . . . 50.0 108.15 178.009 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.43 -174.43 41.91 Favored Glycine 0 C--O 1.242 0.623 0 N-CA-C 108.349 -1.901 . . . . 50.0 108.349 -178.758 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 pt -118.57 152.92 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.615 0 CA-C-O 122.71 1.243 . . . . 50.0 111.793 -172.238 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.9 m -143.92 150.91 51.27 Favored Pre-proline 0 C--N 1.306 -1.288 0 CA-C-N 112.384 -2.189 . . . . 50.0 110.807 -174.842 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.3 128.17 10.3 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 O-C-N 121.949 0.447 . . . . 50.0 112.565 -179.318 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.57 -22.42 78.99 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 118.962 -1.59 . . . . 50.0 115.642 -174.624 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -28.18 69.78 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 122.094 -0.651 . . . . 50.0 112.38 -175.54 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -108.35 28.02 8.75 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 122.013 0.911 . . . . 50.0 110.322 178.985 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.5 mt -121.37 159.17 26.7 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 114.423 1.268 . . . . 50.0 114.423 175.126 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -134.94 115.51 13.66 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.779 0.832 . . . . 50.0 109.729 176.36 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.7 mm -67.03 129.15 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 112.422 0.527 . . . . 50.0 112.422 177.834 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.5 mt -105.53 78.03 1.33 Allowed 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.131 -1.433 . . . . 50.0 107.131 179.219 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.16 163.21 3.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.744 -0.465 . . . . 50.0 109.744 178.0 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -157.15 146.06 13.04 Favored Glycine 0 C--O 1.203 -1.827 0 O-C-N 125.032 1.457 . . . . 25.0 109.702 177.483 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 28.0 ttt -167.6 -61.41 0.03 OUTLIER 'General case' 0 C--O 1.205 -1.26 0 N-CA-C 101.853 -3.388 . . . . 25.0 101.853 174.947 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.69 -55.12 0.38 Allowed 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 113.8 1.037 . . . . 25.0 113.8 177.855 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -73.07 -36.32 66.83 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.91 -0.586 . . . . 25.0 111.68 -179.27 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.2 tttt 69.63 -65.05 0.32 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.593 1.957 . . . . 50.0 114.681 -179.364 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -148.18 152.86 40.42 Favored Pre-proline 0 C--O 1.263 1.791 0 N-CA-C 107.525 -1.287 . . . . 50.0 107.525 -178.033 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.36 143.35 57.81 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 114.026 -3.516 . . . . 50.0 109.776 -178.079 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.97 76.02 4.15 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 106.719 -1.586 . . . . 25.0 106.719 175.98 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.26 -179.85 39.9 Favored Glycine 0 CA--C 1.505 -0.548 0 CA-C-O 122.904 1.28 . . . . 25.0 112.018 -179.053 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.5 p -76.57 177.54 7.39 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 108.029 -1.1 . . . . 25.0 108.029 177.944 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.84 -34.41 2.22 Favored Glycine 0 C--O 1.21 -1.38 0 N-CA-C 109.057 -1.617 . . . . 25.0 109.057 177.972 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.91 157.15 22.7 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.091 -0.576 . . . . 25.0 112.34 173.605 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.2 m -79.8 141.54 36.16 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.165 -0.614 . . . . 25.0 110.664 -179.336 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.73 -166.91 34.84 Favored Glycine 0 C--O 1.22 -0.746 0 N-CA-C 108.929 -1.668 . . . . 25.0 108.929 173.472 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 p -72.32 140.49 48.55 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 119.849 1.825 . . . . 25.0 106.553 174.284 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.48 54.95 0.43 Allowed Glycine 0 CA--C 1.538 1.525 0 N-CA-C 111.247 -0.741 . . . . 25.0 111.247 -175.764 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 m 56.61 -165.3 0.14 Allowed 'General case' 0 C--O 1.255 1.369 0 N-CA-C 115.169 1.544 . . . . 25.0 115.169 -178.692 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -87.39 122.35 31.02 Favored 'General case' 0 C--O 1.207 -1.175 0 N-CA-C 112.083 0.401 . . . . 50.0 112.083 179.388 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -140.66 122.23 15.17 Favored 'General case' 0 C--O 1.259 1.561 0 CA-C-O 117.79 -1.1 . . . . 25.0 110.041 178.244 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -82.06 116.34 21.61 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 124.52 1.138 . . . . 50.0 112.225 178.879 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -154.3 170.19 21.89 Favored 'General case' 0 C--O 1.249 1.059 0 N-CA-C 107.659 -1.237 . . . . 25.0 107.659 176.971 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.8 m -118.5 150.46 48.06 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 114.174 1.176 . . . . 25.0 114.174 -177.52 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -64.31 160.67 37.8 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 121.746 1.63 . . . . 50.0 114.386 -178.685 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.92 149.85 86.07 Favored 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 118.51 -0.527 . . . . 50.0 110.892 179.765 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.16 172.39 16.1 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 116.87 -1.62 . . . . 50.0 113.933 -170.652 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -85.07 139.88 36.88 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 106.71 -1.589 . . . . 50.0 106.71 179.307 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -69.69 166.51 27.25 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 117.565 -1.157 . . . . 50.0 110.278 174.203 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.29 149.29 40.06 Favored 'Trans proline' 0 C--O 1.209 -0.962 0 N-CA-C 114.875 1.067 . . . . 50.0 114.875 -178.242 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.7 mtt85 -97.21 -20.7 17.75 Favored 'General case' 0 C--O 1.194 -1.819 0 CA-C-O 121.17 0.509 . . . . 50.0 111.528 -179.359 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.2 p -130.22 147.62 51.97 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 103.517 -2.771 . . . . 25.0 103.517 178.077 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -131.21 112.17 12.58 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 106.224 -1.769 . . . . 50.0 106.224 177.708 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.2 t -142.05 79.4 1.67 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.455 -0.898 . . . . 25.0 112.118 -172.264 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 73.8 m -128.43 99.89 5.58 Favored 'General case' 0 C--O 1.195 -1.764 0 N-CA-C 109.527 -0.546 . . . . 25.0 109.527 178.161 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 C--O 1.241 0.614 0 CA-C-O 126.596 3.093 . . . . 25.0 110.72 -173.139 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 120.871 0.367 . . . . 25.0 110.802 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.8 mt -65.48 -42.15 92.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.598 -0.728 . . . . 25.0 110.294 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 56.27 30.92 17.56 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.206 1.002 . . . . 25.0 111.882 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.7 m -88.62 163.47 2.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 105.526 -2.027 . . . . 25.0 105.526 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.61 173.4 6.56 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.89 -0.782 . . . . 25.0 108.89 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.78 162.46 40.99 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.72 -0.474 . . . . 25.0 109.72 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -126.69 135.6 51.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.817 -1.083 . . . . 25.0 109.648 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.492 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -72.62 120.63 18.5 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.803 -0.635 . . . . 25.0 109.295 172.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.62 -23.25 24.33 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.922 -0.77 . . . . 25.0 108.922 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -140.54 172.28 12.94 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.456 -1.312 . . . . 25.0 107.456 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.72 164.34 18.62 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 123.129 0.572 . . . . 25.0 110.417 174.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -153.73 130.74 11.01 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.962 0.505 . . . . 25.0 110.725 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.23 118.94 48.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 106.035 -1.839 . . . . 25.0 106.035 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.43 143.08 51.93 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.276 -0.874 . . . . 25.0 109.896 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -116.69 -34.84 4.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.039 -0.982 . . . . 25.0 109.685 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.5 m -93.44 153.97 41.34 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.068 -0.716 . . . . 25.0 109.068 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.43 -22.27 33.83 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 117.782 -1.012 . . . . 25.0 113.645 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -81.12 -16.18 53.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.73 0.776 . . . . 25.0 110.85 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -84.52 138.36 32.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.489 0.661 . . . . 25.0 110.299 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.6 mt -92.84 130.49 38.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.61 0.719 . . . . 25.0 110.048 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.6 t -91.55 137.57 32.26 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.686 -1.598 . . . . 25.0 106.686 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -154.09 166.19 33.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.679 0.752 . . . . 25.0 112.642 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -110.09 158.87 17.84 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.638 -0.875 . . . . 25.0 108.638 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -57.48 131.03 48.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.701 -1.222 . . . . 25.0 107.701 171.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.23 -19.9 46.98 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-O 119.154 -0.803 . . . . 25.0 113.889 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -59.74 144.71 47.47 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.76 0.79 . . . . 25.0 110.545 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.4 mm -114.04 130.69 67.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.58 -1.191 . . . . 25.0 107.836 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -135.34 156.47 48.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.967 -0.383 . . . . 25.0 109.967 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.7 m -92.66 126.17 37.63 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.159 -1.052 . . . . 25.0 108.159 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.5 t -89.86 122.82 41.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.259 -1.015 . . . . 25.0 108.259 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.644 HD12 HD22 ' A' ' 47' ' ' LEU . 77.4 mt -88.26 -48.07 7.95 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.646 -0.706 . . . . 25.0 109.14 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -152.52 167.03 30.14 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.345 -0.983 . . . . 25.0 108.345 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -116.84 154.29 30.99 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 106.811 -1.551 . . . . 25.0 106.811 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 58.13 40.6 24.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.918 1.818 . . . . 25.0 108.982 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -64.87 149.64 49.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 112.59 -2.095 . . . . 25.0 110.925 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 60.33 9.56 2.02 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.98 0.912 . . . . 25.0 113.37 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.99 12.95 80.35 Favored Glycine 0 C--N 1.33 0.244 0 N-CA-C 111.114 -0.795 . . . . 25.0 111.114 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 99.0 mt -91.24 117.87 30.0 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.42 -0.585 . . . . 25.0 109.42 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -63.6 126.47 27.63 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.707 -0.679 . . . . 25.0 110.928 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.12 -0.28 84.02 Favored Glycine 0 CA--C 1.518 0.261 0 N-CA-C 115.515 0.966 . . . . 25.0 115.515 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -100.89 133.49 45.29 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 119.012 1.406 . . . . 25.0 109.873 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -113.47 141.97 46.48 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.771 -0.825 . . . . 25.0 108.771 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.644 HD22 HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -82.39 121.66 27.0 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.596 -2.001 . . . . 25.0 105.596 177.785 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 88.4 m -129.88 160.92 32.05 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.829 -0.348 . . . . 25.0 111.39 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -113.9 122.03 45.75 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.989 -1.856 . . . . 25.0 105.989 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.0 tp -145.5 139.7 26.98 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.819 -1.178 . . . . 25.0 107.819 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.9 m170 57.25 27.0 12.98 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.412 0.685 . . . . 25.0 111.97 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.1 0.29 89.46 Favored Glycine 0 C--O 1.221 -0.704 0 N-CA-C 114.9 0.72 . . . . 25.0 114.9 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -124.15 156.14 37.23 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 117.89 0.845 . . . . 25.0 109.757 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -102.37 154.98 18.55 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.326 -0.62 . . . . 25.0 109.326 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.43 -162.12 29.9 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 106.427 -2.669 . . . . 25.0 106.427 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 pt -118.55 151.49 20.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.649 0.737 . . . . 25.0 111.876 -174.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.2 m -140.38 146.93 47.59 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 114.929 -1.032 . . . . 25.0 110.025 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.87 122.16 7.09 Favored 'Trans proline' 0 C--O 1.241 0.65 0 C-N-CA 118.35 -0.633 . . . . 25.0 112.434 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.94 -23.09 65.38 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 121.607 -0.33 . . . . 25.0 113.01 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.39 -20.42 64.42 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 122.335 -0.509 . . . . 25.0 112.203 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -109.48 12.28 24.58 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 122.194 -0.317 . . . . 25.0 111.777 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -126.72 156.79 40.57 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 114.946 1.461 . . . . 25.0 114.946 -174.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -129.29 123.1 31.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.444 -0.798 . . . . 25.0 110.297 175.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.4 mm -67.76 137.21 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.772 -0.825 . . . . 25.0 108.772 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.6 mt -117.76 115.75 25.63 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.43 -1.693 . . . . 25.0 106.43 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.322 -0.618 0 N-CA-C 109.38 -0.6 . . . . 25.0 109.38 -179.824 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt . . . . . 0 CA--C 1.547 0.852 0 N-CA-C 106.029 -1.841 . . . . 25.0 106.029 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 CA--C 1.539 0.766 0 O-C-N 121.992 0.469 . . . . 25.0 112.864 -177.453 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 121.634 0.731 . . . . 25.0 111.849 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.9 mt -69.79 -40.72 75.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.045 -0.98 . . . . 25.0 109.899 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.2 m120 57.6 23.61 9.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.614 1.165 . . . . 25.0 113.157 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.7 m -85.65 162.98 2.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.387 -0.968 . . . . 25.0 108.387 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.74 168.18 10.49 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.374 -0.829 . . . . 25.0 110.098 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.6 166.81 26.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.014 0.435 . . . . 25.0 110.781 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HB2' HD11 ' A' ' 65' ' ' LEU . 29.2 ttmt -133.31 135.59 44.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.951 -1.022 . . . . 25.0 110.737 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.477 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -73.38 131.99 42.5 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.703 0.627 . . . . 25.0 110.583 173.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.22 -21.96 15.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.983 0.421 . . . . 25.0 110.898 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -143.47 168.38 19.98 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.344 -1.725 . . . . 25.0 106.344 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -75.69 160.44 30.06 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 123.459 0.474 . . . . 25.0 111.027 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -146.81 147.81 31.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.215 -0.291 . . . . 25.0 110.215 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.6 t -120.76 132.11 71.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 104.519 -2.4 . . . . 25.0 104.519 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.58 122.06 21.64 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.336 -0.987 . . . . 25.0 108.336 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -108.86 4.94 24.04 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.324 -0.991 . . . . 25.0 108.324 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.6 m -145.05 152.4 51.22 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 106.771 -1.566 . . . . 25.0 106.771 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.9 -21.58 32.64 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 N-CA-C 115.936 1.475 . . . . 25.0 115.936 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.28 -12.7 54.23 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.95 0.881 . . . . 25.0 110.238 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -82.98 139.34 33.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.943 0.878 . . . . 25.0 111.406 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.415 ' HB2' HG13 ' A' ' 57' ' ' VAL . 67.1 mt -90.98 127.68 36.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.185 0.993 . . . . 25.0 109.672 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -88.88 139.54 30.35 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 106.225 -1.769 . . . . 25.0 106.225 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -156.66 165.18 36.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.963 0.411 . . . . 25.0 110.605 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -110.83 162.79 14.44 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.566 -0.531 . . . . 25.0 109.566 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -58.5 131.25 50.19 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.545 -0.752 . . . . 25.0 109.386 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.09 -11.17 72.81 Favored Glycine 0 CA--C 1.517 0.205 0 CA-C-O 119.039 -0.867 . . . . 25.0 114.48 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -62.49 150.57 39.79 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 118.193 0.996 . . . . 25.0 109.636 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.6 mm -116.28 134.31 60.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.9 -1.045 . . . . 25.0 109.289 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -139.89 160.27 40.29 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.167 -0.679 . . . . 25.0 109.167 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.7 m -97.22 127.25 43.01 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.043 -1.095 . . . . 25.0 108.043 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.9 t -90.5 126.48 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 107.343 -1.354 . . . . 25.0 107.343 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.636 HD12 HD22 ' A' ' 47' ' ' LEU . 82.1 mt -94.96 -43.1 8.32 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.889 -0.782 . . . . 25.0 108.889 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -150.23 155.08 39.07 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.679 -0.86 . . . . 25.0 108.679 -177.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -111.65 149.67 31.21 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.105 -0.702 . . . . 25.0 109.105 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 56.38 39.9 29.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 123.61 1.672 . . . . 25.0 108.654 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -64.31 153.56 37.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 112.591 -2.095 . . . . 25.0 110.777 -176.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 60.76 8.95 1.98 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.683 0.793 . . . . 25.0 111.976 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.39 13.62 81.46 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.114 -0.794 . . . . 25.0 111.114 -176.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.5 mt -88.05 126.75 35.26 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.066 0.46 . . . . 25.0 109.8 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -67.64 125.03 24.92 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.352 -0.385 . . . . 25.0 110.665 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.0 1.46 85.26 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 117.038 1.575 . . . . 25.0 117.038 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -100.94 134.23 44.23 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 119.176 1.488 . . . . 25.0 109.849 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -113.79 140.68 48.1 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.909 -0.775 . . . . 25.0 108.909 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.636 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -79.81 123.62 27.89 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 104.821 -2.288 . . . . 25.0 104.821 176.633 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 98.0 m -134.98 163.07 30.69 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.668 -0.413 . . . . 25.0 111.562 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.0 t -117.21 126.5 52.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.908 -1.886 . . . . 25.0 105.908 170.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.0 tp -138.7 126.82 22.65 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.072 -1.455 . . . . 25.0 107.072 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.0 m170 55.54 30.38 15.13 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.273 0.559 . . . . 25.0 111.6 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.42 -4.87 80.11 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 116.115 1.206 . . . . 25.0 116.115 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -110.01 152.58 25.74 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.865 -1.161 . . . . 25.0 107.865 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -106.75 160.43 15.48 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.57 -0.53 . . . . 25.0 109.57 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.11 -160.11 31.52 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 105.398 -3.081 . . . . 25.0 105.398 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.1 pt -120.48 152.84 23.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.794 0.807 . . . . 25.0 111.485 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.415 HG13 ' HB2' ' A' ' 24' ' ' LEU . 2.9 m -139.0 145.56 45.88 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 114.714 -1.13 . . . . 25.0 109.111 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.73 124.54 7.59 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 117.045 -1.504 . . . . 25.0 112.19 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.84 -10.27 72.01 Favored Glycine 0 C--O 1.223 -0.537 0 CA-C-N 116.032 -0.531 . . . . 25.0 112.774 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.76 -19.32 62.34 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.39 -0.476 . . . . 25.0 112.083 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -130.7 27.34 4.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.117 -0.492 . . . . 25.0 110.47 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 12' ' ' ALA . 0.9 OUTLIER -129.26 156.2 44.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.303 0.573 . . . . 25.0 111.329 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -129.64 127.74 41.22 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.811 -0.631 . . . . 25.0 110.59 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.8 mm -72.09 135.26 28.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.131 -1.063 . . . . 25.0 108.131 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 11' ' ' LYS . 83.4 mt -119.35 104.6 10.52 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.161 -0.681 . . . . 25.0 109.161 176.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 CA--C 1.544 0.712 0 CA-C-O 122.044 0.926 . . . . 25.0 109.208 176.132 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt . . . . . 0 CA--C 1.535 0.404 0 N-CA-C 110.162 -0.31 . . . . 25.0 110.162 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 CA--C 1.546 1.109 0 O-C-N 122.201 0.579 . . . . 25.0 112.988 178.251 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 . . . . . 0 CA--C 1.519 -0.229 0 N-CA-C 114.327 1.232 . . . . 25.0 114.327 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.8 mt -65.59 -39.22 91.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.512 -1.222 . . . . 25.0 110.687 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 57.27 28.72 15.62 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.173 0.989 . . . . 25.0 112.444 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 m -90.35 152.11 3.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.143 -1.058 . . . . 25.0 108.143 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.98 167.38 12.84 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.187 -0.671 . . . . 25.0 109.187 -176.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.35 161.17 43.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.732 0.301 . . . . 25.0 111.27 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -126.9 129.58 48.48 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.688 0.795 . . . . 25.0 110.157 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.46 131.28 43.81 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.746 -0.464 . . . . 25.0 109.746 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.0 mt -95.83 -21.16 18.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.074 0.464 . . . . 25.0 111.034 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -144.48 175.95 9.75 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 103.814 -2.661 . . . . 25.0 103.814 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -92.05 179.17 5.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.301 0.5 . . . . 25.0 111.53 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -159.04 154.77 26.26 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.075 0.55 . . . . 25.0 110.135 173.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.4 t -124.6 127.4 72.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 105.986 -1.857 . . . . 25.0 105.986 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.74 129.6 38.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.961 -0.563 . . . . 25.0 110.783 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -105.33 1.11 27.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.536 0.684 . . . . 25.0 109.838 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.9 p -151.83 158.86 33.83 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.016 -1.105 . . . . 25.0 108.016 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.75 -16.85 33.39 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 118.321 -0.652 . . . . 25.0 112.873 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.75 -21.68 54.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.419 0.628 . . . . 25.0 110.044 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -95.46 146.21 24.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.522 0.677 . . . . 25.0 111.411 -176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.4 ' HB2' HG13 ' A' ' 57' ' ' VAL . 55.1 mt -100.14 132.61 45.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.55 0.691 . . . . 25.0 110.166 177.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.6 m -82.64 146.44 29.1 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 105.527 -2.027 . . . . 25.0 105.527 172.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -157.73 164.87 36.67 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.358 -0.608 . . . . 25.0 109.358 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.86 158.59 23.73 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.526 -0.916 . . . . 25.0 108.526 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -56.24 128.13 34.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.571 -0.741 . . . . 25.0 109.891 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.72 -10.85 64.63 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-O 118.985 -0.897 . . . . 25.0 114.061 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -61.52 148.7 41.22 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.033 0.916 . . . . 25.0 110.775 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.4 mm -112.02 134.02 55.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.457 -1.247 . . . . 25.0 108.481 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.4 ptp -143.19 162.23 36.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.057 -0.72 . . . . 25.0 109.057 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.9 m -98.81 125.87 44.29 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.042 -1.096 . . . . 25.0 108.042 177.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.8 t -89.6 125.61 42.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.786 -1.19 . . . . 25.0 107.786 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.714 HD12 HD22 ' A' ' 47' ' ' LEU . 73.1 mt -94.54 -49.48 5.64 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.455 -1.248 . . . . 25.0 109.644 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -143.34 160.39 40.61 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.545 -1.279 . . . . 25.0 107.545 -174.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -125.68 150.71 47.41 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 106.899 -1.519 . . . . 25.0 106.899 175.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 56.27 39.15 30.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.398 1.571 . . . . 25.0 108.274 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -66.08 148.61 51.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.443 -1.708 . . . . 25.0 109.813 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 60.18 11.81 2.96 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.72 0.808 . . . . 25.0 113.013 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.61 13.62 81.25 Favored Glycine 0 C--O 1.229 -0.177 0 N-CA-C 111.296 -0.721 . . . . 25.0 111.296 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.9 mt -91.19 112.19 23.99 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.709 -0.478 . . . . 25.0 109.709 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -58.52 124.92 21.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.497 -0.774 . . . . 25.0 110.858 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.0 -0.19 83.79 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 116.02 1.168 . . . . 25.0 116.02 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -98.03 132.26 43.73 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 119.303 1.552 . . . . 25.0 110.76 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -111.15 138.58 47.42 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.206 -1.035 . . . . 25.0 108.206 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.714 HD22 HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -82.21 125.82 31.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 104.681 -2.34 . . . . 25.0 104.681 178.727 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.9 m -134.65 164.29 27.84 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 111.951 0.352 . . . . 25.0 111.951 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.0 t -117.27 123.84 47.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.828 -1.545 . . . . 25.0 106.828 171.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.8 tp -151.73 142.63 22.99 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 106.875 -1.528 . . . . 25.0 106.875 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 42.5 m80 56.4 28.25 13.29 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.319 0.647 . . . . 25.0 112.073 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.75 1.15 76.95 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 115.006 0.762 . . . . 25.0 115.006 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -123.62 161.05 25.79 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.026 -0.731 . . . . 25.0 109.026 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -108.53 156.63 19.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.174 -0.676 . . . . 25.0 109.174 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.58 -161.22 28.37 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 105.383 -3.087 . . . . 25.0 105.383 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.9 pt -120.73 153.18 23.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-O 121.728 0.775 . . . . 25.0 111.034 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 24' ' ' LEU . 3.2 m -141.74 147.38 45.16 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 114.473 -1.239 . . . . 25.0 107.674 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.82 126.48 8.83 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 117.086 -1.476 . . . . 25.0 111.713 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.17 -12.0 75.63 Favored Glycine 0 C--O 1.222 -0.621 0 CA-C-N 116.293 -0.412 . . . . 25.0 113.131 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -66.67 -13.54 61.37 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.781 0.66 . . . . 25.0 112.781 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -131.97 27.13 4.58 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.215 -0.661 . . . . 25.0 109.215 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.8 tp -131.96 147.44 52.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.737 -0.665 . . . . 25.0 109.709 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -125.55 120.09 29.92 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.408 -0.36 . . . . 25.0 111.743 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.98 136.1 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.037 -0.727 . . . . 25.0 109.037 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.1 mt -116.78 81.66 1.67 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.945 -1.502 . . . . 25.0 106.945 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 121.158 0.504 . . . . 25.0 111.704 -176.06 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt . . . . . 0 CA--C 1.542 0.639 0 N-CA-C 109.132 -0.692 . . . . 25.0 109.132 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 CA--C 1.546 1.086 0 O-C-N 121.963 0.454 . . . . 25.0 112.704 179.833 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 . . . . . 0 CA--C 1.514 -0.439 0 CA-C-O 120.704 0.287 . . . . 25.0 110.354 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.2 mt -67.73 -39.86 84.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.652 -0.704 . . . . 25.0 109.228 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 56.45 32.38 20.57 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.947 0.899 . . . . 25.0 111.795 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.4 m -94.6 153.91 3.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 107.032 -1.47 . . . . 25.0 107.032 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.7 167.08 11.68 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.042 -1.095 . . . . 25.0 108.042 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.96 154.46 37.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.674 0.273 . . . . 25.0 110.489 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -118.69 132.13 56.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.835 -0.62 . . . . 25.0 110.838 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.63 125.64 27.38 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.184 -0.673 . . . . 25.0 109.184 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.9 mt -91.7 -21.23 20.86 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.257 0.551 . . . . 25.0 110.397 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -141.97 176.05 9.25 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 104.565 -2.383 . . . . 25.0 104.565 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -91.48 177.78 6.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.715 0.293 . . . . 25.0 110.906 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -155.64 155.1 32.66 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.355 0.262 . . . . 25.0 111.647 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.8 t -124.85 132.28 71.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 103.736 -2.69 . . . . 25.0 103.736 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.73 127.64 33.15 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.857 -0.423 . . . . 25.0 109.857 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -101.83 2.72 38.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.727 0.775 . . . . 25.0 110.535 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.2 p -149.88 157.73 37.74 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 108.014 -1.106 . . . . 25.0 108.014 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.8 -15.21 33.19 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 118.177 -0.749 . . . . 25.0 113.007 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -76.55 -21.43 55.69 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.407 0.622 . . . . 25.0 109.475 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -93.75 139.45 30.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.987 0.898 . . . . 25.0 111.829 -172.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.467 ' HB2' HG13 ' A' ' 57' ' ' VAL . 55.4 mt -90.16 129.32 36.45 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.21 -0.905 . . . . 25.0 109.546 177.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -88.21 143.05 27.27 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 105.411 -2.07 . . . . 25.0 105.411 175.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -157.25 167.97 28.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.732 0.301 . . . . 25.0 110.297 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.69 165.4 12.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.737 0.78 . . . . 25.0 110.327 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.1 128.41 36.28 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.218 -0.901 . . . . 25.0 110.069 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.83 -12.49 64.23 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-O 118.922 -0.932 . . . . 25.0 114.933 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -59.65 152.98 21.11 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.977 0.894 . . . . 25.0 112.001 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.0 mm -114.77 130.65 68.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.428 -1.26 . . . . 25.0 109.14 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.8 ptp -137.84 151.57 48.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.469 -0.567 . . . . 25.0 109.469 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.0 m -90.78 124.75 35.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.291 -1.003 . . . . 25.0 108.291 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t -87.34 123.14 39.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 107.893 -1.151 . . . . 25.0 107.893 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.7 mt -89.74 -46.23 8.75 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.051 -0.722 . . . . 25.0 109.051 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -149.56 165.15 33.11 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.771 -0.826 . . . . 25.0 108.771 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HE ' ' HB3' ' A' ' 37' ' ' ARG . 38.2 mtp180 -115.77 154.61 29.31 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.19 -0.67 . . . . 25.0 109.19 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 57.67 40.76 26.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 124.12 1.914 . . . . 25.0 107.463 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.6 t -65.74 151.65 46.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 111.808 -2.451 . . . . 25.0 111.699 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 58.03 18.13 4.92 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.373 0.879 . . . . 25.0 113.373 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.52 16.6 80.53 Favored Glycine 0 C--O 1.227 -0.285 0 N-CA-C 111.699 -0.56 . . . . 25.0 111.699 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.7 mt -98.45 113.93 26.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.088 0.471 . . . . 25.0 110.759 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -59.34 127.7 33.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.682 -0.69 . . . . 25.0 110.755 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.09 -2.03 67.07 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 115.85 1.1 . . . . 25.0 115.85 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -95.83 132.8 40.71 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 119.028 1.414 . . . . 25.0 109.023 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -113.52 138.23 50.43 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.793 -1.188 . . . . 25.0 107.793 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.5 tp -81.41 125.43 30.41 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 105.922 -1.881 . . . . 25.0 105.922 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 91.4 m -134.0 161.99 33.3 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.201 0.524 . . . . 25.0 111.784 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.6 t -113.64 122.5 47.35 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.123 -1.436 . . . . 25.0 107.123 170.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.1 tp -144.62 133.03 21.91 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.919 -0.771 . . . . 25.0 108.919 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 42.8 m80 54.09 31.98 14.82 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.427 0.691 . . . . 25.0 112.275 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.16 0.15 88.44 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.087 -0.578 . . . . 25.0 114.507 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -109.11 141.63 41.02 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 117.77 0.785 . . . . 25.0 109.346 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -96.89 143.19 28.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 106.553 -1.647 . . . . 25.0 106.553 169.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.69 -163.72 29.45 Favored Glycine 0 CA--C 1.496 -1.117 0 N-CA-C 103.647 -3.781 . . . . 25.0 103.647 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.7 pt -121.82 158.54 25.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-O 121.3 0.571 . . . . 25.0 110.56 -174.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.467 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.2 m -142.53 148.68 47.92 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 115.297 -0.865 . . . . 25.0 109.214 -177.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.54 120.43 6.71 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 118.359 -0.627 . . . . 25.0 110.967 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.74 -10.42 80.08 Favored Glycine 0 C--O 1.226 -0.371 0 O-C-N 121.878 -0.514 . . . . 25.0 114.049 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -72.8 -5.88 41.02 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.788 0.662 . . . . 25.0 112.788 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -130.01 26.49 5.21 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.6 mt -124.03 155.38 38.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.807 0.813 . . . . 25.0 111.435 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -126.73 120.04 28.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.843 -1.072 . . . . 25.0 109.428 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.1 mm -71.33 136.15 26.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.882 -0.785 . . . . 25.0 108.882 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.4 mt -115.42 94.73 4.84 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.546 -1.279 . . . . 25.0 107.546 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.54 0 CA-C-O 121.299 0.571 . . . . 25.0 111.562 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 92.4 mttt . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 110.184 -0.302 . . . . 25.0 110.184 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.539 0.755 0 C-N-CA 117.881 -0.946 . . . . 25.0 111.57 176.064 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 . . . . . 0 N--CA 1.463 0.209 0 N-CA-C 112.204 0.446 . . . . 25.0 112.204 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.2 mt -64.73 -41.63 95.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.248 -0.887 . . . . 25.0 111.161 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 54.91 34.82 23.06 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.919 0.887 . . . . 25.0 112.249 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 m -95.48 158.47 3.0 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 104.485 -2.413 . . . . 25.0 104.485 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.13 174.03 7.11 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.776 -0.824 . . . . 25.0 108.776 -175.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.19 161.54 41.79 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.176 -0.305 . . . . 25.0 110.176 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -128.23 130.52 48.07 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.513 0.725 . . . . 25.0 110.031 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.59 133.66 47.87 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.438 0.461 . . . . 25.0 110.141 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.78 -19.68 16.6 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.351 0.596 . . . . 25.0 110.579 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -143.22 171.73 13.69 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.681 -1.6 . . . . 25.0 106.681 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -77.86 167.46 21.49 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.324 0.39 . . . . 25.0 110.868 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -151.75 150.15 29.86 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-O 120.749 0.309 . . . . 25.0 111.07 170.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.6 t -124.93 136.28 61.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 104.528 -2.397 . . . . 25.0 104.528 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.07 136.96 48.5 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 124.27 0.982 . . . . 25.0 108.548 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -117.9 1.09 12.05 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.864 0.84 . . . . 25.0 109.653 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -128.02 146.29 58.64 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 105.799 -1.926 . . . . 25.0 105.799 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -69.89 -18.34 36.46 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 117.386 -1.276 . . . . 25.0 112.638 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -77.53 -15.64 59.14 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.18 -0.464 . . . . 25.0 110.624 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -101.47 140.58 35.57 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.421 -0.955 . . . . 25.0 108.421 -176.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.8 mt -101.37 126.16 48.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.992 0.901 . . . . 25.0 111.688 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.18 145.57 26.35 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.605 -1.257 . . . . 25.0 107.605 175.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -159.29 165.07 34.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.261 0.553 . . . . 25.0 110.856 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -107.34 153.09 23.27 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.509 -1.293 . . . . 25.0 107.509 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -54.65 129.84 38.1 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.996 -0.742 . . . . 25.0 108.996 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.14 -11.28 70.85 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-O 118.899 -0.945 . . . . 25.0 114.518 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -64.06 156.7 27.38 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.989 0.894 . . . . 25.0 110.077 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.6 mm -120.13 135.36 60.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.68 -1.146 . . . . 25.0 109.322 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -141.81 158.2 44.09 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.5 -0.556 . . . . 25.0 109.5 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 m -92.09 128.93 38.12 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 108.287 -1.005 . . . . 25.0 108.287 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.2 t -92.08 123.82 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 N-CA-C 108.279 -1.008 . . . . 25.0 108.279 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.59 HD12 HD22 ' A' ' 47' ' ' LEU . 77.9 mt -88.96 -45.81 9.38 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.414 -0.812 . . . . 25.0 109.284 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -155.31 168.78 25.96 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.512 -0.921 . . . . 25.0 108.512 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -120.39 152.63 37.64 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 106.621 -1.622 . . . . 25.0 106.621 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 58.03 43.93 20.26 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 125.731 1.894 . . . . 25.0 109.119 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 t -69.41 155.79 39.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 112.65 -2.068 . . . . 25.0 111.112 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 58.72 14.75 3.33 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.801 1.037 . . . . 25.0 113.801 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.88 13.86 81.64 Favored Glycine 0 C--O 1.23 -0.148 0 N-CA-C 111.59 -0.604 . . . . 25.0 111.59 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.8 mt -94.33 132.61 38.76 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 110.107 -0.331 . . . . 25.0 110.107 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -78.41 128.64 33.92 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.855 -0.795 . . . . 25.0 108.855 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.96 -2.55 83.41 Favored Glycine 0 C--O 1.239 0.423 0 N-CA-C 116.319 1.288 . . . . 25.0 116.319 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -101.87 133.94 45.85 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 118.428 1.114 . . . . 25.0 108.307 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.3 m0 -115.62 143.23 45.64 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.59 HD22 HD12 ' A' ' 35' ' ' LEU . 0.7 OUTLIER -85.08 123.76 30.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.916 -1.883 . . . . 25.0 105.916 179.032 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.1 m -130.71 162.1 30.2 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.022 0.379 . . . . 25.0 112.022 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.0 t -114.34 119.79 38.15 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.038 -1.838 . . . . 25.0 106.038 171.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.8 tp -141.0 126.87 19.21 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.294 -1.002 . . . . 25.0 108.294 -175.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.0 m170 55.64 31.85 18.13 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.262 0.625 . . . . 25.0 111.279 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.63 0.95 88.65 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 114.676 0.63 . . . . 25.0 114.676 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -107.97 155.2 20.59 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 106.691 -1.596 . . . . 25.0 106.691 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -121.89 144.44 48.85 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.043 -1.466 . . . . 25.0 107.043 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.65 -161.6 27.25 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 107.1 -2.4 . . . . 25.0 107.1 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.7 pt -115.77 150.15 17.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.707 0.765 . . . . 25.0 111.053 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -138.28 145.41 47.09 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 114.639 -1.164 . . . . 25.0 108.565 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.62 120.95 6.72 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 CA-C-O 121.606 0.586 . . . . 25.0 110.821 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.65 -17.04 77.84 Favored Glycine 0 C--O 1.216 -1.007 0 N-CA-C 115.038 0.775 . . . . 25.0 115.038 -174.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -77.93 -1.56 32.49 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.151 0.797 . . . . 25.0 113.151 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -127.74 25.57 5.98 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.682 -1.229 . . . . 25.0 107.682 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.8 tp -135.46 150.34 49.79 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.193 -0.912 . . . . 25.0 109.368 -173.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -126.28 120.75 30.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.568 -0.287 . . . . 25.0 111.556 -177.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.5 mm -67.76 135.45 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.795 -0.446 . . . . 25.0 109.795 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.2 mt -117.1 92.52 3.88 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.457 -1.312 . . . . 25.0 107.457 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 C--N 1.322 -0.611 0 N-CA-C 108.427 -0.953 . . . . 25.0 108.427 179.63 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 N--CA 1.469 0.523 0 N-CA-C 109.395 -0.594 . . . . 25.0 109.395 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 CA--C 1.542 0.919 0 C-N-CA 116.908 -1.595 . . . . 25.0 110.944 174.171 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 . . . . . 0 C--O 1.221 -0.436 0 N-CA-C 115.1 1.519 . . . . 25.0 115.1 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.4 mt -75.56 -36.51 60.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.459 -1.246 . . . . 25.0 110.74 -177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.5 m120 55.88 25.08 8.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.632 1.173 . . . . 25.0 112.768 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.2 m -88.88 177.13 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 105.731 -1.952 . . . . 25.0 105.731 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.22 174.07 6.56 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.083 -0.71 . . . . 25.0 109.083 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.9 161.19 42.36 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.551 -0.537 . . . . 25.0 109.551 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -123.6 135.43 53.95 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.393 -0.822 . . . . 25.0 110.1 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.528 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -72.29 126.74 30.56 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 123.869 0.73 . . . . 25.0 110.276 174.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.5 mt -93.09 -23.51 18.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.236 0.541 . . . . 25.0 110.697 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -142.43 168.1 20.52 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.737 -1.579 . . . . 25.0 106.737 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -76.73 162.99 27.25 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.307 0.379 . . . . 25.0 110.865 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -150.35 133.09 15.89 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 114.041 1.126 . . . . 25.0 114.041 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.8 t -109.55 124.68 66.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 105.473 -2.047 . . . . 25.0 105.473 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.06 139.69 50.48 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.475 -0.784 . . . . 25.0 110.373 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -112.6 -28.84 7.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.296 0.569 . . . . 25.0 109.589 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -102.15 152.35 38.23 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 107.481 -1.303 . . . . 25.0 107.481 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.4 -22.54 33.58 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 117.688 -1.074 . . . . 25.0 113.105 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -83.97 -10.72 57.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.849 -0.614 . . . . 25.0 110.898 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -85.86 135.64 33.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.747 0.785 . . . . 25.0 109.747 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.9 mt -87.89 128.93 35.36 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.731 0.777 . . . . 25.0 109.576 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.1 t -88.31 140.33 29.59 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 105.461 -2.051 . . . . 25.0 105.461 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -156.87 168.95 25.93 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.785 -0.82 . . . . 25.0 108.785 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.5 mtt-85 -122.91 166.98 14.15 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.179 0.514 . . . . 25.0 111.442 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.22 129.32 41.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.893 -0.594 . . . . 25.0 110.631 -176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.04 -13.02 65.36 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-O 119.491 -0.616 . . . . 25.0 113.508 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -62.32 150.11 40.31 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 117.659 0.73 . . . . 25.0 109.751 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.7 mm -116.41 133.25 63.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 107.922 -1.14 . . . . 25.0 107.922 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -136.25 148.86 48.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.143 -0.688 . . . . 25.0 109.143 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 51.8 m -85.14 129.68 34.76 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.967 -1.494 . . . . 25.0 106.967 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.1 t -94.01 126.17 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.805 -0.813 . . . . 25.0 108.805 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.1 mt -95.95 -45.05 7.09 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.368 -0.604 . . . . 25.0 109.368 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -147.48 159.07 44.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.271 -0.172 . . . . 25.0 110.785 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -117.08 153.95 31.84 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.537 -0.912 . . . . 25.0 108.537 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 53.76 39.8 30.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 123.482 1.611 . . . . 25.0 109.685 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.9 t -69.85 157.17 37.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.153 -1.839 . . . . 25.0 111.625 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 59.92 10.51 2.18 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.22 1.008 . . . . 25.0 112.678 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.74 13.66 81.06 Favored Glycine 0 C--O 1.239 0.41 0 N-CA-C 111.184 -0.766 . . . . 25.0 111.184 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.43 125.26 39.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.947 0.403 . . . . 25.0 110.069 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -67.45 126.84 30.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.958 -0.564 . . . . 25.0 110.349 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.74 -0.6 85.89 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 116.466 1.346 . . . . 25.0 116.466 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -99.05 132.95 43.99 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 119.146 1.473 . . . . 25.0 110.066 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -113.45 137.69 51.17 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.483 -0.562 . . . . 25.0 109.483 -177.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.9 tp -80.77 121.09 25.48 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 106.376 -1.712 . . . . 25.0 106.376 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 98.8 m -133.75 167.7 20.05 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.768 0.318 . . . . 25.0 111.151 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.7 t -118.8 126.16 51.22 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.0 -0.741 . . . . 25.0 109.0 172.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.3 tp -147.4 139.59 24.44 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.115 -1.068 . . . . 25.0 108.115 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 27.3 m170 55.99 29.82 15.02 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.364 0.665 . . . . 25.0 112.022 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.26 1.81 86.42 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 120.994 -0.622 . . . . 25.0 114.094 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -109.91 145.97 35.94 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.45 -0.945 . . . . 25.0 108.45 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -99.99 144.91 28.48 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 105.306 -2.109 . . . . 25.0 105.306 170.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.21 -163.58 29.49 Favored Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 105.525 -3.03 . . . . 25.0 105.525 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.9 pt -120.86 154.25 24.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.467 0.651 . . . . 25.0 111.097 -173.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.6 146.03 46.08 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 114.993 -1.003 . . . . 25.0 108.758 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.64 122.15 7.18 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 117.979 -0.881 . . . . 25.0 111.684 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.96 -13.95 72.89 Favored Glycine 0 C--O 1.223 -0.532 0 CA-C-N 116.277 -0.419 . . . . 25.0 114.032 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -68.94 -8.54 45.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.085 0.772 . . . . 25.0 113.085 -178.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -132.63 26.01 4.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.619 -0.882 . . . . 25.0 108.619 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 12' ' ' ALA . 1.4 tp -129.88 157.19 42.95 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.445 -0.798 . . . . 25.0 110.67 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -131.58 120.35 22.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.807 -0.633 . . . . 25.0 110.773 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.9 mm -65.81 136.59 26.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 123.662 0.601 . . . . 25.0 109.511 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.3 mt -117.64 111.56 19.33 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.28 -2.118 . . . . 25.0 105.28 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 108.272 -1.011 . . . . 25.0 108.272 -178.537 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.6 mttt . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 111.538 0.199 . . . . 25.0 111.538 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 CA--C 1.544 0.993 0 O-C-N 121.849 0.394 . . . . 25.0 112.015 174.717 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 . . . . . 0 CA--C 1.513 -0.456 0 N-CA-C 109.651 -0.5 . . . . 25.0 109.651 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.2 mt -61.74 -41.48 97.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.842 -0.617 . . . . 25.0 109.346 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.76 28.16 11.84 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.07 0.948 . . . . 25.0 111.976 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.2 m -87.48 176.24 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 104.72 -2.326 . . . . 25.0 104.72 173.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mp -118.74 173.99 6.54 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 121.732 -0.605 . . . . 25.0 109.58 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.37 160.18 42.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.818 0.342 . . . . 25.0 110.712 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -122.19 129.89 52.69 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.444 -0.798 . . . . 25.0 109.794 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.93 130.64 43.35 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.781 -0.452 . . . . 25.0 109.781 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.6 mt -93.67 -23.78 18.11 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 111.877 0.325 . . . . 25.0 111.877 -177.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -143.88 168.25 20.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.279 -1.378 . . . . 25.0 107.279 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -73.82 165.35 25.28 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.559 0.537 . . . . 25.0 110.178 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.74 163.31 35.34 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.324 -0.991 . . . . 25.0 108.324 177.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.8 t -130.45 129.49 64.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 102.026 -3.324 . . . . 25.0 102.026 169.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.15 122.69 27.13 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.293 -1.373 . . . . 25.0 107.293 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -113.03 12.32 19.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.318 1.056 . . . . 25.0 110.306 -175.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.7 m -148.31 152.83 39.89 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 106.202 -1.777 . . . . 25.0 106.202 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.43 -23.22 32.54 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 118.176 -0.749 . . . . 25.0 113.677 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.8 -17.0 52.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.417 0.627 . . . . 25.0 110.86 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -84.24 131.53 34.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.636 0.731 . . . . 25.0 109.343 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.477 ' HB2' HG13 ' A' ' 57' ' ' VAL . 45.9 mt -81.69 135.06 35.52 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.315 -0.624 . . . . 25.0 109.315 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -87.35 135.81 33.18 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.253 -1.017 . . . . 25.0 108.253 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -156.09 163.06 40.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.348 0.594 . . . . 25.0 111.948 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -119.63 169.02 10.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.408 0.623 . . . . 25.0 109.832 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -61.29 129.46 41.35 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.668 -0.696 . . . . 25.0 111.297 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.61 -12.41 67.62 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-O 119.012 -0.882 . . . . 25.0 113.836 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -60.08 148.5 35.54 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.595 0.712 . . . . 25.0 110.48 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.1 mm -114.22 132.32 63.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.54 -1.209 . . . . 25.0 108.852 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.0 ptp -137.07 156.55 48.26 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.553 -0.906 . . . . 25.0 108.553 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.7 m -89.53 129.59 35.98 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.377 -1.342 . . . . 25.0 107.377 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.24 126.59 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 107.76 -1.2 . . . . 25.0 107.76 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.61 HD12 HD22 ' A' ' 47' ' ' LEU . 69.8 mt -95.83 -44.7 7.29 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.487 -0.779 . . . . 25.0 109.418 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -153.32 164.02 38.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.353 -0.61 . . . . 25.0 109.353 -175.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -120.35 153.83 35.92 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.234 -1.024 . . . . 25.0 108.234 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 54.98 38.28 30.26 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 123.405 1.574 . . . . 25.0 109.943 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -65.05 151.29 46.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.359 -1.746 . . . . 25.0 110.812 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 61.05 10.72 3.0 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.803 0.841 . . . . 25.0 113.003 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.73 17.46 77.34 Favored Glycine 0 C--O 1.228 -0.234 0 N-CA-C 110.77 -0.932 . . . . 25.0 110.77 -178.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.9 mt -94.37 119.18 32.73 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.741 -0.837 . . . . 25.0 108.741 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.53 129.26 39.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.13 0.491 . . . . 25.0 110.568 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.27 -0.72 67.25 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 116.075 1.19 . . . . 25.0 116.075 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -98.75 129.98 45.2 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 119.349 1.575 . . . . 25.0 109.736 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -110.3 140.1 44.81 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.082 -0.71 . . . . 25.0 109.082 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.61 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -80.79 120.93 25.29 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.785 -1.931 . . . . 25.0 105.785 177.693 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.2 m -132.5 166.23 22.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.961 0.41 . . . . 25.0 111.686 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -120.64 122.77 41.22 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.799 -1.186 . . . . 25.0 107.799 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.5 tp -155.0 145.92 22.57 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 107.024 -1.473 . . . . 25.0 107.024 -175.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 56.36 31.97 19.67 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.091 0.556 . . . . 25.0 112.368 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.05 6.11 72.82 Favored Glycine 0 C--O 1.225 -0.41 0 N-CA-C 114.926 0.73 . . . . 25.0 114.926 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -129.95 165.96 21.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.696 -0.853 . . . . 25.0 108.696 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -112.59 152.1 29.29 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.774 -1.195 . . . . 25.0 107.774 176.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.74 -159.5 22.26 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 106.444 -2.662 . . . . 25.0 106.444 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.5 pt -120.05 153.56 22.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.465 0.65 . . . . 25.0 111.845 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.477 HG13 ' HB2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -141.63 147.39 45.6 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 114.996 -1.002 . . . . 25.0 109.607 -179.547 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.96 120.06 5.62 Favored 'Trans proline' 0 C--O 1.239 0.558 0 CA-C-O 121.398 0.499 . . . . 25.0 112.532 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.04 -18.76 67.18 Favored Glycine 0 C--O 1.222 -0.638 0 CA-C-O 121.45 0.472 . . . . 25.0 112.663 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.17 -20.69 59.69 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.307 0.854 . . . . 25.0 113.307 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -130.79 29.41 4.76 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.151 0.5 . . . . 25.0 110.021 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.0 tp -132.65 150.41 52.16 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.05 -0.523 . . . . 25.0 110.346 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -127.71 120.55 28.23 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.726 0.639 . . . . 25.0 112.726 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.4 mm -65.32 136.94 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.138 0.494 . . . . 25.0 110.256 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.4 mt -121.71 106.42 11.3 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.068 0.947 . . . . 25.0 108.527 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.472 0.673 0 CA-C-O 120.912 0.387 . . . . 25.0 110.933 178.793 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 95.3 mttt . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 107.452 -1.314 . . . . 25.0 107.452 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo . . . . . 0 CA--C 1.543 0.957 0 C-N-CA 116.938 -1.575 . . . . 25.0 110.749 174.438 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 . . . . . 0 CA--C 1.514 -0.411 0 CA-C-O 120.951 0.405 . . . . 25.0 110.382 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.2 mt -67.52 -38.07 83.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.391 -0.822 . . . . 25.0 110.484 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 57.27 31.51 20.22 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.864 0.866 . . . . 25.0 111.64 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.5 m -97.79 176.96 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 105.585 -2.005 . . . . 25.0 105.585 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -120.18 174.02 6.75 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.348 -0.612 . . . . 25.0 109.348 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.69 162.95 34.13 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.899 -0.408 . . . . 25.0 109.899 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -125.68 130.47 51.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.416 -0.811 . . . . 25.0 110.755 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.461 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -71.49 124.53 24.85 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 123.655 0.597 . . . . 25.0 109.516 176.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.3 mt -94.53 -20.3 19.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.326 0.584 . . . . 25.0 109.83 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -142.71 169.64 17.19 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.559 -1.645 . . . . 25.0 106.559 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -78.07 165.45 23.99 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.901 -0.407 . . . . 25.0 109.901 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -146.1 156.24 43.31 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.96 -0.385 . . . . 25.0 109.96 173.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.4 t -127.73 127.59 68.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 105.724 -1.954 . . . . 25.0 105.724 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.46 135.83 36.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.155 -0.683 . . . . 25.0 109.155 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -120.49 10.19 11.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.304 1.05 . . . . 25.0 109.302 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 t -150.82 150.15 27.26 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 107.103 -1.443 . . . . 25.0 107.103 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.63 -17.59 42.9 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 117.715 -1.057 . . . . 25.0 113.43 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -77.86 -19.98 53.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.188 0.518 . . . . 25.0 110.373 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -93.1 138.4 31.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.721 0.772 . . . . 25.0 111.407 -173.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.465 ' HB2' HG13 ' A' ' 57' ' ' VAL . 58.3 mt -91.86 128.01 37.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.809 0.814 . . . . 25.0 110.502 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.8 t -88.66 142.56 27.58 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.939 -1.874 . . . . 25.0 105.939 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -158.11 164.37 36.71 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.677 -0.49 . . . . 25.0 109.677 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -110.46 164.94 12.2 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.705 0.764 . . . . 25.0 109.055 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.15 131.81 51.98 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.747 -0.835 . . . . 25.0 108.747 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.15 -12.15 68.53 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-O 118.849 -0.973 . . . . 25.0 114.152 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.65 148.65 33.03 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 118.176 0.988 . . . . 25.0 110.51 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.5 mm -117.99 126.43 74.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.272 -1.331 . . . . 25.0 108.241 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -128.95 152.52 48.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.365 -0.379 . . . . 25.0 110.004 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -84.7 130.97 34.63 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.117 -1.438 . . . . 25.0 107.117 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.88 123.41 51.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.142 -1.058 . . . . 25.0 108.142 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.626 HD12 HD22 ' A' ' 47' ' ' LEU . 80.8 mt -89.38 -49.35 6.75 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.744 -0.836 . . . . 25.0 108.744 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -151.94 169.25 22.78 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.097 -1.075 . . . . 25.0 108.097 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.9 mtm105 -118.65 157.94 26.45 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 107.053 -1.462 . . . . 25.0 107.053 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 58.21 39.41 25.85 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 125.108 1.505 . . . . 25.0 109.153 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.1 t -67.74 155.81 38.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.19 -1.823 . . . . 25.0 110.162 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 59.96 10.82 2.33 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.084 0.954 . . . . 25.0 113.527 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.19 14.86 81.23 Favored Glycine 0 C--O 1.242 0.61 0 N-CA-C 110.94 -0.864 . . . . 25.0 110.94 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.2 mt -93.51 127.76 39.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.361 0.6 . . . . 25.0 109.495 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -69.95 124.05 23.06 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.498 -0.773 . . . . 25.0 109.545 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.01 2.3 86.72 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 117.03 1.572 . . . . 25.0 117.03 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -100.3 132.31 45.75 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 118.799 1.299 . . . . 25.0 109.224 176.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -114.28 141.59 47.39 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.512 -0.551 . . . . 25.0 109.512 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.626 HD22 HD12 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -83.6 120.01 25.44 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.2 -1.778 . . . . 25.0 106.2 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.5 m -133.07 165.65 24.25 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.016 0.436 . . . . 25.0 112.029 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.0 t -118.65 118.06 30.62 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.459 -1.311 . . . . 25.0 107.459 172.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -147.71 145.68 28.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.511 -1.662 . . . . 25.0 106.511 -174.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 57.23 27.22 13.28 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.412 0.625 . . . . 25.0 111.497 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.45 6.91 86.97 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 114.948 0.739 . . . . 25.0 114.948 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -132.09 160.86 34.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.108 0.954 . . . . 25.0 109.303 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -100.27 152.69 20.01 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.781 -0.822 . . . . 25.0 108.781 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.62 -162.1 28.49 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 105.632 -2.987 . . . . 25.0 105.632 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.9 pt -118.45 154.71 20.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.542 0.687 . . . . 25.0 110.97 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.465 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -140.78 146.75 45.59 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.129 -0.941 . . . . 25.0 109.743 -178.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -73.95 115.56 4.36 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 CA-C-O 121.544 0.56 . . . . 25.0 111.937 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.2 -17.64 68.34 Favored Glycine 0 C--O 1.224 -0.495 0 CA-C-O 121.463 0.48 . . . . 25.0 113.586 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -62.28 -19.0 62.8 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.959 0.725 . . . . 25.0 112.959 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -122.84 27.37 7.75 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.143 0.497 . . . . 25.0 110.686 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 12' ' ' ALA . 20.2 mt -123.81 160.64 26.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.054 0.931 . . . . 25.0 112.613 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -125.59 124.17 40.66 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 114.338 -1.301 . . . . 25.0 109.862 174.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.7 mm -73.64 134.25 30.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.413 -0.958 . . . . 25.0 108.413 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.0 mt -116.33 97.91 6.3 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.938 -1.134 . . . . 25.0 107.938 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 C--N 1.325 -0.495 0 N-CA-C 108.416 -0.957 . . . . 25.0 108.416 178.18 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.6 mttt . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 108.098 -1.075 . . . . 25.0 108.098 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.546 1.11 0 C-N-CA 116.539 -1.841 . . . . 25.0 110.589 172.537 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 . . . . . 0 CA--C 1.519 -0.226 0 CA-C-O 121.41 0.624 . . . . 25.0 112.153 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.7 mt -64.29 -41.13 97.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.073 -0.967 . . . . 25.0 110.543 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 55.63 30.1 14.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.918 0.887 . . . . 25.0 111.648 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.1 m -90.0 153.33 3.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.083 -1.451 . . . . 25.0 107.083 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.41 167.98 11.88 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.761 -0.829 . . . . 25.0 108.761 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.36 161.32 41.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.752 0.311 . . . . 25.0 110.693 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -130.84 130.47 43.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.407 -0.815 . . . . 25.0 110.009 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.29 131.52 42.02 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.322 -0.621 . . . . 25.0 109.322 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 74.8 mt -99.99 -18.84 16.85 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.981 0.419 . . . . 25.0 110.897 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -143.38 169.11 18.29 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.269 -2.122 . . . . 25.0 105.269 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.28 165.85 21.05 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 122.873 0.469 . . . . 25.0 110.6 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -151.36 143.05 23.71 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.939 0.348 . . . . 25.0 111.939 174.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 83.9 t -116.71 125.71 73.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 105.154 -2.165 . . . . 25.0 105.154 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.24 137.91 43.31 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.426 -0.806 . . . . 25.0 109.519 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -113.25 4.81 16.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.654 0.74 . . . . 25.0 110.223 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.3 m -152.02 155.69 33.65 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 106.953 -1.499 . . . . 25.0 106.953 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.67 -21.03 39.68 Favored 'Trans proline' 0 C--N 1.346 0.398 0 N-CA-C 113.692 0.612 . . . . 25.0 113.692 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.02 -16.98 59.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.215 0.531 . . . . 25.0 110.629 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -93.78 141.76 28.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.38 0.609 . . . . 25.0 109.672 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.455 ' HB2' HG13 ' A' ' 57' ' ' VAL . 61.4 mt -95.62 131.26 42.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.735 0.779 . . . . 25.0 110.17 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.0 t -90.44 146.62 23.99 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 105.099 -2.186 . . . . 25.0 105.099 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -157.32 162.77 39.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.085 0.469 . . . . 25.0 110.492 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -103.88 155.88 18.28 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.421 -1.326 . . . . 25.0 107.421 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -60.73 129.31 40.89 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.632 -0.877 . . . . 25.0 108.632 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.07 -5.35 68.44 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-O 119.312 -0.715 . . . . 25.0 113.445 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -63.97 152.25 40.53 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.8 0.81 . . . . 25.0 110.156 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.2 mm -116.84 135.22 57.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.465 -1.243 . . . . 25.0 108.627 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.7 ptp -142.65 166.11 25.55 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.022 -0.732 . . . . 25.0 109.022 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 57.3 m -106.99 123.6 48.42 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.545 -0.909 . . . . 25.0 108.545 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.3 t -86.87 125.48 40.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.301 -1.0 . . . . 25.0 108.301 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -93.43 -44.52 8.22 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.023 -0.732 . . . . 25.0 109.023 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -146.96 159.1 43.96 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.887 -0.412 . . . . 25.0 109.887 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.1 mtm105 -118.75 154.54 32.63 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.579 -0.526 . . . . 25.0 109.579 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 55.08 38.02 29.84 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 123.628 1.68 . . . . 25.0 108.639 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.7 t -72.48 159.68 33.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 112.644 -2.071 . . . . 25.0 111.158 -173.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 58.87 11.52 1.92 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.906 1.076 . . . . 25.0 113.906 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.64 12.63 83.44 Favored Glycine 0 C--O 1.239 0.468 0 N-CA-C 110.847 -0.901 . . . . 25.0 110.847 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.7 mt -97.25 115.82 28.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.806 0.812 . . . . 25.0 109.289 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -65.34 129.11 38.54 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.883 -1.053 . . . . 25.0 109.664 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.57 -0.94 74.32 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 115.659 1.024 . . . . 25.0 115.659 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -98.73 130.88 45.22 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 118.853 1.326 . . . . 25.0 110.281 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -113.54 137.58 51.37 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.734 -0.839 . . . . 25.0 108.734 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.9 tp -80.63 124.71 29.22 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.047 -1.464 . . . . 25.0 107.047 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.9 m -133.6 162.76 31.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.286 0.565 . . . . 25.0 112.234 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.3 t -112.97 123.67 50.85 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.034 -1.839 . . . . 25.0 106.034 171.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 tp -151.58 140.85 21.38 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.653 -1.24 . . . . 25.0 107.653 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.97 27.2 12.82 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.991 0.737 . . . . 25.0 112.991 176.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.47 3.87 90.36 Favored Glycine 0 C--O 1.226 -0.378 0 N-CA-C 114.692 0.637 . . . . 25.0 114.692 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -129.47 161.01 31.38 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 117.951 0.876 . . . . 25.0 110.185 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -105.76 153.5 21.8 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.129 -1.063 . . . . 25.0 108.129 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.61 -163.74 31.8 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 104.03 -3.628 . . . . 25.0 104.03 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.5 pt -121.93 156.84 26.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.532 0.682 . . . . 25.0 110.855 -175.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.455 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.7 m -140.15 147.57 50.93 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.013 -0.994 . . . . 25.0 109.328 -177.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -75.74 119.97 5.65 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 CA-C-O 121.349 0.479 . . . . 25.0 111.947 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.28 -20.05 66.98 Favored Glycine 0 C--O 1.221 -0.665 0 C-N-CA 121.517 -0.373 . . . . 25.0 113.354 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -66.34 -9.2 30.92 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.699 1.0 . . . . 25.0 113.699 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -134.65 26.11 3.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.265 0.555 . . . . 25.0 109.792 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 24.3 tp -131.23 149.57 52.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.739 -0.664 . . . . 25.0 110.819 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -119.44 127.85 53.47 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 122.838 0.455 . . . . 25.0 110.963 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.2 mm -76.12 135.56 26.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.191 -1.04 . . . . 25.0 108.191 174.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.4 mt -114.66 80.58 1.43 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.192 -0.669 . . . . 25.0 109.192 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.568 0 N-CA-C 107.707 -1.22 . . . . 25.0 107.707 175.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 88.0 mttt . . . . . 0 N--CA 1.466 0.354 0 N-CA-C 108.835 -0.802 . . . . 25.0 108.835 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 CA--C 1.545 1.058 0 C-N-CA 116.562 -1.826 . . . . 25.0 110.376 171.643 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 . . . . . 0 CA--C 1.519 -0.232 0 CA-C-O 121.565 0.697 . . . . 25.0 111.302 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt -65.48 -38.97 91.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.221 -0.899 . . . . 25.0 110.506 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.4 m120 57.0 25.63 10.91 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.306 1.042 . . . . 25.0 112.295 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -89.56 169.81 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.005 -1.85 . . . . 25.0 106.005 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -115.42 170.23 8.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.037 0.446 . . . . 25.0 110.06 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.83 160.64 41.49 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.689 -0.687 . . . . 25.0 111.017 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -123.87 131.81 53.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.072 -0.967 . . . . 25.0 110.749 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.99 126.2 30.51 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.053 -0.522 . . . . 25.0 109.871 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.7 mt -93.75 -22.07 18.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.198 0.523 . . . . 25.0 110.536 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -138.06 161.44 36.74 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.246 -1.39 . . . . 25.0 107.246 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.71 175.98 7.42 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.032 0.933 . . . . 25.0 110.959 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -156.85 160.01 38.75 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.499 0.555 . . . . 25.0 112.499 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.1 t -127.76 128.67 69.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 104.408 -2.442 . . . . 25.0 104.408 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.41 132.19 44.45 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.29 -0.633 . . . . 25.0 109.29 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -122.22 10.16 9.94 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.719 0.771 . . . . 25.0 109.714 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.2 m -143.93 153.14 56.87 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 105.378 -2.082 . . . . 25.0 105.378 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.03 -23.08 34.52 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 117.919 -0.921 . . . . 25.0 113.165 -177.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.83 -15.97 46.27 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.982 -0.554 . . . . 25.0 110.916 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -80.9 135.51 35.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.97 0.89 . . . . 25.0 111.515 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.8 mt -83.69 130.94 34.97 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.304 -0.862 . . . . 25.0 110.88 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 m -85.5 132.42 34.2 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.837 -1.542 . . . . 25.0 106.837 173.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.408 ' CE2' HG12 ' A' ' 57' ' ' VAL . 40.0 p90 -159.42 169.55 23.7 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.019 -1.104 . . . . 25.0 108.019 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 mtp85 -125.35 174.45 8.14 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.347 0.869 . . . . 25.0 113.347 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.12 131.85 48.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.191 -0.913 . . . . 25.0 110.878 -175.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.94 -13.97 66.16 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.44 -0.8 . . . . 25.0 113.343 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -60.06 147.7 38.37 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.868 0.842 . . . . 25.0 110.993 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.3 mm -111.07 134.29 53.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.286 -1.324 . . . . 25.0 107.958 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.4 ptp -138.98 150.67 46.13 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.337 -0.616 . . . . 25.0 109.337 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.6 m -85.98 130.98 34.38 Favored 'General case' 0 C--O 1.217 -0.607 0 N-CA-C 107.242 -1.392 . . . . 25.0 107.242 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.9 t -97.9 125.32 51.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.347 -0.983 . . . . 25.0 108.347 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.696 HD12 HD22 ' A' ' 47' ' ' LEU . 78.3 mt -90.94 -51.27 5.43 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.991 -0.744 . . . . 25.0 108.991 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -152.04 171.25 18.14 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.382 -0.97 . . . . 25.0 108.382 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -120.71 155.6 33.57 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 107.342 -1.355 . . . . 25.0 107.342 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 57.7 39.78 27.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 123.331 1.538 . . . . 25.0 108.592 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.9 t -64.85 147.62 52.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 113.235 -1.802 . . . . 25.0 110.547 -176.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 58.5 15.25 3.45 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.146 0.795 . . . . 25.0 113.146 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.62 12.39 84.28 Favored Glycine 0 C--O 1.225 -0.462 0 C-N-CA 121.161 -0.542 . . . . 25.0 111.833 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.6 mt -88.85 109.7 20.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.381 0.61 . . . . 25.0 110.048 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -53.73 118.43 3.93 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.979 -1.009 . . . . 25.0 112.08 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.69 0.37 89.21 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 115.914 1.126 . . . . 25.0 115.914 175.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -97.75 133.62 42.02 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 119.059 1.429 . . . . 25.0 109.234 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -113.36 140.69 47.83 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.883 -0.784 . . . . 25.0 108.883 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.696 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -82.34 121.47 26.73 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 105.973 -1.862 . . . . 25.0 105.973 179.36 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 84.4 m -131.3 163.55 27.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.124 0.488 . . . . 25.0 112.161 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.5 t -118.04 126.44 52.3 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.794 -1.188 . . . . 25.0 107.794 174.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 tp -154.4 142.67 20.45 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 107.326 -1.361 . . . . 25.0 107.326 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 55.46 32.03 18.14 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.317 0.579 . . . . 25.0 112.315 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.12 7.05 76.06 Favored Glycine 0 C--O 1.224 -0.472 0 N-CA-C 114.807 0.683 . . . . 25.0 114.807 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -128.2 165.64 20.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.082 -0.71 . . . . 25.0 109.082 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -117.21 155.08 30.03 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.002 -1.11 . . . . 25.0 108.002 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.0 -159.87 25.83 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 106.195 -2.762 . . . . 25.0 106.195 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.5 pt -117.68 153.47 19.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.684 0.754 . . . . 25.0 111.656 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.408 HG12 ' CE2' ' A' ' 26' ' ' PHE . 2.7 m -143.71 147.22 38.13 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 114.653 -1.158 . . . . 25.0 108.37 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.2 125.08 8.96 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 118.569 -0.488 . . . . 25.0 112.051 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.78 -19.46 79.9 Favored Glycine 0 C--O 1.222 -0.607 0 N-CA-C 116.035 1.174 . . . . 25.0 116.035 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -70.0 -7.26 39.43 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.189 1.552 . . . . 25.0 115.189 -175.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.17 21.64 5.28 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.264 -1.013 . . . . 25.0 108.264 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.0 tp -123.68 149.68 45.18 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.047 -1.094 . . . . 25.0 108.047 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -120.73 123.82 43.63 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 116.706 -0.224 . . . . 25.0 111.147 -178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.3 mm -74.99 133.52 31.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.223 -1.029 . . . . 25.0 108.223 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.3 mt -116.85 75.53 0.97 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.621 -1.622 . . . . 25.0 106.621 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 115.748 1.759 . . . . 25.0 115.748 -168.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.7 mttt . . . . . 0 CA--C 1.534 0.342 0 N-CA-C 110.463 -0.199 . . . . 25.0 110.463 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--O 1.243 0.747 0 O-C-N 121.973 0.459 . . . . 25.0 111.744 175.664 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 120.898 0.38 . . . . 25.0 111.894 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.11 -41.17 95.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.72 -0.673 . . . . 25.0 110.729 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 55.5 40.73 31.23 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.927 0.891 . . . . 25.0 112.144 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.7 m -105.35 151.37 7.55 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.802 0 N-CA-C 107.316 -1.364 . . . . 25.0 107.316 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.38 167.0 12.97 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.485 -0.561 . . . . 25.0 109.485 -172.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.86 157.41 41.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.083 0.468 . . . . 25.0 111.134 175.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -123.9 131.31 53.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.172 -0.922 . . . . 25.0 110.659 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.08 129.32 38.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.992 -0.744 . . . . 25.0 108.992 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.4 mt -96.63 -17.55 20.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.755 0.312 . . . . 25.0 110.368 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -144.99 167.65 22.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.649 -1.611 . . . . 25.0 106.649 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -77.49 168.86 19.3 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 123.447 0.467 . . . . 25.0 110.85 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -153.48 154.01 33.57 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.074 0.464 . . . . 25.0 111.462 176.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -124.53 129.69 73.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 105.073 -2.195 . . . . 25.0 105.073 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.84 121.88 21.59 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.368 -0.975 . . . . 25.0 108.368 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -102.94 1.67 34.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 122.036 0.922 . . . . 25.0 109.495 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.2 m -144.69 153.75 55.0 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 106.499 -1.667 . . . . 25.0 106.499 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.92 -23.83 34.29 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 117.811 -0.992 . . . . 25.0 113.427 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.78 -16.97 59.31 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.339 0.59 . . . . 25.0 110.629 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -84.05 139.54 32.43 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.61 0.719 . . . . 25.0 110.092 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.429 ' HB2' HG13 ' A' ' 57' ' ' VAL . 40.0 mt -87.42 130.25 34.74 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.95 -0.759 . . . . 25.0 108.95 177.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 t -87.13 137.94 31.91 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.435 -1.691 . . . . 25.0 106.435 175.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -155.42 164.19 39.05 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 120.777 0.322 . . . . 25.0 110.482 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 -117.05 168.24 10.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.984 0.421 . . . . 25.0 110.821 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -60.88 130.17 45.13 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.89 -8.26 78.34 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-O 118.647 -1.085 . . . . 25.0 114.623 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.21 142.35 51.98 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.649 1.224 . . . . 25.0 109.714 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.7 mm -108.68 129.79 62.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 107.627 -1.249 . . . . 25.0 107.627 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 14.3 ptp -134.83 163.4 29.91 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.836 -0.801 . . . . 25.0 108.836 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.1 m -104.4 122.58 45.79 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.411 -1.329 . . . . 25.0 107.411 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.7 t -86.34 122.69 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 108.191 -1.041 . . . . 25.0 108.191 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.24 -41.58 8.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.575 -0.739 . . . . 25.0 109.391 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -142.94 156.63 44.92 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.498 -1.297 . . . . 25.0 107.498 -173.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -124.38 150.76 45.21 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 105.111 -2.181 . . . . 25.0 105.111 172.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 57.43 38.93 28.43 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 123.707 1.717 . . . . 25.0 108.504 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -67.98 157.71 34.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 112.671 -2.059 . . . . 25.0 111.818 -177.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 60.35 12.51 3.46 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.078 1.14 . . . . 25.0 114.078 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.12 13.11 81.56 Favored Glycine 0 C--O 1.244 0.723 0 N-CA-C 111.265 -0.734 . . . . 25.0 111.265 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.2 mt -96.24 137.57 35.12 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 122.357 -0.496 . . . . 25.0 109.899 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -81.19 130.45 35.03 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.352 -0.61 . . . . 25.0 109.352 176.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.93 -0.42 82.85 Favored Glycine 0 C--O 1.241 0.566 0 N-CA-C 116.675 1.43 . . . . 25.0 116.675 173.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -99.8 134.42 42.72 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.388 -0.968 . . . . 25.0 108.388 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.7 m0 -114.61 140.35 48.88 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.078 -1.082 . . . . 25.0 108.078 -177.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.4 tp -82.33 127.74 33.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.051 -1.833 . . . . 25.0 106.051 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.2 m -134.9 162.45 32.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.166 0.508 . . . . 25.0 111.811 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.2 t -112.35 123.09 49.51 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.629 -1.989 . . . . 25.0 105.629 169.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.2 tp -153.14 139.26 18.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.893 0.477 . . . . 25.0 110.122 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.6 m170 56.93 32.0 20.76 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.113 0.565 . . . . 25.0 111.548 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.99 -1.17 89.1 Favored Glycine 0 C--O 1.225 -0.429 0 N-CA-C 116.478 1.351 . . . . 25.0 116.478 177.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.5 ptt85 -130.64 158.59 39.62 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 118.798 1.299 . . . . 25.0 111.402 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -97.72 153.6 18.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.82 -1.178 . . . . 25.0 107.82 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.67 -165.9 35.88 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 103.89 -3.684 . . . . 25.0 103.89 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.4 pt -119.78 158.63 21.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.398 0.618 . . . . 25.0 111.443 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.7 m -144.76 148.95 41.42 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.558 -0.747 . . . . 25.0 110.171 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.3 121.72 7.41 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 118.247 -0.702 . . . . 25.0 112.932 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.38 -18.13 73.13 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 121.267 -0.492 . . . . 25.0 113.568 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -67.3 -9.97 46.24 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.602 0.964 . . . . 25.0 113.602 -177.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -129.89 27.61 5.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.472 0.653 . . . . 25.0 109.804 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -123.08 156.52 34.74 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.356 -0.838 . . . . 25.0 112.423 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -122.69 125.27 45.24 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 108.725 -0.842 . . . . 25.0 108.725 174.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.0 mm -77.97 137.1 22.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.224 -1.028 . . . . 25.0 108.224 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.6 mt -116.96 87.13 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.964 -1.124 . . . . 25.0 107.964 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.699 0 CA-C-N 115.392 -0.822 . . . . 25.0 111.841 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 109.322 -0.621 . . . . 25.0 109.322 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 CA--C 1.541 0.868 0 O-C-N 121.785 0.361 . . . . 25.0 112.018 178.68 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 . . . . . 0 CA--C 1.516 -0.332 0 CA-C-O 120.72 0.295 . . . . 25.0 110.53 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.0 mt -65.0 -42.5 94.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.63 -0.714 . . . . 25.0 110.203 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 53.98 36.18 23.81 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.0 0.92 . . . . 25.0 112.02 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.9 m -96.09 159.79 2.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 N-CA-C 106.18 -1.785 . . . . 25.0 106.18 177.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.02 170.94 8.8 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.992 -0.744 . . . . 25.0 108.992 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.58 162.19 41.41 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.228 -0.295 . . . . 25.0 110.701 175.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.75 136.56 52.58 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.846 0.716 . . . . 25.0 111.353 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.5 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -73.02 123.09 22.83 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.695 0.622 . . . . 25.0 111.679 173.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.2 mt -90.81 -25.2 20.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.222 0.534 . . . . 25.0 110.091 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -142.82 171.68 13.72 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 103.476 -2.787 . . . . 25.0 103.476 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -84.41 175.7 9.17 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 118.056 0.389 . . . . 25.0 110.818 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -149.41 132.29 16.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.761 0.315 . . . . 25.0 110.737 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.7 t -104.04 125.19 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 104.759 -2.312 . . . . 25.0 104.759 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.23 137.86 43.31 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.565 -0.743 . . . . 25.0 110.205 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -119.05 5.33 11.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.783 0.801 . . . . 25.0 109.099 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -147.37 155.65 46.08 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 106.479 -1.675 . . . . 25.0 106.479 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.59 -24.04 26.33 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 118.167 -0.756 . . . . 25.0 113.514 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -77.73 -17.2 57.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.507 0.67 . . . . 25.0 110.203 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -87.09 133.01 33.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.526 0.679 . . . . 25.0 109.969 -176.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.8 mt -87.15 125.97 34.5 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.823 0.82 . . . . 25.0 109.945 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.68 134.01 33.73 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.252 -1.758 . . . . 25.0 106.252 174.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -154.84 166.93 31.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.526 -0.546 . . . . 25.0 109.526 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -113.4 160.51 18.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.365 0.602 . . . . 25.0 110.068 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -57.41 132.56 53.48 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.468 -0.938 . . . . 25.0 108.468 177.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.57 -18.18 57.32 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-O 119.168 -0.795 . . . . 25.0 113.11 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -61.42 147.87 43.6 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.778 0.799 . . . . 25.0 109.988 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.4 mm -115.67 132.95 63.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.296 -1.32 . . . . 25.0 107.894 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -135.24 165.51 25.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.049 -0.723 . . . . 25.0 109.049 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.4 m -104.18 123.47 47.36 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.891 -1.151 . . . . 25.0 107.891 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.1 t -87.47 121.52 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 N-CA-C 108.248 -1.019 . . . . 25.0 108.248 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.584 HD12 HD22 ' A' ' 47' ' ' LEU . 81.1 mt -91.23 -42.71 10.26 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.984 -1.007 . . . . 25.0 109.277 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -150.46 155.87 40.36 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.43 -0.952 . . . . 25.0 108.43 -176.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -115.58 153.11 31.81 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.91 -1.515 . . . . 25.0 106.91 174.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 55.98 41.23 30.05 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 123.63 1.681 . . . . 25.0 109.176 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.2 t -71.05 159.79 34.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 113.234 -1.803 . . . . 25.0 110.665 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 59.51 12.03 2.59 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.18 0.992 . . . . 25.0 112.352 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.61 17.01 78.38 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 111.262 -0.735 . . . . 25.0 111.262 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.4 mt -97.73 131.37 44.33 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 122.44 0.296 . . . . 25.0 110.282 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -71.26 128.3 35.44 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.536 -0.542 . . . . 25.0 109.536 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.5 -1.32 82.64 Favored Glycine 0 CA--C 1.518 0.244 0 N-CA-C 116.569 1.388 . . . . 25.0 116.569 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -100.63 132.99 45.74 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 118.423 1.111 . . . . 25.0 109.621 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -113.05 141.6 46.69 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.939 -0.763 . . . . 25.0 108.939 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.584 HD22 HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -81.14 122.51 27.46 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 104.823 -2.288 . . . . 25.0 104.823 177.501 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.7 m -133.89 161.7 34.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.823 0.345 . . . . 25.0 111.902 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.6 t -114.63 125.14 53.41 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.833 -1.173 . . . . 25.0 107.833 172.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 tp -145.17 136.98 25.55 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.674 -1.232 . . . . 25.0 107.674 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 55.89 28.39 12.47 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.234 0.54 . . . . 25.0 112.173 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.68 2.53 90.56 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 114.877 0.711 . . . . 25.0 114.877 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -122.55 159.3 28.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 118.282 1.041 . . . . 25.0 108.422 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -112.09 150.34 30.85 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.633 -0.877 . . . . 25.0 108.633 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.84 -160.46 24.4 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 106.547 -2.621 . . . . 25.0 106.547 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.1 pt -116.84 150.36 18.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.796 0.808 . . . . 25.0 111.5 -175.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.98 146.59 52.93 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 114.846 -1.07 . . . . 25.0 108.814 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.44 122.82 6.71 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 117.951 -0.899 . . . . 25.0 111.706 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.2 -12.71 72.54 Favored Glycine 0 C--O 1.222 -0.615 0 O-C-N 121.909 -0.494 . . . . 25.0 113.24 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.3 -16.12 63.24 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.486 0.921 . . . . 25.0 113.486 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -129.36 27.65 5.3 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.142 -0.688 . . . . 25.0 109.142 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 12' ' ' ALA . 6.6 tp -129.32 152.22 49.12 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.276 -0.875 . . . . 25.0 111.472 -177.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -131.64 120.66 23.12 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-N 115.777 -0.647 . . . . 25.0 111.755 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.4 mm -66.13 136.13 27.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 O-C-N 123.53 0.519 . . . . 25.0 110.102 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.6 mt -118.75 98.51 6.25 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.303 -1.369 . . . . 25.0 107.303 175.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.3 t . . . . . 0 C--N 1.32 -0.685 0 N-CA-C 107.302 -1.37 . . . . 25.0 107.302 -179.713 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.0 mttt . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 110.123 -0.325 . . . . 25.0 110.123 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 CA--C 1.542 0.916 0 C-N-CA 118.276 -0.683 . . . . 25.0 112.263 176.398 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 CA--C 1.515 -0.386 0 N-CA-C 109.499 -0.556 . . . . 25.0 109.499 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.8 mt -71.88 -33.16 68.13 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.756 -0.656 . . . . 25.0 111.079 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.3 m120 53.43 41.75 32.07 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.35 -0.841 . . . . 25.0 111.954 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.4 m -109.51 165.38 5.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.526 -1.287 . . . . 25.0 107.526 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.73 170.6 7.91 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.467 -0.568 . . . . 25.0 109.467 -176.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.38 162.08 40.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 25.0 110.954 173.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -127.82 130.51 48.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.6 -0.727 . . . . 25.0 109.729 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.38 131.94 46.18 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.061 0.545 . . . . 25.0 109.874 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.9 mt -94.96 -23.19 17.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.24 0.543 . . . . 25.0 110.769 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -144.56 172.09 13.47 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 104.222 -2.51 . . . . 25.0 104.222 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.95 173.89 10.81 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.949 -0.389 . . . . 25.0 109.949 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -155.07 141.01 18.28 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.507 0.323 . . . . 25.0 111.648 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.7 t -108.7 124.48 65.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 105.8 -1.926 . . . . 25.0 105.8 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.53 130.82 41.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.343 -0.844 . . . . 25.0 108.867 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -112.48 11.27 19.8 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.185 0.993 . . . . 25.0 109.044 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 t -153.15 151.26 25.64 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 107.5 -1.296 . . . . 25.0 107.5 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -69.21 -18.2 39.7 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 117.689 -1.074 . . . . 25.0 112.509 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -76.6 -19.62 57.64 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.431 0.634 . . . . 25.0 109.819 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -94.11 140.99 29.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.704 0.764 . . . . 25.0 111.034 -172.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.423 ' HB2' HG13 ' A' ' 57' ' ' VAL . 55.3 mt -91.17 129.61 37.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.469 -0.787 . . . . 25.0 110.157 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.69 139.52 30.48 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.106 -2.183 . . . . 25.0 105.106 173.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -157.77 166.46 32.7 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.594 -0.521 . . . . 25.0 109.594 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -112.73 164.03 13.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.105 0.955 . . . . 25.0 110.362 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -58.48 129.66 43.09 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.447 -1.252 . . . . 25.0 109.45 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.74 -16.21 61.39 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-O 118.758 -1.024 . . . . 25.0 114.867 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -57.79 146.7 30.58 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 117.984 0.892 . . . . 25.0 111.408 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.4 mm -109.47 133.89 53.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.595 -1.184 . . . . 25.0 108.139 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.2 ptp -138.79 162.61 34.31 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.358 -0.979 . . . . 25.0 108.358 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.8 m -101.38 125.5 48.03 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 108.363 -0.977 . . . . 25.0 108.363 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.53 126.01 43.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.044 -1.095 . . . . 25.0 108.044 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.615 HD12 HD22 ' A' ' 47' ' ' LEU . 76.8 mt -95.47 -43.65 7.89 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.865 -1.061 . . . . 25.0 108.918 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -150.21 162.19 40.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.178 -0.675 . . . . 25.0 109.178 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -121.82 152.34 39.64 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 107.076 -1.453 . . . . 25.0 107.076 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 56.22 39.9 30.14 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 123.309 1.528 . . . . 25.0 108.703 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -69.87 157.51 37.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.737 -1.574 . . . . 25.0 110.177 -175.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 60.53 11.05 2.81 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.611 0.967 . . . . 25.0 113.611 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.57 16.5 77.61 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.173 -0.771 . . . . 25.0 111.173 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.7 mt -103.68 113.71 27.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.003 0.43 . . . . 25.0 110.77 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -63.74 128.08 34.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.973 -0.558 . . . . 25.0 109.696 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.61 -1.92 88.05 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 118.757 -1.024 . . . . 25.0 115.103 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -98.93 131.79 44.74 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 118.969 1.384 . . . . 25.0 109.687 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -111.76 140.06 46.71 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.926 -0.768 . . . . 25.0 108.926 -176.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.615 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -82.05 120.79 25.72 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 105.44 -2.059 . . . . 25.0 105.44 178.067 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 92.0 m -132.26 163.55 28.37 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.476 0.547 . . . . 25.0 112.476 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.8 t -115.89 119.26 35.39 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 106.588 -1.634 . . . . 25.0 106.588 171.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -147.37 139.28 24.24 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 107.055 -1.461 . . . . 25.0 107.055 -174.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 56.72 31.49 19.47 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.678 0.752 . . . . 25.0 111.86 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.49 5.27 85.74 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 115.479 0.952 . . . . 25.0 115.479 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -129.78 161.26 31.13 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.125 -1.065 . . . . 25.0 108.125 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -107.09 152.42 24.05 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.385 -0.598 . . . . 25.0 109.385 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.59 -160.55 24.9 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 106.565 -2.614 . . . . 25.0 106.565 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.1 pt -117.28 156.82 18.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.308 0.575 . . . . 25.0 111.043 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.4 m -144.67 146.95 33.97 Favored Pre-proline 0 C--O 1.241 0.64 0 CA-C-N 114.96 -1.018 . . . . 25.0 109.874 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -74.45 118.44 5.35 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 CA-C-O 121.441 0.517 . . . . 25.0 112.708 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.8 -20.04 68.02 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 114.784 0.674 . . . . 25.0 114.784 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -25.22 67.3 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.109 0.781 . . . . 25.0 113.109 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -119.18 28.33 8.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.285 0.564 . . . . 25.0 110.347 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.0 tp -133.51 150.06 51.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.132 -0.485 . . . . 25.0 110.162 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -127.94 120.21 27.15 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.851 0.686 . . . . 25.0 112.851 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.7 mm -65.43 137.6 24.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.494 -0.558 . . . . 25.0 109.494 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.9 mt -118.44 105.36 11.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.915 -1.142 . . . . 25.0 107.915 175.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.9 m . . . . . 0 C--N 1.323 -0.55 0 N-CA-C 108.092 -1.077 . . . . 25.0 108.092 177.299 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 108.956 -0.757 . . . . 25.0 108.956 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo . . . . . 0 CA--C 1.545 1.075 0 C-N-CA 117.171 -1.42 . . . . 25.0 110.518 170.957 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 . . . . . 0 C--O 1.235 0.324 0 N-CA-C 112.608 0.596 . . . . 25.0 112.608 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.04 -39.88 90.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.141 -0.936 . . . . 25.0 111.419 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 54.22 41.6 31.92 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.289 1.042 . . . . 25.0 111.91 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.447 HG23 ' HB ' ' A' ' 34' ' ' VAL . 15.9 m -102.7 171.27 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 N-CA-C 103.743 -2.688 . . . . 25.0 103.743 175.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -118.96 173.93 6.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 119.42 1.009 . . . . 25.0 110.693 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.04 158.74 44.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.12 -0.491 . . . . 25.0 109.746 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -120.9 132.26 54.86 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.311 0.644 . . . . 25.0 109.793 177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.59 130.43 42.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.016 0.436 . . . . 25.0 110.078 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.8 mt -97.46 -22.18 16.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.337 -0.392 . . . . 25.0 110.944 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -141.88 164.76 29.3 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -71.78 167.74 19.31 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.598 0.562 . . . . 25.0 110.785 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.45 160.04 42.17 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.516 -0.55 . . . . 25.0 109.516 175.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.1 t -130.85 127.7 61.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 102.87 -3.011 . . . . 25.0 102.87 169.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.53 123.6 31.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.788 -0.819 . . . . 25.0 108.788 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -117.18 -17.28 10.28 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.541 0.686 . . . . 25.0 110.41 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.55 152.91 37.97 Favored Pre-proline 0 N--CA 1.471 0.58 0 N-CA-C 107.973 -1.121 . . . . 25.0 107.973 176.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.8 -24.51 34.31 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 117.906 -0.929 . . . . 25.0 113.59 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -84.13 -16.36 43.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.938 0.399 . . . . 25.0 111.135 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -79.03 129.64 34.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.077 0.941 . . . . 25.0 110.644 -173.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.414 ' HB2' HG13 ' A' ' 57' ' ' VAL . 24.3 mt -82.77 138.48 34.01 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.497 -0.774 . . . . 25.0 109.605 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.65 130.73 34.69 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.474 -0.935 . . . . 25.0 108.474 177.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -158.37 162.92 37.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.27 0.557 . . . . 25.0 110.958 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.13 166.06 17.73 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.964 -0.562 . . . . 25.0 110.099 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -56.97 131.46 49.84 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 121.116 0.484 . . . . 25.0 109.8 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.06 -19.68 53.24 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-O 118.569 -1.128 . . . . 25.0 113.028 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -62.3 149.07 43.07 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 118.118 0.959 . . . . 25.0 109.98 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.4 mm -116.63 125.3 73.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 114.325 -1.307 . . . . 25.0 108.365 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -126.74 153.22 45.79 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.172 -0.677 . . . . 25.0 109.172 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.8 m -87.26 126.63 34.95 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.736 -1.579 . . . . 25.0 106.736 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.447 ' HB ' HG23 ' A' ' 8' ' ' VAL . 62.1 t -92.19 119.89 40.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.362 -1.348 . . . . 25.0 107.362 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.547 HD12 HD22 ' A' ' 47' ' ' LEU . 83.1 mt -91.03 -43.92 9.63 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.15 -0.932 . . . . 25.0 110.155 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -150.19 159.61 44.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.831 -1.174 . . . . 25.0 107.831 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -121.62 149.41 43.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.556 -1.275 . . . . 25.0 107.556 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 58.06 39.27 26.42 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 123.517 1.627 . . . . 25.0 109.603 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.3 t -65.29 151.81 45.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.742 -1.572 . . . . 25.0 110.468 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 59.59 11.75 2.51 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.93 0.892 . . . . 25.0 113.265 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.53 18.72 78.84 Favored Glycine 0 C--O 1.241 0.585 0 N-CA-C 110.987 -0.845 . . . . 25.0 110.987 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.9 mt -91.87 123.83 35.54 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.348 -0.612 . . . . 25.0 109.348 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -64.23 118.8 9.13 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.158 -0.928 . . . . 25.0 110.998 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.28 2.63 90.57 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 116.931 1.533 . . . . 25.0 116.931 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -100.82 132.02 46.42 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.809 1.305 . . . . 25.0 110.579 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -110.16 140.8 43.87 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.75 -0.593 . . . . 25.0 110.196 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.547 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -81.25 122.01 26.88 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 104.386 -2.449 . . . . 25.0 104.386 176.738 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.8 m -132.51 164.42 26.63 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.179 0.514 . . . . 25.0 111.362 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.5 t -121.55 125.16 46.12 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 107.485 -1.302 . . . . 25.0 107.485 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.2 tp -148.78 138.49 22.02 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 106.495 -1.668 . . . . 25.0 106.495 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 55.24 28.93 11.91 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.221 0.608 . . . . 25.0 112.168 -176.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.34 1.35 75.13 Favored Glycine 0 C--O 1.226 -0.349 0 N-CA-C 115.151 0.82 . . . . 25.0 115.151 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -117.09 161.47 19.37 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.083 -1.451 . . . . 25.0 107.083 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -118.35 156.75 28.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.508 -0.553 . . . . 25.0 109.508 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.21 -156.82 21.1 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 106.525 -2.63 . . . . 25.0 106.525 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.8 pt -121.12 151.9 24.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.742 0.782 . . . . 25.0 111.545 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 24' ' ' LEU . 2.4 m -141.18 146.85 44.77 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 114.438 -1.255 . . . . 25.0 109.591 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.65 121.21 5.84 Favored 'Trans proline' 0 C--O 1.24 0.586 0 CA-C-O 121.444 0.518 . . . . 25.0 113.133 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.3 -16.16 68.78 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-O 121.717 0.62 . . . . 25.0 114.334 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -18.3 63.55 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.018 0.527 . . . . 25.0 112.081 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -126.73 30.39 5.51 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.951 0.405 . . . . 25.0 110.692 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.5 mt -126.25 157.09 39.2 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.885 1.068 . . . . 25.0 113.885 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -129.76 119.82 24.06 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.16 -0.927 . . . . 25.0 109.649 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.7 mm -67.81 140.39 19.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 O-C-N 123.902 0.751 . . . . 25.0 109.613 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.4 mt -118.65 101.84 8.41 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.826 0.85 . . . . 25.0 109.152 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 112.701 0.63 . . . . 25.0 112.701 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.8 mttt . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 106.404 -1.702 . . . . 25.0 106.404 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.543 0.942 0 C-N-CA 118.306 -0.662 . . . . 25.0 112.361 177.497 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 . . . . . 0 CA--C 1.53 0.173 0 N-CA-C 114.829 1.418 . . . . 25.0 114.829 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.5 mt -73.57 -42.48 61.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.652 -1.158 . . . . 25.0 110.291 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 55.75 30.05 14.96 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.396 1.078 . . . . 25.0 111.822 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 m -89.65 163.89 2.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 104.842 -2.281 . . . . 25.0 104.842 176.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.23 171.9 7.33 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.966 -1.124 . . . . 25.0 107.966 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.47 157.24 43.34 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.52 -0.548 . . . . 25.0 109.52 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -120.34 131.79 55.01 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 123.901 0.751 . . . . 25.0 109.393 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.436 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -68.8 126.94 31.32 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.658 0.599 . . . . 25.0 110.095 173.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.5 mt -92.56 -26.59 17.83 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.859 -0.423 . . . . 25.0 109.859 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -142.19 166.02 25.83 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.048 -1.834 . . . . 25.0 106.048 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -75.3 163.35 27.57 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 122.998 0.519 . . . . 25.0 112.369 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -143.07 144.03 32.09 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.625 0.602 . . . . 25.0 112.625 173.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -114.14 126.83 71.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 103.355 -2.832 . . . . 25.0 103.355 173.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.42 140.51 33.4 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 108.237 -1.023 . . . . 25.0 108.237 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -125.06 9.77 8.1 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.693 0.759 . . . . 25.0 111.186 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.5 m -145.73 150.98 45.0 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 106.575 -1.639 . . . . 25.0 106.575 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.62 -29.96 84.94 Favored 'Trans proline' 0 C--N 1.351 0.663 0 N-CA-C 114.954 1.098 . . . . 25.0 114.954 -175.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.7 -17.4 59.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.203 -0.453 . . . . 25.0 111.769 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -86.15 136.33 33.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 122.055 0.931 . . . . 25.0 111.886 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.9 mt -91.14 130.95 36.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.508 0.67 . . . . 25.0 111.089 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.6 p -90.92 144.69 25.42 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.61 -1.256 . . . . 25.0 107.61 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -160.09 168.55 25.29 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.61 0.243 . . . . 25.0 110.669 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -116.95 163.55 16.03 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.406 -0.59 . . . . 25.0 109.406 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -59.74 133.78 56.41 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.727 -0.842 . . . . 25.0 108.727 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.4 -21.35 46.45 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-O 118.903 -0.943 . . . . 25.0 113.003 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -57.14 145.69 30.34 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.031 0.919 . . . . 25.0 111.116 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.3 mm -115.7 126.83 73.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.486 -1.234 . . . . 25.0 109.159 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -131.39 153.95 49.14 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.665 -0.494 . . . . 25.0 109.665 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.5 m -89.55 123.69 33.86 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.474 -0.935 . . . . 25.0 108.474 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.9 t -87.1 123.15 39.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.069 -0.715 . . . . 25.0 109.069 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.661 HD12 HD22 ' A' ' 47' ' ' LEU . 77.5 mt -89.85 -46.05 8.83 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.244 -1.021 . . . . 25.0 108.244 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -153.94 172.85 16.78 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.881 -0.512 . . . . 25.0 109.708 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 mtm105 -120.25 154.5 34.82 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.087 -1.449 . . . . 25.0 107.087 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 59.71 40.47 19.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 123.527 1.632 . . . . 25.0 109.228 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t -66.84 154.77 40.06 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 113.081 -1.872 . . . . 25.0 110.36 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 57.59 14.37 2.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.213 1.005 . . . . 25.0 112.147 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.05 14.84 81.85 Favored Glycine 0 C--O 1.24 0.481 0 N-CA-C 111.287 -0.725 . . . . 25.0 111.287 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.3 mt -93.16 129.07 39.29 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 117.479 0.639 . . . . 25.0 109.602 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -67.84 125.92 27.78 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.039 -0.528 . . . . 25.0 110.305 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.29 -1.76 84.12 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 117.051 1.58 . . . . 25.0 117.051 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -97.75 135.11 40.0 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 117.879 0.839 . . . . 25.0 110.391 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -112.88 143.43 44.16 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.711 -1.218 . . . . 25.0 107.711 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.661 HD22 HD12 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -86.3 124.34 32.57 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.178 -2.527 . . . . 25.0 104.178 176.586 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 93.2 m -133.16 164.11 27.77 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.162 0.506 . . . . 25.0 111.762 177.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.0 t -118.66 124.9 48.53 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.688 -1.227 . . . . 25.0 107.688 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.0 tp -139.78 133.14 30.0 Favored 'General case' 0 C--O 1.212 -0.911 0 N-CA-C 107.306 -1.368 . . . . 25.0 107.306 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.5 m170 54.95 31.62 16.33 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.465 0.706 . . . . 25.0 111.404 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.31 1.2 85.57 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 116.018 1.167 . . . . 25.0 116.018 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -118.46 152.8 35.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 119.09 1.445 . . . . 25.0 107.661 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -108.18 157.14 18.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.353 -0.385 . . . . 25.0 110.176 -178.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.44 -161.37 29.51 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 106.609 -2.597 . . . . 25.0 106.609 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.7 pt -117.13 150.03 19.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.349 0.595 . . . . 25.0 111.032 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.53 146.87 46.88 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.084 -0.962 . . . . 25.0 109.107 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.45 122.02 5.42 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 CA-C-O 121.546 0.561 . . . . 25.0 112.904 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.56 -18.23 71.66 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 115.934 1.134 . . . . 25.0 115.934 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -17.74 63.84 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 122.223 -0.575 . . . . 25.0 111.778 -177.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -123.13 27.94 7.37 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.712 0.291 . . . . 25.0 110.523 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 12' ' ' ALA . 14.4 mt -127.74 156.03 43.08 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.879 0.847 . . . . 25.0 112.26 178.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -128.81 121.99 29.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.724 -1.125 . . . . 25.0 110.443 175.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.6 mm -68.75 139.23 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.409 -0.96 . . . . 25.0 108.409 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.6 mt -117.49 103.02 9.68 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.325 -1.361 . . . . 25.0 107.325 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.0 m . . . . . 0 C--N 1.327 -0.406 0 CA-C-O 121.361 0.601 . . . . 25.0 111.287 -177.733 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt . . . . . 0 CA--C 1.542 0.666 0 N-CA-C 106.721 -1.585 . . . . 25.0 106.721 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 CA--C 1.551 1.345 0 O-C-N 122.463 0.717 . . . . 25.0 112.757 178.158 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 . . . . . 0 CA--C 1.52 -0.211 0 N-CA-C 109.794 -0.447 . . . . 25.0 109.794 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.27 -40.74 97.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.017 -0.538 . . . . 25.0 109.758 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 57.3 24.83 10.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.039 0.935 . . . . 25.0 111.856 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.5 m -88.21 175.81 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 N-CA-C 105.531 -2.026 . . . . 25.0 105.531 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mp -117.88 172.28 7.5 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 118.842 0.746 . . . . 25.0 110.813 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.72 163.38 34.19 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.792 -0.64 . . . . 25.0 110.256 177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -126.63 130.52 50.64 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.644 -0.707 . . . . 25.0 110.313 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.426 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -67.78 123.81 21.58 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.143 0.577 . . . . 25.0 110.237 174.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.0 mt -90.54 -23.92 20.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.801 -0.444 . . . . 25.0 109.801 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -141.26 172.53 12.55 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 102.887 -3.005 . . . . 25.0 102.887 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.52 176.4 9.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -151.61 135.23 16.26 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.199 0.523 . . . . 25.0 112.103 175.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.9 t -101.53 121.38 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 105.333 -2.099 . . . . 25.0 105.333 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.42 131.52 43.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.516 -0.92 . . . . 25.0 108.516 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -105.22 -6.51 19.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.688 0.756 . . . . 25.0 109.897 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 m -138.57 152.61 71.32 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 107.076 -1.453 . . . . 25.0 107.076 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.81 -19.29 36.05 Favored 'Trans proline' 0 C--O 1.222 -0.296 0 C-N-CA 117.721 -1.053 . . . . 25.0 112.374 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -79.41 -15.88 57.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 25.0 110.862 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -91.86 139.38 30.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.87 0.843 . . . . 25.0 110.428 -176.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.427 ' HB2' HG13 ' A' ' 57' ' ' VAL . 56.2 mt -90.62 129.72 36.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.059 0.933 . . . . 25.0 110.24 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.58 147.18 23.51 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.644 -1.613 . . . . 25.0 106.644 175.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -157.47 167.81 29.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.283 0.564 . . . . 25.0 111.023 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -107.09 159.13 16.54 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.971 -0.752 . . . . 25.0 108.971 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -58.0 128.2 35.89 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.72 -1.215 . . . . 25.0 107.72 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.18 -18.87 53.56 Favored Glycine 0 CA--C 1.517 0.194 0 CA-C-O 118.731 -1.039 . . . . 25.0 113.915 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -59.51 147.61 36.17 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 118.063 0.932 . . . . 25.0 110.738 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.5 mm -115.39 128.52 72.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.453 -1.249 . . . . 25.0 108.92 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -131.09 153.05 49.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.044 -0.354 . . . . 25.0 110.044 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.6 m -84.19 130.09 34.85 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 177.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.51 125.25 47.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.709 -0.849 . . . . 25.0 108.709 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.621 HD12 HD22 ' A' ' 47' ' ' LEU . 60.4 mt -91.09 -48.62 6.86 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.797 -0.816 . . . . 25.0 108.797 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -155.06 173.21 16.91 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.655 -0.869 . . . . 25.0 108.655 177.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -121.99 151.62 40.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.04 -1.096 . . . . 25.0 108.04 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 59.29 40.32 21.45 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 123.329 1.537 . . . . 25.0 108.936 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -65.06 153.78 39.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 112.866 -1.97 . . . . 25.0 110.5 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 59.79 11.61 2.58 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.585 0.957 . . . . 25.0 113.585 176.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.11 19.13 75.39 Favored Glycine 0 C--O 1.225 -0.447 0 N-CA-C 111.052 -0.819 . . . . 25.0 111.052 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 71.9 mt -96.95 112.33 24.13 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.124 0.488 . . . . 25.0 111.288 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.96 119.36 6.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.888 -0.596 . . . . 25.0 111.828 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.99 -0.01 89.55 Favored Glycine 0 C--O 1.239 0.417 0 N-CA-C 115.521 0.968 . . . . 25.0 115.521 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -100.19 134.6 42.88 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 118.525 1.163 . . . . 25.0 109.485 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -112.0 143.09 43.56 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.322 -0.992 . . . . 25.0 108.322 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.621 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -85.03 120.01 26.07 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 105.161 -2.163 . . . . 25.0 105.161 177.192 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 92.0 m -130.29 161.14 31.9 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.827 0.346 . . . . 25.0 111.317 178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.3 t -113.71 120.3 40.36 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.184 -1.413 . . . . 25.0 107.184 174.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.5 tp -143.2 135.5 27.19 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.145 -0.687 . . . . 25.0 109.145 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 56.03 28.13 12.35 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.889 1.07 . . . . 25.0 113.889 175.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.28 7.7 86.31 Favored Glycine 0 C--O 1.226 -0.352 0 C-N-CA 121.202 -0.523 . . . . 25.0 113.794 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -118.62 153.22 34.64 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.523 -0.918 . . . . 25.0 108.523 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -117.16 138.46 51.65 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 104.996 -2.224 . . . . 25.0 104.996 173.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.18 -162.71 26.99 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 107.414 -2.274 . . . . 25.0 107.414 -176.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.6 pt -111.31 151.92 13.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 121.599 0.714 . . . . 25.0 111.713 -174.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.2 m -141.47 145.01 35.95 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 114.851 -1.068 . . . . 25.0 108.992 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.72 120.69 6.26 Favored 'Trans proline' 0 C--O 1.238 0.507 0 CA-C-O 121.233 0.431 . . . . 25.0 112.691 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.76 -19.84 71.71 Favored Glycine 0 C--O 1.22 -0.727 0 N-CA-C 114.915 0.726 . . . . 25.0 114.915 -176.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -65.37 -16.68 63.86 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.217 0.821 . . . . 25.0 113.217 -177.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -122.92 27.44 7.69 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.259 0.552 . . . . 25.0 109.817 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 12' ' ' ALA . 12.7 mt -126.8 157.82 38.23 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.019 0.914 . . . . 25.0 113.023 178.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -127.56 125.93 41.22 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 115.01 -0.996 . . . . 25.0 110.194 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.2 mm -75.07 135.85 26.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.699 -0.852 . . . . 25.0 108.699 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.0 mt -115.47 92.13 3.82 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.561 0.744 . . . . 25.0 109.629 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.472 0.654 0 CA-C-N 115.86 -0.609 . . . . 25.0 111.139 179.537 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 107.766 -1.198 . . . . 25.0 107.766 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 CA--C 1.537 0.66 0 O-C-N 122.186 0.571 . . . . 25.0 113.07 -178.739 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 . . . . . 0 CA--C 1.515 -0.367 0 N-CA-C 109.689 -0.486 . . . . 25.0 109.689 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.4 mt -67.34 -39.35 85.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.918 -0.583 . . . . 25.0 109.788 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.7 m120 53.76 30.06 10.6 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.168 0.987 . . . . 25.0 112.683 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.8 m -93.17 175.88 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 104.501 -2.407 . . . . 25.0 104.501 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.55 172.34 7.72 Favored 'General case' 0 CA--C 1.497 -1.093 0 O-C-N 121.934 -0.479 . . . . 25.0 109.837 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.93 162.74 38.69 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.599 -0.728 . . . . 25.0 109.87 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.91 128.19 49.09 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 124.175 0.99 . . . . 25.0 108.333 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.24 138.24 49.28 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 122.763 0.425 . . . . 25.0 110.271 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.2 mt -101.46 -17.38 16.47 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.669 0.618 . . . . 25.0 112.669 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -141.45 159.12 42.87 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.698 -1.223 . . . . 25.0 107.698 -176.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.41 ' C ' HH22 ' A' ' 61' ' ' ARG . 21.5 m-20 -81.18 149.71 28.98 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.036 0.21 . . . . 25.0 111.257 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -133.68 146.29 50.71 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.33 0.652 . . . . 25.0 112.203 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.0 t -119.98 133.38 66.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 103.147 -2.908 . . . . 25.0 103.147 170.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.14 135.53 36.6 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.063 -0.717 . . . . 25.0 109.063 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -108.82 2.44 21.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.39 0.614 . . . . 25.0 111.261 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -142.43 151.73 58.58 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 105.88 -1.896 . . . . 25.0 105.88 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.21 -18.73 34.7 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 118.353 -0.631 . . . . 25.0 112.823 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.03 -16.79 59.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.267 -0.879 . . . . 25.0 110.956 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -97.56 141.68 30.31 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.694 -0.854 . . . . 25.0 108.694 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.3 mt -93.62 127.04 39.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.958 0.885 . . . . 25.0 112.059 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.23 129.3 34.83 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 104.81 -2.293 . . . . 25.0 104.81 174.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -149.35 163.74 36.88 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.998 -0.371 . . . . 25.0 109.998 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -111.01 163.78 13.48 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.577 0.703 . . . . 25.0 110.514 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.52 130.85 46.07 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 107.278 -1.378 . . . . 25.0 107.278 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.14 -9.47 77.56 Favored Glycine 0 C--N 1.312 -0.751 0 CA-C-O 119.03 -0.872 . . . . 25.0 114.279 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -62.38 149.41 42.46 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 117.822 0.811 . . . . 25.0 109.326 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.0 mm -114.77 128.15 72.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.144 -0.935 . . . . 25.0 108.686 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -131.48 149.93 52.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.231 -0.44 . . . . 25.0 109.935 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.1 m -87.18 122.64 31.26 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.746 -1.205 . . . . 25.0 107.746 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -85.4 127.43 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 N-CA-C 108.138 -1.06 . . . . 25.0 108.138 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.621 HD12 HD22 ' A' ' 47' ' ' LEU . 75.9 mt -93.37 -51.0 5.19 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.17 -0.923 . . . . 25.0 109.222 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -152.44 173.75 14.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.332 -0.618 . . . . 25.0 109.332 176.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -121.76 155.46 35.23 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 107.928 -1.138 . . . . 25.0 107.928 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 55.88 42.43 28.88 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 125.641 1.838 . . . . 25.0 109.168 -177.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.8 t -65.98 149.62 49.94 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.415 -1.721 . . . . 25.0 110.517 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 59.72 14.61 4.18 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.774 0.83 . . . . 25.0 112.175 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.29 10.72 85.99 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.28 -0.486 . . . . 25.0 111.982 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.4 mt -89.63 119.4 30.01 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 117.718 0.759 . . . . 25.0 110.001 -178.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -64.32 126.04 26.5 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.238 -0.437 . . . . 25.0 110.064 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.58 -0.09 88.51 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 115.451 0.94 . . . . 25.0 115.451 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -99.45 133.29 43.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 119.101 1.45 . . . . 25.0 108.97 175.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -114.85 142.47 46.52 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.123 -1.436 . . . . 25.0 107.123 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.621 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -87.56 125.49 34.37 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 104.963 -2.236 . . . . 25.0 104.963 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.8 m -135.85 160.82 37.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.834 0.35 . . . . 25.0 110.601 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.2 t -111.46 125.96 54.45 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.314 -1.365 . . . . 25.0 107.314 171.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.7 tp -136.72 128.8 29.56 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.759 -1.2 . . . . 25.0 107.759 -177.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.9 m80 54.9 30.71 14.41 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.942 0.401 . . . . 25.0 110.771 -175.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.66 -7.7 64.62 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 115.937 1.135 . . . . 25.0 115.937 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -110.8 149.05 31.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 118.307 1.053 . . . . 25.0 108.783 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -103.24 154.33 19.46 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.502 -0.772 . . . . 25.0 110.266 -175.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.66 -167.98 39.73 Favored Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 106.429 -2.668 . . . . 25.0 106.429 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.4 pt -111.36 149.84 13.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.976 0.893 . . . . 25.0 111.961 -175.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 m -139.54 145.17 42.54 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 114.29 -1.323 . . . . 25.0 109.413 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.03 123.07 8.1 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 CA-C-O 121.207 0.42 . . . . 25.0 112.646 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.95 -15.01 79.84 Favored Glycine 0 C--O 1.228 -0.27 0 O-C-N 122.088 -0.383 . . . . 25.0 113.525 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -67.57 -5.28 14.65 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.775 0.83 . . . . 25.0 112.368 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.41 HH22 ' C ' ' A' ' 15' ' ' ASP . 0.3 OUTLIER -142.06 27.9 1.75 Allowed 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.139 -1.06 . . . . 25.0 108.139 -178.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 tp -130.65 144.62 51.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.611 -0.722 . . . . 25.0 110.884 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -122.32 117.09 25.26 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.257 -0.429 . . . . 25.0 112.033 -176.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.1 mm -64.92 136.99 25.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 O-C-N 123.961 0.788 . . . . 25.0 109.609 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.5 mt -119.67 106.14 11.87 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.283 -1.377 . . . . 25.0 107.283 176.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.6 0 CA-C-O 121.104 0.478 . . . . 25.0 110.238 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.4 mttt . . . . . 0 C--O 1.226 -0.179 0 N-CA-C 106.957 -1.497 . . . . 25.0 106.957 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 CA--C 1.531 0.33 0 C-N-CA 116.705 -1.73 . . . . 25.0 110.553 173.303 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 . . . . . 0 CA--C 1.513 -0.469 0 N-CA-C 107.182 -1.414 . . . . 25.0 107.182 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.41 -39.97 92.69 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.509 0.506 . . . . 25.0 110.648 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 55.52 31.93 18.05 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.926 0.89 . . . . 25.0 111.695 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.401 HG23 ' HB ' ' A' ' 34' ' ' VAL . 17.5 m -94.31 170.71 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 104.267 -2.494 . . . . 25.0 104.267 175.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -115.83 172.21 7.28 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.264 -1.013 . . . . 25.0 108.264 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.29 156.32 41.91 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 123.281 0.363 . . . . 25.0 110.623 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -116.63 127.86 54.85 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 123.998 0.812 . . . . 25.0 110.104 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.52 127.08 31.38 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.913 -0.773 . . . . 25.0 108.913 176.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.6 mt -88.75 -24.19 22.72 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 120.61 0.243 . . . . 25.0 110.488 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -146.2 171.5 14.84 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 104.09 -2.559 . . . . 25.0 104.09 177.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -82.57 174.24 11.22 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.538 -0.541 . . . . 25.0 109.538 177.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -150.85 133.44 15.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.889 0.376 . . . . 25.0 111.74 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.9 t -101.3 120.07 50.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 105.197 -2.149 . . . . 25.0 105.197 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.05 137.49 49.03 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.644 -0.873 . . . . 25.0 108.644 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -116.02 15.27 16.16 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 122.266 1.031 . . . . 25.0 108.891 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 t -157.21 149.47 17.73 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.118 -0.946 . . . . 25.0 108.501 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -69.48 -16.43 38.73 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 117.326 -1.316 . . . . 25.0 113.006 175.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -78.58 -17.1 56.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.524 0.678 . . . . 25.0 109.805 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -98.52 138.21 36.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.599 -0.728 . . . . 25.0 110.904 -173.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.443 ' HB2' HG13 ' A' ' 57' ' ' VAL . 50.8 mt -89.69 130.77 35.93 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.787 0.804 . . . . 25.0 110.045 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.6 p -90.23 144.49 25.8 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 105.803 -1.925 . . . . 25.0 105.803 174.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -157.9 168.55 26.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.82 0.343 . . . . 25.0 110.268 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.55 161.1 16.04 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.318 0.58 . . . . 25.0 109.789 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -60.31 133.97 56.61 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.318 -0.994 . . . . 25.0 108.318 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.86 -15.46 63.33 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-O 119.079 -0.845 . . . . 25.0 113.69 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -58.41 136.6 57.49 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.553 0.692 . . . . 25.0 109.739 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.0 mm -103.74 127.44 57.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 106.393 -1.706 . . . . 25.0 106.393 176.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 19.5 ptp -131.79 153.62 49.94 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.188 -0.671 . . . . 25.0 109.188 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.1 m -89.33 127.83 35.83 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.046 -1.464 . . . . 25.0 107.046 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.401 ' HB ' HG23 ' A' ' 8' ' ' VAL . 45.9 t -97.01 122.97 49.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.955 -1.128 . . . . 25.0 107.955 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.571 HD12 HD22 ' A' ' 47' ' ' LEU . 78.0 mt -92.78 -45.22 8.12 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.272 -0.876 . . . . 25.0 109.521 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -147.15 161.18 41.41 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.384 -0.969 . . . . 25.0 108.384 -174.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -126.88 149.59 49.69 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.08 -1.452 . . . . 25.0 107.08 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 56.62 38.52 29.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 123.483 1.611 . . . . 25.0 108.452 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 t -63.03 146.71 52.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.339 -1.755 . . . . 25.0 110.01 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 59.44 13.42 3.22 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.482 0.919 . . . . 25.0 113.482 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.89 16.99 79.24 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 111.003 -0.839 . . . . 25.0 111.003 -178.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.448 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 60.3 mt -91.53 103.65 16.23 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.875 -0.787 . . . . 25.0 108.875 178.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -54.49 123.98 14.73 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.422 -0.808 . . . . 25.0 111.606 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.24 0.27 85.89 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 115.345 0.898 . . . . 25.0 115.345 176.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.448 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 95.0 m95 -100.95 130.73 46.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 118.523 1.162 . . . . 25.0 109.193 177.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -112.23 142.6 44.52 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 121.789 -0.569 . . . . 25.0 109.622 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.571 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -84.02 119.07 24.5 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 105.563 -2.014 . . . . 25.0 105.563 178.642 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 95.4 m -129.8 162.28 28.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.088 0.47 . . . . 25.0 112.095 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.1 t -111.97 113.38 25.65 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.522 -1.658 . . . . 25.0 106.522 172.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -143.6 136.79 27.83 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.84 -1.17 . . . . 25.0 107.84 -174.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 55.88 27.42 10.99 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.45 0.7 . . . . 25.0 112.803 -176.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.51 6.4 86.64 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 120.859 -0.686 . . . . 25.0 113.046 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -114.16 160.99 18.35 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.53 -1.285 . . . . 25.0 107.53 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -121.75 142.82 49.81 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 105.89 -1.892 . . . . 25.0 105.89 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.09 -158.34 20.71 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 105.461 -3.055 . . . . 25.0 105.461 -177.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.7 pt -118.5 154.23 20.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.493 0.663 . . . . 25.0 111.238 -175.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 24' ' ' LEU . 2.0 m -141.42 146.26 41.47 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.069 -0.968 . . . . 25.0 109.347 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.24 117.7 5.21 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 CA-C-O 121.484 0.535 . . . . 25.0 112.189 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.95 -14.75 66.16 Favored Glycine 0 C--O 1.22 -0.767 0 O-C-N 122.079 -0.388 . . . . 25.0 113.202 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -64.23 -15.35 59.86 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.832 0.679 . . . . 25.0 112.832 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -131.21 29.55 4.62 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.348 0.594 . . . . 25.0 109.628 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.1 tp -133.63 148.41 51.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.845 -0.616 . . . . 25.0 109.972 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -127.87 120.12 27.07 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 111.984 0.365 . . . . 25.0 111.984 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.4 mm -69.18 135.47 28.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 123.458 0.474 . . . . 25.0 110.45 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.6 mt -120.85 96.66 5.2 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.951 0.9 . . . . 25.0 109.213 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 C--N 1.322 -0.602 0 N-CA-C 107.712 -1.218 . . . . 25.0 107.712 179.319 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.5 mttt . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 108.886 -0.783 . . . . 25.0 108.886 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 CA--C 1.539 0.763 0 C-N-CA 116.92 -1.587 . . . . 25.0 110.604 175.156 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 . . . . . 0 CA--C 1.508 -0.656 0 CA-C-O 120.893 0.378 . . . . 25.0 111.063 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.6 mt -68.3 -40.61 81.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.765 -0.828 . . . . 25.0 108.765 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 53.46 34.78 19.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.037 0.935 . . . . 25.0 111.58 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.0 m -93.38 -179.25 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 103.946 -2.613 . . . . 25.0 103.946 175.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.89 173.86 6.97 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.276 -0.89 . . . . 25.0 109.938 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.75 157.23 43.02 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.506 0.67 . . . . 25.0 109.598 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -116.96 129.95 56.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.177 -0.92 . . . . 25.0 109.875 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.97 128.09 35.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.091 -0.504 . . . . 25.0 109.666 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.64 -21.79 21.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.315 0.579 . . . . 25.0 111.188 -177.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -141.18 173.27 11.64 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.852 -1.166 . . . . 25.0 107.852 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -76.8 -179.07 5.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 124.113 0.883 . . . . 25.0 109.884 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.09 156.79 29.83 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.777 -0.823 . . . . 25.0 108.777 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.36 122.82 60.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 103.394 -2.817 . . . . 25.0 103.394 167.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.31 133.07 34.16 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.133 -1.062 . . . . 25.0 108.133 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -114.01 -23.56 9.49 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.027 0.441 . . . . 25.0 111.021 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -93.44 151.7 40.41 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.285 -1.006 . . . . 25.0 108.285 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.06 -18.88 30.64 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 116.545 -1.837 . . . . 25.0 111.835 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -85.71 -17.0 37.21 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.228 -0.896 . . . . 25.0 110.036 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -83.11 133.67 35.04 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.442 -0.787 . . . . 25.0 110.142 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.2 mt -84.02 132.86 34.7 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.961 0.41 . . . . 25.0 110.546 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 p -83.48 116.82 22.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.214 -1.032 . . . . 25.0 108.214 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -138.96 161.94 36.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.091 0.948 . . . . 25.0 112.491 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -119.23 166.62 12.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.975 -1.011 . . . . 25.0 108.73 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -61.87 131.61 50.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.882 -0.785 . . . . 25.0 108.882 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.62 -13.94 65.66 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-O 118.844 -0.975 . . . . 25.0 114.683 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.39 141.39 54.7 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 118.117 0.959 . . . . 25.0 108.908 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.6 mm -106.51 130.35 58.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 107.358 -1.349 . . . . 25.0 107.358 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.481 ' HB3' HD13 ' A' ' 50' ' ' LEU . 16.3 ptp -131.78 151.68 51.49 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 109.037 -0.727 . . . . 25.0 109.037 -177.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.4 m -87.94 124.33 33.59 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 106.895 -1.521 . . . . 25.0 106.895 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.4 t -91.82 124.2 44.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 N-CA-C 108.418 -0.956 . . . . 25.0 108.418 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.637 HD12 HD22 ' A' ' 47' ' ' LEU . 78.6 mt -90.02 -47.56 7.76 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.765 -0.652 . . . . 25.0 109.411 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -156.9 175.72 13.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.737 -0.468 . . . . 25.0 109.737 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -127.95 156.2 43.04 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 106.219 -1.771 . . . . 25.0 106.219 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.4 t0 61.8 36.15 16.29 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.869 1.319 . . . . 25.0 108.218 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -66.7 144.71 56.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.772 -1.103 . . . . 25.0 108.58 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 57.64 15.25 2.76 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.604 0.964 . . . . 25.0 113.604 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.79 15.59 81.21 Favored Glycine 0 C--O 1.254 1.348 0 C-N-CA 121.335 -0.459 . . . . 25.0 112.076 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.44 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 98.0 mt -92.98 101.24 13.57 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 122.238 1.018 . . . . 25.0 108.69 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -60.11 121.7 12.56 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.592 -1.186 . . . . 25.0 110.206 -175.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.08 -2.44 85.43 Favored Glycine 0 C--N 1.318 -0.418 0 CA-C-O 119.06 -0.856 . . . . 25.0 115.139 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.44 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 93.0 m95 -99.17 139.14 35.26 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.388 1.094 . . . . 25.0 108.62 174.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.41 ' CE3' HD23 ' A' ' 62' ' ' LEU . 41.9 m0 -118.6 139.61 51.21 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.496 -1.298 . . . . 25.0 107.496 -177.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.637 HD22 HD12 ' A' ' 35' ' ' LEU . 0.7 OUTLIER -81.12 124.29 29.11 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 106.359 -1.719 . . . . 25.0 106.359 177.814 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 98.2 m -131.76 163.13 28.87 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.622 0.725 . . . . 25.0 109.975 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -117.91 120.25 37.29 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 104.966 -2.235 . . . . 25.0 104.966 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.481 HD13 ' HB3' ' A' ' 32' ' ' MET . 11.1 tp -147.9 134.32 19.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.932 -0.766 . . . . 25.0 108.932 -175.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.3 m170 54.07 32.26 15.31 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.719 1.007 . . . . 25.0 113.719 174.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.73 5.01 86.96 Favored Glycine 0 C--O 1.224 -0.492 0 C-N-CA 120.452 -0.88 . . . . 25.0 114.867 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -120.06 158.83 26.01 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 107.816 -1.179 . . . . 25.0 107.816 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -111.88 154.55 25.02 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 102.95 -2.982 . . . . 25.0 102.95 166.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.25 -167.88 40.72 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 107.723 -2.151 . . . . 25.0 107.723 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 pt -113.03 151.74 14.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.65 0.738 . . . . 25.0 112.241 -175.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.7 m -143.79 147.12 37.45 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-N 114.722 -1.126 . . . . 25.0 110.235 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.38 118.48 5.37 Favored 'Trans proline' 0 C--O 1.244 0.797 0 O-C-N 121.946 0.445 . . . . 25.0 112.586 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.33 -15.13 65.3 Favored Glycine 0 C--O 1.221 -0.677 0 N-CA-C 114.664 0.626 . . . . 25.0 114.664 -176.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -63.67 -23.95 67.59 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 113.004 0.742 . . . . 25.0 113.004 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -118.34 28.39 8.38 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.393 -0.595 . . . . 25.0 109.393 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.41 HD23 ' CE3' ' A' ' 46' ' ' TRP . 18.1 tp -134.56 150.1 50.7 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.539 -0.755 . . . . 25.0 110.593 -175.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -128.54 119.97 25.84 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.166 0.432 . . . . 25.0 112.166 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.8 mm -64.81 135.86 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.6 0.714 . . . . 25.0 111.33 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.1 mt -118.33 93.71 4.22 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.559 -1.275 . . . . 25.0 107.559 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.321 -0.67 0 N-CA-C 108.629 -0.878 . . . . 25.0 108.629 176.658 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 92.6 mttt . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 108.097 -1.075 . . . . 25.0 108.097 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.542 0.884 0 C-N-CA 118.093 -0.805 . . . . 25.0 110.986 174.922 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 . . . . . 0 C--O 1.224 -0.288 0 N-CA-C 116.345 1.98 . . . . 25.0 116.345 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.5 mt -76.48 -38.73 54.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.496 -1.229 . . . . 25.0 109.645 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.7 m120 54.35 24.96 5.5 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.329 1.052 . . . . 25.0 112.921 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.405 HG23 ' HB ' ' A' ' 34' ' ' VAL . 23.1 m -84.85 175.1 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 105.439 -2.059 . . . . 25.0 105.439 173.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.82 174.04 6.41 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.736 -0.603 . . . . 25.0 109.81 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.56 162.81 36.57 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.158 -0.474 . . . . 25.0 110.459 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -128.42 129.18 45.78 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.018 -0.992 . . . . 25.0 109.23 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.59 136.9 43.99 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.878 -0.601 . . . . 25.0 109.466 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.4 mt -104.82 -15.83 15.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 111.881 0.326 . . . . 25.0 111.881 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -143.15 165.35 27.67 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.976 -1.12 . . . . 25.0 107.976 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.93 165.03 25.01 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.638 -0.504 . . . . 25.0 109.638 174.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.04 159.91 42.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.104 -0.702 . . . . 25.0 109.104 177.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.01 121.79 56.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 104.866 -2.272 . . . . 25.0 104.866 171.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.82 134.73 33.63 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.462 -1.681 . . . . 25.0 106.462 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -114.35 -8.8 12.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.324 0.583 . . . . 25.0 111.166 -177.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.5 p -132.16 155.9 80.75 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 105.541 -2.022 . . . . 25.0 105.541 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.33 -18.31 39.08 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 118.03 -0.846 . . . . 25.0 112.266 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.48 -20.29 58.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.934 -0.576 . . . . 25.0 110.926 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -95.45 137.08 35.01 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.956 -1.127 . . . . 25.0 107.956 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.454 ' HB2' HG13 ' A' ' 57' ' ' VAL . 50.5 mt -86.26 134.53 33.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.886 -0.597 . . . . 25.0 109.947 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.06 130.45 34.61 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.232 -1.025 . . . . 25.0 108.232 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -154.27 163.36 40.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.916 0.865 . . . . 25.0 113.329 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -115.83 163.52 15.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.577 -1.192 . . . . 25.0 110.013 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -58.94 129.62 43.04 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.736 -0.839 . . . . 25.0 108.736 175.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.62 -11.04 72.01 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 118.831 -0.983 . . . . 25.0 114.634 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -63.21 150.34 43.26 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 118.39 1.095 . . . . 25.0 110.457 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.2 mm -115.57 131.28 68.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.37 -1.286 . . . . 25.0 108.917 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -135.37 156.02 49.62 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.214 -0.661 . . . . 25.0 109.214 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.1 m -87.63 130.17 34.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.177 -1.416 . . . . 25.0 107.177 176.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.405 ' HB ' HG23 ' A' ' 8' ' ' VAL . 57.8 t -94.24 124.32 46.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.643 -1.243 . . . . 25.0 107.643 177.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.595 HD12 HD22 ' A' ' 47' ' ' LEU . 81.2 mt -93.27 -44.98 8.05 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -149.43 162.25 40.48 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.961 -0.755 . . . . 25.0 108.961 -175.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 mtm105 -121.81 151.11 40.96 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.872 -1.159 . . . . 25.0 107.872 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.404 ' H ' ' HD1' ' A' ' 46' ' ' TRP . 27.7 m-20 56.11 38.86 30.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 123.51 1.624 . . . . 25.0 108.853 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 t -67.1 153.37 43.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.11 -1.859 . . . . 25.0 110.438 -175.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 60.6 9.56 2.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.911 0.884 . . . . 25.0 113.261 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.36 10.84 84.1 Favored Glycine 0 C--N 1.329 0.17 0 N-CA-C 110.803 -0.919 . . . . 25.0 110.803 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.423 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 93.2 mt -88.42 109.44 20.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.853 -0.795 . . . . 25.0 108.853 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -58.6 126.26 26.87 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.588 -0.733 . . . . 25.0 110.983 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.65 -0.58 76.21 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 115.784 1.074 . . . . 25.0 115.784 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.423 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 94.3 m95 -100.89 129.99 46.83 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 119.028 1.414 . . . . 25.0 109.964 178.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.404 ' HD1' ' H ' ' A' ' 38' ' ' ASP . 47.6 m0 -112.89 140.54 47.6 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 121.873 -0.517 . . . . 25.0 109.926 -175.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.595 HD22 HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -80.3 121.86 26.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 105.949 -1.871 . . . . 25.0 105.949 179.173 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 92.5 m -133.51 168.37 18.76 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.926 0.393 . . . . 25.0 111.583 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 t -123.42 125.77 45.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.747 -1.205 . . . . 25.0 107.747 173.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.0 tp -152.82 143.78 22.98 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.806 -1.553 . . . . 25.0 106.806 -176.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.9 m80 55.69 31.97 18.44 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.153 0.581 . . . . 25.0 112.214 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.36 4.36 68.91 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 115.268 0.867 . . . . 25.0 115.268 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -124.75 165.72 17.47 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.069 -1.086 . . . . 25.0 108.069 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -116.28 154.37 30.28 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.669 -0.863 . . . . 25.0 108.669 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.53 -157.44 20.48 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 106.381 -2.688 . . . . 25.0 106.381 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.4 pt -120.65 157.34 23.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.618 0.723 . . . . 25.0 111.423 -176.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.3 m -143.87 147.12 37.21 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 114.763 -1.108 . . . . 25.0 109.146 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -74.51 117.7 5.06 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 O-C-N 121.999 0.473 . . . . 25.0 112.519 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.51 -19.5 68.93 Favored Glycine 0 C--O 1.22 -0.777 0 CA-C-O 121.422 0.457 . . . . 25.0 114.104 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -66.41 -10.33 42.66 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.552 0.945 . . . . 25.0 113.552 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -130.46 26.34 5.08 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.872 -0.788 . . . . 25.0 108.872 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.2 tp -131.77 150.05 52.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.282 -0.872 . . . . 25.0 111.595 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -121.26 126.67 50.14 Favored 'General case' 0 C--O 1.211 -0.931 0 C-N-CA 122.828 0.451 . . . . 25.0 110.932 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.2 mm -75.59 135.41 27.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.964 -0.754 . . . . 25.0 108.964 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.9 mt -116.66 107.18 14.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.023 -1.843 . . . . 25.0 106.023 174.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.931 -0.577 . . . . 25.0 110.228 -176.961 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 107.69 -1.226 . . . . 25.0 107.69 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo . . . . . 0 C--O 1.244 0.778 0 C-N-CA 117.848 -0.968 . . . . 25.0 111.472 176.886 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 . . . . . 0 CA--C 1.513 -0.476 0 CA-C-O 120.902 0.382 . . . . 25.0 111.389 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.02 -41.23 95.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.109 -0.951 . . . . 25.0 109.661 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 56.65 25.16 9.69 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.268 1.027 . . . . 25.0 111.912 -178.549 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.6 m -83.42 159.94 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 105.805 -1.924 . . . . 25.0 105.805 176.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.43 170.98 8.85 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.821 -1.177 . . . . 25.0 107.821 -177.207 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.13 163.15 36.25 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.941 -0.392 . . . . 25.0 109.941 175.827 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -132.21 128.76 38.64 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.621 -0.718 . . . . 25.0 109.669 177.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.26 130.73 42.8 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.496 -0.557 . . . . 25.0 109.496 177.348 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.9 mt -97.97 -21.86 16.61 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.693 0.282 . . . . 25.0 110.912 -177.808 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -138.97 165.91 25.87 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.676 -0.861 . . . . 25.0 108.676 178.058 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -74.58 165.95 24.35 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.03 0.932 . . . . 25.0 111.302 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.0 156.92 42.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.32 0.581 . . . . 25.0 110.861 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.6 t -130.26 125.7 60.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 102.926 -2.99 . . . . 25.0 102.926 170.867 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.19 136.81 33.11 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.558 -1.275 . . . . 25.0 107.558 178.255 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -128.6 6.26 5.66 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.294 0.569 . . . . 25.0 111.522 -178.777 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.2 m -127.63 151.36 75.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 105.82 -1.918 . . . . 25.0 105.82 176.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.62 -25.96 40.1 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 117.35 -1.3 . . . . 25.0 112.712 -177.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -79.29 -16.94 55.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.192 -0.458 . . . . 25.0 111.498 178.427 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -86.7 132.96 33.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.94 0.876 . . . . 25.0 109.247 -177.707 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.404 ' HB2' HG13 ' A' ' 57' ' ' VAL . 49.1 mt -87.07 133.4 33.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.736 -0.665 . . . . 25.0 110.567 -177.192 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.5 121.2 28.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.223 -0.899 . . . . 25.0 108.954 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -147.75 164.01 34.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.046 0.451 . . . . 25.0 111.022 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 55.8 ttt-85 -126.19 165.92 18.02 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.035 -0.728 . . . . 25.0 109.035 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -57.0 132.6 53.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.958 0.409 . . . . 25.0 110.493 -179.198 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.89 -16.5 61.16 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-O 119.122 -0.821 . . . . 25.0 113.929 178.164 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.98 151.37 26.38 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.837 0.827 . . . . 25.0 111.145 178.591 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.2 mm -117.99 131.39 70.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.067 -1.424 . . . . 25.0 108.917 -179.176 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -138.82 158.05 44.94 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 122.633 0.373 . . . . 25.0 110.202 179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.3 m -89.91 130.19 36.16 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.689 -0.856 . . . . 25.0 108.689 177.384 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.3 t -94.53 126.04 47.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.551 -0.907 . . . . 25.0 108.551 178.063 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.652 HD12 HD22 ' A' ' 47' ' ' LEU . 79.8 mt -90.76 -51.47 5.35 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.097 -0.705 . . . . 25.0 109.097 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -151.84 171.47 17.68 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.04 -1.096 . . . . 25.0 108.04 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -121.9 155.2 35.94 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.049 -1.464 . . . . 25.0 107.049 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 58.17 39.24 26.15 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 123.794 1.759 . . . . 25.0 109.448 178.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.4 t -65.94 155.47 36.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 112.758 -2.019 . . . . 25.0 110.485 -176.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 60.11 9.62 1.92 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.185 0.994 . . . . 25.0 112.992 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.51 20.92 73.63 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.421 -1.071 . . . . 25.0 110.421 -176.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.6 mt -97.4 127.72 43.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.225 0.536 . . . . 25.0 110.279 178.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -67.16 124.08 22.09 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.673 -0.694 . . . . 25.0 110.857 178.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.06 -0.01 84.51 Favored Glycine 0 C--O 1.239 0.426 0 N-CA-C 116.392 1.317 . . . . 25.0 116.392 173.484 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -100.68 132.21 46.19 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 118.384 1.092 . . . . 25.0 109.453 178.175 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -113.07 141.98 46.26 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.183 -0.673 . . . . 25.0 109.183 -176.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.652 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -83.73 123.19 29.6 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 105.644 -1.984 . . . . 25.0 105.644 178.925 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 84.3 m -131.62 164.49 25.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.931 0.396 . . . . 25.0 110.741 177.839 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.0 t -118.85 123.33 44.45 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.771 -1.937 . . . . 25.0 105.771 172.642 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.1 tp -145.43 136.63 24.89 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.11 -1.071 . . . . 25.0 108.11 -176.249 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.64 27.69 12.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.885 0.698 . . . . 25.0 112.885 178.447 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.45 0.1 86.69 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 114.883 0.713 . . . . 25.0 114.883 177.529 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -124.71 158.63 32.76 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 118.124 0.962 . . . . 25.0 110.135 178.466 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -109.59 154.65 22.47 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.095 -0.706 . . . . 25.0 109.095 179.534 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.83 -160.73 28.17 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 107.288 -2.325 . . . . 25.0 107.288 179.452 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.2 pt -117.06 153.16 18.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.919 0.866 . . . . 25.0 112.534 -174.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.9 m -142.88 146.89 39.45 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 114.313 -1.312 . . . . 25.0 109.839 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.12 119.07 5.65 Favored 'Trans proline' 0 C--O 1.239 0.55 0 CA-C-O 121.296 0.457 . . . . 25.0 112.252 178.815 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.9 -25.33 74.28 Favored Glycine 0 C--O 1.219 -0.842 0 N-CA-C 116.72 1.448 . . . . 25.0 116.72 -174.18 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -65.19 -22.32 66.88 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.556 -0.967 . . . . 25.0 113.512 -177.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -110.61 24.63 12.72 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.617 0.722 . . . . 25.0 109.389 178.72 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.9 tp -133.29 150.72 51.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.367 -0.833 . . . . 25.0 109.968 -175.708 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -122.41 125.88 46.79 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-N 116.558 -0.292 . . . . 25.0 110.494 -179.685 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.2 mm -75.69 135.63 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.13 -1.063 . . . . 25.0 108.13 175.292 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.2 mt -118.6 88.72 2.98 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.577 -0.898 . . . . 25.0 108.577 177.363 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 C--N 1.325 -0.462 0 N-CA-C 108.837 -0.801 . . . . 25.0 108.837 178.77 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 106.976 -1.491 . . . . 25.0 106.976 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 CA--C 1.543 0.942 0 CA-C-N 118.748 0.589 . . . . 25.0 112.055 177.908 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 . . . . . 0 CA--C 1.511 -0.529 0 CA-C-O 120.975 0.417 . . . . 25.0 111.22 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.02 -38.85 89.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.141 -0.936 . . . . 25.0 110.132 178.471 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 55.86 36.34 27.11 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.933 0.893 . . . . 25.0 111.492 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 m -100.63 161.59 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 106.36 -1.718 . . . . 25.0 106.36 177.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.55 171.97 7.59 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.02 -1.104 . . . . 25.0 108.02 -177.802 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.75 164.82 34.23 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.694 -0.484 . . . . 25.0 109.694 174.472 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -128.4 136.22 50.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.105 -0.952 . . . . 25.0 108.712 177.256 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.567 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -74.18 136.43 42.83 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.799 0.333 . . . . 25.0 110.827 175.179 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.4 mt -100.6 -20.92 15.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.852 0.358 . . . . 25.0 110.781 -179.754 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -142.5 171.57 13.88 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 103.297 -2.853 . . . . 25.0 103.297 175.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -83.5 178.57 7.95 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.302 -0.999 . . . . 25.0 108.302 174.501 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -153.25 135.86 15.19 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.68 0.276 . . . . 25.0 111.108 175.843 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.8 t -106.04 120.86 57.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 104.946 -2.242 . . . . 25.0 104.946 174.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.6 134.01 46.11 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.37 -0.832 . . . . 25.0 109.394 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -107.53 3.81 25.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.676 0.75 . . . . 25.0 109.683 179.218 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.7 m -149.4 155.82 39.4 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 107.932 -1.136 . . . . 25.0 107.932 179.706 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.39 -19.67 32.85 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 118.398 -0.601 . . . . 25.0 113.491 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -15.96 55.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.158 0.504 . . . . 25.0 110.076 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -90.82 139.45 30.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.6 0.714 . . . . 25.0 109.13 -178.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.423 ' HB2' HG13 ' A' ' 57' ' ' VAL . 59.2 mt -92.06 127.78 37.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.767 0.794 . . . . 25.0 110.567 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.4 p -87.96 143.43 27.11 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 106.042 -1.836 . . . . 25.0 106.042 173.679 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -156.98 166.12 34.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.503 -0.925 . . . . 25.0 108.503 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.5 tpp85 -105.85 158.95 16.39 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.994 -0.743 . . . . 25.0 108.994 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -59.83 128.79 38.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.764 -0.653 . . . . 25.0 109.586 178.609 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.14 -4.45 81.04 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.117 -0.824 . . . . 25.0 114.356 177.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -62.71 160.65 13.8 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 117.885 0.843 . . . . 25.0 110.842 176.511 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.6 mm -119.93 134.79 62.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.643 -1.162 . . . . 25.0 109.49 178.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -139.85 163.43 32.66 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.736 -0.468 . . . . 25.0 109.736 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -97.45 129.49 44.64 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.508 -1.294 . . . . 25.0 107.508 176.538 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.5 t -96.28 122.94 48.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 107.773 -1.195 . . . . 25.0 107.773 177.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.632 HD12 HD22 ' A' ' 47' ' ' LEU . 80.7 mt -91.52 -42.85 10.02 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.164 -0.926 . . . . 25.0 109.267 -179.319 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -151.68 158.85 43.97 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.779 -0.823 . . . . 25.0 108.779 -176.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.8 mtm105 -116.11 153.84 31.04 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.642 -1.244 . . . . 25.0 107.642 175.011 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 56.22 37.54 28.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 123.383 1.563 . . . . 25.0 108.62 178.261 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.0 t -64.36 150.2 46.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.255 -1.793 . . . . 25.0 110.386 -174.653 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 59.47 13.85 3.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.636 0.774 . . . . 25.0 112.121 -178.534 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.71 18.22 79.78 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.294 -0.723 . . . . 25.0 111.294 -178.102 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.2 mt -91.55 121.15 32.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.274 0.537 . . . . 25.0 109.696 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -62.45 125.02 22.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.931 -0.577 . . . . 25.0 110.357 -179.509 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.4 -0.8 73.81 Favored Glycine 0 CA--C 1.519 0.292 0 N-CA-C 116.762 1.465 . . . . 25.0 116.762 175.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -100.1 130.03 46.2 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 119.149 1.475 . . . . 25.0 110.713 179.338 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -110.25 140.77 44.06 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.571 -0.529 . . . . 25.0 109.571 -177.268 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.632 HD22 HD12 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -79.98 120.8 24.66 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 105.628 -1.99 . . . . 25.0 105.628 177.428 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 84.5 m -132.2 164.79 25.56 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.099 0.407 . . . . 25.0 112.099 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.5 t -118.92 116.57 26.74 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.932 -1.507 . . . . 25.0 106.932 172.782 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -146.43 138.99 25.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.936 -1.135 . . . . 25.0 107.936 -175.872 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 56.96 27.37 13.05 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.94 0.719 . . . . 25.0 112.94 -178.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.65 5.98 89.17 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 121.012 -0.613 . . . . 25.0 113.421 178.735 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -116.23 154.39 30.19 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 108.308 -0.997 . . . . 25.0 108.308 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -108.3 145.19 34.76 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.058 -1.83 . . . . 25.0 106.058 170.702 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.36 -155.32 13.54 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 106.877 -2.489 . . . . 25.0 106.877 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.3 pt -123.97 152.86 29.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.449 0.643 . . . . 25.0 110.665 -175.362 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 24' ' ' LEU . 2.8 m -139.63 147.31 51.43 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.148 -0.933 . . . . 25.0 108.626 -179.612 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.94 114.99 4.19 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 CA-C-O 121.379 0.491 . . . . 25.0 110.961 176.71 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.56 -17.12 68.48 Favored Glycine 0 C--O 1.222 -0.631 0 N-CA-C 114.304 0.482 . . . . 25.0 114.304 -175.535 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -63.76 -20.17 65.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.652 0.612 . . . . 25.0 112.652 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -116.48 27.18 9.37 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.746 -0.464 . . . . 25.0 109.746 177.214 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 12' ' ' ALA . 1.5 tp -130.34 158.01 41.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.309 0.576 . . . . 25.0 111.769 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -133.31 120.25 20.79 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.988 -0.551 . . . . 25.0 110.97 178.204 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mm -66.76 136.51 26.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.66 -0.496 . . . . 25.0 109.66 178.494 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.2 mt -117.04 104.58 11.4 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.463 -1.31 . . . . 25.0 107.463 175.864 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 120.855 0.359 . . . . 25.0 110.51 -178.833 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.2 mttt . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 109.651 -0.5 . . . . 25.0 109.651 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 CA--C 1.538 0.695 0 C-N-CA 118.419 -0.587 . . . . 25.0 112.913 178.556 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 CA--C 1.507 -0.698 0 CA-C-O 121.213 0.53 . . . . 25.0 110.444 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 71.4 mt -67.24 -39.28 86.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.783 -1.099 . . . . 25.0 109.901 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 57.4 29.33 16.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.053 0.941 . . . . 25.0 111.894 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.1 m -94.65 160.91 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 107.014 -1.476 . . . . 25.0 107.014 179.038 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.13 168.05 10.5 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.987 -1.116 . . . . 25.0 107.987 -178.646 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.06 156.07 42.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.784 0.326 . . . . 25.0 110.192 175.627 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -121.56 128.38 51.94 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.715 0.806 . . . . 25.0 110.127 178.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.63 131.58 45.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.498 -0.556 . . . . 25.0 109.498 176.777 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.1 mt -94.13 -21.28 19.2 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.064 -0.347 . . . . 25.0 110.064 -179.052 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -146.04 171.31 15.07 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.406 -1.701 . . . . 25.0 106.406 177.69 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -82.01 178.9 8.04 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.257 -0.645 . . . . 25.0 109.257 176.187 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.95 168.87 23.23 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 122.721 0.408 . . . . 25.0 110.125 176.45 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.5 t -128.02 129.88 69.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 104.149 -2.537 . . . . 25.0 104.149 171.238 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.88 119.38 23.85 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.78 -0.452 . . . . 25.0 109.78 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -103.68 8.93 37.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.322 0.582 . . . . 25.0 110.861 -177.913 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.9 m -152.89 155.66 32.36 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 106.827 -1.546 . . . . 25.0 106.827 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.02 -22.11 35.94 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 117.813 -0.991 . . . . 25.0 112.452 178.244 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.4 -20.72 56.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.239 -0.437 . . . . 25.0 110.516 178.435 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -85.89 126.75 34.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.769 0.795 . . . . 25.0 109.095 -176.377 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.437 ' HB2' HG13 ' A' ' 57' ' ' VAL . 46.1 mt -78.62 135.53 37.27 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.328 -0.99 . . . . 25.0 108.328 178.678 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.1 t -91.08 125.41 35.86 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.776 -1.194 . . . . 25.0 107.776 176.61 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -142.21 159.97 41.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.383 0.611 . . . . 25.0 111.531 -179.525 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.513 ' HD3' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -107.9 165.18 11.65 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.938 -0.764 . . . . 25.0 108.938 179.116 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.513 ' H ' ' HD3' ' A' ' 27' ' ' ARG . 87.4 tttt -61.29 129.05 39.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.64 -0.709 . . . . 25.0 109.52 178.459 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.26 -9.83 69.65 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-O 119.316 -0.713 . . . . 25.0 114.059 178.045 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -60.94 150.27 33.83 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.871 0.843 . . . . 25.0 110.92 179.279 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.3 mm -113.95 127.31 71.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.569 -1.196 . . . . 25.0 109.701 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.7 ptp -132.15 163.13 29.2 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.583 -0.525 . . . . 25.0 109.583 179.043 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.4 m -99.92 125.83 45.98 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.579 -1.267 . . . . 25.0 107.579 177.821 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.6 t -90.3 122.13 41.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.118 -1.067 . . . . 25.0 108.118 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.589 HD12 HD22 ' A' ' 47' ' ' LEU . 80.8 mt -90.3 -46.49 8.37 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.226 -0.897 . . . . 25.0 108.608 179.271 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.03 156.32 42.07 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.979 -0.378 . . . . 25.0 109.979 -176.015 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -111.98 152.01 28.61 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.891 -0.411 . . . . 25.0 109.891 174.581 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 55.97 39.49 30.53 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 123.6 1.667 . . . . 25.0 108.759 177.101 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.0 t -66.38 152.98 43.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 112.746 -2.024 . . . . 25.0 110.72 -175.174 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 60.39 9.1 1.85 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.227 1.011 . . . . 25.0 113.618 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.79 15.26 75.87 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 111.071 -0.812 . . . . 25.0 111.071 -176.911 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.8 mt -92.99 113.35 25.61 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.426 -0.583 . . . . 25.0 109.426 179.705 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.87 128.02 33.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.302 0.572 . . . . 25.0 110.005 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.97 0.35 85.17 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 115.813 1.085 . . . . 25.0 115.813 176.094 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -101.03 132.84 46.26 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 119.005 1.403 . . . . 25.0 110.415 178.402 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.6 m0 -112.36 138.68 48.74 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.171 -0.677 . . . . 25.0 109.171 -176.738 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.589 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -80.88 120.81 25.19 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 105.199 -2.148 . . . . 25.0 105.199 177.223 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.9 m -132.34 162.23 31.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.3 0.571 . . . . 25.0 112.488 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.5 t -116.9 123.72 47.69 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 105.987 -1.857 . . . . 25.0 105.987 172.012 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.4 tp -135.73 127.6 29.39 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.234 -1.395 . . . . 25.0 107.234 -177.897 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 29.4 m170 54.79 32.15 17.01 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.143 0.497 . . . . 25.0 112.241 178.684 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.35 -3.41 87.23 Favored Glycine 0 C--O 1.225 -0.462 0 N-CA-C 115.852 1.101 . . . . 25.0 115.852 176.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -114.35 157.25 23.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.677 -1.231 . . . . 25.0 107.677 177.475 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -117.21 154.68 30.71 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.374 -0.232 . . . . 25.0 110.374 -178.47 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.95 -157.11 21.92 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 106.127 -2.789 . . . . 25.0 106.127 178.574 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.8 pt -119.69 155.39 22.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 121.605 0.717 . . . . 25.0 111.39 -177.143 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.4 m -144.33 148.13 39.67 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.01 -0.995 . . . . 25.0 109.661 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.33 121.7 6.21 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 CA-C-O 121.545 0.56 . . . . 25.0 112.965 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.08 -18.25 70.75 Favored Glycine 0 C--O 1.22 -0.729 0 CA-C-N 116.114 -0.494 . . . . 25.0 114.155 -178.17 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -64.1 -17.2 63.2 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.394 0.516 . . . . 25.0 112.394 -177.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -127.33 30.29 5.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.116 0.484 . . . . 25.0 110.2 176.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.8 mt -129.79 156.38 44.42 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.811 -0.631 . . . . 25.0 111.769 177.372 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -128.98 125.92 38.44 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.161 -0.472 . . . . 25.0 110.125 176.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.6 mm -74.5 136.91 24.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.558 -0.904 . . . . 25.0 108.558 178.468 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.6 mt -111.92 77.93 1.08 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.147 0.579 . . . . 25.0 109.597 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.018 0 C-N-CA 123.434 0.693 . . . . 25.0 112.77 179.672 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt . . . . . 0 CA--C 1.543 0.676 0 N-CA-C 107.625 -1.25 . . . . 25.0 107.625 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo . . . . . 0 CA--C 1.542 0.892 0 O-C-N 122.097 0.525 . . . . 25.0 113.214 -177.445 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 121.062 0.458 . . . . 25.0 111.097 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.4 mt -66.05 -41.65 90.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.256 -0.884 . . . . 25.0 110.762 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.1 m120 55.34 24.36 6.49 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.277 1.031 . . . . 25.0 112.381 -177.211 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.6 m -83.29 175.35 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 N-CA-C 105.437 -2.06 . . . . 25.0 105.437 175.068 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -120.0 171.85 8.16 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 118.774 0.715 . . . . 25.0 109.951 -179.796 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.8 162.21 39.69 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.874 0.368 . . . . 25.0 110.354 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -122.24 132.04 54.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.141 -0.936 . . . . 25.0 110.494 178.717 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.413 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -74.08 128.05 34.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.95 0.405 . . . . 25.0 110.558 177.649 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.9 mt -98.81 -19.53 17.37 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.26 0.552 . . . . 25.0 110.985 -177.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -142.7 163.31 33.16 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 106.063 -1.829 . . . . 25.0 106.063 177.413 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -82.57 174.5 10.98 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.719 1.007 . . . . 25.0 113.719 -177.752 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -160.93 157.22 26.1 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 110.125 -0.324 . . . . 25.0 110.125 174.869 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.7 t -126.73 131.71 70.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 104.744 -2.317 . . . . 25.0 104.744 174.399 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.93 124.12 27.93 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 110.235 -0.283 . . . . 25.0 110.235 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -116.57 -12.61 10.93 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.054 0.93 . . . . 25.0 110.316 175.91 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 t -106.76 147.42 35.0 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 107.41 -1.33 . . . . 25.0 107.41 175.339 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.28 -23.74 44.54 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 116.444 -1.904 . . . . 25.0 114.695 -177.185 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -81.92 -13.16 57.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.086 0.47 . . . . 25.0 110.262 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -84.85 139.23 32.05 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.384 0.611 . . . . 25.0 111.508 -171.491 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.5 mt -93.1 131.06 38.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.596 0.713 . . . . 25.0 109.833 176.849 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.2 t -91.87 139.74 30.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.8 -1.556 . . . . 25.0 106.8 177.178 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.448 ' HE2' HG12 ' A' ' 57' ' ' VAL . 29.4 p90 -162.58 171.72 16.52 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.382 -0.97 . . . . 25.0 108.382 -177.289 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -126.75 168.03 14.96 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.769 0.795 . . . . 25.0 110.442 174.244 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.67 133.41 55.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.535 -0.757 . . . . 25.0 109.592 -176.202 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.96 -20.07 51.75 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 118.64 -1.089 . . . . 25.0 112.828 178.267 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -58.6 143.8 45.08 Favored 'General case' 0 C--O 1.249 1.056 0 CA-C-N 118.427 1.113 . . . . 25.0 110.645 179.064 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.6 mm -110.85 128.85 66.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.771 -1.104 . . . . 25.0 108.1 -178.43 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.7 ptp -132.89 149.41 52.25 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.725 0.41 . . . . 25.0 110.235 -177.384 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.0 m -85.48 126.11 33.57 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 107.541 -1.281 . . . . 25.0 107.541 179.344 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.43 124.5 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 107.904 -1.147 . . . . 25.0 107.904 178.862 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.631 HD12 HD22 ' A' ' 47' ' ' LEU . 75.8 mt -90.52 -47.8 7.48 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.723 -0.843 . . . . 25.0 108.723 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -153.69 173.88 15.23 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.426 0.631 . . . . 25.0 109.305 176.302 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -123.73 151.29 43.36 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.361 -1.718 . . . . 25.0 106.361 -179.557 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 57.37 43.4 23.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 123.27 1.509 . . . . 25.0 109.399 -176.803 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.7 t -66.55 149.46 50.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.629 -1.623 . . . . 25.0 110.349 -177.562 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 59.83 15.3 4.76 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.664 0.785 . . . . 25.0 112.642 178.355 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.81 14.62 82.18 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.903 -0.665 . . . . 25.0 112.187 -178.171 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.2 mt -94.36 113.68 25.61 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.342 -0.614 . . . . 25.0 109.342 -178.816 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -59.82 123.26 16.46 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.244 0.545 . . . . 25.0 110.734 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.76 -0.0 89.82 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-O 118.829 -0.984 . . . . 25.0 115.538 175.26 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -100.12 132.7 45.33 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 119.084 1.442 . . . . 25.0 109.335 177.012 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -113.08 140.03 48.2 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.592 -1.262 . . . . 25.0 107.592 -175.9 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.631 HD22 HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -82.47 123.13 28.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.193 -2.151 . . . . 25.0 105.193 177.818 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 95.5 m -130.5 163.39 27.13 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.993 0.425 . . . . 25.0 111.408 178.421 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -116.2 126.9 54.28 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 106.318 -1.734 . . . . 25.0 106.318 173.304 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.2 tp -151.57 135.58 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.26 -1.015 . . . . 25.0 108.26 -175.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 54.23 30.13 11.81 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.654 0.983 . . . . 25.0 113.654 -178.482 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.18 6.18 88.92 Favored Glycine 0 C--O 1.22 -0.777 0 C-N-CA 120.936 -0.649 . . . . 25.0 113.919 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -114.82 161.32 18.37 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.499 -1.297 . . . . 25.0 107.499 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -120.26 146.48 46.03 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 106.016 -1.846 . . . . 25.0 106.016 174.067 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.22 -164.48 31.42 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 108.286 -1.926 . . . . 25.0 108.286 -179.372 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.8 pt -114.51 150.19 16.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.596 0.712 . . . . 25.0 112.053 -174.72 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.448 HG12 ' HE2' ' A' ' 26' ' ' PHE . 3.2 m -144.78 146.18 30.74 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 114.539 -1.21 . . . . 25.0 108.749 -179.629 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.23 122.17 6.94 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 118.383 -0.611 . . . . 25.0 112.393 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.81 -17.88 75.55 Favored Glycine 0 C--O 1.219 -0.789 0 N-CA-C 115.148 0.819 . . . . 25.0 115.148 -176.583 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -59.79 -21.13 60.4 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 113.221 0.823 . . . . 25.0 113.221 -177.26 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.26 26.3 6.92 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.526 0.679 . . . . 25.0 110.368 -178.704 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 12' ' ' ALA . 11.2 mt -117.46 156.08 28.58 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 121.455 0.645 . . . . 25.0 110.365 175.88 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -119.14 122.81 42.88 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 173.438 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.8 mm -73.23 135.1 28.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.887 -1.153 . . . . 25.0 107.887 176.527 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt -115.23 97.2 6.06 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.825 -0.805 . . . . 25.0 108.825 178.412 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.322 -0.628 0 N-CA-C 109.13 -0.692 . . . . 25.0 109.13 178.285 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.6 mttp . . . . . 0 CA--C 1.549 0.941 0 N-CA-C 108.538 -0.912 . . . . 25.0 108.538 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 C--O 1.239 0.57 0 O-C-N 122.539 0.757 . . . . 25.0 111.932 175.681 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 . . . . . 0 C--O 1.225 -0.207 0 N-CA-C 116.614 2.079 . . . . 25.0 116.614 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 mt -71.97 -41.61 67.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.104 -1.407 . . . . 25.0 110.006 -179.595 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 56.5 26.5 11.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.343 1.057 . . . . 25.0 112.304 -178.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.4 m -85.86 158.52 3.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.338 -1.727 . . . . 25.0 106.338 177.522 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.38 172.81 7.97 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 108.77 -0.826 . . . . 25.0 108.77 -177.056 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.14 165.84 32.66 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.719 -0.475 . . . . 25.0 109.719 174.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -131.16 136.26 48.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.092 -0.958 . . . . 25.0 110.113 177.0 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.573 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -73.36 127.16 31.89 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.861 -0.609 . . . . 25.0 110.453 172.883 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.3 mt -93.79 -19.54 20.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.216 0.532 . . . . 25.0 110.247 -178.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -146.67 175.96 10.2 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 103.285 -2.857 . . . . 25.0 103.285 178.082 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -91.42 175.98 6.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 118.719 0.69 . . . . 25.0 111.41 177.553 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -154.59 144.27 21.55 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.678 0.391 . . . . 25.0 111.106 177.848 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 80.0 t -113.38 125.25 70.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.5 -2.037 . . . . 25.0 105.5 176.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.46 131.41 41.77 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.057 -0.974 . . . . 25.0 109.6 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -104.98 -1.99 25.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.593 0.711 . . . . 25.0 109.934 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -147.07 156.77 46.94 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.167 -1.049 . . . . 25.0 108.167 -177.642 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.85 -19.7 40.34 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 118.309 -0.661 . . . . 25.0 112.729 177.388 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -72.96 -16.9 61.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.292 -0.413 . . . . 25.0 111.04 177.502 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -100.37 142.29 32.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.734 0.778 . . . . 25.0 110.887 -172.884 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.408 ' HB2' HG13 ' A' ' 57' ' ' VAL . 57.0 mt -95.3 127.03 41.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.458 -0.792 . . . . 25.0 109.884 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.7 p -87.17 145.91 26.23 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 105.31 -2.107 . . . . 25.0 105.31 173.198 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -159.59 165.09 33.52 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.113 -1.069 . . . . 25.0 108.113 -179.758 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.47 161.76 17.57 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.483 0.658 . . . . 25.0 110.063 177.942 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -56.99 129.4 41.54 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.509 -0.769 . . . . 25.0 110.48 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.58 -16.41 59.78 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-O 118.941 -0.922 . . . . 25.0 113.603 177.391 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -58.55 155.21 12.7 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.924 0.869 . . . . 25.0 111.525 179.459 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.0 mm -118.97 135.57 58.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.225 -1.352 . . . . 25.0 109.262 179.322 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -141.71 156.35 45.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.307 -0.627 . . . . 25.0 109.307 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.9 m -91.15 129.42 37.15 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.179 -1.045 . . . . 25.0 108.179 177.274 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.3 t -94.14 124.97 46.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.121 -1.066 . . . . 25.0 108.121 177.605 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.623 HD12 HD22 ' A' ' 47' ' ' LEU . 82.9 mt -93.69 -43.48 8.63 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.501 -0.772 . . . . 25.0 109.555 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -149.38 165.16 32.88 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.318 -0.993 . . . . 25.0 108.318 -175.261 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -126.64 153.32 45.52 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 107.045 -1.465 . . . . 25.0 107.045 176.112 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 56.48 39.43 29.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 123.477 1.608 . . . . 25.0 109.088 -179.075 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -69.27 155.38 40.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.207 -1.815 . . . . 25.0 110.477 -176.104 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 60.16 11.45 2.77 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.918 0.887 . . . . 25.0 113.209 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.08 16.93 79.11 Favored Glycine 0 CA--C 1.516 0.135 0 N-CA-C 110.9 -0.88 . . . . 25.0 110.9 -177.167 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.405 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 96.6 mt -98.18 114.53 26.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.02 0.438 . . . . 25.0 109.999 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -63.58 127.68 32.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.889 -0.596 . . . . 25.0 109.927 -178.695 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.74 -0.58 85.94 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 115.505 0.962 . . . . 25.0 115.505 176.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.405 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 92.0 m95 -100.86 130.03 46.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 118.565 1.182 . . . . 25.0 109.825 177.651 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -111.27 140.0 46.2 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.77 -0.456 . . . . 25.0 109.77 -175.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.623 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -79.78 120.88 24.65 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 105.585 -2.006 . . . . 25.0 105.585 178.93 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 86.0 m -131.52 163.55 27.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.966 0.412 . . . . 25.0 111.716 178.455 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.8 t -118.87 124.59 47.51 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.706 -1.59 . . . . 25.0 106.706 173.117 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.0 tp -151.72 142.71 23.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.779 -1.193 . . . . 25.0 107.779 -175.773 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 57.49 27.17 13.61 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.324 0.583 . . . . 25.0 112.235 177.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.62 4.49 90.36 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 114.859 0.703 . . . . 25.0 114.859 178.337 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -130.24 161.02 32.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.091 0.945 . . . . 25.0 109.43 179.432 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -107.89 153.29 23.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.221 -0.659 . . . . 25.0 109.221 177.846 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.95 -154.3 11.8 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 107.291 -2.324 . . . . 25.0 107.291 177.815 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.5 pt -124.69 153.22 31.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.378 0.609 . . . . 25.0 110.582 -175.729 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 24' ' ' LEU . 3.3 m -140.48 146.27 44.4 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 114.945 -1.025 . . . . 25.0 108.799 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.68 120.89 6.03 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 118.53 -0.514 . . . . 25.0 112.033 178.426 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.4 -17.05 70.1 Favored Glycine 0 C--O 1.222 -0.652 0 C-N-CA 121.576 -0.345 . . . . 25.0 113.191 -178.651 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -66.88 -6.91 18.26 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.944 0.72 . . . . 25.0 112.944 -179.282 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -135.79 26.63 3.34 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.577 -0.527 . . . . 25.0 109.577 175.282 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' A' ' 12' ' ' ALA . 1.6 tp -130.09 157.15 43.19 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 121.3 0.571 . . . . 25.0 111.603 -179.537 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -129.68 123.2 30.58 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.964 -0.562 . . . . 25.0 110.768 177.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.0 mm -70.09 135.93 27.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.797 -0.816 . . . . 25.0 108.797 176.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.7 mt -119.68 102.54 8.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.652 -1.24 . . . . 25.0 107.652 176.053 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--N 1.322 -0.626 0 N-CA-C 109.074 -0.713 . . . . 25.0 109.074 179.576 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 107.534 -1.284 . . . . 25.0 107.534 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 CA--C 1.54 0.799 0 O-C-N 121.952 0.449 . . . . 25.0 112.753 -178.122 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 . . . . . 0 CA--C 1.508 -0.648 0 N-CA-C 108.89 -0.781 . . . . 25.0 108.89 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.4 mt -68.01 -39.2 83.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.366 -0.833 . . . . 25.0 110.492 178.698 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 57.88 28.58 16.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.142 0.977 . . . . 25.0 111.871 -179.138 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 m -94.79 176.12 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 105.416 -2.068 . . . . 25.0 105.416 176.353 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -119.74 174.11 6.63 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.999 -0.741 . . . . 25.0 108.999 177.963 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.44 154.34 36.42 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.189 -0.3 . . . . 25.0 110.189 177.828 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -111.27 130.89 55.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.924 -0.58 . . . . 25.0 110.172 178.574 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.93 117.67 12.74 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.223 -0.658 . . . . 25.0 109.223 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.6 mt -83.62 -25.64 30.65 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.28 0.562 . . . . 25.0 109.885 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -139.74 164.15 30.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.587 -1.188 . . . . 25.0 108.081 177.771 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.26 178.34 5.87 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 124.285 0.99 . . . . 25.0 112.782 -179.541 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -155.12 158.37 38.91 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.756 0.312 . . . . 25.0 111.269 172.037 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.0 t -127.51 129.11 70.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 104.13 -2.545 . . . . 25.0 104.13 173.37 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.68 135.91 33.96 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -115.51 -15.6 11.45 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.615 0.721 . . . . 25.0 109.653 175.398 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.4 t -112.55 146.72 35.57 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 106.396 -1.705 . . . . 25.0 106.396 179.737 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.65 -16.68 42.59 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 117.822 -0.985 . . . . 25.0 113.391 177.816 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -80.73 -18.02 49.16 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.24 1.019 . . . . 25.0 110.58 177.082 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -86.0 136.06 33.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.72 0.772 . . . . 25.0 111.716 -177.356 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.9 mt -86.08 127.55 34.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.734 -0.666 . . . . 25.0 110.575 179.515 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.2 t -89.95 132.83 35.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.809 -1.182 . . . . 25.0 107.809 174.906 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -160.02 172.78 16.91 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.154 -1.054 . . . . 25.0 108.154 -176.735 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.56 170.4 8.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 122.386 1.088 . . . . 25.0 111.545 178.866 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.33 135.87 57.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.709 -1.132 . . . . 25.0 109.437 -179.639 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.26 -9.04 78.44 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 118.67 -1.072 . . . . 25.0 113.782 179.155 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -63.78 143.51 57.78 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 118.703 1.251 . . . . 25.0 109.233 174.881 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.6 mm -106.31 130.86 57.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 106.877 -1.527 . . . . 25.0 106.877 178.435 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.7 ptp -134.69 146.54 49.56 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.358 0.263 . . . . 25.0 110.294 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -83.13 127.29 33.46 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.161 -1.051 . . . . 25.0 108.161 179.371 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -94.21 124.65 46.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.164 -1.05 . . . . 25.0 108.164 -179.504 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.602 HD12 HD22 ' A' ' 47' ' ' LEU . 77.0 mt -94.8 -45.81 7.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.787 -0.642 . . . . 25.0 109.893 -179.336 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -151.18 159.98 44.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.571 -0.9 . . . . 25.0 108.571 -175.605 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -118.85 148.96 42.32 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.985 -1.117 . . . . 25.0 107.985 177.108 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 56.68 38.95 29.91 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 123.374 1.559 . . . . 25.0 109.401 -179.812 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -64.88 150.02 48.49 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 113.129 -1.85 . . . . 25.0 110.91 -176.78 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 58.97 11.91 2.13 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.644 0.979 . . . . 25.0 113.644 180.0 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.13 10.33 84.99 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 110.958 -0.857 . . . . 25.0 110.958 -178.33 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 90.2 mt -86.5 106.99 17.9 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.15 -1.056 . . . . 25.0 108.15 179.226 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.45 125.07 22.68 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.234 -0.893 . . . . 25.0 110.064 -176.398 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.12 -0.12 89.93 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-O 118.879 -0.956 . . . . 25.0 115.236 178.056 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.403 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 94.5 m95 -101.3 132.6 46.76 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 118.944 1.372 . . . . 25.0 110.638 177.385 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -110.66 140.89 44.59 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.795 -0.817 . . . . 25.0 108.795 -178.481 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.602 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -81.67 121.83 26.86 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.58 -2.007 . . . . 25.0 105.58 178.534 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.4 m -132.02 163.93 27.32 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.852 0.686 . . . . 25.0 112.852 179.57 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.0 t -117.43 127.1 53.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.331 -1.359 . . . . 25.0 107.331 174.224 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tp -140.62 124.7 17.42 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.899 -0.778 . . . . 25.0 108.899 -177.903 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 54.65 35.03 22.8 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.581 0.585 . . . . 25.0 112.581 -179.8 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.48 0.33 89.96 Favored Glycine 0 C--O 1.222 -0.601 0 N-CA-C 115.61 1.004 . . . . 25.0 115.61 176.03 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -119.73 159.64 24.12 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 107.464 -1.31 . . . . 25.0 107.464 176.686 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -117.58 159.6 22.63 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.874 -0.787 . . . . 25.0 108.874 -178.134 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.62 -159.18 27.84 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 105.327 -3.109 . . . . 25.0 105.327 179.259 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.3 pt -119.53 153.66 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.818 0.818 . . . . 25.0 112.253 -176.232 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 m -144.21 148.22 40.43 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.767 -1.106 . . . . 25.0 108.991 -179.311 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.1 125.19 7.75 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 117.259 -1.361 . . . . 25.0 112.133 -178.544 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.59 -17.33 76.38 Favored Glycine 0 C--O 1.219 -0.825 0 N-CA-C 114.982 0.753 . . . . 25.0 114.982 -175.472 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.59 -23.71 63.17 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.106 1.15 . . . . 25.0 114.106 -176.745 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.12 27.21 7.71 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.567 0.698 . . . . 25.0 110.375 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mt -114.65 155.15 27.11 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 121.339 0.59 . . . . 25.0 110.387 173.792 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -125.4 118.82 26.7 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 115.344 -0.844 . . . . 25.0 108.981 174.194 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.54 135.84 27.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.561 -0.533 . . . . 25.0 109.561 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.2 mt -115.46 105.37 12.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.525 -2.028 . . . . 25.0 105.525 175.776 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 120.959 0.409 . . . . 25.0 110.449 -177.349 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 108.255 -1.017 . . . . 25.0 108.255 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo . . . . . 0 CA--C 1.544 1.0 0 O-C-N 122.255 0.608 . . . . 25.0 112.775 -179.156 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 . . . . . 0 C--O 1.222 -0.391 0 CA-C-O 120.924 0.393 . . . . 25.0 112.026 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.14 -38.46 69.23 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 115.006 -0.997 . . . . 25.0 109.554 178.952 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.3 m120 53.37 39.3 29.66 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.295 1.045 . . . . 25.0 112.513 -179.469 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 m -103.11 168.34 2.24 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 N-CA-C 105.558 -2.015 . . . . 25.0 105.558 176.012 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.88 171.85 7.1 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.551 -1.277 . . . . 25.0 107.551 -177.408 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.67 162.27 37.94 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.974 -0.75 . . . . 25.0 108.974 174.649 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -128.18 130.48 48.1 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 123.673 0.789 . . . . 25.0 111.144 175.959 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.08 130.8 43.11 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 123.783 0.677 . . . . 25.0 109.882 177.045 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.3 mt -97.83 -22.06 16.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.938 0.399 . . . . 25.0 111.241 -178.094 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -141.17 170.01 16.53 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 106.912 -1.514 . . . . 25.0 106.912 178.124 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -76.12 165.73 24.5 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 122.78 0.432 . . . . 25.0 111.146 176.325 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -146.98 150.36 34.98 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.743 -0.598 . . . . 25.0 111.831 174.606 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.02 126.76 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 N-CA-C 105.697 -1.964 . . . . 25.0 105.697 178.079 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.46 122.82 30.15 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.758 -0.46 . . . . 25.0 109.758 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -104.03 14.03 31.42 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.985 0.898 . . . . 25.0 110.338 -179.666 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 t -156.47 149.45 18.41 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 106.321 -1.733 . . . . 25.0 106.321 -178.133 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -69.74 -16.4 37.62 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 117.152 -1.432 . . . . 25.0 112.55 175.457 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.28 -21.88 58.18 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 176.849 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -89.25 139.38 30.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.961 0.886 . . . . 25.0 109.338 -178.404 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.425 ' HB2' HG13 ' A' ' 57' ' ' VAL . 61.5 mt -90.14 129.48 36.41 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.848 0.833 . . . . 25.0 110.257 179.441 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.08 134.44 33.83 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.442 -1.688 . . . . 25.0 106.442 178.042 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -154.04 161.97 41.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.831 0.287 . . . . 25.0 111.559 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.71 162.04 17.34 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.722 -1.214 . . . . 25.0 107.722 -179.273 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.19 129.97 44.68 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.974 -0.557 . . . . 25.0 109.8 179.198 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.36 -13.9 63.99 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 119.039 -0.867 . . . . 25.0 114.151 179.587 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -59.77 148.68 33.47 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-N 117.92 0.86 . . . . 25.0 111.07 177.394 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.5 mm -118.84 129.8 74.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.31 -1.313 . . . . 25.0 109.043 -179.002 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -136.16 155.45 50.13 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.336 -0.987 . . . . 25.0 108.336 -178.196 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.7 m -88.83 124.39 34.12 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.385 -0.598 . . . . 25.0 109.385 177.58 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.1 t -87.43 125.08 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 108.424 -0.954 . . . . 25.0 108.424 177.992 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.576 HD12 HD22 ' A' ' 47' ' ' LEU . 81.4 mt -91.0 -46.29 8.23 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.364 -1.347 . . . . 25.0 107.364 178.814 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -155.87 170.7 21.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.646 -0.872 . . . . 25.0 108.646 177.438 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.9 mtm105 -117.37 154.57 31.08 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.25 -1.759 . . . . 25.0 106.25 177.067 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 59.05 42.97 18.22 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 125.478 1.736 . . . . 25.0 109.192 179.465 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -70.83 157.37 38.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.005 -1.452 . . . . 25.0 110.372 -176.627 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 60.15 10.08 2.14 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.019 0.928 . . . . 25.0 113.363 177.786 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.4 20.62 68.87 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.762 -0.732 . . . . 25.0 111.572 -176.821 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 70.6 mt -102.49 122.84 45.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.58 0.229 . . . . 25.0 111.287 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.57 123.63 17.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.256 0.551 . . . . 25.0 111.02 177.522 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.81 -0.24 82.87 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 116.131 1.212 . . . . 25.0 116.131 172.444 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -99.49 131.12 45.71 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 118.879 1.34 . . . . 25.0 109.427 177.705 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.439 ' CE3' HD23 ' A' ' 62' ' ' LEU . 42.6 m0 -110.65 143.45 41.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.729 -0.841 . . . . 25.0 108.729 -176.045 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.576 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -85.15 123.06 30.22 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 106.21 -1.774 . . . . 25.0 106.21 178.407 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.2 m -132.24 166.88 20.86 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.868 -0.333 . . . . 25.0 110.848 178.048 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -118.13 122.03 42.05 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.735 -1.58 . . . . 25.0 106.735 173.897 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.6 tp -150.58 140.02 21.44 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.79 -0.818 . . . . 25.0 108.79 -177.693 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.9 m170 57.5 30.77 19.23 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.628 0.771 . . . . 25.0 110.934 -179.534 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.89 0.03 87.68 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 115.381 0.912 . . . . 25.0 115.381 176.837 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -124.6 158.25 33.5 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 118.006 0.903 . . . . 25.0 110.148 179.266 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -102.1 149.58 24.12 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 106.564 -1.643 . . . . 25.0 106.564 178.661 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.89 -167.49 36.59 Favored Glycine 0 N--CA 1.433 -1.535 0 N-CA-C 107.825 -2.11 . . . . 25.0 107.825 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.6 pt -111.18 153.14 12.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.646 0.736 . . . . 25.0 111.574 -173.364 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.425 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.7 m -143.01 142.95 23.12 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.146 -0.934 . . . . 25.0 109.464 179.334 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.08 124.06 8.8 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 118.374 -0.617 . . . . 25.0 112.065 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.32 -12.3 79.86 Favored Glycine 0 C--O 1.221 -0.706 0 C-N-CA 120.83 -0.7 . . . . 25.0 114.505 -176.155 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -71.45 -7.85 50.03 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.084 0.772 . . . . 25.0 113.084 -176.676 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -132.16 27.23 4.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.666 -0.864 . . . . 25.0 108.666 178.351 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.439 HD23 ' CE3' ' A' ' 46' ' ' TRP . 16.3 tp -134.1 149.55 51.11 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.424 -0.807 . . . . 25.0 111.739 -174.116 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -128.17 123.02 33.31 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.38 0.272 . . . . 25.0 111.628 -178.29 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.9 mm -67.98 136.66 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.225 -0.657 . . . . 25.0 109.225 176.845 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.7 mt -118.43 100.96 7.8 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.396 -1.335 . . . . 25.0 107.396 175.293 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.318 -0.792 0 N-CA-C 107.669 -1.234 . . . . 25.0 107.669 177.244 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.0 mttt . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 108.7 -0.852 . . . . 25.0 108.7 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo . . . . . 0 C--O 1.238 0.481 0 C-N-CA 115.575 -2.483 . . . . 25.0 111.176 173.263 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 . . . . . 0 C--O 1.236 0.388 0 CA-C-O 121.686 0.755 . . . . 25.0 112.502 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.87 -42.21 90.62 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.869 -0.789 . . . . 25.0 108.869 176.659 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.6 m120 51.6 46.74 26.05 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.783 0.802 . . . . 25.0 110.407 -178.752 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 m -109.26 166.7 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 104.348 -2.464 . . . . 25.0 104.348 176.747 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.84 172.16 6.99 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 -176.436 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.86 158.61 43.46 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.927 -0.397 . . . . 25.0 109.927 173.455 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -124.88 129.66 50.83 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.417 -0.81 . . . . 25.0 109.817 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.77 130.53 42.57 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.271 -0.64 . . . . 25.0 109.271 178.69 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.7 mt -95.29 -20.72 18.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.543 -0.299 . . . . 25.0 111.472 -177.536 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -145.96 170.36 16.78 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.31 -0.996 . . . . 25.0 108.31 -179.891 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -73.93 160.4 31.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.598 -0.519 . . . . 25.0 109.598 177.041 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -145.97 154.37 41.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.838 0.352 . . . . 25.0 110.724 172.928 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 p -132.39 136.06 56.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 105.398 -2.075 . . . . 25.0 105.398 178.483 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.94 139.57 33.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.081 -0.509 . . . . 25.0 111.06 -175.192 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -121.68 9.3 10.14 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.577 0.703 . . . . 25.0 109.662 178.177 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 t -148.85 151.02 34.19 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 105.867 -1.901 . . . . 25.0 105.867 -177.733 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -67.52 -21.69 45.9 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 117.799 -1.0 . . . . 25.0 113.024 178.708 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.32 -17.57 58.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.961 0.41 . . . . 25.0 111.197 178.516 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -89.76 134.38 34.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.927 0.87 . . . . 25.0 111.866 -172.267 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.449 ' HB2' HG13 ' A' ' 57' ' ' VAL . 62.6 mt -89.08 126.24 35.36 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.266 -0.879 . . . . 25.0 110.822 178.907 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -86.94 141.31 28.81 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.021 -1.844 . . . . 25.0 106.021 174.082 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.13 168.07 28.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.757 0.313 . . . . 25.0 110.634 -177.467 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -116.33 162.9 16.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.224 0.535 . . . . 25.0 110.105 178.388 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.48 134.55 57.12 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.744 -0.662 . . . . 25.0 109.466 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.99 -12.73 68.75 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 116.132 -0.486 . . . . 25.0 113.014 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -62.46 138.98 58.57 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.692 -0.855 . . . . 25.0 108.692 177.761 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.1 mm -105.86 132.77 52.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.936 -1.029 . . . . 25.0 108.385 177.838 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.1 ptp -139.33 152.05 46.88 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.711 -0.478 . . . . 25.0 109.711 -178.446 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 m -89.76 123.11 33.47 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.515 -0.92 . . . . 25.0 108.515 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.97 125.81 41.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 108.847 -0.797 . . . . 25.0 108.847 178.639 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.691 HD12 HD22 ' A' ' 47' ' ' LEU . 70.8 mt -91.68 -47.77 7.19 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.4 -0.963 . . . . 25.0 108.4 179.464 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -155.37 173.88 16.03 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 110.308 -0.256 . . . . 25.0 110.308 178.443 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.9 mtm105 -123.74 157.96 32.77 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 106.029 -1.841 . . . . 25.0 106.029 176.699 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.8 t0 59.43 40.26 21.01 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 123.419 1.581 . . . . 25.0 107.449 -177.349 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -68.82 144.51 54.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.114 -1.403 . . . . 25.0 107.787 -177.689 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 59.8 12.28 2.92 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.899 0.88 . . . . 25.0 113.241 -179.276 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.29 16.83 79.01 Favored Glycine 0 C--N 1.331 0.265 0 N-CA-C 111.465 -0.654 . . . . 25.0 111.465 -178.231 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.3 mt -94.36 105.1 17.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.183 -0.673 . . . . 25.0 109.183 179.101 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -58.53 130.15 45.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 122.03 0.919 . . . . 25.0 110.807 -177.749 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.7 -6.35 70.16 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.085 -0.961 . . . . 25.0 115.037 178.009 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -95.83 139.26 32.3 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 118.944 1.372 . . . . 25.0 109.306 176.996 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 34.6 m0 -118.88 142.88 47.34 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.756 -1.201 . . . . 25.0 107.756 -176.999 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.691 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -85.71 121.83 28.94 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 105.308 -2.108 . . . . 25.0 105.308 178.888 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.1 m -130.97 157.62 42.46 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.333 0.587 . . . . 25.0 111.907 179.194 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.5 t -107.46 123.62 48.66 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 105.849 -1.908 . . . . 25.0 105.849 171.823 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 tp -144.61 135.08 24.5 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.83 -0.804 . . . . 25.0 108.83 -176.074 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 56.73 27.22 12.37 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 176.334 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.6 4.53 82.85 Favored Glycine 0 C--O 1.228 -0.275 0 N-CA-C 114.417 0.527 . . . . 25.0 114.417 178.481 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -131.78 162.09 31.34 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.959 0.879 . . . . 25.0 109.496 178.602 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -110.38 155.07 22.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.207 -0.664 . . . . 25.0 109.207 179.516 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.98 -163.49 31.16 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 106.832 -2.507 . . . . 25.0 106.832 176.81 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.9 pt -111.77 153.44 13.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 121.671 0.748 . . . . 25.0 110.157 -177.35 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -141.26 145.0 36.56 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.09 -0.959 . . . . 25.0 109.33 179.186 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.17 121.12 6.98 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 CA-C-O 121.659 0.608 . . . . 25.0 111.372 178.417 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.81 -9.21 74.72 Favored Glycine 0 C--O 1.218 -0.846 0 C-N-CA 121.131 -0.557 . . . . 25.0 114.056 -176.218 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -66.43 -17.02 64.55 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.337 -0.507 . . . . 25.0 112.091 -178.073 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -128.2 26.56 5.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.748 -0.66 . . . . 25.0 109.414 -177.578 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.2 tp -132.99 145.0 50.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.532 0.682 . . . . 25.0 109.973 -176.572 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -122.72 120.28 33.17 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.504 -0.771 . . . . 25.0 111.425 -177.112 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.2 mm -67.73 134.39 30.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 O-C-N 123.663 0.602 . . . . 25.0 109.652 177.542 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.3 mt -117.74 99.65 7.08 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.067 -1.827 . . . . 25.0 106.067 174.495 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 C--N 1.322 -0.622 0 CA-C-O 121.03 0.443 . . . . 25.0 109.848 -177.594 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.0 mttt . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 110.147 -0.316 . . . . 25.0 110.147 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--O 1.244 0.807 0 C-N-CA 117.137 -1.442 . . . . 25.0 110.757 172.333 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 . . . . . 0 CA--C 1.517 -0.299 0 N-CA-C 113.071 0.767 . . . . 25.0 113.071 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.6 mt -63.96 -38.72 92.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.984 -1.007 . . . . 25.0 110.83 179.647 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 52.61 41.87 31.35 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.267 1.032 . . . . 25.0 110.87 -179.661 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' A' ' 34' ' ' VAL . 16.0 m -103.29 173.23 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 102.97 -2.974 . . . . 25.0 102.97 174.891 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -118.4 172.61 7.34 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 118.649 0.658 . . . . 25.0 109.401 -178.346 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.43 160.26 43.6 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.918 -0.583 . . . . 25.0 109.533 176.561 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -118.84 133.09 56.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.101 -0.954 . . . . 25.0 108.863 177.023 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.584 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -71.91 126.28 29.33 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 173.75 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.8 mt -88.63 -22.29 23.54 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.433 -0.58 . . . . 25.0 109.433 -178.698 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -144.05 175.17 10.24 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 105.116 -2.179 . . . . 25.0 105.116 179.214 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -86.47 -179.99 6.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 118.15 0.432 . . . . 25.0 109.937 175.904 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -154.99 143.56 20.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.111 0.481 . . . . 25.0 111.721 174.652 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.6 t -107.26 123.9 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 105.084 -2.191 . . . . 25.0 105.084 175.928 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.99 121.67 22.32 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.274 -1.01 . . . . 25.0 108.274 178.394 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -110.97 -2.06 16.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.647 0.737 . . . . 25.0 109.197 -179.71 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.3 m -129.34 152.6 79.78 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 107.55 -1.278 . . . . 25.0 107.55 179.083 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.92 -20.55 33.91 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 118.352 -0.632 . . . . 25.0 113.363 -179.561 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -16.94 46.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.925 -0.579 . . . . 25.0 110.383 179.565 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -87.19 139.82 30.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.627 0.727 . . . . 25.0 111.602 -172.476 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.8 mt -91.88 129.86 37.76 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.69 0.757 . . . . 25.0 109.75 177.336 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.34 142.48 27.85 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 105.708 -1.96 . . . . 25.0 105.708 173.327 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -156.41 167.72 29.58 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.788 -0.449 . . . . 25.0 109.788 -179.037 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.62 161.56 17.29 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.676 0.75 . . . . 25.0 111.142 -179.079 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -56.89 127.19 30.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.993 -1.003 . . . . 25.0 109.71 178.275 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.23 -11.77 70.01 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-O 119.093 -0.837 . . . . 25.0 114.682 178.01 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.51 138.82 54.72 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 118.18 0.99 . . . . 25.0 111.63 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.1 mm -102.28 130.22 52.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.194 -1.039 . . . . 25.0 108.194 175.333 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.0 ptp -135.65 153.28 51.68 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.439 -0.578 . . . . 25.0 109.439 -178.781 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.0 m -88.8 128.21 35.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.25 -1.389 . . . . 25.0 107.25 178.519 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 8' ' ' VAL . 61.8 t -94.22 121.67 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 107.421 -1.326 . . . . 25.0 107.421 178.821 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.624 HD12 HD22 ' A' ' 47' ' ' LEU . 78.4 mt -91.7 -43.66 9.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.157 -0.929 . . . . 25.0 109.947 -177.981 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -152.2 162.6 40.89 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.483 -1.303 . . . . 25.0 107.483 -177.037 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -124.7 153.56 42.15 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.203 -1.036 . . . . 25.0 108.203 176.895 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 55.8 40.17 30.7 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 123.731 1.729 . . . . 25.0 108.393 -178.929 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -70.36 158.96 35.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 112.95 -1.932 . . . . 25.0 110.57 -175.457 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 60.87 8.32 1.8 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.112 0.965 . . . . 25.0 113.389 179.598 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.85 17.85 74.05 Favored Glycine 0 CA--C 1.517 0.174 0 N-CA-C 110.551 -1.019 . . . . 25.0 110.551 -176.861 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.3 mt -99.51 123.3 43.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.007 0.432 . . . . 25.0 110.397 -179.535 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -64.78 129.69 40.73 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.06 -0.518 . . . . 25.0 110.456 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.13 -0.75 66.29 Favored Glycine 0 C--O 1.24 0.488 0 N-CA-C 116.617 1.407 . . . . 25.0 116.617 174.44 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -100.5 129.99 46.52 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 118.692 1.246 . . . . 25.0 109.736 178.728 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -111.65 140.07 46.58 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.74 -0.467 . . . . 25.0 109.74 -175.776 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.624 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -80.45 120.48 24.51 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.237 -1.764 . . . . 25.0 106.237 178.541 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.8 m -131.41 163.75 27.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.096 0.474 . . . . 25.0 111.884 178.683 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.9 t -120.03 123.95 44.69 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.062 -1.458 . . . . 25.0 107.062 173.993 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.8 tp -148.61 136.59 20.87 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.823 -0.806 . . . . 25.0 108.823 -176.707 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 56.17 26.98 10.91 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.551 1.315 . . . . 25.0 114.551 174.758 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.36 8.97 84.37 Favored Glycine 0 C--O 1.227 -0.297 0 C-N-CA 121.006 -0.616 . . . . 25.0 113.197 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -119.9 157.52 28.58 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.127 -1.064 . . . . 25.0 108.127 178.946 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -122.22 147.79 45.76 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 105.353 -2.091 . . . . 25.0 105.353 173.107 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.26 -155.59 17.25 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 107.201 -2.36 . . . . 25.0 107.201 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.9 pt -122.37 149.53 25.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 121.396 0.617 . . . . 25.0 111.05 -174.581 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.6 m -138.22 147.2 54.86 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.087 -0.96 . . . . 25.0 109.166 -178.909 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.84 119.12 5.73 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 O-C-N 122.037 0.493 . . . . 25.0 112.272 178.539 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.39 -18.65 69.84 Favored Glycine 0 C--O 1.223 -0.575 0 C-N-CA 121.226 -0.511 . . . . 25.0 113.429 -178.275 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -64.18 -17.98 64.04 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.202 0.815 . . . . 25.0 113.202 -178.428 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -122.58 27.29 7.9 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.343 0.592 . . . . 25.0 109.628 177.022 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 12' ' ' ALA . 1.4 tp -128.77 157.62 40.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 25.0 111.757 -179.618 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -131.37 120.03 22.52 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.067 -0.515 . . . . 25.0 110.869 177.339 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.7 mm -69.32 136.95 25.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.293 -0.632 . . . . 25.0 109.293 178.739 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.7 mt -115.55 91.82 3.72 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.713 -1.218 . . . . 25.0 107.713 177.103 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 113.353 0.871 . . . . 25.0 113.353 -176.599 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 107.617 -1.253 . . . . 25.0 107.617 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 C--N 1.347 0.478 0 C-N-CA 117.698 -1.068 . . . . 25.0 111.557 -179.024 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 116.769 2.137 . . . . 25.0 116.769 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.6 mt -79.33 -42.07 26.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.082 -0.963 . . . . 25.0 110.568 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 56.42 27.08 11.54 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.414 1.085 . . . . 25.0 112.287 -178.441 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.7 m -86.53 170.94 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 104.441 -2.429 . . . . 25.0 104.441 174.061 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mp -116.33 172.78 6.97 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.033 -0.729 . . . . 25.0 109.033 179.407 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.04 155.17 42.0 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.731 -0.47 . . . . 25.0 109.731 177.292 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -114.02 131.05 56.5 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.535 -0.757 . . . . 25.0 109.553 176.896 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.427 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -69.15 127.13 32.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.133 -0.692 . . . . 25.0 109.133 174.171 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.6 mt -92.44 -23.14 19.26 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.939 -0.393 . . . . 25.0 109.939 -178.319 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -143.16 167.06 23.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.059 -1.089 . . . . 25.0 108.059 -179.159 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -75.73 166.22 23.87 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 122.668 0.387 . . . . 25.0 111.824 177.892 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -145.57 156.83 43.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.968 0.413 . . . . 25.0 111.373 174.252 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.9 t -123.5 122.62 65.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 105.239 -2.134 . . . . 25.0 105.239 173.51 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.23 127.58 32.87 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.363 -0.977 . . . . 25.0 108.363 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -113.17 12.98 19.18 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.961 0.886 . . . . 25.0 109.52 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 t -152.08 147.44 19.79 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 106.3 -1.741 . . . . 25.0 106.3 -179.487 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.98 -23.6 67.73 Favored 'Trans proline' 0 C--N 1.347 0.456 0 O-C-N 122.23 0.595 . . . . 25.0 113.079 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -76.26 -21.12 56.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.343 0.592 . . . . 25.0 110.351 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -88.29 130.74 35.03 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.241 -1.022 . . . . 25.0 108.241 -178.385 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.443 ' HB2' HG13 ' A' ' 57' ' ' VAL . 54.2 mt -81.76 133.18 35.32 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.697 0.76 . . . . 25.0 109.803 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.39 125.09 34.54 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.331 -0.989 . . . . 25.0 108.331 177.568 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -145.43 164.36 31.79 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 120.972 0.415 . . . . 25.0 110.445 -179.31 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.35 167.73 12.01 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.334 0.587 . . . . 25.0 110.086 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -58.83 130.43 46.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.342 -0.844 . . . . 25.0 109.44 -179.092 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.26 -12.15 69.42 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-O 118.504 -1.164 . . . . 25.0 114.938 177.172 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -59.97 150.01 30.23 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.439 1.119 . . . . 25.0 111.483 177.523 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.2 mm -114.81 127.06 72.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.61 -1.177 . . . . 25.0 108.642 177.283 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.8 ptp -132.74 151.06 52.08 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.293 -0.632 . . . . 25.0 109.293 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -84.82 130.35 34.68 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.247 -1.02 . . . . 25.0 108.247 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.8 t -98.18 121.14 48.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.534 -0.913 . . . . 25.0 108.534 179.561 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.609 HD12 HD22 ' A' ' 47' ' ' LEU . 80.7 mt -87.7 -46.81 9.17 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.972 -0.558 . . . . 25.0 109.66 -179.375 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -155.01 171.11 20.27 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.115 -0.698 . . . . 25.0 109.115 178.238 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -117.66 157.81 25.78 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.323 -1.362 . . . . 25.0 107.323 177.681 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 57.63 37.93 27.57 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 125.127 1.517 . . . . 25.0 109.85 177.559 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 t -66.45 152.11 45.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.847 -1.524 . . . . 25.0 110.612 -175.529 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 60.97 6.89 1.32 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.362 1.065 . . . . 25.0 112.766 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.59 12.7 74.65 Favored Glycine 0 C--O 1.224 -0.472 0 N-CA-C 111.414 -0.674 . . . . 25.0 111.414 -177.094 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.2 mt -88.08 125.02 34.35 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.745 -0.465 . . . . 25.0 109.745 179.334 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -64.53 124.79 22.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.699 0.285 . . . . 25.0 110.272 178.085 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.69 -0.63 76.26 Favored Glycine 0 C--O 1.242 0.596 0 N-CA-C 116.68 1.432 . . . . 25.0 116.68 172.568 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -96.67 135.8 38.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.885 1.343 . . . . 25.0 108.984 179.002 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -111.36 144.32 40.75 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.858 -0.793 . . . . 25.0 108.858 -178.14 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.609 HD22 HD12 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -83.92 120.49 26.15 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 104.524 -2.398 . . . . 25.0 104.524 176.572 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 93.2 m -129.17 163.03 26.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 121.006 -0.278 . . . . 25.0 111.503 179.843 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.5 t -116.79 123.84 48.12 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.292 -1.373 . . . . 25.0 107.292 173.619 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.7 tp -146.49 129.1 16.08 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 108.571 -0.9 . . . . 25.0 108.571 -176.303 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 27.7 m170 55.91 32.7 20.25 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.412 0.523 . . . . 25.0 112.412 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.71 3.15 86.93 Favored Glycine 0 C--O 1.222 -0.64 0 C-N-CA 120.816 -0.707 . . . . 25.0 113.987 178.972 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 mtt-85 -111.1 153.95 24.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.575 -1.269 . . . . 25.0 107.575 178.487 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -120.41 147.15 45.45 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 106.683 -1.599 . . . . 25.0 106.683 175.038 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.73 -158.46 22.21 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 106.997 -2.441 . . . . 25.0 106.997 -177.433 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.5 pt -115.36 153.01 16.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.75 0.786 . . . . 25.0 111.572 -175.205 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.5 m -144.47 146.37 32.41 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 114.797 -1.092 . . . . 25.0 109.191 179.348 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.07 114.5 4.06 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 CA-C-O 121.609 0.587 . . . . 25.0 112.175 178.459 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.19 -17.74 68.43 Favored Glycine 0 C--O 1.221 -0.683 0 N-CA-C 114.551 0.58 . . . . 25.0 114.551 -177.572 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -65.06 -15.21 62.1 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.722 0.638 . . . . 25.0 112.722 -178.567 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -123.44 26.24 7.95 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.755 -0.59 . . . . 25.0 110.239 176.817 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 12' ' ' ALA . 12.3 mt -125.88 156.95 38.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.594 0.711 . . . . 25.0 110.949 178.207 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -127.92 119.05 24.74 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.255 -0.884 . . . . 25.0 110.531 177.446 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.0 mm -66.8 133.53 31.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 O-C-N 123.797 0.686 . . . . 25.0 109.531 178.4 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.1 mt -114.3 94.04 4.62 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.712 -1.218 . . . . 25.0 107.712 175.914 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 121.498 0.666 . . . . 25.0 109.973 176.712 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 95.4 mttt . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 106.51 -1.663 . . . . 25.0 106.51 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--O 1.241 0.661 0 C-N-CA 117.384 -1.278 . . . . 25.0 110.959 176.973 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 . . . . . 0 CA--C 1.512 -0.488 0 CA-C-O 120.864 0.364 . . . . 25.0 110.402 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.0 mt -67.87 -40.25 83.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.752 -0.658 . . . . 25.0 109.655 177.836 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.5 m120 55.75 24.7 7.54 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.972 -1.013 . . . . 25.0 112.787 -178.48 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.1 m -84.57 158.19 3.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.519 -1.289 . . . . 25.0 107.519 177.754 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.48 167.74 11.13 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.781 -0.822 . . . . 25.0 108.781 -177.175 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.29 158.76 44.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.991 0.424 . . . . 25.0 110.427 175.665 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -123.79 132.25 53.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.065 -0.971 . . . . 25.0 109.601 -179.808 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.23 132.18 40.91 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.376 -0.601 . . . . 25.0 109.376 177.274 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.5 mt -100.43 -17.4 17.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.42 -0.355 . . . . 25.0 110.388 -179.514 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -145.56 169.95 17.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 104.598 -2.371 . . . . 25.0 104.598 177.951 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -89.44 177.36 6.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.578 0.626 . . . . 25.0 110.618 176.175 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -154.44 136.4 14.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.971 -0.559 . . . . 25.0 110.492 175.297 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.7 t -104.35 121.36 55.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 104.643 -2.354 . . . . 25.0 104.643 175.368 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.22 135.69 49.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.413 -0.812 . . . . 25.0 109.253 -179.029 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -113.1 9.09 18.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.64 0.733 . . . . 25.0 109.271 -178.472 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 t -156.17 152.75 24.04 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.347 -0.842 . . . . 25.0 108.82 -175.577 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -70.31 -19.05 33.99 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 117.941 -0.906 . . . . 25.0 114.312 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.95 -17.01 56.19 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.481 -0.563 . . . . 25.0 109.481 178.048 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -93.74 142.33 27.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.515 0.674 . . . . 25.0 111.107 -175.729 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.433 ' HB2' HG13 ' A' ' 57' ' ' VAL . 55.7 mt -94.69 131.96 39.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.682 0.753 . . . . 25.0 110.102 178.959 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.5 p -90.94 140.17 30.07 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 105.882 -1.896 . . . . 25.0 105.882 174.661 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -156.05 164.91 37.84 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 120.806 0.336 . . . . 25.0 110.251 -179.325 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -108.53 158.58 17.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.037 0.922 . . . . 25.0 109.473 179.171 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -57.64 133.91 55.72 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.842 -1.072 . . . . 25.0 109.645 175.363 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.79 -12.32 70.14 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-O 119.022 -0.877 . . . . 25.0 113.644 178.655 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -60.67 146.44 45.61 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 118.116 0.958 . . . . 25.0 110.721 178.187 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.0 mm -110.86 129.23 66.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 107.935 -1.135 . . . . 25.0 107.935 177.6 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.3 ptp -136.79 165.97 24.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.999 -0.741 . . . . 25.0 108.999 -179.091 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -103.81 123.61 47.39 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.752 -0.833 . . . . 25.0 108.752 178.761 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.7 t -88.2 124.41 41.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.698 -1.223 . . . . 25.0 107.698 177.668 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.625 HD12 HD22 ' A' ' 47' ' ' LEU . 65.7 mt -93.68 -43.56 8.59 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.133 -0.939 . . . . 25.0 108.929 -179.667 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -148.49 155.16 40.81 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 106.784 -1.562 . . . . 25.0 106.784 -172.798 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -118.87 154.35 33.06 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 106.241 -1.763 . . . . 25.0 106.241 173.957 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 58.16 37.7 26.32 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 123.477 1.608 . . . . 25.0 108.324 178.638 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -68.46 159.43 31.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.043 -1.89 . . . . 25.0 111.018 -175.933 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 59.31 12.1 2.47 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.795 1.035 . . . . 25.0 113.795 177.131 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.36 18.35 78.14 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 110.628 -0.989 . . . . 25.0 110.628 -177.213 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.7 mt -104.07 115.94 31.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.069 0.462 . . . . 25.0 109.859 -179.454 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -66.25 131.12 45.4 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 -178.239 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.93 -1.56 78.69 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 115.427 0.931 . . . . 25.0 115.427 176.175 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -99.85 132.55 45.13 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 118.866 1.333 . . . . 25.0 109.014 177.059 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -113.09 139.26 48.86 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.429 -0.582 . . . . 25.0 109.429 -175.961 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.625 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -80.54 122.5 27.11 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 106.08 -1.822 . . . . 25.0 106.08 179.684 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 92.9 m -132.81 163.25 29.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.28 0.562 . . . . 25.0 112.288 178.634 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -115.37 127.98 55.77 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.16 -1.793 . . . . 25.0 106.16 171.248 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.8 tp -154.9 141.22 18.62 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 107.244 -1.391 . . . . 25.0 107.244 -175.343 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 55.91 26.99 10.41 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 112.651 0.612 . . . . 25.0 112.651 178.384 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.06 4.53 88.83 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 114.711 0.644 . . . . 25.0 114.711 178.733 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -126.64 161.4 28.16 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.501 -0.926 . . . . 25.0 108.501 -179.677 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -112.89 156.73 22.44 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.92 -1.141 . . . . 25.0 107.92 179.045 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.89 -161.24 30.66 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 106.509 -2.636 . . . . 25.0 106.509 179.521 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.6 pt -117.36 153.99 19.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.327 0.584 . . . . 25.0 111.878 -175.871 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.6 m -142.81 148.63 46.78 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 114.974 -1.012 . . . . 25.0 109.141 -179.023 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.18 122.42 7.11 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 CA-C-O 121.612 0.588 . . . . 25.0 112.799 -179.799 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.08 -24.44 67.05 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 116.308 -0.406 . . . . 25.0 113.739 -178.431 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -24.1 65.46 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.391 -0.476 . . . . 25.0 112.036 179.049 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -105.65 11.86 31.76 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.938 0.347 . . . . 25.0 111.938 -179.543 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.0 mt -121.78 152.5 39.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.704 1.24 . . . . 25.0 113.946 -177.539 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -120.36 123.53 43.32 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 113.687 -1.597 . . . . 25.0 108.812 176.004 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.0 mm -76.59 138.33 20.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.64 -0.874 . . . . 25.0 108.64 179.103 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.5 mt -117.38 88.06 2.83 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.966 -1.494 . . . . 25.0 106.966 176.7 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.1 m . . . . . 0 C--N 1.325 -0.489 0 CA-C-O 121.0 0.428 . . . . 25.0 109.998 -179.77 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt . . . . . 0 CA--C 1.534 0.342 0 N-CA-C 105.755 -1.943 . . . . 25.0 105.755 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo . . . . . 0 CA--C 1.538 0.684 0 C-N-CA 117.83 -0.98 . . . . 25.0 112.647 -175.98 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 . . . . . 0 CA--C 1.51 -0.586 0 CA-C-O 121.231 0.538 . . . . 25.0 110.539 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.21 -40.59 86.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.896 -1.047 . . . . 25.0 109.139 176.797 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.0 m120 54.99 30.47 14.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.138 0.975 . . . . 25.0 111.906 -178.136 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.7 m -89.22 164.77 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 106.362 -1.718 . . . . 25.0 106.362 175.862 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.37 173.49 6.42 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.68 -1.23 . . . . 25.0 107.68 -178.893 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.9 157.76 43.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.661 0.267 . . . . 25.0 110.42 174.865 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -122.71 130.74 53.29 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.648 -0.705 . . . . 25.0 109.781 175.962 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.54 129.64 38.76 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.01 -0.541 . . . . 25.0 109.549 175.71 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.0 mt -94.42 -21.76 18.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.914 0.388 . . . . 25.0 110.859 -178.006 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -143.95 169.41 17.87 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.993 -2.225 . . . . 25.0 104.993 177.856 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -84.03 167.74 16.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.131 0.491 . . . . 25.0 110.407 177.332 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -148.53 130.9 15.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.934 -0.575 . . . . 25.0 110.341 179.257 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.0 t -102.93 123.46 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 105.078 -2.193 . . . . 25.0 105.078 176.16 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.91 135.74 51.5 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.522 -1.217 . . . . 25.0 110.072 179.558 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -113.98 0.46 14.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.337 0.589 . . . . 25.0 110.284 -179.551 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.0 m -145.6 155.34 52.97 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 107.966 -1.124 . . . . 25.0 107.966 -177.421 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.34 -17.71 39.35 Favored 'Trans proline' 0 C--N 1.347 0.468 0 N-CA-C 113.805 0.656 . . . . 25.0 113.805 -177.415 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.91 -16.99 39.26 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.234 0.54 . . . . 25.0 110.22 179.003 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -87.45 136.03 33.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.98 0.895 . . . . 25.0 111.754 -175.605 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.426 ' HB2' HG13 ' A' ' 57' ' ' VAL . 47.3 mt -86.19 130.79 34.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.746 -0.661 . . . . 25.0 109.4 178.96 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.8 t -91.46 137.15 32.59 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.458 -2.053 . . . . 25.0 105.458 175.025 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -156.46 164.79 37.83 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.924 -0.399 . . . . 25.0 109.924 -177.86 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.49 162.53 15.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.514 0.673 . . . . 25.0 110.465 -177.496 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -57.32 128.39 36.76 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.163 -0.926 . . . . 25.0 109.131 176.165 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.57 -15.67 61.67 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 118.752 -1.027 . . . . 25.0 114.728 178.197 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -59.08 146.19 39.46 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.993 0.897 . . . . 25.0 111.139 -178.845 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.0 mm -110.57 134.17 53.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.448 -1.251 . . . . 25.0 108.627 178.72 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.9 ptp -141.58 157.69 44.78 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.439 0.296 . . . . 25.0 110.334 -177.961 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.5 m -92.27 130.88 37.86 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.531 -0.914 . . . . 25.0 108.531 177.232 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.95 129.6 45.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.322 -0.992 . . . . 25.0 108.322 177.527 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.702 HD12 HD22 ' A' ' 47' ' ' LEU . 76.2 mt -94.43 -52.47 4.32 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.827 -0.805 . . . . 25.0 108.827 -179.671 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -149.99 163.91 36.86 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.902 -1.147 . . . . 25.0 107.902 177.822 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.434 ' HE ' ' HB3' ' A' ' 37' ' ' ARG . 8.6 mtp180 -106.81 157.44 17.75 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 109.672 -0.492 . . . . 25.0 109.672 176.474 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 56.02 39.58 30.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 123.526 1.632 . . . . 25.0 108.859 170.319 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.9 t -64.42 152.29 41.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 112.474 -2.148 . . . . 25.0 110.677 -176.502 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 59.78 11.65 2.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.207 1.003 . . . . 25.0 113.104 -179.595 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.75 20.29 79.56 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.686 -0.965 . . . . 25.0 110.686 -177.402 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.2 mt -94.69 118.89 32.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.293 -1.003 . . . . 25.0 108.293 177.953 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -64.72 128.31 35.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.923 -0.581 . . . . 25.0 110.396 -177.882 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.74 -0.75 70.01 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 115.932 1.133 . . . . 25.0 115.932 176.274 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -99.61 129.98 45.8 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 119.181 1.491 . . . . 25.0 109.59 177.93 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -113.88 141.32 47.49 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.916 -0.772 . . . . 25.0 108.916 -176.149 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.702 HD22 HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -81.68 120.31 24.95 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.14 -1.8 . . . . 25.0 106.14 179.473 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 88.8 m -133.77 167.78 19.91 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.005 0.431 . . . . 25.0 111.578 -179.992 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.4 t -120.33 116.54 25.73 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.463 -1.31 . . . . 25.0 107.463 173.826 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -146.03 144.85 30.33 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.441 -1.318 . . . . 25.0 107.441 -175.902 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.55 27.24 15.39 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.378 0.671 . . . . 25.0 112.334 -179.555 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.95 4.84 90.44 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 114.657 0.623 . . . . 25.0 114.657 177.705 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.1 ptt85 -132.82 161.04 35.18 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.067 0.934 . . . . 25.0 109.775 179.379 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -102.6 154.24 19.32 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.282 -0.636 . . . . 25.0 109.282 177.02 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.24 -158.02 22.46 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 106.54 -2.624 . . . . 25.0 106.54 178.297 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.8 pt -118.39 151.64 20.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.542 0.687 . . . . 25.0 110.877 -175.297 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' A' ' 24' ' ' LEU . 2.4 m -140.8 146.96 46.46 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 114.931 -1.032 . . . . 25.0 108.85 -179.113 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.91 122.59 5.89 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 118.31 -0.66 . . . . 25.0 112.284 179.235 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.21 -14.87 64.64 Favored Glycine 0 C--O 1.223 -0.581 0 CA-C-N 116.11 -0.495 . . . . 25.0 112.821 -179.703 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.73 -28.26 63.72 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 122.957 0.503 . . . . 25.0 112.346 179.693 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.57 25.42 9.77 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.556 0.217 . . . . 25.0 111.51 178.869 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.4 tp -128.57 144.13 51.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.636 0.731 . . . . 25.0 111.611 -174.626 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -119.59 119.98 35.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.332 -0.849 . . . . 25.0 110.935 -177.921 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.0 mm -68.96 134.93 29.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.212 -0.662 . . . . 25.0 109.212 177.509 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.5 mt -117.91 105.17 11.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.675 -1.602 . . . . 25.0 106.675 176.215 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--N 1.322 -0.616 0 CA-C-O 120.965 0.412 . . . . 25.0 110.001 -178.833 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 107.423 -1.325 . . . . 25.0 107.423 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 CA--C 1.54 0.807 0 C-N-CA 118.339 -0.64 . . . . 25.0 111.791 178.023 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 121.676 0.751 . . . . 25.0 112.632 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.2 mt -70.58 -33.25 70.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.483 -0.78 . . . . 25.0 111.724 -176.292 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.8 m120 60.33 17.85 7.47 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.322 1.049 . . . . 25.0 113.257 -178.752 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.2 m -91.26 162.78 2.38 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 N-CA-C 108.845 -0.798 . . . . 25.0 108.845 -179.649 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.79 172.66 6.81 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.713 -1.217 . . . . 25.0 107.713 -178.633 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.52 161.19 42.62 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.197 -0.668 . . . . 25.0 109.197 173.264 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -125.87 131.72 52.31 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 123.808 0.693 . . . . 25.0 110.722 179.22 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.73 122.01 18.33 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 124.015 0.822 . . . . 25.0 110.215 177.513 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.2 mt -89.47 -24.07 21.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.234 0.54 . . . . 25.0 109.855 -178.115 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -138.58 174.27 10.72 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 103.101 -2.925 . . . . 25.0 103.101 175.876 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -85.38 -179.87 7.03 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.635 -0.876 . . . . 25.0 108.635 175.417 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -155.33 147.54 23.72 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 122.865 0.466 . . . . 25.0 109.804 174.127 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.5 t -116.27 123.57 71.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.677 -1.601 . . . . 25.0 106.677 175.992 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.78 145.22 25.73 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.497 -0.774 . . . . 25.0 109.501 177.773 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.15 -7.67 6.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.924 -0.58 . . . . 25.0 111.02 178.322 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 m -119.76 154.65 55.07 Favored Pre-proline 0 C--O 1.22 -0.448 0 N-CA-C 108.406 -0.961 . . . . 25.0 108.406 178.931 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.11 -24.95 38.03 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 117.563 -1.158 . . . . 25.0 114.323 -178.444 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.06 -16.84 57.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.31 0.576 . . . . 25.0 110.459 179.223 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -91.72 135.73 33.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.358 0.599 . . . . 25.0 110.602 -173.861 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.411 ' HB2' HG13 ' A' ' 57' ' ' VAL . 73.9 mt -95.37 128.33 42.13 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.958 0.885 . . . . 25.0 111.109 -179.112 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 t -90.44 143.61 26.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.141 -1.8 . . . . 25.0 106.141 176.841 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -158.03 168.24 27.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.104 0.478 . . . . 25.0 110.871 -179.446 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -114.18 159.5 20.03 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.168 -0.679 . . . . 25.0 109.168 178.041 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -57.83 132.05 52.17 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.339 -1.356 . . . . 25.0 107.339 176.348 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.71 -20.58 47.5 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-O 119.521 -0.599 . . . . 25.0 113.606 179.034 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -59.46 145.81 42.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.73 0.776 . . . . 25.0 110.84 178.885 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.3 mm -115.11 128.79 72.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.517 -1.219 . . . . 25.0 108.524 179.868 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -131.2 152.78 50.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.458 -0.201 . . . . 25.0 110.458 179.209 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.7 m -87.43 126.97 35.21 Favored 'General case' 0 C--O 1.218 -0.603 0 N-CA-C 107.823 -1.177 . . . . 25.0 107.823 177.537 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.74 128.58 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 CA-C-O 121.968 0.89 . . . . 25.0 108.807 179.362 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.646 HD12 HD22 ' A' ' 47' ' ' LEU . 81.7 mt -97.36 -46.09 6.22 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.005 -0.998 . . . . 25.0 108.779 179.631 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.07 158.58 44.14 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.956 -0.757 . . . . 25.0 108.956 -175.844 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -118.29 148.51 42.38 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 106.743 -1.576 . . . . 25.0 106.743 174.924 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 57.17 43.32 24.15 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 123.319 1.533 . . . . 25.0 109.832 -177.912 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -72.04 160.91 31.68 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 113.491 -1.686 . . . . 25.0 112.204 -176.134 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 59.68 9.83 1.76 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.177 0.991 . . . . 25.0 113.234 178.264 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.88 14.81 76.73 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.657 -0.977 . . . . 25.0 110.657 -176.185 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.0 mt -99.58 123.14 43.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.538 0.685 . . . . 25.0 110.565 -179.112 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -70.11 125.38 26.61 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.96 -1.018 . . . . 25.0 110.486 179.18 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.94 -1.41 88.6 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 115.43 0.932 . . . . 25.0 115.43 176.208 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -100.98 131.37 46.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 118.159 0.98 . . . . 25.0 109.796 178.45 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -110.73 142.45 42.65 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.179 -0.675 . . . . 25.0 109.179 -177.176 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.646 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -84.52 121.11 27.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 105.176 -2.157 . . . . 25.0 105.176 178.157 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.1 m -134.37 165.96 23.93 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.963 0.411 . . . . 25.0 111.171 179.087 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 t -121.48 123.08 41.17 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.011 -1.477 . . . . 25.0 107.011 173.165 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.9 tp -135.25 122.0 20.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.873 -0.788 . . . . 25.0 108.873 -177.728 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.2 m170 54.01 33.91 18.58 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.522 0.729 . . . . 25.0 111.548 179.799 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.74 -6.53 83.55 Favored Glycine 0 C--O 1.227 -0.314 0 N-CA-C 115.252 0.861 . . . . 25.0 115.252 177.44 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -101.98 137.22 40.55 Favored 'General case' 0 C--O 1.219 -0.553 0 CA-C-N 118.449 1.124 . . . . 25.0 108.403 176.147 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -99.9 145.02 28.27 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.406 -1.702 . . . . 25.0 106.406 173.93 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.73 -161.48 27.37 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 108.368 -1.893 . . . . 25.0 108.368 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.1 pt -115.41 149.89 17.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.603 0.716 . . . . 25.0 110.759 -175.847 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.8 m -139.32 146.63 49.51 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 114.871 -1.059 . . . . 25.0 108.824 -179.092 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.82 119.79 6.06 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 CA-C-O 121.487 0.536 . . . . 25.0 111.626 177.933 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.02 -15.3 74.14 Favored Glycine 0 C--O 1.226 -0.372 0 CA-C-O 121.649 0.583 . . . . 25.0 113.048 -178.466 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -67.46 -6.89 21.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.299 0.64 . . . . 25.0 112.672 -178.849 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -135.48 28.32 3.35 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.711 -0.478 . . . . 25.0 109.711 176.108 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.3 mt -125.32 156.25 38.96 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.352 0.871 . . . . 25.0 113.352 177.839 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -128.09 120.18 26.88 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.969 -1.014 . . . . 25.0 110.075 174.435 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.7 mm -66.95 137.25 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.581 -0.896 . . . . 25.0 108.581 176.62 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.4 mt -117.57 107.51 14.34 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.817 -1.179 . . . . 25.0 107.817 176.491 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--N 1.322 -0.619 0 N-CA-C 109.636 -0.505 . . . . 25.0 109.636 178.94 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 107.715 -1.217 . . . . 25.0 107.715 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 CA--C 1.54 0.812 0 C-N-CA 116.584 -1.811 . . . . 25.0 110.775 175.208 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 . . . . . 0 CA--C 1.518 -0.278 0 CA-C-O 121.06 0.457 . . . . 25.0 111.314 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.8 mt -71.96 -35.64 69.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.73 -1.123 . . . . 25.0 110.156 -179.988 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.5 m120 53.64 36.93 24.85 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.744 0.817 . . . . 25.0 111.84 -179.1 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.7 m -99.06 163.03 2.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 107.427 -1.323 . . . . 25.0 107.427 176.771 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.08 170.9 8.16 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.193 -1.04 . . . . 25.0 108.193 -178.01 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.48 158.64 44.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.891 0.376 . . . . 25.0 110.939 177.032 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -123.91 129.25 50.67 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.457 -0.792 . . . . 25.0 110.12 177.63 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.46 124.68 26.29 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.005 -0.543 . . . . 25.0 109.911 177.029 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.93 -24.73 19.19 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.278 0.561 . . . . 25.0 109.981 -177.762 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -135.75 166.34 23.5 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 104.673 -2.343 . . . . 25.0 104.673 175.913 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -86.67 -173.77 4.65 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.499 0.72 . . . . 25.0 110.937 177.741 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -161.9 154.03 19.39 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 123.613 0.571 . . . . 25.0 112.385 176.662 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.9 t -122.14 126.78 74.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 104.541 -2.392 . . . . 25.0 104.541 173.022 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.37 137.0 44.44 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 -177.247 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -113.32 6.69 17.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.181 0.991 . . . . 25.0 109.237 179.206 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.0 t -149.68 149.3 27.98 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 106.955 -1.498 . . . . 25.0 106.955 -177.178 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.27 -19.31 38.64 Favored 'Trans proline' 0 N--CA 1.475 0.433 0 C-N-CA 117.622 -1.119 . . . . 25.0 112.568 178.184 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -79.21 -15.76 57.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.888 0.852 . . . . 25.0 110.388 178.985 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -93.12 141.22 28.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.801 0.81 . . . . 25.0 111.491 -176.509 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.6 mt -89.1 129.21 35.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.881 -0.599 . . . . 25.0 111.215 -179.936 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 p -94.5 137.87 33.1 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.481 -1.674 . . . . 25.0 106.481 173.813 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.424 ' HE1' HG12 ' A' ' 57' ' ' VAL . 38.2 p90 -160.86 175.98 11.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.998 -0.742 . . . . 25.0 108.998 -174.634 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.4 167.68 11.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.606 0.717 . . . . 25.0 111.526 177.444 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.48 134.4 56.83 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 107.81 -1.181 . . . . 25.0 107.81 178.39 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.2 -11.32 70.7 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-O 118.98 -0.9 . . . . 25.0 113.782 178.697 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.28 138.57 57.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 118.336 1.068 . . . . 25.0 109.937 176.665 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.3 mm -105.04 129.38 57.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 107.111 -1.44 . . . . 25.0 107.111 177.865 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.0 ptp -137.48 150.1 47.31 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.394 0.277 . . . . 25.0 110.932 -175.706 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.2 m -87.63 122.4 31.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.576 -0.898 . . . . 25.0 108.576 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 63.4 t -89.79 127.59 42.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.404 -0.961 . . . . 25.0 108.404 178.322 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.649 HD12 HD22 ' A' ' 47' ' ' LEU . 84.6 mt -91.46 -52.25 4.88 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.15 -0.932 . . . . 25.0 108.551 179.453 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -151.61 168.69 24.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.487 -0.56 . . . . 25.0 109.487 177.502 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -117.33 154.41 31.31 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.68 -1.6 . . . . 25.0 106.68 179.423 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 56.37 42.73 27.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 123.429 1.585 . . . . 25.0 108.662 -177.559 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -67.98 154.18 42.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.573 -1.649 . . . . 25.0 109.319 -176.701 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 59.09 9.39 1.27 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.544 1.138 . . . . 25.0 113.148 177.955 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.82 13.89 74.1 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 110.804 -0.918 . . . . 25.0 110.804 -179.366 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.3 mt -90.32 134.44 34.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.273 -0.64 . . . . 25.0 109.273 179.721 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -72.44 126.4 29.76 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.268 0.556 . . . . 25.0 110.47 178.534 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.66 2.41 69.53 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 117.576 1.791 . . . . 25.0 117.576 174.914 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -100.63 134.13 44.06 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.128 1.464 . . . . 25.0 110.906 177.916 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -113.1 142.88 45.24 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.798 -0.815 . . . . 25.0 108.798 -174.872 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -86.75 123.84 32.34 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 106.599 -1.63 . . . . 25.0 106.599 179.106 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 97.8 m -132.71 160.83 35.64 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.245 0.545 . . . . 25.0 112.204 179.528 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.2 t -113.14 125.93 54.89 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 107.129 -1.434 . . . . 25.0 107.129 172.281 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 tp -147.19 135.94 22.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.437 -1.32 . . . . 25.0 107.437 -175.715 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 43.7 m80 55.34 27.15 9.52 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.589 0.755 . . . . 25.0 112.073 -175.592 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.52 0.73 84.93 Favored Glycine 0 C--O 1.217 -0.964 0 N-CA-C 115.201 0.84 . . . . 25.0 115.201 -179.515 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -115.22 161.99 17.69 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.435 -1.321 . . . . 25.0 107.435 178.628 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -114.21 153.41 29.67 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.332 -0.618 . . . . 25.0 109.332 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.23 -163.86 30.88 Favored Glycine 0 CA--C 1.503 -0.683 0 N-CA-C 106.137 -2.785 . . . . 25.0 106.137 178.29 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 pt -115.9 155.95 17.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 120.808 0.337 . . . . 25.0 111.416 -175.299 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.424 HG12 ' HE1' ' A' ' 26' ' ' PHE . 2.9 m -144.18 147.64 38.26 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.403 -0.817 . . . . 25.0 109.479 179.525 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -74.87 126.02 9.77 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 CA-C-N 118.165 0.38 . . . . 25.0 112.373 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.8 -21.41 79.74 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 115.625 1.01 . . . . 25.0 115.625 -174.72 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -56.14 -28.2 57.05 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.529 0.937 . . . . 25.0 113.529 -176.59 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.12 20.02 12.77 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.936 -0.478 . . . . 25.0 111.721 -178.292 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.7 tp -119.52 146.51 45.39 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.612 -0.885 . . . . 25.0 108.612 -178.672 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -117.56 124.12 47.9 Favored 'General case' 0 C--O 1.208 -1.082 0 CA-C-N 116.085 -0.507 . . . . 25.0 110.757 -178.16 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.1 mm -76.66 136.63 24.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 109.298 -0.63 . . . . 25.0 109.298 177.471 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.0 mt -119.33 101.5 8.02 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.149 -1.797 . . . . 25.0 106.149 176.714 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--N 1.323 -0.553 0 N-CA-C 108.996 -0.742 . . . . 25.0 108.996 -177.017 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 80.1 mttt . . . . . 0 N--CA 1.456 -0.166 0 N-CA-C 106.845 -1.539 . . . . 25.0 106.845 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 C--O 1.242 0.675 0 C-N-CA 116.268 -2.021 . . . . 25.0 111.17 176.266 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 . . . . . 0 C--O 1.221 -0.415 0 N-CA-C 115.74 1.755 . . . . 25.0 115.74 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.8 mt -79.23 -31.31 43.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.503 -1.226 . . . . 25.0 110.267 -177.941 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.4 m120 54.34 25.09 5.62 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.286 1.034 . . . . 25.0 113.028 -177.011 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.6 m -88.51 162.46 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.257 -1.386 . . . . 25.0 107.257 178.102 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.87 173.94 6.17 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.416 -1.698 . . . . 25.0 106.416 -179.393 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.73 158.18 43.03 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.483 -0.191 . . . . 25.0 110.483 174.599 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -121.5 129.4 52.9 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.377 0.671 . . . . 25.0 110.592 176.892 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.32 132.39 45.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.109 -0.496 . . . . 25.0 110.12 176.807 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -98.31 -22.44 16.11 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.318 0.488 . . . . 25.0 112.318 -176.609 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -142.0 162.82 34.51 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.151 -0.685 . . . . 25.0 109.151 -179.801 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -69.37 158.81 34.35 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.698 -0.482 . . . . 25.0 109.698 177.704 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.35 161.53 38.75 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.651 -1.24 . . . . 25.0 107.651 177.168 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 p -136.25 139.26 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 102.071 -3.307 . . . . 25.0 102.071 171.243 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.34 124.4 34.39 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.577 -0.527 . . . . 25.0 109.577 -175.771 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -110.23 15.7 22.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.968 0.89 . . . . 25.0 110.312 -176.746 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.9 t -152.69 148.66 20.91 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 107.037 -1.468 . . . . 25.0 107.037 -175.87 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.59 -19.48 36.88 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 117.719 -1.054 . . . . 25.0 113.081 178.925 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -82.61 -19.29 38.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.363 0.602 . . . . 25.0 110.228 178.868 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -83.64 132.73 34.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 122.021 0.915 . . . . 25.0 111.029 -176.175 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.449 ' HB2' HG13 ' A' ' 57' ' ' VAL . 40.8 mt -82.75 138.31 34.09 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.711 -0.848 . . . . 25.0 108.711 178.254 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -90.82 131.38 36.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.542 -1.281 . . . . 25.0 107.542 176.404 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -155.27 165.17 37.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.387 0.613 . . . . 25.0 111.313 -178.225 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -125.68 164.28 20.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.855 -0.611 . . . . 25.0 111.174 -177.797 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -56.27 130.81 46.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.209 0.528 . . . . 25.0 110.191 179.333 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.55 -18.65 56.65 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.813 -0.993 . . . . 25.0 113.967 177.484 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -58.83 146.16 38.25 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 117.85 0.825 . . . . 25.0 110.995 179.801 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.4 mm -113.34 133.19 60.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.567 -1.197 . . . . 25.0 108.35 178.682 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.6 ptp -141.92 155.7 45.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.614 -0.513 . . . . 25.0 109.614 -177.96 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.6 m -89.2 128.43 35.81 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 108.69 -0.855 . . . . 25.0 108.69 178.004 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.0 t -93.15 126.54 45.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.929 -1.138 . . . . 25.0 107.929 177.183 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.67 HD12 HD22 ' A' ' 47' ' ' LEU . 72.9 mt -90.94 -51.88 5.13 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.503 -0.925 . . . . 25.0 108.503 179.57 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -149.55 161.04 42.92 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.71 -0.848 . . . . 25.0 108.71 177.985 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -102.86 156.58 17.56 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.729 -0.841 . . . . 25.0 108.729 176.221 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 55.28 41.22 31.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.41 1.576 . . . . 25.0 108.507 172.061 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.405 HG21 HG22 ' A' ' 56' ' ' ILE . 11.4 t -63.66 147.69 50.92 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 112.625 -2.079 . . . . 25.0 110.859 -175.522 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 59.96 9.97 1.98 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.664 0.786 . . . . 25.0 111.993 -176.575 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.74 9.46 86.33 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 111.122 -0.791 . . . . 25.0 111.122 -177.226 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.6 114.22 21.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.296 -1.002 . . . . 25.0 108.296 -179.759 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.21 129.2 39.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.196 0.522 . . . . 25.0 109.891 -176.567 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.08 -1.4 75.12 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-O 118.613 -1.104 . . . . 25.0 115.433 176.694 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -100.92 130.11 46.87 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 119.409 1.604 . . . . 25.0 109.044 177.095 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -113.4 139.94 48.48 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.299 -1.0 . . . . 25.0 108.299 -176.438 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.67 HD22 HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -82.02 122.71 28.15 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 105.467 -2.049 . . . . 25.0 105.467 179.255 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.6 m -130.5 163.51 26.85 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.031 0.443 . . . . 25.0 110.98 178.565 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.6 t -116.21 122.03 43.8 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.976 -1.861 . . . . 25.0 105.976 172.524 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.7 tp -147.14 139.77 24.88 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.521 -1.289 . . . . 25.0 107.521 -176.948 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 57.87 27.2 14.26 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.75 0.648 . . . . 25.0 112.75 177.133 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.8 2.31 90.64 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 114.899 0.72 . . . . 25.0 114.899 178.77 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.4 ptt85 -126.93 160.51 30.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.581 1.19 . . . . 25.0 109.35 177.965 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -109.53 152.68 25.14 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.579 -0.897 . . . . 25.0 108.579 177.627 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.08 -160.59 25.21 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 105.974 -2.851 . . . . 25.0 105.974 179.265 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.405 HG22 HG21 ' A' ' 39' ' ' THR . 33.3 pt -118.36 154.11 20.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.545 0.688 . . . . 25.0 111.253 -175.817 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -141.17 146.96 45.29 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.06 -0.973 . . . . 25.0 109.117 179.444 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.59 120.13 6.04 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 CA-C-O 121.669 0.612 . . . . 25.0 111.326 178.246 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.22 -12.05 75.9 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 116.062 -0.517 . . . . 25.0 113.865 -176.477 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -69.36 -9.21 52.39 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.575 0.583 . . . . 25.0 112.575 -178.64 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -133.11 27.67 4.18 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.829 -0.804 . . . . 25.0 108.829 178.554 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.4 tp -133.16 147.51 52.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.449 -0.796 . . . . 25.0 109.393 -177.855 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -123.12 120.05 32.08 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.556 0.342 . . . . 25.0 110.977 -177.801 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.4 mm -66.91 135.45 28.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.427 -0.583 . . . . 25.0 109.427 177.751 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.0 mt -121.27 95.92 4.88 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.741 -1.207 . . . . 25.0 107.741 175.945 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 106.481 -1.674 . . . . 25.0 106.481 176.699 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 95.9 mttt . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 109.35 -0.611 . . . . 25.0 109.35 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo . . . . . 0 CA--C 1.543 0.962 0 O-C-N 122.084 0.518 . . . . 25.0 111.776 175.35 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 . . . . . 0 C--O 1.221 -0.395 0 N-CA-C 110.299 -0.26 . . . . 25.0 110.299 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.8 mt -66.2 -38.1 87.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.165 0.507 . . . . 25.0 110.831 178.432 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 55.29 26.51 8.66 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.97 -1.014 . . . . 25.0 113.173 -178.576 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.5 m -85.25 171.74 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.848 0 N-CA-C 105.982 -1.859 . . . . 25.0 105.982 175.131 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -118.93 169.57 9.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 118.894 0.77 . . . . 25.0 109.624 -178.453 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.96 153.47 40.11 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.745 -0.661 . . . . 25.0 109.801 178.481 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -116.35 130.42 56.76 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.681 -1.145 . . . . 25.0 110.058 178.796 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.55 128.3 36.12 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.853 -0.425 . . . . 25.0 109.853 176.99 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.83 -22.78 17.26 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 121.003 -0.279 . . . . 25.0 111.469 -178.772 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -141.13 166.18 25.48 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.24 -1.763 . . . . 25.0 106.24 178.485 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -74.18 160.17 31.54 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.376 0.423 . . . . 25.0 110.229 178.95 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -144.94 137.08 25.93 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.559 -0.713 . . . . 25.0 112.263 173.732 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.83 123.89 66.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 106.304 -1.739 . . . . 25.0 106.304 176.217 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.68 125.64 27.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.08 -0.964 . . . . 25.0 108.529 177.26 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.13 -1.28 18.89 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.017 0.913 . . . . 25.0 109.34 176.954 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 t -131.85 145.88 59.37 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 105.121 -2.177 . . . . 25.0 105.121 179.589 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -69.37 -14.66 37.68 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 117.346 -1.303 . . . . 25.0 113.105 178.713 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -83.39 -16.81 44.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.48 0.657 . . . . 25.0 110.338 178.622 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -88.02 142.49 27.74 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.279 -0.637 . . . . 25.0 109.279 -178.709 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.4 mt -92.39 129.87 38.21 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.853 0.835 . . . . 25.0 109.597 177.653 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.94 142.64 28.68 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 105.644 -1.984 . . . . 25.0 105.644 175.842 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -161.68 165.94 27.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.256 0.55 . . . . 25.0 111.329 -179.111 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -113.52 159.5 19.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.497 -0.774 . . . . 25.0 109.12 177.546 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.76 133.66 55.57 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.824 -1.176 . . . . 25.0 107.824 177.626 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.18 -22.92 38.5 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-O 119.205 -0.775 . . . . 25.0 114.051 179.6 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -58.6 140.54 54.22 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.529 0.68 . . . . 25.0 109.69 179.731 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.6 mm -108.84 127.3 65.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.734 -1.121 . . . . 25.0 108.059 -178.849 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 12.2 ptp -128.2 150.92 49.8 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.188 -0.671 . . . . 25.0 109.188 -179.986 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.0 m -84.42 127.48 34.03 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 106.883 -1.525 . . . . 25.0 106.883 176.026 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.0 t -94.07 122.63 45.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 179.013 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.586 HD12 HD22 ' A' ' 47' ' ' LEU . 84.3 mt -89.07 -46.94 8.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.603 -0.726 . . . . 25.0 109.127 -177.662 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -155.26 171.55 19.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.51 -0.314 . . . . 25.0 110.218 177.679 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -123.63 155.75 37.13 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.967 -1.864 . . . . 25.0 105.967 179.32 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.3 t0 58.49 41.35 22.79 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.304 1.526 . . . . 25.0 108.126 -175.881 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 t -68.32 142.03 55.64 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.778 -1.193 . . . . 25.0 107.778 -177.625 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 56.54 18.72 3.72 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 113.978 1.103 . . . . 25.0 113.978 -177.526 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.15 20.57 76.6 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.428 -1.069 . . . . 25.0 110.428 -179.656 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.418 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 65.7 mt -90.53 99.73 12.7 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 107.725 -1.213 . . . . 25.0 107.725 176.551 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -57.65 123.48 15.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.93 -1.032 . . . . 25.0 110.091 -176.099 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.47 -3.03 85.26 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 118.345 -1.253 . . . . 25.0 115.366 178.92 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.418 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 85.1 m95 -100.58 143.63 30.52 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 119.461 1.63 . . . . 25.0 109.569 177.84 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -117.66 140.54 49.52 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.345 -0.983 . . . . 25.0 108.345 -178.896 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.586 HD22 HD12 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -82.71 120.22 25.31 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 103.967 -2.605 . . . . 25.0 103.967 175.84 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 93.8 m -129.72 160.69 32.61 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 110.205 -0.294 . . . . 25.0 110.205 179.158 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.5 t -116.9 121.76 42.39 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.865 -1.161 . . . . 25.0 107.865 173.385 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.5 tp -143.75 141.88 30.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.027 -1.842 . . . . 25.0 106.027 -177.105 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 56.43 27.47 12.18 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.189 0.595 . . . . 25.0 111.388 -176.877 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.39 -0.46 84.7 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-O 119.554 -0.581 . . . . 25.0 114.467 177.682 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -120.93 154.32 36.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.333 1.067 . . . . 25.0 110.06 179.322 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -98.11 157.12 16.33 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.321 -0.992 . . . . 25.0 108.321 178.434 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.61 -168.25 39.7 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 105.515 -3.034 . . . . 25.0 105.515 179.128 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.3 pt -115.89 153.17 17.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 122.339 1.066 . . . . 25.0 110.762 -175.738 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.95 146.07 32.83 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 114.216 -1.356 . . . . 25.0 109.96 -178.987 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.66 119.12 5.58 Favored 'Trans proline' 0 C--O 1.237 0.431 0 O-C-N 122.051 0.501 . . . . 25.0 113.173 -179.869 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.7 -17.55 69.23 Favored Glycine 0 C--O 1.222 -0.601 0 C-N-CA 120.975 -0.631 . . . . 25.0 113.478 -178.306 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -65.65 -12.22 51.57 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.579 0.585 . . . . 25.0 112.579 -177.868 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -130.56 26.52 5.05 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.587 0.708 . . . . 25.0 110.841 177.018 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -126.14 154.92 42.49 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.406 -0.816 . . . . 25.0 111.871 178.511 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -123.43 122.33 37.98 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.866 -0.606 . . . . 25.0 111.357 177.61 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.0 mm -71.7 137.37 23.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.678 -1.23 . . . . 25.0 107.678 177.779 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.3 mt -118.17 106.48 12.88 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.121 -1.066 . . . . 25.0 108.121 175.925 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 121.425 0.631 . . . . 25.0 110.748 179.537 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.1 mttt . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 107.999 -1.112 . . . . 25.0 107.999 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.539 0.729 0 C-N-CA 118.055 -0.83 . . . . 25.0 112.061 178.308 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 114.825 1.417 . . . . 25.0 114.825 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.4 mt -73.82 -41.68 61.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.339 -0.846 . . . . 25.0 109.881 178.485 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 52.76 33.18 13.52 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.271 1.028 . . . . 25.0 111.587 -177.976 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 m -91.56 162.16 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.75 -1.945 . . . . 25.0 105.75 174.571 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.51 170.99 8.22 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.003 -1.11 . . . . 25.0 108.003 -178.76 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.49 159.15 43.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.16 -0.681 . . . . 25.0 109.16 174.714 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -125.34 129.0 49.07 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.392 -0.822 . . . . 25.0 109.863 176.495 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.08 129.54 39.71 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.217 -0.66 . . . . 25.0 109.217 175.283 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.0 mt -96.01 -20.11 18.95 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.024 0.44 . . . . 25.0 110.489 -178.355 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -146.42 173.32 12.38 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 107.697 -1.223 . . . . 25.0 107.697 -177.664 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -76.04 158.68 31.59 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.992 0.425 . . . . 25.0 111.534 175.246 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -141.71 131.5 24.28 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.386 0.612 . . . . 25.0 112.518 168.642 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.9 t -97.05 122.19 48.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 103.539 -2.763 . . . . 25.0 103.539 173.135 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.42 139.98 36.22 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.837 -1.172 . . . . 25.0 107.837 176.304 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -128.91 -19.65 3.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.902 -0.59 . . . . 25.0 110.839 -179.128 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.44 150.98 39.84 Favored Pre-proline 0 N--CA 1.464 0.252 0 N-CA-C 106.759 -1.571 . . . . 25.0 106.759 171.131 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -68.74 -22.09 37.67 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 117.275 -1.35 . . . . 25.0 112.952 -179.183 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -90.4 -2.23 57.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.771 0.796 . . . . 25.0 110.616 -179.207 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -89.39 139.77 30.18 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.315 0.579 . . . . 25.0 110.471 -175.997 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.3 mt -90.74 128.04 36.53 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.105 0.955 . . . . 25.0 111.727 179.77 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.6 p -87.47 140.41 29.55 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.935 -1.876 . . . . 25.0 105.935 174.309 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.71 167.01 31.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.051 0.453 . . . . 25.0 110.1 178.774 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.32 160.85 19.9 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.639 -0.875 . . . . 25.0 108.639 178.441 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -56.23 134.18 53.01 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 115.221 -0.9 . . . . 25.0 110.096 177.56 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.68 -15.27 63.46 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-O 118.175 -1.347 . . . . 25.0 113.863 177.885 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -60.41 150.53 30.63 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 118.207 1.004 . . . . 25.0 110.826 177.512 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.6 mm -118.29 130.07 73.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.473 -1.239 . . . . 25.0 108.7 179.479 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -136.7 152.77 50.75 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.307 -0.627 . . . . 25.0 109.307 -179.085 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -88.36 128.26 35.5 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.357 -0.608 . . . . 25.0 109.357 177.909 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.4 t -91.91 127.83 43.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.176 -1.046 . . . . 25.0 108.176 179.638 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.62 HD12 HD22 ' A' ' 47' ' ' LEU . 77.3 mt -94.61 -47.84 6.34 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.636 -0.875 . . . . 25.0 108.636 179.889 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -152.05 169.08 23.24 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.517 -0.919 . . . . 25.0 108.517 178.111 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -117.75 153.96 32.53 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 108.029 -1.1 . . . . 25.0 108.029 176.404 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 60.05 40.14 18.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 123.472 1.606 . . . . 25.0 109.855 178.474 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 t -68.26 154.77 41.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.204 -1.816 . . . . 25.0 110.729 -177.122 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 59.46 13.97 3.55 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.486 1.114 . . . . 25.0 110.418 -177.392 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.77 11.41 85.27 Favored Glycine 0 CA--C 1.506 -0.489 0 N-CA-C 111.335 -0.706 . . . . 25.0 111.335 -179.827 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.65 128.83 36.12 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 117.761 0.781 . . . . 25.0 110.067 -177.814 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -70.02 123.24 21.06 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.083 -0.508 . . . . 25.0 110.346 -179.473 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.35 -0.79 88.66 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 116.789 1.475 . . . . 25.0 116.789 175.974 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -100.38 131.73 46.15 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.909 0.855 . . . . 25.0 109.373 176.753 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -114.1 143.2 45.18 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.492 -0.929 . . . . 25.0 108.492 -175.224 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.62 HD22 HD12 ' A' ' 35' ' ' LEU . 0.7 OUTLIER -83.68 122.44 28.62 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.735 -1.58 . . . . 25.0 106.735 177.952 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.6 m -133.34 162.28 32.26 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.231 0.538 . . . . 25.0 111.9 178.146 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -113.45 122.4 47.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.856 -1.164 . . . . 25.0 107.856 173.484 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.5 tp -139.77 132.58 29.14 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.882 -1.155 . . . . 25.0 107.882 -178.745 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 54.63 29.11 10.92 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.059 0.544 . . . . 25.0 111.438 -174.719 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.93 -3.79 73.95 Favored Glycine 0 C--O 1.222 -0.603 0 N-CA-C 115.305 0.882 . . . . 25.0 115.305 178.207 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -109.19 157.35 18.88 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.824 -1.547 . . . . 25.0 106.824 178.639 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -115.0 151.81 33.52 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.154 -0.684 . . . . 25.0 109.154 -177.747 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.73 -161.0 26.56 Favored Glycine 0 CA--C 1.504 -0.623 0 N-CA-C 107.051 -2.42 . . . . 25.0 107.051 -179.726 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.0 pt -115.97 150.3 17.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.212 0.53 . . . . 25.0 112.308 -175.083 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.85 144.94 43.61 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.226 -0.897 . . . . 25.0 110.488 -179.716 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.9 121.91 6.07 Favored 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 118.501 -0.533 . . . . 25.0 112.388 -179.769 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.58 -20.33 67.86 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 115.375 0.91 . . . . 25.0 115.375 -177.113 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -23.19 67.3 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.324 0.861 . . . . 25.0 113.324 -176.267 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -120.95 26.64 8.94 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.939 -0.763 . . . . 25.0 108.939 -179.045 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.0 tp -131.51 150.37 52.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.735 -0.666 . . . . 25.0 110.666 -176.985 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -124.74 123.55 40.23 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 122.223 -0.298 . . . . 25.0 111.787 179.186 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.4 mm -70.17 136.37 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 123.839 0.712 . . . . 25.0 110.001 176.6 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.8 mt -118.38 99.19 6.68 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.774 -1.565 . . . . 25.0 106.774 174.855 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 C--N 1.323 -0.554 0 N-CA-C 106.905 -1.517 . . . . 25.0 106.905 179.438 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 106.375 -1.713 . . . . 25.0 106.375 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 CA--C 1.547 1.172 0 C-N-CA 118.021 -0.853 . . . . 25.0 112.783 179.672 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 121.287 0.565 . . . . 25.0 109.799 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.9 mt -68.24 -37.59 80.95 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.144 -0.935 . . . . 25.0 110.389 -177.963 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.1 m120 54.11 29.11 9.82 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 122.861 1.315 . . . . 25.0 112.031 -179.007 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.9 m -91.99 165.0 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 104.817 -2.29 . . . . 25.0 104.817 172.939 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.67 175.69 5.33 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 119.704 1.138 . . . . 25.0 108.612 -178.414 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.96 154.93 40.09 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.987 -1.006 . . . . 25.0 110.824 174.775 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -113.9 130.17 56.52 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 125.299 1.44 . . . . 25.0 110.506 175.96 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.444 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -70.76 128.57 36.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.959 0.885 . . . . 25.0 110.898 177.662 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -94.79 -18.55 21.12 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.669 -0.696 . . . . 25.0 109.403 -179.117 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -145.73 173.79 11.78 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 124.154 0.909 . . . . 25.0 109.238 179.215 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -85.39 164.25 18.04 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 123.408 0.683 . . . . 25.0 111.896 176.032 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -152.32 144.31 23.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.518 0.599 . . . . 25.0 111.705 176.374 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.8 t -113.73 123.48 69.44 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 N-CA-C 106.678 -1.601 . . . . 25.0 106.678 171.218 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.68 124.29 30.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.703 -1.135 . . . . 25.0 108.25 179.537 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -107.3 -11.04 15.65 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.758 -0.83 . . . . 25.0 108.758 -178.711 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.9 t -110.76 147.26 36.11 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 104.883 -2.265 . . . . 25.0 104.883 176.768 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.69 -18.49 32.58 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 O-C-N 121.946 0.445 . . . . 25.0 112.242 179.086 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -85.63 -12.97 50.07 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.654 -0.703 . . . . 25.0 109.346 179.235 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -87.91 143.3 27.19 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-O 121.32 0.581 . . . . 25.0 111.446 179.664 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.1 mt -98.31 128.62 44.82 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-O 121.884 0.85 . . . . 25.0 112.237 177.834 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.69 134.33 34.36 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 105.718 -1.956 . . . . 25.0 105.718 174.157 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -152.58 168.08 26.75 Favored 'General case' 0 C--O 1.266 1.946 0 CA-C-O 121.71 0.767 . . . . 25.0 110.984 -179.782 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -118.92 159.72 23.28 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.367 1.067 . . . . 25.0 110.241 178.845 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -56.96 132.75 53.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.853 -1.166 . . . . 25.0 107.853 174.757 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.59 -25.15 28.55 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 115.349 -0.841 . . . . 25.0 114.089 -179.479 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -60.09 134.85 57.44 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.358 -0.979 . . . . 25.0 108.358 -175.226 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.5 mm -103.78 127.08 58.19 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 109.22 -0.659 . . . . 25.0 109.22 176.061 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.3 ptp -132.74 156.21 47.47 Favored 'General case' 0 C--O 1.2 -1.511 0 CA-C-N 115.416 -0.811 . . . . 25.0 108.918 -179.181 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.9 m -93.87 119.24 32.54 Favored 'General case' 0 C--O 1.198 -1.635 0 N-CA-C 108.918 -0.771 . . . . 25.0 108.918 -178.444 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.2 t -79.9 121.69 33.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 106.697 -1.594 . . . . 25.0 106.697 177.702 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.3 mt -94.51 -42.14 8.99 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.949 0.881 . . . . 25.0 109.735 179.854 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -146.33 152.19 38.73 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.566 -0.743 . . . . 25.0 109.577 -176.859 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -113.79 150.64 33.16 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 105.945 -1.872 . . . . 25.0 105.945 171.74 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 55.54 43.1 28.96 Favored 'General case' 0 C--O 1.268 2.027 0 O-C-N 125.021 1.45 . . . . 25.0 109.893 -176.876 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.2 t -70.49 151.2 45.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.397 -1.274 . . . . 25.0 111.145 -178.924 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 58.51 18.86 6.04 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.491 1.116 . . . . 25.0 112.069 179.359 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.5 5.15 90.16 Favored Glycine 0 C--O 1.208 -1.529 0 CA-C-N 115.139 -0.937 . . . . 25.0 112.071 178.06 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.9 mt -84.84 136.62 33.58 Favored 'General case' 0 C--O 1.211 -0.93 0 CA-C-N 117.289 0.544 . . . . 25.0 109.623 -174.512 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -80.03 108.35 13.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.902 -1.044 . . . . 25.0 113.351 -179.065 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.79 0.91 74.39 Favored Glycine 0 C--O 1.221 -0.691 0 C-N-CA 119.473 -1.346 . . . . 25.0 116.189 177.924 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -99.58 136.13 39.96 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 117.807 0.804 . . . . 25.0 109.232 173.43 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -113.01 146.19 39.52 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.711 -0.848 . . . . 25.0 108.711 -176.601 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.9 tp -89.9 127.61 36.04 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 106.076 -1.824 . . . . 25.0 106.076 -179.938 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.9 m -137.97 160.46 39.27 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 119.59 1.086 . . . . 25.0 113.778 -179.169 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.3 t -109.22 123.01 48.55 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 106.295 -1.742 . . . . 25.0 106.295 171.569 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.9 tp -137.91 127.52 25.1 Favored 'General case' 0 C--O 1.204 -1.313 0 N-CA-C 107.743 -1.206 . . . . 25.0 107.743 -177.562 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.8 m80 54.43 35.53 23.39 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.86 0.838 . . . . 25.0 110.691 -176.504 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.21 6.72 88.81 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.512 -0.852 . . . . 25.0 113.858 175.24 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -127.27 148.9 50.21 Favored 'General case' 0 C--O 1.204 -1.304 0 CA-C-N 119.001 1.4 . . . . 25.0 109.121 -176.3 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -102.03 148.35 25.48 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 123.688 0.618 . . . . 25.0 112.077 -178.02 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.67 -179.94 48.8 Favored Glycine 0 C--O 1.25 1.099 0 N-CA-C 106.76 -2.536 . . . . 25.0 106.76 -177.861 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt -103.52 148.56 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.01 0.924 . . . . 25.0 111.753 -174.831 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.87 148.63 43.18 Favored Pre-proline 0 C--O 1.244 0.795 0 CA-C-O 122.68 1.229 . . . . 25.0 110.863 -177.42 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.05 125.21 7.1 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 116.302 -1.999 . . . . 25.0 114.338 -178.353 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.84 -20.77 60.2 Favored Glycine 0 C--O 1.203 -1.829 0 CA-C-N 116.154 -0.476 . . . . 25.0 113.529 179.3 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -68.2 -15.66 63.67 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 121.053 -1.263 . . . . 25.0 112.36 -178.654 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -115.73 15.48 16.44 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.872 -0.517 . . . . 25.0 109.762 -179.148 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 12' ' ' ALA . 29.6 mt -130.03 152.5 49.42 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 117.366 2.358 . . . . 25.0 117.366 -176.757 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt -119.64 126.52 51.34 Favored 'General case' 0 C--O 1.197 -1.7 0 N-CA-C 108.055 -1.091 . . . . 25.0 108.055 175.53 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.5 mm -75.16 137.01 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 O-C-N 124.167 0.917 . . . . 25.0 110.204 177.111 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.3 mt -117.74 105.38 11.93 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.493 1.117 . . . . 25.0 108.528 177.666 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.21 -1.012 0 CA-C-N 114.915 -1.039 . . . . 25.0 110.658 -172.991 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 90.0 mttt . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 119.102 -0.475 . . . . 25.0 110.926 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo . . . . . 0 CA--C 1.562 1.883 0 O-C-N 123.159 1.084 . . . . 25.0 111.55 174.496 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 . . . . . 0 CA--C 1.5 -0.945 0 N-CA-C 113.713 1.005 . . . . 25.0 113.713 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.4 mt -71.99 -41.88 67.14 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.793 -1.094 . . . . 25.0 110.492 175.878 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.8 m120 54.39 33.35 18.4 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 113.606 -1.634 . . . . 25.0 113.814 -178.388 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 m -97.7 166.48 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.156 0 N-CA-C 106.408 -1.701 . . . . 25.0 106.408 178.253 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.3 171.72 7.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.32 -1.487 . . . . 25.0 107.3 -176.272 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.22 157.74 43.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 119.232 0.923 . . . . 25.0 111.774 176.896 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -120.33 127.55 52.44 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.498 -0.774 . . . . 25.0 110.935 179.579 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.93 122.12 18.67 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.635 -1.246 . . . . 25.0 107.635 179.749 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.3 mt -84.89 -27.91 26.32 Favored 'General case' 0 C--O 1.212 -0.876 0 O-C-N 121.879 -0.513 . . . . 25.0 110.776 -178.949 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -138.41 177.07 8.16 Favored 'General case' 0 C--O 1.198 -1.649 0 N-CA-C 108.622 -0.881 . . . . 25.0 108.622 177.216 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.63 170.57 15.9 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.317 0.647 . . . . 25.0 111.806 173.491 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -155.83 141.64 18.03 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 113.981 1.104 . . . . 25.0 113.981 175.02 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.6 131.99 62.6 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 105.774 -1.936 . . . . 25.0 105.774 -179.454 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.96 111.79 15.5 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 124.639 1.212 . . . . 25.0 110.274 -178.996 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -106.53 -1.33 23.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.64 0.733 . . . . 25.0 112.249 -179.208 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.3 m -131.7 154.36 81.78 Favored Pre-proline 0 CA--C 1.501 -0.923 0 N-CA-C 107.418 -1.327 . . . . 25.0 107.418 174.956 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.51 -26.56 40.25 Favored 'Trans proline' 0 C--O 1.259 1.533 0 C-N-CA 116.582 -1.812 . . . . 25.0 113.323 -175.631 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -82.57 -6.83 59.56 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 115.9 -0.591 . . . . 25.0 110.806 179.695 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -85.54 142.61 29.03 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-O 121.929 0.871 . . . . 25.0 111.988 -178.08 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.1 mt -93.73 135.19 35.28 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.605 -0.725 . . . . 25.0 109.089 176.071 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.47 130.15 39.4 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 106.413 -1.699 . . . . 25.0 106.413 174.629 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -150.93 165.89 32.31 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.607 0.717 . . . . 25.0 109.681 -178.583 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -115.1 170.33 8.44 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.666 -0.697 . . . . 25.0 109.906 -179.18 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -65.06 135.67 55.85 Favored 'General case' 0 C--O 1.203 -1.35 0 N-CA-C 108.488 -0.93 . . . . 25.0 108.488 175.825 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.02 -23.5 30.62 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 109.937 -1.265 . . . . 25.0 109.937 175.63 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -61.56 143.74 55.51 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 122.065 0.936 . . . . 25.0 111.362 -175.974 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.1 mm -116.04 120.09 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 114.116 -1.402 . . . . 25.0 109.571 -177.554 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -124.54 151.97 44.04 Favored 'General case' 0 C--N 1.313 -0.999 0 O-C-N 124.072 0.857 . . . . 25.0 109.161 179.0 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.6 m -84.39 127.63 34.11 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 106.822 -1.547 . . . . 25.0 106.822 177.103 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.9 t -90.19 120.88 39.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.51 -0.922 . . . . 25.0 108.51 176.009 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -90.39 -45.1 9.22 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.602 -0.726 . . . . 25.0 111.285 177.374 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -148.79 157.57 43.53 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.387 -0.968 . . . . 25.0 108.387 -175.264 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -118.73 147.63 43.65 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 106.513 -1.662 . . . . 25.0 106.513 176.672 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 55.75 46.38 22.57 Favored 'General case' 0 C--O 1.255 1.355 0 CA-C-O 124.206 1.955 . . . . 25.0 109.394 -177.805 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.438 HG21 HG22 ' A' ' 56' ' ' ILE . 14.6 t -68.59 157.53 35.89 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-N 112.594 -2.094 . . . . 25.0 110.942 -177.691 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 60.03 13.22 3.6 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.381 0.882 . . . . 25.0 113.381 174.413 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.53 16.09 78.48 Favored Glycine 0 CA--C 1.539 1.558 0 N-CA-C 109.296 -1.522 . . . . 25.0 109.296 179.599 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.6 mt -100.82 129.91 46.77 Favored 'General case' 0 C--O 1.206 -1.207 0 N-CA-C 107.348 -1.353 . . . . 25.0 107.348 -178.67 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.93 123.71 27.53 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 122.169 0.985 . . . . 25.0 111.867 177.93 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.57 -0.35 82.86 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 120.215 -0.993 . . . . 25.0 114.683 175.119 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -100.71 134.15 44.11 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.76 -0.83 . . . . 25.0 108.76 175.575 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -114.85 141.4 47.95 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.54 -0.911 . . . . 25.0 108.54 -178.076 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.4 tp -85.61 120.12 26.69 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.565 -0.902 . . . . 25.0 108.565 178.617 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 98.7 m -135.77 158.56 44.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.183 0.438 . . . . 25.0 112.183 -177.334 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.9 t -105.95 121.34 43.9 Favored 'General case' 0 C--O 1.251 1.168 0 C-N-CA 123.987 0.915 . . . . 25.0 108.787 173.804 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 tp -138.14 132.59 32.2 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.288 1.035 . . . . 25.0 109.164 179.967 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.7 m170 54.09 30.93 12.83 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-O 122.813 1.292 . . . . 25.0 109.655 -176.157 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.45 -5.44 73.38 Favored Glycine 0 N--CA 1.462 0.384 0 N-CA-C 116.528 1.371 . . . . 25.0 116.528 176.727 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -110.83 145.91 37.36 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.919 -0.771 . . . . 25.0 108.919 179.396 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -91.52 151.62 20.68 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 124.451 1.094 . . . . 25.0 108.642 178.849 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.27 -176.19 47.65 Favored Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 107.913 -2.075 . . . . 25.0 107.913 -179.595 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.438 HG22 HG21 ' A' ' 39' ' ' THR . 41.6 pt -104.73 148.94 8.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-O 121.977 0.894 . . . . 25.0 111.761 -175.341 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.7 m -143.48 146.38 35.49 Favored Pre-proline 0 C--O 1.246 0.896 0 C-N-CA 123.254 0.622 . . . . 25.0 111.969 177.256 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.97 122.17 7.05 Favored 'Trans proline' 0 C--N 1.358 1.049 0 N-CA-C 114.296 0.845 . . . . 25.0 114.296 -175.86 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.49 -25.56 71.48 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.842 -0.617 . . . . 25.0 114.379 -178.197 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.26 -24.68 60.17 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.044 0.757 . . . . 25.0 113.044 -179.157 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -119.09 31.38 6.66 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 120.929 -1.107 . . . . 25.0 108.789 178.962 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.4 mt -128.26 159.77 34.21 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.383 1.087 . . . . 25.0 110.747 176.538 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -134.46 127.04 30.7 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 115.106 -0.952 . . . . 25.0 108.784 174.738 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.5 mm -73.54 136.71 24.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.995 -0.743 . . . . 25.0 108.995 -179.347 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.5 mt -112.04 89.08 2.97 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 106.847 -1.538 . . . . 25.0 106.847 174.347 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.483 1.201 0 C-N-CA 119.226 -0.99 . . . . 25.0 108.843 176.559 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 109.69 -0.485 . . . . 25.0 109.69 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 C--O 1.24 0.614 0 C-N-CA 117.577 -1.149 . . . . 25.0 111.023 178.901 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 . . . . . 0 C--O 1.201 -1.483 0 CA-C-O 122.04 0.924 . . . . 25.0 109.565 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.6 mt -71.1 -40.91 71.23 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.249 -1.341 . . . . 25.0 111.424 178.751 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.0 m120 57.48 35.84 26.32 Favored 'General case' 0 C--O 1.253 1.275 0 C-N-CA 124.136 0.975 . . . . 25.0 110.753 -178.865 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.6 m -101.4 157.09 4.4 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 N-CA-C 107.687 -1.227 . . . . 25.0 107.687 176.044 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.07 166.25 12.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 118.324 -0.846 . . . . 25.0 109.173 -176.929 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.94 154.59 40.54 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.901 0.773 . . . . 25.0 112.953 172.651 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -117.9 129.49 55.66 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 124.07 0.948 . . . . 25.0 111.086 -179.527 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.43 126.36 29.43 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-O 118.614 -0.708 . . . . 25.0 109.294 177.866 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt -89.01 -28.81 19.94 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.013 0.925 . . . . 25.0 111.376 178.797 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -139.85 170.11 16.48 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.12 -1.437 . . . . 25.0 107.12 179.919 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -83.91 176.18 9.07 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 122.968 0.507 . . . . 25.0 110.642 -177.801 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -151.12 153.34 34.83 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 108.008 -1.108 . . . . 25.0 108.008 -178.216 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.4 t -125.26 136.0 62.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 104.507 -2.405 . . . . 25.0 104.507 170.832 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.27 134.62 42.95 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 114.475 -1.238 . . . . 25.0 110.238 178.013 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -125.22 11.37 8.15 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 123.628 0.58 . . . . 25.0 110.777 -177.341 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.4 t -151.21 150.91 28.34 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 106.228 -1.767 . . . . 25.0 106.228 -179.289 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.75 -12.12 28.49 Favored 'Trans proline' 0 N--CA 1.48 0.683 0 N-CA-C 116.607 1.733 . . . . 25.0 116.607 -175.91 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -83.1 -20.67 34.42 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 107.802 -1.184 . . . . 25.0 107.802 177.73 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -84.06 136.58 33.97 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.723 0.773 . . . . 25.0 110.063 -178.927 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.3 mt -93.57 131.26 39.01 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 113.929 1.085 . . . . 25.0 113.929 -177.997 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 p -86.75 95.1 9.71 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-N 115.212 -0.904 . . . . 25.0 110.85 -179.408 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -126.43 160.57 30.14 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 121.743 -0.598 . . . . 25.0 111.8 179.645 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -121.57 165.47 15.64 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 105.087 -2.19 . . . . 25.0 105.087 -177.254 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -59.02 131.42 50.99 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.54 0.686 . . . . 25.0 110.656 177.532 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.74 -20.02 51.05 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 121.754 -0.591 . . . . 25.0 114.295 -179.006 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -62.29 131.32 48.95 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 106.932 -1.507 . . . . 25.0 106.932 178.723 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.6 mm -102.23 132.43 48.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 106.939 -1.504 . . . . 25.0 106.939 177.817 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 11.2 ptp -131.8 161.87 31.9 Favored 'General case' 0 CA--C 1.495 -1.145 0 O-C-N 121.241 -0.912 . . . . 25.0 109.244 -179.836 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.2 m -101.62 119.19 38.39 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.678 -1.601 . . . . 25.0 106.678 -177.979 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 t -81.69 130.63 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 123.513 1.625 . . . . 25.0 109.321 -179.83 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.4 mt -100.41 -42.92 6.41 Favored 'General case' 0 C--O 1.204 -1.306 0 O-C-N 121.197 -0.939 . . . . 25.0 112.895 178.311 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -148.3 147.41 29.28 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-O 118.539 -0.743 . . . . 25.0 109.518 178.808 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -107.05 147.32 30.11 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.311 -1.366 . . . . 25.0 107.311 173.188 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 56.4 39.65 29.97 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 123.279 1.514 . . . . 25.0 110.665 -173.91 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -64.18 150.71 45.18 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 113.744 -1.571 . . . . 25.0 110.252 -175.327 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 56.7 22.65 7.03 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.076 -1.42 . . . . 25.0 113.3 178.225 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.32 16.93 73.8 Favored Glycine 0 CA--C 1.501 -0.788 0 C-N-CA 120.492 -0.861 . . . . 25.0 112.347 -179.24 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.3 mt -92.66 130.5 38.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.528 -1.286 . . . . 25.0 107.528 175.438 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -75.2 122.22 23.31 Favored 'General case' 0 C--O 1.258 1.526 0 O-C-N 121.232 -0.918 . . . . 25.0 110.68 176.996 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.83 -5.13 85.36 Favored Glycine 0 C--N 1.331 0.303 0 N-CA-C 116.089 1.196 . . . . 25.0 116.089 172.686 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -97.07 136.04 38.19 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 117.824 0.812 . . . . 25.0 109.764 177.085 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -114.41 142.85 45.82 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-O 117.595 -1.193 . . . . 25.0 108.019 -177.946 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.5 tp -85.42 125.28 32.87 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.128 -2.175 . . . . 25.0 105.128 175.059 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.8 m -135.47 164.08 28.61 Favored 'General case' 0 C--O 1.253 1.289 0 O-C-N 121.705 -0.622 . . . . 25.0 109.862 177.336 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.9 t -112.61 120.61 42.16 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.215 -1.402 . . . . 25.0 107.215 171.052 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.8 tp -132.52 136.45 46.64 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 105.756 -1.942 . . . . 25.0 105.756 -175.785 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.1 m170 54.16 29.69 10.9 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.527 0.68 . . . . 25.0 109.985 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.91 11.04 81.18 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-O 118.454 -1.192 . . . . 25.0 116.061 178.919 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -122.66 146.86 47.08 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.356 -1.35 . . . . 25.0 107.356 175.477 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -89.08 160.8 16.87 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.15 -1.055 . . . . 25.0 108.15 178.009 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.43 -174.43 41.91 Favored Glycine 0 C--O 1.242 0.623 0 N-CA-C 108.349 -1.901 . . . . 25.0 108.349 -178.758 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 pt -118.57 152.92 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.615 0 CA-C-O 122.71 1.243 . . . . 25.0 111.793 -172.238 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.9 m -143.92 150.91 51.27 Favored Pre-proline 0 C--N 1.306 -1.288 0 CA-C-N 112.384 -2.189 . . . . 25.0 110.807 -174.842 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.3 128.17 10.3 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 O-C-N 121.949 0.447 . . . . 25.0 112.565 -179.318 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.57 -22.42 78.99 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 118.962 -1.59 . . . . 25.0 115.642 -174.624 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -28.18 69.78 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 122.094 -0.651 . . . . 25.0 112.38 -175.54 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -108.35 28.02 8.75 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 122.013 0.911 . . . . 25.0 110.322 178.985 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.5 mt -121.37 159.17 26.7 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 114.423 1.268 . . . . 25.0 114.423 175.126 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -134.94 115.51 13.66 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.779 0.832 . . . . 25.0 109.729 176.36 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.7 mm -67.03 129.15 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 112.422 0.527 . . . . 25.0 112.422 177.834 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.5 mt -105.53 78.03 1.33 Allowed 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.131 -1.433 . . . . 25.0 107.131 179.219 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.813 0 N-CA-C 109.744 -0.465 . . . . 25.0 109.744 178.0 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.9 mttt . . . . . 0 CA--C 1.547 0.86 0 N-CA-C 106.71 -1.589 . . . . 25.0 106.71 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 C--N 1.36 1.156 0 C-N-CA 117.565 -1.157 . . . . 25.0 110.278 174.203 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 CA-C-O 123.084 1.38 . . . . 25.0 115.255 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.5 p -119.41 41.71 3.04 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.438 -1.036 . . . . 25.0 110.683 -177.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.82 148.51 42.78 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.844 -0.798 . . . . 25.0 108.844 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -140.38 141.18 35.62 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 120.82 0.343 . . . . 25.0 110.285 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -79.98 167.88 19.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.589 -0.732 . . . . 25.0 110.802 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.8 mt -65.48 -42.15 92.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.598 -0.728 . . . . 25.0 110.294 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 56.27 30.92 17.56 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.206 1.002 . . . . 25.0 111.882 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.7 m -88.62 163.47 2.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 105.526 -2.027 . . . . 25.0 105.526 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.61 173.4 6.56 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.89 -0.782 . . . . 25.0 108.89 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.78 162.46 40.99 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.72 -0.474 . . . . 25.0 109.72 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -126.69 135.6 51.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.817 -1.083 . . . . 25.0 109.648 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.492 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -72.62 120.63 18.5 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.803 -0.635 . . . . 25.0 109.295 172.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.62 -23.25 24.33 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.922 -0.77 . . . . 25.0 108.922 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -140.54 172.28 12.94 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.456 -1.312 . . . . 25.0 107.456 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.72 164.34 18.62 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 123.129 0.572 . . . . 25.0 110.417 174.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -153.73 130.74 11.01 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.962 0.505 . . . . 25.0 110.725 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.23 118.94 48.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 106.035 -1.839 . . . . 25.0 106.035 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.43 143.08 51.93 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.276 -0.874 . . . . 25.0 109.896 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -116.69 -34.84 4.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.039 -0.982 . . . . 25.0 109.685 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.5 m -93.44 153.97 41.34 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.068 -0.716 . . . . 25.0 109.068 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.43 -22.27 33.83 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 117.782 -1.012 . . . . 25.0 113.645 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -81.12 -16.18 53.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.73 0.776 . . . . 25.0 110.85 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -84.52 138.36 32.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.489 0.661 . . . . 25.0 110.299 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.6 mt -92.84 130.49 38.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.61 0.719 . . . . 25.0 110.048 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.6 t -91.55 137.57 32.26 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.686 -1.598 . . . . 25.0 106.686 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -154.09 166.19 33.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.679 0.752 . . . . 25.0 112.642 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -110.09 158.87 17.84 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.638 -0.875 . . . . 25.0 108.638 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -57.48 131.03 48.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.701 -1.222 . . . . 25.0 107.701 171.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.23 -19.9 46.98 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-O 119.154 -0.803 . . . . 25.0 113.889 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -59.74 144.71 47.47 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.76 0.79 . . . . 25.0 110.545 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.4 mm -114.04 130.69 67.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.58 -1.191 . . . . 25.0 107.836 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -135.34 156.47 48.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.967 -0.383 . . . . 25.0 109.967 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.7 m -92.66 126.17 37.63 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.159 -1.052 . . . . 25.0 108.159 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.5 t -89.86 122.82 41.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.259 -1.015 . . . . 25.0 108.259 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.644 HD12 HD22 ' A' ' 47' ' ' LEU . 77.4 mt -88.26 -48.07 7.95 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.646 -0.706 . . . . 25.0 109.14 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -152.52 167.03 30.14 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.345 -0.983 . . . . 25.0 108.345 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -116.84 154.29 30.99 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 106.811 -1.551 . . . . 25.0 106.811 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 58.13 40.6 24.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.918 1.818 . . . . 25.0 108.982 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -64.87 149.64 49.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 112.59 -2.095 . . . . 25.0 110.925 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 60.33 9.56 2.02 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.98 0.912 . . . . 25.0 113.37 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.99 12.95 80.35 Favored Glycine 0 C--N 1.33 0.244 0 N-CA-C 111.114 -0.795 . . . . 25.0 111.114 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 99.0 mt -91.24 117.87 30.0 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.42 -0.585 . . . . 25.0 109.42 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -63.6 126.47 27.63 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.707 -0.679 . . . . 25.0 110.928 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.12 -0.28 84.02 Favored Glycine 0 CA--C 1.518 0.261 0 N-CA-C 115.515 0.966 . . . . 25.0 115.515 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -100.89 133.49 45.29 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 119.012 1.406 . . . . 25.0 109.873 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -113.47 141.97 46.48 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.771 -0.825 . . . . 25.0 108.771 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.644 HD22 HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -82.39 121.66 27.0 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.596 -2.001 . . . . 25.0 105.596 177.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 88.4 m -129.88 160.92 32.05 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.829 -0.348 . . . . 25.0 111.39 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -113.9 122.03 45.75 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.989 -1.856 . . . . 25.0 105.989 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.0 tp -145.5 139.7 26.98 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.819 -1.178 . . . . 25.0 107.819 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.9 m170 57.25 27.0 12.98 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.412 0.685 . . . . 25.0 111.97 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.1 0.29 89.46 Favored Glycine 0 C--O 1.221 -0.704 0 N-CA-C 114.9 0.72 . . . . 25.0 114.9 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -124.15 156.14 37.23 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 117.89 0.845 . . . . 25.0 109.757 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -102.37 154.98 18.55 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.326 -0.62 . . . . 25.0 109.326 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.43 -162.12 29.9 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 106.427 -2.669 . . . . 25.0 106.427 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 pt -118.55 151.49 20.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.649 0.737 . . . . 25.0 111.876 -174.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.2 m -140.38 146.93 47.59 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 114.929 -1.032 . . . . 25.0 110.025 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.87 122.16 7.09 Favored 'Trans proline' 0 C--O 1.241 0.65 0 C-N-CA 118.35 -0.633 . . . . 25.0 112.434 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.94 -23.09 65.38 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 121.607 -0.33 . . . . 25.0 113.01 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.39 -20.42 64.42 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 122.335 -0.509 . . . . 25.0 112.203 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -109.48 12.28 24.58 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 122.194 -0.317 . . . . 25.0 111.777 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -126.72 156.79 40.57 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 114.946 1.461 . . . . 25.0 114.946 -174.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -129.29 123.1 31.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.444 -0.798 . . . . 25.0 110.297 175.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.4 mm -67.76 137.21 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.772 -0.825 . . . . 25.0 108.772 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.6 mt -117.76 115.75 25.63 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.43 -1.693 . . . . 25.0 106.43 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.1 m -98.52 157.5 3.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.38 -0.6 . . . . 25.0 109.38 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.56 -174.81 45.12 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 108.682 -1.767 . . . . 25.0 108.682 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 97.6 mtp -84.43 160.48 20.58 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.888 -1.153 . . . . 25.0 107.888 176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -83.99 140.44 31.89 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.406 -1.702 . . . . 25.0 106.406 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -90.45 157.45 17.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.178 0.513 . . . . 25.0 109.738 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -106.72 20.1 19.51 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.036 -0.529 . . . . 25.0 109.629 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -134.64 153.05 78.74 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 105.671 -1.974 . . . . 25.0 105.671 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -71.73 153.41 59.27 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 117.896 -0.936 . . . . 25.0 113.86 -176.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.01 158.94 23.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.594 -0.521 . . . . 25.0 109.594 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.14 60.43 0.57 Allowed Glycine 0 C--O 1.224 -0.494 0 CA-C-N 116.259 -0.428 . . . . 25.0 112.426 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.7 t -78.76 156.04 29.03 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 122.621 -0.341 . . . . 25.0 110.794 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -164.33 176.77 40.21 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 109.74 -1.344 . . . . 25.0 109.74 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.9 -174.37 39.36 Favored Glycine 0 C--O 1.226 -0.385 0 N-CA-C 110.531 -1.028 . . . . 25.0 110.531 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.7 t -145.59 153.35 40.96 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.043 -0.725 . . . . 25.0 109.043 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.13 88.49 1.18 Allowed Glycine 0 C--O 1.226 -0.371 0 C-N-CA 121.471 -0.395 . . . . 25.0 112.495 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.8 m -79.13 144.28 34.66 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.553 -0.381 . . . . 25.0 110.221 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.91 153.89 52.44 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 108.398 -1.881 . . . . 25.0 108.398 174.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.9 m -118.02 115.19 24.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.476 0.638 . . . . 25.0 111.04 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -105.25 81.78 1.75 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.212 -1.032 . . . . 25.0 108.212 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.6 pttt -158.24 155.87 29.72 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.529 0.566 . . . . 25.0 112.529 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -113.02 -6.22 13.74 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.012 -1.477 . . . . 25.0 107.012 166.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -59.92 116.37 4.08 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.097 -0.956 . . . . 25.0 108.575 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.4 m -108.7 141.73 23.93 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.698 0.285 . . . . 25.0 111.639 -173.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.52 164.17 34.46 Favored 'Trans proline' 0 C--N 1.346 0.431 0 N-CA-C 114.79 1.035 . . . . 25.0 114.79 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -66.24 158.9 52.49 Favored 'Trans proline' 0 C--N 1.351 0.709 0 CA-C-O 120.984 0.327 . . . . 25.0 112.091 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.28 160.63 48.13 Favored 'Trans proline' 0 C--N 1.347 0.46 0 N-CA-C 114.386 0.879 . . . . 25.0 114.386 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -83.15 140.34 42.54 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 106.029 -1.841 . . . . 25.0 106.029 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.42 167.72 25.54 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 O-C-N 121.992 0.469 . . . . 25.0 112.864 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.58 152.66 53.91 Favored 'Trans proline' 0 C--N 1.353 0.797 0 N-CA-C 114.656 0.983 . . . . 25.0 114.656 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -115.4 43.3 2.07 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.827 -0.624 . . . . 25.0 110.19 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.21 123.47 29.6 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.508 -0.923 . . . . 25.0 108.508 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -77.0 -10.69 59.53 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.147 1.166 . . . . 25.0 114.147 -173.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 36.4 t -162.58 135.01 5.58 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.886 -0.783 . . . . 25.0 108.886 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.8 t 56.46 -160.37 0.21 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.631 0.729 . . . . 25.0 111.565 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--O 1.209 -1.074 0 CA-C-O 124.108 1.909 . . . . 25.0 111.011 -177.886 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.113 0 CA-C-O 123.371 1.54 . . . . 25.0 115.613 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.7 p -122.19 65.71 0.93 Allowed 'General case' 0 C--O 1.223 -0.339 0 O-C-N 120.998 -1.295 . . . . 25.0 111.36 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.6 ttm -62.66 -30.34 71.3 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.48 -0.327 . . . . 25.0 111.149 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? 54.99 80.26 0.13 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.756 0.822 . . . . 25.0 112.867 175.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -66.57 162.88 19.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.634 0.731 . . . . 25.0 111.849 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.9 mt -69.79 -40.72 75.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.045 -0.98 . . . . 25.0 109.899 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.2 m120 57.6 23.61 9.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.614 1.165 . . . . 25.0 113.157 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.7 m -85.65 162.98 2.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.387 -0.968 . . . . 25.0 108.387 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.74 168.18 10.49 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.374 -0.829 . . . . 25.0 110.098 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.6 166.81 26.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.014 0.435 . . . . 25.0 110.781 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HB2' HD11 ' A' ' 65' ' ' LEU . 29.2 ttmt -133.31 135.59 44.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.951 -1.022 . . . . 25.0 110.737 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.477 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -73.38 131.99 42.5 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.703 0.627 . . . . 25.0 110.583 173.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.22 -21.96 15.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.983 0.421 . . . . 25.0 110.898 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -143.47 168.38 19.98 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.344 -1.725 . . . . 25.0 106.344 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -75.69 160.44 30.06 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 123.459 0.474 . . . . 25.0 111.027 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -146.81 147.81 31.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.215 -0.291 . . . . 25.0 110.215 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.6 t -120.76 132.11 71.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 104.519 -2.4 . . . . 25.0 104.519 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.58 122.06 21.64 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.336 -0.987 . . . . 25.0 108.336 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -108.86 4.94 24.04 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.324 -0.991 . . . . 25.0 108.324 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.6 m -145.05 152.4 51.22 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 106.771 -1.566 . . . . 25.0 106.771 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.9 -21.58 32.64 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 N-CA-C 115.936 1.475 . . . . 25.0 115.936 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.28 -12.7 54.23 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.95 0.881 . . . . 25.0 110.238 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -82.98 139.34 33.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.943 0.878 . . . . 25.0 111.406 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.415 ' HB2' HG13 ' A' ' 57' ' ' VAL . 67.1 mt -90.98 127.68 36.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.185 0.993 . . . . 25.0 109.672 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -88.88 139.54 30.35 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 106.225 -1.769 . . . . 25.0 106.225 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -156.66 165.18 36.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.963 0.411 . . . . 25.0 110.605 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -110.83 162.79 14.44 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.566 -0.531 . . . . 25.0 109.566 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -58.5 131.25 50.19 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.545 -0.752 . . . . 25.0 109.386 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.09 -11.17 72.81 Favored Glycine 0 CA--C 1.517 0.205 0 CA-C-O 119.039 -0.867 . . . . 25.0 114.48 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -62.49 150.57 39.79 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 118.193 0.996 . . . . 25.0 109.636 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.6 mm -116.28 134.31 60.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.9 -1.045 . . . . 25.0 109.289 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -139.89 160.27 40.29 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.167 -0.679 . . . . 25.0 109.167 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.7 m -97.22 127.25 43.01 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.043 -1.095 . . . . 25.0 108.043 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.9 t -90.5 126.48 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 107.343 -1.354 . . . . 25.0 107.343 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.636 HD12 HD22 ' A' ' 47' ' ' LEU . 82.1 mt -94.96 -43.1 8.32 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.889 -0.782 . . . . 25.0 108.889 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -150.23 155.08 39.07 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.679 -0.86 . . . . 25.0 108.679 -177.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -111.65 149.67 31.21 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.105 -0.702 . . . . 25.0 109.105 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 56.38 39.9 29.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 123.61 1.672 . . . . 25.0 108.654 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -64.31 153.56 37.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 112.591 -2.095 . . . . 25.0 110.777 -176.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 60.76 8.95 1.98 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.683 0.793 . . . . 25.0 111.976 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.39 13.62 81.46 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.114 -0.794 . . . . 25.0 111.114 -176.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.5 mt -88.05 126.75 35.26 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.066 0.46 . . . . 25.0 109.8 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -67.64 125.03 24.92 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.352 -0.385 . . . . 25.0 110.665 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.0 1.46 85.26 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 117.038 1.575 . . . . 25.0 117.038 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -100.94 134.23 44.23 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 119.176 1.488 . . . . 25.0 109.849 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -113.79 140.68 48.1 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.909 -0.775 . . . . 25.0 108.909 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.636 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -79.81 123.62 27.89 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 104.821 -2.288 . . . . 25.0 104.821 176.633 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 98.0 m -134.98 163.07 30.69 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.668 -0.413 . . . . 25.0 111.562 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.0 t -117.21 126.5 52.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.908 -1.886 . . . . 25.0 105.908 170.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.0 tp -138.7 126.82 22.65 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.072 -1.455 . . . . 25.0 107.072 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.0 m170 55.54 30.38 15.13 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.273 0.559 . . . . 25.0 111.6 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.42 -4.87 80.11 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 116.115 1.206 . . . . 25.0 116.115 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -110.01 152.58 25.74 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.865 -1.161 . . . . 25.0 107.865 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -106.75 160.43 15.48 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.57 -0.53 . . . . 25.0 109.57 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.11 -160.11 31.52 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 105.398 -3.081 . . . . 25.0 105.398 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.1 pt -120.48 152.84 23.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.794 0.807 . . . . 25.0 111.485 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.415 HG13 ' HB2' ' A' ' 24' ' ' LEU . 2.9 m -139.0 145.56 45.88 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 114.714 -1.13 . . . . 25.0 109.111 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.73 124.54 7.59 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 117.045 -1.504 . . . . 25.0 112.19 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.84 -10.27 72.01 Favored Glycine 0 C--O 1.223 -0.537 0 CA-C-N 116.032 -0.531 . . . . 25.0 112.774 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.76 -19.32 62.34 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.39 -0.476 . . . . 25.0 112.083 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -130.7 27.34 4.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.117 -0.492 . . . . 25.0 110.47 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 12' ' ' ALA . 0.9 OUTLIER -129.26 156.2 44.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.303 0.573 . . . . 25.0 111.329 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -129.64 127.74 41.22 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.811 -0.631 . . . . 25.0 110.59 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.8 mm -72.09 135.26 28.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.131 -1.063 . . . . 25.0 108.131 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 11' ' ' LYS . 83.4 mt -119.35 104.6 10.52 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.161 -0.681 . . . . 25.0 109.161 176.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.9 m -83.58 61.87 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 122.044 0.926 . . . . 25.0 109.208 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.29 174.07 30.71 Favored Glycine 0 C--O 1.221 -0.714 0 CA-C-N 115.297 -0.865 . . . . 25.0 113.035 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -76.04 7.59 3.95 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.368 0.877 . . . . 25.0 113.368 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -87.66 60.23 5.85 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.439 0.637 . . . . 25.0 112.069 -175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -66.91 -28.91 68.69 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 114.761 -1.109 . . . . 25.0 108.843 173.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -66.8 149.63 50.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.117 -0.947 . . . . 25.0 109.436 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -55.12 146.06 41.78 Favored Pre-proline 0 C--O 1.24 0.601 0 CA-C-N 115.747 -0.66 . . . . 25.0 111.44 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.82 175.33 10.48 Favored 'Trans proline' 0 C--N 1.348 0.532 0 O-C-N 122.177 0.567 . . . . 25.0 112.944 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.14 170.63 14.71 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.961 -1.126 . . . . 25.0 107.961 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.21 -154.61 30.1 Favored Glycine 0 C--O 1.223 -0.545 0 O-C-N 123.476 0.485 . . . . 25.0 112.235 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 m 56.61 48.32 16.75 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.719 1.007 . . . . 25.0 113.719 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.53 163.86 51.82 Favored Glycine 0 CA--C 1.516 0.142 0 N-CA-C 111.252 -0.739 . . . . 25.0 111.252 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.98 62.26 4.56 Favored Glycine 0 C--O 1.222 -0.639 0 O-C-N 122.386 -0.479 . . . . 25.0 113.478 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.4 m -67.28 -19.81 65.55 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 114.057 1.132 . . . . 25.0 114.057 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.65 -170.7 46.43 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.053 -0.594 . . . . 25.0 112.634 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.9 t -157.08 163.64 38.77 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.669 -1.604 . . . . 25.0 106.669 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.1 -173.85 34.96 Favored Glycine 0 C--O 1.235 0.164 0 N-CA-C 110.687 -0.965 . . . . 25.0 110.687 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.8 t -156.03 144.82 20.33 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.836 -0.801 . . . . 25.0 108.836 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -150.34 148.96 29.45 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.044 -1.835 . . . . 25.0 106.044 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -79.96 114.85 19.18 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.157 -0.682 . . . . 25.0 109.157 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -127.19 168.39 14.76 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.405 -0.591 . . . . 25.0 109.405 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -64.58 154.27 36.73 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.255 0.835 . . . . 25.0 113.255 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.3 m -78.98 149.74 73.99 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.365 -0.834 . . . . 25.0 111.008 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.14 161.41 35.42 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 N-CA-C 114.227 0.818 . . . . 25.0 114.227 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.01 152.6 80.21 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 118.254 -0.697 . . . . 25.0 112.088 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.44 150.67 70.44 Favored 'Trans proline' 0 C--N 1.352 0.714 0 N-CA-C 116.006 1.502 . . . . 25.0 116.006 -173.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -85.35 152.56 58.13 Favored Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 115.522 -0.763 . . . . 25.0 110.162 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.09 161.84 42.29 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 O-C-N 122.201 0.579 . . . . 25.0 112.988 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.63 156.8 55.03 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 120.348 0.699 . . . . 25.0 113.853 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 65.2 mtt85 -101.95 -10.8 19.47 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.271 0.471 . . . . 25.0 112.271 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.6 p -141.27 149.3 41.12 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 106.594 -1.632 . . . . 25.0 106.594 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -148.76 29.24 0.83 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.538 0.685 . . . . 25.0 110.045 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.2 m -118.87 164.02 16.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.419 -0.809 . . . . 25.0 109.734 -176.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.6 t 55.39 55.9 6.91 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.77 1.272 . . . . 25.0 112.334 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.5 mp . . . . . 0 C--O 1.216 -0.702 0 CA-C-O 124.349 2.023 . . . . 25.0 110.059 178.62 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.711 0 CA-C-O 123.891 1.828 . . . . 25.0 113.121 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m 56.63 23.78 8.11 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 112.292 -1.954 . . . . 25.0 113.117 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.9 ttt -99.81 -27.84 13.43 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.517 1.673 . . . . 25.0 115.517 -171.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.18 13.27 2.61 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 112.564 0.579 . . . . 25.0 112.564 -176.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -71.06 162.01 30.16 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.327 1.232 . . . . 25.0 114.327 -174.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.8 mt -65.59 -39.22 91.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.512 -1.222 . . . . 25.0 110.687 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 57.27 28.72 15.62 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.173 0.989 . . . . 25.0 112.444 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 m -90.35 152.11 3.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.143 -1.058 . . . . 25.0 108.143 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.98 167.38 12.84 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.187 -0.671 . . . . 25.0 109.187 -176.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.35 161.17 43.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.732 0.301 . . . . 25.0 111.27 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -126.9 129.58 48.48 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.688 0.795 . . . . 25.0 110.157 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.46 131.28 43.81 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.746 -0.464 . . . . 25.0 109.746 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.0 mt -95.83 -21.16 18.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.074 0.464 . . . . 25.0 111.034 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -144.48 175.95 9.75 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 103.814 -2.661 . . . . 25.0 103.814 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -92.05 179.17 5.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.301 0.5 . . . . 25.0 111.53 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -159.04 154.77 26.26 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.075 0.55 . . . . 25.0 110.135 173.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.4 t -124.6 127.4 72.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 105.986 -1.857 . . . . 25.0 105.986 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.74 129.6 38.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.961 -0.563 . . . . 25.0 110.783 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -105.33 1.11 27.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.536 0.684 . . . . 25.0 109.838 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.9 p -151.83 158.86 33.83 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.016 -1.105 . . . . 25.0 108.016 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.75 -16.85 33.39 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 118.321 -0.652 . . . . 25.0 112.873 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.75 -21.68 54.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.419 0.628 . . . . 25.0 110.044 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -95.46 146.21 24.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.522 0.677 . . . . 25.0 111.411 -176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' HB2' HG13 ' A' ' 57' ' ' VAL . 55.1 mt -100.14 132.61 45.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.55 0.691 . . . . 25.0 110.166 177.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.6 m -82.64 146.44 29.1 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 105.527 -2.027 . . . . 25.0 105.527 172.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -157.73 164.87 36.67 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.358 -0.608 . . . . 25.0 109.358 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.86 158.59 23.73 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.526 -0.916 . . . . 25.0 108.526 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -56.24 128.13 34.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.571 -0.741 . . . . 25.0 109.891 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.72 -10.85 64.63 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-O 118.985 -0.897 . . . . 25.0 114.061 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -61.52 148.7 41.22 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.033 0.916 . . . . 25.0 110.775 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.4 mm -112.02 134.02 55.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.457 -1.247 . . . . 25.0 108.481 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.4 ptp -143.19 162.23 36.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.057 -0.72 . . . . 25.0 109.057 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.9 m -98.81 125.87 44.29 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.042 -1.096 . . . . 25.0 108.042 177.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.8 t -89.6 125.61 42.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.786 -1.19 . . . . 25.0 107.786 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.714 HD12 HD22 ' A' ' 47' ' ' LEU . 73.1 mt -94.54 -49.48 5.64 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.455 -1.248 . . . . 25.0 109.644 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -143.34 160.39 40.61 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.545 -1.279 . . . . 25.0 107.545 -174.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -125.68 150.71 47.41 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 106.899 -1.519 . . . . 25.0 106.899 175.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 56.27 39.15 30.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.398 1.571 . . . . 25.0 108.274 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -66.08 148.61 51.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.443 -1.708 . . . . 25.0 109.813 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 60.18 11.81 2.96 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.72 0.808 . . . . 25.0 113.013 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.61 13.62 81.25 Favored Glycine 0 C--O 1.229 -0.177 0 N-CA-C 111.296 -0.721 . . . . 25.0 111.296 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.9 mt -91.19 112.19 23.99 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.709 -0.478 . . . . 25.0 109.709 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -58.52 124.92 21.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.497 -0.774 . . . . 25.0 110.858 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.0 -0.19 83.79 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 116.02 1.168 . . . . 25.0 116.02 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -98.03 132.26 43.73 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 119.303 1.552 . . . . 25.0 110.76 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -111.15 138.58 47.42 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.206 -1.035 . . . . 25.0 108.206 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.714 HD22 HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -82.21 125.82 31.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 104.681 -2.34 . . . . 25.0 104.681 178.727 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.9 m -134.65 164.29 27.84 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 111.951 0.352 . . . . 25.0 111.951 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.0 t -117.27 123.84 47.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.828 -1.545 . . . . 25.0 106.828 171.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.8 tp -151.73 142.63 22.99 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 106.875 -1.528 . . . . 25.0 106.875 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 42.5 m80 56.4 28.25 13.29 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.319 0.647 . . . . 25.0 112.073 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.75 1.15 76.95 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 115.006 0.762 . . . . 25.0 115.006 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -123.62 161.05 25.79 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.026 -0.731 . . . . 25.0 109.026 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -108.53 156.63 19.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.174 -0.676 . . . . 25.0 109.174 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.58 -161.22 28.37 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 105.383 -3.087 . . . . 25.0 105.383 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.9 pt -120.73 153.18 23.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-O 121.728 0.775 . . . . 25.0 111.034 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 24' ' ' LEU . 3.2 m -141.74 147.38 45.16 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 114.473 -1.239 . . . . 25.0 107.674 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.82 126.48 8.83 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 117.086 -1.476 . . . . 25.0 111.713 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.17 -12.0 75.63 Favored Glycine 0 C--O 1.222 -0.621 0 CA-C-N 116.293 -0.412 . . . . 25.0 113.131 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -66.67 -13.54 61.37 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.781 0.66 . . . . 25.0 112.781 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -131.97 27.13 4.58 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.215 -0.661 . . . . 25.0 109.215 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.8 tp -131.96 147.44 52.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.737 -0.665 . . . . 25.0 109.709 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -125.55 120.09 29.92 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.408 -0.36 . . . . 25.0 111.743 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.98 136.1 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.037 -0.727 . . . . 25.0 109.037 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.1 mt -116.78 81.66 1.67 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.945 -1.502 . . . . 25.0 106.945 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.18 -26.04 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.158 0.504 . . . . 25.0 111.704 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.45 162.15 27.61 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 106.272 -2.731 . . . . 25.0 106.272 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 66.2 mmm -157.01 -40.11 0.07 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 117.679 0.739 . . . . 25.0 110.666 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -139.93 148.83 42.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.883 -0.784 . . . . 25.0 108.883 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -95.68 8.67 42.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.729 0.776 . . . . 25.0 111.047 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -117.96 162.64 17.81 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.8 -0.636 . . . . 25.0 110.453 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -59.04 144.57 82.3 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.312 -0.625 . . . . 25.0 109.312 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.36 148.68 68.2 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 117.837 -0.975 . . . . 25.0 113.477 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.93 29.92 0.65 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.647 -0.706 . . . . 25.0 110.052 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.93 118.54 5.88 Favored Glycine 0 C--O 1.22 -0.726 0 C-N-CA 120.954 -0.641 . . . . 25.0 112.174 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.3 t -71.64 -37.65 70.83 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.873 0.694 . . . . 25.0 112.873 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.5 -132.28 10.97 Favored Glycine 0 C--O 1.225 -0.441 0 C-N-CA 120.5 -0.857 . . . . 25.0 111.905 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.85 -14.33 62.07 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 115.071 0.788 . . . . 25.0 115.071 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 65.3 p -87.32 64.84 8.46 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.013 -0.698 . . . . 25.0 112.863 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.75 50.23 0.36 Allowed Glycine 0 C--O 1.219 -0.843 0 N-CA-C 115.717 1.047 . . . . 25.0 115.717 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.8 p -65.58 -32.66 74.37 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.749 1.389 . . . . 25.0 114.749 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.82 33.15 86.13 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 120.827 -0.701 . . . . 25.0 113.924 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.1 t -75.05 145.28 42.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.802 0.301 . . . . 25.0 111.602 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.35 166.0 0.13 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.952 1.301 . . . . 25.0 113.939 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -65.13 -41.15 95.1 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.849 0.685 . . . . 25.0 112.849 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 55.56 -165.36 0.12 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.282 0.845 . . . . 25.0 113.282 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -71.39 148.37 47.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.581 -0.736 . . . . 25.0 110.654 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.7 p -75.29 137.56 71.75 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.429 -0.351 . . . . 25.0 111.008 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.57 158.76 43.56 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 118.263 -0.691 . . . . 25.0 112.772 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.8 148.56 86.65 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 117.705 -1.064 . . . . 25.0 111.75 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.55 151.17 58.49 Favored 'Trans proline' 0 C--N 1.348 0.548 0 N-CA-C 116.481 1.685 . . . . 25.0 116.481 -170.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -73.13 145.11 85.6 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 109.132 -0.692 . . . . 25.0 109.132 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.39 166.47 29.4 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 O-C-N 121.963 0.454 . . . . 25.0 112.704 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -60.37 158.94 29.04 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 120.751 0.968 . . . . 25.0 114.523 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -121.45 24.73 9.76 Favored 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 113.953 1.094 . . . . 25.0 113.953 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.3 p 51.32 -0.57 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 118.828 2.899 . . . . 25.0 118.828 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.8 mtp85 -70.52 -6.99 40.3 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.347 -0.846 . . . . 25.0 111.115 177.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.1 t -150.03 90.88 1.72 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.71 -1.219 . . . . 25.0 107.71 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 30.9 p -154.7 172.55 17.74 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.044 -1.095 . . . . 25.0 108.044 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.214 -0.809 0 CA-C-O 124.671 2.177 . . . . 25.0 110.939 175.235 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 CA-C-O 123.046 1.359 . . . . 25.0 115.215 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.0 m -66.87 140.0 57.77 Favored 'General case' 0 C--N 1.338 0.093 0 O-C-N 121.344 -1.091 . . . . 25.0 110.04 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.1 mtt -129.15 123.55 32.42 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.76 -0.459 . . . . 25.0 109.76 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -150.34 114.61 5.14 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 108.198 -1.038 . . . . 25.0 108.198 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -135.7 168.33 19.48 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 123.233 0.333 . . . . 25.0 110.354 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.2 mt -67.73 -39.86 84.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.652 -0.704 . . . . 25.0 109.228 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 56.45 32.38 20.57 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.947 0.899 . . . . 25.0 111.795 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.4 m -94.6 153.91 3.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 107.032 -1.47 . . . . 25.0 107.032 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.7 167.08 11.68 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.042 -1.095 . . . . 25.0 108.042 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.96 154.46 37.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.674 0.273 . . . . 25.0 110.489 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -118.69 132.13 56.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.835 -0.62 . . . . 25.0 110.838 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.63 125.64 27.38 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.184 -0.673 . . . . 25.0 109.184 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.9 mt -91.7 -21.23 20.86 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.257 0.551 . . . . 25.0 110.397 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -141.97 176.05 9.25 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 104.565 -2.383 . . . . 25.0 104.565 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -91.48 177.78 6.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.715 0.293 . . . . 25.0 110.906 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -155.64 155.1 32.66 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.355 0.262 . . . . 25.0 111.647 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.8 t -124.85 132.28 71.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 103.736 -2.69 . . . . 25.0 103.736 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.73 127.64 33.15 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.857 -0.423 . . . . 25.0 109.857 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -101.83 2.72 38.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.727 0.775 . . . . 25.0 110.535 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.2 p -149.88 157.73 37.74 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 108.014 -1.106 . . . . 25.0 108.014 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.8 -15.21 33.19 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 118.177 -0.749 . . . . 25.0 113.007 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -76.55 -21.43 55.69 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.407 0.622 . . . . 25.0 109.475 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -93.75 139.45 30.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.987 0.898 . . . . 25.0 111.829 -172.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.467 ' HB2' HG13 ' A' ' 57' ' ' VAL . 55.4 mt -90.16 129.32 36.45 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.21 -0.905 . . . . 25.0 109.546 177.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -88.21 143.05 27.27 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 105.411 -2.07 . . . . 25.0 105.411 175.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -157.25 167.97 28.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.732 0.301 . . . . 25.0 110.297 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.69 165.4 12.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.737 0.78 . . . . 25.0 110.327 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.1 128.41 36.28 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.218 -0.901 . . . . 25.0 110.069 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.83 -12.49 64.23 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-O 118.922 -0.932 . . . . 25.0 114.933 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -59.65 152.98 21.11 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.977 0.894 . . . . 25.0 112.001 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.0 mm -114.77 130.65 68.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.428 -1.26 . . . . 25.0 109.14 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.8 ptp -137.84 151.57 48.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.469 -0.567 . . . . 25.0 109.469 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.0 m -90.78 124.75 35.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.291 -1.003 . . . . 25.0 108.291 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t -87.34 123.14 39.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 107.893 -1.151 . . . . 25.0 107.893 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.7 mt -89.74 -46.23 8.75 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.051 -0.722 . . . . 25.0 109.051 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -149.56 165.15 33.11 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.771 -0.826 . . . . 25.0 108.771 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HE ' ' HB3' ' A' ' 37' ' ' ARG . 38.2 mtp180 -115.77 154.61 29.31 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.19 -0.67 . . . . 25.0 109.19 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 57.67 40.76 26.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 124.12 1.914 . . . . 25.0 107.463 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.6 t -65.74 151.65 46.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 111.808 -2.451 . . . . 25.0 111.699 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 58.03 18.13 4.92 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.373 0.879 . . . . 25.0 113.373 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.52 16.6 80.53 Favored Glycine 0 C--O 1.227 -0.285 0 N-CA-C 111.699 -0.56 . . . . 25.0 111.699 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.7 mt -98.45 113.93 26.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.088 0.471 . . . . 25.0 110.759 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -59.34 127.7 33.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.682 -0.69 . . . . 25.0 110.755 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.09 -2.03 67.07 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 115.85 1.1 . . . . 25.0 115.85 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -95.83 132.8 40.71 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 119.028 1.414 . . . . 25.0 109.023 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -113.52 138.23 50.43 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.793 -1.188 . . . . 25.0 107.793 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.5 tp -81.41 125.43 30.41 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 105.922 -1.881 . . . . 25.0 105.922 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 91.4 m -134.0 161.99 33.3 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.201 0.524 . . . . 25.0 111.784 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.6 t -113.64 122.5 47.35 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.123 -1.436 . . . . 25.0 107.123 170.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.1 tp -144.62 133.03 21.91 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.919 -0.771 . . . . 25.0 108.919 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 42.8 m80 54.09 31.98 14.82 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.427 0.691 . . . . 25.0 112.275 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.16 0.15 88.44 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.087 -0.578 . . . . 25.0 114.507 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -109.11 141.63 41.02 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 117.77 0.785 . . . . 25.0 109.346 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -96.89 143.19 28.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 106.553 -1.647 . . . . 25.0 106.553 169.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.69 -163.72 29.45 Favored Glycine 0 CA--C 1.496 -1.117 0 N-CA-C 103.647 -3.781 . . . . 25.0 103.647 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.7 pt -121.82 158.54 25.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-O 121.3 0.571 . . . . 25.0 110.56 -174.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.467 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.2 m -142.53 148.68 47.92 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 115.297 -0.865 . . . . 25.0 109.214 -177.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.54 120.43 6.71 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 118.359 -0.627 . . . . 25.0 110.967 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.74 -10.42 80.08 Favored Glycine 0 C--O 1.226 -0.371 0 O-C-N 121.878 -0.514 . . . . 25.0 114.049 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -72.8 -5.88 41.02 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.788 0.662 . . . . 25.0 112.788 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -130.01 26.49 5.21 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.6 mt -124.03 155.38 38.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.807 0.813 . . . . 25.0 111.435 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -126.73 120.04 28.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.843 -1.072 . . . . 25.0 109.428 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.1 mm -71.33 136.15 26.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.882 -0.785 . . . . 25.0 108.882 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.4 mt -115.42 94.73 4.84 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.546 -1.279 . . . . 25.0 107.546 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.65 108.97 20.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.299 0.571 . . . . 25.0 111.562 -177.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.85 44.91 3.27 Favored Glycine 0 C--O 1.218 -0.86 0 CA-C-N 116.07 -0.514 . . . . 25.0 112.93 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 99.5 mmm -69.84 -26.21 64.11 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.272 0.471 . . . . 25.0 112.272 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -144.56 129.44 18.37 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.927 -1.509 . . . . 25.0 106.927 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -75.44 120.39 20.82 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.93 0.872 . . . . 25.0 110.011 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -127.92 -0.1 5.96 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.151 -0.931 . . . . 25.0 109.107 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -159.92 93.46 1.68 Allowed Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 124.549 1.139 . . . . 25.0 108.061 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.74 2.34 6.0 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 121.336 1.357 . . . . 25.0 114.011 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.27 -2.07 17.64 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.555 1.317 . . . . 25.0 114.555 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.12 -25.7 2.62 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 115.804 1.082 . . . . 25.0 115.804 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.1 m 57.26 37.42 28.22 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.738 1.014 . . . . 25.0 113.738 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -138.43 -171.28 12.12 Favored Glycine 0 C--O 1.223 -0.56 0 N-CA-C 109.741 -1.344 . . . . 25.0 109.741 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.55 -6.45 74.45 Favored Glycine 0 C--O 1.225 -0.459 0 CA-C-N 117.375 0.588 . . . . 25.0 114.486 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.7 m -71.6 147.07 47.95 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.273 -0.545 . . . . 25.0 109.794 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.16 174.09 54.99 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 111.415 -0.674 . . . . 25.0 111.415 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.8 p -68.73 151.83 46.14 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.891 -0.411 . . . . 25.0 109.891 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.29 166.18 31.04 Favored Glycine 0 N--CA 1.453 -0.21 0 N-CA-C 110.204 -1.158 . . . . 25.0 110.204 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.9 p -136.44 166.29 23.83 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.1 -1.444 . . . . 25.0 107.1 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -149.99 152.15 34.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.433 -1.321 . . . . 25.0 107.433 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -92.31 71.58 5.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.795 0.331 . . . . 25.0 110.399 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -135.05 164.77 26.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.471 -0.937 . . . . 25.0 108.471 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -61.76 159.01 14.43 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.872 1.064 . . . . 25.0 113.872 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.0 m -60.72 154.28 58.24 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 114.719 -1.128 . . . . 25.0 112.637 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.14 157.78 55.6 Favored 'Trans proline' 0 C--N 1.348 0.536 0 N-CA-C 114.528 0.934 . . . . 25.0 114.528 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -63.35 154.05 70.58 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 N-CA-C 113.282 0.454 . . . . 25.0 113.282 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -56.97 152.19 45.13 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.41 1.407 . . . . 25.0 115.603 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -65.62 147.34 98.74 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.362 -0.836 . . . . 25.0 110.184 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.65 160.66 48.91 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 117.881 -0.946 . . . . 25.0 111.57 176.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -60.83 153.48 62.59 Favored 'Trans proline' 0 C--N 1.349 0.561 0 N-CA-C 114.087 0.764 . . . . 25.0 114.087 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -104.81 26.92 8.57 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.575 -0.284 . . . . 25.0 110.448 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.4 p 45.35 -136.11 0.64 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.908 0.883 . . . . 25.0 110.553 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 53.9 32.66 15.62 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.053 1.501 . . . . 25.0 115.053 172.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.6 t -143.98 132.22 21.91 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.692 -0.855 . . . . 25.0 108.692 176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 10.9 p -149.08 27.94 0.84 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.871 0.843 . . . . 25.0 109.525 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 C--O 1.211 -0.941 0 CA-C-O 124.879 2.276 . . . . 25.0 111.563 -176.935 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 CA-C-O 122.397 0.998 . . . . 25.0 115.186 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t -80.86 105.09 11.82 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.222 -1.163 . . . . 25.0 109.528 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -142.84 20.38 1.98 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.315 0.579 . . . . 25.0 111.257 -176.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -117.62 87.23 2.67 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.469 -0.332 . . . . 25.0 110.426 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -136.28 164.54 27.85 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.204 0.446 . . . . 25.0 112.204 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.2 mt -64.73 -41.63 95.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.248 -0.887 . . . . 25.0 111.161 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 54.91 34.82 23.06 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.919 0.887 . . . . 25.0 112.249 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 m -95.48 158.47 3.0 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 104.485 -2.413 . . . . 25.0 104.485 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.13 174.03 7.11 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.776 -0.824 . . . . 25.0 108.776 -175.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.19 161.54 41.79 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.176 -0.305 . . . . 25.0 110.176 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -128.23 130.52 48.07 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.513 0.725 . . . . 25.0 110.031 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.59 133.66 47.87 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.438 0.461 . . . . 25.0 110.141 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.78 -19.68 16.6 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.351 0.596 . . . . 25.0 110.579 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -143.22 171.73 13.69 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.681 -1.6 . . . . 25.0 106.681 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -77.86 167.46 21.49 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.324 0.39 . . . . 25.0 110.868 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -151.75 150.15 29.86 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-O 120.749 0.309 . . . . 25.0 111.07 170.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.6 t -124.93 136.28 61.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 104.528 -2.397 . . . . 25.0 104.528 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.07 136.96 48.5 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 124.27 0.982 . . . . 25.0 108.548 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -117.9 1.09 12.05 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.864 0.84 . . . . 25.0 109.653 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -128.02 146.29 58.64 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 105.799 -1.926 . . . . 25.0 105.799 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -69.89 -18.34 36.46 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 117.386 -1.276 . . . . 25.0 112.638 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -77.53 -15.64 59.14 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.18 -0.464 . . . . 25.0 110.624 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -101.47 140.58 35.57 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.421 -0.955 . . . . 25.0 108.421 -176.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.8 mt -101.37 126.16 48.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.992 0.901 . . . . 25.0 111.688 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.18 145.57 26.35 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.605 -1.257 . . . . 25.0 107.605 175.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -159.29 165.07 34.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.261 0.553 . . . . 25.0 110.856 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -107.34 153.09 23.27 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.509 -1.293 . . . . 25.0 107.509 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -54.65 129.84 38.1 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.996 -0.742 . . . . 25.0 108.996 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.14 -11.28 70.85 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-O 118.899 -0.945 . . . . 25.0 114.518 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -64.06 156.7 27.38 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.989 0.894 . . . . 25.0 110.077 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.6 mm -120.13 135.36 60.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.68 -1.146 . . . . 25.0 109.322 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -141.81 158.2 44.09 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.5 -0.556 . . . . 25.0 109.5 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 m -92.09 128.93 38.12 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 108.287 -1.005 . . . . 25.0 108.287 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.2 t -92.08 123.82 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 N-CA-C 108.279 -1.008 . . . . 25.0 108.279 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.59 HD12 HD22 ' A' ' 47' ' ' LEU . 77.9 mt -88.96 -45.81 9.38 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.414 -0.812 . . . . 25.0 109.284 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -155.31 168.78 25.96 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.512 -0.921 . . . . 25.0 108.512 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -120.39 152.63 37.64 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 106.621 -1.622 . . . . 25.0 106.621 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 58.03 43.93 20.26 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 125.731 1.894 . . . . 25.0 109.119 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 t -69.41 155.79 39.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 112.65 -2.068 . . . . 25.0 111.112 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 58.72 14.75 3.33 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.801 1.037 . . . . 25.0 113.801 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.88 13.86 81.64 Favored Glycine 0 C--O 1.23 -0.148 0 N-CA-C 111.59 -0.604 . . . . 25.0 111.59 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.8 mt -94.33 132.61 38.76 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 110.107 -0.331 . . . . 25.0 110.107 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -78.41 128.64 33.92 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.855 -0.795 . . . . 25.0 108.855 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.96 -2.55 83.41 Favored Glycine 0 C--O 1.239 0.423 0 N-CA-C 116.319 1.288 . . . . 25.0 116.319 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -101.87 133.94 45.85 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 118.428 1.114 . . . . 25.0 108.307 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.3 m0 -115.62 143.23 45.64 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.59 HD22 HD12 ' A' ' 35' ' ' LEU . 0.7 OUTLIER -85.08 123.76 30.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.916 -1.883 . . . . 25.0 105.916 179.032 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.1 m -130.71 162.1 30.2 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.022 0.379 . . . . 25.0 112.022 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.0 t -114.34 119.79 38.15 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.038 -1.838 . . . . 25.0 106.038 171.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.8 tp -141.0 126.87 19.21 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.294 -1.002 . . . . 25.0 108.294 -175.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.0 m170 55.64 31.85 18.13 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.262 0.625 . . . . 25.0 111.279 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.63 0.95 88.65 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 114.676 0.63 . . . . 25.0 114.676 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -107.97 155.2 20.59 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 106.691 -1.596 . . . . 25.0 106.691 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -121.89 144.44 48.85 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.043 -1.466 . . . . 25.0 107.043 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.65 -161.6 27.25 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 107.1 -2.4 . . . . 25.0 107.1 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.7 pt -115.77 150.15 17.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.707 0.765 . . . . 25.0 111.053 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -138.28 145.41 47.09 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 114.639 -1.164 . . . . 25.0 108.565 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.62 120.95 6.72 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 CA-C-O 121.606 0.586 . . . . 25.0 110.821 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.65 -17.04 77.84 Favored Glycine 0 C--O 1.216 -1.007 0 N-CA-C 115.038 0.775 . . . . 25.0 115.038 -174.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -77.93 -1.56 32.49 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.151 0.797 . . . . 25.0 113.151 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -127.74 25.57 5.98 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.682 -1.229 . . . . 25.0 107.682 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.8 tp -135.46 150.34 49.79 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.193 -0.912 . . . . 25.0 109.368 -173.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -126.28 120.75 30.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.568 -0.287 . . . . 25.0 111.556 -177.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.5 mm -67.76 135.45 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.795 -0.446 . . . . 25.0 109.795 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.2 mt -117.1 92.52 3.88 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.457 -1.312 . . . . 25.0 107.457 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.5 p -94.41 140.0 17.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.427 -0.953 . . . . 25.0 108.427 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -152.9 155.3 26.05 Favored Glycine 0 C--O 1.222 -0.631 0 N-CA-C 107.427 -2.269 . . . . 25.0 107.427 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -142.24 11.75 1.96 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.484 0.55 . . . . 25.0 112.484 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.71 19.31 5.13 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.715 1.005 . . . . 25.0 113.715 -172.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -122.79 144.09 49.41 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.161 -2.162 . . . . 25.0 105.161 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -81.04 -39.98 24.94 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.781 0.66 . . . . 25.0 112.781 -172.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -148.89 145.87 20.55 Favored Pre-proline 0 N--CA 1.477 0.89 0 N-CA-C 106.007 -1.849 . . . . 25.0 106.007 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -71.57 145.88 48.13 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 117.396 -1.269 . . . . 25.0 114.064 -177.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.26 145.88 24.14 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.522 -1.288 . . . . 25.0 107.522 174.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -131.9 47.14 1.03 Allowed Glycine 0 C--O 1.219 -0.811 0 N-CA-C 114.93 0.732 . . . . 25.0 114.93 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.1 t -122.91 120.48 33.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.323 0.561 . . . . 25.0 110.026 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 139.5 -165.31 25.82 Favored Glycine 0 C--O 1.224 -0.527 0 N-CA-C 109.953 -1.259 . . . . 25.0 109.953 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.93 177.42 43.94 Favored Glycine 0 C--N 1.321 -0.27 0 N-CA-C 108.854 -1.698 . . . . 25.0 108.854 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.9 p -70.05 -33.29 71.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.893 0.846 . . . . 25.0 112.419 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.06 177.87 49.96 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 121.363 -0.446 . . . . 25.0 112.493 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.1 p -90.94 136.94 32.74 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.528 -0.916 . . . . 25.0 108.528 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.68 37.55 0.16 Allowed Glycine 0 C--O 1.225 -0.431 0 C-N-CA 120.514 -0.85 . . . . 25.0 114.915 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.2 t -150.72 118.26 6.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.404 0.602 . . . . 25.0 109.444 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -129.84 1.07 4.85 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 107.341 -1.355 . . . . 25.0 107.341 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -143.49 160.95 39.66 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 105.11 -2.182 . . . . 25.0 105.11 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -69.96 146.08 51.39 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 123.517 0.511 . . . . 25.0 109.983 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.31 161.12 14.22 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.242 -1.392 . . . . 25.0 107.242 175.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.2 t -123.61 95.61 44.63 Favored Pre-proline 0 N--CA 1.47 0.552 0 N-CA-C 108.314 -0.995 . . . . 25.0 108.314 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -79.19 158.35 26.53 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 N-CA-C 114.215 0.814 . . . . 25.0 114.215 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.45 156.36 65.89 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 117.943 -0.905 . . . . 25.0 111.584 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.28 153.62 76.57 Favored 'Trans proline' 0 C--N 1.347 0.451 0 N-CA-C 114.561 0.946 . . . . 25.0 114.561 -174.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -74.33 140.35 76.02 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 109.395 -0.594 . . . . 25.0 109.395 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.67 160.2 46.95 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 116.908 -1.595 . . . . 25.0 110.944 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -62.51 151.16 84.71 Favored 'Trans proline' 0 C--N 1.351 0.691 0 N-CA-C 114.804 1.04 . . . . 25.0 114.804 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -102.71 -1.92 29.16 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 111.855 0.317 . . . . 25.0 111.855 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 34.2 p -140.78 145.53 36.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.511 -0.551 . . . . 25.0 109.511 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -118.29 19.38 13.48 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 116.609 -0.269 . . . . 25.0 111.275 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.0 t 50.5 50.59 18.52 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 123.62 0.575 . . . . 25.0 110.552 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.5 m 57.14 68.74 0.82 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.918 1.342 . . . . 25.0 111.205 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.5 mt . . . . . 0 N--CA 1.479 1.004 0 C-N-CA 126.486 1.914 . . . . 25.0 115.118 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 CA-C-O 124.642 2.245 . . . . 25.0 113.646 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.2 t -146.78 147.66 31.14 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 113.257 -1.471 . . . . 25.0 108.497 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.2 tpt -138.07 40.41 2.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.704 -1.591 . . . . 25.0 106.704 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.66 144.97 26.19 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.036 -1.468 . . . . 25.0 107.036 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 63.66 164.16 0.12 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 115.1 1.519 . . . . 25.0 115.1 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.4 mt -75.56 -36.51 60.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.459 -1.246 . . . . 25.0 110.74 -177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.5 m120 55.88 25.08 8.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.632 1.173 . . . . 25.0 112.768 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.2 m -88.88 177.13 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 105.731 -1.952 . . . . 25.0 105.731 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.22 174.07 6.56 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.083 -0.71 . . . . 25.0 109.083 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.9 161.19 42.36 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.551 -0.537 . . . . 25.0 109.551 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -123.6 135.43 53.95 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.393 -0.822 . . . . 25.0 110.1 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.528 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -72.29 126.74 30.56 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 123.869 0.73 . . . . 25.0 110.276 174.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.5 mt -93.09 -23.51 18.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.236 0.541 . . . . 25.0 110.697 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -142.43 168.1 20.52 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.737 -1.579 . . . . 25.0 106.737 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -76.73 162.99 27.25 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.307 0.379 . . . . 25.0 110.865 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -150.35 133.09 15.89 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 114.041 1.126 . . . . 25.0 114.041 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.8 t -109.55 124.68 66.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 105.473 -2.047 . . . . 25.0 105.473 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.06 139.69 50.48 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.475 -0.784 . . . . 25.0 110.373 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -112.6 -28.84 7.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.296 0.569 . . . . 25.0 109.589 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -102.15 152.35 38.23 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 107.481 -1.303 . . . . 25.0 107.481 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.4 -22.54 33.58 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 117.688 -1.074 . . . . 25.0 113.105 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -83.97 -10.72 57.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.849 -0.614 . . . . 25.0 110.898 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -85.86 135.64 33.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.747 0.785 . . . . 25.0 109.747 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.9 mt -87.89 128.93 35.36 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.731 0.777 . . . . 25.0 109.576 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.1 t -88.31 140.33 29.59 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 105.461 -2.051 . . . . 25.0 105.461 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -156.87 168.95 25.93 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.785 -0.82 . . . . 25.0 108.785 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.5 mtt-85 -122.91 166.98 14.15 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.179 0.514 . . . . 25.0 111.442 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.22 129.32 41.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.893 -0.594 . . . . 25.0 110.631 -176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.04 -13.02 65.36 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-O 119.491 -0.616 . . . . 25.0 113.508 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -62.32 150.11 40.31 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 117.659 0.73 . . . . 25.0 109.751 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.7 mm -116.41 133.25 63.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 107.922 -1.14 . . . . 25.0 107.922 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -136.25 148.86 48.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.143 -0.688 . . . . 25.0 109.143 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 51.8 m -85.14 129.68 34.76 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.967 -1.494 . . . . 25.0 106.967 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.1 t -94.01 126.17 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.805 -0.813 . . . . 25.0 108.805 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.1 mt -95.95 -45.05 7.09 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.368 -0.604 . . . . 25.0 109.368 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -147.48 159.07 44.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.271 -0.172 . . . . 25.0 110.785 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -117.08 153.95 31.84 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.537 -0.912 . . . . 25.0 108.537 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 53.76 39.8 30.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 123.482 1.611 . . . . 25.0 109.685 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.9 t -69.85 157.17 37.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.153 -1.839 . . . . 25.0 111.625 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 59.92 10.51 2.18 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.22 1.008 . . . . 25.0 112.678 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.74 13.66 81.06 Favored Glycine 0 C--O 1.239 0.41 0 N-CA-C 111.184 -0.766 . . . . 25.0 111.184 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.43 125.26 39.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.947 0.403 . . . . 25.0 110.069 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -67.45 126.84 30.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.958 -0.564 . . . . 25.0 110.349 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.74 -0.6 85.89 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 116.466 1.346 . . . . 25.0 116.466 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -99.05 132.95 43.99 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 119.146 1.473 . . . . 25.0 110.066 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -113.45 137.69 51.17 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.483 -0.562 . . . . 25.0 109.483 -177.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.9 tp -80.77 121.09 25.48 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 106.376 -1.712 . . . . 25.0 106.376 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 98.8 m -133.75 167.7 20.05 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.768 0.318 . . . . 25.0 111.151 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.7 t -118.8 126.16 51.22 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.0 -0.741 . . . . 25.0 109.0 172.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.3 tp -147.4 139.59 24.44 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.115 -1.068 . . . . 25.0 108.115 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 27.3 m170 55.99 29.82 15.02 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.364 0.665 . . . . 25.0 112.022 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.26 1.81 86.42 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 120.994 -0.622 . . . . 25.0 114.094 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -109.91 145.97 35.94 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.45 -0.945 . . . . 25.0 108.45 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -99.99 144.91 28.48 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 105.306 -2.109 . . . . 25.0 105.306 170.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.21 -163.58 29.49 Favored Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 105.525 -3.03 . . . . 25.0 105.525 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.9 pt -120.86 154.25 24.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.467 0.651 . . . . 25.0 111.097 -173.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.6 146.03 46.08 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 114.993 -1.003 . . . . 25.0 108.758 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.64 122.15 7.18 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 117.979 -0.881 . . . . 25.0 111.684 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.96 -13.95 72.89 Favored Glycine 0 C--O 1.223 -0.532 0 CA-C-N 116.277 -0.419 . . . . 25.0 114.032 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -68.94 -8.54 45.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.085 0.772 . . . . 25.0 113.085 -178.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -132.63 26.01 4.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.619 -0.882 . . . . 25.0 108.619 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 12' ' ' ALA . 1.4 tp -129.88 157.19 42.95 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.445 -0.798 . . . . 25.0 110.67 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -131.58 120.35 22.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.807 -0.633 . . . . 25.0 110.773 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.9 mm -65.81 136.59 26.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 123.662 0.601 . . . . 25.0 109.511 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.3 mt -117.64 111.56 19.33 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.28 -2.118 . . . . 25.0 105.28 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.66 157.52 3.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.272 -1.011 . . . . 25.0 108.272 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.99 177.82 29.2 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 110.123 -1.191 . . . . 25.0 110.123 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 7.6 tpt -76.58 -41.19 47.19 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.48 0.548 . . . . 25.0 112.48 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -169.23 155.09 6.23 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.457 -0.942 . . . . 25.0 108.457 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -78.13 -41.21 35.7 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.239 0.542 . . . . 25.0 110.546 175.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -169.77 174.92 5.48 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.198 -0.668 . . . . 25.0 109.198 -173.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.88 147.25 98.53 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 107.409 -1.33 . . . . 25.0 107.409 172.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.74 159.9 47.48 Favored 'Trans proline' 0 C--N 1.348 0.508 0 O-C-N 122.039 0.494 . . . . 25.0 112.59 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -117.97 -22.01 8.07 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.989 0.737 . . . . 25.0 112.989 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.73 -145.87 39.23 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 109.759 -1.337 . . . . 25.0 109.759 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 t 58.96 -157.31 0.32 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.32 0.648 . . . . 25.0 111.247 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.25 -145.73 18.65 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 110.011 -1.236 . . . . 25.0 110.011 -176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.4 28.3 69.97 Favored Glycine 0 C--O 1.225 -0.458 0 C-N-CA 120.534 -0.841 . . . . 25.0 114.852 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.5 t -137.28 146.35 44.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.248 0.524 . . . . 25.0 109.645 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 163.12 174.56 33.16 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 107.798 -2.121 . . . . 25.0 107.798 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.0 p -151.98 152.73 32.84 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.05 -1.093 . . . . 25.0 108.05 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.99 10.82 58.72 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 121.653 -0.308 . . . . 25.0 113.858 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -44.63 78.95 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.641 -0.329 . . . . 25.0 111.409 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -83.29 82.48 8.25 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.123 -1.065 . . . . 25.0 108.123 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -78.79 87.31 4.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.694 -0.685 . . . . 25.0 112.007 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -80.89 78.53 7.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.8 0.81 . . . . 25.0 109.536 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.428 ' HB3' ' H ' ' A' ' 88' ' ' SER . 65.6 m-20 53.18 -145.43 0.59 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.715 1.206 . . . . 25.0 114.21 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.428 ' H ' ' HB3' ' A' ' 87' ' ' ASP . 65.1 p -143.56 157.46 58.95 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 122.966 0.506 . . . . 25.0 110.272 -174.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.36 158.85 44.24 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 N-CA-C 113.835 0.667 . . . . 25.0 113.835 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -67.94 154.06 73.76 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 N-CA-C 113.435 0.513 . . . . 25.0 113.435 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.59 152.59 74.61 Favored 'Trans proline' 0 C--N 1.353 0.773 0 N-CA-C 116.715 1.775 . . . . 25.0 116.715 -173.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -67.49 147.25 98.81 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 115.575 -0.739 . . . . 25.0 111.538 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.34 162.14 43.45 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 O-C-N 121.849 0.394 . . . . 25.0 112.015 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -61.27 153.18 67.15 Favored 'Trans proline' 0 C--N 1.351 0.671 0 N-CA-C 115.668 1.372 . . . . 25.0 115.668 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -116.64 1.06 12.8 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.736 -0.666 . . . . 25.0 111.771 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.4 p -139.84 166.49 24.5 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.309 -2.108 . . . . 25.0 105.309 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -123.24 20.95 9.71 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.183 0.438 . . . . 25.0 112.183 -176.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.7 m -65.13 -30.31 71.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.279 0.844 . . . . 25.0 113.279 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 67.6 m -131.84 142.81 49.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.87 0.367 . . . . 25.0 111.222 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 N--CA 1.484 1.233 0 C-N-CA 125.801 1.64 . . . . 25.0 114.353 175.333 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.983 0 CA-C-O 123.988 1.882 . . . . 25.0 115.637 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.4 m -152.51 158.87 43.17 Favored 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 121.209 -1.171 . . . . 25.0 107.977 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.1 tpt -142.03 137.87 31.41 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.516 -1.661 . . . . 25.0 106.516 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -146.23 139.51 25.88 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.226 -1.398 . . . . 25.0 107.226 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -95.68 167.86 11.02 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.651 -0.5 . . . . 25.0 109.651 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.2 mt -61.74 -41.48 97.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.842 -0.617 . . . . 25.0 109.346 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.76 28.16 11.84 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.07 0.948 . . . . 25.0 111.976 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.2 m -87.48 176.24 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 104.72 -2.326 . . . . 25.0 104.72 173.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mp -118.74 173.99 6.54 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 121.732 -0.605 . . . . 25.0 109.58 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.37 160.18 42.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.818 0.342 . . . . 25.0 110.712 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -122.19 129.89 52.69 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.444 -0.798 . . . . 25.0 109.794 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.93 130.64 43.35 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.781 -0.452 . . . . 25.0 109.781 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.6 mt -93.67 -23.78 18.11 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 111.877 0.325 . . . . 25.0 111.877 -177.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -143.88 168.25 20.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.279 -1.378 . . . . 25.0 107.279 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -73.82 165.35 25.28 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.559 0.537 . . . . 25.0 110.178 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.74 163.31 35.34 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.324 -0.991 . . . . 25.0 108.324 177.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.8 t -130.45 129.49 64.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 102.026 -3.324 . . . . 25.0 102.026 169.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.15 122.69 27.13 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.293 -1.373 . . . . 25.0 107.293 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -113.03 12.32 19.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.318 1.056 . . . . 25.0 110.306 -175.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.7 m -148.31 152.83 39.89 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 106.202 -1.777 . . . . 25.0 106.202 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.43 -23.22 32.54 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 118.176 -0.749 . . . . 25.0 113.677 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.8 -17.0 52.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.417 0.627 . . . . 25.0 110.86 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -84.24 131.53 34.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.636 0.731 . . . . 25.0 109.343 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.477 ' HB2' HG13 ' A' ' 57' ' ' VAL . 45.9 mt -81.69 135.06 35.52 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.315 -0.624 . . . . 25.0 109.315 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -87.35 135.81 33.18 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.253 -1.017 . . . . 25.0 108.253 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -156.09 163.06 40.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.348 0.594 . . . . 25.0 111.948 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -119.63 169.02 10.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.408 0.623 . . . . 25.0 109.832 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -61.29 129.46 41.35 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.668 -0.696 . . . . 25.0 111.297 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.61 -12.41 67.62 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-O 119.012 -0.882 . . . . 25.0 113.836 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -60.08 148.5 35.54 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.595 0.712 . . . . 25.0 110.48 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.1 mm -114.22 132.32 63.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.54 -1.209 . . . . 25.0 108.852 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.0 ptp -137.07 156.55 48.26 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.553 -0.906 . . . . 25.0 108.553 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.7 m -89.53 129.59 35.98 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.377 -1.342 . . . . 25.0 107.377 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.24 126.59 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 107.76 -1.2 . . . . 25.0 107.76 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.61 HD12 HD22 ' A' ' 47' ' ' LEU . 69.8 mt -95.83 -44.7 7.29 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.487 -0.779 . . . . 25.0 109.418 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -153.32 164.02 38.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.353 -0.61 . . . . 25.0 109.353 -175.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -120.35 153.83 35.92 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.234 -1.024 . . . . 25.0 108.234 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 54.98 38.28 30.26 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 123.405 1.574 . . . . 25.0 109.943 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -65.05 151.29 46.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.359 -1.746 . . . . 25.0 110.812 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 61.05 10.72 3.0 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.803 0.841 . . . . 25.0 113.003 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.73 17.46 77.34 Favored Glycine 0 C--O 1.228 -0.234 0 N-CA-C 110.77 -0.932 . . . . 25.0 110.77 -178.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.9 mt -94.37 119.18 32.73 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.741 -0.837 . . . . 25.0 108.741 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.53 129.26 39.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.13 0.491 . . . . 25.0 110.568 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.27 -0.72 67.25 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 116.075 1.19 . . . . 25.0 116.075 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -98.75 129.98 45.2 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 119.349 1.575 . . . . 25.0 109.736 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -110.3 140.1 44.81 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.082 -0.71 . . . . 25.0 109.082 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.61 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -80.79 120.93 25.29 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.785 -1.931 . . . . 25.0 105.785 177.693 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.2 m -132.5 166.23 22.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.961 0.41 . . . . 25.0 111.686 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -120.64 122.77 41.22 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.799 -1.186 . . . . 25.0 107.799 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.5 tp -155.0 145.92 22.57 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 107.024 -1.473 . . . . 25.0 107.024 -175.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 56.36 31.97 19.67 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.091 0.556 . . . . 25.0 112.368 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.05 6.11 72.82 Favored Glycine 0 C--O 1.225 -0.41 0 N-CA-C 114.926 0.73 . . . . 25.0 114.926 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -129.95 165.96 21.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.696 -0.853 . . . . 25.0 108.696 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -112.59 152.1 29.29 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.774 -1.195 . . . . 25.0 107.774 176.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.74 -159.5 22.26 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 106.444 -2.662 . . . . 25.0 106.444 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.5 pt -120.05 153.56 22.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.465 0.65 . . . . 25.0 111.845 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.477 HG13 ' HB2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -141.63 147.39 45.6 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 114.996 -1.002 . . . . 25.0 109.607 -179.547 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.96 120.06 5.62 Favored 'Trans proline' 0 C--O 1.239 0.558 0 CA-C-O 121.398 0.499 . . . . 25.0 112.532 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.04 -18.76 67.18 Favored Glycine 0 C--O 1.222 -0.638 0 CA-C-O 121.45 0.472 . . . . 25.0 112.663 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.17 -20.69 59.69 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.307 0.854 . . . . 25.0 113.307 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -130.79 29.41 4.76 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.151 0.5 . . . . 25.0 110.021 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.0 tp -132.65 150.41 52.16 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.05 -0.523 . . . . 25.0 110.346 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -127.71 120.55 28.23 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.726 0.639 . . . . 25.0 112.726 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.4 mm -65.32 136.94 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.138 0.494 . . . . 25.0 110.256 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.4 mt -121.71 106.42 11.3 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.068 0.947 . . . . 25.0 108.527 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.4 m -95.1 -5.82 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.912 0.387 . . . . 25.0 110.933 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.94 143.96 13.83 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 109.486 -1.446 . . . . 25.0 109.486 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -167.38 -60.58 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 117.519 0.66 . . . . 25.0 111.063 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -88.38 137.03 32.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.296 -0.411 . . . . 25.0 111.048 -175.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -38.21 90.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.467 0.651 . . . . 25.0 111.145 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -124.98 158.82 32.7 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.406 0.622 . . . . 25.0 109.901 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -123.3 152.27 63.9 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.197 -1.038 . . . . 25.0 108.197 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.12 163.04 39.98 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 116.536 -1.843 . . . . 25.0 111.237 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.6 148.82 43.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.9 -1.889 . . . . 25.0 105.9 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.62 178.43 39.19 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 108.901 -1.679 . . . . 25.0 108.901 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.4 m -78.83 164.6 24.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.957 0.408 . . . . 25.0 110.607 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.04 -176.79 37.65 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 109.064 -1.614 . . . . 25.0 109.064 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.39 -6.77 57.88 Favored Glycine 0 C--O 1.221 -0.666 0 CA-C-N 117.179 0.489 . . . . 25.0 114.3 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 43.4 t -68.63 128.08 35.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.392 0.596 . . . . 25.0 109.747 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.87 -24.25 77.22 Favored Glycine 0 C--O 1.222 -0.643 0 N-CA-C 111.275 -0.73 . . . . 25.0 111.275 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.9 m 55.34 26.31 8.53 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.622 1.712 . . . . 25.0 115.622 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.6 89.13 0.13 Allowed Glycine 0 C--O 1.227 -0.323 0 C-N-CA 121.226 -0.511 . . . . 25.0 112.565 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.9 p -71.19 146.17 49.25 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.266 -1.013 . . . . 25.0 108.266 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 56.39 23.62 7.55 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.65 0.982 . . . . 25.0 113.65 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -135.88 149.28 48.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.906 -0.405 . . . . 25.0 109.906 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 67.9 mm-40 -122.16 158.45 29.33 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.469 -1.678 . . . . 25.0 106.469 172.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -152.91 166.04 33.61 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.309 -1.737 . . . . 25.0 106.309 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 95.7 p -140.01 150.8 63.41 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 113.288 0.847 . . . . 25.0 113.288 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -76.32 162.0 34.22 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 O-C-N 121.63 0.279 . . . . 25.0 112.624 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.06 151.42 85.8 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 118.456 -0.563 . . . . 25.0 112.674 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.06 172.53 12.75 Favored 'Trans proline' 0 C--N 1.349 0.571 0 N-CA-C 116.255 1.598 . . . . 25.0 116.255 -172.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -86.15 138.68 34.51 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 107.452 -1.314 . . . . 25.0 107.452 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -72.57 162.04 42.42 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 116.938 -1.575 . . . . 25.0 110.749 174.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -63.09 152.88 77.26 Favored 'Trans proline' 0 C--N 1.346 0.417 0 N-CA-C 113.89 0.689 . . . . 25.0 113.89 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -99.73 42.84 1.08 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.17 0.509 . . . . 25.0 109.86 176.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.4 p -138.4 127.36 23.95 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.517 -0.549 . . . . 25.0 109.517 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.7 ptt85 -77.02 -16.05 59.42 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.653 0.612 . . . . 25.0 112.653 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.2 t 46.27 39.37 6.14 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.206 1.558 . . . . 25.0 115.206 175.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 46.6 t -147.57 152.28 37.68 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.525 -0.546 . . . . 25.0 109.525 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--O 1.213 -0.86 0 CA-C-O 124.291 1.996 . . . . 25.0 110.673 176.521 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.59 0 CA-C-O 124.07 1.928 . . . . 25.0 114.111 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 m -66.65 -32.85 74.43 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 113.983 -1.108 . . . . 25.0 111.854 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.1 ttm -157.85 -95.81 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.252 -0.431 . . . . 25.0 110.728 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -126.57 87.15 2.62 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 121.34 0.59 . . . . 25.0 110.077 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -110.73 165.68 11.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.423 -0.808 . . . . 25.0 110.382 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.2 mt -67.52 -38.07 83.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.391 -0.822 . . . . 25.0 110.484 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 57.27 31.51 20.22 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.864 0.866 . . . . 25.0 111.64 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.5 m -97.79 176.96 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 105.585 -2.005 . . . . 25.0 105.585 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -120.18 174.02 6.75 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.348 -0.612 . . . . 25.0 109.348 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.69 162.95 34.13 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.899 -0.408 . . . . 25.0 109.899 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -125.68 130.47 51.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.416 -0.811 . . . . 25.0 110.755 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.461 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -71.49 124.53 24.85 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 123.655 0.597 . . . . 25.0 109.516 176.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.3 mt -94.53 -20.3 19.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.326 0.584 . . . . 25.0 109.83 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -142.71 169.64 17.19 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.559 -1.645 . . . . 25.0 106.559 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -78.07 165.45 23.99 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.901 -0.407 . . . . 25.0 109.901 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -146.1 156.24 43.31 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.96 -0.385 . . . . 25.0 109.96 173.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.4 t -127.73 127.59 68.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 105.724 -1.954 . . . . 25.0 105.724 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.46 135.83 36.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.155 -0.683 . . . . 25.0 109.155 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -120.49 10.19 11.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.304 1.05 . . . . 25.0 109.302 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 t -150.82 150.15 27.26 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 107.103 -1.443 . . . . 25.0 107.103 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.63 -17.59 42.9 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 117.715 -1.057 . . . . 25.0 113.43 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -77.86 -19.98 53.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.188 0.518 . . . . 25.0 110.373 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -93.1 138.4 31.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.721 0.772 . . . . 25.0 111.407 -173.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.465 ' HB2' HG13 ' A' ' 57' ' ' VAL . 58.3 mt -91.86 128.01 37.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.809 0.814 . . . . 25.0 110.502 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.8 t -88.66 142.56 27.58 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.939 -1.874 . . . . 25.0 105.939 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -158.11 164.37 36.71 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.677 -0.49 . . . . 25.0 109.677 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -110.46 164.94 12.2 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.705 0.764 . . . . 25.0 109.055 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.15 131.81 51.98 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.747 -0.835 . . . . 25.0 108.747 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.15 -12.15 68.53 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-O 118.849 -0.973 . . . . 25.0 114.152 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.65 148.65 33.03 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 118.176 0.988 . . . . 25.0 110.51 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.5 mm -117.99 126.43 74.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.272 -1.331 . . . . 25.0 108.241 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -128.95 152.52 48.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.365 -0.379 . . . . 25.0 110.004 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -84.7 130.97 34.63 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.117 -1.438 . . . . 25.0 107.117 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.88 123.41 51.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.142 -1.058 . . . . 25.0 108.142 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.626 HD12 HD22 ' A' ' 47' ' ' LEU . 80.8 mt -89.38 -49.35 6.75 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.744 -0.836 . . . . 25.0 108.744 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -151.94 169.25 22.78 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.097 -1.075 . . . . 25.0 108.097 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.9 mtm105 -118.65 157.94 26.45 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 107.053 -1.462 . . . . 25.0 107.053 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 58.21 39.41 25.85 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 125.108 1.505 . . . . 25.0 109.153 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.1 t -67.74 155.81 38.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.19 -1.823 . . . . 25.0 110.162 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 59.96 10.82 2.33 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.084 0.954 . . . . 25.0 113.527 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.19 14.86 81.23 Favored Glycine 0 C--O 1.242 0.61 0 N-CA-C 110.94 -0.864 . . . . 25.0 110.94 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.2 mt -93.51 127.76 39.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.361 0.6 . . . . 25.0 109.495 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -69.95 124.05 23.06 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.498 -0.773 . . . . 25.0 109.545 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.01 2.3 86.72 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 117.03 1.572 . . . . 25.0 117.03 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -100.3 132.31 45.75 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 118.799 1.299 . . . . 25.0 109.224 176.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -114.28 141.59 47.39 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.512 -0.551 . . . . 25.0 109.512 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.626 HD22 HD12 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -83.6 120.01 25.44 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.2 -1.778 . . . . 25.0 106.2 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.5 m -133.07 165.65 24.25 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.016 0.436 . . . . 25.0 112.029 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.0 t -118.65 118.06 30.62 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.459 -1.311 . . . . 25.0 107.459 172.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -147.71 145.68 28.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.511 -1.662 . . . . 25.0 106.511 -174.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 57.23 27.22 13.28 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.412 0.625 . . . . 25.0 111.497 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.45 6.91 86.97 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 114.948 0.739 . . . . 25.0 114.948 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -132.09 160.86 34.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.108 0.954 . . . . 25.0 109.303 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -100.27 152.69 20.01 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.781 -0.822 . . . . 25.0 108.781 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.62 -162.1 28.49 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 105.632 -2.987 . . . . 25.0 105.632 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.9 pt -118.45 154.71 20.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.542 0.687 . . . . 25.0 110.97 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.465 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -140.78 146.75 45.59 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.129 -0.941 . . . . 25.0 109.743 -178.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -73.95 115.56 4.36 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 CA-C-O 121.544 0.56 . . . . 25.0 111.937 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.2 -17.64 68.34 Favored Glycine 0 C--O 1.224 -0.495 0 CA-C-O 121.463 0.48 . . . . 25.0 113.586 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -62.28 -19.0 62.8 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.959 0.725 . . . . 25.0 112.959 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -122.84 27.37 7.75 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.143 0.497 . . . . 25.0 110.686 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 12' ' ' ALA . 20.2 mt -123.81 160.64 26.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.054 0.931 . . . . 25.0 112.613 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -125.59 124.17 40.66 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 114.338 -1.301 . . . . 25.0 109.862 174.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.7 mm -73.64 134.25 30.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.413 -0.958 . . . . 25.0 108.413 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.0 mt -116.33 97.91 6.3 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.938 -1.134 . . . . 25.0 107.938 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.3 m -82.96 164.15 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.416 -0.957 . . . . 25.0 108.416 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -115.19 140.66 16.47 Favored Glycine 0 C--O 1.221 -0.711 0 N-CA-C 110.484 -1.046 . . . . 25.0 110.484 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.3 ttp -79.82 -33.6 40.23 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.695 0.759 . . . . 25.0 109.172 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -147.0 -116.04 0.07 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 104.13 -2.545 . . . . 25.0 104.13 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -123.93 -50.07 1.83 Allowed 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 114.804 1.409 . . . . 25.0 114.804 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -72.33 129.0 37.38 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.648 -0.658 . . . . 25.0 109.997 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -82.37 151.96 66.63 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 109.444 -0.576 . . . . 25.0 109.444 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -73.04 168.74 23.95 Favored 'Trans proline' 0 C--N 1.352 0.758 0 O-C-N 122.046 0.498 . . . . 25.0 112.285 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.64 -32.55 73.61 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.506 0.928 . . . . 25.0 113.506 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.58 -44.43 3.09 Favored Glycine 0 C--O 1.225 -0.417 0 CA-C-O 119.597 -0.557 . . . . 25.0 113.794 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.3 m 51.63 44.72 28.98 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.728 1.01 . . . . 25.0 113.728 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -135.46 147.53 19.22 Favored Glycine 0 C--O 1.226 -0.399 0 C-N-CA 120.876 -0.678 . . . . 25.0 111.928 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.27 172.55 20.25 Favored Glycine 0 CA--C 1.51 -0.265 0 N-CA-C 106.807 -2.517 . . . . 25.0 106.807 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 61.9 p -142.58 147.67 36.26 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.623 -0.88 . . . . 25.0 108.623 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -141.84 -173.69 14.15 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 111.292 -0.723 . . . . 25.0 111.292 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.9 p -80.15 177.58 8.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.351 -0.981 . . . . 25.0 108.351 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.32 38.89 10.38 Favored Glycine 0 C--O 1.218 -0.859 0 C-N-CA 120.25 -0.976 . . . . 25.0 112.007 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.2 p -72.96 89.16 1.4 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.238 -0.566 . . . . 25.0 111.762 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -53.85 -37.65 63.86 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 115.94 1.83 . . . . 25.0 115.94 -175.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -57.1 -34.16 68.05 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.227 1.195 . . . . 25.0 114.227 -172.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 35.26 61.59 0.63 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 115.336 1.606 . . . . 25.0 115.336 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -129.42 159.15 37.14 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.428 0.899 . . . . 25.0 113.428 -174.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 95.9 p -81.33 159.46 67.41 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 114.92 1.452 . . . . 25.0 114.92 -174.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -81.19 155.85 19.55 Favored 'Trans proline' 0 C--N 1.352 0.761 0 N-CA-C 114.278 0.838 . . . . 25.0 114.278 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.12 154.3 52.14 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 117.747 -1.036 . . . . 25.0 111.448 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -61.56 160.0 29.83 Favored 'Trans proline' 0 C--N 1.35 0.616 0 N-CA-C 116.781 1.8 . . . . 25.0 116.781 -175.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -76.79 138.26 66.18 Favored Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 108.098 -1.075 . . . . 25.0 108.098 173.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.06 161.4 43.47 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 116.539 -1.841 . . . . 25.0 110.589 172.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -63.72 152.37 80.8 Favored 'Trans proline' 0 C--N 1.348 0.522 0 N-CA-C 115.325 1.24 . . . . 25.0 115.325 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -105.7 -1.94 23.89 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.209 0.818 . . . . 25.0 113.209 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 79.5 p -140.06 169.17 18.19 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.013 -1.106 . . . . 25.0 108.013 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -119.18 23.2 11.46 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 107.695 -1.224 . . . . 25.0 107.695 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.3 m -66.62 -23.8 66.22 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.862 1.06 . . . . 25.0 113.862 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 24.6 p -155.31 159.5 40.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.16 -1.422 . . . . 25.0 107.16 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.484 1.247 0 C-N-CA 124.659 1.184 . . . . 25.0 113.887 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.681 0 CA-C-O 124.789 2.327 . . . . 25.0 113.666 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.3 m -148.25 144.66 27.8 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 113.493 -1.353 . . . . 25.0 109.693 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.6 ptm -139.49 75.02 1.49 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.636 0.731 . . . . 25.0 109.559 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.77 30.49 7.31 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.658 -0.701 . . . . 25.0 111.163 -177.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -62.28 162.43 9.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.657 -0.701 . . . . 25.0 112.153 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.7 mt -64.29 -41.13 97.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.073 -0.967 . . . . 25.0 110.543 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 55.63 30.1 14.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.918 0.887 . . . . 25.0 111.648 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.1 m -90.0 153.33 3.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.083 -1.451 . . . . 25.0 107.083 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.41 167.98 11.88 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.761 -0.829 . . . . 25.0 108.761 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.36 161.32 41.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.752 0.311 . . . . 25.0 110.693 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -130.84 130.47 43.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.407 -0.815 . . . . 25.0 110.009 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.29 131.52 42.02 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.322 -0.621 . . . . 25.0 109.322 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 74.8 mt -99.99 -18.84 16.85 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.981 0.419 . . . . 25.0 110.897 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -143.38 169.11 18.29 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.269 -2.122 . . . . 25.0 105.269 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.28 165.85 21.05 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 122.873 0.469 . . . . 25.0 110.6 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -151.36 143.05 23.71 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.939 0.348 . . . . 25.0 111.939 174.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 83.9 t -116.71 125.71 73.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 105.154 -2.165 . . . . 25.0 105.154 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.24 137.91 43.31 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.426 -0.806 . . . . 25.0 109.519 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -113.25 4.81 16.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.654 0.74 . . . . 25.0 110.223 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.3 m -152.02 155.69 33.65 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 106.953 -1.499 . . . . 25.0 106.953 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.67 -21.03 39.68 Favored 'Trans proline' 0 C--N 1.346 0.398 0 N-CA-C 113.692 0.612 . . . . 25.0 113.692 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.02 -16.98 59.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.215 0.531 . . . . 25.0 110.629 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -93.78 141.76 28.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.38 0.609 . . . . 25.0 109.672 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.455 ' HB2' HG13 ' A' ' 57' ' ' VAL . 61.4 mt -95.62 131.26 42.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.735 0.779 . . . . 25.0 110.17 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.0 t -90.44 146.62 23.99 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 105.099 -2.186 . . . . 25.0 105.099 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -157.32 162.77 39.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.085 0.469 . . . . 25.0 110.492 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -103.88 155.88 18.28 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.421 -1.326 . . . . 25.0 107.421 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -60.73 129.31 40.89 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.632 -0.877 . . . . 25.0 108.632 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.07 -5.35 68.44 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-O 119.312 -0.715 . . . . 25.0 113.445 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -63.97 152.25 40.53 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.8 0.81 . . . . 25.0 110.156 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.2 mm -116.84 135.22 57.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.465 -1.243 . . . . 25.0 108.627 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.7 ptp -142.65 166.11 25.55 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.022 -0.732 . . . . 25.0 109.022 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 57.3 m -106.99 123.6 48.42 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.545 -0.909 . . . . 25.0 108.545 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.3 t -86.87 125.48 40.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.301 -1.0 . . . . 25.0 108.301 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -93.43 -44.52 8.22 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.023 -0.732 . . . . 25.0 109.023 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -146.96 159.1 43.96 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.887 -0.412 . . . . 25.0 109.887 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.1 mtm105 -118.75 154.54 32.63 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.579 -0.526 . . . . 25.0 109.579 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 55.08 38.02 29.84 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 123.628 1.68 . . . . 25.0 108.639 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.7 t -72.48 159.68 33.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 112.644 -2.071 . . . . 25.0 111.158 -173.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 58.87 11.52 1.92 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.906 1.076 . . . . 25.0 113.906 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.64 12.63 83.44 Favored Glycine 0 C--O 1.239 0.468 0 N-CA-C 110.847 -0.901 . . . . 25.0 110.847 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.7 mt -97.25 115.82 28.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.806 0.812 . . . . 25.0 109.289 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -65.34 129.11 38.54 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.883 -1.053 . . . . 25.0 109.664 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.57 -0.94 74.32 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 115.659 1.024 . . . . 25.0 115.659 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -98.73 130.88 45.22 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 118.853 1.326 . . . . 25.0 110.281 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -113.54 137.58 51.37 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.734 -0.839 . . . . 25.0 108.734 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.9 tp -80.63 124.71 29.22 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.047 -1.464 . . . . 25.0 107.047 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.9 m -133.6 162.76 31.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.286 0.565 . . . . 25.0 112.234 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.3 t -112.97 123.67 50.85 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.034 -1.839 . . . . 25.0 106.034 171.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 tp -151.58 140.85 21.38 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.653 -1.24 . . . . 25.0 107.653 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.97 27.2 12.82 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.991 0.737 . . . . 25.0 112.991 176.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.47 3.87 90.36 Favored Glycine 0 C--O 1.226 -0.378 0 N-CA-C 114.692 0.637 . . . . 25.0 114.692 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -129.47 161.01 31.38 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 117.951 0.876 . . . . 25.0 110.185 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -105.76 153.5 21.8 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.129 -1.063 . . . . 25.0 108.129 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.61 -163.74 31.8 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 104.03 -3.628 . . . . 25.0 104.03 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.5 pt -121.93 156.84 26.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.532 0.682 . . . . 25.0 110.855 -175.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.455 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.7 m -140.15 147.57 50.93 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.013 -0.994 . . . . 25.0 109.328 -177.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -75.74 119.97 5.65 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 CA-C-O 121.349 0.479 . . . . 25.0 111.947 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.28 -20.05 66.98 Favored Glycine 0 C--O 1.221 -0.665 0 C-N-CA 121.517 -0.373 . . . . 25.0 113.354 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -66.34 -9.2 30.92 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.699 1.0 . . . . 25.0 113.699 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -134.65 26.11 3.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.265 0.555 . . . . 25.0 109.792 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 24.3 tp -131.23 149.57 52.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.739 -0.664 . . . . 25.0 110.819 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -119.44 127.85 53.47 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 122.838 0.455 . . . . 25.0 110.963 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.2 mm -76.12 135.56 26.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.191 -1.04 . . . . 25.0 108.191 174.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.4 mt -114.66 80.58 1.43 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.192 -0.669 . . . . 25.0 109.192 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -76.38 126.96 37.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 107.707 -1.22 . . . . 25.0 107.707 175.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.79 87.98 1.05 Allowed Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.599 -0.81 . . . . 25.0 112.397 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.4 mtm -109.62 -50.54 2.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.273 0.472 . . . . 25.0 112.273 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -110.29 -51.92 2.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.034 0.445 . . . . 25.0 111.53 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -95.16 51.39 1.33 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 122.16 0.981 . . . . 25.0 110.354 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.34 105.2 0.32 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.88 -1.055 . . . . 25.0 111.599 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -125.86 103.55 27.43 Favored Pre-proline 0 N--CA 1.47 0.535 0 N-CA-C 108.802 -0.814 . . . . 25.0 108.802 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.57 1.75 8.94 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 N-CA-C 115.086 1.148 . . . . 25.0 115.086 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.52 -90.18 0.58 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.029 0.443 . . . . 25.0 111.282 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.61 -169.53 37.42 Favored Glycine 0 C--O 1.228 -0.229 0 N-CA-C 110.0 -1.24 . . . . 25.0 110.0 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.4 m -147.61 31.75 0.88 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.202 0.501 . . . . 25.0 111.779 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.74 -158.64 30.98 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.744 -0.741 . . . . 25.0 112.156 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -162.68 173.78 38.97 Favored Glycine 0 C--O 1.227 -0.297 0 N-CA-C 108.477 -1.849 . . . . 25.0 108.477 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.8 t -159.91 167.82 27.15 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.797 -1.186 . . . . 25.0 107.797 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.9 168.49 40.31 Favored Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.022 -1.231 . . . . 25.0 110.022 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.3 m -148.41 -67.29 0.23 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 117.273 0.536 . . . . 25.0 111.849 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.42 -156.95 23.62 Favored Glycine 0 N--CA 1.46 0.236 0 N-CA-C 110.586 -1.005 . . . . 25.0 110.586 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.6 m -141.93 149.98 40.85 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.817 -0.809 . . . . 25.0 108.817 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.22 148.46 47.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.823 0.344 . . . . 25.0 111.69 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt 57.59 17.98 4.34 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.127 1.158 . . . . 25.0 114.127 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -89.14 63.87 6.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.514 0.673 . . . . 25.0 109.693 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.51 -154.39 0.33 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.552 -1.204 . . . . 25.0 112.329 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.0 m -140.01 156.67 70.33 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 112.899 0.703 . . . . 25.0 112.899 -176.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -62.99 156.52 54.08 Favored 'Trans proline' 0 C--N 1.353 0.775 0 N-CA-C 114.696 0.999 . . . . 25.0 114.696 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.84 152.61 80.15 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 O-C-N 121.68 0.305 . . . . 25.0 112.438 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -70.71 163.74 37.97 Favored 'Trans proline' 0 C--N 1.348 0.512 0 N-CA-C 116.695 1.767 . . . . 25.0 116.695 -171.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -79.66 140.91 55.43 Favored Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 115.117 -0.947 . . . . 25.0 108.835 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.71 159.28 51.32 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 116.562 -1.826 . . . . 25.0 110.376 171.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -62.91 149.92 90.0 Favored 'Trans proline' 0 C--N 1.349 0.598 0 N-CA-C 115.283 1.224 . . . . 25.0 115.283 -176.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.3 mtm105 -105.43 15.9 26.42 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.26 -0.427 . . . . 25.0 111.526 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 40.7 p -134.9 139.55 45.07 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.073 0.768 . . . . 25.0 113.073 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.26 112.69 11.26 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 105.15 -2.167 . . . . 25.0 105.15 175.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 26.0 t -140.4 71.68 1.38 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.799 0.666 . . . . 25.0 112.799 -175.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 7.7 t 41.46 59.64 2.34 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.459 1.281 . . . . 25.0 114.459 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 C--O 1.214 -0.8 0 CA-C-O 124.582 2.135 . . . . 25.0 110.759 -179.756 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 CA-C-O 122.843 1.246 . . . . 25.0 115.292 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.5 m -64.69 -34.18 77.71 Favored 'General case' 0 C--O 1.22 -0.495 0 O-C-N 121.256 -1.143 . . . . 25.0 113.057 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 93.3 mtp 49.71 36.76 11.47 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.305 0.854 . . . . 25.0 113.305 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt 60.56 10.84 2.72 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.849 1.426 . . . . 25.0 114.849 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -75.79 168.87 19.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.565 0.697 . . . . 25.0 111.302 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt -65.48 -38.97 91.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.221 -0.899 . . . . 25.0 110.506 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.4 m120 57.0 25.63 10.91 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.306 1.042 . . . . 25.0 112.295 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -89.56 169.81 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.005 -1.85 . . . . 25.0 106.005 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -115.42 170.23 8.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.037 0.446 . . . . 25.0 110.06 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.83 160.64 41.49 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.689 -0.687 . . . . 25.0 111.017 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -123.87 131.81 53.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.072 -0.967 . . . . 25.0 110.749 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.99 126.2 30.51 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.053 -0.522 . . . . 25.0 109.871 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.7 mt -93.75 -22.07 18.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.198 0.523 . . . . 25.0 110.536 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -138.06 161.44 36.74 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.246 -1.39 . . . . 25.0 107.246 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.71 175.98 7.42 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.032 0.933 . . . . 25.0 110.959 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -156.85 160.01 38.75 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.499 0.555 . . . . 25.0 112.499 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.1 t -127.76 128.67 69.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 104.408 -2.442 . . . . 25.0 104.408 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.41 132.19 44.45 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.29 -0.633 . . . . 25.0 109.29 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -122.22 10.16 9.94 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.719 0.771 . . . . 25.0 109.714 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.2 m -143.93 153.14 56.87 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 105.378 -2.082 . . . . 25.0 105.378 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.03 -23.08 34.52 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 117.919 -0.921 . . . . 25.0 113.165 -177.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.83 -15.97 46.27 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.982 -0.554 . . . . 25.0 110.916 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -80.9 135.51 35.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.97 0.89 . . . . 25.0 111.515 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.8 mt -83.69 130.94 34.97 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.304 -0.862 . . . . 25.0 110.88 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 m -85.5 132.42 34.2 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.837 -1.542 . . . . 25.0 106.837 173.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.408 ' CE2' HG12 ' A' ' 57' ' ' VAL . 40.0 p90 -159.42 169.55 23.7 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.019 -1.104 . . . . 25.0 108.019 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 mtp85 -125.35 174.45 8.14 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.347 0.869 . . . . 25.0 113.347 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.12 131.85 48.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.191 -0.913 . . . . 25.0 110.878 -175.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.94 -13.97 66.16 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.44 -0.8 . . . . 25.0 113.343 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -60.06 147.7 38.37 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.868 0.842 . . . . 25.0 110.993 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.3 mm -111.07 134.29 53.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.286 -1.324 . . . . 25.0 107.958 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.4 ptp -138.98 150.67 46.13 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.337 -0.616 . . . . 25.0 109.337 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.6 m -85.98 130.98 34.38 Favored 'General case' 0 C--O 1.217 -0.607 0 N-CA-C 107.242 -1.392 . . . . 25.0 107.242 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.9 t -97.9 125.32 51.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.347 -0.983 . . . . 25.0 108.347 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.696 HD12 HD22 ' A' ' 47' ' ' LEU . 78.3 mt -90.94 -51.27 5.43 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.991 -0.744 . . . . 25.0 108.991 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -152.04 171.25 18.14 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.382 -0.97 . . . . 25.0 108.382 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -120.71 155.6 33.57 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 107.342 -1.355 . . . . 25.0 107.342 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 57.7 39.78 27.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 123.331 1.538 . . . . 25.0 108.592 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.9 t -64.85 147.62 52.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 113.235 -1.802 . . . . 25.0 110.547 -176.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 58.5 15.25 3.45 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.146 0.795 . . . . 25.0 113.146 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.62 12.39 84.28 Favored Glycine 0 C--O 1.225 -0.462 0 C-N-CA 121.161 -0.542 . . . . 25.0 111.833 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.6 mt -88.85 109.7 20.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.381 0.61 . . . . 25.0 110.048 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -53.73 118.43 3.93 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.979 -1.009 . . . . 25.0 112.08 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.69 0.37 89.21 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 115.914 1.126 . . . . 25.0 115.914 175.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -97.75 133.62 42.02 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 119.059 1.429 . . . . 25.0 109.234 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -113.36 140.69 47.83 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.883 -0.784 . . . . 25.0 108.883 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.696 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -82.34 121.47 26.73 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 105.973 -1.862 . . . . 25.0 105.973 179.36 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 84.4 m -131.3 163.55 27.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.124 0.488 . . . . 25.0 112.161 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.5 t -118.04 126.44 52.3 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.794 -1.188 . . . . 25.0 107.794 174.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 tp -154.4 142.67 20.45 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 107.326 -1.361 . . . . 25.0 107.326 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 55.46 32.03 18.14 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.317 0.579 . . . . 25.0 112.315 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.12 7.05 76.06 Favored Glycine 0 C--O 1.224 -0.472 0 N-CA-C 114.807 0.683 . . . . 25.0 114.807 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -128.2 165.64 20.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.082 -0.71 . . . . 25.0 109.082 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -117.21 155.08 30.03 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.002 -1.11 . . . . 25.0 108.002 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.0 -159.87 25.83 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 106.195 -2.762 . . . . 25.0 106.195 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.5 pt -117.68 153.47 19.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.684 0.754 . . . . 25.0 111.656 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.408 HG12 ' CE2' ' A' ' 26' ' ' PHE . 2.7 m -143.71 147.22 38.13 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 114.653 -1.158 . . . . 25.0 108.37 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.2 125.08 8.96 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 118.569 -0.488 . . . . 25.0 112.051 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.78 -19.46 79.9 Favored Glycine 0 C--O 1.222 -0.607 0 N-CA-C 116.035 1.174 . . . . 25.0 116.035 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -70.0 -7.26 39.43 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.189 1.552 . . . . 25.0 115.189 -175.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.17 21.64 5.28 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.264 -1.013 . . . . 25.0 108.264 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.0 tp -123.68 149.68 45.18 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.047 -1.094 . . . . 25.0 108.047 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -120.73 123.82 43.63 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 116.706 -0.224 . . . . 25.0 111.147 -178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.3 mm -74.99 133.52 31.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.223 -1.029 . . . . 25.0 108.223 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.3 mt -116.85 75.53 0.97 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.621 -1.622 . . . . 25.0 106.621 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -50.34 -42.78 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 115.748 1.759 . . . . 25.0 115.748 -168.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -111.77 7.82 27.77 Favored Glycine 0 C--O 1.228 -0.235 0 C-N-CA 121.072 -0.585 . . . . 25.0 114.479 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 7.2 tpt -94.41 82.79 4.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.782 0.791 . . . . 25.0 111.569 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -77.38 -8.99 58.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.19 -0.914 . . . . 25.0 109.482 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 t0 65.92 149.47 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.993 1.717 . . . . 25.0 113.569 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -114.11 5.21 15.9 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.999 -1.0 . . . . 25.0 110.414 -171.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -149.21 156.09 39.92 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 106.351 -1.722 . . . . 25.0 106.351 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.12 159.89 46.6 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 117.383 -1.278 . . . . 25.0 113.309 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -156.05 179.58 9.09 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.201 -2.148 . . . . 25.0 105.201 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.71 5.51 22.2 Favored Glycine 0 C--O 1.225 -0.416 0 N-CA-C 115.91 1.124 . . . . 25.0 115.91 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.9 m -146.33 154.37 41.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.774 0.787 . . . . 25.0 109.748 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.54 162.71 28.64 Favored Glycine 0 C--O 1.224 -0.511 0 N-CA-C 108.785 -1.726 . . . . 25.0 108.785 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.73 36.41 0.43 Allowed Glycine 0 C--O 1.218 -0.891 0 CA-C-N 117.702 0.751 . . . . 25.0 112.851 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.6 t -76.38 -4.47 42.47 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.819 1.044 . . . . 25.0 113.819 -175.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.63 -170.27 20.55 Favored Glycine 0 C--O 1.236 0.258 0 N-CA-C 111.941 -0.464 . . . . 25.0 111.941 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 84.7 p -155.59 178.16 10.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.22 -92.28 1.76 Allowed Glycine 0 C--O 1.228 -0.248 0 CA-C-O 119.35 -0.694 . . . . 25.0 112.103 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 95.5 p 55.44 -174.6 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.624 1.17 . . . . 25.0 112.734 -177.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.55 149.72 40.06 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.533 -0.543 . . . . 25.0 109.533 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -163.2 158.66 21.94 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.858 -0.793 . . . . 25.0 108.858 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -152.7 -60.17 0.15 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.76 -1.2 . . . . 25.0 107.76 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -70.27 157.86 36.94 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.417 0.627 . . . . 25.0 111.307 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.3 p -104.92 153.07 39.64 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 108.772 -0.825 . . . . 25.0 108.772 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -61.31 159.62 30.34 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 117.83 -0.98 . . . . 25.0 111.682 173.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -66.37 155.75 68.5 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 117.33 -1.313 . . . . 25.0 111.919 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.14 157.58 59.2 Favored 'Trans proline' 0 C--N 1.345 0.356 0 N-CA-C 113.692 0.612 . . . . 25.0 113.692 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -71.39 146.23 91.54 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.713 -0.676 . . . . 25.0 110.463 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.24 165.26 32.09 Favored 'Trans proline' 0 C--O 1.243 0.747 0 O-C-N 121.973 0.459 . . . . 25.0 111.744 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.03 154.61 43.96 Favored 'Trans proline' 0 C--N 1.35 0.646 0 N-CA-C 113.33 0.473 . . . . 25.0 113.33 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -109.7 35.34 3.38 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.484 -0.932 . . . . 25.0 108.484 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.7 p 48.16 -153.39 0.09 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.163 -1.38 . . . . 25.0 111.924 -176.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 54.79 30.86 14.43 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.542 0.737 . . . . 25.0 111.753 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.3 m -64.83 136.76 57.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.421 -0.809 . . . . 25.0 112.219 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.5 t -68.75 -33.53 74.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.978 0.895 . . . . 25.0 109.702 175.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.208 -1.106 0 CA-C-O 124.465 2.079 . . . . 25.0 111.515 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.405 0 CA-C-O 122.601 1.112 . . . . 25.0 114.835 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t 55.55 29.74 13.99 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.311 1.044 . . . . 25.0 112.592 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.1 tpt -66.18 134.42 52.7 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.014 -0.736 . . . . 25.0 109.014 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -124.64 107.74 11.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.245 0.545 . . . . 25.0 110.776 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -90.24 169.18 11.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.275 -0.875 . . . . 25.0 111.894 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.11 -41.17 95.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.72 -0.673 . . . . 25.0 110.729 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 55.5 40.73 31.23 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.927 0.891 . . . . 25.0 112.144 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.7 m -105.35 151.37 7.55 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.802 0 N-CA-C 107.316 -1.364 . . . . 25.0 107.316 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.38 167.0 12.97 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.485 -0.561 . . . . 25.0 109.485 -172.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.86 157.41 41.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.083 0.468 . . . . 25.0 111.134 175.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -123.9 131.31 53.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.172 -0.922 . . . . 25.0 110.659 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.08 129.32 38.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.992 -0.744 . . . . 25.0 108.992 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.4 mt -96.63 -17.55 20.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.755 0.312 . . . . 25.0 110.368 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -144.99 167.65 22.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.649 -1.611 . . . . 25.0 106.649 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -77.49 168.86 19.3 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 123.447 0.467 . . . . 25.0 110.85 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -153.48 154.01 33.57 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.074 0.464 . . . . 25.0 111.462 176.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -124.53 129.69 73.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 105.073 -2.195 . . . . 25.0 105.073 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.84 121.88 21.59 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.368 -0.975 . . . . 25.0 108.368 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -102.94 1.67 34.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 122.036 0.922 . . . . 25.0 109.495 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.2 m -144.69 153.75 55.0 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 106.499 -1.667 . . . . 25.0 106.499 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.92 -23.83 34.29 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 117.811 -0.992 . . . . 25.0 113.427 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.78 -16.97 59.31 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.339 0.59 . . . . 25.0 110.629 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -84.05 139.54 32.43 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.61 0.719 . . . . 25.0 110.092 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.429 ' HB2' HG13 ' A' ' 57' ' ' VAL . 40.0 mt -87.42 130.25 34.74 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.95 -0.759 . . . . 25.0 108.95 177.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 t -87.13 137.94 31.91 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.435 -1.691 . . . . 25.0 106.435 175.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -155.42 164.19 39.05 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 120.777 0.322 . . . . 25.0 110.482 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 -117.05 168.24 10.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.984 0.421 . . . . 25.0 110.821 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -60.88 130.17 45.13 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.89 -8.26 78.34 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-O 118.647 -1.085 . . . . 25.0 114.623 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.21 142.35 51.98 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.649 1.224 . . . . 25.0 109.714 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.7 mm -108.68 129.79 62.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 107.627 -1.249 . . . . 25.0 107.627 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 14.3 ptp -134.83 163.4 29.91 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.836 -0.801 . . . . 25.0 108.836 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.1 m -104.4 122.58 45.79 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.411 -1.329 . . . . 25.0 107.411 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.7 t -86.34 122.69 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 108.191 -1.041 . . . . 25.0 108.191 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.24 -41.58 8.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.575 -0.739 . . . . 25.0 109.391 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -142.94 156.63 44.92 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.498 -1.297 . . . . 25.0 107.498 -173.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -124.38 150.76 45.21 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 105.111 -2.181 . . . . 25.0 105.111 172.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 57.43 38.93 28.43 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 123.707 1.717 . . . . 25.0 108.504 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -67.98 157.71 34.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 112.671 -2.059 . . . . 25.0 111.818 -177.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 60.35 12.51 3.46 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.078 1.14 . . . . 25.0 114.078 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.12 13.11 81.56 Favored Glycine 0 C--O 1.244 0.723 0 N-CA-C 111.265 -0.734 . . . . 25.0 111.265 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.2 mt -96.24 137.57 35.12 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 122.357 -0.496 . . . . 25.0 109.899 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -81.19 130.45 35.03 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.352 -0.61 . . . . 25.0 109.352 176.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.93 -0.42 82.85 Favored Glycine 0 C--O 1.241 0.566 0 N-CA-C 116.675 1.43 . . . . 25.0 116.675 173.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -99.8 134.42 42.72 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.388 -0.968 . . . . 25.0 108.388 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.7 m0 -114.61 140.35 48.88 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.078 -1.082 . . . . 25.0 108.078 -177.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.4 tp -82.33 127.74 33.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.051 -1.833 . . . . 25.0 106.051 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.2 m -134.9 162.45 32.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.166 0.508 . . . . 25.0 111.811 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.2 t -112.35 123.09 49.51 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.629 -1.989 . . . . 25.0 105.629 169.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.2 tp -153.14 139.26 18.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.893 0.477 . . . . 25.0 110.122 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.6 m170 56.93 32.0 20.76 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.113 0.565 . . . . 25.0 111.548 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.99 -1.17 89.1 Favored Glycine 0 C--O 1.225 -0.429 0 N-CA-C 116.478 1.351 . . . . 25.0 116.478 177.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.5 ptt85 -130.64 158.59 39.62 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 118.798 1.299 . . . . 25.0 111.402 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -97.72 153.6 18.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.82 -1.178 . . . . 25.0 107.82 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.67 -165.9 35.88 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 103.89 -3.684 . . . . 25.0 103.89 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.4 pt -119.78 158.63 21.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.398 0.618 . . . . 25.0 111.443 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.7 m -144.76 148.95 41.42 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.558 -0.747 . . . . 25.0 110.171 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.3 121.72 7.41 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 118.247 -0.702 . . . . 25.0 112.932 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.38 -18.13 73.13 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 121.267 -0.492 . . . . 25.0 113.568 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -67.3 -9.97 46.24 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.602 0.964 . . . . 25.0 113.602 -177.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -129.89 27.61 5.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.472 0.653 . . . . 25.0 109.804 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -123.08 156.52 34.74 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.356 -0.838 . . . . 25.0 112.423 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -122.69 125.27 45.24 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 108.725 -0.842 . . . . 25.0 108.725 174.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.0 mm -77.97 137.1 22.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.224 -1.028 . . . . 25.0 108.224 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.6 mt -116.96 87.13 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.964 -1.124 . . . . 25.0 107.964 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.41 2.18 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.392 -0.822 . . . . 25.0 111.841 -177.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -156.67 177.92 33.37 Favored Glycine 0 CA--C 1.508 -0.378 0 N-CA-C 109.056 -1.618 . . . . 25.0 109.056 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 9.2 tpt 54.78 63.26 2.2 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 122.174 0.988 . . . . 25.0 111.333 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -65.85 -32.68 74.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.171 -0.922 . . . . 25.0 112.077 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 t0 61.28 139.45 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.874 1.67 . . . . 25.0 115.111 -175.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -81.65 -3.26 53.04 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.396 -0.815 . . . . 25.0 111.025 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -140.91 145.9 41.53 Favored Pre-proline 0 N--CA 1.469 0.5 0 N-CA-C 108.721 -0.844 . . . . 25.0 108.721 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -72.65 153.25 54.24 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 116.885 -1.61 . . . . 25.0 111.906 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.39 129.18 37.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.112 -0.699 . . . . 25.0 109.112 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.47 -36.78 6.4 Favored Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.849 -0.691 . . . . 25.0 114.097 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.7 m -153.55 166.22 33.41 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.042 -0.725 . . . . 25.0 109.042 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -109.11 178.14 20.59 Favored Glycine 0 C--O 1.225 -0.408 0 N-CA-C 110.137 -1.185 . . . . 25.0 110.137 177.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.22 -17.39 65.92 Favored Glycine 0 N--CA 1.463 0.435 0 C-N-CA 120.872 -0.68 . . . . 25.0 113.12 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.4 m 59.99 -171.96 0.13 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.068 0.947 . . . . 25.0 113.42 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.03 -176.36 54.74 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.973 -0.632 . . . . 25.0 113.098 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.9 m 61.75 -48.55 0.15 Allowed 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 119.269 3.063 . . . . 25.0 119.269 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.32 87.54 1.34 Allowed Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.801 -0.919 . . . . 25.0 110.801 -173.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.49 98.52 10.66 Favored 'General case' 0 C--O 1.238 0.483 0 O-C-N 121.643 -0.916 . . . . 25.0 110.367 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -141.14 178.79 7.15 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 123.377 0.671 . . . . 25.0 109.729 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -130.92 89.5 2.76 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.103 -1.814 . . . . 25.0 106.103 172.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 71.73 -46.46 0.64 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.258 1.423 . . . . 25.0 111.882 -174.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 177.94 -66.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 104.838 -2.282 . . . . 25.0 104.838 175.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.3 m -79.89 155.83 75.14 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 114.528 1.307 . . . . 25.0 114.528 -173.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.54 159.87 42.27 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 N-CA-C 113.752 0.635 . . . . 25.0 113.752 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -69.66 154.56 67.97 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 118.575 -0.483 . . . . 25.0 112.284 176.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.91 164.1 36.74 Favored 'Trans proline' 0 C--N 1.346 0.433 0 N-CA-C 115.579 1.338 . . . . 25.0 115.579 -174.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -90.15 150.11 42.69 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 109.322 -0.621 . . . . 25.0 109.322 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -72.95 163.9 37.06 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 O-C-N 121.785 0.361 . . . . 25.0 112.018 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -62.86 159.77 36.36 Favored 'Trans proline' 0 C--N 1.351 0.658 0 N-CA-C 114.827 1.049 . . . . 25.0 114.827 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.1 mtp85 -114.89 -14.9 11.89 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 116.859 2.17 . . . . 25.0 116.859 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 23.5 p -137.58 140.53 41.05 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.415 -0.958 . . . . 25.0 108.415 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -82.2 -36.96 26.76 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 107.247 -1.39 . . . . 25.0 107.247 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 83.2 p -157.68 163.41 38.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.112 -1.81 . . . . 25.0 106.112 174.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 93.8 m -130.0 89.15 2.76 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.207 -1.034 . . . . 25.0 108.207 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.4 tp . . . . . 0 N--CA 1.485 1.293 0 C-N-CA 124.441 1.097 . . . . 25.0 112.057 -174.692 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 115.446 0.938 . . . . 25.0 115.446 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 64.94 -28.57 0.1 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 126.989 2.116 . . . . 25.0 115.325 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.7 mtt -101.9 90.26 3.93 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 122.951 0.501 . . . . 25.0 111.46 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -75.64 131.35 39.88 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.993 -1.484 . . . . 25.0 106.993 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -138.16 167.51 21.68 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.459 0.474 . . . . 25.0 110.53 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.0 mt -65.0 -42.5 94.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.63 -0.714 . . . . 25.0 110.203 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 53.98 36.18 23.81 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.0 0.92 . . . . 25.0 112.02 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.9 m -96.09 159.79 2.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 N-CA-C 106.18 -1.785 . . . . 25.0 106.18 177.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.02 170.94 8.8 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.992 -0.744 . . . . 25.0 108.992 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.58 162.19 41.41 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.228 -0.295 . . . . 25.0 110.701 175.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.75 136.56 52.58 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.846 0.716 . . . . 25.0 111.353 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.5 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -73.02 123.09 22.83 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.695 0.622 . . . . 25.0 111.679 173.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.2 mt -90.81 -25.2 20.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.222 0.534 . . . . 25.0 110.091 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -142.82 171.68 13.72 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 103.476 -2.787 . . . . 25.0 103.476 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -84.41 175.7 9.17 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 118.056 0.389 . . . . 25.0 110.818 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -149.41 132.29 16.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.761 0.315 . . . . 25.0 110.737 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.7 t -104.04 125.19 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 104.759 -2.312 . . . . 25.0 104.759 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.23 137.86 43.31 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.565 -0.743 . . . . 25.0 110.205 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -119.05 5.33 11.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.783 0.801 . . . . 25.0 109.099 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -147.37 155.65 46.08 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 106.479 -1.675 . . . . 25.0 106.479 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.59 -24.04 26.33 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 118.167 -0.756 . . . . 25.0 113.514 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -77.73 -17.2 57.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.507 0.67 . . . . 25.0 110.203 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -87.09 133.01 33.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.526 0.679 . . . . 25.0 109.969 -176.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.8 mt -87.15 125.97 34.5 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.823 0.82 . . . . 25.0 109.945 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.68 134.01 33.73 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.252 -1.758 . . . . 25.0 106.252 174.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -154.84 166.93 31.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.526 -0.546 . . . . 25.0 109.526 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -113.4 160.51 18.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.365 0.602 . . . . 25.0 110.068 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -57.41 132.56 53.48 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.468 -0.938 . . . . 25.0 108.468 177.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.57 -18.18 57.32 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-O 119.168 -0.795 . . . . 25.0 113.11 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -61.42 147.87 43.6 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.778 0.799 . . . . 25.0 109.988 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.4 mm -115.67 132.95 63.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.296 -1.32 . . . . 25.0 107.894 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -135.24 165.51 25.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.049 -0.723 . . . . 25.0 109.049 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.4 m -104.18 123.47 47.36 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.891 -1.151 . . . . 25.0 107.891 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.1 t -87.47 121.52 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 N-CA-C 108.248 -1.019 . . . . 25.0 108.248 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.584 HD12 HD22 ' A' ' 47' ' ' LEU . 81.1 mt -91.23 -42.71 10.26 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.984 -1.007 . . . . 25.0 109.277 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -150.46 155.87 40.36 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.43 -0.952 . . . . 25.0 108.43 -176.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -115.58 153.11 31.81 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.91 -1.515 . . . . 25.0 106.91 174.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 55.98 41.23 30.05 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 123.63 1.681 . . . . 25.0 109.176 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.2 t -71.05 159.79 34.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 113.234 -1.803 . . . . 25.0 110.665 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 59.51 12.03 2.59 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.18 0.992 . . . . 25.0 112.352 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.61 17.01 78.38 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 111.262 -0.735 . . . . 25.0 111.262 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.4 mt -97.73 131.37 44.33 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 122.44 0.296 . . . . 25.0 110.282 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -71.26 128.3 35.44 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.536 -0.542 . . . . 25.0 109.536 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.5 -1.32 82.64 Favored Glycine 0 CA--C 1.518 0.244 0 N-CA-C 116.569 1.388 . . . . 25.0 116.569 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -100.63 132.99 45.74 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 118.423 1.111 . . . . 25.0 109.621 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -113.05 141.6 46.69 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.939 -0.763 . . . . 25.0 108.939 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.584 HD22 HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -81.14 122.51 27.46 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 104.823 -2.288 . . . . 25.0 104.823 177.501 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.7 m -133.89 161.7 34.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.823 0.345 . . . . 25.0 111.902 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.6 t -114.63 125.14 53.41 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.833 -1.173 . . . . 25.0 107.833 172.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 tp -145.17 136.98 25.55 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.674 -1.232 . . . . 25.0 107.674 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 55.89 28.39 12.47 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.234 0.54 . . . . 25.0 112.173 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.68 2.53 90.56 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 114.877 0.711 . . . . 25.0 114.877 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -122.55 159.3 28.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 118.282 1.041 . . . . 25.0 108.422 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -112.09 150.34 30.85 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.633 -0.877 . . . . 25.0 108.633 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.84 -160.46 24.4 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 106.547 -2.621 . . . . 25.0 106.547 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.1 pt -116.84 150.36 18.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.796 0.808 . . . . 25.0 111.5 -175.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.98 146.59 52.93 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 114.846 -1.07 . . . . 25.0 108.814 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.44 122.82 6.71 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 117.951 -0.899 . . . . 25.0 111.706 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.2 -12.71 72.54 Favored Glycine 0 C--O 1.222 -0.615 0 O-C-N 121.909 -0.494 . . . . 25.0 113.24 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.3 -16.12 63.24 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.486 0.921 . . . . 25.0 113.486 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -129.36 27.65 5.3 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.142 -0.688 . . . . 25.0 109.142 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 12' ' ' ALA . 6.6 tp -129.32 152.22 49.12 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.276 -0.875 . . . . 25.0 111.472 -177.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -131.64 120.66 23.12 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-N 115.777 -0.647 . . . . 25.0 111.755 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.4 mm -66.13 136.13 27.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 O-C-N 123.53 0.519 . . . . 25.0 110.102 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.6 mt -118.75 98.51 6.25 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.303 -1.369 . . . . 25.0 107.303 175.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.3 t -72.47 134.07 30.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 107.302 -1.37 . . . . 25.0 107.302 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -123.72 44.26 1.32 Allowed Glycine 0 C--O 1.228 -0.259 0 C-N-CA 121.68 -0.295 . . . . 25.0 113.181 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 45.7 ttp -128.68 72.68 1.46 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.42 -0.956 . . . . 25.0 108.42 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -140.38 -172.45 3.43 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.731 -1.581 . . . . 25.0 106.731 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -56.49 -37.05 69.85 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.125 0.57 . . . . 25.0 112.051 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.29 162.88 39.18 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.76 -0.83 . . . . 25.0 108.76 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -147.49 143.95 18.73 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 107.544 -1.28 . . . . 25.0 107.544 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.15 156.53 46.83 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 116.621 -1.786 . . . . 25.0 111.316 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.97 -22.65 49.13 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.838 -0.43 . . . . 25.0 109.838 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.96 170.4 43.51 Favored Glycine 0 N--CA 1.453 -0.202 0 N-CA-C 108.636 -1.786 . . . . 25.0 108.636 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.4 m -153.81 75.52 1.04 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.481 -0.563 . . . . 25.0 109.481 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -90.16 -176.3 44.98 Favored Glycine 0 C--O 1.225 -0.426 0 CA-C-N 115.903 -0.59 . . . . 25.0 112.531 -176.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.11 -174.0 43.14 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 107.736 -2.146 . . . . 25.0 107.736 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.5 t -145.99 -176.59 5.21 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.068 -1.827 . . . . 25.0 106.068 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.6 54.57 1.53 Allowed Glycine 0 C--O 1.228 -0.252 0 N-CA-C 111.268 -0.733 . . . . 25.0 111.268 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.6 p -95.08 153.15 17.78 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.134 -0.691 . . . . 25.0 109.134 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.74 124.19 3.3 Favored Glycine 0 C--O 1.224 -0.525 0 N-CA-C 110.201 -1.16 . . . . 25.0 110.201 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.4 m -153.5 148.94 27.18 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.666 -1.235 . . . . 25.0 107.666 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -97.83 161.59 13.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.604 0.183 . . . . 25.0 110.999 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.2 mttm 52.87 39.47 29.08 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.208 0.818 . . . . 25.0 113.208 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -72.97 140.46 47.39 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.25 -0.432 . . . . 25.0 111.954 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.49 161.92 13.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.762 -0.654 . . . . 25.0 110.071 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.9 m -75.22 151.08 85.69 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 114.391 1.256 . . . . 25.0 114.391 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -65.39 154.78 72.08 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 N-CA-C 114.298 0.845 . . . . 25.0 114.298 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.57 152.61 81.08 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 O-C-N 121.695 0.313 . . . . 25.0 112.701 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.63 155.15 63.63 Favored 'Trans proline' 0 C--N 1.352 0.735 0 N-CA-C 117.441 2.054 . . . . 25.0 117.441 -171.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -68.91 145.67 96.87 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 115.138 -0.937 . . . . 25.0 110.123 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.76 161.66 41.24 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 118.276 -0.683 . . . . 25.0 112.263 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -61.98 156.88 46.77 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 N-CA-C 114.985 1.109 . . . . 25.0 114.985 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -113.46 43.53 1.75 Allowed 'General case' 0 N--CA 1.478 0.927 0 O-C-N 122.186 -0.321 . . . . 25.0 111.494 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 80.8 p 44.64 13.25 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 120.305 3.446 . . . . 25.0 120.305 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.9 mtp85 -88.15 -40.79 13.46 Favored 'General case' 0 C--O 1.211 -0.949 0 O-C-N 121.901 -0.5 . . . . 25.0 111.503 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.0 m -101.98 -11.47 18.92 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.515 0.674 . . . . 25.0 110.207 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 50.9 t -105.37 123.27 47.58 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 104.421 -2.437 . . . . 25.0 104.421 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.6 tt . . . . . 0 C--O 1.207 -1.132 0 C-N-CA 124.282 1.033 . . . . 25.0 110.987 -174.601 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 CA-C-O 123.292 1.496 . . . . 25.0 115.478 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 t 55.19 34.26 22.29 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.645 1.178 . . . . 25.0 113.42 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -72.82 102.16 3.32 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.056 -0.72 . . . . 25.0 109.056 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -77.27 108.79 10.64 Favored 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.378 -0.971 . . . . 25.0 108.378 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -133.33 164.78 26.33 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.499 -0.556 . . . . 25.0 109.499 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.8 mt -71.88 -33.16 68.13 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.756 -0.656 . . . . 25.0 111.079 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.3 m120 53.43 41.75 32.07 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.35 -0.841 . . . . 25.0 111.954 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.4 m -109.51 165.38 5.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.526 -1.287 . . . . 25.0 107.526 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.73 170.6 7.91 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.467 -0.568 . . . . 25.0 109.467 -176.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.38 162.08 40.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 25.0 110.954 173.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -127.82 130.51 48.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.6 -0.727 . . . . 25.0 109.729 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.38 131.94 46.18 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.061 0.545 . . . . 25.0 109.874 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.9 mt -94.96 -23.19 17.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.24 0.543 . . . . 25.0 110.769 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -144.56 172.09 13.47 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 104.222 -2.51 . . . . 25.0 104.222 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.95 173.89 10.81 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.949 -0.389 . . . . 25.0 109.949 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -155.07 141.01 18.28 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.507 0.323 . . . . 25.0 111.648 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.7 t -108.7 124.48 65.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 105.8 -1.926 . . . . 25.0 105.8 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.53 130.82 41.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.343 -0.844 . . . . 25.0 108.867 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -112.48 11.27 19.8 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.185 0.993 . . . . 25.0 109.044 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 t -153.15 151.26 25.64 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 107.5 -1.296 . . . . 25.0 107.5 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -69.21 -18.2 39.7 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 117.689 -1.074 . . . . 25.0 112.509 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -76.6 -19.62 57.64 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.431 0.634 . . . . 25.0 109.819 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -94.11 140.99 29.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.704 0.764 . . . . 25.0 111.034 -172.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.423 ' HB2' HG13 ' A' ' 57' ' ' VAL . 55.3 mt -91.17 129.61 37.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.469 -0.787 . . . . 25.0 110.157 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.69 139.52 30.48 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.106 -2.183 . . . . 25.0 105.106 173.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -157.77 166.46 32.7 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.594 -0.521 . . . . 25.0 109.594 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -112.73 164.03 13.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.105 0.955 . . . . 25.0 110.362 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -58.48 129.66 43.09 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.447 -1.252 . . . . 25.0 109.45 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.74 -16.21 61.39 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-O 118.758 -1.024 . . . . 25.0 114.867 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -57.79 146.7 30.58 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 117.984 0.892 . . . . 25.0 111.408 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.4 mm -109.47 133.89 53.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.595 -1.184 . . . . 25.0 108.139 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.2 ptp -138.79 162.61 34.31 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.358 -0.979 . . . . 25.0 108.358 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.8 m -101.38 125.5 48.03 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 108.363 -0.977 . . . . 25.0 108.363 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.53 126.01 43.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.044 -1.095 . . . . 25.0 108.044 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.615 HD12 HD22 ' A' ' 47' ' ' LEU . 76.8 mt -95.47 -43.65 7.89 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.865 -1.061 . . . . 25.0 108.918 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -150.21 162.19 40.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.178 -0.675 . . . . 25.0 109.178 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -121.82 152.34 39.64 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 107.076 -1.453 . . . . 25.0 107.076 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 56.22 39.9 30.14 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 123.309 1.528 . . . . 25.0 108.703 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -69.87 157.51 37.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.737 -1.574 . . . . 25.0 110.177 -175.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 60.53 11.05 2.81 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.611 0.967 . . . . 25.0 113.611 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.57 16.5 77.61 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.173 -0.771 . . . . 25.0 111.173 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.7 mt -103.68 113.71 27.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.003 0.43 . . . . 25.0 110.77 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -63.74 128.08 34.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.973 -0.558 . . . . 25.0 109.696 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.61 -1.92 88.05 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 118.757 -1.024 . . . . 25.0 115.103 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -98.93 131.79 44.74 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 118.969 1.384 . . . . 25.0 109.687 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -111.76 140.06 46.71 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.926 -0.768 . . . . 25.0 108.926 -176.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.615 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -82.05 120.79 25.72 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 105.44 -2.059 . . . . 25.0 105.44 178.067 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 92.0 m -132.26 163.55 28.37 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.476 0.547 . . . . 25.0 112.476 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.8 t -115.89 119.26 35.39 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 106.588 -1.634 . . . . 25.0 106.588 171.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -147.37 139.28 24.24 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 107.055 -1.461 . . . . 25.0 107.055 -174.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 56.72 31.49 19.47 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.678 0.752 . . . . 25.0 111.86 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.49 5.27 85.74 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 115.479 0.952 . . . . 25.0 115.479 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -129.78 161.26 31.13 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.125 -1.065 . . . . 25.0 108.125 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -107.09 152.42 24.05 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.385 -0.598 . . . . 25.0 109.385 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.59 -160.55 24.9 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 106.565 -2.614 . . . . 25.0 106.565 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.1 pt -117.28 156.82 18.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.308 0.575 . . . . 25.0 111.043 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.4 m -144.67 146.95 33.97 Favored Pre-proline 0 C--O 1.241 0.64 0 CA-C-N 114.96 -1.018 . . . . 25.0 109.874 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -74.45 118.44 5.35 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 CA-C-O 121.441 0.517 . . . . 25.0 112.708 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.8 -20.04 68.02 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 114.784 0.674 . . . . 25.0 114.784 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -25.22 67.3 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.109 0.781 . . . . 25.0 113.109 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -119.18 28.33 8.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.285 0.564 . . . . 25.0 110.347 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.0 tp -133.51 150.06 51.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.132 -0.485 . . . . 25.0 110.162 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -127.94 120.21 27.15 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.851 0.686 . . . . 25.0 112.851 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.7 mm -65.43 137.6 24.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.494 -0.558 . . . . 25.0 109.494 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.9 mt -118.44 105.36 11.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.915 -1.142 . . . . 25.0 107.915 175.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.9 m -89.89 161.63 2.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.092 -1.077 . . . . 25.0 108.092 177.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.89 -27.6 73.44 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.567 -0.825 . . . . 25.0 113.497 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.5 mtp -72.68 115.16 11.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.457 0.646 . . . . 25.0 110.793 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -89.84 2.58 54.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.368 -0.833 . . . . 25.0 109.443 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -77.91 51.74 0.98 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 122.526 1.155 . . . . 25.0 109.907 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -160.73 29.68 0.15 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.866 -1.061 . . . . 25.0 108.718 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -145.16 149.52 42.05 Favored Pre-proline 0 C--O 1.218 -0.566 0 N-CA-C 107.972 -1.122 . . . . 25.0 107.972 -177.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -80.85 11.04 3.11 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 N-CA-C 114.171 0.797 . . . . 25.0 114.171 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 65.73 -29.79 0.13 Allowed 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.974 1.842 . . . . 25.0 115.974 -177.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.41 100.7 0.32 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 115.857 1.103 . . . . 25.0 115.857 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.1 m 51.15 79.13 0.1 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.852 1.797 . . . . 25.0 115.852 173.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.33 35.68 1.54 Allowed Glycine 0 CA--C 1.526 0.767 0 N-CA-C 115.75 1.06 . . . . 25.0 115.75 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.58 168.92 35.54 Favored Glycine 0 C--O 1.225 -0.438 0 N-CA-C 109.465 -1.454 . . . . 25.0 109.465 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.0 m -152.78 167.15 29.96 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.453 -1.314 . . . . 25.0 107.453 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.41 -160.19 14.34 Favored Glycine 0 C--O 1.224 -0.53 0 N-CA-C 110.454 -1.058 . . . . 25.0 110.454 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.0 m 58.79 29.7 19.06 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.373 1.62 . . . . 25.0 115.373 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.97 -146.75 18.87 Favored Glycine 0 N--CA 1.455 -0.07 0 C-N-CA 121.259 -0.496 . . . . 25.0 113.257 175.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.0 t -154.87 162.05 41.24 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 103.555 -2.757 . . . . 25.0 103.555 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -119.55 160.26 22.77 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.97 -0.381 . . . . 25.0 109.97 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 66.1 163.51 0.17 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.15 1.78 . . . . 25.0 113.365 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -121.06 99.53 6.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 105.255 -2.128 . . . . 25.0 105.255 174.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -148.69 156.45 42.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.244 -1.391 . . . . 25.0 107.244 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 61.8 p -88.56 152.18 49.07 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 112.501 0.556 . . . . 25.0 112.501 -175.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.0 156.91 55.54 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 117.524 -1.184 . . . . 25.0 111.866 174.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.68 151.1 79.5 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 117.478 -1.215 . . . . 25.0 112.309 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -71.66 169.69 20.45 Favored 'Trans proline' 0 C--N 1.349 0.564 0 N-CA-C 115.931 1.473 . . . . 25.0 115.931 -172.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -80.69 141.93 52.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.231 -0.895 . . . . 25.0 108.956 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.39 161.03 43.56 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 117.171 -1.42 . . . . 25.0 110.518 170.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -63.24 155.47 61.39 Favored 'Trans proline' 0 C--N 1.345 0.387 0 N-CA-C 114.818 1.045 . . . . 25.0 114.818 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -106.57 -1.54 22.83 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.072 0.397 . . . . 25.0 112.072 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.5 p -138.16 147.69 44.12 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.737 -1.209 . . . . 25.0 107.737 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -158.24 -33.44 0.07 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.389 0.885 . . . . 25.0 113.389 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.0 t 59.13 -165.12 0.19 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.508 0.723 . . . . 25.0 110.353 -177.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 60.9 m 47.3 48.63 16.14 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.033 1.123 . . . . 25.0 114.033 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.213 -0.83 0 CA-C-O 123.707 1.718 . . . . 25.0 111.211 179.323 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.111 0 CA-C-O 125.4 2.667 . . . . 25.0 112.768 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.7 m -78.54 11.62 2.42 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 111.37 -2.415 . . . . 25.0 115.524 -173.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.0 mtt -112.75 27.09 9.93 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.387 0.613 . . . . 25.0 112.213 -176.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -81.44 88.34 6.15 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.872 -0.518 . . . . 25.0 110.333 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -133.17 166.75 21.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.669 -0.696 . . . . 25.0 112.608 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.04 -39.88 90.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.141 -0.936 . . . . 25.0 111.419 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 54.22 41.6 31.92 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.289 1.042 . . . . 25.0 111.91 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.447 HG23 ' HB ' ' A' ' 34' ' ' VAL . 15.9 m -102.7 171.27 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 N-CA-C 103.743 -2.688 . . . . 25.0 103.743 175.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -118.96 173.93 6.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 119.42 1.009 . . . . 25.0 110.693 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.04 158.74 44.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.12 -0.491 . . . . 25.0 109.746 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -120.9 132.26 54.86 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.311 0.644 . . . . 25.0 109.793 177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.59 130.43 42.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.016 0.436 . . . . 25.0 110.078 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.8 mt -97.46 -22.18 16.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.337 -0.392 . . . . 25.0 110.944 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -141.88 164.76 29.3 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -71.78 167.74 19.31 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.598 0.562 . . . . 25.0 110.785 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.45 160.04 42.17 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.516 -0.55 . . . . 25.0 109.516 175.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.1 t -130.85 127.7 61.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 102.87 -3.011 . . . . 25.0 102.87 169.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.53 123.6 31.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.788 -0.819 . . . . 25.0 108.788 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -117.18 -17.28 10.28 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.541 0.686 . . . . 25.0 110.41 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.55 152.91 37.97 Favored Pre-proline 0 N--CA 1.471 0.58 0 N-CA-C 107.973 -1.121 . . . . 25.0 107.973 176.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.8 -24.51 34.31 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 117.906 -0.929 . . . . 25.0 113.59 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -84.13 -16.36 43.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.938 0.399 . . . . 25.0 111.135 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -79.03 129.64 34.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.077 0.941 . . . . 25.0 110.644 -173.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.414 ' HB2' HG13 ' A' ' 57' ' ' VAL . 24.3 mt -82.77 138.48 34.01 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.497 -0.774 . . . . 25.0 109.605 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.65 130.73 34.69 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.474 -0.935 . . . . 25.0 108.474 177.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -158.37 162.92 37.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.27 0.557 . . . . 25.0 110.958 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.13 166.06 17.73 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.964 -0.562 . . . . 25.0 110.099 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -56.97 131.46 49.84 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 121.116 0.484 . . . . 25.0 109.8 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.06 -19.68 53.24 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-O 118.569 -1.128 . . . . 25.0 113.028 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -62.3 149.07 43.07 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 118.118 0.959 . . . . 25.0 109.98 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.4 mm -116.63 125.3 73.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 114.325 -1.307 . . . . 25.0 108.365 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -126.74 153.22 45.79 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.172 -0.677 . . . . 25.0 109.172 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.8 m -87.26 126.63 34.95 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.736 -1.579 . . . . 25.0 106.736 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.447 ' HB ' HG23 ' A' ' 8' ' ' VAL . 62.1 t -92.19 119.89 40.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.362 -1.348 . . . . 25.0 107.362 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.547 HD12 HD22 ' A' ' 47' ' ' LEU . 83.1 mt -91.03 -43.92 9.63 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.15 -0.932 . . . . 25.0 110.155 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -150.19 159.61 44.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.831 -1.174 . . . . 25.0 107.831 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -121.62 149.41 43.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.556 -1.275 . . . . 25.0 107.556 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 58.06 39.27 26.42 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 123.517 1.627 . . . . 25.0 109.603 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.3 t -65.29 151.81 45.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.742 -1.572 . . . . 25.0 110.468 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 59.59 11.75 2.51 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.93 0.892 . . . . 25.0 113.265 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.53 18.72 78.84 Favored Glycine 0 C--O 1.241 0.585 0 N-CA-C 110.987 -0.845 . . . . 25.0 110.987 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.9 mt -91.87 123.83 35.54 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.348 -0.612 . . . . 25.0 109.348 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -64.23 118.8 9.13 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.158 -0.928 . . . . 25.0 110.998 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.28 2.63 90.57 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 116.931 1.533 . . . . 25.0 116.931 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -100.82 132.02 46.42 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.809 1.305 . . . . 25.0 110.579 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -110.16 140.8 43.87 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.75 -0.593 . . . . 25.0 110.196 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.547 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -81.25 122.01 26.88 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 104.386 -2.449 . . . . 25.0 104.386 176.738 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.8 m -132.51 164.42 26.63 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.179 0.514 . . . . 25.0 111.362 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.5 t -121.55 125.16 46.12 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 107.485 -1.302 . . . . 25.0 107.485 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.2 tp -148.78 138.49 22.02 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 106.495 -1.668 . . . . 25.0 106.495 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 55.24 28.93 11.91 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.221 0.608 . . . . 25.0 112.168 -176.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.34 1.35 75.13 Favored Glycine 0 C--O 1.226 -0.349 0 N-CA-C 115.151 0.82 . . . . 25.0 115.151 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -117.09 161.47 19.37 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.083 -1.451 . . . . 25.0 107.083 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -118.35 156.75 28.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.508 -0.553 . . . . 25.0 109.508 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.21 -156.82 21.1 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 106.525 -2.63 . . . . 25.0 106.525 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.8 pt -121.12 151.9 24.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.742 0.782 . . . . 25.0 111.545 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 24' ' ' LEU . 2.4 m -141.18 146.85 44.77 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 114.438 -1.255 . . . . 25.0 109.591 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.65 121.21 5.84 Favored 'Trans proline' 0 C--O 1.24 0.586 0 CA-C-O 121.444 0.518 . . . . 25.0 113.133 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.3 -16.16 68.78 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-O 121.717 0.62 . . . . 25.0 114.334 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -18.3 63.55 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.018 0.527 . . . . 25.0 112.081 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -126.73 30.39 5.51 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.951 0.405 . . . . 25.0 110.692 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.5 mt -126.25 157.09 39.2 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.885 1.068 . . . . 25.0 113.885 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -129.76 119.82 24.06 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.16 -0.927 . . . . 25.0 109.649 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.7 mm -67.81 140.39 19.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 O-C-N 123.902 0.751 . . . . 25.0 109.613 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.4 mt -118.65 101.84 8.41 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.826 0.85 . . . . 25.0 109.152 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.45 -3.08 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 112.701 0.63 . . . . 25.0 112.701 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.85 67.93 1.71 Allowed Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.3 -0.952 . . . . 25.0 111.004 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 40.6 ttm -55.12 128.91 36.01 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 122.247 -0.561 . . . . 25.0 110.618 -177.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 58.16 11.52 1.56 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 117.067 2.247 . . . . 25.0 117.067 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -141.26 -30.09 0.62 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.132 0.79 . . . . 25.0 113.132 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.4 tttt 57.71 36.64 26.8 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.729 1.211 . . . . 25.0 112.115 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -122.49 158.67 55.56 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 106.879 -1.526 . . . . 25.0 106.879 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.37 160.77 48.51 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 117.469 -1.22 . . . . 25.0 111.985 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.98 146.47 54.67 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.831 -0.803 . . . . 25.0 108.831 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.44 164.24 54.6 Favored Glycine 0 C--O 1.235 0.187 0 C-N-CA 120.563 -0.827 . . . . 25.0 111.542 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.5 m -69.69 154.26 42.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.926 0.393 . . . . 25.0 110.188 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.06 81.34 0.14 Allowed Glycine 0 N--CA 1.46 0.262 0 N-CA-C 109.874 -1.29 . . . . 25.0 109.874 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.24 -178.69 23.37 Favored Glycine 0 C--O 1.22 -0.721 0 N-CA-C 111.99 -0.444 . . . . 25.0 111.99 -177.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.9 m 56.64 13.29 1.34 Allowed 'General case' 0 C--O 1.215 -0.716 0 N-CA-C 117.968 2.581 . . . . 25.0 117.968 174.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.31 43.6 2.31 Favored Glycine 0 C--O 1.219 -0.798 0 N-CA-C 114.654 0.622 . . . . 25.0 114.654 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.2 t -117.0 125.27 51.11 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.265 -1.013 . . . . 25.0 108.265 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.04 -1.09 47.22 Favored Glycine 0 C--O 1.214 -1.095 0 O-C-N 123.146 0.279 . . . . 25.0 113.641 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.2 m 55.77 52.15 11.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.658 0.742 . . . . 25.0 111.468 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -67.41 153.03 44.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.715 -1.13 . . . . 25.0 109.762 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.0 tptt 65.38 175.43 0.21 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.784 1.303 . . . . 25.0 112.206 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -139.45 20.74 2.56 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.214 0.53 . . . . 25.0 109.924 -172.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -85.75 157.49 20.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.629 0.728 . . . . 25.0 110.529 -177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -79.03 151.99 76.48 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 116.079 -0.51 . . . . 25.0 112.094 -175.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.84 156.99 40.27 Favored 'Trans proline' 0 C--N 1.349 0.6 0 N-CA-C 113.45 0.519 . . . . 25.0 113.45 178.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.44 147.18 90.55 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 118.203 -0.731 . . . . 25.0 112.126 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.71 157.86 26.34 Favored 'Trans proline' 0 C--N 1.351 0.674 0 N-CA-C 116.323 1.624 . . . . 25.0 116.323 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -78.87 138.36 57.56 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.404 -1.702 . . . . 25.0 106.404 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.81 160.97 47.69 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 118.306 -0.662 . . . . 25.0 112.361 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -61.98 151.38 81.74 Favored 'Trans proline' 0 C--N 1.347 0.5 0 N-CA-C 115.448 1.288 . . . . 25.0 115.448 -175.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -105.18 -23.11 12.96 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 115.599 -0.728 . . . . 25.0 112.133 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.7 p -127.92 22.44 6.26 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.348 -0.982 . . . . 25.0 108.348 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 66.43 160.95 0.15 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.753 1.221 . . . . 25.0 110.109 -170.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 44.7 t -165.0 124.94 1.88 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.51 -1.663 . . . . 25.0 106.51 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.4 m -140.44 -63.28 0.48 Allowed 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 121.851 0.834 . . . . 25.0 108.982 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 C--O 1.215 -0.72 0 CA-C-O 124.517 2.103 . . . . 25.0 110.29 176.463 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.202 -1.851 0 N-CA-C 114.699 0.64 . . . . 25.0 114.699 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t 54.69 35.52 24.05 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 123.634 0.774 . . . . 25.0 112.302 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.5 mtt -78.85 60.98 2.97 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.022 0.529 . . . . 25.0 111.879 -176.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -140.87 147.42 38.9 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.097 -1.445 . . . . 25.0 107.097 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 60.32 164.37 0.06 Allowed 'General case' 0 CA--C 1.53 0.173 0 O-C-N 125.013 1.445 . . . . 25.0 114.829 -176.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.5 mt -73.57 -42.48 61.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.652 -1.158 . . . . 25.0 110.291 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 55.75 30.05 14.96 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.396 1.078 . . . . 25.0 111.822 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 m -89.65 163.89 2.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 104.842 -2.281 . . . . 25.0 104.842 176.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.23 171.9 7.33 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.966 -1.124 . . . . 25.0 107.966 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.47 157.24 43.34 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.52 -0.548 . . . . 25.0 109.52 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -120.34 131.79 55.01 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 123.901 0.751 . . . . 25.0 109.393 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.436 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -68.8 126.94 31.32 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.658 0.599 . . . . 25.0 110.095 173.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.5 mt -92.56 -26.59 17.83 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.859 -0.423 . . . . 25.0 109.859 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -142.19 166.02 25.83 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.048 -1.834 . . . . 25.0 106.048 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -75.3 163.35 27.57 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 122.998 0.519 . . . . 25.0 112.369 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -143.07 144.03 32.09 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.625 0.602 . . . . 25.0 112.625 173.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -114.14 126.83 71.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 103.355 -2.832 . . . . 25.0 103.355 173.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.42 140.51 33.4 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 108.237 -1.023 . . . . 25.0 108.237 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -125.06 9.77 8.1 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.693 0.759 . . . . 25.0 111.186 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.5 m -145.73 150.98 45.0 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 106.575 -1.639 . . . . 25.0 106.575 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.62 -29.96 84.94 Favored 'Trans proline' 0 C--N 1.351 0.663 0 N-CA-C 114.954 1.098 . . . . 25.0 114.954 -175.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.7 -17.4 59.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.203 -0.453 . . . . 25.0 111.769 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -86.15 136.33 33.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 122.055 0.931 . . . . 25.0 111.886 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.9 mt -91.14 130.95 36.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.508 0.67 . . . . 25.0 111.089 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.6 p -90.92 144.69 25.42 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.61 -1.256 . . . . 25.0 107.61 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -160.09 168.55 25.29 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.61 0.243 . . . . 25.0 110.669 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -116.95 163.55 16.03 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.406 -0.59 . . . . 25.0 109.406 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -59.74 133.78 56.41 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.727 -0.842 . . . . 25.0 108.727 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.4 -21.35 46.45 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-O 118.903 -0.943 . . . . 25.0 113.003 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -57.14 145.69 30.34 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.031 0.919 . . . . 25.0 111.116 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.3 mm -115.7 126.83 73.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.486 -1.234 . . . . 25.0 109.159 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -131.39 153.95 49.14 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.665 -0.494 . . . . 25.0 109.665 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.5 m -89.55 123.69 33.86 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.474 -0.935 . . . . 25.0 108.474 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.9 t -87.1 123.15 39.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.069 -0.715 . . . . 25.0 109.069 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.661 HD12 HD22 ' A' ' 47' ' ' LEU . 77.5 mt -89.85 -46.05 8.83 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.244 -1.021 . . . . 25.0 108.244 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -153.94 172.85 16.78 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.881 -0.512 . . . . 25.0 109.708 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 mtm105 -120.25 154.5 34.82 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.087 -1.449 . . . . 25.0 107.087 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 59.71 40.47 19.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 123.527 1.632 . . . . 25.0 109.228 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t -66.84 154.77 40.06 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 113.081 -1.872 . . . . 25.0 110.36 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 57.59 14.37 2.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.213 1.005 . . . . 25.0 112.147 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.05 14.84 81.85 Favored Glycine 0 C--O 1.24 0.481 0 N-CA-C 111.287 -0.725 . . . . 25.0 111.287 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.3 mt -93.16 129.07 39.29 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 117.479 0.639 . . . . 25.0 109.602 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -67.84 125.92 27.78 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.039 -0.528 . . . . 25.0 110.305 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.29 -1.76 84.12 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 117.051 1.58 . . . . 25.0 117.051 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -97.75 135.11 40.0 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 117.879 0.839 . . . . 25.0 110.391 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -112.88 143.43 44.16 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.711 -1.218 . . . . 25.0 107.711 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.661 HD22 HD12 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -86.3 124.34 32.57 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.178 -2.527 . . . . 25.0 104.178 176.586 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 93.2 m -133.16 164.11 27.77 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.162 0.506 . . . . 25.0 111.762 177.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.0 t -118.66 124.9 48.53 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.688 -1.227 . . . . 25.0 107.688 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.0 tp -139.78 133.14 30.0 Favored 'General case' 0 C--O 1.212 -0.911 0 N-CA-C 107.306 -1.368 . . . . 25.0 107.306 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.5 m170 54.95 31.62 16.33 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.465 0.706 . . . . 25.0 111.404 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.31 1.2 85.57 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 116.018 1.167 . . . . 25.0 116.018 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -118.46 152.8 35.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 119.09 1.445 . . . . 25.0 107.661 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -108.18 157.14 18.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.353 -0.385 . . . . 25.0 110.176 -178.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.44 -161.37 29.51 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 106.609 -2.597 . . . . 25.0 106.609 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.7 pt -117.13 150.03 19.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.349 0.595 . . . . 25.0 111.032 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.53 146.87 46.88 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.084 -0.962 . . . . 25.0 109.107 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.45 122.02 5.42 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 CA-C-O 121.546 0.561 . . . . 25.0 112.904 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.56 -18.23 71.66 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 115.934 1.134 . . . . 25.0 115.934 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -17.74 63.84 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 122.223 -0.575 . . . . 25.0 111.778 -177.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -123.13 27.94 7.37 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.712 0.291 . . . . 25.0 110.523 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 12' ' ' ALA . 14.4 mt -127.74 156.03 43.08 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.879 0.847 . . . . 25.0 112.26 178.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -128.81 121.99 29.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.724 -1.125 . . . . 25.0 110.443 175.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.6 mm -68.75 139.23 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.409 -0.96 . . . . 25.0 108.409 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.6 mt -117.49 103.02 9.68 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.325 -1.361 . . . . 25.0 107.325 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.0 m -85.63 144.5 9.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.361 0.601 . . . . 25.0 111.287 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.4 42.06 2.21 Favored Glycine 0 C--O 1.226 -0.384 0 CA-C-O 119.761 -0.466 . . . . 25.0 113.238 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 97.2 mtp -60.85 -45.83 92.97 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 117.6 0.7 . . . . 25.0 110.755 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -139.69 -43.15 0.44 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.882 -0.599 . . . . 25.0 109.979 177.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -80.6 60.84 4.09 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.208 1.004 . . . . 25.0 110.996 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -75.63 125.05 28.27 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.262 -1.384 . . . . 25.0 107.262 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -157.78 153.97 23.81 Favored Pre-proline 0 C--N 1.327 -0.408 0 O-C-N 121.986 -0.446 . . . . 25.0 110.032 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -76.86 -175.13 2.47 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 120.209 0.606 . . . . 25.0 111.242 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.53 149.6 42.55 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.327 -1.36 . . . . 25.0 107.327 172.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.53 -28.01 66.9 Favored Glycine 0 C--O 1.216 -0.978 0 C-N-CA 120.528 -0.844 . . . . 25.0 112.879 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.4 m 55.78 23.29 6.22 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.988 1.477 . . . . 25.0 114.988 174.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -98.78 161.98 20.33 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.223 -0.751 . . . . 25.0 111.223 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.46 43.71 1.65 Allowed Glycine 0 C--O 1.221 -0.673 0 N-CA-C 111.171 -0.772 . . . . 25.0 111.171 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 t -146.72 149.73 33.99 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.484 -0.421 . . . . 25.0 111.201 -176.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.85 48.92 0.93 Allowed Glycine 0 C--O 1.223 -0.544 0 N-CA-C 109.794 -1.322 . . . . 25.0 109.794 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.8 m -55.62 135.47 51.09 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.917 1.08 . . . . 25.0 113.917 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.9 178.89 45.12 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 104.793 -3.323 . . . . 25.0 104.793 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.1 m -141.17 146.64 37.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.54 1.17 . . . . 25.0 109.045 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 51.7 -148.63 0.37 Allowed 'General case' 0 CA--C 1.547 0.837 0 O-C-N 124.627 1.204 . . . . 25.0 112.656 176.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? 50.65 42.39 27.07 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.05 1.5 . . . . 25.0 115.05 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -80.17 29.58 0.28 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.642 0.978 . . . . 25.0 113.642 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.74 145.83 48.12 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.705 0.631 . . . . 25.0 112.705 -175.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.0 m -62.17 148.44 89.01 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 114.268 1.211 . . . . 25.0 114.268 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.22 155.85 46.69 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 N-CA-C 114.535 0.937 . . . . 25.0 114.535 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -70.44 161.02 47.52 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 117.852 -0.966 . . . . 25.0 111.738 173.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.47 168.2 18.69 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 N-CA-C 113.523 0.547 . . . . 25.0 113.523 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -107.47 147.06 34.57 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 106.721 -1.585 . . . . 25.0 106.721 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.88 162.47 41.85 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 O-C-N 122.463 0.717 . . . . 25.0 112.757 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -62.05 161.37 26.38 Favored 'Trans proline' 0 C--N 1.351 0.706 0 N-CA-C 113.119 0.392 . . . . 25.0 113.119 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.2 mtm-85 -106.88 11.0 30.46 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.008 0.432 . . . . 25.0 111.813 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.3 p -137.5 157.39 46.65 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.897 -1.52 . . . . 25.0 106.897 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -129.08 -45.27 1.26 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 111.332 0.123 . . . . 25.0 111.332 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 t 48.64 35.74 6.65 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 115.728 1.751 . . . . 25.0 115.728 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 44.3 m -72.67 116.23 12.91 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.831 -0.543 . . . . 25.0 110.317 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.8 mm? . . . . . 0 C--O 1.207 -1.174 0 CA-C-O 124.813 2.244 . . . . 25.0 113.174 179.285 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.978 0 CA-C-O 123.709 1.727 . . . . 25.0 115.642 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.3 p -152.39 168.96 23.77 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 121.193 -1.181 . . . . 25.0 108.79 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.5 mmt 61.13 178.69 0.11 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.454 1.096 . . . . 25.0 112.919 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -136.13 79.16 1.75 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.129 -0.693 . . . . 25.0 109.129 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -72.88 168.77 18.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.033 -0.985 . . . . 25.0 109.794 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.27 -40.74 97.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.017 -0.538 . . . . 25.0 109.758 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 57.3 24.83 10.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.039 0.935 . . . . 25.0 111.856 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.5 m -88.21 175.81 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 N-CA-C 105.531 -2.026 . . . . 25.0 105.531 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mp -117.88 172.28 7.5 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 118.842 0.746 . . . . 25.0 110.813 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.72 163.38 34.19 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.792 -0.64 . . . . 25.0 110.256 177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -126.63 130.52 50.64 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.644 -0.707 . . . . 25.0 110.313 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.426 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -67.78 123.81 21.58 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.143 0.577 . . . . 25.0 110.237 174.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.0 mt -90.54 -23.92 20.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.801 -0.444 . . . . 25.0 109.801 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -141.26 172.53 12.55 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 102.887 -3.005 . . . . 25.0 102.887 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.52 176.4 9.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -151.61 135.23 16.26 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.199 0.523 . . . . 25.0 112.103 175.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.9 t -101.53 121.38 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 105.333 -2.099 . . . . 25.0 105.333 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.42 131.52 43.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.516 -0.92 . . . . 25.0 108.516 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -105.22 -6.51 19.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.688 0.756 . . . . 25.0 109.897 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 m -138.57 152.61 71.32 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 107.076 -1.453 . . . . 25.0 107.076 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.81 -19.29 36.05 Favored 'Trans proline' 0 C--O 1.222 -0.296 0 C-N-CA 117.721 -1.053 . . . . 25.0 112.374 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -79.41 -15.88 57.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 25.0 110.862 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -91.86 139.38 30.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.87 0.843 . . . . 25.0 110.428 -176.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.427 ' HB2' HG13 ' A' ' 57' ' ' VAL . 56.2 mt -90.62 129.72 36.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.059 0.933 . . . . 25.0 110.24 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.58 147.18 23.51 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.644 -1.613 . . . . 25.0 106.644 175.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -157.47 167.81 29.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.283 0.564 . . . . 25.0 111.023 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -107.09 159.13 16.54 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.971 -0.752 . . . . 25.0 108.971 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -58.0 128.2 35.89 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.72 -1.215 . . . . 25.0 107.72 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.18 -18.87 53.56 Favored Glycine 0 CA--C 1.517 0.194 0 CA-C-O 118.731 -1.039 . . . . 25.0 113.915 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -59.51 147.61 36.17 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 118.063 0.932 . . . . 25.0 110.738 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.5 mm -115.39 128.52 72.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.453 -1.249 . . . . 25.0 108.92 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -131.09 153.05 49.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.044 -0.354 . . . . 25.0 110.044 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.6 m -84.19 130.09 34.85 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 177.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.51 125.25 47.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.709 -0.849 . . . . 25.0 108.709 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.621 HD12 HD22 ' A' ' 47' ' ' LEU . 60.4 mt -91.09 -48.62 6.86 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.797 -0.816 . . . . 25.0 108.797 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -155.06 173.21 16.91 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.655 -0.869 . . . . 25.0 108.655 177.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -121.99 151.62 40.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.04 -1.096 . . . . 25.0 108.04 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 59.29 40.32 21.45 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 123.329 1.537 . . . . 25.0 108.936 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -65.06 153.78 39.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 112.866 -1.97 . . . . 25.0 110.5 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 59.79 11.61 2.58 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.585 0.957 . . . . 25.0 113.585 176.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.11 19.13 75.39 Favored Glycine 0 C--O 1.225 -0.447 0 N-CA-C 111.052 -0.819 . . . . 25.0 111.052 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 71.9 mt -96.95 112.33 24.13 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.124 0.488 . . . . 25.0 111.288 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.96 119.36 6.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.888 -0.596 . . . . 25.0 111.828 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.99 -0.01 89.55 Favored Glycine 0 C--O 1.239 0.417 0 N-CA-C 115.521 0.968 . . . . 25.0 115.521 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -100.19 134.6 42.88 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 118.525 1.163 . . . . 25.0 109.485 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -112.0 143.09 43.56 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.322 -0.992 . . . . 25.0 108.322 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.621 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -85.03 120.01 26.07 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 105.161 -2.163 . . . . 25.0 105.161 177.192 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 92.0 m -130.29 161.14 31.9 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.827 0.346 . . . . 25.0 111.317 178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.3 t -113.71 120.3 40.36 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.184 -1.413 . . . . 25.0 107.184 174.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.5 tp -143.2 135.5 27.19 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.145 -0.687 . . . . 25.0 109.145 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 56.03 28.13 12.35 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.889 1.07 . . . . 25.0 113.889 175.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.28 7.7 86.31 Favored Glycine 0 C--O 1.226 -0.352 0 C-N-CA 121.202 -0.523 . . . . 25.0 113.794 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -118.62 153.22 34.64 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.523 -0.918 . . . . 25.0 108.523 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -117.16 138.46 51.65 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 104.996 -2.224 . . . . 25.0 104.996 173.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.18 -162.71 26.99 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 107.414 -2.274 . . . . 25.0 107.414 -176.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.6 pt -111.31 151.92 13.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 121.599 0.714 . . . . 25.0 111.713 -174.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.2 m -141.47 145.01 35.95 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 114.851 -1.068 . . . . 25.0 108.992 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.72 120.69 6.26 Favored 'Trans proline' 0 C--O 1.238 0.507 0 CA-C-O 121.233 0.431 . . . . 25.0 112.691 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.76 -19.84 71.71 Favored Glycine 0 C--O 1.22 -0.727 0 N-CA-C 114.915 0.726 . . . . 25.0 114.915 -176.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -65.37 -16.68 63.86 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.217 0.821 . . . . 25.0 113.217 -177.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -122.92 27.44 7.69 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.259 0.552 . . . . 25.0 109.817 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 12' ' ' ALA . 12.7 mt -126.8 157.82 38.23 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.019 0.914 . . . . 25.0 113.023 178.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -127.56 125.93 41.22 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 115.01 -0.996 . . . . 25.0 110.194 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.2 mm -75.07 135.85 26.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.699 -0.852 . . . . 25.0 108.699 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.0 mt -115.47 92.13 3.82 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.561 0.744 . . . . 25.0 109.629 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 m -105.56 16.77 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.86 -0.609 . . . . 25.0 111.139 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.57 22.27 75.58 Favored Glycine 0 C--O 1.224 -0.49 0 C-N-CA 121.03 -0.605 . . . . 25.0 113.566 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 19.2 ttt -78.09 123.0 26.35 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.908 -0.775 . . . . 25.0 108.908 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 67.36 151.05 0.07 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.685 1.594 . . . . 25.0 111.822 -172.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -55.51 -45.98 77.03 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.279 -0.418 . . . . 25.0 111.81 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt 39.01 44.98 0.94 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.647 0.98 . . . . 25.0 113.647 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -55.44 138.7 68.01 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.804 -0.634 . . . . 25.0 110.472 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.73 151.7 69.29 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 117.853 -0.964 . . . . 25.0 111.959 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -157.15 170.83 21.62 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 104.714 -2.328 . . . . 25.0 104.714 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.05 -96.44 0.17 Allowed Glycine 0 C--O 1.217 -0.947 0 N-CA-C 109.982 -1.247 . . . . 25.0 109.982 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 t 55.12 39.48 31.51 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.359 0.664 . . . . 25.0 111.42 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.24 -163.61 20.18 Favored Glycine 0 CA--C 1.51 -0.254 0 N-CA-C 109.865 -1.294 . . . . 25.0 109.865 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.47 -155.48 11.54 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 114.86 0.704 . . . . 25.0 114.86 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 t 65.51 -155.93 0.27 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.056 0.943 . . . . 25.0 110.343 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.47 -11.41 30.69 Favored Glycine 0 CA--C 1.52 0.35 0 CA-C-O 121.253 0.363 . . . . 25.0 113.052 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.9 t -71.07 156.23 39.86 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.972 -1.121 . . . . 25.0 107.972 176.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.08 28.7 1.84 Allowed Glycine 0 C--O 1.222 -0.63 0 C-N-CA 121.023 -0.608 . . . . 25.0 112.921 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.0 t -95.59 137.1 35.11 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 104.922 -2.251 . . . . 25.0 104.922 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -109.19 134.67 51.44 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.626 -1.62 . . . . 25.0 106.626 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.99 22.03 5.48 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.951 0.723 . . . . 25.0 112.951 -177.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 62.81 25.48 15.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.837 0.855 . . . . 25.0 111.281 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -81.81 167.6 18.87 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 121.61 0.719 . . . . 25.0 112.877 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.3 m -78.03 159.62 75.46 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.474 1.11 . . . . 25.0 113.726 -175.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.02 155.34 68.7 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 118.044 -0.837 . . . . 25.0 112.424 176.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.82 153.53 77.64 Favored 'Trans proline' 0 C--N 1.351 0.702 0 O-C-N 121.623 0.275 . . . . 25.0 112.718 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.56 161.53 44.71 Favored 'Trans proline' 0 C--N 1.345 0.377 0 N-CA-C 115.677 1.376 . . . . 25.0 115.677 -172.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -91.65 149.49 39.34 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 107.766 -1.198 . . . . 25.0 107.766 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.69 165.75 31.57 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 O-C-N 122.186 0.571 . . . . 25.0 113.07 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.91 169.02 9.52 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 118.433 -0.578 . . . . 25.0 111.422 173.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.5 mtm-85 -106.24 -82.24 0.54 Allowed 'General case' 0 C--O 1.206 -1.188 0 CA-C-O 120.863 0.364 . . . . 25.0 110.617 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.95 -42.94 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.666 0.746 . . . . 25.0 110.272 -177.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -129.29 148.06 51.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.259 -0.882 . . . . 25.0 110.677 -174.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.0 m -83.54 117.98 23.48 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.186 -1.412 . . . . 25.0 107.186 176.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 64.4 m -101.02 153.19 19.75 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.065 -0.717 . . . . 25.0 109.065 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.5 tp . . . . . 0 C--O 1.213 -0.851 0 CA-C-O 124.513 2.102 . . . . 25.0 109.877 177.874 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.235 0 CA-C-O 125.322 2.623 . . . . 25.0 114.259 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.8 m -88.55 37.0 0.81 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 112.579 -1.81 . . . . 25.0 113.17 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -72.09 152.91 42.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.188 0.518 . . . . 25.0 109.96 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.14 75.1 5.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.622 -0.51 . . . . 25.0 109.622 177.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -118.31 168.21 10.83 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.641 -0.709 . . . . 25.0 109.689 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.4 mt -67.34 -39.35 85.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.918 -0.583 . . . . 25.0 109.788 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.7 m120 53.76 30.06 10.6 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.168 0.987 . . . . 25.0 112.683 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.8 m -93.17 175.88 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 104.501 -2.407 . . . . 25.0 104.501 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.55 172.34 7.72 Favored 'General case' 0 CA--C 1.497 -1.093 0 O-C-N 121.934 -0.479 . . . . 25.0 109.837 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.93 162.74 38.69 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.599 -0.728 . . . . 25.0 109.87 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.91 128.19 49.09 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 124.175 0.99 . . . . 25.0 108.333 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.24 138.24 49.28 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 122.763 0.425 . . . . 25.0 110.271 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.2 mt -101.46 -17.38 16.47 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.669 0.618 . . . . 25.0 112.669 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -141.45 159.12 42.87 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.698 -1.223 . . . . 25.0 107.698 -176.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.41 ' C ' HH22 ' A' ' 61' ' ' ARG . 21.5 m-20 -81.18 149.71 28.98 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.036 0.21 . . . . 25.0 111.257 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -133.68 146.29 50.71 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.33 0.652 . . . . 25.0 112.203 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.0 t -119.98 133.38 66.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 103.147 -2.908 . . . . 25.0 103.147 170.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.14 135.53 36.6 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.063 -0.717 . . . . 25.0 109.063 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -108.82 2.44 21.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.39 0.614 . . . . 25.0 111.261 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -142.43 151.73 58.58 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 105.88 -1.896 . . . . 25.0 105.88 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.21 -18.73 34.7 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 118.353 -0.631 . . . . 25.0 112.823 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.03 -16.79 59.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.267 -0.879 . . . . 25.0 110.956 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -97.56 141.68 30.31 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.694 -0.854 . . . . 25.0 108.694 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.3 mt -93.62 127.04 39.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.958 0.885 . . . . 25.0 112.059 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.23 129.3 34.83 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 104.81 -2.293 . . . . 25.0 104.81 174.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -149.35 163.74 36.88 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.998 -0.371 . . . . 25.0 109.998 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -111.01 163.78 13.48 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.577 0.703 . . . . 25.0 110.514 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.52 130.85 46.07 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 107.278 -1.378 . . . . 25.0 107.278 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.14 -9.47 77.56 Favored Glycine 0 C--N 1.312 -0.751 0 CA-C-O 119.03 -0.872 . . . . 25.0 114.279 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -62.38 149.41 42.46 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 117.822 0.811 . . . . 25.0 109.326 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.0 mm -114.77 128.15 72.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.144 -0.935 . . . . 25.0 108.686 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -131.48 149.93 52.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.231 -0.44 . . . . 25.0 109.935 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.1 m -87.18 122.64 31.26 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.746 -1.205 . . . . 25.0 107.746 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -85.4 127.43 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 N-CA-C 108.138 -1.06 . . . . 25.0 108.138 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.621 HD12 HD22 ' A' ' 47' ' ' LEU . 75.9 mt -93.37 -51.0 5.19 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.17 -0.923 . . . . 25.0 109.222 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -152.44 173.75 14.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.332 -0.618 . . . . 25.0 109.332 176.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -121.76 155.46 35.23 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 107.928 -1.138 . . . . 25.0 107.928 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 55.88 42.43 28.88 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 125.641 1.838 . . . . 25.0 109.168 -177.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.8 t -65.98 149.62 49.94 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.415 -1.721 . . . . 25.0 110.517 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 59.72 14.61 4.18 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.774 0.83 . . . . 25.0 112.175 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.29 10.72 85.99 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.28 -0.486 . . . . 25.0 111.982 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.4 mt -89.63 119.4 30.01 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 117.718 0.759 . . . . 25.0 110.001 -178.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -64.32 126.04 26.5 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.238 -0.437 . . . . 25.0 110.064 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.58 -0.09 88.51 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 115.451 0.94 . . . . 25.0 115.451 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -99.45 133.29 43.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 119.101 1.45 . . . . 25.0 108.97 175.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -114.85 142.47 46.52 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.123 -1.436 . . . . 25.0 107.123 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.621 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -87.56 125.49 34.37 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 104.963 -2.236 . . . . 25.0 104.963 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.8 m -135.85 160.82 37.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.834 0.35 . . . . 25.0 110.601 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.2 t -111.46 125.96 54.45 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.314 -1.365 . . . . 25.0 107.314 171.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.7 tp -136.72 128.8 29.56 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.759 -1.2 . . . . 25.0 107.759 -177.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.9 m80 54.9 30.71 14.41 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.942 0.401 . . . . 25.0 110.771 -175.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.66 -7.7 64.62 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 115.937 1.135 . . . . 25.0 115.937 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -110.8 149.05 31.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 118.307 1.053 . . . . 25.0 108.783 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -103.24 154.33 19.46 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.502 -0.772 . . . . 25.0 110.266 -175.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.66 -167.98 39.73 Favored Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 106.429 -2.668 . . . . 25.0 106.429 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.4 pt -111.36 149.84 13.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.976 0.893 . . . . 25.0 111.961 -175.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 m -139.54 145.17 42.54 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 114.29 -1.323 . . . . 25.0 109.413 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.03 123.07 8.1 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 CA-C-O 121.207 0.42 . . . . 25.0 112.646 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.95 -15.01 79.84 Favored Glycine 0 C--O 1.228 -0.27 0 O-C-N 122.088 -0.383 . . . . 25.0 113.525 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -67.57 -5.28 14.65 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.775 0.83 . . . . 25.0 112.368 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.41 HH22 ' C ' ' A' ' 15' ' ' ASP . 0.3 OUTLIER -142.06 27.9 1.75 Allowed 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.139 -1.06 . . . . 25.0 108.139 -178.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 tp -130.65 144.62 51.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.611 -0.722 . . . . 25.0 110.884 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -122.32 117.09 25.26 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.257 -0.429 . . . . 25.0 112.033 -176.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.1 mm -64.92 136.99 25.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 O-C-N 123.961 0.788 . . . . 25.0 109.609 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.5 mt -119.67 106.14 11.87 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.283 -1.377 . . . . 25.0 107.283 176.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.42 142.69 13.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.104 0.478 . . . . 25.0 110.238 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.19 -38.88 24.77 Favored Glycine 0 C--O 1.218 -0.869 0 N-CA-C 110.495 -1.042 . . . . 25.0 110.495 177.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.2 ttp 56.99 -2.39 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 117.94 2.57 . . . . 25.0 117.94 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -137.8 148.9 45.91 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.065 0.765 . . . . 25.0 113.065 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -124.59 44.1 2.85 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 105.651 -1.981 . . . . 25.0 105.651 171.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -116.49 -58.52 2.08 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.989 -1.005 . . . . 25.0 111.873 -175.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -156.58 158.53 31.44 Favored Pre-proline 0 CA--C 1.511 -0.532 0 N-CA-C 104.113 -2.551 . . . . 25.0 104.113 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -71.79 162.94 40.48 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 116.395 -1.937 . . . . 25.0 112.112 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.75 -59.65 0.56 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.341 0.591 . . . . 25.0 110.392 176.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.81 -168.42 34.35 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.805 -0.442 . . . . 25.0 112.536 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.7 m -153.23 -43.64 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.939 1.089 . . . . 25.0 113.939 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.86 -139.55 34.9 Favored Glycine 0 C--O 1.246 0.861 0 C-N-CA 120.875 -0.678 . . . . 25.0 113.258 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.89 53.69 3.44 Favored Glycine 0 C--O 1.224 -0.525 0 N-CA-C 115.992 1.157 . . . . 25.0 115.992 175.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -70.55 -27.34 64.07 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.872 1.064 . . . . 25.0 113.872 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.61 -61.6 4.73 Favored Glycine 0 C--O 1.22 -0.779 0 CA-C-O 119.696 -0.502 . . . . 25.0 113.399 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.9 m 54.0 35.43 22.04 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.633 1.345 . . . . 25.0 114.633 178.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.99 172.49 39.85 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 110.814 -0.915 . . . . 25.0 110.814 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.2 t -148.52 147.83 29.51 Favored 'General case' 0 C--O 1.22 -0.482 0 N-CA-C 106.791 -1.559 . . . . 25.0 106.791 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -122.17 117.91 27.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.707 0.289 . . . . 25.0 110.576 -177.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.3 tttt 54.13 -166.53 0.08 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.857 0.837 . . . . 25.0 112.865 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -98.77 67.07 1.67 Allowed 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.437 -1.32 . . . . 25.0 107.437 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -72.96 145.97 46.37 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.934 -1.136 . . . . 25.0 107.934 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.7 t -96.35 134.72 23.13 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 108.626 -0.879 . . . . 25.0 108.626 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -67.36 154.54 73.63 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 116.664 -1.758 . . . . 25.0 111.527 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -70.68 160.05 50.71 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 117.011 -1.526 . . . . 25.0 111.906 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -69.58 155.57 66.17 Favored 'Trans proline' 0 C--N 1.352 0.76 0 N-CA-C 114.395 0.883 . . . . 25.0 114.395 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -83.12 140.78 42.76 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 106.957 -1.497 . . . . 25.0 106.957 176.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.92 164.71 33.67 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 116.705 -1.73 . . . . 25.0 110.553 173.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.77 153.89 64.05 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 118.578 -0.482 . . . . 25.0 113.138 -176.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -97.14 35.01 1.65 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 120.634 0.254 . . . . 25.0 111.226 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.7 p -138.78 145.07 39.72 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.414 -0.958 . . . . 25.0 108.414 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -163.93 -39.8 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.975 -0.557 . . . . 25.0 111.371 175.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.7 p 54.1 109.22 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 116.726 2.121 . . . . 25.0 116.726 177.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 47.1 t -63.09 -43.37 98.69 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.052 -0.976 . . . . 25.0 112.908 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.8 tp . . . . . 0 N--CA 1.494 1.736 0 C-N-CA 125.354 1.462 . . . . 25.0 112.586 -177.615 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.761 0 CA-C-O 123.511 1.617 . . . . 25.0 113.607 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 m 64.7 -65.27 0.14 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 127.822 2.449 . . . . 25.0 112.608 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.4 -50.59 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.299 -1.741 . . . . 25.0 106.299 176.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -158.95 134.31 8.51 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 106.163 -1.792 . . . . 25.0 106.163 175.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.79 165.81 10.81 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.182 -1.414 . . . . 25.0 107.182 174.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.41 -39.97 92.69 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.509 0.506 . . . . 25.0 110.648 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 55.52 31.93 18.05 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.926 0.89 . . . . 25.0 111.695 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.401 HG23 ' HB ' ' A' ' 34' ' ' VAL . 17.5 m -94.31 170.71 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 104.267 -2.494 . . . . 25.0 104.267 175.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -115.83 172.21 7.28 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.264 -1.013 . . . . 25.0 108.264 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.29 156.32 41.91 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 123.281 0.363 . . . . 25.0 110.623 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -116.63 127.86 54.85 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 123.998 0.812 . . . . 25.0 110.104 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.52 127.08 31.38 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.913 -0.773 . . . . 25.0 108.913 176.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.6 mt -88.75 -24.19 22.72 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 120.61 0.243 . . . . 25.0 110.488 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -146.2 171.5 14.84 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 104.09 -2.559 . . . . 25.0 104.09 177.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -82.57 174.24 11.22 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.538 -0.541 . . . . 25.0 109.538 177.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -150.85 133.44 15.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.889 0.376 . . . . 25.0 111.74 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.9 t -101.3 120.07 50.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 105.197 -2.149 . . . . 25.0 105.197 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.05 137.49 49.03 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.644 -0.873 . . . . 25.0 108.644 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -116.02 15.27 16.16 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 122.266 1.031 . . . . 25.0 108.891 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 t -157.21 149.47 17.73 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.118 -0.946 . . . . 25.0 108.501 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -69.48 -16.43 38.73 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 117.326 -1.316 . . . . 25.0 113.006 175.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -78.58 -17.1 56.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.524 0.678 . . . . 25.0 109.805 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -98.52 138.21 36.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.599 -0.728 . . . . 25.0 110.904 -173.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.443 ' HB2' HG13 ' A' ' 57' ' ' VAL . 50.8 mt -89.69 130.77 35.93 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.787 0.804 . . . . 25.0 110.045 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.6 p -90.23 144.49 25.8 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 105.803 -1.925 . . . . 25.0 105.803 174.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -157.9 168.55 26.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.82 0.343 . . . . 25.0 110.268 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.55 161.1 16.04 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.318 0.58 . . . . 25.0 109.789 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -60.31 133.97 56.61 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.318 -0.994 . . . . 25.0 108.318 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.86 -15.46 63.33 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-O 119.079 -0.845 . . . . 25.0 113.69 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -58.41 136.6 57.49 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.553 0.692 . . . . 25.0 109.739 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.0 mm -103.74 127.44 57.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 106.393 -1.706 . . . . 25.0 106.393 176.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 19.5 ptp -131.79 153.62 49.94 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.188 -0.671 . . . . 25.0 109.188 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.1 m -89.33 127.83 35.83 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.046 -1.464 . . . . 25.0 107.046 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.401 ' HB ' HG23 ' A' ' 8' ' ' VAL . 45.9 t -97.01 122.97 49.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.955 -1.128 . . . . 25.0 107.955 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.571 HD12 HD22 ' A' ' 47' ' ' LEU . 78.0 mt -92.78 -45.22 8.12 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.272 -0.876 . . . . 25.0 109.521 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -147.15 161.18 41.41 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.384 -0.969 . . . . 25.0 108.384 -174.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -126.88 149.59 49.69 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.08 -1.452 . . . . 25.0 107.08 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 56.62 38.52 29.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 123.483 1.611 . . . . 25.0 108.452 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 t -63.03 146.71 52.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.339 -1.755 . . . . 25.0 110.01 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 59.44 13.42 3.22 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.482 0.919 . . . . 25.0 113.482 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.89 16.99 79.24 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 111.003 -0.839 . . . . 25.0 111.003 -178.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.448 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 60.3 mt -91.53 103.65 16.23 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.875 -0.787 . . . . 25.0 108.875 178.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -54.49 123.98 14.73 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.422 -0.808 . . . . 25.0 111.606 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.24 0.27 85.89 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 115.345 0.898 . . . . 25.0 115.345 176.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.448 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 95.0 m95 -100.95 130.73 46.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 118.523 1.162 . . . . 25.0 109.193 177.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -112.23 142.6 44.52 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 121.789 -0.569 . . . . 25.0 109.622 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.571 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -84.02 119.07 24.5 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 105.563 -2.014 . . . . 25.0 105.563 178.642 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 95.4 m -129.8 162.28 28.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.088 0.47 . . . . 25.0 112.095 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.1 t -111.97 113.38 25.65 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.522 -1.658 . . . . 25.0 106.522 172.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -143.6 136.79 27.83 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.84 -1.17 . . . . 25.0 107.84 -174.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 55.88 27.42 10.99 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.45 0.7 . . . . 25.0 112.803 -176.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.51 6.4 86.64 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 120.859 -0.686 . . . . 25.0 113.046 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -114.16 160.99 18.35 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.53 -1.285 . . . . 25.0 107.53 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -121.75 142.82 49.81 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 105.89 -1.892 . . . . 25.0 105.89 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.09 -158.34 20.71 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 105.461 -3.055 . . . . 25.0 105.461 -177.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.7 pt -118.5 154.23 20.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.493 0.663 . . . . 25.0 111.238 -175.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 24' ' ' LEU . 2.0 m -141.42 146.26 41.47 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.069 -0.968 . . . . 25.0 109.347 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.24 117.7 5.21 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 CA-C-O 121.484 0.535 . . . . 25.0 112.189 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.95 -14.75 66.16 Favored Glycine 0 C--O 1.22 -0.767 0 O-C-N 122.079 -0.388 . . . . 25.0 113.202 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -64.23 -15.35 59.86 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.832 0.679 . . . . 25.0 112.832 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -131.21 29.55 4.62 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.348 0.594 . . . . 25.0 109.628 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.1 tp -133.63 148.41 51.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.845 -0.616 . . . . 25.0 109.972 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -127.87 120.12 27.07 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 111.984 0.365 . . . . 25.0 111.984 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.4 mm -69.18 135.47 28.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 123.458 0.474 . . . . 25.0 110.45 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.6 mt -120.85 96.66 5.2 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.951 0.9 . . . . 25.0 109.213 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.3 t -84.66 146.46 6.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.712 -1.218 . . . . 25.0 107.712 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.13 -47.27 0.43 Allowed Glycine 0 C--O 1.216 -1.004 0 C-N-CA 120.496 -0.859 . . . . 25.0 114.6 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 92.5 mmm -145.74 143.0 29.47 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 106.378 -1.712 . . . . 25.0 106.378 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -86.93 -18.27 31.2 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.802 -1.185 . . . . 25.0 107.802 173.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -80.93 90.44 5.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.961 -1.018 . . . . 25.0 111.37 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 10.7 76.72 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 116.792 2.145 . . . . 25.0 116.792 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -56.97 142.69 73.38 Favored Pre-proline 0 C--O 1.237 0.419 0 N-CA-C 108.701 -0.852 . . . . 25.0 108.701 177.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -66.7 157.29 61.78 Favored 'Trans proline' 0 C--N 1.347 0.488 0 N-CA-C 113.703 0.617 . . . . 25.0 113.703 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.68 164.38 26.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.985 -1.007 . . . . 25.0 108.443 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.16 162.86 34.02 Favored Glycine 0 C--O 1.225 -0.411 0 N-CA-C 108.648 -1.781 . . . . 25.0 108.648 174.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 m -77.89 -11.97 59.94 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.063 0.764 . . . . 25.0 113.063 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.19 -155.96 21.01 Favored Glycine 0 C--O 1.229 -0.198 0 N-CA-C 109.176 -1.57 . . . . 25.0 109.176 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -178.38 -176.95 46.72 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 109.01 -1.636 . . . . 25.0 109.01 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.6 m -65.25 153.45 41.01 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.438 -0.579 . . . . 25.0 109.438 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.35 -148.94 8.04 Favored Glycine 0 C--O 1.223 -0.583 0 C-N-CA 120.653 -0.784 . . . . 25.0 111.887 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.0 t 67.03 16.32 10.3 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.188 0.995 . . . . 25.0 113.157 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.47 34.16 2.0 Favored Glycine 0 CA--C 1.517 0.157 0 N-CA-C 109.072 -1.611 . . . . 25.0 109.072 175.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.6 m 55.67 -153.07 0.35 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.222 0.609 . . . . 25.0 109.824 -173.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -145.04 32.99 1.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.188 -1.042 . . . . 25.0 108.188 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 72.7 tttt 61.87 -141.41 0.45 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 104.63 -2.359 . . . . 25.0 104.63 -171.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 55.91 -150.56 0.42 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.455 0.702 . . . . 25.0 109.985 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -117.11 163.44 16.27 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.54 -0.541 . . . . 25.0 109.54 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.2 m -60.22 147.62 80.82 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 112.506 0.558 . . . . 25.0 112.506 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.4 159.07 54.95 Favored 'Trans proline' 0 C--N 1.35 0.637 0 N-CA-C 113.306 0.464 . . . . 25.0 113.306 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.7 155.55 69.55 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 118.435 -0.577 . . . . 25.0 113.067 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.85 163.24 38.13 Favored 'Trans proline' 0 C--N 1.347 0.48 0 N-CA-C 115.463 1.294 . . . . 25.0 115.463 -174.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.62 143.27 92.51 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.056 -0.974 . . . . 25.0 108.886 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.03 161.7 45.17 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 116.92 -1.587 . . . . 25.0 110.604 175.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -61.11 151.47 78.41 Favored 'Trans proline' 0 C--N 1.349 0.592 0 N-CA-C 114.49 0.919 . . . . 25.0 114.49 -177.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -101.27 76.67 1.73 Allowed 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.713 -0.847 . . . . 25.0 108.713 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -63.8 143.14 58.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.843 -0.617 . . . . 25.0 110.285 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -144.11 43.59 1.44 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 105.494 -2.039 . . . . 25.0 105.494 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.9 p -149.26 150.44 32.57 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.418 -1.697 . . . . 25.0 106.418 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 34.7 m -115.52 157.92 23.36 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.62 -0.511 . . . . 25.0 109.62 -177.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.0 tp . . . . . 0 N--CA 1.483 1.207 0 C-N-CA 124.801 1.24 . . . . 25.0 114.024 178.669 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.055 0 N-CA-C 116.066 1.187 . . . . 25.0 116.066 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m 60.95 -167.28 0.19 Allowed 'General case' 0 C--N 1.351 0.666 0 C-N-CA 124.99 1.316 . . . . 25.0 111.247 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.6 ptt? -141.84 137.72 31.65 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.347 -1.353 . . . . 25.0 107.347 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -109.46 79.18 1.19 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.55 0.691 . . . . 25.0 109.944 -176.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -96.1 161.71 13.85 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.362 -0.835 . . . . 25.0 111.063 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.6 mt -68.3 -40.61 81.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.765 -0.828 . . . . 25.0 108.765 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 53.46 34.78 19.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.037 0.935 . . . . 25.0 111.58 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.0 m -93.38 -179.25 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 103.946 -2.613 . . . . 25.0 103.946 175.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.89 173.86 6.97 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.276 -0.89 . . . . 25.0 109.938 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.75 157.23 43.02 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.506 0.67 . . . . 25.0 109.598 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -116.96 129.95 56.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.177 -0.92 . . . . 25.0 109.875 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.97 128.09 35.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.091 -0.504 . . . . 25.0 109.666 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.64 -21.79 21.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.315 0.579 . . . . 25.0 111.188 -177.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -141.18 173.27 11.64 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.852 -1.166 . . . . 25.0 107.852 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -76.8 -179.07 5.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 124.113 0.883 . . . . 25.0 109.884 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.09 156.79 29.83 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.777 -0.823 . . . . 25.0 108.777 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.36 122.82 60.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 103.394 -2.817 . . . . 25.0 103.394 167.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.31 133.07 34.16 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.133 -1.062 . . . . 25.0 108.133 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -114.01 -23.56 9.49 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.027 0.441 . . . . 25.0 111.021 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -93.44 151.7 40.41 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.285 -1.006 . . . . 25.0 108.285 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.06 -18.88 30.64 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 116.545 -1.837 . . . . 25.0 111.835 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -85.71 -17.0 37.21 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.228 -0.896 . . . . 25.0 110.036 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -83.11 133.67 35.04 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.442 -0.787 . . . . 25.0 110.142 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.2 mt -84.02 132.86 34.7 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.961 0.41 . . . . 25.0 110.546 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 p -83.48 116.82 22.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.214 -1.032 . . . . 25.0 108.214 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -138.96 161.94 36.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.091 0.948 . . . . 25.0 112.491 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -119.23 166.62 12.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.975 -1.011 . . . . 25.0 108.73 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -61.87 131.61 50.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.882 -0.785 . . . . 25.0 108.882 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.62 -13.94 65.66 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-O 118.844 -0.975 . . . . 25.0 114.683 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.39 141.39 54.7 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 118.117 0.959 . . . . 25.0 108.908 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.6 mm -106.51 130.35 58.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 107.358 -1.349 . . . . 25.0 107.358 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.481 ' HB3' HD13 ' A' ' 50' ' ' LEU . 16.3 ptp -131.78 151.68 51.49 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 109.037 -0.727 . . . . 25.0 109.037 -177.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.4 m -87.94 124.33 33.59 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 106.895 -1.521 . . . . 25.0 106.895 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.4 t -91.82 124.2 44.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 N-CA-C 108.418 -0.956 . . . . 25.0 108.418 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.637 HD12 HD22 ' A' ' 47' ' ' LEU . 78.6 mt -90.02 -47.56 7.76 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.765 -0.652 . . . . 25.0 109.411 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -156.9 175.72 13.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.737 -0.468 . . . . 25.0 109.737 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -127.95 156.2 43.04 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 106.219 -1.771 . . . . 25.0 106.219 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.4 t0 61.8 36.15 16.29 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.869 1.319 . . . . 25.0 108.218 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -66.7 144.71 56.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.772 -1.103 . . . . 25.0 108.58 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 57.64 15.25 2.76 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.604 0.964 . . . . 25.0 113.604 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.79 15.59 81.21 Favored Glycine 0 C--O 1.254 1.348 0 C-N-CA 121.335 -0.459 . . . . 25.0 112.076 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.44 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 98.0 mt -92.98 101.24 13.57 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 122.238 1.018 . . . . 25.0 108.69 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -60.11 121.7 12.56 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.592 -1.186 . . . . 25.0 110.206 -175.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.08 -2.44 85.43 Favored Glycine 0 C--N 1.318 -0.418 0 CA-C-O 119.06 -0.856 . . . . 25.0 115.139 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.44 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 93.0 m95 -99.17 139.14 35.26 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.388 1.094 . . . . 25.0 108.62 174.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.41 ' CE3' HD23 ' A' ' 62' ' ' LEU . 41.9 m0 -118.6 139.61 51.21 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.496 -1.298 . . . . 25.0 107.496 -177.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.637 HD22 HD12 ' A' ' 35' ' ' LEU . 0.7 OUTLIER -81.12 124.29 29.11 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 106.359 -1.719 . . . . 25.0 106.359 177.814 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 98.2 m -131.76 163.13 28.87 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.622 0.725 . . . . 25.0 109.975 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -117.91 120.25 37.29 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 104.966 -2.235 . . . . 25.0 104.966 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.481 HD13 ' HB3' ' A' ' 32' ' ' MET . 11.1 tp -147.9 134.32 19.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.932 -0.766 . . . . 25.0 108.932 -175.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.3 m170 54.07 32.26 15.31 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.719 1.007 . . . . 25.0 113.719 174.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.73 5.01 86.96 Favored Glycine 0 C--O 1.224 -0.492 0 C-N-CA 120.452 -0.88 . . . . 25.0 114.867 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -120.06 158.83 26.01 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 107.816 -1.179 . . . . 25.0 107.816 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -111.88 154.55 25.02 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 102.95 -2.982 . . . . 25.0 102.95 166.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.25 -167.88 40.72 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 107.723 -2.151 . . . . 25.0 107.723 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 pt -113.03 151.74 14.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.65 0.738 . . . . 25.0 112.241 -175.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.7 m -143.79 147.12 37.45 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-N 114.722 -1.126 . . . . 25.0 110.235 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.38 118.48 5.37 Favored 'Trans proline' 0 C--O 1.244 0.797 0 O-C-N 121.946 0.445 . . . . 25.0 112.586 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.33 -15.13 65.3 Favored Glycine 0 C--O 1.221 -0.677 0 N-CA-C 114.664 0.626 . . . . 25.0 114.664 -176.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -63.67 -23.95 67.59 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 113.004 0.742 . . . . 25.0 113.004 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -118.34 28.39 8.38 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.393 -0.595 . . . . 25.0 109.393 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.41 HD23 ' CE3' ' A' ' 46' ' ' TRP . 18.1 tp -134.56 150.1 50.7 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.539 -0.755 . . . . 25.0 110.593 -175.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -128.54 119.97 25.84 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.166 0.432 . . . . 25.0 112.166 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.8 mm -64.81 135.86 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.6 0.714 . . . . 25.0 111.33 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.1 mt -118.33 93.71 4.22 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.559 -1.275 . . . . 25.0 107.559 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 m -83.26 149.92 4.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.629 -0.878 . . . . 25.0 108.629 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -135.54 49.67 0.88 Allowed Glycine 0 C--O 1.214 -1.102 0 CA-C-N 116.395 -0.366 . . . . 25.0 112.755 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -80.77 3.22 23.11 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.658 -0.907 . . . . 25.0 112.601 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -110.81 146.09 37.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.576 -0.284 . . . . 25.0 110.996 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -114.81 -177.53 3.15 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.898 -1.149 . . . . 25.0 107.898 173.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm 57.21 19.52 4.97 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.829 1.418 . . . . 25.0 114.829 175.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -131.21 146.64 62.94 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 106.521 -1.659 . . . . 25.0 106.521 175.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.55 135.48 31.07 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 116.267 -2.022 . . . . 25.0 112.804 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.27 -37.48 32.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.348 -0.387 . . . . 25.0 110.116 176.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.53 -170.07 54.93 Favored Glycine 0 C--O 1.216 -0.985 0 N-CA-C 110.46 -1.056 . . . . 25.0 110.46 -177.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.6 t -156.46 -60.58 0.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.194 0.521 . . . . 25.0 110.399 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.54 -146.79 18.77 Favored Glycine 0 C--O 1.222 -0.629 0 N-CA-C 108.172 -1.971 . . . . 25.0 108.172 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.08 -15.61 56.4 Favored Glycine 0 C--O 1.226 -0.392 0 CA-C-N 117.018 0.409 . . . . 25.0 113.095 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.8 m -64.56 138.33 58.34 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.325 -0.62 . . . . 25.0 109.325 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.96 161.97 52.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.855 -0.688 . . . . 25.0 111.767 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.0 m -146.0 -32.87 0.34 Allowed 'General case' 0 C--O 1.211 -0.972 0 N-CA-C 112.519 0.563 . . . . 25.0 112.519 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.82 172.0 39.08 Favored Glycine 0 C--N 1.318 -0.438 0 C-N-CA 121.209 -0.52 . . . . 25.0 112.18 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.3 m -104.07 85.35 2.38 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.628 -0.336 . . . . 25.0 110.916 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -131.68 86.6 2.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.016 0.436 . . . . 25.0 110.982 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -149.83 140.21 22.34 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.215 0.82 . . . . 25.0 113.215 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -136.18 21.04 3.21 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.81 0.814 . . . . 25.0 109.999 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -104.85 178.47 4.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.568 -0.742 . . . . 25.0 111.202 -176.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.3 t -135.7 140.62 34.29 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.007 -0.542 . . . . 25.0 110.035 -176.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -72.17 158.83 51.25 Favored 'Trans proline' 0 C--N 1.349 0.595 0 N-CA-C 116.248 1.595 . . . . 25.0 116.248 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.86 157.09 61.37 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 117.909 -0.928 . . . . 25.0 112.361 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -68.82 162.42 41.46 Favored 'Trans proline' 0 C--N 1.349 0.558 0 N-CA-C 116.552 1.712 . . . . 25.0 116.552 -174.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -79.47 140.75 56.08 Favored Pre-proline 0 N--CA 1.473 0.723 0 CA-C-N 114.634 -1.166 . . . . 25.0 108.097 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.77 165.75 30.8 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 118.093 -0.805 . . . . 25.0 110.986 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -64.41 155.38 66.32 Favored 'Trans proline' 0 C--N 1.352 0.736 0 N-CA-C 114.975 1.106 . . . . 25.0 114.975 -175.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.4 mtp-105 -111.54 -23.45 10.7 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.24 1.2 . . . . 25.0 114.24 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.2 p -135.63 41.2 2.74 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.154 0.502 . . . . 25.0 112.153 -172.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -65.44 138.66 58.26 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.577 -0.897 . . . . 25.0 108.577 176.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.0 m -80.99 -31.17 34.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.035 0.445 . . . . 25.0 110.391 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 74.1 m -139.52 165.37 27.41 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.342 -0.614 . . . . 25.0 109.342 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 67.7 tp . . . . . 0 C--O 1.206 -1.229 0 CA-C-O 124.691 2.186 . . . . 25.0 110.918 175.459 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 CA-C-O 122.909 1.283 . . . . 25.0 115.191 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.4 m -67.05 136.29 55.0 Favored 'General case' 0 C--O 1.23 0.062 0 O-C-N 121.381 -1.07 . . . . 25.0 110.5 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.3 ptp -153.3 165.22 36.44 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.319 -1.363 . . . . 25.0 107.319 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -156.53 159.11 38.27 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 104.551 -2.389 . . . . 25.0 104.551 177.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 58.01 168.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 116.345 1.98 . . . . 25.0 116.345 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.5 mt -76.48 -38.73 54.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.496 -1.229 . . . . 25.0 109.645 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.7 m120 54.35 24.96 5.5 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.329 1.052 . . . . 25.0 112.921 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG23 ' HB ' ' A' ' 34' ' ' VAL . 23.1 m -84.85 175.1 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 105.439 -2.059 . . . . 25.0 105.439 173.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.82 174.04 6.41 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.736 -0.603 . . . . 25.0 109.81 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.56 162.81 36.57 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.158 -0.474 . . . . 25.0 110.459 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -128.42 129.18 45.78 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.018 -0.992 . . . . 25.0 109.23 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.59 136.9 43.99 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.878 -0.601 . . . . 25.0 109.466 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.4 mt -104.82 -15.83 15.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 111.881 0.326 . . . . 25.0 111.881 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -143.15 165.35 27.67 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.976 -1.12 . . . . 25.0 107.976 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.93 165.03 25.01 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.638 -0.504 . . . . 25.0 109.638 174.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.04 159.91 42.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.104 -0.702 . . . . 25.0 109.104 177.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.01 121.79 56.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 104.866 -2.272 . . . . 25.0 104.866 171.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.82 134.73 33.63 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.462 -1.681 . . . . 25.0 106.462 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -114.35 -8.8 12.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.324 0.583 . . . . 25.0 111.166 -177.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.5 p -132.16 155.9 80.75 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 105.541 -2.022 . . . . 25.0 105.541 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.33 -18.31 39.08 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 118.03 -0.846 . . . . 25.0 112.266 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.48 -20.29 58.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.934 -0.576 . . . . 25.0 110.926 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -95.45 137.08 35.01 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.956 -1.127 . . . . 25.0 107.956 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.454 ' HB2' HG13 ' A' ' 57' ' ' VAL . 50.5 mt -86.26 134.53 33.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.886 -0.597 . . . . 25.0 109.947 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.06 130.45 34.61 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.232 -1.025 . . . . 25.0 108.232 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -154.27 163.36 40.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.916 0.865 . . . . 25.0 113.329 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -115.83 163.52 15.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.577 -1.192 . . . . 25.0 110.013 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -58.94 129.62 43.04 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.736 -0.839 . . . . 25.0 108.736 175.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.62 -11.04 72.01 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 118.831 -0.983 . . . . 25.0 114.634 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -63.21 150.34 43.26 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 118.39 1.095 . . . . 25.0 110.457 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.2 mm -115.57 131.28 68.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.37 -1.286 . . . . 25.0 108.917 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -135.37 156.02 49.62 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.214 -0.661 . . . . 25.0 109.214 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.1 m -87.63 130.17 34.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.177 -1.416 . . . . 25.0 107.177 176.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.405 ' HB ' HG23 ' A' ' 8' ' ' VAL . 57.8 t -94.24 124.32 46.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.643 -1.243 . . . . 25.0 107.643 177.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.595 HD12 HD22 ' A' ' 47' ' ' LEU . 81.2 mt -93.27 -44.98 8.05 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -149.43 162.25 40.48 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.961 -0.755 . . . . 25.0 108.961 -175.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 mtm105 -121.81 151.11 40.96 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.872 -1.159 . . . . 25.0 107.872 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.404 ' H ' ' HD1' ' A' ' 46' ' ' TRP . 27.7 m-20 56.11 38.86 30.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 123.51 1.624 . . . . 25.0 108.853 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 t -67.1 153.37 43.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.11 -1.859 . . . . 25.0 110.438 -175.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 60.6 9.56 2.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.911 0.884 . . . . 25.0 113.261 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.36 10.84 84.1 Favored Glycine 0 C--N 1.329 0.17 0 N-CA-C 110.803 -0.919 . . . . 25.0 110.803 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.423 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 93.2 mt -88.42 109.44 20.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.853 -0.795 . . . . 25.0 108.853 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -58.6 126.26 26.87 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.588 -0.733 . . . . 25.0 110.983 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.65 -0.58 76.21 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 115.784 1.074 . . . . 25.0 115.784 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.423 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 94.3 m95 -100.89 129.99 46.83 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 119.028 1.414 . . . . 25.0 109.964 178.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.404 ' HD1' ' H ' ' A' ' 38' ' ' ASP . 47.6 m0 -112.89 140.54 47.6 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 121.873 -0.517 . . . . 25.0 109.926 -175.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.595 HD22 HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -80.3 121.86 26.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 105.949 -1.871 . . . . 25.0 105.949 179.173 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 92.5 m -133.51 168.37 18.76 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.926 0.393 . . . . 25.0 111.583 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 t -123.42 125.77 45.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.747 -1.205 . . . . 25.0 107.747 173.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.0 tp -152.82 143.78 22.98 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.806 -1.553 . . . . 25.0 106.806 -176.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.9 m80 55.69 31.97 18.44 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.153 0.581 . . . . 25.0 112.214 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.36 4.36 68.91 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 115.268 0.867 . . . . 25.0 115.268 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -124.75 165.72 17.47 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.069 -1.086 . . . . 25.0 108.069 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -116.28 154.37 30.28 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.669 -0.863 . . . . 25.0 108.669 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.53 -157.44 20.48 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 106.381 -2.688 . . . . 25.0 106.381 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.4 pt -120.65 157.34 23.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.618 0.723 . . . . 25.0 111.423 -176.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.3 m -143.87 147.12 37.21 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 114.763 -1.108 . . . . 25.0 109.146 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -74.51 117.7 5.06 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 O-C-N 121.999 0.473 . . . . 25.0 112.519 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.51 -19.5 68.93 Favored Glycine 0 C--O 1.22 -0.777 0 CA-C-O 121.422 0.457 . . . . 25.0 114.104 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -66.41 -10.33 42.66 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.552 0.945 . . . . 25.0 113.552 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -130.46 26.34 5.08 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.872 -0.788 . . . . 25.0 108.872 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.2 tp -131.77 150.05 52.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.282 -0.872 . . . . 25.0 111.595 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -121.26 126.67 50.14 Favored 'General case' 0 C--O 1.211 -0.931 0 C-N-CA 122.828 0.451 . . . . 25.0 110.932 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.2 mm -75.59 135.41 27.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.964 -0.754 . . . . 25.0 108.964 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.9 mt -116.66 107.18 14.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.023 -1.843 . . . . 25.0 106.023 174.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.0 m -78.99 167.67 2.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.931 -0.577 . . . . 25.0 110.228 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -153.98 -176.76 26.71 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 106.981 -2.447 . . . . 25.0 106.981 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 44.1 ttm 104.05 146.59 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 128.321 2.649 . . . . 25.0 106.347 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 61.86 27.11 16.5 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.756 0.822 . . . . 25.0 111.899 -176.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -73.69 58.49 0.61 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.121 0.968 . . . . 25.0 111.959 177.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -68.32 -18.05 64.41 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.419 0.526 . . . . 25.0 112.419 -174.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -147.66 140.05 14.4 Favored Pre-proline 0 N--CA 1.468 0.467 0 N-CA-C 106.18 -1.785 . . . . 25.0 106.18 174.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.42 142.97 37.87 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 115.775 -2.35 . . . . 25.0 110.715 175.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.13 -37.0 24.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.187 0.518 . . . . 25.0 111.191 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.66 165.08 39.13 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.775 -0.93 . . . . 25.0 110.775 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.3 p -160.36 158.94 30.52 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.967 -0.753 . . . . 25.0 108.967 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.29 168.99 20.28 Favored Glycine 0 CA--C 1.517 0.168 0 N-CA-C 110.516 -1.034 . . . . 25.0 110.516 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.81 -166.64 37.47 Favored Glycine 0 C--O 1.227 -0.335 0 N-CA-C 110.872 -0.891 . . . . 25.0 110.872 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.8 t -153.69 173.9 15.2 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.356 -1.72 . . . . 25.0 106.356 177.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -171.02 -39.64 0.03 OUTLIER Glycine 0 C--O 1.22 -0.748 0 N-CA-C 111.823 -0.511 . . . . 25.0 111.823 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.9 p -69.79 137.37 51.81 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.477 -0.425 . . . . 25.0 110.033 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 147.54 -165.68 28.72 Favored Glycine 0 C--O 1.226 -0.344 0 N-CA-C 109.574 -1.41 . . . . 25.0 109.574 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.59 120.11 15.73 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.928 -0.768 . . . . 25.0 108.928 176.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.33 -0.51 10.4 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.603 0.594 . . . . 25.0 112.603 -177.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -131.63 70.72 1.46 Allowed 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.033 -0.417 . . . . 25.0 110.104 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.99 163.04 0.24 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.909 1.284 . . . . 25.0 111.084 -176.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -151.57 176.51 11.26 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.644 -1.243 . . . . 25.0 107.644 -176.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.7 m -118.89 84.99 27.38 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-O 120.859 0.362 . . . . 25.0 110.043 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.8 160.39 40.78 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 N-CA-C 114.314 0.851 . . . . 25.0 114.314 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.03 158.99 54.12 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 118.782 -0.346 . . . . 25.0 111.975 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -66.56 158.08 57.48 Favored 'Trans proline' 0 C--N 1.346 0.395 0 N-CA-C 115.179 1.184 . . . . 25.0 115.179 -174.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -71.56 143.51 87.6 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.69 -1.226 . . . . 25.0 107.69 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -69.63 162.47 41.86 Favored 'Trans proline' 0 C--O 1.244 0.778 0 C-N-CA 117.848 -0.968 . . . . 25.0 111.472 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -60.68 147.21 95.59 Favored 'Trans proline' 0 C--N 1.348 0.524 0 N-CA-C 114.473 0.913 . . . . 25.0 114.473 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -100.55 52.42 0.87 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.323 -0.621 . . . . 25.0 109.323 176.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 42.4 p 39.55 48.19 1.77 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 114.451 1.278 . . . . 25.0 114.451 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -142.36 39.91 1.58 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.406 1.098 . . . . 25.0 108.378 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.7 m -84.14 172.92 11.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.88 -1.509 . . . . 25.0 109.612 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 7.2 t 52.71 56.55 7.46 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 122.426 1.108 . . . . 25.0 113.252 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.1 tt . . . . . 0 C--O 1.214 -0.802 0 CA-C-O 124.784 2.23 . . . . 25.0 110.207 176.621 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.096 0 CA-C-O 124.947 2.415 . . . . 25.0 113.438 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.7 t -68.03 -44.82 75.61 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 111.193 -2.503 . . . . 25.0 109.03 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 76.2 mtm -92.91 150.39 20.61 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.175 -1.417 . . . . 25.0 107.175 175.145 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -129.09 137.7 51.41 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 106.469 -1.678 . . . . 25.0 106.469 177.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -117.47 165.13 13.89 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 123.745 0.653 . . . . 25.0 111.389 -175.607 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.02 -41.23 95.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.109 -0.951 . . . . 25.0 109.661 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 56.65 25.16 9.69 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.268 1.027 . . . . 25.0 111.912 -178.549 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.6 m -83.42 159.94 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 105.805 -1.924 . . . . 25.0 105.805 176.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.43 170.98 8.85 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.821 -1.177 . . . . 25.0 107.821 -177.207 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.13 163.15 36.25 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.941 -0.392 . . . . 25.0 109.941 175.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -132.21 128.76 38.64 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.621 -0.718 . . . . 25.0 109.669 177.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.26 130.73 42.8 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.496 -0.557 . . . . 25.0 109.496 177.348 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.9 mt -97.97 -21.86 16.61 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.693 0.282 . . . . 25.0 110.912 -177.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -138.97 165.91 25.87 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.676 -0.861 . . . . 25.0 108.676 178.058 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -74.58 165.95 24.35 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.03 0.932 . . . . 25.0 111.302 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.0 156.92 42.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.32 0.581 . . . . 25.0 110.861 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.6 t -130.26 125.7 60.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 102.926 -2.99 . . . . 25.0 102.926 170.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.19 136.81 33.11 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.558 -1.275 . . . . 25.0 107.558 178.255 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -128.6 6.26 5.66 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.294 0.569 . . . . 25.0 111.522 -178.777 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.2 m -127.63 151.36 75.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 105.82 -1.918 . . . . 25.0 105.82 176.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.62 -25.96 40.1 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 117.35 -1.3 . . . . 25.0 112.712 -177.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -79.29 -16.94 55.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.192 -0.458 . . . . 25.0 111.498 178.427 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -86.7 132.96 33.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.94 0.876 . . . . 25.0 109.247 -177.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.404 ' HB2' HG13 ' A' ' 57' ' ' VAL . 49.1 mt -87.07 133.4 33.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.736 -0.665 . . . . 25.0 110.567 -177.192 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.5 121.2 28.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.223 -0.899 . . . . 25.0 108.954 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -147.75 164.01 34.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.046 0.451 . . . . 25.0 111.022 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.506 HH22 ' HB2' ' A' ' 84' ' ' GLU . 55.8 ttt-85 -126.19 165.92 18.02 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.035 -0.728 . . . . 25.0 109.035 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -57.0 132.6 53.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.958 0.409 . . . . 25.0 110.493 -179.198 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.89 -16.5 61.16 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-O 119.122 -0.821 . . . . 25.0 113.929 178.164 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.98 151.37 26.38 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.837 0.827 . . . . 25.0 111.145 178.591 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.2 mm -117.99 131.39 70.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.067 -1.424 . . . . 25.0 108.917 -179.176 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -138.82 158.05 44.94 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 122.633 0.373 . . . . 25.0 110.202 179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.3 m -89.91 130.19 36.16 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.689 -0.856 . . . . 25.0 108.689 177.384 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.3 t -94.53 126.04 47.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.551 -0.907 . . . . 25.0 108.551 178.063 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.652 HD12 HD22 ' A' ' 47' ' ' LEU . 79.8 mt -90.76 -51.47 5.35 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.097 -0.705 . . . . 25.0 109.097 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -151.84 171.47 17.68 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.04 -1.096 . . . . 25.0 108.04 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -121.9 155.2 35.94 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.049 -1.464 . . . . 25.0 107.049 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 58.17 39.24 26.15 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 123.794 1.759 . . . . 25.0 109.448 178.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.4 t -65.94 155.47 36.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 112.758 -2.019 . . . . 25.0 110.485 -176.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 60.11 9.62 1.92 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.185 0.994 . . . . 25.0 112.992 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.51 20.92 73.63 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.421 -1.071 . . . . 25.0 110.421 -176.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.6 mt -97.4 127.72 43.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.225 0.536 . . . . 25.0 110.279 178.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -67.16 124.08 22.09 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.673 -0.694 . . . . 25.0 110.857 178.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.06 -0.01 84.51 Favored Glycine 0 C--O 1.239 0.426 0 N-CA-C 116.392 1.317 . . . . 25.0 116.392 173.484 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -100.68 132.21 46.19 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 118.384 1.092 . . . . 25.0 109.453 178.175 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -113.07 141.98 46.26 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.183 -0.673 . . . . 25.0 109.183 -176.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.652 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -83.73 123.19 29.6 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 105.644 -1.984 . . . . 25.0 105.644 178.925 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 84.3 m -131.62 164.49 25.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.931 0.396 . . . . 25.0 110.741 177.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.0 t -118.85 123.33 44.45 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.771 -1.937 . . . . 25.0 105.771 172.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.1 tp -145.43 136.63 24.89 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.11 -1.071 . . . . 25.0 108.11 -176.249 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.64 27.69 12.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.885 0.698 . . . . 25.0 112.885 178.447 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.45 0.1 86.69 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 114.883 0.713 . . . . 25.0 114.883 177.529 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -124.71 158.63 32.76 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 118.124 0.962 . . . . 25.0 110.135 178.466 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -109.59 154.65 22.47 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.095 -0.706 . . . . 25.0 109.095 179.534 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.83 -160.73 28.17 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 107.288 -2.325 . . . . 25.0 107.288 179.452 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.2 pt -117.06 153.16 18.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.919 0.866 . . . . 25.0 112.534 -174.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.9 m -142.88 146.89 39.45 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 114.313 -1.312 . . . . 25.0 109.839 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.12 119.07 5.65 Favored 'Trans proline' 0 C--O 1.239 0.55 0 CA-C-O 121.296 0.457 . . . . 25.0 112.252 178.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.9 -25.33 74.28 Favored Glycine 0 C--O 1.219 -0.842 0 N-CA-C 116.72 1.448 . . . . 25.0 116.72 -174.18 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -65.19 -22.32 66.88 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.556 -0.967 . . . . 25.0 113.512 -177.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -110.61 24.63 12.72 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.617 0.722 . . . . 25.0 109.389 178.72 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.9 tp -133.29 150.72 51.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.367 -0.833 . . . . 25.0 109.968 -175.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -122.41 125.88 46.79 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-N 116.558 -0.292 . . . . 25.0 110.494 -179.685 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.2 mm -75.69 135.63 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.13 -1.063 . . . . 25.0 108.13 175.292 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.2 mt -118.6 88.72 2.98 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.577 -0.898 . . . . 25.0 108.577 177.363 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.1 t -77.4 -38.76 27.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.837 -0.801 . . . . 25.0 108.837 178.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.35 170.77 27.43 Favored Glycine 0 C--O 1.234 0.112 0 CA-C-N 115.877 -0.601 . . . . 25.0 112.588 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.27 172.75 10.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.37 0.605 . . . . 25.0 111.55 179.162 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -65.91 143.86 57.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.89 -0.595 . . . . 25.0 110.118 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -115.24 162.99 16.31 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.861 -1.163 . . . . 25.0 107.861 178.622 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -63.31 169.23 3.77 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.509 1.124 . . . . 25.0 113.455 179.141 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.84 152.22 77.05 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 105.393 -2.077 . . . . 25.0 105.393 176.04 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.12 -26.61 21.17 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 116.953 -1.565 . . . . 25.0 113.039 179.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.42 160.13 34.47 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.064 -1.828 . . . . 25.0 106.064 177.23 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.07 155.31 13.92 Favored Glycine 0 C--O 1.229 -0.212 0 N-CA-C 109.191 -1.564 . . . . 25.0 109.191 176.524 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.8 t -162.0 176.02 11.19 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.642 -1.614 . . . . 25.0 106.642 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -94.86 -175.19 38.16 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 109.17 -1.572 . . . . 25.0 109.17 174.805 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 167.14 -37.78 0.23 Allowed Glycine 0 C--O 1.225 -0.42 0 C-N-CA 120.33 -0.938 . . . . 25.0 113.675 177.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.5 p -73.72 147.91 43.13 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.168 -0.679 . . . . 25.0 109.168 177.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.84 168.24 34.14 Favored Glycine 0 C--O 1.228 -0.232 0 N-CA-C 110.625 -0.99 . . . . 25.0 110.625 178.803 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.1 p -62.86 -27.21 69.18 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.118 0.485 . . . . 25.0 112.089 -179.48 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.95 89.04 0.43 Allowed Glycine 0 C--O 1.227 -0.288 0 N-CA-C 108.701 -1.76 . . . . 25.0 108.701 174.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.7 p -152.67 -174.27 4.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.604 0.702 . . . . 25.0 110.272 -176.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.506 ' HB2' HH22 ' A' ' 27' ' ' ARG . 72.1 mt-10 61.89 -162.46 0.28 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.353 1.061 . . . . 25.0 112.924 178.668 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -142.48 167.78 21.29 Favored 'General case' 0 C--O 1.215 -0.763 0 N-CA-C 107.817 -1.179 . . . . 25.0 107.817 -175.459 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -74.28 -21.9 59.54 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.721 -0.474 . . . . 25.0 109.721 171.276 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 t70 56.73 -157.17 0.28 Allowed 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.05 0.844 . . . . 25.0 112.843 177.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.0 m -123.75 84.81 53.71 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.796 -0.816 . . . . 25.0 108.796 177.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.96 162.29 34.84 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 120.22 0.614 . . . . 25.0 113.591 -178.048 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -62.66 149.72 90.23 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 118.444 -0.571 . . . . 25.0 111.624 179.139 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.52 158.42 55.68 Favored 'Trans proline' 0 C--N 1.345 0.388 0 N-CA-C 117.149 1.942 . . . . 25.0 117.149 -167.365 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.5 138.75 70.88 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 106.976 -1.491 . . . . 25.0 106.976 176.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.87 166.69 28.77 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 CA-C-N 118.748 0.589 . . . . 25.0 112.055 177.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.57 152.92 58.69 Favored 'Trans proline' 0 C--N 1.348 0.538 0 N-CA-C 113.569 0.565 . . . . 25.0 113.569 -179.109 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.9 mtt85 -109.86 4.71 21.9 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.441 0.638 . . . . 25.0 109.792 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.4 p -143.27 146.24 33.44 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.68 -1.6 . . . . 25.0 106.68 -179.337 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -93.2 75.41 4.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.84 -1.17 . . . . 25.0 107.84 177.488 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.2 m -64.57 121.18 13.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.0 -0.545 . . . . 25.0 111.886 -177.243 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 24.2 t -138.4 98.26 3.56 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.19 -1.041 . . . . 25.0 108.19 177.151 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.1 tp . . . . . 0 C--O 1.211 -0.967 0 CA-C-O 123.584 1.659 . . . . 25.0 113.237 -174.826 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 115.322 0.889 . . . . 25.0 115.322 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.8 t 65.2 -23.72 0.09 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 127.004 2.121 . . . . 25.0 115.861 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.2 mtt -65.17 149.5 49.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.575 -0.528 . . . . 25.0 109.575 177.612 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -139.35 133.88 31.74 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.053 -1.832 . . . . 25.0 106.053 178.472 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -118.54 163.16 17.2 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 123.527 0.517 . . . . 25.0 111.22 -177.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.02 -38.85 89.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.141 -0.936 . . . . 25.0 110.132 178.471 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 55.86 36.34 27.11 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.933 0.893 . . . . 25.0 111.492 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 m -100.63 161.59 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 106.36 -1.718 . . . . 25.0 106.36 177.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.55 171.97 7.59 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.02 -1.104 . . . . 25.0 108.02 -177.802 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.75 164.82 34.23 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.694 -0.484 . . . . 25.0 109.694 174.472 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -128.4 136.22 50.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.105 -0.952 . . . . 25.0 108.712 177.256 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.567 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -74.18 136.43 42.83 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.799 0.333 . . . . 25.0 110.827 175.179 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.4 mt -100.6 -20.92 15.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.852 0.358 . . . . 25.0 110.781 -179.754 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -142.5 171.57 13.88 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 103.297 -2.853 . . . . 25.0 103.297 175.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -83.5 178.57 7.95 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.302 -0.999 . . . . 25.0 108.302 174.501 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -153.25 135.86 15.19 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.68 0.276 . . . . 25.0 111.108 175.843 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.8 t -106.04 120.86 57.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 104.946 -2.242 . . . . 25.0 104.946 174.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.6 134.01 46.11 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.37 -0.832 . . . . 25.0 109.394 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -107.53 3.81 25.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.676 0.75 . . . . 25.0 109.683 179.218 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.7 m -149.4 155.82 39.4 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 107.932 -1.136 . . . . 25.0 107.932 179.706 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.39 -19.67 32.85 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 118.398 -0.601 . . . . 25.0 113.491 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -15.96 55.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.158 0.504 . . . . 25.0 110.076 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -90.82 139.45 30.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.6 0.714 . . . . 25.0 109.13 -178.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.423 ' HB2' HG13 ' A' ' 57' ' ' VAL . 59.2 mt -92.06 127.78 37.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.767 0.794 . . . . 25.0 110.567 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.4 p -87.96 143.43 27.11 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 106.042 -1.836 . . . . 25.0 106.042 173.679 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -156.98 166.12 34.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.503 -0.925 . . . . 25.0 108.503 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.5 tpp85 -105.85 158.95 16.39 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.994 -0.743 . . . . 25.0 108.994 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -59.83 128.79 38.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.764 -0.653 . . . . 25.0 109.586 178.609 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.14 -4.45 81.04 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.117 -0.824 . . . . 25.0 114.356 177.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -62.71 160.65 13.8 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 117.885 0.843 . . . . 25.0 110.842 176.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.6 mm -119.93 134.79 62.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.643 -1.162 . . . . 25.0 109.49 178.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -139.85 163.43 32.66 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.736 -0.468 . . . . 25.0 109.736 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -97.45 129.49 44.64 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.508 -1.294 . . . . 25.0 107.508 176.538 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.5 t -96.28 122.94 48.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 107.773 -1.195 . . . . 25.0 107.773 177.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.632 HD12 HD22 ' A' ' 47' ' ' LEU . 80.7 mt -91.52 -42.85 10.02 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.164 -0.926 . . . . 25.0 109.267 -179.319 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -151.68 158.85 43.97 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.779 -0.823 . . . . 25.0 108.779 -176.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.8 mtm105 -116.11 153.84 31.04 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.642 -1.244 . . . . 25.0 107.642 175.011 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 56.22 37.54 28.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 123.383 1.563 . . . . 25.0 108.62 178.261 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.0 t -64.36 150.2 46.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.255 -1.793 . . . . 25.0 110.386 -174.653 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 59.47 13.85 3.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.636 0.774 . . . . 25.0 112.121 -178.534 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.71 18.22 79.78 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.294 -0.723 . . . . 25.0 111.294 -178.102 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.2 mt -91.55 121.15 32.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.274 0.537 . . . . 25.0 109.696 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -62.45 125.02 22.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.931 -0.577 . . . . 25.0 110.357 -179.509 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.4 -0.8 73.81 Favored Glycine 0 CA--C 1.519 0.292 0 N-CA-C 116.762 1.465 . . . . 25.0 116.762 175.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -100.1 130.03 46.2 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 119.149 1.475 . . . . 25.0 110.713 179.338 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -110.25 140.77 44.06 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.571 -0.529 . . . . 25.0 109.571 -177.268 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.632 HD22 HD12 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -79.98 120.8 24.66 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 105.628 -1.99 . . . . 25.0 105.628 177.428 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 84.5 m -132.2 164.79 25.56 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.099 0.407 . . . . 25.0 112.099 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.5 t -118.92 116.57 26.74 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.932 -1.507 . . . . 25.0 106.932 172.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -146.43 138.99 25.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.936 -1.135 . . . . 25.0 107.936 -175.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 56.96 27.37 13.05 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.94 0.719 . . . . 25.0 112.94 -178.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.65 5.98 89.17 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 121.012 -0.613 . . . . 25.0 113.421 178.735 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -116.23 154.39 30.19 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 108.308 -0.997 . . . . 25.0 108.308 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -108.3 145.19 34.76 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.058 -1.83 . . . . 25.0 106.058 170.702 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.36 -155.32 13.54 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 106.877 -2.489 . . . . 25.0 106.877 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.3 pt -123.97 152.86 29.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.449 0.643 . . . . 25.0 110.665 -175.362 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 24' ' ' LEU . 2.8 m -139.63 147.31 51.43 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.148 -0.933 . . . . 25.0 108.626 -179.612 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.94 114.99 4.19 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 CA-C-O 121.379 0.491 . . . . 25.0 110.961 176.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.56 -17.12 68.48 Favored Glycine 0 C--O 1.222 -0.631 0 N-CA-C 114.304 0.482 . . . . 25.0 114.304 -175.535 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -63.76 -20.17 65.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.652 0.612 . . . . 25.0 112.652 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -116.48 27.18 9.37 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.746 -0.464 . . . . 25.0 109.746 177.214 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 12' ' ' ALA . 1.5 tp -130.34 158.01 41.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.309 0.576 . . . . 25.0 111.769 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -133.31 120.25 20.79 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.988 -0.551 . . . . 25.0 110.97 178.204 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mm -66.76 136.51 26.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.66 -0.496 . . . . 25.0 109.66 178.494 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.2 mt -117.04 104.58 11.4 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.463 -1.31 . . . . 25.0 107.463 175.864 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.7 m -76.75 155.76 5.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.855 0.359 . . . . 25.0 110.51 -178.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.92 39.0 3.13 Favored Glycine 0 N--CA 1.462 0.38 0 N-CA-C 112.06 -0.416 . . . . 25.0 112.06 178.611 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 22.3 ttt -131.96 169.39 16.37 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.771 -1.566 . . . . 25.0 106.771 -175.186 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 63.02 45.43 5.3 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.888 0.852 . . . . 25.0 110.261 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 t0 64.9 176.96 0.2 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 113.427 -1.715 . . . . 25.0 113.648 178.26 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -99.49 164.39 12.11 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.46 -0.941 . . . . 25.0 108.46 -176.461 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 mtmm -146.03 152.26 47.07 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 104.721 -2.326 . . . . 25.0 104.721 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -73.25 162.32 40.77 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 117.815 -0.99 . . . . 25.0 113.192 -179.382 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.08 168.2 19.45 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.439 -0.948 . . . . 25.0 108.439 175.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.16 -65.5 0.29 Allowed Glycine 0 C--O 1.22 -0.748 0 N-CA-C 110.398 -1.081 . . . . 25.0 110.398 176.634 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.0 m 55.18 23.21 5.21 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.818 1.784 . . . . 25.0 115.818 175.572 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.42 165.15 36.95 Favored Glycine 0 C--O 1.228 -0.246 0 N-CA-C 109.192 -1.563 . . . . 25.0 109.192 175.631 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.42 -175.2 29.08 Favored Glycine 0 C--O 1.229 -0.186 0 N-CA-C 110.265 -1.134 . . . . 25.0 110.265 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 89.2 p -142.48 159.58 41.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.188 -0.671 . . . . 25.0 109.188 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.0 -35.46 34.77 Favored Glycine 0 C--O 1.22 -0.731 0 C-N-CA 120.818 -0.706 . . . . 25.0 112.825 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.8 t -152.19 -54.68 0.13 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.883 0.373 . . . . 25.0 110.71 179.439 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.58 -159.94 13.42 Favored Glycine 0 C--O 1.225 -0.463 0 N-CA-C 109.106 -1.598 . . . . 25.0 109.106 -177.68 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.4 t -127.17 31.28 5.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.243 0.544 . . . . 25.0 109.552 -179.048 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.41 159.19 43.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.358 -0.978 . . . . 25.0 108.358 179.448 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -84.05 60.58 5.96 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.062 0.764 . . . . 25.0 113.062 -176.346 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 74.57 145.3 0.08 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.526 1.531 . . . . 25.0 113.785 177.196 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -75.68 160.8 29.68 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.842 -0.799 . . . . 25.0 108.842 178.29 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.7 m -117.11 85.47 18.57 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 122.825 0.45 . . . . 25.0 110.802 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.16 156.79 46.74 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 N-CA-C 114.393 0.882 . . . . 25.0 114.393 -177.662 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.02 162.81 40.73 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 O-C-N 121.499 0.21 . . . . 25.0 112.344 177.682 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.03 160.79 47.07 Favored 'Trans proline' 0 C--O 1.236 0.414 0 N-CA-C 114.208 0.811 . . . . 25.0 114.208 -177.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -80.94 144.31 54.98 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 115.486 -0.779 . . . . 25.0 109.651 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.98 155.36 57.53 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 118.419 -0.587 . . . . 25.0 112.913 178.556 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -63.12 131.23 31.64 Favored 'Trans proline' 0 C--N 1.348 0.518 0 N-CA-C 114.535 0.936 . . . . 25.0 114.535 -178.109 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -78.89 20.72 0.45 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.026 0.441 . . . . 25.0 110.661 175.285 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 55.2 p -138.42 1.55 2.18 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.799 0.666 . . . . 25.0 112.799 -176.274 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 56.14 26.23 9.98 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.974 0.731 . . . . 25.0 112.974 -175.385 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.1 p -71.58 140.69 49.91 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.998 -0.438 . . . . 25.0 110.5 -178.55 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 79.9 m -126.83 157.3 39.64 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.887 -1.153 . . . . 25.0 107.887 178.383 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.5 mt . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 125.734 2.683 . . . . 25.0 113.023 -179.188 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.756 0 CA-C-O 124.435 2.131 . . . . 25.0 113.104 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m -69.89 -16.11 63.18 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 112.278 -1.961 . . . . 25.0 111.57 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 58.7 ttm -125.53 130.79 52.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.794 -1.558 . . . . 25.0 106.794 176.766 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -130.24 80.49 1.96 Allowed 'General case' 0 C--O 1.213 -0.865 0 N-CA-C 108.953 -0.758 . . . . 25.0 108.953 -178.51 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -115.95 157.21 24.91 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.213 0.53 . . . . 25.0 110.444 179.111 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 71.4 mt -67.24 -39.28 86.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.783 -1.099 . . . . 25.0 109.901 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 57.4 29.33 16.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.053 0.941 . . . . 25.0 111.894 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.1 m -94.65 160.91 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 107.014 -1.476 . . . . 25.0 107.014 179.038 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.13 168.05 10.5 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.987 -1.116 . . . . 25.0 107.987 -178.646 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.06 156.07 42.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.784 0.326 . . . . 25.0 110.192 175.627 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -121.56 128.38 51.94 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.715 0.806 . . . . 25.0 110.127 178.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.63 131.58 45.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.498 -0.556 . . . . 25.0 109.498 176.777 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.1 mt -94.13 -21.28 19.2 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.064 -0.347 . . . . 25.0 110.064 -179.052 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -146.04 171.31 15.07 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.406 -1.701 . . . . 25.0 106.406 177.69 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -82.01 178.9 8.04 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.257 -0.645 . . . . 25.0 109.257 176.187 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.95 168.87 23.23 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 122.721 0.408 . . . . 25.0 110.125 176.45 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.5 t -128.02 129.88 69.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 104.149 -2.537 . . . . 25.0 104.149 171.238 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.88 119.38 23.85 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.78 -0.452 . . . . 25.0 109.78 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -103.68 8.93 37.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.322 0.582 . . . . 25.0 110.861 -177.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.9 m -152.89 155.66 32.36 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 106.827 -1.546 . . . . 25.0 106.827 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.02 -22.11 35.94 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 117.813 -0.991 . . . . 25.0 112.452 178.244 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.4 -20.72 56.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.239 -0.437 . . . . 25.0 110.516 178.435 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -85.89 126.75 34.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.769 0.795 . . . . 25.0 109.095 -176.377 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.437 ' HB2' HG13 ' A' ' 57' ' ' VAL . 46.1 mt -78.62 135.53 37.27 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.328 -0.99 . . . . 25.0 108.328 178.678 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.1 t -91.08 125.41 35.86 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.776 -1.194 . . . . 25.0 107.776 176.61 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -142.21 159.97 41.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.383 0.611 . . . . 25.0 111.531 -179.525 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.513 ' HD3' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -107.9 165.18 11.65 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.938 -0.764 . . . . 25.0 108.938 179.116 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.513 ' H ' ' HD3' ' A' ' 27' ' ' ARG . 87.4 tttt -61.29 129.05 39.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.64 -0.709 . . . . 25.0 109.52 178.459 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.26 -9.83 69.65 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-O 119.316 -0.713 . . . . 25.0 114.059 178.045 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -60.94 150.27 33.83 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.871 0.843 . . . . 25.0 110.92 179.279 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.3 mm -113.95 127.31 71.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.569 -1.196 . . . . 25.0 109.701 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.7 ptp -132.15 163.13 29.2 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.583 -0.525 . . . . 25.0 109.583 179.043 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.4 m -99.92 125.83 45.98 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.579 -1.267 . . . . 25.0 107.579 177.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.6 t -90.3 122.13 41.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.118 -1.067 . . . . 25.0 108.118 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.589 HD12 HD22 ' A' ' 47' ' ' LEU . 80.8 mt -90.3 -46.49 8.37 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.226 -0.897 . . . . 25.0 108.608 179.271 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.03 156.32 42.07 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.979 -0.378 . . . . 25.0 109.979 -176.015 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -111.98 152.01 28.61 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.891 -0.411 . . . . 25.0 109.891 174.581 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 55.97 39.49 30.53 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 123.6 1.667 . . . . 25.0 108.759 177.101 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.0 t -66.38 152.98 43.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 112.746 -2.024 . . . . 25.0 110.72 -175.174 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 60.39 9.1 1.85 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.227 1.011 . . . . 25.0 113.618 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.79 15.26 75.87 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 111.071 -0.812 . . . . 25.0 111.071 -176.911 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.8 mt -92.99 113.35 25.61 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.426 -0.583 . . . . 25.0 109.426 179.705 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.87 128.02 33.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.302 0.572 . . . . 25.0 110.005 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.97 0.35 85.17 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 115.813 1.085 . . . . 25.0 115.813 176.094 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -101.03 132.84 46.26 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 119.005 1.403 . . . . 25.0 110.415 178.402 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.6 m0 -112.36 138.68 48.74 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.171 -0.677 . . . . 25.0 109.171 -176.738 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.589 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -80.88 120.81 25.19 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 105.199 -2.148 . . . . 25.0 105.199 177.223 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.9 m -132.34 162.23 31.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.3 0.571 . . . . 25.0 112.488 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.5 t -116.9 123.72 47.69 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 105.987 -1.857 . . . . 25.0 105.987 172.012 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.4 tp -135.73 127.6 29.39 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.234 -1.395 . . . . 25.0 107.234 -177.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 29.4 m170 54.79 32.15 17.01 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.143 0.497 . . . . 25.0 112.241 178.684 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.35 -3.41 87.23 Favored Glycine 0 C--O 1.225 -0.462 0 N-CA-C 115.852 1.101 . . . . 25.0 115.852 176.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -114.35 157.25 23.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.677 -1.231 . . . . 25.0 107.677 177.475 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -117.21 154.68 30.71 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.374 -0.232 . . . . 25.0 110.374 -178.47 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.95 -157.11 21.92 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 106.127 -2.789 . . . . 25.0 106.127 178.574 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.8 pt -119.69 155.39 22.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 121.605 0.717 . . . . 25.0 111.39 -177.143 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.4 m -144.33 148.13 39.67 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.01 -0.995 . . . . 25.0 109.661 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.33 121.7 6.21 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 CA-C-O 121.545 0.56 . . . . 25.0 112.965 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.08 -18.25 70.75 Favored Glycine 0 C--O 1.22 -0.729 0 CA-C-N 116.114 -0.494 . . . . 25.0 114.155 -178.17 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -64.1 -17.2 63.2 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.394 0.516 . . . . 25.0 112.394 -177.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -127.33 30.29 5.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.116 0.484 . . . . 25.0 110.2 176.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.8 mt -129.79 156.38 44.42 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.811 -0.631 . . . . 25.0 111.769 177.372 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -128.98 125.92 38.44 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.161 -0.472 . . . . 25.0 110.125 176.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.6 mm -74.5 136.91 24.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.558 -0.904 . . . . 25.0 108.558 178.468 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.6 mt -111.92 77.93 1.08 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.147 0.579 . . . . 25.0 109.597 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.07 27.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.434 0.693 . . . . 25.0 112.77 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.4 -0.69 68.14 Favored Glycine 0 C--O 1.219 -0.821 0 N-CA-C 115.058 0.783 . . . . 25.0 115.058 178.442 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.7 ttp -59.12 -27.84 65.97 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 117.637 0.718 . . . . 25.0 112.652 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -94.13 -0.74 55.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.409 -0.359 . . . . 25.0 110.969 -178.777 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 56.5 t0 60.89 -77.8 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.08 1.352 . . . . 25.0 113.217 -175.754 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 58.87 45.93 14.6 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.891 0.876 . . . . 25.0 109.628 -173.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -52.98 151.2 8.99 Favored Pre-proline 0 C--O 1.245 0.841 0 CA-C-N 114.663 -1.153 . . . . 25.0 109.796 174.743 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.83 166.54 25.99 Favored 'Trans proline' 0 C--O 1.24 0.58 0 N-CA-C 115.46 1.292 . . . . 25.0 115.46 -173.735 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.02 147.97 29.18 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.817 -1.549 . . . . 25.0 106.817 177.356 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.21 23.47 18.12 Favored Glycine 0 C--O 1.22 -0.764 0 N-CA-C 114.856 0.702 . . . . 25.0 114.856 -177.188 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 72.4 p -98.05 -7.07 30.52 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.206 0.817 . . . . 25.0 113.206 -176.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.29 -161.12 53.6 Favored Glycine 0 C--O 1.237 0.305 0 N-CA-C 108.604 -1.798 . . . . 25.0 108.604 -172.287 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.45 160.65 27.53 Favored Glycine 0 N--CA 1.453 -0.169 0 CA-C-N 117.593 0.697 . . . . 25.0 111.42 178.201 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 82.3 p -161.17 -178.28 6.63 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.276 -1.75 . . . . 25.0 106.276 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.21 -142.96 16.72 Favored Glycine 0 C--O 1.222 -0.639 0 C-N-CA 121.114 -0.565 . . . . 25.0 113.683 176.129 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 t 62.64 13.01 5.97 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.072 1.508 . . . . 25.0 115.072 -178.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.79 159.42 53.61 Favored Glycine 0 CA--C 1.518 0.221 0 N-CA-C 110.211 -1.156 . . . . 25.0 110.211 175.082 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 p -152.34 156.32 39.36 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.359 -0.608 . . . . 25.0 109.359 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.72 165.69 23.17 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.526 -0.916 . . . . 25.0 108.526 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 93.8 mttt 63.53 174.46 0.17 Allowed 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.637 1.211 . . . . 25.0 111.811 179.152 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -97.6 146.83 24.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.408 -0.59 . . . . 25.0 109.408 -177.713 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -108.7 179.27 4.24 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.15 -1.796 . . . . 25.0 106.15 178.401 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.3 m -114.45 85.1 10.44 Favored Pre-proline 0 N--CA 1.47 0.569 0 CA-C-O 120.885 0.374 . . . . 25.0 110.317 177.038 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -80.54 153.05 20.39 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 N-CA-C 114.802 1.039 . . . . 25.0 114.802 -177.505 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.81 157.24 52.09 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 118.008 -0.861 . . . . 25.0 111.438 173.683 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.75 158.61 55.18 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 N-CA-C 115.261 1.216 . . . . 25.0 115.261 -173.658 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -77.78 141.62 64.44 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 107.625 -1.25 . . . . 25.0 107.625 176.723 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -73.03 167.68 26.72 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 O-C-N 122.097 0.525 . . . . 25.0 113.214 -177.445 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.53 152.78 52.76 Favored 'Trans proline' 0 C--N 1.352 0.736 0 N-CA-C 114.642 0.978 . . . . 25.0 114.642 -178.353 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -115.95 71.47 0.78 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.443 -0.577 . . . . 25.0 109.443 178.844 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 49.73 33.53 6.31 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.977 0.894 . . . . 25.0 111.797 -174.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.7 ptm85 -146.76 112.3 5.59 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.041 -1.096 . . . . 25.0 108.041 -179.132 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.7 m 65.27 164.41 0.16 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.628 -1.169 . . . . 25.0 112.129 -173.201 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 35.0 m -110.08 32.75 4.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.66 0.743 . . . . 25.0 110.964 -176.756 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.208 -1.121 0 CA-C-O 124.873 2.273 . . . . 25.0 111.676 -177.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 CA-C-O 123.49 1.606 . . . . 25.0 115.116 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.4 p -106.32 17.73 23.0 Favored 'General case' 0 C--O 1.24 0.588 0 O-C-N 120.873 -1.369 . . . . 25.0 110.934 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.09 144.77 53.84 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.176 -1.046 . . . . 25.0 108.176 178.376 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -90.4 78.7 6.37 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.089 -1.448 . . . . 25.0 107.089 -177.544 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -75.62 164.83 25.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.12 -0.946 . . . . 25.0 111.097 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.4 mt -66.05 -41.65 90.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.256 -0.884 . . . . 25.0 110.762 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.1 m120 55.34 24.36 6.49 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.277 1.031 . . . . 25.0 112.381 -177.211 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.6 m -83.29 175.35 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 N-CA-C 105.437 -2.06 . . . . 25.0 105.437 175.068 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -120.0 171.85 8.16 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 118.774 0.715 . . . . 25.0 109.951 -179.796 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.8 162.21 39.69 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.874 0.368 . . . . 25.0 110.354 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -122.24 132.04 54.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.141 -0.936 . . . . 25.0 110.494 178.717 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.413 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -74.08 128.05 34.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.95 0.405 . . . . 25.0 110.558 177.649 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.9 mt -98.81 -19.53 17.37 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.26 0.552 . . . . 25.0 110.985 -177.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -142.7 163.31 33.16 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 106.063 -1.829 . . . . 25.0 106.063 177.413 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -82.57 174.5 10.98 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.719 1.007 . . . . 25.0 113.719 -177.752 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -160.93 157.22 26.1 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 110.125 -0.324 . . . . 25.0 110.125 174.869 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.7 t -126.73 131.71 70.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 104.744 -2.317 . . . . 25.0 104.744 174.399 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.93 124.12 27.93 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 110.235 -0.283 . . . . 25.0 110.235 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -116.57 -12.61 10.93 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.054 0.93 . . . . 25.0 110.316 175.91 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 t -106.76 147.42 35.0 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 107.41 -1.33 . . . . 25.0 107.41 175.339 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.28 -23.74 44.54 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 116.444 -1.904 . . . . 25.0 114.695 -177.185 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -81.92 -13.16 57.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.086 0.47 . . . . 25.0 110.262 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -84.85 139.23 32.05 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.384 0.611 . . . . 25.0 111.508 -171.491 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.5 mt -93.1 131.06 38.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.596 0.713 . . . . 25.0 109.833 176.849 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.2 t -91.87 139.74 30.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.8 -1.556 . . . . 25.0 106.8 177.178 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.448 ' HE2' HG12 ' A' ' 57' ' ' VAL . 29.4 p90 -162.58 171.72 16.52 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.382 -0.97 . . . . 25.0 108.382 -177.289 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -126.75 168.03 14.96 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.769 0.795 . . . . 25.0 110.442 174.244 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.67 133.41 55.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.535 -0.757 . . . . 25.0 109.592 -176.202 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.96 -20.07 51.75 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 118.64 -1.089 . . . . 25.0 112.828 178.267 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -58.6 143.8 45.08 Favored 'General case' 0 C--O 1.249 1.056 0 CA-C-N 118.427 1.113 . . . . 25.0 110.645 179.064 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.6 mm -110.85 128.85 66.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.771 -1.104 . . . . 25.0 108.1 -178.43 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.7 ptp -132.89 149.41 52.25 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.725 0.41 . . . . 25.0 110.235 -177.384 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.0 m -85.48 126.11 33.57 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 107.541 -1.281 . . . . 25.0 107.541 179.344 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.43 124.5 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 107.904 -1.147 . . . . 25.0 107.904 178.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.631 HD12 HD22 ' A' ' 47' ' ' LEU . 75.8 mt -90.52 -47.8 7.48 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.723 -0.843 . . . . 25.0 108.723 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -153.69 173.88 15.23 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.426 0.631 . . . . 25.0 109.305 176.302 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -123.73 151.29 43.36 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.361 -1.718 . . . . 25.0 106.361 -179.557 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 57.37 43.4 23.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 123.27 1.509 . . . . 25.0 109.399 -176.803 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.7 t -66.55 149.46 50.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.629 -1.623 . . . . 25.0 110.349 -177.562 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 59.83 15.3 4.76 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.664 0.785 . . . . 25.0 112.642 178.355 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.81 14.62 82.18 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.903 -0.665 . . . . 25.0 112.187 -178.171 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.2 mt -94.36 113.68 25.61 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.342 -0.614 . . . . 25.0 109.342 -178.816 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -59.82 123.26 16.46 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.244 0.545 . . . . 25.0 110.734 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.76 -0.0 89.82 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-O 118.829 -0.984 . . . . 25.0 115.538 175.26 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -100.12 132.7 45.33 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 119.084 1.442 . . . . 25.0 109.335 177.012 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -113.08 140.03 48.2 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.592 -1.262 . . . . 25.0 107.592 -175.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.631 HD22 HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -82.47 123.13 28.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.193 -2.151 . . . . 25.0 105.193 177.818 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 95.5 m -130.5 163.39 27.13 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.993 0.425 . . . . 25.0 111.408 178.421 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -116.2 126.9 54.28 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 106.318 -1.734 . . . . 25.0 106.318 173.304 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.2 tp -151.57 135.58 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.26 -1.015 . . . . 25.0 108.26 -175.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 54.23 30.13 11.81 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.654 0.983 . . . . 25.0 113.654 -178.482 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.18 6.18 88.92 Favored Glycine 0 C--O 1.22 -0.777 0 C-N-CA 120.936 -0.649 . . . . 25.0 113.919 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -114.82 161.32 18.37 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.499 -1.297 . . . . 25.0 107.499 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -120.26 146.48 46.03 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 106.016 -1.846 . . . . 25.0 106.016 174.067 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.22 -164.48 31.42 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 108.286 -1.926 . . . . 25.0 108.286 -179.372 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.8 pt -114.51 150.19 16.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.596 0.712 . . . . 25.0 112.053 -174.72 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.448 HG12 ' HE2' ' A' ' 26' ' ' PHE . 3.2 m -144.78 146.18 30.74 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 114.539 -1.21 . . . . 25.0 108.749 -179.629 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.23 122.17 6.94 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 118.383 -0.611 . . . . 25.0 112.393 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.81 -17.88 75.55 Favored Glycine 0 C--O 1.219 -0.789 0 N-CA-C 115.148 0.819 . . . . 25.0 115.148 -176.583 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -59.79 -21.13 60.4 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 113.221 0.823 . . . . 25.0 113.221 -177.26 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.26 26.3 6.92 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.526 0.679 . . . . 25.0 110.368 -178.704 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 12' ' ' ALA . 11.2 mt -117.46 156.08 28.58 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 121.455 0.645 . . . . 25.0 110.365 175.88 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -119.14 122.81 42.88 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 173.438 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.8 mm -73.23 135.1 28.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.887 -1.153 . . . . 25.0 107.887 176.527 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt -115.23 97.2 6.06 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.825 -0.805 . . . . 25.0 108.825 178.412 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -88.64 165.46 2.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.13 -0.692 . . . . 25.0 109.13 178.285 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.5 155.87 21.01 Favored Glycine 0 C--O 1.219 -0.803 0 C-N-CA 120.687 -0.768 . . . . 25.0 111.758 178.652 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -137.47 1.69 2.4 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.697 0.399 . . . . 25.0 111.965 179.504 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -139.21 140.51 37.79 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.628 -1.249 . . . . 25.0 107.628 177.688 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -81.25 159.26 24.56 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 124.233 0.958 . . . . 25.0 110.073 179.584 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 65.3 mttm 46.0 35.8 2.65 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.909 1.818 . . . . 25.0 115.909 174.905 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -66.74 128.3 93.8 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 109.413 -0.588 . . . . 25.0 109.413 -179.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -87.41 -4.39 7.56 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 118.138 -0.775 . . . . 25.0 113.187 178.033 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.68 140.39 35.66 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 113.729 1.011 . . . . 25.0 113.729 -173.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.41 175.21 42.52 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 109.162 -1.575 . . . . 25.0 109.162 175.868 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.5 t 60.57 -173.18 0.13 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.882 0.873 . . . . 25.0 112.271 -177.806 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.27 -177.8 49.07 Favored Glycine 0 C--O 1.222 -0.63 0 N-CA-C 111.269 -0.732 . . . . 25.0 111.269 -178.631 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.88 88.06 1.21 Allowed Glycine 0 C--O 1.216 -1.016 0 C-N-CA 121.646 -0.311 . . . . 25.0 112.587 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.8 t -146.46 -179.69 6.93 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.9 -1.889 . . . . 25.0 105.9 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.87 20.86 27.39 Favored Glycine 0 C--O 1.226 -0.351 0 N-CA-C 111.717 -0.553 . . . . 25.0 111.717 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 55.9 m -64.68 139.27 58.75 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.123 -0.633 . . . . 25.0 110.698 178.337 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.36 -85.5 0.06 OUTLIER Glycine 0 CA--C 1.509 -0.316 0 N-CA-C 108.657 -1.777 . . . . 25.0 108.657 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.6 t 58.67 -157.06 0.32 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.539 0.736 . . . . 25.0 109.904 176.342 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.45 166.77 23.86 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.959 -1.126 . . . . 25.0 107.959 177.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.37 154.88 32.68 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.327 -0.62 . . . . 25.0 109.327 -175.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -137.71 -51.99 0.63 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.543 -0.91 . . . . 25.0 108.543 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -78.35 158.79 28.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.751 -0.659 . . . . 25.0 109.708 176.594 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.4 p -77.27 154.73 82.18 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 115.708 -0.678 . . . . 25.0 111.39 -179.155 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.54 159.32 51.57 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 117.827 -0.982 . . . . 25.0 111.923 178.091 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -65.74 154.39 74.08 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 118.81 -0.327 . . . . 25.0 112.486 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.09 153.88 62.6 Favored 'Trans proline' 0 C--O 1.237 0.473 0 N-CA-C 115.168 1.18 . . . . 25.0 115.168 -173.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -76.8 141.0 67.85 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 108.538 -0.912 . . . . 25.0 108.538 176.137 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.78 162.93 39.85 Favored 'Trans proline' 0 C--O 1.239 0.57 0 O-C-N 122.539 0.757 . . . . 25.0 111.932 175.681 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.79 150.76 39.73 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 118.282 -0.679 . . . . 25.0 113.485 -177.771 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -93.72 50.87 1.49 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.488 -0.56 . . . . 25.0 109.488 176.479 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.2 p 41.08 46.94 2.64 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.117 0.967 . . . . 25.0 112.331 -175.826 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -87.99 -10.49 50.27 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.127 -0.488 . . . . 25.0 110.874 -177.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 49.6 m -95.95 120.65 36.6 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.83 -0.804 . . . . 25.0 108.83 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 29.8 m 67.31 177.93 0.24 Allowed 'General case' 0 N--CA 1.469 0.501 0 O-C-N 124.377 1.048 . . . . 25.0 111.131 -177.186 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.6 tp . . . . . 0 C--O 1.208 -1.079 0 CA-C-O 125.117 2.389 . . . . 25.0 111.624 -177.202 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.806 0 CA-C-O 124.225 2.014 . . . . 25.0 113.127 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t 58.09 26.41 13.6 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 111.984 -2.108 . . . . 25.0 112.253 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.6 ttm -78.02 110.05 12.62 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.518 -0.549 . . . . 25.0 109.518 179.407 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -150.84 145.05 25.43 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.6 -1.63 . . . . 25.0 106.6 178.454 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 61.9 163.47 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 116.614 2.079 . . . . 25.0 116.614 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 mt -71.97 -41.61 67.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.104 -1.407 . . . . 25.0 110.006 -179.595 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 56.5 26.5 11.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.343 1.057 . . . . 25.0 112.304 -178.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.4 m -85.86 158.52 3.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.338 -1.727 . . . . 25.0 106.338 177.522 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.38 172.81 7.97 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 108.77 -0.826 . . . . 25.0 108.77 -177.056 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.14 165.84 32.66 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.719 -0.475 . . . . 25.0 109.719 174.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -131.16 136.26 48.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.092 -0.958 . . . . 25.0 110.113 177.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.573 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -73.36 127.16 31.89 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.861 -0.609 . . . . 25.0 110.453 172.883 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.3 mt -93.79 -19.54 20.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.216 0.532 . . . . 25.0 110.247 -178.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -146.67 175.96 10.2 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 103.285 -2.857 . . . . 25.0 103.285 178.082 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -91.42 175.98 6.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 118.719 0.69 . . . . 25.0 111.41 177.553 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -154.59 144.27 21.55 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.678 0.391 . . . . 25.0 111.106 177.848 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 80.0 t -113.38 125.25 70.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.5 -2.037 . . . . 25.0 105.5 176.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.46 131.41 41.77 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.057 -0.974 . . . . 25.0 109.6 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -104.98 -1.99 25.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.593 0.711 . . . . 25.0 109.934 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -147.07 156.77 46.94 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.167 -1.049 . . . . 25.0 108.167 -177.642 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.85 -19.7 40.34 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 118.309 -0.661 . . . . 25.0 112.729 177.388 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -72.96 -16.9 61.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.292 -0.413 . . . . 25.0 111.04 177.502 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -100.37 142.29 32.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.734 0.778 . . . . 25.0 110.887 -172.884 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.408 ' HB2' HG13 ' A' ' 57' ' ' VAL . 57.0 mt -95.3 127.03 41.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.458 -0.792 . . . . 25.0 109.884 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.7 p -87.17 145.91 26.23 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 105.31 -2.107 . . . . 25.0 105.31 173.198 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -159.59 165.09 33.52 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.113 -1.069 . . . . 25.0 108.113 -179.758 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.47 161.76 17.57 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.483 0.658 . . . . 25.0 110.063 177.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -56.99 129.4 41.54 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.509 -0.769 . . . . 25.0 110.48 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.58 -16.41 59.78 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-O 118.941 -0.922 . . . . 25.0 113.603 177.391 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -58.55 155.21 12.7 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.924 0.869 . . . . 25.0 111.525 179.459 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.0 mm -118.97 135.57 58.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.225 -1.352 . . . . 25.0 109.262 179.322 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -141.71 156.35 45.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.307 -0.627 . . . . 25.0 109.307 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.9 m -91.15 129.42 37.15 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.179 -1.045 . . . . 25.0 108.179 177.274 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.3 t -94.14 124.97 46.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.121 -1.066 . . . . 25.0 108.121 177.605 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.623 HD12 HD22 ' A' ' 47' ' ' LEU . 82.9 mt -93.69 -43.48 8.63 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.501 -0.772 . . . . 25.0 109.555 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -149.38 165.16 32.88 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.318 -0.993 . . . . 25.0 108.318 -175.261 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -126.64 153.32 45.52 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 107.045 -1.465 . . . . 25.0 107.045 176.112 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 56.48 39.43 29.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 123.477 1.608 . . . . 25.0 109.088 -179.075 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -69.27 155.38 40.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.207 -1.815 . . . . 25.0 110.477 -176.104 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 60.16 11.45 2.77 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.918 0.887 . . . . 25.0 113.209 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.08 16.93 79.11 Favored Glycine 0 CA--C 1.516 0.135 0 N-CA-C 110.9 -0.88 . . . . 25.0 110.9 -177.167 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.405 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 96.6 mt -98.18 114.53 26.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.02 0.438 . . . . 25.0 109.999 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -63.58 127.68 32.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.889 -0.596 . . . . 25.0 109.927 -178.695 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.74 -0.58 85.94 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 115.505 0.962 . . . . 25.0 115.505 176.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.405 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 92.0 m95 -100.86 130.03 46.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 118.565 1.182 . . . . 25.0 109.825 177.651 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -111.27 140.0 46.2 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.77 -0.456 . . . . 25.0 109.77 -175.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.623 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -79.78 120.88 24.65 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 105.585 -2.006 . . . . 25.0 105.585 178.93 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 86.0 m -131.52 163.55 27.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.966 0.412 . . . . 25.0 111.716 178.455 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.8 t -118.87 124.59 47.51 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.706 -1.59 . . . . 25.0 106.706 173.117 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.0 tp -151.72 142.71 23.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.779 -1.193 . . . . 25.0 107.779 -175.773 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 57.49 27.17 13.61 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.324 0.583 . . . . 25.0 112.235 177.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.62 4.49 90.36 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 114.859 0.703 . . . . 25.0 114.859 178.337 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -130.24 161.02 32.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.091 0.945 . . . . 25.0 109.43 179.432 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -107.89 153.29 23.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.221 -0.659 . . . . 25.0 109.221 177.846 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.95 -154.3 11.8 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 107.291 -2.324 . . . . 25.0 107.291 177.815 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.5 pt -124.69 153.22 31.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.378 0.609 . . . . 25.0 110.582 -175.729 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 24' ' ' LEU . 3.3 m -140.48 146.27 44.4 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 114.945 -1.025 . . . . 25.0 108.799 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.68 120.89 6.03 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 118.53 -0.514 . . . . 25.0 112.033 178.426 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.4 -17.05 70.1 Favored Glycine 0 C--O 1.222 -0.652 0 C-N-CA 121.576 -0.345 . . . . 25.0 113.191 -178.651 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -66.88 -6.91 18.26 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.944 0.72 . . . . 25.0 112.944 -179.282 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -135.79 26.63 3.34 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.577 -0.527 . . . . 25.0 109.577 175.282 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' A' ' 12' ' ' ALA . 1.6 tp -130.09 157.15 43.19 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 121.3 0.571 . . . . 25.0 111.603 -179.537 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -129.68 123.2 30.58 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.964 -0.562 . . . . 25.0 110.768 177.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.0 mm -70.09 135.93 27.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.797 -0.816 . . . . 25.0 108.797 176.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.7 mt -119.68 102.54 8.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.652 -1.24 . . . . 25.0 107.652 176.053 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.41 162.21 3.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.074 -0.713 . . . . 25.0 109.074 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -160.42 175.37 37.17 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 107.555 -2.218 . . . . 25.0 107.555 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.3 mtp -134.05 140.2 46.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.838 0.819 . . . . 25.0 109.614 -179.122 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 63.18 -29.19 0.09 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 118.526 2.787 . . . . 25.0 118.526 175.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -67.44 123.27 19.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.501 -0.925 . . . . 25.0 108.501 178.78 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -117.5 23.23 11.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.987 -1.006 . . . . 25.0 109.724 -174.524 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -144.05 160.84 48.03 Favored Pre-proline 0 C--O 1.22 -0.482 0 N-CA-C 106.226 -1.768 . . . . 25.0 106.226 177.39 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -69.86 150.04 67.04 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 114.165 -3.423 . . . . 25.0 110.071 171.424 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.62 4.45 3.14 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.077 1.51 . . . . 25.0 115.077 -176.353 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.92 16.8 74.06 Favored Glycine 0 CA--C 1.519 0.289 0 N-CA-C 115.899 1.12 . . . . 25.0 115.899 176.235 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.7 p -86.99 156.08 19.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.117 -0.698 . . . . 25.0 109.117 177.071 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.08 57.45 0.85 Allowed Glycine 0 C--O 1.224 -0.496 0 N-CA-C 111.876 -0.49 . . . . 25.0 111.876 -177.72 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.39 -156.45 25.76 Favored Glycine 0 C--O 1.227 -0.306 0 CA-C-O 121.4 0.444 . . . . 25.0 114.019 -177.395 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.9 p -62.8 144.79 56.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.126 0.489 . . . . 25.0 112.226 -179.421 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.61 -166.47 37.37 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 106.373 -2.691 . . . . 25.0 106.373 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.8 t -147.94 -65.36 0.25 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 117.79 0.795 . . . . 25.0 109.613 176.321 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.59 -152.75 46.65 Favored Glycine 0 C--O 1.226 -0.399 0 C-N-CA 120.478 -0.867 . . . . 25.0 111.477 178.456 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.5 t -159.49 140.93 12.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.597 -2.001 . . . . 25.0 105.597 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -66.71 138.77 57.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.973 -1.121 . . . . 25.0 107.973 178.461 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -103.44 -15.34 15.92 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 112.377 0.51 . . . . 25.0 112.377 -178.912 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 49.51 52.09 15.18 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.288 0.992 . . . . 25.0 110.341 178.093 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.98 161.28 8.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.596 -1.183 . . . . 25.0 112.02 -176.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.4 m -107.71 90.87 6.67 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 116.141 -0.481 . . . . 25.0 110.372 177.543 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.74 161.37 30.62 Favored 'Trans proline' 0 C--N 1.345 0.395 0 N-CA-C 115.877 1.453 . . . . 25.0 115.877 -176.108 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -69.57 160.54 49.37 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 117.34 -1.306 . . . . 25.0 110.404 169.538 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.87 156.48 65.76 Favored 'Trans proline' 0 C--N 1.344 0.307 0 N-CA-C 114.8 1.038 . . . . 25.0 114.8 -174.606 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -76.78 145.97 75.47 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 107.534 -1.284 . . . . 25.0 107.534 177.481 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.86 164.84 34.41 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 O-C-N 121.952 0.449 . . . . 25.0 112.753 -178.122 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.91 155.08 34.8 Favored 'Trans proline' 0 C--N 1.354 0.849 0 N-CA-C 114.205 0.81 . . . . 25.0 114.205 -178.348 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -116.08 22.48 12.92 Favored 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 112.876 0.695 . . . . 25.0 112.876 -175.758 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 44.9 p 55.06 14.53 0.98 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 116.542 2.052 . . . . 25.0 116.542 179.397 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.9 ptt-85 -158.29 -172.5 3.9 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.614 -1.995 . . . . 25.0 105.614 178.201 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.9 m 62.51 53.32 2.7 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 124.226 0.953 . . . . 25.0 111.324 -176.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.1 p -145.49 166.71 24.9 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 105.49 -2.041 . . . . 25.0 105.49 176.823 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 C--O 1.208 -1.1 0 CA-C-O 124.535 2.112 . . . . 25.0 111.43 -179.231 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.656 0 CA-C-O 124.149 1.972 . . . . 25.0 113.968 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m -64.79 -32.44 74.13 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 113.367 -1.417 . . . . 25.0 111.467 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.2 ttm 54.68 17.81 1.84 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.085 1.883 . . . . 25.0 116.085 176.83 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -86.38 74.62 9.93 Favored 'General case' 0 C--O 1.215 -0.744 0 O-C-N 121.873 -0.517 . . . . 25.0 109.821 178.163 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -136.1 163.53 30.13 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.379 -0.828 . . . . 25.0 108.89 179.52 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.4 mt -68.01 -39.2 83.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.366 -0.833 . . . . 25.0 110.492 178.698 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 57.88 28.58 16.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.142 0.977 . . . . 25.0 111.871 -179.138 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 m -94.79 176.12 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 105.416 -2.068 . . . . 25.0 105.416 176.353 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -119.74 174.11 6.63 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.999 -0.741 . . . . 25.0 108.999 177.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.44 154.34 36.42 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.189 -0.3 . . . . 25.0 110.189 177.828 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -111.27 130.89 55.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.924 -0.58 . . . . 25.0 110.172 178.574 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.93 117.67 12.74 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.223 -0.658 . . . . 25.0 109.223 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.6 mt -83.62 -25.64 30.65 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.28 0.562 . . . . 25.0 109.885 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -139.74 164.15 30.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.587 -1.188 . . . . 25.0 108.081 177.771 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.26 178.34 5.87 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 124.285 0.99 . . . . 25.0 112.782 -179.541 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -155.12 158.37 38.91 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.756 0.312 . . . . 25.0 111.269 172.037 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.0 t -127.51 129.11 70.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 104.13 -2.545 . . . . 25.0 104.13 173.37 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.68 135.91 33.96 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -115.51 -15.6 11.45 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.615 0.721 . . . . 25.0 109.653 175.398 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.4 t -112.55 146.72 35.57 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 106.396 -1.705 . . . . 25.0 106.396 179.737 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.65 -16.68 42.59 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 117.822 -0.985 . . . . 25.0 113.391 177.816 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -80.73 -18.02 49.16 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.24 1.019 . . . . 25.0 110.58 177.082 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -86.0 136.06 33.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.72 0.772 . . . . 25.0 111.716 -177.356 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.9 mt -86.08 127.55 34.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.734 -0.666 . . . . 25.0 110.575 179.515 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.2 t -89.95 132.83 35.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.809 -1.182 . . . . 25.0 107.809 174.906 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -160.02 172.78 16.91 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.154 -1.054 . . . . 25.0 108.154 -176.735 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.56 170.4 8.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 122.386 1.088 . . . . 25.0 111.545 178.866 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.33 135.87 57.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.709 -1.132 . . . . 25.0 109.437 -179.639 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.26 -9.04 78.44 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 118.67 -1.072 . . . . 25.0 113.782 179.155 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -63.78 143.51 57.78 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 118.703 1.251 . . . . 25.0 109.233 174.881 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.6 mm -106.31 130.86 57.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 106.877 -1.527 . . . . 25.0 106.877 178.435 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.7 ptp -134.69 146.54 49.56 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.358 0.263 . . . . 25.0 110.294 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -83.13 127.29 33.46 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.161 -1.051 . . . . 25.0 108.161 179.371 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -94.21 124.65 46.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.164 -1.05 . . . . 25.0 108.164 -179.504 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.602 HD12 HD22 ' A' ' 47' ' ' LEU . 77.0 mt -94.8 -45.81 7.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.787 -0.642 . . . . 25.0 109.893 -179.336 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -151.18 159.98 44.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.571 -0.9 . . . . 25.0 108.571 -175.605 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -118.85 148.96 42.32 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.985 -1.117 . . . . 25.0 107.985 177.108 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 56.68 38.95 29.91 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 123.374 1.559 . . . . 25.0 109.401 -179.812 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -64.88 150.02 48.49 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 113.129 -1.85 . . . . 25.0 110.91 -176.78 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 58.97 11.91 2.13 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.644 0.979 . . . . 25.0 113.644 180.0 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.13 10.33 84.99 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 110.958 -0.857 . . . . 25.0 110.958 -178.33 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 90.2 mt -86.5 106.99 17.9 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.15 -1.056 . . . . 25.0 108.15 179.226 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.45 125.07 22.68 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.234 -0.893 . . . . 25.0 110.064 -176.398 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.12 -0.12 89.93 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-O 118.879 -0.956 . . . . 25.0 115.236 178.056 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.403 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 94.5 m95 -101.3 132.6 46.76 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 118.944 1.372 . . . . 25.0 110.638 177.385 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -110.66 140.89 44.59 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.795 -0.817 . . . . 25.0 108.795 -178.481 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.602 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -81.67 121.83 26.86 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.58 -2.007 . . . . 25.0 105.58 178.534 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.4 m -132.02 163.93 27.32 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.852 0.686 . . . . 25.0 112.852 179.57 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.0 t -117.43 127.1 53.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.331 -1.359 . . . . 25.0 107.331 174.224 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tp -140.62 124.7 17.42 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.899 -0.778 . . . . 25.0 108.899 -177.903 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.4 m80 54.65 35.03 22.8 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.581 0.585 . . . . 25.0 112.581 -179.8 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.48 0.33 89.96 Favored Glycine 0 C--O 1.222 -0.601 0 N-CA-C 115.61 1.004 . . . . 25.0 115.61 176.03 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -119.73 159.64 24.12 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 107.464 -1.31 . . . . 25.0 107.464 176.686 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -117.58 159.6 22.63 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.874 -0.787 . . . . 25.0 108.874 -178.134 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.62 -159.18 27.84 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 105.327 -3.109 . . . . 25.0 105.327 179.259 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.3 pt -119.53 153.66 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.818 0.818 . . . . 25.0 112.253 -176.232 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 m -144.21 148.22 40.43 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.767 -1.106 . . . . 25.0 108.991 -179.311 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.1 125.19 7.75 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 117.259 -1.361 . . . . 25.0 112.133 -178.544 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.59 -17.33 76.38 Favored Glycine 0 C--O 1.219 -0.825 0 N-CA-C 114.982 0.753 . . . . 25.0 114.982 -175.472 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.59 -23.71 63.17 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.106 1.15 . . . . 25.0 114.106 -176.745 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.12 27.21 7.71 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.567 0.698 . . . . 25.0 110.375 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mt -114.65 155.15 27.11 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 121.339 0.59 . . . . 25.0 110.387 173.792 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -125.4 118.82 26.7 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 115.344 -0.844 . . . . 25.0 108.981 174.194 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.54 135.84 27.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.561 -0.533 . . . . 25.0 109.561 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.2 mt -115.46 105.37 12.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.525 -2.028 . . . . 25.0 105.525 175.776 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -78.5 162.21 4.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.959 0.409 . . . . 25.0 110.449 -177.349 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -147.03 178.55 24.59 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 107.453 -2.259 . . . . 25.0 107.453 178.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 28.1 ttt -133.61 110.35 9.83 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 118.354 1.077 . . . . 25.0 112.0 -177.517 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 55.32 24.42 6.51 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.175 1.546 . . . . 25.0 115.175 176.812 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -80.27 155.03 27.49 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.508 -0.923 . . . . 25.0 108.508 174.984 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.07 151.6 12.28 Favored 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 109.608 -0.515 . . . . 25.0 109.608 -174.868 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm 59.73 101.49 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.276 0 N-CA-C 114.212 1.19 . . . . 25.0 114.212 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -70.24 161.29 46.54 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 117.166 -1.423 . . . . 25.0 112.627 178.226 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.34 162.18 40.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 105.912 -1.885 . . . . 25.0 105.912 177.35 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.51 -168.22 52.59 Favored Glycine 0 C--N 1.323 -0.159 0 N-CA-C 110.842 -0.903 . . . . 25.0 110.842 -177.311 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.5 t -156.14 160.42 39.89 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.061 -1.459 . . . . 25.0 107.061 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.0 179.26 45.47 Favored Glycine 0 C--O 1.236 0.265 0 N-CA-C 110.002 -1.239 . . . . 25.0 110.002 -179.528 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 161.16 -163.8 34.55 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.442 -1.063 . . . . 25.0 110.442 -179.659 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 m 55.78 58.48 4.44 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.403 0.89 . . . . 25.0 113.403 176.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.17 147.55 38.18 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 121.98 0.767 . . . . 25.0 112.934 177.907 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.3 m -75.82 88.28 2.84 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 114.703 1.371 . . . . 25.0 114.703 -175.313 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.0 86.47 0.78 Allowed Glycine 0 C--O 1.226 -0.375 0 N-CA-C 109.667 -1.373 . . . . 25.0 109.667 171.425 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.7 m -89.82 159.01 17.22 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.068 -0.345 . . . . 25.0 110.068 -178.586 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 62.72 -164.27 0.25 Allowed 'General case' 0 N--CA 1.473 0.681 0 O-C-N 124.439 1.087 . . . . 25.0 111.907 -179.347 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.8 165.58 33.94 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.645 -1.613 . . . . 25.0 106.645 -175.969 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 61.23 -154.26 0.36 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.093 -1.077 . . . . 25.0 108.093 -175.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 t0 53.6 66.51 1.21 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 122.41 1.1 . . . . 25.0 108.564 -170.42 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -56.25 138.67 73.87 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 114.64 -1.164 . . . . 25.0 111.168 -174.065 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -62.18 158.96 36.93 Favored 'Trans proline' 0 C--O 1.243 0.763 0 N-CA-C 114.392 0.882 . . . . 25.0 114.392 -177.246 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.8 161.29 39.83 Favored 'Trans proline' 0 C--O 1.24 0.593 0 O-C-N 121.81 0.374 . . . . 25.0 111.389 175.175 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.36 158.22 56.28 Favored 'Trans proline' 0 C--N 1.348 0.54 0 N-CA-C 114.738 1.014 . . . . 25.0 114.738 -176.333 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -108.07 147.92 36.47 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 114.766 -1.106 . . . . 25.0 108.255 179.214 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.06 164.29 34.74 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 O-C-N 122.255 0.608 . . . . 25.0 112.775 -179.156 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -64.46 157.26 55.82 Favored 'Trans proline' 0 C--N 1.356 0.931 0 N-CA-C 113.711 0.62 . . . . 25.0 113.711 179.38 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.1 mtt85 -100.94 24.66 8.97 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.162 1.171 . . . . 25.0 114.162 -177.089 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.9 p -132.67 -63.64 0.78 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.2 -0.296 . . . . 25.0 110.2 177.319 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.95 150.12 33.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 103.597 -2.742 . . . . 25.0 103.597 174.942 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.1 t -78.87 151.82 31.6 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.593 -0.891 . . . . 25.0 108.593 179.485 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 75.7 m -114.84 19.94 15.53 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.571 -0.9 . . . . 25.0 108.571 176.366 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.3 tp . . . . . 0 C--O 1.212 -0.905 0 CA-C-O 124.793 2.235 . . . . 25.0 109.969 179.593 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.219 0 CA-C-O 124.153 1.974 . . . . 25.0 116.145 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 t -94.08 52.91 1.68 Allowed 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.286 -1.126 . . . . 25.0 112.016 -177.487 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 79.0 mtm -131.68 135.67 47.07 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.285 -0.635 . . . . 25.0 109.285 177.403 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -134.36 82.81 1.99 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.514 -1.661 . . . . 25.0 106.514 178.814 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -120.59 167.67 12.17 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.933 -0.576 . . . . 25.0 112.026 -173.512 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.14 -38.46 69.23 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 115.006 -0.997 . . . . 25.0 109.554 178.952 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.3 m120 53.37 39.3 29.66 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.295 1.045 . . . . 25.0 112.513 -179.469 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 m -103.11 168.34 2.24 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 N-CA-C 105.558 -2.015 . . . . 25.0 105.558 176.012 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.88 171.85 7.1 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.551 -1.277 . . . . 25.0 107.551 -177.408 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.67 162.27 37.94 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.974 -0.75 . . . . 25.0 108.974 174.649 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -128.18 130.48 48.1 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 123.673 0.789 . . . . 25.0 111.144 175.959 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.08 130.8 43.11 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 123.783 0.677 . . . . 25.0 109.882 177.045 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.3 mt -97.83 -22.06 16.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.938 0.399 . . . . 25.0 111.241 -178.094 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -141.17 170.01 16.53 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 106.912 -1.514 . . . . 25.0 106.912 178.124 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -76.12 165.73 24.5 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 122.78 0.432 . . . . 25.0 111.146 176.325 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -146.98 150.36 34.98 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.743 -0.598 . . . . 25.0 111.831 174.606 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.02 126.76 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 N-CA-C 105.697 -1.964 . . . . 25.0 105.697 178.079 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.46 122.82 30.15 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.758 -0.46 . . . . 25.0 109.758 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -104.03 14.03 31.42 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.985 0.898 . . . . 25.0 110.338 -179.666 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 t -156.47 149.45 18.41 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 106.321 -1.733 . . . . 25.0 106.321 -178.133 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -69.74 -16.4 37.62 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 117.152 -1.432 . . . . 25.0 112.55 175.457 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.28 -21.88 58.18 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 176.849 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -89.25 139.38 30.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.961 0.886 . . . . 25.0 109.338 -178.404 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.425 ' HB2' HG13 ' A' ' 57' ' ' VAL . 61.5 mt -90.14 129.48 36.41 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.848 0.833 . . . . 25.0 110.257 179.441 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.08 134.44 33.83 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.442 -1.688 . . . . 25.0 106.442 178.042 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -154.04 161.97 41.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.831 0.287 . . . . 25.0 111.559 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.71 162.04 17.34 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.722 -1.214 . . . . 25.0 107.722 -179.273 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.19 129.97 44.68 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.974 -0.557 . . . . 25.0 109.8 179.198 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.36 -13.9 63.99 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 119.039 -0.867 . . . . 25.0 114.151 179.587 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -59.77 148.68 33.47 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-N 117.92 0.86 . . . . 25.0 111.07 177.394 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.5 mm -118.84 129.8 74.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.31 -1.313 . . . . 25.0 109.043 -179.002 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -136.16 155.45 50.13 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.336 -0.987 . . . . 25.0 108.336 -178.196 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.7 m -88.83 124.39 34.12 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.385 -0.598 . . . . 25.0 109.385 177.58 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.1 t -87.43 125.08 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 108.424 -0.954 . . . . 25.0 108.424 177.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.576 HD12 HD22 ' A' ' 47' ' ' LEU . 81.4 mt -91.0 -46.29 8.23 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.364 -1.347 . . . . 25.0 107.364 178.814 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -155.87 170.7 21.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.646 -0.872 . . . . 25.0 108.646 177.438 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.9 mtm105 -117.37 154.57 31.08 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.25 -1.759 . . . . 25.0 106.25 177.067 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 59.05 42.97 18.22 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 125.478 1.736 . . . . 25.0 109.192 179.465 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -70.83 157.37 38.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.005 -1.452 . . . . 25.0 110.372 -176.627 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 60.15 10.08 2.14 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.019 0.928 . . . . 25.0 113.363 177.786 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.4 20.62 68.87 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.762 -0.732 . . . . 25.0 111.572 -176.821 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 70.6 mt -102.49 122.84 45.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.58 0.229 . . . . 25.0 111.287 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.57 123.63 17.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.256 0.551 . . . . 25.0 111.02 177.522 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.81 -0.24 82.87 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 116.131 1.212 . . . . 25.0 116.131 172.444 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -99.49 131.12 45.71 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 118.879 1.34 . . . . 25.0 109.427 177.705 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.439 ' CE3' HD23 ' A' ' 62' ' ' LEU . 42.6 m0 -110.65 143.45 41.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.729 -0.841 . . . . 25.0 108.729 -176.045 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.576 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -85.15 123.06 30.22 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 106.21 -1.774 . . . . 25.0 106.21 178.407 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.2 m -132.24 166.88 20.86 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.868 -0.333 . . . . 25.0 110.848 178.048 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -118.13 122.03 42.05 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.735 -1.58 . . . . 25.0 106.735 173.897 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.6 tp -150.58 140.02 21.44 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.79 -0.818 . . . . 25.0 108.79 -177.693 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.9 m170 57.5 30.77 19.23 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.628 0.771 . . . . 25.0 110.934 -179.534 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.89 0.03 87.68 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 115.381 0.912 . . . . 25.0 115.381 176.837 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -124.6 158.25 33.5 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 118.006 0.903 . . . . 25.0 110.148 179.266 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -102.1 149.58 24.12 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 106.564 -1.643 . . . . 25.0 106.564 178.661 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.89 -167.49 36.59 Favored Glycine 0 N--CA 1.433 -1.535 0 N-CA-C 107.825 -2.11 . . . . 25.0 107.825 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.6 pt -111.18 153.14 12.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.646 0.736 . . . . 25.0 111.574 -173.364 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.425 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.7 m -143.01 142.95 23.12 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.146 -0.934 . . . . 25.0 109.464 179.334 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.08 124.06 8.8 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 118.374 -0.617 . . . . 25.0 112.065 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.32 -12.3 79.86 Favored Glycine 0 C--O 1.221 -0.706 0 C-N-CA 120.83 -0.7 . . . . 25.0 114.505 -176.155 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -71.45 -7.85 50.03 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.084 0.772 . . . . 25.0 113.084 -176.676 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -132.16 27.23 4.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.666 -0.864 . . . . 25.0 108.666 178.351 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.439 HD23 ' CE3' ' A' ' 46' ' ' TRP . 16.3 tp -134.1 149.55 51.11 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.424 -0.807 . . . . 25.0 111.739 -174.116 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -128.17 123.02 33.31 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.38 0.272 . . . . 25.0 111.628 -178.29 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.9 mm -67.98 136.66 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.225 -0.657 . . . . 25.0 109.225 176.845 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.7 mt -118.43 100.96 7.8 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.396 -1.335 . . . . 25.0 107.396 175.293 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -86.6 132.77 31.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 107.669 -1.234 . . . . 25.0 107.669 177.244 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 170.07 176.82 39.95 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 109.677 -1.369 . . . . 25.0 109.677 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 15.8 tpt -78.48 145.23 35.09 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.114 -1.069 . . . . 25.0 108.114 178.096 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -77.12 160.65 28.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.632 -0.507 . . . . 25.0 109.632 177.884 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -141.16 154.6 45.94 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 109.924 -0.399 . . . . 25.0 109.924 178.617 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -72.24 148.58 45.35 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 123.426 0.69 . . . . 25.0 110.344 -178.259 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -141.79 149.0 51.78 Favored Pre-proline 0 N--CA 1.468 0.464 0 N-CA-C 106.122 -1.807 . . . . 25.0 106.122 178.043 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.26 -13.43 20.89 Favored 'Trans proline' 0 C--N 1.347 0.466 0 N-CA-C 115.415 1.275 . . . . 25.0 115.415 -175.565 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.95 -44.6 0.12 Allowed 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 121.231 0.539 . . . . 25.0 110.47 -179.823 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.85 -78.12 0.24 Allowed Glycine 0 CA--C 1.511 -0.216 0 N-CA-C 110.953 -0.859 . . . . 25.0 110.953 178.902 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.8 p -151.35 171.86 16.82 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.512 -0.921 . . . . 25.0 108.512 179.396 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.6 176.21 53.8 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 106.947 -2.461 . . . . 25.0 106.947 170.549 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -163.5 -173.31 32.05 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.655 -1.26 . . . . 25.0 110.509 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.3 p 67.94 176.81 0.25 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.812 1.245 . . . . 25.0 112.009 -175.645 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.0 129.69 3.14 Favored Glycine 0 C--O 1.243 0.706 0 N-CA-C 110.463 -1.055 . . . . 25.0 110.463 -176.462 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.7 m -98.75 155.03 17.55 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.85 0.357 . . . . 25.0 110.411 -175.665 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.27 -109.14 2.71 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.015 -0.612 . . . . 25.0 114.539 177.191 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 t 57.55 48.26 14.66 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.431 -0.951 . . . . 25.0 108.431 -173.753 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -126.89 24.96 6.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 113.968 -1.469 . . . . 25.0 110.391 -174.229 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -102.99 162.56 12.83 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.317 -0.856 . . . . 25.0 110.6 -175.894 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.426 ' HG2' ' H ' ' A' ' 87' ' ' ASP . 4.5 tt0 71.42 -171.84 0.16 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.933 1.396 . . . . 25.0 112.154 178.562 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.426 ' H ' ' HG2' ' A' ' 86' ' ' GLN . 9.0 m-20 -67.9 150.86 48.01 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.6 0.714 . . . . 25.0 112.71 -175.311 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.1 m -65.84 140.9 97.43 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.924 -0.58 . . . . 25.0 112.459 -178.643 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -62.73 157.94 44.85 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 119.753 0.302 . . . . 25.0 112.617 177.376 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -62.21 148.23 93.6 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 117.31 -1.327 . . . . 25.0 111.935 176.945 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.68 147.88 82.18 Favored 'Trans proline' 0 C--O 1.217 -0.545 0 N-CA-C 114.985 1.11 . . . . 25.0 114.985 -169.485 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -64.07 146.91 97.16 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.7 -0.852 . . . . 25.0 108.7 -177.937 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.94 156.76 64.34 Favored 'Trans proline' 0 C--O 1.238 0.481 0 C-N-CA 115.575 -2.483 . . . . 25.0 111.176 173.263 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -60.69 154.75 52.77 Favored 'Trans proline' 0 C--O 1.212 -0.814 0 C-N-CA 118.389 -0.607 . . . . 25.0 110.552 175.43 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -89.3 -77.42 0.38 Allowed 'General case' 0 C--O 1.211 -0.959 0 CA-C-O 121.009 0.433 . . . . 25.0 110.599 178.065 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.91 -36.46 0.12 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.936 0.874 . . . . 25.0 111.518 -179.74 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -132.57 35.62 3.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.688 -0.687 . . . . 25.0 110.964 -174.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 48.8 m -81.54 152.35 27.32 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.001 -1.0 . . . . 25.0 108.449 178.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 25.8 p -146.77 164.5 32.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.839 -1.912 . . . . 25.0 105.839 175.582 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 C--O 1.206 -1.219 0 CA-C-O 124.137 1.922 . . . . 25.0 112.926 -178.841 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.989 0 CA-C-O 124.202 2.001 . . . . 25.0 113.269 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 m 56.68 31.74 19.83 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 112.359 -1.92 . . . . 25.0 113.043 179.676 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 83.1 mtp -97.53 144.12 27.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.281 -0.418 . . . . 25.0 110.646 179.474 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -81.2 108.66 15.03 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.444 -0.576 . . . . 25.0 109.444 179.858 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -135.0 169.02 18.05 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.686 0.755 . . . . 25.0 112.502 -179.712 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.87 -42.21 90.62 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.869 -0.789 . . . . 25.0 108.869 176.659 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.6 m120 51.6 46.74 26.05 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.783 0.802 . . . . 25.0 110.407 -178.752 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 m -109.26 166.7 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 104.348 -2.464 . . . . 25.0 104.348 176.747 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.84 172.16 6.99 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 -176.436 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.86 158.61 43.46 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.927 -0.397 . . . . 25.0 109.927 173.455 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -124.88 129.66 50.83 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.417 -0.81 . . . . 25.0 109.817 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.77 130.53 42.57 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.271 -0.64 . . . . 25.0 109.271 178.69 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.7 mt -95.29 -20.72 18.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.543 -0.299 . . . . 25.0 111.472 -177.536 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -145.96 170.36 16.78 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.31 -0.996 . . . . 25.0 108.31 -179.891 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -73.93 160.4 31.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.598 -0.519 . . . . 25.0 109.598 177.041 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -145.97 154.37 41.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.838 0.352 . . . . 25.0 110.724 172.928 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 p -132.39 136.06 56.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 105.398 -2.075 . . . . 25.0 105.398 178.483 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.94 139.57 33.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.081 -0.509 . . . . 25.0 111.06 -175.192 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -121.68 9.3 10.14 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.577 0.703 . . . . 25.0 109.662 178.177 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 t -148.85 151.02 34.19 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 105.867 -1.901 . . . . 25.0 105.867 -177.733 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -67.52 -21.69 45.9 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 117.799 -1.0 . . . . 25.0 113.024 178.708 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.32 -17.57 58.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.961 0.41 . . . . 25.0 111.197 178.516 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -89.76 134.38 34.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.927 0.87 . . . . 25.0 111.866 -172.267 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.449 ' HB2' HG13 ' A' ' 57' ' ' VAL . 62.6 mt -89.08 126.24 35.36 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.266 -0.879 . . . . 25.0 110.822 178.907 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -86.94 141.31 28.81 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.021 -1.844 . . . . 25.0 106.021 174.082 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.13 168.07 28.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.757 0.313 . . . . 25.0 110.634 -177.467 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -116.33 162.9 16.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.224 0.535 . . . . 25.0 110.105 178.388 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.48 134.55 57.12 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.744 -0.662 . . . . 25.0 109.466 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.99 -12.73 68.75 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 116.132 -0.486 . . . . 25.0 113.014 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -62.46 138.98 58.57 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.692 -0.855 . . . . 25.0 108.692 177.761 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.1 mm -105.86 132.77 52.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.936 -1.029 . . . . 25.0 108.385 177.838 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.1 ptp -139.33 152.05 46.88 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.711 -0.478 . . . . 25.0 109.711 -178.446 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 m -89.76 123.11 33.47 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.515 -0.92 . . . . 25.0 108.515 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.97 125.81 41.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 108.847 -0.797 . . . . 25.0 108.847 178.639 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.691 HD12 HD22 ' A' ' 47' ' ' LEU . 70.8 mt -91.68 -47.77 7.19 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.4 -0.963 . . . . 25.0 108.4 179.464 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -155.37 173.88 16.03 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 110.308 -0.256 . . . . 25.0 110.308 178.443 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.9 mtm105 -123.74 157.96 32.77 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 106.029 -1.841 . . . . 25.0 106.029 176.699 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.8 t0 59.43 40.26 21.01 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 123.419 1.581 . . . . 25.0 107.449 -177.349 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -68.82 144.51 54.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.114 -1.403 . . . . 25.0 107.787 -177.689 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 59.8 12.28 2.92 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.899 0.88 . . . . 25.0 113.241 -179.276 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.29 16.83 79.01 Favored Glycine 0 C--N 1.331 0.265 0 N-CA-C 111.465 -0.654 . . . . 25.0 111.465 -178.231 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.3 mt -94.36 105.1 17.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.183 -0.673 . . . . 25.0 109.183 179.101 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -58.53 130.15 45.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 122.03 0.919 . . . . 25.0 110.807 -177.749 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.7 -6.35 70.16 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.085 -0.961 . . . . 25.0 115.037 178.009 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -95.83 139.26 32.3 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 118.944 1.372 . . . . 25.0 109.306 176.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 34.6 m0 -118.88 142.88 47.34 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.756 -1.201 . . . . 25.0 107.756 -176.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.691 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -85.71 121.83 28.94 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 105.308 -2.108 . . . . 25.0 105.308 178.888 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.1 m -130.97 157.62 42.46 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.333 0.587 . . . . 25.0 111.907 179.194 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.5 t -107.46 123.62 48.66 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 105.849 -1.908 . . . . 25.0 105.849 171.823 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 tp -144.61 135.08 24.5 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.83 -0.804 . . . . 25.0 108.83 -176.074 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 56.73 27.22 12.37 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 176.334 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.6 4.53 82.85 Favored Glycine 0 C--O 1.228 -0.275 0 N-CA-C 114.417 0.527 . . . . 25.0 114.417 178.481 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -131.78 162.09 31.34 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.959 0.879 . . . . 25.0 109.496 178.602 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -110.38 155.07 22.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.207 -0.664 . . . . 25.0 109.207 179.516 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.98 -163.49 31.16 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 106.832 -2.507 . . . . 25.0 106.832 176.81 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.9 pt -111.77 153.44 13.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 121.671 0.748 . . . . 25.0 110.157 -177.35 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -141.26 145.0 36.56 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.09 -0.959 . . . . 25.0 109.33 179.186 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.17 121.12 6.98 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 CA-C-O 121.659 0.608 . . . . 25.0 111.372 178.417 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.81 -9.21 74.72 Favored Glycine 0 C--O 1.218 -0.846 0 C-N-CA 121.131 -0.557 . . . . 25.0 114.056 -176.218 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -66.43 -17.02 64.55 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.337 -0.507 . . . . 25.0 112.091 -178.073 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -128.2 26.56 5.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.748 -0.66 . . . . 25.0 109.414 -177.578 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.2 tp -132.99 145.0 50.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.532 0.682 . . . . 25.0 109.973 -176.572 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -122.72 120.28 33.17 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.504 -0.771 . . . . 25.0 111.425 -177.112 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.2 mm -67.73 134.39 30.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 O-C-N 123.663 0.602 . . . . 25.0 109.652 177.542 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.3 mt -117.74 99.65 7.08 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.067 -1.827 . . . . 25.0 106.067 174.495 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.5 m -74.87 157.09 6.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.03 0.443 . . . . 25.0 109.848 -177.594 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.78 83.43 1.45 Allowed Glycine 0 C--O 1.218 -0.903 0 N-CA-C 109.28 -1.528 . . . . 25.0 109.28 175.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.48 -13.96 60.4 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.109 0.481 . . . . 25.0 110.29 -179.539 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -116.77 138.02 51.78 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 106.025 -1.843 . . . . 25.0 106.025 176.567 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 58.84 177.46 0.07 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.451 1.095 . . . . 25.0 113.503 -176.622 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -101.76 80.32 2.02 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.334 -1.358 . . . . 25.0 107.334 -177.659 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 mttt 54.72 72.39 1.1 Allowed Pre-proline 0 N--CA 1.479 0.998 0 CA-C-N 114.685 -1.143 . . . . 25.0 112.624 -176.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -72.42 -8.97 23.55 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 121.66 1.573 . . . . 25.0 114.882 -178.554 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 59.0 16.89 4.97 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.94 1.459 . . . . 25.0 114.94 177.575 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.63 160.68 39.74 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 121.179 -0.534 . . . . 25.0 112.102 178.952 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.1 m -139.77 164.61 29.49 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 109.381 -0.6 . . . . 25.0 109.381 -179.346 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.32 -51.27 0.32 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 116.681 1.432 . . . . 25.0 116.681 174.336 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.69 82.41 1.41 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 116.177 1.231 . . . . 25.0 116.177 -174.839 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 66.4 p -65.0 -37.92 89.25 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 112.708 0.633 . . . . 25.0 112.708 -179.239 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.4 -155.51 17.52 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 109.853 -1.299 . . . . 25.0 109.853 -179.166 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.3 m -147.82 163.52 36.51 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.886 -0.783 . . . . 25.0 108.886 -178.863 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.56 152.2 7.69 Favored Glycine 0 C--O 1.226 -0.404 0 N-CA-C 109.528 -1.429 . . . . 25.0 109.528 179.361 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.7 t -139.19 21.96 2.59 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.567 0.683 . . . . 25.0 111.886 -176.144 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -109.06 -50.66 2.97 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.429 1.27 . . . . 25.0 114.429 -176.605 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt 63.43 -160.18 0.3 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.571 -0.9 . . . . 25.0 108.571 -173.288 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -144.05 130.02 19.48 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.712 -1.588 . . . . 25.0 106.712 178.969 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -73.17 -30.27 63.44 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.906 0.706 . . . . 25.0 112.906 -177.655 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.2 m -121.54 84.91 42.87 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 112.122 0.416 . . . . 25.0 112.122 -178.801 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -77.78 164.32 27.99 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 N-CA-C 113.365 0.486 . . . . 25.0 113.365 178.121 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -64.1 150.71 87.79 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 118.279 -0.681 . . . . 25.0 111.62 175.721 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.51 160.57 48.06 Favored 'Trans proline' 0 C--N 1.35 0.618 0 N-CA-C 116.456 1.675 . . . . 25.0 116.456 -172.328 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -67.34 149.84 98.19 Favored Pre-proline 0 N--CA 1.468 0.433 0 CA-C-N 115.543 -0.753 . . . . 25.0 110.147 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.25 156.55 61.81 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 117.137 -1.442 . . . . 25.0 110.757 172.333 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.72 151.42 80.7 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 117.133 -1.445 . . . . 25.0 110.364 174.653 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -81.62 -61.36 1.95 Allowed 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 119.836 -0.746 . . . . 25.0 109.943 177.136 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.65 -40.13 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 105.537 -2.023 . . . . 25.0 105.537 -176.55 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -56.87 121.12 9.14 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 114.264 -1.335 . . . . 25.0 112.878 -178.461 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.4 m -97.52 4.88 50.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.719 -0.673 . . . . 25.0 110.909 173.791 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 48.7 t -140.9 140.88 34.6 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.982 0.896 . . . . 25.0 110.93 -176.17 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 C--O 1.208 -1.089 0 CA-C-O 123.966 1.841 . . . . 25.0 111.218 179.661 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 116.166 1.226 . . . . 25.0 116.166 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 m 71.3 161.73 0.24 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.549 1.939 . . . . 25.0 113.083 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -111.9 27.99 9.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.42 -0.809 . . . . 25.0 109.84 -179.057 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.3 tptp -96.69 17.24 16.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.864 -0.607 . . . . 25.0 110.616 -177.249 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -131.09 159.2 38.28 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.071 0.767 . . . . 25.0 113.071 -175.45 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.6 mt -63.96 -38.72 92.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.984 -1.007 . . . . 25.0 110.83 179.647 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 52.61 41.87 31.35 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.267 1.032 . . . . 25.0 110.87 -179.661 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' A' ' 34' ' ' VAL . 16.0 m -103.29 173.23 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 102.97 -2.974 . . . . 25.0 102.97 174.891 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -118.4 172.61 7.34 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 118.649 0.658 . . . . 25.0 109.401 -178.346 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.43 160.26 43.6 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.918 -0.583 . . . . 25.0 109.533 176.561 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -118.84 133.09 56.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.101 -0.954 . . . . 25.0 108.863 177.023 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.584 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -71.91 126.28 29.33 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 173.75 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.8 mt -88.63 -22.29 23.54 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.433 -0.58 . . . . 25.0 109.433 -178.698 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -144.05 175.17 10.24 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 105.116 -2.179 . . . . 25.0 105.116 179.214 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -86.47 -179.99 6.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 118.15 0.432 . . . . 25.0 109.937 175.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -154.99 143.56 20.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.111 0.481 . . . . 25.0 111.721 174.652 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.6 t -107.26 123.9 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 105.084 -2.191 . . . . 25.0 105.084 175.928 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.99 121.67 22.32 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.274 -1.01 . . . . 25.0 108.274 178.394 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -110.97 -2.06 16.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.647 0.737 . . . . 25.0 109.197 -179.71 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.3 m -129.34 152.6 79.78 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 107.55 -1.278 . . . . 25.0 107.55 179.083 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.92 -20.55 33.91 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 118.352 -0.632 . . . . 25.0 113.363 -179.561 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -16.94 46.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.925 -0.579 . . . . 25.0 110.383 179.565 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -87.19 139.82 30.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.627 0.727 . . . . 25.0 111.602 -172.476 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.8 mt -91.88 129.86 37.76 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.69 0.757 . . . . 25.0 109.75 177.336 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.34 142.48 27.85 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 105.708 -1.96 . . . . 25.0 105.708 173.327 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -156.41 167.72 29.58 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.788 -0.449 . . . . 25.0 109.788 -179.037 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.62 161.56 17.29 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.676 0.75 . . . . 25.0 111.142 -179.079 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -56.89 127.19 30.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.993 -1.003 . . . . 25.0 109.71 178.275 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.23 -11.77 70.01 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-O 119.093 -0.837 . . . . 25.0 114.682 178.01 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.51 138.82 54.72 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 118.18 0.99 . . . . 25.0 111.63 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.1 mm -102.28 130.22 52.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.194 -1.039 . . . . 25.0 108.194 175.333 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.0 ptp -135.65 153.28 51.68 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.439 -0.578 . . . . 25.0 109.439 -178.781 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.0 m -88.8 128.21 35.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.25 -1.389 . . . . 25.0 107.25 178.519 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 8' ' ' VAL . 61.8 t -94.22 121.67 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 107.421 -1.326 . . . . 25.0 107.421 178.821 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.624 HD12 HD22 ' A' ' 47' ' ' LEU . 78.4 mt -91.7 -43.66 9.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.157 -0.929 . . . . 25.0 109.947 -177.981 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -152.2 162.6 40.89 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.483 -1.303 . . . . 25.0 107.483 -177.037 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -124.7 153.56 42.15 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.203 -1.036 . . . . 25.0 108.203 176.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 55.8 40.17 30.7 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 123.731 1.729 . . . . 25.0 108.393 -178.929 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -70.36 158.96 35.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 112.95 -1.932 . . . . 25.0 110.57 -175.457 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 60.87 8.32 1.8 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.112 0.965 . . . . 25.0 113.389 179.598 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.85 17.85 74.05 Favored Glycine 0 CA--C 1.517 0.174 0 N-CA-C 110.551 -1.019 . . . . 25.0 110.551 -176.861 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.3 mt -99.51 123.3 43.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.007 0.432 . . . . 25.0 110.397 -179.535 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -64.78 129.69 40.73 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.06 -0.518 . . . . 25.0 110.456 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.13 -0.75 66.29 Favored Glycine 0 C--O 1.24 0.488 0 N-CA-C 116.617 1.407 . . . . 25.0 116.617 174.44 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -100.5 129.99 46.52 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 118.692 1.246 . . . . 25.0 109.736 178.728 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -111.65 140.07 46.58 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.74 -0.467 . . . . 25.0 109.74 -175.776 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.624 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -80.45 120.48 24.51 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.237 -1.764 . . . . 25.0 106.237 178.541 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.8 m -131.41 163.75 27.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.096 0.474 . . . . 25.0 111.884 178.683 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.9 t -120.03 123.95 44.69 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.062 -1.458 . . . . 25.0 107.062 173.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.8 tp -148.61 136.59 20.87 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.823 -0.806 . . . . 25.0 108.823 -176.707 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 56.17 26.98 10.91 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.551 1.315 . . . . 25.0 114.551 174.758 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.36 8.97 84.37 Favored Glycine 0 C--O 1.227 -0.297 0 C-N-CA 121.006 -0.616 . . . . 25.0 113.197 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -119.9 157.52 28.58 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.127 -1.064 . . . . 25.0 108.127 178.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -122.22 147.79 45.76 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 105.353 -2.091 . . . . 25.0 105.353 173.107 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.26 -155.59 17.25 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 107.201 -2.36 . . . . 25.0 107.201 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.9 pt -122.37 149.53 25.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 121.396 0.617 . . . . 25.0 111.05 -174.581 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.6 m -138.22 147.2 54.86 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.087 -0.96 . . . . 25.0 109.166 -178.909 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.84 119.12 5.73 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 O-C-N 122.037 0.493 . . . . 25.0 112.272 178.539 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.39 -18.65 69.84 Favored Glycine 0 C--O 1.223 -0.575 0 C-N-CA 121.226 -0.511 . . . . 25.0 113.429 -178.275 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -64.18 -17.98 64.04 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.202 0.815 . . . . 25.0 113.202 -178.428 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -122.58 27.29 7.9 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.343 0.592 . . . . 25.0 109.628 177.022 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 12' ' ' ALA . 1.4 tp -128.77 157.62 40.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 25.0 111.757 -179.618 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -131.37 120.03 22.52 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.067 -0.515 . . . . 25.0 110.869 177.339 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.7 mm -69.32 136.95 25.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.293 -0.632 . . . . 25.0 109.293 178.739 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.7 mt -115.55 91.82 3.72 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.713 -1.218 . . . . 25.0 107.713 177.103 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.7 m -81.37 -14.47 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 113.353 0.871 . . . . 25.0 113.353 -176.599 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.58 89.55 1.61 Allowed Glycine 0 C--O 1.226 -0.356 0 N-CA-C 106.381 -2.688 . . . . 25.0 106.381 -169.72 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 98.4 mtp -80.53 95.72 6.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 121.892 -0.77 . . . . 25.0 110.959 -173.967 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 65.49 12.39 8.14 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.628 1.171 . . . . 25.0 113.293 178.237 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -144.11 169.06 18.58 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.125 -1.435 . . . . 25.0 107.125 174.967 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -69.96 151.75 45.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.361 0.601 . . . . 25.0 111.543 -176.53 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -69.12 153.34 96.12 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 105.781 -1.933 . . . . 25.0 105.781 172.143 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -66.62 151.76 82.11 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 117.007 -1.529 . . . . 25.0 112.91 -177.855 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.95 12.31 3.39 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.177 0.806 . . . . 25.0 113.177 -176.977 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.35 176.3 46.04 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.717 -0.953 . . . . 25.0 110.717 -179.437 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.4 m -68.24 148.67 50.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.661 0.267 . . . . 25.0 110.994 179.586 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.0 -178.45 48.25 Favored Glycine 0 CA--C 1.508 -0.347 0 N-CA-C 109.915 -1.274 . . . . 25.0 109.915 179.413 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 144.6 -51.7 0.62 Allowed Glycine 0 C--O 1.229 -0.212 0 N-CA-C 110.928 -0.869 . . . . 25.0 110.928 178.676 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.8 m 62.34 164.76 0.1 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 115.531 1.678 . . . . 25.0 115.531 177.276 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.14 169.6 35.81 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 107.752 -2.139 . . . . 25.0 107.752 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.8 m -135.7 11.13 3.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.826 0.813 . . . . 25.0 111.933 -178.726 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.15 -127.48 29.96 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 110.683 -0.967 . . . . 25.0 110.683 -177.237 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.2 t 71.01 -53.77 0.67 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.498 1.519 . . . . 25.0 112.38 -178.367 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.37 139.81 54.18 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.985 -1.117 . . . . 25.0 107.985 174.71 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -158.75 10.61 0.14 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.172 0.804 . . . . 25.0 113.172 -174.71 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.08 113.13 10.42 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 108.095 -1.076 . . . . 25.0 108.095 -179.329 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -153.73 166.22 33.54 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.747 -1.205 . . . . 25.0 107.747 -178.429 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.0 t -122.3 92.72 48.87 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.908 0.385 . . . . 25.0 110.401 -179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.21 154.04 36.62 Favored 'Trans proline' 0 C--N 1.346 0.418 0 N-CA-C 115.754 1.405 . . . . 25.0 115.754 -176.293 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -71.91 158.98 51.63 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 118.064 -0.824 . . . . 25.0 110.701 173.163 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -67.94 155.16 70.79 Favored 'Trans proline' 0 C--O 1.234 0.317 0 N-CA-C 114.977 1.106 . . . . 25.0 114.977 -173.267 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -81.95 144.45 51.48 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 107.617 -1.253 . . . . 25.0 107.617 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.04 156.91 55.41 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 117.698 -1.068 . . . . 25.0 111.557 -179.024 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -64.67 146.06 88.0 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 116.991 -1.539 . . . . 25.0 113.834 -177.915 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -85.6 49.38 1.75 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.039 -0.413 . . . . 25.0 110.866 174.506 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 77.6 p 47.27 10.21 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 118.745 2.869 . . . . 25.0 118.745 -178.669 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -124.5 -12.99 7.18 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.699 1.37 . . . . 25.0 114.699 -178.257 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.9 t 48.56 30.59 2.53 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 116.74 2.126 . . . . 25.0 116.74 177.24 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 81.1 m -72.22 122.6 21.34 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 121.467 -0.77 . . . . 25.0 109.576 177.908 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.296 0 C-N-CA 126.07 1.748 . . . . 25.0 113.761 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 CA-C-O 123.843 1.801 . . . . 25.0 114.116 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 t -143.02 127.73 18.14 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.067 -1.457 . . . . 25.0 107.067 177.324 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.0 ttm -157.99 -68.39 0.09 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.115 0.783 . . . . 25.0 113.115 -175.547 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 65.0 179.57 0.18 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.804 1.242 . . . . 25.0 109.245 -173.797 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 55.53 174.38 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 116.769 2.137 . . . . 25.0 116.769 -177.733 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.6 mt -79.33 -42.07 26.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.082 -0.963 . . . . 25.0 110.568 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 56.42 27.08 11.54 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.414 1.085 . . . . 25.0 112.287 -178.441 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.7 m -86.53 170.94 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 104.441 -2.429 . . . . 25.0 104.441 174.061 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mp -116.33 172.78 6.97 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.033 -0.729 . . . . 25.0 109.033 179.407 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.04 155.17 42.0 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.731 -0.47 . . . . 25.0 109.731 177.292 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -114.02 131.05 56.5 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.535 -0.757 . . . . 25.0 109.553 176.896 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.427 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -69.15 127.13 32.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.133 -0.692 . . . . 25.0 109.133 174.171 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.6 mt -92.44 -23.14 19.26 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.939 -0.393 . . . . 25.0 109.939 -178.319 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -143.16 167.06 23.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.059 -1.089 . . . . 25.0 108.059 -179.159 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -75.73 166.22 23.87 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 122.668 0.387 . . . . 25.0 111.824 177.892 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -145.57 156.83 43.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.968 0.413 . . . . 25.0 111.373 174.252 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.9 t -123.5 122.62 65.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 105.239 -2.134 . . . . 25.0 105.239 173.51 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.23 127.58 32.87 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.363 -0.977 . . . . 25.0 108.363 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -113.17 12.98 19.18 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.961 0.886 . . . . 25.0 109.52 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 t -152.08 147.44 19.79 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 106.3 -1.741 . . . . 25.0 106.3 -179.487 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.98 -23.6 67.73 Favored 'Trans proline' 0 C--N 1.347 0.456 0 O-C-N 122.23 0.595 . . . . 25.0 113.079 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -76.26 -21.12 56.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.343 0.592 . . . . 25.0 110.351 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -88.29 130.74 35.03 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.241 -1.022 . . . . 25.0 108.241 -178.385 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.443 ' HB2' HG13 ' A' ' 57' ' ' VAL . 54.2 mt -81.76 133.18 35.32 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.697 0.76 . . . . 25.0 109.803 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.39 125.09 34.54 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.331 -0.989 . . . . 25.0 108.331 177.568 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -145.43 164.36 31.79 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 120.972 0.415 . . . . 25.0 110.445 -179.31 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.35 167.73 12.01 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.334 0.587 . . . . 25.0 110.086 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -58.83 130.43 46.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.342 -0.844 . . . . 25.0 109.44 -179.092 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.26 -12.15 69.42 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-O 118.504 -1.164 . . . . 25.0 114.938 177.172 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -59.97 150.01 30.23 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.439 1.119 . . . . 25.0 111.483 177.523 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.2 mm -114.81 127.06 72.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.61 -1.177 . . . . 25.0 108.642 177.283 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.8 ptp -132.74 151.06 52.08 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.293 -0.632 . . . . 25.0 109.293 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -84.82 130.35 34.68 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.247 -1.02 . . . . 25.0 108.247 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.8 t -98.18 121.14 48.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.534 -0.913 . . . . 25.0 108.534 179.561 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.609 HD12 HD22 ' A' ' 47' ' ' LEU . 80.7 mt -87.7 -46.81 9.17 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.972 -0.558 . . . . 25.0 109.66 -179.375 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -155.01 171.11 20.27 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.115 -0.698 . . . . 25.0 109.115 178.238 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -117.66 157.81 25.78 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.323 -1.362 . . . . 25.0 107.323 177.681 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 57.63 37.93 27.57 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 125.127 1.517 . . . . 25.0 109.85 177.559 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 t -66.45 152.11 45.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.847 -1.524 . . . . 25.0 110.612 -175.529 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 60.97 6.89 1.32 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.362 1.065 . . . . 25.0 112.766 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.59 12.7 74.65 Favored Glycine 0 C--O 1.224 -0.472 0 N-CA-C 111.414 -0.674 . . . . 25.0 111.414 -177.094 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.2 mt -88.08 125.02 34.35 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.745 -0.465 . . . . 25.0 109.745 179.334 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -64.53 124.79 22.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.699 0.285 . . . . 25.0 110.272 178.085 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.69 -0.63 76.26 Favored Glycine 0 C--O 1.242 0.596 0 N-CA-C 116.68 1.432 . . . . 25.0 116.68 172.568 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -96.67 135.8 38.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.885 1.343 . . . . 25.0 108.984 179.002 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -111.36 144.32 40.75 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.858 -0.793 . . . . 25.0 108.858 -178.14 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.609 HD22 HD12 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -83.92 120.49 26.15 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 104.524 -2.398 . . . . 25.0 104.524 176.572 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 93.2 m -129.17 163.03 26.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 121.006 -0.278 . . . . 25.0 111.503 179.843 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.5 t -116.79 123.84 48.12 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.292 -1.373 . . . . 25.0 107.292 173.619 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.7 tp -146.49 129.1 16.08 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 108.571 -0.9 . . . . 25.0 108.571 -176.303 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 27.7 m170 55.91 32.7 20.25 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.412 0.523 . . . . 25.0 112.412 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.71 3.15 86.93 Favored Glycine 0 C--O 1.222 -0.64 0 C-N-CA 120.816 -0.707 . . . . 25.0 113.987 178.972 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 mtt-85 -111.1 153.95 24.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.575 -1.269 . . . . 25.0 107.575 178.487 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -120.41 147.15 45.45 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 106.683 -1.599 . . . . 25.0 106.683 175.038 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.73 -158.46 22.21 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 106.997 -2.441 . . . . 25.0 106.997 -177.433 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.5 pt -115.36 153.01 16.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.75 0.786 . . . . 25.0 111.572 -175.205 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.5 m -144.47 146.37 32.41 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 114.797 -1.092 . . . . 25.0 109.191 179.348 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.07 114.5 4.06 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 CA-C-O 121.609 0.587 . . . . 25.0 112.175 178.459 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.19 -17.74 68.43 Favored Glycine 0 C--O 1.221 -0.683 0 N-CA-C 114.551 0.58 . . . . 25.0 114.551 -177.572 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -65.06 -15.21 62.1 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.722 0.638 . . . . 25.0 112.722 -178.567 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -123.44 26.24 7.95 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.755 -0.59 . . . . 25.0 110.239 176.817 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 12' ' ' ALA . 12.3 mt -125.88 156.95 38.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.594 0.711 . . . . 25.0 110.949 178.207 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -127.92 119.05 24.74 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.255 -0.884 . . . . 25.0 110.531 177.446 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.0 mm -66.8 133.53 31.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 O-C-N 123.797 0.686 . . . . 25.0 109.531 178.4 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.1 mt -114.3 94.04 4.62 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.712 -1.218 . . . . 25.0 107.712 175.914 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 m -80.26 7.54 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.498 0.666 . . . . 25.0 109.973 176.712 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.79 28.59 71.84 Favored Glycine 0 C--O 1.22 -0.771 0 CA-C-N 116.109 -0.496 . . . . 25.0 112.022 -179.474 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 43.7 ttp -18.51 -54.5 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 120.239 3.422 . . . . 25.0 120.239 -173.598 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -66.4 -27.72 68.06 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 115.597 1.702 . . . . 25.0 115.597 -173.987 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -138.83 9.22 2.59 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 122.394 1.092 . . . . 25.0 109.903 -176.534 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 69.1 tttt 58.54 25.53 13.22 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 114.45 -1.25 . . . . 25.0 110.192 -171.856 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -145.33 149.21 40.41 Favored Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 106.59 -1.633 . . . . 25.0 106.59 -178.231 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.52 151.26 75.55 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 118.309 -0.661 . . . . 25.0 113.461 -176.569 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.1 -27.26 60.8 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.905 1.076 . . . . 25.0 113.905 -176.656 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 136.82 -175.33 21.13 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.759 -0.734 . . . . 25.0 112.086 -178.459 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.1 p -141.08 60.27 1.51 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 122.888 0.475 . . . . 25.0 110.116 -177.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.4 -0.21 56.99 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 115.602 1.001 . . . . 25.0 115.602 -177.557 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.32 164.31 11.29 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 109.257 -1.537 . . . . 25.0 109.257 -179.065 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.1 m -162.77 100.77 1.01 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.689 0.745 . . . . 25.0 111.408 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.4 -176.19 31.2 Favored Glycine 0 C--O 1.22 -0.769 0 C-N-CA 121.182 -0.533 . . . . 25.0 113.034 176.766 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.9 t -161.02 -59.8 0.05 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.637 -1.245 . . . . 25.0 107.637 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.05 167.0 24.96 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 107.897 -2.081 . . . . 25.0 107.897 172.161 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.0 m -119.39 148.24 43.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.684 -0.858 . . . . 25.0 108.684 178.884 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -98.9 160.66 14.11 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.506 -0.553 . . . . 25.0 109.506 -178.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -132.79 10.82 4.32 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.875 0.369 . . . . 25.0 111.567 178.543 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -107.99 -8.47 15.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.805 -0.634 . . . . 25.0 110.928 -177.173 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.87 136.92 57.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.119 -0.492 . . . . 25.0 110.304 -179.13 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.1 m -118.43 86.75 28.96 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.768 -0.651 . . . . 25.0 109.851 -179.668 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.3 155.93 59.72 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 117.87 -0.954 . . . . 25.0 113.36 -178.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -69.72 158.16 57.98 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 116.755 -1.697 . . . . 25.0 111.191 176.258 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -59.21 153.71 51.02 Favored 'Trans proline' 0 C--N 1.346 0.397 0 N-CA-C 113.817 0.66 . . . . 25.0 113.817 -178.613 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -67.21 140.56 95.61 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 106.51 -1.663 . . . . 25.0 106.51 176.207 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.12 160.31 50.41 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 117.384 -1.278 . . . . 25.0 110.959 176.973 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.57 147.09 96.23 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 116.86 -1.627 . . . . 25.0 114.438 -176.079 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -88.97 64.9 7.34 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.051 -1.092 . . . . 25.0 108.051 174.987 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.57 110.14 10.89 Favored 'General case' 0 C--O 1.212 -0.868 0 CA-C-N 115.078 -0.964 . . . . 25.0 109.558 -177.894 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -92.49 29.82 1.64 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.075 0.464 . . . . 25.0 111.87 -176.688 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.5 m -82.78 75.43 9.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.76 -0.654 . . . . 25.0 110.848 -179.37 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 14.8 t -130.95 156.0 45.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.414 -0.588 . . . . 25.0 109.414 -178.266 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.21 -0.975 0 CA-C-O 124.595 2.14 . . . . 25.0 112.179 178.934 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 CA-C-O 122.578 1.099 . . . . 25.0 115.484 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 t 57.27 36.94 27.96 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.401 1.081 . . . . 25.0 113.862 176.867 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -78.73 76.81 5.22 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.15 -0.685 . . . . 25.0 109.15 175.252 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -78.1 109.63 12.35 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.177 -0.675 . . . . 25.0 109.177 -177.73 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -133.53 167.23 20.84 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.707 -0.678 . . . . 25.0 110.402 -177.344 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.0 mt -67.87 -40.25 83.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.752 -0.658 . . . . 25.0 109.655 177.836 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.5 m120 55.75 24.7 7.54 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.972 -1.013 . . . . 25.0 112.787 -178.48 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.1 m -84.57 158.19 3.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.519 -1.289 . . . . 25.0 107.519 177.754 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.48 167.74 11.13 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.781 -0.822 . . . . 25.0 108.781 -177.175 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.29 158.76 44.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.991 0.424 . . . . 25.0 110.427 175.665 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -123.79 132.25 53.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.065 -0.971 . . . . 25.0 109.601 -179.808 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.23 132.18 40.91 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.376 -0.601 . . . . 25.0 109.376 177.274 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.5 mt -100.43 -17.4 17.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.42 -0.355 . . . . 25.0 110.388 -179.514 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -145.56 169.95 17.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 104.598 -2.371 . . . . 25.0 104.598 177.951 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -89.44 177.36 6.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.578 0.626 . . . . 25.0 110.618 176.175 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -154.44 136.4 14.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.971 -0.559 . . . . 25.0 110.492 175.297 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.7 t -104.35 121.36 55.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 104.643 -2.354 . . . . 25.0 104.643 175.368 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.22 135.69 49.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.413 -0.812 . . . . 25.0 109.253 -179.029 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -113.1 9.09 18.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.64 0.733 . . . . 25.0 109.271 -178.472 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 t -156.17 152.75 24.04 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.347 -0.842 . . . . 25.0 108.82 -175.577 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -70.31 -19.05 33.99 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 117.941 -0.906 . . . . 25.0 114.312 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.95 -17.01 56.19 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.481 -0.563 . . . . 25.0 109.481 178.048 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -93.74 142.33 27.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.515 0.674 . . . . 25.0 111.107 -175.729 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.433 ' HB2' HG13 ' A' ' 57' ' ' VAL . 55.7 mt -94.69 131.96 39.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.682 0.753 . . . . 25.0 110.102 178.959 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.5 p -90.94 140.17 30.07 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 105.882 -1.896 . . . . 25.0 105.882 174.661 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -156.05 164.91 37.84 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 120.806 0.336 . . . . 25.0 110.251 -179.325 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.427 HH22 ' HB2' ' A' ' 84' ' ' GLU . 16.2 mmt180 -108.53 158.58 17.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.037 0.922 . . . . 25.0 109.473 179.171 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -57.64 133.91 55.72 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.842 -1.072 . . . . 25.0 109.645 175.363 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.79 -12.32 70.14 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-O 119.022 -0.877 . . . . 25.0 113.644 178.655 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -60.67 146.44 45.61 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 118.116 0.958 . . . . 25.0 110.721 178.187 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.0 mm -110.86 129.23 66.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 107.935 -1.135 . . . . 25.0 107.935 177.6 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.3 ptp -136.79 165.97 24.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.999 -0.741 . . . . 25.0 108.999 -179.091 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -103.81 123.61 47.39 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.752 -0.833 . . . . 25.0 108.752 178.761 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.7 t -88.2 124.41 41.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.698 -1.223 . . . . 25.0 107.698 177.668 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.625 HD12 HD22 ' A' ' 47' ' ' LEU . 65.7 mt -93.68 -43.56 8.59 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.133 -0.939 . . . . 25.0 108.929 -179.667 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -148.49 155.16 40.81 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 106.784 -1.562 . . . . 25.0 106.784 -172.798 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -118.87 154.35 33.06 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 106.241 -1.763 . . . . 25.0 106.241 173.957 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 58.16 37.7 26.32 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 123.477 1.608 . . . . 25.0 108.324 178.638 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -68.46 159.43 31.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.043 -1.89 . . . . 25.0 111.018 -175.933 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 59.31 12.1 2.47 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.795 1.035 . . . . 25.0 113.795 177.131 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.36 18.35 78.14 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 110.628 -0.989 . . . . 25.0 110.628 -177.213 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.7 mt -104.07 115.94 31.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.069 0.462 . . . . 25.0 109.859 -179.454 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -66.25 131.12 45.4 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 -178.239 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.93 -1.56 78.69 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 115.427 0.931 . . . . 25.0 115.427 176.175 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -99.85 132.55 45.13 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 118.866 1.333 . . . . 25.0 109.014 177.059 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -113.09 139.26 48.86 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.429 -0.582 . . . . 25.0 109.429 -175.961 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.625 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -80.54 122.5 27.11 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 106.08 -1.822 . . . . 25.0 106.08 179.684 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 92.9 m -132.81 163.25 29.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.28 0.562 . . . . 25.0 112.288 178.634 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -115.37 127.98 55.77 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.16 -1.793 . . . . 25.0 106.16 171.248 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.8 tp -154.9 141.22 18.62 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 107.244 -1.391 . . . . 25.0 107.244 -175.343 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 55.91 26.99 10.41 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 112.651 0.612 . . . . 25.0 112.651 178.384 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.06 4.53 88.83 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 114.711 0.644 . . . . 25.0 114.711 178.733 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -126.64 161.4 28.16 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.501 -0.926 . . . . 25.0 108.501 -179.677 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -112.89 156.73 22.44 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.92 -1.141 . . . . 25.0 107.92 179.045 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.89 -161.24 30.66 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 106.509 -2.636 . . . . 25.0 106.509 179.521 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.6 pt -117.36 153.99 19.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.327 0.584 . . . . 25.0 111.878 -175.871 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.6 m -142.81 148.63 46.78 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 114.974 -1.012 . . . . 25.0 109.141 -179.023 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.18 122.42 7.11 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 CA-C-O 121.612 0.588 . . . . 25.0 112.799 -179.799 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.08 -24.44 67.05 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 116.308 -0.406 . . . . 25.0 113.739 -178.431 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -24.1 65.46 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.391 -0.476 . . . . 25.0 112.036 179.049 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -105.65 11.86 31.76 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.938 0.347 . . . . 25.0 111.938 -179.543 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.0 mt -121.78 152.5 39.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.704 1.24 . . . . 25.0 113.946 -177.539 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -120.36 123.53 43.32 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 113.687 -1.597 . . . . 25.0 108.812 176.004 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.0 mm -76.59 138.33 20.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.64 -0.874 . . . . 25.0 108.64 179.103 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.5 mt -117.38 88.06 2.83 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.966 -1.494 . . . . 25.0 106.966 176.7 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.1 m -73.07 150.57 8.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.0 0.428 . . . . 25.0 109.998 -179.77 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.83 177.39 29.92 Favored Glycine 0 C--O 1.227 -0.324 0 N-CA-C 108.21 -1.956 . . . . 25.0 108.21 179.606 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 23.6 ttt -134.41 126.89 30.46 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 105.783 -1.932 . . . . 25.0 105.783 178.467 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 56.25 75.53 0.34 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 116.325 1.972 . . . . 25.0 116.325 -178.823 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -89.45 -90.48 0.14 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.107 0.48 . . . . 25.0 111.481 173.634 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -136.01 156.89 48.07 Favored 'General case' 0 CA--C 1.512 -0.495 0 O-C-N 121.564 -0.71 . . . . 25.0 110.168 -176.234 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -126.99 84.04 64.47 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.232 -0.655 . . . . 25.0 109.232 177.435 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.29 -19.17 17.51 Favored 'Trans proline' 0 C--N 1.346 0.406 0 N-CA-C 114.523 0.932 . . . . 25.0 114.523 -176.308 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 67.69 -41.64 0.43 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.189 1.552 . . . . 25.0 115.189 -177.864 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.54 -174.7 39.37 Favored Glycine 0 C--O 1.229 -0.204 0 N-CA-C 111.401 -0.68 . . . . 25.0 111.401 178.747 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.2 m -131.85 147.39 52.48 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.729 -0.841 . . . . 25.0 108.729 179.754 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.86 43.54 3.09 Favored Glycine 0 C--O 1.225 -0.459 0 N-CA-C 115.171 0.828 . . . . 25.0 115.171 -176.537 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.77 175.77 44.36 Favored Glycine 0 CA--C 1.511 -0.166 0 CA-C-N 117.857 0.828 . . . . 25.0 112.023 179.684 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 69.6 m -148.35 150.41 33.53 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.832 -1.544 . . . . 25.0 106.832 178.294 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.38 -36.29 20.91 Favored Glycine 0 C--O 1.227 -0.314 0 N-CA-C 115.92 1.128 . . . . 25.0 115.92 -174.783 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.9 m 54.11 -151.44 0.35 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.956 0.378 . . . . 25.0 110.548 -176.611 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.07 -39.65 2.26 Favored Glycine 0 C--O 1.221 -0.682 0 N-CA-C 116.501 1.36 . . . . 25.0 116.501 175.78 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.3 t 62.76 17.01 9.49 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.015 0.926 . . . . 25.0 112.121 -177.134 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.427 ' HB2' HH22 ' A' ' 27' ' ' ARG . 52.2 mt-10 -81.97 170.89 15.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.767 -0.652 . . . . 25.0 109.474 177.621 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.35 163.82 31.76 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.398 -1.334 . . . . 25.0 107.398 179.317 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -138.74 171.86 13.72 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.74 0.644 . . . . 25.0 112.74 -174.376 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 58.77 -164.73 0.19 Allowed 'General case' 0 N--CA 1.474 0.753 0 O-C-N 124.411 1.07 . . . . 25.0 112.797 178.028 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.5 m -120.64 84.95 37.81 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 105.524 -2.028 . . . . 25.0 105.524 172.452 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.89 156.41 30.83 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 N-CA-C 114.969 1.104 . . . . 25.0 114.969 -171.46 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.77 164.75 34.44 Favored 'Trans proline' 0 C--O 1.243 0.728 0 C-N-CA 119.914 0.41 . . . . 25.0 111.349 175.231 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.7 166.71 25.16 Favored 'Trans proline' 0 C--N 1.344 0.335 0 N-CA-C 114.429 0.896 . . . . 25.0 114.429 -177.297 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -99.29 136.96 20.31 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 105.755 -1.943 . . . . 25.0 105.755 174.561 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.76 162.5 41.85 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 117.83 -0.98 . . . . 25.0 112.647 -175.98 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -61.1 155.24 51.92 Favored 'Trans proline' 0 C--N 1.348 0.547 0 N-CA-C 113.867 0.68 . . . . 25.0 113.867 -178.986 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -111.91 41.11 2.01 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.189 -0.46 . . . . 25.0 110.983 179.181 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.0 p 52.56 -21.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 120.406 3.484 . . . . 25.0 120.406 -178.109 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -71.78 32.9 0.05 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.632 1.173 . . . . 25.0 113.538 179.119 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.3 t -90.15 -30.06 17.88 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 122.692 0.397 . . . . 25.0 110.861 -179.029 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.17 -47.2 10.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.842 0.829 . . . . 25.0 111.504 -178.619 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 C--O 1.218 -0.573 0 CA-C-O 123.836 1.779 . . . . 25.0 110.234 179.748 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.632 0 CA-C-O 123.66 1.7 . . . . 25.0 114.152 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.0 m 57.91 31.17 20.2 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 113.159 -1.521 . . . . 25.0 111.611 -179.261 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 48.2 ttm -82.31 54.96 2.72 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.797 -0.638 . . . . 25.0 109.379 178.563 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? 60.46 18.64 8.4 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.524 1.129 . . . . 25.0 112.156 -175.851 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -97.37 161.29 13.86 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.231 0.538 . . . . 25.0 110.539 177.751 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.21 -40.59 86.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.896 -1.047 . . . . 25.0 109.139 176.797 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.0 m120 54.99 30.47 14.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.138 0.975 . . . . 25.0 111.906 -178.136 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.7 m -89.22 164.77 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 106.362 -1.718 . . . . 25.0 106.362 175.862 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.37 173.49 6.42 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.68 -1.23 . . . . 25.0 107.68 -178.893 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.9 157.76 43.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.661 0.267 . . . . 25.0 110.42 174.865 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -122.71 130.74 53.29 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.648 -0.705 . . . . 25.0 109.781 175.962 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.54 129.64 38.76 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.01 -0.541 . . . . 25.0 109.549 175.71 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.0 mt -94.42 -21.76 18.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.914 0.388 . . . . 25.0 110.859 -178.006 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -143.95 169.41 17.87 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.993 -2.225 . . . . 25.0 104.993 177.856 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -84.03 167.74 16.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.131 0.491 . . . . 25.0 110.407 177.332 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -148.53 130.9 15.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.934 -0.575 . . . . 25.0 110.341 179.257 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.0 t -102.93 123.46 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 105.078 -2.193 . . . . 25.0 105.078 176.16 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.91 135.74 51.5 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.522 -1.217 . . . . 25.0 110.072 179.558 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -113.98 0.46 14.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.337 0.589 . . . . 25.0 110.284 -179.551 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.0 m -145.6 155.34 52.97 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 107.966 -1.124 . . . . 25.0 107.966 -177.421 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.34 -17.71 39.35 Favored 'Trans proline' 0 C--N 1.347 0.468 0 N-CA-C 113.805 0.656 . . . . 25.0 113.805 -177.415 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.91 -16.99 39.26 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.234 0.54 . . . . 25.0 110.22 179.003 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -87.45 136.03 33.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.98 0.895 . . . . 25.0 111.754 -175.605 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.426 ' HB2' HG13 ' A' ' 57' ' ' VAL . 47.3 mt -86.19 130.79 34.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.746 -0.661 . . . . 25.0 109.4 178.96 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.8 t -91.46 137.15 32.59 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.458 -2.053 . . . . 25.0 105.458 175.025 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -156.46 164.79 37.83 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.924 -0.399 . . . . 25.0 109.924 -177.86 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.49 162.53 15.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.514 0.673 . . . . 25.0 110.465 -177.496 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -57.32 128.39 36.76 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.163 -0.926 . . . . 25.0 109.131 176.165 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.57 -15.67 61.67 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 118.752 -1.027 . . . . 25.0 114.728 178.197 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -59.08 146.19 39.46 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.993 0.897 . . . . 25.0 111.139 -178.845 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.0 mm -110.57 134.17 53.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.448 -1.251 . . . . 25.0 108.627 178.72 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.9 ptp -141.58 157.69 44.78 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.439 0.296 . . . . 25.0 110.334 -177.961 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.5 m -92.27 130.88 37.86 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.531 -0.914 . . . . 25.0 108.531 177.232 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.95 129.6 45.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.322 -0.992 . . . . 25.0 108.322 177.527 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.702 HD12 HD22 ' A' ' 47' ' ' LEU . 76.2 mt -94.43 -52.47 4.32 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.827 -0.805 . . . . 25.0 108.827 -179.671 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -149.99 163.91 36.86 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.902 -1.147 . . . . 25.0 107.902 177.822 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.434 ' HE ' ' HB3' ' A' ' 37' ' ' ARG . 8.6 mtp180 -106.81 157.44 17.75 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 109.672 -0.492 . . . . 25.0 109.672 176.474 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 56.02 39.58 30.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 123.526 1.632 . . . . 25.0 108.859 170.319 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.9 t -64.42 152.29 41.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 112.474 -2.148 . . . . 25.0 110.677 -176.502 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 59.78 11.65 2.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.207 1.003 . . . . 25.0 113.104 -179.595 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.75 20.29 79.56 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.686 -0.965 . . . . 25.0 110.686 -177.402 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.2 mt -94.69 118.89 32.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.293 -1.003 . . . . 25.0 108.293 177.953 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -64.72 128.31 35.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.923 -0.581 . . . . 25.0 110.396 -177.882 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.74 -0.75 70.01 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 115.932 1.133 . . . . 25.0 115.932 176.274 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -99.61 129.98 45.8 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 119.181 1.491 . . . . 25.0 109.59 177.93 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -113.88 141.32 47.49 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.916 -0.772 . . . . 25.0 108.916 -176.149 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.702 HD22 HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -81.68 120.31 24.95 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.14 -1.8 . . . . 25.0 106.14 179.473 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 88.8 m -133.77 167.78 19.91 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.005 0.431 . . . . 25.0 111.578 -179.992 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.4 t -120.33 116.54 25.73 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.463 -1.31 . . . . 25.0 107.463 173.826 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -146.03 144.85 30.33 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.441 -1.318 . . . . 25.0 107.441 -175.902 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.55 27.24 15.39 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.378 0.671 . . . . 25.0 112.334 -179.555 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.95 4.84 90.44 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 114.657 0.623 . . . . 25.0 114.657 177.705 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.1 ptt85 -132.82 161.04 35.18 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.067 0.934 . . . . 25.0 109.775 179.379 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -102.6 154.24 19.32 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.282 -0.636 . . . . 25.0 109.282 177.02 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.24 -158.02 22.46 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 106.54 -2.624 . . . . 25.0 106.54 178.297 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.8 pt -118.39 151.64 20.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.542 0.687 . . . . 25.0 110.877 -175.297 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' A' ' 24' ' ' LEU . 2.4 m -140.8 146.96 46.46 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 114.931 -1.032 . . . . 25.0 108.85 -179.113 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.91 122.59 5.89 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 118.31 -0.66 . . . . 25.0 112.284 179.235 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.21 -14.87 64.64 Favored Glycine 0 C--O 1.223 -0.581 0 CA-C-N 116.11 -0.495 . . . . 25.0 112.821 -179.703 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.73 -28.26 63.72 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 122.957 0.503 . . . . 25.0 112.346 179.693 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.57 25.42 9.77 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.556 0.217 . . . . 25.0 111.51 178.869 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.4 tp -128.57 144.13 51.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.636 0.731 . . . . 25.0 111.611 -174.626 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -119.59 119.98 35.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.332 -0.849 . . . . 25.0 110.935 -177.921 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.0 mm -68.96 134.93 29.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.212 -0.662 . . . . 25.0 109.212 177.509 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.5 mt -117.91 105.17 11.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.675 -1.602 . . . . 25.0 106.675 176.215 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.8 m -68.83 159.57 5.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.965 0.412 . . . . 25.0 110.001 -178.833 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -164.61 175.37 40.61 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 108.569 -1.812 . . . . 25.0 108.569 -179.845 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 97.2 mtp -80.73 150.94 29.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.27 0.535 . . . . 25.0 110.555 -179.429 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -82.87 17.07 2.0 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.302 0.641 . . . . 25.0 111.188 176.902 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -65.69 131.26 45.9 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.983 -1.118 . . . . 25.0 107.983 179.051 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -86.23 70.43 10.54 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.429 0.529 . . . . 25.0 112.429 -170.167 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -113.9 89.82 17.43 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.006 -0.543 . . . . 25.0 110.196 177.762 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -79.28 42.76 1.35 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.724 2.283 . . . . 25.0 114.707 -175.574 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.69 -39.11 90.92 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.127 0.489 . . . . 25.0 110.973 -179.294 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.25 173.72 46.52 Favored Glycine 0 CA--C 1.518 0.271 0 CA-C-N 115.95 -0.568 . . . . 25.0 112.472 -179.386 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.4 m -158.58 156.23 29.75 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.264 -1.384 . . . . 25.0 107.264 179.447 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 146.23 -174.56 26.09 Favored Glycine 0 C--O 1.224 -0.531 0 N-CA-C 109.95 -1.26 . . . . 25.0 109.95 178.81 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.18 12.87 84.21 Favored Glycine 0 C--O 1.224 -0.49 0 N-CA-C 114.658 0.623 . . . . 25.0 114.658 177.316 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.0 t -149.31 155.99 41.39 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.626 -0.879 . . . . 25.0 108.626 -179.319 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.08 143.59 8.43 Favored Glycine 0 C--O 1.227 -0.292 0 N-CA-C 110.791 -0.924 . . . . 25.0 110.791 -178.373 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.3 m -163.05 -179.53 6.78 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 105.756 -1.942 . . . . 25.0 105.756 -177.556 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.28 15.19 39.13 Favored Glycine 0 C--O 1.226 -0.374 0 N-CA-C 115.263 0.865 . . . . 25.0 115.263 174.802 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.8 m -73.26 116.73 14.15 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 176.131 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -148.59 146.28 28.18 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.608 -1.627 . . . . 25.0 106.608 -179.551 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 69.4 tttt 64.65 132.36 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.596 1.558 . . . . 25.0 114.867 -179.547 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -73.19 -7.13 50.09 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.492 -0.776 . . . . 25.0 112.424 179.645 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 t0 59.56 -150.7 0.43 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.973 -0.751 . . . . 25.0 108.973 -179.398 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.3 m -118.9 84.97 27.35 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 108.022 -1.103 . . . . 25.0 108.022 175.693 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.39 147.73 20.46 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 N-CA-C 115.532 1.32 . . . . 25.0 115.532 -172.061 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.87 167.65 25.79 Favored 'Trans proline' 0 C--O 1.241 0.668 0 C-N-CA 119.807 0.338 . . . . 25.0 112.185 176.036 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.03 172.2 15.18 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 118.36 -0.627 . . . . 25.0 112.156 176.21 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -107.83 147.4 35.36 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 107.423 -1.325 . . . . 25.0 107.423 174.958 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.47 162.01 42.61 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 118.339 -0.64 . . . . 25.0 111.791 178.023 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -63.12 153.79 71.62 Favored 'Trans proline' 0 C--N 1.35 0.625 0 N-CA-C 114.323 0.855 . . . . 25.0 114.323 -178.861 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -102.7 4.81 38.52 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 120.67 0.271 . . . . 25.0 111.604 177.161 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 44.5 p -135.32 153.77 51.75 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.166 -0.679 . . . . 25.0 109.166 -178.857 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -122.48 79.81 1.66 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 109.324 -0.621 . . . . 25.0 109.324 -177.518 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.9 t -57.35 -37.76 73.09 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.915 1.08 . . . . 25.0 113.915 -176.325 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.9 t 56.51 28.86 14.45 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.942 0.877 . . . . 25.0 112.853 -179.257 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.1 tp . . . . . 0 C--O 1.214 -0.773 0 CA-C-O 124.604 2.145 . . . . 25.0 110.856 178.66 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.647 0 CA-C-O 122.157 0.865 . . . . 25.0 115.151 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.49 31.01 20.52 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.165 0.986 . . . . 25.0 112.878 178.834 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -118.06 97.89 6.04 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.861 -0.792 . . . . 25.0 108.861 178.433 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -145.72 140.08 26.97 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 105.842 -1.91 . . . . 25.0 105.842 -179.819 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 61.63 167.81 0.1 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.898 1.279 . . . . 25.0 112.632 -173.621 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.2 mt -70.58 -33.25 70.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.483 -0.78 . . . . 25.0 111.724 -176.292 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.8 m120 60.33 17.85 7.47 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.322 1.049 . . . . 25.0 113.257 -178.752 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.2 m -91.26 162.78 2.38 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 N-CA-C 108.845 -0.798 . . . . 25.0 108.845 -179.649 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.79 172.66 6.81 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.713 -1.217 . . . . 25.0 107.713 -178.633 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.52 161.19 42.62 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.197 -0.668 . . . . 25.0 109.197 173.264 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -125.87 131.72 52.31 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 123.808 0.693 . . . . 25.0 110.722 179.22 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.73 122.01 18.33 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 124.015 0.822 . . . . 25.0 110.215 177.513 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.2 mt -89.47 -24.07 21.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.234 0.54 . . . . 25.0 109.855 -178.115 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -138.58 174.27 10.72 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 103.101 -2.925 . . . . 25.0 103.101 175.876 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -85.38 -179.87 7.03 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.635 -0.876 . . . . 25.0 108.635 175.417 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -155.33 147.54 23.72 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 122.865 0.466 . . . . 25.0 109.804 174.127 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.5 t -116.27 123.57 71.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.677 -1.601 . . . . 25.0 106.677 175.992 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.78 145.22 25.73 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.497 -0.774 . . . . 25.0 109.501 177.773 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.15 -7.67 6.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.924 -0.58 . . . . 25.0 111.02 178.322 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 m -119.76 154.65 55.07 Favored Pre-proline 0 C--O 1.22 -0.448 0 N-CA-C 108.406 -0.961 . . . . 25.0 108.406 178.931 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.11 -24.95 38.03 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 117.563 -1.158 . . . . 25.0 114.323 -178.444 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.06 -16.84 57.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.31 0.576 . . . . 25.0 110.459 179.223 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -91.72 135.73 33.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.358 0.599 . . . . 25.0 110.602 -173.861 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.411 ' HB2' HG13 ' A' ' 57' ' ' VAL . 73.9 mt -95.37 128.33 42.13 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.958 0.885 . . . . 25.0 111.109 -179.112 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 t -90.44 143.61 26.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.141 -1.8 . . . . 25.0 106.141 176.841 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -158.03 168.24 27.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.104 0.478 . . . . 25.0 110.871 -179.446 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -114.18 159.5 20.03 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.168 -0.679 . . . . 25.0 109.168 178.041 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -57.83 132.05 52.17 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.339 -1.356 . . . . 25.0 107.339 176.348 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.71 -20.58 47.5 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-O 119.521 -0.599 . . . . 25.0 113.606 179.034 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -59.46 145.81 42.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.73 0.776 . . . . 25.0 110.84 178.885 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.3 mm -115.11 128.79 72.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.517 -1.219 . . . . 25.0 108.524 179.868 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -131.2 152.78 50.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.458 -0.201 . . . . 25.0 110.458 179.209 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.7 m -87.43 126.97 35.21 Favored 'General case' 0 C--O 1.218 -0.603 0 N-CA-C 107.823 -1.177 . . . . 25.0 107.823 177.537 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.74 128.58 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 CA-C-O 121.968 0.89 . . . . 25.0 108.807 179.362 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.646 HD12 HD22 ' A' ' 47' ' ' LEU . 81.7 mt -97.36 -46.09 6.22 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.005 -0.998 . . . . 25.0 108.779 179.631 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.07 158.58 44.14 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.956 -0.757 . . . . 25.0 108.956 -175.844 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -118.29 148.51 42.38 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 106.743 -1.576 . . . . 25.0 106.743 174.924 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 57.17 43.32 24.15 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 123.319 1.533 . . . . 25.0 109.832 -177.912 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -72.04 160.91 31.68 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 113.491 -1.686 . . . . 25.0 112.204 -176.134 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 59.68 9.83 1.76 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.177 0.991 . . . . 25.0 113.234 178.264 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.88 14.81 76.73 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.657 -0.977 . . . . 25.0 110.657 -176.185 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.0 mt -99.58 123.14 43.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.538 0.685 . . . . 25.0 110.565 -179.112 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -70.11 125.38 26.61 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.96 -1.018 . . . . 25.0 110.486 179.18 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.94 -1.41 88.6 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 115.43 0.932 . . . . 25.0 115.43 176.208 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -100.98 131.37 46.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 118.159 0.98 . . . . 25.0 109.796 178.45 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -110.73 142.45 42.65 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.179 -0.675 . . . . 25.0 109.179 -177.176 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.646 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -84.52 121.11 27.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 105.176 -2.157 . . . . 25.0 105.176 178.157 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.1 m -134.37 165.96 23.93 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.963 0.411 . . . . 25.0 111.171 179.087 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 t -121.48 123.08 41.17 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.011 -1.477 . . . . 25.0 107.011 173.165 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.9 tp -135.25 122.0 20.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.873 -0.788 . . . . 25.0 108.873 -177.728 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.2 m170 54.01 33.91 18.58 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.522 0.729 . . . . 25.0 111.548 179.799 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.74 -6.53 83.55 Favored Glycine 0 C--O 1.227 -0.314 0 N-CA-C 115.252 0.861 . . . . 25.0 115.252 177.44 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -101.98 137.22 40.55 Favored 'General case' 0 C--O 1.219 -0.553 0 CA-C-N 118.449 1.124 . . . . 25.0 108.403 176.147 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -99.9 145.02 28.27 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.406 -1.702 . . . . 25.0 106.406 173.93 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.73 -161.48 27.37 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 108.368 -1.893 . . . . 25.0 108.368 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.1 pt -115.41 149.89 17.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.603 0.716 . . . . 25.0 110.759 -175.847 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.8 m -139.32 146.63 49.51 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 114.871 -1.059 . . . . 25.0 108.824 -179.092 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.82 119.79 6.06 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 CA-C-O 121.487 0.536 . . . . 25.0 111.626 177.933 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.02 -15.3 74.14 Favored Glycine 0 C--O 1.226 -0.372 0 CA-C-O 121.649 0.583 . . . . 25.0 113.048 -178.466 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -67.46 -6.89 21.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.299 0.64 . . . . 25.0 112.672 -178.849 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -135.48 28.32 3.35 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.711 -0.478 . . . . 25.0 109.711 176.108 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.3 mt -125.32 156.25 38.96 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.352 0.871 . . . . 25.0 113.352 177.839 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -128.09 120.18 26.88 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.969 -1.014 . . . . 25.0 110.075 174.435 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.7 mm -66.95 137.25 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.581 -0.896 . . . . 25.0 108.581 176.62 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.4 mt -117.57 107.51 14.34 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.817 -1.179 . . . . 25.0 107.817 176.491 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.0 m -94.17 157.16 3.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.636 -0.505 . . . . 25.0 109.636 178.94 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.81 144.41 6.02 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.089 -1.605 . . . . 25.0 109.089 178.282 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -142.44 -7.47 0.89 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.122 1.156 . . . . 25.0 114.122 -177.906 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -69.33 -50.16 49.05 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 114.019 1.118 . . . . 25.0 114.019 -172.952 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -81.86 -24.65 35.64 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.238 -0.653 . . . . 25.0 109.238 177.136 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.6 tttm 61.25 -160.21 0.31 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.019 -0.991 . . . . 25.0 108.821 -178.894 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt 66.85 160.65 0.14 Allowed Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 124.387 1.075 . . . . 25.0 111.51 -179.923 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -79.15 4.69 6.34 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 117.39 -1.273 . . . . 25.0 114.019 178.182 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.27 162.1 28.74 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.889 -0.782 . . . . 25.0 108.889 179.737 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.13 -94.71 0.1 OUTLIER Glycine 0 C--O 1.223 -0.573 0 N-CA-C 110.816 -0.913 . . . . 25.0 110.816 178.136 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.6 m 52.59 39.73 28.68 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 113.405 0.891 . . . . 25.0 113.405 177.769 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.89 5.14 19.36 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 114.82 0.688 . . . . 25.0 114.82 -177.268 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.83 161.53 24.1 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 109.444 -1.462 . . . . 25.0 109.444 177.692 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 28.3 t -145.23 -59.48 0.35 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.349 -0.982 . . . . 25.0 108.349 178.34 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.94 25.59 59.74 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.509 -0.853 . . . . 25.0 112.067 177.748 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.3 t -60.14 146.31 43.72 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.853 -0.795 . . . . 25.0 108.853 178.765 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.96 17.09 36.26 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.436 -0.411 . . . . 25.0 113.707 -177.965 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 98.5 p -138.25 147.0 43.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.514 0.657 . . . . 25.0 110.414 177.774 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -140.97 152.69 45.16 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.26 -1.756 . . . . 25.0 106.26 177.005 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.14 -22.68 7.66 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 113.51 0.93 . . . . 25.0 113.51 -178.518 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 47.19 43.27 14.42 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 122.151 0.977 . . . . 25.0 110.943 -177.68 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -89.99 166.48 13.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.847 -1.07 . . . . 25.0 109.925 -176.778 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.8 m -88.62 109.2 27.69 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 110.39 -0.226 . . . . 25.0 110.39 178.227 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -80.61 157.42 21.77 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 116.854 -1.631 . . . . 25.0 113.287 -178.427 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -71.61 155.37 59.2 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 117.96 -0.893 . . . . 25.0 111.193 176.044 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -59.3 156.26 36.32 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 N-CA-C 115.991 1.496 . . . . 25.0 115.991 -175.808 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -70.21 142.37 89.82 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 107.715 -1.217 . . . . 25.0 107.715 175.378 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.94 158.26 53.04 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 116.584 -1.811 . . . . 25.0 110.775 175.208 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -62.93 143.71 91.8 Favored 'Trans proline' 0 C--N 1.35 0.645 0 N-CA-C 115.059 1.138 . . . . 25.0 115.059 -175.458 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -100.57 -16.68 17.39 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.339 0.59 . . . . 25.0 112.014 177.709 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.9 p -129.45 12.76 5.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.263 0.554 . . . . 25.0 110.187 -177.511 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 54.53 20.66 2.94 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.565 0.95 . . . . 25.0 113.565 -178.238 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.0 m -80.15 47.67 0.92 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.212 0.819 . . . . 25.0 113.212 -178.043 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 64.7 m 56.47 -169.2 0.09 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.963 1.097 . . . . 25.0 113.963 -179.429 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.4 tp . . . . . 0 C--O 1.217 -0.614 0 CA-C-O 124.794 2.235 . . . . 25.0 109.155 179.17 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.879 0 CA-C-O 123.727 1.737 . . . . 25.0 113.014 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t 61.13 32.29 19.63 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 111.976 -2.112 . . . . 25.0 113.185 -178.977 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 62.1 mtt -100.75 -12.29 19.22 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.086 1.143 . . . . 25.0 114.086 -176.092 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -142.92 37.04 1.42 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.092 -0.38 . . . . 25.0 111.228 -175.127 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -128.36 158.69 37.55 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 121.956 -0.465 . . . . 25.0 111.314 -179.088 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.8 mt -71.96 -35.64 69.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.73 -1.123 . . . . 25.0 110.156 -179.988 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.5 m120 53.64 36.93 24.85 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.744 0.817 . . . . 25.0 111.84 -179.1 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.7 m -99.06 163.03 2.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 107.427 -1.323 . . . . 25.0 107.427 176.771 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.08 170.9 8.16 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.193 -1.04 . . . . 25.0 108.193 -178.01 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.48 158.64 44.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.891 0.376 . . . . 25.0 110.939 177.032 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -123.91 129.25 50.67 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.457 -0.792 . . . . 25.0 110.12 177.63 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.46 124.68 26.29 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.005 -0.543 . . . . 25.0 109.911 177.029 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.93 -24.73 19.19 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.278 0.561 . . . . 25.0 109.981 -177.762 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -135.75 166.34 23.5 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 104.673 -2.343 . . . . 25.0 104.673 175.913 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -86.67 -173.77 4.65 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.499 0.72 . . . . 25.0 110.937 177.741 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -161.9 154.03 19.39 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 123.613 0.571 . . . . 25.0 112.385 176.662 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.9 t -122.14 126.78 74.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 104.541 -2.392 . . . . 25.0 104.541 173.022 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.37 137.0 44.44 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 -177.247 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -113.32 6.69 17.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.181 0.991 . . . . 25.0 109.237 179.206 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.0 t -149.68 149.3 27.98 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 106.955 -1.498 . . . . 25.0 106.955 -177.178 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.27 -19.31 38.64 Favored 'Trans proline' 0 N--CA 1.475 0.433 0 C-N-CA 117.622 -1.119 . . . . 25.0 112.568 178.184 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -79.21 -15.76 57.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.888 0.852 . . . . 25.0 110.388 178.985 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -93.12 141.22 28.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.801 0.81 . . . . 25.0 111.491 -176.509 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.6 mt -89.1 129.21 35.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.881 -0.599 . . . . 25.0 111.215 -179.936 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 p -94.5 137.87 33.1 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.481 -1.674 . . . . 25.0 106.481 173.813 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.424 ' HE1' HG12 ' A' ' 57' ' ' VAL . 38.2 p90 -160.86 175.98 11.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.998 -0.742 . . . . 25.0 108.998 -174.634 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.4 167.68 11.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.606 0.717 . . . . 25.0 111.526 177.444 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.48 134.4 56.83 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 107.81 -1.181 . . . . 25.0 107.81 178.39 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.2 -11.32 70.7 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-O 118.98 -0.9 . . . . 25.0 113.782 178.697 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.28 138.57 57.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 118.336 1.068 . . . . 25.0 109.937 176.665 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.3 mm -105.04 129.38 57.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 107.111 -1.44 . . . . 25.0 107.111 177.865 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.0 ptp -137.48 150.1 47.31 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.394 0.277 . . . . 25.0 110.932 -175.706 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.2 m -87.63 122.4 31.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.576 -0.898 . . . . 25.0 108.576 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 63.4 t -89.79 127.59 42.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.404 -0.961 . . . . 25.0 108.404 178.322 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.649 HD12 HD22 ' A' ' 47' ' ' LEU . 84.6 mt -91.46 -52.25 4.88 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.15 -0.932 . . . . 25.0 108.551 179.453 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -151.61 168.69 24.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.487 -0.56 . . . . 25.0 109.487 177.502 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -117.33 154.41 31.31 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.68 -1.6 . . . . 25.0 106.68 179.423 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 56.37 42.73 27.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 123.429 1.585 . . . . 25.0 108.662 -177.559 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -67.98 154.18 42.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.573 -1.649 . . . . 25.0 109.319 -176.701 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 59.09 9.39 1.27 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.544 1.138 . . . . 25.0 113.148 177.955 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.82 13.89 74.1 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 110.804 -0.918 . . . . 25.0 110.804 -179.366 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.3 mt -90.32 134.44 34.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.273 -0.64 . . . . 25.0 109.273 179.721 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -72.44 126.4 29.76 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.268 0.556 . . . . 25.0 110.47 178.534 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.66 2.41 69.53 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 117.576 1.791 . . . . 25.0 117.576 174.914 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -100.63 134.13 44.06 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.128 1.464 . . . . 25.0 110.906 177.916 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -113.1 142.88 45.24 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.798 -0.815 . . . . 25.0 108.798 -174.872 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -86.75 123.84 32.34 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 106.599 -1.63 . . . . 25.0 106.599 179.106 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 97.8 m -132.71 160.83 35.64 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.245 0.545 . . . . 25.0 112.204 179.528 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.2 t -113.14 125.93 54.89 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 107.129 -1.434 . . . . 25.0 107.129 172.281 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 tp -147.19 135.94 22.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.437 -1.32 . . . . 25.0 107.437 -175.715 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 43.7 m80 55.34 27.15 9.52 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.589 0.755 . . . . 25.0 112.073 -175.592 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.52 0.73 84.93 Favored Glycine 0 C--O 1.217 -0.964 0 N-CA-C 115.201 0.84 . . . . 25.0 115.201 -179.515 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -115.22 161.99 17.69 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.435 -1.321 . . . . 25.0 107.435 178.628 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -114.21 153.41 29.67 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.332 -0.618 . . . . 25.0 109.332 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.23 -163.86 30.88 Favored Glycine 0 CA--C 1.503 -0.683 0 N-CA-C 106.137 -2.785 . . . . 25.0 106.137 178.29 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 pt -115.9 155.95 17.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 120.808 0.337 . . . . 25.0 111.416 -175.299 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.424 HG12 ' HE1' ' A' ' 26' ' ' PHE . 2.9 m -144.18 147.64 38.26 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.403 -0.817 . . . . 25.0 109.479 179.525 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -74.87 126.02 9.77 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 CA-C-N 118.165 0.38 . . . . 25.0 112.373 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.8 -21.41 79.74 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 115.625 1.01 . . . . 25.0 115.625 -174.72 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -56.14 -28.2 57.05 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.529 0.937 . . . . 25.0 113.529 -176.59 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.12 20.02 12.77 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.936 -0.478 . . . . 25.0 111.721 -178.292 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.7 tp -119.52 146.51 45.39 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.612 -0.885 . . . . 25.0 108.612 -178.672 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -117.56 124.12 47.9 Favored 'General case' 0 C--O 1.208 -1.082 0 CA-C-N 116.085 -0.507 . . . . 25.0 110.757 -178.16 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.1 mm -76.66 136.63 24.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 109.298 -0.63 . . . . 25.0 109.298 177.471 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.0 mt -119.33 101.5 8.02 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.149 -1.797 . . . . 25.0 106.149 176.714 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.7 m -78.57 155.92 4.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.996 -0.742 . . . . 25.0 108.996 -177.017 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.47 -164.1 35.45 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 108.4 -1.88 . . . . 25.0 108.4 -177.728 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 25.1 ptm -121.76 175.57 6.19 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.981 -1.489 . . . . 25.0 106.981 177.319 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -68.11 160.87 28.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.545 0.688 . . . . 25.0 112.211 -179.091 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -137.56 159.74 41.12 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 104.281 -2.489 . . . . 25.0 104.281 174.269 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -114.74 -4.12 12.75 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 122.269 0.228 . . . . 25.0 111.169 178.615 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -90.13 149.31 41.23 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 110.478 -0.193 . . . . 25.0 110.478 179.772 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -72.62 157.72 51.96 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 117.451 -1.233 . . . . 25.0 111.669 177.746 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.18 -32.85 73.39 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.907 0.384 . . . . 25.0 111.681 179.872 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 136.21 -173.89 21.73 Favored Glycine 0 C--O 1.227 -0.309 0 N-CA-C 108.358 -1.897 . . . . 25.0 108.358 -177.911 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.7 m -76.52 -28.64 56.46 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.435 0.531 . . . . 25.0 112.435 -178.754 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.61 -148.94 44.34 Favored Glycine 0 C--O 1.231 -0.081 0 N-CA-C 111.871 -0.491 . . . . 25.0 111.871 -178.819 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -178.16 176.06 47.81 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 105.993 -2.843 . . . . 25.0 105.993 -178.167 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.6 t -154.5 161.73 41.51 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 108.199 -1.037 . . . . 25.0 108.199 -178.739 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.96 170.5 42.88 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 108.82 -1.712 . . . . 25.0 108.82 179.148 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.7 m -150.8 159.06 44.79 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 108.328 -0.99 . . . . 25.0 108.328 179.306 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.08 170.05 42.26 Favored Glycine 0 C--N 1.323 -0.171 0 N-CA-C 108.002 -2.039 . . . . 25.0 108.002 175.849 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.42 87.25 7.37 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.311 -0.626 . . . . 25.0 109.311 179.009 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.05 142.7 58.28 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.166 -0.47 . . . . 25.0 110.101 -179.809 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -138.54 17.84 2.72 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.734 0.778 . . . . 25.0 112.078 -178.919 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -73.21 170.46 14.94 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.489 -0.93 . . . . 25.0 108.489 173.412 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -65.13 157.3 29.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.972 -0.558 . . . . 25.0 111.776 -179.698 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -58.43 148.63 63.94 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.436 -0.802 . . . . 25.0 109.935 -179.598 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.03 158.83 52.29 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 117.069 -1.488 . . . . 25.0 112.043 177.76 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.04 152.17 80.91 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 117.099 -1.468 . . . . 25.0 112.998 -178.242 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -58.42 148.81 78.3 Favored 'Trans proline' 0 C--N 1.35 0.65 0 N-CA-C 115.581 1.339 . . . . 25.0 115.581 -174.652 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -75.45 143.29 75.79 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 106.845 -1.539 . . . . 25.0 106.845 177.921 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -68.84 156.64 64.77 Favored 'Trans proline' 0 C--O 1.242 0.675 0 C-N-CA 116.268 -2.021 . . . . 25.0 111.17 176.266 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -59.55 147.36 91.98 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 117.776 -1.016 . . . . 25.0 110.494 175.647 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.0 mtt-85 -81.47 -66.18 0.92 Allowed 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 109.057 -0.72 . . . . 25.0 109.057 -177.96 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.65 -46.93 0.09 Allowed 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 121.341 0.591 . . . . 25.0 111.996 -179.68 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.49 150.62 50.76 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 121.815 -0.553 . . . . 25.0 109.949 -179.331 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.0 p -121.92 -80.88 0.63 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.372 0.42 . . . . 25.0 111.016 176.084 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.7 t 69.6 -158.43 0.16 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.118 1.367 . . . . 25.0 108.36 -175.932 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 77.2 mt . . . . . 0 C--O 1.207 -1.152 0 CA-C-O 125.514 2.578 . . . . 25.0 111.795 -177.311 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.452 0 CA-C-O 121.611 0.562 . . . . 25.0 113.662 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.77 -8.71 22.78 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.898 1.444 . . . . 25.0 114.898 -177.336 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.8 ptp -130.44 18.99 5.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.468 0.651 . . . . 25.0 109.606 178.433 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -83.66 116.14 22.5 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 108.552 -0.907 . . . . 25.0 108.552 -179.215 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 65.97 164.41 0.18 Allowed 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 115.74 1.755 . . . . 25.0 115.74 177.215 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.8 mt -79.23 -31.31 43.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.503 -1.226 . . . . 25.0 110.267 -177.941 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.4 m120 54.34 25.09 5.62 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.286 1.034 . . . . 25.0 113.028 -177.011 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.6 m -88.51 162.46 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.257 -1.386 . . . . 25.0 107.257 178.102 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.87 173.94 6.17 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.416 -1.698 . . . . 25.0 106.416 -179.393 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.73 158.18 43.03 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.483 -0.191 . . . . 25.0 110.483 174.599 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -121.5 129.4 52.9 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.377 0.671 . . . . 25.0 110.592 176.892 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.32 132.39 45.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.109 -0.496 . . . . 25.0 110.12 176.807 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -98.31 -22.44 16.11 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.318 0.488 . . . . 25.0 112.318 -176.609 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -142.0 162.82 34.51 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.151 -0.685 . . . . 25.0 109.151 -179.801 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -69.37 158.81 34.35 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.698 -0.482 . . . . 25.0 109.698 177.704 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.35 161.53 38.75 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.651 -1.24 . . . . 25.0 107.651 177.168 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 p -136.25 139.26 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 102.071 -3.307 . . . . 25.0 102.071 171.243 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.34 124.4 34.39 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.577 -0.527 . . . . 25.0 109.577 -175.771 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -110.23 15.7 22.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.968 0.89 . . . . 25.0 110.312 -176.746 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.9 t -152.69 148.66 20.91 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 107.037 -1.468 . . . . 25.0 107.037 -175.87 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.59 -19.48 36.88 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 117.719 -1.054 . . . . 25.0 113.081 178.925 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -82.61 -19.29 38.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.363 0.602 . . . . 25.0 110.228 178.868 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -83.64 132.73 34.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 122.021 0.915 . . . . 25.0 111.029 -176.175 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.449 ' HB2' HG13 ' A' ' 57' ' ' VAL . 40.8 mt -82.75 138.31 34.09 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.711 -0.848 . . . . 25.0 108.711 178.254 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -90.82 131.38 36.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.542 -1.281 . . . . 25.0 107.542 176.404 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -155.27 165.17 37.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.387 0.613 . . . . 25.0 111.313 -178.225 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -125.68 164.28 20.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.855 -0.611 . . . . 25.0 111.174 -177.797 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -56.27 130.81 46.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.209 0.528 . . . . 25.0 110.191 179.333 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.55 -18.65 56.65 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.813 -0.993 . . . . 25.0 113.967 177.484 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -58.83 146.16 38.25 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 117.85 0.825 . . . . 25.0 110.995 179.801 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.4 mm -113.34 133.19 60.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.567 -1.197 . . . . 25.0 108.35 178.682 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.6 ptp -141.92 155.7 45.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.614 -0.513 . . . . 25.0 109.614 -177.96 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.6 m -89.2 128.43 35.81 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 108.69 -0.855 . . . . 25.0 108.69 178.004 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.0 t -93.15 126.54 45.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.929 -1.138 . . . . 25.0 107.929 177.183 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.67 HD12 HD22 ' A' ' 47' ' ' LEU . 72.9 mt -90.94 -51.88 5.13 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.503 -0.925 . . . . 25.0 108.503 179.57 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -149.55 161.04 42.92 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.71 -0.848 . . . . 25.0 108.71 177.985 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -102.86 156.58 17.56 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.729 -0.841 . . . . 25.0 108.729 176.221 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 55.28 41.22 31.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.41 1.576 . . . . 25.0 108.507 172.061 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.405 HG21 HG22 ' A' ' 56' ' ' ILE . 11.4 t -63.66 147.69 50.92 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 112.625 -2.079 . . . . 25.0 110.859 -175.522 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 59.96 9.97 1.98 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.664 0.786 . . . . 25.0 111.993 -176.575 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.74 9.46 86.33 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 111.122 -0.791 . . . . 25.0 111.122 -177.226 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.6 114.22 21.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.296 -1.002 . . . . 25.0 108.296 -179.759 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.21 129.2 39.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.196 0.522 . . . . 25.0 109.891 -176.567 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.08 -1.4 75.12 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-O 118.613 -1.104 . . . . 25.0 115.433 176.694 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -100.92 130.11 46.87 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 119.409 1.604 . . . . 25.0 109.044 177.095 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -113.4 139.94 48.48 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.299 -1.0 . . . . 25.0 108.299 -176.438 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.67 HD22 HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -82.02 122.71 28.15 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 105.467 -2.049 . . . . 25.0 105.467 179.255 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.6 m -130.5 163.51 26.85 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.031 0.443 . . . . 25.0 110.98 178.565 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.6 t -116.21 122.03 43.8 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.976 -1.861 . . . . 25.0 105.976 172.524 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.7 tp -147.14 139.77 24.88 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.521 -1.289 . . . . 25.0 107.521 -176.948 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 57.87 27.2 14.26 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.75 0.648 . . . . 25.0 112.75 177.133 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.8 2.31 90.64 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 114.899 0.72 . . . . 25.0 114.899 178.77 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.4 ptt85 -126.93 160.51 30.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.581 1.19 . . . . 25.0 109.35 177.965 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -109.53 152.68 25.14 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.579 -0.897 . . . . 25.0 108.579 177.627 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.08 -160.59 25.21 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 105.974 -2.851 . . . . 25.0 105.974 179.265 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.405 HG22 HG21 ' A' ' 39' ' ' THR . 33.3 pt -118.36 154.11 20.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.545 0.688 . . . . 25.0 111.253 -175.817 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -141.17 146.96 45.29 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.06 -0.973 . . . . 25.0 109.117 179.444 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.59 120.13 6.04 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 CA-C-O 121.669 0.612 . . . . 25.0 111.326 178.246 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.22 -12.05 75.9 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 116.062 -0.517 . . . . 25.0 113.865 -176.477 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -69.36 -9.21 52.39 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.575 0.583 . . . . 25.0 112.575 -178.64 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -133.11 27.67 4.18 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.829 -0.804 . . . . 25.0 108.829 178.554 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.4 tp -133.16 147.51 52.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.449 -0.796 . . . . 25.0 109.393 -177.855 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -123.12 120.05 32.08 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.556 0.342 . . . . 25.0 110.977 -177.801 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.4 mm -66.91 135.45 28.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.427 -0.583 . . . . 25.0 109.427 177.751 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.0 mt -121.27 95.92 4.88 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.741 -1.207 . . . . 25.0 107.741 175.945 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.4 p -70.08 149.49 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.481 -1.674 . . . . 25.0 106.481 176.699 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.66 -88.37 0.37 Allowed Glycine 0 C--O 1.221 -0.703 0 C-N-CA 120.818 -0.706 . . . . 25.0 113.297 -178.689 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 21.9 ttt 53.72 70.05 0.64 Allowed 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.561 0.696 . . . . 25.0 110.948 -176.956 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 73.73 150.55 0.11 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.712 1.605 . . . . 25.0 111.772 -175.262 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -102.85 -19.06 14.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.147 -0.933 . . . . 25.0 113.047 -175.849 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -73.94 94.94 2.4 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.478 0.918 . . . . 25.0 113.478 -173.143 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -135.43 147.06 60.34 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 107.869 -1.16 . . . . 25.0 107.869 177.645 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -70.75 154.59 63.74 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 116.258 -2.028 . . . . 25.0 111.439 176.65 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.83 165.53 11.0 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.399 -0.593 . . . . 25.0 109.399 179.418 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.76 -167.34 35.19 Favored Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 110.687 -0.965 . . . . 25.0 110.687 -179.658 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.9 t 77.61 171.25 0.21 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.535 1.534 . . . . 25.0 111.602 -179.54 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.21 -164.2 34.6 Favored Glycine 0 C--O 1.225 -0.468 0 N-CA-C 108.795 -1.722 . . . . 25.0 108.795 -175.694 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.07 -41.43 0.29 Allowed Glycine 0 C--O 1.22 -0.767 0 CA-C-N 117.675 0.737 . . . . 25.0 112.666 177.491 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.9 t 54.58 28.34 9.73 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.439 1.274 . . . . 25.0 114.439 177.412 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.08 -168.81 40.35 Favored Glycine 0 CA--C 1.511 -0.189 0 N-CA-C 109.009 -1.636 . . . . 25.0 109.009 -179.121 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.2 m -144.1 140.05 29.23 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.452 -0.944 . . . . 25.0 108.452 177.829 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.28 18.83 32.8 Favored Glycine 0 C--O 1.222 -0.621 0 O-C-N 123.421 0.451 . . . . 25.0 114.108 -177.229 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.2 m 54.73 35.67 24.49 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.031 0.752 . . . . 25.0 113.031 -178.611 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -74.04 85.65 1.81 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.65 0.738 . . . . 25.0 111.738 -179.432 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.01 58.57 1.76 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.344 -0.984 . . . . 25.0 108.344 179.491 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -69.52 141.06 53.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.1 -0.954 . . . . 25.0 109.811 -179.972 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 50.62 -150.75 0.23 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.71 1.004 . . . . 25.0 113.71 177.507 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 77.4 p -132.32 150.05 74.87 Favored Pre-proline 0 C--N 1.327 -0.38 0 O-C-N 121.85 -0.531 . . . . 25.0 110.214 -176.115 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.3 155.43 60.5 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 117.403 -1.265 . . . . 25.0 112.933 179.374 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -63.99 151.38 85.51 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 O-C-N 121.936 0.44 . . . . 25.0 112.748 179.391 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -68.18 151.0 77.3 Favored 'Trans proline' 0 C--N 1.349 0.6 0 N-CA-C 116.212 1.581 . . . . 25.0 116.212 -171.427 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -67.77 144.99 97.84 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 115.606 -0.725 . . . . 25.0 109.35 179.854 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -70.93 162.35 42.96 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 O-C-N 122.084 0.518 . . . . 25.0 111.776 175.35 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -61.12 149.78 87.54 Favored 'Trans proline' 0 C--N 1.349 0.604 0 N-CA-C 114.149 0.788 . . . . 25.0 114.149 -178.157 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -95.79 17.76 14.48 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.799 0.333 . . . . 25.0 110.653 177.658 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.1 p -138.21 164.22 29.76 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.345 -0.983 . . . . 25.0 108.345 -179.16 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -113.01 12.78 19.34 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.158 -0.682 . . . . 25.0 109.158 177.351 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.7 m -118.53 55.48 0.91 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.654 -0.703 . . . . 25.0 112.222 -172.876 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 41.9 t -65.7 -44.94 84.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.582 0.706 . . . . 25.0 110.59 179.978 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.214 -0.814 0 CA-C-O 124.558 2.123 . . . . 25.0 110.842 179.208 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.695 0 CA-C-O 124.722 2.29 . . . . 25.0 111.648 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.0 p -160.52 141.07 11.63 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 112.276 -1.962 . . . . 25.0 107.623 179.215 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.6 ttm -144.93 -41.54 0.24 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.517 0.675 . . . . 25.0 112.338 178.484 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -130.37 79.1 1.88 Allowed 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 116.268 -0.424 . . . . 25.0 111.631 -175.939 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -139.29 168.19 20.38 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.539 -0.301 . . . . 25.0 110.299 -177.689 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.8 mt -66.2 -38.1 87.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.165 0.507 . . . . 25.0 110.831 178.432 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 55.29 26.51 8.66 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.97 -1.014 . . . . 25.0 113.173 -178.576 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.5 m -85.25 171.74 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.848 0 N-CA-C 105.982 -1.859 . . . . 25.0 105.982 175.131 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -118.93 169.57 9.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 118.894 0.77 . . . . 25.0 109.624 -178.453 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.96 153.47 40.11 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.745 -0.661 . . . . 25.0 109.801 178.481 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -116.35 130.42 56.76 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.681 -1.145 . . . . 25.0 110.058 178.796 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.55 128.3 36.12 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.853 -0.425 . . . . 25.0 109.853 176.99 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.83 -22.78 17.26 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 121.003 -0.279 . . . . 25.0 111.469 -178.772 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -141.13 166.18 25.48 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.24 -1.763 . . . . 25.0 106.24 178.485 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -74.18 160.17 31.54 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.376 0.423 . . . . 25.0 110.229 178.95 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -144.94 137.08 25.93 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.559 -0.713 . . . . 25.0 112.263 173.732 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.83 123.89 66.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 106.304 -1.739 . . . . 25.0 106.304 176.217 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.68 125.64 27.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.08 -0.964 . . . . 25.0 108.529 177.26 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.13 -1.28 18.89 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.017 0.913 . . . . 25.0 109.34 176.954 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 t -131.85 145.88 59.37 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 105.121 -2.177 . . . . 25.0 105.121 179.589 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -69.37 -14.66 37.68 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 117.346 -1.303 . . . . 25.0 113.105 178.713 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -83.39 -16.81 44.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.48 0.657 . . . . 25.0 110.338 178.622 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -88.02 142.49 27.74 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.279 -0.637 . . . . 25.0 109.279 -178.709 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.4 mt -92.39 129.87 38.21 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.853 0.835 . . . . 25.0 109.597 177.653 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.94 142.64 28.68 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 105.644 -1.984 . . . . 25.0 105.644 175.842 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -161.68 165.94 27.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.256 0.55 . . . . 25.0 111.329 -179.111 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -113.52 159.5 19.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.497 -0.774 . . . . 25.0 109.12 177.546 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.76 133.66 55.57 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.824 -1.176 . . . . 25.0 107.824 177.626 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.18 -22.92 38.5 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-O 119.205 -0.775 . . . . 25.0 114.051 179.6 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -58.6 140.54 54.22 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.529 0.68 . . . . 25.0 109.69 179.731 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.6 mm -108.84 127.3 65.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.734 -1.121 . . . . 25.0 108.059 -178.849 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 12.2 ptp -128.2 150.92 49.8 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.188 -0.671 . . . . 25.0 109.188 -179.986 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.0 m -84.42 127.48 34.03 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 106.883 -1.525 . . . . 25.0 106.883 176.026 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.0 t -94.07 122.63 45.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 179.013 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.586 HD12 HD22 ' A' ' 47' ' ' LEU . 84.3 mt -89.07 -46.94 8.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.603 -0.726 . . . . 25.0 109.127 -177.662 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -155.26 171.55 19.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.51 -0.314 . . . . 25.0 110.218 177.679 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -123.63 155.75 37.13 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.967 -1.864 . . . . 25.0 105.967 179.32 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.3 t0 58.49 41.35 22.79 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.304 1.526 . . . . 25.0 108.126 -175.881 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 t -68.32 142.03 55.64 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.778 -1.193 . . . . 25.0 107.778 -177.625 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 56.54 18.72 3.72 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 113.978 1.103 . . . . 25.0 113.978 -177.526 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.15 20.57 76.6 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.428 -1.069 . . . . 25.0 110.428 -179.656 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.418 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 65.7 mt -90.53 99.73 12.7 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 107.725 -1.213 . . . . 25.0 107.725 176.551 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -57.65 123.48 15.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.93 -1.032 . . . . 25.0 110.091 -176.099 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.47 -3.03 85.26 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 118.345 -1.253 . . . . 25.0 115.366 178.92 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.418 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 85.1 m95 -100.58 143.63 30.52 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 119.461 1.63 . . . . 25.0 109.569 177.84 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -117.66 140.54 49.52 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.345 -0.983 . . . . 25.0 108.345 -178.896 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.586 HD22 HD12 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -82.71 120.22 25.31 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 103.967 -2.605 . . . . 25.0 103.967 175.84 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 93.8 m -129.72 160.69 32.61 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 110.205 -0.294 . . . . 25.0 110.205 179.158 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.5 t -116.9 121.76 42.39 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.865 -1.161 . . . . 25.0 107.865 173.385 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.5 tp -143.75 141.88 30.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.027 -1.842 . . . . 25.0 106.027 -177.105 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 56.43 27.47 12.18 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.189 0.595 . . . . 25.0 111.388 -176.877 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.39 -0.46 84.7 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-O 119.554 -0.581 . . . . 25.0 114.467 177.682 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -120.93 154.32 36.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.333 1.067 . . . . 25.0 110.06 179.322 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -98.11 157.12 16.33 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.321 -0.992 . . . . 25.0 108.321 178.434 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.61 -168.25 39.7 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 105.515 -3.034 . . . . 25.0 105.515 179.128 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.3 pt -115.89 153.17 17.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 122.339 1.066 . . . . 25.0 110.762 -175.738 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.95 146.07 32.83 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 114.216 -1.356 . . . . 25.0 109.96 -178.987 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.66 119.12 5.58 Favored 'Trans proline' 0 C--O 1.237 0.431 0 O-C-N 122.051 0.501 . . . . 25.0 113.173 -179.869 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.7 -17.55 69.23 Favored Glycine 0 C--O 1.222 -0.601 0 C-N-CA 120.975 -0.631 . . . . 25.0 113.478 -178.306 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -65.65 -12.22 51.57 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.579 0.585 . . . . 25.0 112.579 -177.868 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -130.56 26.52 5.05 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.587 0.708 . . . . 25.0 110.841 177.018 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -126.14 154.92 42.49 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.406 -0.816 . . . . 25.0 111.871 178.511 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -123.43 122.33 37.98 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.866 -0.606 . . . . 25.0 111.357 177.61 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.0 mm -71.7 137.37 23.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.678 -1.23 . . . . 25.0 107.678 177.779 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.3 mt -118.17 106.48 12.88 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.121 -1.066 . . . . 25.0 108.121 175.925 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.5 m -97.01 13.04 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 121.425 0.631 . . . . 25.0 110.748 179.537 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.85 30.3 57.92 Favored Glycine 0 C--O 1.219 -0.818 0 C-N-CA 120.444 -0.884 . . . . 25.0 112.268 -176.72 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 7.6 tpt -71.84 97.93 1.9 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.907 -0.761 . . . . 25.0 111.301 -179.296 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 67.2 160.25 0.15 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.44 1.496 . . . . 25.0 112.81 -178.2 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -73.61 156.01 38.49 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.845 0.355 . . . . 25.0 110.509 179.421 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -156.07 117.82 3.96 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.958 0.903 . . . . 25.0 108.568 177.602 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -129.39 150.25 75.05 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 108.024 -1.102 . . . . 25.0 108.024 178.971 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -70.06 156.78 61.73 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 117.839 -0.974 . . . . 25.0 111.309 177.994 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -121.04 -10.32 9.06 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.123 1.157 . . . . 25.0 114.123 -177.196 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.06 179.29 48.68 Favored Glycine 0 C--N 1.319 -0.372 0 C-N-CA 120.277 -0.963 . . . . 25.0 112.48 -176.171 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.4 p -71.81 149.94 44.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.921 0.391 . . . . 25.0 111.243 179.733 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 161.49 -166.46 35.96 Favored Glycine 0 CA--C 1.505 -0.571 0 N-CA-C 107.862 -2.095 . . . . 25.0 107.862 -179.177 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 162.25 -52.87 0.31 Allowed Glycine 0 CA--C 1.512 -0.095 0 C-N-CA 120.421 -0.895 . . . . 25.0 112.692 177.279 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.2 t 54.5 38.1 29.08 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.709 0.633 . . . . 25.0 112.709 178.303 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.07 36.18 0.15 Allowed Glycine 0 C--O 1.218 -0.883 0 N-CA-C 115.137 0.815 . . . . 25.0 115.137 -178.315 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.2 m -85.5 1.81 47.34 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.032 0.753 . . . . 25.0 113.032 -177.029 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.77 -172.92 33.72 Favored Glycine 0 CA--C 1.508 -0.387 0 N-CA-C 106.617 -2.593 . . . . 25.0 106.617 179.304 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.4 p -72.86 158.69 35.04 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.552 0.575 . . . . 25.0 112.552 -179.482 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -120.56 179.7 4.25 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.765 -1.198 . . . . 25.0 107.765 175.649 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.64 141.69 48.09 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.918 0.487 . . . . 25.0 111.158 -178.446 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 61.49 -166.96 0.2 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.303 1.041 . . . . 25.0 110.957 -178.782 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.3 t0 50.6 52.55 14.65 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 122.737 1.256 . . . . 25.0 113.016 -178.361 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -58.57 148.34 66.45 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 114.719 -1.128 . . . . 25.0 112.433 -178.776 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -68.09 157.1 63.26 Favored 'Trans proline' 0 C--O 1.239 0.566 0 N-CA-C 113.989 0.727 . . . . 25.0 113.989 -177.348 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -64.69 153.42 77.67 Favored 'Trans proline' 0 C--N 1.355 0.878 0 O-C-N 121.819 0.378 . . . . 25.0 112.941 -179.031 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -67.78 158.06 58.96 Favored 'Trans proline' 0 C--O 1.241 0.646 0 N-CA-C 115.381 1.262 . . . . 25.0 115.381 -171.691 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -75.02 140.33 73.67 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 107.999 -1.112 . . . . 25.0 107.999 177.264 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.54 167.2 27.7 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 118.055 -0.83 . . . . 25.0 112.061 178.308 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -60.11 156.29 40.5 Favored 'Trans proline' 0 C--N 1.351 0.662 0 N-CA-C 114.82 1.046 . . . . 25.0 114.82 -177.491 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -122.17 47.26 1.94 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.17 -0.468 . . . . 25.0 111.938 -176.874 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 m 66.05 -49.02 0.41 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 115.628 1.714 . . . . 25.0 115.628 178.425 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -54.62 -12.93 0.83 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.672 1.73 . . . . 25.0 115.672 -177.973 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.7 m -80.06 -26.96 39.45 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.844 1.054 . . . . 25.0 113.844 -179.436 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.3 m -165.5 -38.99 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.904 1.076 . . . . 25.0 113.904 -173.025 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.3 tp . . . . . 0 C--O 1.209 -1.064 0 CA-C-O 125.132 2.396 . . . . 25.0 112.135 -172.024 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 CA-C-O 123.149 1.416 . . . . 25.0 114.942 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.44 4.41 3.03 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.685 1.365 . . . . 25.0 114.685 -174.524 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.3 mtt -86.53 0.49 54.19 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.914 -0.491 . . . . 25.0 112.058 -179.185 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -87.33 108.63 19.05 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.061 -0.718 . . . . 25.0 109.061 178.997 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 61.98 166.97 0.11 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.825 1.417 . . . . 25.0 114.825 -179.151 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.4 mt -73.82 -41.68 61.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.339 -0.846 . . . . 25.0 109.881 178.485 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 52.76 33.18 13.52 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.271 1.028 . . . . 25.0 111.587 -177.976 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 m -91.56 162.16 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.75 -1.945 . . . . 25.0 105.75 174.571 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.51 170.99 8.22 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.003 -1.11 . . . . 25.0 108.003 -178.76 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.49 159.15 43.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.16 -0.681 . . . . 25.0 109.16 174.714 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -125.34 129.0 49.07 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.392 -0.822 . . . . 25.0 109.863 176.495 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.08 129.54 39.71 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.217 -0.66 . . . . 25.0 109.217 175.283 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.0 mt -96.01 -20.11 18.95 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.024 0.44 . . . . 25.0 110.489 -178.355 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -146.42 173.32 12.38 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 107.697 -1.223 . . . . 25.0 107.697 -177.664 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -76.04 158.68 31.59 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.992 0.425 . . . . 25.0 111.534 175.246 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -141.71 131.5 24.28 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.386 0.612 . . . . 25.0 112.518 168.642 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.9 t -97.05 122.19 48.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 103.539 -2.763 . . . . 25.0 103.539 173.135 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.42 139.98 36.22 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.837 -1.172 . . . . 25.0 107.837 176.304 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -128.91 -19.65 3.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.902 -0.59 . . . . 25.0 110.839 -179.128 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.44 150.98 39.84 Favored Pre-proline 0 N--CA 1.464 0.252 0 N-CA-C 106.759 -1.571 . . . . 25.0 106.759 171.131 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -68.74 -22.09 37.67 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 117.275 -1.35 . . . . 25.0 112.952 -179.183 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -90.4 -2.23 57.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.771 0.796 . . . . 25.0 110.616 -179.207 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -89.39 139.77 30.18 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.315 0.579 . . . . 25.0 110.471 -175.997 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.3 mt -90.74 128.04 36.53 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.105 0.955 . . . . 25.0 111.727 179.77 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.6 p -87.47 140.41 29.55 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.935 -1.876 . . . . 25.0 105.935 174.309 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.71 167.01 31.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.051 0.453 . . . . 25.0 110.1 178.774 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.32 160.85 19.9 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.639 -0.875 . . . . 25.0 108.639 178.441 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -56.23 134.18 53.01 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 115.221 -0.9 . . . . 25.0 110.096 177.56 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.68 -15.27 63.46 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-O 118.175 -1.347 . . . . 25.0 113.863 177.885 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -60.41 150.53 30.63 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 118.207 1.004 . . . . 25.0 110.826 177.512 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.6 mm -118.29 130.07 73.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.473 -1.239 . . . . 25.0 108.7 179.479 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -136.7 152.77 50.75 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.307 -0.627 . . . . 25.0 109.307 -179.085 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -88.36 128.26 35.5 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.357 -0.608 . . . . 25.0 109.357 177.909 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.4 t -91.91 127.83 43.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.176 -1.046 . . . . 25.0 108.176 179.638 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.62 HD12 HD22 ' A' ' 47' ' ' LEU . 77.3 mt -94.61 -47.84 6.34 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.636 -0.875 . . . . 25.0 108.636 179.889 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -152.05 169.08 23.24 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.517 -0.919 . . . . 25.0 108.517 178.111 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -117.75 153.96 32.53 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 108.029 -1.1 . . . . 25.0 108.029 176.404 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 60.05 40.14 18.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 123.472 1.606 . . . . 25.0 109.855 178.474 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 t -68.26 154.77 41.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.204 -1.816 . . . . 25.0 110.729 -177.122 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 59.46 13.97 3.55 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.486 1.114 . . . . 25.0 110.418 -177.392 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.77 11.41 85.27 Favored Glycine 0 CA--C 1.506 -0.489 0 N-CA-C 111.335 -0.706 . . . . 25.0 111.335 -179.827 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.65 128.83 36.12 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 117.761 0.781 . . . . 25.0 110.067 -177.814 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -70.02 123.24 21.06 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.083 -0.508 . . . . 25.0 110.346 -179.473 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.35 -0.79 88.66 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 116.789 1.475 . . . . 25.0 116.789 175.974 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -100.38 131.73 46.15 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.909 0.855 . . . . 25.0 109.373 176.753 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -114.1 143.2 45.18 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.492 -0.929 . . . . 25.0 108.492 -175.224 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.62 HD22 HD12 ' A' ' 35' ' ' LEU . 0.7 OUTLIER -83.68 122.44 28.62 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.735 -1.58 . . . . 25.0 106.735 177.952 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.6 m -133.34 162.28 32.26 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.231 0.538 . . . . 25.0 111.9 178.146 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -113.45 122.4 47.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.856 -1.164 . . . . 25.0 107.856 173.484 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.5 tp -139.77 132.58 29.14 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.882 -1.155 . . . . 25.0 107.882 -178.745 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 54.63 29.11 10.92 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.059 0.544 . . . . 25.0 111.438 -174.719 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.93 -3.79 73.95 Favored Glycine 0 C--O 1.222 -0.603 0 N-CA-C 115.305 0.882 . . . . 25.0 115.305 178.207 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -109.19 157.35 18.88 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.824 -1.547 . . . . 25.0 106.824 178.639 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -115.0 151.81 33.52 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.154 -0.684 . . . . 25.0 109.154 -177.747 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.73 -161.0 26.56 Favored Glycine 0 CA--C 1.504 -0.623 0 N-CA-C 107.051 -2.42 . . . . 25.0 107.051 -179.726 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.0 pt -115.97 150.3 17.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.212 0.53 . . . . 25.0 112.308 -175.083 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.85 144.94 43.61 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.226 -0.897 . . . . 25.0 110.488 -179.716 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.9 121.91 6.07 Favored 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 118.501 -0.533 . . . . 25.0 112.388 -179.769 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.58 -20.33 67.86 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 115.375 0.91 . . . . 25.0 115.375 -177.113 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -23.19 67.3 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.324 0.861 . . . . 25.0 113.324 -176.267 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -120.95 26.64 8.94 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.939 -0.763 . . . . 25.0 108.939 -179.045 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.0 tp -131.51 150.37 52.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.735 -0.666 . . . . 25.0 110.666 -176.985 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -124.74 123.55 40.23 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 122.223 -0.298 . . . . 25.0 111.787 179.186 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.4 mm -70.17 136.37 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 123.839 0.712 . . . . 25.0 110.001 176.6 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.8 mt -118.38 99.19 6.68 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.774 -1.565 . . . . 25.0 106.774 174.855 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.46 131.83 34.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 106.905 -1.517 . . . . 25.0 106.905 179.438 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.18 107.91 2.28 Favored Glycine 0 C--O 1.225 -0.413 0 N-CA-C 109.938 -1.265 . . . . 25.0 109.938 179.088 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 96.6 mmm -137.29 -42.67 0.56 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 113.202 0.816 . . . . 25.0 113.202 -176.133 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -137.48 46.47 2.13 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-O 121.264 0.554 . . . . 25.0 110.552 -173.099 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.0 67.22 2.96 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 122.475 1.131 . . . . 25.0 112.541 -173.416 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -72.79 -2.38 20.3 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.751 -1.113 . . . . 25.0 113.048 177.924 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -149.09 154.88 39.92 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 104.405 -2.443 . . . . 25.0 104.405 176.235 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.3 156.89 54.47 Favored 'Trans proline' 0 C--N 1.349 0.577 0 N-CA-C 114.727 1.01 . . . . 25.0 114.727 -178.153 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.27 162.22 14.51 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 106.213 -1.773 . . . . 25.0 106.213 173.246 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.71 15.95 81.16 Favored Glycine 0 C--O 1.218 -0.906 0 C-N-CA 119.836 -1.173 . . . . 25.0 111.843 -179.681 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.1 t -70.22 -8.08 47.15 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.344 0.868 . . . . 25.0 113.344 -177.449 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.32 173.57 39.06 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 109.205 -1.558 . . . . 25.0 109.205 -179.446 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -179.52 167.63 37.69 Favored Glycine 0 C--O 1.24 0.47 0 N-CA-C 107.131 -2.387 . . . . 25.0 107.131 178.304 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t 54.88 -156.63 0.23 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 117.931 0.865 . . . . 25.0 111.366 -179.504 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.0 158.53 28.37 Favored Glycine 0 C--O 1.228 -0.275 0 CA-C-N 116.549 -0.296 . . . . 25.0 113.338 178.191 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 t 59.23 -175.23 0.1 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.922 1.453 . . . . 25.0 114.922 178.983 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.45 90.17 1.42 Allowed Glycine 0 N--CA 1.459 0.167 0 N-CA-C 109.86 -1.296 . . . . 25.0 109.86 178.802 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.0 t -100.2 -23.79 14.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.368 0.877 . . . . 25.0 113.368 -176.201 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 39.02 -123.82 0.33 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.113 0.965 . . . . 25.0 112.234 -177.344 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -121.97 94.52 4.33 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.043 -1.465 . . . . 25.0 107.043 176.463 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -94.94 167.35 11.46 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.4 0.518 . . . . 25.0 112.4 -174.442 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 t0 64.71 179.84 0.18 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.536 1.68 . . . . 25.0 115.536 170.267 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.3 p -124.32 85.05 55.77 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 108.671 -0.863 . . . . 25.0 108.671 180.0 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.24 153.08 50.96 Favored 'Trans proline' 0 C--O 1.239 0.573 0 N-CA-C 116.711 1.774 . . . . 25.0 116.711 -175.09 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -69.77 164.47 34.42 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 N-CA-C 110.762 -0.514 . . . . 25.0 110.762 171.864 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.15 157.65 52.46 Favored 'Trans proline' 0 C--N 1.349 0.555 0 N-CA-C 114.279 0.838 . . . . 25.0 114.279 -175.801 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -95.23 144.17 27.34 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 106.375 -1.713 . . . . 25.0 106.375 175.487 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.46 161.15 46.43 Favored 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 118.021 -0.853 . . . . 25.0 112.783 179.672 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.65 157.24 48.19 Favored 'Trans proline' 0 C--N 1.352 0.713 0 N-CA-C 113.613 0.582 . . . . 25.0 113.613 -179.696 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -103.58 7.91 37.62 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.331 0.586 . . . . 25.0 110.189 177.728 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.3 p -137.13 142.54 42.25 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.109 -1.441 . . . . 25.0 107.109 178.756 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -150.57 21.42 0.82 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.065 0.46 . . . . 25.0 111.793 -177.825 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.5 p -124.84 171.36 10.22 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.751 -0.833 . . . . 25.0 108.751 -177.063 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 66.6 m 48.95 64.74 1.6 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 122.778 1.275 . . . . 25.0 113.494 178.471 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 123.955 1.836 . . . . 25.0 110.56 177.756 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.208 -1.49 0 N-CA-C 118.487 2.155 . . . . 25.0 118.487 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 t 51.84 52.26 14.89 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.658 1.183 . . . . 25.0 111.989 177.908 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.1 ttt -125.75 70.66 1.21 Allowed 'General case' 0 C--O 1.21 -1.013 0 CA-C-O 122.015 0.912 . . . . 25.0 109.668 -179.748 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -135.97 78.66 1.73 Allowed 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 114.186 -1.37 . . . . 25.0 108.793 179.875 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -116.56 167.09 11.37 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.903 -1.044 . . . . 25.0 109.799 -177.646 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.9 mt -68.24 -37.59 80.95 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.144 -0.935 . . . . 25.0 110.389 -177.963 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.1 m120 54.11 29.11 9.82 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 122.861 1.315 . . . . 25.0 112.031 -179.007 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.9 m -91.99 165.0 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 104.817 -2.29 . . . . 25.0 104.817 172.939 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.67 175.69 5.33 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 119.704 1.138 . . . . 25.0 108.612 -178.414 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.96 154.93 40.09 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.987 -1.006 . . . . 25.0 110.824 174.775 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -113.9 130.17 56.52 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 125.299 1.44 . . . . 25.0 110.506 175.96 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.444 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -70.76 128.57 36.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.959 0.885 . . . . 25.0 110.898 177.662 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -94.79 -18.55 21.12 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.669 -0.696 . . . . 25.0 109.403 -179.117 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -145.73 173.79 11.78 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 124.154 0.909 . . . . 25.0 109.238 179.215 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -85.39 164.25 18.04 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 123.408 0.683 . . . . 25.0 111.896 176.032 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -152.32 144.31 23.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.518 0.599 . . . . 25.0 111.705 176.374 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.8 t -113.73 123.48 69.44 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 N-CA-C 106.678 -1.601 . . . . 25.0 106.678 171.218 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.68 124.29 30.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.703 -1.135 . . . . 25.0 108.25 179.537 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -107.3 -11.04 15.65 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.758 -0.83 . . . . 25.0 108.758 -178.711 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.9 t -110.76 147.26 36.11 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 104.883 -2.265 . . . . 25.0 104.883 176.768 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.69 -18.49 32.58 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 O-C-N 121.946 0.445 . . . . 25.0 112.242 179.086 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -85.63 -12.97 50.07 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.654 -0.703 . . . . 25.0 109.346 179.235 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -87.91 143.3 27.19 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-O 121.32 0.581 . . . . 25.0 111.446 179.664 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.1 mt -98.31 128.62 44.82 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-O 121.884 0.85 . . . . 25.0 112.237 177.834 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.69 134.33 34.36 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 105.718 -1.956 . . . . 25.0 105.718 174.157 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -152.58 168.08 26.75 Favored 'General case' 0 C--O 1.266 1.946 0 CA-C-O 121.71 0.767 . . . . 25.0 110.984 -179.782 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -118.92 159.72 23.28 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.367 1.067 . . . . 25.0 110.241 178.845 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -56.96 132.75 53.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.853 -1.166 . . . . 25.0 107.853 174.757 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.59 -25.15 28.55 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 115.349 -0.841 . . . . 25.0 114.089 -179.479 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -60.09 134.85 57.44 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.358 -0.979 . . . . 25.0 108.358 -175.226 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.5 mm -103.78 127.08 58.19 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 109.22 -0.659 . . . . 25.0 109.22 176.061 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.3 ptp -132.74 156.21 47.47 Favored 'General case' 0 C--O 1.2 -1.511 0 CA-C-N 115.416 -0.811 . . . . 25.0 108.918 -179.181 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.9 m -93.87 119.24 32.54 Favored 'General case' 0 C--O 1.198 -1.635 0 N-CA-C 108.918 -0.771 . . . . 25.0 108.918 -178.444 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.2 t -79.9 121.69 33.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 106.697 -1.594 . . . . 25.0 106.697 177.702 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.3 mt -94.51 -42.14 8.99 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.949 0.881 . . . . 25.0 109.735 179.854 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -146.33 152.19 38.73 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.566 -0.743 . . . . 25.0 109.577 -176.859 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -113.79 150.64 33.16 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 105.945 -1.872 . . . . 25.0 105.945 171.74 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 55.54 43.1 28.96 Favored 'General case' 0 C--O 1.268 2.027 0 O-C-N 125.021 1.45 . . . . 25.0 109.893 -176.876 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.2 t -70.49 151.2 45.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.397 -1.274 . . . . 25.0 111.145 -178.924 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 58.51 18.86 6.04 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.491 1.116 . . . . 25.0 112.069 179.359 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.5 5.15 90.16 Favored Glycine 0 C--O 1.208 -1.529 0 CA-C-N 115.139 -0.937 . . . . 25.0 112.071 178.06 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.9 mt -84.84 136.62 33.58 Favored 'General case' 0 C--O 1.211 -0.93 0 CA-C-N 117.289 0.544 . . . . 25.0 109.623 -174.512 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -80.03 108.35 13.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.902 -1.044 . . . . 25.0 113.351 -179.065 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.79 0.91 74.39 Favored Glycine 0 C--O 1.221 -0.691 0 C-N-CA 119.473 -1.346 . . . . 25.0 116.189 177.924 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -99.58 136.13 39.96 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 117.807 0.804 . . . . 25.0 109.232 173.43 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -113.01 146.19 39.52 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.711 -0.848 . . . . 25.0 108.711 -176.601 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.9 tp -89.9 127.61 36.04 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 106.076 -1.824 . . . . 25.0 106.076 -179.938 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.9 m -137.97 160.46 39.27 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 119.59 1.086 . . . . 25.0 113.778 -179.169 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.3 t -109.22 123.01 48.55 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 106.295 -1.742 . . . . 25.0 106.295 171.569 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.9 tp -137.91 127.52 25.1 Favored 'General case' 0 C--O 1.204 -1.313 0 N-CA-C 107.743 -1.206 . . . . 25.0 107.743 -177.562 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.8 m80 54.43 35.53 23.39 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.86 0.838 . . . . 25.0 110.691 -176.504 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.21 6.72 88.81 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.512 -0.852 . . . . 25.0 113.858 175.24 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -127.27 148.9 50.21 Favored 'General case' 0 C--O 1.204 -1.304 0 CA-C-N 119.001 1.4 . . . . 25.0 109.121 -176.3 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -102.03 148.35 25.48 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 123.688 0.618 . . . . 25.0 112.077 -178.02 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.67 -179.94 48.8 Favored Glycine 0 C--O 1.25 1.099 0 N-CA-C 106.76 -2.536 . . . . 25.0 106.76 -177.861 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt -103.52 148.56 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.01 0.924 . . . . 25.0 111.753 -174.831 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.87 148.63 43.18 Favored Pre-proline 0 C--O 1.244 0.795 0 CA-C-O 122.68 1.229 . . . . 25.0 110.863 -177.42 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.05 125.21 7.1 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 116.302 -1.999 . . . . 25.0 114.338 -178.353 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.84 -20.77 60.2 Favored Glycine 0 C--O 1.203 -1.829 0 CA-C-N 116.154 -0.476 . . . . 25.0 113.529 179.3 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -68.2 -15.66 63.67 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 121.053 -1.263 . . . . 25.0 112.36 -178.654 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -115.73 15.48 16.44 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.872 -0.517 . . . . 25.0 109.762 -179.148 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 12' ' ' ALA . 29.6 mt -130.03 152.5 49.42 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 117.366 2.358 . . . . 25.0 117.366 -176.757 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt -119.64 126.52 51.34 Favored 'General case' 0 C--O 1.197 -1.7 0 N-CA-C 108.055 -1.091 . . . . 25.0 108.055 175.53 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.5 mm -75.16 137.01 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 O-C-N 124.167 0.917 . . . . 25.0 110.204 177.111 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.3 mt -117.74 105.38 11.93 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.493 1.117 . . . . 25.0 108.528 177.666 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.09 162.41 2.49 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 CA-C-N 114.915 -1.039 . . . . 25.0 110.658 -172.991 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -103.28 38.44 3.23 Favored Glycine 0 C--O 1.207 -1.543 0 N-CA-C 116.813 1.485 . . . . 25.0 116.813 176.953 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.2 ttt -85.53 178.46 7.4 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.841 0.829 . . . . 25.0 109.337 -178.269 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -63.81 124.58 21.87 Favored 'General case' 0 C--O 1.199 -1.564 0 CA-C-N 115.992 -0.549 . . . . 25.0 110.944 -178.651 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -139.42 -54.94 0.57 Allowed 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 114.886 1.439 . . . . 25.0 114.886 175.661 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 57.04 37.4 28.67 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.644 -0.707 . . . . 25.0 111.389 -173.445 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.8 mttt -118.91 107.86 41.58 Favored Pre-proline 0 N--CA 1.485 1.319 0 O-C-N 121.899 -0.5 . . . . 25.0 109.892 -179.934 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.28 174.38 12.9 Favored 'Trans proline' 0 C--N 1.351 0.686 0 N-CA-C 113.913 0.697 . . . . 25.0 113.913 176.794 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.88 -58.12 0.31 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.988 0.515 . . . . 25.0 110.47 179.582 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.94 7.21 86.44 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 115.069 0.788 . . . . 25.0 115.069 178.291 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.3 m -60.41 141.06 56.85 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 109.258 -0.645 . . . . 25.0 109.258 179.713 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -159.48 51.23 0.38 Allowed Glycine 0 CA--C 1.531 1.055 0 CA-C-O 119.456 -0.636 . . . . 25.0 114.459 -179.213 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.99 148.08 16.53 Favored Glycine 0 C--O 1.216 -0.975 0 CA-C-N 119.67 1.735 . . . . 25.0 110.713 -178.338 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 62.6 p -163.29 173.09 13.75 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 123.665 0.786 . . . . 25.0 109.277 -175.949 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.72 -11.71 61.05 Favored Glycine 0 C--O 1.202 -1.85 0 CA-C-O 118.379 -1.234 . . . . 25.0 115.044 171.077 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 95.7 p -81.29 155.78 25.87 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 118.643 1.222 . . . . 25.0 111.075 179.755 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 173.47 134.17 1.79 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.36 -1.096 . . . . 25.0 110.36 173.584 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.0 t -161.0 132.53 5.62 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 104.609 -2.367 . . . . 25.0 104.609 178.303 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 61.64 159.2 0.05 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 125.561 1.788 . . . . 25.0 115.519 -172.414 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.0 tttm 61.16 169.91 0.1 Allowed 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 124.24 1.016 . . . . 25.0 112.616 179.579 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.28 156.92 29.6 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 108.405 -0.961 . . . . 25.0 108.405 -176.141 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -116.83 156.16 27.75 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.217 0.607 . . . . 25.0 109.719 179.167 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.3 p -111.06 93.43 17.73 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 123.717 0.807 . . . . 25.0 111.475 178.51 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.78 156.2 63.89 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 116.663 -1.758 . . . . 25.0 113.912 -175.427 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.85 154.14 63.57 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 116.624 -1.784 . . . . 25.0 112.517 178.011 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.47 157.89 57.65 Favored 'Trans proline' 0 C--N 1.354 0.846 0 N-CA-C 114.251 0.827 . . . . 25.0 114.251 -177.818 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -69.54 138.26 88.63 Favored Pre-proline 0 N--CA 1.479 1.022 0 CA-C-O 119.102 -0.475 . . . . 25.0 110.926 -177.822 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -69.36 166.4 27.23 Favored 'Trans proline' 0 CA--C 1.562 1.883 0 O-C-N 123.159 1.084 . . . . 25.0 111.55 174.496 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.2 150.09 89.58 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 N-CA-C 116.05 1.519 . . . . 25.0 116.05 -174.208 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.9 mtm180 -110.32 10.32 23.55 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.594 -0.276 . . . . 25.0 110.261 -179.598 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.8 p 54.21 -164.83 0.1 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.87 1.804 . . . . 25.0 115.87 -178.978 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 61.3 -164.19 0.24 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.727 1.211 . . . . 25.0 108.758 -176.706 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.5 t 54.16 59.91 3.93 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 115.128 1.529 . . . . 25.0 115.128 178.493 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.5 t 59.09 60.44 2.41 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 123.115 1.436 . . . . 25.0 109.559 -178.041 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.0 tp . . . . . 0 C--N 1.316 -0.871 0 CA-C-N 112.871 -1.968 . . . . 25.0 113.971 -175.187 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.763 0 CA-C-O 124.008 1.893 . . . . 25.0 115.944 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.0 m -142.0 140.3 32.63 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 120.424 -1.633 . . . . 25.0 110.936 177.37 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.15 148.27 31.0 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 103.074 -2.935 . . . . 25.0 103.074 174.581 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.07 111.19 8.99 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 106.338 -1.726 . . . . 25.0 106.338 179.261 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -110.16 171.55 7.39 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 113.713 1.005 . . . . 25.0 113.713 -177.392 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.4 mt -71.99 -41.88 67.14 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.793 -1.094 . . . . 25.0 110.492 175.878 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.8 m120 54.39 33.35 18.4 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 113.606 -1.634 . . . . 25.0 113.814 -178.388 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 m -97.7 166.48 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.156 0 N-CA-C 106.408 -1.701 . . . . 25.0 106.408 178.253 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.3 171.72 7.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.32 -1.487 . . . . 25.0 107.3 -176.272 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.22 157.74 43.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 119.232 0.923 . . . . 25.0 111.774 176.896 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -120.33 127.55 52.44 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.498 -0.774 . . . . 25.0 110.935 179.579 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.93 122.12 18.67 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.635 -1.246 . . . . 25.0 107.635 179.749 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.3 mt -84.89 -27.91 26.32 Favored 'General case' 0 C--O 1.212 -0.876 0 O-C-N 121.879 -0.513 . . . . 25.0 110.776 -178.949 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -138.41 177.07 8.16 Favored 'General case' 0 C--O 1.198 -1.649 0 N-CA-C 108.622 -0.881 . . . . 25.0 108.622 177.216 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.63 170.57 15.9 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.317 0.647 . . . . 25.0 111.806 173.491 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -155.83 141.64 18.03 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 113.981 1.104 . . . . 25.0 113.981 175.02 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.6 131.99 62.6 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 105.774 -1.936 . . . . 25.0 105.774 -179.454 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.96 111.79 15.5 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 124.639 1.212 . . . . 25.0 110.274 -178.996 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -106.53 -1.33 23.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.64 0.733 . . . . 25.0 112.249 -179.208 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.3 m -131.7 154.36 81.78 Favored Pre-proline 0 CA--C 1.501 -0.923 0 N-CA-C 107.418 -1.327 . . . . 25.0 107.418 174.956 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.51 -26.56 40.25 Favored 'Trans proline' 0 C--O 1.259 1.533 0 C-N-CA 116.582 -1.812 . . . . 25.0 113.323 -175.631 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -82.57 -6.83 59.56 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 115.9 -0.591 . . . . 25.0 110.806 179.695 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -85.54 142.61 29.03 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-O 121.929 0.871 . . . . 25.0 111.988 -178.08 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.1 mt -93.73 135.19 35.28 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.605 -0.725 . . . . 25.0 109.089 176.071 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.47 130.15 39.4 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 106.413 -1.699 . . . . 25.0 106.413 174.629 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -150.93 165.89 32.31 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.607 0.717 . . . . 25.0 109.681 -178.583 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -115.1 170.33 8.44 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.666 -0.697 . . . . 25.0 109.906 -179.18 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -65.06 135.67 55.85 Favored 'General case' 0 C--O 1.203 -1.35 0 N-CA-C 108.488 -0.93 . . . . 25.0 108.488 175.825 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.02 -23.5 30.62 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 109.937 -1.265 . . . . 25.0 109.937 175.63 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -61.56 143.74 55.51 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 122.065 0.936 . . . . 25.0 111.362 -175.974 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.1 mm -116.04 120.09 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 114.116 -1.402 . . . . 25.0 109.571 -177.554 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -124.54 151.97 44.04 Favored 'General case' 0 C--N 1.313 -0.999 0 O-C-N 124.072 0.857 . . . . 25.0 109.161 179.0 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.6 m -84.39 127.63 34.11 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 106.822 -1.547 . . . . 25.0 106.822 177.103 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.9 t -90.19 120.88 39.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.51 -0.922 . . . . 25.0 108.51 176.009 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -90.39 -45.1 9.22 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.602 -0.726 . . . . 25.0 111.285 177.374 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -148.79 157.57 43.53 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.387 -0.968 . . . . 25.0 108.387 -175.264 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -118.73 147.63 43.65 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 106.513 -1.662 . . . . 25.0 106.513 176.672 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 55.75 46.38 22.57 Favored 'General case' 0 C--O 1.255 1.355 0 CA-C-O 124.206 1.955 . . . . 25.0 109.394 -177.805 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.438 HG21 HG22 ' A' ' 56' ' ' ILE . 14.6 t -68.59 157.53 35.89 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-N 112.594 -2.094 . . . . 25.0 110.942 -177.691 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 60.03 13.22 3.6 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.381 0.882 . . . . 25.0 113.381 174.413 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.53 16.09 78.48 Favored Glycine 0 CA--C 1.539 1.558 0 N-CA-C 109.296 -1.522 . . . . 25.0 109.296 179.599 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.6 mt -100.82 129.91 46.77 Favored 'General case' 0 C--O 1.206 -1.207 0 N-CA-C 107.348 -1.353 . . . . 25.0 107.348 -178.67 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.93 123.71 27.53 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 122.169 0.985 . . . . 25.0 111.867 177.93 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.57 -0.35 82.86 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 120.215 -0.993 . . . . 25.0 114.683 175.119 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -100.71 134.15 44.11 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.76 -0.83 . . . . 25.0 108.76 175.575 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -114.85 141.4 47.95 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.54 -0.911 . . . . 25.0 108.54 -178.076 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.4 tp -85.61 120.12 26.69 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.565 -0.902 . . . . 25.0 108.565 178.617 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 98.7 m -135.77 158.56 44.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.183 0.438 . . . . 25.0 112.183 -177.334 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.9 t -105.95 121.34 43.9 Favored 'General case' 0 C--O 1.251 1.168 0 C-N-CA 123.987 0.915 . . . . 25.0 108.787 173.804 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 tp -138.14 132.59 32.2 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.288 1.035 . . . . 25.0 109.164 179.967 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.7 m170 54.09 30.93 12.83 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-O 122.813 1.292 . . . . 25.0 109.655 -176.157 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.45 -5.44 73.38 Favored Glycine 0 N--CA 1.462 0.384 0 N-CA-C 116.528 1.371 . . . . 25.0 116.528 176.727 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -110.83 145.91 37.36 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.919 -0.771 . . . . 25.0 108.919 179.396 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -91.52 151.62 20.68 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 124.451 1.094 . . . . 25.0 108.642 178.849 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.27 -176.19 47.65 Favored Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 107.913 -2.075 . . . . 25.0 107.913 -179.595 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.438 HG22 HG21 ' A' ' 39' ' ' THR . 41.6 pt -104.73 148.94 8.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-O 121.977 0.894 . . . . 25.0 111.761 -175.341 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.7 m -143.48 146.38 35.49 Favored Pre-proline 0 C--O 1.246 0.896 0 C-N-CA 123.254 0.622 . . . . 25.0 111.969 177.256 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.97 122.17 7.05 Favored 'Trans proline' 0 C--N 1.358 1.049 0 N-CA-C 114.296 0.845 . . . . 25.0 114.296 -175.86 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.49 -25.56 71.48 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.842 -0.617 . . . . 25.0 114.379 -178.197 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.26 -24.68 60.17 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.044 0.757 . . . . 25.0 113.044 -179.157 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -119.09 31.38 6.66 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 120.929 -1.107 . . . . 25.0 108.789 178.962 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.4 mt -128.26 159.77 34.21 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.383 1.087 . . . . 25.0 110.747 176.538 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -134.46 127.04 30.7 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 115.106 -0.952 . . . . 25.0 108.784 174.738 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.5 mm -73.54 136.71 24.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.995 -0.743 . . . . 25.0 108.995 -179.347 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.5 mt -112.04 89.08 2.97 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 106.847 -1.538 . . . . 25.0 106.847 174.347 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.7 m -74.54 158.19 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 119.226 -0.99 . . . . 25.0 108.843 176.559 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.38 -173.62 24.19 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-N 114.003 -1.453 . . . . 25.0 113.311 176.46 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 13.8 tpt -144.23 119.57 10.24 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 107.855 -1.165 . . . . 25.0 107.855 178.952 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 60.23 2.34 0.43 Allowed 'General case' 0 CA--C 1.577 2.006 0 C-N-CA 123.051 0.541 . . . . 25.0 112.366 -169.302 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.13 -31.54 67.28 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.558 0.743 . . . . 25.0 112.186 174.272 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -132.1 -35.51 1.21 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.104 1.15 . . . . 25.0 114.104 -179.046 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.7 mttt 62.05 159.36 0.12 Allowed Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 125.347 1.459 . . . . 25.0 110.969 -171.563 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.99 -10.19 21.12 Favored 'Trans proline' 0 C--O 1.205 -1.14 0 C-N-CA 115.386 -2.61 . . . . 25.0 114.908 -178.54 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -157.37 168.71 26.56 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.717 -1.586 . . . . 25.0 106.717 -179.646 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -157.98 95.87 0.15 Allowed Glycine 0 N--CA 1.472 1.039 0 N-CA-C 110.541 -1.024 . . . . 25.0 110.541 176.153 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.0 t 57.12 40.71 28.11 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 121.671 0.748 . . . . 25.0 111.237 -175.589 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.26 -172.86 14.53 Favored Glycine 0 C--O 1.247 0.945 0 N-CA-C 108.75 -1.74 . . . . 25.0 108.75 -176.15 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.0 179.53 39.56 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.708 -1.051 . . . . 25.0 112.195 -178.986 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.1 m -89.15 150.23 22.8 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 118.66 1.23 . . . . 25.0 109.829 -179.034 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.24 -34.04 0.65 Allowed Glycine 0 C--O 1.201 -1.944 0 CA-C-N 116.042 -0.526 . . . . 25.0 113.568 178.483 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.93 81.55 3.48 Favored 'General case' 0 C--O 1.206 -1.236 0 CA-C-O 124.033 1.873 . . . . 25.0 113.14 -179.711 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.83 166.68 39.84 Favored Glycine 0 C--O 1.203 -1.819 0 O-C-N 119.845 -1.784 . . . . 25.0 111.933 -176.681 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.5 m -130.76 26.53 4.99 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 114.006 1.113 . . . . 25.0 114.006 -175.874 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -64.6 143.76 57.69 Favored 'General case' 0 CA--C 1.501 -0.906 0 O-C-N 120.823 -1.173 . . . . 25.0 108.85 -172.872 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -76.23 58.6 1.28 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.527 1.156 . . . . 25.0 113.186 -179.903 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -64.06 142.52 58.38 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-N 115.208 -0.905 . . . . 25.0 110.596 179.44 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -77.95 166.39 22.92 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.494 -0.775 . . . . 25.0 111.673 -177.033 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.4 m -56.0 152.6 20.53 Favored Pre-proline 0 CA--C 1.559 1.321 0 C-N-CA 125.515 1.526 . . . . 25.0 113.133 -178.742 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -71.6 159.79 50.11 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 N-CA-C 114.051 0.75 . . . . 25.0 114.051 179.418 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.73 152.09 78.11 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 120.652 0.901 . . . . 25.0 111.157 169.938 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.58 155.68 65.87 Favored 'Trans proline' 0 C--N 1.352 0.733 0 N-CA-C 115.279 1.223 . . . . 25.0 115.279 -173.269 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -85.05 147.4 47.82 Favored Pre-proline 0 N--CA 1.478 0.963 0 CA-C-N 115.652 -0.704 . . . . 25.0 109.69 176.732 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.03 161.69 42.8 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 117.577 -1.149 . . . . 25.0 111.023 178.901 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -65.29 160.32 42.95 Favored 'Trans proline' 0 C--N 1.348 0.512 0 N-CA-C 114.62 0.969 . . . . 25.0 114.62 179.17 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -107.36 -25.38 11.47 Favored 'General case' 0 C--O 1.193 -1.906 0 CA-C-N 115.869 -0.605 . . . . 25.0 112.353 178.339 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.5 p -138.44 133.51 32.88 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.225 1.012 . . . . 25.0 109.822 -175.859 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -161.24 150.31 16.4 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.149 1.379 . . . . 25.0 109.37 -178.734 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.9 t -145.35 140.54 27.78 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.865 -0.791 . . . . 25.0 108.865 179.133 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 80.4 m -80.62 147.93 30.49 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.618 -0.882 . . . . 25.0 108.618 176.596 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 124.479 2.085 . . . . 25.0 112.784 -178.196 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.618 0 N-CA-C 115.24 0.856 . . . . 25.0 115.24 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.4 m 57.39 39.74 27.98 Favored 'General case' 0 C--O 1.19 -2.052 0 C-N-CA 124.835 1.254 . . . . 25.0 112.407 178.62 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 61.2 mtt -92.11 -68.94 0.77 Allowed 'General case' 0 C--O 1.206 -1.194 0 N-CA-C 114.124 1.157 . . . . 25.0 114.124 -179.067 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -125.95 61.96 1.25 Allowed 'General case' 0 C--O 1.198 -1.629 0 N-CA-C 106.361 -1.718 . . . . 25.0 106.361 -178.814 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -124.27 163.02 22.51 Favored 'General case' 0 C--O 1.201 -1.483 0 CA-C-N 113.54 -1.664 . . . . 25.0 109.565 -175.168 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.6 mt -71.1 -40.91 71.23 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.249 -1.341 . . . . 25.0 111.424 178.751 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.0 m120 57.48 35.84 26.32 Favored 'General case' 0 C--O 1.253 1.275 0 C-N-CA 124.136 0.975 . . . . 25.0 110.753 -178.865 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.6 m -101.4 157.09 4.4 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 N-CA-C 107.687 -1.227 . . . . 25.0 107.687 176.044 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.07 166.25 12.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 118.324 -0.846 . . . . 25.0 109.173 -176.929 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.94 154.59 40.54 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.901 0.773 . . . . 25.0 112.953 172.651 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -117.9 129.49 55.66 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 124.07 0.948 . . . . 25.0 111.086 -179.527 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.43 126.36 29.43 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-O 118.614 -0.708 . . . . 25.0 109.294 177.866 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt -89.01 -28.81 19.94 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.013 0.925 . . . . 25.0 111.376 178.797 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -139.85 170.11 16.48 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.12 -1.437 . . . . 25.0 107.12 179.919 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -83.91 176.18 9.07 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 122.968 0.507 . . . . 25.0 110.642 -177.801 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -151.12 153.34 34.83 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 108.008 -1.108 . . . . 25.0 108.008 -178.216 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.4 t -125.26 136.0 62.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 104.507 -2.405 . . . . 25.0 104.507 170.832 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.27 134.62 42.95 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 114.475 -1.238 . . . . 25.0 110.238 178.013 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -125.22 11.37 8.15 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 123.628 0.58 . . . . 25.0 110.777 -177.341 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.4 t -151.21 150.91 28.34 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 106.228 -1.767 . . . . 25.0 106.228 -179.289 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.75 -12.12 28.49 Favored 'Trans proline' 0 N--CA 1.48 0.683 0 N-CA-C 116.607 1.733 . . . . 25.0 116.607 -175.91 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -83.1 -20.67 34.42 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 107.802 -1.184 . . . . 25.0 107.802 177.73 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -84.06 136.58 33.97 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.723 0.773 . . . . 25.0 110.063 -178.927 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.3 mt -93.57 131.26 39.01 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 113.929 1.085 . . . . 25.0 113.929 -177.997 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 p -86.75 95.1 9.71 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-N 115.212 -0.904 . . . . 25.0 110.85 -179.408 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -126.43 160.57 30.14 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 121.743 -0.598 . . . . 25.0 111.8 179.645 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -121.57 165.47 15.64 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 105.087 -2.19 . . . . 25.0 105.087 -177.254 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -59.02 131.42 50.99 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.54 0.686 . . . . 25.0 110.656 177.532 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.74 -20.02 51.05 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 121.754 -0.591 . . . . 25.0 114.295 -179.006 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -62.29 131.32 48.95 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 106.932 -1.507 . . . . 25.0 106.932 178.723 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.6 mm -102.23 132.43 48.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 106.939 -1.504 . . . . 25.0 106.939 177.817 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 11.2 ptp -131.8 161.87 31.9 Favored 'General case' 0 CA--C 1.495 -1.145 0 O-C-N 121.241 -0.912 . . . . 25.0 109.244 -179.836 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.2 m -101.62 119.19 38.39 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.678 -1.601 . . . . 25.0 106.678 -177.979 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 t -81.69 130.63 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 123.513 1.625 . . . . 25.0 109.321 -179.83 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.4 mt -100.41 -42.92 6.41 Favored 'General case' 0 C--O 1.204 -1.306 0 O-C-N 121.197 -0.939 . . . . 25.0 112.895 178.311 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -148.3 147.41 29.28 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-O 118.539 -0.743 . . . . 25.0 109.518 178.808 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -107.05 147.32 30.11 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.311 -1.366 . . . . 25.0 107.311 173.188 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 56.4 39.65 29.97 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 123.279 1.514 . . . . 25.0 110.665 -173.91 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -64.18 150.71 45.18 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 113.744 -1.571 . . . . 25.0 110.252 -175.327 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 56.7 22.65 7.03 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.076 -1.42 . . . . 25.0 113.3 178.225 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.32 16.93 73.8 Favored Glycine 0 CA--C 1.501 -0.788 0 C-N-CA 120.492 -0.861 . . . . 25.0 112.347 -179.24 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.3 mt -92.66 130.5 38.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.528 -1.286 . . . . 25.0 107.528 175.438 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -75.2 122.22 23.31 Favored 'General case' 0 C--O 1.258 1.526 0 O-C-N 121.232 -0.918 . . . . 25.0 110.68 176.996 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.83 -5.13 85.36 Favored Glycine 0 C--N 1.331 0.303 0 N-CA-C 116.089 1.196 . . . . 25.0 116.089 172.686 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -97.07 136.04 38.19 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 117.824 0.812 . . . . 25.0 109.764 177.085 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -114.41 142.85 45.82 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-O 117.595 -1.193 . . . . 25.0 108.019 -177.946 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.5 tp -85.42 125.28 32.87 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.128 -2.175 . . . . 25.0 105.128 175.059 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.8 m -135.47 164.08 28.61 Favored 'General case' 0 C--O 1.253 1.289 0 O-C-N 121.705 -0.622 . . . . 25.0 109.862 177.336 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.9 t -112.61 120.61 42.16 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.215 -1.402 . . . . 25.0 107.215 171.052 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.8 tp -132.52 136.45 46.64 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 105.756 -1.942 . . . . 25.0 105.756 -175.785 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.1 m170 54.16 29.69 10.9 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.527 0.68 . . . . 25.0 109.985 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.91 11.04 81.18 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-O 118.454 -1.192 . . . . 25.0 116.061 178.919 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -122.66 146.86 47.08 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.356 -1.35 . . . . 25.0 107.356 175.477 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -89.08 160.8 16.87 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.15 -1.055 . . . . 25.0 108.15 178.009 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.43 -174.43 41.91 Favored Glycine 0 C--O 1.242 0.623 0 N-CA-C 108.349 -1.901 . . . . 25.0 108.349 -178.758 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 pt -118.57 152.92 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.615 0 CA-C-O 122.71 1.243 . . . . 25.0 111.793 -172.238 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.9 m -143.92 150.91 51.27 Favored Pre-proline 0 C--N 1.306 -1.288 0 CA-C-N 112.384 -2.189 . . . . 25.0 110.807 -174.842 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.3 128.17 10.3 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 O-C-N 121.949 0.447 . . . . 25.0 112.565 -179.318 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.57 -22.42 78.99 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 118.962 -1.59 . . . . 25.0 115.642 -174.624 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -28.18 69.78 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 122.094 -0.651 . . . . 25.0 112.38 -175.54 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -108.35 28.02 8.75 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 122.013 0.911 . . . . 25.0 110.322 178.985 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.5 mt -121.37 159.17 26.7 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 114.423 1.268 . . . . 25.0 114.423 175.126 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -134.94 115.51 13.66 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.779 0.832 . . . . 25.0 109.729 176.36 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.7 mm -67.03 129.15 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 112.422 0.527 . . . . 25.0 112.422 177.834 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.5 mt -105.53 78.03 1.33 Allowed 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.131 -1.433 . . . . 25.0 107.131 179.219 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -78.16 163.21 3.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.744 -0.465 . . . . 25.0 109.744 178.0 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -157.15 146.06 13.04 Favored Glycine 0 C--O 1.203 -1.827 0 O-C-N 125.032 1.457 . . . . 25.0 109.702 177.483 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 28.0 ttt -167.6 -61.41 0.03 OUTLIER 'General case' 0 C--O 1.205 -1.26 0 N-CA-C 101.853 -3.388 . . . . 25.0 101.853 174.947 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.69 -55.12 0.38 Allowed 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 113.8 1.037 . . . . 25.0 113.8 177.855 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -73.07 -36.32 66.83 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.91 -0.586 . . . . 25.0 111.68 -179.27 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.2 tttt 69.63 -65.05 0.32 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.593 1.957 . . . . 25.0 114.681 -179.364 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -148.18 152.86 40.42 Favored Pre-proline 0 C--O 1.263 1.791 0 N-CA-C 107.525 -1.287 . . . . 25.0 107.525 -178.033 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.36 143.35 57.81 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 114.026 -3.516 . . . . 25.0 109.776 -178.079 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.97 76.02 4.15 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 106.719 -1.586 . . . . 25.0 106.719 175.98 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.26 -179.85 39.9 Favored Glycine 0 CA--C 1.505 -0.548 0 CA-C-O 122.904 1.28 . . . . 25.0 112.018 -179.053 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.5 p -76.57 177.54 7.39 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 108.029 -1.1 . . . . 25.0 108.029 177.944 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.84 -34.41 2.22 Favored Glycine 0 C--O 1.21 -1.38 0 N-CA-C 109.057 -1.617 . . . . 25.0 109.057 177.972 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.91 157.15 22.7 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.091 -0.576 . . . . 25.0 112.34 173.605 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.2 m -79.8 141.54 36.16 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.165 -0.614 . . . . 25.0 110.664 -179.336 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.73 -166.91 34.84 Favored Glycine 0 C--O 1.22 -0.746 0 N-CA-C 108.929 -1.668 . . . . 25.0 108.929 173.472 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 p -72.32 140.49 48.55 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 119.849 1.825 . . . . 25.0 106.553 174.284 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.48 54.95 0.43 Allowed Glycine 0 CA--C 1.538 1.525 0 N-CA-C 111.247 -0.741 . . . . 25.0 111.247 -175.764 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 m 56.61 -165.3 0.14 Allowed 'General case' 0 C--O 1.255 1.369 0 N-CA-C 115.169 1.544 . . . . 25.0 115.169 -178.692 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -87.39 122.35 31.02 Favored 'General case' 0 C--O 1.207 -1.175 0 N-CA-C 112.083 0.401 . . . . 25.0 112.083 179.388 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -140.66 122.23 15.17 Favored 'General case' 0 C--O 1.259 1.561 0 CA-C-O 117.79 -1.1 . . . . 25.0 110.041 178.244 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -82.06 116.34 21.61 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 124.52 1.138 . . . . 25.0 112.225 178.879 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -154.3 170.19 21.89 Favored 'General case' 0 C--O 1.249 1.059 0 N-CA-C 107.659 -1.237 . . . . 25.0 107.659 176.971 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.8 m -118.5 150.46 48.06 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 114.174 1.176 . . . . 25.0 114.174 -177.52 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -64.31 160.67 37.8 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 121.746 1.63 . . . . 25.0 114.386 -178.685 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.92 149.85 86.07 Favored 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 118.51 -0.527 . . . . 25.0 110.892 179.765 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.16 172.39 16.1 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 116.87 -1.62 . . . . 25.0 113.933 -170.652 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -85.07 139.88 36.88 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 106.71 -1.589 . . . . 25.0 106.71 179.307 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -69.69 166.51 27.25 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 117.565 -1.157 . . . . 25.0 110.278 174.203 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.29 149.29 40.06 Favored 'Trans proline' 0 C--O 1.209 -0.962 0 N-CA-C 114.875 1.067 . . . . 25.0 114.875 -178.242 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.7 mtt85 -97.21 -20.7 17.75 Favored 'General case' 0 C--O 1.194 -1.819 0 CA-C-O 121.17 0.509 . . . . 25.0 111.528 -179.359 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.2 p -130.22 147.62 51.97 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 103.517 -2.771 . . . . 25.0 103.517 178.077 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -131.21 112.17 12.58 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 106.224 -1.769 . . . . 25.0 106.224 177.708 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.2 t -142.05 79.4 1.67 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.455 -0.898 . . . . 25.0 112.118 -172.264 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 73.8 m -128.43 99.89 5.58 Favored 'General case' 0 C--O 1.195 -1.764 0 N-CA-C 109.527 -0.546 . . . . 25.0 109.527 178.161 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 C--O 1.241 0.614 0 CA-C-O 126.596 3.093 . . . . 25.0 110.72 -173.139 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 120.871 0.367 . . . . 25.0 110.802 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.8 mt -65.48 -42.15 92.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.598 -0.728 . . . . 25.0 110.294 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 56.27 30.92 17.56 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.206 1.002 . . . . 25.0 111.882 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.7 m -88.62 163.47 2.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 105.526 -2.027 . . . . 25.0 105.526 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.61 173.4 6.56 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.89 -0.782 . . . . 25.0 108.89 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.78 162.46 40.99 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.72 -0.474 . . . . 25.0 109.72 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -126.69 135.6 51.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.817 -1.083 . . . . 25.0 109.648 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.492 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -72.62 120.63 18.5 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.803 -0.635 . . . . 25.0 109.295 172.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.62 -23.25 24.33 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.922 -0.77 . . . . 25.0 108.922 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -140.54 172.28 12.94 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.456 -1.312 . . . . 25.0 107.456 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.72 164.34 18.62 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 123.129 0.572 . . . . 25.0 110.417 174.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -153.73 130.74 11.01 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.962 0.505 . . . . 25.0 110.725 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.23 118.94 48.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 106.035 -1.839 . . . . 25.0 106.035 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.43 143.08 51.93 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.276 -0.874 . . . . 25.0 109.896 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -116.69 -34.84 4.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.039 -0.982 . . . . 25.0 109.685 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.5 m -93.44 153.97 41.34 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.068 -0.716 . . . . 25.0 109.068 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.43 -22.27 33.83 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 117.782 -1.012 . . . . 25.0 113.645 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -81.12 -16.18 53.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.73 0.776 . . . . 25.0 110.85 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -84.52 138.36 32.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.489 0.661 . . . . 25.0 110.299 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.6 mt -92.84 130.49 38.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.61 0.719 . . . . 25.0 110.048 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.6 t -91.55 137.57 32.26 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.686 -1.598 . . . . 25.0 106.686 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -154.09 166.19 33.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.679 0.752 . . . . 25.0 112.642 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -110.09 158.87 17.84 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.638 -0.875 . . . . 25.0 108.638 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -57.48 131.03 48.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.701 -1.222 . . . . 25.0 107.701 171.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.23 -19.9 46.98 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-O 119.154 -0.803 . . . . 25.0 113.889 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -59.74 144.71 47.47 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.76 0.79 . . . . 25.0 110.545 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.4 mm -114.04 130.69 67.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.58 -1.191 . . . . 25.0 107.836 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -135.34 156.47 48.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.967 -0.383 . . . . 25.0 109.967 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.7 m -92.66 126.17 37.63 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.159 -1.052 . . . . 25.0 108.159 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.5 t -89.86 122.82 41.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.259 -1.015 . . . . 25.0 108.259 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.644 HD12 HD22 ' A' ' 47' ' ' LEU . 77.4 mt -88.26 -48.07 7.95 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.646 -0.706 . . . . 25.0 109.14 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -152.52 167.03 30.14 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.345 -0.983 . . . . 25.0 108.345 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -116.84 154.29 30.99 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 106.811 -1.551 . . . . 25.0 106.811 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 58.13 40.6 24.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.918 1.818 . . . . 25.0 108.982 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -64.87 149.64 49.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 112.59 -2.095 . . . . 25.0 110.925 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 60.33 9.56 2.02 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.98 0.912 . . . . 25.0 113.37 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.99 12.95 80.35 Favored Glycine 0 C--N 1.33 0.244 0 N-CA-C 111.114 -0.795 . . . . 25.0 111.114 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 99.0 mt -91.24 117.87 30.0 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.42 -0.585 . . . . 25.0 109.42 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -63.6 126.47 27.63 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.707 -0.679 . . . . 25.0 110.928 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.12 -0.28 84.02 Favored Glycine 0 CA--C 1.518 0.261 0 N-CA-C 115.515 0.966 . . . . 25.0 115.515 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -100.89 133.49 45.29 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 119.012 1.406 . . . . 25.0 109.873 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -113.47 141.97 46.48 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.771 -0.825 . . . . 25.0 108.771 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.644 HD22 HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -82.39 121.66 27.0 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.596 -2.001 . . . . 25.0 105.596 177.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 88.4 m -129.88 160.92 32.05 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.829 -0.348 . . . . 25.0 111.39 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -113.9 122.03 45.75 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.989 -1.856 . . . . 25.0 105.989 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.0 tp -145.5 139.7 26.98 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.819 -1.178 . . . . 25.0 107.819 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.9 m170 57.25 27.0 12.98 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.412 0.685 . . . . 25.0 111.97 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.1 0.29 89.46 Favored Glycine 0 C--O 1.221 -0.704 0 N-CA-C 114.9 0.72 . . . . 25.0 114.9 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -124.15 156.14 37.23 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 117.89 0.845 . . . . 25.0 109.757 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -102.37 154.98 18.55 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.326 -0.62 . . . . 25.0 109.326 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.43 -162.12 29.9 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 106.427 -2.669 . . . . 25.0 106.427 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 pt -118.55 151.49 20.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.649 0.737 . . . . 25.0 111.876 -174.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.2 m -140.38 146.93 47.59 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 114.929 -1.032 . . . . 25.0 110.025 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.87 122.16 7.09 Favored 'Trans proline' 0 C--O 1.241 0.65 0 C-N-CA 118.35 -0.633 . . . . 25.0 112.434 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.94 -23.09 65.38 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 121.607 -0.33 . . . . 25.0 113.01 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.39 -20.42 64.42 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 122.335 -0.509 . . . . 25.0 112.203 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -109.48 12.28 24.58 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 122.194 -0.317 . . . . 25.0 111.777 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -126.72 156.79 40.57 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 114.946 1.461 . . . . 25.0 114.946 -174.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -129.29 123.1 31.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.444 -0.798 . . . . 25.0 110.297 175.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.4 mm -67.76 137.21 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.772 -0.825 . . . . 25.0 108.772 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.6 mt -117.76 115.75 25.63 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.43 -1.693 . . . . 25.0 106.43 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.322 -0.618 0 N-CA-C 109.38 -0.6 . . . . 25.0 109.38 -179.824 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt . . . . . 0 CA--C 1.547 0.852 0 N-CA-C 106.029 -1.841 . . . . 25.0 106.029 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 CA--C 1.539 0.766 0 O-C-N 121.992 0.469 . . . . 25.0 112.864 -177.453 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 121.634 0.731 . . . . 25.0 111.849 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.9 mt -69.79 -40.72 75.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.045 -0.98 . . . . 25.0 109.899 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.2 m120 57.6 23.61 9.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.614 1.165 . . . . 25.0 113.157 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.7 m -85.65 162.98 2.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.387 -0.968 . . . . 25.0 108.387 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.74 168.18 10.49 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.374 -0.829 . . . . 25.0 110.098 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.6 166.81 26.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.014 0.435 . . . . 25.0 110.781 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HB2' HD11 ' A' ' 65' ' ' LEU . 29.2 ttmt -133.31 135.59 44.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.951 -1.022 . . . . 25.0 110.737 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.477 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -73.38 131.99 42.5 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.703 0.627 . . . . 25.0 110.583 173.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.22 -21.96 15.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.983 0.421 . . . . 25.0 110.898 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -143.47 168.38 19.98 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.344 -1.725 . . . . 25.0 106.344 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -75.69 160.44 30.06 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 123.459 0.474 . . . . 25.0 111.027 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -146.81 147.81 31.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.215 -0.291 . . . . 25.0 110.215 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.6 t -120.76 132.11 71.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 104.519 -2.4 . . . . 25.0 104.519 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.58 122.06 21.64 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.336 -0.987 . . . . 25.0 108.336 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -108.86 4.94 24.04 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.324 -0.991 . . . . 25.0 108.324 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.6 m -145.05 152.4 51.22 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 106.771 -1.566 . . . . 25.0 106.771 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.9 -21.58 32.64 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 N-CA-C 115.936 1.475 . . . . 25.0 115.936 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.28 -12.7 54.23 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.95 0.881 . . . . 25.0 110.238 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -82.98 139.34 33.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.943 0.878 . . . . 25.0 111.406 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.415 ' HB2' HG13 ' A' ' 57' ' ' VAL . 67.1 mt -90.98 127.68 36.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.185 0.993 . . . . 25.0 109.672 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -88.88 139.54 30.35 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 106.225 -1.769 . . . . 25.0 106.225 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -156.66 165.18 36.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.963 0.411 . . . . 25.0 110.605 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -110.83 162.79 14.44 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.566 -0.531 . . . . 25.0 109.566 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -58.5 131.25 50.19 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.545 -0.752 . . . . 25.0 109.386 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.09 -11.17 72.81 Favored Glycine 0 CA--C 1.517 0.205 0 CA-C-O 119.039 -0.867 . . . . 25.0 114.48 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -62.49 150.57 39.79 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 118.193 0.996 . . . . 25.0 109.636 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.6 mm -116.28 134.31 60.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.9 -1.045 . . . . 25.0 109.289 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -139.89 160.27 40.29 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.167 -0.679 . . . . 25.0 109.167 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.7 m -97.22 127.25 43.01 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.043 -1.095 . . . . 25.0 108.043 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.9 t -90.5 126.48 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 107.343 -1.354 . . . . 25.0 107.343 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.636 HD12 HD22 ' A' ' 47' ' ' LEU . 82.1 mt -94.96 -43.1 8.32 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.889 -0.782 . . . . 25.0 108.889 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -150.23 155.08 39.07 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.679 -0.86 . . . . 25.0 108.679 -177.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -111.65 149.67 31.21 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.105 -0.702 . . . . 25.0 109.105 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 56.38 39.9 29.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 123.61 1.672 . . . . 25.0 108.654 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -64.31 153.56 37.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 112.591 -2.095 . . . . 25.0 110.777 -176.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 60.76 8.95 1.98 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.683 0.793 . . . . 25.0 111.976 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.39 13.62 81.46 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.114 -0.794 . . . . 25.0 111.114 -176.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.5 mt -88.05 126.75 35.26 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.066 0.46 . . . . 25.0 109.8 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -67.64 125.03 24.92 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.352 -0.385 . . . . 25.0 110.665 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.0 1.46 85.26 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 117.038 1.575 . . . . 25.0 117.038 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -100.94 134.23 44.23 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 119.176 1.488 . . . . 25.0 109.849 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -113.79 140.68 48.1 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.909 -0.775 . . . . 25.0 108.909 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.636 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -79.81 123.62 27.89 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 104.821 -2.288 . . . . 25.0 104.821 176.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 98.0 m -134.98 163.07 30.69 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.668 -0.413 . . . . 25.0 111.562 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.0 t -117.21 126.5 52.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.908 -1.886 . . . . 25.0 105.908 170.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.0 tp -138.7 126.82 22.65 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.072 -1.455 . . . . 25.0 107.072 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.0 m170 55.54 30.38 15.13 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.273 0.559 . . . . 25.0 111.6 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.42 -4.87 80.11 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 116.115 1.206 . . . . 25.0 116.115 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -110.01 152.58 25.74 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.865 -1.161 . . . . 25.0 107.865 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -106.75 160.43 15.48 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.57 -0.53 . . . . 25.0 109.57 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.11 -160.11 31.52 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 105.398 -3.081 . . . . 25.0 105.398 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.1 pt -120.48 152.84 23.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.794 0.807 . . . . 25.0 111.485 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.415 HG13 ' HB2' ' A' ' 24' ' ' LEU . 2.9 m -139.0 145.56 45.88 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 114.714 -1.13 . . . . 25.0 109.111 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.73 124.54 7.59 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 117.045 -1.504 . . . . 25.0 112.19 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.84 -10.27 72.01 Favored Glycine 0 C--O 1.223 -0.537 0 CA-C-N 116.032 -0.531 . . . . 25.0 112.774 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.76 -19.32 62.34 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.39 -0.476 . . . . 25.0 112.083 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -130.7 27.34 4.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.117 -0.492 . . . . 25.0 110.47 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 12' ' ' ALA . 0.9 OUTLIER -129.26 156.2 44.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.303 0.573 . . . . 25.0 111.329 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -129.64 127.74 41.22 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.811 -0.631 . . . . 25.0 110.59 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.8 mm -72.09 135.26 28.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.131 -1.063 . . . . 25.0 108.131 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 11' ' ' LYS . 83.4 mt -119.35 104.6 10.52 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.161 -0.681 . . . . 25.0 109.161 176.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 CA--C 1.544 0.712 0 CA-C-O 122.044 0.926 . . . . 25.0 109.208 176.132 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt . . . . . 0 CA--C 1.535 0.404 0 N-CA-C 110.162 -0.31 . . . . 25.0 110.162 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 CA--C 1.546 1.109 0 O-C-N 122.201 0.579 . . . . 25.0 112.988 178.251 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 . . . . . 0 CA--C 1.519 -0.229 0 N-CA-C 114.327 1.232 . . . . 25.0 114.327 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.8 mt -65.59 -39.22 91.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.512 -1.222 . . . . 25.0 110.687 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 57.27 28.72 15.62 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.173 0.989 . . . . 25.0 112.444 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 m -90.35 152.11 3.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.143 -1.058 . . . . 25.0 108.143 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.98 167.38 12.84 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.187 -0.671 . . . . 25.0 109.187 -176.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.35 161.17 43.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.732 0.301 . . . . 25.0 111.27 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -126.9 129.58 48.48 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.688 0.795 . . . . 25.0 110.157 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.46 131.28 43.81 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.746 -0.464 . . . . 25.0 109.746 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.0 mt -95.83 -21.16 18.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.074 0.464 . . . . 25.0 111.034 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -144.48 175.95 9.75 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 103.814 -2.661 . . . . 25.0 103.814 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -92.05 179.17 5.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.301 0.5 . . . . 25.0 111.53 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -159.04 154.77 26.26 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.075 0.55 . . . . 25.0 110.135 173.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.4 t -124.6 127.4 72.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 105.986 -1.857 . . . . 25.0 105.986 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.74 129.6 38.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.961 -0.563 . . . . 25.0 110.783 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -105.33 1.11 27.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.536 0.684 . . . . 25.0 109.838 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.9 p -151.83 158.86 33.83 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.016 -1.105 . . . . 25.0 108.016 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.75 -16.85 33.39 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 118.321 -0.652 . . . . 25.0 112.873 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.75 -21.68 54.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.419 0.628 . . . . 25.0 110.044 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -95.46 146.21 24.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.522 0.677 . . . . 25.0 111.411 -176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.4 ' HB2' HG13 ' A' ' 57' ' ' VAL . 55.1 mt -100.14 132.61 45.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.55 0.691 . . . . 25.0 110.166 177.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.6 m -82.64 146.44 29.1 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 105.527 -2.027 . . . . 25.0 105.527 172.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -157.73 164.87 36.67 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.358 -0.608 . . . . 25.0 109.358 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.86 158.59 23.73 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.526 -0.916 . . . . 25.0 108.526 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -56.24 128.13 34.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.571 -0.741 . . . . 25.0 109.891 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.72 -10.85 64.63 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-O 118.985 -0.897 . . . . 25.0 114.061 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -61.52 148.7 41.22 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.033 0.916 . . . . 25.0 110.775 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.4 mm -112.02 134.02 55.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.457 -1.247 . . . . 25.0 108.481 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.4 ptp -143.19 162.23 36.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.057 -0.72 . . . . 25.0 109.057 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.9 m -98.81 125.87 44.29 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.042 -1.096 . . . . 25.0 108.042 177.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.8 t -89.6 125.61 42.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.786 -1.19 . . . . 25.0 107.786 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.714 HD12 HD22 ' A' ' 47' ' ' LEU . 73.1 mt -94.54 -49.48 5.64 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.455 -1.248 . . . . 25.0 109.644 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -143.34 160.39 40.61 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.545 -1.279 . . . . 25.0 107.545 -174.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -125.68 150.71 47.41 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 106.899 -1.519 . . . . 25.0 106.899 175.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 56.27 39.15 30.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.398 1.571 . . . . 25.0 108.274 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -66.08 148.61 51.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.443 -1.708 . . . . 25.0 109.813 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 60.18 11.81 2.96 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.72 0.808 . . . . 25.0 113.013 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.61 13.62 81.25 Favored Glycine 0 C--O 1.229 -0.177 0 N-CA-C 111.296 -0.721 . . . . 25.0 111.296 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.9 mt -91.19 112.19 23.99 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.709 -0.478 . . . . 25.0 109.709 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -58.52 124.92 21.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.497 -0.774 . . . . 25.0 110.858 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.0 -0.19 83.79 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 116.02 1.168 . . . . 25.0 116.02 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -98.03 132.26 43.73 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 119.303 1.552 . . . . 25.0 110.76 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -111.15 138.58 47.42 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.206 -1.035 . . . . 25.0 108.206 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.714 HD22 HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -82.21 125.82 31.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 104.681 -2.34 . . . . 25.0 104.681 178.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.9 m -134.65 164.29 27.84 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 111.951 0.352 . . . . 25.0 111.951 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.0 t -117.27 123.84 47.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.828 -1.545 . . . . 25.0 106.828 171.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.8 tp -151.73 142.63 22.99 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 106.875 -1.528 . . . . 25.0 106.875 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 56.4 28.25 13.29 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.319 0.647 . . . . 25.0 112.073 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.75 1.15 76.95 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 115.006 0.762 . . . . 25.0 115.006 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -123.62 161.05 25.79 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.026 -0.731 . . . . 25.0 109.026 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -108.53 156.63 19.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.174 -0.676 . . . . 25.0 109.174 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.58 -161.22 28.37 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 105.383 -3.087 . . . . 25.0 105.383 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.9 pt -120.73 153.18 23.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-O 121.728 0.775 . . . . 25.0 111.034 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 24' ' ' LEU . 3.2 m -141.74 147.38 45.16 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 114.473 -1.239 . . . . 25.0 107.674 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.82 126.48 8.83 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 117.086 -1.476 . . . . 25.0 111.713 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.17 -12.0 75.63 Favored Glycine 0 C--O 1.222 -0.621 0 CA-C-N 116.293 -0.412 . . . . 25.0 113.131 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -66.67 -13.54 61.37 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.781 0.66 . . . . 25.0 112.781 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -131.97 27.13 4.58 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.215 -0.661 . . . . 25.0 109.215 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.8 tp -131.96 147.44 52.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.737 -0.665 . . . . 25.0 109.709 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -125.55 120.09 29.92 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.408 -0.36 . . . . 25.0 111.743 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.98 136.1 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.037 -0.727 . . . . 25.0 109.037 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.1 mt -116.78 81.66 1.67 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.945 -1.502 . . . . 25.0 106.945 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 121.158 0.504 . . . . 25.0 111.704 -176.06 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt . . . . . 0 CA--C 1.542 0.639 0 N-CA-C 109.132 -0.692 . . . . 25.0 109.132 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 CA--C 1.546 1.086 0 O-C-N 121.963 0.454 . . . . 25.0 112.704 179.833 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 . . . . . 0 CA--C 1.514 -0.439 0 CA-C-O 120.704 0.287 . . . . 25.0 110.354 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.2 mt -67.73 -39.86 84.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.652 -0.704 . . . . 25.0 109.228 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 56.45 32.38 20.57 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.947 0.899 . . . . 25.0 111.795 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.4 m -94.6 153.91 3.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 107.032 -1.47 . . . . 25.0 107.032 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.7 167.08 11.68 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.042 -1.095 . . . . 25.0 108.042 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.96 154.46 37.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.674 0.273 . . . . 25.0 110.489 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -118.69 132.13 56.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.835 -0.62 . . . . 25.0 110.838 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.63 125.64 27.38 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.184 -0.673 . . . . 25.0 109.184 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.9 mt -91.7 -21.23 20.86 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.257 0.551 . . . . 25.0 110.397 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -141.97 176.05 9.25 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 104.565 -2.383 . . . . 25.0 104.565 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -91.48 177.78 6.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.715 0.293 . . . . 25.0 110.906 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -155.64 155.1 32.66 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.355 0.262 . . . . 25.0 111.647 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.8 t -124.85 132.28 71.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 103.736 -2.69 . . . . 25.0 103.736 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.73 127.64 33.15 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.857 -0.423 . . . . 25.0 109.857 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -101.83 2.72 38.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.727 0.775 . . . . 25.0 110.535 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.2 p -149.88 157.73 37.74 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 108.014 -1.106 . . . . 25.0 108.014 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.8 -15.21 33.19 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 118.177 -0.749 . . . . 25.0 113.007 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -76.55 -21.43 55.69 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.407 0.622 . . . . 25.0 109.475 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -93.75 139.45 30.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.987 0.898 . . . . 25.0 111.829 -172.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.467 ' HB2' HG13 ' A' ' 57' ' ' VAL . 55.4 mt -90.16 129.32 36.45 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.21 -0.905 . . . . 25.0 109.546 177.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -88.21 143.05 27.27 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 105.411 -2.07 . . . . 25.0 105.411 175.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -157.25 167.97 28.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.732 0.301 . . . . 25.0 110.297 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.69 165.4 12.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.737 0.78 . . . . 25.0 110.327 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.1 128.41 36.28 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.218 -0.901 . . . . 25.0 110.069 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.83 -12.49 64.23 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-O 118.922 -0.932 . . . . 25.0 114.933 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -59.65 152.98 21.11 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.977 0.894 . . . . 25.0 112.001 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.0 mm -114.77 130.65 68.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.428 -1.26 . . . . 25.0 109.14 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.8 ptp -137.84 151.57 48.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.469 -0.567 . . . . 25.0 109.469 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.0 m -90.78 124.75 35.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.291 -1.003 . . . . 25.0 108.291 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t -87.34 123.14 39.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 107.893 -1.151 . . . . 25.0 107.893 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.7 mt -89.74 -46.23 8.75 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.051 -0.722 . . . . 25.0 109.051 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -149.56 165.15 33.11 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.771 -0.826 . . . . 25.0 108.771 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HE ' ' HB3' ' A' ' 37' ' ' ARG . 38.2 mtp180 -115.77 154.61 29.31 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.19 -0.67 . . . . 25.0 109.19 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 57.67 40.76 26.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 124.12 1.914 . . . . 25.0 107.463 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.6 t -65.74 151.65 46.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 111.808 -2.451 . . . . 25.0 111.699 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 58.03 18.13 4.92 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.373 0.879 . . . . 25.0 113.373 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.52 16.6 80.53 Favored Glycine 0 C--O 1.227 -0.285 0 N-CA-C 111.699 -0.56 . . . . 25.0 111.699 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.7 mt -98.45 113.93 26.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.088 0.471 . . . . 25.0 110.759 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -59.34 127.7 33.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.682 -0.69 . . . . 25.0 110.755 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.09 -2.03 67.07 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 115.85 1.1 . . . . 25.0 115.85 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -95.83 132.8 40.71 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 119.028 1.414 . . . . 25.0 109.023 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -113.52 138.23 50.43 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.793 -1.188 . . . . 25.0 107.793 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.5 tp -81.41 125.43 30.41 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 105.922 -1.881 . . . . 25.0 105.922 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 91.4 m -134.0 161.99 33.3 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.201 0.524 . . . . 25.0 111.784 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.6 t -113.64 122.5 47.35 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.123 -1.436 . . . . 25.0 107.123 170.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.1 tp -144.62 133.03 21.91 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.919 -0.771 . . . . 25.0 108.919 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 54.09 31.98 14.82 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.427 0.691 . . . . 25.0 112.275 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.16 0.15 88.44 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.087 -0.578 . . . . 25.0 114.507 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -109.11 141.63 41.02 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 117.77 0.785 . . . . 25.0 109.346 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -96.89 143.19 28.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 106.553 -1.647 . . . . 25.0 106.553 169.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.69 -163.72 29.45 Favored Glycine 0 CA--C 1.496 -1.117 0 N-CA-C 103.647 -3.781 . . . . 25.0 103.647 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.7 pt -121.82 158.54 25.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-O 121.3 0.571 . . . . 25.0 110.56 -174.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.467 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.2 m -142.53 148.68 47.92 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 115.297 -0.865 . . . . 25.0 109.214 -177.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.54 120.43 6.71 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 118.359 -0.627 . . . . 25.0 110.967 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.74 -10.42 80.08 Favored Glycine 0 C--O 1.226 -0.371 0 O-C-N 121.878 -0.514 . . . . 25.0 114.049 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -72.8 -5.88 41.02 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.788 0.662 . . . . 25.0 112.788 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -130.01 26.49 5.21 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.6 mt -124.03 155.38 38.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.807 0.813 . . . . 25.0 111.435 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -126.73 120.04 28.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.843 -1.072 . . . . 25.0 109.428 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.1 mm -71.33 136.15 26.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.882 -0.785 . . . . 25.0 108.882 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.4 mt -115.42 94.73 4.84 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.546 -1.279 . . . . 25.0 107.546 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.54 0 CA-C-O 121.299 0.571 . . . . 25.0 111.562 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 92.4 mttt . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 110.184 -0.302 . . . . 25.0 110.184 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.539 0.755 0 C-N-CA 117.881 -0.946 . . . . 25.0 111.57 176.064 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 . . . . . 0 N--CA 1.463 0.209 0 N-CA-C 112.204 0.446 . . . . 25.0 112.204 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.2 mt -64.73 -41.63 95.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.248 -0.887 . . . . 25.0 111.161 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 54.91 34.82 23.06 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.919 0.887 . . . . 25.0 112.249 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 m -95.48 158.47 3.0 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 104.485 -2.413 . . . . 25.0 104.485 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.13 174.03 7.11 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.776 -0.824 . . . . 25.0 108.776 -175.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.19 161.54 41.79 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.176 -0.305 . . . . 25.0 110.176 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -128.23 130.52 48.07 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.513 0.725 . . . . 25.0 110.031 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.59 133.66 47.87 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.438 0.461 . . . . 25.0 110.141 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.78 -19.68 16.6 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.351 0.596 . . . . 25.0 110.579 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -143.22 171.73 13.69 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.681 -1.6 . . . . 25.0 106.681 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -77.86 167.46 21.49 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.324 0.39 . . . . 25.0 110.868 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -151.75 150.15 29.86 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-O 120.749 0.309 . . . . 25.0 111.07 170.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.6 t -124.93 136.28 61.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 104.528 -2.397 . . . . 25.0 104.528 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.07 136.96 48.5 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 124.27 0.982 . . . . 25.0 108.548 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -117.9 1.09 12.05 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.864 0.84 . . . . 25.0 109.653 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -128.02 146.29 58.64 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 105.799 -1.926 . . . . 25.0 105.799 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -69.89 -18.34 36.46 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 117.386 -1.276 . . . . 25.0 112.638 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -77.53 -15.64 59.14 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.18 -0.464 . . . . 25.0 110.624 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -101.47 140.58 35.57 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.421 -0.955 . . . . 25.0 108.421 -176.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.8 mt -101.37 126.16 48.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.992 0.901 . . . . 25.0 111.688 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.18 145.57 26.35 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.605 -1.257 . . . . 25.0 107.605 175.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -159.29 165.07 34.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.261 0.553 . . . . 25.0 110.856 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -107.34 153.09 23.27 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.509 -1.293 . . . . 25.0 107.509 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -54.65 129.84 38.1 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.996 -0.742 . . . . 25.0 108.996 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.14 -11.28 70.85 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-O 118.899 -0.945 . . . . 25.0 114.518 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -64.06 156.7 27.38 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.989 0.894 . . . . 25.0 110.077 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.6 mm -120.13 135.36 60.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.68 -1.146 . . . . 25.0 109.322 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -141.81 158.2 44.09 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.5 -0.556 . . . . 25.0 109.5 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 m -92.09 128.93 38.12 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 108.287 -1.005 . . . . 25.0 108.287 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.2 t -92.08 123.82 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 N-CA-C 108.279 -1.008 . . . . 25.0 108.279 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.59 HD12 HD22 ' A' ' 47' ' ' LEU . 77.9 mt -88.96 -45.81 9.38 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.414 -0.812 . . . . 25.0 109.284 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -155.31 168.78 25.96 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.512 -0.921 . . . . 25.0 108.512 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -120.39 152.63 37.64 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 106.621 -1.622 . . . . 25.0 106.621 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 58.03 43.93 20.26 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 125.731 1.894 . . . . 25.0 109.119 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 t -69.41 155.79 39.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 112.65 -2.068 . . . . 25.0 111.112 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 58.72 14.75 3.33 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.801 1.037 . . . . 25.0 113.801 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.88 13.86 81.64 Favored Glycine 0 C--O 1.23 -0.148 0 N-CA-C 111.59 -0.604 . . . . 25.0 111.59 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.8 mt -94.33 132.61 38.76 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 110.107 -0.331 . . . . 25.0 110.107 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -78.41 128.64 33.92 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.855 -0.795 . . . . 25.0 108.855 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.96 -2.55 83.41 Favored Glycine 0 C--O 1.239 0.423 0 N-CA-C 116.319 1.288 . . . . 25.0 116.319 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -101.87 133.94 45.85 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 118.428 1.114 . . . . 25.0 108.307 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.3 m0 -115.62 143.23 45.64 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.59 HD22 HD12 ' A' ' 35' ' ' LEU . 0.7 OUTLIER -85.08 123.76 30.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.916 -1.883 . . . . 25.0 105.916 179.032 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.1 m -130.71 162.1 30.2 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.022 0.379 . . . . 25.0 112.022 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.0 t -114.34 119.79 38.15 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.038 -1.838 . . . . 25.0 106.038 171.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.8 tp -141.0 126.87 19.21 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.294 -1.002 . . . . 25.0 108.294 -175.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.0 m170 55.64 31.85 18.13 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.262 0.625 . . . . 25.0 111.279 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.63 0.95 88.65 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 114.676 0.63 . . . . 25.0 114.676 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -107.97 155.2 20.59 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 106.691 -1.596 . . . . 25.0 106.691 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -121.89 144.44 48.85 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.043 -1.466 . . . . 25.0 107.043 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.65 -161.6 27.25 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 107.1 -2.4 . . . . 25.0 107.1 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.7 pt -115.77 150.15 17.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.707 0.765 . . . . 25.0 111.053 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -138.28 145.41 47.09 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 114.639 -1.164 . . . . 25.0 108.565 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.62 120.95 6.72 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 CA-C-O 121.606 0.586 . . . . 25.0 110.821 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.65 -17.04 77.84 Favored Glycine 0 C--O 1.216 -1.007 0 N-CA-C 115.038 0.775 . . . . 25.0 115.038 -174.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -77.93 -1.56 32.49 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.151 0.797 . . . . 25.0 113.151 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -127.74 25.57 5.98 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.682 -1.229 . . . . 25.0 107.682 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.8 tp -135.46 150.34 49.79 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.193 -0.912 . . . . 25.0 109.368 -173.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -126.28 120.75 30.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.568 -0.287 . . . . 25.0 111.556 -177.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.5 mm -67.76 135.45 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.795 -0.446 . . . . 25.0 109.795 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.2 mt -117.1 92.52 3.88 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.457 -1.312 . . . . 25.0 107.457 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 C--N 1.322 -0.611 0 N-CA-C 108.427 -0.953 . . . . 25.0 108.427 179.63 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 N--CA 1.469 0.523 0 N-CA-C 109.395 -0.594 . . . . 25.0 109.395 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 CA--C 1.542 0.919 0 C-N-CA 116.908 -1.595 . . . . 25.0 110.944 174.171 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 . . . . . 0 C--O 1.221 -0.436 0 N-CA-C 115.1 1.519 . . . . 25.0 115.1 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.4 mt -75.56 -36.51 60.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.459 -1.246 . . . . 25.0 110.74 -177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.5 m120 55.88 25.08 8.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.632 1.173 . . . . 25.0 112.768 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.2 m -88.88 177.13 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 105.731 -1.952 . . . . 25.0 105.731 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.22 174.07 6.56 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.083 -0.71 . . . . 25.0 109.083 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.9 161.19 42.36 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.551 -0.537 . . . . 25.0 109.551 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -123.6 135.43 53.95 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.393 -0.822 . . . . 25.0 110.1 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.528 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -72.29 126.74 30.56 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 123.869 0.73 . . . . 25.0 110.276 174.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.5 mt -93.09 -23.51 18.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.236 0.541 . . . . 25.0 110.697 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -142.43 168.1 20.52 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.737 -1.579 . . . . 25.0 106.737 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -76.73 162.99 27.25 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.307 0.379 . . . . 25.0 110.865 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -150.35 133.09 15.89 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 114.041 1.126 . . . . 25.0 114.041 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.8 t -109.55 124.68 66.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 105.473 -2.047 . . . . 25.0 105.473 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.06 139.69 50.48 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.475 -0.784 . . . . 25.0 110.373 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -112.6 -28.84 7.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.296 0.569 . . . . 25.0 109.589 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -102.15 152.35 38.23 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 107.481 -1.303 . . . . 25.0 107.481 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.4 -22.54 33.58 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 117.688 -1.074 . . . . 25.0 113.105 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -83.97 -10.72 57.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.849 -0.614 . . . . 25.0 110.898 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -85.86 135.64 33.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.747 0.785 . . . . 25.0 109.747 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.9 mt -87.89 128.93 35.36 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.731 0.777 . . . . 25.0 109.576 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.1 t -88.31 140.33 29.59 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 105.461 -2.051 . . . . 25.0 105.461 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -156.87 168.95 25.93 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.785 -0.82 . . . . 25.0 108.785 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.5 mtt-85 -122.91 166.98 14.15 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.179 0.514 . . . . 25.0 111.442 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.22 129.32 41.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.893 -0.594 . . . . 25.0 110.631 -176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.04 -13.02 65.36 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-O 119.491 -0.616 . . . . 25.0 113.508 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -62.32 150.11 40.31 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 117.659 0.73 . . . . 25.0 109.751 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.7 mm -116.41 133.25 63.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 107.922 -1.14 . . . . 25.0 107.922 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -136.25 148.86 48.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.143 -0.688 . . . . 25.0 109.143 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 51.8 m -85.14 129.68 34.76 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.967 -1.494 . . . . 25.0 106.967 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.1 t -94.01 126.17 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.805 -0.813 . . . . 25.0 108.805 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.1 mt -95.95 -45.05 7.09 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.368 -0.604 . . . . 25.0 109.368 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -147.48 159.07 44.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.271 -0.172 . . . . 25.0 110.785 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -117.08 153.95 31.84 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.537 -0.912 . . . . 25.0 108.537 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 53.76 39.8 30.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 123.482 1.611 . . . . 25.0 109.685 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.9 t -69.85 157.17 37.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.153 -1.839 . . . . 25.0 111.625 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 59.92 10.51 2.18 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.22 1.008 . . . . 25.0 112.678 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.74 13.66 81.06 Favored Glycine 0 C--O 1.239 0.41 0 N-CA-C 111.184 -0.766 . . . . 25.0 111.184 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.43 125.26 39.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.947 0.403 . . . . 25.0 110.069 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -67.45 126.84 30.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.958 -0.564 . . . . 25.0 110.349 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.74 -0.6 85.89 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 116.466 1.346 . . . . 25.0 116.466 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -99.05 132.95 43.99 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 119.146 1.473 . . . . 25.0 110.066 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -113.45 137.69 51.17 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.483 -0.562 . . . . 25.0 109.483 -177.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.9 tp -80.77 121.09 25.48 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 106.376 -1.712 . . . . 25.0 106.376 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 98.8 m -133.75 167.7 20.05 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.768 0.318 . . . . 25.0 111.151 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.7 t -118.8 126.16 51.22 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.0 -0.741 . . . . 25.0 109.0 172.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.3 tp -147.4 139.59 24.44 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.115 -1.068 . . . . 25.0 108.115 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 27.3 m170 55.99 29.82 15.02 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.364 0.665 . . . . 25.0 112.022 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.26 1.81 86.42 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 120.994 -0.622 . . . . 25.0 114.094 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -109.91 145.97 35.94 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.45 -0.945 . . . . 25.0 108.45 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -99.99 144.91 28.48 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 105.306 -2.109 . . . . 25.0 105.306 170.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.21 -163.58 29.49 Favored Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 105.525 -3.03 . . . . 25.0 105.525 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.9 pt -120.86 154.25 24.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.467 0.651 . . . . 25.0 111.097 -173.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.6 146.03 46.08 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 114.993 -1.003 . . . . 25.0 108.758 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.64 122.15 7.18 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 117.979 -0.881 . . . . 25.0 111.684 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.96 -13.95 72.89 Favored Glycine 0 C--O 1.223 -0.532 0 CA-C-N 116.277 -0.419 . . . . 25.0 114.032 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -68.94 -8.54 45.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.085 0.772 . . . . 25.0 113.085 -178.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -132.63 26.01 4.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.619 -0.882 . . . . 25.0 108.619 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 12' ' ' ALA . 1.4 tp -129.88 157.19 42.95 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.445 -0.798 . . . . 25.0 110.67 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -131.58 120.35 22.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.807 -0.633 . . . . 25.0 110.773 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.9 mm -65.81 136.59 26.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 123.662 0.601 . . . . 25.0 109.511 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.3 mt -117.64 111.56 19.33 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.28 -2.118 . . . . 25.0 105.28 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 108.272 -1.011 . . . . 25.0 108.272 -178.537 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.6 mttt . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 111.538 0.199 . . . . 25.0 111.538 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 CA--C 1.544 0.993 0 O-C-N 121.849 0.394 . . . . 25.0 112.015 174.717 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 . . . . . 0 CA--C 1.513 -0.456 0 N-CA-C 109.651 -0.5 . . . . 25.0 109.651 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.2 mt -61.74 -41.48 97.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.842 -0.617 . . . . 25.0 109.346 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.76 28.16 11.84 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.07 0.948 . . . . 25.0 111.976 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.2 m -87.48 176.24 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 104.72 -2.326 . . . . 25.0 104.72 173.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mp -118.74 173.99 6.54 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 121.732 -0.605 . . . . 25.0 109.58 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.37 160.18 42.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.818 0.342 . . . . 25.0 110.712 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -122.19 129.89 52.69 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.444 -0.798 . . . . 25.0 109.794 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.93 130.64 43.35 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.781 -0.452 . . . . 25.0 109.781 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.6 mt -93.67 -23.78 18.11 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 111.877 0.325 . . . . 25.0 111.877 -177.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -143.88 168.25 20.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.279 -1.378 . . . . 25.0 107.279 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -73.82 165.35 25.28 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.559 0.537 . . . . 25.0 110.178 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.74 163.31 35.34 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.324 -0.991 . . . . 25.0 108.324 177.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.8 t -130.45 129.49 64.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 102.026 -3.324 . . . . 25.0 102.026 169.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.15 122.69 27.13 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.293 -1.373 . . . . 25.0 107.293 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -113.03 12.32 19.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.318 1.056 . . . . 25.0 110.306 -175.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.7 m -148.31 152.83 39.89 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 106.202 -1.777 . . . . 25.0 106.202 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.43 -23.22 32.54 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 118.176 -0.749 . . . . 25.0 113.677 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.8 -17.0 52.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.417 0.627 . . . . 25.0 110.86 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -84.24 131.53 34.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.636 0.731 . . . . 25.0 109.343 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.477 ' HB2' HG13 ' A' ' 57' ' ' VAL . 45.9 mt -81.69 135.06 35.52 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.315 -0.624 . . . . 25.0 109.315 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -87.35 135.81 33.18 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.253 -1.017 . . . . 25.0 108.253 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -156.09 163.06 40.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.348 0.594 . . . . 25.0 111.948 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -119.63 169.02 10.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.408 0.623 . . . . 25.0 109.832 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -61.29 129.46 41.35 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.668 -0.696 . . . . 25.0 111.297 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.61 -12.41 67.62 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-O 119.012 -0.882 . . . . 25.0 113.836 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -60.08 148.5 35.54 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.595 0.712 . . . . 25.0 110.48 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.1 mm -114.22 132.32 63.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.54 -1.209 . . . . 25.0 108.852 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.0 ptp -137.07 156.55 48.26 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.553 -0.906 . . . . 25.0 108.553 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.7 m -89.53 129.59 35.98 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.377 -1.342 . . . . 25.0 107.377 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.24 126.59 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 107.76 -1.2 . . . . 25.0 107.76 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.61 HD12 HD22 ' A' ' 47' ' ' LEU . 69.8 mt -95.83 -44.7 7.29 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.487 -0.779 . . . . 25.0 109.418 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -153.32 164.02 38.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.353 -0.61 . . . . 25.0 109.353 -175.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -120.35 153.83 35.92 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.234 -1.024 . . . . 25.0 108.234 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 54.98 38.28 30.26 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 123.405 1.574 . . . . 25.0 109.943 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -65.05 151.29 46.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.359 -1.746 . . . . 25.0 110.812 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 61.05 10.72 3.0 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.803 0.841 . . . . 25.0 113.003 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.73 17.46 77.34 Favored Glycine 0 C--O 1.228 -0.234 0 N-CA-C 110.77 -0.932 . . . . 25.0 110.77 -178.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.9 mt -94.37 119.18 32.73 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.741 -0.837 . . . . 25.0 108.741 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.53 129.26 39.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.13 0.491 . . . . 25.0 110.568 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.27 -0.72 67.25 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 116.075 1.19 . . . . 25.0 116.075 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -98.75 129.98 45.2 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 119.349 1.575 . . . . 25.0 109.736 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -110.3 140.1 44.81 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.082 -0.71 . . . . 25.0 109.082 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.61 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -80.79 120.93 25.29 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.785 -1.931 . . . . 25.0 105.785 177.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.2 m -132.5 166.23 22.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.961 0.41 . . . . 25.0 111.686 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -120.64 122.77 41.22 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.799 -1.186 . . . . 25.0 107.799 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.5 tp -155.0 145.92 22.57 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 107.024 -1.473 . . . . 25.0 107.024 -175.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 56.36 31.97 19.67 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.091 0.556 . . . . 25.0 112.368 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.05 6.11 72.82 Favored Glycine 0 C--O 1.225 -0.41 0 N-CA-C 114.926 0.73 . . . . 25.0 114.926 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -129.95 165.96 21.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.696 -0.853 . . . . 25.0 108.696 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -112.59 152.1 29.29 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.774 -1.195 . . . . 25.0 107.774 176.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.74 -159.5 22.26 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 106.444 -2.662 . . . . 25.0 106.444 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.5 pt -120.05 153.56 22.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.465 0.65 . . . . 25.0 111.845 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.477 HG13 ' HB2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -141.63 147.39 45.6 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 114.996 -1.002 . . . . 25.0 109.607 -179.547 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.96 120.06 5.62 Favored 'Trans proline' 0 C--O 1.239 0.558 0 CA-C-O 121.398 0.499 . . . . 25.0 112.532 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.04 -18.76 67.18 Favored Glycine 0 C--O 1.222 -0.638 0 CA-C-O 121.45 0.472 . . . . 25.0 112.663 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.17 -20.69 59.69 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.307 0.854 . . . . 25.0 113.307 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -130.79 29.41 4.76 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.151 0.5 . . . . 25.0 110.021 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.0 tp -132.65 150.41 52.16 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.05 -0.523 . . . . 25.0 110.346 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -127.71 120.55 28.23 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.726 0.639 . . . . 25.0 112.726 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.4 mm -65.32 136.94 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.138 0.494 . . . . 25.0 110.256 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.4 mt -121.71 106.42 11.3 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.068 0.947 . . . . 25.0 108.527 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.472 0.673 0 CA-C-O 120.912 0.387 . . . . 25.0 110.933 178.793 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 95.3 mttt . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 107.452 -1.314 . . . . 25.0 107.452 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo . . . . . 0 CA--C 1.543 0.957 0 C-N-CA 116.938 -1.575 . . . . 25.0 110.749 174.438 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 . . . . . 0 CA--C 1.514 -0.411 0 CA-C-O 120.951 0.405 . . . . 25.0 110.382 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.2 mt -67.52 -38.07 83.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.391 -0.822 . . . . 25.0 110.484 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 57.27 31.51 20.22 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.864 0.866 . . . . 25.0 111.64 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.5 m -97.79 176.96 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 105.585 -2.005 . . . . 25.0 105.585 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -120.18 174.02 6.75 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.348 -0.612 . . . . 25.0 109.348 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.69 162.95 34.13 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.899 -0.408 . . . . 25.0 109.899 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -125.68 130.47 51.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.416 -0.811 . . . . 25.0 110.755 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.461 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -71.49 124.53 24.85 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 123.655 0.597 . . . . 25.0 109.516 176.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.3 mt -94.53 -20.3 19.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.326 0.584 . . . . 25.0 109.83 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -142.71 169.64 17.19 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.559 -1.645 . . . . 25.0 106.559 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -78.07 165.45 23.99 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.901 -0.407 . . . . 25.0 109.901 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -146.1 156.24 43.31 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.96 -0.385 . . . . 25.0 109.96 173.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.4 t -127.73 127.59 68.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 105.724 -1.954 . . . . 25.0 105.724 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.46 135.83 36.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.155 -0.683 . . . . 25.0 109.155 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -120.49 10.19 11.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.304 1.05 . . . . 25.0 109.302 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 t -150.82 150.15 27.26 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 107.103 -1.443 . . . . 25.0 107.103 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.63 -17.59 42.9 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 117.715 -1.057 . . . . 25.0 113.43 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -77.86 -19.98 53.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.188 0.518 . . . . 25.0 110.373 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -93.1 138.4 31.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.721 0.772 . . . . 25.0 111.407 -173.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.465 ' HB2' HG13 ' A' ' 57' ' ' VAL . 58.3 mt -91.86 128.01 37.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.809 0.814 . . . . 25.0 110.502 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.8 t -88.66 142.56 27.58 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.939 -1.874 . . . . 25.0 105.939 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -158.11 164.37 36.71 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.677 -0.49 . . . . 25.0 109.677 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -110.46 164.94 12.2 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.705 0.764 . . . . 25.0 109.055 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.15 131.81 51.98 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.747 -0.835 . . . . 25.0 108.747 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.15 -12.15 68.53 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-O 118.849 -0.973 . . . . 25.0 114.152 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.65 148.65 33.03 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 118.176 0.988 . . . . 25.0 110.51 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.5 mm -117.99 126.43 74.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.272 -1.331 . . . . 25.0 108.241 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -128.95 152.52 48.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.365 -0.379 . . . . 25.0 110.004 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -84.7 130.97 34.63 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.117 -1.438 . . . . 25.0 107.117 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.88 123.41 51.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.142 -1.058 . . . . 25.0 108.142 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.626 HD12 HD22 ' A' ' 47' ' ' LEU . 80.8 mt -89.38 -49.35 6.75 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.744 -0.836 . . . . 25.0 108.744 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -151.94 169.25 22.78 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.097 -1.075 . . . . 25.0 108.097 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.9 mtm105 -118.65 157.94 26.45 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 107.053 -1.462 . . . . 25.0 107.053 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 58.21 39.41 25.85 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 125.108 1.505 . . . . 25.0 109.153 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.1 t -67.74 155.81 38.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.19 -1.823 . . . . 25.0 110.162 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 59.96 10.82 2.33 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.084 0.954 . . . . 25.0 113.527 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.19 14.86 81.23 Favored Glycine 0 C--O 1.242 0.61 0 N-CA-C 110.94 -0.864 . . . . 25.0 110.94 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.2 mt -93.51 127.76 39.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.361 0.6 . . . . 25.0 109.495 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -69.95 124.05 23.06 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.498 -0.773 . . . . 25.0 109.545 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.01 2.3 86.72 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 117.03 1.572 . . . . 25.0 117.03 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -100.3 132.31 45.75 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 118.799 1.299 . . . . 25.0 109.224 176.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -114.28 141.59 47.39 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.512 -0.551 . . . . 25.0 109.512 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.626 HD22 HD12 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -83.6 120.01 25.44 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.2 -1.778 . . . . 25.0 106.2 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.5 m -133.07 165.65 24.25 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.016 0.436 . . . . 25.0 112.029 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.0 t -118.65 118.06 30.62 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.459 -1.311 . . . . 25.0 107.459 172.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -147.71 145.68 28.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.511 -1.662 . . . . 25.0 106.511 -174.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 57.23 27.22 13.28 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.412 0.625 . . . . 25.0 111.497 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.45 6.91 86.97 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 114.948 0.739 . . . . 25.0 114.948 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -132.09 160.86 34.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.108 0.954 . . . . 25.0 109.303 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -100.27 152.69 20.01 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.781 -0.822 . . . . 25.0 108.781 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.62 -162.1 28.49 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 105.632 -2.987 . . . . 25.0 105.632 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.9 pt -118.45 154.71 20.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.542 0.687 . . . . 25.0 110.97 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.465 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -140.78 146.75 45.59 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.129 -0.941 . . . . 25.0 109.743 -178.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -73.95 115.56 4.36 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 CA-C-O 121.544 0.56 . . . . 25.0 111.937 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.2 -17.64 68.34 Favored Glycine 0 C--O 1.224 -0.495 0 CA-C-O 121.463 0.48 . . . . 25.0 113.586 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -62.28 -19.0 62.8 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.959 0.725 . . . . 25.0 112.959 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -122.84 27.37 7.75 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.143 0.497 . . . . 25.0 110.686 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 12' ' ' ALA . 20.2 mt -123.81 160.64 26.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.054 0.931 . . . . 25.0 112.613 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -125.59 124.17 40.66 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 114.338 -1.301 . . . . 25.0 109.862 174.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.7 mm -73.64 134.25 30.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.413 -0.958 . . . . 25.0 108.413 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.0 mt -116.33 97.91 6.3 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.938 -1.134 . . . . 25.0 107.938 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 C--N 1.325 -0.495 0 N-CA-C 108.416 -0.957 . . . . 25.0 108.416 178.18 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.6 mttt . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 108.098 -1.075 . . . . 25.0 108.098 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.546 1.11 0 C-N-CA 116.539 -1.841 . . . . 25.0 110.589 172.537 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 . . . . . 0 CA--C 1.519 -0.226 0 CA-C-O 121.41 0.624 . . . . 25.0 112.153 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.7 mt -64.29 -41.13 97.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.073 -0.967 . . . . 25.0 110.543 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 55.63 30.1 14.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.918 0.887 . . . . 25.0 111.648 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.1 m -90.0 153.33 3.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.083 -1.451 . . . . 25.0 107.083 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.41 167.98 11.88 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.761 -0.829 . . . . 25.0 108.761 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.36 161.32 41.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.752 0.311 . . . . 25.0 110.693 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -130.84 130.47 43.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.407 -0.815 . . . . 25.0 110.009 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.29 131.52 42.02 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.322 -0.621 . . . . 25.0 109.322 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 74.8 mt -99.99 -18.84 16.85 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.981 0.419 . . . . 25.0 110.897 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -143.38 169.11 18.29 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.269 -2.122 . . . . 25.0 105.269 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.28 165.85 21.05 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 122.873 0.469 . . . . 25.0 110.6 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -151.36 143.05 23.71 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.939 0.348 . . . . 25.0 111.939 174.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 83.9 t -116.71 125.71 73.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 105.154 -2.165 . . . . 25.0 105.154 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.24 137.91 43.31 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.426 -0.806 . . . . 25.0 109.519 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -113.25 4.81 16.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.654 0.74 . . . . 25.0 110.223 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.3 m -152.02 155.69 33.65 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 106.953 -1.499 . . . . 25.0 106.953 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.67 -21.03 39.68 Favored 'Trans proline' 0 C--N 1.346 0.398 0 N-CA-C 113.692 0.612 . . . . 25.0 113.692 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.02 -16.98 59.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.215 0.531 . . . . 25.0 110.629 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -93.78 141.76 28.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.38 0.609 . . . . 25.0 109.672 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.455 ' HB2' HG13 ' A' ' 57' ' ' VAL . 61.4 mt -95.62 131.26 42.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.735 0.779 . . . . 25.0 110.17 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.0 t -90.44 146.62 23.99 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 105.099 -2.186 . . . . 25.0 105.099 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -157.32 162.77 39.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.085 0.469 . . . . 25.0 110.492 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -103.88 155.88 18.28 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.421 -1.326 . . . . 25.0 107.421 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -60.73 129.31 40.89 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.632 -0.877 . . . . 25.0 108.632 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.07 -5.35 68.44 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-O 119.312 -0.715 . . . . 25.0 113.445 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -63.97 152.25 40.53 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.8 0.81 . . . . 25.0 110.156 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.2 mm -116.84 135.22 57.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.465 -1.243 . . . . 25.0 108.627 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.7 ptp -142.65 166.11 25.55 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.022 -0.732 . . . . 25.0 109.022 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 57.3 m -106.99 123.6 48.42 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.545 -0.909 . . . . 25.0 108.545 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.3 t -86.87 125.48 40.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.301 -1.0 . . . . 25.0 108.301 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -93.43 -44.52 8.22 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.023 -0.732 . . . . 25.0 109.023 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -146.96 159.1 43.96 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.887 -0.412 . . . . 25.0 109.887 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.1 mtm105 -118.75 154.54 32.63 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.579 -0.526 . . . . 25.0 109.579 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 55.08 38.02 29.84 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 123.628 1.68 . . . . 25.0 108.639 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.7 t -72.48 159.68 33.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 112.644 -2.071 . . . . 25.0 111.158 -173.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 58.87 11.52 1.92 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.906 1.076 . . . . 25.0 113.906 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.64 12.63 83.44 Favored Glycine 0 C--O 1.239 0.468 0 N-CA-C 110.847 -0.901 . . . . 25.0 110.847 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.7 mt -97.25 115.82 28.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.806 0.812 . . . . 25.0 109.289 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -65.34 129.11 38.54 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.883 -1.053 . . . . 25.0 109.664 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.57 -0.94 74.32 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 115.659 1.024 . . . . 25.0 115.659 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -98.73 130.88 45.22 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 118.853 1.326 . . . . 25.0 110.281 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -113.54 137.58 51.37 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.734 -0.839 . . . . 25.0 108.734 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.9 tp -80.63 124.71 29.22 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.047 -1.464 . . . . 25.0 107.047 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.9 m -133.6 162.76 31.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.286 0.565 . . . . 25.0 112.234 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.3 t -112.97 123.67 50.85 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.034 -1.839 . . . . 25.0 106.034 171.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 tp -151.58 140.85 21.38 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.653 -1.24 . . . . 25.0 107.653 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.97 27.2 12.82 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.991 0.737 . . . . 25.0 112.991 176.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.47 3.87 90.36 Favored Glycine 0 C--O 1.226 -0.378 0 N-CA-C 114.692 0.637 . . . . 25.0 114.692 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -129.47 161.01 31.38 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 117.951 0.876 . . . . 25.0 110.185 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -105.76 153.5 21.8 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.129 -1.063 . . . . 25.0 108.129 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.61 -163.74 31.8 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 104.03 -3.628 . . . . 25.0 104.03 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.5 pt -121.93 156.84 26.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.532 0.682 . . . . 25.0 110.855 -175.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.455 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.7 m -140.15 147.57 50.93 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.013 -0.994 . . . . 25.0 109.328 -177.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -75.74 119.97 5.65 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 CA-C-O 121.349 0.479 . . . . 25.0 111.947 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.28 -20.05 66.98 Favored Glycine 0 C--O 1.221 -0.665 0 C-N-CA 121.517 -0.373 . . . . 25.0 113.354 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -66.34 -9.2 30.92 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.699 1.0 . . . . 25.0 113.699 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -134.65 26.11 3.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.265 0.555 . . . . 25.0 109.792 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 24.3 tp -131.23 149.57 52.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.739 -0.664 . . . . 25.0 110.819 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -119.44 127.85 53.47 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 122.838 0.455 . . . . 25.0 110.963 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.2 mm -76.12 135.56 26.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.191 -1.04 . . . . 25.0 108.191 174.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.4 mt -114.66 80.58 1.43 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.192 -0.669 . . . . 25.0 109.192 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.568 0 N-CA-C 107.707 -1.22 . . . . 25.0 107.707 175.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 88.0 mttt . . . . . 0 N--CA 1.466 0.354 0 N-CA-C 108.835 -0.802 . . . . 25.0 108.835 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 CA--C 1.545 1.058 0 C-N-CA 116.562 -1.826 . . . . 25.0 110.376 171.643 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 . . . . . 0 CA--C 1.519 -0.232 0 CA-C-O 121.565 0.697 . . . . 25.0 111.302 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt -65.48 -38.97 91.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.221 -0.899 . . . . 25.0 110.506 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.4 m120 57.0 25.63 10.91 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.306 1.042 . . . . 25.0 112.295 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -89.56 169.81 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.005 -1.85 . . . . 25.0 106.005 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -115.42 170.23 8.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.037 0.446 . . . . 25.0 110.06 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.83 160.64 41.49 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.689 -0.687 . . . . 25.0 111.017 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -123.87 131.81 53.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.072 -0.967 . . . . 25.0 110.749 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.99 126.2 30.51 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.053 -0.522 . . . . 25.0 109.871 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.7 mt -93.75 -22.07 18.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.198 0.523 . . . . 25.0 110.536 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -138.06 161.44 36.74 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.246 -1.39 . . . . 25.0 107.246 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.71 175.98 7.42 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.032 0.933 . . . . 25.0 110.959 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -156.85 160.01 38.75 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.499 0.555 . . . . 25.0 112.499 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.1 t -127.76 128.67 69.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 104.408 -2.442 . . . . 25.0 104.408 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.41 132.19 44.45 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.29 -0.633 . . . . 25.0 109.29 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -122.22 10.16 9.94 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.719 0.771 . . . . 25.0 109.714 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.2 m -143.93 153.14 56.87 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 105.378 -2.082 . . . . 25.0 105.378 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.03 -23.08 34.52 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 117.919 -0.921 . . . . 25.0 113.165 -177.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.83 -15.97 46.27 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.982 -0.554 . . . . 25.0 110.916 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -80.9 135.51 35.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.97 0.89 . . . . 25.0 111.515 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.8 mt -83.69 130.94 34.97 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.304 -0.862 . . . . 25.0 110.88 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 m -85.5 132.42 34.2 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.837 -1.542 . . . . 25.0 106.837 173.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.408 ' CE2' HG12 ' A' ' 57' ' ' VAL . 40.0 p90 -159.42 169.55 23.7 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.019 -1.104 . . . . 25.0 108.019 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 mtp85 -125.35 174.45 8.14 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.347 0.869 . . . . 25.0 113.347 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.12 131.85 48.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.191 -0.913 . . . . 25.0 110.878 -175.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.94 -13.97 66.16 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.44 -0.8 . . . . 25.0 113.343 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -60.06 147.7 38.37 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.868 0.842 . . . . 25.0 110.993 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.3 mm -111.07 134.29 53.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.286 -1.324 . . . . 25.0 107.958 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.4 ptp -138.98 150.67 46.13 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.337 -0.616 . . . . 25.0 109.337 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.6 m -85.98 130.98 34.38 Favored 'General case' 0 C--O 1.217 -0.607 0 N-CA-C 107.242 -1.392 . . . . 25.0 107.242 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.9 t -97.9 125.32 51.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.347 -0.983 . . . . 25.0 108.347 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.696 HD12 HD22 ' A' ' 47' ' ' LEU . 78.3 mt -90.94 -51.27 5.43 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.991 -0.744 . . . . 25.0 108.991 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -152.04 171.25 18.14 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.382 -0.97 . . . . 25.0 108.382 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -120.71 155.6 33.57 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 107.342 -1.355 . . . . 25.0 107.342 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 57.7 39.78 27.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 123.331 1.538 . . . . 25.0 108.592 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.9 t -64.85 147.62 52.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 113.235 -1.802 . . . . 25.0 110.547 -176.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 58.5 15.25 3.45 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.146 0.795 . . . . 25.0 113.146 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.62 12.39 84.28 Favored Glycine 0 C--O 1.225 -0.462 0 C-N-CA 121.161 -0.542 . . . . 25.0 111.833 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.6 mt -88.85 109.7 20.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.381 0.61 . . . . 25.0 110.048 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -53.73 118.43 3.93 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.979 -1.009 . . . . 25.0 112.08 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.69 0.37 89.21 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 115.914 1.126 . . . . 25.0 115.914 175.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -97.75 133.62 42.02 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 119.059 1.429 . . . . 25.0 109.234 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -113.36 140.69 47.83 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.883 -0.784 . . . . 25.0 108.883 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.696 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -82.34 121.47 26.73 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 105.973 -1.862 . . . . 25.0 105.973 179.36 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 84.4 m -131.3 163.55 27.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.124 0.488 . . . . 25.0 112.161 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.5 t -118.04 126.44 52.3 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.794 -1.188 . . . . 25.0 107.794 174.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 tp -154.4 142.67 20.45 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 107.326 -1.361 . . . . 25.0 107.326 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 55.46 32.03 18.14 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.317 0.579 . . . . 25.0 112.315 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.12 7.05 76.06 Favored Glycine 0 C--O 1.224 -0.472 0 N-CA-C 114.807 0.683 . . . . 25.0 114.807 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -128.2 165.64 20.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.082 -0.71 . . . . 25.0 109.082 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -117.21 155.08 30.03 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.002 -1.11 . . . . 25.0 108.002 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.0 -159.87 25.83 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 106.195 -2.762 . . . . 25.0 106.195 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.5 pt -117.68 153.47 19.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.684 0.754 . . . . 25.0 111.656 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.408 HG12 ' CE2' ' A' ' 26' ' ' PHE . 2.7 m -143.71 147.22 38.13 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 114.653 -1.158 . . . . 25.0 108.37 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.2 125.08 8.96 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 118.569 -0.488 . . . . 25.0 112.051 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.78 -19.46 79.9 Favored Glycine 0 C--O 1.222 -0.607 0 N-CA-C 116.035 1.174 . . . . 25.0 116.035 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -70.0 -7.26 39.43 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.189 1.552 . . . . 25.0 115.189 -175.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.17 21.64 5.28 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.264 -1.013 . . . . 25.0 108.264 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.0 tp -123.68 149.68 45.18 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.047 -1.094 . . . . 25.0 108.047 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -120.73 123.82 43.63 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 116.706 -0.224 . . . . 25.0 111.147 -178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.3 mm -74.99 133.52 31.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.223 -1.029 . . . . 25.0 108.223 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.3 mt -116.85 75.53 0.97 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.621 -1.622 . . . . 25.0 106.621 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 115.748 1.759 . . . . 25.0 115.748 -168.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.7 mttt . . . . . 0 CA--C 1.534 0.342 0 N-CA-C 110.463 -0.199 . . . . 25.0 110.463 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--O 1.243 0.747 0 O-C-N 121.973 0.459 . . . . 25.0 111.744 175.664 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 120.898 0.38 . . . . 25.0 111.894 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.11 -41.17 95.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.72 -0.673 . . . . 25.0 110.729 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 55.5 40.73 31.23 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.927 0.891 . . . . 25.0 112.144 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.7 m -105.35 151.37 7.55 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.802 0 N-CA-C 107.316 -1.364 . . . . 25.0 107.316 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.38 167.0 12.97 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.485 -0.561 . . . . 25.0 109.485 -172.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.86 157.41 41.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.083 0.468 . . . . 25.0 111.134 175.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -123.9 131.31 53.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.172 -0.922 . . . . 25.0 110.659 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.08 129.32 38.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.992 -0.744 . . . . 25.0 108.992 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.4 mt -96.63 -17.55 20.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.755 0.312 . . . . 25.0 110.368 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -144.99 167.65 22.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.649 -1.611 . . . . 25.0 106.649 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -77.49 168.86 19.3 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 123.447 0.467 . . . . 25.0 110.85 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -153.48 154.01 33.57 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.074 0.464 . . . . 25.0 111.462 176.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -124.53 129.69 73.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 105.073 -2.195 . . . . 25.0 105.073 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.84 121.88 21.59 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.368 -0.975 . . . . 25.0 108.368 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -102.94 1.67 34.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 122.036 0.922 . . . . 25.0 109.495 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.2 m -144.69 153.75 55.0 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 106.499 -1.667 . . . . 25.0 106.499 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.92 -23.83 34.29 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 117.811 -0.992 . . . . 25.0 113.427 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.78 -16.97 59.31 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.339 0.59 . . . . 25.0 110.629 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -84.05 139.54 32.43 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.61 0.719 . . . . 25.0 110.092 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.429 ' HB2' HG13 ' A' ' 57' ' ' VAL . 40.0 mt -87.42 130.25 34.74 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.95 -0.759 . . . . 25.0 108.95 177.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 t -87.13 137.94 31.91 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.435 -1.691 . . . . 25.0 106.435 175.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -155.42 164.19 39.05 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 120.777 0.322 . . . . 25.0 110.482 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 -117.05 168.24 10.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.984 0.421 . . . . 25.0 110.821 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -60.88 130.17 45.13 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.89 -8.26 78.34 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-O 118.647 -1.085 . . . . 25.0 114.623 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.21 142.35 51.98 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.649 1.224 . . . . 25.0 109.714 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.7 mm -108.68 129.79 62.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 107.627 -1.249 . . . . 25.0 107.627 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 14.3 ptp -134.83 163.4 29.91 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.836 -0.801 . . . . 25.0 108.836 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.1 m -104.4 122.58 45.79 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.411 -1.329 . . . . 25.0 107.411 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.7 t -86.34 122.69 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 108.191 -1.041 . . . . 25.0 108.191 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.24 -41.58 8.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.575 -0.739 . . . . 25.0 109.391 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -142.94 156.63 44.92 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.498 -1.297 . . . . 25.0 107.498 -173.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -124.38 150.76 45.21 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 105.111 -2.181 . . . . 25.0 105.111 172.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 57.43 38.93 28.43 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 123.707 1.717 . . . . 25.0 108.504 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -67.98 157.71 34.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 112.671 -2.059 . . . . 25.0 111.818 -177.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 60.35 12.51 3.46 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.078 1.14 . . . . 25.0 114.078 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.12 13.11 81.56 Favored Glycine 0 C--O 1.244 0.723 0 N-CA-C 111.265 -0.734 . . . . 25.0 111.265 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.2 mt -96.24 137.57 35.12 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 122.357 -0.496 . . . . 25.0 109.899 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -81.19 130.45 35.03 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.352 -0.61 . . . . 25.0 109.352 176.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.93 -0.42 82.85 Favored Glycine 0 C--O 1.241 0.566 0 N-CA-C 116.675 1.43 . . . . 25.0 116.675 173.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -99.8 134.42 42.72 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.388 -0.968 . . . . 25.0 108.388 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.7 m0 -114.61 140.35 48.88 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.078 -1.082 . . . . 25.0 108.078 -177.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.4 tp -82.33 127.74 33.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.051 -1.833 . . . . 25.0 106.051 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.2 m -134.9 162.45 32.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.166 0.508 . . . . 25.0 111.811 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.2 t -112.35 123.09 49.51 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.629 -1.989 . . . . 25.0 105.629 169.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.2 tp -153.14 139.26 18.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.893 0.477 . . . . 25.0 110.122 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.6 m170 56.93 32.0 20.76 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.113 0.565 . . . . 25.0 111.548 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.99 -1.17 89.1 Favored Glycine 0 C--O 1.225 -0.429 0 N-CA-C 116.478 1.351 . . . . 25.0 116.478 177.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.5 ptt85 -130.64 158.59 39.62 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 118.798 1.299 . . . . 25.0 111.402 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -97.72 153.6 18.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.82 -1.178 . . . . 25.0 107.82 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.67 -165.9 35.88 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 103.89 -3.684 . . . . 25.0 103.89 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.4 pt -119.78 158.63 21.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.398 0.618 . . . . 25.0 111.443 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.7 m -144.76 148.95 41.42 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.558 -0.747 . . . . 25.0 110.171 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.3 121.72 7.41 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 118.247 -0.702 . . . . 25.0 112.932 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.38 -18.13 73.13 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 121.267 -0.492 . . . . 25.0 113.568 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -67.3 -9.97 46.24 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.602 0.964 . . . . 25.0 113.602 -177.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -129.89 27.61 5.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.472 0.653 . . . . 25.0 109.804 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -123.08 156.52 34.74 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.356 -0.838 . . . . 25.0 112.423 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -122.69 125.27 45.24 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 108.725 -0.842 . . . . 25.0 108.725 174.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.0 mm -77.97 137.1 22.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.224 -1.028 . . . . 25.0 108.224 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.6 mt -116.96 87.13 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.964 -1.124 . . . . 25.0 107.964 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.699 0 CA-C-N 115.392 -0.822 . . . . 25.0 111.841 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 109.322 -0.621 . . . . 25.0 109.322 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 CA--C 1.541 0.868 0 O-C-N 121.785 0.361 . . . . 25.0 112.018 178.68 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 . . . . . 0 CA--C 1.516 -0.332 0 CA-C-O 120.72 0.295 . . . . 25.0 110.53 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.0 mt -65.0 -42.5 94.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.63 -0.714 . . . . 25.0 110.203 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 53.98 36.18 23.81 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.0 0.92 . . . . 25.0 112.02 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.9 m -96.09 159.79 2.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 N-CA-C 106.18 -1.785 . . . . 25.0 106.18 177.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.02 170.94 8.8 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.992 -0.744 . . . . 25.0 108.992 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.58 162.19 41.41 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.228 -0.295 . . . . 25.0 110.701 175.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.75 136.56 52.58 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.846 0.716 . . . . 25.0 111.353 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.5 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -73.02 123.09 22.83 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.695 0.622 . . . . 25.0 111.679 173.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.2 mt -90.81 -25.2 20.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.222 0.534 . . . . 25.0 110.091 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -142.82 171.68 13.72 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 103.476 -2.787 . . . . 25.0 103.476 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -84.41 175.7 9.17 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 118.056 0.389 . . . . 25.0 110.818 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -149.41 132.29 16.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.761 0.315 . . . . 25.0 110.737 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.7 t -104.04 125.19 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 104.759 -2.312 . . . . 25.0 104.759 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.23 137.86 43.31 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.565 -0.743 . . . . 25.0 110.205 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -119.05 5.33 11.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.783 0.801 . . . . 25.0 109.099 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -147.37 155.65 46.08 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 106.479 -1.675 . . . . 25.0 106.479 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.59 -24.04 26.33 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 118.167 -0.756 . . . . 25.0 113.514 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -77.73 -17.2 57.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.507 0.67 . . . . 25.0 110.203 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -87.09 133.01 33.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.526 0.679 . . . . 25.0 109.969 -176.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.8 mt -87.15 125.97 34.5 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.823 0.82 . . . . 25.0 109.945 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.68 134.01 33.73 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.252 -1.758 . . . . 25.0 106.252 174.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -154.84 166.93 31.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.526 -0.546 . . . . 25.0 109.526 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -113.4 160.51 18.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.365 0.602 . . . . 25.0 110.068 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -57.41 132.56 53.48 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.468 -0.938 . . . . 25.0 108.468 177.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.57 -18.18 57.32 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-O 119.168 -0.795 . . . . 25.0 113.11 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -61.42 147.87 43.6 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.778 0.799 . . . . 25.0 109.988 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.4 mm -115.67 132.95 63.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.296 -1.32 . . . . 25.0 107.894 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -135.24 165.51 25.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.049 -0.723 . . . . 25.0 109.049 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.4 m -104.18 123.47 47.36 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.891 -1.151 . . . . 25.0 107.891 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.1 t -87.47 121.52 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 N-CA-C 108.248 -1.019 . . . . 25.0 108.248 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.584 HD12 HD22 ' A' ' 47' ' ' LEU . 81.1 mt -91.23 -42.71 10.26 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.984 -1.007 . . . . 25.0 109.277 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -150.46 155.87 40.36 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.43 -0.952 . . . . 25.0 108.43 -176.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -115.58 153.11 31.81 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.91 -1.515 . . . . 25.0 106.91 174.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 55.98 41.23 30.05 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 123.63 1.681 . . . . 25.0 109.176 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.2 t -71.05 159.79 34.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 113.234 -1.803 . . . . 25.0 110.665 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 59.51 12.03 2.59 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.18 0.992 . . . . 25.0 112.352 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.61 17.01 78.38 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 111.262 -0.735 . . . . 25.0 111.262 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.4 mt -97.73 131.37 44.33 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 122.44 0.296 . . . . 25.0 110.282 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -71.26 128.3 35.44 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.536 -0.542 . . . . 25.0 109.536 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.5 -1.32 82.64 Favored Glycine 0 CA--C 1.518 0.244 0 N-CA-C 116.569 1.388 . . . . 25.0 116.569 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -100.63 132.99 45.74 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 118.423 1.111 . . . . 25.0 109.621 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -113.05 141.6 46.69 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.939 -0.763 . . . . 25.0 108.939 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.584 HD22 HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -81.14 122.51 27.46 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 104.823 -2.288 . . . . 25.0 104.823 177.501 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.7 m -133.89 161.7 34.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.823 0.345 . . . . 25.0 111.902 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.6 t -114.63 125.14 53.41 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.833 -1.173 . . . . 25.0 107.833 172.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 tp -145.17 136.98 25.55 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.674 -1.232 . . . . 25.0 107.674 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 55.89 28.39 12.47 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.234 0.54 . . . . 25.0 112.173 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.68 2.53 90.56 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 114.877 0.711 . . . . 25.0 114.877 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -122.55 159.3 28.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 118.282 1.041 . . . . 25.0 108.422 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -112.09 150.34 30.85 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.633 -0.877 . . . . 25.0 108.633 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.84 -160.46 24.4 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 106.547 -2.621 . . . . 25.0 106.547 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.1 pt -116.84 150.36 18.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.796 0.808 . . . . 25.0 111.5 -175.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.98 146.59 52.93 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 114.846 -1.07 . . . . 25.0 108.814 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.44 122.82 6.71 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 117.951 -0.899 . . . . 25.0 111.706 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.2 -12.71 72.54 Favored Glycine 0 C--O 1.222 -0.615 0 O-C-N 121.909 -0.494 . . . . 25.0 113.24 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.3 -16.12 63.24 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.486 0.921 . . . . 25.0 113.486 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -129.36 27.65 5.3 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.142 -0.688 . . . . 25.0 109.142 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 12' ' ' ALA . 6.6 tp -129.32 152.22 49.12 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.276 -0.875 . . . . 25.0 111.472 -177.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -131.64 120.66 23.12 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-N 115.777 -0.647 . . . . 25.0 111.755 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.4 mm -66.13 136.13 27.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 O-C-N 123.53 0.519 . . . . 25.0 110.102 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.6 mt -118.75 98.51 6.25 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.303 -1.369 . . . . 25.0 107.303 175.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.3 t . . . . . 0 C--N 1.32 -0.685 0 N-CA-C 107.302 -1.37 . . . . 25.0 107.302 -179.713 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.0 mttt . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 110.123 -0.325 . . . . 25.0 110.123 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 CA--C 1.542 0.916 0 C-N-CA 118.276 -0.683 . . . . 25.0 112.263 176.398 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 CA--C 1.515 -0.386 0 N-CA-C 109.499 -0.556 . . . . 25.0 109.499 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.8 mt -71.88 -33.16 68.13 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.756 -0.656 . . . . 25.0 111.079 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.3 m120 53.43 41.75 32.07 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.35 -0.841 . . . . 25.0 111.954 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.4 m -109.51 165.38 5.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.526 -1.287 . . . . 25.0 107.526 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.73 170.6 7.91 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.467 -0.568 . . . . 25.0 109.467 -176.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.38 162.08 40.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 25.0 110.954 173.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -127.82 130.51 48.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.6 -0.727 . . . . 25.0 109.729 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.38 131.94 46.18 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.061 0.545 . . . . 25.0 109.874 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.9 mt -94.96 -23.19 17.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.24 0.543 . . . . 25.0 110.769 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -144.56 172.09 13.47 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 104.222 -2.51 . . . . 25.0 104.222 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.95 173.89 10.81 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.949 -0.389 . . . . 25.0 109.949 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -155.07 141.01 18.28 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.507 0.323 . . . . 25.0 111.648 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.7 t -108.7 124.48 65.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 105.8 -1.926 . . . . 25.0 105.8 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.53 130.82 41.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.343 -0.844 . . . . 25.0 108.867 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -112.48 11.27 19.8 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.185 0.993 . . . . 25.0 109.044 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 t -153.15 151.26 25.64 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 107.5 -1.296 . . . . 25.0 107.5 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -69.21 -18.2 39.7 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 117.689 -1.074 . . . . 25.0 112.509 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -76.6 -19.62 57.64 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.431 0.634 . . . . 25.0 109.819 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -94.11 140.99 29.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.704 0.764 . . . . 25.0 111.034 -172.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.423 ' HB2' HG13 ' A' ' 57' ' ' VAL . 55.3 mt -91.17 129.61 37.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.469 -0.787 . . . . 25.0 110.157 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.69 139.52 30.48 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.106 -2.183 . . . . 25.0 105.106 173.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -157.77 166.46 32.7 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.594 -0.521 . . . . 25.0 109.594 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -112.73 164.03 13.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.105 0.955 . . . . 25.0 110.362 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -58.48 129.66 43.09 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.447 -1.252 . . . . 25.0 109.45 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.74 -16.21 61.39 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-O 118.758 -1.024 . . . . 25.0 114.867 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -57.79 146.7 30.58 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 117.984 0.892 . . . . 25.0 111.408 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.4 mm -109.47 133.89 53.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.595 -1.184 . . . . 25.0 108.139 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.2 ptp -138.79 162.61 34.31 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.358 -0.979 . . . . 25.0 108.358 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.8 m -101.38 125.5 48.03 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 108.363 -0.977 . . . . 25.0 108.363 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.53 126.01 43.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.044 -1.095 . . . . 25.0 108.044 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.615 HD12 HD22 ' A' ' 47' ' ' LEU . 76.8 mt -95.47 -43.65 7.89 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.865 -1.061 . . . . 25.0 108.918 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -150.21 162.19 40.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.178 -0.675 . . . . 25.0 109.178 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -121.82 152.34 39.64 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 107.076 -1.453 . . . . 25.0 107.076 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 56.22 39.9 30.14 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 123.309 1.528 . . . . 25.0 108.703 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -69.87 157.51 37.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.737 -1.574 . . . . 25.0 110.177 -175.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 60.53 11.05 2.81 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.611 0.967 . . . . 25.0 113.611 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.57 16.5 77.61 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.173 -0.771 . . . . 25.0 111.173 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.7 mt -103.68 113.71 27.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.003 0.43 . . . . 25.0 110.77 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -63.74 128.08 34.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.973 -0.558 . . . . 25.0 109.696 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.61 -1.92 88.05 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 118.757 -1.024 . . . . 25.0 115.103 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -98.93 131.79 44.74 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 118.969 1.384 . . . . 25.0 109.687 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -111.76 140.06 46.71 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.926 -0.768 . . . . 25.0 108.926 -176.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.615 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -82.05 120.79 25.72 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 105.44 -2.059 . . . . 25.0 105.44 178.067 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 92.0 m -132.26 163.55 28.37 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.476 0.547 . . . . 25.0 112.476 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.8 t -115.89 119.26 35.39 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 106.588 -1.634 . . . . 25.0 106.588 171.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -147.37 139.28 24.24 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 107.055 -1.461 . . . . 25.0 107.055 -174.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 56.72 31.49 19.47 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.678 0.752 . . . . 25.0 111.86 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.49 5.27 85.74 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 115.479 0.952 . . . . 25.0 115.479 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -129.78 161.26 31.13 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.125 -1.065 . . . . 25.0 108.125 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -107.09 152.42 24.05 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.385 -0.598 . . . . 25.0 109.385 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.59 -160.55 24.9 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 106.565 -2.614 . . . . 25.0 106.565 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.1 pt -117.28 156.82 18.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.308 0.575 . . . . 25.0 111.043 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.4 m -144.67 146.95 33.97 Favored Pre-proline 0 C--O 1.241 0.64 0 CA-C-N 114.96 -1.018 . . . . 25.0 109.874 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -74.45 118.44 5.35 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 CA-C-O 121.441 0.517 . . . . 25.0 112.708 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.8 -20.04 68.02 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 114.784 0.674 . . . . 25.0 114.784 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -25.22 67.3 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.109 0.781 . . . . 25.0 113.109 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -119.18 28.33 8.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.285 0.564 . . . . 25.0 110.347 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.0 tp -133.51 150.06 51.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.132 -0.485 . . . . 25.0 110.162 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -127.94 120.21 27.15 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.851 0.686 . . . . 25.0 112.851 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.7 mm -65.43 137.6 24.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.494 -0.558 . . . . 25.0 109.494 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.9 mt -118.44 105.36 11.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.915 -1.142 . . . . 25.0 107.915 175.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.9 m . . . . . 0 C--N 1.323 -0.55 0 N-CA-C 108.092 -1.077 . . . . 25.0 108.092 177.299 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 108.956 -0.757 . . . . 25.0 108.956 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo . . . . . 0 CA--C 1.545 1.075 0 C-N-CA 117.171 -1.42 . . . . 25.0 110.518 170.957 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 . . . . . 0 C--O 1.235 0.324 0 N-CA-C 112.608 0.596 . . . . 25.0 112.608 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.04 -39.88 90.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.141 -0.936 . . . . 25.0 111.419 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 54.22 41.6 31.92 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.289 1.042 . . . . 25.0 111.91 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.447 HG23 ' HB ' ' A' ' 34' ' ' VAL . 15.9 m -102.7 171.27 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 N-CA-C 103.743 -2.688 . . . . 25.0 103.743 175.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -118.96 173.93 6.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 119.42 1.009 . . . . 25.0 110.693 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.04 158.74 44.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.12 -0.491 . . . . 25.0 109.746 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -120.9 132.26 54.86 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.311 0.644 . . . . 25.0 109.793 177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.59 130.43 42.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.016 0.436 . . . . 25.0 110.078 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.8 mt -97.46 -22.18 16.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.337 -0.392 . . . . 25.0 110.944 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -141.88 164.76 29.3 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -71.78 167.74 19.31 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.598 0.562 . . . . 25.0 110.785 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.45 160.04 42.17 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.516 -0.55 . . . . 25.0 109.516 175.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.1 t -130.85 127.7 61.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 102.87 -3.011 . . . . 25.0 102.87 169.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.53 123.6 31.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.788 -0.819 . . . . 25.0 108.788 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -117.18 -17.28 10.28 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.541 0.686 . . . . 25.0 110.41 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.55 152.91 37.97 Favored Pre-proline 0 N--CA 1.471 0.58 0 N-CA-C 107.973 -1.121 . . . . 25.0 107.973 176.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.8 -24.51 34.31 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 117.906 -0.929 . . . . 25.0 113.59 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -84.13 -16.36 43.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.938 0.399 . . . . 25.0 111.135 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -79.03 129.64 34.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.077 0.941 . . . . 25.0 110.644 -173.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.414 ' HB2' HG13 ' A' ' 57' ' ' VAL . 24.3 mt -82.77 138.48 34.01 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.497 -0.774 . . . . 25.0 109.605 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.65 130.73 34.69 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.474 -0.935 . . . . 25.0 108.474 177.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -158.37 162.92 37.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.27 0.557 . . . . 25.0 110.958 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.13 166.06 17.73 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.964 -0.562 . . . . 25.0 110.099 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -56.97 131.46 49.84 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 121.116 0.484 . . . . 25.0 109.8 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.06 -19.68 53.24 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-O 118.569 -1.128 . . . . 25.0 113.028 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -62.3 149.07 43.07 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 118.118 0.959 . . . . 25.0 109.98 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.4 mm -116.63 125.3 73.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 114.325 -1.307 . . . . 25.0 108.365 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -126.74 153.22 45.79 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.172 -0.677 . . . . 25.0 109.172 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.8 m -87.26 126.63 34.95 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.736 -1.579 . . . . 25.0 106.736 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.447 ' HB ' HG23 ' A' ' 8' ' ' VAL . 62.1 t -92.19 119.89 40.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.362 -1.348 . . . . 25.0 107.362 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.547 HD12 HD22 ' A' ' 47' ' ' LEU . 83.1 mt -91.03 -43.92 9.63 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.15 -0.932 . . . . 25.0 110.155 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -150.19 159.61 44.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.831 -1.174 . . . . 25.0 107.831 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -121.62 149.41 43.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.556 -1.275 . . . . 25.0 107.556 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 58.06 39.27 26.42 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 123.517 1.627 . . . . 25.0 109.603 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.3 t -65.29 151.81 45.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.742 -1.572 . . . . 25.0 110.468 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 59.59 11.75 2.51 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.93 0.892 . . . . 25.0 113.265 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.53 18.72 78.84 Favored Glycine 0 C--O 1.241 0.585 0 N-CA-C 110.987 -0.845 . . . . 25.0 110.987 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.9 mt -91.87 123.83 35.54 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.348 -0.612 . . . . 25.0 109.348 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -64.23 118.8 9.13 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.158 -0.928 . . . . 25.0 110.998 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.28 2.63 90.57 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 116.931 1.533 . . . . 25.0 116.931 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -100.82 132.02 46.42 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.809 1.305 . . . . 25.0 110.579 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -110.16 140.8 43.87 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.75 -0.593 . . . . 25.0 110.196 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.547 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -81.25 122.01 26.88 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 104.386 -2.449 . . . . 25.0 104.386 176.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.8 m -132.51 164.42 26.63 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.179 0.514 . . . . 25.0 111.362 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.5 t -121.55 125.16 46.12 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 107.485 -1.302 . . . . 25.0 107.485 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.2 tp -148.78 138.49 22.02 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 106.495 -1.668 . . . . 25.0 106.495 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 55.24 28.93 11.91 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.221 0.608 . . . . 25.0 112.168 -176.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.34 1.35 75.13 Favored Glycine 0 C--O 1.226 -0.349 0 N-CA-C 115.151 0.82 . . . . 25.0 115.151 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -117.09 161.47 19.37 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.083 -1.451 . . . . 25.0 107.083 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -118.35 156.75 28.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.508 -0.553 . . . . 25.0 109.508 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.21 -156.82 21.1 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 106.525 -2.63 . . . . 25.0 106.525 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.8 pt -121.12 151.9 24.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.742 0.782 . . . . 25.0 111.545 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 24' ' ' LEU . 2.4 m -141.18 146.85 44.77 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 114.438 -1.255 . . . . 25.0 109.591 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.65 121.21 5.84 Favored 'Trans proline' 0 C--O 1.24 0.586 0 CA-C-O 121.444 0.518 . . . . 25.0 113.133 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.3 -16.16 68.78 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-O 121.717 0.62 . . . . 25.0 114.334 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -18.3 63.55 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.018 0.527 . . . . 25.0 112.081 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -126.73 30.39 5.51 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.951 0.405 . . . . 25.0 110.692 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.5 mt -126.25 157.09 39.2 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.885 1.068 . . . . 25.0 113.885 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -129.76 119.82 24.06 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.16 -0.927 . . . . 25.0 109.649 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.7 mm -67.81 140.39 19.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 O-C-N 123.902 0.751 . . . . 25.0 109.613 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.4 mt -118.65 101.84 8.41 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.826 0.85 . . . . 25.0 109.152 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 112.701 0.63 . . . . 25.0 112.701 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.8 mttt . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 106.404 -1.702 . . . . 25.0 106.404 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.543 0.942 0 C-N-CA 118.306 -0.662 . . . . 25.0 112.361 177.497 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 . . . . . 0 CA--C 1.53 0.173 0 N-CA-C 114.829 1.418 . . . . 25.0 114.829 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.5 mt -73.57 -42.48 61.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.652 -1.158 . . . . 25.0 110.291 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 55.75 30.05 14.96 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.396 1.078 . . . . 25.0 111.822 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 m -89.65 163.89 2.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 104.842 -2.281 . . . . 25.0 104.842 176.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.23 171.9 7.33 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.966 -1.124 . . . . 25.0 107.966 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.47 157.24 43.34 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.52 -0.548 . . . . 25.0 109.52 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -120.34 131.79 55.01 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 123.901 0.751 . . . . 25.0 109.393 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.436 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -68.8 126.94 31.32 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.658 0.599 . . . . 25.0 110.095 173.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.5 mt -92.56 -26.59 17.83 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.859 -0.423 . . . . 25.0 109.859 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -142.19 166.02 25.83 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.048 -1.834 . . . . 25.0 106.048 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -75.3 163.35 27.57 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 122.998 0.519 . . . . 25.0 112.369 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -143.07 144.03 32.09 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.625 0.602 . . . . 25.0 112.625 173.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -114.14 126.83 71.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 103.355 -2.832 . . . . 25.0 103.355 173.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.42 140.51 33.4 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 108.237 -1.023 . . . . 25.0 108.237 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -125.06 9.77 8.1 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.693 0.759 . . . . 25.0 111.186 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.5 m -145.73 150.98 45.0 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 106.575 -1.639 . . . . 25.0 106.575 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.62 -29.96 84.94 Favored 'Trans proline' 0 C--N 1.351 0.663 0 N-CA-C 114.954 1.098 . . . . 25.0 114.954 -175.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.7 -17.4 59.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.203 -0.453 . . . . 25.0 111.769 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -86.15 136.33 33.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 122.055 0.931 . . . . 25.0 111.886 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.9 mt -91.14 130.95 36.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.508 0.67 . . . . 25.0 111.089 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.6 p -90.92 144.69 25.42 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.61 -1.256 . . . . 25.0 107.61 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -160.09 168.55 25.29 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.61 0.243 . . . . 25.0 110.669 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -116.95 163.55 16.03 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.406 -0.59 . . . . 25.0 109.406 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -59.74 133.78 56.41 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.727 -0.842 . . . . 25.0 108.727 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.4 -21.35 46.45 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-O 118.903 -0.943 . . . . 25.0 113.003 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -57.14 145.69 30.34 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.031 0.919 . . . . 25.0 111.116 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.3 mm -115.7 126.83 73.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.486 -1.234 . . . . 25.0 109.159 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -131.39 153.95 49.14 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.665 -0.494 . . . . 25.0 109.665 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.5 m -89.55 123.69 33.86 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.474 -0.935 . . . . 25.0 108.474 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.9 t -87.1 123.15 39.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.069 -0.715 . . . . 25.0 109.069 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.661 HD12 HD22 ' A' ' 47' ' ' LEU . 77.5 mt -89.85 -46.05 8.83 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.244 -1.021 . . . . 25.0 108.244 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -153.94 172.85 16.78 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.881 -0.512 . . . . 25.0 109.708 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 mtm105 -120.25 154.5 34.82 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.087 -1.449 . . . . 25.0 107.087 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 59.71 40.47 19.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 123.527 1.632 . . . . 25.0 109.228 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t -66.84 154.77 40.06 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 113.081 -1.872 . . . . 25.0 110.36 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 57.59 14.37 2.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.213 1.005 . . . . 25.0 112.147 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.05 14.84 81.85 Favored Glycine 0 C--O 1.24 0.481 0 N-CA-C 111.287 -0.725 . . . . 25.0 111.287 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.3 mt -93.16 129.07 39.29 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 117.479 0.639 . . . . 25.0 109.602 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -67.84 125.92 27.78 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.039 -0.528 . . . . 25.0 110.305 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.29 -1.76 84.12 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 117.051 1.58 . . . . 25.0 117.051 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -97.75 135.11 40.0 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 117.879 0.839 . . . . 25.0 110.391 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -112.88 143.43 44.16 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.711 -1.218 . . . . 25.0 107.711 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.661 HD22 HD12 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -86.3 124.34 32.57 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.178 -2.527 . . . . 25.0 104.178 176.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 93.2 m -133.16 164.11 27.77 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.162 0.506 . . . . 25.0 111.762 177.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.0 t -118.66 124.9 48.53 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.688 -1.227 . . . . 25.0 107.688 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.0 tp -139.78 133.14 30.0 Favored 'General case' 0 C--O 1.212 -0.911 0 N-CA-C 107.306 -1.368 . . . . 25.0 107.306 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.5 m170 54.95 31.62 16.33 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.465 0.706 . . . . 25.0 111.404 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.31 1.2 85.57 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 116.018 1.167 . . . . 25.0 116.018 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -118.46 152.8 35.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 119.09 1.445 . . . . 25.0 107.661 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -108.18 157.14 18.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.353 -0.385 . . . . 25.0 110.176 -178.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.44 -161.37 29.51 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 106.609 -2.597 . . . . 25.0 106.609 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.7 pt -117.13 150.03 19.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.349 0.595 . . . . 25.0 111.032 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.53 146.87 46.88 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.084 -0.962 . . . . 25.0 109.107 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.45 122.02 5.42 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 CA-C-O 121.546 0.561 . . . . 25.0 112.904 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.56 -18.23 71.66 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 115.934 1.134 . . . . 25.0 115.934 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -17.74 63.84 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 122.223 -0.575 . . . . 25.0 111.778 -177.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -123.13 27.94 7.37 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.712 0.291 . . . . 25.0 110.523 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 12' ' ' ALA . 14.4 mt -127.74 156.03 43.08 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.879 0.847 . . . . 25.0 112.26 178.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -128.81 121.99 29.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.724 -1.125 . . . . 25.0 110.443 175.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.6 mm -68.75 139.23 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.409 -0.96 . . . . 25.0 108.409 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.6 mt -117.49 103.02 9.68 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.325 -1.361 . . . . 25.0 107.325 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.0 m . . . . . 0 C--N 1.327 -0.406 0 CA-C-O 121.361 0.601 . . . . 25.0 111.287 -177.733 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt . . . . . 0 CA--C 1.542 0.666 0 N-CA-C 106.721 -1.585 . . . . 25.0 106.721 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 CA--C 1.551 1.345 0 O-C-N 122.463 0.717 . . . . 25.0 112.757 178.158 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 . . . . . 0 CA--C 1.52 -0.211 0 N-CA-C 109.794 -0.447 . . . . 25.0 109.794 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.27 -40.74 97.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.017 -0.538 . . . . 25.0 109.758 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 57.3 24.83 10.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.039 0.935 . . . . 25.0 111.856 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.5 m -88.21 175.81 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 N-CA-C 105.531 -2.026 . . . . 25.0 105.531 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mp -117.88 172.28 7.5 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 118.842 0.746 . . . . 25.0 110.813 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.72 163.38 34.19 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.792 -0.64 . . . . 25.0 110.256 177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -126.63 130.52 50.64 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.644 -0.707 . . . . 25.0 110.313 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.426 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -67.78 123.81 21.58 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.143 0.577 . . . . 25.0 110.237 174.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.0 mt -90.54 -23.92 20.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.801 -0.444 . . . . 25.0 109.801 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -141.26 172.53 12.55 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 102.887 -3.005 . . . . 25.0 102.887 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.52 176.4 9.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -151.61 135.23 16.26 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.199 0.523 . . . . 25.0 112.103 175.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.9 t -101.53 121.38 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 105.333 -2.099 . . . . 25.0 105.333 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.42 131.52 43.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.516 -0.92 . . . . 25.0 108.516 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -105.22 -6.51 19.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.688 0.756 . . . . 25.0 109.897 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 m -138.57 152.61 71.32 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 107.076 -1.453 . . . . 25.0 107.076 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.81 -19.29 36.05 Favored 'Trans proline' 0 C--O 1.222 -0.296 0 C-N-CA 117.721 -1.053 . . . . 25.0 112.374 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -79.41 -15.88 57.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 25.0 110.862 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -91.86 139.38 30.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.87 0.843 . . . . 25.0 110.428 -176.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.427 ' HB2' HG13 ' A' ' 57' ' ' VAL . 56.2 mt -90.62 129.72 36.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.059 0.933 . . . . 25.0 110.24 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.58 147.18 23.51 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.644 -1.613 . . . . 25.0 106.644 175.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -157.47 167.81 29.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.283 0.564 . . . . 25.0 111.023 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -107.09 159.13 16.54 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.971 -0.752 . . . . 25.0 108.971 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -58.0 128.2 35.89 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.72 -1.215 . . . . 25.0 107.72 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.18 -18.87 53.56 Favored Glycine 0 CA--C 1.517 0.194 0 CA-C-O 118.731 -1.039 . . . . 25.0 113.915 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -59.51 147.61 36.17 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 118.063 0.932 . . . . 25.0 110.738 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.5 mm -115.39 128.52 72.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.453 -1.249 . . . . 25.0 108.92 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -131.09 153.05 49.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.044 -0.354 . . . . 25.0 110.044 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.6 m -84.19 130.09 34.85 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 177.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.51 125.25 47.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.709 -0.849 . . . . 25.0 108.709 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.621 HD12 HD22 ' A' ' 47' ' ' LEU . 60.4 mt -91.09 -48.62 6.86 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.797 -0.816 . . . . 25.0 108.797 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -155.06 173.21 16.91 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.655 -0.869 . . . . 25.0 108.655 177.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -121.99 151.62 40.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.04 -1.096 . . . . 25.0 108.04 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 59.29 40.32 21.45 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 123.329 1.537 . . . . 25.0 108.936 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -65.06 153.78 39.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 112.866 -1.97 . . . . 25.0 110.5 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 59.79 11.61 2.58 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.585 0.957 . . . . 25.0 113.585 176.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.11 19.13 75.39 Favored Glycine 0 C--O 1.225 -0.447 0 N-CA-C 111.052 -0.819 . . . . 25.0 111.052 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 71.9 mt -96.95 112.33 24.13 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.124 0.488 . . . . 25.0 111.288 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.96 119.36 6.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.888 -0.596 . . . . 25.0 111.828 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.99 -0.01 89.55 Favored Glycine 0 C--O 1.239 0.417 0 N-CA-C 115.521 0.968 . . . . 25.0 115.521 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -100.19 134.6 42.88 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 118.525 1.163 . . . . 25.0 109.485 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -112.0 143.09 43.56 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.322 -0.992 . . . . 25.0 108.322 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.621 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -85.03 120.01 26.07 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 105.161 -2.163 . . . . 25.0 105.161 177.192 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 92.0 m -130.29 161.14 31.9 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.827 0.346 . . . . 25.0 111.317 178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.3 t -113.71 120.3 40.36 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.184 -1.413 . . . . 25.0 107.184 174.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.5 tp -143.2 135.5 27.19 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.145 -0.687 . . . . 25.0 109.145 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 56.03 28.13 12.35 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.889 1.07 . . . . 25.0 113.889 175.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.28 7.7 86.31 Favored Glycine 0 C--O 1.226 -0.352 0 C-N-CA 121.202 -0.523 . . . . 25.0 113.794 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -118.62 153.22 34.64 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.523 -0.918 . . . . 25.0 108.523 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -117.16 138.46 51.65 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 104.996 -2.224 . . . . 25.0 104.996 173.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.18 -162.71 26.99 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 107.414 -2.274 . . . . 25.0 107.414 -176.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.6 pt -111.31 151.92 13.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 121.599 0.714 . . . . 25.0 111.713 -174.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.2 m -141.47 145.01 35.95 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 114.851 -1.068 . . . . 25.0 108.992 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.72 120.69 6.26 Favored 'Trans proline' 0 C--O 1.238 0.507 0 CA-C-O 121.233 0.431 . . . . 25.0 112.691 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.76 -19.84 71.71 Favored Glycine 0 C--O 1.22 -0.727 0 N-CA-C 114.915 0.726 . . . . 25.0 114.915 -176.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -65.37 -16.68 63.86 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.217 0.821 . . . . 25.0 113.217 -177.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -122.92 27.44 7.69 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.259 0.552 . . . . 25.0 109.817 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 12' ' ' ALA . 12.7 mt -126.8 157.82 38.23 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.019 0.914 . . . . 25.0 113.023 178.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -127.56 125.93 41.22 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 115.01 -0.996 . . . . 25.0 110.194 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.2 mm -75.07 135.85 26.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.699 -0.852 . . . . 25.0 108.699 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.0 mt -115.47 92.13 3.82 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.561 0.744 . . . . 25.0 109.629 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.472 0.654 0 CA-C-N 115.86 -0.609 . . . . 25.0 111.139 179.537 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 107.766 -1.198 . . . . 25.0 107.766 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 CA--C 1.537 0.66 0 O-C-N 122.186 0.571 . . . . 25.0 113.07 -178.739 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 . . . . . 0 CA--C 1.515 -0.367 0 N-CA-C 109.689 -0.486 . . . . 25.0 109.689 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.4 mt -67.34 -39.35 85.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.918 -0.583 . . . . 25.0 109.788 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.7 m120 53.76 30.06 10.6 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.168 0.987 . . . . 25.0 112.683 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.8 m -93.17 175.88 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 104.501 -2.407 . . . . 25.0 104.501 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.55 172.34 7.72 Favored 'General case' 0 CA--C 1.497 -1.093 0 O-C-N 121.934 -0.479 . . . . 25.0 109.837 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.93 162.74 38.69 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.599 -0.728 . . . . 25.0 109.87 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.91 128.19 49.09 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 124.175 0.99 . . . . 25.0 108.333 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.24 138.24 49.28 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 122.763 0.425 . . . . 25.0 110.271 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.2 mt -101.46 -17.38 16.47 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.669 0.618 . . . . 25.0 112.669 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -141.45 159.12 42.87 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.698 -1.223 . . . . 25.0 107.698 -176.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.41 ' C ' HH22 ' A' ' 61' ' ' ARG . 21.5 m-20 -81.18 149.71 28.98 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.036 0.21 . . . . 25.0 111.257 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -133.68 146.29 50.71 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.33 0.652 . . . . 25.0 112.203 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.0 t -119.98 133.38 66.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 103.147 -2.908 . . . . 25.0 103.147 170.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.14 135.53 36.6 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.063 -0.717 . . . . 25.0 109.063 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -108.82 2.44 21.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.39 0.614 . . . . 25.0 111.261 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -142.43 151.73 58.58 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 105.88 -1.896 . . . . 25.0 105.88 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.21 -18.73 34.7 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 118.353 -0.631 . . . . 25.0 112.823 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.03 -16.79 59.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.267 -0.879 . . . . 25.0 110.956 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -97.56 141.68 30.31 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.694 -0.854 . . . . 25.0 108.694 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.3 mt -93.62 127.04 39.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.958 0.885 . . . . 25.0 112.059 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.23 129.3 34.83 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 104.81 -2.293 . . . . 25.0 104.81 174.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -149.35 163.74 36.88 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.998 -0.371 . . . . 25.0 109.998 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -111.01 163.78 13.48 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.577 0.703 . . . . 25.0 110.514 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.52 130.85 46.07 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 107.278 -1.378 . . . . 25.0 107.278 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.14 -9.47 77.56 Favored Glycine 0 C--N 1.312 -0.751 0 CA-C-O 119.03 -0.872 . . . . 25.0 114.279 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -62.38 149.41 42.46 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 117.822 0.811 . . . . 25.0 109.326 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.0 mm -114.77 128.15 72.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.144 -0.935 . . . . 25.0 108.686 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -131.48 149.93 52.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.231 -0.44 . . . . 25.0 109.935 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.1 m -87.18 122.64 31.26 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.746 -1.205 . . . . 25.0 107.746 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -85.4 127.43 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 N-CA-C 108.138 -1.06 . . . . 25.0 108.138 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.621 HD12 HD22 ' A' ' 47' ' ' LEU . 75.9 mt -93.37 -51.0 5.19 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.17 -0.923 . . . . 25.0 109.222 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -152.44 173.75 14.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.332 -0.618 . . . . 25.0 109.332 176.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -121.76 155.46 35.23 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 107.928 -1.138 . . . . 25.0 107.928 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 55.88 42.43 28.88 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 125.641 1.838 . . . . 25.0 109.168 -177.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.8 t -65.98 149.62 49.94 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.415 -1.721 . . . . 25.0 110.517 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 59.72 14.61 4.18 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.774 0.83 . . . . 25.0 112.175 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.29 10.72 85.99 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.28 -0.486 . . . . 25.0 111.982 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.4 mt -89.63 119.4 30.01 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 117.718 0.759 . . . . 25.0 110.001 -178.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -64.32 126.04 26.5 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.238 -0.437 . . . . 25.0 110.064 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.58 -0.09 88.51 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 115.451 0.94 . . . . 25.0 115.451 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -99.45 133.29 43.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 119.101 1.45 . . . . 25.0 108.97 175.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -114.85 142.47 46.52 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.123 -1.436 . . . . 25.0 107.123 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.621 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -87.56 125.49 34.37 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 104.963 -2.236 . . . . 25.0 104.963 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.8 m -135.85 160.82 37.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.834 0.35 . . . . 25.0 110.601 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.2 t -111.46 125.96 54.45 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.314 -1.365 . . . . 25.0 107.314 171.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.7 tp -136.72 128.8 29.56 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.759 -1.2 . . . . 25.0 107.759 -177.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.9 m170 54.9 30.71 14.41 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.942 0.401 . . . . 25.0 110.771 -175.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.66 -7.7 64.62 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 115.937 1.135 . . . . 25.0 115.937 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -110.8 149.05 31.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 118.307 1.053 . . . . 25.0 108.783 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -103.24 154.33 19.46 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.502 -0.772 . . . . 25.0 110.266 -175.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.66 -167.98 39.73 Favored Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 106.429 -2.668 . . . . 25.0 106.429 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.4 pt -111.36 149.84 13.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.976 0.893 . . . . 25.0 111.961 -175.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 m -139.54 145.17 42.54 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 114.29 -1.323 . . . . 25.0 109.413 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.03 123.07 8.1 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 CA-C-O 121.207 0.42 . . . . 25.0 112.646 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.95 -15.01 79.84 Favored Glycine 0 C--O 1.228 -0.27 0 O-C-N 122.088 -0.383 . . . . 25.0 113.525 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -67.57 -5.28 14.65 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.775 0.83 . . . . 25.0 112.368 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.41 HH22 ' C ' ' A' ' 15' ' ' ASP . 0.3 OUTLIER -142.06 27.9 1.75 Allowed 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.139 -1.06 . . . . 25.0 108.139 -178.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 tp -130.65 144.62 51.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.611 -0.722 . . . . 25.0 110.884 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -122.32 117.09 25.26 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.257 -0.429 . . . . 25.0 112.033 -176.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.1 mm -64.92 136.99 25.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 O-C-N 123.961 0.788 . . . . 25.0 109.609 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.5 mt -119.67 106.14 11.87 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.283 -1.377 . . . . 25.0 107.283 176.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.6 0 CA-C-O 121.104 0.478 . . . . 25.0 110.238 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.4 mttt . . . . . 0 C--O 1.226 -0.179 0 N-CA-C 106.957 -1.497 . . . . 25.0 106.957 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 CA--C 1.531 0.33 0 C-N-CA 116.705 -1.73 . . . . 25.0 110.553 173.303 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 . . . . . 0 CA--C 1.513 -0.469 0 N-CA-C 107.182 -1.414 . . . . 25.0 107.182 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.41 -39.97 92.69 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.509 0.506 . . . . 25.0 110.648 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 55.52 31.93 18.05 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.926 0.89 . . . . 25.0 111.695 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.401 HG23 ' HB ' ' A' ' 34' ' ' VAL . 17.5 m -94.31 170.71 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 104.267 -2.494 . . . . 25.0 104.267 175.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -115.83 172.21 7.28 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.264 -1.013 . . . . 25.0 108.264 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.29 156.32 41.91 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 123.281 0.363 . . . . 25.0 110.623 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -116.63 127.86 54.85 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 123.998 0.812 . . . . 25.0 110.104 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.52 127.08 31.38 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.913 -0.773 . . . . 25.0 108.913 176.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.6 mt -88.75 -24.19 22.72 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 120.61 0.243 . . . . 25.0 110.488 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -146.2 171.5 14.84 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 104.09 -2.559 . . . . 25.0 104.09 177.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -82.57 174.24 11.22 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.538 -0.541 . . . . 25.0 109.538 177.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -150.85 133.44 15.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.889 0.376 . . . . 25.0 111.74 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.9 t -101.3 120.07 50.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 105.197 -2.149 . . . . 25.0 105.197 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.05 137.49 49.03 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.644 -0.873 . . . . 25.0 108.644 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -116.02 15.27 16.16 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 122.266 1.031 . . . . 25.0 108.891 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 t -157.21 149.47 17.73 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.118 -0.946 . . . . 25.0 108.501 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -69.48 -16.43 38.73 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 117.326 -1.316 . . . . 25.0 113.006 175.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -78.58 -17.1 56.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.524 0.678 . . . . 25.0 109.805 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -98.52 138.21 36.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.599 -0.728 . . . . 25.0 110.904 -173.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.443 ' HB2' HG13 ' A' ' 57' ' ' VAL . 50.8 mt -89.69 130.77 35.93 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.787 0.804 . . . . 25.0 110.045 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.6 p -90.23 144.49 25.8 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 105.803 -1.925 . . . . 25.0 105.803 174.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -157.9 168.55 26.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.82 0.343 . . . . 25.0 110.268 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.55 161.1 16.04 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.318 0.58 . . . . 25.0 109.789 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -60.31 133.97 56.61 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.318 -0.994 . . . . 25.0 108.318 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.86 -15.46 63.33 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-O 119.079 -0.845 . . . . 25.0 113.69 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -58.41 136.6 57.49 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.553 0.692 . . . . 25.0 109.739 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.0 mm -103.74 127.44 57.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 106.393 -1.706 . . . . 25.0 106.393 176.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 19.5 ptp -131.79 153.62 49.94 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.188 -0.671 . . . . 25.0 109.188 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.1 m -89.33 127.83 35.83 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.046 -1.464 . . . . 25.0 107.046 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.401 ' HB ' HG23 ' A' ' 8' ' ' VAL . 45.9 t -97.01 122.97 49.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.955 -1.128 . . . . 25.0 107.955 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.571 HD12 HD22 ' A' ' 47' ' ' LEU . 78.0 mt -92.78 -45.22 8.12 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.272 -0.876 . . . . 25.0 109.521 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -147.15 161.18 41.41 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.384 -0.969 . . . . 25.0 108.384 -174.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -126.88 149.59 49.69 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.08 -1.452 . . . . 25.0 107.08 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 56.62 38.52 29.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 123.483 1.611 . . . . 25.0 108.452 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 t -63.03 146.71 52.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.339 -1.755 . . . . 25.0 110.01 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 59.44 13.42 3.22 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.482 0.919 . . . . 25.0 113.482 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.89 16.99 79.24 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 111.003 -0.839 . . . . 25.0 111.003 -178.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.448 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 60.3 mt -91.53 103.65 16.23 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.875 -0.787 . . . . 25.0 108.875 178.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -54.49 123.98 14.73 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.422 -0.808 . . . . 25.0 111.606 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.24 0.27 85.89 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 115.345 0.898 . . . . 25.0 115.345 176.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.448 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 95.0 m95 -100.95 130.73 46.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 118.523 1.162 . . . . 25.0 109.193 177.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -112.23 142.6 44.52 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 121.789 -0.569 . . . . 25.0 109.622 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.571 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -84.02 119.07 24.5 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 105.563 -2.014 . . . . 25.0 105.563 178.642 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 95.4 m -129.8 162.28 28.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.088 0.47 . . . . 25.0 112.095 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.1 t -111.97 113.38 25.65 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.522 -1.658 . . . . 25.0 106.522 172.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -143.6 136.79 27.83 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.84 -1.17 . . . . 25.0 107.84 -174.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 55.88 27.42 10.99 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.45 0.7 . . . . 25.0 112.803 -176.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.51 6.4 86.64 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 120.859 -0.686 . . . . 25.0 113.046 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -114.16 160.99 18.35 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.53 -1.285 . . . . 25.0 107.53 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -121.75 142.82 49.81 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 105.89 -1.892 . . . . 25.0 105.89 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.09 -158.34 20.71 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 105.461 -3.055 . . . . 25.0 105.461 -177.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.7 pt -118.5 154.23 20.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.493 0.663 . . . . 25.0 111.238 -175.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 24' ' ' LEU . 2.0 m -141.42 146.26 41.47 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.069 -0.968 . . . . 25.0 109.347 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.24 117.7 5.21 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 CA-C-O 121.484 0.535 . . . . 25.0 112.189 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.95 -14.75 66.16 Favored Glycine 0 C--O 1.22 -0.767 0 O-C-N 122.079 -0.388 . . . . 25.0 113.202 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -64.23 -15.35 59.86 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.832 0.679 . . . . 25.0 112.832 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -131.21 29.55 4.62 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.348 0.594 . . . . 25.0 109.628 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.1 tp -133.63 148.41 51.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.845 -0.616 . . . . 25.0 109.972 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -127.87 120.12 27.07 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 111.984 0.365 . . . . 25.0 111.984 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.4 mm -69.18 135.47 28.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 123.458 0.474 . . . . 25.0 110.45 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.6 mt -120.85 96.66 5.2 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.951 0.9 . . . . 25.0 109.213 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 C--N 1.322 -0.602 0 N-CA-C 107.712 -1.218 . . . . 25.0 107.712 179.319 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.5 mttt . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 108.886 -0.783 . . . . 25.0 108.886 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 CA--C 1.539 0.763 0 C-N-CA 116.92 -1.587 . . . . 25.0 110.604 175.156 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 . . . . . 0 CA--C 1.508 -0.656 0 CA-C-O 120.893 0.378 . . . . 25.0 111.063 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.6 mt -68.3 -40.61 81.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.765 -0.828 . . . . 25.0 108.765 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 53.46 34.78 19.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.037 0.935 . . . . 25.0 111.58 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.0 m -93.38 -179.25 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 103.946 -2.613 . . . . 25.0 103.946 175.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.89 173.86 6.97 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.276 -0.89 . . . . 25.0 109.938 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.75 157.23 43.02 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.506 0.67 . . . . 25.0 109.598 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -116.96 129.95 56.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.177 -0.92 . . . . 25.0 109.875 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.97 128.09 35.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.091 -0.504 . . . . 25.0 109.666 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.64 -21.79 21.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.315 0.579 . . . . 25.0 111.188 -177.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -141.18 173.27 11.64 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.852 -1.166 . . . . 25.0 107.852 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -76.8 -179.07 5.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 124.113 0.883 . . . . 25.0 109.884 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.09 156.79 29.83 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.777 -0.823 . . . . 25.0 108.777 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.36 122.82 60.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 103.394 -2.817 . . . . 25.0 103.394 167.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.31 133.07 34.16 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.133 -1.062 . . . . 25.0 108.133 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -114.01 -23.56 9.49 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.027 0.441 . . . . 25.0 111.021 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -93.44 151.7 40.41 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.285 -1.006 . . . . 25.0 108.285 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.06 -18.88 30.64 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 116.545 -1.837 . . . . 25.0 111.835 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -85.71 -17.0 37.21 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.228 -0.896 . . . . 25.0 110.036 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -83.11 133.67 35.04 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.442 -0.787 . . . . 25.0 110.142 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.2 mt -84.02 132.86 34.7 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.961 0.41 . . . . 25.0 110.546 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 p -83.48 116.82 22.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.214 -1.032 . . . . 25.0 108.214 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -138.96 161.94 36.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.091 0.948 . . . . 25.0 112.491 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -119.23 166.62 12.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.975 -1.011 . . . . 25.0 108.73 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -61.87 131.61 50.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.882 -0.785 . . . . 25.0 108.882 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.62 -13.94 65.66 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-O 118.844 -0.975 . . . . 25.0 114.683 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.39 141.39 54.7 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 118.117 0.959 . . . . 25.0 108.908 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.6 mm -106.51 130.35 58.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 107.358 -1.349 . . . . 25.0 107.358 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.481 ' HB3' HD13 ' A' ' 50' ' ' LEU . 16.3 ptp -131.78 151.68 51.49 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 109.037 -0.727 . . . . 25.0 109.037 -177.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.4 m -87.94 124.33 33.59 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 106.895 -1.521 . . . . 25.0 106.895 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.4 t -91.82 124.2 44.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 N-CA-C 108.418 -0.956 . . . . 25.0 108.418 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.637 HD12 HD22 ' A' ' 47' ' ' LEU . 78.6 mt -90.02 -47.56 7.76 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.765 -0.652 . . . . 25.0 109.411 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -156.9 175.72 13.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.737 -0.468 . . . . 25.0 109.737 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -127.95 156.2 43.04 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 106.219 -1.771 . . . . 25.0 106.219 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.4 t0 61.8 36.15 16.29 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.869 1.319 . . . . 25.0 108.218 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -66.7 144.71 56.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.772 -1.103 . . . . 25.0 108.58 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 57.64 15.25 2.76 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.604 0.964 . . . . 25.0 113.604 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.79 15.59 81.21 Favored Glycine 0 C--O 1.254 1.348 0 C-N-CA 121.335 -0.459 . . . . 25.0 112.076 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.44 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 98.0 mt -92.98 101.24 13.57 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 122.238 1.018 . . . . 25.0 108.69 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -60.11 121.7 12.56 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.592 -1.186 . . . . 25.0 110.206 -175.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.08 -2.44 85.43 Favored Glycine 0 C--N 1.318 -0.418 0 CA-C-O 119.06 -0.856 . . . . 25.0 115.139 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.44 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 93.0 m95 -99.17 139.14 35.26 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.388 1.094 . . . . 25.0 108.62 174.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.41 ' CE3' HD23 ' A' ' 62' ' ' LEU . 41.9 m0 -118.6 139.61 51.21 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.496 -1.298 . . . . 25.0 107.496 -177.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.637 HD22 HD12 ' A' ' 35' ' ' LEU . 0.7 OUTLIER -81.12 124.29 29.11 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 106.359 -1.719 . . . . 25.0 106.359 177.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 98.2 m -131.76 163.13 28.87 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.622 0.725 . . . . 25.0 109.975 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -117.91 120.25 37.29 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 104.966 -2.235 . . . . 25.0 104.966 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.481 HD13 ' HB3' ' A' ' 32' ' ' MET . 11.1 tp -147.9 134.32 19.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.932 -0.766 . . . . 25.0 108.932 -175.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.3 m170 54.07 32.26 15.31 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.719 1.007 . . . . 25.0 113.719 174.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.73 5.01 86.96 Favored Glycine 0 C--O 1.224 -0.492 0 C-N-CA 120.452 -0.88 . . . . 25.0 114.867 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -120.06 158.83 26.01 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 107.816 -1.179 . . . . 25.0 107.816 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -111.88 154.55 25.02 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 102.95 -2.982 . . . . 25.0 102.95 166.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.25 -167.88 40.72 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 107.723 -2.151 . . . . 25.0 107.723 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 pt -113.03 151.74 14.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.65 0.738 . . . . 25.0 112.241 -175.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.7 m -143.79 147.12 37.45 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-N 114.722 -1.126 . . . . 25.0 110.235 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.38 118.48 5.37 Favored 'Trans proline' 0 C--O 1.244 0.797 0 O-C-N 121.946 0.445 . . . . 25.0 112.586 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.33 -15.13 65.3 Favored Glycine 0 C--O 1.221 -0.677 0 N-CA-C 114.664 0.626 . . . . 25.0 114.664 -176.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -63.67 -23.95 67.59 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 113.004 0.742 . . . . 25.0 113.004 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -118.34 28.39 8.38 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.393 -0.595 . . . . 25.0 109.393 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.41 HD23 ' CE3' ' A' ' 46' ' ' TRP . 18.1 tp -134.56 150.1 50.7 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.539 -0.755 . . . . 25.0 110.593 -175.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -128.54 119.97 25.84 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.166 0.432 . . . . 25.0 112.166 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.8 mm -64.81 135.86 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.6 0.714 . . . . 25.0 111.33 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.1 mt -118.33 93.71 4.22 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.559 -1.275 . . . . 25.0 107.559 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.321 -0.67 0 N-CA-C 108.629 -0.878 . . . . 25.0 108.629 176.658 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 92.6 mttt . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 108.097 -1.075 . . . . 25.0 108.097 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.542 0.884 0 C-N-CA 118.093 -0.805 . . . . 25.0 110.986 174.922 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 . . . . . 0 C--O 1.224 -0.288 0 N-CA-C 116.345 1.98 . . . . 25.0 116.345 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.5 mt -76.48 -38.73 54.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.496 -1.229 . . . . 25.0 109.645 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.7 m120 54.35 24.96 5.5 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.329 1.052 . . . . 25.0 112.921 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.405 HG23 ' HB ' ' A' ' 34' ' ' VAL . 23.1 m -84.85 175.1 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 105.439 -2.059 . . . . 25.0 105.439 173.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.82 174.04 6.41 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.736 -0.603 . . . . 25.0 109.81 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.56 162.81 36.57 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.158 -0.474 . . . . 25.0 110.459 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -128.42 129.18 45.78 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.018 -0.992 . . . . 25.0 109.23 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.59 136.9 43.99 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.878 -0.601 . . . . 25.0 109.466 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.4 mt -104.82 -15.83 15.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 111.881 0.326 . . . . 25.0 111.881 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -143.15 165.35 27.67 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.976 -1.12 . . . . 25.0 107.976 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.93 165.03 25.01 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.638 -0.504 . . . . 25.0 109.638 174.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.04 159.91 42.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.104 -0.702 . . . . 25.0 109.104 177.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.01 121.79 56.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 104.866 -2.272 . . . . 25.0 104.866 171.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.82 134.73 33.63 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.462 -1.681 . . . . 25.0 106.462 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -114.35 -8.8 12.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.324 0.583 . . . . 25.0 111.166 -177.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.5 p -132.16 155.9 80.75 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 105.541 -2.022 . . . . 25.0 105.541 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.33 -18.31 39.08 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 118.03 -0.846 . . . . 25.0 112.266 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.48 -20.29 58.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.934 -0.576 . . . . 25.0 110.926 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -95.45 137.08 35.01 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.956 -1.127 . . . . 25.0 107.956 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.454 ' HB2' HG13 ' A' ' 57' ' ' VAL . 50.5 mt -86.26 134.53 33.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.886 -0.597 . . . . 25.0 109.947 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.06 130.45 34.61 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.232 -1.025 . . . . 25.0 108.232 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -154.27 163.36 40.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.916 0.865 . . . . 25.0 113.329 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -115.83 163.52 15.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.577 -1.192 . . . . 25.0 110.013 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -58.94 129.62 43.04 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.736 -0.839 . . . . 25.0 108.736 175.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.62 -11.04 72.01 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 118.831 -0.983 . . . . 25.0 114.634 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -63.21 150.34 43.26 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 118.39 1.095 . . . . 25.0 110.457 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.2 mm -115.57 131.28 68.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.37 -1.286 . . . . 25.0 108.917 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -135.37 156.02 49.62 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.214 -0.661 . . . . 25.0 109.214 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.1 m -87.63 130.17 34.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.177 -1.416 . . . . 25.0 107.177 176.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.405 ' HB ' HG23 ' A' ' 8' ' ' VAL . 57.8 t -94.24 124.32 46.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.643 -1.243 . . . . 25.0 107.643 177.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.595 HD12 HD22 ' A' ' 47' ' ' LEU . 81.2 mt -93.27 -44.98 8.05 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -149.43 162.25 40.48 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.961 -0.755 . . . . 25.0 108.961 -175.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 mtm105 -121.81 151.11 40.96 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.872 -1.159 . . . . 25.0 107.872 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.404 ' H ' ' HD1' ' A' ' 46' ' ' TRP . 27.7 m-20 56.11 38.86 30.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 123.51 1.624 . . . . 25.0 108.853 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 t -67.1 153.37 43.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.11 -1.859 . . . . 25.0 110.438 -175.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 60.6 9.56 2.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.911 0.884 . . . . 25.0 113.261 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.36 10.84 84.1 Favored Glycine 0 C--N 1.329 0.17 0 N-CA-C 110.803 -0.919 . . . . 25.0 110.803 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.423 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 93.2 mt -88.42 109.44 20.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.853 -0.795 . . . . 25.0 108.853 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -58.6 126.26 26.87 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.588 -0.733 . . . . 25.0 110.983 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.65 -0.58 76.21 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 115.784 1.074 . . . . 25.0 115.784 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.423 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 94.3 m95 -100.89 129.99 46.83 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 119.028 1.414 . . . . 25.0 109.964 178.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.404 ' HD1' ' H ' ' A' ' 38' ' ' ASP . 47.6 m0 -112.89 140.54 47.6 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 121.873 -0.517 . . . . 25.0 109.926 -175.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.595 HD22 HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -80.3 121.86 26.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 105.949 -1.871 . . . . 25.0 105.949 179.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 92.5 m -133.51 168.37 18.76 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.926 0.393 . . . . 25.0 111.583 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 t -123.42 125.77 45.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.747 -1.205 . . . . 25.0 107.747 173.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.0 tp -152.82 143.78 22.98 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.806 -1.553 . . . . 25.0 106.806 -176.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 55.69 31.97 18.44 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.153 0.581 . . . . 25.0 112.214 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.36 4.36 68.91 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 115.268 0.867 . . . . 25.0 115.268 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -124.75 165.72 17.47 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.069 -1.086 . . . . 25.0 108.069 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -116.28 154.37 30.28 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.669 -0.863 . . . . 25.0 108.669 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.53 -157.44 20.48 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 106.381 -2.688 . . . . 25.0 106.381 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.4 pt -120.65 157.34 23.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.618 0.723 . . . . 25.0 111.423 -176.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.3 m -143.87 147.12 37.21 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 114.763 -1.108 . . . . 25.0 109.146 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -74.51 117.7 5.06 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 O-C-N 121.999 0.473 . . . . 25.0 112.519 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.51 -19.5 68.93 Favored Glycine 0 C--O 1.22 -0.777 0 CA-C-O 121.422 0.457 . . . . 25.0 114.104 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -66.41 -10.33 42.66 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.552 0.945 . . . . 25.0 113.552 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -130.46 26.34 5.08 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.872 -0.788 . . . . 25.0 108.872 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.2 tp -131.77 150.05 52.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.282 -0.872 . . . . 25.0 111.595 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -121.26 126.67 50.14 Favored 'General case' 0 C--O 1.211 -0.931 0 C-N-CA 122.828 0.451 . . . . 25.0 110.932 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.2 mm -75.59 135.41 27.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.964 -0.754 . . . . 25.0 108.964 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.9 mt -116.66 107.18 14.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.023 -1.843 . . . . 25.0 106.023 174.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.931 -0.577 . . . . 25.0 110.228 -176.961 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 107.69 -1.226 . . . . 25.0 107.69 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo . . . . . 0 C--O 1.244 0.778 0 C-N-CA 117.848 -0.968 . . . . 25.0 111.472 176.886 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 . . . . . 0 CA--C 1.513 -0.476 0 CA-C-O 120.902 0.382 . . . . 25.0 111.389 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.02 -41.23 95.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.109 -0.951 . . . . 25.0 109.661 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 56.65 25.16 9.69 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.268 1.027 . . . . 25.0 111.912 -178.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.6 m -83.42 159.94 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 105.805 -1.924 . . . . 25.0 105.805 176.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.43 170.98 8.85 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.821 -1.177 . . . . 25.0 107.821 -177.207 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.13 163.15 36.25 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.941 -0.392 . . . . 25.0 109.941 175.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -132.21 128.76 38.64 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.621 -0.718 . . . . 25.0 109.669 177.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.26 130.73 42.8 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.496 -0.557 . . . . 25.0 109.496 177.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.9 mt -97.97 -21.86 16.61 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.693 0.282 . . . . 25.0 110.912 -177.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -138.97 165.91 25.87 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.676 -0.861 . . . . 25.0 108.676 178.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -74.58 165.95 24.35 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.03 0.932 . . . . 25.0 111.302 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.0 156.92 42.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.32 0.581 . . . . 25.0 110.861 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.6 t -130.26 125.7 60.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 102.926 -2.99 . . . . 25.0 102.926 170.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.19 136.81 33.11 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.558 -1.275 . . . . 25.0 107.558 178.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -128.6 6.26 5.66 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.294 0.569 . . . . 25.0 111.522 -178.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.2 m -127.63 151.36 75.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 105.82 -1.918 . . . . 25.0 105.82 176.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.62 -25.96 40.1 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 117.35 -1.3 . . . . 25.0 112.712 -177.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -79.29 -16.94 55.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.192 -0.458 . . . . 25.0 111.498 178.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -86.7 132.96 33.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.94 0.876 . . . . 25.0 109.247 -177.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.404 ' HB2' HG13 ' A' ' 57' ' ' VAL . 49.1 mt -87.07 133.4 33.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.736 -0.665 . . . . 25.0 110.567 -177.192 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.5 121.2 28.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.223 -0.899 . . . . 25.0 108.954 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -147.75 164.01 34.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.046 0.451 . . . . 25.0 111.022 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 55.8 ttt-85 -126.19 165.92 18.02 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.035 -0.728 . . . . 25.0 109.035 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -57.0 132.6 53.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.958 0.409 . . . . 25.0 110.493 -179.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.89 -16.5 61.16 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-O 119.122 -0.821 . . . . 25.0 113.929 178.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.98 151.37 26.38 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.837 0.827 . . . . 25.0 111.145 178.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.2 mm -117.99 131.39 70.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.067 -1.424 . . . . 25.0 108.917 -179.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -138.82 158.05 44.94 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 122.633 0.373 . . . . 25.0 110.202 179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.3 m -89.91 130.19 36.16 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.689 -0.856 . . . . 25.0 108.689 177.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.3 t -94.53 126.04 47.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.551 -0.907 . . . . 25.0 108.551 178.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.652 HD12 HD22 ' A' ' 47' ' ' LEU . 79.8 mt -90.76 -51.47 5.35 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.097 -0.705 . . . . 25.0 109.097 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -151.84 171.47 17.68 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.04 -1.096 . . . . 25.0 108.04 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -121.9 155.2 35.94 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.049 -1.464 . . . . 25.0 107.049 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 58.17 39.24 26.15 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 123.794 1.759 . . . . 25.0 109.448 178.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.4 t -65.94 155.47 36.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 112.758 -2.019 . . . . 25.0 110.485 -176.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 60.11 9.62 1.92 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.185 0.994 . . . . 25.0 112.992 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.51 20.92 73.63 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.421 -1.071 . . . . 25.0 110.421 -176.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.6 mt -97.4 127.72 43.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.225 0.536 . . . . 25.0 110.279 178.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -67.16 124.08 22.09 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.673 -0.694 . . . . 25.0 110.857 178.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.06 -0.01 84.51 Favored Glycine 0 C--O 1.239 0.426 0 N-CA-C 116.392 1.317 . . . . 25.0 116.392 173.484 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -100.68 132.21 46.19 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 118.384 1.092 . . . . 25.0 109.453 178.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -113.07 141.98 46.26 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.183 -0.673 . . . . 25.0 109.183 -176.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.652 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -83.73 123.19 29.6 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 105.644 -1.984 . . . . 25.0 105.644 178.925 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 84.3 m -131.62 164.49 25.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.931 0.396 . . . . 25.0 110.741 177.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.0 t -118.85 123.33 44.45 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.771 -1.937 . . . . 25.0 105.771 172.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.1 tp -145.43 136.63 24.89 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.11 -1.071 . . . . 25.0 108.11 -176.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.64 27.69 12.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.885 0.698 . . . . 25.0 112.885 178.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.45 0.1 86.69 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 114.883 0.713 . . . . 25.0 114.883 177.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -124.71 158.63 32.76 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 118.124 0.962 . . . . 25.0 110.135 178.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -109.59 154.65 22.47 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.095 -0.706 . . . . 25.0 109.095 179.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.83 -160.73 28.17 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 107.288 -2.325 . . . . 25.0 107.288 179.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.2 pt -117.06 153.16 18.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.919 0.866 . . . . 25.0 112.534 -174.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.9 m -142.88 146.89 39.45 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 114.313 -1.312 . . . . 25.0 109.839 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.12 119.07 5.65 Favored 'Trans proline' 0 C--O 1.239 0.55 0 CA-C-O 121.296 0.457 . . . . 25.0 112.252 178.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.9 -25.33 74.28 Favored Glycine 0 C--O 1.219 -0.842 0 N-CA-C 116.72 1.448 . . . . 25.0 116.72 -174.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -65.19 -22.32 66.88 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.556 -0.967 . . . . 25.0 113.512 -177.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -110.61 24.63 12.72 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.617 0.722 . . . . 25.0 109.389 178.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.9 tp -133.29 150.72 51.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.367 -0.833 . . . . 25.0 109.968 -175.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -122.41 125.88 46.79 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-N 116.558 -0.292 . . . . 25.0 110.494 -179.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.2 mm -75.69 135.63 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.13 -1.063 . . . . 25.0 108.13 175.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.2 mt -118.6 88.72 2.98 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.577 -0.898 . . . . 25.0 108.577 177.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 C--N 1.325 -0.462 0 N-CA-C 108.837 -0.801 . . . . 25.0 108.837 178.77 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 106.976 -1.491 . . . . 25.0 106.976 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 CA--C 1.543 0.942 0 CA-C-N 118.748 0.589 . . . . 25.0 112.055 177.908 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 . . . . . 0 CA--C 1.511 -0.529 0 CA-C-O 120.975 0.417 . . . . 25.0 111.22 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.02 -38.85 89.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.141 -0.936 . . . . 25.0 110.132 178.471 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 55.86 36.34 27.11 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.933 0.893 . . . . 25.0 111.492 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 m -100.63 161.59 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 106.36 -1.718 . . . . 25.0 106.36 177.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.55 171.97 7.59 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.02 -1.104 . . . . 25.0 108.02 -177.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.75 164.82 34.23 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.694 -0.484 . . . . 25.0 109.694 174.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -128.4 136.22 50.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.105 -0.952 . . . . 25.0 108.712 177.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.567 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -74.18 136.43 42.83 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.799 0.333 . . . . 25.0 110.827 175.179 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.4 mt -100.6 -20.92 15.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.852 0.358 . . . . 25.0 110.781 -179.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -142.5 171.57 13.88 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 103.297 -2.853 . . . . 25.0 103.297 175.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -83.5 178.57 7.95 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.302 -0.999 . . . . 25.0 108.302 174.501 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -153.25 135.86 15.19 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.68 0.276 . . . . 25.0 111.108 175.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.8 t -106.04 120.86 57.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 104.946 -2.242 . . . . 25.0 104.946 174.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.6 134.01 46.11 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.37 -0.832 . . . . 25.0 109.394 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -107.53 3.81 25.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.676 0.75 . . . . 25.0 109.683 179.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.7 m -149.4 155.82 39.4 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 107.932 -1.136 . . . . 25.0 107.932 179.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.39 -19.67 32.85 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 118.398 -0.601 . . . . 25.0 113.491 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -15.96 55.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.158 0.504 . . . . 25.0 110.076 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -90.82 139.45 30.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.6 0.714 . . . . 25.0 109.13 -178.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.423 ' HB2' HG13 ' A' ' 57' ' ' VAL . 59.2 mt -92.06 127.78 37.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.767 0.794 . . . . 25.0 110.567 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.4 p -87.96 143.43 27.11 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 106.042 -1.836 . . . . 25.0 106.042 173.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -156.98 166.12 34.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.503 -0.925 . . . . 25.0 108.503 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.5 tpp85 -105.85 158.95 16.39 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.994 -0.743 . . . . 25.0 108.994 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -59.83 128.79 38.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.764 -0.653 . . . . 25.0 109.586 178.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.14 -4.45 81.04 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.117 -0.824 . . . . 25.0 114.356 177.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -62.71 160.65 13.8 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 117.885 0.843 . . . . 25.0 110.842 176.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.6 mm -119.93 134.79 62.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.643 -1.162 . . . . 25.0 109.49 178.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -139.85 163.43 32.66 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.736 -0.468 . . . . 25.0 109.736 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -97.45 129.49 44.64 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.508 -1.294 . . . . 25.0 107.508 176.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.5 t -96.28 122.94 48.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 107.773 -1.195 . . . . 25.0 107.773 177.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.632 HD12 HD22 ' A' ' 47' ' ' LEU . 80.7 mt -91.52 -42.85 10.02 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.164 -0.926 . . . . 25.0 109.267 -179.319 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -151.68 158.85 43.97 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.779 -0.823 . . . . 25.0 108.779 -176.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.8 mtm105 -116.11 153.84 31.04 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.642 -1.244 . . . . 25.0 107.642 175.011 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 56.22 37.54 28.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 123.383 1.563 . . . . 25.0 108.62 178.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.0 t -64.36 150.2 46.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.255 -1.793 . . . . 25.0 110.386 -174.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 59.47 13.85 3.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.636 0.774 . . . . 25.0 112.121 -178.534 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.71 18.22 79.78 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.294 -0.723 . . . . 25.0 111.294 -178.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.2 mt -91.55 121.15 32.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.274 0.537 . . . . 25.0 109.696 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -62.45 125.02 22.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.931 -0.577 . . . . 25.0 110.357 -179.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.4 -0.8 73.81 Favored Glycine 0 CA--C 1.519 0.292 0 N-CA-C 116.762 1.465 . . . . 25.0 116.762 175.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -100.1 130.03 46.2 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 119.149 1.475 . . . . 25.0 110.713 179.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -110.25 140.77 44.06 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.571 -0.529 . . . . 25.0 109.571 -177.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.632 HD22 HD12 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -79.98 120.8 24.66 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 105.628 -1.99 . . . . 25.0 105.628 177.428 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 84.5 m -132.2 164.79 25.56 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.099 0.407 . . . . 25.0 112.099 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.5 t -118.92 116.57 26.74 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.932 -1.507 . . . . 25.0 106.932 172.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -146.43 138.99 25.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.936 -1.135 . . . . 25.0 107.936 -175.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 56.96 27.37 13.05 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.94 0.719 . . . . 25.0 112.94 -178.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.65 5.98 89.17 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 121.012 -0.613 . . . . 25.0 113.421 178.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -116.23 154.39 30.19 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 108.308 -0.997 . . . . 25.0 108.308 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -108.3 145.19 34.76 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.058 -1.83 . . . . 25.0 106.058 170.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.36 -155.32 13.54 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 106.877 -2.489 . . . . 25.0 106.877 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.3 pt -123.97 152.86 29.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.449 0.643 . . . . 25.0 110.665 -175.362 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 24' ' ' LEU . 2.8 m -139.63 147.31 51.43 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.148 -0.933 . . . . 25.0 108.626 -179.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.94 114.99 4.19 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 CA-C-O 121.379 0.491 . . . . 25.0 110.961 176.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.56 -17.12 68.48 Favored Glycine 0 C--O 1.222 -0.631 0 N-CA-C 114.304 0.482 . . . . 25.0 114.304 -175.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -63.76 -20.17 65.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.652 0.612 . . . . 25.0 112.652 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -116.48 27.18 9.37 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.746 -0.464 . . . . 25.0 109.746 177.214 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 12' ' ' ALA . 1.5 tp -130.34 158.01 41.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.309 0.576 . . . . 25.0 111.769 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -133.31 120.25 20.79 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.988 -0.551 . . . . 25.0 110.97 178.204 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mm -66.76 136.51 26.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.66 -0.496 . . . . 25.0 109.66 178.494 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.2 mt -117.04 104.58 11.4 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.463 -1.31 . . . . 25.0 107.463 175.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 120.855 0.359 . . . . 25.0 110.51 -178.833 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.2 mttt . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 109.651 -0.5 . . . . 25.0 109.651 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 CA--C 1.538 0.695 0 C-N-CA 118.419 -0.587 . . . . 25.0 112.913 178.556 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 CA--C 1.507 -0.698 0 CA-C-O 121.213 0.53 . . . . 25.0 110.444 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 71.4 mt -67.24 -39.28 86.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.783 -1.099 . . . . 25.0 109.901 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 57.4 29.33 16.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.053 0.941 . . . . 25.0 111.894 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.1 m -94.65 160.91 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 107.014 -1.476 . . . . 25.0 107.014 179.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.13 168.05 10.5 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.987 -1.116 . . . . 25.0 107.987 -178.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.06 156.07 42.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.784 0.326 . . . . 25.0 110.192 175.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -121.56 128.38 51.94 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.715 0.806 . . . . 25.0 110.127 178.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.63 131.58 45.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.498 -0.556 . . . . 25.0 109.498 176.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.1 mt -94.13 -21.28 19.2 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.064 -0.347 . . . . 25.0 110.064 -179.052 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -146.04 171.31 15.07 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.406 -1.701 . . . . 25.0 106.406 177.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -82.01 178.9 8.04 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.257 -0.645 . . . . 25.0 109.257 176.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.95 168.87 23.23 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 122.721 0.408 . . . . 25.0 110.125 176.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.5 t -128.02 129.88 69.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 104.149 -2.537 . . . . 25.0 104.149 171.238 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.88 119.38 23.85 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.78 -0.452 . . . . 25.0 109.78 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -103.68 8.93 37.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.322 0.582 . . . . 25.0 110.861 -177.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.9 m -152.89 155.66 32.36 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 106.827 -1.546 . . . . 25.0 106.827 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.02 -22.11 35.94 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 117.813 -0.991 . . . . 25.0 112.452 178.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.4 -20.72 56.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.239 -0.437 . . . . 25.0 110.516 178.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -85.89 126.75 34.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.769 0.795 . . . . 25.0 109.095 -176.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.437 ' HB2' HG13 ' A' ' 57' ' ' VAL . 46.1 mt -78.62 135.53 37.27 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.328 -0.99 . . . . 25.0 108.328 178.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.1 t -91.08 125.41 35.86 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.776 -1.194 . . . . 25.0 107.776 176.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -142.21 159.97 41.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.383 0.611 . . . . 25.0 111.531 -179.525 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.513 ' HD3' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -107.9 165.18 11.65 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.938 -0.764 . . . . 25.0 108.938 179.116 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.513 ' H ' ' HD3' ' A' ' 27' ' ' ARG . 87.4 tttt -61.29 129.05 39.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.64 -0.709 . . . . 25.0 109.52 178.459 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.26 -9.83 69.65 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-O 119.316 -0.713 . . . . 25.0 114.059 178.045 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -60.94 150.27 33.83 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.871 0.843 . . . . 25.0 110.92 179.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.3 mm -113.95 127.31 71.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.569 -1.196 . . . . 25.0 109.701 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.7 ptp -132.15 163.13 29.2 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.583 -0.525 . . . . 25.0 109.583 179.043 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.4 m -99.92 125.83 45.98 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.579 -1.267 . . . . 25.0 107.579 177.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.6 t -90.3 122.13 41.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.118 -1.067 . . . . 25.0 108.118 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.589 HD12 HD22 ' A' ' 47' ' ' LEU . 80.8 mt -90.3 -46.49 8.37 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.226 -0.897 . . . . 25.0 108.608 179.271 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.03 156.32 42.07 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.979 -0.378 . . . . 25.0 109.979 -176.015 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -111.98 152.01 28.61 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.891 -0.411 . . . . 25.0 109.891 174.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 55.97 39.49 30.53 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 123.6 1.667 . . . . 25.0 108.759 177.101 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.0 t -66.38 152.98 43.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 112.746 -2.024 . . . . 25.0 110.72 -175.174 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 60.39 9.1 1.85 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.227 1.011 . . . . 25.0 113.618 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.79 15.26 75.87 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 111.071 -0.812 . . . . 25.0 111.071 -176.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.8 mt -92.99 113.35 25.61 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.426 -0.583 . . . . 25.0 109.426 179.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.87 128.02 33.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.302 0.572 . . . . 25.0 110.005 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.97 0.35 85.17 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 115.813 1.085 . . . . 25.0 115.813 176.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -101.03 132.84 46.26 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 119.005 1.403 . . . . 25.0 110.415 178.402 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.6 m0 -112.36 138.68 48.74 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.171 -0.677 . . . . 25.0 109.171 -176.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.589 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -80.88 120.81 25.19 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 105.199 -2.148 . . . . 25.0 105.199 177.223 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.9 m -132.34 162.23 31.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.3 0.571 . . . . 25.0 112.488 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.5 t -116.9 123.72 47.69 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 105.987 -1.857 . . . . 25.0 105.987 172.012 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.4 tp -135.73 127.6 29.39 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.234 -1.395 . . . . 25.0 107.234 -177.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 29.4 m170 54.79 32.15 17.01 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.143 0.497 . . . . 25.0 112.241 178.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.35 -3.41 87.23 Favored Glycine 0 C--O 1.225 -0.462 0 N-CA-C 115.852 1.101 . . . . 25.0 115.852 176.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -114.35 157.25 23.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.677 -1.231 . . . . 25.0 107.677 177.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -117.21 154.68 30.71 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.374 -0.232 . . . . 25.0 110.374 -178.47 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.95 -157.11 21.92 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 106.127 -2.789 . . . . 25.0 106.127 178.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.8 pt -119.69 155.39 22.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 121.605 0.717 . . . . 25.0 111.39 -177.143 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.4 m -144.33 148.13 39.67 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.01 -0.995 . . . . 25.0 109.661 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.33 121.7 6.21 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 CA-C-O 121.545 0.56 . . . . 25.0 112.965 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.08 -18.25 70.75 Favored Glycine 0 C--O 1.22 -0.729 0 CA-C-N 116.114 -0.494 . . . . 25.0 114.155 -178.17 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -64.1 -17.2 63.2 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.394 0.516 . . . . 25.0 112.394 -177.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -127.33 30.29 5.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.116 0.484 . . . . 25.0 110.2 176.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.8 mt -129.79 156.38 44.42 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.811 -0.631 . . . . 25.0 111.769 177.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -128.98 125.92 38.44 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.161 -0.472 . . . . 25.0 110.125 176.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.6 mm -74.5 136.91 24.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.558 -0.904 . . . . 25.0 108.558 178.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.6 mt -111.92 77.93 1.08 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.147 0.579 . . . . 25.0 109.597 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.018 0 C-N-CA 123.434 0.693 . . . . 25.0 112.77 179.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt . . . . . 0 CA--C 1.543 0.676 0 N-CA-C 107.625 -1.25 . . . . 25.0 107.625 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo . . . . . 0 CA--C 1.542 0.892 0 O-C-N 122.097 0.525 . . . . 25.0 113.214 -177.445 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 121.062 0.458 . . . . 25.0 111.097 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.4 mt -66.05 -41.65 90.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.256 -0.884 . . . . 25.0 110.762 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.1 m120 55.34 24.36 6.49 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.277 1.031 . . . . 25.0 112.381 -177.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.6 m -83.29 175.35 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 N-CA-C 105.437 -2.06 . . . . 25.0 105.437 175.068 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -120.0 171.85 8.16 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 118.774 0.715 . . . . 25.0 109.951 -179.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.8 162.21 39.69 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.874 0.368 . . . . 25.0 110.354 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -122.24 132.04 54.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.141 -0.936 . . . . 25.0 110.494 178.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.413 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -74.08 128.05 34.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.95 0.405 . . . . 25.0 110.558 177.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.9 mt -98.81 -19.53 17.37 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.26 0.552 . . . . 25.0 110.985 -177.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -142.7 163.31 33.16 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 106.063 -1.829 . . . . 25.0 106.063 177.413 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -82.57 174.5 10.98 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.719 1.007 . . . . 25.0 113.719 -177.752 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -160.93 157.22 26.1 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 110.125 -0.324 . . . . 25.0 110.125 174.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.7 t -126.73 131.71 70.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 104.744 -2.317 . . . . 25.0 104.744 174.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.93 124.12 27.93 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 110.235 -0.283 . . . . 25.0 110.235 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -116.57 -12.61 10.93 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.054 0.93 . . . . 25.0 110.316 175.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 t -106.76 147.42 35.0 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 107.41 -1.33 . . . . 25.0 107.41 175.339 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.28 -23.74 44.54 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 116.444 -1.904 . . . . 25.0 114.695 -177.185 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -81.92 -13.16 57.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.086 0.47 . . . . 25.0 110.262 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -84.85 139.23 32.05 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.384 0.611 . . . . 25.0 111.508 -171.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.5 mt -93.1 131.06 38.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.596 0.713 . . . . 25.0 109.833 176.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.2 t -91.87 139.74 30.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.8 -1.556 . . . . 25.0 106.8 177.178 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.448 ' HE2' HG12 ' A' ' 57' ' ' VAL . 29.4 p90 -162.58 171.72 16.52 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.382 -0.97 . . . . 25.0 108.382 -177.289 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -126.75 168.03 14.96 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.769 0.795 . . . . 25.0 110.442 174.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.67 133.41 55.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.535 -0.757 . . . . 25.0 109.592 -176.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.96 -20.07 51.75 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 118.64 -1.089 . . . . 25.0 112.828 178.267 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -58.6 143.8 45.08 Favored 'General case' 0 C--O 1.249 1.056 0 CA-C-N 118.427 1.113 . . . . 25.0 110.645 179.064 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.6 mm -110.85 128.85 66.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.771 -1.104 . . . . 25.0 108.1 -178.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.7 ptp -132.89 149.41 52.25 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.725 0.41 . . . . 25.0 110.235 -177.384 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.0 m -85.48 126.11 33.57 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 107.541 -1.281 . . . . 25.0 107.541 179.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.43 124.5 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 107.904 -1.147 . . . . 25.0 107.904 178.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.631 HD12 HD22 ' A' ' 47' ' ' LEU . 75.8 mt -90.52 -47.8 7.48 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.723 -0.843 . . . . 25.0 108.723 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -153.69 173.88 15.23 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.426 0.631 . . . . 25.0 109.305 176.302 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -123.73 151.29 43.36 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.361 -1.718 . . . . 25.0 106.361 -179.557 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 57.37 43.4 23.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 123.27 1.509 . . . . 25.0 109.399 -176.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.7 t -66.55 149.46 50.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.629 -1.623 . . . . 25.0 110.349 -177.562 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 59.83 15.3 4.76 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.664 0.785 . . . . 25.0 112.642 178.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.81 14.62 82.18 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.903 -0.665 . . . . 25.0 112.187 -178.171 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.2 mt -94.36 113.68 25.61 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.342 -0.614 . . . . 25.0 109.342 -178.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -59.82 123.26 16.46 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.244 0.545 . . . . 25.0 110.734 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.76 -0.0 89.82 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-O 118.829 -0.984 . . . . 25.0 115.538 175.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -100.12 132.7 45.33 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 119.084 1.442 . . . . 25.0 109.335 177.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -113.08 140.03 48.2 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.592 -1.262 . . . . 25.0 107.592 -175.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.631 HD22 HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -82.47 123.13 28.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.193 -2.151 . . . . 25.0 105.193 177.818 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 95.5 m -130.5 163.39 27.13 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.993 0.425 . . . . 25.0 111.408 178.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -116.2 126.9 54.28 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 106.318 -1.734 . . . . 25.0 106.318 173.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.2 tp -151.57 135.58 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.26 -1.015 . . . . 25.0 108.26 -175.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 54.23 30.13 11.81 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.654 0.983 . . . . 25.0 113.654 -178.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.18 6.18 88.92 Favored Glycine 0 C--O 1.22 -0.777 0 C-N-CA 120.936 -0.649 . . . . 25.0 113.919 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -114.82 161.32 18.37 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.499 -1.297 . . . . 25.0 107.499 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -120.26 146.48 46.03 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 106.016 -1.846 . . . . 25.0 106.016 174.067 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.22 -164.48 31.42 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 108.286 -1.926 . . . . 25.0 108.286 -179.372 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.8 pt -114.51 150.19 16.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.596 0.712 . . . . 25.0 112.053 -174.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.448 HG12 ' HE2' ' A' ' 26' ' ' PHE . 3.2 m -144.78 146.18 30.74 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 114.539 -1.21 . . . . 25.0 108.749 -179.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.23 122.17 6.94 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 118.383 -0.611 . . . . 25.0 112.393 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.81 -17.88 75.55 Favored Glycine 0 C--O 1.219 -0.789 0 N-CA-C 115.148 0.819 . . . . 25.0 115.148 -176.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -59.79 -21.13 60.4 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 113.221 0.823 . . . . 25.0 113.221 -177.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.26 26.3 6.92 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.526 0.679 . . . . 25.0 110.368 -178.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 12' ' ' ALA . 11.2 mt -117.46 156.08 28.58 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 121.455 0.645 . . . . 25.0 110.365 175.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -119.14 122.81 42.88 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 173.438 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.8 mm -73.23 135.1 28.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.887 -1.153 . . . . 25.0 107.887 176.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt -115.23 97.2 6.06 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.825 -0.805 . . . . 25.0 108.825 178.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.322 -0.628 0 N-CA-C 109.13 -0.692 . . . . 25.0 109.13 178.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.6 mttp . . . . . 0 CA--C 1.549 0.941 0 N-CA-C 108.538 -0.912 . . . . 25.0 108.538 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 C--O 1.239 0.57 0 O-C-N 122.539 0.757 . . . . 25.0 111.932 175.681 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 . . . . . 0 C--O 1.225 -0.207 0 N-CA-C 116.614 2.079 . . . . 25.0 116.614 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 mt -71.97 -41.61 67.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.104 -1.407 . . . . 25.0 110.006 -179.595 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 56.5 26.5 11.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.343 1.057 . . . . 25.0 112.304 -178.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.4 m -85.86 158.52 3.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.338 -1.727 . . . . 25.0 106.338 177.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.38 172.81 7.97 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 108.77 -0.826 . . . . 25.0 108.77 -177.056 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.14 165.84 32.66 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.719 -0.475 . . . . 25.0 109.719 174.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -131.16 136.26 48.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.092 -0.958 . . . . 25.0 110.113 177.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.573 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -73.36 127.16 31.89 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.861 -0.609 . . . . 25.0 110.453 172.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.3 mt -93.79 -19.54 20.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.216 0.532 . . . . 25.0 110.247 -178.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -146.67 175.96 10.2 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 103.285 -2.857 . . . . 25.0 103.285 178.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -91.42 175.98 6.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 118.719 0.69 . . . . 25.0 111.41 177.553 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -154.59 144.27 21.55 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.678 0.391 . . . . 25.0 111.106 177.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 80.0 t -113.38 125.25 70.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.5 -2.037 . . . . 25.0 105.5 176.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.46 131.41 41.77 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.057 -0.974 . . . . 25.0 109.6 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -104.98 -1.99 25.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.593 0.711 . . . . 25.0 109.934 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -147.07 156.77 46.94 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.167 -1.049 . . . . 25.0 108.167 -177.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.85 -19.7 40.34 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 118.309 -0.661 . . . . 25.0 112.729 177.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -72.96 -16.9 61.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.292 -0.413 . . . . 25.0 111.04 177.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -100.37 142.29 32.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.734 0.778 . . . . 25.0 110.887 -172.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.408 ' HB2' HG13 ' A' ' 57' ' ' VAL . 57.0 mt -95.3 127.03 41.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.458 -0.792 . . . . 25.0 109.884 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.7 p -87.17 145.91 26.23 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 105.31 -2.107 . . . . 25.0 105.31 173.198 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -159.59 165.09 33.52 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.113 -1.069 . . . . 25.0 108.113 -179.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.47 161.76 17.57 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.483 0.658 . . . . 25.0 110.063 177.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -56.99 129.4 41.54 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.509 -0.769 . . . . 25.0 110.48 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.58 -16.41 59.78 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-O 118.941 -0.922 . . . . 25.0 113.603 177.391 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -58.55 155.21 12.7 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.924 0.869 . . . . 25.0 111.525 179.459 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.0 mm -118.97 135.57 58.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.225 -1.352 . . . . 25.0 109.262 179.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -141.71 156.35 45.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.307 -0.627 . . . . 25.0 109.307 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.9 m -91.15 129.42 37.15 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.179 -1.045 . . . . 25.0 108.179 177.274 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.3 t -94.14 124.97 46.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.121 -1.066 . . . . 25.0 108.121 177.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.623 HD12 HD22 ' A' ' 47' ' ' LEU . 82.9 mt -93.69 -43.48 8.63 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.501 -0.772 . . . . 25.0 109.555 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -149.38 165.16 32.88 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.318 -0.993 . . . . 25.0 108.318 -175.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -126.64 153.32 45.52 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 107.045 -1.465 . . . . 25.0 107.045 176.112 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 56.48 39.43 29.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 123.477 1.608 . . . . 25.0 109.088 -179.075 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -69.27 155.38 40.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.207 -1.815 . . . . 25.0 110.477 -176.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 60.16 11.45 2.77 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.918 0.887 . . . . 25.0 113.209 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.08 16.93 79.11 Favored Glycine 0 CA--C 1.516 0.135 0 N-CA-C 110.9 -0.88 . . . . 25.0 110.9 -177.167 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.405 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 96.6 mt -98.18 114.53 26.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.02 0.438 . . . . 25.0 109.999 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -63.58 127.68 32.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.889 -0.596 . . . . 25.0 109.927 -178.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.74 -0.58 85.94 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 115.505 0.962 . . . . 25.0 115.505 176.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.405 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 92.0 m95 -100.86 130.03 46.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 118.565 1.182 . . . . 25.0 109.825 177.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -111.27 140.0 46.2 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.77 -0.456 . . . . 25.0 109.77 -175.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.623 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -79.78 120.88 24.65 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 105.585 -2.006 . . . . 25.0 105.585 178.93 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 86.0 m -131.52 163.55 27.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.966 0.412 . . . . 25.0 111.716 178.455 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.8 t -118.87 124.59 47.51 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.706 -1.59 . . . . 25.0 106.706 173.117 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.0 tp -151.72 142.71 23.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.779 -1.193 . . . . 25.0 107.779 -175.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 57.49 27.17 13.61 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.324 0.583 . . . . 25.0 112.235 177.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.62 4.49 90.36 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 114.859 0.703 . . . . 25.0 114.859 178.337 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -130.24 161.02 32.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.091 0.945 . . . . 25.0 109.43 179.432 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -107.89 153.29 23.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.221 -0.659 . . . . 25.0 109.221 177.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.95 -154.3 11.8 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 107.291 -2.324 . . . . 25.0 107.291 177.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.5 pt -124.69 153.22 31.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.378 0.609 . . . . 25.0 110.582 -175.729 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 24' ' ' LEU . 3.3 m -140.48 146.27 44.4 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 114.945 -1.025 . . . . 25.0 108.799 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.68 120.89 6.03 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 118.53 -0.514 . . . . 25.0 112.033 178.426 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.4 -17.05 70.1 Favored Glycine 0 C--O 1.222 -0.652 0 C-N-CA 121.576 -0.345 . . . . 25.0 113.191 -178.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -66.88 -6.91 18.26 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.944 0.72 . . . . 25.0 112.944 -179.282 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -135.79 26.63 3.34 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.577 -0.527 . . . . 25.0 109.577 175.282 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' A' ' 12' ' ' ALA . 1.6 tp -130.09 157.15 43.19 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 121.3 0.571 . . . . 25.0 111.603 -179.537 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -129.68 123.2 30.58 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.964 -0.562 . . . . 25.0 110.768 177.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.0 mm -70.09 135.93 27.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.797 -0.816 . . . . 25.0 108.797 176.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.7 mt -119.68 102.54 8.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.652 -1.24 . . . . 25.0 107.652 176.053 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--N 1.322 -0.626 0 N-CA-C 109.074 -0.713 . . . . 25.0 109.074 179.576 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 107.534 -1.284 . . . . 25.0 107.534 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 CA--C 1.54 0.799 0 O-C-N 121.952 0.449 . . . . 25.0 112.753 -178.122 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 . . . . . 0 CA--C 1.508 -0.648 0 N-CA-C 108.89 -0.781 . . . . 25.0 108.89 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.4 mt -68.01 -39.2 83.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.366 -0.833 . . . . 25.0 110.492 178.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 57.88 28.58 16.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.142 0.977 . . . . 25.0 111.871 -179.138 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 m -94.79 176.12 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 105.416 -2.068 . . . . 25.0 105.416 176.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -119.74 174.11 6.63 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.999 -0.741 . . . . 25.0 108.999 177.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.44 154.34 36.42 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.189 -0.3 . . . . 25.0 110.189 177.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -111.27 130.89 55.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.924 -0.58 . . . . 25.0 110.172 178.574 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.93 117.67 12.74 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.223 -0.658 . . . . 25.0 109.223 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.6 mt -83.62 -25.64 30.65 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.28 0.562 . . . . 25.0 109.885 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -139.74 164.15 30.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.587 -1.188 . . . . 25.0 108.081 177.771 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.26 178.34 5.87 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 124.285 0.99 . . . . 25.0 112.782 -179.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -155.12 158.37 38.91 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.756 0.312 . . . . 25.0 111.269 172.037 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.0 t -127.51 129.11 70.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 104.13 -2.545 . . . . 25.0 104.13 173.37 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.68 135.91 33.96 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -115.51 -15.6 11.45 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.615 0.721 . . . . 25.0 109.653 175.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.4 t -112.55 146.72 35.57 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 106.396 -1.705 . . . . 25.0 106.396 179.737 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.65 -16.68 42.59 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 117.822 -0.985 . . . . 25.0 113.391 177.816 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -80.73 -18.02 49.16 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.24 1.019 . . . . 25.0 110.58 177.082 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -86.0 136.06 33.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.72 0.772 . . . . 25.0 111.716 -177.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.9 mt -86.08 127.55 34.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.734 -0.666 . . . . 25.0 110.575 179.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.2 t -89.95 132.83 35.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.809 -1.182 . . . . 25.0 107.809 174.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -160.02 172.78 16.91 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.154 -1.054 . . . . 25.0 108.154 -176.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.56 170.4 8.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 122.386 1.088 . . . . 25.0 111.545 178.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.33 135.87 57.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.709 -1.132 . . . . 25.0 109.437 -179.639 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.26 -9.04 78.44 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 118.67 -1.072 . . . . 25.0 113.782 179.155 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -63.78 143.51 57.78 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 118.703 1.251 . . . . 25.0 109.233 174.881 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.6 mm -106.31 130.86 57.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 106.877 -1.527 . . . . 25.0 106.877 178.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.7 ptp -134.69 146.54 49.56 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.358 0.263 . . . . 25.0 110.294 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -83.13 127.29 33.46 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.161 -1.051 . . . . 25.0 108.161 179.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -94.21 124.65 46.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.164 -1.05 . . . . 25.0 108.164 -179.504 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.602 HD12 HD22 ' A' ' 47' ' ' LEU . 77.0 mt -94.8 -45.81 7.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.787 -0.642 . . . . 25.0 109.893 -179.336 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -151.18 159.98 44.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.571 -0.9 . . . . 25.0 108.571 -175.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -118.85 148.96 42.32 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.985 -1.117 . . . . 25.0 107.985 177.108 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 56.68 38.95 29.91 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 123.374 1.559 . . . . 25.0 109.401 -179.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -64.88 150.02 48.49 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 113.129 -1.85 . . . . 25.0 110.91 -176.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 58.97 11.91 2.13 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.644 0.979 . . . . 25.0 113.644 180.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.13 10.33 84.99 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 110.958 -0.857 . . . . 25.0 110.958 -178.33 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 90.2 mt -86.5 106.99 17.9 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.15 -1.056 . . . . 25.0 108.15 179.226 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.45 125.07 22.68 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.234 -0.893 . . . . 25.0 110.064 -176.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.12 -0.12 89.93 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-O 118.879 -0.956 . . . . 25.0 115.236 178.056 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.403 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 94.5 m95 -101.3 132.6 46.76 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 118.944 1.372 . . . . 25.0 110.638 177.385 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -110.66 140.89 44.59 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.795 -0.817 . . . . 25.0 108.795 -178.481 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.602 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -81.67 121.83 26.86 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.58 -2.007 . . . . 25.0 105.58 178.534 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.4 m -132.02 163.93 27.32 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.852 0.686 . . . . 25.0 112.852 179.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.0 t -117.43 127.1 53.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.331 -1.359 . . . . 25.0 107.331 174.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tp -140.62 124.7 17.42 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.899 -0.778 . . . . 25.0 108.899 -177.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 54.65 35.03 22.8 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.581 0.585 . . . . 25.0 112.581 -179.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.48 0.33 89.96 Favored Glycine 0 C--O 1.222 -0.601 0 N-CA-C 115.61 1.004 . . . . 25.0 115.61 176.03 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -119.73 159.64 24.12 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 107.464 -1.31 . . . . 25.0 107.464 176.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -117.58 159.6 22.63 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.874 -0.787 . . . . 25.0 108.874 -178.134 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.62 -159.18 27.84 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 105.327 -3.109 . . . . 25.0 105.327 179.259 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.3 pt -119.53 153.66 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.818 0.818 . . . . 25.0 112.253 -176.232 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 m -144.21 148.22 40.43 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.767 -1.106 . . . . 25.0 108.991 -179.311 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.1 125.19 7.75 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 117.259 -1.361 . . . . 25.0 112.133 -178.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.59 -17.33 76.38 Favored Glycine 0 C--O 1.219 -0.825 0 N-CA-C 114.982 0.753 . . . . 25.0 114.982 -175.472 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.59 -23.71 63.17 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.106 1.15 . . . . 25.0 114.106 -176.745 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.12 27.21 7.71 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.567 0.698 . . . . 25.0 110.375 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mt -114.65 155.15 27.11 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 121.339 0.59 . . . . 25.0 110.387 173.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -125.4 118.82 26.7 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 115.344 -0.844 . . . . 25.0 108.981 174.194 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.54 135.84 27.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.561 -0.533 . . . . 25.0 109.561 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.2 mt -115.46 105.37 12.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.525 -2.028 . . . . 25.0 105.525 175.776 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 120.959 0.409 . . . . 25.0 110.449 -177.349 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 108.255 -1.017 . . . . 25.0 108.255 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo . . . . . 0 CA--C 1.544 1.0 0 O-C-N 122.255 0.608 . . . . 25.0 112.775 -179.156 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 . . . . . 0 C--O 1.222 -0.391 0 CA-C-O 120.924 0.393 . . . . 25.0 112.026 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.14 -38.46 69.23 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 115.006 -0.997 . . . . 25.0 109.554 178.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.3 m120 53.37 39.3 29.66 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.295 1.045 . . . . 25.0 112.513 -179.469 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 m -103.11 168.34 2.24 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 N-CA-C 105.558 -2.015 . . . . 25.0 105.558 176.012 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.88 171.85 7.1 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.551 -1.277 . . . . 25.0 107.551 -177.408 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.67 162.27 37.94 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.974 -0.75 . . . . 25.0 108.974 174.649 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -128.18 130.48 48.1 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 123.673 0.789 . . . . 25.0 111.144 175.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.08 130.8 43.11 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 123.783 0.677 . . . . 25.0 109.882 177.045 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.3 mt -97.83 -22.06 16.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.938 0.399 . . . . 25.0 111.241 -178.094 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -141.17 170.01 16.53 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 106.912 -1.514 . . . . 25.0 106.912 178.124 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -76.12 165.73 24.5 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 122.78 0.432 . . . . 25.0 111.146 176.325 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -146.98 150.36 34.98 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.743 -0.598 . . . . 25.0 111.831 174.606 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.02 126.76 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 N-CA-C 105.697 -1.964 . . . . 25.0 105.697 178.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.46 122.82 30.15 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.758 -0.46 . . . . 25.0 109.758 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -104.03 14.03 31.42 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.985 0.898 . . . . 25.0 110.338 -179.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 t -156.47 149.45 18.41 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 106.321 -1.733 . . . . 25.0 106.321 -178.133 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -69.74 -16.4 37.62 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 117.152 -1.432 . . . . 25.0 112.55 175.457 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.28 -21.88 58.18 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 176.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -89.25 139.38 30.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.961 0.886 . . . . 25.0 109.338 -178.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.425 ' HB2' HG13 ' A' ' 57' ' ' VAL . 61.5 mt -90.14 129.48 36.41 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.848 0.833 . . . . 25.0 110.257 179.441 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.08 134.44 33.83 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.442 -1.688 . . . . 25.0 106.442 178.042 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -154.04 161.97 41.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.831 0.287 . . . . 25.0 111.559 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.71 162.04 17.34 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.722 -1.214 . . . . 25.0 107.722 -179.273 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.19 129.97 44.68 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.974 -0.557 . . . . 25.0 109.8 179.198 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.36 -13.9 63.99 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 119.039 -0.867 . . . . 25.0 114.151 179.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -59.77 148.68 33.47 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-N 117.92 0.86 . . . . 25.0 111.07 177.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.5 mm -118.84 129.8 74.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.31 -1.313 . . . . 25.0 109.043 -179.002 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -136.16 155.45 50.13 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.336 -0.987 . . . . 25.0 108.336 -178.196 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.7 m -88.83 124.39 34.12 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.385 -0.598 . . . . 25.0 109.385 177.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.1 t -87.43 125.08 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 108.424 -0.954 . . . . 25.0 108.424 177.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.576 HD12 HD22 ' A' ' 47' ' ' LEU . 81.4 mt -91.0 -46.29 8.23 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.364 -1.347 . . . . 25.0 107.364 178.814 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -155.87 170.7 21.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.646 -0.872 . . . . 25.0 108.646 177.438 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.9 mtm105 -117.37 154.57 31.08 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.25 -1.759 . . . . 25.0 106.25 177.067 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 59.05 42.97 18.22 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 125.478 1.736 . . . . 25.0 109.192 179.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -70.83 157.37 38.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.005 -1.452 . . . . 25.0 110.372 -176.627 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 60.15 10.08 2.14 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.019 0.928 . . . . 25.0 113.363 177.786 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.4 20.62 68.87 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.762 -0.732 . . . . 25.0 111.572 -176.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 70.6 mt -102.49 122.84 45.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.58 0.229 . . . . 25.0 111.287 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.57 123.63 17.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.256 0.551 . . . . 25.0 111.02 177.522 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.81 -0.24 82.87 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 116.131 1.212 . . . . 25.0 116.131 172.444 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -99.49 131.12 45.71 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 118.879 1.34 . . . . 25.0 109.427 177.705 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.439 ' CE3' HD23 ' A' ' 62' ' ' LEU . 42.6 m0 -110.65 143.45 41.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.729 -0.841 . . . . 25.0 108.729 -176.045 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.576 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -85.15 123.06 30.22 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 106.21 -1.774 . . . . 25.0 106.21 178.407 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.2 m -132.24 166.88 20.86 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.868 -0.333 . . . . 25.0 110.848 178.048 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -118.13 122.03 42.05 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.735 -1.58 . . . . 25.0 106.735 173.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.6 tp -150.58 140.02 21.44 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.79 -0.818 . . . . 25.0 108.79 -177.693 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.9 m170 57.5 30.77 19.23 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.628 0.771 . . . . 25.0 110.934 -179.534 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.89 0.03 87.68 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 115.381 0.912 . . . . 25.0 115.381 176.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -124.6 158.25 33.5 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 118.006 0.903 . . . . 25.0 110.148 179.266 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -102.1 149.58 24.12 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 106.564 -1.643 . . . . 25.0 106.564 178.661 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.89 -167.49 36.59 Favored Glycine 0 N--CA 1.433 -1.535 0 N-CA-C 107.825 -2.11 . . . . 25.0 107.825 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.6 pt -111.18 153.14 12.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.646 0.736 . . . . 25.0 111.574 -173.364 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.425 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.7 m -143.01 142.95 23.12 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.146 -0.934 . . . . 25.0 109.464 179.334 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.08 124.06 8.8 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 118.374 -0.617 . . . . 25.0 112.065 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.32 -12.3 79.86 Favored Glycine 0 C--O 1.221 -0.706 0 C-N-CA 120.83 -0.7 . . . . 25.0 114.505 -176.155 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -71.45 -7.85 50.03 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.084 0.772 . . . . 25.0 113.084 -176.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -132.16 27.23 4.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.666 -0.864 . . . . 25.0 108.666 178.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.439 HD23 ' CE3' ' A' ' 46' ' ' TRP . 16.3 tp -134.1 149.55 51.11 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.424 -0.807 . . . . 25.0 111.739 -174.116 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -128.17 123.02 33.31 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.38 0.272 . . . . 25.0 111.628 -178.29 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.9 mm -67.98 136.66 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.225 -0.657 . . . . 25.0 109.225 176.845 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.7 mt -118.43 100.96 7.8 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.396 -1.335 . . . . 25.0 107.396 175.293 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.318 -0.792 0 N-CA-C 107.669 -1.234 . . . . 25.0 107.669 177.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.0 mttt . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 108.7 -0.852 . . . . 25.0 108.7 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo . . . . . 0 C--O 1.238 0.481 0 C-N-CA 115.575 -2.483 . . . . 25.0 111.176 173.263 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 . . . . . 0 C--O 1.236 0.388 0 CA-C-O 121.686 0.755 . . . . 25.0 112.502 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.87 -42.21 90.62 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.869 -0.789 . . . . 25.0 108.869 176.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.6 m120 51.6 46.74 26.05 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.783 0.802 . . . . 25.0 110.407 -178.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 m -109.26 166.7 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 104.348 -2.464 . . . . 25.0 104.348 176.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.84 172.16 6.99 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 -176.436 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.86 158.61 43.46 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.927 -0.397 . . . . 25.0 109.927 173.455 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -124.88 129.66 50.83 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.417 -0.81 . . . . 25.0 109.817 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.77 130.53 42.57 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.271 -0.64 . . . . 25.0 109.271 178.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.7 mt -95.29 -20.72 18.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.543 -0.299 . . . . 25.0 111.472 -177.536 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -145.96 170.36 16.78 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.31 -0.996 . . . . 25.0 108.31 -179.891 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -73.93 160.4 31.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.598 -0.519 . . . . 25.0 109.598 177.041 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -145.97 154.37 41.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.838 0.352 . . . . 25.0 110.724 172.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 p -132.39 136.06 56.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 105.398 -2.075 . . . . 25.0 105.398 178.483 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.94 139.57 33.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.081 -0.509 . . . . 25.0 111.06 -175.192 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -121.68 9.3 10.14 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.577 0.703 . . . . 25.0 109.662 178.177 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 t -148.85 151.02 34.19 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 105.867 -1.901 . . . . 25.0 105.867 -177.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -67.52 -21.69 45.9 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 117.799 -1.0 . . . . 25.0 113.024 178.708 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.32 -17.57 58.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.961 0.41 . . . . 25.0 111.197 178.516 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -89.76 134.38 34.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.927 0.87 . . . . 25.0 111.866 -172.267 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.449 ' HB2' HG13 ' A' ' 57' ' ' VAL . 62.6 mt -89.08 126.24 35.36 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.266 -0.879 . . . . 25.0 110.822 178.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -86.94 141.31 28.81 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.021 -1.844 . . . . 25.0 106.021 174.082 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.13 168.07 28.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.757 0.313 . . . . 25.0 110.634 -177.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -116.33 162.9 16.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.224 0.535 . . . . 25.0 110.105 178.388 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.48 134.55 57.12 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.744 -0.662 . . . . 25.0 109.466 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.99 -12.73 68.75 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 116.132 -0.486 . . . . 25.0 113.014 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -62.46 138.98 58.57 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.692 -0.855 . . . . 25.0 108.692 177.761 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.1 mm -105.86 132.77 52.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.936 -1.029 . . . . 25.0 108.385 177.838 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.1 ptp -139.33 152.05 46.88 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.711 -0.478 . . . . 25.0 109.711 -178.446 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 m -89.76 123.11 33.47 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.515 -0.92 . . . . 25.0 108.515 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.97 125.81 41.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 108.847 -0.797 . . . . 25.0 108.847 178.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.691 HD12 HD22 ' A' ' 47' ' ' LEU . 70.8 mt -91.68 -47.77 7.19 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.4 -0.963 . . . . 25.0 108.4 179.464 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -155.37 173.88 16.03 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 110.308 -0.256 . . . . 25.0 110.308 178.443 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.9 mtm105 -123.74 157.96 32.77 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 106.029 -1.841 . . . . 25.0 106.029 176.699 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.8 t0 59.43 40.26 21.01 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 123.419 1.581 . . . . 25.0 107.449 -177.349 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -68.82 144.51 54.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.114 -1.403 . . . . 25.0 107.787 -177.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 59.8 12.28 2.92 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.899 0.88 . . . . 25.0 113.241 -179.276 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.29 16.83 79.01 Favored Glycine 0 C--N 1.331 0.265 0 N-CA-C 111.465 -0.654 . . . . 25.0 111.465 -178.231 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.3 mt -94.36 105.1 17.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.183 -0.673 . . . . 25.0 109.183 179.101 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -58.53 130.15 45.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 122.03 0.919 . . . . 25.0 110.807 -177.749 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.7 -6.35 70.16 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.085 -0.961 . . . . 25.0 115.037 178.009 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -95.83 139.26 32.3 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 118.944 1.372 . . . . 25.0 109.306 176.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 34.6 m0 -118.88 142.88 47.34 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.756 -1.201 . . . . 25.0 107.756 -176.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.691 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -85.71 121.83 28.94 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 105.308 -2.108 . . . . 25.0 105.308 178.888 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.1 m -130.97 157.62 42.46 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.333 0.587 . . . . 25.0 111.907 179.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.5 t -107.46 123.62 48.66 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 105.849 -1.908 . . . . 25.0 105.849 171.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 tp -144.61 135.08 24.5 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.83 -0.804 . . . . 25.0 108.83 -176.074 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 56.73 27.22 12.37 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 176.334 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.6 4.53 82.85 Favored Glycine 0 C--O 1.228 -0.275 0 N-CA-C 114.417 0.527 . . . . 25.0 114.417 178.481 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -131.78 162.09 31.34 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.959 0.879 . . . . 25.0 109.496 178.602 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -110.38 155.07 22.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.207 -0.664 . . . . 25.0 109.207 179.516 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.98 -163.49 31.16 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 106.832 -2.507 . . . . 25.0 106.832 176.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.9 pt -111.77 153.44 13.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 121.671 0.748 . . . . 25.0 110.157 -177.35 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -141.26 145.0 36.56 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.09 -0.959 . . . . 25.0 109.33 179.186 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.17 121.12 6.98 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 CA-C-O 121.659 0.608 . . . . 25.0 111.372 178.417 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.81 -9.21 74.72 Favored Glycine 0 C--O 1.218 -0.846 0 C-N-CA 121.131 -0.557 . . . . 25.0 114.056 -176.218 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -66.43 -17.02 64.55 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.337 -0.507 . . . . 25.0 112.091 -178.073 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -128.2 26.56 5.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.748 -0.66 . . . . 25.0 109.414 -177.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.2 tp -132.99 145.0 50.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.532 0.682 . . . . 25.0 109.973 -176.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -122.72 120.28 33.17 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.504 -0.771 . . . . 25.0 111.425 -177.112 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.2 mm -67.73 134.39 30.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 O-C-N 123.663 0.602 . . . . 25.0 109.652 177.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.3 mt -117.74 99.65 7.08 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.067 -1.827 . . . . 25.0 106.067 174.495 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 C--N 1.322 -0.622 0 CA-C-O 121.03 0.443 . . . . 25.0 109.848 -177.594 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.0 mttt . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 110.147 -0.316 . . . . 25.0 110.147 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--O 1.244 0.807 0 C-N-CA 117.137 -1.442 . . . . 25.0 110.757 172.333 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 . . . . . 0 CA--C 1.517 -0.299 0 N-CA-C 113.071 0.767 . . . . 25.0 113.071 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.6 mt -63.96 -38.72 92.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.984 -1.007 . . . . 25.0 110.83 179.647 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 52.61 41.87 31.35 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.267 1.032 . . . . 25.0 110.87 -179.661 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' A' ' 34' ' ' VAL . 16.0 m -103.29 173.23 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 102.97 -2.974 . . . . 25.0 102.97 174.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -118.4 172.61 7.34 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 118.649 0.658 . . . . 25.0 109.401 -178.346 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.43 160.26 43.6 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.918 -0.583 . . . . 25.0 109.533 176.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -118.84 133.09 56.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.101 -0.954 . . . . 25.0 108.863 177.023 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.584 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -71.91 126.28 29.33 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 173.75 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.8 mt -88.63 -22.29 23.54 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.433 -0.58 . . . . 25.0 109.433 -178.698 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -144.05 175.17 10.24 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 105.116 -2.179 . . . . 25.0 105.116 179.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -86.47 -179.99 6.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 118.15 0.432 . . . . 25.0 109.937 175.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -154.99 143.56 20.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.111 0.481 . . . . 25.0 111.721 174.652 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.6 t -107.26 123.9 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 105.084 -2.191 . . . . 25.0 105.084 175.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.99 121.67 22.32 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.274 -1.01 . . . . 25.0 108.274 178.394 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -110.97 -2.06 16.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.647 0.737 . . . . 25.0 109.197 -179.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.3 m -129.34 152.6 79.78 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 107.55 -1.278 . . . . 25.0 107.55 179.083 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.92 -20.55 33.91 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 118.352 -0.632 . . . . 25.0 113.363 -179.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -16.94 46.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.925 -0.579 . . . . 25.0 110.383 179.565 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -87.19 139.82 30.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.627 0.727 . . . . 25.0 111.602 -172.476 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.8 mt -91.88 129.86 37.76 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.69 0.757 . . . . 25.0 109.75 177.336 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.34 142.48 27.85 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 105.708 -1.96 . . . . 25.0 105.708 173.327 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -156.41 167.72 29.58 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.788 -0.449 . . . . 25.0 109.788 -179.037 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.62 161.56 17.29 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.676 0.75 . . . . 25.0 111.142 -179.079 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -56.89 127.19 30.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.993 -1.003 . . . . 25.0 109.71 178.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.23 -11.77 70.01 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-O 119.093 -0.837 . . . . 25.0 114.682 178.01 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.51 138.82 54.72 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 118.18 0.99 . . . . 25.0 111.63 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.1 mm -102.28 130.22 52.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.194 -1.039 . . . . 25.0 108.194 175.333 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.0 ptp -135.65 153.28 51.68 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.439 -0.578 . . . . 25.0 109.439 -178.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.0 m -88.8 128.21 35.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.25 -1.389 . . . . 25.0 107.25 178.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 8' ' ' VAL . 61.8 t -94.22 121.67 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 107.421 -1.326 . . . . 25.0 107.421 178.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.624 HD12 HD22 ' A' ' 47' ' ' LEU . 78.4 mt -91.7 -43.66 9.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.157 -0.929 . . . . 25.0 109.947 -177.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -152.2 162.6 40.89 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.483 -1.303 . . . . 25.0 107.483 -177.037 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -124.7 153.56 42.15 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.203 -1.036 . . . . 25.0 108.203 176.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 55.8 40.17 30.7 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 123.731 1.729 . . . . 25.0 108.393 -178.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -70.36 158.96 35.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 112.95 -1.932 . . . . 25.0 110.57 -175.457 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 60.87 8.32 1.8 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.112 0.965 . . . . 25.0 113.389 179.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.85 17.85 74.05 Favored Glycine 0 CA--C 1.517 0.174 0 N-CA-C 110.551 -1.019 . . . . 25.0 110.551 -176.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.3 mt -99.51 123.3 43.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.007 0.432 . . . . 25.0 110.397 -179.535 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -64.78 129.69 40.73 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.06 -0.518 . . . . 25.0 110.456 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.13 -0.75 66.29 Favored Glycine 0 C--O 1.24 0.488 0 N-CA-C 116.617 1.407 . . . . 25.0 116.617 174.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -100.5 129.99 46.52 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 118.692 1.246 . . . . 25.0 109.736 178.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -111.65 140.07 46.58 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.74 -0.467 . . . . 25.0 109.74 -175.776 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.624 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -80.45 120.48 24.51 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.237 -1.764 . . . . 25.0 106.237 178.541 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.8 m -131.41 163.75 27.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.096 0.474 . . . . 25.0 111.884 178.683 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.9 t -120.03 123.95 44.69 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.062 -1.458 . . . . 25.0 107.062 173.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.8 tp -148.61 136.59 20.87 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.823 -0.806 . . . . 25.0 108.823 -176.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 56.17 26.98 10.91 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.551 1.315 . . . . 25.0 114.551 174.758 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.36 8.97 84.37 Favored Glycine 0 C--O 1.227 -0.297 0 C-N-CA 121.006 -0.616 . . . . 25.0 113.197 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -119.9 157.52 28.58 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.127 -1.064 . . . . 25.0 108.127 178.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -122.22 147.79 45.76 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 105.353 -2.091 . . . . 25.0 105.353 173.107 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.26 -155.59 17.25 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 107.201 -2.36 . . . . 25.0 107.201 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.9 pt -122.37 149.53 25.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 121.396 0.617 . . . . 25.0 111.05 -174.581 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.6 m -138.22 147.2 54.86 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.087 -0.96 . . . . 25.0 109.166 -178.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.84 119.12 5.73 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 O-C-N 122.037 0.493 . . . . 25.0 112.272 178.539 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.39 -18.65 69.84 Favored Glycine 0 C--O 1.223 -0.575 0 C-N-CA 121.226 -0.511 . . . . 25.0 113.429 -178.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -64.18 -17.98 64.04 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.202 0.815 . . . . 25.0 113.202 -178.428 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -122.58 27.29 7.9 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.343 0.592 . . . . 25.0 109.628 177.022 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 12' ' ' ALA . 1.4 tp -128.77 157.62 40.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 25.0 111.757 -179.618 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -131.37 120.03 22.52 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.067 -0.515 . . . . 25.0 110.869 177.339 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.7 mm -69.32 136.95 25.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.293 -0.632 . . . . 25.0 109.293 178.739 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.7 mt -115.55 91.82 3.72 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.713 -1.218 . . . . 25.0 107.713 177.103 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 113.353 0.871 . . . . 25.0 113.353 -176.599 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 107.617 -1.253 . . . . 25.0 107.617 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 C--N 1.347 0.478 0 C-N-CA 117.698 -1.068 . . . . 25.0 111.557 -179.024 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 116.769 2.137 . . . . 25.0 116.769 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.6 mt -79.33 -42.07 26.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.082 -0.963 . . . . 25.0 110.568 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 56.42 27.08 11.54 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.414 1.085 . . . . 25.0 112.287 -178.441 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.7 m -86.53 170.94 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 104.441 -2.429 . . . . 25.0 104.441 174.061 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mp -116.33 172.78 6.97 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.033 -0.729 . . . . 25.0 109.033 179.407 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.04 155.17 42.0 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.731 -0.47 . . . . 25.0 109.731 177.292 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -114.02 131.05 56.5 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.535 -0.757 . . . . 25.0 109.553 176.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.427 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -69.15 127.13 32.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.133 -0.692 . . . . 25.0 109.133 174.171 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.6 mt -92.44 -23.14 19.26 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.939 -0.393 . . . . 25.0 109.939 -178.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -143.16 167.06 23.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.059 -1.089 . . . . 25.0 108.059 -179.159 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -75.73 166.22 23.87 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 122.668 0.387 . . . . 25.0 111.824 177.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -145.57 156.83 43.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.968 0.413 . . . . 25.0 111.373 174.252 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.9 t -123.5 122.62 65.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 105.239 -2.134 . . . . 25.0 105.239 173.51 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.23 127.58 32.87 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.363 -0.977 . . . . 25.0 108.363 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -113.17 12.98 19.18 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.961 0.886 . . . . 25.0 109.52 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 t -152.08 147.44 19.79 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 106.3 -1.741 . . . . 25.0 106.3 -179.487 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.98 -23.6 67.73 Favored 'Trans proline' 0 C--N 1.347 0.456 0 O-C-N 122.23 0.595 . . . . 25.0 113.079 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -76.26 -21.12 56.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.343 0.592 . . . . 25.0 110.351 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -88.29 130.74 35.03 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.241 -1.022 . . . . 25.0 108.241 -178.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.443 ' HB2' HG13 ' A' ' 57' ' ' VAL . 54.2 mt -81.76 133.18 35.32 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.697 0.76 . . . . 25.0 109.803 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.39 125.09 34.54 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.331 -0.989 . . . . 25.0 108.331 177.568 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -145.43 164.36 31.79 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 120.972 0.415 . . . . 25.0 110.445 -179.31 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.35 167.73 12.01 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.334 0.587 . . . . 25.0 110.086 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -58.83 130.43 46.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.342 -0.844 . . . . 25.0 109.44 -179.092 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.26 -12.15 69.42 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-O 118.504 -1.164 . . . . 25.0 114.938 177.172 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -59.97 150.01 30.23 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.439 1.119 . . . . 25.0 111.483 177.523 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.2 mm -114.81 127.06 72.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.61 -1.177 . . . . 25.0 108.642 177.283 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.8 ptp -132.74 151.06 52.08 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.293 -0.632 . . . . 25.0 109.293 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -84.82 130.35 34.68 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.247 -1.02 . . . . 25.0 108.247 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.8 t -98.18 121.14 48.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.534 -0.913 . . . . 25.0 108.534 179.561 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.609 HD12 HD22 ' A' ' 47' ' ' LEU . 80.7 mt -87.7 -46.81 9.17 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.972 -0.558 . . . . 25.0 109.66 -179.375 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -155.01 171.11 20.27 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.115 -0.698 . . . . 25.0 109.115 178.238 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -117.66 157.81 25.78 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.323 -1.362 . . . . 25.0 107.323 177.681 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 57.63 37.93 27.57 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 125.127 1.517 . . . . 25.0 109.85 177.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 t -66.45 152.11 45.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.847 -1.524 . . . . 25.0 110.612 -175.529 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 60.97 6.89 1.32 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.362 1.065 . . . . 25.0 112.766 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.59 12.7 74.65 Favored Glycine 0 C--O 1.224 -0.472 0 N-CA-C 111.414 -0.674 . . . . 25.0 111.414 -177.094 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.2 mt -88.08 125.02 34.35 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.745 -0.465 . . . . 25.0 109.745 179.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -64.53 124.79 22.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.699 0.285 . . . . 25.0 110.272 178.085 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.69 -0.63 76.26 Favored Glycine 0 C--O 1.242 0.596 0 N-CA-C 116.68 1.432 . . . . 25.0 116.68 172.568 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -96.67 135.8 38.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.885 1.343 . . . . 25.0 108.984 179.002 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -111.36 144.32 40.75 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.858 -0.793 . . . . 25.0 108.858 -178.14 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.609 HD22 HD12 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -83.92 120.49 26.15 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 104.524 -2.398 . . . . 25.0 104.524 176.572 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 93.2 m -129.17 163.03 26.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 121.006 -0.278 . . . . 25.0 111.503 179.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.5 t -116.79 123.84 48.12 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.292 -1.373 . . . . 25.0 107.292 173.619 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.7 tp -146.49 129.1 16.08 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 108.571 -0.9 . . . . 25.0 108.571 -176.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 27.7 m170 55.91 32.7 20.25 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.412 0.523 . . . . 25.0 112.412 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.71 3.15 86.93 Favored Glycine 0 C--O 1.222 -0.64 0 C-N-CA 120.816 -0.707 . . . . 25.0 113.987 178.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 mtt-85 -111.1 153.95 24.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.575 -1.269 . . . . 25.0 107.575 178.487 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -120.41 147.15 45.45 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 106.683 -1.599 . . . . 25.0 106.683 175.038 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.73 -158.46 22.21 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 106.997 -2.441 . . . . 25.0 106.997 -177.433 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.5 pt -115.36 153.01 16.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.75 0.786 . . . . 25.0 111.572 -175.205 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.5 m -144.47 146.37 32.41 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 114.797 -1.092 . . . . 25.0 109.191 179.348 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.07 114.5 4.06 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 CA-C-O 121.609 0.587 . . . . 25.0 112.175 178.459 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.19 -17.74 68.43 Favored Glycine 0 C--O 1.221 -0.683 0 N-CA-C 114.551 0.58 . . . . 25.0 114.551 -177.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -65.06 -15.21 62.1 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.722 0.638 . . . . 25.0 112.722 -178.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -123.44 26.24 7.95 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.755 -0.59 . . . . 25.0 110.239 176.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 12' ' ' ALA . 12.3 mt -125.88 156.95 38.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.594 0.711 . . . . 25.0 110.949 178.207 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -127.92 119.05 24.74 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.255 -0.884 . . . . 25.0 110.531 177.446 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.0 mm -66.8 133.53 31.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 O-C-N 123.797 0.686 . . . . 25.0 109.531 178.4 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.1 mt -114.3 94.04 4.62 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.712 -1.218 . . . . 25.0 107.712 175.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 121.498 0.666 . . . . 25.0 109.973 176.712 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 95.4 mttt . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 106.51 -1.663 . . . . 25.0 106.51 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--O 1.241 0.661 0 C-N-CA 117.384 -1.278 . . . . 25.0 110.959 176.973 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 . . . . . 0 CA--C 1.512 -0.488 0 CA-C-O 120.864 0.364 . . . . 25.0 110.402 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.0 mt -67.87 -40.25 83.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.752 -0.658 . . . . 25.0 109.655 177.836 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.5 m120 55.75 24.7 7.54 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.972 -1.013 . . . . 25.0 112.787 -178.48 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.1 m -84.57 158.19 3.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.519 -1.289 . . . . 25.0 107.519 177.754 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.48 167.74 11.13 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.781 -0.822 . . . . 25.0 108.781 -177.175 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.29 158.76 44.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.991 0.424 . . . . 25.0 110.427 175.665 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -123.79 132.25 53.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.065 -0.971 . . . . 25.0 109.601 -179.808 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.23 132.18 40.91 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.376 -0.601 . . . . 25.0 109.376 177.274 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.5 mt -100.43 -17.4 17.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.42 -0.355 . . . . 25.0 110.388 -179.514 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -145.56 169.95 17.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 104.598 -2.371 . . . . 25.0 104.598 177.951 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -89.44 177.36 6.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.578 0.626 . . . . 25.0 110.618 176.175 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -154.44 136.4 14.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.971 -0.559 . . . . 25.0 110.492 175.297 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.7 t -104.35 121.36 55.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 104.643 -2.354 . . . . 25.0 104.643 175.368 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.22 135.69 49.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.413 -0.812 . . . . 25.0 109.253 -179.029 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -113.1 9.09 18.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.64 0.733 . . . . 25.0 109.271 -178.472 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 t -156.17 152.75 24.04 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.347 -0.842 . . . . 25.0 108.82 -175.577 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -70.31 -19.05 33.99 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 117.941 -0.906 . . . . 25.0 114.312 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.95 -17.01 56.19 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.481 -0.563 . . . . 25.0 109.481 178.048 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -93.74 142.33 27.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.515 0.674 . . . . 25.0 111.107 -175.729 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.433 ' HB2' HG13 ' A' ' 57' ' ' VAL . 55.7 mt -94.69 131.96 39.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.682 0.753 . . . . 25.0 110.102 178.959 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.5 p -90.94 140.17 30.07 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 105.882 -1.896 . . . . 25.0 105.882 174.661 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -156.05 164.91 37.84 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 120.806 0.336 . . . . 25.0 110.251 -179.325 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -108.53 158.58 17.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.037 0.922 . . . . 25.0 109.473 179.171 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -57.64 133.91 55.72 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.842 -1.072 . . . . 25.0 109.645 175.363 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.79 -12.32 70.14 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-O 119.022 -0.877 . . . . 25.0 113.644 178.655 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -60.67 146.44 45.61 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 118.116 0.958 . . . . 25.0 110.721 178.187 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.0 mm -110.86 129.23 66.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 107.935 -1.135 . . . . 25.0 107.935 177.6 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.3 ptp -136.79 165.97 24.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.999 -0.741 . . . . 25.0 108.999 -179.091 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -103.81 123.61 47.39 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.752 -0.833 . . . . 25.0 108.752 178.761 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.7 t -88.2 124.41 41.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.698 -1.223 . . . . 25.0 107.698 177.668 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.625 HD12 HD22 ' A' ' 47' ' ' LEU . 65.7 mt -93.68 -43.56 8.59 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.133 -0.939 . . . . 25.0 108.929 -179.667 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -148.49 155.16 40.81 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 106.784 -1.562 . . . . 25.0 106.784 -172.798 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -118.87 154.35 33.06 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 106.241 -1.763 . . . . 25.0 106.241 173.957 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 58.16 37.7 26.32 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 123.477 1.608 . . . . 25.0 108.324 178.638 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -68.46 159.43 31.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.043 -1.89 . . . . 25.0 111.018 -175.933 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 59.31 12.1 2.47 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.795 1.035 . . . . 25.0 113.795 177.131 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.36 18.35 78.14 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 110.628 -0.989 . . . . 25.0 110.628 -177.213 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.7 mt -104.07 115.94 31.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.069 0.462 . . . . 25.0 109.859 -179.454 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -66.25 131.12 45.4 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 -178.239 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.93 -1.56 78.69 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 115.427 0.931 . . . . 25.0 115.427 176.175 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -99.85 132.55 45.13 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 118.866 1.333 . . . . 25.0 109.014 177.059 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -113.09 139.26 48.86 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.429 -0.582 . . . . 25.0 109.429 -175.961 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.625 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -80.54 122.5 27.11 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 106.08 -1.822 . . . . 25.0 106.08 179.684 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 92.9 m -132.81 163.25 29.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.28 0.562 . . . . 25.0 112.288 178.634 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -115.37 127.98 55.77 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.16 -1.793 . . . . 25.0 106.16 171.248 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.8 tp -154.9 141.22 18.62 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 107.244 -1.391 . . . . 25.0 107.244 -175.343 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 55.91 26.99 10.41 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 112.651 0.612 . . . . 25.0 112.651 178.384 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.06 4.53 88.83 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 114.711 0.644 . . . . 25.0 114.711 178.733 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -126.64 161.4 28.16 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.501 -0.926 . . . . 25.0 108.501 -179.677 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -112.89 156.73 22.44 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.92 -1.141 . . . . 25.0 107.92 179.045 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.89 -161.24 30.66 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 106.509 -2.636 . . . . 25.0 106.509 179.521 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.6 pt -117.36 153.99 19.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.327 0.584 . . . . 25.0 111.878 -175.871 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.6 m -142.81 148.63 46.78 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 114.974 -1.012 . . . . 25.0 109.141 -179.023 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.18 122.42 7.11 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 CA-C-O 121.612 0.588 . . . . 25.0 112.799 -179.799 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.08 -24.44 67.05 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 116.308 -0.406 . . . . 25.0 113.739 -178.431 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -24.1 65.46 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.391 -0.476 . . . . 25.0 112.036 179.049 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -105.65 11.86 31.76 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.938 0.347 . . . . 25.0 111.938 -179.543 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.0 mt -121.78 152.5 39.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.704 1.24 . . . . 25.0 113.946 -177.539 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -120.36 123.53 43.32 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 113.687 -1.597 . . . . 25.0 108.812 176.004 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.0 mm -76.59 138.33 20.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.64 -0.874 . . . . 25.0 108.64 179.103 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.5 mt -117.38 88.06 2.83 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.966 -1.494 . . . . 25.0 106.966 176.7 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.1 m . . . . . 0 C--N 1.325 -0.489 0 CA-C-O 121.0 0.428 . . . . 25.0 109.998 -179.77 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt . . . . . 0 CA--C 1.534 0.342 0 N-CA-C 105.755 -1.943 . . . . 25.0 105.755 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo . . . . . 0 CA--C 1.538 0.684 0 C-N-CA 117.83 -0.98 . . . . 25.0 112.647 -175.98 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 . . . . . 0 CA--C 1.51 -0.586 0 CA-C-O 121.231 0.538 . . . . 25.0 110.539 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.21 -40.59 86.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.896 -1.047 . . . . 25.0 109.139 176.797 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.0 m120 54.99 30.47 14.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.138 0.975 . . . . 25.0 111.906 -178.136 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.7 m -89.22 164.77 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 106.362 -1.718 . . . . 25.0 106.362 175.862 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.37 173.49 6.42 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.68 -1.23 . . . . 25.0 107.68 -178.893 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.9 157.76 43.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.661 0.267 . . . . 25.0 110.42 174.865 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -122.71 130.74 53.29 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.648 -0.705 . . . . 25.0 109.781 175.962 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.54 129.64 38.76 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.01 -0.541 . . . . 25.0 109.549 175.71 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.0 mt -94.42 -21.76 18.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.914 0.388 . . . . 25.0 110.859 -178.006 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -143.95 169.41 17.87 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.993 -2.225 . . . . 25.0 104.993 177.856 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -84.03 167.74 16.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.131 0.491 . . . . 25.0 110.407 177.332 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -148.53 130.9 15.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.934 -0.575 . . . . 25.0 110.341 179.257 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.0 t -102.93 123.46 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 105.078 -2.193 . . . . 25.0 105.078 176.16 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.91 135.74 51.5 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.522 -1.217 . . . . 25.0 110.072 179.558 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -113.98 0.46 14.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.337 0.589 . . . . 25.0 110.284 -179.551 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.0 m -145.6 155.34 52.97 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 107.966 -1.124 . . . . 25.0 107.966 -177.421 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.34 -17.71 39.35 Favored 'Trans proline' 0 C--N 1.347 0.468 0 N-CA-C 113.805 0.656 . . . . 25.0 113.805 -177.415 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.91 -16.99 39.26 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.234 0.54 . . . . 25.0 110.22 179.003 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -87.45 136.03 33.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.98 0.895 . . . . 25.0 111.754 -175.605 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.426 ' HB2' HG13 ' A' ' 57' ' ' VAL . 47.3 mt -86.19 130.79 34.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.746 -0.661 . . . . 25.0 109.4 178.96 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.8 t -91.46 137.15 32.59 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.458 -2.053 . . . . 25.0 105.458 175.025 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -156.46 164.79 37.83 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.924 -0.399 . . . . 25.0 109.924 -177.86 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.49 162.53 15.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.514 0.673 . . . . 25.0 110.465 -177.496 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -57.32 128.39 36.76 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.163 -0.926 . . . . 25.0 109.131 176.165 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.57 -15.67 61.67 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 118.752 -1.027 . . . . 25.0 114.728 178.197 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -59.08 146.19 39.46 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.993 0.897 . . . . 25.0 111.139 -178.845 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.0 mm -110.57 134.17 53.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.448 -1.251 . . . . 25.0 108.627 178.72 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.9 ptp -141.58 157.69 44.78 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.439 0.296 . . . . 25.0 110.334 -177.961 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.5 m -92.27 130.88 37.86 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.531 -0.914 . . . . 25.0 108.531 177.232 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.95 129.6 45.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.322 -0.992 . . . . 25.0 108.322 177.527 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.702 HD12 HD22 ' A' ' 47' ' ' LEU . 76.2 mt -94.43 -52.47 4.32 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.827 -0.805 . . . . 25.0 108.827 -179.671 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -149.99 163.91 36.86 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.902 -1.147 . . . . 25.0 107.902 177.822 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.434 ' HE ' ' HB3' ' A' ' 37' ' ' ARG . 8.6 mtp180 -106.81 157.44 17.75 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 109.672 -0.492 . . . . 25.0 109.672 176.474 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 56.02 39.58 30.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 123.526 1.632 . . . . 25.0 108.859 170.319 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.9 t -64.42 152.29 41.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 112.474 -2.148 . . . . 25.0 110.677 -176.502 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 59.78 11.65 2.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.207 1.003 . . . . 25.0 113.104 -179.595 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.75 20.29 79.56 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.686 -0.965 . . . . 25.0 110.686 -177.402 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.2 mt -94.69 118.89 32.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.293 -1.003 . . . . 25.0 108.293 177.953 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -64.72 128.31 35.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.923 -0.581 . . . . 25.0 110.396 -177.882 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.74 -0.75 70.01 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 115.932 1.133 . . . . 25.0 115.932 176.274 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -99.61 129.98 45.8 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 119.181 1.491 . . . . 25.0 109.59 177.93 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -113.88 141.32 47.49 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.916 -0.772 . . . . 25.0 108.916 -176.149 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.702 HD22 HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -81.68 120.31 24.95 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.14 -1.8 . . . . 25.0 106.14 179.473 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 88.8 m -133.77 167.78 19.91 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.005 0.431 . . . . 25.0 111.578 -179.992 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.4 t -120.33 116.54 25.73 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.463 -1.31 . . . . 25.0 107.463 173.826 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -146.03 144.85 30.33 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.441 -1.318 . . . . 25.0 107.441 -175.902 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.55 27.24 15.39 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.378 0.671 . . . . 25.0 112.334 -179.555 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.95 4.84 90.44 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 114.657 0.623 . . . . 25.0 114.657 177.705 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.1 ptt85 -132.82 161.04 35.18 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.067 0.934 . . . . 25.0 109.775 179.379 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -102.6 154.24 19.32 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.282 -0.636 . . . . 25.0 109.282 177.02 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.24 -158.02 22.46 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 106.54 -2.624 . . . . 25.0 106.54 178.297 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.8 pt -118.39 151.64 20.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.542 0.687 . . . . 25.0 110.877 -175.297 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' A' ' 24' ' ' LEU . 2.4 m -140.8 146.96 46.46 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 114.931 -1.032 . . . . 25.0 108.85 -179.113 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.91 122.59 5.89 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 118.31 -0.66 . . . . 25.0 112.284 179.235 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.21 -14.87 64.64 Favored Glycine 0 C--O 1.223 -0.581 0 CA-C-N 116.11 -0.495 . . . . 25.0 112.821 -179.703 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.73 -28.26 63.72 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 122.957 0.503 . . . . 25.0 112.346 179.693 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.57 25.42 9.77 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.556 0.217 . . . . 25.0 111.51 178.869 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.4 tp -128.57 144.13 51.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.636 0.731 . . . . 25.0 111.611 -174.626 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -119.59 119.98 35.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.332 -0.849 . . . . 25.0 110.935 -177.921 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.0 mm -68.96 134.93 29.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.212 -0.662 . . . . 25.0 109.212 177.509 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.5 mt -117.91 105.17 11.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.675 -1.602 . . . . 25.0 106.675 176.215 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--N 1.322 -0.616 0 CA-C-O 120.965 0.412 . . . . 25.0 110.001 -178.833 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 107.423 -1.325 . . . . 25.0 107.423 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 CA--C 1.54 0.807 0 C-N-CA 118.339 -0.64 . . . . 25.0 111.791 178.023 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 121.676 0.751 . . . . 25.0 112.632 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.2 mt -70.58 -33.25 70.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.483 -0.78 . . . . 25.0 111.724 -176.292 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.8 m120 60.33 17.85 7.47 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.322 1.049 . . . . 25.0 113.257 -178.752 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.2 m -91.26 162.78 2.38 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 N-CA-C 108.845 -0.798 . . . . 25.0 108.845 -179.649 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.79 172.66 6.81 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.713 -1.217 . . . . 25.0 107.713 -178.633 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.52 161.19 42.62 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.197 -0.668 . . . . 25.0 109.197 173.264 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -125.87 131.72 52.31 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 123.808 0.693 . . . . 25.0 110.722 179.22 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.73 122.01 18.33 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 124.015 0.822 . . . . 25.0 110.215 177.513 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.2 mt -89.47 -24.07 21.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.234 0.54 . . . . 25.0 109.855 -178.115 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -138.58 174.27 10.72 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 103.101 -2.925 . . . . 25.0 103.101 175.876 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -85.38 -179.87 7.03 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.635 -0.876 . . . . 25.0 108.635 175.417 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -155.33 147.54 23.72 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 122.865 0.466 . . . . 25.0 109.804 174.127 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.5 t -116.27 123.57 71.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.677 -1.601 . . . . 25.0 106.677 175.992 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.78 145.22 25.73 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.497 -0.774 . . . . 25.0 109.501 177.773 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.15 -7.67 6.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.924 -0.58 . . . . 25.0 111.02 178.322 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 m -119.76 154.65 55.07 Favored Pre-proline 0 C--O 1.22 -0.448 0 N-CA-C 108.406 -0.961 . . . . 25.0 108.406 178.931 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.11 -24.95 38.03 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 117.563 -1.158 . . . . 25.0 114.323 -178.444 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.06 -16.84 57.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.31 0.576 . . . . 25.0 110.459 179.223 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -91.72 135.73 33.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.358 0.599 . . . . 25.0 110.602 -173.861 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.411 ' HB2' HG13 ' A' ' 57' ' ' VAL . 73.9 mt -95.37 128.33 42.13 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.958 0.885 . . . . 25.0 111.109 -179.112 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 t -90.44 143.61 26.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.141 -1.8 . . . . 25.0 106.141 176.841 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -158.03 168.24 27.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.104 0.478 . . . . 25.0 110.871 -179.446 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -114.18 159.5 20.03 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.168 -0.679 . . . . 25.0 109.168 178.041 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -57.83 132.05 52.17 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.339 -1.356 . . . . 25.0 107.339 176.348 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.71 -20.58 47.5 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-O 119.521 -0.599 . . . . 25.0 113.606 179.034 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -59.46 145.81 42.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.73 0.776 . . . . 25.0 110.84 178.885 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.3 mm -115.11 128.79 72.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.517 -1.219 . . . . 25.0 108.524 179.868 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -131.2 152.78 50.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.458 -0.201 . . . . 25.0 110.458 179.209 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.7 m -87.43 126.97 35.21 Favored 'General case' 0 C--O 1.218 -0.603 0 N-CA-C 107.823 -1.177 . . . . 25.0 107.823 177.537 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.74 128.58 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 CA-C-O 121.968 0.89 . . . . 25.0 108.807 179.362 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.646 HD12 HD22 ' A' ' 47' ' ' LEU . 81.7 mt -97.36 -46.09 6.22 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.005 -0.998 . . . . 25.0 108.779 179.631 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.07 158.58 44.14 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.956 -0.757 . . . . 25.0 108.956 -175.844 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -118.29 148.51 42.38 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 106.743 -1.576 . . . . 25.0 106.743 174.924 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 57.17 43.32 24.15 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 123.319 1.533 . . . . 25.0 109.832 -177.912 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -72.04 160.91 31.68 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 113.491 -1.686 . . . . 25.0 112.204 -176.134 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 59.68 9.83 1.76 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.177 0.991 . . . . 25.0 113.234 178.264 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.88 14.81 76.73 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.657 -0.977 . . . . 25.0 110.657 -176.185 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.0 mt -99.58 123.14 43.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.538 0.685 . . . . 25.0 110.565 -179.112 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -70.11 125.38 26.61 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.96 -1.018 . . . . 25.0 110.486 179.18 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.94 -1.41 88.6 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 115.43 0.932 . . . . 25.0 115.43 176.208 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -100.98 131.37 46.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 118.159 0.98 . . . . 25.0 109.796 178.45 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -110.73 142.45 42.65 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.179 -0.675 . . . . 25.0 109.179 -177.176 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.646 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -84.52 121.11 27.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 105.176 -2.157 . . . . 25.0 105.176 178.157 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.1 m -134.37 165.96 23.93 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.963 0.411 . . . . 25.0 111.171 179.087 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 t -121.48 123.08 41.17 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.011 -1.477 . . . . 25.0 107.011 173.165 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.9 tp -135.25 122.0 20.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.873 -0.788 . . . . 25.0 108.873 -177.728 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.2 m170 54.01 33.91 18.58 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.522 0.729 . . . . 25.0 111.548 179.799 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.74 -6.53 83.55 Favored Glycine 0 C--O 1.227 -0.314 0 N-CA-C 115.252 0.861 . . . . 25.0 115.252 177.44 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -101.98 137.22 40.55 Favored 'General case' 0 C--O 1.219 -0.553 0 CA-C-N 118.449 1.124 . . . . 25.0 108.403 176.147 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -99.9 145.02 28.27 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.406 -1.702 . . . . 25.0 106.406 173.93 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.73 -161.48 27.37 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 108.368 -1.893 . . . . 25.0 108.368 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.1 pt -115.41 149.89 17.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.603 0.716 . . . . 25.0 110.759 -175.847 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.8 m -139.32 146.63 49.51 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 114.871 -1.059 . . . . 25.0 108.824 -179.092 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.82 119.79 6.06 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 CA-C-O 121.487 0.536 . . . . 25.0 111.626 177.933 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.02 -15.3 74.14 Favored Glycine 0 C--O 1.226 -0.372 0 CA-C-O 121.649 0.583 . . . . 25.0 113.048 -178.466 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -67.46 -6.89 21.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.299 0.64 . . . . 25.0 112.672 -178.849 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -135.48 28.32 3.35 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.711 -0.478 . . . . 25.0 109.711 176.108 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.3 mt -125.32 156.25 38.96 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.352 0.871 . . . . 25.0 113.352 177.839 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -128.09 120.18 26.88 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.969 -1.014 . . . . 25.0 110.075 174.435 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.7 mm -66.95 137.25 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.581 -0.896 . . . . 25.0 108.581 176.62 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.4 mt -117.57 107.51 14.34 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.817 -1.179 . . . . 25.0 107.817 176.491 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--N 1.322 -0.619 0 N-CA-C 109.636 -0.505 . . . . 25.0 109.636 178.94 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 107.715 -1.217 . . . . 25.0 107.715 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 CA--C 1.54 0.812 0 C-N-CA 116.584 -1.811 . . . . 25.0 110.775 175.208 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 . . . . . 0 CA--C 1.518 -0.278 0 CA-C-O 121.06 0.457 . . . . 25.0 111.314 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.8 mt -71.96 -35.64 69.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.73 -1.123 . . . . 25.0 110.156 -179.988 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.5 m120 53.64 36.93 24.85 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.744 0.817 . . . . 25.0 111.84 -179.1 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.7 m -99.06 163.03 2.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 107.427 -1.323 . . . . 25.0 107.427 176.771 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.08 170.9 8.16 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.193 -1.04 . . . . 25.0 108.193 -178.01 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.48 158.64 44.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.891 0.376 . . . . 25.0 110.939 177.032 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -123.91 129.25 50.67 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.457 -0.792 . . . . 25.0 110.12 177.63 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.46 124.68 26.29 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.005 -0.543 . . . . 25.0 109.911 177.029 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.93 -24.73 19.19 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.278 0.561 . . . . 25.0 109.981 -177.762 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -135.75 166.34 23.5 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 104.673 -2.343 . . . . 25.0 104.673 175.913 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -86.67 -173.77 4.65 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.499 0.72 . . . . 25.0 110.937 177.741 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -161.9 154.03 19.39 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 123.613 0.571 . . . . 25.0 112.385 176.662 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.9 t -122.14 126.78 74.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 104.541 -2.392 . . . . 25.0 104.541 173.022 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.37 137.0 44.44 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 -177.247 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -113.32 6.69 17.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.181 0.991 . . . . 25.0 109.237 179.206 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.0 t -149.68 149.3 27.98 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 106.955 -1.498 . . . . 25.0 106.955 -177.178 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.27 -19.31 38.64 Favored 'Trans proline' 0 N--CA 1.475 0.433 0 C-N-CA 117.622 -1.119 . . . . 25.0 112.568 178.184 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -79.21 -15.76 57.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.888 0.852 . . . . 25.0 110.388 178.985 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -93.12 141.22 28.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.801 0.81 . . . . 25.0 111.491 -176.509 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.6 mt -89.1 129.21 35.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.881 -0.599 . . . . 25.0 111.215 -179.936 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 p -94.5 137.87 33.1 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.481 -1.674 . . . . 25.0 106.481 173.813 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.424 ' HE1' HG12 ' A' ' 57' ' ' VAL . 38.2 p90 -160.86 175.98 11.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.998 -0.742 . . . . 25.0 108.998 -174.634 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.4 167.68 11.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.606 0.717 . . . . 25.0 111.526 177.444 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.48 134.4 56.83 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 107.81 -1.181 . . . . 25.0 107.81 178.39 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.2 -11.32 70.7 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-O 118.98 -0.9 . . . . 25.0 113.782 178.697 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.28 138.57 57.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 118.336 1.068 . . . . 25.0 109.937 176.665 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.3 mm -105.04 129.38 57.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 107.111 -1.44 . . . . 25.0 107.111 177.865 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.0 ptp -137.48 150.1 47.31 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.394 0.277 . . . . 25.0 110.932 -175.706 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.2 m -87.63 122.4 31.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.576 -0.898 . . . . 25.0 108.576 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 63.4 t -89.79 127.59 42.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.404 -0.961 . . . . 25.0 108.404 178.322 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.649 HD12 HD22 ' A' ' 47' ' ' LEU . 84.6 mt -91.46 -52.25 4.88 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.15 -0.932 . . . . 25.0 108.551 179.453 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -151.61 168.69 24.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.487 -0.56 . . . . 25.0 109.487 177.502 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -117.33 154.41 31.31 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.68 -1.6 . . . . 25.0 106.68 179.423 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 56.37 42.73 27.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 123.429 1.585 . . . . 25.0 108.662 -177.559 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -67.98 154.18 42.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.573 -1.649 . . . . 25.0 109.319 -176.701 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 59.09 9.39 1.27 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.544 1.138 . . . . 25.0 113.148 177.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.82 13.89 74.1 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 110.804 -0.918 . . . . 25.0 110.804 -179.366 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.3 mt -90.32 134.44 34.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.273 -0.64 . . . . 25.0 109.273 179.721 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -72.44 126.4 29.76 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.268 0.556 . . . . 25.0 110.47 178.534 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.66 2.41 69.53 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 117.576 1.791 . . . . 25.0 117.576 174.914 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -100.63 134.13 44.06 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.128 1.464 . . . . 25.0 110.906 177.916 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -113.1 142.88 45.24 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.798 -0.815 . . . . 25.0 108.798 -174.872 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -86.75 123.84 32.34 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 106.599 -1.63 . . . . 25.0 106.599 179.106 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 97.8 m -132.71 160.83 35.64 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.245 0.545 . . . . 25.0 112.204 179.528 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.2 t -113.14 125.93 54.89 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 107.129 -1.434 . . . . 25.0 107.129 172.281 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 tp -147.19 135.94 22.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.437 -1.32 . . . . 25.0 107.437 -175.715 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 55.34 27.15 9.52 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.589 0.755 . . . . 25.0 112.073 -175.592 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.52 0.73 84.93 Favored Glycine 0 C--O 1.217 -0.964 0 N-CA-C 115.201 0.84 . . . . 25.0 115.201 -179.515 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -115.22 161.99 17.69 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.435 -1.321 . . . . 25.0 107.435 178.628 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -114.21 153.41 29.67 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.332 -0.618 . . . . 25.0 109.332 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.23 -163.86 30.88 Favored Glycine 0 CA--C 1.503 -0.683 0 N-CA-C 106.137 -2.785 . . . . 25.0 106.137 178.29 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 pt -115.9 155.95 17.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 120.808 0.337 . . . . 25.0 111.416 -175.299 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.424 HG12 ' HE1' ' A' ' 26' ' ' PHE . 2.9 m -144.18 147.64 38.26 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.403 -0.817 . . . . 25.0 109.479 179.525 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -74.87 126.02 9.77 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 CA-C-N 118.165 0.38 . . . . 25.0 112.373 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.8 -21.41 79.74 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 115.625 1.01 . . . . 25.0 115.625 -174.72 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -56.14 -28.2 57.05 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.529 0.937 . . . . 25.0 113.529 -176.59 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.12 20.02 12.77 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.936 -0.478 . . . . 25.0 111.721 -178.292 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.7 tp -119.52 146.51 45.39 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.612 -0.885 . . . . 25.0 108.612 -178.672 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -117.56 124.12 47.9 Favored 'General case' 0 C--O 1.208 -1.082 0 CA-C-N 116.085 -0.507 . . . . 25.0 110.757 -178.16 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.1 mm -76.66 136.63 24.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 109.298 -0.63 . . . . 25.0 109.298 177.471 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.0 mt -119.33 101.5 8.02 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.149 -1.797 . . . . 25.0 106.149 176.714 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--N 1.323 -0.553 0 N-CA-C 108.996 -0.742 . . . . 25.0 108.996 -177.017 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 80.1 mttt . . . . . 0 N--CA 1.456 -0.166 0 N-CA-C 106.845 -1.539 . . . . 25.0 106.845 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 C--O 1.242 0.675 0 C-N-CA 116.268 -2.021 . . . . 25.0 111.17 176.266 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 . . . . . 0 C--O 1.221 -0.415 0 N-CA-C 115.74 1.755 . . . . 25.0 115.74 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.8 mt -79.23 -31.31 43.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.503 -1.226 . . . . 25.0 110.267 -177.941 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.4 m120 54.34 25.09 5.62 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.286 1.034 . . . . 25.0 113.028 -177.011 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.6 m -88.51 162.46 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.257 -1.386 . . . . 25.0 107.257 178.102 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.87 173.94 6.17 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.416 -1.698 . . . . 25.0 106.416 -179.393 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.73 158.18 43.03 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.483 -0.191 . . . . 25.0 110.483 174.599 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -121.5 129.4 52.9 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.377 0.671 . . . . 25.0 110.592 176.892 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.32 132.39 45.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.109 -0.496 . . . . 25.0 110.12 176.807 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -98.31 -22.44 16.11 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.318 0.488 . . . . 25.0 112.318 -176.609 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -142.0 162.82 34.51 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.151 -0.685 . . . . 25.0 109.151 -179.801 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -69.37 158.81 34.35 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.698 -0.482 . . . . 25.0 109.698 177.704 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.35 161.53 38.75 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.651 -1.24 . . . . 25.0 107.651 177.168 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 p -136.25 139.26 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 102.071 -3.307 . . . . 25.0 102.071 171.243 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.34 124.4 34.39 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.577 -0.527 . . . . 25.0 109.577 -175.771 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -110.23 15.7 22.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.968 0.89 . . . . 25.0 110.312 -176.746 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.9 t -152.69 148.66 20.91 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 107.037 -1.468 . . . . 25.0 107.037 -175.87 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.59 -19.48 36.88 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 117.719 -1.054 . . . . 25.0 113.081 178.925 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -82.61 -19.29 38.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.363 0.602 . . . . 25.0 110.228 178.868 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -83.64 132.73 34.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 122.021 0.915 . . . . 25.0 111.029 -176.175 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.449 ' HB2' HG13 ' A' ' 57' ' ' VAL . 40.8 mt -82.75 138.31 34.09 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.711 -0.848 . . . . 25.0 108.711 178.254 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -90.82 131.38 36.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.542 -1.281 . . . . 25.0 107.542 176.404 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -155.27 165.17 37.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.387 0.613 . . . . 25.0 111.313 -178.225 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -125.68 164.28 20.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.855 -0.611 . . . . 25.0 111.174 -177.797 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -56.27 130.81 46.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.209 0.528 . . . . 25.0 110.191 179.333 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.55 -18.65 56.65 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.813 -0.993 . . . . 25.0 113.967 177.484 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -58.83 146.16 38.25 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 117.85 0.825 . . . . 25.0 110.995 179.801 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.4 mm -113.34 133.19 60.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.567 -1.197 . . . . 25.0 108.35 178.682 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.6 ptp -141.92 155.7 45.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.614 -0.513 . . . . 25.0 109.614 -177.96 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.6 m -89.2 128.43 35.81 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 108.69 -0.855 . . . . 25.0 108.69 178.004 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.0 t -93.15 126.54 45.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.929 -1.138 . . . . 25.0 107.929 177.183 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.67 HD12 HD22 ' A' ' 47' ' ' LEU . 72.9 mt -90.94 -51.88 5.13 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.503 -0.925 . . . . 25.0 108.503 179.57 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -149.55 161.04 42.92 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.71 -0.848 . . . . 25.0 108.71 177.985 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -102.86 156.58 17.56 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.729 -0.841 . . . . 25.0 108.729 176.221 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 55.28 41.22 31.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.41 1.576 . . . . 25.0 108.507 172.061 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.405 HG21 HG22 ' A' ' 56' ' ' ILE . 11.4 t -63.66 147.69 50.92 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 112.625 -2.079 . . . . 25.0 110.859 -175.522 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 59.96 9.97 1.98 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.664 0.786 . . . . 25.0 111.993 -176.575 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.74 9.46 86.33 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 111.122 -0.791 . . . . 25.0 111.122 -177.226 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.6 114.22 21.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.296 -1.002 . . . . 25.0 108.296 -179.759 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.21 129.2 39.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.196 0.522 . . . . 25.0 109.891 -176.567 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.08 -1.4 75.12 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-O 118.613 -1.104 . . . . 25.0 115.433 176.694 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -100.92 130.11 46.87 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 119.409 1.604 . . . . 25.0 109.044 177.095 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -113.4 139.94 48.48 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.299 -1.0 . . . . 25.0 108.299 -176.438 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.67 HD22 HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -82.02 122.71 28.15 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 105.467 -2.049 . . . . 25.0 105.467 179.255 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.6 m -130.5 163.51 26.85 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.031 0.443 . . . . 25.0 110.98 178.565 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.6 t -116.21 122.03 43.8 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.976 -1.861 . . . . 25.0 105.976 172.524 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.7 tp -147.14 139.77 24.88 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.521 -1.289 . . . . 25.0 107.521 -176.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 57.87 27.2 14.26 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.75 0.648 . . . . 25.0 112.75 177.133 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.8 2.31 90.64 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 114.899 0.72 . . . . 25.0 114.899 178.77 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.4 ptt85 -126.93 160.51 30.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.581 1.19 . . . . 25.0 109.35 177.965 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -109.53 152.68 25.14 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.579 -0.897 . . . . 25.0 108.579 177.627 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.08 -160.59 25.21 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 105.974 -2.851 . . . . 25.0 105.974 179.265 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.405 HG22 HG21 ' A' ' 39' ' ' THR . 33.3 pt -118.36 154.11 20.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.545 0.688 . . . . 25.0 111.253 -175.817 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -141.17 146.96 45.29 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.06 -0.973 . . . . 25.0 109.117 179.444 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.59 120.13 6.04 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 CA-C-O 121.669 0.612 . . . . 25.0 111.326 178.246 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.22 -12.05 75.9 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 116.062 -0.517 . . . . 25.0 113.865 -176.477 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -69.36 -9.21 52.39 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.575 0.583 . . . . 25.0 112.575 -178.64 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -133.11 27.67 4.18 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.829 -0.804 . . . . 25.0 108.829 178.554 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.4 tp -133.16 147.51 52.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.449 -0.796 . . . . 25.0 109.393 -177.855 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -123.12 120.05 32.08 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.556 0.342 . . . . 25.0 110.977 -177.801 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.4 mm -66.91 135.45 28.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.427 -0.583 . . . . 25.0 109.427 177.751 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.0 mt -121.27 95.92 4.88 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.741 -1.207 . . . . 25.0 107.741 175.945 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 106.481 -1.674 . . . . 25.0 106.481 176.699 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 95.9 mttt . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 109.35 -0.611 . . . . 25.0 109.35 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo . . . . . 0 CA--C 1.543 0.962 0 O-C-N 122.084 0.518 . . . . 25.0 111.776 175.35 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 . . . . . 0 C--O 1.221 -0.395 0 N-CA-C 110.299 -0.26 . . . . 25.0 110.299 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.8 mt -66.2 -38.1 87.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.165 0.507 . . . . 25.0 110.831 178.432 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 55.29 26.51 8.66 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.97 -1.014 . . . . 25.0 113.173 -178.576 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.5 m -85.25 171.74 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.848 0 N-CA-C 105.982 -1.859 . . . . 25.0 105.982 175.131 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -118.93 169.57 9.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 118.894 0.77 . . . . 25.0 109.624 -178.453 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.96 153.47 40.11 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.745 -0.661 . . . . 25.0 109.801 178.481 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -116.35 130.42 56.76 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.681 -1.145 . . . . 25.0 110.058 178.796 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.55 128.3 36.12 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.853 -0.425 . . . . 25.0 109.853 176.99 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.83 -22.78 17.26 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 121.003 -0.279 . . . . 25.0 111.469 -178.772 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -141.13 166.18 25.48 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.24 -1.763 . . . . 25.0 106.24 178.485 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -74.18 160.17 31.54 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.376 0.423 . . . . 25.0 110.229 178.95 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -144.94 137.08 25.93 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.559 -0.713 . . . . 25.0 112.263 173.732 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.83 123.89 66.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 106.304 -1.739 . . . . 25.0 106.304 176.217 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.68 125.64 27.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.08 -0.964 . . . . 25.0 108.529 177.26 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.13 -1.28 18.89 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.017 0.913 . . . . 25.0 109.34 176.954 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 t -131.85 145.88 59.37 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 105.121 -2.177 . . . . 25.0 105.121 179.589 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -69.37 -14.66 37.68 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 117.346 -1.303 . . . . 25.0 113.105 178.713 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -83.39 -16.81 44.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.48 0.657 . . . . 25.0 110.338 178.622 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -88.02 142.49 27.74 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.279 -0.637 . . . . 25.0 109.279 -178.709 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.4 mt -92.39 129.87 38.21 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.853 0.835 . . . . 25.0 109.597 177.653 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.94 142.64 28.68 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 105.644 -1.984 . . . . 25.0 105.644 175.842 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -161.68 165.94 27.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.256 0.55 . . . . 25.0 111.329 -179.111 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -113.52 159.5 19.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.497 -0.774 . . . . 25.0 109.12 177.546 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.76 133.66 55.57 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.824 -1.176 . . . . 25.0 107.824 177.626 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.18 -22.92 38.5 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-O 119.205 -0.775 . . . . 25.0 114.051 179.6 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -58.6 140.54 54.22 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.529 0.68 . . . . 25.0 109.69 179.731 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.6 mm -108.84 127.3 65.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.734 -1.121 . . . . 25.0 108.059 -178.849 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 12.2 ptp -128.2 150.92 49.8 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.188 -0.671 . . . . 25.0 109.188 -179.986 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.0 m -84.42 127.48 34.03 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 106.883 -1.525 . . . . 25.0 106.883 176.026 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.0 t -94.07 122.63 45.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 179.013 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.586 HD12 HD22 ' A' ' 47' ' ' LEU . 84.3 mt -89.07 -46.94 8.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.603 -0.726 . . . . 25.0 109.127 -177.662 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -155.26 171.55 19.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.51 -0.314 . . . . 25.0 110.218 177.679 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -123.63 155.75 37.13 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.967 -1.864 . . . . 25.0 105.967 179.32 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.3 t0 58.49 41.35 22.79 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.304 1.526 . . . . 25.0 108.126 -175.881 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 t -68.32 142.03 55.64 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.778 -1.193 . . . . 25.0 107.778 -177.625 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 56.54 18.72 3.72 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 113.978 1.103 . . . . 25.0 113.978 -177.526 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.15 20.57 76.6 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.428 -1.069 . . . . 25.0 110.428 -179.656 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.418 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 65.7 mt -90.53 99.73 12.7 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 107.725 -1.213 . . . . 25.0 107.725 176.551 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -57.65 123.48 15.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.93 -1.032 . . . . 25.0 110.091 -176.099 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.47 -3.03 85.26 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 118.345 -1.253 . . . . 25.0 115.366 178.92 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.418 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 85.1 m95 -100.58 143.63 30.52 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 119.461 1.63 . . . . 25.0 109.569 177.84 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -117.66 140.54 49.52 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.345 -0.983 . . . . 25.0 108.345 -178.896 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.586 HD22 HD12 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -82.71 120.22 25.31 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 103.967 -2.605 . . . . 25.0 103.967 175.84 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 93.8 m -129.72 160.69 32.61 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 110.205 -0.294 . . . . 25.0 110.205 179.158 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.5 t -116.9 121.76 42.39 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.865 -1.161 . . . . 25.0 107.865 173.385 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.5 tp -143.75 141.88 30.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.027 -1.842 . . . . 25.0 106.027 -177.105 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 56.43 27.47 12.18 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.189 0.595 . . . . 25.0 111.388 -176.877 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.39 -0.46 84.7 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-O 119.554 -0.581 . . . . 25.0 114.467 177.682 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -120.93 154.32 36.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.333 1.067 . . . . 25.0 110.06 179.322 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -98.11 157.12 16.33 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.321 -0.992 . . . . 25.0 108.321 178.434 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.61 -168.25 39.7 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 105.515 -3.034 . . . . 25.0 105.515 179.128 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.3 pt -115.89 153.17 17.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 122.339 1.066 . . . . 25.0 110.762 -175.738 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.95 146.07 32.83 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 114.216 -1.356 . . . . 25.0 109.96 -178.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.66 119.12 5.58 Favored 'Trans proline' 0 C--O 1.237 0.431 0 O-C-N 122.051 0.501 . . . . 25.0 113.173 -179.869 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.7 -17.55 69.23 Favored Glycine 0 C--O 1.222 -0.601 0 C-N-CA 120.975 -0.631 . . . . 25.0 113.478 -178.306 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -65.65 -12.22 51.57 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.579 0.585 . . . . 25.0 112.579 -177.868 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -130.56 26.52 5.05 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.587 0.708 . . . . 25.0 110.841 177.018 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -126.14 154.92 42.49 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.406 -0.816 . . . . 25.0 111.871 178.511 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -123.43 122.33 37.98 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.866 -0.606 . . . . 25.0 111.357 177.61 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.0 mm -71.7 137.37 23.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.678 -1.23 . . . . 25.0 107.678 177.779 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.3 mt -118.17 106.48 12.88 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.121 -1.066 . . . . 25.0 108.121 175.925 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 121.425 0.631 . . . . 25.0 110.748 179.537 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.1 mttt . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 107.999 -1.112 . . . . 25.0 107.999 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.539 0.729 0 C-N-CA 118.055 -0.83 . . . . 25.0 112.061 178.308 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 114.825 1.417 . . . . 25.0 114.825 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.4 mt -73.82 -41.68 61.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.339 -0.846 . . . . 25.0 109.881 178.485 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 52.76 33.18 13.52 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.271 1.028 . . . . 25.0 111.587 -177.976 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 m -91.56 162.16 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.75 -1.945 . . . . 25.0 105.75 174.571 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.51 170.99 8.22 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.003 -1.11 . . . . 25.0 108.003 -178.76 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.49 159.15 43.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.16 -0.681 . . . . 25.0 109.16 174.714 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -125.34 129.0 49.07 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.392 -0.822 . . . . 25.0 109.863 176.495 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.08 129.54 39.71 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.217 -0.66 . . . . 25.0 109.217 175.283 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.0 mt -96.01 -20.11 18.95 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.024 0.44 . . . . 25.0 110.489 -178.355 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -146.42 173.32 12.38 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 107.697 -1.223 . . . . 25.0 107.697 -177.664 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -76.04 158.68 31.59 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.992 0.425 . . . . 25.0 111.534 175.246 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -141.71 131.5 24.28 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.386 0.612 . . . . 25.0 112.518 168.642 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.9 t -97.05 122.19 48.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 103.539 -2.763 . . . . 25.0 103.539 173.135 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.42 139.98 36.22 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.837 -1.172 . . . . 25.0 107.837 176.304 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -128.91 -19.65 3.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.902 -0.59 . . . . 25.0 110.839 -179.128 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.44 150.98 39.84 Favored Pre-proline 0 N--CA 1.464 0.252 0 N-CA-C 106.759 -1.571 . . . . 25.0 106.759 171.131 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -68.74 -22.09 37.67 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 117.275 -1.35 . . . . 25.0 112.952 -179.183 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -90.4 -2.23 57.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.771 0.796 . . . . 25.0 110.616 -179.207 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -89.39 139.77 30.18 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.315 0.579 . . . . 25.0 110.471 -175.997 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.3 mt -90.74 128.04 36.53 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.105 0.955 . . . . 25.0 111.727 179.77 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.6 p -87.47 140.41 29.55 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.935 -1.876 . . . . 25.0 105.935 174.309 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.71 167.01 31.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.051 0.453 . . . . 25.0 110.1 178.774 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.32 160.85 19.9 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.639 -0.875 . . . . 25.0 108.639 178.441 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -56.23 134.18 53.01 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 115.221 -0.9 . . . . 25.0 110.096 177.56 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.68 -15.27 63.46 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-O 118.175 -1.347 . . . . 25.0 113.863 177.885 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -60.41 150.53 30.63 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 118.207 1.004 . . . . 25.0 110.826 177.512 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.6 mm -118.29 130.07 73.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.473 -1.239 . . . . 25.0 108.7 179.479 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -136.7 152.77 50.75 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.307 -0.627 . . . . 25.0 109.307 -179.085 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -88.36 128.26 35.5 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.357 -0.608 . . . . 25.0 109.357 177.909 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.4 t -91.91 127.83 43.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.176 -1.046 . . . . 25.0 108.176 179.638 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.62 HD12 HD22 ' A' ' 47' ' ' LEU . 77.3 mt -94.61 -47.84 6.34 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.636 -0.875 . . . . 25.0 108.636 179.889 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -152.05 169.08 23.24 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.517 -0.919 . . . . 25.0 108.517 178.111 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -117.75 153.96 32.53 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 108.029 -1.1 . . . . 25.0 108.029 176.404 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 60.05 40.14 18.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 123.472 1.606 . . . . 25.0 109.855 178.474 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 t -68.26 154.77 41.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.204 -1.816 . . . . 25.0 110.729 -177.122 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 59.46 13.97 3.55 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.486 1.114 . . . . 25.0 110.418 -177.392 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.77 11.41 85.27 Favored Glycine 0 CA--C 1.506 -0.489 0 N-CA-C 111.335 -0.706 . . . . 25.0 111.335 -179.827 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.65 128.83 36.12 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 117.761 0.781 . . . . 25.0 110.067 -177.814 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -70.02 123.24 21.06 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.083 -0.508 . . . . 25.0 110.346 -179.473 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.35 -0.79 88.66 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 116.789 1.475 . . . . 25.0 116.789 175.974 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -100.38 131.73 46.15 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.909 0.855 . . . . 25.0 109.373 176.753 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -114.1 143.2 45.18 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.492 -0.929 . . . . 25.0 108.492 -175.224 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.62 HD22 HD12 ' A' ' 35' ' ' LEU . 0.7 OUTLIER -83.68 122.44 28.62 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.735 -1.58 . . . . 25.0 106.735 177.952 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.6 m -133.34 162.28 32.26 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.231 0.538 . . . . 25.0 111.9 178.146 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -113.45 122.4 47.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.856 -1.164 . . . . 25.0 107.856 173.484 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.5 tp -139.77 132.58 29.14 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.882 -1.155 . . . . 25.0 107.882 -178.745 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 54.63 29.11 10.92 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.059 0.544 . . . . 25.0 111.438 -174.719 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.93 -3.79 73.95 Favored Glycine 0 C--O 1.222 -0.603 0 N-CA-C 115.305 0.882 . . . . 25.0 115.305 178.207 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -109.19 157.35 18.88 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.824 -1.547 . . . . 25.0 106.824 178.639 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -115.0 151.81 33.52 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.154 -0.684 . . . . 25.0 109.154 -177.747 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.73 -161.0 26.56 Favored Glycine 0 CA--C 1.504 -0.623 0 N-CA-C 107.051 -2.42 . . . . 25.0 107.051 -179.726 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.0 pt -115.97 150.3 17.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.212 0.53 . . . . 25.0 112.308 -175.083 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.85 144.94 43.61 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.226 -0.897 . . . . 25.0 110.488 -179.716 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.9 121.91 6.07 Favored 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 118.501 -0.533 . . . . 25.0 112.388 -179.769 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.58 -20.33 67.86 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 115.375 0.91 . . . . 25.0 115.375 -177.113 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -23.19 67.3 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.324 0.861 . . . . 25.0 113.324 -176.267 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -120.95 26.64 8.94 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.939 -0.763 . . . . 25.0 108.939 -179.045 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.0 tp -131.51 150.37 52.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.735 -0.666 . . . . 25.0 110.666 -176.985 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -124.74 123.55 40.23 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 122.223 -0.298 . . . . 25.0 111.787 179.186 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.4 mm -70.17 136.37 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 123.839 0.712 . . . . 25.0 110.001 176.6 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.8 mt -118.38 99.19 6.68 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.774 -1.565 . . . . 25.0 106.774 174.855 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 C--N 1.323 -0.554 0 N-CA-C 106.905 -1.517 . . . . 25.0 106.905 179.438 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 106.375 -1.713 . . . . 25.0 106.375 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 CA--C 1.547 1.172 0 C-N-CA 118.021 -0.853 . . . . 25.0 112.783 179.672 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 121.287 0.565 . . . . 25.0 109.799 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.9 mt -68.24 -37.59 80.95 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.144 -0.935 . . . . 25.0 110.389 -177.963 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.1 m120 54.11 29.11 9.82 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 122.861 1.315 . . . . 25.0 112.031 -179.007 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.9 m -91.99 165.0 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 104.817 -2.29 . . . . 25.0 104.817 172.939 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.67 175.69 5.33 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 119.704 1.138 . . . . 25.0 108.612 -178.414 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.96 154.93 40.09 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.987 -1.006 . . . . 25.0 110.824 174.775 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -113.9 130.17 56.52 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 125.299 1.44 . . . . 25.0 110.506 175.96 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.444 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -70.76 128.57 36.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.959 0.885 . . . . 25.0 110.898 177.662 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -94.79 -18.55 21.12 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.669 -0.696 . . . . 25.0 109.403 -179.117 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -145.73 173.79 11.78 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 124.154 0.909 . . . . 25.0 109.238 179.215 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -85.39 164.25 18.04 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 123.408 0.683 . . . . 25.0 111.896 176.032 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -152.32 144.31 23.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.518 0.599 . . . . 25.0 111.705 176.374 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.8 t -113.73 123.48 69.44 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 N-CA-C 106.678 -1.601 . . . . 25.0 106.678 171.218 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.68 124.29 30.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.703 -1.135 . . . . 25.0 108.25 179.537 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -107.3 -11.04 15.65 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.758 -0.83 . . . . 25.0 108.758 -178.711 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.9 t -110.76 147.26 36.11 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 104.883 -2.265 . . . . 25.0 104.883 176.768 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.69 -18.49 32.58 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 O-C-N 121.946 0.445 . . . . 25.0 112.242 179.086 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -85.63 -12.97 50.07 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.654 -0.703 . . . . 25.0 109.346 179.235 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -87.91 143.3 27.19 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-O 121.32 0.581 . . . . 25.0 111.446 179.664 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.1 mt -98.31 128.62 44.82 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-O 121.884 0.85 . . . . 25.0 112.237 177.834 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.69 134.33 34.36 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 105.718 -1.956 . . . . 25.0 105.718 174.157 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -152.58 168.08 26.75 Favored 'General case' 0 C--O 1.266 1.946 0 CA-C-O 121.71 0.767 . . . . 25.0 110.984 -179.782 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -118.92 159.72 23.28 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.367 1.067 . . . . 25.0 110.241 178.845 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -56.96 132.75 53.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.853 -1.166 . . . . 25.0 107.853 174.757 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.59 -25.15 28.55 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 115.349 -0.841 . . . . 25.0 114.089 -179.479 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -60.09 134.85 57.44 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.358 -0.979 . . . . 25.0 108.358 -175.226 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.5 mm -103.78 127.08 58.19 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 109.22 -0.659 . . . . 25.0 109.22 176.061 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.3 ptp -132.74 156.21 47.47 Favored 'General case' 0 C--O 1.2 -1.511 0 CA-C-N 115.416 -0.811 . . . . 25.0 108.918 -179.181 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.9 m -93.87 119.24 32.54 Favored 'General case' 0 C--O 1.198 -1.635 0 N-CA-C 108.918 -0.771 . . . . 25.0 108.918 -178.444 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.2 t -79.9 121.69 33.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 106.697 -1.594 . . . . 25.0 106.697 177.702 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.3 mt -94.51 -42.14 8.99 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.949 0.881 . . . . 25.0 109.735 179.854 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -146.33 152.19 38.73 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.566 -0.743 . . . . 25.0 109.577 -176.859 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -113.79 150.64 33.16 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 105.945 -1.872 . . . . 25.0 105.945 171.74 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 55.54 43.1 28.96 Favored 'General case' 0 C--O 1.268 2.027 0 O-C-N 125.021 1.45 . . . . 25.0 109.893 -176.876 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.2 t -70.49 151.2 45.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.397 -1.274 . . . . 25.0 111.145 -178.924 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 58.51 18.86 6.04 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.491 1.116 . . . . 25.0 112.069 179.359 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.5 5.15 90.16 Favored Glycine 0 C--O 1.208 -1.529 0 CA-C-N 115.139 -0.937 . . . . 25.0 112.071 178.06 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.9 mt -84.84 136.62 33.58 Favored 'General case' 0 C--O 1.211 -0.93 0 CA-C-N 117.289 0.544 . . . . 25.0 109.623 -174.512 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -80.03 108.35 13.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.902 -1.044 . . . . 25.0 113.351 -179.065 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.79 0.91 74.39 Favored Glycine 0 C--O 1.221 -0.691 0 C-N-CA 119.473 -1.346 . . . . 25.0 116.189 177.924 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -99.58 136.13 39.96 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 117.807 0.804 . . . . 25.0 109.232 173.43 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -113.01 146.19 39.52 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.711 -0.848 . . . . 25.0 108.711 -176.601 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.9 tp -89.9 127.61 36.04 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 106.076 -1.824 . . . . 25.0 106.076 -179.938 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.9 m -137.97 160.46 39.27 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 119.59 1.086 . . . . 25.0 113.778 -179.169 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.3 t -109.22 123.01 48.55 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 106.295 -1.742 . . . . 25.0 106.295 171.569 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.9 tp -137.91 127.52 25.1 Favored 'General case' 0 C--O 1.204 -1.313 0 N-CA-C 107.743 -1.206 . . . . 25.0 107.743 -177.562 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 54.43 35.53 23.39 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.86 0.838 . . . . 25.0 110.691 -176.504 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.21 6.72 88.81 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.512 -0.852 . . . . 25.0 113.858 175.24 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -127.27 148.9 50.21 Favored 'General case' 0 C--O 1.204 -1.304 0 CA-C-N 119.001 1.4 . . . . 25.0 109.121 -176.3 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -102.03 148.35 25.48 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 123.688 0.618 . . . . 25.0 112.077 -178.02 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.67 -179.94 48.8 Favored Glycine 0 C--O 1.25 1.099 0 N-CA-C 106.76 -2.536 . . . . 25.0 106.76 -177.861 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt -103.52 148.56 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.01 0.924 . . . . 25.0 111.753 -174.831 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.87 148.63 43.18 Favored Pre-proline 0 C--O 1.244 0.795 0 CA-C-O 122.68 1.229 . . . . 25.0 110.863 -177.42 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.05 125.21 7.1 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 116.302 -1.999 . . . . 25.0 114.338 -178.353 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.84 -20.77 60.2 Favored Glycine 0 C--O 1.203 -1.829 0 CA-C-N 116.154 -0.476 . . . . 25.0 113.529 179.3 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -68.2 -15.66 63.67 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 121.053 -1.263 . . . . 25.0 112.36 -178.654 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -115.73 15.48 16.44 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.872 -0.517 . . . . 25.0 109.762 -179.148 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 12' ' ' ALA . 29.6 mt -130.03 152.5 49.42 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 117.366 2.358 . . . . 25.0 117.366 -176.757 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt -119.64 126.52 51.34 Favored 'General case' 0 C--O 1.197 -1.7 0 N-CA-C 108.055 -1.091 . . . . 25.0 108.055 175.53 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.5 mm -75.16 137.01 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 O-C-N 124.167 0.917 . . . . 25.0 110.204 177.111 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.3 mt -117.74 105.38 11.93 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.493 1.117 . . . . 25.0 108.528 177.666 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.21 -1.012 0 CA-C-N 114.915 -1.039 . . . . 25.0 110.658 -172.991 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 90.0 mttt . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 119.102 -0.475 . . . . 25.0 110.926 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo . . . . . 0 CA--C 1.562 1.883 0 O-C-N 123.159 1.084 . . . . 25.0 111.55 174.496 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 . . . . . 0 CA--C 1.5 -0.945 0 N-CA-C 113.713 1.005 . . . . 25.0 113.713 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.4 mt -71.99 -41.88 67.14 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.793 -1.094 . . . . 25.0 110.492 175.878 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.8 m120 54.39 33.35 18.4 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 113.606 -1.634 . . . . 25.0 113.814 -178.388 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 m -97.7 166.48 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.156 0 N-CA-C 106.408 -1.701 . . . . 25.0 106.408 178.253 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.3 171.72 7.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.32 -1.487 . . . . 25.0 107.3 -176.272 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.22 157.74 43.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 119.232 0.923 . . . . 25.0 111.774 176.896 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -120.33 127.55 52.44 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.498 -0.774 . . . . 25.0 110.935 179.579 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.93 122.12 18.67 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.635 -1.246 . . . . 25.0 107.635 179.749 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.3 mt -84.89 -27.91 26.32 Favored 'General case' 0 C--O 1.212 -0.876 0 O-C-N 121.879 -0.513 . . . . 25.0 110.776 -178.949 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -138.41 177.07 8.16 Favored 'General case' 0 C--O 1.198 -1.649 0 N-CA-C 108.622 -0.881 . . . . 25.0 108.622 177.216 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.63 170.57 15.9 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.317 0.647 . . . . 25.0 111.806 173.491 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -155.83 141.64 18.03 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 113.981 1.104 . . . . 25.0 113.981 175.02 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.6 131.99 62.6 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 105.774 -1.936 . . . . 25.0 105.774 -179.454 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.96 111.79 15.5 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 124.639 1.212 . . . . 25.0 110.274 -178.996 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -106.53 -1.33 23.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.64 0.733 . . . . 25.0 112.249 -179.208 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.3 m -131.7 154.36 81.78 Favored Pre-proline 0 CA--C 1.501 -0.923 0 N-CA-C 107.418 -1.327 . . . . 25.0 107.418 174.956 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.51 -26.56 40.25 Favored 'Trans proline' 0 C--O 1.259 1.533 0 C-N-CA 116.582 -1.812 . . . . 25.0 113.323 -175.631 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -82.57 -6.83 59.56 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 115.9 -0.591 . . . . 25.0 110.806 179.695 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -85.54 142.61 29.03 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-O 121.929 0.871 . . . . 25.0 111.988 -178.08 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.1 mt -93.73 135.19 35.28 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.605 -0.725 . . . . 25.0 109.089 176.071 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.47 130.15 39.4 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 106.413 -1.699 . . . . 25.0 106.413 174.629 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -150.93 165.89 32.31 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.607 0.717 . . . . 25.0 109.681 -178.583 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -115.1 170.33 8.44 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.666 -0.697 . . . . 25.0 109.906 -179.18 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -65.06 135.67 55.85 Favored 'General case' 0 C--O 1.203 -1.35 0 N-CA-C 108.488 -0.93 . . . . 25.0 108.488 175.825 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.02 -23.5 30.62 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 109.937 -1.265 . . . . 25.0 109.937 175.63 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -61.56 143.74 55.51 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 122.065 0.936 . . . . 25.0 111.362 -175.974 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.1 mm -116.04 120.09 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 114.116 -1.402 . . . . 25.0 109.571 -177.554 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -124.54 151.97 44.04 Favored 'General case' 0 C--N 1.313 -0.999 0 O-C-N 124.072 0.857 . . . . 25.0 109.161 179.0 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.6 m -84.39 127.63 34.11 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 106.822 -1.547 . . . . 25.0 106.822 177.103 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.9 t -90.19 120.88 39.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.51 -0.922 . . . . 25.0 108.51 176.009 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -90.39 -45.1 9.22 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.602 -0.726 . . . . 25.0 111.285 177.374 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -148.79 157.57 43.53 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.387 -0.968 . . . . 25.0 108.387 -175.264 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -118.73 147.63 43.65 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 106.513 -1.662 . . . . 25.0 106.513 176.672 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 55.75 46.38 22.57 Favored 'General case' 0 C--O 1.255 1.355 0 CA-C-O 124.206 1.955 . . . . 25.0 109.394 -177.805 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.438 HG21 HG22 ' A' ' 56' ' ' ILE . 14.6 t -68.59 157.53 35.89 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-N 112.594 -2.094 . . . . 25.0 110.942 -177.691 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 60.03 13.22 3.6 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.381 0.882 . . . . 25.0 113.381 174.413 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.53 16.09 78.48 Favored Glycine 0 CA--C 1.539 1.558 0 N-CA-C 109.296 -1.522 . . . . 25.0 109.296 179.599 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.6 mt -100.82 129.91 46.77 Favored 'General case' 0 C--O 1.206 -1.207 0 N-CA-C 107.348 -1.353 . . . . 25.0 107.348 -178.67 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.93 123.71 27.53 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 122.169 0.985 . . . . 25.0 111.867 177.93 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.57 -0.35 82.86 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 120.215 -0.993 . . . . 25.0 114.683 175.119 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -100.71 134.15 44.11 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.76 -0.83 . . . . 25.0 108.76 175.575 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -114.85 141.4 47.95 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.54 -0.911 . . . . 25.0 108.54 -178.076 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.4 tp -85.61 120.12 26.69 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.565 -0.902 . . . . 25.0 108.565 178.617 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 98.7 m -135.77 158.56 44.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.183 0.438 . . . . 25.0 112.183 -177.334 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.9 t -105.95 121.34 43.9 Favored 'General case' 0 C--O 1.251 1.168 0 C-N-CA 123.987 0.915 . . . . 25.0 108.787 173.804 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 tp -138.14 132.59 32.2 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.288 1.035 . . . . 25.0 109.164 179.967 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.7 m170 54.09 30.93 12.83 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-O 122.813 1.292 . . . . 25.0 109.655 -176.157 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.45 -5.44 73.38 Favored Glycine 0 N--CA 1.462 0.384 0 N-CA-C 116.528 1.371 . . . . 25.0 116.528 176.727 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -110.83 145.91 37.36 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.919 -0.771 . . . . 25.0 108.919 179.396 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -91.52 151.62 20.68 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 124.451 1.094 . . . . 25.0 108.642 178.849 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.27 -176.19 47.65 Favored Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 107.913 -2.075 . . . . 25.0 107.913 -179.595 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.438 HG22 HG21 ' A' ' 39' ' ' THR . 41.6 pt -104.73 148.94 8.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-O 121.977 0.894 . . . . 25.0 111.761 -175.341 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.7 m -143.48 146.38 35.49 Favored Pre-proline 0 C--O 1.246 0.896 0 C-N-CA 123.254 0.622 . . . . 25.0 111.969 177.256 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.97 122.17 7.05 Favored 'Trans proline' 0 C--N 1.358 1.049 0 N-CA-C 114.296 0.845 . . . . 25.0 114.296 -175.86 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.49 -25.56 71.48 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.842 -0.617 . . . . 25.0 114.379 -178.197 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.26 -24.68 60.17 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.044 0.757 . . . . 25.0 113.044 -179.157 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -119.09 31.38 6.66 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 120.929 -1.107 . . . . 25.0 108.789 178.962 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.4 mt -128.26 159.77 34.21 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.383 1.087 . . . . 25.0 110.747 176.538 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -134.46 127.04 30.7 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 115.106 -0.952 . . . . 25.0 108.784 174.738 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.5 mm -73.54 136.71 24.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.995 -0.743 . . . . 25.0 108.995 -179.347 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.5 mt -112.04 89.08 2.97 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 106.847 -1.538 . . . . 25.0 106.847 174.347 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.483 1.201 0 C-N-CA 119.226 -0.99 . . . . 25.0 108.843 176.559 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 109.69 -0.485 . . . . 25.0 109.69 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 C--O 1.24 0.614 0 C-N-CA 117.577 -1.149 . . . . 25.0 111.023 178.901 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 . . . . . 0 C--O 1.201 -1.483 0 CA-C-O 122.04 0.924 . . . . 25.0 109.565 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.6 mt -71.1 -40.91 71.23 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.249 -1.341 . . . . 25.0 111.424 178.751 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.0 m120 57.48 35.84 26.32 Favored 'General case' 0 C--O 1.253 1.275 0 C-N-CA 124.136 0.975 . . . . 25.0 110.753 -178.865 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.6 m -101.4 157.09 4.4 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 N-CA-C 107.687 -1.227 . . . . 25.0 107.687 176.044 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.07 166.25 12.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 118.324 -0.846 . . . . 25.0 109.173 -176.929 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.94 154.59 40.54 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.901 0.773 . . . . 25.0 112.953 172.651 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -117.9 129.49 55.66 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 124.07 0.948 . . . . 25.0 111.086 -179.527 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.43 126.36 29.43 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-O 118.614 -0.708 . . . . 25.0 109.294 177.866 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt -89.01 -28.81 19.94 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.013 0.925 . . . . 25.0 111.376 178.797 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -139.85 170.11 16.48 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.12 -1.437 . . . . 25.0 107.12 179.919 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -83.91 176.18 9.07 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 122.968 0.507 . . . . 25.0 110.642 -177.801 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -151.12 153.34 34.83 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 108.008 -1.108 . . . . 25.0 108.008 -178.216 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.4 t -125.26 136.0 62.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 104.507 -2.405 . . . . 25.0 104.507 170.832 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.27 134.62 42.95 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 114.475 -1.238 . . . . 25.0 110.238 178.013 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -125.22 11.37 8.15 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 123.628 0.58 . . . . 25.0 110.777 -177.341 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.4 t -151.21 150.91 28.34 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 106.228 -1.767 . . . . 25.0 106.228 -179.289 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.75 -12.12 28.49 Favored 'Trans proline' 0 N--CA 1.48 0.683 0 N-CA-C 116.607 1.733 . . . . 25.0 116.607 -175.91 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -83.1 -20.67 34.42 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 107.802 -1.184 . . . . 25.0 107.802 177.73 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -84.06 136.58 33.97 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.723 0.773 . . . . 25.0 110.063 -178.927 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.3 mt -93.57 131.26 39.01 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 113.929 1.085 . . . . 25.0 113.929 -177.997 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 p -86.75 95.1 9.71 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-N 115.212 -0.904 . . . . 25.0 110.85 -179.408 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -126.43 160.57 30.14 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 121.743 -0.598 . . . . 25.0 111.8 179.645 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -121.57 165.47 15.64 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 105.087 -2.19 . . . . 25.0 105.087 -177.254 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -59.02 131.42 50.99 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.54 0.686 . . . . 25.0 110.656 177.532 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.74 -20.02 51.05 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 121.754 -0.591 . . . . 25.0 114.295 -179.006 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -62.29 131.32 48.95 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 106.932 -1.507 . . . . 25.0 106.932 178.723 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.6 mm -102.23 132.43 48.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 106.939 -1.504 . . . . 25.0 106.939 177.817 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 11.2 ptp -131.8 161.87 31.9 Favored 'General case' 0 CA--C 1.495 -1.145 0 O-C-N 121.241 -0.912 . . . . 25.0 109.244 -179.836 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.2 m -101.62 119.19 38.39 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.678 -1.601 . . . . 25.0 106.678 -177.979 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 t -81.69 130.63 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 123.513 1.625 . . . . 25.0 109.321 -179.83 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.4 mt -100.41 -42.92 6.41 Favored 'General case' 0 C--O 1.204 -1.306 0 O-C-N 121.197 -0.939 . . . . 25.0 112.895 178.311 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -148.3 147.41 29.28 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-O 118.539 -0.743 . . . . 25.0 109.518 178.808 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -107.05 147.32 30.11 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.311 -1.366 . . . . 25.0 107.311 173.188 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 56.4 39.65 29.97 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 123.279 1.514 . . . . 25.0 110.665 -173.91 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -64.18 150.71 45.18 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 113.744 -1.571 . . . . 25.0 110.252 -175.327 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 56.7 22.65 7.03 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.076 -1.42 . . . . 25.0 113.3 178.225 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.32 16.93 73.8 Favored Glycine 0 CA--C 1.501 -0.788 0 C-N-CA 120.492 -0.861 . . . . 25.0 112.347 -179.24 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.3 mt -92.66 130.5 38.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.528 -1.286 . . . . 25.0 107.528 175.438 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -75.2 122.22 23.31 Favored 'General case' 0 C--O 1.258 1.526 0 O-C-N 121.232 -0.918 . . . . 25.0 110.68 176.996 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.83 -5.13 85.36 Favored Glycine 0 C--N 1.331 0.303 0 N-CA-C 116.089 1.196 . . . . 25.0 116.089 172.686 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -97.07 136.04 38.19 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 117.824 0.812 . . . . 25.0 109.764 177.085 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -114.41 142.85 45.82 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-O 117.595 -1.193 . . . . 25.0 108.019 -177.946 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.5 tp -85.42 125.28 32.87 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.128 -2.175 . . . . 25.0 105.128 175.059 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.8 m -135.47 164.08 28.61 Favored 'General case' 0 C--O 1.253 1.289 0 O-C-N 121.705 -0.622 . . . . 25.0 109.862 177.336 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.9 t -112.61 120.61 42.16 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.215 -1.402 . . . . 25.0 107.215 171.052 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.8 tp -132.52 136.45 46.64 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 105.756 -1.942 . . . . 25.0 105.756 -175.785 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.1 m170 54.16 29.69 10.9 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.527 0.68 . . . . 25.0 109.985 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.91 11.04 81.18 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-O 118.454 -1.192 . . . . 25.0 116.061 178.919 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -122.66 146.86 47.08 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.356 -1.35 . . . . 25.0 107.356 175.477 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -89.08 160.8 16.87 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.15 -1.055 . . . . 25.0 108.15 178.009 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.43 -174.43 41.91 Favored Glycine 0 C--O 1.242 0.623 0 N-CA-C 108.349 -1.901 . . . . 25.0 108.349 -178.758 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 pt -118.57 152.92 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.615 0 CA-C-O 122.71 1.243 . . . . 25.0 111.793 -172.238 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.9 m -143.92 150.91 51.27 Favored Pre-proline 0 C--N 1.306 -1.288 0 CA-C-N 112.384 -2.189 . . . . 25.0 110.807 -174.842 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.3 128.17 10.3 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 O-C-N 121.949 0.447 . . . . 25.0 112.565 -179.318 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.57 -22.42 78.99 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 118.962 -1.59 . . . . 25.0 115.642 -174.624 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -28.18 69.78 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 122.094 -0.651 . . . . 25.0 112.38 -175.54 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -108.35 28.02 8.75 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 122.013 0.911 . . . . 25.0 110.322 178.985 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.5 mt -121.37 159.17 26.7 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 114.423 1.268 . . . . 25.0 114.423 175.126 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -134.94 115.51 13.66 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.779 0.832 . . . . 25.0 109.729 176.36 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.7 mm -67.03 129.15 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 112.422 0.527 . . . . 25.0 112.422 177.834 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.5 mt -105.53 78.03 1.33 Allowed 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.131 -1.433 . . . . 25.0 107.131 179.219 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.813 0 N-CA-C 109.744 -0.465 . . . . 25.0 109.744 178.0 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.9 mttt . . . . . 0 CA--C 1.547 0.86 0 N-CA-C 106.71 -1.589 . . . . 25.0 106.71 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 C--N 1.36 1.156 0 C-N-CA 117.565 -1.157 . . . . 25.0 110.278 174.203 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 CA-C-O 123.084 1.38 . . . . 25.0 115.255 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.5 p -119.41 41.71 3.04 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.438 -1.036 . . . . 25.0 110.683 -177.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.82 148.51 42.78 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.844 -0.798 . . . . 25.0 108.844 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -140.38 141.18 35.62 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 120.82 0.343 . . . . 25.0 110.285 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -79.98 167.88 19.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.589 -0.732 . . . . 25.0 110.802 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.8 mt -65.48 -42.15 92.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.598 -0.728 . . . . 25.0 110.294 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 56.27 30.92 17.56 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.206 1.002 . . . . 25.0 111.882 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.7 m -88.62 163.47 2.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 105.526 -2.027 . . . . 25.0 105.526 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.61 173.4 6.56 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.89 -0.782 . . . . 25.0 108.89 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.78 162.46 40.99 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.72 -0.474 . . . . 25.0 109.72 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -126.69 135.6 51.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.817 -1.083 . . . . 25.0 109.648 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.492 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -72.62 120.63 18.5 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.803 -0.635 . . . . 25.0 109.295 172.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.62 -23.25 24.33 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.922 -0.77 . . . . 25.0 108.922 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -140.54 172.28 12.94 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.456 -1.312 . . . . 25.0 107.456 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.72 164.34 18.62 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 123.129 0.572 . . . . 25.0 110.417 174.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -153.73 130.74 11.01 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.962 0.505 . . . . 25.0 110.725 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.23 118.94 48.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 106.035 -1.839 . . . . 25.0 106.035 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.43 143.08 51.93 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.276 -0.874 . . . . 25.0 109.896 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -116.69 -34.84 4.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.039 -0.982 . . . . 25.0 109.685 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.5 m -93.44 153.97 41.34 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.068 -0.716 . . . . 25.0 109.068 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.43 -22.27 33.83 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 117.782 -1.012 . . . . 25.0 113.645 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -81.12 -16.18 53.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.73 0.776 . . . . 25.0 110.85 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -84.52 138.36 32.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.489 0.661 . . . . 25.0 110.299 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.6 mt -92.84 130.49 38.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.61 0.719 . . . . 25.0 110.048 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.6 t -91.55 137.57 32.26 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.686 -1.598 . . . . 25.0 106.686 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -154.09 166.19 33.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.679 0.752 . . . . 25.0 112.642 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -110.09 158.87 17.84 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.638 -0.875 . . . . 25.0 108.638 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -57.48 131.03 48.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.701 -1.222 . . . . 25.0 107.701 171.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.23 -19.9 46.98 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-O 119.154 -0.803 . . . . 25.0 113.889 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -59.74 144.71 47.47 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.76 0.79 . . . . 25.0 110.545 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.4 mm -114.04 130.69 67.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.58 -1.191 . . . . 25.0 107.836 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -135.34 156.47 48.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.967 -0.383 . . . . 25.0 109.967 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.7 m -92.66 126.17 37.63 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.159 -1.052 . . . . 25.0 108.159 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.5 t -89.86 122.82 41.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.259 -1.015 . . . . 25.0 108.259 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.644 HD12 HD22 ' A' ' 47' ' ' LEU . 77.4 mt -88.26 -48.07 7.95 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.646 -0.706 . . . . 25.0 109.14 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -152.52 167.03 30.14 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.345 -0.983 . . . . 25.0 108.345 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -116.84 154.29 30.99 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 106.811 -1.551 . . . . 25.0 106.811 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 58.13 40.6 24.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.918 1.818 . . . . 25.0 108.982 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -64.87 149.64 49.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 112.59 -2.095 . . . . 25.0 110.925 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 60.33 9.56 2.02 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.98 0.912 . . . . 25.0 113.37 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.99 12.95 80.35 Favored Glycine 0 C--N 1.33 0.244 0 N-CA-C 111.114 -0.795 . . . . 25.0 111.114 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 99.0 mt -91.24 117.87 30.0 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.42 -0.585 . . . . 25.0 109.42 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -63.6 126.47 27.63 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.707 -0.679 . . . . 25.0 110.928 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.12 -0.28 84.02 Favored Glycine 0 CA--C 1.518 0.261 0 N-CA-C 115.515 0.966 . . . . 25.0 115.515 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -100.89 133.49 45.29 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 119.012 1.406 . . . . 25.0 109.873 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -113.47 141.97 46.48 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.771 -0.825 . . . . 25.0 108.771 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.644 HD22 HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -82.39 121.66 27.0 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.596 -2.001 . . . . 25.0 105.596 177.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 88.4 m -129.88 160.92 32.05 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.829 -0.348 . . . . 25.0 111.39 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -113.9 122.03 45.75 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.989 -1.856 . . . . 25.0 105.989 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.0 tp -145.5 139.7 26.98 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.819 -1.178 . . . . 25.0 107.819 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.9 m170 57.25 27.0 12.98 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.412 0.685 . . . . 25.0 111.97 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.1 0.29 89.46 Favored Glycine 0 C--O 1.221 -0.704 0 N-CA-C 114.9 0.72 . . . . 25.0 114.9 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -124.15 156.14 37.23 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 117.89 0.845 . . . . 25.0 109.757 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -102.37 154.98 18.55 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.326 -0.62 . . . . 25.0 109.326 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.43 -162.12 29.9 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 106.427 -2.669 . . . . 25.0 106.427 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 pt -118.55 151.49 20.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.649 0.737 . . . . 25.0 111.876 -174.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.2 m -140.38 146.93 47.59 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 114.929 -1.032 . . . . 25.0 110.025 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.87 122.16 7.09 Favored 'Trans proline' 0 C--O 1.241 0.65 0 C-N-CA 118.35 -0.633 . . . . 25.0 112.434 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.94 -23.09 65.38 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 121.607 -0.33 . . . . 25.0 113.01 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.39 -20.42 64.42 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 122.335 -0.509 . . . . 25.0 112.203 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -109.48 12.28 24.58 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 122.194 -0.317 . . . . 25.0 111.777 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -126.72 156.79 40.57 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 114.946 1.461 . . . . 25.0 114.946 -174.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -129.29 123.1 31.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.444 -0.798 . . . . 25.0 110.297 175.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.4 mm -67.76 137.21 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.772 -0.825 . . . . 25.0 108.772 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.6 mt -117.76 115.75 25.63 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.43 -1.693 . . . . 25.0 106.43 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.1 m -98.52 157.5 3.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.38 -0.6 . . . . 25.0 109.38 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.56 -174.81 45.12 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 108.682 -1.767 . . . . 25.0 108.682 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 97.6 mtp -84.43 160.48 20.58 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.888 -1.153 . . . . 25.0 107.888 176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -83.99 140.44 31.89 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.406 -1.702 . . . . 25.0 106.406 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -90.45 157.45 17.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.178 0.513 . . . . 25.0 109.738 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -106.72 20.1 19.51 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.036 -0.529 . . . . 25.0 109.629 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -134.64 153.05 78.74 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 105.671 -1.974 . . . . 25.0 105.671 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -71.73 153.41 59.27 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 117.896 -0.936 . . . . 25.0 113.86 -176.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.01 158.94 23.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.594 -0.521 . . . . 25.0 109.594 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.14 60.43 0.57 Allowed Glycine 0 C--O 1.224 -0.494 0 CA-C-N 116.259 -0.428 . . . . 25.0 112.426 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.7 t -78.76 156.04 29.03 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 122.621 -0.341 . . . . 25.0 110.794 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -164.33 176.77 40.21 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 109.74 -1.344 . . . . 25.0 109.74 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.9 -174.37 39.36 Favored Glycine 0 C--O 1.226 -0.385 0 N-CA-C 110.531 -1.028 . . . . 25.0 110.531 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.7 t -145.59 153.35 40.96 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.043 -0.725 . . . . 25.0 109.043 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.13 88.49 1.18 Allowed Glycine 0 C--O 1.226 -0.371 0 C-N-CA 121.471 -0.395 . . . . 25.0 112.495 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.8 m -79.13 144.28 34.66 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.553 -0.381 . . . . 25.0 110.221 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.91 153.89 52.44 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 108.398 -1.881 . . . . 25.0 108.398 174.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.9 m -118.02 115.19 24.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.476 0.638 . . . . 25.0 111.04 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -105.25 81.78 1.75 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.212 -1.032 . . . . 25.0 108.212 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.6 pttt -158.24 155.87 29.72 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.529 0.566 . . . . 25.0 112.529 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -113.02 -6.22 13.74 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.012 -1.477 . . . . 25.0 107.012 166.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -59.92 116.37 4.08 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.097 -0.956 . . . . 25.0 108.575 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.4 m -108.7 141.73 23.93 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.698 0.285 . . . . 25.0 111.639 -173.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.52 164.17 34.46 Favored 'Trans proline' 0 C--N 1.346 0.431 0 N-CA-C 114.79 1.035 . . . . 25.0 114.79 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -66.24 158.9 52.49 Favored 'Trans proline' 0 C--N 1.351 0.709 0 CA-C-O 120.984 0.327 . . . . 25.0 112.091 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.28 160.63 48.13 Favored 'Trans proline' 0 C--N 1.347 0.46 0 N-CA-C 114.386 0.879 . . . . 25.0 114.386 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -83.15 140.34 42.54 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 106.029 -1.841 . . . . 25.0 106.029 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.42 167.72 25.54 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 O-C-N 121.992 0.469 . . . . 25.0 112.864 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.58 152.66 53.91 Favored 'Trans proline' 0 C--N 1.353 0.797 0 N-CA-C 114.656 0.983 . . . . 25.0 114.656 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -115.4 43.3 2.07 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.827 -0.624 . . . . 25.0 110.19 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.21 123.47 29.6 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.508 -0.923 . . . . 25.0 108.508 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -77.0 -10.69 59.53 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.147 1.166 . . . . 25.0 114.147 -173.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 36.4 t -162.58 135.01 5.58 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.886 -0.783 . . . . 25.0 108.886 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.8 t 56.46 -160.37 0.21 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.631 0.729 . . . . 25.0 111.565 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--O 1.209 -1.074 0 CA-C-O 124.108 1.909 . . . . 25.0 111.011 -177.886 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.113 0 CA-C-O 123.371 1.54 . . . . 25.0 115.613 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.7 p -122.19 65.71 0.93 Allowed 'General case' 0 C--O 1.223 -0.339 0 O-C-N 120.998 -1.295 . . . . 25.0 111.36 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.6 ttm -62.66 -30.34 71.3 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.48 -0.327 . . . . 25.0 111.149 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? 54.99 80.26 0.13 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.756 0.822 . . . . 25.0 112.867 175.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -66.57 162.88 19.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.634 0.731 . . . . 25.0 111.849 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.9 mt -69.79 -40.72 75.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.045 -0.98 . . . . 25.0 109.899 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.2 m120 57.6 23.61 9.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.614 1.165 . . . . 25.0 113.157 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.7 m -85.65 162.98 2.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.387 -0.968 . . . . 25.0 108.387 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.74 168.18 10.49 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.374 -0.829 . . . . 25.0 110.098 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.6 166.81 26.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.014 0.435 . . . . 25.0 110.781 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HB2' HD11 ' A' ' 65' ' ' LEU . 29.2 ttmt -133.31 135.59 44.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.951 -1.022 . . . . 25.0 110.737 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.477 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -73.38 131.99 42.5 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.703 0.627 . . . . 25.0 110.583 173.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.22 -21.96 15.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.983 0.421 . . . . 25.0 110.898 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -143.47 168.38 19.98 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.344 -1.725 . . . . 25.0 106.344 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -75.69 160.44 30.06 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 123.459 0.474 . . . . 25.0 111.027 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -146.81 147.81 31.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.215 -0.291 . . . . 25.0 110.215 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.6 t -120.76 132.11 71.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 104.519 -2.4 . . . . 25.0 104.519 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.58 122.06 21.64 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.336 -0.987 . . . . 25.0 108.336 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -108.86 4.94 24.04 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.324 -0.991 . . . . 25.0 108.324 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.6 m -145.05 152.4 51.22 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 106.771 -1.566 . . . . 25.0 106.771 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.9 -21.58 32.64 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 N-CA-C 115.936 1.475 . . . . 25.0 115.936 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.28 -12.7 54.23 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.95 0.881 . . . . 25.0 110.238 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -82.98 139.34 33.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.943 0.878 . . . . 25.0 111.406 -177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.415 ' HB2' HG13 ' A' ' 57' ' ' VAL . 67.1 mt -90.98 127.68 36.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.185 0.993 . . . . 25.0 109.672 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -88.88 139.54 30.35 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 106.225 -1.769 . . . . 25.0 106.225 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -156.66 165.18 36.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.963 0.411 . . . . 25.0 110.605 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -110.83 162.79 14.44 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.566 -0.531 . . . . 25.0 109.566 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -58.5 131.25 50.19 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.545 -0.752 . . . . 25.0 109.386 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.09 -11.17 72.81 Favored Glycine 0 CA--C 1.517 0.205 0 CA-C-O 119.039 -0.867 . . . . 25.0 114.48 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -62.49 150.57 39.79 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 118.193 0.996 . . . . 25.0 109.636 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.6 mm -116.28 134.31 60.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.9 -1.045 . . . . 25.0 109.289 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -139.89 160.27 40.29 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.167 -0.679 . . . . 25.0 109.167 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.7 m -97.22 127.25 43.01 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.043 -1.095 . . . . 25.0 108.043 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.9 t -90.5 126.48 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 107.343 -1.354 . . . . 25.0 107.343 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.636 HD12 HD22 ' A' ' 47' ' ' LEU . 82.1 mt -94.96 -43.1 8.32 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.889 -0.782 . . . . 25.0 108.889 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -150.23 155.08 39.07 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.679 -0.86 . . . . 25.0 108.679 -177.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -111.65 149.67 31.21 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.105 -0.702 . . . . 25.0 109.105 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 56.38 39.9 29.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 123.61 1.672 . . . . 25.0 108.654 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -64.31 153.56 37.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 112.591 -2.095 . . . . 25.0 110.777 -176.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 60.76 8.95 1.98 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.683 0.793 . . . . 25.0 111.976 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.39 13.62 81.46 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.114 -0.794 . . . . 25.0 111.114 -176.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.5 mt -88.05 126.75 35.26 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.066 0.46 . . . . 25.0 109.8 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -67.64 125.03 24.92 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.352 -0.385 . . . . 25.0 110.665 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.0 1.46 85.26 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 117.038 1.575 . . . . 25.0 117.038 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -100.94 134.23 44.23 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 119.176 1.488 . . . . 25.0 109.849 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -113.79 140.68 48.1 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.909 -0.775 . . . . 25.0 108.909 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.636 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -79.81 123.62 27.89 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 104.821 -2.288 . . . . 25.0 104.821 176.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 98.0 m -134.98 163.07 30.69 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.668 -0.413 . . . . 25.0 111.562 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.0 t -117.21 126.5 52.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.908 -1.886 . . . . 25.0 105.908 170.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.0 tp -138.7 126.82 22.65 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.072 -1.455 . . . . 25.0 107.072 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.0 m170 55.54 30.38 15.13 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.273 0.559 . . . . 25.0 111.6 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.42 -4.87 80.11 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 116.115 1.206 . . . . 25.0 116.115 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -110.01 152.58 25.74 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.865 -1.161 . . . . 25.0 107.865 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -106.75 160.43 15.48 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.57 -0.53 . . . . 25.0 109.57 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.11 -160.11 31.52 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 105.398 -3.081 . . . . 25.0 105.398 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.1 pt -120.48 152.84 23.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.794 0.807 . . . . 25.0 111.485 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.415 HG13 ' HB2' ' A' ' 24' ' ' LEU . 2.9 m -139.0 145.56 45.88 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 114.714 -1.13 . . . . 25.0 109.111 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.73 124.54 7.59 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 117.045 -1.504 . . . . 25.0 112.19 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.84 -10.27 72.01 Favored Glycine 0 C--O 1.223 -0.537 0 CA-C-N 116.032 -0.531 . . . . 25.0 112.774 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.76 -19.32 62.34 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.39 -0.476 . . . . 25.0 112.083 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -130.7 27.34 4.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.117 -0.492 . . . . 25.0 110.47 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 12' ' ' ALA . 0.9 OUTLIER -129.26 156.2 44.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.303 0.573 . . . . 25.0 111.329 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -129.64 127.74 41.22 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.811 -0.631 . . . . 25.0 110.59 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.8 mm -72.09 135.26 28.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.131 -1.063 . . . . 25.0 108.131 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 11' ' ' LYS . 83.4 mt -119.35 104.6 10.52 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.161 -0.681 . . . . 25.0 109.161 176.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.9 m -83.58 61.87 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 122.044 0.926 . . . . 25.0 109.208 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.29 174.07 30.71 Favored Glycine 0 C--O 1.221 -0.714 0 CA-C-N 115.297 -0.865 . . . . 25.0 113.035 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -76.04 7.59 3.95 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.368 0.877 . . . . 25.0 113.368 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -87.66 60.23 5.85 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.439 0.637 . . . . 25.0 112.069 -175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -66.91 -28.91 68.69 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 114.761 -1.109 . . . . 25.0 108.843 173.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -66.8 149.63 50.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.117 -0.947 . . . . 25.0 109.436 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -55.12 146.06 41.78 Favored Pre-proline 0 C--O 1.24 0.601 0 CA-C-N 115.747 -0.66 . . . . 25.0 111.44 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.82 175.33 10.48 Favored 'Trans proline' 0 C--N 1.348 0.532 0 O-C-N 122.177 0.567 . . . . 25.0 112.944 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.14 170.63 14.71 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.961 -1.126 . . . . 25.0 107.961 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.21 -154.61 30.1 Favored Glycine 0 C--O 1.223 -0.545 0 O-C-N 123.476 0.485 . . . . 25.0 112.235 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 m 56.61 48.32 16.75 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.719 1.007 . . . . 25.0 113.719 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.53 163.86 51.82 Favored Glycine 0 CA--C 1.516 0.142 0 N-CA-C 111.252 -0.739 . . . . 25.0 111.252 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.98 62.26 4.56 Favored Glycine 0 C--O 1.222 -0.639 0 O-C-N 122.386 -0.479 . . . . 25.0 113.478 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.4 m -67.28 -19.81 65.55 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 114.057 1.132 . . . . 25.0 114.057 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.65 -170.7 46.43 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.053 -0.594 . . . . 25.0 112.634 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.9 t -157.08 163.64 38.77 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.669 -1.604 . . . . 25.0 106.669 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.1 -173.85 34.96 Favored Glycine 0 C--O 1.235 0.164 0 N-CA-C 110.687 -0.965 . . . . 25.0 110.687 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.8 t -156.03 144.82 20.33 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.836 -0.801 . . . . 25.0 108.836 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -150.34 148.96 29.45 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.044 -1.835 . . . . 25.0 106.044 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -79.96 114.85 19.18 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.157 -0.682 . . . . 25.0 109.157 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -127.19 168.39 14.76 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.405 -0.591 . . . . 25.0 109.405 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -64.58 154.27 36.73 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.255 0.835 . . . . 25.0 113.255 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.3 m -78.98 149.74 73.99 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.365 -0.834 . . . . 25.0 111.008 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.14 161.41 35.42 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 N-CA-C 114.227 0.818 . . . . 25.0 114.227 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.01 152.6 80.21 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 118.254 -0.697 . . . . 25.0 112.088 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.44 150.67 70.44 Favored 'Trans proline' 0 C--N 1.352 0.714 0 N-CA-C 116.006 1.502 . . . . 25.0 116.006 -173.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -85.35 152.56 58.13 Favored Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 115.522 -0.763 . . . . 25.0 110.162 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.09 161.84 42.29 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 O-C-N 122.201 0.579 . . . . 25.0 112.988 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.63 156.8 55.03 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 120.348 0.699 . . . . 25.0 113.853 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 65.2 mtt85 -101.95 -10.8 19.47 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.271 0.471 . . . . 25.0 112.271 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.6 p -141.27 149.3 41.12 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 106.594 -1.632 . . . . 25.0 106.594 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -148.76 29.24 0.83 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.538 0.685 . . . . 25.0 110.045 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.2 m -118.87 164.02 16.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.419 -0.809 . . . . 25.0 109.734 -176.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.6 t 55.39 55.9 6.91 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.77 1.272 . . . . 25.0 112.334 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.5 mp . . . . . 0 C--O 1.216 -0.702 0 CA-C-O 124.349 2.023 . . . . 25.0 110.059 178.62 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.711 0 CA-C-O 123.891 1.828 . . . . 25.0 113.121 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m 56.63 23.78 8.11 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 112.292 -1.954 . . . . 25.0 113.117 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.9 ttt -99.81 -27.84 13.43 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.517 1.673 . . . . 25.0 115.517 -171.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.18 13.27 2.61 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 112.564 0.579 . . . . 25.0 112.564 -176.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -71.06 162.01 30.16 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.327 1.232 . . . . 25.0 114.327 -174.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.8 mt -65.59 -39.22 91.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.512 -1.222 . . . . 25.0 110.687 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 57.27 28.72 15.62 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.173 0.989 . . . . 25.0 112.444 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 m -90.35 152.11 3.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.143 -1.058 . . . . 25.0 108.143 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.98 167.38 12.84 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.187 -0.671 . . . . 25.0 109.187 -176.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.35 161.17 43.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.732 0.301 . . . . 25.0 111.27 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -126.9 129.58 48.48 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.688 0.795 . . . . 25.0 110.157 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.46 131.28 43.81 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.746 -0.464 . . . . 25.0 109.746 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.0 mt -95.83 -21.16 18.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.074 0.464 . . . . 25.0 111.034 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -144.48 175.95 9.75 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 103.814 -2.661 . . . . 25.0 103.814 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -92.05 179.17 5.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.301 0.5 . . . . 25.0 111.53 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -159.04 154.77 26.26 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.075 0.55 . . . . 25.0 110.135 173.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.4 t -124.6 127.4 72.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 105.986 -1.857 . . . . 25.0 105.986 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.74 129.6 38.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.961 -0.563 . . . . 25.0 110.783 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -105.33 1.11 27.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.536 0.684 . . . . 25.0 109.838 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.9 p -151.83 158.86 33.83 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.016 -1.105 . . . . 25.0 108.016 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.75 -16.85 33.39 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 118.321 -0.652 . . . . 25.0 112.873 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.75 -21.68 54.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.419 0.628 . . . . 25.0 110.044 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -95.46 146.21 24.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.522 0.677 . . . . 25.0 111.411 -176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' HB2' HG13 ' A' ' 57' ' ' VAL . 55.1 mt -100.14 132.61 45.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.55 0.691 . . . . 25.0 110.166 177.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.6 m -82.64 146.44 29.1 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 105.527 -2.027 . . . . 25.0 105.527 172.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -157.73 164.87 36.67 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.358 -0.608 . . . . 25.0 109.358 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.86 158.59 23.73 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.526 -0.916 . . . . 25.0 108.526 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -56.24 128.13 34.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.571 -0.741 . . . . 25.0 109.891 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.72 -10.85 64.63 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-O 118.985 -0.897 . . . . 25.0 114.061 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -61.52 148.7 41.22 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 118.033 0.916 . . . . 25.0 110.775 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.4 mm -112.02 134.02 55.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.457 -1.247 . . . . 25.0 108.481 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.4 ptp -143.19 162.23 36.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.057 -0.72 . . . . 25.0 109.057 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.9 m -98.81 125.87 44.29 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.042 -1.096 . . . . 25.0 108.042 177.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.8 t -89.6 125.61 42.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.786 -1.19 . . . . 25.0 107.786 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.714 HD12 HD22 ' A' ' 47' ' ' LEU . 73.1 mt -94.54 -49.48 5.64 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.455 -1.248 . . . . 25.0 109.644 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -143.34 160.39 40.61 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.545 -1.279 . . . . 25.0 107.545 -174.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -125.68 150.71 47.41 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 106.899 -1.519 . . . . 25.0 106.899 175.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 56.27 39.15 30.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.398 1.571 . . . . 25.0 108.274 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -66.08 148.61 51.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.443 -1.708 . . . . 25.0 109.813 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 60.18 11.81 2.96 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.72 0.808 . . . . 25.0 113.013 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.61 13.62 81.25 Favored Glycine 0 C--O 1.229 -0.177 0 N-CA-C 111.296 -0.721 . . . . 25.0 111.296 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.9 mt -91.19 112.19 23.99 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.709 -0.478 . . . . 25.0 109.709 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -58.52 124.92 21.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.497 -0.774 . . . . 25.0 110.858 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.0 -0.19 83.79 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 116.02 1.168 . . . . 25.0 116.02 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -98.03 132.26 43.73 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 119.303 1.552 . . . . 25.0 110.76 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -111.15 138.58 47.42 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.206 -1.035 . . . . 25.0 108.206 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.714 HD22 HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -82.21 125.82 31.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 104.681 -2.34 . . . . 25.0 104.681 178.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.9 m -134.65 164.29 27.84 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 111.951 0.352 . . . . 25.0 111.951 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.0 t -117.27 123.84 47.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.828 -1.545 . . . . 25.0 106.828 171.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.8 tp -151.73 142.63 22.99 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 106.875 -1.528 . . . . 25.0 106.875 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 56.4 28.25 13.29 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.319 0.647 . . . . 25.0 112.073 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.75 1.15 76.95 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 115.006 0.762 . . . . 25.0 115.006 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -123.62 161.05 25.79 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.026 -0.731 . . . . 25.0 109.026 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -108.53 156.63 19.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.174 -0.676 . . . . 25.0 109.174 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.58 -161.22 28.37 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 105.383 -3.087 . . . . 25.0 105.383 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.9 pt -120.73 153.18 23.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-O 121.728 0.775 . . . . 25.0 111.034 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 24' ' ' LEU . 3.2 m -141.74 147.38 45.16 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 114.473 -1.239 . . . . 25.0 107.674 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.82 126.48 8.83 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 117.086 -1.476 . . . . 25.0 111.713 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.17 -12.0 75.63 Favored Glycine 0 C--O 1.222 -0.621 0 CA-C-N 116.293 -0.412 . . . . 25.0 113.131 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -66.67 -13.54 61.37 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.781 0.66 . . . . 25.0 112.781 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -131.97 27.13 4.58 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.215 -0.661 . . . . 25.0 109.215 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.8 tp -131.96 147.44 52.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.737 -0.665 . . . . 25.0 109.709 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -125.55 120.09 29.92 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.408 -0.36 . . . . 25.0 111.743 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.98 136.1 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.037 -0.727 . . . . 25.0 109.037 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.1 mt -116.78 81.66 1.67 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.945 -1.502 . . . . 25.0 106.945 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.18 -26.04 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.158 0.504 . . . . 25.0 111.704 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.45 162.15 27.61 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 106.272 -2.731 . . . . 25.0 106.272 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 66.2 mmm -157.01 -40.11 0.07 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 117.679 0.739 . . . . 25.0 110.666 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -139.93 148.83 42.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.883 -0.784 . . . . 25.0 108.883 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -95.68 8.67 42.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.729 0.776 . . . . 25.0 111.047 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -117.96 162.64 17.81 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.8 -0.636 . . . . 25.0 110.453 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -59.04 144.57 82.3 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.312 -0.625 . . . . 25.0 109.312 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.36 148.68 68.2 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 117.837 -0.975 . . . . 25.0 113.477 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.93 29.92 0.65 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.647 -0.706 . . . . 25.0 110.052 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.93 118.54 5.88 Favored Glycine 0 C--O 1.22 -0.726 0 C-N-CA 120.954 -0.641 . . . . 25.0 112.174 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.3 t -71.64 -37.65 70.83 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.873 0.694 . . . . 25.0 112.873 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.5 -132.28 10.97 Favored Glycine 0 C--O 1.225 -0.441 0 C-N-CA 120.5 -0.857 . . . . 25.0 111.905 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.85 -14.33 62.07 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 115.071 0.788 . . . . 25.0 115.071 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 65.3 p -87.32 64.84 8.46 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.013 -0.698 . . . . 25.0 112.863 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.75 50.23 0.36 Allowed Glycine 0 C--O 1.219 -0.843 0 N-CA-C 115.717 1.047 . . . . 25.0 115.717 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.8 p -65.58 -32.66 74.37 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.749 1.389 . . . . 25.0 114.749 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.82 33.15 86.13 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 120.827 -0.701 . . . . 25.0 113.924 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.1 t -75.05 145.28 42.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.802 0.301 . . . . 25.0 111.602 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.35 166.0 0.13 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.952 1.301 . . . . 25.0 113.939 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -65.13 -41.15 95.1 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.849 0.685 . . . . 25.0 112.849 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 55.56 -165.36 0.12 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.282 0.845 . . . . 25.0 113.282 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -71.39 148.37 47.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.581 -0.736 . . . . 25.0 110.654 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.7 p -75.29 137.56 71.75 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.429 -0.351 . . . . 25.0 111.008 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.57 158.76 43.56 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 118.263 -0.691 . . . . 25.0 112.772 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.8 148.56 86.65 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 117.705 -1.064 . . . . 25.0 111.75 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.55 151.17 58.49 Favored 'Trans proline' 0 C--N 1.348 0.548 0 N-CA-C 116.481 1.685 . . . . 25.0 116.481 -170.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -73.13 145.11 85.6 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 109.132 -0.692 . . . . 25.0 109.132 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.39 166.47 29.4 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 O-C-N 121.963 0.454 . . . . 25.0 112.704 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -60.37 158.94 29.04 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 120.751 0.968 . . . . 25.0 114.523 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -121.45 24.73 9.76 Favored 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 113.953 1.094 . . . . 25.0 113.953 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.3 p 51.32 -0.57 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 118.828 2.899 . . . . 25.0 118.828 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.8 mtp85 -70.52 -6.99 40.3 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.347 -0.846 . . . . 25.0 111.115 177.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.1 t -150.03 90.88 1.72 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.71 -1.219 . . . . 25.0 107.71 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 30.9 p -154.7 172.55 17.74 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.044 -1.095 . . . . 25.0 108.044 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.214 -0.809 0 CA-C-O 124.671 2.177 . . . . 25.0 110.939 175.235 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 CA-C-O 123.046 1.359 . . . . 25.0 115.215 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.0 m -66.87 140.0 57.77 Favored 'General case' 0 C--N 1.338 0.093 0 O-C-N 121.344 -1.091 . . . . 25.0 110.04 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.1 mtt -129.15 123.55 32.42 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.76 -0.459 . . . . 25.0 109.76 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -150.34 114.61 5.14 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 108.198 -1.038 . . . . 25.0 108.198 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -135.7 168.33 19.48 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 123.233 0.333 . . . . 25.0 110.354 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.2 mt -67.73 -39.86 84.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.652 -0.704 . . . . 25.0 109.228 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 56.45 32.38 20.57 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.947 0.899 . . . . 25.0 111.795 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.4 m -94.6 153.91 3.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 107.032 -1.47 . . . . 25.0 107.032 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.7 167.08 11.68 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.042 -1.095 . . . . 25.0 108.042 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.96 154.46 37.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.674 0.273 . . . . 25.0 110.489 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -118.69 132.13 56.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.835 -0.62 . . . . 25.0 110.838 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.63 125.64 27.38 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.184 -0.673 . . . . 25.0 109.184 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.9 mt -91.7 -21.23 20.86 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.257 0.551 . . . . 25.0 110.397 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -141.97 176.05 9.25 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 104.565 -2.383 . . . . 25.0 104.565 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -91.48 177.78 6.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.715 0.293 . . . . 25.0 110.906 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -155.64 155.1 32.66 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.355 0.262 . . . . 25.0 111.647 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.8 t -124.85 132.28 71.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 103.736 -2.69 . . . . 25.0 103.736 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.73 127.64 33.15 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.857 -0.423 . . . . 25.0 109.857 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -101.83 2.72 38.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.727 0.775 . . . . 25.0 110.535 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.2 p -149.88 157.73 37.74 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 108.014 -1.106 . . . . 25.0 108.014 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.8 -15.21 33.19 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 118.177 -0.749 . . . . 25.0 113.007 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -76.55 -21.43 55.69 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.407 0.622 . . . . 25.0 109.475 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -93.75 139.45 30.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.987 0.898 . . . . 25.0 111.829 -172.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.467 ' HB2' HG13 ' A' ' 57' ' ' VAL . 55.4 mt -90.16 129.32 36.45 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.21 -0.905 . . . . 25.0 109.546 177.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -88.21 143.05 27.27 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 105.411 -2.07 . . . . 25.0 105.411 175.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -157.25 167.97 28.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.732 0.301 . . . . 25.0 110.297 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.69 165.4 12.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.737 0.78 . . . . 25.0 110.327 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.1 128.41 36.28 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.218 -0.901 . . . . 25.0 110.069 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.83 -12.49 64.23 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-O 118.922 -0.932 . . . . 25.0 114.933 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -59.65 152.98 21.11 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.977 0.894 . . . . 25.0 112.001 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.0 mm -114.77 130.65 68.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.428 -1.26 . . . . 25.0 109.14 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.8 ptp -137.84 151.57 48.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.469 -0.567 . . . . 25.0 109.469 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.0 m -90.78 124.75 35.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.291 -1.003 . . . . 25.0 108.291 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t -87.34 123.14 39.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 107.893 -1.151 . . . . 25.0 107.893 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.7 mt -89.74 -46.23 8.75 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.051 -0.722 . . . . 25.0 109.051 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -149.56 165.15 33.11 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.771 -0.826 . . . . 25.0 108.771 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HE ' ' HB3' ' A' ' 37' ' ' ARG . 38.2 mtp180 -115.77 154.61 29.31 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.19 -0.67 . . . . 25.0 109.19 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 57.67 40.76 26.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 124.12 1.914 . . . . 25.0 107.463 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.6 t -65.74 151.65 46.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 111.808 -2.451 . . . . 25.0 111.699 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 58.03 18.13 4.92 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.373 0.879 . . . . 25.0 113.373 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.52 16.6 80.53 Favored Glycine 0 C--O 1.227 -0.285 0 N-CA-C 111.699 -0.56 . . . . 25.0 111.699 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.7 mt -98.45 113.93 26.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.088 0.471 . . . . 25.0 110.759 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -59.34 127.7 33.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.682 -0.69 . . . . 25.0 110.755 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.09 -2.03 67.07 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 115.85 1.1 . . . . 25.0 115.85 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -95.83 132.8 40.71 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 119.028 1.414 . . . . 25.0 109.023 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -113.52 138.23 50.43 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.793 -1.188 . . . . 25.0 107.793 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.5 tp -81.41 125.43 30.41 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 105.922 -1.881 . . . . 25.0 105.922 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 91.4 m -134.0 161.99 33.3 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.201 0.524 . . . . 25.0 111.784 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.6 t -113.64 122.5 47.35 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.123 -1.436 . . . . 25.0 107.123 170.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.1 tp -144.62 133.03 21.91 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.919 -0.771 . . . . 25.0 108.919 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 54.09 31.98 14.82 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.427 0.691 . . . . 25.0 112.275 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.16 0.15 88.44 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.087 -0.578 . . . . 25.0 114.507 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -109.11 141.63 41.02 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 117.77 0.785 . . . . 25.0 109.346 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -96.89 143.19 28.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 106.553 -1.647 . . . . 25.0 106.553 169.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.69 -163.72 29.45 Favored Glycine 0 CA--C 1.496 -1.117 0 N-CA-C 103.647 -3.781 . . . . 25.0 103.647 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.7 pt -121.82 158.54 25.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-O 121.3 0.571 . . . . 25.0 110.56 -174.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.467 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.2 m -142.53 148.68 47.92 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 115.297 -0.865 . . . . 25.0 109.214 -177.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.54 120.43 6.71 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 118.359 -0.627 . . . . 25.0 110.967 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.74 -10.42 80.08 Favored Glycine 0 C--O 1.226 -0.371 0 O-C-N 121.878 -0.514 . . . . 25.0 114.049 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -72.8 -5.88 41.02 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.788 0.662 . . . . 25.0 112.788 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -130.01 26.49 5.21 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.6 mt -124.03 155.38 38.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.807 0.813 . . . . 25.0 111.435 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -126.73 120.04 28.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.843 -1.072 . . . . 25.0 109.428 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.1 mm -71.33 136.15 26.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.882 -0.785 . . . . 25.0 108.882 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.4 mt -115.42 94.73 4.84 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.546 -1.279 . . . . 25.0 107.546 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.65 108.97 20.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.299 0.571 . . . . 25.0 111.562 -177.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.85 44.91 3.27 Favored Glycine 0 C--O 1.218 -0.86 0 CA-C-N 116.07 -0.514 . . . . 25.0 112.93 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 99.5 mmm -69.84 -26.21 64.11 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.272 0.471 . . . . 25.0 112.272 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -144.56 129.44 18.37 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.927 -1.509 . . . . 25.0 106.927 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -75.44 120.39 20.82 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.93 0.872 . . . . 25.0 110.011 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -127.92 -0.1 5.96 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.151 -0.931 . . . . 25.0 109.107 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -159.92 93.46 1.68 Allowed Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 124.549 1.139 . . . . 25.0 108.061 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.74 2.34 6.0 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 121.336 1.357 . . . . 25.0 114.011 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.27 -2.07 17.64 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.555 1.317 . . . . 25.0 114.555 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.12 -25.7 2.62 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 115.804 1.082 . . . . 25.0 115.804 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.1 m 57.26 37.42 28.22 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.738 1.014 . . . . 25.0 113.738 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -138.43 -171.28 12.12 Favored Glycine 0 C--O 1.223 -0.56 0 N-CA-C 109.741 -1.344 . . . . 25.0 109.741 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.55 -6.45 74.45 Favored Glycine 0 C--O 1.225 -0.459 0 CA-C-N 117.375 0.588 . . . . 25.0 114.486 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.7 m -71.6 147.07 47.95 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.273 -0.545 . . . . 25.0 109.794 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.16 174.09 54.99 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 111.415 -0.674 . . . . 25.0 111.415 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.8 p -68.73 151.83 46.14 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.891 -0.411 . . . . 25.0 109.891 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.29 166.18 31.04 Favored Glycine 0 N--CA 1.453 -0.21 0 N-CA-C 110.204 -1.158 . . . . 25.0 110.204 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.9 p -136.44 166.29 23.83 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.1 -1.444 . . . . 25.0 107.1 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -149.99 152.15 34.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.433 -1.321 . . . . 25.0 107.433 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -92.31 71.58 5.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.795 0.331 . . . . 25.0 110.399 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -135.05 164.77 26.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.471 -0.937 . . . . 25.0 108.471 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -61.76 159.01 14.43 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.872 1.064 . . . . 25.0 113.872 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.0 m -60.72 154.28 58.24 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 114.719 -1.128 . . . . 25.0 112.637 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.14 157.78 55.6 Favored 'Trans proline' 0 C--N 1.348 0.536 0 N-CA-C 114.528 0.934 . . . . 25.0 114.528 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -63.35 154.05 70.58 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 N-CA-C 113.282 0.454 . . . . 25.0 113.282 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -56.97 152.19 45.13 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.41 1.407 . . . . 25.0 115.603 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -65.62 147.34 98.74 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.362 -0.836 . . . . 25.0 110.184 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.65 160.66 48.91 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 117.881 -0.946 . . . . 25.0 111.57 176.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -60.83 153.48 62.59 Favored 'Trans proline' 0 C--N 1.349 0.561 0 N-CA-C 114.087 0.764 . . . . 25.0 114.087 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -104.81 26.92 8.57 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.575 -0.284 . . . . 25.0 110.448 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.4 p 45.35 -136.11 0.64 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.908 0.883 . . . . 25.0 110.553 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 53.9 32.66 15.62 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.053 1.501 . . . . 25.0 115.053 172.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.6 t -143.98 132.22 21.91 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.692 -0.855 . . . . 25.0 108.692 176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 10.9 p -149.08 27.94 0.84 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.871 0.843 . . . . 25.0 109.525 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 C--O 1.211 -0.941 0 CA-C-O 124.879 2.276 . . . . 25.0 111.563 -176.935 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 CA-C-O 122.397 0.998 . . . . 25.0 115.186 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t -80.86 105.09 11.82 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.222 -1.163 . . . . 25.0 109.528 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -142.84 20.38 1.98 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.315 0.579 . . . . 25.0 111.257 -176.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -117.62 87.23 2.67 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.469 -0.332 . . . . 25.0 110.426 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -136.28 164.54 27.85 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.204 0.446 . . . . 25.0 112.204 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.2 mt -64.73 -41.63 95.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.248 -0.887 . . . . 25.0 111.161 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 54.91 34.82 23.06 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.919 0.887 . . . . 25.0 112.249 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 m -95.48 158.47 3.0 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 104.485 -2.413 . . . . 25.0 104.485 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.13 174.03 7.11 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.776 -0.824 . . . . 25.0 108.776 -175.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.19 161.54 41.79 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.176 -0.305 . . . . 25.0 110.176 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -128.23 130.52 48.07 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.513 0.725 . . . . 25.0 110.031 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.59 133.66 47.87 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.438 0.461 . . . . 25.0 110.141 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.78 -19.68 16.6 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.351 0.596 . . . . 25.0 110.579 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -143.22 171.73 13.69 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.681 -1.6 . . . . 25.0 106.681 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -77.86 167.46 21.49 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.324 0.39 . . . . 25.0 110.868 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -151.75 150.15 29.86 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-O 120.749 0.309 . . . . 25.0 111.07 170.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.6 t -124.93 136.28 61.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 104.528 -2.397 . . . . 25.0 104.528 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.07 136.96 48.5 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 124.27 0.982 . . . . 25.0 108.548 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -117.9 1.09 12.05 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.864 0.84 . . . . 25.0 109.653 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -128.02 146.29 58.64 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 105.799 -1.926 . . . . 25.0 105.799 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -69.89 -18.34 36.46 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 117.386 -1.276 . . . . 25.0 112.638 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -77.53 -15.64 59.14 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.18 -0.464 . . . . 25.0 110.624 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -101.47 140.58 35.57 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.421 -0.955 . . . . 25.0 108.421 -176.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.8 mt -101.37 126.16 48.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.992 0.901 . . . . 25.0 111.688 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.18 145.57 26.35 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.605 -1.257 . . . . 25.0 107.605 175.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -159.29 165.07 34.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.261 0.553 . . . . 25.0 110.856 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -107.34 153.09 23.27 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.509 -1.293 . . . . 25.0 107.509 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -54.65 129.84 38.1 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.996 -0.742 . . . . 25.0 108.996 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.14 -11.28 70.85 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-O 118.899 -0.945 . . . . 25.0 114.518 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -64.06 156.7 27.38 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.989 0.894 . . . . 25.0 110.077 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.6 mm -120.13 135.36 60.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.68 -1.146 . . . . 25.0 109.322 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -141.81 158.2 44.09 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.5 -0.556 . . . . 25.0 109.5 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 m -92.09 128.93 38.12 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 108.287 -1.005 . . . . 25.0 108.287 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.2 t -92.08 123.82 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 N-CA-C 108.279 -1.008 . . . . 25.0 108.279 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.59 HD12 HD22 ' A' ' 47' ' ' LEU . 77.9 mt -88.96 -45.81 9.38 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.414 -0.812 . . . . 25.0 109.284 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -155.31 168.78 25.96 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.512 -0.921 . . . . 25.0 108.512 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -120.39 152.63 37.64 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 106.621 -1.622 . . . . 25.0 106.621 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 58.03 43.93 20.26 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 125.731 1.894 . . . . 25.0 109.119 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 t -69.41 155.79 39.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 112.65 -2.068 . . . . 25.0 111.112 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 58.72 14.75 3.33 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.801 1.037 . . . . 25.0 113.801 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.88 13.86 81.64 Favored Glycine 0 C--O 1.23 -0.148 0 N-CA-C 111.59 -0.604 . . . . 25.0 111.59 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.8 mt -94.33 132.61 38.76 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 110.107 -0.331 . . . . 25.0 110.107 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -78.41 128.64 33.92 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.855 -0.795 . . . . 25.0 108.855 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.96 -2.55 83.41 Favored Glycine 0 C--O 1.239 0.423 0 N-CA-C 116.319 1.288 . . . . 25.0 116.319 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -101.87 133.94 45.85 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 118.428 1.114 . . . . 25.0 108.307 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.3 m0 -115.62 143.23 45.64 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.59 HD22 HD12 ' A' ' 35' ' ' LEU . 0.7 OUTLIER -85.08 123.76 30.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.916 -1.883 . . . . 25.0 105.916 179.032 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.1 m -130.71 162.1 30.2 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.022 0.379 . . . . 25.0 112.022 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.0 t -114.34 119.79 38.15 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.038 -1.838 . . . . 25.0 106.038 171.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.8 tp -141.0 126.87 19.21 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.294 -1.002 . . . . 25.0 108.294 -175.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.0 m170 55.64 31.85 18.13 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.262 0.625 . . . . 25.0 111.279 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.63 0.95 88.65 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 114.676 0.63 . . . . 25.0 114.676 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -107.97 155.2 20.59 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 106.691 -1.596 . . . . 25.0 106.691 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -121.89 144.44 48.85 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.043 -1.466 . . . . 25.0 107.043 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.65 -161.6 27.25 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 107.1 -2.4 . . . . 25.0 107.1 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.7 pt -115.77 150.15 17.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.707 0.765 . . . . 25.0 111.053 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -138.28 145.41 47.09 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 114.639 -1.164 . . . . 25.0 108.565 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.62 120.95 6.72 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 CA-C-O 121.606 0.586 . . . . 25.0 110.821 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.65 -17.04 77.84 Favored Glycine 0 C--O 1.216 -1.007 0 N-CA-C 115.038 0.775 . . . . 25.0 115.038 -174.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -77.93 -1.56 32.49 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.151 0.797 . . . . 25.0 113.151 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -127.74 25.57 5.98 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.682 -1.229 . . . . 25.0 107.682 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.8 tp -135.46 150.34 49.79 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.193 -0.912 . . . . 25.0 109.368 -173.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -126.28 120.75 30.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.568 -0.287 . . . . 25.0 111.556 -177.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.5 mm -67.76 135.45 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.795 -0.446 . . . . 25.0 109.795 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.2 mt -117.1 92.52 3.88 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.457 -1.312 . . . . 25.0 107.457 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.5 p -94.41 140.0 17.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.427 -0.953 . . . . 25.0 108.427 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -152.9 155.3 26.05 Favored Glycine 0 C--O 1.222 -0.631 0 N-CA-C 107.427 -2.269 . . . . 25.0 107.427 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -142.24 11.75 1.96 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.484 0.55 . . . . 25.0 112.484 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.71 19.31 5.13 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.715 1.005 . . . . 25.0 113.715 -172.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -122.79 144.09 49.41 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.161 -2.162 . . . . 25.0 105.161 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -81.04 -39.98 24.94 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.781 0.66 . . . . 25.0 112.781 -172.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -148.89 145.87 20.55 Favored Pre-proline 0 N--CA 1.477 0.89 0 N-CA-C 106.007 -1.849 . . . . 25.0 106.007 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -71.57 145.88 48.13 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 117.396 -1.269 . . . . 25.0 114.064 -177.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.26 145.88 24.14 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.522 -1.288 . . . . 25.0 107.522 174.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -131.9 47.14 1.03 Allowed Glycine 0 C--O 1.219 -0.811 0 N-CA-C 114.93 0.732 . . . . 25.0 114.93 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.1 t -122.91 120.48 33.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.323 0.561 . . . . 25.0 110.026 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 139.5 -165.31 25.82 Favored Glycine 0 C--O 1.224 -0.527 0 N-CA-C 109.953 -1.259 . . . . 25.0 109.953 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.93 177.42 43.94 Favored Glycine 0 C--N 1.321 -0.27 0 N-CA-C 108.854 -1.698 . . . . 25.0 108.854 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.9 p -70.05 -33.29 71.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.893 0.846 . . . . 25.0 112.419 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.06 177.87 49.96 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 121.363 -0.446 . . . . 25.0 112.493 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.1 p -90.94 136.94 32.74 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.528 -0.916 . . . . 25.0 108.528 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.68 37.55 0.16 Allowed Glycine 0 C--O 1.225 -0.431 0 C-N-CA 120.514 -0.85 . . . . 25.0 114.915 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.2 t -150.72 118.26 6.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.404 0.602 . . . . 25.0 109.444 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -129.84 1.07 4.85 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 107.341 -1.355 . . . . 25.0 107.341 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -143.49 160.95 39.66 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 105.11 -2.182 . . . . 25.0 105.11 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -69.96 146.08 51.39 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 123.517 0.511 . . . . 25.0 109.983 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.31 161.12 14.22 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.242 -1.392 . . . . 25.0 107.242 175.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.2 t -123.61 95.61 44.63 Favored Pre-proline 0 N--CA 1.47 0.552 0 N-CA-C 108.314 -0.995 . . . . 25.0 108.314 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -79.19 158.35 26.53 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 N-CA-C 114.215 0.814 . . . . 25.0 114.215 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.45 156.36 65.89 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 117.943 -0.905 . . . . 25.0 111.584 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.28 153.62 76.57 Favored 'Trans proline' 0 C--N 1.347 0.451 0 N-CA-C 114.561 0.946 . . . . 25.0 114.561 -174.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -74.33 140.35 76.02 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 109.395 -0.594 . . . . 25.0 109.395 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.67 160.2 46.95 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 116.908 -1.595 . . . . 25.0 110.944 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -62.51 151.16 84.71 Favored 'Trans proline' 0 C--N 1.351 0.691 0 N-CA-C 114.804 1.04 . . . . 25.0 114.804 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -102.71 -1.92 29.16 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 111.855 0.317 . . . . 25.0 111.855 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 34.2 p -140.78 145.53 36.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.511 -0.551 . . . . 25.0 109.511 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -118.29 19.38 13.48 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 116.609 -0.269 . . . . 25.0 111.275 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.0 t 50.5 50.59 18.52 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 123.62 0.575 . . . . 25.0 110.552 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.5 m 57.14 68.74 0.82 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.918 1.342 . . . . 25.0 111.205 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.5 mt . . . . . 0 N--CA 1.479 1.004 0 C-N-CA 126.486 1.914 . . . . 25.0 115.118 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 CA-C-O 124.642 2.245 . . . . 25.0 113.646 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.2 t -146.78 147.66 31.14 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 113.257 -1.471 . . . . 25.0 108.497 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.2 tpt -138.07 40.41 2.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.704 -1.591 . . . . 25.0 106.704 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.66 144.97 26.19 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.036 -1.468 . . . . 25.0 107.036 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 63.66 164.16 0.12 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 115.1 1.519 . . . . 25.0 115.1 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.4 mt -75.56 -36.51 60.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.459 -1.246 . . . . 25.0 110.74 -177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.5 m120 55.88 25.08 8.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.632 1.173 . . . . 25.0 112.768 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.2 m -88.88 177.13 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 105.731 -1.952 . . . . 25.0 105.731 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.22 174.07 6.56 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.083 -0.71 . . . . 25.0 109.083 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.9 161.19 42.36 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.551 -0.537 . . . . 25.0 109.551 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -123.6 135.43 53.95 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.393 -0.822 . . . . 25.0 110.1 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.528 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -72.29 126.74 30.56 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 123.869 0.73 . . . . 25.0 110.276 174.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.5 mt -93.09 -23.51 18.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.236 0.541 . . . . 25.0 110.697 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -142.43 168.1 20.52 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.737 -1.579 . . . . 25.0 106.737 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -76.73 162.99 27.25 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.307 0.379 . . . . 25.0 110.865 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -150.35 133.09 15.89 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 114.041 1.126 . . . . 25.0 114.041 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.8 t -109.55 124.68 66.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 105.473 -2.047 . . . . 25.0 105.473 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.06 139.69 50.48 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.475 -0.784 . . . . 25.0 110.373 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -112.6 -28.84 7.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.296 0.569 . . . . 25.0 109.589 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -102.15 152.35 38.23 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 107.481 -1.303 . . . . 25.0 107.481 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.4 -22.54 33.58 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 117.688 -1.074 . . . . 25.0 113.105 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -83.97 -10.72 57.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.849 -0.614 . . . . 25.0 110.898 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -85.86 135.64 33.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.747 0.785 . . . . 25.0 109.747 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.9 mt -87.89 128.93 35.36 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.731 0.777 . . . . 25.0 109.576 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.1 t -88.31 140.33 29.59 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 105.461 -2.051 . . . . 25.0 105.461 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -156.87 168.95 25.93 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.785 -0.82 . . . . 25.0 108.785 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.5 mtt-85 -122.91 166.98 14.15 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.179 0.514 . . . . 25.0 111.442 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.22 129.32 41.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.893 -0.594 . . . . 25.0 110.631 -176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.04 -13.02 65.36 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-O 119.491 -0.616 . . . . 25.0 113.508 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -62.32 150.11 40.31 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 117.659 0.73 . . . . 25.0 109.751 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.7 mm -116.41 133.25 63.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 107.922 -1.14 . . . . 25.0 107.922 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -136.25 148.86 48.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.143 -0.688 . . . . 25.0 109.143 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 51.8 m -85.14 129.68 34.76 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.967 -1.494 . . . . 25.0 106.967 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.1 t -94.01 126.17 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.805 -0.813 . . . . 25.0 108.805 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.1 mt -95.95 -45.05 7.09 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.368 -0.604 . . . . 25.0 109.368 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -147.48 159.07 44.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.271 -0.172 . . . . 25.0 110.785 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -117.08 153.95 31.84 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.537 -0.912 . . . . 25.0 108.537 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 53.76 39.8 30.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 123.482 1.611 . . . . 25.0 109.685 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.9 t -69.85 157.17 37.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.153 -1.839 . . . . 25.0 111.625 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 59.92 10.51 2.18 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.22 1.008 . . . . 25.0 112.678 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.74 13.66 81.06 Favored Glycine 0 C--O 1.239 0.41 0 N-CA-C 111.184 -0.766 . . . . 25.0 111.184 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.43 125.26 39.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.947 0.403 . . . . 25.0 110.069 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -67.45 126.84 30.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.958 -0.564 . . . . 25.0 110.349 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.74 -0.6 85.89 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 116.466 1.346 . . . . 25.0 116.466 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -99.05 132.95 43.99 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 119.146 1.473 . . . . 25.0 110.066 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -113.45 137.69 51.17 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.483 -0.562 . . . . 25.0 109.483 -177.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.9 tp -80.77 121.09 25.48 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 106.376 -1.712 . . . . 25.0 106.376 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 98.8 m -133.75 167.7 20.05 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.768 0.318 . . . . 25.0 111.151 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.7 t -118.8 126.16 51.22 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.0 -0.741 . . . . 25.0 109.0 172.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.3 tp -147.4 139.59 24.44 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.115 -1.068 . . . . 25.0 108.115 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 27.3 m170 55.99 29.82 15.02 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.364 0.665 . . . . 25.0 112.022 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.26 1.81 86.42 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 120.994 -0.622 . . . . 25.0 114.094 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -109.91 145.97 35.94 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.45 -0.945 . . . . 25.0 108.45 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -99.99 144.91 28.48 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 105.306 -2.109 . . . . 25.0 105.306 170.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.21 -163.58 29.49 Favored Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 105.525 -3.03 . . . . 25.0 105.525 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.9 pt -120.86 154.25 24.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.467 0.651 . . . . 25.0 111.097 -173.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.6 146.03 46.08 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 114.993 -1.003 . . . . 25.0 108.758 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.64 122.15 7.18 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 117.979 -0.881 . . . . 25.0 111.684 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.96 -13.95 72.89 Favored Glycine 0 C--O 1.223 -0.532 0 CA-C-N 116.277 -0.419 . . . . 25.0 114.032 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -68.94 -8.54 45.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.085 0.772 . . . . 25.0 113.085 -178.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -132.63 26.01 4.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.619 -0.882 . . . . 25.0 108.619 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 12' ' ' ALA . 1.4 tp -129.88 157.19 42.95 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.445 -0.798 . . . . 25.0 110.67 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -131.58 120.35 22.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.807 -0.633 . . . . 25.0 110.773 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.9 mm -65.81 136.59 26.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 123.662 0.601 . . . . 25.0 109.511 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.3 mt -117.64 111.56 19.33 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.28 -2.118 . . . . 25.0 105.28 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.66 157.52 3.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.272 -1.011 . . . . 25.0 108.272 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.99 177.82 29.2 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 110.123 -1.191 . . . . 25.0 110.123 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 7.6 tpt -76.58 -41.19 47.19 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.48 0.548 . . . . 25.0 112.48 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -169.23 155.09 6.23 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.457 -0.942 . . . . 25.0 108.457 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -78.13 -41.21 35.7 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.239 0.542 . . . . 25.0 110.546 175.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -169.77 174.92 5.48 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.198 -0.668 . . . . 25.0 109.198 -173.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.88 147.25 98.53 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 107.409 -1.33 . . . . 25.0 107.409 172.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.74 159.9 47.48 Favored 'Trans proline' 0 C--N 1.348 0.508 0 O-C-N 122.039 0.494 . . . . 25.0 112.59 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -117.97 -22.01 8.07 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.989 0.737 . . . . 25.0 112.989 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.73 -145.87 39.23 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 109.759 -1.337 . . . . 25.0 109.759 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 t 58.96 -157.31 0.32 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.32 0.648 . . . . 25.0 111.247 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.25 -145.73 18.65 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 110.011 -1.236 . . . . 25.0 110.011 -176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.4 28.3 69.97 Favored Glycine 0 C--O 1.225 -0.458 0 C-N-CA 120.534 -0.841 . . . . 25.0 114.852 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.5 t -137.28 146.35 44.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.248 0.524 . . . . 25.0 109.645 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 163.12 174.56 33.16 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 107.798 -2.121 . . . . 25.0 107.798 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.0 p -151.98 152.73 32.84 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.05 -1.093 . . . . 25.0 108.05 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.99 10.82 58.72 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 121.653 -0.308 . . . . 25.0 113.858 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -44.63 78.95 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.641 -0.329 . . . . 25.0 111.409 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -83.29 82.48 8.25 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.123 -1.065 . . . . 25.0 108.123 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -78.79 87.31 4.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.694 -0.685 . . . . 25.0 112.007 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -80.89 78.53 7.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.8 0.81 . . . . 25.0 109.536 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.428 ' HB3' ' H ' ' A' ' 88' ' ' SER . 65.6 m-20 53.18 -145.43 0.59 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.715 1.206 . . . . 25.0 114.21 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.428 ' H ' ' HB3' ' A' ' 87' ' ' ASP . 65.1 p -143.56 157.46 58.95 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 122.966 0.506 . . . . 25.0 110.272 -174.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.36 158.85 44.24 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 N-CA-C 113.835 0.667 . . . . 25.0 113.835 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -67.94 154.06 73.76 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 N-CA-C 113.435 0.513 . . . . 25.0 113.435 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.59 152.59 74.61 Favored 'Trans proline' 0 C--N 1.353 0.773 0 N-CA-C 116.715 1.775 . . . . 25.0 116.715 -173.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -67.49 147.25 98.81 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 115.575 -0.739 . . . . 25.0 111.538 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.34 162.14 43.45 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 O-C-N 121.849 0.394 . . . . 25.0 112.015 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -61.27 153.18 67.15 Favored 'Trans proline' 0 C--N 1.351 0.671 0 N-CA-C 115.668 1.372 . . . . 25.0 115.668 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -116.64 1.06 12.8 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.736 -0.666 . . . . 25.0 111.771 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.4 p -139.84 166.49 24.5 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.309 -2.108 . . . . 25.0 105.309 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -123.24 20.95 9.71 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.183 0.438 . . . . 25.0 112.183 -176.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.7 m -65.13 -30.31 71.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.279 0.844 . . . . 25.0 113.279 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 67.6 m -131.84 142.81 49.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.87 0.367 . . . . 25.0 111.222 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 N--CA 1.484 1.233 0 C-N-CA 125.801 1.64 . . . . 25.0 114.353 175.333 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.983 0 CA-C-O 123.988 1.882 . . . . 25.0 115.637 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.4 m -152.51 158.87 43.17 Favored 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 121.209 -1.171 . . . . 25.0 107.977 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.1 tpt -142.03 137.87 31.41 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.516 -1.661 . . . . 25.0 106.516 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -146.23 139.51 25.88 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.226 -1.398 . . . . 25.0 107.226 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -95.68 167.86 11.02 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.651 -0.5 . . . . 25.0 109.651 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.2 mt -61.74 -41.48 97.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.842 -0.617 . . . . 25.0 109.346 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.76 28.16 11.84 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.07 0.948 . . . . 25.0 111.976 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.2 m -87.48 176.24 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 104.72 -2.326 . . . . 25.0 104.72 173.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mp -118.74 173.99 6.54 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 121.732 -0.605 . . . . 25.0 109.58 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.37 160.18 42.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.818 0.342 . . . . 25.0 110.712 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -122.19 129.89 52.69 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.444 -0.798 . . . . 25.0 109.794 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.93 130.64 43.35 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.781 -0.452 . . . . 25.0 109.781 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.6 mt -93.67 -23.78 18.11 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 111.877 0.325 . . . . 25.0 111.877 -177.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -143.88 168.25 20.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.279 -1.378 . . . . 25.0 107.279 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -73.82 165.35 25.28 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.559 0.537 . . . . 25.0 110.178 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.74 163.31 35.34 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.324 -0.991 . . . . 25.0 108.324 177.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.8 t -130.45 129.49 64.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 102.026 -3.324 . . . . 25.0 102.026 169.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.15 122.69 27.13 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.293 -1.373 . . . . 25.0 107.293 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -113.03 12.32 19.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.318 1.056 . . . . 25.0 110.306 -175.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.7 m -148.31 152.83 39.89 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 106.202 -1.777 . . . . 25.0 106.202 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.43 -23.22 32.54 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 118.176 -0.749 . . . . 25.0 113.677 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.8 -17.0 52.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.417 0.627 . . . . 25.0 110.86 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -84.24 131.53 34.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.636 0.731 . . . . 25.0 109.343 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.477 ' HB2' HG13 ' A' ' 57' ' ' VAL . 45.9 mt -81.69 135.06 35.52 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.315 -0.624 . . . . 25.0 109.315 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -87.35 135.81 33.18 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.253 -1.017 . . . . 25.0 108.253 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -156.09 163.06 40.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.348 0.594 . . . . 25.0 111.948 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -119.63 169.02 10.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.408 0.623 . . . . 25.0 109.832 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -61.29 129.46 41.35 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.668 -0.696 . . . . 25.0 111.297 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.61 -12.41 67.62 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-O 119.012 -0.882 . . . . 25.0 113.836 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -60.08 148.5 35.54 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.595 0.712 . . . . 25.0 110.48 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.1 mm -114.22 132.32 63.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.54 -1.209 . . . . 25.0 108.852 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.0 ptp -137.07 156.55 48.26 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.553 -0.906 . . . . 25.0 108.553 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.7 m -89.53 129.59 35.98 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.377 -1.342 . . . . 25.0 107.377 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.24 126.59 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 107.76 -1.2 . . . . 25.0 107.76 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.61 HD12 HD22 ' A' ' 47' ' ' LEU . 69.8 mt -95.83 -44.7 7.29 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.487 -0.779 . . . . 25.0 109.418 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -153.32 164.02 38.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.353 -0.61 . . . . 25.0 109.353 -175.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -120.35 153.83 35.92 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.234 -1.024 . . . . 25.0 108.234 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 54.98 38.28 30.26 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 123.405 1.574 . . . . 25.0 109.943 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -65.05 151.29 46.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.359 -1.746 . . . . 25.0 110.812 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 61.05 10.72 3.0 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.803 0.841 . . . . 25.0 113.003 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.73 17.46 77.34 Favored Glycine 0 C--O 1.228 -0.234 0 N-CA-C 110.77 -0.932 . . . . 25.0 110.77 -178.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.9 mt -94.37 119.18 32.73 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.741 -0.837 . . . . 25.0 108.741 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.53 129.26 39.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.13 0.491 . . . . 25.0 110.568 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.27 -0.72 67.25 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 116.075 1.19 . . . . 25.0 116.075 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -98.75 129.98 45.2 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 119.349 1.575 . . . . 25.0 109.736 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -110.3 140.1 44.81 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.082 -0.71 . . . . 25.0 109.082 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.61 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -80.79 120.93 25.29 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.785 -1.931 . . . . 25.0 105.785 177.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.2 m -132.5 166.23 22.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.961 0.41 . . . . 25.0 111.686 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -120.64 122.77 41.22 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.799 -1.186 . . . . 25.0 107.799 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.5 tp -155.0 145.92 22.57 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 107.024 -1.473 . . . . 25.0 107.024 -175.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 56.36 31.97 19.67 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.091 0.556 . . . . 25.0 112.368 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.05 6.11 72.82 Favored Glycine 0 C--O 1.225 -0.41 0 N-CA-C 114.926 0.73 . . . . 25.0 114.926 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -129.95 165.96 21.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.696 -0.853 . . . . 25.0 108.696 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -112.59 152.1 29.29 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.774 -1.195 . . . . 25.0 107.774 176.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.74 -159.5 22.26 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 106.444 -2.662 . . . . 25.0 106.444 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.5 pt -120.05 153.56 22.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.465 0.65 . . . . 25.0 111.845 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.477 HG13 ' HB2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -141.63 147.39 45.6 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 114.996 -1.002 . . . . 25.0 109.607 -179.547 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.96 120.06 5.62 Favored 'Trans proline' 0 C--O 1.239 0.558 0 CA-C-O 121.398 0.499 . . . . 25.0 112.532 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.04 -18.76 67.18 Favored Glycine 0 C--O 1.222 -0.638 0 CA-C-O 121.45 0.472 . . . . 25.0 112.663 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.17 -20.69 59.69 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.307 0.854 . . . . 25.0 113.307 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -130.79 29.41 4.76 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.151 0.5 . . . . 25.0 110.021 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.0 tp -132.65 150.41 52.16 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.05 -0.523 . . . . 25.0 110.346 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -127.71 120.55 28.23 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.726 0.639 . . . . 25.0 112.726 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.4 mm -65.32 136.94 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.138 0.494 . . . . 25.0 110.256 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.4 mt -121.71 106.42 11.3 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.068 0.947 . . . . 25.0 108.527 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.4 m -95.1 -5.82 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.912 0.387 . . . . 25.0 110.933 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.94 143.96 13.83 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 109.486 -1.446 . . . . 25.0 109.486 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -167.38 -60.58 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 117.519 0.66 . . . . 25.0 111.063 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -88.38 137.03 32.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.296 -0.411 . . . . 25.0 111.048 -175.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -38.21 90.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.467 0.651 . . . . 25.0 111.145 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -124.98 158.82 32.7 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.406 0.622 . . . . 25.0 109.901 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -123.3 152.27 63.9 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.197 -1.038 . . . . 25.0 108.197 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.12 163.04 39.98 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 116.536 -1.843 . . . . 25.0 111.237 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.6 148.82 43.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.9 -1.889 . . . . 25.0 105.9 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.62 178.43 39.19 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 108.901 -1.679 . . . . 25.0 108.901 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.4 m -78.83 164.6 24.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.957 0.408 . . . . 25.0 110.607 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.04 -176.79 37.65 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 109.064 -1.614 . . . . 25.0 109.064 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.39 -6.77 57.88 Favored Glycine 0 C--O 1.221 -0.666 0 CA-C-N 117.179 0.489 . . . . 25.0 114.3 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 43.4 t -68.63 128.08 35.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.392 0.596 . . . . 25.0 109.747 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.87 -24.25 77.22 Favored Glycine 0 C--O 1.222 -0.643 0 N-CA-C 111.275 -0.73 . . . . 25.0 111.275 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.9 m 55.34 26.31 8.53 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.622 1.712 . . . . 25.0 115.622 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.6 89.13 0.13 Allowed Glycine 0 C--O 1.227 -0.323 0 C-N-CA 121.226 -0.511 . . . . 25.0 112.565 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.9 p -71.19 146.17 49.25 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.266 -1.013 . . . . 25.0 108.266 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 56.39 23.62 7.55 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.65 0.982 . . . . 25.0 113.65 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -135.88 149.28 48.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.906 -0.405 . . . . 25.0 109.906 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 67.9 mm-40 -122.16 158.45 29.33 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.469 -1.678 . . . . 25.0 106.469 172.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -152.91 166.04 33.61 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.309 -1.737 . . . . 25.0 106.309 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 95.7 p -140.01 150.8 63.41 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 113.288 0.847 . . . . 25.0 113.288 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -76.32 162.0 34.22 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 O-C-N 121.63 0.279 . . . . 25.0 112.624 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.06 151.42 85.8 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 118.456 -0.563 . . . . 25.0 112.674 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.06 172.53 12.75 Favored 'Trans proline' 0 C--N 1.349 0.571 0 N-CA-C 116.255 1.598 . . . . 25.0 116.255 -172.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -86.15 138.68 34.51 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 107.452 -1.314 . . . . 25.0 107.452 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -72.57 162.04 42.42 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 116.938 -1.575 . . . . 25.0 110.749 174.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -63.09 152.88 77.26 Favored 'Trans proline' 0 C--N 1.346 0.417 0 N-CA-C 113.89 0.689 . . . . 25.0 113.89 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -99.73 42.84 1.08 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.17 0.509 . . . . 25.0 109.86 176.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.4 p -138.4 127.36 23.95 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.517 -0.549 . . . . 25.0 109.517 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.7 ptt85 -77.02 -16.05 59.42 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.653 0.612 . . . . 25.0 112.653 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.2 t 46.27 39.37 6.14 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.206 1.558 . . . . 25.0 115.206 175.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 46.6 t -147.57 152.28 37.68 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.525 -0.546 . . . . 25.0 109.525 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--O 1.213 -0.86 0 CA-C-O 124.291 1.996 . . . . 25.0 110.673 176.521 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.59 0 CA-C-O 124.07 1.928 . . . . 25.0 114.111 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 m -66.65 -32.85 74.43 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 113.983 -1.108 . . . . 25.0 111.854 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.1 ttm -157.85 -95.81 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.252 -0.431 . . . . 25.0 110.728 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -126.57 87.15 2.62 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 121.34 0.59 . . . . 25.0 110.077 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -110.73 165.68 11.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.423 -0.808 . . . . 25.0 110.382 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.2 mt -67.52 -38.07 83.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.391 -0.822 . . . . 25.0 110.484 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 57.27 31.51 20.22 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.864 0.866 . . . . 25.0 111.64 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.5 m -97.79 176.96 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 105.585 -2.005 . . . . 25.0 105.585 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -120.18 174.02 6.75 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.348 -0.612 . . . . 25.0 109.348 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.69 162.95 34.13 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.899 -0.408 . . . . 25.0 109.899 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -125.68 130.47 51.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.416 -0.811 . . . . 25.0 110.755 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.461 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -71.49 124.53 24.85 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 123.655 0.597 . . . . 25.0 109.516 176.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.3 mt -94.53 -20.3 19.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.326 0.584 . . . . 25.0 109.83 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -142.71 169.64 17.19 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.559 -1.645 . . . . 25.0 106.559 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -78.07 165.45 23.99 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.901 -0.407 . . . . 25.0 109.901 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -146.1 156.24 43.31 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.96 -0.385 . . . . 25.0 109.96 173.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.4 t -127.73 127.59 68.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 105.724 -1.954 . . . . 25.0 105.724 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.46 135.83 36.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.155 -0.683 . . . . 25.0 109.155 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -120.49 10.19 11.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.304 1.05 . . . . 25.0 109.302 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 t -150.82 150.15 27.26 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 107.103 -1.443 . . . . 25.0 107.103 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.63 -17.59 42.9 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 117.715 -1.057 . . . . 25.0 113.43 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -77.86 -19.98 53.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.188 0.518 . . . . 25.0 110.373 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -93.1 138.4 31.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.721 0.772 . . . . 25.0 111.407 -173.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.465 ' HB2' HG13 ' A' ' 57' ' ' VAL . 58.3 mt -91.86 128.01 37.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.809 0.814 . . . . 25.0 110.502 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.8 t -88.66 142.56 27.58 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.939 -1.874 . . . . 25.0 105.939 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -158.11 164.37 36.71 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.677 -0.49 . . . . 25.0 109.677 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -110.46 164.94 12.2 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.705 0.764 . . . . 25.0 109.055 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.15 131.81 51.98 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.747 -0.835 . . . . 25.0 108.747 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.15 -12.15 68.53 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-O 118.849 -0.973 . . . . 25.0 114.152 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.65 148.65 33.03 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 118.176 0.988 . . . . 25.0 110.51 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.5 mm -117.99 126.43 74.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.272 -1.331 . . . . 25.0 108.241 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -128.95 152.52 48.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.365 -0.379 . . . . 25.0 110.004 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -84.7 130.97 34.63 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.117 -1.438 . . . . 25.0 107.117 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.88 123.41 51.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.142 -1.058 . . . . 25.0 108.142 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.626 HD12 HD22 ' A' ' 47' ' ' LEU . 80.8 mt -89.38 -49.35 6.75 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.744 -0.836 . . . . 25.0 108.744 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -151.94 169.25 22.78 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.097 -1.075 . . . . 25.0 108.097 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.9 mtm105 -118.65 157.94 26.45 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 107.053 -1.462 . . . . 25.0 107.053 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 58.21 39.41 25.85 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 125.108 1.505 . . . . 25.0 109.153 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.1 t -67.74 155.81 38.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.19 -1.823 . . . . 25.0 110.162 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 59.96 10.82 2.33 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.084 0.954 . . . . 25.0 113.527 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.19 14.86 81.23 Favored Glycine 0 C--O 1.242 0.61 0 N-CA-C 110.94 -0.864 . . . . 25.0 110.94 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.2 mt -93.51 127.76 39.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.361 0.6 . . . . 25.0 109.495 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -69.95 124.05 23.06 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.498 -0.773 . . . . 25.0 109.545 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.01 2.3 86.72 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 117.03 1.572 . . . . 25.0 117.03 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -100.3 132.31 45.75 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 118.799 1.299 . . . . 25.0 109.224 176.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -114.28 141.59 47.39 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.512 -0.551 . . . . 25.0 109.512 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.626 HD22 HD12 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -83.6 120.01 25.44 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.2 -1.778 . . . . 25.0 106.2 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.5 m -133.07 165.65 24.25 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.016 0.436 . . . . 25.0 112.029 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.0 t -118.65 118.06 30.62 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.459 -1.311 . . . . 25.0 107.459 172.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -147.71 145.68 28.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.511 -1.662 . . . . 25.0 106.511 -174.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 57.23 27.22 13.28 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.412 0.625 . . . . 25.0 111.497 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.45 6.91 86.97 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 114.948 0.739 . . . . 25.0 114.948 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -132.09 160.86 34.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.108 0.954 . . . . 25.0 109.303 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -100.27 152.69 20.01 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.781 -0.822 . . . . 25.0 108.781 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.62 -162.1 28.49 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 105.632 -2.987 . . . . 25.0 105.632 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.9 pt -118.45 154.71 20.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.542 0.687 . . . . 25.0 110.97 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.465 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -140.78 146.75 45.59 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.129 -0.941 . . . . 25.0 109.743 -178.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -73.95 115.56 4.36 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 CA-C-O 121.544 0.56 . . . . 25.0 111.937 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.2 -17.64 68.34 Favored Glycine 0 C--O 1.224 -0.495 0 CA-C-O 121.463 0.48 . . . . 25.0 113.586 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -62.28 -19.0 62.8 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.959 0.725 . . . . 25.0 112.959 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -122.84 27.37 7.75 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.143 0.497 . . . . 25.0 110.686 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 12' ' ' ALA . 20.2 mt -123.81 160.64 26.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.054 0.931 . . . . 25.0 112.613 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -125.59 124.17 40.66 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 114.338 -1.301 . . . . 25.0 109.862 174.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.7 mm -73.64 134.25 30.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.413 -0.958 . . . . 25.0 108.413 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.0 mt -116.33 97.91 6.3 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.938 -1.134 . . . . 25.0 107.938 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.3 m -82.96 164.15 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.416 -0.957 . . . . 25.0 108.416 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -115.19 140.66 16.47 Favored Glycine 0 C--O 1.221 -0.711 0 N-CA-C 110.484 -1.046 . . . . 25.0 110.484 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.3 ttp -79.82 -33.6 40.23 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.695 0.759 . . . . 25.0 109.172 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -147.0 -116.04 0.07 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 104.13 -2.545 . . . . 25.0 104.13 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -123.93 -50.07 1.83 Allowed 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 114.804 1.409 . . . . 25.0 114.804 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -72.33 129.0 37.38 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.648 -0.658 . . . . 25.0 109.997 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -82.37 151.96 66.63 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 109.444 -0.576 . . . . 25.0 109.444 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -73.04 168.74 23.95 Favored 'Trans proline' 0 C--N 1.352 0.758 0 O-C-N 122.046 0.498 . . . . 25.0 112.285 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.64 -32.55 73.61 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.506 0.928 . . . . 25.0 113.506 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.58 -44.43 3.09 Favored Glycine 0 C--O 1.225 -0.417 0 CA-C-O 119.597 -0.557 . . . . 25.0 113.794 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.3 m 51.63 44.72 28.98 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.728 1.01 . . . . 25.0 113.728 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -135.46 147.53 19.22 Favored Glycine 0 C--O 1.226 -0.399 0 C-N-CA 120.876 -0.678 . . . . 25.0 111.928 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.27 172.55 20.25 Favored Glycine 0 CA--C 1.51 -0.265 0 N-CA-C 106.807 -2.517 . . . . 25.0 106.807 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 61.9 p -142.58 147.67 36.26 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.623 -0.88 . . . . 25.0 108.623 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -141.84 -173.69 14.15 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 111.292 -0.723 . . . . 25.0 111.292 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.9 p -80.15 177.58 8.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.351 -0.981 . . . . 25.0 108.351 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.32 38.89 10.38 Favored Glycine 0 C--O 1.218 -0.859 0 C-N-CA 120.25 -0.976 . . . . 25.0 112.007 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.2 p -72.96 89.16 1.4 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.238 -0.566 . . . . 25.0 111.762 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -53.85 -37.65 63.86 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 115.94 1.83 . . . . 25.0 115.94 -175.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -57.1 -34.16 68.05 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.227 1.195 . . . . 25.0 114.227 -172.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 35.26 61.59 0.63 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 115.336 1.606 . . . . 25.0 115.336 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -129.42 159.15 37.14 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.428 0.899 . . . . 25.0 113.428 -174.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 95.9 p -81.33 159.46 67.41 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 114.92 1.452 . . . . 25.0 114.92 -174.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -81.19 155.85 19.55 Favored 'Trans proline' 0 C--N 1.352 0.761 0 N-CA-C 114.278 0.838 . . . . 25.0 114.278 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.12 154.3 52.14 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 117.747 -1.036 . . . . 25.0 111.448 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -61.56 160.0 29.83 Favored 'Trans proline' 0 C--N 1.35 0.616 0 N-CA-C 116.781 1.8 . . . . 25.0 116.781 -175.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -76.79 138.26 66.18 Favored Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 108.098 -1.075 . . . . 25.0 108.098 173.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.06 161.4 43.47 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 116.539 -1.841 . . . . 25.0 110.589 172.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -63.72 152.37 80.8 Favored 'Trans proline' 0 C--N 1.348 0.522 0 N-CA-C 115.325 1.24 . . . . 25.0 115.325 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -105.7 -1.94 23.89 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.209 0.818 . . . . 25.0 113.209 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 79.5 p -140.06 169.17 18.19 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.013 -1.106 . . . . 25.0 108.013 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -119.18 23.2 11.46 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 107.695 -1.224 . . . . 25.0 107.695 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.3 m -66.62 -23.8 66.22 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.862 1.06 . . . . 25.0 113.862 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 24.6 p -155.31 159.5 40.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.16 -1.422 . . . . 25.0 107.16 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.484 1.247 0 C-N-CA 124.659 1.184 . . . . 25.0 113.887 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.681 0 CA-C-O 124.789 2.327 . . . . 25.0 113.666 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.3 m -148.25 144.66 27.8 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 113.493 -1.353 . . . . 25.0 109.693 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.6 ptm -139.49 75.02 1.49 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.636 0.731 . . . . 25.0 109.559 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.77 30.49 7.31 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.658 -0.701 . . . . 25.0 111.163 -177.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -62.28 162.43 9.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.657 -0.701 . . . . 25.0 112.153 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.7 mt -64.29 -41.13 97.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.073 -0.967 . . . . 25.0 110.543 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 55.63 30.1 14.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.918 0.887 . . . . 25.0 111.648 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.1 m -90.0 153.33 3.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.083 -1.451 . . . . 25.0 107.083 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.41 167.98 11.88 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.761 -0.829 . . . . 25.0 108.761 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.36 161.32 41.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.752 0.311 . . . . 25.0 110.693 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -130.84 130.47 43.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.407 -0.815 . . . . 25.0 110.009 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.29 131.52 42.02 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.322 -0.621 . . . . 25.0 109.322 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 74.8 mt -99.99 -18.84 16.85 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.981 0.419 . . . . 25.0 110.897 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -143.38 169.11 18.29 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.269 -2.122 . . . . 25.0 105.269 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.28 165.85 21.05 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 122.873 0.469 . . . . 25.0 110.6 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -151.36 143.05 23.71 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.939 0.348 . . . . 25.0 111.939 174.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 83.9 t -116.71 125.71 73.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 105.154 -2.165 . . . . 25.0 105.154 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.24 137.91 43.31 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.426 -0.806 . . . . 25.0 109.519 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -113.25 4.81 16.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.654 0.74 . . . . 25.0 110.223 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.3 m -152.02 155.69 33.65 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 106.953 -1.499 . . . . 25.0 106.953 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.67 -21.03 39.68 Favored 'Trans proline' 0 C--N 1.346 0.398 0 N-CA-C 113.692 0.612 . . . . 25.0 113.692 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.02 -16.98 59.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.215 0.531 . . . . 25.0 110.629 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -93.78 141.76 28.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.38 0.609 . . . . 25.0 109.672 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.455 ' HB2' HG13 ' A' ' 57' ' ' VAL . 61.4 mt -95.62 131.26 42.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.735 0.779 . . . . 25.0 110.17 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.0 t -90.44 146.62 23.99 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 105.099 -2.186 . . . . 25.0 105.099 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -157.32 162.77 39.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.085 0.469 . . . . 25.0 110.492 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -103.88 155.88 18.28 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.421 -1.326 . . . . 25.0 107.421 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -60.73 129.31 40.89 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.632 -0.877 . . . . 25.0 108.632 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.07 -5.35 68.44 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-O 119.312 -0.715 . . . . 25.0 113.445 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -63.97 152.25 40.53 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.8 0.81 . . . . 25.0 110.156 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.2 mm -116.84 135.22 57.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.465 -1.243 . . . . 25.0 108.627 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.7 ptp -142.65 166.11 25.55 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.022 -0.732 . . . . 25.0 109.022 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 57.3 m -106.99 123.6 48.42 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.545 -0.909 . . . . 25.0 108.545 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.3 t -86.87 125.48 40.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.301 -1.0 . . . . 25.0 108.301 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -93.43 -44.52 8.22 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.023 -0.732 . . . . 25.0 109.023 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -146.96 159.1 43.96 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.887 -0.412 . . . . 25.0 109.887 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.1 mtm105 -118.75 154.54 32.63 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.579 -0.526 . . . . 25.0 109.579 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 55.08 38.02 29.84 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 123.628 1.68 . . . . 25.0 108.639 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.7 t -72.48 159.68 33.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 112.644 -2.071 . . . . 25.0 111.158 -173.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 58.87 11.52 1.92 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.906 1.076 . . . . 25.0 113.906 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.64 12.63 83.44 Favored Glycine 0 C--O 1.239 0.468 0 N-CA-C 110.847 -0.901 . . . . 25.0 110.847 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.7 mt -97.25 115.82 28.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.806 0.812 . . . . 25.0 109.289 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -65.34 129.11 38.54 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.883 -1.053 . . . . 25.0 109.664 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.57 -0.94 74.32 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 115.659 1.024 . . . . 25.0 115.659 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -98.73 130.88 45.22 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 118.853 1.326 . . . . 25.0 110.281 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -113.54 137.58 51.37 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.734 -0.839 . . . . 25.0 108.734 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.9 tp -80.63 124.71 29.22 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.047 -1.464 . . . . 25.0 107.047 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.9 m -133.6 162.76 31.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.286 0.565 . . . . 25.0 112.234 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.3 t -112.97 123.67 50.85 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.034 -1.839 . . . . 25.0 106.034 171.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 tp -151.58 140.85 21.38 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.653 -1.24 . . . . 25.0 107.653 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.97 27.2 12.82 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.991 0.737 . . . . 25.0 112.991 176.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.47 3.87 90.36 Favored Glycine 0 C--O 1.226 -0.378 0 N-CA-C 114.692 0.637 . . . . 25.0 114.692 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -129.47 161.01 31.38 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 117.951 0.876 . . . . 25.0 110.185 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -105.76 153.5 21.8 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.129 -1.063 . . . . 25.0 108.129 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.61 -163.74 31.8 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 104.03 -3.628 . . . . 25.0 104.03 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.5 pt -121.93 156.84 26.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.532 0.682 . . . . 25.0 110.855 -175.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.455 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.7 m -140.15 147.57 50.93 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.013 -0.994 . . . . 25.0 109.328 -177.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -75.74 119.97 5.65 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 CA-C-O 121.349 0.479 . . . . 25.0 111.947 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.28 -20.05 66.98 Favored Glycine 0 C--O 1.221 -0.665 0 C-N-CA 121.517 -0.373 . . . . 25.0 113.354 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -66.34 -9.2 30.92 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.699 1.0 . . . . 25.0 113.699 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -134.65 26.11 3.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.265 0.555 . . . . 25.0 109.792 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 24.3 tp -131.23 149.57 52.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.739 -0.664 . . . . 25.0 110.819 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -119.44 127.85 53.47 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 122.838 0.455 . . . . 25.0 110.963 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.2 mm -76.12 135.56 26.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.191 -1.04 . . . . 25.0 108.191 174.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.4 mt -114.66 80.58 1.43 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.192 -0.669 . . . . 25.0 109.192 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -76.38 126.96 37.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 107.707 -1.22 . . . . 25.0 107.707 175.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.79 87.98 1.05 Allowed Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.599 -0.81 . . . . 25.0 112.397 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.4 mtm -109.62 -50.54 2.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.273 0.472 . . . . 25.0 112.273 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -110.29 -51.92 2.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.034 0.445 . . . . 25.0 111.53 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -95.16 51.39 1.33 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 122.16 0.981 . . . . 25.0 110.354 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.34 105.2 0.32 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.88 -1.055 . . . . 25.0 111.599 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -125.86 103.55 27.43 Favored Pre-proline 0 N--CA 1.47 0.535 0 N-CA-C 108.802 -0.814 . . . . 25.0 108.802 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.57 1.75 8.94 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 N-CA-C 115.086 1.148 . . . . 25.0 115.086 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.52 -90.18 0.58 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.029 0.443 . . . . 25.0 111.282 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.61 -169.53 37.42 Favored Glycine 0 C--O 1.228 -0.229 0 N-CA-C 110.0 -1.24 . . . . 25.0 110.0 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.4 m -147.61 31.75 0.88 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.202 0.501 . . . . 25.0 111.779 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.74 -158.64 30.98 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.744 -0.741 . . . . 25.0 112.156 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -162.68 173.78 38.97 Favored Glycine 0 C--O 1.227 -0.297 0 N-CA-C 108.477 -1.849 . . . . 25.0 108.477 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.8 t -159.91 167.82 27.15 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.797 -1.186 . . . . 25.0 107.797 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.9 168.49 40.31 Favored Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.022 -1.231 . . . . 25.0 110.022 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.3 m -148.41 -67.29 0.23 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 117.273 0.536 . . . . 25.0 111.849 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.42 -156.95 23.62 Favored Glycine 0 N--CA 1.46 0.236 0 N-CA-C 110.586 -1.005 . . . . 25.0 110.586 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.6 m -141.93 149.98 40.85 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.817 -0.809 . . . . 25.0 108.817 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.22 148.46 47.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.823 0.344 . . . . 25.0 111.69 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt 57.59 17.98 4.34 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.127 1.158 . . . . 25.0 114.127 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -89.14 63.87 6.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.514 0.673 . . . . 25.0 109.693 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.51 -154.39 0.33 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.552 -1.204 . . . . 25.0 112.329 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.0 m -140.01 156.67 70.33 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 112.899 0.703 . . . . 25.0 112.899 -176.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -62.99 156.52 54.08 Favored 'Trans proline' 0 C--N 1.353 0.775 0 N-CA-C 114.696 0.999 . . . . 25.0 114.696 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.84 152.61 80.15 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 O-C-N 121.68 0.305 . . . . 25.0 112.438 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -70.71 163.74 37.97 Favored 'Trans proline' 0 C--N 1.348 0.512 0 N-CA-C 116.695 1.767 . . . . 25.0 116.695 -171.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -79.66 140.91 55.43 Favored Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 115.117 -0.947 . . . . 25.0 108.835 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.71 159.28 51.32 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 116.562 -1.826 . . . . 25.0 110.376 171.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -62.91 149.92 90.0 Favored 'Trans proline' 0 C--N 1.349 0.598 0 N-CA-C 115.283 1.224 . . . . 25.0 115.283 -176.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.3 mtm105 -105.43 15.9 26.42 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.26 -0.427 . . . . 25.0 111.526 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 40.7 p -134.9 139.55 45.07 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.073 0.768 . . . . 25.0 113.073 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.26 112.69 11.26 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 105.15 -2.167 . . . . 25.0 105.15 175.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 26.0 t -140.4 71.68 1.38 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.799 0.666 . . . . 25.0 112.799 -175.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 7.7 t 41.46 59.64 2.34 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.459 1.281 . . . . 25.0 114.459 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 C--O 1.214 -0.8 0 CA-C-O 124.582 2.135 . . . . 25.0 110.759 -179.756 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 CA-C-O 122.843 1.246 . . . . 25.0 115.292 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.5 m -64.69 -34.18 77.71 Favored 'General case' 0 C--O 1.22 -0.495 0 O-C-N 121.256 -1.143 . . . . 25.0 113.057 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 93.3 mtp 49.71 36.76 11.47 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.305 0.854 . . . . 25.0 113.305 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt 60.56 10.84 2.72 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.849 1.426 . . . . 25.0 114.849 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -75.79 168.87 19.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.565 0.697 . . . . 25.0 111.302 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt -65.48 -38.97 91.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.221 -0.899 . . . . 25.0 110.506 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.4 m120 57.0 25.63 10.91 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.306 1.042 . . . . 25.0 112.295 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -89.56 169.81 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.005 -1.85 . . . . 25.0 106.005 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -115.42 170.23 8.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.037 0.446 . . . . 25.0 110.06 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.83 160.64 41.49 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.689 -0.687 . . . . 25.0 111.017 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -123.87 131.81 53.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.072 -0.967 . . . . 25.0 110.749 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.99 126.2 30.51 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.053 -0.522 . . . . 25.0 109.871 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.7 mt -93.75 -22.07 18.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.198 0.523 . . . . 25.0 110.536 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -138.06 161.44 36.74 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.246 -1.39 . . . . 25.0 107.246 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.71 175.98 7.42 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.032 0.933 . . . . 25.0 110.959 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -156.85 160.01 38.75 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.499 0.555 . . . . 25.0 112.499 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.1 t -127.76 128.67 69.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 104.408 -2.442 . . . . 25.0 104.408 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.41 132.19 44.45 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.29 -0.633 . . . . 25.0 109.29 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -122.22 10.16 9.94 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.719 0.771 . . . . 25.0 109.714 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.2 m -143.93 153.14 56.87 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 105.378 -2.082 . . . . 25.0 105.378 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.03 -23.08 34.52 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 117.919 -0.921 . . . . 25.0 113.165 -177.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.83 -15.97 46.27 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.982 -0.554 . . . . 25.0 110.916 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -80.9 135.51 35.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.97 0.89 . . . . 25.0 111.515 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.8 mt -83.69 130.94 34.97 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.304 -0.862 . . . . 25.0 110.88 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 m -85.5 132.42 34.2 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.837 -1.542 . . . . 25.0 106.837 173.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.408 ' CE2' HG12 ' A' ' 57' ' ' VAL . 40.0 p90 -159.42 169.55 23.7 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.019 -1.104 . . . . 25.0 108.019 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 mtp85 -125.35 174.45 8.14 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.347 0.869 . . . . 25.0 113.347 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.12 131.85 48.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.191 -0.913 . . . . 25.0 110.878 -175.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.94 -13.97 66.16 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.44 -0.8 . . . . 25.0 113.343 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -60.06 147.7 38.37 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.868 0.842 . . . . 25.0 110.993 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.3 mm -111.07 134.29 53.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.286 -1.324 . . . . 25.0 107.958 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.4 ptp -138.98 150.67 46.13 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.337 -0.616 . . . . 25.0 109.337 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.6 m -85.98 130.98 34.38 Favored 'General case' 0 C--O 1.217 -0.607 0 N-CA-C 107.242 -1.392 . . . . 25.0 107.242 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.9 t -97.9 125.32 51.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.347 -0.983 . . . . 25.0 108.347 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.696 HD12 HD22 ' A' ' 47' ' ' LEU . 78.3 mt -90.94 -51.27 5.43 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.991 -0.744 . . . . 25.0 108.991 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -152.04 171.25 18.14 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.382 -0.97 . . . . 25.0 108.382 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -120.71 155.6 33.57 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 107.342 -1.355 . . . . 25.0 107.342 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 57.7 39.78 27.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 123.331 1.538 . . . . 25.0 108.592 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.9 t -64.85 147.62 52.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 113.235 -1.802 . . . . 25.0 110.547 -176.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 58.5 15.25 3.45 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.146 0.795 . . . . 25.0 113.146 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.62 12.39 84.28 Favored Glycine 0 C--O 1.225 -0.462 0 C-N-CA 121.161 -0.542 . . . . 25.0 111.833 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.6 mt -88.85 109.7 20.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.381 0.61 . . . . 25.0 110.048 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -53.73 118.43 3.93 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.979 -1.009 . . . . 25.0 112.08 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.69 0.37 89.21 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 115.914 1.126 . . . . 25.0 115.914 175.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -97.75 133.62 42.02 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 119.059 1.429 . . . . 25.0 109.234 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -113.36 140.69 47.83 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.883 -0.784 . . . . 25.0 108.883 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.696 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -82.34 121.47 26.73 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 105.973 -1.862 . . . . 25.0 105.973 179.36 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 84.4 m -131.3 163.55 27.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.124 0.488 . . . . 25.0 112.161 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.5 t -118.04 126.44 52.3 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.794 -1.188 . . . . 25.0 107.794 174.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 tp -154.4 142.67 20.45 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 107.326 -1.361 . . . . 25.0 107.326 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 55.46 32.03 18.14 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.317 0.579 . . . . 25.0 112.315 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.12 7.05 76.06 Favored Glycine 0 C--O 1.224 -0.472 0 N-CA-C 114.807 0.683 . . . . 25.0 114.807 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -128.2 165.64 20.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.082 -0.71 . . . . 25.0 109.082 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -117.21 155.08 30.03 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.002 -1.11 . . . . 25.0 108.002 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.0 -159.87 25.83 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 106.195 -2.762 . . . . 25.0 106.195 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.5 pt -117.68 153.47 19.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.684 0.754 . . . . 25.0 111.656 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.408 HG12 ' CE2' ' A' ' 26' ' ' PHE . 2.7 m -143.71 147.22 38.13 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 114.653 -1.158 . . . . 25.0 108.37 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.2 125.08 8.96 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 118.569 -0.488 . . . . 25.0 112.051 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.78 -19.46 79.9 Favored Glycine 0 C--O 1.222 -0.607 0 N-CA-C 116.035 1.174 . . . . 25.0 116.035 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -70.0 -7.26 39.43 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.189 1.552 . . . . 25.0 115.189 -175.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.17 21.64 5.28 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.264 -1.013 . . . . 25.0 108.264 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.0 tp -123.68 149.68 45.18 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.047 -1.094 . . . . 25.0 108.047 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -120.73 123.82 43.63 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 116.706 -0.224 . . . . 25.0 111.147 -178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.3 mm -74.99 133.52 31.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.223 -1.029 . . . . 25.0 108.223 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.3 mt -116.85 75.53 0.97 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.621 -1.622 . . . . 25.0 106.621 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -50.34 -42.78 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 115.748 1.759 . . . . 25.0 115.748 -168.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -111.77 7.82 27.77 Favored Glycine 0 C--O 1.228 -0.235 0 C-N-CA 121.072 -0.585 . . . . 25.0 114.479 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 7.2 tpt -94.41 82.79 4.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.782 0.791 . . . . 25.0 111.569 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -77.38 -8.99 58.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.19 -0.914 . . . . 25.0 109.482 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 t0 65.92 149.47 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.993 1.717 . . . . 25.0 113.569 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -114.11 5.21 15.9 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.999 -1.0 . . . . 25.0 110.414 -171.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -149.21 156.09 39.92 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 106.351 -1.722 . . . . 25.0 106.351 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.12 159.89 46.6 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 117.383 -1.278 . . . . 25.0 113.309 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -156.05 179.58 9.09 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.201 -2.148 . . . . 25.0 105.201 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.71 5.51 22.2 Favored Glycine 0 C--O 1.225 -0.416 0 N-CA-C 115.91 1.124 . . . . 25.0 115.91 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.9 m -146.33 154.37 41.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.774 0.787 . . . . 25.0 109.748 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.54 162.71 28.64 Favored Glycine 0 C--O 1.224 -0.511 0 N-CA-C 108.785 -1.726 . . . . 25.0 108.785 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.73 36.41 0.43 Allowed Glycine 0 C--O 1.218 -0.891 0 CA-C-N 117.702 0.751 . . . . 25.0 112.851 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.6 t -76.38 -4.47 42.47 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.819 1.044 . . . . 25.0 113.819 -175.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.63 -170.27 20.55 Favored Glycine 0 C--O 1.236 0.258 0 N-CA-C 111.941 -0.464 . . . . 25.0 111.941 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 84.7 p -155.59 178.16 10.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.22 -92.28 1.76 Allowed Glycine 0 C--O 1.228 -0.248 0 CA-C-O 119.35 -0.694 . . . . 25.0 112.103 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 95.5 p 55.44 -174.6 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.624 1.17 . . . . 25.0 112.734 -177.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.55 149.72 40.06 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.533 -0.543 . . . . 25.0 109.533 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -163.2 158.66 21.94 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.858 -0.793 . . . . 25.0 108.858 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -152.7 -60.17 0.15 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.76 -1.2 . . . . 25.0 107.76 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -70.27 157.86 36.94 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.417 0.627 . . . . 25.0 111.307 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.3 p -104.92 153.07 39.64 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 108.772 -0.825 . . . . 25.0 108.772 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -61.31 159.62 30.34 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 117.83 -0.98 . . . . 25.0 111.682 173.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -66.37 155.75 68.5 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 117.33 -1.313 . . . . 25.0 111.919 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.14 157.58 59.2 Favored 'Trans proline' 0 C--N 1.345 0.356 0 N-CA-C 113.692 0.612 . . . . 25.0 113.692 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -71.39 146.23 91.54 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.713 -0.676 . . . . 25.0 110.463 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.24 165.26 32.09 Favored 'Trans proline' 0 C--O 1.243 0.747 0 O-C-N 121.973 0.459 . . . . 25.0 111.744 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.03 154.61 43.96 Favored 'Trans proline' 0 C--N 1.35 0.646 0 N-CA-C 113.33 0.473 . . . . 25.0 113.33 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -109.7 35.34 3.38 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.484 -0.932 . . . . 25.0 108.484 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.7 p 48.16 -153.39 0.09 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.163 -1.38 . . . . 25.0 111.924 -176.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 54.79 30.86 14.43 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.542 0.737 . . . . 25.0 111.753 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.3 m -64.83 136.76 57.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.421 -0.809 . . . . 25.0 112.219 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.5 t -68.75 -33.53 74.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.978 0.895 . . . . 25.0 109.702 175.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.208 -1.106 0 CA-C-O 124.465 2.079 . . . . 25.0 111.515 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.405 0 CA-C-O 122.601 1.112 . . . . 25.0 114.835 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t 55.55 29.74 13.99 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.311 1.044 . . . . 25.0 112.592 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.1 tpt -66.18 134.42 52.7 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.014 -0.736 . . . . 25.0 109.014 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -124.64 107.74 11.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.245 0.545 . . . . 25.0 110.776 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -90.24 169.18 11.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.275 -0.875 . . . . 25.0 111.894 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.11 -41.17 95.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.72 -0.673 . . . . 25.0 110.729 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 55.5 40.73 31.23 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.927 0.891 . . . . 25.0 112.144 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.7 m -105.35 151.37 7.55 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.802 0 N-CA-C 107.316 -1.364 . . . . 25.0 107.316 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.38 167.0 12.97 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.485 -0.561 . . . . 25.0 109.485 -172.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.86 157.41 41.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.083 0.468 . . . . 25.0 111.134 175.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -123.9 131.31 53.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.172 -0.922 . . . . 25.0 110.659 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.08 129.32 38.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.992 -0.744 . . . . 25.0 108.992 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.4 mt -96.63 -17.55 20.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.755 0.312 . . . . 25.0 110.368 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -144.99 167.65 22.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.649 -1.611 . . . . 25.0 106.649 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -77.49 168.86 19.3 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 123.447 0.467 . . . . 25.0 110.85 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -153.48 154.01 33.57 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.074 0.464 . . . . 25.0 111.462 176.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -124.53 129.69 73.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 105.073 -2.195 . . . . 25.0 105.073 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.84 121.88 21.59 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.368 -0.975 . . . . 25.0 108.368 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -102.94 1.67 34.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 122.036 0.922 . . . . 25.0 109.495 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.2 m -144.69 153.75 55.0 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 106.499 -1.667 . . . . 25.0 106.499 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.92 -23.83 34.29 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 117.811 -0.992 . . . . 25.0 113.427 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.78 -16.97 59.31 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.339 0.59 . . . . 25.0 110.629 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -84.05 139.54 32.43 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.61 0.719 . . . . 25.0 110.092 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.429 ' HB2' HG13 ' A' ' 57' ' ' VAL . 40.0 mt -87.42 130.25 34.74 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.95 -0.759 . . . . 25.0 108.95 177.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 t -87.13 137.94 31.91 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.435 -1.691 . . . . 25.0 106.435 175.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -155.42 164.19 39.05 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 120.777 0.322 . . . . 25.0 110.482 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 -117.05 168.24 10.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.984 0.421 . . . . 25.0 110.821 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -60.88 130.17 45.13 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.89 -8.26 78.34 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-O 118.647 -1.085 . . . . 25.0 114.623 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.21 142.35 51.98 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.649 1.224 . . . . 25.0 109.714 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.7 mm -108.68 129.79 62.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 107.627 -1.249 . . . . 25.0 107.627 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 14.3 ptp -134.83 163.4 29.91 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.836 -0.801 . . . . 25.0 108.836 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.1 m -104.4 122.58 45.79 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.411 -1.329 . . . . 25.0 107.411 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.7 t -86.34 122.69 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 108.191 -1.041 . . . . 25.0 108.191 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.24 -41.58 8.99 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.575 -0.739 . . . . 25.0 109.391 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -142.94 156.63 44.92 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.498 -1.297 . . . . 25.0 107.498 -173.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.2 mtm180 -124.38 150.76 45.21 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 105.111 -2.181 . . . . 25.0 105.111 172.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 57.43 38.93 28.43 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 123.707 1.717 . . . . 25.0 108.504 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -67.98 157.71 34.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 112.671 -2.059 . . . . 25.0 111.818 -177.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 60.35 12.51 3.46 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.078 1.14 . . . . 25.0 114.078 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.12 13.11 81.56 Favored Glycine 0 C--O 1.244 0.723 0 N-CA-C 111.265 -0.734 . . . . 25.0 111.265 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.2 mt -96.24 137.57 35.12 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 122.357 -0.496 . . . . 25.0 109.899 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -81.19 130.45 35.03 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.352 -0.61 . . . . 25.0 109.352 176.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.93 -0.42 82.85 Favored Glycine 0 C--O 1.241 0.566 0 N-CA-C 116.675 1.43 . . . . 25.0 116.675 173.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -99.8 134.42 42.72 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.388 -0.968 . . . . 25.0 108.388 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.7 m0 -114.61 140.35 48.88 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.078 -1.082 . . . . 25.0 108.078 -177.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.4 tp -82.33 127.74 33.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.051 -1.833 . . . . 25.0 106.051 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.2 m -134.9 162.45 32.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.166 0.508 . . . . 25.0 111.811 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.2 t -112.35 123.09 49.51 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.629 -1.989 . . . . 25.0 105.629 169.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.2 tp -153.14 139.26 18.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.893 0.477 . . . . 25.0 110.122 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.6 m170 56.93 32.0 20.76 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.113 0.565 . . . . 25.0 111.548 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.99 -1.17 89.1 Favored Glycine 0 C--O 1.225 -0.429 0 N-CA-C 116.478 1.351 . . . . 25.0 116.478 177.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.5 ptt85 -130.64 158.59 39.62 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 118.798 1.299 . . . . 25.0 111.402 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -97.72 153.6 18.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.82 -1.178 . . . . 25.0 107.82 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.67 -165.9 35.88 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 103.89 -3.684 . . . . 25.0 103.89 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.4 pt -119.78 158.63 21.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.398 0.618 . . . . 25.0 111.443 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.7 m -144.76 148.95 41.42 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.558 -0.747 . . . . 25.0 110.171 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.3 121.72 7.41 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 118.247 -0.702 . . . . 25.0 112.932 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.38 -18.13 73.13 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 121.267 -0.492 . . . . 25.0 113.568 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -67.3 -9.97 46.24 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.602 0.964 . . . . 25.0 113.602 -177.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -129.89 27.61 5.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.472 0.653 . . . . 25.0 109.804 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -123.08 156.52 34.74 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.356 -0.838 . . . . 25.0 112.423 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -122.69 125.27 45.24 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 108.725 -0.842 . . . . 25.0 108.725 174.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.0 mm -77.97 137.1 22.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.224 -1.028 . . . . 25.0 108.224 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.6 mt -116.96 87.13 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.964 -1.124 . . . . 25.0 107.964 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.41 2.18 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.392 -0.822 . . . . 25.0 111.841 -177.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -156.67 177.92 33.37 Favored Glycine 0 CA--C 1.508 -0.378 0 N-CA-C 109.056 -1.618 . . . . 25.0 109.056 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 9.2 tpt 54.78 63.26 2.2 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 122.174 0.988 . . . . 25.0 111.333 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -65.85 -32.68 74.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.171 -0.922 . . . . 25.0 112.077 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 t0 61.28 139.45 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.874 1.67 . . . . 25.0 115.111 -175.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -81.65 -3.26 53.04 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.396 -0.815 . . . . 25.0 111.025 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -140.91 145.9 41.53 Favored Pre-proline 0 N--CA 1.469 0.5 0 N-CA-C 108.721 -0.844 . . . . 25.0 108.721 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -72.65 153.25 54.24 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 116.885 -1.61 . . . . 25.0 111.906 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.39 129.18 37.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.112 -0.699 . . . . 25.0 109.112 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.47 -36.78 6.4 Favored Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.849 -0.691 . . . . 25.0 114.097 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.7 m -153.55 166.22 33.41 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.042 -0.725 . . . . 25.0 109.042 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -109.11 178.14 20.59 Favored Glycine 0 C--O 1.225 -0.408 0 N-CA-C 110.137 -1.185 . . . . 25.0 110.137 177.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.22 -17.39 65.92 Favored Glycine 0 N--CA 1.463 0.435 0 C-N-CA 120.872 -0.68 . . . . 25.0 113.12 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.4 m 59.99 -171.96 0.13 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.068 0.947 . . . . 25.0 113.42 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.03 -176.36 54.74 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.973 -0.632 . . . . 25.0 113.098 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.9 m 61.75 -48.55 0.15 Allowed 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 119.269 3.063 . . . . 25.0 119.269 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.32 87.54 1.34 Allowed Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.801 -0.919 . . . . 25.0 110.801 -173.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.49 98.52 10.66 Favored 'General case' 0 C--O 1.238 0.483 0 O-C-N 121.643 -0.916 . . . . 25.0 110.367 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -141.14 178.79 7.15 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 123.377 0.671 . . . . 25.0 109.729 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -130.92 89.5 2.76 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.103 -1.814 . . . . 25.0 106.103 172.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 71.73 -46.46 0.64 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.258 1.423 . . . . 25.0 111.882 -174.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 177.94 -66.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 104.838 -2.282 . . . . 25.0 104.838 175.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.3 m -79.89 155.83 75.14 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 114.528 1.307 . . . . 25.0 114.528 -173.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.54 159.87 42.27 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 N-CA-C 113.752 0.635 . . . . 25.0 113.752 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -69.66 154.56 67.97 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 118.575 -0.483 . . . . 25.0 112.284 176.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.91 164.1 36.74 Favored 'Trans proline' 0 C--N 1.346 0.433 0 N-CA-C 115.579 1.338 . . . . 25.0 115.579 -174.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -90.15 150.11 42.69 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 109.322 -0.621 . . . . 25.0 109.322 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -72.95 163.9 37.06 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 O-C-N 121.785 0.361 . . . . 25.0 112.018 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -62.86 159.77 36.36 Favored 'Trans proline' 0 C--N 1.351 0.658 0 N-CA-C 114.827 1.049 . . . . 25.0 114.827 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.1 mtp85 -114.89 -14.9 11.89 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 116.859 2.17 . . . . 25.0 116.859 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 23.5 p -137.58 140.53 41.05 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.415 -0.958 . . . . 25.0 108.415 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -82.2 -36.96 26.76 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 107.247 -1.39 . . . . 25.0 107.247 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 83.2 p -157.68 163.41 38.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.112 -1.81 . . . . 25.0 106.112 174.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 93.8 m -130.0 89.15 2.76 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.207 -1.034 . . . . 25.0 108.207 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.4 tp . . . . . 0 N--CA 1.485 1.293 0 C-N-CA 124.441 1.097 . . . . 25.0 112.057 -174.692 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 115.446 0.938 . . . . 25.0 115.446 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 64.94 -28.57 0.1 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 126.989 2.116 . . . . 25.0 115.325 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.7 mtt -101.9 90.26 3.93 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 122.951 0.501 . . . . 25.0 111.46 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -75.64 131.35 39.88 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.993 -1.484 . . . . 25.0 106.993 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -138.16 167.51 21.68 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.459 0.474 . . . . 25.0 110.53 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.0 mt -65.0 -42.5 94.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.63 -0.714 . . . . 25.0 110.203 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 53.98 36.18 23.81 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.0 0.92 . . . . 25.0 112.02 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.9 m -96.09 159.79 2.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 N-CA-C 106.18 -1.785 . . . . 25.0 106.18 177.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.02 170.94 8.8 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.992 -0.744 . . . . 25.0 108.992 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.58 162.19 41.41 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.228 -0.295 . . . . 25.0 110.701 175.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.75 136.56 52.58 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.846 0.716 . . . . 25.0 111.353 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.5 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -73.02 123.09 22.83 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.695 0.622 . . . . 25.0 111.679 173.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.2 mt -90.81 -25.2 20.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.222 0.534 . . . . 25.0 110.091 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -142.82 171.68 13.72 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 103.476 -2.787 . . . . 25.0 103.476 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -84.41 175.7 9.17 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 118.056 0.389 . . . . 25.0 110.818 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -149.41 132.29 16.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.761 0.315 . . . . 25.0 110.737 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.7 t -104.04 125.19 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 104.759 -2.312 . . . . 25.0 104.759 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.23 137.86 43.31 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.565 -0.743 . . . . 25.0 110.205 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -119.05 5.33 11.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.783 0.801 . . . . 25.0 109.099 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -147.37 155.65 46.08 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 106.479 -1.675 . . . . 25.0 106.479 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.59 -24.04 26.33 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 118.167 -0.756 . . . . 25.0 113.514 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -77.73 -17.2 57.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.507 0.67 . . . . 25.0 110.203 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -87.09 133.01 33.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.526 0.679 . . . . 25.0 109.969 -176.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.8 mt -87.15 125.97 34.5 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.823 0.82 . . . . 25.0 109.945 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.68 134.01 33.73 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.252 -1.758 . . . . 25.0 106.252 174.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -154.84 166.93 31.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.526 -0.546 . . . . 25.0 109.526 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -113.4 160.51 18.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.365 0.602 . . . . 25.0 110.068 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -57.41 132.56 53.48 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.468 -0.938 . . . . 25.0 108.468 177.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.57 -18.18 57.32 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-O 119.168 -0.795 . . . . 25.0 113.11 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -61.42 147.87 43.6 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.778 0.799 . . . . 25.0 109.988 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.4 mm -115.67 132.95 63.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.296 -1.32 . . . . 25.0 107.894 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -135.24 165.51 25.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.049 -0.723 . . . . 25.0 109.049 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.4 m -104.18 123.47 47.36 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.891 -1.151 . . . . 25.0 107.891 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.1 t -87.47 121.52 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 N-CA-C 108.248 -1.019 . . . . 25.0 108.248 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.584 HD12 HD22 ' A' ' 47' ' ' LEU . 81.1 mt -91.23 -42.71 10.26 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.984 -1.007 . . . . 25.0 109.277 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -150.46 155.87 40.36 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.43 -0.952 . . . . 25.0 108.43 -176.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -115.58 153.11 31.81 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.91 -1.515 . . . . 25.0 106.91 174.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 55.98 41.23 30.05 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 123.63 1.681 . . . . 25.0 109.176 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.2 t -71.05 159.79 34.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 113.234 -1.803 . . . . 25.0 110.665 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 59.51 12.03 2.59 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.18 0.992 . . . . 25.0 112.352 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.61 17.01 78.38 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 111.262 -0.735 . . . . 25.0 111.262 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.4 mt -97.73 131.37 44.33 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 122.44 0.296 . . . . 25.0 110.282 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -71.26 128.3 35.44 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.536 -0.542 . . . . 25.0 109.536 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.5 -1.32 82.64 Favored Glycine 0 CA--C 1.518 0.244 0 N-CA-C 116.569 1.388 . . . . 25.0 116.569 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -100.63 132.99 45.74 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 118.423 1.111 . . . . 25.0 109.621 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -113.05 141.6 46.69 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.939 -0.763 . . . . 25.0 108.939 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.584 HD22 HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -81.14 122.51 27.46 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 104.823 -2.288 . . . . 25.0 104.823 177.501 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.7 m -133.89 161.7 34.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.823 0.345 . . . . 25.0 111.902 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.6 t -114.63 125.14 53.41 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.833 -1.173 . . . . 25.0 107.833 172.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 tp -145.17 136.98 25.55 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.674 -1.232 . . . . 25.0 107.674 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 55.89 28.39 12.47 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.234 0.54 . . . . 25.0 112.173 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.68 2.53 90.56 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 114.877 0.711 . . . . 25.0 114.877 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -122.55 159.3 28.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 118.282 1.041 . . . . 25.0 108.422 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -112.09 150.34 30.85 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.633 -0.877 . . . . 25.0 108.633 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.84 -160.46 24.4 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 106.547 -2.621 . . . . 25.0 106.547 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.1 pt -116.84 150.36 18.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.796 0.808 . . . . 25.0 111.5 -175.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.98 146.59 52.93 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 114.846 -1.07 . . . . 25.0 108.814 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.44 122.82 6.71 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 117.951 -0.899 . . . . 25.0 111.706 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.2 -12.71 72.54 Favored Glycine 0 C--O 1.222 -0.615 0 O-C-N 121.909 -0.494 . . . . 25.0 113.24 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.3 -16.12 63.24 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.486 0.921 . . . . 25.0 113.486 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -129.36 27.65 5.3 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.142 -0.688 . . . . 25.0 109.142 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 12' ' ' ALA . 6.6 tp -129.32 152.22 49.12 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.276 -0.875 . . . . 25.0 111.472 -177.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -131.64 120.66 23.12 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-N 115.777 -0.647 . . . . 25.0 111.755 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.4 mm -66.13 136.13 27.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 O-C-N 123.53 0.519 . . . . 25.0 110.102 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.6 mt -118.75 98.51 6.25 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.303 -1.369 . . . . 25.0 107.303 175.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.3 t -72.47 134.07 30.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 107.302 -1.37 . . . . 25.0 107.302 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -123.72 44.26 1.32 Allowed Glycine 0 C--O 1.228 -0.259 0 C-N-CA 121.68 -0.295 . . . . 25.0 113.181 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 45.7 ttp -128.68 72.68 1.46 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.42 -0.956 . . . . 25.0 108.42 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -140.38 -172.45 3.43 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.731 -1.581 . . . . 25.0 106.731 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -56.49 -37.05 69.85 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.125 0.57 . . . . 25.0 112.051 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.29 162.88 39.18 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.76 -0.83 . . . . 25.0 108.76 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -147.49 143.95 18.73 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 107.544 -1.28 . . . . 25.0 107.544 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.15 156.53 46.83 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 116.621 -1.786 . . . . 25.0 111.316 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.97 -22.65 49.13 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.838 -0.43 . . . . 25.0 109.838 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.96 170.4 43.51 Favored Glycine 0 N--CA 1.453 -0.202 0 N-CA-C 108.636 -1.786 . . . . 25.0 108.636 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.4 m -153.81 75.52 1.04 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.481 -0.563 . . . . 25.0 109.481 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -90.16 -176.3 44.98 Favored Glycine 0 C--O 1.225 -0.426 0 CA-C-N 115.903 -0.59 . . . . 25.0 112.531 -176.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.11 -174.0 43.14 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 107.736 -2.146 . . . . 25.0 107.736 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.5 t -145.99 -176.59 5.21 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.068 -1.827 . . . . 25.0 106.068 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.6 54.57 1.53 Allowed Glycine 0 C--O 1.228 -0.252 0 N-CA-C 111.268 -0.733 . . . . 25.0 111.268 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.6 p -95.08 153.15 17.78 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.134 -0.691 . . . . 25.0 109.134 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.74 124.19 3.3 Favored Glycine 0 C--O 1.224 -0.525 0 N-CA-C 110.201 -1.16 . . . . 25.0 110.201 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.4 m -153.5 148.94 27.18 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.666 -1.235 . . . . 25.0 107.666 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -97.83 161.59 13.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.604 0.183 . . . . 25.0 110.999 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.2 mttm 52.87 39.47 29.08 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.208 0.818 . . . . 25.0 113.208 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -72.97 140.46 47.39 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.25 -0.432 . . . . 25.0 111.954 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.49 161.92 13.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.762 -0.654 . . . . 25.0 110.071 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.9 m -75.22 151.08 85.69 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 114.391 1.256 . . . . 25.0 114.391 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -65.39 154.78 72.08 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 N-CA-C 114.298 0.845 . . . . 25.0 114.298 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.57 152.61 81.08 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 O-C-N 121.695 0.313 . . . . 25.0 112.701 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.63 155.15 63.63 Favored 'Trans proline' 0 C--N 1.352 0.735 0 N-CA-C 117.441 2.054 . . . . 25.0 117.441 -171.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -68.91 145.67 96.87 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 115.138 -0.937 . . . . 25.0 110.123 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.76 161.66 41.24 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 118.276 -0.683 . . . . 25.0 112.263 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -61.98 156.88 46.77 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 N-CA-C 114.985 1.109 . . . . 25.0 114.985 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -113.46 43.53 1.75 Allowed 'General case' 0 N--CA 1.478 0.927 0 O-C-N 122.186 -0.321 . . . . 25.0 111.494 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 80.8 p 44.64 13.25 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 120.305 3.446 . . . . 25.0 120.305 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.9 mtp85 -88.15 -40.79 13.46 Favored 'General case' 0 C--O 1.211 -0.949 0 O-C-N 121.901 -0.5 . . . . 25.0 111.503 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.0 m -101.98 -11.47 18.92 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.515 0.674 . . . . 25.0 110.207 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 50.9 t -105.37 123.27 47.58 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 104.421 -2.437 . . . . 25.0 104.421 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.6 tt . . . . . 0 C--O 1.207 -1.132 0 C-N-CA 124.282 1.033 . . . . 25.0 110.987 -174.601 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 CA-C-O 123.292 1.496 . . . . 25.0 115.478 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 t 55.19 34.26 22.29 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.645 1.178 . . . . 25.0 113.42 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -72.82 102.16 3.32 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.056 -0.72 . . . . 25.0 109.056 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -77.27 108.79 10.64 Favored 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.378 -0.971 . . . . 25.0 108.378 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -133.33 164.78 26.33 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.499 -0.556 . . . . 25.0 109.499 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.8 mt -71.88 -33.16 68.13 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.756 -0.656 . . . . 25.0 111.079 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.3 m120 53.43 41.75 32.07 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.35 -0.841 . . . . 25.0 111.954 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.4 m -109.51 165.38 5.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.526 -1.287 . . . . 25.0 107.526 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.73 170.6 7.91 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.467 -0.568 . . . . 25.0 109.467 -176.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.38 162.08 40.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 25.0 110.954 173.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -127.82 130.51 48.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.6 -0.727 . . . . 25.0 109.729 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.38 131.94 46.18 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.061 0.545 . . . . 25.0 109.874 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.9 mt -94.96 -23.19 17.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.24 0.543 . . . . 25.0 110.769 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -144.56 172.09 13.47 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 104.222 -2.51 . . . . 25.0 104.222 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.95 173.89 10.81 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.949 -0.389 . . . . 25.0 109.949 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -155.07 141.01 18.28 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.507 0.323 . . . . 25.0 111.648 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.7 t -108.7 124.48 65.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 105.8 -1.926 . . . . 25.0 105.8 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.53 130.82 41.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.343 -0.844 . . . . 25.0 108.867 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -112.48 11.27 19.8 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.185 0.993 . . . . 25.0 109.044 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 t -153.15 151.26 25.64 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 107.5 -1.296 . . . . 25.0 107.5 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -69.21 -18.2 39.7 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 117.689 -1.074 . . . . 25.0 112.509 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -76.6 -19.62 57.64 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.431 0.634 . . . . 25.0 109.819 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -94.11 140.99 29.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.704 0.764 . . . . 25.0 111.034 -172.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.423 ' HB2' HG13 ' A' ' 57' ' ' VAL . 55.3 mt -91.17 129.61 37.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.469 -0.787 . . . . 25.0 110.157 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.69 139.52 30.48 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.106 -2.183 . . . . 25.0 105.106 173.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -157.77 166.46 32.7 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.594 -0.521 . . . . 25.0 109.594 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -112.73 164.03 13.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.105 0.955 . . . . 25.0 110.362 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -58.48 129.66 43.09 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.447 -1.252 . . . . 25.0 109.45 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.74 -16.21 61.39 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-O 118.758 -1.024 . . . . 25.0 114.867 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -57.79 146.7 30.58 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 117.984 0.892 . . . . 25.0 111.408 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.4 mm -109.47 133.89 53.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.595 -1.184 . . . . 25.0 108.139 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.2 ptp -138.79 162.61 34.31 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.358 -0.979 . . . . 25.0 108.358 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.8 m -101.38 125.5 48.03 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 108.363 -0.977 . . . . 25.0 108.363 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.53 126.01 43.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.044 -1.095 . . . . 25.0 108.044 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.615 HD12 HD22 ' A' ' 47' ' ' LEU . 76.8 mt -95.47 -43.65 7.89 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.865 -1.061 . . . . 25.0 108.918 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -150.21 162.19 40.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.178 -0.675 . . . . 25.0 109.178 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -121.82 152.34 39.64 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 107.076 -1.453 . . . . 25.0 107.076 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 56.22 39.9 30.14 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 123.309 1.528 . . . . 25.0 108.703 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -69.87 157.51 37.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.737 -1.574 . . . . 25.0 110.177 -175.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 60.53 11.05 2.81 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.611 0.967 . . . . 25.0 113.611 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.57 16.5 77.61 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.173 -0.771 . . . . 25.0 111.173 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.7 mt -103.68 113.71 27.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.003 0.43 . . . . 25.0 110.77 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -63.74 128.08 34.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.973 -0.558 . . . . 25.0 109.696 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.61 -1.92 88.05 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 118.757 -1.024 . . . . 25.0 115.103 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -98.93 131.79 44.74 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 118.969 1.384 . . . . 25.0 109.687 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -111.76 140.06 46.71 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.926 -0.768 . . . . 25.0 108.926 -176.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.615 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -82.05 120.79 25.72 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 105.44 -2.059 . . . . 25.0 105.44 178.067 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 92.0 m -132.26 163.55 28.37 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.476 0.547 . . . . 25.0 112.476 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.8 t -115.89 119.26 35.39 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 106.588 -1.634 . . . . 25.0 106.588 171.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -147.37 139.28 24.24 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 107.055 -1.461 . . . . 25.0 107.055 -174.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 56.72 31.49 19.47 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.678 0.752 . . . . 25.0 111.86 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.49 5.27 85.74 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 115.479 0.952 . . . . 25.0 115.479 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -129.78 161.26 31.13 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.125 -1.065 . . . . 25.0 108.125 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -107.09 152.42 24.05 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.385 -0.598 . . . . 25.0 109.385 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.59 -160.55 24.9 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 106.565 -2.614 . . . . 25.0 106.565 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.1 pt -117.28 156.82 18.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.308 0.575 . . . . 25.0 111.043 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.4 m -144.67 146.95 33.97 Favored Pre-proline 0 C--O 1.241 0.64 0 CA-C-N 114.96 -1.018 . . . . 25.0 109.874 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -74.45 118.44 5.35 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 CA-C-O 121.441 0.517 . . . . 25.0 112.708 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.8 -20.04 68.02 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 114.784 0.674 . . . . 25.0 114.784 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -25.22 67.3 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.109 0.781 . . . . 25.0 113.109 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -119.18 28.33 8.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.285 0.564 . . . . 25.0 110.347 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.0 tp -133.51 150.06 51.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.132 -0.485 . . . . 25.0 110.162 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -127.94 120.21 27.15 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.851 0.686 . . . . 25.0 112.851 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.7 mm -65.43 137.6 24.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.494 -0.558 . . . . 25.0 109.494 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.9 mt -118.44 105.36 11.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.915 -1.142 . . . . 25.0 107.915 175.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.9 m -89.89 161.63 2.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.092 -1.077 . . . . 25.0 108.092 177.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.89 -27.6 73.44 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.567 -0.825 . . . . 25.0 113.497 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.5 mtp -72.68 115.16 11.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.457 0.646 . . . . 25.0 110.793 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -89.84 2.58 54.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.368 -0.833 . . . . 25.0 109.443 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -77.91 51.74 0.98 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 122.526 1.155 . . . . 25.0 109.907 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -160.73 29.68 0.15 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.866 -1.061 . . . . 25.0 108.718 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -145.16 149.52 42.05 Favored Pre-proline 0 C--O 1.218 -0.566 0 N-CA-C 107.972 -1.122 . . . . 25.0 107.972 -177.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -80.85 11.04 3.11 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 N-CA-C 114.171 0.797 . . . . 25.0 114.171 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 65.73 -29.79 0.13 Allowed 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.974 1.842 . . . . 25.0 115.974 -177.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.41 100.7 0.32 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 115.857 1.103 . . . . 25.0 115.857 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.1 m 51.15 79.13 0.1 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.852 1.797 . . . . 25.0 115.852 173.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.33 35.68 1.54 Allowed Glycine 0 CA--C 1.526 0.767 0 N-CA-C 115.75 1.06 . . . . 25.0 115.75 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.58 168.92 35.54 Favored Glycine 0 C--O 1.225 -0.438 0 N-CA-C 109.465 -1.454 . . . . 25.0 109.465 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.0 m -152.78 167.15 29.96 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.453 -1.314 . . . . 25.0 107.453 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.41 -160.19 14.34 Favored Glycine 0 C--O 1.224 -0.53 0 N-CA-C 110.454 -1.058 . . . . 25.0 110.454 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.0 m 58.79 29.7 19.06 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.373 1.62 . . . . 25.0 115.373 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.97 -146.75 18.87 Favored Glycine 0 N--CA 1.455 -0.07 0 C-N-CA 121.259 -0.496 . . . . 25.0 113.257 175.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.0 t -154.87 162.05 41.24 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 103.555 -2.757 . . . . 25.0 103.555 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -119.55 160.26 22.77 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.97 -0.381 . . . . 25.0 109.97 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 66.1 163.51 0.17 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.15 1.78 . . . . 25.0 113.365 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -121.06 99.53 6.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 105.255 -2.128 . . . . 25.0 105.255 174.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -148.69 156.45 42.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.244 -1.391 . . . . 25.0 107.244 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 61.8 p -88.56 152.18 49.07 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 112.501 0.556 . . . . 25.0 112.501 -175.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.0 156.91 55.54 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 117.524 -1.184 . . . . 25.0 111.866 174.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.68 151.1 79.5 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 117.478 -1.215 . . . . 25.0 112.309 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -71.66 169.69 20.45 Favored 'Trans proline' 0 C--N 1.349 0.564 0 N-CA-C 115.931 1.473 . . . . 25.0 115.931 -172.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -80.69 141.93 52.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.231 -0.895 . . . . 25.0 108.956 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.39 161.03 43.56 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 117.171 -1.42 . . . . 25.0 110.518 170.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -63.24 155.47 61.39 Favored 'Trans proline' 0 C--N 1.345 0.387 0 N-CA-C 114.818 1.045 . . . . 25.0 114.818 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -106.57 -1.54 22.83 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.072 0.397 . . . . 25.0 112.072 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.5 p -138.16 147.69 44.12 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.737 -1.209 . . . . 25.0 107.737 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -158.24 -33.44 0.07 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.389 0.885 . . . . 25.0 113.389 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.0 t 59.13 -165.12 0.19 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.508 0.723 . . . . 25.0 110.353 -177.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 60.9 m 47.3 48.63 16.14 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.033 1.123 . . . . 25.0 114.033 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.213 -0.83 0 CA-C-O 123.707 1.718 . . . . 25.0 111.211 179.323 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.111 0 CA-C-O 125.4 2.667 . . . . 25.0 112.768 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.7 m -78.54 11.62 2.42 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 111.37 -2.415 . . . . 25.0 115.524 -173.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.0 mtt -112.75 27.09 9.93 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.387 0.613 . . . . 25.0 112.213 -176.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -81.44 88.34 6.15 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.872 -0.518 . . . . 25.0 110.333 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -133.17 166.75 21.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.669 -0.696 . . . . 25.0 112.608 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.04 -39.88 90.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.141 -0.936 . . . . 25.0 111.419 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 54.22 41.6 31.92 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.289 1.042 . . . . 25.0 111.91 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.447 HG23 ' HB ' ' A' ' 34' ' ' VAL . 15.9 m -102.7 171.27 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 N-CA-C 103.743 -2.688 . . . . 25.0 103.743 175.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -118.96 173.93 6.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 119.42 1.009 . . . . 25.0 110.693 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.04 158.74 44.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.12 -0.491 . . . . 25.0 109.746 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -120.9 132.26 54.86 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.311 0.644 . . . . 25.0 109.793 177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.59 130.43 42.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.016 0.436 . . . . 25.0 110.078 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.8 mt -97.46 -22.18 16.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.337 -0.392 . . . . 25.0 110.944 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -141.88 164.76 29.3 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -71.78 167.74 19.31 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.598 0.562 . . . . 25.0 110.785 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.45 160.04 42.17 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.516 -0.55 . . . . 25.0 109.516 175.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.1 t -130.85 127.7 61.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 102.87 -3.011 . . . . 25.0 102.87 169.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.53 123.6 31.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.788 -0.819 . . . . 25.0 108.788 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -117.18 -17.28 10.28 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.541 0.686 . . . . 25.0 110.41 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.55 152.91 37.97 Favored Pre-proline 0 N--CA 1.471 0.58 0 N-CA-C 107.973 -1.121 . . . . 25.0 107.973 176.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.8 -24.51 34.31 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 117.906 -0.929 . . . . 25.0 113.59 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -84.13 -16.36 43.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.938 0.399 . . . . 25.0 111.135 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -79.03 129.64 34.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.077 0.941 . . . . 25.0 110.644 -173.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.414 ' HB2' HG13 ' A' ' 57' ' ' VAL . 24.3 mt -82.77 138.48 34.01 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.497 -0.774 . . . . 25.0 109.605 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.65 130.73 34.69 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.474 -0.935 . . . . 25.0 108.474 177.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -158.37 162.92 37.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.27 0.557 . . . . 25.0 110.958 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.13 166.06 17.73 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.964 -0.562 . . . . 25.0 110.099 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -56.97 131.46 49.84 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 121.116 0.484 . . . . 25.0 109.8 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.06 -19.68 53.24 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-O 118.569 -1.128 . . . . 25.0 113.028 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -62.3 149.07 43.07 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 118.118 0.959 . . . . 25.0 109.98 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.4 mm -116.63 125.3 73.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 114.325 -1.307 . . . . 25.0 108.365 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -126.74 153.22 45.79 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.172 -0.677 . . . . 25.0 109.172 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.8 m -87.26 126.63 34.95 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.736 -1.579 . . . . 25.0 106.736 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.447 ' HB ' HG23 ' A' ' 8' ' ' VAL . 62.1 t -92.19 119.89 40.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.362 -1.348 . . . . 25.0 107.362 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.547 HD12 HD22 ' A' ' 47' ' ' LEU . 83.1 mt -91.03 -43.92 9.63 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.15 -0.932 . . . . 25.0 110.155 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -150.19 159.61 44.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.831 -1.174 . . . . 25.0 107.831 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -121.62 149.41 43.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.556 -1.275 . . . . 25.0 107.556 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 58.06 39.27 26.42 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 123.517 1.627 . . . . 25.0 109.603 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.3 t -65.29 151.81 45.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.742 -1.572 . . . . 25.0 110.468 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 59.59 11.75 2.51 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.93 0.892 . . . . 25.0 113.265 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.53 18.72 78.84 Favored Glycine 0 C--O 1.241 0.585 0 N-CA-C 110.987 -0.845 . . . . 25.0 110.987 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.9 mt -91.87 123.83 35.54 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.348 -0.612 . . . . 25.0 109.348 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -64.23 118.8 9.13 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.158 -0.928 . . . . 25.0 110.998 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.28 2.63 90.57 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 116.931 1.533 . . . . 25.0 116.931 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -100.82 132.02 46.42 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.809 1.305 . . . . 25.0 110.579 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -110.16 140.8 43.87 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.75 -0.593 . . . . 25.0 110.196 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.547 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -81.25 122.01 26.88 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 104.386 -2.449 . . . . 25.0 104.386 176.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.8 m -132.51 164.42 26.63 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.179 0.514 . . . . 25.0 111.362 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.5 t -121.55 125.16 46.12 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 107.485 -1.302 . . . . 25.0 107.485 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.2 tp -148.78 138.49 22.02 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 106.495 -1.668 . . . . 25.0 106.495 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 55.24 28.93 11.91 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.221 0.608 . . . . 25.0 112.168 -176.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.34 1.35 75.13 Favored Glycine 0 C--O 1.226 -0.349 0 N-CA-C 115.151 0.82 . . . . 25.0 115.151 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -117.09 161.47 19.37 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.083 -1.451 . . . . 25.0 107.083 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -118.35 156.75 28.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.508 -0.553 . . . . 25.0 109.508 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.21 -156.82 21.1 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 106.525 -2.63 . . . . 25.0 106.525 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.8 pt -121.12 151.9 24.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.742 0.782 . . . . 25.0 111.545 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 24' ' ' LEU . 2.4 m -141.18 146.85 44.77 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 114.438 -1.255 . . . . 25.0 109.591 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.65 121.21 5.84 Favored 'Trans proline' 0 C--O 1.24 0.586 0 CA-C-O 121.444 0.518 . . . . 25.0 113.133 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.3 -16.16 68.78 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-O 121.717 0.62 . . . . 25.0 114.334 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -18.3 63.55 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.018 0.527 . . . . 25.0 112.081 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -126.73 30.39 5.51 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.951 0.405 . . . . 25.0 110.692 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.5 mt -126.25 157.09 39.2 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.885 1.068 . . . . 25.0 113.885 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -129.76 119.82 24.06 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.16 -0.927 . . . . 25.0 109.649 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.7 mm -67.81 140.39 19.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 O-C-N 123.902 0.751 . . . . 25.0 109.613 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.4 mt -118.65 101.84 8.41 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.826 0.85 . . . . 25.0 109.152 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.45 -3.08 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 112.701 0.63 . . . . 25.0 112.701 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.85 67.93 1.71 Allowed Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.3 -0.952 . . . . 25.0 111.004 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 40.6 ttm -55.12 128.91 36.01 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 122.247 -0.561 . . . . 25.0 110.618 -177.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 58.16 11.52 1.56 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 117.067 2.247 . . . . 25.0 117.067 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -141.26 -30.09 0.62 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.132 0.79 . . . . 25.0 113.132 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.4 tttt 57.71 36.64 26.8 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.729 1.211 . . . . 25.0 112.115 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -122.49 158.67 55.56 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 106.879 -1.526 . . . . 25.0 106.879 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.37 160.77 48.51 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 117.469 -1.22 . . . . 25.0 111.985 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.98 146.47 54.67 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.831 -0.803 . . . . 25.0 108.831 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.44 164.24 54.6 Favored Glycine 0 C--O 1.235 0.187 0 C-N-CA 120.563 -0.827 . . . . 25.0 111.542 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.5 m -69.69 154.26 42.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.926 0.393 . . . . 25.0 110.188 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.06 81.34 0.14 Allowed Glycine 0 N--CA 1.46 0.262 0 N-CA-C 109.874 -1.29 . . . . 25.0 109.874 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.24 -178.69 23.37 Favored Glycine 0 C--O 1.22 -0.721 0 N-CA-C 111.99 -0.444 . . . . 25.0 111.99 -177.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.9 m 56.64 13.29 1.34 Allowed 'General case' 0 C--O 1.215 -0.716 0 N-CA-C 117.968 2.581 . . . . 25.0 117.968 174.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.31 43.6 2.31 Favored Glycine 0 C--O 1.219 -0.798 0 N-CA-C 114.654 0.622 . . . . 25.0 114.654 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.2 t -117.0 125.27 51.11 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.265 -1.013 . . . . 25.0 108.265 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.04 -1.09 47.22 Favored Glycine 0 C--O 1.214 -1.095 0 O-C-N 123.146 0.279 . . . . 25.0 113.641 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.2 m 55.77 52.15 11.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.658 0.742 . . . . 25.0 111.468 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -67.41 153.03 44.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.715 -1.13 . . . . 25.0 109.762 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.0 tptt 65.38 175.43 0.21 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.784 1.303 . . . . 25.0 112.206 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -139.45 20.74 2.56 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.214 0.53 . . . . 25.0 109.924 -172.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -85.75 157.49 20.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.629 0.728 . . . . 25.0 110.529 -177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -79.03 151.99 76.48 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 116.079 -0.51 . . . . 25.0 112.094 -175.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.84 156.99 40.27 Favored 'Trans proline' 0 C--N 1.349 0.6 0 N-CA-C 113.45 0.519 . . . . 25.0 113.45 178.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.44 147.18 90.55 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 118.203 -0.731 . . . . 25.0 112.126 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.71 157.86 26.34 Favored 'Trans proline' 0 C--N 1.351 0.674 0 N-CA-C 116.323 1.624 . . . . 25.0 116.323 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -78.87 138.36 57.56 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.404 -1.702 . . . . 25.0 106.404 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.81 160.97 47.69 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 118.306 -0.662 . . . . 25.0 112.361 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -61.98 151.38 81.74 Favored 'Trans proline' 0 C--N 1.347 0.5 0 N-CA-C 115.448 1.288 . . . . 25.0 115.448 -175.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -105.18 -23.11 12.96 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 115.599 -0.728 . . . . 25.0 112.133 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.7 p -127.92 22.44 6.26 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.348 -0.982 . . . . 25.0 108.348 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 66.43 160.95 0.15 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.753 1.221 . . . . 25.0 110.109 -170.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 44.7 t -165.0 124.94 1.88 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.51 -1.663 . . . . 25.0 106.51 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.4 m -140.44 -63.28 0.48 Allowed 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 121.851 0.834 . . . . 25.0 108.982 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 C--O 1.215 -0.72 0 CA-C-O 124.517 2.103 . . . . 25.0 110.29 176.463 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.202 -1.851 0 N-CA-C 114.699 0.64 . . . . 25.0 114.699 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t 54.69 35.52 24.05 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 123.634 0.774 . . . . 25.0 112.302 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.5 mtt -78.85 60.98 2.97 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.022 0.529 . . . . 25.0 111.879 -176.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -140.87 147.42 38.9 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.097 -1.445 . . . . 25.0 107.097 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 60.32 164.37 0.06 Allowed 'General case' 0 CA--C 1.53 0.173 0 O-C-N 125.013 1.445 . . . . 25.0 114.829 -176.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.5 mt -73.57 -42.48 61.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.652 -1.158 . . . . 25.0 110.291 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 55.75 30.05 14.96 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.396 1.078 . . . . 25.0 111.822 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 m -89.65 163.89 2.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 104.842 -2.281 . . . . 25.0 104.842 176.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.23 171.9 7.33 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.966 -1.124 . . . . 25.0 107.966 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.47 157.24 43.34 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.52 -0.548 . . . . 25.0 109.52 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -120.34 131.79 55.01 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 123.901 0.751 . . . . 25.0 109.393 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.436 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -68.8 126.94 31.32 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.658 0.599 . . . . 25.0 110.095 173.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.5 mt -92.56 -26.59 17.83 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.859 -0.423 . . . . 25.0 109.859 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -142.19 166.02 25.83 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.048 -1.834 . . . . 25.0 106.048 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -75.3 163.35 27.57 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 122.998 0.519 . . . . 25.0 112.369 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -143.07 144.03 32.09 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.625 0.602 . . . . 25.0 112.625 173.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -114.14 126.83 71.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 103.355 -2.832 . . . . 25.0 103.355 173.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.42 140.51 33.4 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 108.237 -1.023 . . . . 25.0 108.237 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -125.06 9.77 8.1 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.693 0.759 . . . . 25.0 111.186 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.5 m -145.73 150.98 45.0 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 106.575 -1.639 . . . . 25.0 106.575 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.62 -29.96 84.94 Favored 'Trans proline' 0 C--N 1.351 0.663 0 N-CA-C 114.954 1.098 . . . . 25.0 114.954 -175.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.7 -17.4 59.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.203 -0.453 . . . . 25.0 111.769 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -86.15 136.33 33.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 122.055 0.931 . . . . 25.0 111.886 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.9 mt -91.14 130.95 36.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.508 0.67 . . . . 25.0 111.089 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.6 p -90.92 144.69 25.42 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.61 -1.256 . . . . 25.0 107.61 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -160.09 168.55 25.29 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.61 0.243 . . . . 25.0 110.669 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -116.95 163.55 16.03 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.406 -0.59 . . . . 25.0 109.406 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -59.74 133.78 56.41 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.727 -0.842 . . . . 25.0 108.727 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.4 -21.35 46.45 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-O 118.903 -0.943 . . . . 25.0 113.003 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -57.14 145.69 30.34 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.031 0.919 . . . . 25.0 111.116 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.3 mm -115.7 126.83 73.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.486 -1.234 . . . . 25.0 109.159 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -131.39 153.95 49.14 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.665 -0.494 . . . . 25.0 109.665 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.5 m -89.55 123.69 33.86 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.474 -0.935 . . . . 25.0 108.474 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.9 t -87.1 123.15 39.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.069 -0.715 . . . . 25.0 109.069 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.661 HD12 HD22 ' A' ' 47' ' ' LEU . 77.5 mt -89.85 -46.05 8.83 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.244 -1.021 . . . . 25.0 108.244 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -153.94 172.85 16.78 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.881 -0.512 . . . . 25.0 109.708 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 mtm105 -120.25 154.5 34.82 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.087 -1.449 . . . . 25.0 107.087 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 59.71 40.47 19.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 123.527 1.632 . . . . 25.0 109.228 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t -66.84 154.77 40.06 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 113.081 -1.872 . . . . 25.0 110.36 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 57.59 14.37 2.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.213 1.005 . . . . 25.0 112.147 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.05 14.84 81.85 Favored Glycine 0 C--O 1.24 0.481 0 N-CA-C 111.287 -0.725 . . . . 25.0 111.287 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.3 mt -93.16 129.07 39.29 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 117.479 0.639 . . . . 25.0 109.602 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -67.84 125.92 27.78 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.039 -0.528 . . . . 25.0 110.305 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.29 -1.76 84.12 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 117.051 1.58 . . . . 25.0 117.051 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -97.75 135.11 40.0 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 117.879 0.839 . . . . 25.0 110.391 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -112.88 143.43 44.16 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.711 -1.218 . . . . 25.0 107.711 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.661 HD22 HD12 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -86.3 124.34 32.57 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.178 -2.527 . . . . 25.0 104.178 176.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 93.2 m -133.16 164.11 27.77 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.162 0.506 . . . . 25.0 111.762 177.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.0 t -118.66 124.9 48.53 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.688 -1.227 . . . . 25.0 107.688 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.0 tp -139.78 133.14 30.0 Favored 'General case' 0 C--O 1.212 -0.911 0 N-CA-C 107.306 -1.368 . . . . 25.0 107.306 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.5 m170 54.95 31.62 16.33 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.465 0.706 . . . . 25.0 111.404 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.31 1.2 85.57 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 116.018 1.167 . . . . 25.0 116.018 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -118.46 152.8 35.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 119.09 1.445 . . . . 25.0 107.661 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -108.18 157.14 18.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.353 -0.385 . . . . 25.0 110.176 -178.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.44 -161.37 29.51 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 106.609 -2.597 . . . . 25.0 106.609 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.7 pt -117.13 150.03 19.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.349 0.595 . . . . 25.0 111.032 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.53 146.87 46.88 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.084 -0.962 . . . . 25.0 109.107 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.45 122.02 5.42 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 CA-C-O 121.546 0.561 . . . . 25.0 112.904 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.56 -18.23 71.66 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 115.934 1.134 . . . . 25.0 115.934 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -17.74 63.84 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 122.223 -0.575 . . . . 25.0 111.778 -177.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -123.13 27.94 7.37 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.712 0.291 . . . . 25.0 110.523 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 12' ' ' ALA . 14.4 mt -127.74 156.03 43.08 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.879 0.847 . . . . 25.0 112.26 178.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -128.81 121.99 29.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.724 -1.125 . . . . 25.0 110.443 175.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.6 mm -68.75 139.23 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.409 -0.96 . . . . 25.0 108.409 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.6 mt -117.49 103.02 9.68 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.325 -1.361 . . . . 25.0 107.325 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.0 m -85.63 144.5 9.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.361 0.601 . . . . 25.0 111.287 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.4 42.06 2.21 Favored Glycine 0 C--O 1.226 -0.384 0 CA-C-O 119.761 -0.466 . . . . 25.0 113.238 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 97.2 mtp -60.85 -45.83 92.97 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 117.6 0.7 . . . . 25.0 110.755 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -139.69 -43.15 0.44 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.882 -0.599 . . . . 25.0 109.979 177.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -80.6 60.84 4.09 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.208 1.004 . . . . 25.0 110.996 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -75.63 125.05 28.27 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.262 -1.384 . . . . 25.0 107.262 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -157.78 153.97 23.81 Favored Pre-proline 0 C--N 1.327 -0.408 0 O-C-N 121.986 -0.446 . . . . 25.0 110.032 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -76.86 -175.13 2.47 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 120.209 0.606 . . . . 25.0 111.242 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.53 149.6 42.55 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.327 -1.36 . . . . 25.0 107.327 172.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.53 -28.01 66.9 Favored Glycine 0 C--O 1.216 -0.978 0 C-N-CA 120.528 -0.844 . . . . 25.0 112.879 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.4 m 55.78 23.29 6.22 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.988 1.477 . . . . 25.0 114.988 174.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -98.78 161.98 20.33 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.223 -0.751 . . . . 25.0 111.223 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.46 43.71 1.65 Allowed Glycine 0 C--O 1.221 -0.673 0 N-CA-C 111.171 -0.772 . . . . 25.0 111.171 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 t -146.72 149.73 33.99 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.484 -0.421 . . . . 25.0 111.201 -176.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.85 48.92 0.93 Allowed Glycine 0 C--O 1.223 -0.544 0 N-CA-C 109.794 -1.322 . . . . 25.0 109.794 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.8 m -55.62 135.47 51.09 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.917 1.08 . . . . 25.0 113.917 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.9 178.89 45.12 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 104.793 -3.323 . . . . 25.0 104.793 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.1 m -141.17 146.64 37.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.54 1.17 . . . . 25.0 109.045 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 51.7 -148.63 0.37 Allowed 'General case' 0 CA--C 1.547 0.837 0 O-C-N 124.627 1.204 . . . . 25.0 112.656 176.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? 50.65 42.39 27.07 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.05 1.5 . . . . 25.0 115.05 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -80.17 29.58 0.28 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.642 0.978 . . . . 25.0 113.642 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.74 145.83 48.12 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.705 0.631 . . . . 25.0 112.705 -175.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.0 m -62.17 148.44 89.01 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 114.268 1.211 . . . . 25.0 114.268 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.22 155.85 46.69 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 N-CA-C 114.535 0.937 . . . . 25.0 114.535 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -70.44 161.02 47.52 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 117.852 -0.966 . . . . 25.0 111.738 173.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.47 168.2 18.69 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 N-CA-C 113.523 0.547 . . . . 25.0 113.523 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -107.47 147.06 34.57 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 106.721 -1.585 . . . . 25.0 106.721 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.88 162.47 41.85 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 O-C-N 122.463 0.717 . . . . 25.0 112.757 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -62.05 161.37 26.38 Favored 'Trans proline' 0 C--N 1.351 0.706 0 N-CA-C 113.119 0.392 . . . . 25.0 113.119 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.2 mtm-85 -106.88 11.0 30.46 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.008 0.432 . . . . 25.0 111.813 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.3 p -137.5 157.39 46.65 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.897 -1.52 . . . . 25.0 106.897 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -129.08 -45.27 1.26 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 111.332 0.123 . . . . 25.0 111.332 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 t 48.64 35.74 6.65 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 115.728 1.751 . . . . 25.0 115.728 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 44.3 m -72.67 116.23 12.91 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.831 -0.543 . . . . 25.0 110.317 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.8 mm? . . . . . 0 C--O 1.207 -1.174 0 CA-C-O 124.813 2.244 . . . . 25.0 113.174 179.285 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.978 0 CA-C-O 123.709 1.727 . . . . 25.0 115.642 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.3 p -152.39 168.96 23.77 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 121.193 -1.181 . . . . 25.0 108.79 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.5 mmt 61.13 178.69 0.11 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.454 1.096 . . . . 25.0 112.919 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -136.13 79.16 1.75 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.129 -0.693 . . . . 25.0 109.129 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -72.88 168.77 18.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.033 -0.985 . . . . 25.0 109.794 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.27 -40.74 97.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.017 -0.538 . . . . 25.0 109.758 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 57.3 24.83 10.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.039 0.935 . . . . 25.0 111.856 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.5 m -88.21 175.81 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 N-CA-C 105.531 -2.026 . . . . 25.0 105.531 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mp -117.88 172.28 7.5 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 118.842 0.746 . . . . 25.0 110.813 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.72 163.38 34.19 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.792 -0.64 . . . . 25.0 110.256 177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -126.63 130.52 50.64 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.644 -0.707 . . . . 25.0 110.313 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.426 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -67.78 123.81 21.58 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.143 0.577 . . . . 25.0 110.237 174.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.0 mt -90.54 -23.92 20.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.801 -0.444 . . . . 25.0 109.801 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -141.26 172.53 12.55 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 102.887 -3.005 . . . . 25.0 102.887 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.52 176.4 9.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -151.61 135.23 16.26 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.199 0.523 . . . . 25.0 112.103 175.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.9 t -101.53 121.38 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 105.333 -2.099 . . . . 25.0 105.333 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.42 131.52 43.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.516 -0.92 . . . . 25.0 108.516 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -105.22 -6.51 19.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.688 0.756 . . . . 25.0 109.897 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 m -138.57 152.61 71.32 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 107.076 -1.453 . . . . 25.0 107.076 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.81 -19.29 36.05 Favored 'Trans proline' 0 C--O 1.222 -0.296 0 C-N-CA 117.721 -1.053 . . . . 25.0 112.374 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -79.41 -15.88 57.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 25.0 110.862 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -91.86 139.38 30.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.87 0.843 . . . . 25.0 110.428 -176.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.427 ' HB2' HG13 ' A' ' 57' ' ' VAL . 56.2 mt -90.62 129.72 36.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.059 0.933 . . . . 25.0 110.24 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.58 147.18 23.51 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.644 -1.613 . . . . 25.0 106.644 175.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -157.47 167.81 29.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.283 0.564 . . . . 25.0 111.023 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -107.09 159.13 16.54 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.971 -0.752 . . . . 25.0 108.971 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -58.0 128.2 35.89 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.72 -1.215 . . . . 25.0 107.72 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.18 -18.87 53.56 Favored Glycine 0 CA--C 1.517 0.194 0 CA-C-O 118.731 -1.039 . . . . 25.0 113.915 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -59.51 147.61 36.17 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 118.063 0.932 . . . . 25.0 110.738 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.5 mm -115.39 128.52 72.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.453 -1.249 . . . . 25.0 108.92 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -131.09 153.05 49.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.044 -0.354 . . . . 25.0 110.044 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.6 m -84.19 130.09 34.85 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 177.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.51 125.25 47.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.709 -0.849 . . . . 25.0 108.709 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.621 HD12 HD22 ' A' ' 47' ' ' LEU . 60.4 mt -91.09 -48.62 6.86 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.797 -0.816 . . . . 25.0 108.797 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -155.06 173.21 16.91 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.655 -0.869 . . . . 25.0 108.655 177.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -121.99 151.62 40.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.04 -1.096 . . . . 25.0 108.04 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 59.29 40.32 21.45 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 123.329 1.537 . . . . 25.0 108.936 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -65.06 153.78 39.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 112.866 -1.97 . . . . 25.0 110.5 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 59.79 11.61 2.58 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.585 0.957 . . . . 25.0 113.585 176.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.11 19.13 75.39 Favored Glycine 0 C--O 1.225 -0.447 0 N-CA-C 111.052 -0.819 . . . . 25.0 111.052 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 71.9 mt -96.95 112.33 24.13 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.124 0.488 . . . . 25.0 111.288 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.96 119.36 6.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.888 -0.596 . . . . 25.0 111.828 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.99 -0.01 89.55 Favored Glycine 0 C--O 1.239 0.417 0 N-CA-C 115.521 0.968 . . . . 25.0 115.521 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -100.19 134.6 42.88 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 118.525 1.163 . . . . 25.0 109.485 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -112.0 143.09 43.56 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.322 -0.992 . . . . 25.0 108.322 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.621 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -85.03 120.01 26.07 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 105.161 -2.163 . . . . 25.0 105.161 177.192 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 92.0 m -130.29 161.14 31.9 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.827 0.346 . . . . 25.0 111.317 178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.3 t -113.71 120.3 40.36 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.184 -1.413 . . . . 25.0 107.184 174.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.5 tp -143.2 135.5 27.19 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.145 -0.687 . . . . 25.0 109.145 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 56.03 28.13 12.35 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.889 1.07 . . . . 25.0 113.889 175.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.28 7.7 86.31 Favored Glycine 0 C--O 1.226 -0.352 0 C-N-CA 121.202 -0.523 . . . . 25.0 113.794 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -118.62 153.22 34.64 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.523 -0.918 . . . . 25.0 108.523 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -117.16 138.46 51.65 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 104.996 -2.224 . . . . 25.0 104.996 173.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.18 -162.71 26.99 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 107.414 -2.274 . . . . 25.0 107.414 -176.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.6 pt -111.31 151.92 13.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 121.599 0.714 . . . . 25.0 111.713 -174.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.2 m -141.47 145.01 35.95 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 114.851 -1.068 . . . . 25.0 108.992 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.72 120.69 6.26 Favored 'Trans proline' 0 C--O 1.238 0.507 0 CA-C-O 121.233 0.431 . . . . 25.0 112.691 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.76 -19.84 71.71 Favored Glycine 0 C--O 1.22 -0.727 0 N-CA-C 114.915 0.726 . . . . 25.0 114.915 -176.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -65.37 -16.68 63.86 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.217 0.821 . . . . 25.0 113.217 -177.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -122.92 27.44 7.69 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.259 0.552 . . . . 25.0 109.817 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 12' ' ' ALA . 12.7 mt -126.8 157.82 38.23 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.019 0.914 . . . . 25.0 113.023 178.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -127.56 125.93 41.22 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 115.01 -0.996 . . . . 25.0 110.194 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.2 mm -75.07 135.85 26.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.699 -0.852 . . . . 25.0 108.699 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.0 mt -115.47 92.13 3.82 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.561 0.744 . . . . 25.0 109.629 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 m -105.56 16.77 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.86 -0.609 . . . . 25.0 111.139 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.57 22.27 75.58 Favored Glycine 0 C--O 1.224 -0.49 0 C-N-CA 121.03 -0.605 . . . . 25.0 113.566 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 19.2 ttt -78.09 123.0 26.35 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.908 -0.775 . . . . 25.0 108.908 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 67.36 151.05 0.07 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.685 1.594 . . . . 25.0 111.822 -172.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -55.51 -45.98 77.03 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.279 -0.418 . . . . 25.0 111.81 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt 39.01 44.98 0.94 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.647 0.98 . . . . 25.0 113.647 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -55.44 138.7 68.01 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.804 -0.634 . . . . 25.0 110.472 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.73 151.7 69.29 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 117.853 -0.964 . . . . 25.0 111.959 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -157.15 170.83 21.62 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 104.714 -2.328 . . . . 25.0 104.714 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.05 -96.44 0.17 Allowed Glycine 0 C--O 1.217 -0.947 0 N-CA-C 109.982 -1.247 . . . . 25.0 109.982 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 t 55.12 39.48 31.51 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.359 0.664 . . . . 25.0 111.42 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -166.24 -163.61 20.18 Favored Glycine 0 CA--C 1.51 -0.254 0 N-CA-C 109.865 -1.294 . . . . 25.0 109.865 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.47 -155.48 11.54 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 114.86 0.704 . . . . 25.0 114.86 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 t 65.51 -155.93 0.27 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.056 0.943 . . . . 25.0 110.343 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.47 -11.41 30.69 Favored Glycine 0 CA--C 1.52 0.35 0 CA-C-O 121.253 0.363 . . . . 25.0 113.052 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.9 t -71.07 156.23 39.86 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.972 -1.121 . . . . 25.0 107.972 176.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.08 28.7 1.84 Allowed Glycine 0 C--O 1.222 -0.63 0 C-N-CA 121.023 -0.608 . . . . 25.0 112.921 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.0 t -95.59 137.1 35.11 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 104.922 -2.251 . . . . 25.0 104.922 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -109.19 134.67 51.44 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.626 -1.62 . . . . 25.0 106.626 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.99 22.03 5.48 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.951 0.723 . . . . 25.0 112.951 -177.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 62.81 25.48 15.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.837 0.855 . . . . 25.0 111.281 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -81.81 167.6 18.87 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 121.61 0.719 . . . . 25.0 112.877 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.3 m -78.03 159.62 75.46 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.474 1.11 . . . . 25.0 113.726 -175.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.02 155.34 68.7 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 118.044 -0.837 . . . . 25.0 112.424 176.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.82 153.53 77.64 Favored 'Trans proline' 0 C--N 1.351 0.702 0 O-C-N 121.623 0.275 . . . . 25.0 112.718 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.56 161.53 44.71 Favored 'Trans proline' 0 C--N 1.345 0.377 0 N-CA-C 115.677 1.376 . . . . 25.0 115.677 -172.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -91.65 149.49 39.34 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 107.766 -1.198 . . . . 25.0 107.766 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.69 165.75 31.57 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 O-C-N 122.186 0.571 . . . . 25.0 113.07 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.91 169.02 9.52 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 118.433 -0.578 . . . . 25.0 111.422 173.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.5 mtm-85 -106.24 -82.24 0.54 Allowed 'General case' 0 C--O 1.206 -1.188 0 CA-C-O 120.863 0.364 . . . . 25.0 110.617 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.95 -42.94 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.666 0.746 . . . . 25.0 110.272 -177.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -129.29 148.06 51.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.259 -0.882 . . . . 25.0 110.677 -174.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.0 m -83.54 117.98 23.48 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.186 -1.412 . . . . 25.0 107.186 176.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 64.4 m -101.02 153.19 19.75 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.065 -0.717 . . . . 25.0 109.065 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.5 tp . . . . . 0 C--O 1.213 -0.851 0 CA-C-O 124.513 2.102 . . . . 25.0 109.877 177.874 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.235 0 CA-C-O 125.322 2.623 . . . . 25.0 114.259 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.8 m -88.55 37.0 0.81 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 112.579 -1.81 . . . . 25.0 113.17 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -72.09 152.91 42.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.188 0.518 . . . . 25.0 109.96 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.14 75.1 5.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.622 -0.51 . . . . 25.0 109.622 177.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -118.31 168.21 10.83 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.641 -0.709 . . . . 25.0 109.689 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.4 mt -67.34 -39.35 85.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.918 -0.583 . . . . 25.0 109.788 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.7 m120 53.76 30.06 10.6 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.168 0.987 . . . . 25.0 112.683 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.8 m -93.17 175.88 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 104.501 -2.407 . . . . 25.0 104.501 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.55 172.34 7.72 Favored 'General case' 0 CA--C 1.497 -1.093 0 O-C-N 121.934 -0.479 . . . . 25.0 109.837 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.93 162.74 38.69 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.599 -0.728 . . . . 25.0 109.87 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.91 128.19 49.09 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 124.175 0.99 . . . . 25.0 108.333 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.24 138.24 49.28 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 122.763 0.425 . . . . 25.0 110.271 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.2 mt -101.46 -17.38 16.47 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.669 0.618 . . . . 25.0 112.669 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -141.45 159.12 42.87 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.698 -1.223 . . . . 25.0 107.698 -176.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.41 ' C ' HH22 ' A' ' 61' ' ' ARG . 21.5 m-20 -81.18 149.71 28.98 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.036 0.21 . . . . 25.0 111.257 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -133.68 146.29 50.71 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.33 0.652 . . . . 25.0 112.203 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.0 t -119.98 133.38 66.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 103.147 -2.908 . . . . 25.0 103.147 170.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.14 135.53 36.6 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.063 -0.717 . . . . 25.0 109.063 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -108.82 2.44 21.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.39 0.614 . . . . 25.0 111.261 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -142.43 151.73 58.58 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 105.88 -1.896 . . . . 25.0 105.88 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.21 -18.73 34.7 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 118.353 -0.631 . . . . 25.0 112.823 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.03 -16.79 59.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.267 -0.879 . . . . 25.0 110.956 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -97.56 141.68 30.31 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.694 -0.854 . . . . 25.0 108.694 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.3 mt -93.62 127.04 39.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.958 0.885 . . . . 25.0 112.059 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.23 129.3 34.83 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 104.81 -2.293 . . . . 25.0 104.81 174.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -149.35 163.74 36.88 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.998 -0.371 . . . . 25.0 109.998 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -111.01 163.78 13.48 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.577 0.703 . . . . 25.0 110.514 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.52 130.85 46.07 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 107.278 -1.378 . . . . 25.0 107.278 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.14 -9.47 77.56 Favored Glycine 0 C--N 1.312 -0.751 0 CA-C-O 119.03 -0.872 . . . . 25.0 114.279 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -62.38 149.41 42.46 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 117.822 0.811 . . . . 25.0 109.326 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.0 mm -114.77 128.15 72.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.144 -0.935 . . . . 25.0 108.686 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -131.48 149.93 52.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.231 -0.44 . . . . 25.0 109.935 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.1 m -87.18 122.64 31.26 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.746 -1.205 . . . . 25.0 107.746 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -85.4 127.43 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 N-CA-C 108.138 -1.06 . . . . 25.0 108.138 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.621 HD12 HD22 ' A' ' 47' ' ' LEU . 75.9 mt -93.37 -51.0 5.19 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.17 -0.923 . . . . 25.0 109.222 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -152.44 173.75 14.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.332 -0.618 . . . . 25.0 109.332 176.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -121.76 155.46 35.23 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 107.928 -1.138 . . . . 25.0 107.928 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 55.88 42.43 28.88 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 125.641 1.838 . . . . 25.0 109.168 -177.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.8 t -65.98 149.62 49.94 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 113.415 -1.721 . . . . 25.0 110.517 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 59.72 14.61 4.18 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.774 0.83 . . . . 25.0 112.175 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.29 10.72 85.99 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.28 -0.486 . . . . 25.0 111.982 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.4 mt -89.63 119.4 30.01 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 117.718 0.759 . . . . 25.0 110.001 -178.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -64.32 126.04 26.5 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.238 -0.437 . . . . 25.0 110.064 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.58 -0.09 88.51 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 115.451 0.94 . . . . 25.0 115.451 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -99.45 133.29 43.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 119.101 1.45 . . . . 25.0 108.97 175.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -114.85 142.47 46.52 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.123 -1.436 . . . . 25.0 107.123 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.621 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -87.56 125.49 34.37 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 104.963 -2.236 . . . . 25.0 104.963 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.8 m -135.85 160.82 37.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.834 0.35 . . . . 25.0 110.601 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.2 t -111.46 125.96 54.45 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.314 -1.365 . . . . 25.0 107.314 171.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.7 tp -136.72 128.8 29.56 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.759 -1.2 . . . . 25.0 107.759 -177.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.9 m170 54.9 30.71 14.41 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.942 0.401 . . . . 25.0 110.771 -175.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.66 -7.7 64.62 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 115.937 1.135 . . . . 25.0 115.937 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -110.8 149.05 31.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 118.307 1.053 . . . . 25.0 108.783 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -103.24 154.33 19.46 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.502 -0.772 . . . . 25.0 110.266 -175.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.66 -167.98 39.73 Favored Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 106.429 -2.668 . . . . 25.0 106.429 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.4 pt -111.36 149.84 13.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.976 0.893 . . . . 25.0 111.961 -175.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 m -139.54 145.17 42.54 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 114.29 -1.323 . . . . 25.0 109.413 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.03 123.07 8.1 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 CA-C-O 121.207 0.42 . . . . 25.0 112.646 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.95 -15.01 79.84 Favored Glycine 0 C--O 1.228 -0.27 0 O-C-N 122.088 -0.383 . . . . 25.0 113.525 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -67.57 -5.28 14.65 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.775 0.83 . . . . 25.0 112.368 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.41 HH22 ' C ' ' A' ' 15' ' ' ASP . 0.3 OUTLIER -142.06 27.9 1.75 Allowed 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.139 -1.06 . . . . 25.0 108.139 -178.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 tp -130.65 144.62 51.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.611 -0.722 . . . . 25.0 110.884 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -122.32 117.09 25.26 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.257 -0.429 . . . . 25.0 112.033 -176.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.1 mm -64.92 136.99 25.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 O-C-N 123.961 0.788 . . . . 25.0 109.609 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.5 mt -119.67 106.14 11.87 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.283 -1.377 . . . . 25.0 107.283 176.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.42 142.69 13.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.104 0.478 . . . . 25.0 110.238 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.19 -38.88 24.77 Favored Glycine 0 C--O 1.218 -0.869 0 N-CA-C 110.495 -1.042 . . . . 25.0 110.495 177.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.2 ttp 56.99 -2.39 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 117.94 2.57 . . . . 25.0 117.94 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -137.8 148.9 45.91 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.065 0.765 . . . . 25.0 113.065 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -124.59 44.1 2.85 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 105.651 -1.981 . . . . 25.0 105.651 171.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -116.49 -58.52 2.08 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.989 -1.005 . . . . 25.0 111.873 -175.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -156.58 158.53 31.44 Favored Pre-proline 0 CA--C 1.511 -0.532 0 N-CA-C 104.113 -2.551 . . . . 25.0 104.113 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -71.79 162.94 40.48 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 116.395 -1.937 . . . . 25.0 112.112 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.75 -59.65 0.56 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.341 0.591 . . . . 25.0 110.392 176.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.81 -168.42 34.35 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.805 -0.442 . . . . 25.0 112.536 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.7 m -153.23 -43.64 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.939 1.089 . . . . 25.0 113.939 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.86 -139.55 34.9 Favored Glycine 0 C--O 1.246 0.861 0 C-N-CA 120.875 -0.678 . . . . 25.0 113.258 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.89 53.69 3.44 Favored Glycine 0 C--O 1.224 -0.525 0 N-CA-C 115.992 1.157 . . . . 25.0 115.992 175.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -70.55 -27.34 64.07 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.872 1.064 . . . . 25.0 113.872 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.61 -61.6 4.73 Favored Glycine 0 C--O 1.22 -0.779 0 CA-C-O 119.696 -0.502 . . . . 25.0 113.399 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.9 m 54.0 35.43 22.04 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.633 1.345 . . . . 25.0 114.633 178.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.99 172.49 39.85 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 110.814 -0.915 . . . . 25.0 110.814 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.2 t -148.52 147.83 29.51 Favored 'General case' 0 C--O 1.22 -0.482 0 N-CA-C 106.791 -1.559 . . . . 25.0 106.791 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -122.17 117.91 27.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.707 0.289 . . . . 25.0 110.576 -177.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.3 tttt 54.13 -166.53 0.08 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.857 0.837 . . . . 25.0 112.865 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -98.77 67.07 1.67 Allowed 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.437 -1.32 . . . . 25.0 107.437 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -72.96 145.97 46.37 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.934 -1.136 . . . . 25.0 107.934 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.7 t -96.35 134.72 23.13 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 108.626 -0.879 . . . . 25.0 108.626 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -67.36 154.54 73.63 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 116.664 -1.758 . . . . 25.0 111.527 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -70.68 160.05 50.71 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 117.011 -1.526 . . . . 25.0 111.906 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -69.58 155.57 66.17 Favored 'Trans proline' 0 C--N 1.352 0.76 0 N-CA-C 114.395 0.883 . . . . 25.0 114.395 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -83.12 140.78 42.76 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 106.957 -1.497 . . . . 25.0 106.957 176.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.92 164.71 33.67 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 116.705 -1.73 . . . . 25.0 110.553 173.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.77 153.89 64.05 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 118.578 -0.482 . . . . 25.0 113.138 -176.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -97.14 35.01 1.65 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 120.634 0.254 . . . . 25.0 111.226 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.7 p -138.78 145.07 39.72 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.414 -0.958 . . . . 25.0 108.414 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -163.93 -39.8 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.975 -0.557 . . . . 25.0 111.371 175.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.7 p 54.1 109.22 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 116.726 2.121 . . . . 25.0 116.726 177.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 47.1 t -63.09 -43.37 98.69 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.052 -0.976 . . . . 25.0 112.908 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.8 tp . . . . . 0 N--CA 1.494 1.736 0 C-N-CA 125.354 1.462 . . . . 25.0 112.586 -177.615 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.761 0 CA-C-O 123.511 1.617 . . . . 25.0 113.607 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 m 64.7 -65.27 0.14 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 127.822 2.449 . . . . 25.0 112.608 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.4 -50.59 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.299 -1.741 . . . . 25.0 106.299 176.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -158.95 134.31 8.51 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 106.163 -1.792 . . . . 25.0 106.163 175.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.79 165.81 10.81 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.182 -1.414 . . . . 25.0 107.182 174.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.41 -39.97 92.69 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.509 0.506 . . . . 25.0 110.648 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 55.52 31.93 18.05 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.926 0.89 . . . . 25.0 111.695 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.401 HG23 ' HB ' ' A' ' 34' ' ' VAL . 17.5 m -94.31 170.71 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 104.267 -2.494 . . . . 25.0 104.267 175.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -115.83 172.21 7.28 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.264 -1.013 . . . . 25.0 108.264 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.29 156.32 41.91 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 123.281 0.363 . . . . 25.0 110.623 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -116.63 127.86 54.85 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 123.998 0.812 . . . . 25.0 110.104 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.52 127.08 31.38 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.913 -0.773 . . . . 25.0 108.913 176.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.6 mt -88.75 -24.19 22.72 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 120.61 0.243 . . . . 25.0 110.488 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -146.2 171.5 14.84 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 104.09 -2.559 . . . . 25.0 104.09 177.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -82.57 174.24 11.22 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.538 -0.541 . . . . 25.0 109.538 177.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -150.85 133.44 15.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.889 0.376 . . . . 25.0 111.74 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.9 t -101.3 120.07 50.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 105.197 -2.149 . . . . 25.0 105.197 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.05 137.49 49.03 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.644 -0.873 . . . . 25.0 108.644 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -116.02 15.27 16.16 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 122.266 1.031 . . . . 25.0 108.891 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 t -157.21 149.47 17.73 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.118 -0.946 . . . . 25.0 108.501 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -69.48 -16.43 38.73 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 117.326 -1.316 . . . . 25.0 113.006 175.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -78.58 -17.1 56.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.524 0.678 . . . . 25.0 109.805 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -98.52 138.21 36.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.599 -0.728 . . . . 25.0 110.904 -173.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.443 ' HB2' HG13 ' A' ' 57' ' ' VAL . 50.8 mt -89.69 130.77 35.93 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.787 0.804 . . . . 25.0 110.045 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.6 p -90.23 144.49 25.8 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 105.803 -1.925 . . . . 25.0 105.803 174.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -157.9 168.55 26.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.82 0.343 . . . . 25.0 110.268 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.55 161.1 16.04 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.318 0.58 . . . . 25.0 109.789 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -60.31 133.97 56.61 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.318 -0.994 . . . . 25.0 108.318 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.86 -15.46 63.33 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-O 119.079 -0.845 . . . . 25.0 113.69 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -58.41 136.6 57.49 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.553 0.692 . . . . 25.0 109.739 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.0 mm -103.74 127.44 57.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 106.393 -1.706 . . . . 25.0 106.393 176.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 19.5 ptp -131.79 153.62 49.94 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.188 -0.671 . . . . 25.0 109.188 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.1 m -89.33 127.83 35.83 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.046 -1.464 . . . . 25.0 107.046 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.401 ' HB ' HG23 ' A' ' 8' ' ' VAL . 45.9 t -97.01 122.97 49.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.955 -1.128 . . . . 25.0 107.955 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.571 HD12 HD22 ' A' ' 47' ' ' LEU . 78.0 mt -92.78 -45.22 8.12 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.272 -0.876 . . . . 25.0 109.521 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -147.15 161.18 41.41 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.384 -0.969 . . . . 25.0 108.384 -174.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -126.88 149.59 49.69 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.08 -1.452 . . . . 25.0 107.08 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 56.62 38.52 29.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 123.483 1.611 . . . . 25.0 108.452 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 t -63.03 146.71 52.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.339 -1.755 . . . . 25.0 110.01 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 59.44 13.42 3.22 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.482 0.919 . . . . 25.0 113.482 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.89 16.99 79.24 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 111.003 -0.839 . . . . 25.0 111.003 -178.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.448 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 60.3 mt -91.53 103.65 16.23 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.875 -0.787 . . . . 25.0 108.875 178.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -54.49 123.98 14.73 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.422 -0.808 . . . . 25.0 111.606 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.24 0.27 85.89 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 115.345 0.898 . . . . 25.0 115.345 176.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.448 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 95.0 m95 -100.95 130.73 46.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 118.523 1.162 . . . . 25.0 109.193 177.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -112.23 142.6 44.52 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 121.789 -0.569 . . . . 25.0 109.622 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.571 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -84.02 119.07 24.5 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 105.563 -2.014 . . . . 25.0 105.563 178.642 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 95.4 m -129.8 162.28 28.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.088 0.47 . . . . 25.0 112.095 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.1 t -111.97 113.38 25.65 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.522 -1.658 . . . . 25.0 106.522 172.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -143.6 136.79 27.83 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.84 -1.17 . . . . 25.0 107.84 -174.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 55.88 27.42 10.99 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.45 0.7 . . . . 25.0 112.803 -176.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.51 6.4 86.64 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 120.859 -0.686 . . . . 25.0 113.046 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -114.16 160.99 18.35 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.53 -1.285 . . . . 25.0 107.53 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -121.75 142.82 49.81 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 105.89 -1.892 . . . . 25.0 105.89 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.09 -158.34 20.71 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 105.461 -3.055 . . . . 25.0 105.461 -177.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.7 pt -118.5 154.23 20.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.493 0.663 . . . . 25.0 111.238 -175.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 24' ' ' LEU . 2.0 m -141.42 146.26 41.47 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.069 -0.968 . . . . 25.0 109.347 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.24 117.7 5.21 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 CA-C-O 121.484 0.535 . . . . 25.0 112.189 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.95 -14.75 66.16 Favored Glycine 0 C--O 1.22 -0.767 0 O-C-N 122.079 -0.388 . . . . 25.0 113.202 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -64.23 -15.35 59.86 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.832 0.679 . . . . 25.0 112.832 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -131.21 29.55 4.62 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.348 0.594 . . . . 25.0 109.628 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.1 tp -133.63 148.41 51.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.845 -0.616 . . . . 25.0 109.972 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -127.87 120.12 27.07 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 111.984 0.365 . . . . 25.0 111.984 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.4 mm -69.18 135.47 28.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 123.458 0.474 . . . . 25.0 110.45 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.6 mt -120.85 96.66 5.2 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.951 0.9 . . . . 25.0 109.213 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.3 t -84.66 146.46 6.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.712 -1.218 . . . . 25.0 107.712 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.13 -47.27 0.43 Allowed Glycine 0 C--O 1.216 -1.004 0 C-N-CA 120.496 -0.859 . . . . 25.0 114.6 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 92.5 mmm -145.74 143.0 29.47 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 106.378 -1.712 . . . . 25.0 106.378 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -86.93 -18.27 31.2 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.802 -1.185 . . . . 25.0 107.802 173.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -80.93 90.44 5.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.961 -1.018 . . . . 25.0 111.37 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 10.7 76.72 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 116.792 2.145 . . . . 25.0 116.792 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -56.97 142.69 73.38 Favored Pre-proline 0 C--O 1.237 0.419 0 N-CA-C 108.701 -0.852 . . . . 25.0 108.701 177.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -66.7 157.29 61.78 Favored 'Trans proline' 0 C--N 1.347 0.488 0 N-CA-C 113.703 0.617 . . . . 25.0 113.703 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.68 164.38 26.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.985 -1.007 . . . . 25.0 108.443 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.16 162.86 34.02 Favored Glycine 0 C--O 1.225 -0.411 0 N-CA-C 108.648 -1.781 . . . . 25.0 108.648 174.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 m -77.89 -11.97 59.94 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.063 0.764 . . . . 25.0 113.063 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.19 -155.96 21.01 Favored Glycine 0 C--O 1.229 -0.198 0 N-CA-C 109.176 -1.57 . . . . 25.0 109.176 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -178.38 -176.95 46.72 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 109.01 -1.636 . . . . 25.0 109.01 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.6 m -65.25 153.45 41.01 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.438 -0.579 . . . . 25.0 109.438 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.35 -148.94 8.04 Favored Glycine 0 C--O 1.223 -0.583 0 C-N-CA 120.653 -0.784 . . . . 25.0 111.887 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.0 t 67.03 16.32 10.3 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.188 0.995 . . . . 25.0 113.157 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.47 34.16 2.0 Favored Glycine 0 CA--C 1.517 0.157 0 N-CA-C 109.072 -1.611 . . . . 25.0 109.072 175.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.6 m 55.67 -153.07 0.35 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.222 0.609 . . . . 25.0 109.824 -173.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -145.04 32.99 1.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.188 -1.042 . . . . 25.0 108.188 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 72.7 tttt 61.87 -141.41 0.45 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 104.63 -2.359 . . . . 25.0 104.63 -171.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 55.91 -150.56 0.42 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.455 0.702 . . . . 25.0 109.985 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -117.11 163.44 16.27 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.54 -0.541 . . . . 25.0 109.54 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.2 m -60.22 147.62 80.82 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 112.506 0.558 . . . . 25.0 112.506 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.4 159.07 54.95 Favored 'Trans proline' 0 C--N 1.35 0.637 0 N-CA-C 113.306 0.464 . . . . 25.0 113.306 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.7 155.55 69.55 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 118.435 -0.577 . . . . 25.0 113.067 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.85 163.24 38.13 Favored 'Trans proline' 0 C--N 1.347 0.48 0 N-CA-C 115.463 1.294 . . . . 25.0 115.463 -174.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.62 143.27 92.51 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.056 -0.974 . . . . 25.0 108.886 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.03 161.7 45.17 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 116.92 -1.587 . . . . 25.0 110.604 175.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -61.11 151.47 78.41 Favored 'Trans proline' 0 C--N 1.349 0.592 0 N-CA-C 114.49 0.919 . . . . 25.0 114.49 -177.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -101.27 76.67 1.73 Allowed 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.713 -0.847 . . . . 25.0 108.713 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -63.8 143.14 58.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.843 -0.617 . . . . 25.0 110.285 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -144.11 43.59 1.44 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 105.494 -2.039 . . . . 25.0 105.494 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.9 p -149.26 150.44 32.57 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.418 -1.697 . . . . 25.0 106.418 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 34.7 m -115.52 157.92 23.36 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.62 -0.511 . . . . 25.0 109.62 -177.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.0 tp . . . . . 0 N--CA 1.483 1.207 0 C-N-CA 124.801 1.24 . . . . 25.0 114.024 178.669 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.055 0 N-CA-C 116.066 1.187 . . . . 25.0 116.066 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m 60.95 -167.28 0.19 Allowed 'General case' 0 C--N 1.351 0.666 0 C-N-CA 124.99 1.316 . . . . 25.0 111.247 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.6 ptt? -141.84 137.72 31.65 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.347 -1.353 . . . . 25.0 107.347 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -109.46 79.18 1.19 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.55 0.691 . . . . 25.0 109.944 -176.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -96.1 161.71 13.85 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.362 -0.835 . . . . 25.0 111.063 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.6 mt -68.3 -40.61 81.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.765 -0.828 . . . . 25.0 108.765 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 53.46 34.78 19.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.037 0.935 . . . . 25.0 111.58 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.0 m -93.38 -179.25 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 103.946 -2.613 . . . . 25.0 103.946 175.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.89 173.86 6.97 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.276 -0.89 . . . . 25.0 109.938 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.75 157.23 43.02 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.506 0.67 . . . . 25.0 109.598 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -116.96 129.95 56.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.177 -0.92 . . . . 25.0 109.875 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.97 128.09 35.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.091 -0.504 . . . . 25.0 109.666 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.64 -21.79 21.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.315 0.579 . . . . 25.0 111.188 -177.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -141.18 173.27 11.64 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.852 -1.166 . . . . 25.0 107.852 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -76.8 -179.07 5.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 124.113 0.883 . . . . 25.0 109.884 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.09 156.79 29.83 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.777 -0.823 . . . . 25.0 108.777 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.36 122.82 60.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 103.394 -2.817 . . . . 25.0 103.394 167.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.31 133.07 34.16 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.133 -1.062 . . . . 25.0 108.133 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -114.01 -23.56 9.49 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.027 0.441 . . . . 25.0 111.021 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -93.44 151.7 40.41 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.285 -1.006 . . . . 25.0 108.285 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.06 -18.88 30.64 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 116.545 -1.837 . . . . 25.0 111.835 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -85.71 -17.0 37.21 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.228 -0.896 . . . . 25.0 110.036 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -83.11 133.67 35.04 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.442 -0.787 . . . . 25.0 110.142 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.2 mt -84.02 132.86 34.7 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.961 0.41 . . . . 25.0 110.546 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 p -83.48 116.82 22.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.214 -1.032 . . . . 25.0 108.214 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -138.96 161.94 36.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.091 0.948 . . . . 25.0 112.491 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -119.23 166.62 12.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.975 -1.011 . . . . 25.0 108.73 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -61.87 131.61 50.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.882 -0.785 . . . . 25.0 108.882 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.62 -13.94 65.66 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-O 118.844 -0.975 . . . . 25.0 114.683 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.39 141.39 54.7 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 118.117 0.959 . . . . 25.0 108.908 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.6 mm -106.51 130.35 58.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 107.358 -1.349 . . . . 25.0 107.358 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.481 ' HB3' HD13 ' A' ' 50' ' ' LEU . 16.3 ptp -131.78 151.68 51.49 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 109.037 -0.727 . . . . 25.0 109.037 -177.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.4 m -87.94 124.33 33.59 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 106.895 -1.521 . . . . 25.0 106.895 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.4 t -91.82 124.2 44.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 N-CA-C 108.418 -0.956 . . . . 25.0 108.418 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.637 HD12 HD22 ' A' ' 47' ' ' LEU . 78.6 mt -90.02 -47.56 7.76 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.765 -0.652 . . . . 25.0 109.411 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -156.9 175.72 13.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.737 -0.468 . . . . 25.0 109.737 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -127.95 156.2 43.04 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 106.219 -1.771 . . . . 25.0 106.219 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.4 t0 61.8 36.15 16.29 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.869 1.319 . . . . 25.0 108.218 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -66.7 144.71 56.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.772 -1.103 . . . . 25.0 108.58 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 57.64 15.25 2.76 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.604 0.964 . . . . 25.0 113.604 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.79 15.59 81.21 Favored Glycine 0 C--O 1.254 1.348 0 C-N-CA 121.335 -0.459 . . . . 25.0 112.076 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.44 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 98.0 mt -92.98 101.24 13.57 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 122.238 1.018 . . . . 25.0 108.69 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -60.11 121.7 12.56 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.592 -1.186 . . . . 25.0 110.206 -175.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.08 -2.44 85.43 Favored Glycine 0 C--N 1.318 -0.418 0 CA-C-O 119.06 -0.856 . . . . 25.0 115.139 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.44 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 93.0 m95 -99.17 139.14 35.26 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 118.388 1.094 . . . . 25.0 108.62 174.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.41 ' CE3' HD23 ' A' ' 62' ' ' LEU . 41.9 m0 -118.6 139.61 51.21 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.496 -1.298 . . . . 25.0 107.496 -177.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.637 HD22 HD12 ' A' ' 35' ' ' LEU . 0.7 OUTLIER -81.12 124.29 29.11 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 106.359 -1.719 . . . . 25.0 106.359 177.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 98.2 m -131.76 163.13 28.87 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.622 0.725 . . . . 25.0 109.975 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -117.91 120.25 37.29 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 104.966 -2.235 . . . . 25.0 104.966 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.481 HD13 ' HB3' ' A' ' 32' ' ' MET . 11.1 tp -147.9 134.32 19.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.932 -0.766 . . . . 25.0 108.932 -175.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.3 m170 54.07 32.26 15.31 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.719 1.007 . . . . 25.0 113.719 174.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.73 5.01 86.96 Favored Glycine 0 C--O 1.224 -0.492 0 C-N-CA 120.452 -0.88 . . . . 25.0 114.867 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -120.06 158.83 26.01 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 107.816 -1.179 . . . . 25.0 107.816 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -111.88 154.55 25.02 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 102.95 -2.982 . . . . 25.0 102.95 166.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.25 -167.88 40.72 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 107.723 -2.151 . . . . 25.0 107.723 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 pt -113.03 151.74 14.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.65 0.738 . . . . 25.0 112.241 -175.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.7 m -143.79 147.12 37.45 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-N 114.722 -1.126 . . . . 25.0 110.235 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.38 118.48 5.37 Favored 'Trans proline' 0 C--O 1.244 0.797 0 O-C-N 121.946 0.445 . . . . 25.0 112.586 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.33 -15.13 65.3 Favored Glycine 0 C--O 1.221 -0.677 0 N-CA-C 114.664 0.626 . . . . 25.0 114.664 -176.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -63.67 -23.95 67.59 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 113.004 0.742 . . . . 25.0 113.004 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -118.34 28.39 8.38 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.393 -0.595 . . . . 25.0 109.393 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.41 HD23 ' CE3' ' A' ' 46' ' ' TRP . 18.1 tp -134.56 150.1 50.7 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.539 -0.755 . . . . 25.0 110.593 -175.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -128.54 119.97 25.84 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.166 0.432 . . . . 25.0 112.166 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.8 mm -64.81 135.86 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.6 0.714 . . . . 25.0 111.33 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.1 mt -118.33 93.71 4.22 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.559 -1.275 . . . . 25.0 107.559 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 m -83.26 149.92 4.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.629 -0.878 . . . . 25.0 108.629 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -135.54 49.67 0.88 Allowed Glycine 0 C--O 1.214 -1.102 0 CA-C-N 116.395 -0.366 . . . . 25.0 112.755 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -80.77 3.22 23.11 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.658 -0.907 . . . . 25.0 112.601 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -110.81 146.09 37.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.576 -0.284 . . . . 25.0 110.996 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -114.81 -177.53 3.15 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.898 -1.149 . . . . 25.0 107.898 173.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm 57.21 19.52 4.97 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.829 1.418 . . . . 25.0 114.829 175.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -131.21 146.64 62.94 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 106.521 -1.659 . . . . 25.0 106.521 175.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.55 135.48 31.07 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 116.267 -2.022 . . . . 25.0 112.804 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.27 -37.48 32.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.348 -0.387 . . . . 25.0 110.116 176.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.53 -170.07 54.93 Favored Glycine 0 C--O 1.216 -0.985 0 N-CA-C 110.46 -1.056 . . . . 25.0 110.46 -177.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.6 t -156.46 -60.58 0.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.194 0.521 . . . . 25.0 110.399 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.54 -146.79 18.77 Favored Glycine 0 C--O 1.222 -0.629 0 N-CA-C 108.172 -1.971 . . . . 25.0 108.172 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.08 -15.61 56.4 Favored Glycine 0 C--O 1.226 -0.392 0 CA-C-N 117.018 0.409 . . . . 25.0 113.095 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.8 m -64.56 138.33 58.34 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.325 -0.62 . . . . 25.0 109.325 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.96 161.97 52.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.855 -0.688 . . . . 25.0 111.767 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.0 m -146.0 -32.87 0.34 Allowed 'General case' 0 C--O 1.211 -0.972 0 N-CA-C 112.519 0.563 . . . . 25.0 112.519 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.82 172.0 39.08 Favored Glycine 0 C--N 1.318 -0.438 0 C-N-CA 121.209 -0.52 . . . . 25.0 112.18 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.3 m -104.07 85.35 2.38 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.628 -0.336 . . . . 25.0 110.916 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -131.68 86.6 2.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.016 0.436 . . . . 25.0 110.982 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -149.83 140.21 22.34 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.215 0.82 . . . . 25.0 113.215 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -136.18 21.04 3.21 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.81 0.814 . . . . 25.0 109.999 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -104.85 178.47 4.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.568 -0.742 . . . . 25.0 111.202 -176.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.3 t -135.7 140.62 34.29 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.007 -0.542 . . . . 25.0 110.035 -176.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -72.17 158.83 51.25 Favored 'Trans proline' 0 C--N 1.349 0.595 0 N-CA-C 116.248 1.595 . . . . 25.0 116.248 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.86 157.09 61.37 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 117.909 -0.928 . . . . 25.0 112.361 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -68.82 162.42 41.46 Favored 'Trans proline' 0 C--N 1.349 0.558 0 N-CA-C 116.552 1.712 . . . . 25.0 116.552 -174.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -79.47 140.75 56.08 Favored Pre-proline 0 N--CA 1.473 0.723 0 CA-C-N 114.634 -1.166 . . . . 25.0 108.097 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.77 165.75 30.8 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 118.093 -0.805 . . . . 25.0 110.986 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -64.41 155.38 66.32 Favored 'Trans proline' 0 C--N 1.352 0.736 0 N-CA-C 114.975 1.106 . . . . 25.0 114.975 -175.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.4 mtp-105 -111.54 -23.45 10.7 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.24 1.2 . . . . 25.0 114.24 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.2 p -135.63 41.2 2.74 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.154 0.502 . . . . 25.0 112.153 -172.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -65.44 138.66 58.26 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.577 -0.897 . . . . 25.0 108.577 176.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.0 m -80.99 -31.17 34.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.035 0.445 . . . . 25.0 110.391 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 74.1 m -139.52 165.37 27.41 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.342 -0.614 . . . . 25.0 109.342 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 67.7 tp . . . . . 0 C--O 1.206 -1.229 0 CA-C-O 124.691 2.186 . . . . 25.0 110.918 175.459 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 CA-C-O 122.909 1.283 . . . . 25.0 115.191 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.4 m -67.05 136.29 55.0 Favored 'General case' 0 C--O 1.23 0.062 0 O-C-N 121.381 -1.07 . . . . 25.0 110.5 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.3 ptp -153.3 165.22 36.44 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.319 -1.363 . . . . 25.0 107.319 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -156.53 159.11 38.27 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 104.551 -2.389 . . . . 25.0 104.551 177.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 58.01 168.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 116.345 1.98 . . . . 25.0 116.345 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.5 mt -76.48 -38.73 54.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.496 -1.229 . . . . 25.0 109.645 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.7 m120 54.35 24.96 5.5 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.329 1.052 . . . . 25.0 112.921 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG23 ' HB ' ' A' ' 34' ' ' VAL . 23.1 m -84.85 175.1 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 105.439 -2.059 . . . . 25.0 105.439 173.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.82 174.04 6.41 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.736 -0.603 . . . . 25.0 109.81 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.56 162.81 36.57 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.158 -0.474 . . . . 25.0 110.459 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -128.42 129.18 45.78 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.018 -0.992 . . . . 25.0 109.23 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.59 136.9 43.99 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.878 -0.601 . . . . 25.0 109.466 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.4 mt -104.82 -15.83 15.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 111.881 0.326 . . . . 25.0 111.881 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -143.15 165.35 27.67 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.976 -1.12 . . . . 25.0 107.976 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.93 165.03 25.01 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.638 -0.504 . . . . 25.0 109.638 174.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.04 159.91 42.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.104 -0.702 . . . . 25.0 109.104 177.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.01 121.79 56.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 104.866 -2.272 . . . . 25.0 104.866 171.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.82 134.73 33.63 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.462 -1.681 . . . . 25.0 106.462 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -114.35 -8.8 12.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.324 0.583 . . . . 25.0 111.166 -177.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.5 p -132.16 155.9 80.75 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 105.541 -2.022 . . . . 25.0 105.541 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.33 -18.31 39.08 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 118.03 -0.846 . . . . 25.0 112.266 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.48 -20.29 58.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.934 -0.576 . . . . 25.0 110.926 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -95.45 137.08 35.01 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.956 -1.127 . . . . 25.0 107.956 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.454 ' HB2' HG13 ' A' ' 57' ' ' VAL . 50.5 mt -86.26 134.53 33.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.886 -0.597 . . . . 25.0 109.947 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.06 130.45 34.61 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.232 -1.025 . . . . 25.0 108.232 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -154.27 163.36 40.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.916 0.865 . . . . 25.0 113.329 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -115.83 163.52 15.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.577 -1.192 . . . . 25.0 110.013 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -58.94 129.62 43.04 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.736 -0.839 . . . . 25.0 108.736 175.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.62 -11.04 72.01 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 118.831 -0.983 . . . . 25.0 114.634 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -63.21 150.34 43.26 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 118.39 1.095 . . . . 25.0 110.457 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.2 mm -115.57 131.28 68.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.37 -1.286 . . . . 25.0 108.917 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -135.37 156.02 49.62 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.214 -0.661 . . . . 25.0 109.214 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.1 m -87.63 130.17 34.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.177 -1.416 . . . . 25.0 107.177 176.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.405 ' HB ' HG23 ' A' ' 8' ' ' VAL . 57.8 t -94.24 124.32 46.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.643 -1.243 . . . . 25.0 107.643 177.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.595 HD12 HD22 ' A' ' 47' ' ' LEU . 81.2 mt -93.27 -44.98 8.05 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -149.43 162.25 40.48 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.961 -0.755 . . . . 25.0 108.961 -175.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 mtm105 -121.81 151.11 40.96 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.872 -1.159 . . . . 25.0 107.872 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.404 ' H ' ' HD1' ' A' ' 46' ' ' TRP . 27.7 m-20 56.11 38.86 30.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 123.51 1.624 . . . . 25.0 108.853 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 t -67.1 153.37 43.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.11 -1.859 . . . . 25.0 110.438 -175.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 60.6 9.56 2.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.911 0.884 . . . . 25.0 113.261 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.36 10.84 84.1 Favored Glycine 0 C--N 1.329 0.17 0 N-CA-C 110.803 -0.919 . . . . 25.0 110.803 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.423 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 93.2 mt -88.42 109.44 20.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.853 -0.795 . . . . 25.0 108.853 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -58.6 126.26 26.87 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.588 -0.733 . . . . 25.0 110.983 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.65 -0.58 76.21 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 115.784 1.074 . . . . 25.0 115.784 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.423 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 94.3 m95 -100.89 129.99 46.83 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 119.028 1.414 . . . . 25.0 109.964 178.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.404 ' HD1' ' H ' ' A' ' 38' ' ' ASP . 47.6 m0 -112.89 140.54 47.6 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 121.873 -0.517 . . . . 25.0 109.926 -175.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.595 HD22 HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -80.3 121.86 26.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 105.949 -1.871 . . . . 25.0 105.949 179.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 92.5 m -133.51 168.37 18.76 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.926 0.393 . . . . 25.0 111.583 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 t -123.42 125.77 45.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.747 -1.205 . . . . 25.0 107.747 173.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.0 tp -152.82 143.78 22.98 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.806 -1.553 . . . . 25.0 106.806 -176.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 55.69 31.97 18.44 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.153 0.581 . . . . 25.0 112.214 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.36 4.36 68.91 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 115.268 0.867 . . . . 25.0 115.268 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -124.75 165.72 17.47 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.069 -1.086 . . . . 25.0 108.069 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -116.28 154.37 30.28 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.669 -0.863 . . . . 25.0 108.669 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.53 -157.44 20.48 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 106.381 -2.688 . . . . 25.0 106.381 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.4 pt -120.65 157.34 23.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.618 0.723 . . . . 25.0 111.423 -176.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.3 m -143.87 147.12 37.21 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 114.763 -1.108 . . . . 25.0 109.146 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -74.51 117.7 5.06 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 O-C-N 121.999 0.473 . . . . 25.0 112.519 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.51 -19.5 68.93 Favored Glycine 0 C--O 1.22 -0.777 0 CA-C-O 121.422 0.457 . . . . 25.0 114.104 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -66.41 -10.33 42.66 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.552 0.945 . . . . 25.0 113.552 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -130.46 26.34 5.08 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.872 -0.788 . . . . 25.0 108.872 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.2 tp -131.77 150.05 52.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.282 -0.872 . . . . 25.0 111.595 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -121.26 126.67 50.14 Favored 'General case' 0 C--O 1.211 -0.931 0 C-N-CA 122.828 0.451 . . . . 25.0 110.932 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.2 mm -75.59 135.41 27.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.964 -0.754 . . . . 25.0 108.964 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.9 mt -116.66 107.18 14.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.023 -1.843 . . . . 25.0 106.023 174.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.0 m -78.99 167.67 2.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.931 -0.577 . . . . 25.0 110.228 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -153.98 -176.76 26.71 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 106.981 -2.447 . . . . 25.0 106.981 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 44.1 ttm 104.05 146.59 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 128.321 2.649 . . . . 25.0 106.347 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 61.86 27.11 16.5 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.756 0.822 . . . . 25.0 111.899 -176.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -73.69 58.49 0.61 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.121 0.968 . . . . 25.0 111.959 177.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -68.32 -18.05 64.41 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.419 0.526 . . . . 25.0 112.419 -174.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -147.66 140.05 14.4 Favored Pre-proline 0 N--CA 1.468 0.467 0 N-CA-C 106.18 -1.785 . . . . 25.0 106.18 174.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.42 142.97 37.87 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 115.775 -2.35 . . . . 25.0 110.715 175.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.13 -37.0 24.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.187 0.518 . . . . 25.0 111.191 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.66 165.08 39.13 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.775 -0.93 . . . . 25.0 110.775 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.3 p -160.36 158.94 30.52 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.967 -0.753 . . . . 25.0 108.967 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.29 168.99 20.28 Favored Glycine 0 CA--C 1.517 0.168 0 N-CA-C 110.516 -1.034 . . . . 25.0 110.516 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.81 -166.64 37.47 Favored Glycine 0 C--O 1.227 -0.335 0 N-CA-C 110.872 -0.891 . . . . 25.0 110.872 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.8 t -153.69 173.9 15.2 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.356 -1.72 . . . . 25.0 106.356 177.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -171.02 -39.64 0.03 OUTLIER Glycine 0 C--O 1.22 -0.748 0 N-CA-C 111.823 -0.511 . . . . 25.0 111.823 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.9 p -69.79 137.37 51.81 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.477 -0.425 . . . . 25.0 110.033 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 147.54 -165.68 28.72 Favored Glycine 0 C--O 1.226 -0.344 0 N-CA-C 109.574 -1.41 . . . . 25.0 109.574 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.59 120.11 15.73 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.928 -0.768 . . . . 25.0 108.928 176.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.33 -0.51 10.4 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.603 0.594 . . . . 25.0 112.603 -177.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -131.63 70.72 1.46 Allowed 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.033 -0.417 . . . . 25.0 110.104 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.99 163.04 0.24 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.909 1.284 . . . . 25.0 111.084 -176.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -151.57 176.51 11.26 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.644 -1.243 . . . . 25.0 107.644 -176.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.7 m -118.89 84.99 27.38 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-O 120.859 0.362 . . . . 25.0 110.043 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.8 160.39 40.78 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 N-CA-C 114.314 0.851 . . . . 25.0 114.314 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.03 158.99 54.12 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 118.782 -0.346 . . . . 25.0 111.975 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -66.56 158.08 57.48 Favored 'Trans proline' 0 C--N 1.346 0.395 0 N-CA-C 115.179 1.184 . . . . 25.0 115.179 -174.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -71.56 143.51 87.6 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.69 -1.226 . . . . 25.0 107.69 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -69.63 162.47 41.86 Favored 'Trans proline' 0 C--O 1.244 0.778 0 C-N-CA 117.848 -0.968 . . . . 25.0 111.472 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -60.68 147.21 95.59 Favored 'Trans proline' 0 C--N 1.348 0.524 0 N-CA-C 114.473 0.913 . . . . 25.0 114.473 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -100.55 52.42 0.87 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.323 -0.621 . . . . 25.0 109.323 176.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 42.4 p 39.55 48.19 1.77 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 114.451 1.278 . . . . 25.0 114.451 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -142.36 39.91 1.58 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.406 1.098 . . . . 25.0 108.378 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.7 m -84.14 172.92 11.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.88 -1.509 . . . . 25.0 109.612 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 7.2 t 52.71 56.55 7.46 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 122.426 1.108 . . . . 25.0 113.252 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.1 tt . . . . . 0 C--O 1.214 -0.802 0 CA-C-O 124.784 2.23 . . . . 25.0 110.207 176.621 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.096 0 CA-C-O 124.947 2.415 . . . . 25.0 113.438 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.7 t -68.03 -44.82 75.61 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 111.193 -2.503 . . . . 25.0 109.03 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 76.2 mtm -92.91 150.39 20.61 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.175 -1.417 . . . . 25.0 107.175 175.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -129.09 137.7 51.41 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 106.469 -1.678 . . . . 25.0 106.469 177.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -117.47 165.13 13.89 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 123.745 0.653 . . . . 25.0 111.389 -175.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.02 -41.23 95.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.109 -0.951 . . . . 25.0 109.661 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 56.65 25.16 9.69 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.268 1.027 . . . . 25.0 111.912 -178.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.6 m -83.42 159.94 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 105.805 -1.924 . . . . 25.0 105.805 176.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.43 170.98 8.85 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.821 -1.177 . . . . 25.0 107.821 -177.207 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.13 163.15 36.25 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.941 -0.392 . . . . 25.0 109.941 175.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -132.21 128.76 38.64 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.621 -0.718 . . . . 25.0 109.669 177.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.26 130.73 42.8 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.496 -0.557 . . . . 25.0 109.496 177.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.9 mt -97.97 -21.86 16.61 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.693 0.282 . . . . 25.0 110.912 -177.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -138.97 165.91 25.87 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.676 -0.861 . . . . 25.0 108.676 178.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -74.58 165.95 24.35 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.03 0.932 . . . . 25.0 111.302 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.0 156.92 42.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.32 0.581 . . . . 25.0 110.861 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.6 t -130.26 125.7 60.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 102.926 -2.99 . . . . 25.0 102.926 170.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.19 136.81 33.11 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.558 -1.275 . . . . 25.0 107.558 178.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -128.6 6.26 5.66 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.294 0.569 . . . . 25.0 111.522 -178.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.2 m -127.63 151.36 75.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 105.82 -1.918 . . . . 25.0 105.82 176.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.62 -25.96 40.1 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 117.35 -1.3 . . . . 25.0 112.712 -177.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -79.29 -16.94 55.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.192 -0.458 . . . . 25.0 111.498 178.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -86.7 132.96 33.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.94 0.876 . . . . 25.0 109.247 -177.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.404 ' HB2' HG13 ' A' ' 57' ' ' VAL . 49.1 mt -87.07 133.4 33.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.736 -0.665 . . . . 25.0 110.567 -177.192 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.5 121.2 28.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.223 -0.899 . . . . 25.0 108.954 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -147.75 164.01 34.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.046 0.451 . . . . 25.0 111.022 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.506 HH22 ' HB2' ' A' ' 84' ' ' GLU . 55.8 ttt-85 -126.19 165.92 18.02 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.035 -0.728 . . . . 25.0 109.035 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -57.0 132.6 53.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.958 0.409 . . . . 25.0 110.493 -179.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.89 -16.5 61.16 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-O 119.122 -0.821 . . . . 25.0 113.929 178.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.98 151.37 26.38 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.837 0.827 . . . . 25.0 111.145 178.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.2 mm -117.99 131.39 70.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.067 -1.424 . . . . 25.0 108.917 -179.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -138.82 158.05 44.94 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 122.633 0.373 . . . . 25.0 110.202 179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.3 m -89.91 130.19 36.16 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.689 -0.856 . . . . 25.0 108.689 177.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.3 t -94.53 126.04 47.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.551 -0.907 . . . . 25.0 108.551 178.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.652 HD12 HD22 ' A' ' 47' ' ' LEU . 79.8 mt -90.76 -51.47 5.35 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.097 -0.705 . . . . 25.0 109.097 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -151.84 171.47 17.68 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.04 -1.096 . . . . 25.0 108.04 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -121.9 155.2 35.94 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.049 -1.464 . . . . 25.0 107.049 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 58.17 39.24 26.15 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 123.794 1.759 . . . . 25.0 109.448 178.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.4 t -65.94 155.47 36.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 112.758 -2.019 . . . . 25.0 110.485 -176.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 60.11 9.62 1.92 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.185 0.994 . . . . 25.0 112.992 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.51 20.92 73.63 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.421 -1.071 . . . . 25.0 110.421 -176.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.6 mt -97.4 127.72 43.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.225 0.536 . . . . 25.0 110.279 178.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -67.16 124.08 22.09 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.673 -0.694 . . . . 25.0 110.857 178.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.06 -0.01 84.51 Favored Glycine 0 C--O 1.239 0.426 0 N-CA-C 116.392 1.317 . . . . 25.0 116.392 173.484 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -100.68 132.21 46.19 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 118.384 1.092 . . . . 25.0 109.453 178.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -113.07 141.98 46.26 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.183 -0.673 . . . . 25.0 109.183 -176.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.652 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -83.73 123.19 29.6 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 105.644 -1.984 . . . . 25.0 105.644 178.925 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 84.3 m -131.62 164.49 25.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.931 0.396 . . . . 25.0 110.741 177.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.0 t -118.85 123.33 44.45 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.771 -1.937 . . . . 25.0 105.771 172.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.1 tp -145.43 136.63 24.89 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.11 -1.071 . . . . 25.0 108.11 -176.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.64 27.69 12.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.885 0.698 . . . . 25.0 112.885 178.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.45 0.1 86.69 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 114.883 0.713 . . . . 25.0 114.883 177.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -124.71 158.63 32.76 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 118.124 0.962 . . . . 25.0 110.135 178.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -109.59 154.65 22.47 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.095 -0.706 . . . . 25.0 109.095 179.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.83 -160.73 28.17 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 107.288 -2.325 . . . . 25.0 107.288 179.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.2 pt -117.06 153.16 18.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.919 0.866 . . . . 25.0 112.534 -174.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.9 m -142.88 146.89 39.45 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 114.313 -1.312 . . . . 25.0 109.839 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.12 119.07 5.65 Favored 'Trans proline' 0 C--O 1.239 0.55 0 CA-C-O 121.296 0.457 . . . . 25.0 112.252 178.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.9 -25.33 74.28 Favored Glycine 0 C--O 1.219 -0.842 0 N-CA-C 116.72 1.448 . . . . 25.0 116.72 -174.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -65.19 -22.32 66.88 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.556 -0.967 . . . . 25.0 113.512 -177.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -110.61 24.63 12.72 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.617 0.722 . . . . 25.0 109.389 178.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.9 tp -133.29 150.72 51.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.367 -0.833 . . . . 25.0 109.968 -175.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -122.41 125.88 46.79 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-N 116.558 -0.292 . . . . 25.0 110.494 -179.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.2 mm -75.69 135.63 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.13 -1.063 . . . . 25.0 108.13 175.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.2 mt -118.6 88.72 2.98 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.577 -0.898 . . . . 25.0 108.577 177.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.1 t -77.4 -38.76 27.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.837 -0.801 . . . . 25.0 108.837 178.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.35 170.77 27.43 Favored Glycine 0 C--O 1.234 0.112 0 CA-C-N 115.877 -0.601 . . . . 25.0 112.588 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.27 172.75 10.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.37 0.605 . . . . 25.0 111.55 179.162 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -65.91 143.86 57.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.89 -0.595 . . . . 25.0 110.118 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -115.24 162.99 16.31 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.861 -1.163 . . . . 25.0 107.861 178.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -63.31 169.23 3.77 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.509 1.124 . . . . 25.0 113.455 179.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.84 152.22 77.05 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 105.393 -2.077 . . . . 25.0 105.393 176.04 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.12 -26.61 21.17 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 116.953 -1.565 . . . . 25.0 113.039 179.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.42 160.13 34.47 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.064 -1.828 . . . . 25.0 106.064 177.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.07 155.31 13.92 Favored Glycine 0 C--O 1.229 -0.212 0 N-CA-C 109.191 -1.564 . . . . 25.0 109.191 176.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.8 t -162.0 176.02 11.19 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.642 -1.614 . . . . 25.0 106.642 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -94.86 -175.19 38.16 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 109.17 -1.572 . . . . 25.0 109.17 174.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 167.14 -37.78 0.23 Allowed Glycine 0 C--O 1.225 -0.42 0 C-N-CA 120.33 -0.938 . . . . 25.0 113.675 177.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.5 p -73.72 147.91 43.13 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.168 -0.679 . . . . 25.0 109.168 177.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.84 168.24 34.14 Favored Glycine 0 C--O 1.228 -0.232 0 N-CA-C 110.625 -0.99 . . . . 25.0 110.625 178.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.1 p -62.86 -27.21 69.18 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.118 0.485 . . . . 25.0 112.089 -179.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.95 89.04 0.43 Allowed Glycine 0 C--O 1.227 -0.288 0 N-CA-C 108.701 -1.76 . . . . 25.0 108.701 174.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.7 p -152.67 -174.27 4.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 117.604 0.702 . . . . 25.0 110.272 -176.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.506 ' HB2' HH22 ' A' ' 27' ' ' ARG . 72.1 mt-10 61.89 -162.46 0.28 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.353 1.061 . . . . 25.0 112.924 178.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -142.48 167.78 21.29 Favored 'General case' 0 C--O 1.215 -0.763 0 N-CA-C 107.817 -1.179 . . . . 25.0 107.817 -175.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -74.28 -21.9 59.54 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.721 -0.474 . . . . 25.0 109.721 171.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 t70 56.73 -157.17 0.28 Allowed 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.05 0.844 . . . . 25.0 112.843 177.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.0 m -123.75 84.81 53.71 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.796 -0.816 . . . . 25.0 108.796 177.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.96 162.29 34.84 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 120.22 0.614 . . . . 25.0 113.591 -178.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -62.66 149.72 90.23 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 118.444 -0.571 . . . . 25.0 111.624 179.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.52 158.42 55.68 Favored 'Trans proline' 0 C--N 1.345 0.388 0 N-CA-C 117.149 1.942 . . . . 25.0 117.149 -167.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.5 138.75 70.88 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 106.976 -1.491 . . . . 25.0 106.976 176.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.87 166.69 28.77 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 CA-C-N 118.748 0.589 . . . . 25.0 112.055 177.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.57 152.92 58.69 Favored 'Trans proline' 0 C--N 1.348 0.538 0 N-CA-C 113.569 0.565 . . . . 25.0 113.569 -179.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.9 mtt85 -109.86 4.71 21.9 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.441 0.638 . . . . 25.0 109.792 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.4 p -143.27 146.24 33.44 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.68 -1.6 . . . . 25.0 106.68 -179.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -93.2 75.41 4.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.84 -1.17 . . . . 25.0 107.84 177.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.2 m -64.57 121.18 13.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.0 -0.545 . . . . 25.0 111.886 -177.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 24.2 t -138.4 98.26 3.56 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.19 -1.041 . . . . 25.0 108.19 177.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.1 tp . . . . . 0 C--O 1.211 -0.967 0 CA-C-O 123.584 1.659 . . . . 25.0 113.237 -174.826 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 115.322 0.889 . . . . 25.0 115.322 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.8 t 65.2 -23.72 0.09 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 127.004 2.121 . . . . 25.0 115.861 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.2 mtt -65.17 149.5 49.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.575 -0.528 . . . . 25.0 109.575 177.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -139.35 133.88 31.74 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.053 -1.832 . . . . 25.0 106.053 178.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -118.54 163.16 17.2 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 123.527 0.517 . . . . 25.0 111.22 -177.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.02 -38.85 89.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.141 -0.936 . . . . 25.0 110.132 178.471 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 55.86 36.34 27.11 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.933 0.893 . . . . 25.0 111.492 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 m -100.63 161.59 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 106.36 -1.718 . . . . 25.0 106.36 177.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.55 171.97 7.59 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.02 -1.104 . . . . 25.0 108.02 -177.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.75 164.82 34.23 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.694 -0.484 . . . . 25.0 109.694 174.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -128.4 136.22 50.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.105 -0.952 . . . . 25.0 108.712 177.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.567 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -74.18 136.43 42.83 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.799 0.333 . . . . 25.0 110.827 175.179 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.4 mt -100.6 -20.92 15.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.852 0.358 . . . . 25.0 110.781 -179.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -142.5 171.57 13.88 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 103.297 -2.853 . . . . 25.0 103.297 175.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -83.5 178.57 7.95 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.302 -0.999 . . . . 25.0 108.302 174.501 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -153.25 135.86 15.19 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.68 0.276 . . . . 25.0 111.108 175.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.8 t -106.04 120.86 57.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 104.946 -2.242 . . . . 25.0 104.946 174.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.6 134.01 46.11 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.37 -0.832 . . . . 25.0 109.394 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -107.53 3.81 25.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.676 0.75 . . . . 25.0 109.683 179.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.7 m -149.4 155.82 39.4 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 107.932 -1.136 . . . . 25.0 107.932 179.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.39 -19.67 32.85 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 118.398 -0.601 . . . . 25.0 113.491 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -15.96 55.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.158 0.504 . . . . 25.0 110.076 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -90.82 139.45 30.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.6 0.714 . . . . 25.0 109.13 -178.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.423 ' HB2' HG13 ' A' ' 57' ' ' VAL . 59.2 mt -92.06 127.78 37.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.767 0.794 . . . . 25.0 110.567 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.4 p -87.96 143.43 27.11 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 106.042 -1.836 . . . . 25.0 106.042 173.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -156.98 166.12 34.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.503 -0.925 . . . . 25.0 108.503 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.5 tpp85 -105.85 158.95 16.39 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.994 -0.743 . . . . 25.0 108.994 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -59.83 128.79 38.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.764 -0.653 . . . . 25.0 109.586 178.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.14 -4.45 81.04 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.117 -0.824 . . . . 25.0 114.356 177.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -62.71 160.65 13.8 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 117.885 0.843 . . . . 25.0 110.842 176.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.6 mm -119.93 134.79 62.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.643 -1.162 . . . . 25.0 109.49 178.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -139.85 163.43 32.66 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.736 -0.468 . . . . 25.0 109.736 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -97.45 129.49 44.64 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.508 -1.294 . . . . 25.0 107.508 176.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.5 t -96.28 122.94 48.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 107.773 -1.195 . . . . 25.0 107.773 177.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.632 HD12 HD22 ' A' ' 47' ' ' LEU . 80.7 mt -91.52 -42.85 10.02 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.164 -0.926 . . . . 25.0 109.267 -179.319 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -151.68 158.85 43.97 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.779 -0.823 . . . . 25.0 108.779 -176.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.8 mtm105 -116.11 153.84 31.04 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.642 -1.244 . . . . 25.0 107.642 175.011 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 56.22 37.54 28.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 123.383 1.563 . . . . 25.0 108.62 178.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.0 t -64.36 150.2 46.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.255 -1.793 . . . . 25.0 110.386 -174.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 59.47 13.85 3.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.636 0.774 . . . . 25.0 112.121 -178.534 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.71 18.22 79.78 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.294 -0.723 . . . . 25.0 111.294 -178.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.2 mt -91.55 121.15 32.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.274 0.537 . . . . 25.0 109.696 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -62.45 125.02 22.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.931 -0.577 . . . . 25.0 110.357 -179.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.4 -0.8 73.81 Favored Glycine 0 CA--C 1.519 0.292 0 N-CA-C 116.762 1.465 . . . . 25.0 116.762 175.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -100.1 130.03 46.2 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 119.149 1.475 . . . . 25.0 110.713 179.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -110.25 140.77 44.06 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.571 -0.529 . . . . 25.0 109.571 -177.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.632 HD22 HD12 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -79.98 120.8 24.66 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 105.628 -1.99 . . . . 25.0 105.628 177.428 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 84.5 m -132.2 164.79 25.56 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.099 0.407 . . . . 25.0 112.099 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.5 t -118.92 116.57 26.74 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.932 -1.507 . . . . 25.0 106.932 172.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -146.43 138.99 25.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.936 -1.135 . . . . 25.0 107.936 -175.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 56.96 27.37 13.05 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.94 0.719 . . . . 25.0 112.94 -178.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.65 5.98 89.17 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 121.012 -0.613 . . . . 25.0 113.421 178.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -116.23 154.39 30.19 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 108.308 -0.997 . . . . 25.0 108.308 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -108.3 145.19 34.76 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.058 -1.83 . . . . 25.0 106.058 170.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.36 -155.32 13.54 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 106.877 -2.489 . . . . 25.0 106.877 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.3 pt -123.97 152.86 29.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.449 0.643 . . . . 25.0 110.665 -175.362 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 24' ' ' LEU . 2.8 m -139.63 147.31 51.43 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.148 -0.933 . . . . 25.0 108.626 -179.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.94 114.99 4.19 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 CA-C-O 121.379 0.491 . . . . 25.0 110.961 176.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.56 -17.12 68.48 Favored Glycine 0 C--O 1.222 -0.631 0 N-CA-C 114.304 0.482 . . . . 25.0 114.304 -175.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -63.76 -20.17 65.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.652 0.612 . . . . 25.0 112.652 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -116.48 27.18 9.37 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.746 -0.464 . . . . 25.0 109.746 177.214 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 12' ' ' ALA . 1.5 tp -130.34 158.01 41.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.309 0.576 . . . . 25.0 111.769 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -133.31 120.25 20.79 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.988 -0.551 . . . . 25.0 110.97 178.204 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mm -66.76 136.51 26.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.66 -0.496 . . . . 25.0 109.66 178.494 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.2 mt -117.04 104.58 11.4 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.463 -1.31 . . . . 25.0 107.463 175.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.7 m -76.75 155.76 5.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.855 0.359 . . . . 25.0 110.51 -178.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.92 39.0 3.13 Favored Glycine 0 N--CA 1.462 0.38 0 N-CA-C 112.06 -0.416 . . . . 25.0 112.06 178.611 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 22.3 ttt -131.96 169.39 16.37 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.771 -1.566 . . . . 25.0 106.771 -175.186 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 63.02 45.43 5.3 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.888 0.852 . . . . 25.0 110.261 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 t0 64.9 176.96 0.2 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 113.427 -1.715 . . . . 25.0 113.648 178.26 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -99.49 164.39 12.11 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.46 -0.941 . . . . 25.0 108.46 -176.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 mtmm -146.03 152.26 47.07 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 104.721 -2.326 . . . . 25.0 104.721 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -73.25 162.32 40.77 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 117.815 -0.99 . . . . 25.0 113.192 -179.382 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.08 168.2 19.45 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.439 -0.948 . . . . 25.0 108.439 175.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.16 -65.5 0.29 Allowed Glycine 0 C--O 1.22 -0.748 0 N-CA-C 110.398 -1.081 . . . . 25.0 110.398 176.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.0 m 55.18 23.21 5.21 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.818 1.784 . . . . 25.0 115.818 175.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.42 165.15 36.95 Favored Glycine 0 C--O 1.228 -0.246 0 N-CA-C 109.192 -1.563 . . . . 25.0 109.192 175.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.42 -175.2 29.08 Favored Glycine 0 C--O 1.229 -0.186 0 N-CA-C 110.265 -1.134 . . . . 25.0 110.265 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 89.2 p -142.48 159.58 41.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.188 -0.671 . . . . 25.0 109.188 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.0 -35.46 34.77 Favored Glycine 0 C--O 1.22 -0.731 0 C-N-CA 120.818 -0.706 . . . . 25.0 112.825 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.8 t -152.19 -54.68 0.13 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.883 0.373 . . . . 25.0 110.71 179.439 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.58 -159.94 13.42 Favored Glycine 0 C--O 1.225 -0.463 0 N-CA-C 109.106 -1.598 . . . . 25.0 109.106 -177.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.4 t -127.17 31.28 5.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.243 0.544 . . . . 25.0 109.552 -179.048 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.41 159.19 43.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.358 -0.978 . . . . 25.0 108.358 179.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -84.05 60.58 5.96 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.062 0.764 . . . . 25.0 113.062 -176.346 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 74.57 145.3 0.08 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.526 1.531 . . . . 25.0 113.785 177.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -75.68 160.8 29.68 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.842 -0.799 . . . . 25.0 108.842 178.29 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.7 m -117.11 85.47 18.57 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 122.825 0.45 . . . . 25.0 110.802 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.16 156.79 46.74 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 N-CA-C 114.393 0.882 . . . . 25.0 114.393 -177.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.02 162.81 40.73 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 O-C-N 121.499 0.21 . . . . 25.0 112.344 177.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.03 160.79 47.07 Favored 'Trans proline' 0 C--O 1.236 0.414 0 N-CA-C 114.208 0.811 . . . . 25.0 114.208 -177.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -80.94 144.31 54.98 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 115.486 -0.779 . . . . 25.0 109.651 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.98 155.36 57.53 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 118.419 -0.587 . . . . 25.0 112.913 178.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -63.12 131.23 31.64 Favored 'Trans proline' 0 C--N 1.348 0.518 0 N-CA-C 114.535 0.936 . . . . 25.0 114.535 -178.109 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -78.89 20.72 0.45 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.026 0.441 . . . . 25.0 110.661 175.285 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 55.2 p -138.42 1.55 2.18 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.799 0.666 . . . . 25.0 112.799 -176.274 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 56.14 26.23 9.98 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.974 0.731 . . . . 25.0 112.974 -175.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.1 p -71.58 140.69 49.91 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.998 -0.438 . . . . 25.0 110.5 -178.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 79.9 m -126.83 157.3 39.64 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.887 -1.153 . . . . 25.0 107.887 178.383 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.5 mt . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 125.734 2.683 . . . . 25.0 113.023 -179.188 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.756 0 CA-C-O 124.435 2.131 . . . . 25.0 113.104 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m -69.89 -16.11 63.18 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 112.278 -1.961 . . . . 25.0 111.57 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 58.7 ttm -125.53 130.79 52.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.794 -1.558 . . . . 25.0 106.794 176.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -130.24 80.49 1.96 Allowed 'General case' 0 C--O 1.213 -0.865 0 N-CA-C 108.953 -0.758 . . . . 25.0 108.953 -178.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -115.95 157.21 24.91 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.213 0.53 . . . . 25.0 110.444 179.111 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 71.4 mt -67.24 -39.28 86.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.783 -1.099 . . . . 25.0 109.901 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 57.4 29.33 16.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.053 0.941 . . . . 25.0 111.894 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.1 m -94.65 160.91 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 107.014 -1.476 . . . . 25.0 107.014 179.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.13 168.05 10.5 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.987 -1.116 . . . . 25.0 107.987 -178.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.06 156.07 42.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.784 0.326 . . . . 25.0 110.192 175.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -121.56 128.38 51.94 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.715 0.806 . . . . 25.0 110.127 178.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.63 131.58 45.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.498 -0.556 . . . . 25.0 109.498 176.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.1 mt -94.13 -21.28 19.2 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.064 -0.347 . . . . 25.0 110.064 -179.052 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -146.04 171.31 15.07 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.406 -1.701 . . . . 25.0 106.406 177.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -82.01 178.9 8.04 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.257 -0.645 . . . . 25.0 109.257 176.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.95 168.87 23.23 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 122.721 0.408 . . . . 25.0 110.125 176.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.5 t -128.02 129.88 69.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 104.149 -2.537 . . . . 25.0 104.149 171.238 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.88 119.38 23.85 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.78 -0.452 . . . . 25.0 109.78 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -103.68 8.93 37.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.322 0.582 . . . . 25.0 110.861 -177.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.9 m -152.89 155.66 32.36 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 106.827 -1.546 . . . . 25.0 106.827 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.02 -22.11 35.94 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 117.813 -0.991 . . . . 25.0 112.452 178.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.4 -20.72 56.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.239 -0.437 . . . . 25.0 110.516 178.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -85.89 126.75 34.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.769 0.795 . . . . 25.0 109.095 -176.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.437 ' HB2' HG13 ' A' ' 57' ' ' VAL . 46.1 mt -78.62 135.53 37.27 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.328 -0.99 . . . . 25.0 108.328 178.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.1 t -91.08 125.41 35.86 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.776 -1.194 . . . . 25.0 107.776 176.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -142.21 159.97 41.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.383 0.611 . . . . 25.0 111.531 -179.525 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.513 ' HD3' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -107.9 165.18 11.65 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.938 -0.764 . . . . 25.0 108.938 179.116 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.513 ' H ' ' HD3' ' A' ' 27' ' ' ARG . 87.4 tttt -61.29 129.05 39.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.64 -0.709 . . . . 25.0 109.52 178.459 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.26 -9.83 69.65 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-O 119.316 -0.713 . . . . 25.0 114.059 178.045 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -60.94 150.27 33.83 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.871 0.843 . . . . 25.0 110.92 179.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.3 mm -113.95 127.31 71.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.569 -1.196 . . . . 25.0 109.701 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.7 ptp -132.15 163.13 29.2 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.583 -0.525 . . . . 25.0 109.583 179.043 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.4 m -99.92 125.83 45.98 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.579 -1.267 . . . . 25.0 107.579 177.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.6 t -90.3 122.13 41.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.118 -1.067 . . . . 25.0 108.118 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.589 HD12 HD22 ' A' ' 47' ' ' LEU . 80.8 mt -90.3 -46.49 8.37 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.226 -0.897 . . . . 25.0 108.608 179.271 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.03 156.32 42.07 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.979 -0.378 . . . . 25.0 109.979 -176.015 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -111.98 152.01 28.61 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.891 -0.411 . . . . 25.0 109.891 174.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 55.97 39.49 30.53 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 123.6 1.667 . . . . 25.0 108.759 177.101 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.0 t -66.38 152.98 43.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 112.746 -2.024 . . . . 25.0 110.72 -175.174 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 60.39 9.1 1.85 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.227 1.011 . . . . 25.0 113.618 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.79 15.26 75.87 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 111.071 -0.812 . . . . 25.0 111.071 -176.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.8 mt -92.99 113.35 25.61 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.426 -0.583 . . . . 25.0 109.426 179.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.87 128.02 33.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.302 0.572 . . . . 25.0 110.005 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.97 0.35 85.17 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 115.813 1.085 . . . . 25.0 115.813 176.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -101.03 132.84 46.26 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 119.005 1.403 . . . . 25.0 110.415 178.402 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.6 m0 -112.36 138.68 48.74 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.171 -0.677 . . . . 25.0 109.171 -176.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.589 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -80.88 120.81 25.19 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 105.199 -2.148 . . . . 25.0 105.199 177.223 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.9 m -132.34 162.23 31.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.3 0.571 . . . . 25.0 112.488 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.5 t -116.9 123.72 47.69 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 105.987 -1.857 . . . . 25.0 105.987 172.012 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.4 tp -135.73 127.6 29.39 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.234 -1.395 . . . . 25.0 107.234 -177.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 29.4 m170 54.79 32.15 17.01 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.143 0.497 . . . . 25.0 112.241 178.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.35 -3.41 87.23 Favored Glycine 0 C--O 1.225 -0.462 0 N-CA-C 115.852 1.101 . . . . 25.0 115.852 176.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -114.35 157.25 23.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.677 -1.231 . . . . 25.0 107.677 177.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -117.21 154.68 30.71 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.374 -0.232 . . . . 25.0 110.374 -178.47 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.95 -157.11 21.92 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 106.127 -2.789 . . . . 25.0 106.127 178.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.8 pt -119.69 155.39 22.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 121.605 0.717 . . . . 25.0 111.39 -177.143 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.4 m -144.33 148.13 39.67 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.01 -0.995 . . . . 25.0 109.661 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.33 121.7 6.21 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 CA-C-O 121.545 0.56 . . . . 25.0 112.965 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.08 -18.25 70.75 Favored Glycine 0 C--O 1.22 -0.729 0 CA-C-N 116.114 -0.494 . . . . 25.0 114.155 -178.17 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -64.1 -17.2 63.2 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.394 0.516 . . . . 25.0 112.394 -177.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -127.33 30.29 5.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.116 0.484 . . . . 25.0 110.2 176.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.8 mt -129.79 156.38 44.42 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.811 -0.631 . . . . 25.0 111.769 177.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -128.98 125.92 38.44 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.161 -0.472 . . . . 25.0 110.125 176.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.6 mm -74.5 136.91 24.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.558 -0.904 . . . . 25.0 108.558 178.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.6 mt -111.92 77.93 1.08 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.147 0.579 . . . . 25.0 109.597 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.07 27.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.434 0.693 . . . . 25.0 112.77 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.4 -0.69 68.14 Favored Glycine 0 C--O 1.219 -0.821 0 N-CA-C 115.058 0.783 . . . . 25.0 115.058 178.442 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.7 ttp -59.12 -27.84 65.97 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 117.637 0.718 . . . . 25.0 112.652 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -94.13 -0.74 55.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.409 -0.359 . . . . 25.0 110.969 -178.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 56.5 t0 60.89 -77.8 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.08 1.352 . . . . 25.0 113.217 -175.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 58.87 45.93 14.6 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.891 0.876 . . . . 25.0 109.628 -173.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -52.98 151.2 8.99 Favored Pre-proline 0 C--O 1.245 0.841 0 CA-C-N 114.663 -1.153 . . . . 25.0 109.796 174.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.83 166.54 25.99 Favored 'Trans proline' 0 C--O 1.24 0.58 0 N-CA-C 115.46 1.292 . . . . 25.0 115.46 -173.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.02 147.97 29.18 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.817 -1.549 . . . . 25.0 106.817 177.356 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.21 23.47 18.12 Favored Glycine 0 C--O 1.22 -0.764 0 N-CA-C 114.856 0.702 . . . . 25.0 114.856 -177.188 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 72.4 p -98.05 -7.07 30.52 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.206 0.817 . . . . 25.0 113.206 -176.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.29 -161.12 53.6 Favored Glycine 0 C--O 1.237 0.305 0 N-CA-C 108.604 -1.798 . . . . 25.0 108.604 -172.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.45 160.65 27.53 Favored Glycine 0 N--CA 1.453 -0.169 0 CA-C-N 117.593 0.697 . . . . 25.0 111.42 178.201 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 82.3 p -161.17 -178.28 6.63 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.276 -1.75 . . . . 25.0 106.276 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.21 -142.96 16.72 Favored Glycine 0 C--O 1.222 -0.639 0 C-N-CA 121.114 -0.565 . . . . 25.0 113.683 176.129 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 t 62.64 13.01 5.97 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.072 1.508 . . . . 25.0 115.072 -178.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.79 159.42 53.61 Favored Glycine 0 CA--C 1.518 0.221 0 N-CA-C 110.211 -1.156 . . . . 25.0 110.211 175.082 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 p -152.34 156.32 39.36 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.359 -0.608 . . . . 25.0 109.359 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.72 165.69 23.17 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.526 -0.916 . . . . 25.0 108.526 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 93.8 mttt 63.53 174.46 0.17 Allowed 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.637 1.211 . . . . 25.0 111.811 179.152 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -97.6 146.83 24.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.408 -0.59 . . . . 25.0 109.408 -177.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -108.7 179.27 4.24 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.15 -1.796 . . . . 25.0 106.15 178.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.3 m -114.45 85.1 10.44 Favored Pre-proline 0 N--CA 1.47 0.569 0 CA-C-O 120.885 0.374 . . . . 25.0 110.317 177.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -80.54 153.05 20.39 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 N-CA-C 114.802 1.039 . . . . 25.0 114.802 -177.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.81 157.24 52.09 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 118.008 -0.861 . . . . 25.0 111.438 173.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.75 158.61 55.18 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 N-CA-C 115.261 1.216 . . . . 25.0 115.261 -173.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -77.78 141.62 64.44 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 107.625 -1.25 . . . . 25.0 107.625 176.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -73.03 167.68 26.72 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 O-C-N 122.097 0.525 . . . . 25.0 113.214 -177.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.53 152.78 52.76 Favored 'Trans proline' 0 C--N 1.352 0.736 0 N-CA-C 114.642 0.978 . . . . 25.0 114.642 -178.353 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -115.95 71.47 0.78 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.443 -0.577 . . . . 25.0 109.443 178.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 49.73 33.53 6.31 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.977 0.894 . . . . 25.0 111.797 -174.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.7 ptm85 -146.76 112.3 5.59 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.041 -1.096 . . . . 25.0 108.041 -179.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.7 m 65.27 164.41 0.16 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.628 -1.169 . . . . 25.0 112.129 -173.201 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 35.0 m -110.08 32.75 4.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.66 0.743 . . . . 25.0 110.964 -176.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.208 -1.121 0 CA-C-O 124.873 2.273 . . . . 25.0 111.676 -177.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 CA-C-O 123.49 1.606 . . . . 25.0 115.116 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.4 p -106.32 17.73 23.0 Favored 'General case' 0 C--O 1.24 0.588 0 O-C-N 120.873 -1.369 . . . . 25.0 110.934 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.09 144.77 53.84 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.176 -1.046 . . . . 25.0 108.176 178.376 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -90.4 78.7 6.37 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.089 -1.448 . . . . 25.0 107.089 -177.544 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -75.62 164.83 25.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.12 -0.946 . . . . 25.0 111.097 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.4 mt -66.05 -41.65 90.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.256 -0.884 . . . . 25.0 110.762 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.1 m120 55.34 24.36 6.49 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.277 1.031 . . . . 25.0 112.381 -177.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.6 m -83.29 175.35 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 N-CA-C 105.437 -2.06 . . . . 25.0 105.437 175.068 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -120.0 171.85 8.16 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 118.774 0.715 . . . . 25.0 109.951 -179.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.8 162.21 39.69 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.874 0.368 . . . . 25.0 110.354 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -122.24 132.04 54.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.141 -0.936 . . . . 25.0 110.494 178.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.413 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -74.08 128.05 34.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.95 0.405 . . . . 25.0 110.558 177.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.9 mt -98.81 -19.53 17.37 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.26 0.552 . . . . 25.0 110.985 -177.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -142.7 163.31 33.16 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 106.063 -1.829 . . . . 25.0 106.063 177.413 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -82.57 174.5 10.98 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.719 1.007 . . . . 25.0 113.719 -177.752 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -160.93 157.22 26.1 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 110.125 -0.324 . . . . 25.0 110.125 174.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.7 t -126.73 131.71 70.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 104.744 -2.317 . . . . 25.0 104.744 174.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.93 124.12 27.93 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 110.235 -0.283 . . . . 25.0 110.235 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -116.57 -12.61 10.93 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.054 0.93 . . . . 25.0 110.316 175.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 t -106.76 147.42 35.0 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 107.41 -1.33 . . . . 25.0 107.41 175.339 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.28 -23.74 44.54 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 116.444 -1.904 . . . . 25.0 114.695 -177.185 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -81.92 -13.16 57.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.086 0.47 . . . . 25.0 110.262 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -84.85 139.23 32.05 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.384 0.611 . . . . 25.0 111.508 -171.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.5 mt -93.1 131.06 38.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.596 0.713 . . . . 25.0 109.833 176.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.2 t -91.87 139.74 30.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.8 -1.556 . . . . 25.0 106.8 177.178 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.448 ' HE2' HG12 ' A' ' 57' ' ' VAL . 29.4 p90 -162.58 171.72 16.52 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.382 -0.97 . . . . 25.0 108.382 -177.289 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -126.75 168.03 14.96 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.769 0.795 . . . . 25.0 110.442 174.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.67 133.41 55.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.535 -0.757 . . . . 25.0 109.592 -176.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.96 -20.07 51.75 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 118.64 -1.089 . . . . 25.0 112.828 178.267 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -58.6 143.8 45.08 Favored 'General case' 0 C--O 1.249 1.056 0 CA-C-N 118.427 1.113 . . . . 25.0 110.645 179.064 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.6 mm -110.85 128.85 66.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.771 -1.104 . . . . 25.0 108.1 -178.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.7 ptp -132.89 149.41 52.25 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.725 0.41 . . . . 25.0 110.235 -177.384 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.0 m -85.48 126.11 33.57 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 107.541 -1.281 . . . . 25.0 107.541 179.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.43 124.5 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 107.904 -1.147 . . . . 25.0 107.904 178.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.631 HD12 HD22 ' A' ' 47' ' ' LEU . 75.8 mt -90.52 -47.8 7.48 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.723 -0.843 . . . . 25.0 108.723 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -153.69 173.88 15.23 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.426 0.631 . . . . 25.0 109.305 176.302 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -123.73 151.29 43.36 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.361 -1.718 . . . . 25.0 106.361 -179.557 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 57.37 43.4 23.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 123.27 1.509 . . . . 25.0 109.399 -176.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.7 t -66.55 149.46 50.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.629 -1.623 . . . . 25.0 110.349 -177.562 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 59.83 15.3 4.76 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.664 0.785 . . . . 25.0 112.642 178.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.81 14.62 82.18 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.903 -0.665 . . . . 25.0 112.187 -178.171 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.2 mt -94.36 113.68 25.61 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.342 -0.614 . . . . 25.0 109.342 -178.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -59.82 123.26 16.46 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.244 0.545 . . . . 25.0 110.734 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.76 -0.0 89.82 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-O 118.829 -0.984 . . . . 25.0 115.538 175.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -100.12 132.7 45.33 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 119.084 1.442 . . . . 25.0 109.335 177.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -113.08 140.03 48.2 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.592 -1.262 . . . . 25.0 107.592 -175.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.631 HD22 HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -82.47 123.13 28.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.193 -2.151 . . . . 25.0 105.193 177.818 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 95.5 m -130.5 163.39 27.13 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.993 0.425 . . . . 25.0 111.408 178.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -116.2 126.9 54.28 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 106.318 -1.734 . . . . 25.0 106.318 173.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.2 tp -151.57 135.58 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.26 -1.015 . . . . 25.0 108.26 -175.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 54.23 30.13 11.81 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.654 0.983 . . . . 25.0 113.654 -178.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.18 6.18 88.92 Favored Glycine 0 C--O 1.22 -0.777 0 C-N-CA 120.936 -0.649 . . . . 25.0 113.919 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -114.82 161.32 18.37 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.499 -1.297 . . . . 25.0 107.499 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -120.26 146.48 46.03 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 106.016 -1.846 . . . . 25.0 106.016 174.067 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.22 -164.48 31.42 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 108.286 -1.926 . . . . 25.0 108.286 -179.372 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.8 pt -114.51 150.19 16.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.596 0.712 . . . . 25.0 112.053 -174.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.448 HG12 ' HE2' ' A' ' 26' ' ' PHE . 3.2 m -144.78 146.18 30.74 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 114.539 -1.21 . . . . 25.0 108.749 -179.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.23 122.17 6.94 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 118.383 -0.611 . . . . 25.0 112.393 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.81 -17.88 75.55 Favored Glycine 0 C--O 1.219 -0.789 0 N-CA-C 115.148 0.819 . . . . 25.0 115.148 -176.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -59.79 -21.13 60.4 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 113.221 0.823 . . . . 25.0 113.221 -177.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.26 26.3 6.92 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.526 0.679 . . . . 25.0 110.368 -178.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 12' ' ' ALA . 11.2 mt -117.46 156.08 28.58 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 121.455 0.645 . . . . 25.0 110.365 175.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -119.14 122.81 42.88 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 173.438 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.8 mm -73.23 135.1 28.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.887 -1.153 . . . . 25.0 107.887 176.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt -115.23 97.2 6.06 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.825 -0.805 . . . . 25.0 108.825 178.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -88.64 165.46 2.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.13 -0.692 . . . . 25.0 109.13 178.285 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.5 155.87 21.01 Favored Glycine 0 C--O 1.219 -0.803 0 C-N-CA 120.687 -0.768 . . . . 25.0 111.758 178.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -137.47 1.69 2.4 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.697 0.399 . . . . 25.0 111.965 179.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -139.21 140.51 37.79 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.628 -1.249 . . . . 25.0 107.628 177.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -81.25 159.26 24.56 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 124.233 0.958 . . . . 25.0 110.073 179.584 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 65.3 mttm 46.0 35.8 2.65 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.909 1.818 . . . . 25.0 115.909 174.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -66.74 128.3 93.8 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 109.413 -0.588 . . . . 25.0 109.413 -179.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -87.41 -4.39 7.56 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 118.138 -0.775 . . . . 25.0 113.187 178.033 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.68 140.39 35.66 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 113.729 1.011 . . . . 25.0 113.729 -173.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.41 175.21 42.52 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 109.162 -1.575 . . . . 25.0 109.162 175.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.5 t 60.57 -173.18 0.13 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.882 0.873 . . . . 25.0 112.271 -177.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.27 -177.8 49.07 Favored Glycine 0 C--O 1.222 -0.63 0 N-CA-C 111.269 -0.732 . . . . 25.0 111.269 -178.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.88 88.06 1.21 Allowed Glycine 0 C--O 1.216 -1.016 0 C-N-CA 121.646 -0.311 . . . . 25.0 112.587 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.8 t -146.46 -179.69 6.93 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.9 -1.889 . . . . 25.0 105.9 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.87 20.86 27.39 Favored Glycine 0 C--O 1.226 -0.351 0 N-CA-C 111.717 -0.553 . . . . 25.0 111.717 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 55.9 m -64.68 139.27 58.75 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.123 -0.633 . . . . 25.0 110.698 178.337 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.36 -85.5 0.06 OUTLIER Glycine 0 CA--C 1.509 -0.316 0 N-CA-C 108.657 -1.777 . . . . 25.0 108.657 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.6 t 58.67 -157.06 0.32 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.539 0.736 . . . . 25.0 109.904 176.342 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.45 166.77 23.86 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.959 -1.126 . . . . 25.0 107.959 177.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.37 154.88 32.68 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.327 -0.62 . . . . 25.0 109.327 -175.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -137.71 -51.99 0.63 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.543 -0.91 . . . . 25.0 108.543 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -78.35 158.79 28.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.751 -0.659 . . . . 25.0 109.708 176.594 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.4 p -77.27 154.73 82.18 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 115.708 -0.678 . . . . 25.0 111.39 -179.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.54 159.32 51.57 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 117.827 -0.982 . . . . 25.0 111.923 178.091 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -65.74 154.39 74.08 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 118.81 -0.327 . . . . 25.0 112.486 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.09 153.88 62.6 Favored 'Trans proline' 0 C--O 1.237 0.473 0 N-CA-C 115.168 1.18 . . . . 25.0 115.168 -173.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -76.8 141.0 67.85 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 108.538 -0.912 . . . . 25.0 108.538 176.137 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.78 162.93 39.85 Favored 'Trans proline' 0 C--O 1.239 0.57 0 O-C-N 122.539 0.757 . . . . 25.0 111.932 175.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.79 150.76 39.73 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 118.282 -0.679 . . . . 25.0 113.485 -177.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -93.72 50.87 1.49 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.488 -0.56 . . . . 25.0 109.488 176.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.2 p 41.08 46.94 2.64 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.117 0.967 . . . . 25.0 112.331 -175.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -87.99 -10.49 50.27 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.127 -0.488 . . . . 25.0 110.874 -177.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 49.6 m -95.95 120.65 36.6 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.83 -0.804 . . . . 25.0 108.83 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 29.8 m 67.31 177.93 0.24 Allowed 'General case' 0 N--CA 1.469 0.501 0 O-C-N 124.377 1.048 . . . . 25.0 111.131 -177.186 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.6 tp . . . . . 0 C--O 1.208 -1.079 0 CA-C-O 125.117 2.389 . . . . 25.0 111.624 -177.202 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.806 0 CA-C-O 124.225 2.014 . . . . 25.0 113.127 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t 58.09 26.41 13.6 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 111.984 -2.108 . . . . 25.0 112.253 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.6 ttm -78.02 110.05 12.62 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.518 -0.549 . . . . 25.0 109.518 179.407 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -150.84 145.05 25.43 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.6 -1.63 . . . . 25.0 106.6 178.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 61.9 163.47 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 116.614 2.079 . . . . 25.0 116.614 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 mt -71.97 -41.61 67.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.104 -1.407 . . . . 25.0 110.006 -179.595 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 56.5 26.5 11.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.343 1.057 . . . . 25.0 112.304 -178.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.4 m -85.86 158.52 3.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.338 -1.727 . . . . 25.0 106.338 177.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.38 172.81 7.97 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 108.77 -0.826 . . . . 25.0 108.77 -177.056 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.14 165.84 32.66 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.719 -0.475 . . . . 25.0 109.719 174.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -131.16 136.26 48.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.092 -0.958 . . . . 25.0 110.113 177.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.573 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -73.36 127.16 31.89 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.861 -0.609 . . . . 25.0 110.453 172.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.3 mt -93.79 -19.54 20.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.216 0.532 . . . . 25.0 110.247 -178.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -146.67 175.96 10.2 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 103.285 -2.857 . . . . 25.0 103.285 178.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -91.42 175.98 6.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 118.719 0.69 . . . . 25.0 111.41 177.553 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -154.59 144.27 21.55 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.678 0.391 . . . . 25.0 111.106 177.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 80.0 t -113.38 125.25 70.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.5 -2.037 . . . . 25.0 105.5 176.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.46 131.41 41.77 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.057 -0.974 . . . . 25.0 109.6 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -104.98 -1.99 25.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.593 0.711 . . . . 25.0 109.934 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -147.07 156.77 46.94 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.167 -1.049 . . . . 25.0 108.167 -177.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.85 -19.7 40.34 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 118.309 -0.661 . . . . 25.0 112.729 177.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -72.96 -16.9 61.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.292 -0.413 . . . . 25.0 111.04 177.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -100.37 142.29 32.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.734 0.778 . . . . 25.0 110.887 -172.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.408 ' HB2' HG13 ' A' ' 57' ' ' VAL . 57.0 mt -95.3 127.03 41.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.458 -0.792 . . . . 25.0 109.884 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.7 p -87.17 145.91 26.23 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 105.31 -2.107 . . . . 25.0 105.31 173.198 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -159.59 165.09 33.52 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.113 -1.069 . . . . 25.0 108.113 -179.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.47 161.76 17.57 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.483 0.658 . . . . 25.0 110.063 177.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -56.99 129.4 41.54 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.509 -0.769 . . . . 25.0 110.48 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.58 -16.41 59.78 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-O 118.941 -0.922 . . . . 25.0 113.603 177.391 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -58.55 155.21 12.7 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.924 0.869 . . . . 25.0 111.525 179.459 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.0 mm -118.97 135.57 58.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.225 -1.352 . . . . 25.0 109.262 179.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -141.71 156.35 45.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.307 -0.627 . . . . 25.0 109.307 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.9 m -91.15 129.42 37.15 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.179 -1.045 . . . . 25.0 108.179 177.274 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.3 t -94.14 124.97 46.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.121 -1.066 . . . . 25.0 108.121 177.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.623 HD12 HD22 ' A' ' 47' ' ' LEU . 82.9 mt -93.69 -43.48 8.63 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.501 -0.772 . . . . 25.0 109.555 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -149.38 165.16 32.88 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.318 -0.993 . . . . 25.0 108.318 -175.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -126.64 153.32 45.52 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 107.045 -1.465 . . . . 25.0 107.045 176.112 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 56.48 39.43 29.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 123.477 1.608 . . . . 25.0 109.088 -179.075 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -69.27 155.38 40.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.207 -1.815 . . . . 25.0 110.477 -176.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 60.16 11.45 2.77 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.918 0.887 . . . . 25.0 113.209 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.08 16.93 79.11 Favored Glycine 0 CA--C 1.516 0.135 0 N-CA-C 110.9 -0.88 . . . . 25.0 110.9 -177.167 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.405 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 96.6 mt -98.18 114.53 26.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.02 0.438 . . . . 25.0 109.999 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -63.58 127.68 32.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.889 -0.596 . . . . 25.0 109.927 -178.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.74 -0.58 85.94 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 115.505 0.962 . . . . 25.0 115.505 176.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.405 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 92.0 m95 -100.86 130.03 46.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 118.565 1.182 . . . . 25.0 109.825 177.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -111.27 140.0 46.2 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.77 -0.456 . . . . 25.0 109.77 -175.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.623 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -79.78 120.88 24.65 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 105.585 -2.006 . . . . 25.0 105.585 178.93 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 86.0 m -131.52 163.55 27.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.966 0.412 . . . . 25.0 111.716 178.455 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.8 t -118.87 124.59 47.51 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.706 -1.59 . . . . 25.0 106.706 173.117 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.0 tp -151.72 142.71 23.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.779 -1.193 . . . . 25.0 107.779 -175.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 57.49 27.17 13.61 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.324 0.583 . . . . 25.0 112.235 177.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.62 4.49 90.36 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 114.859 0.703 . . . . 25.0 114.859 178.337 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -130.24 161.02 32.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.091 0.945 . . . . 25.0 109.43 179.432 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -107.89 153.29 23.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.221 -0.659 . . . . 25.0 109.221 177.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.95 -154.3 11.8 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 107.291 -2.324 . . . . 25.0 107.291 177.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.5 pt -124.69 153.22 31.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.378 0.609 . . . . 25.0 110.582 -175.729 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 24' ' ' LEU . 3.3 m -140.48 146.27 44.4 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 114.945 -1.025 . . . . 25.0 108.799 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.68 120.89 6.03 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 118.53 -0.514 . . . . 25.0 112.033 178.426 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.4 -17.05 70.1 Favored Glycine 0 C--O 1.222 -0.652 0 C-N-CA 121.576 -0.345 . . . . 25.0 113.191 -178.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -66.88 -6.91 18.26 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.944 0.72 . . . . 25.0 112.944 -179.282 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -135.79 26.63 3.34 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.577 -0.527 . . . . 25.0 109.577 175.282 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' A' ' 12' ' ' ALA . 1.6 tp -130.09 157.15 43.19 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 121.3 0.571 . . . . 25.0 111.603 -179.537 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -129.68 123.2 30.58 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.964 -0.562 . . . . 25.0 110.768 177.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.0 mm -70.09 135.93 27.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.797 -0.816 . . . . 25.0 108.797 176.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.7 mt -119.68 102.54 8.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.652 -1.24 . . . . 25.0 107.652 176.053 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.41 162.21 3.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.074 -0.713 . . . . 25.0 109.074 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -160.42 175.37 37.17 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 107.555 -2.218 . . . . 25.0 107.555 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.3 mtp -134.05 140.2 46.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.838 0.819 . . . . 25.0 109.614 -179.122 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 63.18 -29.19 0.09 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 118.526 2.787 . . . . 25.0 118.526 175.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -67.44 123.27 19.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.501 -0.925 . . . . 25.0 108.501 178.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -117.5 23.23 11.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.987 -1.006 . . . . 25.0 109.724 -174.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -144.05 160.84 48.03 Favored Pre-proline 0 C--O 1.22 -0.482 0 N-CA-C 106.226 -1.768 . . . . 25.0 106.226 177.39 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -69.86 150.04 67.04 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 114.165 -3.423 . . . . 25.0 110.071 171.424 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.62 4.45 3.14 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.077 1.51 . . . . 25.0 115.077 -176.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.92 16.8 74.06 Favored Glycine 0 CA--C 1.519 0.289 0 N-CA-C 115.899 1.12 . . . . 25.0 115.899 176.235 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.7 p -86.99 156.08 19.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.117 -0.698 . . . . 25.0 109.117 177.071 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.08 57.45 0.85 Allowed Glycine 0 C--O 1.224 -0.496 0 N-CA-C 111.876 -0.49 . . . . 25.0 111.876 -177.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.39 -156.45 25.76 Favored Glycine 0 C--O 1.227 -0.306 0 CA-C-O 121.4 0.444 . . . . 25.0 114.019 -177.395 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.9 p -62.8 144.79 56.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.126 0.489 . . . . 25.0 112.226 -179.421 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.61 -166.47 37.37 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 106.373 -2.691 . . . . 25.0 106.373 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.8 t -147.94 -65.36 0.25 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 117.79 0.795 . . . . 25.0 109.613 176.321 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.59 -152.75 46.65 Favored Glycine 0 C--O 1.226 -0.399 0 C-N-CA 120.478 -0.867 . . . . 25.0 111.477 178.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.5 t -159.49 140.93 12.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.597 -2.001 . . . . 25.0 105.597 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -66.71 138.77 57.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.973 -1.121 . . . . 25.0 107.973 178.461 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -103.44 -15.34 15.92 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 112.377 0.51 . . . . 25.0 112.377 -178.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 49.51 52.09 15.18 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.288 0.992 . . . . 25.0 110.341 178.093 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.98 161.28 8.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.596 -1.183 . . . . 25.0 112.02 -176.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.4 m -107.71 90.87 6.67 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 116.141 -0.481 . . . . 25.0 110.372 177.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.74 161.37 30.62 Favored 'Trans proline' 0 C--N 1.345 0.395 0 N-CA-C 115.877 1.453 . . . . 25.0 115.877 -176.108 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -69.57 160.54 49.37 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 117.34 -1.306 . . . . 25.0 110.404 169.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.87 156.48 65.76 Favored 'Trans proline' 0 C--N 1.344 0.307 0 N-CA-C 114.8 1.038 . . . . 25.0 114.8 -174.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -76.78 145.97 75.47 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 107.534 -1.284 . . . . 25.0 107.534 177.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.86 164.84 34.41 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 O-C-N 121.952 0.449 . . . . 25.0 112.753 -178.122 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.91 155.08 34.8 Favored 'Trans proline' 0 C--N 1.354 0.849 0 N-CA-C 114.205 0.81 . . . . 25.0 114.205 -178.348 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -116.08 22.48 12.92 Favored 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 112.876 0.695 . . . . 25.0 112.876 -175.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 44.9 p 55.06 14.53 0.98 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 116.542 2.052 . . . . 25.0 116.542 179.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.9 ptt-85 -158.29 -172.5 3.9 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.614 -1.995 . . . . 25.0 105.614 178.201 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.9 m 62.51 53.32 2.7 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 124.226 0.953 . . . . 25.0 111.324 -176.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.1 p -145.49 166.71 24.9 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 105.49 -2.041 . . . . 25.0 105.49 176.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 C--O 1.208 -1.1 0 CA-C-O 124.535 2.112 . . . . 25.0 111.43 -179.231 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.656 0 CA-C-O 124.149 1.972 . . . . 25.0 113.968 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m -64.79 -32.44 74.13 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 113.367 -1.417 . . . . 25.0 111.467 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.2 ttm 54.68 17.81 1.84 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.085 1.883 . . . . 25.0 116.085 176.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -86.38 74.62 9.93 Favored 'General case' 0 C--O 1.215 -0.744 0 O-C-N 121.873 -0.517 . . . . 25.0 109.821 178.163 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -136.1 163.53 30.13 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.379 -0.828 . . . . 25.0 108.89 179.52 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.4 mt -68.01 -39.2 83.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.366 -0.833 . . . . 25.0 110.492 178.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 57.88 28.58 16.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.142 0.977 . . . . 25.0 111.871 -179.138 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 m -94.79 176.12 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 105.416 -2.068 . . . . 25.0 105.416 176.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -119.74 174.11 6.63 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.999 -0.741 . . . . 25.0 108.999 177.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.44 154.34 36.42 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.189 -0.3 . . . . 25.0 110.189 177.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -111.27 130.89 55.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.924 -0.58 . . . . 25.0 110.172 178.574 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.93 117.67 12.74 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.223 -0.658 . . . . 25.0 109.223 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.6 mt -83.62 -25.64 30.65 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.28 0.562 . . . . 25.0 109.885 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -139.74 164.15 30.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.587 -1.188 . . . . 25.0 108.081 177.771 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.26 178.34 5.87 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 124.285 0.99 . . . . 25.0 112.782 -179.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -155.12 158.37 38.91 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.756 0.312 . . . . 25.0 111.269 172.037 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.0 t -127.51 129.11 70.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 104.13 -2.545 . . . . 25.0 104.13 173.37 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.68 135.91 33.96 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -115.51 -15.6 11.45 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.615 0.721 . . . . 25.0 109.653 175.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.4 t -112.55 146.72 35.57 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 106.396 -1.705 . . . . 25.0 106.396 179.737 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.65 -16.68 42.59 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 117.822 -0.985 . . . . 25.0 113.391 177.816 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -80.73 -18.02 49.16 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.24 1.019 . . . . 25.0 110.58 177.082 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -86.0 136.06 33.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.72 0.772 . . . . 25.0 111.716 -177.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.9 mt -86.08 127.55 34.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.734 -0.666 . . . . 25.0 110.575 179.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.2 t -89.95 132.83 35.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.809 -1.182 . . . . 25.0 107.809 174.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -160.02 172.78 16.91 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.154 -1.054 . . . . 25.0 108.154 -176.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.56 170.4 8.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 122.386 1.088 . . . . 25.0 111.545 178.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.33 135.87 57.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.709 -1.132 . . . . 25.0 109.437 -179.639 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.26 -9.04 78.44 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 118.67 -1.072 . . . . 25.0 113.782 179.155 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -63.78 143.51 57.78 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 118.703 1.251 . . . . 25.0 109.233 174.881 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.6 mm -106.31 130.86 57.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 106.877 -1.527 . . . . 25.0 106.877 178.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.7 ptp -134.69 146.54 49.56 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.358 0.263 . . . . 25.0 110.294 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -83.13 127.29 33.46 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.161 -1.051 . . . . 25.0 108.161 179.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -94.21 124.65 46.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.164 -1.05 . . . . 25.0 108.164 -179.504 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.602 HD12 HD22 ' A' ' 47' ' ' LEU . 77.0 mt -94.8 -45.81 7.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.787 -0.642 . . . . 25.0 109.893 -179.336 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -151.18 159.98 44.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.571 -0.9 . . . . 25.0 108.571 -175.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -118.85 148.96 42.32 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.985 -1.117 . . . . 25.0 107.985 177.108 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 56.68 38.95 29.91 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 123.374 1.559 . . . . 25.0 109.401 -179.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -64.88 150.02 48.49 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 113.129 -1.85 . . . . 25.0 110.91 -176.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 58.97 11.91 2.13 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.644 0.979 . . . . 25.0 113.644 180.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.13 10.33 84.99 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 110.958 -0.857 . . . . 25.0 110.958 -178.33 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 90.2 mt -86.5 106.99 17.9 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.15 -1.056 . . . . 25.0 108.15 179.226 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.45 125.07 22.68 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.234 -0.893 . . . . 25.0 110.064 -176.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.12 -0.12 89.93 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-O 118.879 -0.956 . . . . 25.0 115.236 178.056 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.403 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 94.5 m95 -101.3 132.6 46.76 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 118.944 1.372 . . . . 25.0 110.638 177.385 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -110.66 140.89 44.59 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.795 -0.817 . . . . 25.0 108.795 -178.481 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.602 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -81.67 121.83 26.86 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.58 -2.007 . . . . 25.0 105.58 178.534 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.4 m -132.02 163.93 27.32 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.852 0.686 . . . . 25.0 112.852 179.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.0 t -117.43 127.1 53.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.331 -1.359 . . . . 25.0 107.331 174.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tp -140.62 124.7 17.42 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.899 -0.778 . . . . 25.0 108.899 -177.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 54.65 35.03 22.8 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.581 0.585 . . . . 25.0 112.581 -179.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.48 0.33 89.96 Favored Glycine 0 C--O 1.222 -0.601 0 N-CA-C 115.61 1.004 . . . . 25.0 115.61 176.03 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -119.73 159.64 24.12 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 107.464 -1.31 . . . . 25.0 107.464 176.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -117.58 159.6 22.63 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.874 -0.787 . . . . 25.0 108.874 -178.134 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.62 -159.18 27.84 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 105.327 -3.109 . . . . 25.0 105.327 179.259 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.3 pt -119.53 153.66 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.818 0.818 . . . . 25.0 112.253 -176.232 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 m -144.21 148.22 40.43 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.767 -1.106 . . . . 25.0 108.991 -179.311 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.1 125.19 7.75 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 117.259 -1.361 . . . . 25.0 112.133 -178.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.59 -17.33 76.38 Favored Glycine 0 C--O 1.219 -0.825 0 N-CA-C 114.982 0.753 . . . . 25.0 114.982 -175.472 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.59 -23.71 63.17 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.106 1.15 . . . . 25.0 114.106 -176.745 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.12 27.21 7.71 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.567 0.698 . . . . 25.0 110.375 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mt -114.65 155.15 27.11 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 121.339 0.59 . . . . 25.0 110.387 173.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -125.4 118.82 26.7 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 115.344 -0.844 . . . . 25.0 108.981 174.194 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.54 135.84 27.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.561 -0.533 . . . . 25.0 109.561 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.2 mt -115.46 105.37 12.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.525 -2.028 . . . . 25.0 105.525 175.776 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -78.5 162.21 4.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.959 0.409 . . . . 25.0 110.449 -177.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -147.03 178.55 24.59 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 107.453 -2.259 . . . . 25.0 107.453 178.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 28.1 ttt -133.61 110.35 9.83 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 118.354 1.077 . . . . 25.0 112.0 -177.517 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 55.32 24.42 6.51 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.175 1.546 . . . . 25.0 115.175 176.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -80.27 155.03 27.49 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.508 -0.923 . . . . 25.0 108.508 174.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.07 151.6 12.28 Favored 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 109.608 -0.515 . . . . 25.0 109.608 -174.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm 59.73 101.49 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.276 0 N-CA-C 114.212 1.19 . . . . 25.0 114.212 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -70.24 161.29 46.54 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 117.166 -1.423 . . . . 25.0 112.627 178.226 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.34 162.18 40.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 105.912 -1.885 . . . . 25.0 105.912 177.35 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.51 -168.22 52.59 Favored Glycine 0 C--N 1.323 -0.159 0 N-CA-C 110.842 -0.903 . . . . 25.0 110.842 -177.311 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.5 t -156.14 160.42 39.89 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.061 -1.459 . . . . 25.0 107.061 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.0 179.26 45.47 Favored Glycine 0 C--O 1.236 0.265 0 N-CA-C 110.002 -1.239 . . . . 25.0 110.002 -179.528 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 161.16 -163.8 34.55 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.442 -1.063 . . . . 25.0 110.442 -179.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 m 55.78 58.48 4.44 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.403 0.89 . . . . 25.0 113.403 176.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.17 147.55 38.18 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 121.98 0.767 . . . . 25.0 112.934 177.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.3 m -75.82 88.28 2.84 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 114.703 1.371 . . . . 25.0 114.703 -175.313 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.0 86.47 0.78 Allowed Glycine 0 C--O 1.226 -0.375 0 N-CA-C 109.667 -1.373 . . . . 25.0 109.667 171.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.7 m -89.82 159.01 17.22 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.068 -0.345 . . . . 25.0 110.068 -178.586 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 62.72 -164.27 0.25 Allowed 'General case' 0 N--CA 1.473 0.681 0 O-C-N 124.439 1.087 . . . . 25.0 111.907 -179.347 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.8 165.58 33.94 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.645 -1.613 . . . . 25.0 106.645 -175.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 61.23 -154.26 0.36 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.093 -1.077 . . . . 25.0 108.093 -175.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 t0 53.6 66.51 1.21 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 122.41 1.1 . . . . 25.0 108.564 -170.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -56.25 138.67 73.87 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 114.64 -1.164 . . . . 25.0 111.168 -174.065 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -62.18 158.96 36.93 Favored 'Trans proline' 0 C--O 1.243 0.763 0 N-CA-C 114.392 0.882 . . . . 25.0 114.392 -177.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.8 161.29 39.83 Favored 'Trans proline' 0 C--O 1.24 0.593 0 O-C-N 121.81 0.374 . . . . 25.0 111.389 175.175 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.36 158.22 56.28 Favored 'Trans proline' 0 C--N 1.348 0.54 0 N-CA-C 114.738 1.014 . . . . 25.0 114.738 -176.333 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -108.07 147.92 36.47 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 114.766 -1.106 . . . . 25.0 108.255 179.214 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.06 164.29 34.74 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 O-C-N 122.255 0.608 . . . . 25.0 112.775 -179.156 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -64.46 157.26 55.82 Favored 'Trans proline' 0 C--N 1.356 0.931 0 N-CA-C 113.711 0.62 . . . . 25.0 113.711 179.38 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.1 mtt85 -100.94 24.66 8.97 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.162 1.171 . . . . 25.0 114.162 -177.089 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.9 p -132.67 -63.64 0.78 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.2 -0.296 . . . . 25.0 110.2 177.319 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.95 150.12 33.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 103.597 -2.742 . . . . 25.0 103.597 174.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.1 t -78.87 151.82 31.6 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.593 -0.891 . . . . 25.0 108.593 179.485 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 75.7 m -114.84 19.94 15.53 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.571 -0.9 . . . . 25.0 108.571 176.366 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.3 tp . . . . . 0 C--O 1.212 -0.905 0 CA-C-O 124.793 2.235 . . . . 25.0 109.969 179.593 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.219 0 CA-C-O 124.153 1.974 . . . . 25.0 116.145 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 t -94.08 52.91 1.68 Allowed 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.286 -1.126 . . . . 25.0 112.016 -177.487 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 79.0 mtm -131.68 135.67 47.07 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.285 -0.635 . . . . 25.0 109.285 177.403 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -134.36 82.81 1.99 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.514 -1.661 . . . . 25.0 106.514 178.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -120.59 167.67 12.17 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.933 -0.576 . . . . 25.0 112.026 -173.512 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.14 -38.46 69.23 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 115.006 -0.997 . . . . 25.0 109.554 178.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.3 m120 53.37 39.3 29.66 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.295 1.045 . . . . 25.0 112.513 -179.469 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 m -103.11 168.34 2.24 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 N-CA-C 105.558 -2.015 . . . . 25.0 105.558 176.012 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.88 171.85 7.1 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.551 -1.277 . . . . 25.0 107.551 -177.408 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.67 162.27 37.94 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.974 -0.75 . . . . 25.0 108.974 174.649 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -128.18 130.48 48.1 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 123.673 0.789 . . . . 25.0 111.144 175.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.08 130.8 43.11 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 123.783 0.677 . . . . 25.0 109.882 177.045 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.3 mt -97.83 -22.06 16.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.938 0.399 . . . . 25.0 111.241 -178.094 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -141.17 170.01 16.53 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 106.912 -1.514 . . . . 25.0 106.912 178.124 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -76.12 165.73 24.5 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 122.78 0.432 . . . . 25.0 111.146 176.325 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -146.98 150.36 34.98 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.743 -0.598 . . . . 25.0 111.831 174.606 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.02 126.76 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 N-CA-C 105.697 -1.964 . . . . 25.0 105.697 178.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.46 122.82 30.15 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.758 -0.46 . . . . 25.0 109.758 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -104.03 14.03 31.42 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.985 0.898 . . . . 25.0 110.338 -179.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 t -156.47 149.45 18.41 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 106.321 -1.733 . . . . 25.0 106.321 -178.133 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -69.74 -16.4 37.62 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 117.152 -1.432 . . . . 25.0 112.55 175.457 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.28 -21.88 58.18 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 176.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -89.25 139.38 30.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.961 0.886 . . . . 25.0 109.338 -178.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.425 ' HB2' HG13 ' A' ' 57' ' ' VAL . 61.5 mt -90.14 129.48 36.41 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.848 0.833 . . . . 25.0 110.257 179.441 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.08 134.44 33.83 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.442 -1.688 . . . . 25.0 106.442 178.042 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -154.04 161.97 41.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.831 0.287 . . . . 25.0 111.559 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.71 162.04 17.34 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.722 -1.214 . . . . 25.0 107.722 -179.273 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.19 129.97 44.68 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.974 -0.557 . . . . 25.0 109.8 179.198 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.36 -13.9 63.99 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 119.039 -0.867 . . . . 25.0 114.151 179.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -59.77 148.68 33.47 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-N 117.92 0.86 . . . . 25.0 111.07 177.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.5 mm -118.84 129.8 74.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.31 -1.313 . . . . 25.0 109.043 -179.002 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -136.16 155.45 50.13 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.336 -0.987 . . . . 25.0 108.336 -178.196 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.7 m -88.83 124.39 34.12 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.385 -0.598 . . . . 25.0 109.385 177.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.1 t -87.43 125.08 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 108.424 -0.954 . . . . 25.0 108.424 177.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.576 HD12 HD22 ' A' ' 47' ' ' LEU . 81.4 mt -91.0 -46.29 8.23 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.364 -1.347 . . . . 25.0 107.364 178.814 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -155.87 170.7 21.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.646 -0.872 . . . . 25.0 108.646 177.438 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.9 mtm105 -117.37 154.57 31.08 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.25 -1.759 . . . . 25.0 106.25 177.067 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 59.05 42.97 18.22 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 125.478 1.736 . . . . 25.0 109.192 179.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -70.83 157.37 38.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.005 -1.452 . . . . 25.0 110.372 -176.627 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 60.15 10.08 2.14 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.019 0.928 . . . . 25.0 113.363 177.786 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.4 20.62 68.87 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.762 -0.732 . . . . 25.0 111.572 -176.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 70.6 mt -102.49 122.84 45.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.58 0.229 . . . . 25.0 111.287 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.57 123.63 17.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.256 0.551 . . . . 25.0 111.02 177.522 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.81 -0.24 82.87 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 116.131 1.212 . . . . 25.0 116.131 172.444 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -99.49 131.12 45.71 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 118.879 1.34 . . . . 25.0 109.427 177.705 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.439 ' CE3' HD23 ' A' ' 62' ' ' LEU . 42.6 m0 -110.65 143.45 41.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.729 -0.841 . . . . 25.0 108.729 -176.045 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.576 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -85.15 123.06 30.22 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 106.21 -1.774 . . . . 25.0 106.21 178.407 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.2 m -132.24 166.88 20.86 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.868 -0.333 . . . . 25.0 110.848 178.048 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -118.13 122.03 42.05 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.735 -1.58 . . . . 25.0 106.735 173.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.6 tp -150.58 140.02 21.44 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.79 -0.818 . . . . 25.0 108.79 -177.693 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.9 m170 57.5 30.77 19.23 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.628 0.771 . . . . 25.0 110.934 -179.534 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.89 0.03 87.68 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 115.381 0.912 . . . . 25.0 115.381 176.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -124.6 158.25 33.5 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 118.006 0.903 . . . . 25.0 110.148 179.266 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -102.1 149.58 24.12 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 106.564 -1.643 . . . . 25.0 106.564 178.661 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.89 -167.49 36.59 Favored Glycine 0 N--CA 1.433 -1.535 0 N-CA-C 107.825 -2.11 . . . . 25.0 107.825 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.6 pt -111.18 153.14 12.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.646 0.736 . . . . 25.0 111.574 -173.364 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.425 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.7 m -143.01 142.95 23.12 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.146 -0.934 . . . . 25.0 109.464 179.334 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.08 124.06 8.8 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 118.374 -0.617 . . . . 25.0 112.065 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.32 -12.3 79.86 Favored Glycine 0 C--O 1.221 -0.706 0 C-N-CA 120.83 -0.7 . . . . 25.0 114.505 -176.155 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -71.45 -7.85 50.03 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.084 0.772 . . . . 25.0 113.084 -176.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -132.16 27.23 4.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.666 -0.864 . . . . 25.0 108.666 178.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.439 HD23 ' CE3' ' A' ' 46' ' ' TRP . 16.3 tp -134.1 149.55 51.11 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.424 -0.807 . . . . 25.0 111.739 -174.116 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -128.17 123.02 33.31 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.38 0.272 . . . . 25.0 111.628 -178.29 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.9 mm -67.98 136.66 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.225 -0.657 . . . . 25.0 109.225 176.845 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.7 mt -118.43 100.96 7.8 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.396 -1.335 . . . . 25.0 107.396 175.293 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -86.6 132.77 31.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 107.669 -1.234 . . . . 25.0 107.669 177.244 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 170.07 176.82 39.95 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 109.677 -1.369 . . . . 25.0 109.677 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 15.8 tpt -78.48 145.23 35.09 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.114 -1.069 . . . . 25.0 108.114 178.096 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -77.12 160.65 28.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.632 -0.507 . . . . 25.0 109.632 177.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -141.16 154.6 45.94 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 109.924 -0.399 . . . . 25.0 109.924 178.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -72.24 148.58 45.35 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 123.426 0.69 . . . . 25.0 110.344 -178.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -141.79 149.0 51.78 Favored Pre-proline 0 N--CA 1.468 0.464 0 N-CA-C 106.122 -1.807 . . . . 25.0 106.122 178.043 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.26 -13.43 20.89 Favored 'Trans proline' 0 C--N 1.347 0.466 0 N-CA-C 115.415 1.275 . . . . 25.0 115.415 -175.565 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.95 -44.6 0.12 Allowed 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 121.231 0.539 . . . . 25.0 110.47 -179.823 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.85 -78.12 0.24 Allowed Glycine 0 CA--C 1.511 -0.216 0 N-CA-C 110.953 -0.859 . . . . 25.0 110.953 178.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.8 p -151.35 171.86 16.82 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.512 -0.921 . . . . 25.0 108.512 179.396 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.6 176.21 53.8 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 106.947 -2.461 . . . . 25.0 106.947 170.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -163.5 -173.31 32.05 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.655 -1.26 . . . . 25.0 110.509 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.3 p 67.94 176.81 0.25 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.812 1.245 . . . . 25.0 112.009 -175.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.0 129.69 3.14 Favored Glycine 0 C--O 1.243 0.706 0 N-CA-C 110.463 -1.055 . . . . 25.0 110.463 -176.462 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.7 m -98.75 155.03 17.55 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.85 0.357 . . . . 25.0 110.411 -175.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.27 -109.14 2.71 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.015 -0.612 . . . . 25.0 114.539 177.191 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 t 57.55 48.26 14.66 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.431 -0.951 . . . . 25.0 108.431 -173.753 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -126.89 24.96 6.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 113.968 -1.469 . . . . 25.0 110.391 -174.229 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -102.99 162.56 12.83 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.317 -0.856 . . . . 25.0 110.6 -175.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.426 ' HG2' ' H ' ' A' ' 87' ' ' ASP . 4.5 tt0 71.42 -171.84 0.16 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.933 1.396 . . . . 25.0 112.154 178.562 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.426 ' H ' ' HG2' ' A' ' 86' ' ' GLN . 9.0 m-20 -67.9 150.86 48.01 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.6 0.714 . . . . 25.0 112.71 -175.311 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.1 m -65.84 140.9 97.43 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.924 -0.58 . . . . 25.0 112.459 -178.643 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -62.73 157.94 44.85 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 119.753 0.302 . . . . 25.0 112.617 177.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -62.21 148.23 93.6 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 117.31 -1.327 . . . . 25.0 111.935 176.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.68 147.88 82.18 Favored 'Trans proline' 0 C--O 1.217 -0.545 0 N-CA-C 114.985 1.11 . . . . 25.0 114.985 -169.485 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -64.07 146.91 97.16 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.7 -0.852 . . . . 25.0 108.7 -177.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.94 156.76 64.34 Favored 'Trans proline' 0 C--O 1.238 0.481 0 C-N-CA 115.575 -2.483 . . . . 25.0 111.176 173.263 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -60.69 154.75 52.77 Favored 'Trans proline' 0 C--O 1.212 -0.814 0 C-N-CA 118.389 -0.607 . . . . 25.0 110.552 175.43 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -89.3 -77.42 0.38 Allowed 'General case' 0 C--O 1.211 -0.959 0 CA-C-O 121.009 0.433 . . . . 25.0 110.599 178.065 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.91 -36.46 0.12 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.936 0.874 . . . . 25.0 111.518 -179.74 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -132.57 35.62 3.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.688 -0.687 . . . . 25.0 110.964 -174.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 48.8 m -81.54 152.35 27.32 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.001 -1.0 . . . . 25.0 108.449 178.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 25.8 p -146.77 164.5 32.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.839 -1.912 . . . . 25.0 105.839 175.582 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 C--O 1.206 -1.219 0 CA-C-O 124.137 1.922 . . . . 25.0 112.926 -178.841 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.989 0 CA-C-O 124.202 2.001 . . . . 25.0 113.269 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 m 56.68 31.74 19.83 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 112.359 -1.92 . . . . 25.0 113.043 179.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 83.1 mtp -97.53 144.12 27.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.281 -0.418 . . . . 25.0 110.646 179.474 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -81.2 108.66 15.03 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.444 -0.576 . . . . 25.0 109.444 179.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -135.0 169.02 18.05 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.686 0.755 . . . . 25.0 112.502 -179.712 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.87 -42.21 90.62 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.869 -0.789 . . . . 25.0 108.869 176.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.6 m120 51.6 46.74 26.05 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.783 0.802 . . . . 25.0 110.407 -178.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 m -109.26 166.7 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 104.348 -2.464 . . . . 25.0 104.348 176.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.84 172.16 6.99 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 -176.436 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.86 158.61 43.46 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.927 -0.397 . . . . 25.0 109.927 173.455 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -124.88 129.66 50.83 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.417 -0.81 . . . . 25.0 109.817 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.77 130.53 42.57 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.271 -0.64 . . . . 25.0 109.271 178.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.7 mt -95.29 -20.72 18.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.543 -0.299 . . . . 25.0 111.472 -177.536 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -145.96 170.36 16.78 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.31 -0.996 . . . . 25.0 108.31 -179.891 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -73.93 160.4 31.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.598 -0.519 . . . . 25.0 109.598 177.041 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -145.97 154.37 41.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.838 0.352 . . . . 25.0 110.724 172.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 p -132.39 136.06 56.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 105.398 -2.075 . . . . 25.0 105.398 178.483 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.94 139.57 33.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.081 -0.509 . . . . 25.0 111.06 -175.192 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -121.68 9.3 10.14 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.577 0.703 . . . . 25.0 109.662 178.177 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 t -148.85 151.02 34.19 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 105.867 -1.901 . . . . 25.0 105.867 -177.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -67.52 -21.69 45.9 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 117.799 -1.0 . . . . 25.0 113.024 178.708 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.32 -17.57 58.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.961 0.41 . . . . 25.0 111.197 178.516 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -89.76 134.38 34.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.927 0.87 . . . . 25.0 111.866 -172.267 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.449 ' HB2' HG13 ' A' ' 57' ' ' VAL . 62.6 mt -89.08 126.24 35.36 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.266 -0.879 . . . . 25.0 110.822 178.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -86.94 141.31 28.81 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.021 -1.844 . . . . 25.0 106.021 174.082 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.13 168.07 28.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.757 0.313 . . . . 25.0 110.634 -177.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -116.33 162.9 16.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.224 0.535 . . . . 25.0 110.105 178.388 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.48 134.55 57.12 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.744 -0.662 . . . . 25.0 109.466 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.99 -12.73 68.75 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 116.132 -0.486 . . . . 25.0 113.014 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -62.46 138.98 58.57 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.692 -0.855 . . . . 25.0 108.692 177.761 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.1 mm -105.86 132.77 52.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.936 -1.029 . . . . 25.0 108.385 177.838 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.1 ptp -139.33 152.05 46.88 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.711 -0.478 . . . . 25.0 109.711 -178.446 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 m -89.76 123.11 33.47 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.515 -0.92 . . . . 25.0 108.515 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.97 125.81 41.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 108.847 -0.797 . . . . 25.0 108.847 178.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.691 HD12 HD22 ' A' ' 47' ' ' LEU . 70.8 mt -91.68 -47.77 7.19 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.4 -0.963 . . . . 25.0 108.4 179.464 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -155.37 173.88 16.03 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 110.308 -0.256 . . . . 25.0 110.308 178.443 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.9 mtm105 -123.74 157.96 32.77 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 106.029 -1.841 . . . . 25.0 106.029 176.699 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.8 t0 59.43 40.26 21.01 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 123.419 1.581 . . . . 25.0 107.449 -177.349 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -68.82 144.51 54.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.114 -1.403 . . . . 25.0 107.787 -177.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 59.8 12.28 2.92 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.899 0.88 . . . . 25.0 113.241 -179.276 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.29 16.83 79.01 Favored Glycine 0 C--N 1.331 0.265 0 N-CA-C 111.465 -0.654 . . . . 25.0 111.465 -178.231 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.3 mt -94.36 105.1 17.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.183 -0.673 . . . . 25.0 109.183 179.101 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -58.53 130.15 45.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 122.03 0.919 . . . . 25.0 110.807 -177.749 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.7 -6.35 70.16 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.085 -0.961 . . . . 25.0 115.037 178.009 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -95.83 139.26 32.3 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 118.944 1.372 . . . . 25.0 109.306 176.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 34.6 m0 -118.88 142.88 47.34 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.756 -1.201 . . . . 25.0 107.756 -176.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.691 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -85.71 121.83 28.94 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 105.308 -2.108 . . . . 25.0 105.308 178.888 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.1 m -130.97 157.62 42.46 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.333 0.587 . . . . 25.0 111.907 179.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.5 t -107.46 123.62 48.66 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 105.849 -1.908 . . . . 25.0 105.849 171.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 tp -144.61 135.08 24.5 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.83 -0.804 . . . . 25.0 108.83 -176.074 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 56.73 27.22 12.37 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 176.334 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.6 4.53 82.85 Favored Glycine 0 C--O 1.228 -0.275 0 N-CA-C 114.417 0.527 . . . . 25.0 114.417 178.481 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -131.78 162.09 31.34 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.959 0.879 . . . . 25.0 109.496 178.602 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -110.38 155.07 22.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.207 -0.664 . . . . 25.0 109.207 179.516 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.98 -163.49 31.16 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 106.832 -2.507 . . . . 25.0 106.832 176.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.9 pt -111.77 153.44 13.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 121.671 0.748 . . . . 25.0 110.157 -177.35 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -141.26 145.0 36.56 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.09 -0.959 . . . . 25.0 109.33 179.186 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.17 121.12 6.98 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 CA-C-O 121.659 0.608 . . . . 25.0 111.372 178.417 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.81 -9.21 74.72 Favored Glycine 0 C--O 1.218 -0.846 0 C-N-CA 121.131 -0.557 . . . . 25.0 114.056 -176.218 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -66.43 -17.02 64.55 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.337 -0.507 . . . . 25.0 112.091 -178.073 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -128.2 26.56 5.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.748 -0.66 . . . . 25.0 109.414 -177.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.2 tp -132.99 145.0 50.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.532 0.682 . . . . 25.0 109.973 -176.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -122.72 120.28 33.17 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.504 -0.771 . . . . 25.0 111.425 -177.112 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.2 mm -67.73 134.39 30.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 O-C-N 123.663 0.602 . . . . 25.0 109.652 177.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.3 mt -117.74 99.65 7.08 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.067 -1.827 . . . . 25.0 106.067 174.495 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.5 m -74.87 157.09 6.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.03 0.443 . . . . 25.0 109.848 -177.594 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.78 83.43 1.45 Allowed Glycine 0 C--O 1.218 -0.903 0 N-CA-C 109.28 -1.528 . . . . 25.0 109.28 175.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.48 -13.96 60.4 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.109 0.481 . . . . 25.0 110.29 -179.539 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -116.77 138.02 51.78 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 106.025 -1.843 . . . . 25.0 106.025 176.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 58.84 177.46 0.07 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.451 1.095 . . . . 25.0 113.503 -176.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -101.76 80.32 2.02 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.334 -1.358 . . . . 25.0 107.334 -177.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 mttt 54.72 72.39 1.1 Allowed Pre-proline 0 N--CA 1.479 0.998 0 CA-C-N 114.685 -1.143 . . . . 25.0 112.624 -176.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -72.42 -8.97 23.55 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 121.66 1.573 . . . . 25.0 114.882 -178.554 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 59.0 16.89 4.97 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.94 1.459 . . . . 25.0 114.94 177.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.63 160.68 39.74 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 121.179 -0.534 . . . . 25.0 112.102 178.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.1 m -139.77 164.61 29.49 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 109.381 -0.6 . . . . 25.0 109.381 -179.346 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.32 -51.27 0.32 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 116.681 1.432 . . . . 25.0 116.681 174.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.69 82.41 1.41 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 116.177 1.231 . . . . 25.0 116.177 -174.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 66.4 p -65.0 -37.92 89.25 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 112.708 0.633 . . . . 25.0 112.708 -179.239 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.4 -155.51 17.52 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 109.853 -1.299 . . . . 25.0 109.853 -179.166 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.3 m -147.82 163.52 36.51 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.886 -0.783 . . . . 25.0 108.886 -178.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.56 152.2 7.69 Favored Glycine 0 C--O 1.226 -0.404 0 N-CA-C 109.528 -1.429 . . . . 25.0 109.528 179.361 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.7 t -139.19 21.96 2.59 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.567 0.683 . . . . 25.0 111.886 -176.144 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -109.06 -50.66 2.97 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.429 1.27 . . . . 25.0 114.429 -176.605 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt 63.43 -160.18 0.3 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.571 -0.9 . . . . 25.0 108.571 -173.288 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -144.05 130.02 19.48 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.712 -1.588 . . . . 25.0 106.712 178.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -73.17 -30.27 63.44 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.906 0.706 . . . . 25.0 112.906 -177.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.2 m -121.54 84.91 42.87 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 112.122 0.416 . . . . 25.0 112.122 -178.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -77.78 164.32 27.99 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 N-CA-C 113.365 0.486 . . . . 25.0 113.365 178.121 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -64.1 150.71 87.79 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 118.279 -0.681 . . . . 25.0 111.62 175.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.51 160.57 48.06 Favored 'Trans proline' 0 C--N 1.35 0.618 0 N-CA-C 116.456 1.675 . . . . 25.0 116.456 -172.328 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -67.34 149.84 98.19 Favored Pre-proline 0 N--CA 1.468 0.433 0 CA-C-N 115.543 -0.753 . . . . 25.0 110.147 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.25 156.55 61.81 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 117.137 -1.442 . . . . 25.0 110.757 172.333 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.72 151.42 80.7 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 117.133 -1.445 . . . . 25.0 110.364 174.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -81.62 -61.36 1.95 Allowed 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 119.836 -0.746 . . . . 25.0 109.943 177.136 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.65 -40.13 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 105.537 -2.023 . . . . 25.0 105.537 -176.55 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -56.87 121.12 9.14 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 114.264 -1.335 . . . . 25.0 112.878 -178.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.4 m -97.52 4.88 50.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.719 -0.673 . . . . 25.0 110.909 173.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 48.7 t -140.9 140.88 34.6 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.982 0.896 . . . . 25.0 110.93 -176.17 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 C--O 1.208 -1.089 0 CA-C-O 123.966 1.841 . . . . 25.0 111.218 179.661 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 116.166 1.226 . . . . 25.0 116.166 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 m 71.3 161.73 0.24 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.549 1.939 . . . . 25.0 113.083 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -111.9 27.99 9.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.42 -0.809 . . . . 25.0 109.84 -179.057 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.3 tptp -96.69 17.24 16.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.864 -0.607 . . . . 25.0 110.616 -177.249 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -131.09 159.2 38.28 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.071 0.767 . . . . 25.0 113.071 -175.45 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.6 mt -63.96 -38.72 92.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.984 -1.007 . . . . 25.0 110.83 179.647 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 52.61 41.87 31.35 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.267 1.032 . . . . 25.0 110.87 -179.661 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' A' ' 34' ' ' VAL . 16.0 m -103.29 173.23 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 102.97 -2.974 . . . . 25.0 102.97 174.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -118.4 172.61 7.34 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 118.649 0.658 . . . . 25.0 109.401 -178.346 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.43 160.26 43.6 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.918 -0.583 . . . . 25.0 109.533 176.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -118.84 133.09 56.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.101 -0.954 . . . . 25.0 108.863 177.023 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.584 ' HA ' HD12 ' A' ' 62' ' ' LEU . . . -71.91 126.28 29.33 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 173.75 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.8 mt -88.63 -22.29 23.54 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.433 -0.58 . . . . 25.0 109.433 -178.698 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -144.05 175.17 10.24 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 105.116 -2.179 . . . . 25.0 105.116 179.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -86.47 -179.99 6.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 118.15 0.432 . . . . 25.0 109.937 175.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -154.99 143.56 20.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.111 0.481 . . . . 25.0 111.721 174.652 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.6 t -107.26 123.9 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 105.084 -2.191 . . . . 25.0 105.084 175.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.99 121.67 22.32 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.274 -1.01 . . . . 25.0 108.274 178.394 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -110.97 -2.06 16.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.647 0.737 . . . . 25.0 109.197 -179.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.3 m -129.34 152.6 79.78 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 107.55 -1.278 . . . . 25.0 107.55 179.083 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.92 -20.55 33.91 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 118.352 -0.632 . . . . 25.0 113.363 -179.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -16.94 46.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.925 -0.579 . . . . 25.0 110.383 179.565 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -87.19 139.82 30.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.627 0.727 . . . . 25.0 111.602 -172.476 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.8 mt -91.88 129.86 37.76 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.69 0.757 . . . . 25.0 109.75 177.336 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.34 142.48 27.85 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 105.708 -1.96 . . . . 25.0 105.708 173.327 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -156.41 167.72 29.58 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.788 -0.449 . . . . 25.0 109.788 -179.037 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.62 161.56 17.29 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.676 0.75 . . . . 25.0 111.142 -179.079 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -56.89 127.19 30.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.993 -1.003 . . . . 25.0 109.71 178.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.23 -11.77 70.01 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-O 119.093 -0.837 . . . . 25.0 114.682 178.01 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.51 138.82 54.72 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 118.18 0.99 . . . . 25.0 111.63 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.1 mm -102.28 130.22 52.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.194 -1.039 . . . . 25.0 108.194 175.333 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.0 ptp -135.65 153.28 51.68 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.439 -0.578 . . . . 25.0 109.439 -178.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.0 m -88.8 128.21 35.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.25 -1.389 . . . . 25.0 107.25 178.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 8' ' ' VAL . 61.8 t -94.22 121.67 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 107.421 -1.326 . . . . 25.0 107.421 178.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.624 HD12 HD22 ' A' ' 47' ' ' LEU . 78.4 mt -91.7 -43.66 9.46 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.157 -0.929 . . . . 25.0 109.947 -177.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -152.2 162.6 40.89 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.483 -1.303 . . . . 25.0 107.483 -177.037 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -124.7 153.56 42.15 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.203 -1.036 . . . . 25.0 108.203 176.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 55.8 40.17 30.7 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 123.731 1.729 . . . . 25.0 108.393 -178.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -70.36 158.96 35.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 112.95 -1.932 . . . . 25.0 110.57 -175.457 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 60.87 8.32 1.8 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.112 0.965 . . . . 25.0 113.389 179.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.85 17.85 74.05 Favored Glycine 0 CA--C 1.517 0.174 0 N-CA-C 110.551 -1.019 . . . . 25.0 110.551 -176.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.3 mt -99.51 123.3 43.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.007 0.432 . . . . 25.0 110.397 -179.535 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -64.78 129.69 40.73 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.06 -0.518 . . . . 25.0 110.456 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.13 -0.75 66.29 Favored Glycine 0 C--O 1.24 0.488 0 N-CA-C 116.617 1.407 . . . . 25.0 116.617 174.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -100.5 129.99 46.52 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 118.692 1.246 . . . . 25.0 109.736 178.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -111.65 140.07 46.58 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.74 -0.467 . . . . 25.0 109.74 -175.776 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.624 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -80.45 120.48 24.51 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.237 -1.764 . . . . 25.0 106.237 178.541 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.8 m -131.41 163.75 27.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.096 0.474 . . . . 25.0 111.884 178.683 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.9 t -120.03 123.95 44.69 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.062 -1.458 . . . . 25.0 107.062 173.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.8 tp -148.61 136.59 20.87 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.823 -0.806 . . . . 25.0 108.823 -176.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 56.17 26.98 10.91 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.551 1.315 . . . . 25.0 114.551 174.758 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.36 8.97 84.37 Favored Glycine 0 C--O 1.227 -0.297 0 C-N-CA 121.006 -0.616 . . . . 25.0 113.197 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -119.9 157.52 28.58 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.127 -1.064 . . . . 25.0 108.127 178.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -122.22 147.79 45.76 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 105.353 -2.091 . . . . 25.0 105.353 173.107 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.26 -155.59 17.25 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 107.201 -2.36 . . . . 25.0 107.201 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.9 pt -122.37 149.53 25.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 121.396 0.617 . . . . 25.0 111.05 -174.581 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.6 m -138.22 147.2 54.86 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.087 -0.96 . . . . 25.0 109.166 -178.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.84 119.12 5.73 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 O-C-N 122.037 0.493 . . . . 25.0 112.272 178.539 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.39 -18.65 69.84 Favored Glycine 0 C--O 1.223 -0.575 0 C-N-CA 121.226 -0.511 . . . . 25.0 113.429 -178.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -64.18 -17.98 64.04 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.202 0.815 . . . . 25.0 113.202 -178.428 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -122.58 27.29 7.9 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.343 0.592 . . . . 25.0 109.628 177.022 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 12' ' ' ALA . 1.4 tp -128.77 157.62 40.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 25.0 111.757 -179.618 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -131.37 120.03 22.52 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.067 -0.515 . . . . 25.0 110.869 177.339 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.7 mm -69.32 136.95 25.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.293 -0.632 . . . . 25.0 109.293 178.739 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.7 mt -115.55 91.82 3.72 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.713 -1.218 . . . . 25.0 107.713 177.103 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.7 m -81.37 -14.47 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 113.353 0.871 . . . . 25.0 113.353 -176.599 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.58 89.55 1.61 Allowed Glycine 0 C--O 1.226 -0.356 0 N-CA-C 106.381 -2.688 . . . . 25.0 106.381 -169.72 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 98.4 mtp -80.53 95.72 6.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 121.892 -0.77 . . . . 25.0 110.959 -173.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 65.49 12.39 8.14 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.628 1.171 . . . . 25.0 113.293 178.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -144.11 169.06 18.58 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.125 -1.435 . . . . 25.0 107.125 174.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -69.96 151.75 45.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.361 0.601 . . . . 25.0 111.543 -176.53 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -69.12 153.34 96.12 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 105.781 -1.933 . . . . 25.0 105.781 172.143 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -66.62 151.76 82.11 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 117.007 -1.529 . . . . 25.0 112.91 -177.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.95 12.31 3.39 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.177 0.806 . . . . 25.0 113.177 -176.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.35 176.3 46.04 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.717 -0.953 . . . . 25.0 110.717 -179.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.4 m -68.24 148.67 50.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.661 0.267 . . . . 25.0 110.994 179.586 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.0 -178.45 48.25 Favored Glycine 0 CA--C 1.508 -0.347 0 N-CA-C 109.915 -1.274 . . . . 25.0 109.915 179.413 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 144.6 -51.7 0.62 Allowed Glycine 0 C--O 1.229 -0.212 0 N-CA-C 110.928 -0.869 . . . . 25.0 110.928 178.676 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.8 m 62.34 164.76 0.1 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 115.531 1.678 . . . . 25.0 115.531 177.276 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.14 169.6 35.81 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 107.752 -2.139 . . . . 25.0 107.752 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.8 m -135.7 11.13 3.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.826 0.813 . . . . 25.0 111.933 -178.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.15 -127.48 29.96 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 110.683 -0.967 . . . . 25.0 110.683 -177.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.2 t 71.01 -53.77 0.67 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.498 1.519 . . . . 25.0 112.38 -178.367 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.37 139.81 54.18 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.985 -1.117 . . . . 25.0 107.985 174.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -158.75 10.61 0.14 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.172 0.804 . . . . 25.0 113.172 -174.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.08 113.13 10.42 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 108.095 -1.076 . . . . 25.0 108.095 -179.329 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -153.73 166.22 33.54 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.747 -1.205 . . . . 25.0 107.747 -178.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.0 t -122.3 92.72 48.87 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.908 0.385 . . . . 25.0 110.401 -179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.21 154.04 36.62 Favored 'Trans proline' 0 C--N 1.346 0.418 0 N-CA-C 115.754 1.405 . . . . 25.0 115.754 -176.293 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -71.91 158.98 51.63 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 118.064 -0.824 . . . . 25.0 110.701 173.163 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -67.94 155.16 70.79 Favored 'Trans proline' 0 C--O 1.234 0.317 0 N-CA-C 114.977 1.106 . . . . 25.0 114.977 -173.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -81.95 144.45 51.48 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 107.617 -1.253 . . . . 25.0 107.617 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.04 156.91 55.41 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 117.698 -1.068 . . . . 25.0 111.557 -179.024 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -64.67 146.06 88.0 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 116.991 -1.539 . . . . 25.0 113.834 -177.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -85.6 49.38 1.75 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.039 -0.413 . . . . 25.0 110.866 174.506 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 77.6 p 47.27 10.21 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 118.745 2.869 . . . . 25.0 118.745 -178.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -124.5 -12.99 7.18 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.699 1.37 . . . . 25.0 114.699 -178.257 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.9 t 48.56 30.59 2.53 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 116.74 2.126 . . . . 25.0 116.74 177.24 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 81.1 m -72.22 122.6 21.34 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 121.467 -0.77 . . . . 25.0 109.576 177.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.296 0 C-N-CA 126.07 1.748 . . . . 25.0 113.761 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 CA-C-O 123.843 1.801 . . . . 25.0 114.116 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 t -143.02 127.73 18.14 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.067 -1.457 . . . . 25.0 107.067 177.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.0 ttm -157.99 -68.39 0.09 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.115 0.783 . . . . 25.0 113.115 -175.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 65.0 179.57 0.18 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.804 1.242 . . . . 25.0 109.245 -173.797 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 55.53 174.38 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 116.769 2.137 . . . . 25.0 116.769 -177.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.6 mt -79.33 -42.07 26.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.082 -0.963 . . . . 25.0 110.568 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 56.42 27.08 11.54 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.414 1.085 . . . . 25.0 112.287 -178.441 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.7 m -86.53 170.94 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 104.441 -2.429 . . . . 25.0 104.441 174.061 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mp -116.33 172.78 6.97 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.033 -0.729 . . . . 25.0 109.033 179.407 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.04 155.17 42.0 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.731 -0.47 . . . . 25.0 109.731 177.292 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -114.02 131.05 56.5 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.535 -0.757 . . . . 25.0 109.553 176.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.427 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -69.15 127.13 32.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.133 -0.692 . . . . 25.0 109.133 174.171 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.6 mt -92.44 -23.14 19.26 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.939 -0.393 . . . . 25.0 109.939 -178.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -143.16 167.06 23.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.059 -1.089 . . . . 25.0 108.059 -179.159 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -75.73 166.22 23.87 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 122.668 0.387 . . . . 25.0 111.824 177.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -145.57 156.83 43.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.968 0.413 . . . . 25.0 111.373 174.252 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.9 t -123.5 122.62 65.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 105.239 -2.134 . . . . 25.0 105.239 173.51 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.23 127.58 32.87 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.363 -0.977 . . . . 25.0 108.363 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -113.17 12.98 19.18 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.961 0.886 . . . . 25.0 109.52 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 t -152.08 147.44 19.79 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 106.3 -1.741 . . . . 25.0 106.3 -179.487 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.98 -23.6 67.73 Favored 'Trans proline' 0 C--N 1.347 0.456 0 O-C-N 122.23 0.595 . . . . 25.0 113.079 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -76.26 -21.12 56.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.343 0.592 . . . . 25.0 110.351 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -88.29 130.74 35.03 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.241 -1.022 . . . . 25.0 108.241 -178.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.443 ' HB2' HG13 ' A' ' 57' ' ' VAL . 54.2 mt -81.76 133.18 35.32 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.697 0.76 . . . . 25.0 109.803 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.39 125.09 34.54 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.331 -0.989 . . . . 25.0 108.331 177.568 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -145.43 164.36 31.79 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 120.972 0.415 . . . . 25.0 110.445 -179.31 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.35 167.73 12.01 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.334 0.587 . . . . 25.0 110.086 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -58.83 130.43 46.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.342 -0.844 . . . . 25.0 109.44 -179.092 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.26 -12.15 69.42 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-O 118.504 -1.164 . . . . 25.0 114.938 177.172 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -59.97 150.01 30.23 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.439 1.119 . . . . 25.0 111.483 177.523 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.2 mm -114.81 127.06 72.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.61 -1.177 . . . . 25.0 108.642 177.283 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.8 ptp -132.74 151.06 52.08 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.293 -0.632 . . . . 25.0 109.293 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -84.82 130.35 34.68 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.247 -1.02 . . . . 25.0 108.247 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.8 t -98.18 121.14 48.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.534 -0.913 . . . . 25.0 108.534 179.561 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.609 HD12 HD22 ' A' ' 47' ' ' LEU . 80.7 mt -87.7 -46.81 9.17 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.972 -0.558 . . . . 25.0 109.66 -179.375 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -155.01 171.11 20.27 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.115 -0.698 . . . . 25.0 109.115 178.238 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -117.66 157.81 25.78 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.323 -1.362 . . . . 25.0 107.323 177.681 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 57.63 37.93 27.57 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 125.127 1.517 . . . . 25.0 109.85 177.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 t -66.45 152.11 45.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.847 -1.524 . . . . 25.0 110.612 -175.529 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 60.97 6.89 1.32 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.362 1.065 . . . . 25.0 112.766 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.59 12.7 74.65 Favored Glycine 0 C--O 1.224 -0.472 0 N-CA-C 111.414 -0.674 . . . . 25.0 111.414 -177.094 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.2 mt -88.08 125.02 34.35 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.745 -0.465 . . . . 25.0 109.745 179.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -64.53 124.79 22.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.699 0.285 . . . . 25.0 110.272 178.085 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.69 -0.63 76.26 Favored Glycine 0 C--O 1.242 0.596 0 N-CA-C 116.68 1.432 . . . . 25.0 116.68 172.568 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -96.67 135.8 38.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.885 1.343 . . . . 25.0 108.984 179.002 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -111.36 144.32 40.75 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.858 -0.793 . . . . 25.0 108.858 -178.14 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.609 HD22 HD12 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -83.92 120.49 26.15 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 104.524 -2.398 . . . . 25.0 104.524 176.572 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 93.2 m -129.17 163.03 26.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 121.006 -0.278 . . . . 25.0 111.503 179.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.5 t -116.79 123.84 48.12 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.292 -1.373 . . . . 25.0 107.292 173.619 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.7 tp -146.49 129.1 16.08 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 108.571 -0.9 . . . . 25.0 108.571 -176.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 27.7 m170 55.91 32.7 20.25 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.412 0.523 . . . . 25.0 112.412 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.71 3.15 86.93 Favored Glycine 0 C--O 1.222 -0.64 0 C-N-CA 120.816 -0.707 . . . . 25.0 113.987 178.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 mtt-85 -111.1 153.95 24.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.575 -1.269 . . . . 25.0 107.575 178.487 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -120.41 147.15 45.45 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 106.683 -1.599 . . . . 25.0 106.683 175.038 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.73 -158.46 22.21 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 106.997 -2.441 . . . . 25.0 106.997 -177.433 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.5 pt -115.36 153.01 16.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.75 0.786 . . . . 25.0 111.572 -175.205 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.5 m -144.47 146.37 32.41 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 114.797 -1.092 . . . . 25.0 109.191 179.348 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.07 114.5 4.06 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 CA-C-O 121.609 0.587 . . . . 25.0 112.175 178.459 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.19 -17.74 68.43 Favored Glycine 0 C--O 1.221 -0.683 0 N-CA-C 114.551 0.58 . . . . 25.0 114.551 -177.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -65.06 -15.21 62.1 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.722 0.638 . . . . 25.0 112.722 -178.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -123.44 26.24 7.95 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.755 -0.59 . . . . 25.0 110.239 176.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 12' ' ' ALA . 12.3 mt -125.88 156.95 38.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.594 0.711 . . . . 25.0 110.949 178.207 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -127.92 119.05 24.74 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.255 -0.884 . . . . 25.0 110.531 177.446 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.0 mm -66.8 133.53 31.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 O-C-N 123.797 0.686 . . . . 25.0 109.531 178.4 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.1 mt -114.3 94.04 4.62 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.712 -1.218 . . . . 25.0 107.712 175.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 m -80.26 7.54 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.498 0.666 . . . . 25.0 109.973 176.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.79 28.59 71.84 Favored Glycine 0 C--O 1.22 -0.771 0 CA-C-N 116.109 -0.496 . . . . 25.0 112.022 -179.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 43.7 ttp -18.51 -54.5 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 120.239 3.422 . . . . 25.0 120.239 -173.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -66.4 -27.72 68.06 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 115.597 1.702 . . . . 25.0 115.597 -173.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -138.83 9.22 2.59 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 122.394 1.092 . . . . 25.0 109.903 -176.534 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 69.1 tttt 58.54 25.53 13.22 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 114.45 -1.25 . . . . 25.0 110.192 -171.856 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -145.33 149.21 40.41 Favored Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 106.59 -1.633 . . . . 25.0 106.59 -178.231 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.52 151.26 75.55 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 118.309 -0.661 . . . . 25.0 113.461 -176.569 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.1 -27.26 60.8 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.905 1.076 . . . . 25.0 113.905 -176.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 136.82 -175.33 21.13 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.759 -0.734 . . . . 25.0 112.086 -178.459 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.1 p -141.08 60.27 1.51 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 122.888 0.475 . . . . 25.0 110.116 -177.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.4 -0.21 56.99 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 115.602 1.001 . . . . 25.0 115.602 -177.557 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.32 164.31 11.29 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 109.257 -1.537 . . . . 25.0 109.257 -179.065 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.1 m -162.77 100.77 1.01 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.689 0.745 . . . . 25.0 111.408 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.4 -176.19 31.2 Favored Glycine 0 C--O 1.22 -0.769 0 C-N-CA 121.182 -0.533 . . . . 25.0 113.034 176.766 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.9 t -161.02 -59.8 0.05 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.637 -1.245 . . . . 25.0 107.637 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.05 167.0 24.96 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 107.897 -2.081 . . . . 25.0 107.897 172.161 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.0 m -119.39 148.24 43.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.684 -0.858 . . . . 25.0 108.684 178.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -98.9 160.66 14.11 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.506 -0.553 . . . . 25.0 109.506 -178.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -132.79 10.82 4.32 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.875 0.369 . . . . 25.0 111.567 178.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -107.99 -8.47 15.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.805 -0.634 . . . . 25.0 110.928 -177.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.87 136.92 57.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.119 -0.492 . . . . 25.0 110.304 -179.13 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.1 m -118.43 86.75 28.96 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.768 -0.651 . . . . 25.0 109.851 -179.668 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.3 155.93 59.72 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 117.87 -0.954 . . . . 25.0 113.36 -178.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -69.72 158.16 57.98 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 116.755 -1.697 . . . . 25.0 111.191 176.258 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -59.21 153.71 51.02 Favored 'Trans proline' 0 C--N 1.346 0.397 0 N-CA-C 113.817 0.66 . . . . 25.0 113.817 -178.613 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -67.21 140.56 95.61 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 106.51 -1.663 . . . . 25.0 106.51 176.207 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.12 160.31 50.41 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 117.384 -1.278 . . . . 25.0 110.959 176.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.57 147.09 96.23 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 116.86 -1.627 . . . . 25.0 114.438 -176.079 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -88.97 64.9 7.34 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.051 -1.092 . . . . 25.0 108.051 174.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.57 110.14 10.89 Favored 'General case' 0 C--O 1.212 -0.868 0 CA-C-N 115.078 -0.964 . . . . 25.0 109.558 -177.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -92.49 29.82 1.64 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.075 0.464 . . . . 25.0 111.87 -176.688 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.5 m -82.78 75.43 9.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.76 -0.654 . . . . 25.0 110.848 -179.37 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 14.8 t -130.95 156.0 45.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.414 -0.588 . . . . 25.0 109.414 -178.266 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.21 -0.975 0 CA-C-O 124.595 2.14 . . . . 25.0 112.179 178.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 CA-C-O 122.578 1.099 . . . . 25.0 115.484 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 t 57.27 36.94 27.96 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.401 1.081 . . . . 25.0 113.862 176.867 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -78.73 76.81 5.22 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.15 -0.685 . . . . 25.0 109.15 175.252 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -78.1 109.63 12.35 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.177 -0.675 . . . . 25.0 109.177 -177.73 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -133.53 167.23 20.84 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.707 -0.678 . . . . 25.0 110.402 -177.344 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.0 mt -67.87 -40.25 83.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.752 -0.658 . . . . 25.0 109.655 177.836 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.5 m120 55.75 24.7 7.54 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.972 -1.013 . . . . 25.0 112.787 -178.48 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.1 m -84.57 158.19 3.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.519 -1.289 . . . . 25.0 107.519 177.754 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.48 167.74 11.13 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.781 -0.822 . . . . 25.0 108.781 -177.175 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.29 158.76 44.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.991 0.424 . . . . 25.0 110.427 175.665 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -123.79 132.25 53.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.065 -0.971 . . . . 25.0 109.601 -179.808 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.23 132.18 40.91 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.376 -0.601 . . . . 25.0 109.376 177.274 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.5 mt -100.43 -17.4 17.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.42 -0.355 . . . . 25.0 110.388 -179.514 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -145.56 169.95 17.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 104.598 -2.371 . . . . 25.0 104.598 177.951 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -89.44 177.36 6.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.578 0.626 . . . . 25.0 110.618 176.175 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -154.44 136.4 14.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.971 -0.559 . . . . 25.0 110.492 175.297 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.7 t -104.35 121.36 55.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 104.643 -2.354 . . . . 25.0 104.643 175.368 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.22 135.69 49.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.413 -0.812 . . . . 25.0 109.253 -179.029 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -113.1 9.09 18.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.64 0.733 . . . . 25.0 109.271 -178.472 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 t -156.17 152.75 24.04 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.347 -0.842 . . . . 25.0 108.82 -175.577 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -70.31 -19.05 33.99 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 117.941 -0.906 . . . . 25.0 114.312 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.95 -17.01 56.19 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.481 -0.563 . . . . 25.0 109.481 178.048 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -93.74 142.33 27.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.515 0.674 . . . . 25.0 111.107 -175.729 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.433 ' HB2' HG13 ' A' ' 57' ' ' VAL . 55.7 mt -94.69 131.96 39.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.682 0.753 . . . . 25.0 110.102 178.959 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.5 p -90.94 140.17 30.07 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 105.882 -1.896 . . . . 25.0 105.882 174.661 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -156.05 164.91 37.84 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 120.806 0.336 . . . . 25.0 110.251 -179.325 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.427 HH22 ' HB2' ' A' ' 84' ' ' GLU . 16.2 mmt180 -108.53 158.58 17.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.037 0.922 . . . . 25.0 109.473 179.171 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -57.64 133.91 55.72 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.842 -1.072 . . . . 25.0 109.645 175.363 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.79 -12.32 70.14 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-O 119.022 -0.877 . . . . 25.0 113.644 178.655 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -60.67 146.44 45.61 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 118.116 0.958 . . . . 25.0 110.721 178.187 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.0 mm -110.86 129.23 66.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 107.935 -1.135 . . . . 25.0 107.935 177.6 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.3 ptp -136.79 165.97 24.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.999 -0.741 . . . . 25.0 108.999 -179.091 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -103.81 123.61 47.39 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.752 -0.833 . . . . 25.0 108.752 178.761 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.7 t -88.2 124.41 41.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.698 -1.223 . . . . 25.0 107.698 177.668 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.625 HD12 HD22 ' A' ' 47' ' ' LEU . 65.7 mt -93.68 -43.56 8.59 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.133 -0.939 . . . . 25.0 108.929 -179.667 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -148.49 155.16 40.81 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 106.784 -1.562 . . . . 25.0 106.784 -172.798 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -118.87 154.35 33.06 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 106.241 -1.763 . . . . 25.0 106.241 173.957 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 58.16 37.7 26.32 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 123.477 1.608 . . . . 25.0 108.324 178.638 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -68.46 159.43 31.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.043 -1.89 . . . . 25.0 111.018 -175.933 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 59.31 12.1 2.47 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.795 1.035 . . . . 25.0 113.795 177.131 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.36 18.35 78.14 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 110.628 -0.989 . . . . 25.0 110.628 -177.213 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.7 mt -104.07 115.94 31.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.069 0.462 . . . . 25.0 109.859 -179.454 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -66.25 131.12 45.4 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 -178.239 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.93 -1.56 78.69 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 115.427 0.931 . . . . 25.0 115.427 176.175 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -99.85 132.55 45.13 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 118.866 1.333 . . . . 25.0 109.014 177.059 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -113.09 139.26 48.86 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.429 -0.582 . . . . 25.0 109.429 -175.961 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.625 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -80.54 122.5 27.11 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 106.08 -1.822 . . . . 25.0 106.08 179.684 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 92.9 m -132.81 163.25 29.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.28 0.562 . . . . 25.0 112.288 178.634 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -115.37 127.98 55.77 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.16 -1.793 . . . . 25.0 106.16 171.248 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.8 tp -154.9 141.22 18.62 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 107.244 -1.391 . . . . 25.0 107.244 -175.343 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 55.91 26.99 10.41 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 112.651 0.612 . . . . 25.0 112.651 178.384 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.06 4.53 88.83 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 114.711 0.644 . . . . 25.0 114.711 178.733 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -126.64 161.4 28.16 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.501 -0.926 . . . . 25.0 108.501 -179.677 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -112.89 156.73 22.44 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.92 -1.141 . . . . 25.0 107.92 179.045 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.89 -161.24 30.66 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 106.509 -2.636 . . . . 25.0 106.509 179.521 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.6 pt -117.36 153.99 19.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.327 0.584 . . . . 25.0 111.878 -175.871 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.6 m -142.81 148.63 46.78 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 114.974 -1.012 . . . . 25.0 109.141 -179.023 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.18 122.42 7.11 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 CA-C-O 121.612 0.588 . . . . 25.0 112.799 -179.799 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.08 -24.44 67.05 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 116.308 -0.406 . . . . 25.0 113.739 -178.431 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -24.1 65.46 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.391 -0.476 . . . . 25.0 112.036 179.049 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -105.65 11.86 31.76 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.938 0.347 . . . . 25.0 111.938 -179.543 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.0 mt -121.78 152.5 39.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.704 1.24 . . . . 25.0 113.946 -177.539 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -120.36 123.53 43.32 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 113.687 -1.597 . . . . 25.0 108.812 176.004 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.0 mm -76.59 138.33 20.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.64 -0.874 . . . . 25.0 108.64 179.103 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.5 mt -117.38 88.06 2.83 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.966 -1.494 . . . . 25.0 106.966 176.7 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.1 m -73.07 150.57 8.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.0 0.428 . . . . 25.0 109.998 -179.77 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.83 177.39 29.92 Favored Glycine 0 C--O 1.227 -0.324 0 N-CA-C 108.21 -1.956 . . . . 25.0 108.21 179.606 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 23.6 ttt -134.41 126.89 30.46 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 105.783 -1.932 . . . . 25.0 105.783 178.467 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 56.25 75.53 0.34 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 116.325 1.972 . . . . 25.0 116.325 -178.823 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -89.45 -90.48 0.14 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.107 0.48 . . . . 25.0 111.481 173.634 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -136.01 156.89 48.07 Favored 'General case' 0 CA--C 1.512 -0.495 0 O-C-N 121.564 -0.71 . . . . 25.0 110.168 -176.234 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -126.99 84.04 64.47 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.232 -0.655 . . . . 25.0 109.232 177.435 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.29 -19.17 17.51 Favored 'Trans proline' 0 C--N 1.346 0.406 0 N-CA-C 114.523 0.932 . . . . 25.0 114.523 -176.308 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 67.69 -41.64 0.43 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.189 1.552 . . . . 25.0 115.189 -177.864 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.54 -174.7 39.37 Favored Glycine 0 C--O 1.229 -0.204 0 N-CA-C 111.401 -0.68 . . . . 25.0 111.401 178.747 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.2 m -131.85 147.39 52.48 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.729 -0.841 . . . . 25.0 108.729 179.754 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.86 43.54 3.09 Favored Glycine 0 C--O 1.225 -0.459 0 N-CA-C 115.171 0.828 . . . . 25.0 115.171 -176.537 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.77 175.77 44.36 Favored Glycine 0 CA--C 1.511 -0.166 0 CA-C-N 117.857 0.828 . . . . 25.0 112.023 179.684 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 69.6 m -148.35 150.41 33.53 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.832 -1.544 . . . . 25.0 106.832 178.294 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.38 -36.29 20.91 Favored Glycine 0 C--O 1.227 -0.314 0 N-CA-C 115.92 1.128 . . . . 25.0 115.92 -174.783 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.9 m 54.11 -151.44 0.35 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.956 0.378 . . . . 25.0 110.548 -176.611 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.07 -39.65 2.26 Favored Glycine 0 C--O 1.221 -0.682 0 N-CA-C 116.501 1.36 . . . . 25.0 116.501 175.78 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.3 t 62.76 17.01 9.49 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.015 0.926 . . . . 25.0 112.121 -177.134 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.427 ' HB2' HH22 ' A' ' 27' ' ' ARG . 52.2 mt-10 -81.97 170.89 15.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.767 -0.652 . . . . 25.0 109.474 177.621 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.35 163.82 31.76 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.398 -1.334 . . . . 25.0 107.398 179.317 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -138.74 171.86 13.72 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.74 0.644 . . . . 25.0 112.74 -174.376 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 58.77 -164.73 0.19 Allowed 'General case' 0 N--CA 1.474 0.753 0 O-C-N 124.411 1.07 . . . . 25.0 112.797 178.028 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.5 m -120.64 84.95 37.81 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 105.524 -2.028 . . . . 25.0 105.524 172.452 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.89 156.41 30.83 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 N-CA-C 114.969 1.104 . . . . 25.0 114.969 -171.46 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.77 164.75 34.44 Favored 'Trans proline' 0 C--O 1.243 0.728 0 C-N-CA 119.914 0.41 . . . . 25.0 111.349 175.231 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.7 166.71 25.16 Favored 'Trans proline' 0 C--N 1.344 0.335 0 N-CA-C 114.429 0.896 . . . . 25.0 114.429 -177.297 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -99.29 136.96 20.31 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 105.755 -1.943 . . . . 25.0 105.755 174.561 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.76 162.5 41.85 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 117.83 -0.98 . . . . 25.0 112.647 -175.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -61.1 155.24 51.92 Favored 'Trans proline' 0 C--N 1.348 0.547 0 N-CA-C 113.867 0.68 . . . . 25.0 113.867 -178.986 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -111.91 41.11 2.01 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.189 -0.46 . . . . 25.0 110.983 179.181 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.0 p 52.56 -21.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 120.406 3.484 . . . . 25.0 120.406 -178.109 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -71.78 32.9 0.05 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.632 1.173 . . . . 25.0 113.538 179.119 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.3 t -90.15 -30.06 17.88 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 122.692 0.397 . . . . 25.0 110.861 -179.029 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.17 -47.2 10.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.842 0.829 . . . . 25.0 111.504 -178.619 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 C--O 1.218 -0.573 0 CA-C-O 123.836 1.779 . . . . 25.0 110.234 179.748 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.632 0 CA-C-O 123.66 1.7 . . . . 25.0 114.152 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.0 m 57.91 31.17 20.2 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 113.159 -1.521 . . . . 25.0 111.611 -179.261 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 48.2 ttm -82.31 54.96 2.72 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.797 -0.638 . . . . 25.0 109.379 178.563 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? 60.46 18.64 8.4 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.524 1.129 . . . . 25.0 112.156 -175.851 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -97.37 161.29 13.86 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.231 0.538 . . . . 25.0 110.539 177.751 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.21 -40.59 86.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.896 -1.047 . . . . 25.0 109.139 176.797 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.0 m120 54.99 30.47 14.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.138 0.975 . . . . 25.0 111.906 -178.136 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.7 m -89.22 164.77 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 106.362 -1.718 . . . . 25.0 106.362 175.862 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.37 173.49 6.42 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.68 -1.23 . . . . 25.0 107.68 -178.893 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.9 157.76 43.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.661 0.267 . . . . 25.0 110.42 174.865 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -122.71 130.74 53.29 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.648 -0.705 . . . . 25.0 109.781 175.962 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.54 129.64 38.76 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.01 -0.541 . . . . 25.0 109.549 175.71 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.0 mt -94.42 -21.76 18.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.914 0.388 . . . . 25.0 110.859 -178.006 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -143.95 169.41 17.87 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.993 -2.225 . . . . 25.0 104.993 177.856 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -84.03 167.74 16.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.131 0.491 . . . . 25.0 110.407 177.332 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -148.53 130.9 15.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.934 -0.575 . . . . 25.0 110.341 179.257 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.0 t -102.93 123.46 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 105.078 -2.193 . . . . 25.0 105.078 176.16 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.91 135.74 51.5 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.522 -1.217 . . . . 25.0 110.072 179.558 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -113.98 0.46 14.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.337 0.589 . . . . 25.0 110.284 -179.551 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.0 m -145.6 155.34 52.97 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 107.966 -1.124 . . . . 25.0 107.966 -177.421 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.34 -17.71 39.35 Favored 'Trans proline' 0 C--N 1.347 0.468 0 N-CA-C 113.805 0.656 . . . . 25.0 113.805 -177.415 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.91 -16.99 39.26 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.234 0.54 . . . . 25.0 110.22 179.003 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -87.45 136.03 33.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.98 0.895 . . . . 25.0 111.754 -175.605 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.426 ' HB2' HG13 ' A' ' 57' ' ' VAL . 47.3 mt -86.19 130.79 34.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.746 -0.661 . . . . 25.0 109.4 178.96 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.8 t -91.46 137.15 32.59 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.458 -2.053 . . . . 25.0 105.458 175.025 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -156.46 164.79 37.83 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.924 -0.399 . . . . 25.0 109.924 -177.86 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.49 162.53 15.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.514 0.673 . . . . 25.0 110.465 -177.496 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -57.32 128.39 36.76 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.163 -0.926 . . . . 25.0 109.131 176.165 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.57 -15.67 61.67 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 118.752 -1.027 . . . . 25.0 114.728 178.197 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -59.08 146.19 39.46 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.993 0.897 . . . . 25.0 111.139 -178.845 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.0 mm -110.57 134.17 53.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.448 -1.251 . . . . 25.0 108.627 178.72 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.9 ptp -141.58 157.69 44.78 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.439 0.296 . . . . 25.0 110.334 -177.961 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.5 m -92.27 130.88 37.86 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.531 -0.914 . . . . 25.0 108.531 177.232 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.95 129.6 45.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.322 -0.992 . . . . 25.0 108.322 177.527 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.702 HD12 HD22 ' A' ' 47' ' ' LEU . 76.2 mt -94.43 -52.47 4.32 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.827 -0.805 . . . . 25.0 108.827 -179.671 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -149.99 163.91 36.86 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.902 -1.147 . . . . 25.0 107.902 177.822 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.434 ' HE ' ' HB3' ' A' ' 37' ' ' ARG . 8.6 mtp180 -106.81 157.44 17.75 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 109.672 -0.492 . . . . 25.0 109.672 176.474 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 56.02 39.58 30.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 123.526 1.632 . . . . 25.0 108.859 170.319 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.9 t -64.42 152.29 41.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 112.474 -2.148 . . . . 25.0 110.677 -176.502 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 59.78 11.65 2.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.207 1.003 . . . . 25.0 113.104 -179.595 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.75 20.29 79.56 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.686 -0.965 . . . . 25.0 110.686 -177.402 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.2 mt -94.69 118.89 32.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.293 -1.003 . . . . 25.0 108.293 177.953 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -64.72 128.31 35.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.923 -0.581 . . . . 25.0 110.396 -177.882 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.74 -0.75 70.01 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 115.932 1.133 . . . . 25.0 115.932 176.274 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -99.61 129.98 45.8 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 119.181 1.491 . . . . 25.0 109.59 177.93 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -113.88 141.32 47.49 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.916 -0.772 . . . . 25.0 108.916 -176.149 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.702 HD22 HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -81.68 120.31 24.95 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.14 -1.8 . . . . 25.0 106.14 179.473 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 88.8 m -133.77 167.78 19.91 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.005 0.431 . . . . 25.0 111.578 -179.992 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.4 t -120.33 116.54 25.73 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.463 -1.31 . . . . 25.0 107.463 173.826 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -146.03 144.85 30.33 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.441 -1.318 . . . . 25.0 107.441 -175.902 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.55 27.24 15.39 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.378 0.671 . . . . 25.0 112.334 -179.555 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.95 4.84 90.44 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 114.657 0.623 . . . . 25.0 114.657 177.705 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.1 ptt85 -132.82 161.04 35.18 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.067 0.934 . . . . 25.0 109.775 179.379 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -102.6 154.24 19.32 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.282 -0.636 . . . . 25.0 109.282 177.02 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.24 -158.02 22.46 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 106.54 -2.624 . . . . 25.0 106.54 178.297 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.8 pt -118.39 151.64 20.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.542 0.687 . . . . 25.0 110.877 -175.297 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' A' ' 24' ' ' LEU . 2.4 m -140.8 146.96 46.46 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 114.931 -1.032 . . . . 25.0 108.85 -179.113 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.91 122.59 5.89 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 118.31 -0.66 . . . . 25.0 112.284 179.235 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.21 -14.87 64.64 Favored Glycine 0 C--O 1.223 -0.581 0 CA-C-N 116.11 -0.495 . . . . 25.0 112.821 -179.703 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.73 -28.26 63.72 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 122.957 0.503 . . . . 25.0 112.346 179.693 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.57 25.42 9.77 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.556 0.217 . . . . 25.0 111.51 178.869 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.4 tp -128.57 144.13 51.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.636 0.731 . . . . 25.0 111.611 -174.626 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -119.59 119.98 35.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.332 -0.849 . . . . 25.0 110.935 -177.921 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.0 mm -68.96 134.93 29.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.212 -0.662 . . . . 25.0 109.212 177.509 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.5 mt -117.91 105.17 11.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.675 -1.602 . . . . 25.0 106.675 176.215 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.8 m -68.83 159.57 5.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.965 0.412 . . . . 25.0 110.001 -178.833 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -164.61 175.37 40.61 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 108.569 -1.812 . . . . 25.0 108.569 -179.845 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 97.2 mtp -80.73 150.94 29.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.27 0.535 . . . . 25.0 110.555 -179.429 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -82.87 17.07 2.0 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.302 0.641 . . . . 25.0 111.188 176.902 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -65.69 131.26 45.9 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.983 -1.118 . . . . 25.0 107.983 179.051 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -86.23 70.43 10.54 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.429 0.529 . . . . 25.0 112.429 -170.167 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -113.9 89.82 17.43 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.006 -0.543 . . . . 25.0 110.196 177.762 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -79.28 42.76 1.35 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.724 2.283 . . . . 25.0 114.707 -175.574 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.69 -39.11 90.92 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.127 0.489 . . . . 25.0 110.973 -179.294 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.25 173.72 46.52 Favored Glycine 0 CA--C 1.518 0.271 0 CA-C-N 115.95 -0.568 . . . . 25.0 112.472 -179.386 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.4 m -158.58 156.23 29.75 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.264 -1.384 . . . . 25.0 107.264 179.447 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 146.23 -174.56 26.09 Favored Glycine 0 C--O 1.224 -0.531 0 N-CA-C 109.95 -1.26 . . . . 25.0 109.95 178.81 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.18 12.87 84.21 Favored Glycine 0 C--O 1.224 -0.49 0 N-CA-C 114.658 0.623 . . . . 25.0 114.658 177.316 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.0 t -149.31 155.99 41.39 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.626 -0.879 . . . . 25.0 108.626 -179.319 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.08 143.59 8.43 Favored Glycine 0 C--O 1.227 -0.292 0 N-CA-C 110.791 -0.924 . . . . 25.0 110.791 -178.373 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.3 m -163.05 -179.53 6.78 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 105.756 -1.942 . . . . 25.0 105.756 -177.556 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.28 15.19 39.13 Favored Glycine 0 C--O 1.226 -0.374 0 N-CA-C 115.263 0.865 . . . . 25.0 115.263 174.802 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.8 m -73.26 116.73 14.15 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 176.131 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -148.59 146.28 28.18 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.608 -1.627 . . . . 25.0 106.608 -179.551 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 69.4 tttt 64.65 132.36 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.596 1.558 . . . . 25.0 114.867 -179.547 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -73.19 -7.13 50.09 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.492 -0.776 . . . . 25.0 112.424 179.645 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 t0 59.56 -150.7 0.43 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.973 -0.751 . . . . 25.0 108.973 -179.398 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.3 m -118.9 84.97 27.35 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 108.022 -1.103 . . . . 25.0 108.022 175.693 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.39 147.73 20.46 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 N-CA-C 115.532 1.32 . . . . 25.0 115.532 -172.061 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.87 167.65 25.79 Favored 'Trans proline' 0 C--O 1.241 0.668 0 C-N-CA 119.807 0.338 . . . . 25.0 112.185 176.036 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.03 172.2 15.18 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 118.36 -0.627 . . . . 25.0 112.156 176.21 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -107.83 147.4 35.36 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 107.423 -1.325 . . . . 25.0 107.423 174.958 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.47 162.01 42.61 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 118.339 -0.64 . . . . 25.0 111.791 178.023 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -63.12 153.79 71.62 Favored 'Trans proline' 0 C--N 1.35 0.625 0 N-CA-C 114.323 0.855 . . . . 25.0 114.323 -178.861 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -102.7 4.81 38.52 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 120.67 0.271 . . . . 25.0 111.604 177.161 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 44.5 p -135.32 153.77 51.75 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.166 -0.679 . . . . 25.0 109.166 -178.857 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -122.48 79.81 1.66 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 109.324 -0.621 . . . . 25.0 109.324 -177.518 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.9 t -57.35 -37.76 73.09 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.915 1.08 . . . . 25.0 113.915 -176.325 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.9 t 56.51 28.86 14.45 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.942 0.877 . . . . 25.0 112.853 -179.257 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.1 tp . . . . . 0 C--O 1.214 -0.773 0 CA-C-O 124.604 2.145 . . . . 25.0 110.856 178.66 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.647 0 CA-C-O 122.157 0.865 . . . . 25.0 115.151 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.49 31.01 20.52 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.165 0.986 . . . . 25.0 112.878 178.834 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -118.06 97.89 6.04 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.861 -0.792 . . . . 25.0 108.861 178.433 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -145.72 140.08 26.97 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 105.842 -1.91 . . . . 25.0 105.842 -179.819 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 61.63 167.81 0.1 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.898 1.279 . . . . 25.0 112.632 -173.621 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.2 mt -70.58 -33.25 70.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.483 -0.78 . . . . 25.0 111.724 -176.292 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.8 m120 60.33 17.85 7.47 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.322 1.049 . . . . 25.0 113.257 -178.752 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.2 m -91.26 162.78 2.38 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 N-CA-C 108.845 -0.798 . . . . 25.0 108.845 -179.649 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.79 172.66 6.81 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.713 -1.217 . . . . 25.0 107.713 -178.633 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.52 161.19 42.62 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.197 -0.668 . . . . 25.0 109.197 173.264 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -125.87 131.72 52.31 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 123.808 0.693 . . . . 25.0 110.722 179.22 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.73 122.01 18.33 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 124.015 0.822 . . . . 25.0 110.215 177.513 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.2 mt -89.47 -24.07 21.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.234 0.54 . . . . 25.0 109.855 -178.115 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -138.58 174.27 10.72 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 103.101 -2.925 . . . . 25.0 103.101 175.876 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -85.38 -179.87 7.03 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.635 -0.876 . . . . 25.0 108.635 175.417 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -155.33 147.54 23.72 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 122.865 0.466 . . . . 25.0 109.804 174.127 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.5 t -116.27 123.57 71.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.677 -1.601 . . . . 25.0 106.677 175.992 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.78 145.22 25.73 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.497 -0.774 . . . . 25.0 109.501 177.773 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.15 -7.67 6.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.924 -0.58 . . . . 25.0 111.02 178.322 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 m -119.76 154.65 55.07 Favored Pre-proline 0 C--O 1.22 -0.448 0 N-CA-C 108.406 -0.961 . . . . 25.0 108.406 178.931 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.11 -24.95 38.03 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 117.563 -1.158 . . . . 25.0 114.323 -178.444 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.06 -16.84 57.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.31 0.576 . . . . 25.0 110.459 179.223 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -91.72 135.73 33.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.358 0.599 . . . . 25.0 110.602 -173.861 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.411 ' HB2' HG13 ' A' ' 57' ' ' VAL . 73.9 mt -95.37 128.33 42.13 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.958 0.885 . . . . 25.0 111.109 -179.112 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 t -90.44 143.61 26.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.141 -1.8 . . . . 25.0 106.141 176.841 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -158.03 168.24 27.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.104 0.478 . . . . 25.0 110.871 -179.446 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -114.18 159.5 20.03 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.168 -0.679 . . . . 25.0 109.168 178.041 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -57.83 132.05 52.17 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.339 -1.356 . . . . 25.0 107.339 176.348 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.71 -20.58 47.5 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-O 119.521 -0.599 . . . . 25.0 113.606 179.034 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -59.46 145.81 42.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.73 0.776 . . . . 25.0 110.84 178.885 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.3 mm -115.11 128.79 72.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.517 -1.219 . . . . 25.0 108.524 179.868 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -131.2 152.78 50.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.458 -0.201 . . . . 25.0 110.458 179.209 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.7 m -87.43 126.97 35.21 Favored 'General case' 0 C--O 1.218 -0.603 0 N-CA-C 107.823 -1.177 . . . . 25.0 107.823 177.537 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.74 128.58 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 CA-C-O 121.968 0.89 . . . . 25.0 108.807 179.362 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.646 HD12 HD22 ' A' ' 47' ' ' LEU . 81.7 mt -97.36 -46.09 6.22 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.005 -0.998 . . . . 25.0 108.779 179.631 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.07 158.58 44.14 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.956 -0.757 . . . . 25.0 108.956 -175.844 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -118.29 148.51 42.38 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 106.743 -1.576 . . . . 25.0 106.743 174.924 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 57.17 43.32 24.15 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 123.319 1.533 . . . . 25.0 109.832 -177.912 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -72.04 160.91 31.68 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 113.491 -1.686 . . . . 25.0 112.204 -176.134 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 59.68 9.83 1.76 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.177 0.991 . . . . 25.0 113.234 178.264 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.88 14.81 76.73 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.657 -0.977 . . . . 25.0 110.657 -176.185 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.0 mt -99.58 123.14 43.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.538 0.685 . . . . 25.0 110.565 -179.112 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -70.11 125.38 26.61 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.96 -1.018 . . . . 25.0 110.486 179.18 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.94 -1.41 88.6 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 115.43 0.932 . . . . 25.0 115.43 176.208 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -100.98 131.37 46.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 118.159 0.98 . . . . 25.0 109.796 178.45 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -110.73 142.45 42.65 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.179 -0.675 . . . . 25.0 109.179 -177.176 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.646 HD22 HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -84.52 121.11 27.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 105.176 -2.157 . . . . 25.0 105.176 178.157 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.1 m -134.37 165.96 23.93 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.963 0.411 . . . . 25.0 111.171 179.087 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 t -121.48 123.08 41.17 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.011 -1.477 . . . . 25.0 107.011 173.165 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.9 tp -135.25 122.0 20.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.873 -0.788 . . . . 25.0 108.873 -177.728 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.2 m170 54.01 33.91 18.58 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.522 0.729 . . . . 25.0 111.548 179.799 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.74 -6.53 83.55 Favored Glycine 0 C--O 1.227 -0.314 0 N-CA-C 115.252 0.861 . . . . 25.0 115.252 177.44 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -101.98 137.22 40.55 Favored 'General case' 0 C--O 1.219 -0.553 0 CA-C-N 118.449 1.124 . . . . 25.0 108.403 176.147 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -99.9 145.02 28.27 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.406 -1.702 . . . . 25.0 106.406 173.93 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.73 -161.48 27.37 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 108.368 -1.893 . . . . 25.0 108.368 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.1 pt -115.41 149.89 17.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.603 0.716 . . . . 25.0 110.759 -175.847 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' A' ' 24' ' ' LEU . 1.8 m -139.32 146.63 49.51 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 114.871 -1.059 . . . . 25.0 108.824 -179.092 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.82 119.79 6.06 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 CA-C-O 121.487 0.536 . . . . 25.0 111.626 177.933 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.02 -15.3 74.14 Favored Glycine 0 C--O 1.226 -0.372 0 CA-C-O 121.649 0.583 . . . . 25.0 113.048 -178.466 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -67.46 -6.89 21.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.299 0.64 . . . . 25.0 112.672 -178.849 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -135.48 28.32 3.35 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.711 -0.478 . . . . 25.0 109.711 176.108 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.3 mt -125.32 156.25 38.96 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.352 0.871 . . . . 25.0 113.352 177.839 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -128.09 120.18 26.88 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.969 -1.014 . . . . 25.0 110.075 174.435 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.7 mm -66.95 137.25 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.581 -0.896 . . . . 25.0 108.581 176.62 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.4 mt -117.57 107.51 14.34 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.817 -1.179 . . . . 25.0 107.817 176.491 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.0 m -94.17 157.16 3.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.636 -0.505 . . . . 25.0 109.636 178.94 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.81 144.41 6.02 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.089 -1.605 . . . . 25.0 109.089 178.282 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -142.44 -7.47 0.89 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.122 1.156 . . . . 25.0 114.122 -177.906 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -69.33 -50.16 49.05 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 114.019 1.118 . . . . 25.0 114.019 -172.952 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -81.86 -24.65 35.64 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.238 -0.653 . . . . 25.0 109.238 177.136 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.6 tttm 61.25 -160.21 0.31 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.019 -0.991 . . . . 25.0 108.821 -178.894 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt 66.85 160.65 0.14 Allowed Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 124.387 1.075 . . . . 25.0 111.51 -179.923 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -79.15 4.69 6.34 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 117.39 -1.273 . . . . 25.0 114.019 178.182 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.27 162.1 28.74 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.889 -0.782 . . . . 25.0 108.889 179.737 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.13 -94.71 0.1 OUTLIER Glycine 0 C--O 1.223 -0.573 0 N-CA-C 110.816 -0.913 . . . . 25.0 110.816 178.136 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.6 m 52.59 39.73 28.68 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 113.405 0.891 . . . . 25.0 113.405 177.769 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.89 5.14 19.36 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 114.82 0.688 . . . . 25.0 114.82 -177.268 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.83 161.53 24.1 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 109.444 -1.462 . . . . 25.0 109.444 177.692 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 28.3 t -145.23 -59.48 0.35 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.349 -0.982 . . . . 25.0 108.349 178.34 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.94 25.59 59.74 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.509 -0.853 . . . . 25.0 112.067 177.748 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.3 t -60.14 146.31 43.72 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.853 -0.795 . . . . 25.0 108.853 178.765 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.96 17.09 36.26 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.436 -0.411 . . . . 25.0 113.707 -177.965 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 98.5 p -138.25 147.0 43.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.514 0.657 . . . . 25.0 110.414 177.774 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -140.97 152.69 45.16 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.26 -1.756 . . . . 25.0 106.26 177.005 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.14 -22.68 7.66 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 113.51 0.93 . . . . 25.0 113.51 -178.518 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 47.19 43.27 14.42 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 122.151 0.977 . . . . 25.0 110.943 -177.68 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -89.99 166.48 13.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.847 -1.07 . . . . 25.0 109.925 -176.778 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.8 m -88.62 109.2 27.69 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 110.39 -0.226 . . . . 25.0 110.39 178.227 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -80.61 157.42 21.77 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 116.854 -1.631 . . . . 25.0 113.287 -178.427 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -71.61 155.37 59.2 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 117.96 -0.893 . . . . 25.0 111.193 176.044 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -59.3 156.26 36.32 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 N-CA-C 115.991 1.496 . . . . 25.0 115.991 -175.808 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -70.21 142.37 89.82 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 107.715 -1.217 . . . . 25.0 107.715 175.378 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.94 158.26 53.04 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 116.584 -1.811 . . . . 25.0 110.775 175.208 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -62.93 143.71 91.8 Favored 'Trans proline' 0 C--N 1.35 0.645 0 N-CA-C 115.059 1.138 . . . . 25.0 115.059 -175.458 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -100.57 -16.68 17.39 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.339 0.59 . . . . 25.0 112.014 177.709 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.9 p -129.45 12.76 5.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.263 0.554 . . . . 25.0 110.187 -177.511 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 54.53 20.66 2.94 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.565 0.95 . . . . 25.0 113.565 -178.238 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.0 m -80.15 47.67 0.92 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.212 0.819 . . . . 25.0 113.212 -178.043 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 64.7 m 56.47 -169.2 0.09 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.963 1.097 . . . . 25.0 113.963 -179.429 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.4 tp . . . . . 0 C--O 1.217 -0.614 0 CA-C-O 124.794 2.235 . . . . 25.0 109.155 179.17 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.879 0 CA-C-O 123.727 1.737 . . . . 25.0 113.014 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t 61.13 32.29 19.63 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 111.976 -2.112 . . . . 25.0 113.185 -178.977 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 62.1 mtt -100.75 -12.29 19.22 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.086 1.143 . . . . 25.0 114.086 -176.092 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -142.92 37.04 1.42 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.092 -0.38 . . . . 25.0 111.228 -175.127 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -128.36 158.69 37.55 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 121.956 -0.465 . . . . 25.0 111.314 -179.088 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.8 mt -71.96 -35.64 69.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.73 -1.123 . . . . 25.0 110.156 -179.988 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.5 m120 53.64 36.93 24.85 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.744 0.817 . . . . 25.0 111.84 -179.1 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.7 m -99.06 163.03 2.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 107.427 -1.323 . . . . 25.0 107.427 176.771 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.08 170.9 8.16 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.193 -1.04 . . . . 25.0 108.193 -178.01 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.48 158.64 44.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.891 0.376 . . . . 25.0 110.939 177.032 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -123.91 129.25 50.67 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.457 -0.792 . . . . 25.0 110.12 177.63 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.46 124.68 26.29 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.005 -0.543 . . . . 25.0 109.911 177.029 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.93 -24.73 19.19 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.278 0.561 . . . . 25.0 109.981 -177.762 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -135.75 166.34 23.5 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 104.673 -2.343 . . . . 25.0 104.673 175.913 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -86.67 -173.77 4.65 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.499 0.72 . . . . 25.0 110.937 177.741 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -161.9 154.03 19.39 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 123.613 0.571 . . . . 25.0 112.385 176.662 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.9 t -122.14 126.78 74.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 104.541 -2.392 . . . . 25.0 104.541 173.022 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.37 137.0 44.44 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 -177.247 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -113.32 6.69 17.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.181 0.991 . . . . 25.0 109.237 179.206 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.0 t -149.68 149.3 27.98 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 106.955 -1.498 . . . . 25.0 106.955 -177.178 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.27 -19.31 38.64 Favored 'Trans proline' 0 N--CA 1.475 0.433 0 C-N-CA 117.622 -1.119 . . . . 25.0 112.568 178.184 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -79.21 -15.76 57.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.888 0.852 . . . . 25.0 110.388 178.985 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -93.12 141.22 28.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.801 0.81 . . . . 25.0 111.491 -176.509 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.6 mt -89.1 129.21 35.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.881 -0.599 . . . . 25.0 111.215 -179.936 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 p -94.5 137.87 33.1 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.481 -1.674 . . . . 25.0 106.481 173.813 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.424 ' HE1' HG12 ' A' ' 57' ' ' VAL . 38.2 p90 -160.86 175.98 11.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.998 -0.742 . . . . 25.0 108.998 -174.634 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.4 167.68 11.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.606 0.717 . . . . 25.0 111.526 177.444 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.48 134.4 56.83 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 107.81 -1.181 . . . . 25.0 107.81 178.39 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.2 -11.32 70.7 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-O 118.98 -0.9 . . . . 25.0 113.782 178.697 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.28 138.57 57.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 118.336 1.068 . . . . 25.0 109.937 176.665 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.3 mm -105.04 129.38 57.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 107.111 -1.44 . . . . 25.0 107.111 177.865 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.0 ptp -137.48 150.1 47.31 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.394 0.277 . . . . 25.0 110.932 -175.706 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.2 m -87.63 122.4 31.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.576 -0.898 . . . . 25.0 108.576 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 63.4 t -89.79 127.59 42.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.404 -0.961 . . . . 25.0 108.404 178.322 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.649 HD12 HD22 ' A' ' 47' ' ' LEU . 84.6 mt -91.46 -52.25 4.88 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.15 -0.932 . . . . 25.0 108.551 179.453 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -151.61 168.69 24.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.487 -0.56 . . . . 25.0 109.487 177.502 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -117.33 154.41 31.31 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.68 -1.6 . . . . 25.0 106.68 179.423 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 56.37 42.73 27.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 123.429 1.585 . . . . 25.0 108.662 -177.559 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -67.98 154.18 42.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.573 -1.649 . . . . 25.0 109.319 -176.701 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 59.09 9.39 1.27 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.544 1.138 . . . . 25.0 113.148 177.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.82 13.89 74.1 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 110.804 -0.918 . . . . 25.0 110.804 -179.366 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.3 mt -90.32 134.44 34.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.273 -0.64 . . . . 25.0 109.273 179.721 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -72.44 126.4 29.76 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.268 0.556 . . . . 25.0 110.47 178.534 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.66 2.41 69.53 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 117.576 1.791 . . . . 25.0 117.576 174.914 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -100.63 134.13 44.06 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.128 1.464 . . . . 25.0 110.906 177.916 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -113.1 142.88 45.24 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.798 -0.815 . . . . 25.0 108.798 -174.872 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -86.75 123.84 32.34 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 106.599 -1.63 . . . . 25.0 106.599 179.106 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 97.8 m -132.71 160.83 35.64 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.245 0.545 . . . . 25.0 112.204 179.528 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.2 t -113.14 125.93 54.89 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 107.129 -1.434 . . . . 25.0 107.129 172.281 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 tp -147.19 135.94 22.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.437 -1.32 . . . . 25.0 107.437 -175.715 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 55.34 27.15 9.52 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.589 0.755 . . . . 25.0 112.073 -175.592 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.52 0.73 84.93 Favored Glycine 0 C--O 1.217 -0.964 0 N-CA-C 115.201 0.84 . . . . 25.0 115.201 -179.515 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -115.22 161.99 17.69 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.435 -1.321 . . . . 25.0 107.435 178.628 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -114.21 153.41 29.67 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.332 -0.618 . . . . 25.0 109.332 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.23 -163.86 30.88 Favored Glycine 0 CA--C 1.503 -0.683 0 N-CA-C 106.137 -2.785 . . . . 25.0 106.137 178.29 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 pt -115.9 155.95 17.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 120.808 0.337 . . . . 25.0 111.416 -175.299 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.424 HG12 ' HE1' ' A' ' 26' ' ' PHE . 2.9 m -144.18 147.64 38.26 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.403 -0.817 . . . . 25.0 109.479 179.525 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -74.87 126.02 9.77 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 CA-C-N 118.165 0.38 . . . . 25.0 112.373 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.8 -21.41 79.74 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 115.625 1.01 . . . . 25.0 115.625 -174.72 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -56.14 -28.2 57.05 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.529 0.937 . . . . 25.0 113.529 -176.59 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.12 20.02 12.77 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.936 -0.478 . . . . 25.0 111.721 -178.292 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.7 tp -119.52 146.51 45.39 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.612 -0.885 . . . . 25.0 108.612 -178.672 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -117.56 124.12 47.9 Favored 'General case' 0 C--O 1.208 -1.082 0 CA-C-N 116.085 -0.507 . . . . 25.0 110.757 -178.16 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.1 mm -76.66 136.63 24.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 109.298 -0.63 . . . . 25.0 109.298 177.471 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.0 mt -119.33 101.5 8.02 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.149 -1.797 . . . . 25.0 106.149 176.714 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.7 m -78.57 155.92 4.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.996 -0.742 . . . . 25.0 108.996 -177.017 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.47 -164.1 35.45 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 108.4 -1.88 . . . . 25.0 108.4 -177.728 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 25.1 ptm -121.76 175.57 6.19 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.981 -1.489 . . . . 25.0 106.981 177.319 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -68.11 160.87 28.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.545 0.688 . . . . 25.0 112.211 -179.091 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -137.56 159.74 41.12 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 104.281 -2.489 . . . . 25.0 104.281 174.269 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -114.74 -4.12 12.75 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 122.269 0.228 . . . . 25.0 111.169 178.615 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -90.13 149.31 41.23 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 110.478 -0.193 . . . . 25.0 110.478 179.772 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -72.62 157.72 51.96 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 117.451 -1.233 . . . . 25.0 111.669 177.746 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.18 -32.85 73.39 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.907 0.384 . . . . 25.0 111.681 179.872 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 136.21 -173.89 21.73 Favored Glycine 0 C--O 1.227 -0.309 0 N-CA-C 108.358 -1.897 . . . . 25.0 108.358 -177.911 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.7 m -76.52 -28.64 56.46 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.435 0.531 . . . . 25.0 112.435 -178.754 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.61 -148.94 44.34 Favored Glycine 0 C--O 1.231 -0.081 0 N-CA-C 111.871 -0.491 . . . . 25.0 111.871 -178.819 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -178.16 176.06 47.81 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 105.993 -2.843 . . . . 25.0 105.993 -178.167 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.6 t -154.5 161.73 41.51 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 108.199 -1.037 . . . . 25.0 108.199 -178.739 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.96 170.5 42.88 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 108.82 -1.712 . . . . 25.0 108.82 179.148 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.7 m -150.8 159.06 44.79 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 108.328 -0.99 . . . . 25.0 108.328 179.306 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.08 170.05 42.26 Favored Glycine 0 C--N 1.323 -0.171 0 N-CA-C 108.002 -2.039 . . . . 25.0 108.002 175.849 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.42 87.25 7.37 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.311 -0.626 . . . . 25.0 109.311 179.009 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.05 142.7 58.28 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.166 -0.47 . . . . 25.0 110.101 -179.809 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -138.54 17.84 2.72 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.734 0.778 . . . . 25.0 112.078 -178.919 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -73.21 170.46 14.94 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.489 -0.93 . . . . 25.0 108.489 173.412 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -65.13 157.3 29.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.972 -0.558 . . . . 25.0 111.776 -179.698 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -58.43 148.63 63.94 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.436 -0.802 . . . . 25.0 109.935 -179.598 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.03 158.83 52.29 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 117.069 -1.488 . . . . 25.0 112.043 177.76 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.04 152.17 80.91 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 117.099 -1.468 . . . . 25.0 112.998 -178.242 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -58.42 148.81 78.3 Favored 'Trans proline' 0 C--N 1.35 0.65 0 N-CA-C 115.581 1.339 . . . . 25.0 115.581 -174.652 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -75.45 143.29 75.79 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 106.845 -1.539 . . . . 25.0 106.845 177.921 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -68.84 156.64 64.77 Favored 'Trans proline' 0 C--O 1.242 0.675 0 C-N-CA 116.268 -2.021 . . . . 25.0 111.17 176.266 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -59.55 147.36 91.98 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 117.776 -1.016 . . . . 25.0 110.494 175.647 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.0 mtt-85 -81.47 -66.18 0.92 Allowed 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 109.057 -0.72 . . . . 25.0 109.057 -177.96 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.65 -46.93 0.09 Allowed 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 121.341 0.591 . . . . 25.0 111.996 -179.68 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.49 150.62 50.76 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 121.815 -0.553 . . . . 25.0 109.949 -179.331 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.0 p -121.92 -80.88 0.63 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.372 0.42 . . . . 25.0 111.016 176.084 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.7 t 69.6 -158.43 0.16 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.118 1.367 . . . . 25.0 108.36 -175.932 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 77.2 mt . . . . . 0 C--O 1.207 -1.152 0 CA-C-O 125.514 2.578 . . . . 25.0 111.795 -177.311 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.452 0 CA-C-O 121.611 0.562 . . . . 25.0 113.662 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.77 -8.71 22.78 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.898 1.444 . . . . 25.0 114.898 -177.336 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.8 ptp -130.44 18.99 5.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.468 0.651 . . . . 25.0 109.606 178.433 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -83.66 116.14 22.5 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 108.552 -0.907 . . . . 25.0 108.552 -179.215 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 65.97 164.41 0.18 Allowed 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 115.74 1.755 . . . . 25.0 115.74 177.215 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.8 mt -79.23 -31.31 43.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.503 -1.226 . . . . 25.0 110.267 -177.941 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.4 m120 54.34 25.09 5.62 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.286 1.034 . . . . 25.0 113.028 -177.011 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.6 m -88.51 162.46 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.257 -1.386 . . . . 25.0 107.257 178.102 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.87 173.94 6.17 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.416 -1.698 . . . . 25.0 106.416 -179.393 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.73 158.18 43.03 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.483 -0.191 . . . . 25.0 110.483 174.599 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -121.5 129.4 52.9 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.377 0.671 . . . . 25.0 110.592 176.892 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.32 132.39 45.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.109 -0.496 . . . . 25.0 110.12 176.807 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -98.31 -22.44 16.11 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.318 0.488 . . . . 25.0 112.318 -176.609 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -142.0 162.82 34.51 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.151 -0.685 . . . . 25.0 109.151 -179.801 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -69.37 158.81 34.35 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.698 -0.482 . . . . 25.0 109.698 177.704 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.35 161.53 38.75 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.651 -1.24 . . . . 25.0 107.651 177.168 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 p -136.25 139.26 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 102.071 -3.307 . . . . 25.0 102.071 171.243 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.34 124.4 34.39 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.577 -0.527 . . . . 25.0 109.577 -175.771 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -110.23 15.7 22.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.968 0.89 . . . . 25.0 110.312 -176.746 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.9 t -152.69 148.66 20.91 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 107.037 -1.468 . . . . 25.0 107.037 -175.87 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.59 -19.48 36.88 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 117.719 -1.054 . . . . 25.0 113.081 178.925 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -82.61 -19.29 38.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.363 0.602 . . . . 25.0 110.228 178.868 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -83.64 132.73 34.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 122.021 0.915 . . . . 25.0 111.029 -176.175 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.449 ' HB2' HG13 ' A' ' 57' ' ' VAL . 40.8 mt -82.75 138.31 34.09 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.711 -0.848 . . . . 25.0 108.711 178.254 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -90.82 131.38 36.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.542 -1.281 . . . . 25.0 107.542 176.404 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -155.27 165.17 37.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.387 0.613 . . . . 25.0 111.313 -178.225 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -125.68 164.28 20.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.855 -0.611 . . . . 25.0 111.174 -177.797 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -56.27 130.81 46.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.209 0.528 . . . . 25.0 110.191 179.333 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.55 -18.65 56.65 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.813 -0.993 . . . . 25.0 113.967 177.484 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -58.83 146.16 38.25 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 117.85 0.825 . . . . 25.0 110.995 179.801 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.4 mm -113.34 133.19 60.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.567 -1.197 . . . . 25.0 108.35 178.682 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.6 ptp -141.92 155.7 45.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.614 -0.513 . . . . 25.0 109.614 -177.96 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.6 m -89.2 128.43 35.81 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 108.69 -0.855 . . . . 25.0 108.69 178.004 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.0 t -93.15 126.54 45.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.929 -1.138 . . . . 25.0 107.929 177.183 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.67 HD12 HD22 ' A' ' 47' ' ' LEU . 72.9 mt -90.94 -51.88 5.13 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.503 -0.925 . . . . 25.0 108.503 179.57 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -149.55 161.04 42.92 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.71 -0.848 . . . . 25.0 108.71 177.985 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -102.86 156.58 17.56 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.729 -0.841 . . . . 25.0 108.729 176.221 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 55.28 41.22 31.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.41 1.576 . . . . 25.0 108.507 172.061 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.405 HG21 HG22 ' A' ' 56' ' ' ILE . 11.4 t -63.66 147.69 50.92 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 112.625 -2.079 . . . . 25.0 110.859 -175.522 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 59.96 9.97 1.98 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.664 0.786 . . . . 25.0 111.993 -176.575 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.74 9.46 86.33 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 111.122 -0.791 . . . . 25.0 111.122 -177.226 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.6 114.22 21.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.296 -1.002 . . . . 25.0 108.296 -179.759 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.21 129.2 39.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.196 0.522 . . . . 25.0 109.891 -176.567 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.08 -1.4 75.12 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-O 118.613 -1.104 . . . . 25.0 115.433 176.694 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -100.92 130.11 46.87 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 119.409 1.604 . . . . 25.0 109.044 177.095 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -113.4 139.94 48.48 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.299 -1.0 . . . . 25.0 108.299 -176.438 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.67 HD22 HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -82.02 122.71 28.15 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 105.467 -2.049 . . . . 25.0 105.467 179.255 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.6 m -130.5 163.51 26.85 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.031 0.443 . . . . 25.0 110.98 178.565 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.6 t -116.21 122.03 43.8 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.976 -1.861 . . . . 25.0 105.976 172.524 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.7 tp -147.14 139.77 24.88 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.521 -1.289 . . . . 25.0 107.521 -176.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 57.87 27.2 14.26 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.75 0.648 . . . . 25.0 112.75 177.133 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.8 2.31 90.64 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 114.899 0.72 . . . . 25.0 114.899 178.77 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.4 ptt85 -126.93 160.51 30.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.581 1.19 . . . . 25.0 109.35 177.965 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -109.53 152.68 25.14 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.579 -0.897 . . . . 25.0 108.579 177.627 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.08 -160.59 25.21 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 105.974 -2.851 . . . . 25.0 105.974 179.265 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.405 HG22 HG21 ' A' ' 39' ' ' THR . 33.3 pt -118.36 154.11 20.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.545 0.688 . . . . 25.0 111.253 -175.817 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -141.17 146.96 45.29 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.06 -0.973 . . . . 25.0 109.117 179.444 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.59 120.13 6.04 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 CA-C-O 121.669 0.612 . . . . 25.0 111.326 178.246 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.22 -12.05 75.9 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 116.062 -0.517 . . . . 25.0 113.865 -176.477 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -69.36 -9.21 52.39 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.575 0.583 . . . . 25.0 112.575 -178.64 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -133.11 27.67 4.18 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.829 -0.804 . . . . 25.0 108.829 178.554 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.4 tp -133.16 147.51 52.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.449 -0.796 . . . . 25.0 109.393 -177.855 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -123.12 120.05 32.08 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.556 0.342 . . . . 25.0 110.977 -177.801 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.4 mm -66.91 135.45 28.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.427 -0.583 . . . . 25.0 109.427 177.751 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.0 mt -121.27 95.92 4.88 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.741 -1.207 . . . . 25.0 107.741 175.945 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.4 p -70.08 149.49 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.481 -1.674 . . . . 25.0 106.481 176.699 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.66 -88.37 0.37 Allowed Glycine 0 C--O 1.221 -0.703 0 C-N-CA 120.818 -0.706 . . . . 25.0 113.297 -178.689 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 21.9 ttt 53.72 70.05 0.64 Allowed 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.561 0.696 . . . . 25.0 110.948 -176.956 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 73.73 150.55 0.11 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.712 1.605 . . . . 25.0 111.772 -175.262 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -102.85 -19.06 14.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.147 -0.933 . . . . 25.0 113.047 -175.849 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -73.94 94.94 2.4 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.478 0.918 . . . . 25.0 113.478 -173.143 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -135.43 147.06 60.34 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 107.869 -1.16 . . . . 25.0 107.869 177.645 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -70.75 154.59 63.74 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 116.258 -2.028 . . . . 25.0 111.439 176.65 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.83 165.53 11.0 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.399 -0.593 . . . . 25.0 109.399 179.418 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.76 -167.34 35.19 Favored Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 110.687 -0.965 . . . . 25.0 110.687 -179.658 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.9 t 77.61 171.25 0.21 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.535 1.534 . . . . 25.0 111.602 -179.54 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.21 -164.2 34.6 Favored Glycine 0 C--O 1.225 -0.468 0 N-CA-C 108.795 -1.722 . . . . 25.0 108.795 -175.694 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.07 -41.43 0.29 Allowed Glycine 0 C--O 1.22 -0.767 0 CA-C-N 117.675 0.737 . . . . 25.0 112.666 177.491 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.9 t 54.58 28.34 9.73 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.439 1.274 . . . . 25.0 114.439 177.412 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.08 -168.81 40.35 Favored Glycine 0 CA--C 1.511 -0.189 0 N-CA-C 109.009 -1.636 . . . . 25.0 109.009 -179.121 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.2 m -144.1 140.05 29.23 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.452 -0.944 . . . . 25.0 108.452 177.829 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.28 18.83 32.8 Favored Glycine 0 C--O 1.222 -0.621 0 O-C-N 123.421 0.451 . . . . 25.0 114.108 -177.229 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.2 m 54.73 35.67 24.49 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.031 0.752 . . . . 25.0 113.031 -178.611 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -74.04 85.65 1.81 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.65 0.738 . . . . 25.0 111.738 -179.432 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.01 58.57 1.76 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.344 -0.984 . . . . 25.0 108.344 179.491 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -69.52 141.06 53.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.1 -0.954 . . . . 25.0 109.811 -179.972 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 50.62 -150.75 0.23 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.71 1.004 . . . . 25.0 113.71 177.507 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 77.4 p -132.32 150.05 74.87 Favored Pre-proline 0 C--N 1.327 -0.38 0 O-C-N 121.85 -0.531 . . . . 25.0 110.214 -176.115 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.3 155.43 60.5 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 117.403 -1.265 . . . . 25.0 112.933 179.374 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -63.99 151.38 85.51 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 O-C-N 121.936 0.44 . . . . 25.0 112.748 179.391 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -68.18 151.0 77.3 Favored 'Trans proline' 0 C--N 1.349 0.6 0 N-CA-C 116.212 1.581 . . . . 25.0 116.212 -171.427 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -67.77 144.99 97.84 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 115.606 -0.725 . . . . 25.0 109.35 179.854 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -70.93 162.35 42.96 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 O-C-N 122.084 0.518 . . . . 25.0 111.776 175.35 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -61.12 149.78 87.54 Favored 'Trans proline' 0 C--N 1.349 0.604 0 N-CA-C 114.149 0.788 . . . . 25.0 114.149 -178.157 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -95.79 17.76 14.48 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.799 0.333 . . . . 25.0 110.653 177.658 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.1 p -138.21 164.22 29.76 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.345 -0.983 . . . . 25.0 108.345 -179.16 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -113.01 12.78 19.34 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.158 -0.682 . . . . 25.0 109.158 177.351 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.7 m -118.53 55.48 0.91 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.654 -0.703 . . . . 25.0 112.222 -172.876 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 41.9 t -65.7 -44.94 84.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.582 0.706 . . . . 25.0 110.59 179.978 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.214 -0.814 0 CA-C-O 124.558 2.123 . . . . 25.0 110.842 179.208 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.695 0 CA-C-O 124.722 2.29 . . . . 25.0 111.648 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.0 p -160.52 141.07 11.63 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 112.276 -1.962 . . . . 25.0 107.623 179.215 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.6 ttm -144.93 -41.54 0.24 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.517 0.675 . . . . 25.0 112.338 178.484 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -130.37 79.1 1.88 Allowed 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 116.268 -0.424 . . . . 25.0 111.631 -175.939 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -139.29 168.19 20.38 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.539 -0.301 . . . . 25.0 110.299 -177.689 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.8 mt -66.2 -38.1 87.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.165 0.507 . . . . 25.0 110.831 178.432 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 55.29 26.51 8.66 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.97 -1.014 . . . . 25.0 113.173 -178.576 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.5 m -85.25 171.74 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.848 0 N-CA-C 105.982 -1.859 . . . . 25.0 105.982 175.131 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mp -118.93 169.57 9.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 118.894 0.77 . . . . 25.0 109.624 -178.453 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.96 153.47 40.11 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.745 -0.661 . . . . 25.0 109.801 178.481 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -116.35 130.42 56.76 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.681 -1.145 . . . . 25.0 110.058 178.796 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.55 128.3 36.12 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.853 -0.425 . . . . 25.0 109.853 176.99 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.83 -22.78 17.26 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 121.003 -0.279 . . . . 25.0 111.469 -178.772 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -141.13 166.18 25.48 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.24 -1.763 . . . . 25.0 106.24 178.485 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -74.18 160.17 31.54 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.376 0.423 . . . . 25.0 110.229 178.95 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -144.94 137.08 25.93 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.559 -0.713 . . . . 25.0 112.263 173.732 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.83 123.89 66.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 106.304 -1.739 . . . . 25.0 106.304 176.217 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.68 125.64 27.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.08 -0.964 . . . . 25.0 108.529 177.26 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.13 -1.28 18.89 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.017 0.913 . . . . 25.0 109.34 176.954 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 t -131.85 145.88 59.37 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 105.121 -2.177 . . . . 25.0 105.121 179.589 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -69.37 -14.66 37.68 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 117.346 -1.303 . . . . 25.0 113.105 178.713 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -83.39 -16.81 44.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.48 0.657 . . . . 25.0 110.338 178.622 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -88.02 142.49 27.74 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.279 -0.637 . . . . 25.0 109.279 -178.709 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.4 mt -92.39 129.87 38.21 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.853 0.835 . . . . 25.0 109.597 177.653 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.94 142.64 28.68 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 105.644 -1.984 . . . . 25.0 105.644 175.842 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -161.68 165.94 27.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.256 0.55 . . . . 25.0 111.329 -179.111 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -113.52 159.5 19.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.497 -0.774 . . . . 25.0 109.12 177.546 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.76 133.66 55.57 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.824 -1.176 . . . . 25.0 107.824 177.626 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.18 -22.92 38.5 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-O 119.205 -0.775 . . . . 25.0 114.051 179.6 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -58.6 140.54 54.22 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.529 0.68 . . . . 25.0 109.69 179.731 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.6 mm -108.84 127.3 65.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.734 -1.121 . . . . 25.0 108.059 -178.849 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 12.2 ptp -128.2 150.92 49.8 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.188 -0.671 . . . . 25.0 109.188 -179.986 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.0 m -84.42 127.48 34.03 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 106.883 -1.525 . . . . 25.0 106.883 176.026 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.0 t -94.07 122.63 45.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 179.013 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.586 HD12 HD22 ' A' ' 47' ' ' LEU . 84.3 mt -89.07 -46.94 8.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.603 -0.726 . . . . 25.0 109.127 -177.662 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -155.26 171.55 19.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.51 -0.314 . . . . 25.0 110.218 177.679 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -123.63 155.75 37.13 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.967 -1.864 . . . . 25.0 105.967 179.32 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.3 t0 58.49 41.35 22.79 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.304 1.526 . . . . 25.0 108.126 -175.881 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 t -68.32 142.03 55.64 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.778 -1.193 . . . . 25.0 107.778 -177.625 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 56.54 18.72 3.72 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 113.978 1.103 . . . . 25.0 113.978 -177.526 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.15 20.57 76.6 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.428 -1.069 . . . . 25.0 110.428 -179.656 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.418 ' HB3' ' CD1' ' A' ' 45' ' ' TRP . 65.7 mt -90.53 99.73 12.7 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 107.725 -1.213 . . . . 25.0 107.725 176.551 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -57.65 123.48 15.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.93 -1.032 . . . . 25.0 110.091 -176.099 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.47 -3.03 85.26 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 118.345 -1.253 . . . . 25.0 115.366 178.92 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.418 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 85.1 m95 -100.58 143.63 30.52 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 119.461 1.63 . . . . 25.0 109.569 177.84 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -117.66 140.54 49.52 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.345 -0.983 . . . . 25.0 108.345 -178.896 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.586 HD22 HD12 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -82.71 120.22 25.31 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 103.967 -2.605 . . . . 25.0 103.967 175.84 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 93.8 m -129.72 160.69 32.61 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 110.205 -0.294 . . . . 25.0 110.205 179.158 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.5 t -116.9 121.76 42.39 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.865 -1.161 . . . . 25.0 107.865 173.385 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.5 tp -143.75 141.88 30.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.027 -1.842 . . . . 25.0 106.027 -177.105 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 56.43 27.47 12.18 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.189 0.595 . . . . 25.0 111.388 -176.877 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.39 -0.46 84.7 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-O 119.554 -0.581 . . . . 25.0 114.467 177.682 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -120.93 154.32 36.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.333 1.067 . . . . 25.0 110.06 179.322 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -98.11 157.12 16.33 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.321 -0.992 . . . . 25.0 108.321 178.434 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.61 -168.25 39.7 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 105.515 -3.034 . . . . 25.0 105.515 179.128 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.3 pt -115.89 153.17 17.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 122.339 1.066 . . . . 25.0 110.762 -175.738 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.95 146.07 32.83 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 114.216 -1.356 . . . . 25.0 109.96 -178.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.66 119.12 5.58 Favored 'Trans proline' 0 C--O 1.237 0.431 0 O-C-N 122.051 0.501 . . . . 25.0 113.173 -179.869 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.7 -17.55 69.23 Favored Glycine 0 C--O 1.222 -0.601 0 C-N-CA 120.975 -0.631 . . . . 25.0 113.478 -178.306 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -65.65 -12.22 51.57 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.579 0.585 . . . . 25.0 112.579 -177.868 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -130.56 26.52 5.05 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.587 0.708 . . . . 25.0 110.841 177.018 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -126.14 154.92 42.49 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.406 -0.816 . . . . 25.0 111.871 178.511 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -123.43 122.33 37.98 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.866 -0.606 . . . . 25.0 111.357 177.61 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.0 mm -71.7 137.37 23.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.678 -1.23 . . . . 25.0 107.678 177.779 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.3 mt -118.17 106.48 12.88 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.121 -1.066 . . . . 25.0 108.121 175.925 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.5 m -97.01 13.04 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 121.425 0.631 . . . . 25.0 110.748 179.537 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.85 30.3 57.92 Favored Glycine 0 C--O 1.219 -0.818 0 C-N-CA 120.444 -0.884 . . . . 25.0 112.268 -176.72 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 7.6 tpt -71.84 97.93 1.9 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.907 -0.761 . . . . 25.0 111.301 -179.296 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 67.2 160.25 0.15 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.44 1.496 . . . . 25.0 112.81 -178.2 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -73.61 156.01 38.49 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.845 0.355 . . . . 25.0 110.509 179.421 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -156.07 117.82 3.96 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.958 0.903 . . . . 25.0 108.568 177.602 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -129.39 150.25 75.05 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 108.024 -1.102 . . . . 25.0 108.024 178.971 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -70.06 156.78 61.73 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 117.839 -0.974 . . . . 25.0 111.309 177.994 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -121.04 -10.32 9.06 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.123 1.157 . . . . 25.0 114.123 -177.196 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.06 179.29 48.68 Favored Glycine 0 C--N 1.319 -0.372 0 C-N-CA 120.277 -0.963 . . . . 25.0 112.48 -176.171 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.4 p -71.81 149.94 44.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.921 0.391 . . . . 25.0 111.243 179.733 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 161.49 -166.46 35.96 Favored Glycine 0 CA--C 1.505 -0.571 0 N-CA-C 107.862 -2.095 . . . . 25.0 107.862 -179.177 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 162.25 -52.87 0.31 Allowed Glycine 0 CA--C 1.512 -0.095 0 C-N-CA 120.421 -0.895 . . . . 25.0 112.692 177.279 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.2 t 54.5 38.1 29.08 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.709 0.633 . . . . 25.0 112.709 178.303 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.07 36.18 0.15 Allowed Glycine 0 C--O 1.218 -0.883 0 N-CA-C 115.137 0.815 . . . . 25.0 115.137 -178.315 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.2 m -85.5 1.81 47.34 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.032 0.753 . . . . 25.0 113.032 -177.029 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.77 -172.92 33.72 Favored Glycine 0 CA--C 1.508 -0.387 0 N-CA-C 106.617 -2.593 . . . . 25.0 106.617 179.304 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.4 p -72.86 158.69 35.04 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.552 0.575 . . . . 25.0 112.552 -179.482 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -120.56 179.7 4.25 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.765 -1.198 . . . . 25.0 107.765 175.649 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.64 141.69 48.09 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.918 0.487 . . . . 25.0 111.158 -178.446 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 61.49 -166.96 0.2 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.303 1.041 . . . . 25.0 110.957 -178.782 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.3 t0 50.6 52.55 14.65 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 122.737 1.256 . . . . 25.0 113.016 -178.361 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -58.57 148.34 66.45 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 114.719 -1.128 . . . . 25.0 112.433 -178.776 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -68.09 157.1 63.26 Favored 'Trans proline' 0 C--O 1.239 0.566 0 N-CA-C 113.989 0.727 . . . . 25.0 113.989 -177.348 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -64.69 153.42 77.67 Favored 'Trans proline' 0 C--N 1.355 0.878 0 O-C-N 121.819 0.378 . . . . 25.0 112.941 -179.031 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -67.78 158.06 58.96 Favored 'Trans proline' 0 C--O 1.241 0.646 0 N-CA-C 115.381 1.262 . . . . 25.0 115.381 -171.691 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -75.02 140.33 73.67 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 107.999 -1.112 . . . . 25.0 107.999 177.264 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.54 167.2 27.7 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 118.055 -0.83 . . . . 25.0 112.061 178.308 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -60.11 156.29 40.5 Favored 'Trans proline' 0 C--N 1.351 0.662 0 N-CA-C 114.82 1.046 . . . . 25.0 114.82 -177.491 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -122.17 47.26 1.94 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.17 -0.468 . . . . 25.0 111.938 -176.874 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 m 66.05 -49.02 0.41 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 115.628 1.714 . . . . 25.0 115.628 178.425 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -54.62 -12.93 0.83 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.672 1.73 . . . . 25.0 115.672 -177.973 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.7 m -80.06 -26.96 39.45 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.844 1.054 . . . . 25.0 113.844 -179.436 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.3 m -165.5 -38.99 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.904 1.076 . . . . 25.0 113.904 -173.025 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.3 tp . . . . . 0 C--O 1.209 -1.064 0 CA-C-O 125.132 2.396 . . . . 25.0 112.135 -172.024 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 CA-C-O 123.149 1.416 . . . . 25.0 114.942 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.44 4.41 3.03 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.685 1.365 . . . . 25.0 114.685 -174.524 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.3 mtt -86.53 0.49 54.19 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.914 -0.491 . . . . 25.0 112.058 -179.185 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -87.33 108.63 19.05 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.061 -0.718 . . . . 25.0 109.061 178.997 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 61.98 166.97 0.11 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.825 1.417 . . . . 25.0 114.825 -179.151 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.4 mt -73.82 -41.68 61.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.339 -0.846 . . . . 25.0 109.881 178.485 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 52.76 33.18 13.52 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.271 1.028 . . . . 25.0 111.587 -177.976 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 m -91.56 162.16 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.75 -1.945 . . . . 25.0 105.75 174.571 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.51 170.99 8.22 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.003 -1.11 . . . . 25.0 108.003 -178.76 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.49 159.15 43.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.16 -0.681 . . . . 25.0 109.16 174.714 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -125.34 129.0 49.07 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.392 -0.822 . . . . 25.0 109.863 176.495 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.08 129.54 39.71 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.217 -0.66 . . . . 25.0 109.217 175.283 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.0 mt -96.01 -20.11 18.95 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.024 0.44 . . . . 25.0 110.489 -178.355 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -146.42 173.32 12.38 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 107.697 -1.223 . . . . 25.0 107.697 -177.664 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -76.04 158.68 31.59 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.992 0.425 . . . . 25.0 111.534 175.246 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -141.71 131.5 24.28 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.386 0.612 . . . . 25.0 112.518 168.642 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.9 t -97.05 122.19 48.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 103.539 -2.763 . . . . 25.0 103.539 173.135 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.42 139.98 36.22 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.837 -1.172 . . . . 25.0 107.837 176.304 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -128.91 -19.65 3.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.902 -0.59 . . . . 25.0 110.839 -179.128 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.44 150.98 39.84 Favored Pre-proline 0 N--CA 1.464 0.252 0 N-CA-C 106.759 -1.571 . . . . 25.0 106.759 171.131 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -68.74 -22.09 37.67 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 117.275 -1.35 . . . . 25.0 112.952 -179.183 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -90.4 -2.23 57.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.771 0.796 . . . . 25.0 110.616 -179.207 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -89.39 139.77 30.18 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.315 0.579 . . . . 25.0 110.471 -175.997 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.3 mt -90.74 128.04 36.53 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.105 0.955 . . . . 25.0 111.727 179.77 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.6 p -87.47 140.41 29.55 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.935 -1.876 . . . . 25.0 105.935 174.309 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.71 167.01 31.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.051 0.453 . . . . 25.0 110.1 178.774 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.32 160.85 19.9 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.639 -0.875 . . . . 25.0 108.639 178.441 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -56.23 134.18 53.01 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 115.221 -0.9 . . . . 25.0 110.096 177.56 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.68 -15.27 63.46 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-O 118.175 -1.347 . . . . 25.0 113.863 177.885 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -60.41 150.53 30.63 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 118.207 1.004 . . . . 25.0 110.826 177.512 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.6 mm -118.29 130.07 73.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.473 -1.239 . . . . 25.0 108.7 179.479 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -136.7 152.77 50.75 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.307 -0.627 . . . . 25.0 109.307 -179.085 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -88.36 128.26 35.5 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.357 -0.608 . . . . 25.0 109.357 177.909 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.4 t -91.91 127.83 43.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.176 -1.046 . . . . 25.0 108.176 179.638 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.62 HD12 HD22 ' A' ' 47' ' ' LEU . 77.3 mt -94.61 -47.84 6.34 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.636 -0.875 . . . . 25.0 108.636 179.889 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -152.05 169.08 23.24 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.517 -0.919 . . . . 25.0 108.517 178.111 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -117.75 153.96 32.53 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 108.029 -1.1 . . . . 25.0 108.029 176.404 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 60.05 40.14 18.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 123.472 1.606 . . . . 25.0 109.855 178.474 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 t -68.26 154.77 41.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.204 -1.816 . . . . 25.0 110.729 -177.122 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 59.46 13.97 3.55 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.486 1.114 . . . . 25.0 110.418 -177.392 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.77 11.41 85.27 Favored Glycine 0 CA--C 1.506 -0.489 0 N-CA-C 111.335 -0.706 . . . . 25.0 111.335 -179.827 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.65 128.83 36.12 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 117.761 0.781 . . . . 25.0 110.067 -177.814 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -70.02 123.24 21.06 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.083 -0.508 . . . . 25.0 110.346 -179.473 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.35 -0.79 88.66 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 116.789 1.475 . . . . 25.0 116.789 175.974 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -100.38 131.73 46.15 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.909 0.855 . . . . 25.0 109.373 176.753 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -114.1 143.2 45.18 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.492 -0.929 . . . . 25.0 108.492 -175.224 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.62 HD22 HD12 ' A' ' 35' ' ' LEU . 0.7 OUTLIER -83.68 122.44 28.62 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.735 -1.58 . . . . 25.0 106.735 177.952 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 94.6 m -133.34 162.28 32.26 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.231 0.538 . . . . 25.0 111.9 178.146 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -113.45 122.4 47.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.856 -1.164 . . . . 25.0 107.856 173.484 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.5 tp -139.77 132.58 29.14 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.882 -1.155 . . . . 25.0 107.882 -178.745 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 54.63 29.11 10.92 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.059 0.544 . . . . 25.0 111.438 -174.719 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.93 -3.79 73.95 Favored Glycine 0 C--O 1.222 -0.603 0 N-CA-C 115.305 0.882 . . . . 25.0 115.305 178.207 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -109.19 157.35 18.88 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.824 -1.547 . . . . 25.0 106.824 178.639 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -115.0 151.81 33.52 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.154 -0.684 . . . . 25.0 109.154 -177.747 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.73 -161.0 26.56 Favored Glycine 0 CA--C 1.504 -0.623 0 N-CA-C 107.051 -2.42 . . . . 25.0 107.051 -179.726 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.0 pt -115.97 150.3 17.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.212 0.53 . . . . 25.0 112.308 -175.083 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.85 144.94 43.61 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.226 -0.897 . . . . 25.0 110.488 -179.716 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.9 121.91 6.07 Favored 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 118.501 -0.533 . . . . 25.0 112.388 -179.769 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.58 -20.33 67.86 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 115.375 0.91 . . . . 25.0 115.375 -177.113 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -23.19 67.3 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.324 0.861 . . . . 25.0 113.324 -176.267 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -120.95 26.64 8.94 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.939 -0.763 . . . . 25.0 108.939 -179.045 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.0 tp -131.51 150.37 52.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.735 -0.666 . . . . 25.0 110.666 -176.985 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -124.74 123.55 40.23 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 122.223 -0.298 . . . . 25.0 111.787 179.186 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.4 mm -70.17 136.37 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 123.839 0.712 . . . . 25.0 110.001 176.6 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.8 mt -118.38 99.19 6.68 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.774 -1.565 . . . . 25.0 106.774 174.855 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.46 131.83 34.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 106.905 -1.517 . . . . 25.0 106.905 179.438 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.18 107.91 2.28 Favored Glycine 0 C--O 1.225 -0.413 0 N-CA-C 109.938 -1.265 . . . . 25.0 109.938 179.088 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 96.6 mmm -137.29 -42.67 0.56 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 113.202 0.816 . . . . 25.0 113.202 -176.133 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -137.48 46.47 2.13 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-O 121.264 0.554 . . . . 25.0 110.552 -173.099 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.0 67.22 2.96 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 122.475 1.131 . . . . 25.0 112.541 -173.416 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -72.79 -2.38 20.3 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.751 -1.113 . . . . 25.0 113.048 177.924 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -149.09 154.88 39.92 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 104.405 -2.443 . . . . 25.0 104.405 176.235 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.3 156.89 54.47 Favored 'Trans proline' 0 C--N 1.349 0.577 0 N-CA-C 114.727 1.01 . . . . 25.0 114.727 -178.153 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.27 162.22 14.51 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 106.213 -1.773 . . . . 25.0 106.213 173.246 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.71 15.95 81.16 Favored Glycine 0 C--O 1.218 -0.906 0 C-N-CA 119.836 -1.173 . . . . 25.0 111.843 -179.681 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.1 t -70.22 -8.08 47.15 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.344 0.868 . . . . 25.0 113.344 -177.449 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.32 173.57 39.06 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 109.205 -1.558 . . . . 25.0 109.205 -179.446 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -179.52 167.63 37.69 Favored Glycine 0 C--O 1.24 0.47 0 N-CA-C 107.131 -2.387 . . . . 25.0 107.131 178.304 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t 54.88 -156.63 0.23 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 117.931 0.865 . . . . 25.0 111.366 -179.504 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.0 158.53 28.37 Favored Glycine 0 C--O 1.228 -0.275 0 CA-C-N 116.549 -0.296 . . . . 25.0 113.338 178.191 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 t 59.23 -175.23 0.1 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.922 1.453 . . . . 25.0 114.922 178.983 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.45 90.17 1.42 Allowed Glycine 0 N--CA 1.459 0.167 0 N-CA-C 109.86 -1.296 . . . . 25.0 109.86 178.802 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.0 t -100.2 -23.79 14.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.368 0.877 . . . . 25.0 113.368 -176.201 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 39.02 -123.82 0.33 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.113 0.965 . . . . 25.0 112.234 -177.344 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -121.97 94.52 4.33 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.043 -1.465 . . . . 25.0 107.043 176.463 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -94.94 167.35 11.46 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.4 0.518 . . . . 25.0 112.4 -174.442 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 t0 64.71 179.84 0.18 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.536 1.68 . . . . 25.0 115.536 170.267 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.3 p -124.32 85.05 55.77 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 108.671 -0.863 . . . . 25.0 108.671 180.0 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.24 153.08 50.96 Favored 'Trans proline' 0 C--O 1.239 0.573 0 N-CA-C 116.711 1.774 . . . . 25.0 116.711 -175.09 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -69.77 164.47 34.42 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 N-CA-C 110.762 -0.514 . . . . 25.0 110.762 171.864 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.15 157.65 52.46 Favored 'Trans proline' 0 C--N 1.349 0.555 0 N-CA-C 114.279 0.838 . . . . 25.0 114.279 -175.801 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -95.23 144.17 27.34 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 106.375 -1.713 . . . . 25.0 106.375 175.487 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.46 161.15 46.43 Favored 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 118.021 -0.853 . . . . 25.0 112.783 179.672 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.65 157.24 48.19 Favored 'Trans proline' 0 C--N 1.352 0.713 0 N-CA-C 113.613 0.582 . . . . 25.0 113.613 -179.696 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -103.58 7.91 37.62 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.331 0.586 . . . . 25.0 110.189 177.728 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.3 p -137.13 142.54 42.25 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.109 -1.441 . . . . 25.0 107.109 178.756 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -150.57 21.42 0.82 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.065 0.46 . . . . 25.0 111.793 -177.825 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.5 p -124.84 171.36 10.22 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.751 -0.833 . . . . 25.0 108.751 -177.063 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 66.6 m 48.95 64.74 1.6 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 122.778 1.275 . . . . 25.0 113.494 178.471 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 123.955 1.836 . . . . 25.0 110.56 177.756 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.208 -1.49 0 N-CA-C 118.487 2.155 . . . . 25.0 118.487 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 t 51.84 52.26 14.89 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.658 1.183 . . . . 25.0 111.989 177.908 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.1 ttt -125.75 70.66 1.21 Allowed 'General case' 0 C--O 1.21 -1.013 0 CA-C-O 122.015 0.912 . . . . 25.0 109.668 -179.748 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -135.97 78.66 1.73 Allowed 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 114.186 -1.37 . . . . 25.0 108.793 179.875 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -116.56 167.09 11.37 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.903 -1.044 . . . . 25.0 109.799 -177.646 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.9 mt -68.24 -37.59 80.95 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.144 -0.935 . . . . 25.0 110.389 -177.963 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.1 m120 54.11 29.11 9.82 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 122.861 1.315 . . . . 25.0 112.031 -179.007 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.9 m -91.99 165.0 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 104.817 -2.29 . . . . 25.0 104.817 172.939 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.67 175.69 5.33 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 119.704 1.138 . . . . 25.0 108.612 -178.414 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.96 154.93 40.09 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.987 -1.006 . . . . 25.0 110.824 174.775 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -113.9 130.17 56.52 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 125.299 1.44 . . . . 25.0 110.506 175.96 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.444 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -70.76 128.57 36.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.959 0.885 . . . . 25.0 110.898 177.662 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -94.79 -18.55 21.12 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.669 -0.696 . . . . 25.0 109.403 -179.117 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -145.73 173.79 11.78 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 124.154 0.909 . . . . 25.0 109.238 179.215 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -85.39 164.25 18.04 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 123.408 0.683 . . . . 25.0 111.896 176.032 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -152.32 144.31 23.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.518 0.599 . . . . 25.0 111.705 176.374 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.8 t -113.73 123.48 69.44 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 N-CA-C 106.678 -1.601 . . . . 25.0 106.678 171.218 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.68 124.29 30.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.703 -1.135 . . . . 25.0 108.25 179.537 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -107.3 -11.04 15.65 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.758 -0.83 . . . . 25.0 108.758 -178.711 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.9 t -110.76 147.26 36.11 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 104.883 -2.265 . . . . 25.0 104.883 176.768 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.69 -18.49 32.58 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 O-C-N 121.946 0.445 . . . . 25.0 112.242 179.086 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -85.63 -12.97 50.07 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.654 -0.703 . . . . 25.0 109.346 179.235 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -87.91 143.3 27.19 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-O 121.32 0.581 . . . . 25.0 111.446 179.664 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.1 mt -98.31 128.62 44.82 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-O 121.884 0.85 . . . . 25.0 112.237 177.834 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.69 134.33 34.36 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 105.718 -1.956 . . . . 25.0 105.718 174.157 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -152.58 168.08 26.75 Favored 'General case' 0 C--O 1.266 1.946 0 CA-C-O 121.71 0.767 . . . . 25.0 110.984 -179.782 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -118.92 159.72 23.28 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.367 1.067 . . . . 25.0 110.241 178.845 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -56.96 132.75 53.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.853 -1.166 . . . . 25.0 107.853 174.757 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.59 -25.15 28.55 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 115.349 -0.841 . . . . 25.0 114.089 -179.479 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -60.09 134.85 57.44 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.358 -0.979 . . . . 25.0 108.358 -175.226 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.5 mm -103.78 127.08 58.19 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 109.22 -0.659 . . . . 25.0 109.22 176.061 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.3 ptp -132.74 156.21 47.47 Favored 'General case' 0 C--O 1.2 -1.511 0 CA-C-N 115.416 -0.811 . . . . 25.0 108.918 -179.181 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.9 m -93.87 119.24 32.54 Favored 'General case' 0 C--O 1.198 -1.635 0 N-CA-C 108.918 -0.771 . . . . 25.0 108.918 -178.444 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.2 t -79.9 121.69 33.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 106.697 -1.594 . . . . 25.0 106.697 177.702 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.3 mt -94.51 -42.14 8.99 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.949 0.881 . . . . 25.0 109.735 179.854 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -146.33 152.19 38.73 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.566 -0.743 . . . . 25.0 109.577 -176.859 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -113.79 150.64 33.16 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 105.945 -1.872 . . . . 25.0 105.945 171.74 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 55.54 43.1 28.96 Favored 'General case' 0 C--O 1.268 2.027 0 O-C-N 125.021 1.45 . . . . 25.0 109.893 -176.876 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.2 t -70.49 151.2 45.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.397 -1.274 . . . . 25.0 111.145 -178.924 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 58.51 18.86 6.04 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.491 1.116 . . . . 25.0 112.069 179.359 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.5 5.15 90.16 Favored Glycine 0 C--O 1.208 -1.529 0 CA-C-N 115.139 -0.937 . . . . 25.0 112.071 178.06 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.9 mt -84.84 136.62 33.58 Favored 'General case' 0 C--O 1.211 -0.93 0 CA-C-N 117.289 0.544 . . . . 25.0 109.623 -174.512 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -80.03 108.35 13.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.902 -1.044 . . . . 25.0 113.351 -179.065 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.79 0.91 74.39 Favored Glycine 0 C--O 1.221 -0.691 0 C-N-CA 119.473 -1.346 . . . . 25.0 116.189 177.924 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -99.58 136.13 39.96 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 117.807 0.804 . . . . 25.0 109.232 173.43 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -113.01 146.19 39.52 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.711 -0.848 . . . . 25.0 108.711 -176.601 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.9 tp -89.9 127.61 36.04 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 106.076 -1.824 . . . . 25.0 106.076 -179.938 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.9 m -137.97 160.46 39.27 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 119.59 1.086 . . . . 25.0 113.778 -179.169 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.3 t -109.22 123.01 48.55 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 106.295 -1.742 . . . . 25.0 106.295 171.569 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.9 tp -137.91 127.52 25.1 Favored 'General case' 0 C--O 1.204 -1.313 0 N-CA-C 107.743 -1.206 . . . . 25.0 107.743 -177.562 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 54.43 35.53 23.39 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.86 0.838 . . . . 25.0 110.691 -176.504 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.21 6.72 88.81 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.512 -0.852 . . . . 25.0 113.858 175.24 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -127.27 148.9 50.21 Favored 'General case' 0 C--O 1.204 -1.304 0 CA-C-N 119.001 1.4 . . . . 25.0 109.121 -176.3 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -102.03 148.35 25.48 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 123.688 0.618 . . . . 25.0 112.077 -178.02 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.67 -179.94 48.8 Favored Glycine 0 C--O 1.25 1.099 0 N-CA-C 106.76 -2.536 . . . . 25.0 106.76 -177.861 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt -103.52 148.56 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.01 0.924 . . . . 25.0 111.753 -174.831 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.87 148.63 43.18 Favored Pre-proline 0 C--O 1.244 0.795 0 CA-C-O 122.68 1.229 . . . . 25.0 110.863 -177.42 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.05 125.21 7.1 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 116.302 -1.999 . . . . 25.0 114.338 -178.353 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.84 -20.77 60.2 Favored Glycine 0 C--O 1.203 -1.829 0 CA-C-N 116.154 -0.476 . . . . 25.0 113.529 179.3 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -68.2 -15.66 63.67 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 121.053 -1.263 . . . . 25.0 112.36 -178.654 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -115.73 15.48 16.44 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.872 -0.517 . . . . 25.0 109.762 -179.148 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 12' ' ' ALA . 29.6 mt -130.03 152.5 49.42 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 117.366 2.358 . . . . 25.0 117.366 -176.757 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt -119.64 126.52 51.34 Favored 'General case' 0 C--O 1.197 -1.7 0 N-CA-C 108.055 -1.091 . . . . 25.0 108.055 175.53 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.5 mm -75.16 137.01 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 O-C-N 124.167 0.917 . . . . 25.0 110.204 177.111 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.3 mt -117.74 105.38 11.93 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.493 1.117 . . . . 25.0 108.528 177.666 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.09 162.41 2.49 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 CA-C-N 114.915 -1.039 . . . . 25.0 110.658 -172.991 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -103.28 38.44 3.23 Favored Glycine 0 C--O 1.207 -1.543 0 N-CA-C 116.813 1.485 . . . . 25.0 116.813 176.953 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.2 ttt -85.53 178.46 7.4 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.841 0.829 . . . . 25.0 109.337 -178.269 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -63.81 124.58 21.87 Favored 'General case' 0 C--O 1.199 -1.564 0 CA-C-N 115.992 -0.549 . . . . 25.0 110.944 -178.651 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -139.42 -54.94 0.57 Allowed 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 114.886 1.439 . . . . 25.0 114.886 175.661 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 57.04 37.4 28.67 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.644 -0.707 . . . . 25.0 111.389 -173.445 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.8 mttt -118.91 107.86 41.58 Favored Pre-proline 0 N--CA 1.485 1.319 0 O-C-N 121.899 -0.5 . . . . 25.0 109.892 -179.934 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.28 174.38 12.9 Favored 'Trans proline' 0 C--N 1.351 0.686 0 N-CA-C 113.913 0.697 . . . . 25.0 113.913 176.794 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.88 -58.12 0.31 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.988 0.515 . . . . 25.0 110.47 179.582 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.94 7.21 86.44 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 115.069 0.788 . . . . 25.0 115.069 178.291 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.3 m -60.41 141.06 56.85 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 109.258 -0.645 . . . . 25.0 109.258 179.713 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -159.48 51.23 0.38 Allowed Glycine 0 CA--C 1.531 1.055 0 CA-C-O 119.456 -0.636 . . . . 25.0 114.459 -179.213 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.99 148.08 16.53 Favored Glycine 0 C--O 1.216 -0.975 0 CA-C-N 119.67 1.735 . . . . 25.0 110.713 -178.338 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 62.6 p -163.29 173.09 13.75 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 123.665 0.786 . . . . 25.0 109.277 -175.949 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.72 -11.71 61.05 Favored Glycine 0 C--O 1.202 -1.85 0 CA-C-O 118.379 -1.234 . . . . 25.0 115.044 171.077 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 95.7 p -81.29 155.78 25.87 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 118.643 1.222 . . . . 25.0 111.075 179.755 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 173.47 134.17 1.79 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.36 -1.096 . . . . 25.0 110.36 173.584 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.0 t -161.0 132.53 5.62 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 104.609 -2.367 . . . . 25.0 104.609 178.303 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 61.64 159.2 0.05 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 125.561 1.788 . . . . 25.0 115.519 -172.414 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.0 tttm 61.16 169.91 0.1 Allowed 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 124.24 1.016 . . . . 25.0 112.616 179.579 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.28 156.92 29.6 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 108.405 -0.961 . . . . 25.0 108.405 -176.141 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -116.83 156.16 27.75 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.217 0.607 . . . . 25.0 109.719 179.167 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.3 p -111.06 93.43 17.73 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 123.717 0.807 . . . . 25.0 111.475 178.51 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.78 156.2 63.89 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 116.663 -1.758 . . . . 25.0 113.912 -175.427 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.85 154.14 63.57 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 116.624 -1.784 . . . . 25.0 112.517 178.011 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.47 157.89 57.65 Favored 'Trans proline' 0 C--N 1.354 0.846 0 N-CA-C 114.251 0.827 . . . . 25.0 114.251 -177.818 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -69.54 138.26 88.63 Favored Pre-proline 0 N--CA 1.479 1.022 0 CA-C-O 119.102 -0.475 . . . . 25.0 110.926 -177.822 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -69.36 166.4 27.23 Favored 'Trans proline' 0 CA--C 1.562 1.883 0 O-C-N 123.159 1.084 . . . . 25.0 111.55 174.496 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.2 150.09 89.58 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 N-CA-C 116.05 1.519 . . . . 25.0 116.05 -174.208 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.9 mtm180 -110.32 10.32 23.55 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.594 -0.276 . . . . 25.0 110.261 -179.598 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.8 p 54.21 -164.83 0.1 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.87 1.804 . . . . 25.0 115.87 -178.978 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 61.3 -164.19 0.24 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.727 1.211 . . . . 25.0 108.758 -176.706 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.5 t 54.16 59.91 3.93 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 115.128 1.529 . . . . 25.0 115.128 178.493 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.5 t 59.09 60.44 2.41 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 123.115 1.436 . . . . 25.0 109.559 -178.041 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.0 tp . . . . . 0 C--N 1.316 -0.871 0 CA-C-N 112.871 -1.968 . . . . 25.0 113.971 -175.187 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.763 0 CA-C-O 124.008 1.893 . . . . 25.0 115.944 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.0 m -142.0 140.3 32.63 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 120.424 -1.633 . . . . 25.0 110.936 177.37 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.15 148.27 31.0 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 103.074 -2.935 . . . . 25.0 103.074 174.581 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.07 111.19 8.99 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 106.338 -1.726 . . . . 25.0 106.338 179.261 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -110.16 171.55 7.39 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 113.713 1.005 . . . . 25.0 113.713 -177.392 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.4 mt -71.99 -41.88 67.14 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.793 -1.094 . . . . 25.0 110.492 175.878 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.8 m120 54.39 33.35 18.4 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 113.606 -1.634 . . . . 25.0 113.814 -178.388 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 m -97.7 166.48 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.156 0 N-CA-C 106.408 -1.701 . . . . 25.0 106.408 178.253 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.3 171.72 7.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.32 -1.487 . . . . 25.0 107.3 -176.272 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.22 157.74 43.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 119.232 0.923 . . . . 25.0 111.774 176.896 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -120.33 127.55 52.44 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.498 -0.774 . . . . 25.0 110.935 179.579 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.93 122.12 18.67 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.635 -1.246 . . . . 25.0 107.635 179.749 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.3 mt -84.89 -27.91 26.32 Favored 'General case' 0 C--O 1.212 -0.876 0 O-C-N 121.879 -0.513 . . . . 25.0 110.776 -178.949 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -138.41 177.07 8.16 Favored 'General case' 0 C--O 1.198 -1.649 0 N-CA-C 108.622 -0.881 . . . . 25.0 108.622 177.216 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.63 170.57 15.9 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.317 0.647 . . . . 25.0 111.806 173.491 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -155.83 141.64 18.03 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 113.981 1.104 . . . . 25.0 113.981 175.02 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.6 131.99 62.6 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 105.774 -1.936 . . . . 25.0 105.774 -179.454 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.96 111.79 15.5 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 124.639 1.212 . . . . 25.0 110.274 -178.996 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -106.53 -1.33 23.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.64 0.733 . . . . 25.0 112.249 -179.208 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.3 m -131.7 154.36 81.78 Favored Pre-proline 0 CA--C 1.501 -0.923 0 N-CA-C 107.418 -1.327 . . . . 25.0 107.418 174.956 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.51 -26.56 40.25 Favored 'Trans proline' 0 C--O 1.259 1.533 0 C-N-CA 116.582 -1.812 . . . . 25.0 113.323 -175.631 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -82.57 -6.83 59.56 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 115.9 -0.591 . . . . 25.0 110.806 179.695 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -85.54 142.61 29.03 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-O 121.929 0.871 . . . . 25.0 111.988 -178.08 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.1 mt -93.73 135.19 35.28 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.605 -0.725 . . . . 25.0 109.089 176.071 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.47 130.15 39.4 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 106.413 -1.699 . . . . 25.0 106.413 174.629 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -150.93 165.89 32.31 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.607 0.717 . . . . 25.0 109.681 -178.583 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -115.1 170.33 8.44 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.666 -0.697 . . . . 25.0 109.906 -179.18 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -65.06 135.67 55.85 Favored 'General case' 0 C--O 1.203 -1.35 0 N-CA-C 108.488 -0.93 . . . . 25.0 108.488 175.825 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.02 -23.5 30.62 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 109.937 -1.265 . . . . 25.0 109.937 175.63 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -61.56 143.74 55.51 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 122.065 0.936 . . . . 25.0 111.362 -175.974 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.1 mm -116.04 120.09 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 114.116 -1.402 . . . . 25.0 109.571 -177.554 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -124.54 151.97 44.04 Favored 'General case' 0 C--N 1.313 -0.999 0 O-C-N 124.072 0.857 . . . . 25.0 109.161 179.0 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.6 m -84.39 127.63 34.11 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 106.822 -1.547 . . . . 25.0 106.822 177.103 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.9 t -90.19 120.88 39.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.51 -0.922 . . . . 25.0 108.51 176.009 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -90.39 -45.1 9.22 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.602 -0.726 . . . . 25.0 111.285 177.374 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -148.79 157.57 43.53 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.387 -0.968 . . . . 25.0 108.387 -175.264 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -118.73 147.63 43.65 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 106.513 -1.662 . . . . 25.0 106.513 176.672 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 55.75 46.38 22.57 Favored 'General case' 0 C--O 1.255 1.355 0 CA-C-O 124.206 1.955 . . . . 25.0 109.394 -177.805 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.438 HG21 HG22 ' A' ' 56' ' ' ILE . 14.6 t -68.59 157.53 35.89 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-N 112.594 -2.094 . . . . 25.0 110.942 -177.691 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 60.03 13.22 3.6 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.381 0.882 . . . . 25.0 113.381 174.413 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.53 16.09 78.48 Favored Glycine 0 CA--C 1.539 1.558 0 N-CA-C 109.296 -1.522 . . . . 25.0 109.296 179.599 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.6 mt -100.82 129.91 46.77 Favored 'General case' 0 C--O 1.206 -1.207 0 N-CA-C 107.348 -1.353 . . . . 25.0 107.348 -178.67 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.93 123.71 27.53 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 122.169 0.985 . . . . 25.0 111.867 177.93 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.57 -0.35 82.86 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 120.215 -0.993 . . . . 25.0 114.683 175.119 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -100.71 134.15 44.11 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.76 -0.83 . . . . 25.0 108.76 175.575 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -114.85 141.4 47.95 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.54 -0.911 . . . . 25.0 108.54 -178.076 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.4 tp -85.61 120.12 26.69 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.565 -0.902 . . . . 25.0 108.565 178.617 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 98.7 m -135.77 158.56 44.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.183 0.438 . . . . 25.0 112.183 -177.334 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.9 t -105.95 121.34 43.9 Favored 'General case' 0 C--O 1.251 1.168 0 C-N-CA 123.987 0.915 . . . . 25.0 108.787 173.804 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 tp -138.14 132.59 32.2 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.288 1.035 . . . . 25.0 109.164 179.967 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.7 m170 54.09 30.93 12.83 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-O 122.813 1.292 . . . . 25.0 109.655 -176.157 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.45 -5.44 73.38 Favored Glycine 0 N--CA 1.462 0.384 0 N-CA-C 116.528 1.371 . . . . 25.0 116.528 176.727 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -110.83 145.91 37.36 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.919 -0.771 . . . . 25.0 108.919 179.396 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -91.52 151.62 20.68 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 124.451 1.094 . . . . 25.0 108.642 178.849 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.27 -176.19 47.65 Favored Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 107.913 -2.075 . . . . 25.0 107.913 -179.595 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.438 HG22 HG21 ' A' ' 39' ' ' THR . 41.6 pt -104.73 148.94 8.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-O 121.977 0.894 . . . . 25.0 111.761 -175.341 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.7 m -143.48 146.38 35.49 Favored Pre-proline 0 C--O 1.246 0.896 0 C-N-CA 123.254 0.622 . . . . 25.0 111.969 177.256 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.97 122.17 7.05 Favored 'Trans proline' 0 C--N 1.358 1.049 0 N-CA-C 114.296 0.845 . . . . 25.0 114.296 -175.86 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.49 -25.56 71.48 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.842 -0.617 . . . . 25.0 114.379 -178.197 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.26 -24.68 60.17 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.044 0.757 . . . . 25.0 113.044 -179.157 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -119.09 31.38 6.66 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 120.929 -1.107 . . . . 25.0 108.789 178.962 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.4 mt -128.26 159.77 34.21 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.383 1.087 . . . . 25.0 110.747 176.538 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -134.46 127.04 30.7 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 115.106 -0.952 . . . . 25.0 108.784 174.738 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.5 mm -73.54 136.71 24.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.995 -0.743 . . . . 25.0 108.995 -179.347 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.5 mt -112.04 89.08 2.97 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 106.847 -1.538 . . . . 25.0 106.847 174.347 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.7 m -74.54 158.19 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 119.226 -0.99 . . . . 25.0 108.843 176.559 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.38 -173.62 24.19 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-N 114.003 -1.453 . . . . 25.0 113.311 176.46 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 13.8 tpt -144.23 119.57 10.24 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 107.855 -1.165 . . . . 25.0 107.855 178.952 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 60.23 2.34 0.43 Allowed 'General case' 0 CA--C 1.577 2.006 0 C-N-CA 123.051 0.541 . . . . 25.0 112.366 -169.302 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.13 -31.54 67.28 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.558 0.743 . . . . 25.0 112.186 174.272 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -132.1 -35.51 1.21 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.104 1.15 . . . . 25.0 114.104 -179.046 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.7 mttt 62.05 159.36 0.12 Allowed Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 125.347 1.459 . . . . 25.0 110.969 -171.563 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.99 -10.19 21.12 Favored 'Trans proline' 0 C--O 1.205 -1.14 0 C-N-CA 115.386 -2.61 . . . . 25.0 114.908 -178.54 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -157.37 168.71 26.56 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.717 -1.586 . . . . 25.0 106.717 -179.646 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -157.98 95.87 0.15 Allowed Glycine 0 N--CA 1.472 1.039 0 N-CA-C 110.541 -1.024 . . . . 25.0 110.541 176.153 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.0 t 57.12 40.71 28.11 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 121.671 0.748 . . . . 25.0 111.237 -175.589 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.26 -172.86 14.53 Favored Glycine 0 C--O 1.247 0.945 0 N-CA-C 108.75 -1.74 . . . . 25.0 108.75 -176.15 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.0 179.53 39.56 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.708 -1.051 . . . . 25.0 112.195 -178.986 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.1 m -89.15 150.23 22.8 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 118.66 1.23 . . . . 25.0 109.829 -179.034 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.24 -34.04 0.65 Allowed Glycine 0 C--O 1.201 -1.944 0 CA-C-N 116.042 -0.526 . . . . 25.0 113.568 178.483 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.93 81.55 3.48 Favored 'General case' 0 C--O 1.206 -1.236 0 CA-C-O 124.033 1.873 . . . . 25.0 113.14 -179.711 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.83 166.68 39.84 Favored Glycine 0 C--O 1.203 -1.819 0 O-C-N 119.845 -1.784 . . . . 25.0 111.933 -176.681 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.5 m -130.76 26.53 4.99 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 114.006 1.113 . . . . 25.0 114.006 -175.874 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -64.6 143.76 57.69 Favored 'General case' 0 CA--C 1.501 -0.906 0 O-C-N 120.823 -1.173 . . . . 25.0 108.85 -172.872 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -76.23 58.6 1.28 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.527 1.156 . . . . 25.0 113.186 -179.903 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -64.06 142.52 58.38 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-N 115.208 -0.905 . . . . 25.0 110.596 179.44 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -77.95 166.39 22.92 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.494 -0.775 . . . . 25.0 111.673 -177.033 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.4 m -56.0 152.6 20.53 Favored Pre-proline 0 CA--C 1.559 1.321 0 C-N-CA 125.515 1.526 . . . . 25.0 113.133 -178.742 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -71.6 159.79 50.11 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 N-CA-C 114.051 0.75 . . . . 25.0 114.051 179.418 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.73 152.09 78.11 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 120.652 0.901 . . . . 25.0 111.157 169.938 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.58 155.68 65.87 Favored 'Trans proline' 0 C--N 1.352 0.733 0 N-CA-C 115.279 1.223 . . . . 25.0 115.279 -173.269 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -85.05 147.4 47.82 Favored Pre-proline 0 N--CA 1.478 0.963 0 CA-C-N 115.652 -0.704 . . . . 25.0 109.69 176.732 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.03 161.69 42.8 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 117.577 -1.149 . . . . 25.0 111.023 178.901 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -65.29 160.32 42.95 Favored 'Trans proline' 0 C--N 1.348 0.512 0 N-CA-C 114.62 0.969 . . . . 25.0 114.62 179.17 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -107.36 -25.38 11.47 Favored 'General case' 0 C--O 1.193 -1.906 0 CA-C-N 115.869 -0.605 . . . . 25.0 112.353 178.339 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.5 p -138.44 133.51 32.88 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.225 1.012 . . . . 25.0 109.822 -175.859 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -161.24 150.31 16.4 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.149 1.379 . . . . 25.0 109.37 -178.734 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.9 t -145.35 140.54 27.78 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.865 -0.791 . . . . 25.0 108.865 179.133 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 80.4 m -80.62 147.93 30.49 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.618 -0.882 . . . . 25.0 108.618 176.596 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 124.479 2.085 . . . . 25.0 112.784 -178.196 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.618 0 N-CA-C 115.24 0.856 . . . . 25.0 115.24 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.4 m 57.39 39.74 27.98 Favored 'General case' 0 C--O 1.19 -2.052 0 C-N-CA 124.835 1.254 . . . . 25.0 112.407 178.62 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 61.2 mtt -92.11 -68.94 0.77 Allowed 'General case' 0 C--O 1.206 -1.194 0 N-CA-C 114.124 1.157 . . . . 25.0 114.124 -179.067 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -125.95 61.96 1.25 Allowed 'General case' 0 C--O 1.198 -1.629 0 N-CA-C 106.361 -1.718 . . . . 25.0 106.361 -178.814 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -124.27 163.02 22.51 Favored 'General case' 0 C--O 1.201 -1.483 0 CA-C-N 113.54 -1.664 . . . . 25.0 109.565 -175.168 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.6 mt -71.1 -40.91 71.23 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.249 -1.341 . . . . 25.0 111.424 178.751 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.0 m120 57.48 35.84 26.32 Favored 'General case' 0 C--O 1.253 1.275 0 C-N-CA 124.136 0.975 . . . . 25.0 110.753 -178.865 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.6 m -101.4 157.09 4.4 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.827 0 N-CA-C 107.687 -1.227 . . . . 25.0 107.687 176.044 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.07 166.25 12.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 118.324 -0.846 . . . . 25.0 109.173 -176.929 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.94 154.59 40.54 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.901 0.773 . . . . 25.0 112.953 172.651 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -117.9 129.49 55.66 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 124.07 0.948 . . . . 25.0 111.086 -179.527 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.43 126.36 29.43 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-O 118.614 -0.708 . . . . 25.0 109.294 177.866 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt -89.01 -28.81 19.94 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.013 0.925 . . . . 25.0 111.376 178.797 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -139.85 170.11 16.48 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.12 -1.437 . . . . 25.0 107.12 179.919 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -83.91 176.18 9.07 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 122.968 0.507 . . . . 25.0 110.642 -177.801 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -151.12 153.34 34.83 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 108.008 -1.108 . . . . 25.0 108.008 -178.216 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.4 t -125.26 136.0 62.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 104.507 -2.405 . . . . 25.0 104.507 170.832 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.27 134.62 42.95 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 114.475 -1.238 . . . . 25.0 110.238 178.013 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -125.22 11.37 8.15 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 123.628 0.58 . . . . 25.0 110.777 -177.341 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.4 t -151.21 150.91 28.34 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 106.228 -1.767 . . . . 25.0 106.228 -179.289 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.75 -12.12 28.49 Favored 'Trans proline' 0 N--CA 1.48 0.683 0 N-CA-C 116.607 1.733 . . . . 25.0 116.607 -175.91 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -83.1 -20.67 34.42 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 107.802 -1.184 . . . . 25.0 107.802 177.73 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -84.06 136.58 33.97 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.723 0.773 . . . . 25.0 110.063 -178.927 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.3 mt -93.57 131.26 39.01 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 113.929 1.085 . . . . 25.0 113.929 -177.997 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 p -86.75 95.1 9.71 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-N 115.212 -0.904 . . . . 25.0 110.85 -179.408 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -126.43 160.57 30.14 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 121.743 -0.598 . . . . 25.0 111.8 179.645 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -121.57 165.47 15.64 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 105.087 -2.19 . . . . 25.0 105.087 -177.254 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -59.02 131.42 50.99 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.54 0.686 . . . . 25.0 110.656 177.532 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.74 -20.02 51.05 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 121.754 -0.591 . . . . 25.0 114.295 -179.006 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -62.29 131.32 48.95 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 106.932 -1.507 . . . . 25.0 106.932 178.723 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.6 mm -102.23 132.43 48.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 106.939 -1.504 . . . . 25.0 106.939 177.817 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 11.2 ptp -131.8 161.87 31.9 Favored 'General case' 0 CA--C 1.495 -1.145 0 O-C-N 121.241 -0.912 . . . . 25.0 109.244 -179.836 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.2 m -101.62 119.19 38.39 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.678 -1.601 . . . . 25.0 106.678 -177.979 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 t -81.69 130.63 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 123.513 1.625 . . . . 25.0 109.321 -179.83 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.4 mt -100.41 -42.92 6.41 Favored 'General case' 0 C--O 1.204 -1.306 0 O-C-N 121.197 -0.939 . . . . 25.0 112.895 178.311 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -148.3 147.41 29.28 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-O 118.539 -0.743 . . . . 25.0 109.518 178.808 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -107.05 147.32 30.11 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.311 -1.366 . . . . 25.0 107.311 173.188 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 56.4 39.65 29.97 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 123.279 1.514 . . . . 25.0 110.665 -173.91 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -64.18 150.71 45.18 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 113.744 -1.571 . . . . 25.0 110.252 -175.327 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 56.7 22.65 7.03 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.076 -1.42 . . . . 25.0 113.3 178.225 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.32 16.93 73.8 Favored Glycine 0 CA--C 1.501 -0.788 0 C-N-CA 120.492 -0.861 . . . . 25.0 112.347 -179.24 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.3 mt -92.66 130.5 38.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.528 -1.286 . . . . 25.0 107.528 175.438 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -75.2 122.22 23.31 Favored 'General case' 0 C--O 1.258 1.526 0 O-C-N 121.232 -0.918 . . . . 25.0 110.68 176.996 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.83 -5.13 85.36 Favored Glycine 0 C--N 1.331 0.303 0 N-CA-C 116.089 1.196 . . . . 25.0 116.089 172.686 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -97.07 136.04 38.19 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 117.824 0.812 . . . . 25.0 109.764 177.085 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -114.41 142.85 45.82 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-O 117.595 -1.193 . . . . 25.0 108.019 -177.946 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.5 tp -85.42 125.28 32.87 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.128 -2.175 . . . . 25.0 105.128 175.059 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.8 m -135.47 164.08 28.61 Favored 'General case' 0 C--O 1.253 1.289 0 O-C-N 121.705 -0.622 . . . . 25.0 109.862 177.336 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.9 t -112.61 120.61 42.16 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.215 -1.402 . . . . 25.0 107.215 171.052 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.8 tp -132.52 136.45 46.64 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 105.756 -1.942 . . . . 25.0 105.756 -175.785 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.1 m170 54.16 29.69 10.9 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.527 0.68 . . . . 25.0 109.985 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.91 11.04 81.18 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-O 118.454 -1.192 . . . . 25.0 116.061 178.919 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -122.66 146.86 47.08 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.356 -1.35 . . . . 25.0 107.356 175.477 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -89.08 160.8 16.87 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.15 -1.055 . . . . 25.0 108.15 178.009 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.43 -174.43 41.91 Favored Glycine 0 C--O 1.242 0.623 0 N-CA-C 108.349 -1.901 . . . . 25.0 108.349 -178.758 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 pt -118.57 152.92 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.615 0 CA-C-O 122.71 1.243 . . . . 25.0 111.793 -172.238 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.9 m -143.92 150.91 51.27 Favored Pre-proline 0 C--N 1.306 -1.288 0 CA-C-N 112.384 -2.189 . . . . 25.0 110.807 -174.842 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.3 128.17 10.3 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 O-C-N 121.949 0.447 . . . . 25.0 112.565 -179.318 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.57 -22.42 78.99 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 118.962 -1.59 . . . . 25.0 115.642 -174.624 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -28.18 69.78 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 122.094 -0.651 . . . . 25.0 112.38 -175.54 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -108.35 28.02 8.75 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 122.013 0.911 . . . . 25.0 110.322 178.985 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.5 mt -121.37 159.17 26.7 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 114.423 1.268 . . . . 25.0 114.423 175.126 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -134.94 115.51 13.66 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.779 0.832 . . . . 25.0 109.729 176.36 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.7 mm -67.03 129.15 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 112.422 0.527 . . . . 25.0 112.422 177.834 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.5 mt -105.53 78.03 1.33 Allowed 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.131 -1.433 . . . . 25.0 107.131 179.219 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -78.16 163.21 3.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.744 -0.465 . . . . 25.0 109.744 178.0 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -157.15 146.06 13.04 Favored Glycine 0 C--O 1.203 -1.827 0 O-C-N 125.032 1.457 . . . . 25.0 109.702 177.483 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 28.0 ttt -167.6 -61.41 0.03 OUTLIER 'General case' 0 C--O 1.205 -1.26 0 N-CA-C 101.853 -3.388 . . . . 25.0 101.853 174.947 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.69 -55.12 0.38 Allowed 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 113.8 1.037 . . . . 25.0 113.8 177.855 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -73.07 -36.32 66.83 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.91 -0.586 . . . . 25.0 111.68 -179.27 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.2 tttt 69.63 -65.05 0.32 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.593 1.957 . . . . 25.0 114.681 -179.364 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -148.18 152.86 40.42 Favored Pre-proline 0 C--O 1.263 1.791 0 N-CA-C 107.525 -1.287 . . . . 25.0 107.525 -178.033 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.36 143.35 57.81 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 114.026 -3.516 . . . . 25.0 109.776 -178.079 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.97 76.02 4.15 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 106.719 -1.586 . . . . 25.0 106.719 175.98 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.26 -179.85 39.9 Favored Glycine 0 CA--C 1.505 -0.548 0 CA-C-O 122.904 1.28 . . . . 25.0 112.018 -179.053 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.5 p -76.57 177.54 7.39 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 108.029 -1.1 . . . . 25.0 108.029 177.944 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.84 -34.41 2.22 Favored Glycine 0 C--O 1.21 -1.38 0 N-CA-C 109.057 -1.617 . . . . 25.0 109.057 177.972 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.91 157.15 22.7 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.091 -0.576 . . . . 25.0 112.34 173.605 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.2 m -79.8 141.54 36.16 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.165 -0.614 . . . . 25.0 110.664 -179.336 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.73 -166.91 34.84 Favored Glycine 0 C--O 1.22 -0.746 0 N-CA-C 108.929 -1.668 . . . . 25.0 108.929 173.472 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 p -72.32 140.49 48.55 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 119.849 1.825 . . . . 25.0 106.553 174.284 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.48 54.95 0.43 Allowed Glycine 0 CA--C 1.538 1.525 0 N-CA-C 111.247 -0.741 . . . . 25.0 111.247 -175.764 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 m 56.61 -165.3 0.14 Allowed 'General case' 0 C--O 1.255 1.369 0 N-CA-C 115.169 1.544 . . . . 25.0 115.169 -178.692 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -87.39 122.35 31.02 Favored 'General case' 0 C--O 1.207 -1.175 0 N-CA-C 112.083 0.401 . . . . 25.0 112.083 179.388 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -140.66 122.23 15.17 Favored 'General case' 0 C--O 1.259 1.561 0 CA-C-O 117.79 -1.1 . . . . 25.0 110.041 178.244 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -82.06 116.34 21.61 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 124.52 1.138 . . . . 25.0 112.225 178.879 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -154.3 170.19 21.89 Favored 'General case' 0 C--O 1.249 1.059 0 N-CA-C 107.659 -1.237 . . . . 25.0 107.659 176.971 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.8 m -118.5 150.46 48.06 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 114.174 1.176 . . . . 25.0 114.174 -177.52 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -64.31 160.67 37.8 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 121.746 1.63 . . . . 25.0 114.386 -178.685 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.92 149.85 86.07 Favored 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 118.51 -0.527 . . . . 25.0 110.892 179.765 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.16 172.39 16.1 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 116.87 -1.62 . . . . 25.0 113.933 -170.652 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -85.07 139.88 36.88 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 106.71 -1.589 . . . . 25.0 106.71 179.307 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -69.69 166.51 27.25 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 117.565 -1.157 . . . . 25.0 110.278 174.203 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.29 149.29 40.06 Favored 'Trans proline' 0 C--O 1.209 -0.962 0 N-CA-C 114.875 1.067 . . . . 25.0 114.875 -178.242 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.7 mtt85 -97.21 -20.7 17.75 Favored 'General case' 0 C--O 1.194 -1.819 0 CA-C-O 121.17 0.509 . . . . 25.0 111.528 -179.359 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.2 p -130.22 147.62 51.97 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 103.517 -2.771 . . . . 25.0 103.517 178.077 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -131.21 112.17 12.58 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 106.224 -1.769 . . . . 25.0 106.224 177.708 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.2 t -142.05 79.4 1.67 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.455 -0.898 . . . . 25.0 112.118 -172.264 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 73.8 m -128.43 99.89 5.58 Favored 'General case' 0 C--O 1.195 -1.764 0 N-CA-C 109.527 -0.546 . . . . 25.0 109.527 178.161 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 C--O 1.241 0.614 0 CA-C-O 126.596 3.093 . . . . 25.0 110.72 -173.139 . . . . . . . . 0 0 . 1 stop_ save_